data_2poj_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 2poj _Structure_validation_residue.Date_analyzed 2016-10-08 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 16.0 p80 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.801 0.334 . . . . 74.510000000000005 110.845 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -121.37 110.96 16.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 74.409999999999997 110.921 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.422 ' CG2' ' N ' ' A' ' 115' ' ' THR . 4.9 mp -141.06 162.1 22.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 74.530000000000001 111.129 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.422 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.5 OUTLIER -157.58 163.54 38.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 73.099999999999994 111.135 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.622 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 4.2 p90 -134.53 146.91 50.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 73.430000000000007 110.956 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -141.63 111.82 6.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 75.040000000000006 110.901 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.9 mt -73.83 106.86 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 73.030000000000001 111.137 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -58.89 -50.43 74.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 71.319999999999993 110.893 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -140.17 165.22 27.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 74.439999999999998 110.907 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -118.15 138.88 51.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 74.010000000000005 110.896 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.404 HG23 ' HB2' ' A' ' 124' ' ' ASP . 2.5 t -88.11 143.01 32.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.538 0.685 . . . . 74.140000000000001 111.163 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.402 ' HD2' ' OG1' ' A' ' 122' ' ' THR . 53.6 Cg_endo -69.77 -3.11 11.37 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.658 2.239 . . . . 75.400000000000006 112.361 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.404 ' HB2' HG23 ' A' ' 122' ' ' THR . 13.7 m-20 -80.83 -23.27 39.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 73.109999999999999 110.855 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.424 ' HE3' ' HB2' ' A' ' 125' ' ' MET . 16.2 mtm -115.05 166.03 12.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 63.240000000000002 110.869 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -98.17 145.62 26.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 75.099999999999994 110.863 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -45.43 -34.49 3.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 74.209999999999994 110.928 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -82.32 -40.73 21.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 73.549999999999997 110.896 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -63.78 -31.13 72.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 73.200000000000003 110.839 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.86 -45.46 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 73.129999999999995 111.158 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.3 -23.47 40.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.151 -0.477 . . . . 73.530000000000001 110.879 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -75.26 -47.33 28.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 73.209999999999994 110.941 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.2 -31.07 67.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 74.140000000000001 111.108 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.3 mp -73.7 -55.23 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 74.129999999999995 111.145 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -48.56 -42.54 33.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 64.099999999999994 110.896 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -70.87 -35.51 72.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 72.239999999999995 110.905 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.485 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -60.0 -48.85 80.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 63.329999999999998 111.101 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.622 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 93.3 m-85 -72.6 -22.32 60.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 65.310000000000002 110.814 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.522 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.2 OUTLIER -77.28 -6.24 52.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 75.099999999999994 110.941 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.41 ' HB ' HG13 ' A' ' 217' ' ' VAL . 93.8 t -97.31 -17.56 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 65.340000000000003 111.131 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.496 ' HA ' HG21 ' A' ' 144' ' ' VAL . 95.3 m95 -106.18 -36.39 6.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 74.450000000000003 110.939 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.82 -11.54 61.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 74.099999999999994 110.823 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.617 ' N ' HD21 ' A' ' 143' ' ' ASN . 0.9 OUTLIER -95.61 -18.44 20.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 71.019999999999996 110.933 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.496 HG21 ' HA ' ' A' ' 141' ' ' TRP . 19.9 m -98.42 1.24 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 75.450000000000003 111.108 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.52 ' C ' ' H ' ' A' ' 147' ' ' LEU . 39.0 p -151.96 146.24 18.44 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.606 0.717 . . . . 74.140000000000001 111.14 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 30.59 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.625 2.217 . . . . 64.530000000000001 112.379 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.52 ' H ' ' C ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -91.76 177.48 6.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 74.510000000000005 110.939 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.23 125.59 20.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 73.319999999999993 110.904 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -114.94 141.56 47.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 72.129999999999995 110.894 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.1 t -135.72 153.03 51.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 73.239999999999995 110.857 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 19.8 tttt -104.43 143.18 33.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 74.340000000000003 110.888 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 16.9 pt -152.32 155.52 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 73.409999999999997 111.083 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 8.5 m120 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 75.129999999999995 110.877 179.932 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.835 0.35 . . . . 62.0 111.078 . . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.5 OUTLIER -86.15 -52.7 5.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 75.310000000000002 110.86 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.451 HG12 HG21 ' A' ' 220' ' ' ILE . 2.4 mp -90.01 94.21 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 73.329999999999998 111.085 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.9 tp -86.5 107.75 18.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 73.030000000000001 110.895 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 88.4 t -84.97 121.63 37.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 75.329999999999998 111.172 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.25 105.43 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 74.219999999999999 111.127 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -73.31 110.27 7.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 73.019999999999996 110.889 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -126.98 166.83 16.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 74.319999999999993 111.131 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.72 133.1 55.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 75.239999999999995 110.853 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.655 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.36 -158.04 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 63.100000000000001 112.484 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.772 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -50.71 118.81 3.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 74.329999999999998 111.104 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.77 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 4.3 p-80 -137.65 32.5 2.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 75.349999999999994 110.854 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 79.11 53.43 4.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 74.530000000000001 112.478 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.461 ' OD2' ' CE1' ' A' ' 196' ' ' HIS . 23.7 t0 -143.15 9.34 1.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 75.540000000000006 110.88 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 54.16 22.36 3.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 75.439999999999998 110.86 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.77 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 2.1 p-80 -118.62 -38.9 3.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 73.409999999999997 110.848 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.772 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 50.43 99.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 75.430000000000007 111.114 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.655 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.4 m-85 -58.72 -170.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 75.109999999999999 110.862 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.69 21.21 4.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 73.219999999999999 110.862 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.576 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 52.53 -156.05 4.69 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 52.310000000000002 112.477 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.9 OUTLIER -33.77 132.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.829 0.347 . . . . 71.510000000000005 110.911 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.94 163.53 0.13 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.814 -0.708 . . . . 75.340000000000003 112.471 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.18 -142.25 19.64 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 75.540000000000006 112.452 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.2 mt -49.92 97.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 71.230000000000004 111.147 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -66.8 -41.61 87.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 72.230000000000004 110.875 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -174.74 158.47 2.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 71.209999999999994 111.08 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.433 ' CE1' ' OD2' ' A' ' 170' ' ' ASP . 0.3 OUTLIER -148.92 134.3 18.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.449 . . . . 61.32 110.847 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.587 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -131.71 175.39 9.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 72.409999999999997 111.134 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 223' ' ' SER . 65.7 m-85 -105.6 -152.93 0.48 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 73.420000000000002 110.853 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -160.74 -84.44 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.701 -0.761 . . . . 75.430000000000007 112.463 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 52.33 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.721 2.28 . . . . 74.140000000000001 112.331 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.577 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.56 150.02 17.16 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.781 -0.724 . . . . 70.5 112.499 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -105.54 147.75 28.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 63.509999999999998 110.804 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.27 -64.12 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 51.130000000000003 112.5 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 189' ' ' SER . 2.3 pp -107.15 8.42 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 74.010000000000005 111.119 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.577 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -69.53 169.5 44.27 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.775 -0.726 . . . . 72.439999999999998 112.482 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 46.78 18.35 0.38 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 60.030000000000001 112.496 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.14 110.4 2.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.333 . . . . 73.239999999999995 110.894 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.587 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -85.01 130.01 34.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 73.519999999999996 111.116 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.461 ' CE1' ' OD2' ' A' ' 170' ' ' ASP . 1.3 m170 -123.32 123.04 39.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 75.209999999999994 110.84 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.546 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 37.1 m-85 -106.5 138.54 42.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 74.120000000000005 110.889 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -68.37 105.37 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 74.5 110.86 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -55.53 -39.09 70.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 75.340000000000003 110.845 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.576 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 15.8 m-20 -48.37 -25.0 1.41 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 65.019999999999996 110.867 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -77.55 163.11 26.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 75.239999999999995 110.894 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.558 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -101.21 86.61 3.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 74.420000000000002 110.872 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.546 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 24.7 m95 -79.53 122.4 26.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 73.519999999999996 110.881 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.6 p -139.94 -172.83 3.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 64.200000000000003 111.148 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.02 19.6 17.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 74.409999999999997 111.155 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -126.93 -175.4 3.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 75.310000000000002 110.894 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 11.4 p -70.44 -18.84 63.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 74.019999999999996 110.891 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.63 -106.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.742 -0.742 . . . . 50.420000000000002 112.47 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.07 176.54 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.712 -0.756 . . . . 74.409999999999997 112.498 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 55.6 m -66.65 96.93 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 71.430000000000007 111.112 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -43.09 116.93 0.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.427 . . . . 73.420000000000002 110.85 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.0 tp -62.83 -37.31 86.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 73.430000000000007 110.924 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -51.59 -63.9 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 71.140000000000001 110.887 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 8.3 mp -54.6 -55.82 25.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 71.400000000000006 110.917 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.5 m -55.45 -32.92 63.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 75.340000000000003 111.157 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -68.12 -47.99 66.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 74.439999999999998 111.081 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.485 HG22 ' CB ' ' A' ' 137' ' ' ALA . 2.0 t -53.66 -58.01 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 72.019999999999996 111.115 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.544 ' HB2' HG12 ' A' ' 235' ' ' VAL . 1.8 t-80 -64.45 -29.38 70.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 73.010000000000005 110.867 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -62.31 -44.7 95.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 73.129999999999995 111.055 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.548 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.5 mt -68.95 -35.11 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 70.519999999999996 111.121 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.65 -43.94 46.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.718 -0.753 . . . . 72.209999999999994 112.473 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 185' ' ' PHE . 28.2 m-70 -67.79 -39.06 84.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 74.329999999999998 110.868 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 3.1 m -63.3 -27.46 69.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 73.010000000000005 110.834 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 44.6 mt -75.52 -27.99 58.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 73.430000000000007 110.902 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 119.9 15.13 5.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.781 -0.723 . . . . 75.409999999999997 112.471 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 14.4 mt -79.02 158.18 27.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 73.439999999999998 110.912 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -104.07 -136.4 8.87 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.706 -0.759 . . . . 62.049999999999997 112.487 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -125.94 142.16 51.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.849 0.356 . . . . 72.310000000000002 110.817 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 21.7 m -104.7 162.75 13.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 75.219999999999999 110.87 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.0 t -103.86 0.71 30.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 54.439999999999998 110.871 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.24 136.98 95.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.618 0.723 . . . . 72.230000000000004 110.834 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -0.32 6.76 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.661 2.241 . . . . 74.109999999999999 112.322 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.03 17.36 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.42 . . . . 75.409999999999997 110.884 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -86.69 134.18 33.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 73.450000000000003 111.133 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.544 HG12 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -58.15 -36.2 56.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 75.209999999999994 111.129 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.415 ' HG2' ' OD2' ' A' ' 254' ' ' ASP . 44.2 mmm -61.56 -21.96 64.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 73.200000000000003 110.912 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.531 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.7 t80 -54.9 142.7 54.63 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.613 0.721 . . . . 74.540000000000006 110.898 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.531 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.3 Cg_endo -69.73 -1.46 8.49 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.695 2.263 . . . . 71.439999999999998 112.345 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 41.8 m -95.32 141.23 29.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 73.409999999999997 111.126 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -118.36 140.33 50.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 74.019999999999996 110.975 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -157.7 138.05 12.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 74.219999999999999 110.858 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -68.77 145.4 53.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 73.200000000000003 110.923 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -162.27 133.22 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 72.430000000000007 111.081 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -51.37 130.31 26.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 73.430000000000007 110.867 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 16.4 tt -52.26 -30.81 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 74.319999999999993 111.139 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.68 -22.57 65.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 75.219999999999999 110.94 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 28.0 p -109.49 -20.83 12.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 74.420000000000002 111.173 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -69.12 121.28 16.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 72.299999999999997 110.905 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -152.98 143.11 22.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.319999999999993 110.835 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.403 HD11 ' O ' ' A' ' 140' ' ' VAL . 33.2 mt -58.73 123.51 16.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 72.209999999999994 110.927 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 10.3 t -64.32 163.24 13.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 74.099999999999994 110.835 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.2 -37.95 24.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 71.200000000000003 111.101 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -63.81 -45.5 89.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 73.540000000000006 110.87 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . 0.422 ' OD2' ' HB ' ' A' ' 235' ' ' VAL . 5.4 m-20 -61.94 -53.66 52.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 71.540000000000006 110.902 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 23.1 mt -62.03 -34.95 65.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 72.519999999999996 111.112 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -68.36 -40.5 81.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 74.439999999999998 110.831 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.06 -51.84 6.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 73.209999999999994 112.5 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 5.8 tp -52.51 -35.07 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.775 0.321 . . . . 71.409999999999997 111.1 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.431 ' O ' ' N ' ' A' ' 263' ' ' GLY . 75.3 mt-30 -87.46 -17.24 32.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 73.140000000000001 110.911 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.5 t -69.75 -13.69 62.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 74.200000000000003 110.851 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.8 mt -123.55 -18.4 6.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 73.239999999999995 110.937 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -114.56 -33.66 5.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 65.129999999999995 110.9 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.298 0 CA-C-O 119.123 -0.821 . . . . 71.120000000000005 112.505 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 4.5 p80 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.791 0.329 . . . . 70.150000000000006 110.848 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -141.1 106.38 5.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 75.219999999999999 110.995 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.448 ' HB ' ' CD1' ' A' ' 149' ' ' PHE . 4.6 mp -139.77 163.76 24.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 74.439999999999998 111.204 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.436 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.4 OUTLIER -157.91 163.67 37.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 73.299999999999997 111.126 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.61 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.4 p90 -132.67 148.62 52.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.254 -0.43 . . . . 73.150000000000006 110.953 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -142.84 113.33 7.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.515 . . . . 74.540000000000006 110.885 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.9 mt -74.25 106.54 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 75.140000000000001 111.179 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -61.34 -45.26 95.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 75.310000000000002 110.914 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -144.1 161.92 37.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 73.420000000000002 110.931 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -117.23 137.74 52.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 71.239999999999995 110.907 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.3 t -88.31 142.51 31.57 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 121.648 0.737 . . . . 75.150000000000006 111.111 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 0.86 5.0 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.702 2.268 . . . . 73.109999999999999 112.405 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -82.81 -24.55 33.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.257 -0.429 . . . . 75.409999999999997 110.875 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 5.8 mtm -116.46 165.7 12.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.282 -0.417 . . . . 72.409999999999997 110.838 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -96.01 145.48 25.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 65.239999999999995 110.893 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.89 -34.85 4.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 74.450000000000003 110.909 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -83.04 -37.71 23.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 63.539999999999999 110.902 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -66.57 -29.67 69.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 71.439999999999998 110.894 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 77.6 t -65.36 -46.75 89.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 75.049999999999997 111.154 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.52 -23.85 46.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 70.219999999999999 110.893 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -73.55 -46.39 47.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 73.400000000000006 110.943 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -72.66 -32.75 66.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 74.420000000000002 111.112 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.3 mp -71.62 -53.59 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 75.430000000000007 111.155 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 -49.22 -42.53 40.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 73.209999999999994 110.868 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -71.4 -33.93 69.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 74.209999999999994 110.852 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.502 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -60.54 -49.32 78.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 70.299999999999997 111.059 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.61 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.9 m-85 -72.13 -23.11 61.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 73.219999999999999 110.917 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.552 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.6 tt0 -77.05 -6.27 52.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 73.239999999999995 110.921 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.43 ' HB ' HG11 ' A' ' 217' ' ' VAL . 92.7 t -97.22 -16.26 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 75.030000000000001 111.249 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.527 ' HA ' HG21 ' A' ' 144' ' ' VAL . 92.7 m95 -106.32 -33.17 7.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 64.530000000000001 110.869 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 142' ' ' SER . . . . . 0.465 ' OG ' ' CD2' ' A' ' 149' ' ' PHE . 6.5 m -70.41 -15.66 62.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 72.329999999999998 110.832 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.553 ' N ' HD21 ' A' ' 143' ' ' ASN . 1.2 m-80 -91.41 -18.69 23.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 75.040000000000006 110.827 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' A' ' 141' ' ' TRP . 24.5 m -98.62 1.87 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 74.140000000000001 111.164 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.522 ' C ' ' H ' ' A' ' 147' ' ' LEU . 15.7 p -154.79 145.16 15.91 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.62 0.724 . . . . 65.049999999999997 111.114 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 30.36 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.698 2.266 . . . . 72.420000000000002 112.354 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' A' ' 145' ' ' THR . 2.7 mp -91.54 177.28 6.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 74.420000000000002 110.877 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.08 123.11 14.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 72.420000000000002 110.786 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.465 ' CD2' ' OG ' ' A' ' 142' ' ' SER . 3.3 m-30 -114.55 140.12 49.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 74.430000000000007 110.962 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.0 m -132.78 155.81 48.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 61.43 110.878 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 5.0 tttt -102.72 140.52 36.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.114 -0.494 . . . . 75.530000000000001 110.884 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 18.5 pt -150.74 139.04 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 74.0 111.095 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 75.319999999999993 110.928 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.785 0.326 . . . . 72.299999999999997 111.103 . . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.435 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.4 OUTLIER -85.76 -51.96 6.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 71.239999999999995 110.884 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.443 HG12 HG21 ' A' ' 220' ' ' ILE . 2.6 mp -90.45 92.98 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 74.329999999999998 111.079 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.9 tp -84.3 109.94 18.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.49 . . . . 73.019999999999996 110.978 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 92.3 t -87.47 118.57 33.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 73.310000000000002 111.16 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.97 106.09 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.269 -0.423 . . . . 72.349999999999994 111.135 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -73.3 110.73 7.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 74.519999999999996 110.912 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -126.58 167.63 15.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 74.329999999999998 111.168 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -120.44 132.22 55.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 74.439999999999998 110.844 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.647 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.4 -157.44 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.743 -0.741 . . . . 73.409999999999997 112.53 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.766 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -51.08 119.04 3.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.773 0.32 . . . . 74.209999999999994 111.114 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.754 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 4.3 p-80 -137.98 31.9 2.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.434 . . . . 73.030000000000001 110.953 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 79.65 53.38 4.34 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.779 -0.724 . . . . 75.019999999999996 112.483 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.478 ' OD2' ' CE1' ' A' ' 196' ' ' HIS . 22.4 t0 -142.85 8.95 1.72 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 74.430000000000007 110.965 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 54.52 22.44 3.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.492 . . . . 73.019999999999996 110.875 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.754 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 2.0 p-80 -119.06 -38.92 2.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 71.420000000000002 110.873 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.766 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 50.45 99.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 64.340000000000003 111.11 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.647 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.4 m-85 -58.22 -171.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 73.310000000000002 110.919 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.21 20.64 4.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 74.540000000000006 110.856 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 53.01 -156.38 5.01 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.68 -0.771 . . . . 75.540000000000006 112.509 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 176' ' ' GLY . 12.7 tptt -33.34 132.02 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.858 0.361 . . . . 74.099999999999994 110.878 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.66 163.81 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.788 -0.72 . . . . 64.219999999999999 112.504 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.92 -142.25 19.84 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.739 -0.743 . . . . 54.32 112.503 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.1 mt -49.89 97.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 74.530000000000001 111.193 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -66.8 -41.27 87.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 71.329999999999998 110.887 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -174.83 158.25 2.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 73.129999999999995 111.114 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.45 ' CE1' ' CD2' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -148.96 134.69 18.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 72.430000000000007 110.911 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.595 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -131.92 175.53 9.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 75.439999999999998 111.079 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 223' ' ' SER . 39.4 m-85 -104.63 -148.71 0.4 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 73.409999999999997 110.869 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -164.84 -83.58 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.818 -0.706 . . . . 74.219999999999999 112.605 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 51.87 0.95 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.732 2.288 . . . . 75.239999999999995 112.321 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.564 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.68 148.92 17.25 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.79 -0.719 . . . . 53.140000000000001 112.485 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -105.13 145.27 30.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 63.329999999999998 110.878 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.56 -62.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.643 -0.789 . . . . 74.099999999999994 112.588 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 189' ' ' SER . 5.8 mm -107.54 8.76 9.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.799 0.333 . . . . 71.120000000000005 111.076 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.564 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -70.84 171.26 45.33 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 73.439999999999998 112.468 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 45.24 19.67 0.24 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.75 -0.738 . . . . 71.040000000000006 112.478 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 192' ' ' GLY . 2.1 m-20 -65.57 108.45 2.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.772 0.32 . . . . 73.219999999999999 110.886 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.595 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -84.22 129.24 34.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 73.420000000000002 111.108 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.478 ' CE1' ' OD2' ' A' ' 170' ' ' ASP . 1.6 m170 -121.68 123.61 42.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 74.140000000000001 110.867 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.539 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 40.3 m-85 -106.3 137.17 44.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 74.129999999999995 110.925 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -67.17 105.17 1.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 72.340000000000003 110.878 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -55.59 -39.14 70.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 73.540000000000006 110.873 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.564 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 15.5 m-20 -47.92 -25.31 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.497 . . . . 74.25 110.832 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -77.21 162.92 27.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 73.540000000000006 110.907 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.594 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -101.13 85.32 2.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 74.420000000000002 110.811 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.539 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 24.8 m95 -77.61 123.26 26.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.438 . . . . 75.310000000000002 110.903 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 41.0 p -140.21 -173.76 3.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 75.519999999999996 111.102 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.83 18.04 18.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.238 -0.437 . . . . 73.540000000000006 111.094 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.8 -177.64 4.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 74.040000000000006 110.849 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.8 p -66.12 -18.99 65.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 75.099999999999994 110.805 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.1 -107.69 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.748 -0.739 . . . . 73.299999999999997 112.449 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.13 177.29 0.15 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.727 -0.749 . . . . 61.240000000000002 112.523 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 88.1 m -66.78 97.51 0.47 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.755 0.312 . . . . 72.510000000000005 111.17 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -42.11 119.25 1.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 75.450000000000003 110.809 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.4 tp -65.53 -37.55 87.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 72.530000000000001 110.851 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -51.15 -64.96 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 74.540000000000006 110.91 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 22.8 mt -53.53 -55.36 26.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.118 -0.492 . . . . 74.340000000000003 110.954 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.8 m -55.78 -33.28 64.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 71.150000000000006 111.181 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -68.05 -47.98 66.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 64.150000000000006 111.092 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.502 HG22 ' CB ' ' A' ' 137' ' ' ALA . 2.0 t -53.61 -57.93 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 72.040000000000006 111.119 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.582 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.7 t-80 -64.66 -28.14 69.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.123 -0.489 . . . . 73.040000000000006 110.907 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -63.86 -45.32 89.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 75.239999999999995 111.087 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.539 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.5 mt -68.32 -35.89 72.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 72.409999999999997 111.141 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.61 -44.65 47.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.687 -0.768 . . . . 44.32 112.486 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.411 ' O ' ' O ' ' A' ' 185' ' ' PHE . 4.3 m-70 -68.32 -38.06 81.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.706 0.288 . . . . 74.150000000000006 110.809 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 7.1 m -64.27 -24.69 67.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 74.120000000000005 110.827 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.2 mt -78.07 -27.72 48.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.188 -0.46 . . . . 74.519999999999996 110.885 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 121.11 15.47 4.68 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.65 -0.786 . . . . 53.240000000000002 112.428 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.31 156.12 26.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.906 0.384 . . . . 73.400000000000006 110.846 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -99.25 -141.12 11.9 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.759 -0.734 . . . . 74.099999999999994 112.464 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -122.0 139.36 53.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 75.319999999999993 110.904 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.4 t -99.21 163.99 12.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 73.140000000000001 110.884 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.19 -2.86 17.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 74.109999999999999 110.858 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.11 141.45 93.79 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.681 0.753 . . . . 64.5 110.839 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 -3.35 11.83 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.709 2.273 . . . . 64.239999999999995 112.342 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -143.47 19.81 1.87 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 74.25 110.827 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -82.21 139.03 34.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 71.409999999999997 111.09 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.582 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -63.03 -37.73 80.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.415 . . . . 73.030000000000001 111.055 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 48.5 mmm -66.49 -13.75 61.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 75.439999999999998 110.833 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.619 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.5 t80 -58.64 144.4 79.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.736 0.779 . . . . 73.329999999999998 110.853 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.619 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.2 Cg_endo -69.75 -3.42 11.97 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.753 2.302 . . . . 74.219999999999999 112.314 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 16.9 m -95.7 142.42 28.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 63.200000000000003 111.148 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -122.92 134.53 54.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 74.230000000000004 110.94 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -152.67 129.49 10.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.09 -0.504 . . . . 74.420000000000002 110.955 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -57.13 143.77 37.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.318 -0.401 . . . . 74.329999999999998 110.876 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -158.26 130.34 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 74.140000000000001 111.136 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -50.84 132.16 26.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 73.239999999999995 110.945 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 14.3 tt -53.98 -29.89 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 53.219999999999999 111.081 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.98 -18.76 61.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 71.319999999999993 110.973 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 38.4 p -109.33 -21.4 12.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 73.349999999999994 111.194 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -71.58 143.1 49.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 75.409999999999997 110.917 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -177.19 133.37 0.18 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 63.310000000000002 110.834 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 52.9 mt -48.0 127.15 11.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 74.340000000000003 110.915 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.6 m -67.44 163.49 20.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 71.25 110.829 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.89 -35.09 31.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.478 . . . . 61.43 111.144 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.1 -51.58 52.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 74.019999999999996 110.886 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -56.39 -50.26 72.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 45.439999999999998 110.892 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 21.2 mt -61.4 -39.97 84.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 75.109999999999999 111.07 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -65.44 -39.85 92.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.172 -0.467 . . . . 75.120000000000005 110.948 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -73.73 -52.66 7.99 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.752 -0.737 . . . . 61.039999999999999 112.455 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 3.8 tp -52.54 -34.62 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.783 0.325 . . . . 74.019999999999996 111.124 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 263' ' ' GLY . 82.1 mt-30 -86.39 -17.34 34.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 74.219999999999999 110.92 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.7 t -69.49 -13.82 62.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.233 -0.44 . . . . 43.229999999999997 110.851 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.8 mt -123.16 -18.29 6.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 74.409999999999997 110.894 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . 0.425 ' CE1' HD22 ' A' ' 147' ' ' LEU . 36.8 m-85 -114.56 -34.14 5.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.011 0.434 . . . . 74.120000000000005 110.965 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.307 0 CA-C-O 119.099 -0.834 . . . . 62.020000000000003 112.485 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.2 p80 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.791 0.329 . . . . 75.019999999999996 110.867 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -129.48 111.08 12.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 74.129999999999995 110.909 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.425 ' CG2' ' N ' ' A' ' 115' ' ' THR . 4.8 mp -142.33 162.73 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 71.239999999999995 111.14 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.425 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -160.43 163.76 32.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 72.019999999999996 111.074 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.615 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.5 p90 -131.7 152.28 51.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 74.040000000000006 110.953 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -144.35 109.96 5.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 72.530000000000001 110.855 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.7 mt -71.58 105.67 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 74.109999999999999 111.114 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -59.57 -45.47 91.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 74.439999999999998 110.827 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -146.12 163.35 35.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 74.319999999999993 110.878 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -116.27 140.98 48.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 65.329999999999998 110.873 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.418 HG23 ' HB2' ' A' ' 124' ' ' ASP . 2.9 t -90.91 142.67 27.73 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.549 0.69 . . . . 73.349999999999994 111.202 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -2.95 11.04 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.692 2.261 . . . . 65.129999999999995 112.355 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.418 ' HB2' HG23 ' A' ' 122' ' ' THR . 21.9 m-20 -80.4 -23.88 40.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 61.43 110.818 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.419 ' HE2' ' HB2' ' A' ' 125' ' ' MET . 13.3 mtm -115.61 166.25 12.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 75.349999999999994 110.839 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -96.57 144.63 26.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 64.25 110.961 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -45.1 -35.73 3.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.178 -0.465 . . . . 74.319999999999993 110.905 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -83.23 -38.66 21.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 73.239999999999995 110.87 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -65.4 -29.8 70.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 73.319999999999993 110.886 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 73.4 t -66.49 -46.35 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 74.010000000000005 111.156 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.13 -23.29 47.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 73.340000000000003 110.827 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -74.43 -47.2 35.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 73.530000000000001 110.917 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.79 -31.51 66.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 71.439999999999998 111.124 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.4 mp -73.29 -54.13 16.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.218 -0.446 . . . . 74.510000000000005 111.146 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -49.06 -41.92 36.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 72.209999999999994 110.832 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? -72.43 -34.24 67.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 73.109999999999999 110.867 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.503 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -60.5 -48.83 80.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 64.150000000000006 111.168 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.615 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.4 m-85 -72.77 -22.1 60.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 74.310000000000002 110.888 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.523 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.1 OUTLIER -78.64 -5.81 53.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 73.400000000000006 110.937 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.403 ' HB ' HG13 ' A' ' 217' ' ' VAL . 93.4 t -97.1 -16.87 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 72.140000000000001 111.109 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.506 ' HA ' HG21 ' A' ' 144' ' ' VAL . 93.6 m95 -106.48 -35.88 6.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 72.109999999999999 110.878 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.62 -11.47 60.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 70.099999999999994 110.851 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.619 ' N ' HD21 ' A' ' 143' ' ' ASN . 0.9 OUTLIER -95.69 -15.74 22.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.505 . . . . 74.549999999999997 111.018 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.506 HG21 ' HA ' ' A' ' 141' ' ' TRP . 20.9 m -101.51 1.21 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 74.030000000000001 111.079 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.52 ' C ' ' H ' ' A' ' 147' ' ' LEU . 17.1 p -150.31 146.69 20.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.539 0.685 . . . . 63.119999999999997 111.149 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 30.53 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.661 2.241 . . . . 74.120000000000005 112.314 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.52 ' H ' ' C ' ' A' ' 145' ' ' THR . 0.8 OUTLIER -93.32 -178.13 4.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 71.519999999999996 110.914 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -144.34 126.5 15.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 71.310000000000002 110.933 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.405 ' HD2' ' HB3' ' A' ' 138' ' ' PHE . 4.0 m-30 -114.52 142.15 46.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 75.030000000000001 110.906 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.8 m -140.78 137.49 33.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 75.109999999999999 110.893 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.9 OUTLIER -85.88 142.62 28.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 73.400000000000006 110.941 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 18.2 pt -151.07 135.6 9.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 74.409999999999997 111.114 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 74.010000000000005 110.918 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.78 0.324 . . . . 74.140000000000001 111.121 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.6 OUTLIER -83.22 -52.55 6.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 75.040000000000006 110.853 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.499 HG12 HG21 ' A' ' 220' ' ' ILE . 1.9 mp -89.53 95.88 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 74.310000000000002 111.139 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.2 tp -86.87 110.08 19.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 75.439999999999998 110.857 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 87.8 t -89.83 120.54 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 65.530000000000001 111.14 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.2 p -139.83 104.97 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 72.329999999999998 111.138 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -71.87 108.75 5.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 73.409999999999997 110.889 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.11 165.71 20.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 74.450000000000003 111.121 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -114.14 138.29 50.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 74.319999999999993 110.922 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.649 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.74 -154.26 0.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.651 -0.785 . . . . 74.109999999999999 112.496 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.809 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -66.88 116.73 8.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.886 0.374 . . . . 74.219999999999999 111.106 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.695 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.88 -22.7 12.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.204 -0.453 . . . . 74.150000000000006 110.897 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.47 29.39 0.54 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 71.010000000000005 112.498 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.646 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.08 1.43 15.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.389 . . . . 73.299999999999997 110.918 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 72.8 40.34 0.6 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.469 . . . . 74.010000000000005 110.868 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.695 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.72 -41.65 0.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 74.200000000000003 110.888 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.809 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.31 99.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 70.409999999999997 111.074 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.649 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.9 m-85 -60.72 -168.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 75.200000000000003 110.866 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.74 18.66 3.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 70.040000000000006 110.866 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.568 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.2 -157.32 7.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 72.120000000000005 112.526 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 176' ' ' GLY . 11.7 tmtt? -35.29 134.52 0.28 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 74.299999999999997 110.879 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.35 165.49 0.14 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.594 -0.812 . . . . 74.439999999999998 112.496 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.81 -143.23 22.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 73.400000000000006 112.47 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -50.13 96.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.375 . . . . 74.019999999999996 111.174 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 13.4 mt -66.82 -39.48 87.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 73.140000000000001 110.934 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -172.08 167.1 6.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 73.349999999999994 111.142 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.555 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.6 p80 -159.67 139.72 11.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.428 . . . . 75.040000000000006 110.931 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.573 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -137.64 173.44 11.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 71.430000000000007 111.145 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.519 ' O ' ' O ' ' A' ' 222' ' ' HIS . 23.8 m-85 -99.43 -138.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 61.399999999999999 110.818 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -166.98 -99.64 0.14 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.792 -0.718 . . . . 60.350000000000001 112.578 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 59.54 1.66 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.696 2.264 . . . . 73.200000000000003 112.343 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.588 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.06 154.6 16.43 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.748 -0.739 . . . . 74.430000000000007 112.435 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.572 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.52 148.63 26.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.919 0.39 . . . . 72.209999999999994 110.793 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.68 -67.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.718 -0.753 . . . . 64.310000000000002 112.503 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.572 ' N ' ' O ' ' A' ' 189' ' ' SER . 3.6 mt -103.99 6.33 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 74.109999999999999 111.144 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.588 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -63.69 165.29 29.2 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.685 -0.769 . . . . 74.219999999999999 112.511 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 45.05 20.21 0.23 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.73 -0.748 . . . . 62.140000000000001 112.459 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 192' ' ' GLY . 0.8 OUTLIER -64.25 105.77 0.97 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.79 0.329 . . . . 72.519999999999996 110.943 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.573 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -82.15 129.62 34.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 74.120000000000005 111.158 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.555 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 11.2 m170 -119.93 129.93 54.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 75.140000000000001 110.878 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.457 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 47.7 m-85 -114.35 134.22 55.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 75.150000000000006 110.909 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -67.25 109.44 3.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 73.319999999999993 110.916 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -60.22 -37.19 79.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 73.340000000000003 110.861 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.568 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 5.3 m-20 -50.45 -22.89 2.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.233 -0.439 . . . . 73.420000000000002 110.885 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -80.17 163.38 24.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 75.209999999999994 110.835 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.548 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -101.43 89.1 3.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 74.349999999999994 110.843 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.457 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 29.5 m95 -80.59 123.26 27.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.177 -0.465 . . . . 64.230000000000004 110.952 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.3 p -141.26 -174.83 4.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 70.299999999999997 111.183 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.36 20.53 16.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 64.439999999999998 111.104 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -127.74 -173.12 2.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 64.340000000000003 110.903 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.3 p -72.11 -18.87 61.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 71.409999999999997 110.836 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.49 -106.58 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 34.219999999999999 112.502 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.05 176.84 0.1 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.694 -0.765 . . . . 71.310000000000002 112.528 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 89.8 m -66.74 97.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.741 0.305 . . . . 73.439999999999998 111.125 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -42.83 116.93 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 73.519999999999996 110.833 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.8 tp -63.29 -37.94 89.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.083 -0.508 . . . . 75.329999999999998 110.94 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -51.32 -63.91 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 71.329999999999998 110.901 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 8.0 mp -55.51 -54.99 37.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.119 -0.491 . . . . 75.5 110.895 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 2.3 m -55.31 -33.95 63.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 75.219999999999999 111.139 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -67.69 -48.74 65.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 74.310000000000002 111.009 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.503 HG22 ' CB ' ' A' ' 137' ' ' ALA . 2.0 t -53.43 -58.22 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 73.129999999999995 111.067 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.532 ' HB2' HG11 ' A' ' 235' ' ' VAL . 1.8 t-80 -64.46 -28.13 69.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 74.109999999999999 110.775 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -64.39 -44.07 92.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 75.439999999999998 111.104 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.525 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.6 mt -70.28 -34.26 57.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 70.439999999999998 111.172 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -51.79 -45.11 55.53 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.713 -0.756 . . . . 64.319999999999993 112.471 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.519 ' O ' ' O ' ' A' ' 185' ' ' PHE . 4.1 m-70 -68.85 -40.61 79.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.849 0.356 . . . . 73.409999999999997 110.89 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 32.5 p -65.7 -20.2 66.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.11 -0.495 . . . . 74.430000000000007 110.858 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 52.8 mt -80.84 -25.77 37.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 62.530000000000001 110.897 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 122.2 13.18 4.96 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.729 -0.748 . . . . 70.200000000000003 112.441 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 221' ' ' GLY . 17.6 mt -84.81 155.65 21.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.337 . . . . 73.439999999999998 110.973 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -102.95 -138.21 9.86 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.767 -0.73 . . . . 71.430000000000007 112.458 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.76 138.76 53.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.918 0.39 . . . . 73.25 110.886 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 69.8 p -97.26 166.97 11.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 74.219999999999999 110.88 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.18 3.09 19.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 73.540000000000006 110.84 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.3 135.74 81.87 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.683 0.754 . . . . 74.329999999999998 110.844 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.62 0.25 5.8 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.713 2.275 . . . . 74.150000000000006 112.331 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.05 25.42 1.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 71.430000000000007 110.908 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -97.48 143.91 27.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.453 . . . . 63.329999999999998 111.082 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.532 HG11 ' HB2' ' A' ' 218' ' ' HIS . 1.3 t -63.84 -41.75 93.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 73.420000000000002 111.118 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 49.9 mmm -60.33 -17.67 44.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.193 -0.458 . . . . 73.430000000000007 110.904 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.604 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.1 t80 -57.79 144.64 73.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.712 0.768 . . . . 75.5 110.78 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.604 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.5 Cg_endo -69.87 -1.23 8.22 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.552 2.168 . . . . 71.510000000000005 112.385 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 23.3 m -96.32 140.97 30.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 72.409999999999997 111.201 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -122.39 134.48 54.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.185 -0.461 . . . . 72.230000000000004 110.978 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -151.99 135.12 15.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 74.329999999999998 110.9 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -64.5 143.52 57.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 75.319999999999993 110.889 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -161.18 128.92 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 73.420000000000002 111.105 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -50.37 134.69 23.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 75.239999999999995 110.9 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 8.0 tt -51.31 -33.54 14.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 73.239999999999995 111.222 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -65.73 -23.51 66.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 74.120000000000005 110.907 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 10.5 p -107.0 -21.81 12.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 71.109999999999999 111.143 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -73.43 134.02 43.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 74.409999999999997 110.852 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 24.3 ptt85 -171.23 134.08 0.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 74.230000000000004 110.91 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 254' ' ' ASP . 54.7 mt -48.06 127.28 12.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 73.400000000000006 110.998 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 30.9 t -72.46 164.43 26.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 73.439999999999998 110.894 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -47.95 -37.98 15.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 74.430000000000007 111.103 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.56 -45.29 91.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 75.549999999999997 110.869 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . 0.446 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 12.7 m-20 -61.03 -55.35 33.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 70.209999999999994 110.889 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 1.3 mp -58.99 -34.55 53.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 74.5 111.153 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 28.7 mmm-85 -68.08 -40.32 82.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 74.519999999999996 110.908 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -75.59 -50.62 7.92 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.784 -0.722 . . . . 63.530000000000001 112.562 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 5.6 tp -52.38 -34.53 18.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.772 0.32 . . . . 74.430000000000007 111.159 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.422 ' O ' ' N ' ' A' ' 263' ' ' GLY . 57.5 mt-30 -86.73 -16.94 34.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 75.230000000000004 110.876 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 3.2 t -69.47 -13.93 62.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 73.299999999999997 110.853 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.37 -17.71 6.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 74.209999999999994 110.935 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -114.74 -33.28 5.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 75.340000000000003 110.859 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.313 0 CA-C-O 119.122 -0.821 . . . . 72.209999999999994 112.454 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.4 p80 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.813 0.34 . . . . 71.200000000000003 110.829 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -122.34 113.39 19.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 65.129999999999995 110.906 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.433 ' CG2' ' N ' ' A' ' 115' ' ' THR . 5.0 mp -142.96 162.18 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 65.109999999999999 111.141 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.433 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.4 OUTLIER -159.05 164.06 35.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 74.109999999999999 111.157 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.645 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.4 p90 -134.23 145.04 48.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 71.420000000000002 110.879 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -137.47 106.9 6.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 73.049999999999997 110.83 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 62.0 mt -70.41 104.93 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 75.540000000000006 111.16 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -55.56 -50.84 68.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 63.240000000000002 110.825 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -143.08 166.6 24.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 74.420000000000002 110.87 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -116.95 148.89 41.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 64.430000000000007 110.959 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.2 t -93.67 141.58 24.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.595 0.712 . . . . 74.420000000000002 111.075 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -3.42 11.99 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.711 2.274 . . . . 74.239999999999995 112.296 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.63 -29.91 36.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 75.430000000000007 110.93 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 7.3 mtm -107.97 163.73 12.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 73.140000000000001 110.848 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -94.25 150.3 20.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 75.540000000000006 110.866 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.55 -32.93 8.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 74.400000000000006 110.826 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -82.01 -40.44 22.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 60.229999999999997 110.91 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -65.95 -29.1 69.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 74.450000000000003 110.906 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 59.9 t -64.34 -45.62 95.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 75.120000000000005 111.169 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.12 -24.46 35.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 74.310000000000002 110.866 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -72.3 -46.8 54.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 74.439999999999998 110.908 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.52 -33.95 69.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 63.420000000000002 111.12 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.4 mp -72.46 -55.11 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 73.319999999999993 111.126 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.3 ttm180 -48.58 -45.65 38.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.479 . . . . 64.319999999999993 110.874 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -68.25 -34.72 76.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 72.439999999999998 110.994 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.481 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -60.69 -48.94 79.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.504 . . . . 52.130000000000003 111.116 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.645 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 94.4 m-85 -72.82 -22.28 60.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 63.109999999999999 110.921 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.535 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.2 OUTLIER -77.35 -5.93 51.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 74.310000000000002 110.969 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.401 ' HB ' HG13 ' A' ' 217' ' ' VAL . 98.0 t -97.2 -17.14 6.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 71.329999999999998 111.101 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.498 ' HA ' HG21 ' A' ' 144' ' ' VAL . 95.3 m95 -106.05 -35.85 7.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 71.219999999999999 110.876 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.39 -11.39 60.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 62.32 110.822 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.613 ' N ' HD21 ' A' ' 143' ' ' ASN . 0.9 OUTLIER -95.81 -17.71 20.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 75.230000000000004 110.879 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.498 HG21 ' HA ' ' A' ' 141' ' ' TRP . 19.4 m -99.09 1.77 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 72.140000000000001 111.092 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.521 ' C ' ' H ' ' A' ' 147' ' ' LEU . 22.9 p -152.11 146.3 18.41 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.544 0.688 . . . . 75.319999999999993 111.168 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 30.1 0.18 Allowed 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.759 2.306 . . . . 71.109999999999999 112.216 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.521 ' H ' ' C ' ' A' ' 145' ' ' THR . 0.1 OUTLIER -90.0 -176.83 5.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.322 -0.399 . . . . 74.219999999999999 110.894 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -145.49 126.12 14.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 74.319999999999993 110.876 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.42 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 4.1 m-30 -115.35 142.42 46.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 72.030000000000001 110.9 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.5 m -141.05 138.78 33.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.483 . . . . 73.439999999999998 110.815 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 152' ' ' ILE . 2.9 tptm -88.45 142.9 27.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 71.200000000000003 110.894 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.485 ' N ' ' HG3' ' A' ' 151' ' ' LYS . 14.6 pt -150.88 132.27 4.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 72.030000000000001 111.138 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.2 m120 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 74.409999999999997 110.854 -179.975 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.837 0.351 . . . . 71.310000000000002 111.023 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -85.34 -53.58 5.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.427 . . . . 74.120000000000005 110.797 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.444 HG12 HG21 ' A' ' 220' ' ' ILE . 2.4 mp -89.43 94.88 5.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.157 -0.474 . . . . 74.219999999999999 111.109 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.2 tp -85.79 109.18 18.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 74.040000000000006 110.888 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 87.3 t -89.2 124.13 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 72.530000000000001 111.15 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.4 p -143.59 105.73 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 74.430000000000007 111.199 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -71.8 109.51 5.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 74.430000000000007 110.911 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -130.38 167.27 18.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 74.219999999999999 111.001 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.51 137.29 52.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 73.319999999999993 110.933 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.66 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.98 -155.64 0.14 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.773 -0.727 . . . . 75.510000000000005 112.454 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.809 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -64.5 115.53 5.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 75.109999999999999 111.083 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.69 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.25 -22.19 12.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 75.5 110.895 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.24 29.11 0.56 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.713 -0.756 . . . . 72.140000000000001 112.4 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.635 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.94 1.23 15.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.904 0.383 . . . . 74.230000000000004 110.864 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 72.8 40.24 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 74.209999999999994 110.78 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.69 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.58 -41.17 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 75.120000000000005 110.913 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.809 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.08 99.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 71.150000000000006 111.075 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.66 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -59.88 -169.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 71.340000000000003 110.911 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.96 17.13 4.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 72.439999999999998 110.927 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.4 -156.81 8.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.797 -0.716 . . . . 61.329999999999998 112.496 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 176' ' ' GLY . 7.6 tttp -34.98 134.8 0.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.815 0.34 . . . . 72.109999999999999 110.926 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.28 163.11 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.711 -0.757 . . . . 73.239999999999995 112.448 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.61 -143.6 20.88 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.766 -0.73 . . . . 74.010000000000005 112.571 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -49.66 97.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 75.420000000000002 111.147 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 76.2 mt -69.53 -36.96 76.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 71.140000000000001 111.027 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -174.39 162.4 3.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 75.530000000000001 111.081 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.525 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.6 p80 -155.27 140.97 18.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 70.510000000000005 110.823 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.587 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -138.85 171.92 13.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 73.519999999999996 111.172 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.512 ' O ' ' HA ' ' A' ' 223' ' ' SER . 17.1 m-85 -100.32 -148.91 0.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.258 -0.428 . . . . 63.340000000000003 110.816 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.404 ' H ' ' HB3' ' A' ' 185' ' ' PHE . . . -159.43 -94.76 0.1 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.637 -0.792 . . . . 53.219999999999999 112.454 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.68 58.69 1.53 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.733 2.289 . . . . 75.310000000000002 112.356 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.599 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.0 153.44 16.97 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.729 -0.748 . . . . 72.010000000000005 112.467 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.597 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.5 150.5 24.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.788 0.328 . . . . 71.150000000000006 110.927 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 59.45 -67.42 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.743 -0.742 . . . . 64.519999999999996 112.423 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.597 ' N ' ' O ' ' A' ' 189' ' ' SER . 26.4 pt -103.66 6.05 10.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.896 0.379 . . . . 71.219999999999999 111.202 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.599 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -64.25 165.25 31.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.656 -0.783 . . . . 73.430000000000007 112.446 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 46.68 17.05 0.23 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.704 -0.76 . . . . 61.409999999999997 112.541 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 192' ' ' GLY . 0.9 OUTLIER -61.82 108.33 0.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.831 0.348 . . . . 70.120000000000005 110.83 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.587 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -83.76 130.56 34.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.121 -0.49 . . . . 64.219999999999999 111.182 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.525 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 11.1 m170 -121.2 128.93 52.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.297 -0.411 . . . . 74.510000000000005 110.86 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.523 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 50.5 m-85 -113.85 131.03 56.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.249 -0.432 . . . . 75.140000000000001 110.85 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . 0.403 ' HB3' ' HG2' ' A' ' 201' ' ' GLU . 63.4 t0 -65.52 114.46 4.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 71.010000000000005 110.945 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -68.06 -33.25 74.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 64.329999999999998 110.83 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.582 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 14.5 m-20 -51.07 -21.6 1.96 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.155 -0.475 . . . . 65.530000000000001 110.823 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . 0.403 ' HG2' ' HB3' ' A' ' 198' ' ' ASP . 0.6 OUTLIER -86.4 164.99 16.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 72.140000000000001 110.882 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.465 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -97.86 98.95 10.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 71.540000000000006 110.926 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.523 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 52.5 m95 -86.46 123.86 32.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.203 -0.453 . . . . 73.420000000000002 110.895 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 39.9 p -145.57 -177.04 5.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 73.510000000000005 111.143 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.34 21.27 16.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 75.319999999999993 111.157 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -128.4 -177.48 4.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 75.349999999999994 110.837 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 207' ' ' SER . . . . . 0.407 ' HA ' ' CD2' ' A' ' 242' ' ' TYR . 4.0 t -67.14 -18.81 65.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 74.040000000000006 110.888 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.21 -106.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.868 -0.682 . . . . 71.239999999999995 112.42 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.76 178.18 0.2 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.726 -0.75 . . . . 74.439999999999998 112.508 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 99.1 m -66.94 98.09 0.53 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.79 0.329 . . . . 65.25 111.187 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -42.15 116.57 0.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 72.109999999999999 110.953 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.1 tp -63.49 -38.74 92.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 75.230000000000004 110.941 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -51.69 -63.45 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 73.530000000000001 110.903 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 7.7 mp -56.34 -54.43 45.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 65.329999999999998 110.941 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.2 m -56.02 -31.0 62.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 74.049999999999997 111.107 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -70.55 -47.42 60.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 75.439999999999998 111.093 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.481 HG22 ' CB ' ' A' ' 137' ' ' ALA . 2.0 t -54.56 -58.87 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 74.109999999999999 111.082 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.566 ' HB2' HG12 ' A' ' 235' ' ' VAL . 2.2 t-80 -62.37 -29.94 70.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 73.299999999999997 110.888 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -62.51 -45.52 92.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 74.430000000000007 111.129 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.56 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.5 mt -69.28 -34.94 65.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.428 . . . . 75.010000000000005 111.079 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.93 -44.84 41.14 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.81 -0.71 . . . . 74.25 112.487 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.478 ' O ' ' O ' ' A' ' 185' ' ' PHE . 45.8 m-70 -67.32 -40.67 85.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.744 0.307 . . . . 75.230000000000004 110.806 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 2.9 m -62.59 -27.33 69.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.242 -0.436 . . . . 64.230000000000004 110.853 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 62.4 mt -74.57 -28.45 60.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 75.099999999999994 110.907 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 121.11 15.17 4.78 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.75 -0.738 . . . . 63.310000000000002 112.455 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.415 HD21 ' HA ' ' A' ' 258' ' ' ILE . 11.6 mt -83.01 156.03 23.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.338 . . . . 75.310000000000002 110.887 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -102.5 -133.29 7.98 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.694 -0.765 . . . . 64.409999999999997 112.52 179.803 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 1.6 m170 -125.7 142.95 51.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 73.439999999999998 110.882 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 38.1 m -104.19 166.06 10.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 62.140000000000001 110.91 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 42.8 m -108.51 1.87 21.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 75.519999999999996 110.908 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.31 140.38 96.74 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.592 0.711 . . . . 75.239999999999995 110.824 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.7 -3.35 11.79 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.758 2.305 . . . . 75.430000000000007 112.35 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.45 24.89 1.55 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 75.349999999999994 110.882 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -88.85 140.39 29.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 75.109999999999999 111.141 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.566 HG12 ' HB2' ' A' ' 218' ' ' HIS . 1.8 t -63.43 -38.06 81.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 70.030000000000001 111.183 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.42 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 32.1 mmm -66.05 -14.06 61.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 75.140000000000001 110.873 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.596 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.5 t80 -57.91 143.62 76.84 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.635 0.731 . . . . 74.310000000000002 110.866 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.596 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.4 Cg_endo -69.77 -1.62 8.8 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.674 2.249 . . . . 75.420000000000002 112.34 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 6.6 m -100.41 139.66 35.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 75.519999999999996 111.073 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -118.75 128.66 54.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 73.349999999999994 110.876 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.22 126.27 12.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.043 -0.526 . . . . 71.420000000000002 110.803 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . 0.407 ' CD2' ' HA ' ' A' ' 207' ' ' SER . 35.9 t80 -57.18 147.39 25.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.147 -0.479 . . . . 75.129999999999995 110.897 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -160.07 132.93 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.514 . . . . 74.409999999999997 111.091 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -46.77 133.59 10.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 61.119999999999997 110.854 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 5.9 tt -53.32 -34.35 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 75.439999999999998 111.181 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.15 -17.05 61.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 72.510000000000005 110.867 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 24.6 p -107.61 -21.91 12.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 73.450000000000003 111.182 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -72.36 137.82 46.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 73.25 110.829 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -174.48 136.8 0.47 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.147 -0.479 . . . . 72.120000000000005 110.882 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.401 HD11 ' O ' ' A' ' 140' ' ' VAL . 29.2 mt -49.78 129.33 19.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 70.400000000000006 110.921 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 32.5 t -71.3 171.0 11.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 72.200000000000003 110.849 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.16 -37.11 69.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.489 . . . . 75.420000000000002 111.186 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -65.3 -47.49 76.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 75.140000000000001 110.856 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.99 -52.04 65.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.194 -0.457 . . . . 74.239999999999995 110.825 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 30.0 mt -61.36 -35.47 66.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 72.430000000000007 111.107 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -69.68 -39.42 77.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 74.340000000000003 110.892 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.48 -50.1 7.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.791 -0.719 . . . . 63.32 112.459 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.415 ' HA ' HD21 ' A' ' 226' ' ' LEU . 7.0 tp -52.07 -35.25 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.703 0.287 . . . . 74.129999999999995 111.115 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 263' ' ' GLY . 72.1 mt-30 -87.32 -16.68 34.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 74.420000000000002 110.897 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.9 t -70.85 -14.54 62.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 72.209999999999994 110.896 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 5.3 mt -121.95 -18.92 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 71.439999999999998 110.868 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 33.6 m-85 -113.12 -34.37 5.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.248 -0.433 . . . . 74.299999999999997 110.951 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.335 0 CA-C-O 119.097 -0.835 . . . . 72.299999999999997 112.545 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 9.1 p80 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.839 0.352 . . . . 74.129999999999995 110.868 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -134.2 106.71 7.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 73.25 110.939 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 115' ' ' THR . 4.7 mp -138.13 162.71 30.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.478 . . . . 74.0 111.179 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.426 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.5 OUTLIER -158.65 163.8 36.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 71.420000000000002 111.113 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.598 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.0 p90 -132.73 149.02 52.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 74.430000000000007 110.928 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -143.93 112.4 6.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.083 -0.508 . . . . 75.019999999999996 110.862 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.0 mt -72.79 106.64 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 74.409999999999997 111.151 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -60.17 -46.38 89.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 75.129999999999995 110.949 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -146.46 166.08 27.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 71.319999999999993 110.892 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -117.47 139.33 51.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 73.150000000000006 110.87 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.543 HG21 ' HB2' ' A' ' 124' ' ' ASP . 1.0 OUTLIER -91.22 139.31 25.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.549 0.69 . . . . 71.049999999999997 111.183 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 122' ' ' THR . 54.2 Cg_endo -69.75 42.16 0.34 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.742 2.295 . . . . 72.230000000000004 112.353 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.543 ' HB2' HG21 ' A' ' 122' ' ' THR . 2.3 m-20 -126.85 -25.61 3.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 63.200000000000003 110.764 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.69 165.22 12.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.328 -0.396 . . . . 61.350000000000001 110.861 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -94.45 142.2 27.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 72.430000000000007 110.882 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -44.22 -36.38 2.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 73.099999999999994 110.892 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -83.85 -39.18 20.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 73.400000000000006 110.91 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -63.52 -33.25 75.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.495 . . . . 61.420000000000002 110.888 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 73.8 t -63.38 -46.58 95.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.214 -0.448 . . . . 70.109999999999999 111.16 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -78.71 -23.62 45.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 74.140000000000001 110.814 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -75.53 -49.42 18.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 75.230000000000004 110.909 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.57 -30.48 69.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.502 . . . . 61.039999999999999 111.124 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.2 mp -74.15 -54.65 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 72.109999999999999 111.175 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.463 ' HB3' ' O ' ' A' ' 131' ' ' ASP . 3.3 ptm180 -49.08 -37.39 21.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.264 -0.425 . . . . 75.450000000000003 110.93 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -75.48 -36.02 60.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 73.510000000000005 110.942 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.512 ' HA ' HG21 ' A' ' 217' ' ' VAL . . . -59.87 -49.53 77.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 74.430000000000007 111.091 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.598 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 92.1 m-85 -70.71 -22.7 62.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 74.319999999999993 110.935 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.565 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.9 tt0 -77.4 -7.09 55.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 75.340000000000003 110.867 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.427 ' HB ' HG13 ' A' ' 217' ' ' VAL . 89.6 t -95.75 -17.28 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 72.209999999999994 111.138 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.499 ' HA ' HG21 ' A' ' 144' ' ' VAL . 95.9 m95 -106.11 -36.12 7.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 73.209999999999994 110.958 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -11.37 60.87 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.258 -0.428 . . . . 72.400000000000006 110.867 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.612 ' N ' HD21 ' A' ' 143' ' ' ASN . 0.9 OUTLIER -95.3 -17.68 21.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 72.200000000000003 110.906 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.499 HG21 ' HA ' ' A' ' 141' ' ' TRP . 18.2 m -99.38 1.77 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 72.230000000000004 111.112 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.523 ' C ' ' H ' ' A' ' 147' ' ' LEU . 22.8 p -152.48 146.56 18.42 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.576 0.703 . . . . 75.219999999999999 111.103 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 29.72 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.788 2.325 . . . . 73.439999999999998 112.297 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.523 ' H ' ' C ' ' A' ' 145' ' ' THR . 0.7 OUTLIER -91.15 179.22 5.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 73.109999999999999 110.924 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -141.53 126.17 17.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.430000000000007 110.894 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -115.41 143.72 44.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 75.219999999999999 110.911 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.9 t -140.23 151.78 45.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 75.109999999999999 110.833 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 10.2 tttp -101.59 145.21 29.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 74.319999999999993 110.804 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 21.6 pt -151.74 143.54 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 72.0 111.038 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.1 m120 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 73.340000000000003 110.831 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.789 0.328 . . . . 70.140000000000001 111.109 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.5 OUTLIER -85.82 -52.31 5.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 75.310000000000002 110.811 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.503 HG12 HG21 ' A' ' 220' ' ' ILE . 1.9 mp -89.7 94.9 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 71.040000000000006 111.1 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.4 tp -87.17 109.28 19.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 75.239999999999995 110.849 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 83.9 t -87.33 120.48 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 75.319999999999993 111.157 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.2 p -139.52 106.51 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 73.430000000000007 111.168 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.403 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 41.6 m-85 -74.1 112.32 10.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 74.519999999999996 110.952 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.79 168.4 17.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.151 -0.477 . . . . 72.109999999999999 111.084 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.419 ' CG ' ' HB3' ' A' ' 199' ' ' GLU . 37.8 mtp180 -113.07 137.6 51.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 73.239999999999995 110.843 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.641 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 41.18 -151.99 0.13 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.841 -0.695 . . . . 74.209999999999994 112.486 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.813 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -66.41 117.3 8.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.875 0.369 . . . . 74.019999999999996 111.061 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.711 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -109.27 -20.22 13.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 73.230000000000004 110.9 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 129.85 30.03 0.66 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.771 -0.728 . . . . 74.430000000000007 112.478 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.635 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.72 0.21 14.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 71.230000000000004 110.826 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 74.25 38.73 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 71.420000000000002 110.872 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.711 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.3 -41.2 0.81 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 65.349999999999994 110.806 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.813 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.36 99.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 65.329999999999998 111.074 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.641 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.7 m-85 -60.23 -168.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 71.510000000000005 110.8 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.89 19.6 3.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.093 -0.503 . . . . 70.019999999999996 110.898 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 53.25 -157.8 4.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.773 -0.727 . . . . 42.399999999999999 112.461 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.2 OUTLIER -33.82 134.27 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 73.340000000000003 110.926 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.32 165.66 0.15 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.677 -0.773 . . . . 73.510000000000005 112.508 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.3 -144.06 23.26 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.714 -0.755 . . . . 53.32 112.537 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -49.44 97.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 60.520000000000003 111.177 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.79 -41.28 87.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.097 -0.501 . . . . 73.400000000000006 110.938 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -170.96 169.16 6.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 74.409999999999997 111.123 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.471 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.2 p80 -163.75 143.48 8.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.254 -0.43 . . . . 74.150000000000006 110.824 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.555 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -138.09 173.23 11.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 73.129999999999995 111.069 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 223' ' ' SER . 54.0 m-85 -98.82 -140.88 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 62.409999999999997 110.831 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -171.56 -87.57 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.748 -0.739 . . . . 71.109999999999999 112.493 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 54.21 1.12 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.648 2.232 . . . . 75.439999999999998 112.357 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.566 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.16 149.56 16.83 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 41.149999999999999 112.452 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.64 145.72 29.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.988 0.423 . . . . 74.049999999999997 110.804 -179.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.64 -63.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.799 -0.715 . . . . 73.219999999999999 112.479 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.524 ' N ' ' O ' ' A' ' 189' ' ' SER . 5.5 tp -105.29 6.54 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 73.299999999999997 111.14 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.566 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -67.82 169.78 37.7 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.803 -0.713 . . . . 61.299999999999997 112.442 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 45.32 18.9 0.2 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 64.109999999999999 112.561 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 192' ' ' GLY . 0.9 OUTLIER -63.15 103.41 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 71.099999999999994 110.913 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.555 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -77.76 131.15 37.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.223 -0.444 . . . . 63.450000000000003 111.067 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.471 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.7 m170 -121.37 130.23 53.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.45 . . . . 73.299999999999997 110.856 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.476 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 41.8 m-85 -115.13 134.22 55.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 73.430000000000007 110.88 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -67.52 104.69 1.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 71.329999999999998 110.886 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.419 ' HB3' ' CG ' ' A' ' 165' ' ' ARG . 4.2 tm-20 -57.24 -36.7 71.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 75.109999999999999 110.875 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.564 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 14.3 m-20 -50.41 -22.18 1.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 73.310000000000002 110.839 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -82.12 164.21 21.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 74.549999999999997 110.816 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.533 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -100.73 91.77 4.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 75.340000000000003 110.892 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.476 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 33.1 m95 -82.64 123.54 29.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.155 -0.475 . . . . 73.549999999999997 110.887 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.7 p -140.3 -172.4 3.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 74.430000000000007 111.164 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.6 17.34 17.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 71.5 111.098 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.26 -176.59 3.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 74.510000000000005 110.782 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.2 p -66.06 -18.54 65.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 72.430000000000007 110.951 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.91 -108.85 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.799 -0.715 . . . . 52.140000000000001 112.496 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.38 178.26 0.15 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.76 -0.733 . . . . 73.329999999999998 112.495 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 90.0 m -66.52 97.69 0.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.83 0.347 . . . . 72.439999999999998 111.185 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -41.65 116.83 0.83 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.446 . . . . 72.319999999999993 110.908 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 17.4 tp -63.88 -36.01 82.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 75.430000000000007 110.894 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -53.68 -64.27 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 71.150000000000006 110.855 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 19.3 mt -54.81 -54.32 43.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 71.239999999999995 110.913 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 2.5 m -54.53 -34.64 62.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 72.239999999999995 111.212 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.77 -48.98 70.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 72.340000000000003 111.159 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.512 HG21 ' HA ' ' A' ' 137' ' ' ALA . 0.8 OUTLIER -52.5 -58.89 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 71.019999999999996 111.127 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.574 ' HB2' HG12 ' A' ' 235' ' ' VAL . 3.4 t-80 -63.29 -29.38 70.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 70.310000000000002 110.932 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -63.84 -44.5 92.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 75.209999999999994 111.111 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.565 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.4 mt -71.03 -34.23 54.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 64.450000000000003 111.108 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -52.63 -44.81 60.16 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.76 -0.734 . . . . 71.5 112.392 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.508 ' O ' ' O ' ' A' ' 185' ' ' PHE . 3.4 m-70 -69.46 -40.85 76.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 74.239999999999995 110.913 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 43.9 p -64.38 -20.55 66.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 75.129999999999995 110.842 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 61.3 mt -81.74 -26.03 34.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 74.299999999999997 110.886 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 121.97 10.49 6.27 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.784 -0.722 . . . . 71.310000000000002 112.454 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 221' ' ' GLY . 46.0 mt -79.77 149.41 31.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.865 0.364 . . . . 75.329999999999998 110.935 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -95.35 -141.35 11.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.737 -0.745 . . . . 62.43 112.558 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.08 142.6 47.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.801 0.334 . . . . 74.540000000000006 110.86 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 49.3 m -103.5 163.65 12.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 74.430000000000007 110.913 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.4 t -108.51 0.74 21.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.489 . . . . 65.310000000000002 110.891 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.14 141.57 98.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.601 0.715 . . . . 71.239999999999995 110.883 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 -3.84 12.88 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.695 2.263 . . . . 70.299999999999997 112.352 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -144.27 25.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 70.400000000000006 110.806 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -89.28 139.21 30.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 71.209999999999994 111.025 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.574 HG12 ' HB2' ' A' ' 218' ' ' HIS . 1.7 t -62.42 -37.92 79.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 74.340000000000003 111.126 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 37.1 mmm -65.79 -14.41 61.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 75.310000000000002 110.899 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.606 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.4 t80 -58.69 143.93 81.19 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.61 0.719 . . . . 72.040000000000006 110.91 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.606 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.1 Cg_endo -69.71 -0.99 7.67 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.689 2.259 . . . . 64.030000000000001 112.405 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 17.0 m -98.52 139.65 33.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.127 -0.488 . . . . 74.129999999999995 111.249 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -122.1 133.34 54.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 71.409999999999997 110.96 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -151.87 134.43 15.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 75.430000000000007 110.927 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -59.62 144.8 46.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.45 . . . . 74.340000000000003 110.947 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -160.33 131.66 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 73.120000000000005 111.114 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -53.95 134.8 43.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 53.109999999999999 110.912 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 7.2 tt -54.2 -29.74 19.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 75.299999999999997 111.104 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.96 -19.47 62.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 74.340000000000003 110.933 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.9 p -111.21 -20.28 12.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 75.340000000000003 111.145 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -74.44 133.91 42.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 74.409999999999997 110.88 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.1 136.13 1.42 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 73.310000000000002 110.931 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.401 ' HB3' ' HB2' ' A' ' 254' ' ' ASP . 36.5 mt -48.65 127.38 13.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 72.340000000000003 110.927 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.6 p -69.77 164.6 23.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 74.129999999999995 110.866 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.14 -34.77 32.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 74.25 111.093 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.52 -48.02 68.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 74.209999999999994 110.864 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 8.9 m-20 -61.27 -50.87 71.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 73.319999999999993 110.878 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 31.5 mt -61.83 -35.1 65.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 74.430000000000007 111.155 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -69.5 -39.23 77.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 74.129999999999995 110.908 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.32 -50.27 8.51 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.737 -0.744 . . . . 71.010000000000005 112.536 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 5.6 tp -52.56 -35.29 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.812 0.339 . . . . 74.349999999999994 111.091 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.422 ' O ' ' N ' ' A' ' 263' ' ' GLY . 74.7 mt-30 -86.77 -16.45 36.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 74.409999999999997 110.882 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.0 t -70.31 -13.77 62.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 65.010000000000005 110.845 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.1 mt -123.59 -18.06 6.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 73.140000000000001 110.961 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -115.31 -33.56 5.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 75.25 110.861 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.453 -0.227 0 CA-C-O 119.13 -0.817 . . . . 71.230000000000004 112.419 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.2 p80 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.836 0.35 . . . . 75.329999999999998 110.892 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -121.62 101.18 7.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.458 . . . . 73.439999999999998 110.87 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.449 ' CG2' ' N ' ' A' ' 115' ' ' THR . 5.1 mp -126.77 162.25 31.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 73.310000000000002 111.156 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.449 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -155.9 166.91 32.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 74.319999999999993 111.188 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.634 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.5 p90 -137.16 146.27 44.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 73.400000000000006 110.909 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.4 ' HB3' HD13 ' A' ' 160' ' ' LEU . 3.7 tmm_? -139.2 112.46 8.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 75.299999999999997 110.945 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.1 mt -74.08 105.7 3.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.202 -0.454 . . . . 74.450000000000003 111.108 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -57.75 -47.57 82.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 73.549999999999997 110.919 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -144.82 163.81 32.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.116 -0.493 . . . . 74.150000000000006 110.914 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -116.01 139.63 50.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 63.310000000000002 110.902 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.417 HG21 ' HB2' ' A' ' 124' ' ' ASP . 2.5 t -89.95 142.62 29.04 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.608 0.718 . . . . 75.319999999999993 111.138 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -3.99 13.16 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.638 2.225 . . . . 74.549999999999997 112.344 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.417 ' HB2' HG21 ' A' ' 122' ' ' THR . 21.8 m-20 -79.28 -23.28 43.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 75.329999999999998 110.901 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.427 ' HE2' ' HB2' ' A' ' 125' ' ' MET . 12.9 mtm -115.99 166.15 12.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 71.439999999999998 110.878 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -97.23 145.03 26.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 74.040000000000006 110.836 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -45.58 -35.39 3.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 72.140000000000001 110.864 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -82.47 -38.84 23.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 74.329999999999998 110.891 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -65.31 -29.44 70.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 62.420000000000002 110.903 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.48 ' HA ' ' CD2' ' A' ' 212' ' ' LEU . 65.4 t -66.04 -45.34 90.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 73.340000000000003 111.153 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.69 -23.29 42.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 74.230000000000004 110.842 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -74.55 -46.81 36.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.447 . . . . 75.209999999999994 110.958 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -72.34 -31.12 65.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.099 -0.501 . . . . 75.409999999999997 111.118 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.3 mp -72.71 -54.97 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 73.120000000000005 111.172 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -48.66 -43.2 36.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 72.030000000000001 110.868 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -70.64 -34.57 72.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 74.349999999999994 110.991 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.501 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -60.41 -49.24 78.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 65.439999999999998 111.103 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.634 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.9 m-85 -72.29 -22.82 61.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 74.450000000000003 110.884 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.496 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.8 tt0 -76.87 -5.57 48.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 72.109999999999999 110.937 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.9 t -98.83 -16.82 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 74.329999999999998 111.19 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.484 ' HA ' HG21 ' A' ' 144' ' ' VAL . 94.9 m95 -107.37 -37.16 6.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.174 -0.466 . . . . 74.219999999999999 110.9 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.67 -11.92 60.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 73.230000000000004 110.775 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.579 ' N ' HD21 ' A' ' 143' ' ' ASN . 1.0 OUTLIER -95.21 -16.3 22.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 72.420000000000002 110.974 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.484 HG21 ' HA ' ' A' ' 141' ' ' TRP . 19.5 m -98.8 0.67 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 74.030000000000001 111.182 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.511 ' C ' ' H ' ' A' ' 147' ' ' LEU . 62.6 p -150.19 149.14 26.34 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.637 0.732 . . . . 74.140000000000001 111.204 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 32.84 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.675 2.25 . . . . 74.200000000000003 112.357 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.511 ' H ' ' C ' ' A' ' 145' ' ' THR . 13.8 mt -97.98 177.62 5.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 75.400000000000006 110.884 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.42 126.18 18.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 72.129999999999995 110.862 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.414 ' CD1' ' HB ' ' A' ' 114' ' ' ILE . 3.6 m-30 -114.44 143.78 44.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.425 . . . . 74.010000000000005 110.878 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.38 152.51 49.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.483 . . . . 74.409999999999997 110.856 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.3 OUTLIER -100.08 148.27 24.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.489 . . . . 73.409999999999997 110.879 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.9 pt -152.12 168.87 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.146 -0.479 . . . . 74.120000000000005 111.07 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 75.140000000000001 110.892 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.787 0.327 . . . . 50.310000000000002 111.131 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.412 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.8 OUTLIER -85.8 -53.36 5.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 75.219999999999999 110.864 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.455 HG12 HG21 ' A' ' 220' ' ' ILE . 2.6 mp -90.51 96.22 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.228 -0.442 . . . . 74.049999999999997 111.075 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.4 HD13 ' HB3' ' A' ' 117' ' ' ARG . 8.0 tp -87.03 109.57 19.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 73.319999999999993 110.861 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 93.9 t -89.09 120.07 37.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 75.319999999999993 111.145 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.4 p -139.76 105.21 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 72.430000000000007 111.066 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -72.69 108.22 5.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 74.030000000000001 110.886 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.05 166.08 19.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 72.140000000000001 111.207 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.99 137.98 50.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.262 -0.426 . . . . 73.299999999999997 110.893 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.652 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.09 -156.03 0.14 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.721 -0.752 . . . . 74.430000000000007 112.453 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.807 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -64.58 116.55 6.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.769 0.319 . . . . 64.340000000000003 111.101 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.13 -21.48 12.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 74.040000000000006 110.849 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.32 29.38 0.6 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.683 -0.77 . . . . 62.009999999999998 112.507 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.647 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.33 1.36 15.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 64.430000000000007 110.945 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 72.63 40.22 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 73.319999999999993 110.956 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.51 -41.64 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 72.109999999999999 110.819 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.807 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.52 100.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 74.299999999999997 111.079 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.652 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.9 m-85 -60.87 -168.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 70.140000000000001 110.865 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.87 19.43 3.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 51.210000000000001 110.918 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.573 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.43 -156.63 8.93 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.783 -0.722 . . . . 72.150000000000006 112.475 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -37.67 136.54 0.52 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.855 0.359 . . . . 64.129999999999995 110.864 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.97 163.98 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 72.450000000000003 112.48 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.92 -142.28 21.46 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.813 -0.708 . . . . 63.420000000000002 112.479 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.56 95.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 63.420000000000002 111.104 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -65.86 -43.56 88.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 75.530000000000001 110.904 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -169.99 162.62 9.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 61.310000000000002 111.063 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.529 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.5 p80 -154.37 140.9 18.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.235 -0.439 . . . . 72.329999999999998 110.81 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.587 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -138.46 172.92 12.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.174 -0.466 . . . . 74.400000000000006 111.133 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 223' ' ' SER . 13.0 m-85 -101.53 -148.46 0.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 64.319999999999993 110.891 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -159.0 -96.31 0.11 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.789 -0.719 . . . . 52.229999999999997 112.531 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 59.31 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.799 2.333 . . . . 74.519999999999996 112.301 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.591 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.98 153.51 16.78 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.772 -0.728 . . . . 70.019999999999996 112.531 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.575 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.18 148.39 26.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.887 0.375 . . . . 74.519999999999996 110.862 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.55 -66.94 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.746 -0.74 . . . . 72.319999999999993 112.416 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 189' ' ' SER . 1.1 mp -103.58 6.08 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.807 0.337 . . . . 74.120000000000005 111.135 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.591 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -63.93 165.29 30.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.697 -0.763 . . . . 63.329999999999998 112.481 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 45.51 19.07 0.24 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.789 -0.719 . . . . 71.310000000000002 112.473 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 192' ' ' GLY . 0.8 OUTLIER -63.67 107.65 1.22 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.88 0.371 . . . . 72.430000000000007 110.795 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.587 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -82.71 128.95 34.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 71.140000000000001 111.089 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.529 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 9.2 m170 -120.04 130.16 54.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 74.25 110.886 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.501 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 44.2 m-85 -115.29 133.72 55.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 75.109999999999999 110.849 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -66.92 110.15 3.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 74.099999999999994 110.857 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.25 -37.67 81.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 62.119999999999997 110.878 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.573 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 5.5 m-20 -50.62 -21.48 1.59 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 74.400000000000006 110.807 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -81.52 162.47 23.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.308 -0.406 . . . . 73.430000000000007 110.879 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.535 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.4 OUTLIER -100.54 90.0 4.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 71.450000000000003 110.85 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.501 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 27.0 m95 -81.6 121.72 26.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 74.540000000000006 110.951 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 40.6 p -140.21 -175.72 4.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.434 . . . . 73.329999999999998 111.112 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.93 20.79 17.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.455 . . . . 73.010000000000005 111.201 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -127.91 -176.45 3.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 75.239999999999995 110.766 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.2 p -68.96 -19.18 64.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 63.299999999999997 110.882 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.48 -107.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 72.239999999999995 112.39 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -51.9 175.89 0.12 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.718 -0.753 . . . . 54.219999999999999 112.432 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 43.7 m -64.3 98.81 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.786 0.327 . . . . 74.329999999999998 111.173 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -44.96 115.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 74.040000000000006 110.834 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.48 ' CD2' ' HA ' ' A' ' 130' ' ' VAL . 12.5 tp -60.33 -39.12 85.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 74.109999999999999 110.834 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -51.67 -63.66 1.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 75.219999999999999 110.935 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 8.6 mp -54.43 -55.46 28.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 72.109999999999999 110.929 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.3 m -54.81 -36.15 64.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 73.510000000000005 111.197 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.32 -48.55 72.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 52.119999999999997 111.152 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.501 HG22 ' CB ' ' A' ' 137' ' ' ALA . 2.1 t -53.8 -57.93 4.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.166 -0.47 . . . . 70.450000000000003 111.201 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.518 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.8 t-80 -64.48 -28.16 69.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 73.019999999999996 110.847 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -64.68 -45.42 86.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 73.340000000000003 111.071 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.532 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.4 mt -69.5 -35.78 68.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 74.219999999999999 111.094 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.67 -44.74 38.66 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.848 -0.692 . . . . 72.140000000000001 112.402 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.461 ' O ' ' O ' ' A' ' 185' ' ' PHE . 3.8 m-70 -68.85 -39.37 79.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 75.329999999999998 110.851 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 5.0 m -63.05 -25.61 68.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 73.299999999999997 110.814 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 40.3 mt -77.29 -26.1 51.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 73.439999999999998 110.912 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 122.21 15.23 4.26 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.773 -0.727 . . . . 70.099999999999994 112.466 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 40.4 mt -82.18 155.66 24.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.779 0.324 . . . . 71.310000000000002 110.944 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -104.89 -140.68 10.48 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.699 -0.762 . . . . 70.340000000000003 112.473 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -120.97 149.45 42.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.754 0.311 . . . . 74.409999999999997 110.87 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.515 ' N ' ' HB3' ' A' ' 236' ' ' MET . 43.8 m -116.66 164.14 15.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 72.530000000000001 110.781 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.26 4.38 33.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.038 -0.528 . . . . 74.310000000000002 110.881 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.68 135.77 88.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.49 0.662 . . . . 75.099999999999994 110.978 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.57 -1.34 8.15 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.759 2.306 . . . . 72.310000000000002 112.356 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.8 23.95 1.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 75.209999999999994 110.89 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -99.19 130.36 45.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 75.019999999999996 111.098 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.518 HG13 ' HB2' ' A' ' 218' ' ' HIS . 2.0 t -54.59 -31.49 23.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 74.209999999999994 111.164 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.515 ' HB3' ' N ' ' A' ' 229' ' ' SER . 0.0 OUTLIER -65.61 -14.24 60.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 71.340000000000003 110.883 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.574 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.4 t80 -64.06 143.06 98.27 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.623 0.725 . . . . 75.329999999999998 110.866 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.574 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.7 Cg_endo -69.77 -7.53 21.3 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.688 2.259 . . . . 64.230000000000004 112.381 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.1 m -92.87 149.81 21.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 75.230000000000004 111.048 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -125.82 137.39 53.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 74.329999999999998 110.905 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -152.63 128.94 10.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 71.530000000000001 110.877 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -58.4 145.82 37.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 73.040000000000006 110.926 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -160.35 132.21 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 72.120000000000005 111.082 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -46.86 135.2 9.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 71.109999999999999 110.892 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 7.3 tt -53.97 -33.49 24.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.479 . . . . 73.030000000000001 111.154 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.49 -17.19 61.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 73.209999999999994 110.905 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 24.5 p -106.01 -23.2 12.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 72.200000000000003 111.185 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -73.06 130.59 40.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 73.150000000000006 110.881 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -166.37 136.6 3.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 74.230000000000004 110.84 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 254' ' ' ASP . 50.8 mt -50.41 124.91 11.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 74.340000000000003 110.99 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.73 170.37 12.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 73.230000000000004 110.858 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.85 -40.96 61.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 74.150000000000006 111.075 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.31 -47.6 85.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.29 -0.414 . . . . 70.420000000000002 110.844 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 31.0 m-20 -61.3 -54.76 39.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 74.129999999999995 110.846 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 22.7 mt -60.73 -32.84 52.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 73.540000000000006 111.123 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -68.97 -41.31 78.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 75.209999999999994 110.845 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.5 -49.66 8.96 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.744 -0.741 . . . . 70.109999999999999 112.418 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 8.3 tp -53.34 -34.34 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.359 . . . . 75.409999999999997 111.107 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 263' ' ' GLY . 49.2 mt-30 -87.67 -16.25 34.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.464 . . . . 74.140000000000001 110.919 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.4 t -69.63 -14.73 62.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 74.540000000000006 110.83 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.22 -18.68 6.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 72.299999999999997 110.879 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -114.22 -33.06 5.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 74.120000000000005 110.942 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.347 0 CA-C-O 119.085 -0.842 . . . . 72.230000000000004 112.552 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.426 ' HA ' ' HG ' ' A' ' 147' ' ' LEU . 1.7 p80 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.739 0.304 . . . . 65.439999999999998 110.891 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -136.47 108.38 7.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 74.230000000000004 110.955 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 115' ' ' THR . 5.1 mp -136.97 161.26 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 74.439999999999998 111.176 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.423 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.5 OUTLIER -158.41 163.5 37.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 74.040000000000006 111.108 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.634 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.9 p90 -133.04 145.85 51.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 73.319999999999993 110.924 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.56 115.2 10.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 73.329999999999998 110.863 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 62.8 mt -76.58 107.78 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 75.019999999999996 111.128 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -60.49 -49.4 77.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 73.329999999999998 110.863 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -142.1 167.56 21.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 63.399999999999999 110.902 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -118.4 148.93 42.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 110.933 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.515 ' C ' ' H ' ' A' ' 124' ' ' ASP . 87.7 m -100.21 135.48 20.3 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.551 0.691 . . . . 72.409999999999997 111.187 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 21.22 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.611 2.207 . . . . 72.409999999999997 112.347 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.515 ' H ' ' C ' ' A' ' 122' ' ' THR . 1.6 m-20 -101.12 -24.75 14.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.224 -0.444 . . . . 74.420000000000002 110.879 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.403 ' HE3' HG21 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -116.19 166.2 12.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 73.430000000000007 110.835 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -89.56 147.93 23.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 74.219999999999999 110.86 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -47.87 -35.27 10.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 74.329999999999998 110.92 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -81.88 -37.21 27.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 74.329999999999998 110.891 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -64.86 -31.41 72.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 74.310000000000002 110.841 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.403 HG21 ' HE3' ' A' ' 125' ' ' MET . 62.4 t -64.65 -44.85 96.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 73.519999999999996 111.048 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.2 -23.19 38.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 73.420000000000002 110.803 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -75.54 -46.67 30.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 71.019999999999996 110.839 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.43 -35.69 75.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 75.040000000000006 111.14 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.59 -55.17 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 74.120000000000005 111.134 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -48.34 -44.15 34.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.081 -0.509 . . . . 62.520000000000003 110.929 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -69.88 -35.14 74.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 74.340000000000003 110.889 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.453 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -59.84 -49.35 78.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.411 . . . . 71.439999999999998 111.116 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.634 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.8 m-85 -72.47 -22.16 61.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 70.150000000000006 110.848 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.499 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.6 OUTLIER -77.89 -5.87 52.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 74.450000000000003 110.936 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.414 ' HB ' HG11 ' A' ' 217' ' ' VAL . 87.4 t -97.23 -18.65 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 71.409999999999997 111.185 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.444 ' CD1' HG13 ' A' ' 217' ' ' VAL . 95.7 m95 -103.73 -40.19 6.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 71.230000000000004 110.962 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -13.57 62.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 75.510000000000005 110.817 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.589 ' N ' HD21 ' A' ' 143' ' ' ASN . 1.0 OUTLIER -94.07 -4.04 50.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 71.319999999999993 110.876 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 141' ' ' TRP . 31.3 m -120.96 3.59 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 61.530000000000001 111.047 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.531 HG23 ' HD2' ' A' ' 146' ' ' PRO . 3.2 m -145.98 141.66 16.89 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.675 0.75 . . . . 71.439999999999998 111.077 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . 0.531 ' HD2' HG23 ' A' ' 145' ' ' THR . 54.1 Cg_endo -69.78 35.64 0.22 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.695 2.264 . . . . 73.530000000000001 112.328 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.482 ' H ' ' C ' ' A' ' 145' ' ' THR . 3.1 mp -103.22 -177.34 3.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 74.430000000000007 110.88 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -141.64 126.91 18.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 64.0 110.854 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -114.06 146.45 40.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 74.400000000000006 110.887 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.8 t -142.27 151.51 42.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 72.319999999999993 110.877 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 7.2 tttp -102.54 143.13 32.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 75.230000000000004 110.925 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 21.8 pt -151.94 142.02 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 74.310000000000002 111.144 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.517 ' N ' HD21 ' A' ' 153' ' ' ASN . 1.3 m-80 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 64.439999999999998 110.828 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.774 0.321 . . . . 75.430000000000007 111.151 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.26 -53.33 5.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.42 . . . . 73.510000000000005 110.918 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.457 HG12 HG21 ' A' ' 220' ' ' ILE . 2.5 mp -88.68 94.1 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 72.5 111.078 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.5 tp -85.76 108.87 18.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.479 . . . . 74.150000000000006 110.904 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.2 t -86.96 119.11 34.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 74.409999999999997 111.152 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 1.9 p -138.24 104.91 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 74.049999999999997 111.081 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.404 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 39.6 m-85 -73.22 111.68 8.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.195 -0.457 . . . . 71.340000000000003 110.862 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.92 166.41 21.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 75.319999999999993 111.131 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -114.41 136.16 53.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 75.319999999999993 110.987 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.657 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 44.57 -157.78 0.19 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.773 -0.727 . . . . 72.430000000000007 112.499 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.826 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -62.53 116.45 5.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.832 0.348 . . . . 73.530000000000001 110.999 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.25 -22.12 12.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 74.230000000000004 110.884 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.71 30.35 0.54 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.708 -0.758 . . . . 72.310000000000002 112.515 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.633 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.97 0.1 14.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.912 0.387 . . . . 73.120000000000005 110.899 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 74.33 39.04 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 75.319999999999993 110.954 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.96 -41.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 74.109999999999999 110.853 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.826 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.2 100.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 72.439999999999998 111.102 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.657 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.1 m-85 -61.18 -168.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 74.209999999999994 110.898 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.17 18.84 3.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 72.030000000000001 110.825 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.579 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.07 -158.04 5.57 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 62.43 112.477 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.8 OUTLIER -33.76 133.94 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 75.430000000000007 110.884 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.45 165.44 0.15 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.715 -0.755 . . . . 62.039999999999999 112.541 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.64 -143.56 22.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.692 -0.766 . . . . 71.409999999999997 112.486 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.02 96.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.83 0.348 . . . . 75.329999999999998 111.169 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 13.3 mt -66.32 -44.0 84.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 75.430000000000007 110.9 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -170.09 163.09 9.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 73.239999999999995 111.08 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.483 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -155.62 142.66 19.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 75.319999999999993 110.81 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.575 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -139.02 172.26 13.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 73.030000000000001 111.101 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 223' ' ' SER . 48.4 m-85 -100.7 -151.39 0.41 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 64.340000000000003 110.858 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -154.99 -97.07 0.13 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.74 -0.743 . . . . 74.230000000000004 112.481 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 61.31 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.685 2.256 . . . . 73.420000000000002 112.329 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.606 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.65 153.76 17.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 53.240000000000002 112.473 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.58 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.75 149.71 25.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.396 . . . . 62.509999999999998 110.829 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.23 -66.77 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.739 . . . . 71.340000000000003 112.475 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.58 ' N ' ' O ' ' A' ' 189' ' ' SER . 1.1 mp -104.78 6.61 10.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.809 0.338 . . . . 74.019999999999996 111.098 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.606 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -65.33 164.33 37.45 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.763 -0.732 . . . . 40.149999999999999 112.482 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.505 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 47.21 16.73 0.29 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 72.450000000000003 112.457 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 192' ' ' GLY . 1.1 m-20 -63.31 111.77 2.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.78 0.324 . . . . 73.5 110.898 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.575 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -85.49 128.76 34.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 74.349999999999994 111.076 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.483 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.8 m170 -119.29 128.65 54.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 71.120000000000005 110.846 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.516 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 47.8 m-85 -114.27 134.23 55.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.208 -0.451 . . . . 72.209999999999994 110.89 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -67.19 108.91 2.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 71.409999999999997 110.871 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.94 -36.91 78.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 74.439999999999998 110.843 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.579 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 16.8 m-20 -51.38 -21.06 2.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 75.219999999999999 110.854 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -82.61 162.72 21.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 73.140000000000001 110.885 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.51 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -100.66 92.46 5.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 74.409999999999997 110.887 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.516 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 30.0 m95 -82.7 122.47 28.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.02 -0.536 . . . . 75.439999999999998 110.948 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.2 p -139.42 -170.85 2.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 74.099999999999994 111.204 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.09 17.24 15.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.278 -0.419 . . . . 73.140000000000001 111.151 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.58 -177.55 4.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 73.109999999999999 110.804 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.3 p -64.95 -18.66 65.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 72.439999999999998 110.831 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.31 -108.3 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.744 -0.741 . . . . 43.200000000000003 112.452 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.09 177.45 0.14 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.698 -0.763 . . . . 72.310000000000002 112.474 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 96.3 m -66.76 94.55 0.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.8 0.334 . . . . 74.439999999999998 111.187 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -38.12 117.09 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 73.439999999999998 110.875 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 25.0 tp -63.66 -36.59 84.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 73.019999999999996 110.921 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -52.82 -64.63 0.75 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 75.420000000000002 110.932 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 15.2 mt -53.53 -55.54 24.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 73.540000000000006 110.902 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.7 m -55.52 -32.99 63.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.468 . . . . 63.43 111.065 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -68.0 -46.24 71.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 75.340000000000003 111.026 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.453 HG22 ' CB ' ' A' ' 137' ' ' ALA . 1.9 t -55.96 -59.4 2.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.279 -0.419 . . . . 73.200000000000003 111.104 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.514 ' HB2' ' CG1' ' A' ' 235' ' ' VAL . 1.1 t-80 -60.6 -31.7 70.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 75.040000000000006 110.925 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -60.25 -46.75 88.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 70.409999999999997 111.075 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.569 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.3 mt -68.75 -34.54 65.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 111.167 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.01 -42.69 48.42 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.788 -0.72 . . . . 64.340000000000003 112.418 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.44 ' O ' ' O ' ' A' ' 185' ' ' PHE . 24.1 m-70 -67.62 -39.94 84.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 74.310000000000002 110.89 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.505 ' HB3' ' HA3' ' A' ' 193' ' ' GLY . 2.1 m -60.76 -28.87 69.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 72.219999999999999 110.877 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 52.3 mt -76.21 -26.42 56.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 72.140000000000001 110.88 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 117.67 16.53 5.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.803 -0.713 . . . . 72.329999999999998 112.458 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 53.4 mt -77.45 159.25 29.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 65.310000000000002 110.894 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -103.71 -140.14 10.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.702 -0.761 . . . . 74.340000000000003 112.504 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -123.35 136.19 54.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.814 0.34 . . . . 73.209999999999994 110.934 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 29.8 t -104.92 162.56 13.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 73.5 110.89 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.6 t -107.75 5.85 27.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 74.549999999999997 110.751 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.53 140.45 92.31 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-O 121.673 0.749 . . . . 71.150000000000006 110.806 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 0.55 5.47 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.757 2.305 . . . . 75.430000000000007 112.365 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -143.62 14.66 1.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 75.150000000000006 110.813 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -77.33 140.3 39.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 73.200000000000003 111.129 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.514 ' CG1' ' HB2' ' A' ' 218' ' ' HIS . 51.6 t -69.8 -26.18 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 73.209999999999994 111.138 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 55.6 mmm -81.92 -7.03 59.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 63.119999999999997 110.955 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.477 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 2.4 t80 -50.9 138.28 24.48 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.681 0.753 . . . . 73.230000000000004 110.882 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.477 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 53.6 Cg_endo -69.75 -7.87 22.15 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.622 2.215 . . . . 64.540000000000006 112.335 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 239' ' ' THR . . . . . 0.401 ' HB ' ' CD2' ' A' ' 237' ' ' PHE . 22.3 m -110.91 130.99 55.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 63.25 111.18 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -92.24 146.82 23.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.958 0.409 . . . . 73.430000000000007 110.953 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -161.87 132.02 4.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 53.25 110.848 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -61.89 149.06 41.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 74.510000000000005 110.915 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -160.76 137.48 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 74.329999999999998 111.12 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -60.76 127.39 31.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 73.109999999999999 110.825 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 14.4 tt -54.0 -29.48 18.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 75.430000000000007 111.152 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.08 -21.26 64.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 74.239999999999995 110.849 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.8 p -111.89 -18.2 12.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 71.25 111.119 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -62.72 142.2 58.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 73.299999999999997 110.903 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -177.11 136.25 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 75.349999999999994 110.831 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 254' ' ' ASP . 8.7 mt -51.57 127.71 21.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 72.319999999999993 110.914 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 35.8 t -66.89 161.68 23.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 74.109999999999999 110.863 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.27 -30.17 11.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 72.049999999999997 111.128 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -71.75 -45.87 60.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 64.129999999999995 110.9 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 2.1 m-20 -62.36 -50.57 71.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 74.010000000000005 110.82 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 24.2 mt -62.29 -35.63 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 71.239999999999995 111.158 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 29.1 mmt-85 -71.08 -38.04 72.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 74.5 110.848 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.13 -49.93 7.17 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.673 -0.775 . . . . 72.209999999999994 112.523 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 8.4 tp -52.4 -34.84 19.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.786 0.327 . . . . 75.25 111.141 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 263' ' ' GLY . 30.5 mt-30 -87.81 -16.18 34.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 72.530000000000001 110.925 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.6 t -70.16 -14.25 62.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 73.25 110.809 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.37 -19.33 6.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 74.530000000000001 110.923 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . 0.423 ' CG ' HD23 ' A' ' 147' ' ' LEU . 37.6 m-85 -113.8 -35.06 5.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.448 . . . . 74.010000000000005 110.955 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.325 0 CA-C-O 119.157 -0.801 . . . . 50.310000000000002 112.498 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 9.9 p80 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.729 0.299 . . . . 70.239999999999995 110.854 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -141.92 98.67 3.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.149 -0.478 . . . . 73.329999999999998 110.904 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 149' ' ' PHE . 4.6 mp -132.12 163.19 38.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.097 -0.501 . . . . 63.409999999999997 111.136 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.42 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -160.26 163.44 33.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 75.040000000000006 111.238 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.595 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.7 p90 -133.72 155.71 49.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 75.040000000000006 110.854 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -144.87 111.56 5.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 73.299999999999997 110.923 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.0 mt -73.37 104.18 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.31 -0.405 . . . . 74.430000000000007 111.206 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -57.82 -45.72 85.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 62.340000000000003 110.896 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -146.92 164.24 33.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 74.400000000000006 110.862 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -116.5 144.82 43.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 75.409999999999997 110.923 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.406 HG22 ' HB2' ' A' ' 124' ' ' ASP . 3.0 t -94.33 142.15 24.48 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.564 0.697 . . . . 72.049999999999997 111.17 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.87 -3.17 11.54 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.643 2.229 . . . . 73.019999999999996 112.339 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.406 ' HB2' HG22 ' A' ' 122' ' ' THR . 22.8 m-20 -79.96 -23.38 41.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 60.32 110.933 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.409 ' HE3' ' HB2' ' A' ' 125' ' ' MET . 16.6 mtm -115.94 166.63 11.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 73.030000000000001 110.858 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -96.32 143.95 26.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 73.030000000000001 110.909 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.88 -32.83 1.73 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 73.219999999999999 110.911 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -85.73 -40.44 16.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 75.319999999999993 110.9 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -64.88 -29.24 70.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 73.200000000000003 110.906 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.428 ' HA ' ' CD2' ' A' ' 212' ' ' LEU . 78.9 t -67.39 -45.36 85.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 75.409999999999997 111.168 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -80.12 -22.72 41.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 73.540000000000006 110.878 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -73.75 -47.02 42.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 73.239999999999995 110.955 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -73.84 -30.01 62.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.5 . . . . 74.319999999999993 111.094 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.4 mp -73.84 -55.85 11.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 75.420000000000002 111.202 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -48.02 -42.12 27.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 64.530000000000001 110.868 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.88 -33.35 59.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 75.340000000000003 110.902 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.462 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -60.35 -50.78 72.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 71.109999999999999 111.145 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.595 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 80.7 m-85 -67.37 -32.55 73.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 73.299999999999997 110.832 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.581 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.7 tt0 -63.42 -44.2 95.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 64.219999999999999 110.991 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.406 ' HB ' HG12 ' A' ' 217' ' ' VAL . 79.3 t -49.35 -24.81 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 73.319999999999993 111.077 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.434 ' CD1' HG11 ' A' ' 217' ' ' VAL . 97.6 m95 -98.99 -28.36 13.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.253 -0.43 . . . . 75.200000000000003 110.867 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.2 p -76.14 -12.54 60.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.282 -0.417 . . . . 63.43 110.842 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 139' ' ' GLN . 57.8 m-20 -92.73 -24.75 18.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 110.867 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.4 m -93.28 0.8 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 73.120000000000005 111.079 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.522 ' C ' ' H ' ' A' ' 147' ' ' LEU . 77.6 p -152.93 143.98 16.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.642 0.734 . . . . 74.530000000000001 111.146 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 29.33 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.604 2.202 . . . . 74.019999999999996 112.333 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' A' ' 145' ' ' THR . 29.4 mt -87.71 175.59 7.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.444 . . . . 74.25 110.937 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -137.67 126.47 23.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 73.530000000000001 110.983 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 3.4 m-85 -116.6 140.28 49.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 74.109999999999999 110.83 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.9 m -136.09 145.94 46.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 72.120000000000005 110.847 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.425 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 5.5 tttt -94.22 144.87 25.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 73.420000000000002 110.893 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 14.8 pt -151.25 132.85 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 73.349999999999994 111.081 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.155 -0.475 . . . . 73.439999999999998 110.866 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.057 0 CA-C-O 120.788 0.327 . . . . 73.209999999999994 111.104 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.94 -50.95 7.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 72.519999999999996 110.849 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.454 HG12 HG21 ' A' ' 220' ' ' ILE . 2.6 mp -93.14 98.95 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 75.099999999999994 111.203 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.4 tp -88.67 109.89 20.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 75.150000000000006 110.995 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.3 t -89.07 121.44 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 73.319999999999993 111.144 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.98 106.43 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 75.140000000000001 111.175 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -73.66 108.57 6.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 74.319999999999993 110.819 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.91 165.61 20.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.029 -0.532 . . . . 64.030000000000001 111.163 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.08 137.69 51.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 64.129999999999995 110.879 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.658 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.82 -155.48 0.23 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.772 -0.728 . . . . 53.450000000000003 112.473 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.815 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.45 117.07 7.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 73.409999999999997 111.113 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.28 -22.51 12.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 75.439999999999998 110.831 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.32 29.68 0.54 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.805 -0.712 . . . . 75.019999999999996 112.518 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.624 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.1 -0.45 14.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.824 0.345 . . . . 60.210000000000001 110.882 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 74.77 39.39 0.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 74.140000000000001 110.946 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -135.02 -41.28 0.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 74.120000000000005 110.82 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.815 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.19 99.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.43 . . . . 74.5 111.093 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.658 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -60.4 -168.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 71.510000000000005 110.911 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.69 19.12 3.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 72.420000000000002 110.798 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.568 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.5 -157.99 6.18 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.789 -0.72 . . . . 72.319999999999993 112.508 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 176' ' ' GLY . 9.6 ptpt -34.59 134.05 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 73.519999999999996 110.966 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.84 165.42 0.18 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.777 -0.725 . . . . 75.200000000000003 112.491 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.69 -142.9 22.1 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.775 -0.726 . . . . 73.140000000000001 112.488 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.47 96.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.953 0.406 . . . . 72.439999999999998 111.145 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.56 -42.71 91.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 73.409999999999997 110.903 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -171.25 163.55 7.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 72.140000000000001 111.163 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.485 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -156.11 142.13 18.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 72.010000000000005 110.88 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.576 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -137.79 172.93 12.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 62.109999999999999 111.123 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 223' ' ' SER . 12.2 m-85 -101.7 -148.48 0.37 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.24 -0.436 . . . . 75.019999999999996 110.796 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -164.03 -86.85 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.739 -0.744 . . . . 74.239999999999995 112.483 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.82 55.51 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.564 2.176 . . . . 74.120000000000005 112.374 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.569 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.82 149.79 16.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 63.210000000000001 112.502 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.13 146.48 28.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.388 . . . . 74.329999999999998 110.805 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.03 -64.77 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.796 -0.716 . . . . 64.329999999999998 112.512 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' A' ' 189' ' ' SER . 8.2 pt -105.25 8.86 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.871 0.367 . . . . 73.510000000000005 111.214 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.569 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -68.91 169.75 41.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.701 -0.761 . . . . 75.230000000000004 112.433 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 44.67 20.78 0.23 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.727 -0.749 . . . . 74.239999999999995 112.542 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 192' ' ' GLY . 2.3 m-20 -64.98 107.34 1.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.784 0.326 . . . . 72.420000000000002 110.892 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.576 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -81.4 129.06 34.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 71.140000000000001 111.094 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.485 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.8 m170 -119.86 129.82 54.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.312 -0.403 . . . . 71.030000000000001 110.805 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.478 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 47.7 m-85 -114.47 133.9 55.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 70.120000000000005 110.876 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -66.76 107.3 2.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.128 -0.487 . . . . 75.129999999999995 110.769 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -58.4 -37.51 75.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 75.430000000000007 110.794 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.568 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 14.6 m-20 -50.48 -22.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 62.509999999999998 110.875 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -80.79 162.96 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 64.450000000000003 110.853 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.557 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -101.22 88.53 3.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 71.420000000000002 110.853 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.478 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 31.1 m95 -79.54 123.9 28.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 75.420000000000002 110.913 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 25.1 p -142.7 -175.96 4.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.457 . . . . 73.129999999999995 111.086 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.12 21.45 16.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 73.540000000000006 111.158 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -128.29 -174.86 3.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 73.420000000000002 110.884 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.4 p -70.87 -19.2 62.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 65.450000000000003 110.758 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.76 -105.23 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.717 -0.754 . . . . 72.030000000000001 112.519 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.5 177.23 0.11 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.735 -0.745 . . . . 74.319999999999993 112.503 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 68.7 m -66.93 98.14 0.53 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.819 0.342 . . . . 72.319999999999993 111.107 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -42.13 115.72 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 75.140000000000001 110.85 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.428 ' CD2' ' HA ' ' A' ' 130' ' ' VAL . 5.8 tp -63.93 -36.62 84.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 73.349999999999994 110.957 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -51.93 -64.05 0.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 74.439999999999998 110.874 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 18.2 mt -56.1 -54.84 40.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 74.510000000000005 110.855 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 2.5 m -54.5 -34.52 61.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 74.25 111.155 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.83 -49.35 66.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 71.319999999999993 111.069 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.462 HG22 ' CB ' ' A' ' 137' ' ' ALA . 2.0 t -52.81 -58.03 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.326 -0.397 . . . . 74.540000000000006 111.17 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.514 ' HB2' HG12 ' A' ' 235' ' ' VAL . 4.3 t-80 -63.36 -30.81 71.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 73.299999999999997 110.799 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -62.48 -43.27 99.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 75.530000000000001 111.087 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.57 HG12 ' CE2' ' A' ' 138' ' ' PHE . 2.5 mt -71.65 -35.42 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 73.439999999999998 111.053 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.24 -43.95 43.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.644 -0.789 . . . . 74.209999999999994 112.515 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 185' ' ' PHE . 31.5 m-70 -68.52 -39.52 81.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 74.340000000000003 110.915 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 5.0 m -62.15 -27.39 68.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 73.439999999999998 110.843 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 68.2 mt -76.8 -27.23 55.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 75.439999999999998 110.911 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 117.05 16.76 6.08 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.752 -0.737 . . . . 52.409999999999997 112.468 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 32.3 mt -78.85 149.08 32.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.9 0.381 . . . . 72.400000000000006 110.874 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -90.94 -142.65 10.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.733 -0.746 . . . . 71.140000000000001 112.487 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 0.4 OUTLIER -122.31 142.07 50.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.337 . . . . 73.439999999999998 110.833 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 28.7 t -103.49 161.58 13.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 65.109999999999999 110.824 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.25 -1.7 23.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 74.319999999999993 110.875 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.3 140.91 96.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.564 0.697 . . . . 73.299999999999997 110.907 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.71 -2.78 10.71 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.703 2.269 . . . . 70.200000000000003 112.367 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 3.6 ptmt -143.85 21.07 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 72.340000000000003 110.898 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -85.19 135.56 33.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 71.310000000000002 111.062 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.514 HG12 ' HB2' ' A' ' 218' ' ' HIS . 1.3 t -60.56 -35.68 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 75.140000000000001 111.105 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.414 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 41.1 mmm -65.44 -17.99 64.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 73.310000000000002 110.95 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.56 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.2 t80 -56.78 142.72 71.57 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.729 0.776 . . . . 72.319999999999993 110.896 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.56 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.6 Cg_endo -69.7 -1.4 8.36 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.669 2.246 . . . . 75.510000000000005 112.387 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.5 m -96.77 144.33 26.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 51.329999999999998 111.163 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -123.88 140.29 53.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 72.409999999999997 110.899 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -160.42 135.31 7.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 70.540000000000006 110.899 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -59.04 148.69 29.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 73.510000000000005 110.976 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -161.2 133.09 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 75.239999999999995 111.183 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -49.47 131.55 20.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 71.400000000000006 110.811 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 4.3 tt -54.44 -30.86 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 72.129999999999995 111.103 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -77.41 -17.62 57.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 74.25 110.928 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 50.9 p -104.14 -23.06 13.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 74.400000000000006 111.107 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -67.9 140.92 56.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 74.010000000000005 110.86 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.4 ptt85 -175.59 132.24 0.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.074 -0.512 . . . . 73.219999999999999 110.819 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 254' ' ' ASP . 26.9 mt -48.24 125.48 9.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 74.230000000000004 110.998 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.1 p -68.34 166.15 17.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 72.230000000000004 110.806 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.32 -38.46 41.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 63.409999999999997 111.085 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -63.34 -46.69 85.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 72.209999999999994 110.947 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 4.9 m-20 -62.22 -53.53 53.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 72.329999999999998 110.867 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 26.3 mt -59.99 -36.06 64.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 72.310000000000002 111.136 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -68.23 -39.75 82.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 73.209999999999994 110.901 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.3 -53.17 5.74 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 53.299999999999997 112.514 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 6.4 tp -52.21 -35.5 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.673 0.273 . . . . 74.540000000000006 111.083 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.435 ' O ' ' N ' ' A' ' 263' ' ' GLY . 70.0 mt-30 -85.81 -17.51 35.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 71.230000000000004 110.894 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 10.4 t -70.6 -13.63 62.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 75.299999999999997 110.817 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.7 mt -122.35 -17.74 6.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 75.430000000000007 110.883 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -115.75 -34.77 4.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 73.230000000000004 110.987 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.279 0 CA-C-O 119.156 -0.802 . . . . 64.450000000000003 112.464 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.543 ' HA ' ' CD1' ' A' ' 147' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.815 0.341 . . . . 72.430000000000007 110.843 . . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -143.73 82.69 1.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 74.439999999999998 110.963 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.401 ' CG2' ' N ' ' A' ' 115' ' ' THR . 4.2 mp -115.63 164.0 12.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 73.109999999999999 111.12 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.401 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -159.51 162.21 35.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.198 -0.456 . . . . 75.310000000000002 111.112 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.605 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.5 p90 -133.13 148.79 52.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.436 . . . . 74.450000000000003 110.904 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -142.51 113.37 7.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 73.450000000000003 110.875 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.4 mt -73.93 106.03 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 75.219999999999999 111.164 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -59.24 -47.25 86.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 74.510000000000005 110.902 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -143.29 162.88 34.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 74.150000000000006 110.857 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -117.25 137.66 52.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 54.32 110.955 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.409 ' OG1' ' HD2' ' A' ' 123' ' ' PRO . 2.6 t -87.43 143.23 33.91 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.639 0.733 . . . . 72.200000000000003 111.128 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.409 ' HD2' ' OG1' ' A' ' 122' ' ' THR . 53.2 Cg_endo -69.88 -3.62 12.45 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.588 2.192 . . . . 73.519999999999996 112.338 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.402 ' HB2' HG23 ' A' ' 122' ' ' THR . 15.7 m-20 -80.02 -23.74 41.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 65.25 110.875 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.431 ' HE1' ' HB2' ' A' ' 125' ' ' MET . 15.6 mtm -115.67 166.73 11.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 74.519999999999996 110.916 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -97.69 143.93 27.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.429 . . . . 72.120000000000005 110.92 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.47 -35.09 3.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 72.450000000000003 110.869 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -83.36 -38.65 21.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 73.219999999999999 110.914 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -65.26 -30.48 71.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.22 -0.445 . . . . 62.240000000000002 110.776 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.31 -47.37 87.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 71.340000000000003 111.22 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.99 -23.18 48.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 75.549999999999997 110.845 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -74.26 -46.71 39.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.233 -0.439 . . . . 73.420000000000002 110.95 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -72.8 -31.48 64.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 73.530000000000001 111.116 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.4 mp -71.95 -53.79 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 74.209999999999994 111.152 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -48.92 -41.88 35.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 74.129999999999995 110.897 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -70.97 -36.29 72.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 71.450000000000003 110.94 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.487 ' HA ' HG21 ' A' ' 217' ' ' VAL . . . -59.05 -50.83 72.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 63.229999999999997 111.11 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.605 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 93.4 m-85 -69.92 -22.96 63.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 75.030000000000001 110.926 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.477 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.7 tt0 -77.52 -6.87 55.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.119 -0.491 . . . . 73.010000000000005 110.905 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.453 ' HB ' HG12 ' A' ' 217' ' ' VAL . 91.5 t -96.08 -18.34 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 65.340000000000003 111.086 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.482 ' CD1' HG11 ' A' ' 217' ' ' VAL . 96.1 m95 -106.02 -39.82 5.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 74.329999999999998 110.933 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -9.79 58.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 72.310000000000002 110.859 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.553 ' N ' HD21 ' A' ' 143' ' ' ASN . 1.1 m-80 -99.87 -7.92 24.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 74.420000000000002 110.888 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.477 HG21 ' HA ' ' A' ' 141' ' ' TRP . 19.8 m -110.61 -5.24 11.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 74.450000000000003 111.152 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.554 ' HB ' ' CD2' ' A' ' 147' ' ' LEU . 44.8 p -141.36 149.62 55.3 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.555 0.693 . . . . 75.099999999999994 111.132 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 34.85 0.21 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.726 2.284 . . . . 74.25 112.27 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.554 ' CD2' ' HB ' ' A' ' 145' ' ' THR . 2.9 mm? -104.98 167.09 9.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 74.140000000000001 110.924 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -131.12 127.93 39.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 64.129999999999995 110.932 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -114.6 146.52 40.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 64.099999999999994 110.871 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.3 m -137.14 155.33 49.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 72.430000000000007 110.781 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.478 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.4 OUTLIER -106.78 142.36 36.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 72.319999999999993 110.83 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 20.3 pt -151.26 147.97 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 71.319999999999993 111.197 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 72.150000000000006 110.924 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.77 0.319 . . . . 74.129999999999995 111.097 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.416 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.8 OUTLIER -84.25 -54.67 4.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 74.219999999999999 110.863 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.451 HG12 HG21 ' A' ' 220' ' ' ILE . 2.5 mp -87.34 92.8 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.483 . . . . 72.409999999999997 111.123 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.4 tp -84.83 108.61 17.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 73.230000000000004 110.959 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 90.3 t -87.14 120.6 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.429 . . . . 71.450000000000003 111.091 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.2 p -139.45 105.61 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 72.409999999999997 111.124 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -73.23 108.17 5.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 73.120000000000005 110.908 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.64 165.79 20.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 73.010000000000005 111.064 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.91 137.65 51.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 74.340000000000003 110.851 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.658 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.49 -155.67 0.19 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.705 -0.76 . . . . 64.420000000000002 112.565 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.817 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -64.88 116.9 6.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.908 0.385 . . . . 74.540000000000006 111.126 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.696 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.17 -23.09 11.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.289 -0.414 . . . . 64.439999999999998 110.839 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.92 29.7 0.51 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.723 -0.751 . . . . 71.230000000000004 112.486 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.627 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.28 -0.17 14.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.804 0.335 . . . . 73.239999999999995 110.877 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 74.26 39.72 0.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 62.109999999999999 110.924 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.696 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.24 -41.29 0.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.042 -0.526 . . . . 73.150000000000006 110.869 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.817 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.2 100.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 72.140000000000001 111.224 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.658 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.2 m-85 -60.71 -168.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 74.219999999999999 110.84 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.8 18.95 3.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.118 -0.492 . . . . 72.409999999999997 110.827 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.641 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.46 -157.17 6.61 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.789 -0.72 . . . . 72.450000000000003 112.482 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 176' ' ' GLY . 5.7 tmtt? -34.42 133.86 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 74.230000000000004 110.893 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.41 166.5 0.18 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.681 -0.771 . . . . 65.430000000000007 112.565 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.18 -143.71 23.15 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.712 -0.756 . . . . 74.109999999999999 112.496 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -49.99 96.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.896 0.379 . . . . 74.519999999999996 111.101 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 25.0 mt -65.51 -42.7 91.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 74.430000000000007 110.869 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -171.32 162.74 6.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.248 -0.433 . . . . 75.019999999999996 111.2 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.467 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.3 p80 -155.64 143.11 19.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.289 -0.414 . . . . 64.25 110.879 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.585 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -139.3 171.59 14.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 73.0 111.068 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 222' ' ' HIS . 50.2 m-85 -98.67 -146.79 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 75.420000000000002 110.834 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -157.41 -101.44 0.18 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.797 -0.716 . . . . 63.140000000000001 112.552 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.66 63.14 1.73 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.709 2.273 . . . . 73.329999999999998 112.361 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.608 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.06 155.66 17.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 71.25 112.553 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.94 150.19 24.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.859 0.361 . . . . 71.310000000000002 110.881 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 59.35 -67.6 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.7 -0.762 . . . . 73.239999999999995 112.492 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.589 ' N ' ' O ' ' A' ' 189' ' ' SER . 24.3 pt -104.48 7.84 9.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.816 0.341 . . . . 75.420000000000002 111.174 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.608 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -64.32 162.37 36.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 73.420000000000002 112.532 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.459 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 46.58 17.7 0.28 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.736 -0.745 . . . . 62.329999999999998 112.528 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 192' ' ' GLY . 1.7 m-20 -63.09 111.13 2.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 71.219999999999999 110.859 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.585 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -84.31 129.39 34.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 65.299999999999997 111.124 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.467 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.0 m170 -120.16 129.31 54.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 71.200000000000003 110.875 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.48 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 42.5 m-85 -114.52 133.71 55.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 74.230000000000004 110.88 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -66.14 107.09 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 74.430000000000007 110.883 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -58.38 -37.41 75.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.147 -0.479 . . . . 75.0 110.868 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.641 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 9.9 m-20 -50.2 -23.62 2.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 71.219999999999999 110.81 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -80.17 162.95 24.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 72.209999999999994 110.868 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.563 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -100.67 89.91 4.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 72.510000000000005 110.819 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.48 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 33.0 m95 -80.94 123.51 28.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 73.120000000000005 111.007 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.0 p -141.18 -175.08 4.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.225 -0.443 . . . . 75.430000000000007 111.118 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.2 18.39 18.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 65.200000000000003 111.148 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.87 -177.98 4.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 73.200000000000003 110.847 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 17.4 p -65.07 -19.15 65.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 74.109999999999999 110.814 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.02 -108.53 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.706 -0.759 . . . . 73.209999999999994 112.446 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.92 177.5 0.12 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.795 -0.717 . . . . 74.450000000000003 112.525 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 91.6 m -65.86 97.32 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.851 0.358 . . . . 75.140000000000001 111.156 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -42.11 116.81 0.87 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 75.420000000000002 110.903 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 11.8 tp -63.89 -38.46 91.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 72.200000000000003 110.964 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -49.25 -64.93 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 73.439999999999998 110.888 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 21.8 mt -55.3 -54.95 37.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.238 -0.437 . . . . 73.329999999999998 110.873 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 2.1 m -54.51 -31.75 56.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 74.430000000000007 111.082 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.31 -48.88 60.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.429 . . . . 72.340000000000003 111.169 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.487 HG21 ' HA ' ' A' ' 137' ' ' ALA . 0.6 OUTLIER -52.61 -57.85 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 72.530000000000001 111.051 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.536 ' HB2' HG13 ' A' ' 235' ' ' VAL . 2.0 t-80 -64.16 -30.21 71.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 71.349999999999994 110.889 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -62.3 -43.95 97.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 73.310000000000002 111.082 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.572 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.4 mt -70.59 -35.34 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 75.530000000000001 111.148 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.91 -44.61 40.76 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.708 -0.758 . . . . 73.450000000000003 112.533 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 185' ' ' PHE . 34.1 m-70 -67.21 -40.19 86.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.832 0.349 . . . . 72.030000000000001 110.894 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 2.7 m -62.35 -26.25 68.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 71.5 110.885 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 72.9 mt -76.66 -27.87 55.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 72.310000000000002 110.911 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 120.44 18.57 4.05 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.673 -0.775 . . . . 71.030000000000001 112.51 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 13.3 mt -82.84 159.74 22.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.795 0.331 . . . . 75.420000000000002 110.948 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -106.57 -135.23 7.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 74.239999999999995 112.477 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -127.64 143.83 51.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.83 0.348 . . . . 73.450000000000003 110.821 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 62.2 m -108.95 163.52 13.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 74.140000000000001 110.86 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.03 0.69 30.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 73.099999999999994 110.845 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.18 136.57 96.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.629 0.728 . . . . 75.400000000000006 110.836 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 -0.46 6.99 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.699 2.266 . . . . 71.230000000000004 112.346 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.15 19.57 1.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 71.540000000000006 110.956 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -91.07 129.93 37.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 72.319999999999993 111.088 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.536 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.2 t -54.11 -34.93 27.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 70.109999999999999 111.163 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 39.7 mmm -62.16 -21.14 64.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 73.439999999999998 110.885 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.532 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -56.22 142.53 67.02 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.681 0.753 . . . . 72.5 110.831 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.532 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.1 Cg_endo -69.73 -1.28 8.18 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.691 2.26 . . . . 71.319999999999993 112.343 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.8 m -95.55 140.35 30.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 71.219999999999999 111.191 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -120.32 137.14 54.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 75.120000000000005 110.854 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -154.57 132.14 11.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.071 -0.513 . . . . 74.5 110.86 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -59.65 142.85 52.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 110.93 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -158.46 128.85 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 74.409999999999997 111.185 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -51.29 134.37 27.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 72.530000000000001 110.876 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 10.8 tt -54.58 -30.13 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 71.349999999999994 111.183 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.81 -18.1 60.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 71.510000000000005 110.924 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 28.1 p -107.56 -23.31 12.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 74.439999999999998 111.115 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -68.64 146.43 53.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 73.510000000000005 110.833 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -176.28 129.58 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 73.400000000000006 110.802 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 15.1 mt -48.99 131.99 18.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 75.329999999999998 110.955 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 47.0 t -77.35 166.31 23.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 73.409999999999997 110.818 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.03 -37.99 35.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.059 -0.519 . . . . 75.319999999999993 111.074 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.31 -45.01 89.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.219 -0.446 . . . . 72.349999999999994 110.852 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -61.37 -54.8 39.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 72.439999999999998 110.875 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 2.6 mp -60.76 -37.07 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 73.430000000000007 111.052 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -68.36 -37.77 80.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 73.010000000000005 110.881 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -78.23 -51.23 5.81 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.682 -0.771 . . . . 44.509999999999998 112.456 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 6.3 tp -52.8 -33.72 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.763 0.316 . . . . 74.310000000000002 111.159 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 263' ' ' GLY . 30.8 mt-30 -87.66 -16.49 34.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 73.120000000000005 110.855 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 2.6 t -68.98 -16.24 63.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 110.856 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.13 -19.23 7.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 75.129999999999995 110.893 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . 0.45 ' HB3' ' CD2' ' A' ' 147' ' ' LEU . 31.2 m-85 -110.45 -36.67 5.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 110.971 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.638 -0.791 . . . . 51.329999999999998 112.479 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.6 p80 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.829 0.347 . . . . 70.200000000000003 110.822 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -140.59 108.95 5.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 65.5 110.881 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.433 ' CG2' ' N ' ' A' ' 115' ' ' THR . 4.7 mp -142.48 164.01 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 74.109999999999999 111.111 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.433 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -160.37 163.13 33.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 75.439999999999998 111.155 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.572 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.2 p90 -134.2 153.97 51.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.41 . . . . 73.200000000000003 110.888 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.88 110.65 5.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 74.549999999999997 110.838 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 59.5 mt -73.14 106.0 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 74.239999999999995 111.072 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -59.42 -51.03 71.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 74.230000000000004 110.933 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -138.41 166.28 24.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.319999999999993 110.884 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -116.05 154.36 30.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 75.120000000000005 110.919 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.493 ' CG2' ' HD2' ' A' ' 123' ' ' PRO . 11.0 m -102.67 137.42 19.34 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.571 0.7 . . . . 75.340000000000003 111.149 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.493 ' HD2' ' CG2' ' A' ' 122' ' ' THR . 53.3 Cg_endo -69.67 3.45 2.72 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.688 2.258 . . . . 71.120000000000005 112.362 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -87.6 -28.59 21.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 74.310000000000002 110.797 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 5.8 mtm -110.19 167.01 10.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 74.329999999999998 110.861 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -90.14 142.58 27.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 73.430000000000007 110.878 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.36 -37.07 4.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 75.030000000000001 110.898 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -82.53 -36.88 25.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 71.420000000000002 110.887 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -64.84 -32.0 73.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.148 -0.478 . . . . 64.129999999999995 110.868 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 62.4 t -64.78 -43.86 96.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 74.349999999999994 111.124 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.4 -23.27 35.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 75.340000000000003 110.926 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -75.33 -48.1 24.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 73.439999999999998 110.865 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.41 -30.67 66.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 75.450000000000003 111.088 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.3 mp -73.09 -55.58 12.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 75.310000000000002 111.112 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -48.2 -41.75 28.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.214 -0.448 . . . . 75.099999999999994 110.835 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -75.66 -31.75 59.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.213 -0.449 . . . . 74.549999999999997 110.873 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.488 ' HA ' HG21 ' A' ' 217' ' ' VAL . . . -61.9 -50.83 70.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 61.420000000000002 111.119 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.591 ' CE2' HG12 ' A' ' 220' ' ' ILE . 75.5 m-85 -66.21 -30.89 71.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 75.120000000000005 110.972 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.593 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 3.7 tt0 -63.99 -42.62 97.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 72.140000000000001 110.87 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.42 ' HB ' HG12 ' A' ' 217' ' ' VAL . 74.1 t -50.23 -24.43 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 71.400000000000006 111.088 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.419 ' CD1' HG11 ' A' ' 217' ' ' VAL . 98.1 m95 -98.1 -30.35 12.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.185 -0.461 . . . . 75.439999999999998 110.967 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 12.8 t -72.52 -14.74 61.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 70.349999999999994 110.863 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.593 ' ND2' ' O ' ' A' ' 139' ' ' GLN . 63.7 m-80 -89.32 -25.71 21.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.51 . . . . 72.530000000000001 110.914 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.0 m -94.74 2.82 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 73.420000000000002 111.132 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.513 ' C ' ' H ' ' A' ' 147' ' ' LEU . 23.6 p -154.45 142.61 14.26 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.502 0.667 . . . . 62.350000000000001 111.191 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 19.26 0.18 Allowed 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.685 2.257 . . . . 71.430000000000007 112.414 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 145' ' ' THR . 0.6 OUTLIER -74.27 -177.57 3.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 75.530000000000001 110.903 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -144.4 124.52 13.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 73.129999999999995 110.91 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 2.4 m-85 -116.79 140.2 49.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 74.310000000000002 110.815 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.5 t -136.21 145.33 45.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 73.129999999999995 110.821 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.468 ' HG3' ' N ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -93.7 144.25 25.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 74.030000000000001 110.857 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.468 ' N ' ' HG3' ' A' ' 151' ' ' LYS . 11.4 pt -150.65 130.49 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 74.319999999999993 111.127 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.1 m120 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 73.209999999999994 110.893 179.946 . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.819 0.343 . . . . 74.439999999999998 111.075 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.92 -50.87 7.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 74.439999999999998 110.92 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.463 HG12 HG21 ' A' ' 220' ' ' ILE . 2.9 mp -92.65 96.52 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 72.420000000000002 111.098 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.3 tp -87.26 110.49 20.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 75.319999999999993 110.961 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 88.2 t -88.54 119.07 35.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.112 -0.494 . . . . 75.439999999999998 111.139 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.1 p -138.38 106.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 74.510000000000005 111.125 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.432 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 34.4 m-85 -75.88 111.78 11.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 74.129999999999995 110.901 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -130.93 172.7 11.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 63.520000000000003 111.106 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.419 ' CG ' ' HB3' ' A' ' 199' ' ' GLU . 9.1 mtt180 -115.54 139.57 49.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 74.430000000000007 110.912 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.64 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 39.28 -149.05 0.11 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.773 -0.727 . . . . 74.140000000000001 112.476 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.812 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -69.4 117.02 10.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 74.510000000000005 111.125 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.43 -20.65 13.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 73.109999999999999 110.91 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.12 29.79 0.65 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.783 -0.722 . . . . 74.439999999999998 112.496 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.636 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.2 0.28 14.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.82 0.343 . . . . 75.510000000000005 110.812 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 74.1 38.73 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 75.400000000000006 110.895 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.2 -41.74 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 73.150000000000006 110.876 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.812 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.52 99.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 74.010000000000005 111.046 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.64 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -60.5 -168.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.325 -0.398 . . . . 73.549999999999997 110.865 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.15 19.88 3.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 71.239999999999995 110.907 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.563 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 53.74 -157.94 5.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 71.129999999999995 112.536 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 176' ' ' GLY . 9.9 tttt -34.58 134.43 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.339 . . . . 71.540000000000006 110.937 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.55 165.77 0.17 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.663 -0.78 . . . . 61.229999999999997 112.508 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.3 -143.45 22.84 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.734 -0.746 . . . . 73.219999999999999 112.553 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -49.66 96.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.875 0.369 . . . . 71.129999999999995 111.154 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 84.4 mt -65.96 -42.49 89.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 65.420000000000002 110.962 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -171.11 166.69 7.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.288 -0.414 . . . . 65.340000000000003 111.091 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.508 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -159.68 140.74 12.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.134 -0.485 . . . . 63.43 110.831 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.552 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -135.94 173.14 12.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 71.519999999999996 111.086 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.567 ' O ' ' HA ' ' A' ' 223' ' ' SER . 10.4 m-85 -104.66 -151.82 0.45 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 74.420000000000002 110.837 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -161.29 -81.74 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.745 -0.74 . . . . 70.420000000000002 112.531 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.87 53.92 1.17 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.639 2.226 . . . . 65.420000000000002 112.333 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.554 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -124.15 147.37 16.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.775 -0.726 . . . . 54.039999999999999 112.487 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.63 144.2 31.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 74.310000000000002 110.81 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.46 -63.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.721 -0.752 . . . . 74.219999999999999 112.506 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 189' ' ' SER . 2.2 pp -106.2 9.54 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.924 0.392 . . . . 75.519999999999996 111.133 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.554 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -70.72 171.43 44.65 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.734 -0.746 . . . . 70.420000000000002 112.45 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.43 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 44.24 20.44 0.18 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.734 -0.745 . . . . 75.230000000000004 112.476 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 192' ' ' GLY . 4.1 m-20 -64.24 108.59 1.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.776 0.322 . . . . 72.430000000000007 110.954 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.552 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -82.14 121.7 26.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 74.239999999999995 111.1 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.508 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.7 m170 -112.13 130.42 55.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 75.319999999999993 110.893 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.471 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 46.6 m-85 -115.23 136.12 53.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 71.209999999999994 110.897 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -69.29 104.03 2.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 73.109999999999999 110.827 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.434 ' HG2' HG21 ' A' ' 122' ' ' THR . 4.2 tm-20 -55.87 -37.99 69.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 73.239999999999995 110.863 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.563 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 12.7 m-20 -49.26 -22.72 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 71.209999999999994 110.836 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -81.05 161.13 24.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 73.430000000000007 110.867 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.477 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -97.95 89.83 4.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 75.120000000000005 110.919 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.471 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 28.3 m95 -81.54 123.11 28.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 73.349999999999994 110.905 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.9 p -135.56 -174.23 3.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 70.239999999999995 111.225 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.53 12.78 18.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.279 -0.419 . . . . 70.129999999999995 111.167 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -131.04 -176.0 3.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 75.540000000000006 110.897 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.2 p -51.25 -36.06 40.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.433 . . . . 74.239999999999995 110.835 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -64.08 159.64 39.95 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.704 -0.76 . . . . 70.409999999999997 112.451 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . 49.15 -173.71 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.707 -0.759 . . . . 63.240000000000002 112.597 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.7 m -85.66 93.44 8.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.76 0.314 . . . . 75.450000000000003 111.122 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -38.91 111.47 0.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 72.219999999999999 110.822 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.0 tp -60.18 -36.78 78.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 74.140000000000001 110.869 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -51.97 -62.8 1.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.462 . . . . 73.209999999999994 110.935 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 31.6 mt -57.52 -52.4 65.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 74.150000000000006 110.93 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.7 m -53.64 -38.07 63.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 63.119999999999997 111.137 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.74 -51.92 66.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 65.319999999999993 111.09 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.488 HG21 ' HA ' ' A' ' 137' ' ' ALA . 1.4 t -50.21 -58.87 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.458 . . . . 73.400000000000006 111.154 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.571 ' HB2' HG11 ' A' ' 235' ' ' VAL . 2.8 t-80 -62.86 -31.81 72.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 73.310000000000002 110.854 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -62.37 -43.29 99.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 61.350000000000001 111.121 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.591 HG12 ' CE2' ' A' ' 138' ' ' PHE . 2.4 mt -70.51 -33.43 53.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 75.510000000000005 111.093 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.92 -43.45 48.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.738 -0.744 . . . . 52.32 112.474 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.428 ' O ' ' O ' ' A' ' 185' ' ' PHE . 47.8 m-70 -68.37 -39.73 81.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.734 0.302 . . . . 74.439999999999998 110.814 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 2.0 m -62.16 -26.7 68.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 74.329999999999998 110.902 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 79.5 mt -77.25 -26.55 52.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 75.349999999999994 110.934 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 112.16 22.05 6.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.731 . . . . 54.420000000000002 112.487 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.66 146.86 25.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.9 0.381 . . . . 74.109999999999999 110.887 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -88.04 -160.12 35.4 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.731 -0.747 . . . . 73.299999999999997 112.546 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -102.57 125.97 49.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 71.219999999999999 110.872 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.4 m -80.55 162.77 24.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 71.230000000000004 110.836 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.82 -1.1 19.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 70.5 110.894 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.44 142.75 97.9 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.582 0.706 . . . . 75.540000000000006 110.88 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -4.24 13.66 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.637 2.224 . . . . 63.109999999999999 112.344 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.68 23.61 1.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 74.519999999999996 110.867 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -81.54 143.0 32.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 71.329999999999998 111.068 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.571 HG11 ' HB2' ' A' ' 218' ' ' HIS . 1.3 t -65.78 -38.91 83.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.219 -0.446 . . . . 74.150000000000006 111.146 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 83.1 mmm -68.57 -12.27 61.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 72.329999999999998 110.878 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.644 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.5 t80 -57.8 145.1 72.28 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.582 0.706 . . . . 70.439999999999998 110.892 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.644 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.8 Cg_endo -69.77 0.89 5.0 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.666 2.244 . . . . 75.430000000000007 112.372 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 24.6 m -101.72 143.91 31.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 73.129999999999995 111.101 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -123.11 138.31 54.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 74.349999999999994 110.915 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -157.13 129.61 7.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 74.219999999999999 110.854 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -59.66 145.83 43.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 74.230000000000004 110.949 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -161.21 131.27 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 65.409999999999997 111.143 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -52.72 133.67 36.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.053 -0.521 . . . . 75.109999999999999 110.924 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.2 tt -53.69 -30.19 18.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.289 -0.414 . . . . 74.219999999999999 111.151 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.84 -20.26 63.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 74.040000000000006 110.96 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 6.3 p -110.45 -21.24 12.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 64.150000000000006 111.175 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -69.4 142.13 53.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 73.140000000000001 110.905 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -176.5 133.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 72.340000000000003 110.927 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 40.0 mt -47.52 123.58 5.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 75.010000000000005 110.987 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 7.1 t -58.3 158.36 7.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 62.329999999999998 110.954 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.52 -30.49 8.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 74.540000000000006 111.07 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -72.89 -45.69 56.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 75.239999999999995 110.846 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.12 -41.26 98.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 64.409999999999997 110.845 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 42.8 mt -69.6 -43.36 80.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 75.329999999999998 111.145 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . 0.406 ' HG3' ' N ' ' A' ' 257' ' ' GLY . 0.0 OUTLIER -69.07 -28.99 67.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 74.099999999999994 110.919 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -85.06 -49.77 4.36 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.648 -0.787 . . . . 60.340000000000003 112.527 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 4.4 tp -54.22 -32.06 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.734 0.302 . . . . 74.019999999999996 111.123 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 263' ' ' GLY . 69.6 mt-30 -86.72 -17.58 33.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 74.519999999999996 110.942 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 260' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 2.4 t -67.79 -14.35 62.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 75.150000000000006 110.896 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.5 mt -121.8 -19.68 6.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 64.099999999999994 110.932 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -113.41 -35.19 5.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 74.530000000000001 110.871 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 C--O 1.229 -0.218 0 CA-C-O 119.199 -0.778 . . . . 62.420000000000002 112.471 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 14.2 p80 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.931 0.396 . . . . 72.400000000000006 110.939 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -123.77 95.23 4.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 73.310000000000002 110.892 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 115' ' ' THR . 4.8 mp -121.93 162.53 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 75.040000000000006 111.144 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.438 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -156.87 164.77 37.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 73.409999999999997 111.073 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.594 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.4 p90 -134.81 148.57 50.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 74.409999999999997 110.835 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -140.72 110.71 6.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.02 -0.536 . . . . 72.519999999999996 110.908 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 57.0 mt -73.11 104.8 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 73.200000000000003 111.049 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -56.41 -48.97 75.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 70.420000000000002 110.836 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -143.54 163.57 32.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 75.219999999999999 110.876 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -116.38 138.47 51.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 71.519999999999996 110.903 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.1 t -87.86 141.95 32.0 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.55 0.69 . . . . 74.439999999999998 111.154 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -3.77 12.69 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.638 2.226 . . . . 75.25 112.363 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -78.43 -23.3 46.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 74.140000000000001 110.93 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 12.7 mtm -116.79 166.78 11.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 72.0 110.9 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -94.46 144.01 25.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 63.310000000000002 110.867 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -45.42 -36.92 4.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 75.5 110.86 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -82.57 -36.14 26.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 72.430000000000007 110.919 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -66.99 -30.17 70.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 73.400000000000006 110.828 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 82.0 t -66.57 -46.35 86.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 74.530000000000001 111.142 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 0.4 OUTLIER -77.54 -24.72 49.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.187 -0.46 . . . . 71.430000000000007 110.796 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -73.22 -47.84 40.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 75.109999999999999 110.856 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.36 -31.42 69.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.175 -0.466 . . . . 64.439999999999998 111.122 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.3 mp -74.26 -53.46 17.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 73.25 111.102 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 131' ' ' ASP . 7.0 ptp180 -49.22 -37.2 22.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 74.120000000000005 110.806 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -76.88 -34.47 57.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 74.430000000000007 110.869 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.499 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -59.98 -48.66 80.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 72.219999999999999 111.082 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.594 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 94.1 m-85 -72.5 -22.69 61.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 72.040000000000006 110.899 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.487 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.2 OUTLIER -77.13 -5.5 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 72.409999999999997 110.89 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 84.1 t -98.74 -17.05 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 74.5 111.125 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.484 ' HA ' HG21 ' A' ' 144' ' ' VAL . 94.1 m95 -107.01 -37.03 6.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 73.299999999999997 110.906 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.78 -11.81 60.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.427 . . . . 75.230000000000004 110.88 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.602 ' N ' HD21 ' A' ' 143' ' ' ASN . 0.9 OUTLIER -94.99 -17.09 22.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 75.519999999999996 110.912 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.484 HG21 ' HA ' ' A' ' 141' ' ' TRP . 21.2 m -98.76 2.19 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 65.430000000000007 111.098 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.516 ' C ' ' H ' ' A' ' 147' ' ' LEU . 51.4 p -151.66 149.49 24.13 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.525 0.679 . . . . 64.120000000000005 111.219 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 32.01 0.19 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.698 2.265 . . . . 65.230000000000004 112.386 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.516 ' H ' ' C ' ' A' ' 145' ' ' THR . 13.2 mt -97.8 175.92 5.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 75.239999999999995 110.929 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -140.1 125.53 19.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.172 -0.467 . . . . 74.099999999999994 110.954 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.424 ' CD1' ' HB ' ' A' ' 114' ' ' ILE . 3.2 m-30 -114.39 139.88 49.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 72.239999999999995 110.864 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.1 m -134.94 149.4 50.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 65.540000000000006 110.906 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 1.8 tttt -95.58 148.22 22.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 74.530000000000001 110.883 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.413 HD13 ' CB ' ' A' ' 157' ' ' ALA . 3.6 pt -152.46 165.06 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 74.109999999999999 111.153 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 60.340000000000003 110.99 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.413 ' CB ' HD13 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.81 0.338 . . . . 73.5 111.118 . . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.5 OUTLIER -84.67 -53.12 5.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 75.420000000000002 110.846 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.493 HG12 HG21 ' A' ' 220' ' ' ILE . 2.3 mp -90.53 97.61 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 74.310000000000002 111.165 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 8.5 tp -89.29 109.3 20.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 75.25 110.875 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 95.7 t -89.06 123.49 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 71.530000000000001 111.122 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 p -142.64 107.8 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 72.319999999999993 111.144 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -77.18 109.3 10.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 74.310000000000002 110.87 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -130.56 169.76 15.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 42.200000000000003 111.09 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . 0.491 ' HG3' ' HB3' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -112.88 139.22 48.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 74.420000000000002 110.826 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.644 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 41.43 -150.87 0.2 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.667 -0.778 . . . . 64.530000000000001 112.457 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.809 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -68.04 117.93 10.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.723 0.297 . . . . 55.43 111.163 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.706 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.79 -21.56 12.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 55.310000000000002 110.906 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.08 29.54 0.61 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.738 -0.744 . . . . 62.039999999999999 112.499 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.621 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.73 -0.32 15.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.88 0.372 . . . . 71.329999999999998 110.825 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 74.76 38.67 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 74.230000000000004 110.87 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.706 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -134.29 -41.24 0.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 73.329999999999998 110.898 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.809 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 55.04 99.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 72.140000000000001 111.106 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.644 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.7 m-85 -60.73 -166.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 72.129999999999995 110.829 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.59 19.5 2.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.056 -0.52 . . . . 75.120000000000005 110.862 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.579 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.7 -157.53 6.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 62.25 112.453 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 176' ' ' GLY . 12.4 mmtm -36.7 135.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 75.310000000000002 110.917 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.76 162.85 0.15 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.7 -0.762 . . . . 74.549999999999997 112.521 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.53 -140.01 20.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.68 -0.772 . . . . 64.329999999999998 112.513 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.6 mt -49.92 93.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.819 0.342 . . . . 74.349999999999994 111.206 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -67.44 -33.34 74.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 74.409999999999997 110.944 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -178.89 169.31 1.6 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 63.350000000000001 111.06 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.501 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.3 p80 -165.28 139.43 4.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 74.200000000000003 110.855 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.579 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -137.93 173.47 11.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.267 -0.424 . . . . 72.530000000000001 111.125 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.488 ' O ' ' O ' ' A' ' 222' ' ' HIS . 10.2 m-85 -98.85 -141.98 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.006 0.432 . . . . 74.329999999999998 110.809 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -164.42 -101.13 0.15 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.736 -0.745 . . . . 73.310000000000002 112.507 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 61.42 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.66 2.24 . . . . 73.329999999999998 112.349 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.586 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.94 154.66 16.74 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.736 -0.745 . . . . 74.140000000000001 112.442 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.569 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.05 147.95 26.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.938 0.399 . . . . 63.520000000000003 110.821 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.66 -67.2 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 53.32 112.545 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.569 ' N ' ' O ' ' A' ' 189' ' ' SER . 5.2 mm -103.39 6.58 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 75.329999999999998 111.118 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.586 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -64.14 165.43 30.81 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.8 -0.714 . . . . 71.519999999999996 112.483 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 45.35 19.17 0.22 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.735 -0.745 . . . . 73.450000000000003 112.471 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 192' ' ' GLY . 0.8 OUTLIER -63.5 105.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.885 0.374 . . . . 72.510000000000005 110.846 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.579 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -81.84 131.65 35.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 72.420000000000002 111.127 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.501 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 7.7 m170 -122.82 129.77 52.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 75.299999999999997 110.884 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.568 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 34.1 m-85 -115.5 135.5 54.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.292 -0.413 . . . . 75.329999999999998 110.963 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -69.36 106.82 3.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 71.109999999999999 110.961 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.491 ' HB3' ' HG3' ' A' ' 165' ' ' ARG . 3.9 tm-20 -58.35 -37.53 75.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 75.510000000000005 110.916 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.579 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 14.9 m-20 -49.18 -23.22 1.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.506 . . . . 64.510000000000005 110.852 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.75 163.4 24.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 72.430000000000007 110.88 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.482 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.2 OUTLIER -96.9 96.35 8.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 74.519999999999996 110.855 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.568 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 34.0 m95 -87.89 123.89 33.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.475 . . . . 64.219999999999999 110.891 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.8 p -143.73 -179.13 6.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 72.010000000000005 111.127 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.24 18.64 20.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 72.439999999999998 111.128 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.85 -175.51 3.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 74.219999999999999 110.796 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 24.1 p -66.91 -18.11 65.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 64.420000000000002 110.835 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.95 -108.7 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.61 -0.805 . . . . 42.229999999999997 112.538 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.04 178.18 0.12 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.818 -0.706 . . . . 73.340000000000003 112.492 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 210' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 202' ' ' PHE . 96.3 m -66.08 97.42 0.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.338 . . . . 72.25 111.044 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -41.48 111.93 0.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 75.209999999999994 110.843 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.6 tp -58.8 -38.08 77.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 75.439999999999998 110.869 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -52.5 -64.28 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 72.420000000000002 110.845 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 19.3 mt -52.45 -56.22 16.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 75.040000000000006 110.92 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.0 m -54.87 -37.93 66.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 74.549999999999997 111.164 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.06 -48.28 79.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 72.200000000000003 111.059 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.499 HG22 ' CB ' ' A' ' 137' ' ' ALA . 2.1 t -53.84 -58.52 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 72.010000000000005 111.182 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.548 ' HB2' HG12 ' A' ' 235' ' ' VAL . 1.7 t-80 -64.78 -27.65 69.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 71.239999999999995 110.931 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -64.14 -44.77 91.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 73.109999999999999 111.074 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.54 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.6 mt -69.33 -34.54 63.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 73.120000000000005 111.16 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -52.43 -45.25 58.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.698 -0.763 . . . . 74.519999999999996 112.494 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.488 ' O ' ' O ' ' A' ' 185' ' ' PHE . 3.8 m-70 -68.49 -40.22 81.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.784 0.326 . . . . 73.420000000000002 110.847 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 29.8 p -65.39 -21.29 66.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 75.120000000000005 110.84 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 59.6 mt -79.81 -26.84 40.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 63.420000000000002 110.941 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 122.35 12.88 5.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.699 -0.762 . . . . 65.040000000000006 112.447 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 221' ' ' GLY . 11.3 mt -81.71 156.09 25.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.83 0.348 . . . . 73.109999999999999 110.933 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -99.89 -140.5 11.43 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.797 -0.716 . . . . 65.510000000000005 112.493 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -120.91 141.98 50.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.359 . . . . 74.409999999999997 110.808 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 60.9 p -99.16 163.05 12.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 75.430000000000007 110.904 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.67 1.22 21.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 62.329999999999998 110.824 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.17 132.35 73.69 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.553 0.692 . . . . 74.5 110.864 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.87 4.15 2.4 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.638 2.225 . . . . 74.150000000000006 112.321 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.01 11.12 3.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 74.030000000000001 110.884 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -88.82 150.22 23.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 73.150000000000006 111.151 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.548 HG12 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -71.73 -39.67 69.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 74.340000000000003 111.136 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 48.0 mmm -61.73 -15.12 37.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 74.140000000000001 110.861 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.608 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -56.53 144.49 63.66 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.649 0.738 . . . . 75.430000000000007 110.9 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.608 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.0 Cg_endo -69.84 -1.75 9.06 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.582 2.188 . . . . 74.430000000000007 112.313 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 22.0 m -97.88 141.07 31.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.419 . . . . 75.230000000000004 111.19 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -122.64 135.36 54.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 72.25 110.932 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -156.27 137.04 13.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 73.030000000000001 110.905 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -59.2 146.28 39.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 73.140000000000001 110.997 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -158.96 133.01 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 75.319999999999993 111.082 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -51.13 129.32 23.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 71.439999999999998 110.835 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 9.7 tt -53.84 -30.88 19.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 74.430000000000007 111.157 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -73.43 -21.15 60.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 71.519999999999996 110.926 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 69.8 p -104.05 -22.41 13.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 72.049999999999997 111.176 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -67.03 141.86 57.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 74.150000000000006 110.91 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -175.41 132.41 0.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 74.540000000000006 110.83 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 55.5 mt -49.89 122.78 7.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 75.319999999999993 110.907 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 8.6 t -65.96 167.21 10.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 73.510000000000005 110.898 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.01 -38.05 35.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 64.150000000000006 111.048 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -61.86 -49.12 77.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 65.530000000000001 110.826 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . 0.431 ' OD2' ' HB ' ' A' ' 235' ' ' VAL . 2.0 m-20 -59.25 -55.79 30.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.244 -0.435 . . . . 73.439999999999998 110.813 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 18.3 mt -59.68 -33.46 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 72.420000000000002 111.201 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -69.2 -41.06 77.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 74.019999999999996 110.874 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.84 -49.87 7.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.75 -0.738 . . . . 73.340000000000003 112.542 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.4 ' HA ' HD21 ' A' ' 226' ' ' LEU . 7.5 tp -53.08 -33.67 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.72 0.295 . . . . 75.530000000000001 111.098 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 263' ' ' GLY . 52.8 mt-30 -88.21 -16.21 33.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.485 . . . . 75.329999999999998 110.933 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.7 t -69.54 -14.16 62.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 73.200000000000003 110.826 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.99 -18.65 5.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.144 -0.48 . . . . 75.439999999999998 110.934 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -114.3 -32.88 5.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 74.349999999999994 110.896 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.369 0 CA-C-O 119.22 -0.767 . . . . 64.120000000000005 112.468 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.509 ' HA ' ' CD1' ' A' ' 147' ' ' LEU . 2.1 p80 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.876 0.369 . . . . 75.310000000000002 110.894 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -144.62 90.94 2.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 74.409999999999997 110.972 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 115' ' ' THR . 5.0 mp -121.09 162.49 19.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 75.5 111.216 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.445 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -160.09 162.71 34.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 63.119999999999997 111.102 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.594 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.1 p90 -133.4 149.71 51.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.496 . . . . 74.420000000000002 110.952 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -142.5 115.06 8.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 73.329999999999998 110.823 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 52.7 mt -75.35 103.43 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 71.409999999999997 111.128 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -57.15 -45.72 83.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 74.209999999999994 110.933 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -145.01 161.38 39.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.431 . . . . 72.030000000000001 110.914 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -115.53 134.05 55.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 74.129999999999995 110.906 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.405 HG23 ' HB2' ' A' ' 124' ' ' ASP . 2.3 t -82.41 142.05 46.32 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.55 0.691 . . . . 75.439999999999998 111.195 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.89 -5.78 17.11 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.646 2.231 . . . . 64.25 112.308 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.405 ' HB2' HG23 ' A' ' 122' ' ' THR . 40.3 m-20 -77.07 -22.15 53.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.439 . . . . 73.140000000000001 110.876 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 18.2 mtm -117.74 167.15 11.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 72.5 110.884 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -94.09 143.17 26.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 74.349999999999994 110.934 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -44.72 -35.23 2.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.226 -0.443 . . . . 74.519999999999996 110.853 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -84.26 -38.35 20.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 74.129999999999995 110.932 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -65.7 -30.02 70.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 63.240000000000002 110.783 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . 0.411 ' HA ' ' CD2' ' A' ' 212' ' ' LEU . 79.7 t -66.79 -46.78 84.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 71.200000000000003 111.07 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -77.22 -24.29 51.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 61.25 110.894 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -73.89 -47.01 41.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 64.409999999999997 110.91 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.93 -32.19 71.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 63.140000000000001 111.134 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.3 mp -74.72 -53.65 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 74.400000000000006 111.161 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.449 ' HB3' ' O ' ' A' ' 131' ' ' ASP . 6.8 ptp180 -49.18 -38.07 24.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 72.329999999999998 110.937 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -77.18 -31.93 55.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 75.450000000000003 110.916 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.527 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -61.58 -49.14 77.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 55.149999999999999 111.066 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.594 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.6 m-85 -72.82 -22.09 60.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 75.530000000000001 110.844 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.49 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.6 OUTLIER -77.4 -5.54 50.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 61.140000000000001 110.888 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.46 ' HB ' HG11 ' A' ' 217' ' ' VAL . 97.8 t -98.11 -17.21 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 73.230000000000004 111.152 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.494 ' CD1' HG13 ' A' ' 217' ' ' VAL . 95.9 m95 -106.87 -37.19 6.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 73.510000000000005 110.906 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.25 -10.84 60.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 73.129999999999995 110.815 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.591 ' N ' HD21 ' A' ' 143' ' ' ASN . 0.9 OUTLIER -97.07 -19.4 18.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 65.109999999999999 110.939 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.486 HG21 ' HA ' ' A' ' 141' ' ' TRP . 18.3 m -100.23 -2.27 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.47 . . . . 71.219999999999999 111.075 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.555 ' HB ' ' CD2' ' A' ' 147' ' ' LEU . 34.3 p -142.39 147.45 43.36 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.517 0.675 . . . . 73.230000000000004 111.212 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.79 34.72 0.21 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.649 2.233 . . . . 73.040000000000006 112.336 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.555 ' CD2' ' HB ' ' A' ' 145' ' ' THR . 3.0 mm? -104.57 166.47 10.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 70.310000000000002 110.883 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -128.99 125.69 37.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 71.230000000000004 110.926 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.403 ' CD1' ' HB ' ' A' ' 114' ' ' ILE . 3.3 m-30 -114.55 143.49 44.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 70.010000000000005 110.909 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.4 m -140.75 148.24 40.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 75.099999999999994 110.821 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.412 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 12.4 tptm -97.36 146.13 25.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 75.5 110.813 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 16.3 pt -150.31 142.85 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 73.219999999999999 111.076 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 74.329999999999998 111.007 179.801 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.825 0.345 . . . . 61.310000000000002 111.141 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.409 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.3 OUTLIER -82.51 -52.87 6.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 65.099999999999994 110.813 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 193' ' ' GLY . 2.4 mp -91.52 97.96 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 75.239999999999995 111.151 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.9 tp -88.8 110.69 21.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.176 -0.466 . . . . 73.420000000000002 110.947 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 90.6 t -88.81 119.51 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 71.239999999999995 111.16 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 p -138.82 104.52 2.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.174 -0.467 . . . . 72.120000000000005 111.238 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -70.98 110.48 5.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 64.030000000000001 110.891 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -130.32 166.38 20.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 51.409999999999997 111.054 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 21.3 ptt-85 -114.7 140.0 49.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 72.129999999999995 110.82 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.645 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 41.39 -150.85 0.2 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.761 -0.733 . . . . 71.230000000000004 112.471 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.812 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -70.21 117.33 11.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.773 0.32 . . . . 71.099999999999994 111.122 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.698 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.99 -21.09 12.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 75.129999999999995 110.778 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.29 29.4 0.66 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 73.239999999999995 112.587 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.646 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.46 0.03 15.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.78 0.324 . . . . 74.209999999999994 110.863 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 74.32 38.95 0.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 75.329999999999998 110.916 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.698 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.74 -41.02 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 72.140000000000001 110.849 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.812 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 53.44 99.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 74.019999999999996 111.098 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.645 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.9 m-85 -59.88 -168.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 75.099999999999994 110.861 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.59 19.11 3.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.195 -0.457 . . . . 74.409999999999997 110.96 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.579 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.62 -157.09 6.88 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 74.200000000000003 112.48 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -35.23 134.46 0.27 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.836 0.351 . . . . 74.219999999999999 110.89 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.45 165.44 0.15 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.659 -0.781 . . . . 70.219999999999999 112.467 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.96 -143.34 22.13 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.749 . . . . 53.420000000000002 112.447 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -49.95 97.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.869 0.366 . . . . 75.109999999999999 111.166 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.9 mt -67.75 -38.65 83.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 73.299999999999997 110.946 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -172.72 167.87 5.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 64.239999999999995 111.047 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.514 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -161.13 143.04 12.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 74.340000000000003 110.89 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.421 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -134.94 176.44 8.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.304 -0.407 . . . . 74.099999999999994 111.048 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.436 ' O ' ' O ' ' A' ' 222' ' ' HIS . 7.9 m-85 -100.77 -120.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 72.010000000000005 110.947 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.555 ' HA2' ' O ' ' A' ' 223' ' ' SER . . . 166.75 -92.74 0.1 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.715 -0.755 . . . . 75.209999999999994 112.501 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.91 55.37 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.615 2.21 . . . . 64.420000000000002 112.369 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.558 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.32 151.52 16.93 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 53.509999999999998 112.401 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.82 145.1 30.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.898 0.38 . . . . 72.209999999999994 110.82 -179.719 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.63 -65.18 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.7 -0.762 . . . . 73.109999999999999 112.37 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 189' ' ' SER . 1.9 mp -103.63 6.81 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.855 0.36 . . . . 72.340000000000003 111.126 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.558 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -66.82 170.43 32.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.782 -0.723 . . . . 71.219999999999999 112.485 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 42.66 24.74 0.26 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.722 -0.751 . . . . 74.049999999999997 112.455 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.87 102.23 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.775 0.321 . . . . 74.239999999999995 110.911 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.421 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -77.21 128.78 34.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 63.409999999999997 111.073 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.514 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 8.5 m170 -118.53 131.15 56.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 73.510000000000005 110.827 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.454 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 51.4 m-85 -115.23 134.74 54.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 75.319999999999993 110.858 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -67.57 109.07 3.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.089 -0.505 . . . . 63.43 110.802 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.55 -37.19 80.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 74.340000000000003 111.005 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.579 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 5.0 m-20 -50.41 -22.68 1.97 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 72.140000000000001 110.825 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -79.84 163.17 24.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 74.109999999999999 110.889 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.55 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -100.64 88.23 3.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 73.219999999999999 110.938 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.454 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 33.6 m95 -79.48 124.71 28.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.457 . . . . 74.329999999999998 110.944 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 22.7 p -142.6 -177.79 5.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.252 -0.431 . . . . 74.430000000000007 111.178 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.07 19.76 18.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 74.519999999999996 111.219 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.11 -175.62 3.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.914 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.9 p -68.77 -18.31 64.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 74.439999999999998 110.826 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.18 -107.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.667 -0.777 . . . . 74.200000000000003 112.515 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.42 176.87 0.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.763 -0.732 . . . . 72.129999999999995 112.428 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 94.3 m -64.89 97.37 0.22 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.757 0.313 . . . . 74.439999999999998 111.2 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -41.45 116.42 0.76 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 74.040000000000006 110.888 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . 0.411 ' CD2' ' HA ' ' A' ' 130' ' ' VAL . 8.6 tp -64.12 -38.39 90.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 72.340000000000003 110.916 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -51.97 -66.9 0.3 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 73.219999999999999 110.939 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 21.9 mt -52.84 -54.96 26.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.141 -0.482 . . . . 61.25 110.879 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 215' ' ' THR . . . . . 0.452 ' O ' ' CB ' ' A' ' 219' ' ' ALA . 5.1 m -54.8 -37.19 65.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 74.409999999999997 111.092 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.81 -50.57 64.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 75.439999999999998 111.115 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.527 HG22 ' CB ' ' A' ' 137' ' ' ALA . 1.8 t -52.42 -56.61 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 74.0 111.106 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -69.12 -26.49 64.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 63.32 110.904 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 215' ' ' THR . . . -64.83 -45.22 87.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 72.409999999999997 111.126 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.529 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 3.1 mt -67.68 -37.41 78.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.254 -0.43 . . . . 73.439999999999998 111.149 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -52.57 -46.39 58.84 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.804 -0.712 . . . . 74.5 112.428 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.436 ' O ' ' O ' ' A' ' 185' ' ' PHE . 2.5 m-70 -69.39 -38.64 78.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.332 . . . . 75.439999999999998 110.824 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.555 ' O ' ' HA2' ' A' ' 186' ' ' GLY . 0.3 OUTLIER -74.8 -9.77 58.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.005 0.431 . . . . 65.140000000000001 110.934 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.5 mt -90.1 -25.9 20.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 72.450000000000003 110.923 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 124.48 12.94 4.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.785 -0.722 . . . . 63.32 112.529 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 221' ' ' GLY . 0.2 OUTLIER -85.61 160.99 19.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.829 0.347 . . . . 73.129999999999995 110.964 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -105.89 -144.92 12.63 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.754 -0.736 . . . . 74.420000000000002 112.487 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -115.86 146.94 41.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.775 0.321 . . . . 74.5 110.862 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 37.3 m -103.08 162.56 12.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.179 -0.464 . . . . 72.209999999999994 110.846 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.2 t -107.07 1.26 24.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 72.239999999999995 110.852 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.05 141.29 94.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.6 0.714 . . . . 74.219999999999999 110.801 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 -3.36 11.79 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.634 2.222 . . . . 73.230000000000004 112.384 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.72 17.16 1.99 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 63.310000000000002 110.922 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -78.06 137.94 38.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 61.340000000000003 111.024 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.9 p -63.99 -29.59 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 71.319999999999993 111.108 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 61.2 mmm -73.81 -12.61 60.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 74.519999999999996 110.89 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.65 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -59.09 146.27 78.1 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.59 0.71 . . . . 72.040000000000006 110.831 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.65 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.8 Cg_endo -69.75 1.2 4.64 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.739 2.293 . . . . 75.219999999999999 112.33 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 53.2 m -102.89 129.02 49.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 71.549999999999997 111.152 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -110.4 136.33 49.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 74.040000000000006 110.921 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -155.69 133.86 11.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 74.329999999999998 110.851 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -59.24 147.77 34.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 74.450000000000003 110.983 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -159.64 133.24 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 75.439999999999998 111.091 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -49.94 133.26 22.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 64.420000000000002 110.768 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 8.4 tt -55.17 -30.89 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 72.329999999999998 111.063 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -77.3 -17.43 58.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 74.340000000000003 110.836 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 66.6 p -103.21 -24.43 13.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 63.210000000000001 111.195 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -65.7 144.31 56.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 72.239999999999995 110.891 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -176.8 128.65 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 74.319999999999993 110.909 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 54.7 mt -48.66 127.14 13.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 75.430000000000007 110.875 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 38.9 m -72.05 167.27 20.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.140000000000001 110.897 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.4 -38.93 60.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.089 -0.505 . . . . 75.239999999999995 111.11 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -46.67 84.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 74.340000000000003 110.868 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -61.92 -52.12 65.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.237 -0.438 . . . . 73.5 110.848 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 21.1 mt -62.99 -34.66 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 74.299999999999997 111.102 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -69.51 -40.04 77.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 74.540000000000006 110.922 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.3 -49.26 7.53 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.811 -0.709 . . . . 64.430000000000007 112.525 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 3.8 tp -53.01 -32.84 18.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.78 0.324 . . . . 74.420000000000002 111.142 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 263' ' ' GLY . 47.6 mt-30 -88.08 -17.38 31.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 64.219999999999999 110.889 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.4 t -69.17 -16.51 63.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 73.310000000000002 110.792 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.7 mt -118.81 -23.03 7.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 73.219999999999999 110.857 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . 0.47 ' HB3' ' CD2' ' A' ' 147' ' ' LEU . 27.7 m-85 -106.3 -38.33 6.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 74.329999999999998 110.951 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.32 0 CA-C-O 119.149 -0.806 . . . . 73.510000000000005 112.446 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.855 0.359 . . . . 75.239999999999995 110.905 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -128.74 92.47 3.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 75.420000000000002 110.926 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' A' ' 115' ' ' THR . 3.9 mp -121.22 165.71 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 72.430000000000007 111.078 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.424 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -159.29 160.36 35.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 72.109999999999999 111.139 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.592 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 1.9 p90 -132.33 144.32 50.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.267 -0.424 . . . . 75.129999999999995 110.994 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.23 113.34 10.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 74.430000000000007 110.842 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 63.0 mt -76.04 105.4 4.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 74.420000000000002 111.086 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -56.2 -51.28 68.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 75.010000000000005 110.971 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -141.97 166.52 24.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 62.229999999999997 110.86 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -117.07 146.22 43.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 75.430000000000007 110.923 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.404 HG23 ' HB2' ' A' ' 124' ' ' ASP . 3.5 t -93.58 142.67 25.47 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 121.634 0.73 . . . . 72.409999999999997 111.125 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.89 -1.79 9.18 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.643 2.229 . . . . 73.420000000000002 112.291 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.404 ' HB2' HG23 ' A' ' 122' ' ' THR . 15.7 m-20 -81.82 -23.07 36.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 71.010000000000005 110.887 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.424 ' HE2' ' HB2' ' A' ' 125' ' ' MET . 13.2 mtm -116.5 166.51 12.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 74.310000000000002 110.892 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -96.22 145.92 25.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 75.519999999999996 110.816 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -45.52 -34.91 3.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 75.519999999999996 110.887 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -83.29 -38.96 21.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 74.219999999999999 110.941 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -65.67 -29.77 70.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 61.140000000000001 110.812 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 79.5 t -65.79 -45.86 90.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.282 -0.417 . . . . 75.25 111.132 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.75 -23.07 42.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 71.209999999999994 110.925 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -74.83 -47.78 28.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.477 . . . . 73.140000000000001 110.924 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.39 -31.32 67.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 71.519999999999996 110.99 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.3 mp -73.87 -55.57 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.432 . . . . 71.019999999999996 111.106 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -48.67 -42.91 36.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 71.209999999999994 110.85 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -70.56 -34.46 72.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.43 . . . . 72.109999999999999 110.855 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.495 ' HA ' HG21 ' A' ' 217' ' ' VAL . . . -60.99 -50.48 73.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 72.140000000000001 111.001 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.592 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.2 m-85 -70.97 -21.82 62.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 72.209999999999994 110.94 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.574 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.5 tt0 -78.71 -5.93 54.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 75.530000000000001 110.916 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.496 ' HB ' HG11 ' A' ' 217' ' ' VAL . 95.3 t -95.59 -17.41 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 73.450000000000003 111.096 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.481 ' CD1' HG13 ' A' ' 217' ' ' VAL . 95.8 m95 -105.47 -36.73 7.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.211 -0.449 . . . . 73.340000000000003 110.896 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.98 -11.94 61.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 72.439999999999998 110.846 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.61 ' N ' HD21 ' A' ' 143' ' ' ASN . 0.9 OUTLIER -94.5 -18.57 21.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 75.129999999999995 110.909 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.478 HG21 ' HA ' ' A' ' 141' ' ' TRP . 16.9 m -98.03 2.5 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 65.219999999999999 111.189 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.516 ' C ' ' H ' ' A' ' 147' ' ' LEU . 49.9 p -151.2 149.11 23.93 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.619 0.723 . . . . 51.240000000000002 111.146 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 31.57 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.665 2.244 . . . . 64.430000000000007 112.345 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.516 ' H ' ' C ' ' A' ' 145' ' ' THR . 14.4 mt -98.46 173.41 6.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 74.329999999999998 110.895 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -137.59 127.33 25.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 75.439999999999998 110.893 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -114.47 143.8 44.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 73.219999999999999 110.851 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.2 t -138.85 147.87 43.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.12 -0.491 . . . . 72.310000000000002 110.845 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.472 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 2.6 tptm -97.42 141.84 30.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.494 . . . . 71.120000000000005 110.922 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.449 ' N ' ' HG3' ' A' ' 151' ' ' LYS . 17.2 pt -150.07 133.23 7.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 72.450000000000003 111.13 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 74.400000000000006 110.915 179.991 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.773 0.32 . . . . 73.349999999999994 111.116 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 192' ' ' GLY . 1.1 t0 -82.88 -53.03 6.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.226 -0.443 . . . . 73.530000000000001 110.799 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 193' ' ' GLY . 2.8 mp -91.06 97.91 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.26 -0.427 . . . . 71.409999999999997 111.145 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.1 tp -87.4 109.92 19.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.133 -0.485 . . . . 74.349999999999994 111.009 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 95.9 t -88.01 123.22 40.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 75.140000000000001 111.109 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 p -142.1 105.56 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 74.120000000000005 111.143 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -71.61 108.22 4.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 70.109999999999999 110.845 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.1 166.19 18.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 75.310000000000002 111.089 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 -114.25 137.25 52.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 75.409999999999997 110.831 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.657 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.3 -154.92 0.2 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.761 -0.733 . . . . 73.349999999999994 112.458 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.815 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.64 116.96 7.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 75.340000000000003 111.094 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.704 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.96 -22.69 12.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 73.329999999999998 110.855 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.76 28.86 0.55 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.675 -0.774 . . . . 64.040000000000006 112.527 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.624 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.43 0.14 15.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.778 0.323 . . . . 72.409999999999997 110.837 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 74.04 39.08 0.53 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 71.310000000000002 110.927 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.704 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.38 -40.94 0.8 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 72.409999999999997 110.861 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.815 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 53.8 99.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 55.310000000000002 111.131 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.657 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.1 m-85 -60.63 -168.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 72.420000000000002 110.903 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.75 19.03 3.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 75.209999999999994 110.837 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.573 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.5 -158.1 6.1 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.766 -0.73 . . . . 70.430000000000007 112.492 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 176' ' ' GLY . 2.1 ttmm -34.25 134.22 0.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.351 . . . . 74.299999999999997 110.828 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.4 165.55 0.15 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.826 -0.702 . . . . 73.439999999999998 112.524 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.37 -144.01 23.16 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.81 -0.71 . . . . 73.319999999999993 112.533 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -49.51 97.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 75.150000000000006 111.152 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.9 mt -67.04 -41.88 85.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 73.349999999999994 110.953 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -169.52 169.34 8.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 71.150000000000006 111.138 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.486 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -163.24 143.54 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 75.450000000000003 110.884 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.461 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -135.44 174.79 10.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 71.230000000000004 111.159 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.534 ' O ' ' O ' ' A' ' 222' ' ' HIS . 94.9 m-85 -96.93 -122.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 72.349999999999994 110.905 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 223' ' ' SER . . . 172.21 -98.34 0.13 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.721 -0.752 . . . . 42.030000000000001 112.431 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 57.13 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.686 2.257 . . . . 72.310000000000002 112.321 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.554 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -122.16 153.12 16.82 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.772 -0.728 . . . . 71.129999999999995 112.557 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.63 145.92 29.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 63.210000000000001 110.841 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.67 -64.71 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.742 -0.742 . . . . 72.120000000000005 112.554 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 189' ' ' SER . 1.2 mp -104.88 6.18 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.805 0.336 . . . . 71.200000000000003 111.099 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.554 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -64.66 168.14 27.96 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.702 -0.761 . . . . 71.209999999999994 112.486 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 42.77 23.2 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.757 -0.735 . . . . 72.439999999999998 112.43 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 192' ' ' GLY . 0.9 OUTLIER -66.52 99.34 0.57 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.806 0.336 . . . . 75.109999999999999 110.856 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.461 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -74.0 132.87 42.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 73.329999999999998 111.069 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.486 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.8 m170 -123.41 131.27 53.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 71.299999999999997 110.923 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.435 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 40.9 m-85 -115.5 135.07 54.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 73.25 110.866 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -68.03 107.48 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 70.439999999999998 110.827 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.54 -35.93 75.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 71.0 110.904 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.573 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 15.6 m-20 -51.47 -21.59 2.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 73.129999999999995 110.83 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -81.39 163.29 22.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 73.219999999999999 110.893 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.562 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -101.75 85.96 2.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 75.120000000000005 110.917 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.435 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 30.9 m95 -76.62 123.58 26.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.107 -0.497 . . . . 72.519999999999996 110.862 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 35.8 p -141.54 -178.01 5.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 73.25 111.151 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.45 20.94 17.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 75.129999999999995 111.129 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -127.81 -172.97 2.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.432 . . . . 74.409999999999997 110.903 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.1 p -73.14 -18.84 61.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 73.299999999999997 110.856 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -61.24 -104.91 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.751 -0.737 . . . . 72.310000000000002 112.427 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.562 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -51.77 176.18 0.1 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 70.420000000000002 112.462 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 73.1 m -65.9 97.62 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 73.109999999999999 111.14 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -41.88 116.46 0.8 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 73.420000000000002 110.885 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.0 tp -65.44 -36.74 84.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 74.340000000000003 110.945 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -51.88 -64.85 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 73.150000000000006 110.87 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 15.1 mt -56.47 -52.98 62.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.22 -0.445 . . . . 72.430000000000007 110.911 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 8.0 m -53.69 -38.01 63.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 70.540000000000006 111.184 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.97 -50.89 68.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 52.340000000000003 111.14 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.496 HG11 ' HB ' ' A' ' 140' ' ' VAL . 0.3 OUTLIER -52.16 -57.58 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 74.299999999999997 111.17 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.603 ' HB2' HG13 ' A' ' 235' ' ' VAL . 4.3 t-80 -65.29 -29.09 69.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.112 -0.494 . . . . 72.010000000000005 110.891 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -64.42 -46.66 82.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 63.439999999999998 111.059 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.582 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.4 mt -69.2 -35.5 68.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.285 -0.416 . . . . 75.319999999999993 111.126 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -51.98 -46.34 55.68 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.845 -0.693 . . . . 60.520000000000003 112.396 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.534 ' O ' ' O ' ' A' ' 185' ' ' PHE . 3.0 m-70 -69.54 -40.11 77.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.835 0.35 . . . . 74.540000000000006 110.824 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.477 ' O ' ' HA2' ' A' ' 186' ' ' GLY . 0.0 OUTLIER -72.23 -11.37 60.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.17 -0.468 . . . . 73.450000000000003 110.881 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . 0.4 ' HG ' HG23 ' A' ' 220' ' ' ILE . 21.4 mt -88.88 -25.11 22.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 75.439999999999998 110.872 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 122.66 11.19 5.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.741 . . . . 73.109999999999999 112.515 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 221' ' ' GLY . 0.2 OUTLIER -88.52 152.4 21.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.37 . . . . 74.340000000000003 110.891 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -98.02 -141.25 12.02 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.788 -0.72 . . . . 75.439999999999998 112.52 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.95 141.94 46.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.846 0.355 . . . . 74.310000000000002 110.844 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' A' ' 234' ' ' ALA . 49.4 m -92.23 160.55 15.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 74.310000000000002 110.801 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.2 t -109.68 9.75 24.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 74.010000000000005 110.874 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . 0.41 ' O ' ' CD1' ' A' ' 237' ' ' PHE . 0.1 OUTLIER -80.95 143.32 53.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.562 0.696 . . . . 62.140000000000001 110.929 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -3.87 12.92 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.765 2.31 . . . . 72.109999999999999 112.289 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.27 30.8 1.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 72.430000000000007 110.836 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' A' ' 229' ' ' SER . . . -92.59 145.54 24.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 62.340000000000003 111.162 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.603 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.5 t -65.46 -42.2 92.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 75.319999999999993 111.226 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 54.0 mmm -64.74 -14.66 59.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 73.420000000000002 110.902 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.653 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.0 t80 -57.72 146.24 66.95 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.621 0.724 . . . . 71.540000000000006 110.874 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.653 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.1 Cg_endo -69.77 1.0 4.83 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.662 2.241 . . . . 71.319999999999993 112.42 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 38.6 m -102.17 130.0 48.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 74.140000000000001 111.144 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -113.78 135.85 53.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 74.109999999999999 110.922 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -155.51 137.39 14.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 71.239999999999995 110.825 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -62.0 145.21 53.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 65.120000000000005 110.939 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -160.29 133.31 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.5 . . . . 71.409999999999997 111.077 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -57.47 131.32 49.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 74.129999999999995 110.903 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 16.7 tt -53.2 -30.25 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 74.510000000000005 111.161 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.95 -21.85 65.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 73.219999999999999 110.859 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.8 p -110.84 -19.63 12.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 72.010000000000005 111.173 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -67.44 142.78 56.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 73.540000000000006 110.911 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -176.32 132.36 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 73.209999999999994 110.919 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 43.9 mt -49.26 132.64 19.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.452 . . . . 74.219999999999999 110.999 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 32.9 t -74.15 172.8 11.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 64.25 110.853 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.1 -37.61 72.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.115 -0.493 . . . . 73.439999999999998 111.112 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -64.33 -50.56 67.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 60.340000000000003 110.928 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -59.06 -50.91 72.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 73.299999999999997 110.917 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 20.5 mt -63.46 -34.07 65.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 75.239999999999995 111.214 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -69.65 -40.19 76.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 75.040000000000006 110.872 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.65 -50.0 7.52 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.731 -0.747 . . . . 74.329999999999998 112.486 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 3.8 tp -53.5 -33.63 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.299 . . . . 72.540000000000006 111.061 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 263' ' ' GLY . 70.8 mt-30 -88.16 -16.1 34.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 75.239999999999995 110.903 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.5 t -69.23 -15.25 63.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 61.049999999999997 110.849 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.6 mt -122.83 -18.61 6.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.085 -0.507 . . . . 75.230000000000004 110.915 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -113.77 -33.9 5.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 75.409999999999997 110.931 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.362 0 CA-C-O 119.155 -0.803 . . . . 61.149999999999999 112.481 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.556 ' HA ' ' CD1' ' A' ' 147' ' ' LEU . 1.8 p80 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.779 0.323 . . . . 74.239999999999995 110.897 . . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -146.21 92.87 2.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.204 -0.453 . . . . 73.510000000000005 110.93 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 115' ' ' THR . 4.9 mp -122.66 162.61 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 75.409999999999997 111.086 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.429 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.4 OUTLIER -158.66 163.32 37.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 72.200000000000003 111.18 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.608 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.7 p90 -133.68 148.29 51.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.239 -0.437 . . . . 74.319999999999993 110.915 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.413 ' HB3' ' CD1' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -140.37 112.61 7.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 74.099999999999994 110.912 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.2 mt -74.16 105.31 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 73.099999999999994 111.172 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -56.59 -45.96 81.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 72.299999999999997 110.81 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.413 ' N ' HD21 ' A' ' 120' ' ' ASN . 0.1 OUTLIER -150.1 169.12 22.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 75.109999999999999 110.872 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -117.09 157.83 25.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 73.239999999999995 110.916 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.95 146.7 34.02 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.634 0.73 . . . . 74.209999999999994 111.204 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 -2.49 10.29 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.711 2.274 . . . . 72.030000000000001 112.25 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -83.64 -25.82 30.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.314 -0.403 . . . . 72.230000000000004 110.936 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 125' ' ' MET . . . . . 0.402 ' HE2' ' CZ ' ' A' ' 163' ' ' PHE . 6.9 mtm -114.66 164.14 14.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 72.140000000000001 110.77 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.43 143.76 27.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 71.140000000000001 110.974 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -45.09 -37.05 3.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.443 . . . . 75.209999999999994 110.836 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -82.92 -36.11 25.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 75.549999999999997 110.792 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -67.69 -29.46 68.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 71.019999999999996 110.871 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.9 t -66.56 -46.58 85.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.219 -0.446 . . . . 75.409999999999997 111.148 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 10.1 t0 -77.13 -25.82 52.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 65.129999999999995 110.866 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -72.72 -49.26 32.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 72.109999999999999 110.931 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.44 -30.42 68.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 75.200000000000003 111.09 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.2 mp -74.64 -53.77 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 72.140000000000001 111.128 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.445 ' HB3' ' O ' ' A' ' 131' ' ' ASP . 7.2 ptp180 -49.45 -35.4 19.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 71.200000000000003 110.911 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -78.85 -34.1 45.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 74.109999999999999 110.873 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.467 ' HA ' HG21 ' A' ' 217' ' ' VAL . . . -61.07 -49.16 78.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 72.010000000000005 111.059 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.608 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 89.4 m-85 -70.39 -23.54 62.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.419 . . . . 74.439999999999998 110.966 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.464 ' O ' ' HB3' ' A' ' 143' ' ' ASN . 0.2 OUTLIER -75.4 -15.11 60.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 72.120000000000005 110.936 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 93.6 t -85.03 -19.62 8.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.459 . . . . 74.329999999999998 111.147 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.439 ' CD1' HG13 ' A' ' 217' ' ' VAL . 96.9 m95 -104.74 -27.0 12.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 74.510000000000005 110.916 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.63 -7.59 59.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 73.129999999999995 110.846 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 139' ' ' GLN . 0.1 OUTLIER -99.15 -18.39 17.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 73.140000000000001 110.867 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.9 m -100.14 -7.9 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 73.519999999999996 111.139 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.514 ' C ' ' H ' ' A' ' 147' ' ' LEU . 32.5 p -141.97 147.21 43.75 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.642 0.734 . . . . 74.230000000000004 111.096 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 32.43 0.19 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.718 2.279 . . . . 74.540000000000006 112.27 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.556 ' CD1' ' HA ' ' A' ' 112' ' ' HIS . 3.8 mm? -94.49 170.07 9.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.307 -0.406 . . . . 74.129999999999995 111.004 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.24 126.35 29.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 74.519999999999996 110.92 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -117.53 144.04 45.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 74.450000000000003 110.796 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.1 t -137.66 153.03 49.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 74.030000000000001 110.844 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 10.7 tttt -103.37 146.31 28.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 75.420000000000002 110.928 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 24.7 pt -152.12 143.89 15.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 71.409999999999997 111.167 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.3 m120 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 71.540000000000006 110.829 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.733 0.301 . . . . 74.209999999999994 111.077 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.412 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.7 OUTLIER -86.63 -52.82 5.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 70.439999999999998 110.795 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.461 HG12 HG21 ' A' ' 220' ' ' ILE . 2.6 mp -90.4 95.86 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 73.129999999999995 111.042 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.413 ' CD1' ' HB3' ' A' ' 117' ' ' ARG . 8.4 tp -86.75 108.92 18.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 74.219999999999999 110.865 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 96.7 t -87.85 120.02 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 74.150000000000006 111.142 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 p -138.72 104.31 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 63.049999999999997 111.169 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.403 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 35.5 m-85 -73.73 106.49 5.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 75.150000000000006 110.926 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.03 164.13 23.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 75.219999999999999 111.103 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -110.87 140.72 45.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 74.540000000000006 110.885 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.677 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.67 -151.56 0.31 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.732 -0.747 . . . . 34.210000000000001 112.542 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.812 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -68.74 119.24 12.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.79 0.329 . . . . 74.510000000000005 111.084 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.705 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -111.17 -21.55 11.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 74.030000000000001 110.842 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.16 30.67 0.56 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.724 -0.751 . . . . 54.009999999999998 112.466 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.634 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -114.26 0.23 14.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.87 0.367 . . . . 74.239999999999995 110.835 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 74.13 38.91 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 75.040000000000006 110.796 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.705 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -134.71 -41.04 0.77 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.164 -0.471 . . . . 73.409999999999997 110.842 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.812 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 52.94 100.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 63.43 111.153 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.677 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.6 m-85 -60.72 -169.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 73.420000000000002 110.883 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . 0.438 ' OD2' ' HA3' ' A' ' 179' ' ' GLY . 40.9 p30 -134.07 18.92 3.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 73.219999999999999 110.945 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.565 ' HA2' ' CB ' ' A' ' 200' ' ' ASP . . . 57.81 -162.12 9.43 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.743 -0.741 . . . . 73.420000000000002 112.519 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -35.3 136.94 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 74.400000000000006 110.963 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.76 155.56 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.734 -0.746 . . . . 73.510000000000005 112.469 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . 0.438 ' HA3' ' OD2' ' A' ' 175' ' ' ASP . . . 86.04 -142.68 19.22 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.647 -0.787 . . . . 73.019999999999996 112.366 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.0 mt -48.68 98.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.81 0.338 . . . . 72.420000000000002 111.213 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 33.8 mt -71.4 -42.96 67.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 74.129999999999995 110.952 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -170.03 154.35 5.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 73.140000000000001 111.145 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.486 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.1 p80 -148.36 141.65 25.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 74.230000000000004 110.857 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.577 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -137.97 172.78 12.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 54.450000000000003 111.145 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 223' ' ' SER . 37.5 m-85 -102.85 -149.65 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 73.439999999999998 110.853 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -162.66 -86.6 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.84 -0.695 . . . . 73.010000000000005 112.593 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 55.8 1.31 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.661 2.241 . . . . 70.219999999999999 112.346 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.572 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -124.31 150.39 17.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.79 -0.719 . . . . 63.439999999999998 112.427 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.46 147.28 27.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 74.109999999999999 110.884 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.17 -64.73 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.715 -0.755 . . . . 65.219999999999999 112.525 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.537 ' N ' ' O ' ' A' ' 189' ' ' SER . 21.9 pt -105.81 7.69 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.873 0.368 . . . . 74.430000000000007 111.112 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.572 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -67.55 168.04 39.81 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.777 -0.725 . . . . 73.299999999999997 112.502 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 46.35 18.41 0.32 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.743 -0.741 . . . . 73.200000000000003 112.523 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.09 108.72 1.61 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.881 0.372 . . . . 73.120000000000005 110.789 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.577 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -83.32 127.69 33.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 111.114 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.486 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.2 m170 -118.37 127.0 53.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 73.420000000000002 110.866 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.522 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 37.9 m-85 -111.09 132.04 54.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 73.450000000000003 110.848 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -65.08 107.75 1.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 72.349999999999994 110.902 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . 0.408 ' O ' ' CD ' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -58.72 -38.41 78.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.187 -0.461 . . . . 75.540000000000006 110.905 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.565 ' CB ' ' HA2' ' A' ' 176' ' ' GLY . 19.3 m-20 -49.92 -21.32 1.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 63.030000000000001 110.835 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -81.31 164.39 22.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 73.230000000000004 110.903 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.484 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.4 OUTLIER -100.94 89.75 3.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 75.549999999999997 110.862 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.522 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 31.1 m95 -81.87 122.33 27.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 73.540000000000006 110.904 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.8 p -137.35 -175.27 4.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 75.299999999999997 111.147 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.35 15.68 19.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 74.420000000000002 111.138 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -129.73 -174.81 3.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 72.109999999999999 110.917 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.7 p -54.79 -34.91 63.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 73.310000000000002 110.855 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -65.8 162.54 41.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.759 -0.734 . . . . 62.119999999999997 112.483 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . 48.65 -172.38 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.748 . . . . 61.409999999999997 112.571 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 29.8 m -87.3 93.53 9.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.85 0.357 . . . . 71.430000000000007 111.125 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -40.06 110.85 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 55.420000000000002 110.921 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.28 -40.86 78.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 70.150000000000006 110.948 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -48.23 -64.27 0.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 74.450000000000003 110.923 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 17.4 mt -55.81 -52.3 64.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.135 -0.484 . . . . 70.519999999999996 110.865 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.12 -37.31 64.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 75.450000000000003 111.134 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.8 -51.57 64.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 73.310000000000002 111.04 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.467 HG21 ' HA ' ' A' ' 137' ' ' ALA . 0.9 OUTLIER -49.96 -57.5 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 72.049999999999997 111.106 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.523 ' HB2' HG12 ' A' ' 235' ' ' VAL . 3.6 t-80 -66.32 -29.37 69.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.278 -0.419 . . . . 73.409999999999997 110.9 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.76 98.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 75.109999999999999 111.069 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.583 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.2 mt -71.57 -35.0 54.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.263 -0.426 . . . . 71.430000000000007 111.232 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.45 -43.34 44.5 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.623 -0.798 . . . . 75.299999999999997 112.495 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 185' ' ' PHE . 32.7 m-70 -69.27 -39.9 78.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.797 0.332 . . . . 71.209999999999994 110.86 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 3.4 m -62.54 -27.03 68.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 50.229999999999997 110.807 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 74.2 mt -75.72 -27.39 58.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.244 -0.435 . . . . 71.409999999999997 110.988 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 118.0 16.16 5.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.691 -0.766 . . . . 71.430000000000007 112.521 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 29.3 mt -80.78 155.06 26.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.874 0.369 . . . . 73.409999999999997 110.856 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -98.43 -137.09 9.56 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.7 -0.762 . . . . 60.229999999999997 112.513 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 1.1 m170 -125.34 149.78 47.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.861 0.362 . . . . 72.310000000000002 110.848 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 67.7 m -110.87 163.88 13.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 75.040000000000006 110.886 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.66 -3.01 25.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 63.140000000000001 110.892 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.75 137.23 92.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.598 0.713 . . . . 71.420000000000002 110.872 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -3.86 12.91 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.694 2.262 . . . . 72.239999999999995 112.311 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.21 3.07 3.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 74.129999999999995 110.852 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -74.98 128.51 35.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 73.349999999999994 111.109 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -55.33 -34.53 33.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 74.010000000000005 111.187 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.439 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 41.9 mmm -62.21 -21.18 64.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 74.010000000000005 110.937 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.531 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -56.72 142.65 71.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.582 0.706 . . . . 73.409999999999997 110.895 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.531 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.9 Cg_endo -69.74 -2.24 9.82 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.647 2.231 . . . . 73.140000000000001 112.382 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 42.1 m -93.7 143.14 26.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 64.129999999999995 111.066 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -123.68 140.48 52.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 74.030000000000001 110.918 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.32 128.01 3.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 73.420000000000002 110.917 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -54.01 144.55 18.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 73.219999999999999 110.94 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.1 m -158.27 130.78 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 72.099999999999994 111.223 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -52.33 133.01 34.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 74.400000000000006 110.925 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 9.2 tt -53.57 -29.46 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 72.209999999999994 111.171 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.16 -21.12 63.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 64.109999999999999 110.909 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 44.3 p -109.95 -20.66 12.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 75.530000000000001 111.201 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -72.47 130.69 41.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 75.439999999999998 110.863 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -166.87 137.33 3.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.482 . . . . 74.239999999999995 110.877 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 64.5 mt -49.36 124.19 8.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.247 -0.433 . . . . 74.319999999999993 110.881 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 8.4 t -70.26 166.62 19.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 74.299999999999997 110.87 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.63 -40.75 40.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 73.140000000000001 111.063 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.8 -45.76 93.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 75.329999999999998 110.948 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . 0.417 ' OD2' ' HB ' ' A' ' 235' ' ' VAL . 5.2 m-20 -62.99 -54.62 35.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.11 -0.496 . . . . 71.549999999999997 110.827 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 18.7 mt -61.87 -28.08 43.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 75.299999999999997 111.144 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -75.26 -41.47 57.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 74.010000000000005 110.848 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.92 -50.46 6.92 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.732 -0.746 . . . . 64.219999999999999 112.491 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 3.3 tp -54.55 -32.9 25.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.748 0.308 . . . . 73.409999999999997 111.097 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.457 ' O ' ' N ' ' A' ' 263' ' ' GLY . 36.8 mt-30 -87.84 -16.78 33.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 75.409999999999997 110.885 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.5 t -68.21 -15.51 63.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 74.150000000000006 110.783 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 5.8 mt -120.34 -20.68 7.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 75.450000000000003 110.917 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . 0.524 ' CD1' HD11 ' A' ' 147' ' ' LEU . 34.8 m-85 -111.56 -36.45 5.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 72.030000000000001 110.991 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.355 0 CA-C-O 119.147 -0.807 . . . . 54.399999999999999 112.555 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.7 p80 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.853 0.359 . . . . 72.510000000000005 110.861 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -137.9 103.26 4.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.472 . . . . 75.0 110.948 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 115' ' ' THR . 5.4 mp -132.2 160.66 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 72.519999999999996 111.156 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.44 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.4 OUTLIER -157.98 164.46 36.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.227 -0.442 . . . . 75.299999999999997 111.059 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.607 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.9 p90 -134.53 149.14 50.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 72.219999999999999 110.938 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -142.44 113.84 7.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 75.129999999999995 110.943 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 48.4 mt -74.87 106.24 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 74.439999999999998 111.075 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -59.41 -47.03 87.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 75.340000000000003 110.932 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -142.71 161.84 37.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 72.530000000000001 110.96 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -117.4 146.75 43.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.454 . . . . 71.439999999999998 110.926 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.1 t -93.39 141.28 23.74 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.536 0.684 . . . . 65.409999999999997 111.167 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -1.66 8.87 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.732 2.288 . . . . 62.439999999999998 112.289 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.11 -30.26 31.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.268 -0.424 . . . . 74.219999999999999 110.868 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 8.1 mtm -108.06 163.63 12.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 74.319999999999993 110.918 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -95.02 146.42 24.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 71.239999999999995 110.842 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.33 -32.52 3.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 71.319999999999993 110.919 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -83.73 -38.94 20.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 74.340000000000003 110.917 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -66.0 -30.26 70.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 64.129999999999995 110.853 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.2 -47.01 89.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 74.010000000000005 111.158 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.12 -24.1 47.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 74.329999999999998 110.806 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -73.12 -47.02 47.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 72.439999999999998 110.887 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -72.31 -31.21 65.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 75.129999999999995 111.065 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.3 mp -73.93 -54.15 15.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 75.540000000000006 111.148 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -48.88 -43.03 38.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 73.25 110.812 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -70.79 -34.64 71.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 74.439999999999998 110.939 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.497 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -60.07 -49.36 77.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 74.129999999999995 111.128 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.607 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.8 m-85 -72.68 -22.19 60.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 73.400000000000006 110.883 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.529 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.6 tt0 -78.0 -6.34 54.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.068 -0.514 . . . . 72.450000000000003 110.927 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.405 ' HB ' HG13 ' A' ' 217' ' ' VAL . 99.1 t -97.65 -16.93 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 72.420000000000002 111.056 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.48 ' HA ' HG21 ' A' ' 144' ' ' VAL . 89.9 m95 -106.33 -37.74 6.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 75.230000000000004 110.921 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.18 -12.54 61.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 73.25 110.831 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.606 ' N ' HD21 ' A' ' 143' ' ' ASN . 0.9 OUTLIER -93.6 -19.47 21.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 74.409999999999997 110.866 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.48 HG21 ' HA ' ' A' ' 141' ' ' TRP . 17.8 m -98.91 3.19 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 74.129999999999995 111.214 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.518 ' C ' ' H ' ' A' ' 147' ' ' LEU . 23.4 p -149.46 145.04 18.53 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.603 0.716 . . . . 75.25 111.097 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.75 29.96 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.711 2.274 . . . . 73.430000000000007 112.344 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.518 ' H ' ' C ' ' A' ' 145' ' ' THR . 5.0 mp -96.88 176.91 5.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 72.239999999999995 110.94 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -137.51 126.58 24.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 72.519999999999996 110.923 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -112.76 145.29 40.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 73.530000000000001 110.88 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.1 t -139.34 155.2 47.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 72.450000000000003 110.789 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.5 OUTLIER -106.02 141.0 38.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 73.549999999999997 110.836 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 20.5 pt -150.82 144.74 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 60.439999999999998 111.056 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 55.32 110.892 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.763 0.316 . . . . 74.200000000000003 111.144 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.3 OUTLIER -84.61 -51.07 7.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 73.25 110.85 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.488 HG12 HG21 ' A' ' 220' ' ' ILE . 2.0 mp -92.85 97.41 7.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 74.329999999999998 111.18 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.5 tp -88.58 109.56 20.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 72.340000000000003 110.873 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 85.8 t -87.49 123.39 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 74.299999999999997 111.225 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 p -142.2 106.11 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 71.510000000000005 111.125 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -73.18 107.59 5.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 74.450000000000003 110.913 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.5 164.26 23.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 74.209999999999994 111.093 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.82 138.26 48.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 74.219999999999999 110.902 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.662 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 41.83 -154.16 0.12 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.793 -0.718 . . . . 64.030000000000001 112.402 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.813 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.41 117.06 7.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 51.310000000000002 111.025 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.691 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -109.5 -22.34 12.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.25 -0.432 . . . . 71.439999999999998 110.818 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.01 29.68 0.55 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.746 -0.74 . . . . 72.439999999999998 112.534 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.639 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.97 0.18 14.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.861 0.362 . . . . 75.430000000000007 110.859 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 73.96 39.54 0.51 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 74.230000000000004 110.901 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.691 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.16 -41.53 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 73.450000000000003 110.851 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.813 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.26 99.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 72.150000000000006 111.058 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.662 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.1 m-85 -59.73 -169.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.279 -0.418 . . . . 65.420000000000002 110.842 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.68 19.41 3.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 74.129999999999995 110.884 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.563 ' HA2' ' CB ' ' A' ' 200' ' ' ASP . . . 55.26 -162.72 4.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.707 -0.759 . . . . 72.230000000000004 112.517 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 176' ' ' GLY . 1.7 ptpp? -33.42 136.0 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 71.420000000000002 110.904 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 61.02 160.84 0.1 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.74 -0.743 . . . . 62.0 112.552 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.06 -141.41 20.0 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.817 -0.706 . . . . 73.239999999999995 112.444 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.6 97.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.861 0.362 . . . . 74.200000000000003 111.103 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.63 -36.97 79.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 71.450000000000003 110.868 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -174.08 169.96 3.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 71.310000000000002 111.097 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.488 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.3 p80 -163.79 142.12 7.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 73.340000000000003 110.867 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.562 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -136.28 173.37 11.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.299 -0.409 . . . . 65.209999999999994 111.174 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.544 ' O ' ' O ' ' A' ' 222' ' ' HIS . 16.7 m-85 -98.69 -141.15 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 71.040000000000006 110.774 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -174.89 -81.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.799 -0.715 . . . . 64.530000000000001 112.541 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 47.46 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.706 2.271 . . . . 75.420000000000002 112.369 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.547 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -119.71 147.47 18.1 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.71 -0.757 . . . . 72.439999999999998 112.508 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.88 144.96 30.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.347 . . . . 74.049999999999997 110.816 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.56 -64.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.725 -0.75 . . . . 64.530000000000001 112.481 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 189' ' ' SER . 14.6 tt -104.43 8.84 9.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 74.349999999999994 111.183 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.547 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -70.76 174.21 40.0 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.672 -0.775 . . . . 63.450000000000003 112.467 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 223' ' ' SER . . . 42.76 23.19 0.18 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 71.549999999999997 112.486 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 192' ' ' GLY . 1.9 m-20 -65.49 101.2 0.56 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.903 0.383 . . . . 74.209999999999994 110.917 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.562 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -74.72 130.36 39.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 75.209999999999994 111.124 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.488 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.2 m170 -121.05 130.19 53.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 71.129999999999995 110.837 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.523 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 47.6 m-85 -114.91 133.7 55.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 73.129999999999995 110.847 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -64.72 112.84 3.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 72.549999999999997 110.823 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -68.2 -18.99 64.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 73.209999999999994 110.961 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.563 ' CB ' ' HA2' ' A' ' 176' ' ' GLY . 14.4 m-20 -68.89 -8.57 45.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 74.030000000000001 110.841 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -97.27 162.17 13.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 75.519999999999996 110.891 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.503 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.2 OUTLIER -95.94 94.18 7.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 75.400000000000006 110.942 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.523 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 45.4 m95 -82.95 124.69 30.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 73.219999999999999 110.926 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 36.0 p -145.97 -177.6 5.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 72.329999999999998 111.159 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.59 21.08 17.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 73.450000000000003 111.192 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -128.13 -177.72 4.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 73.540000000000006 110.875 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.7 t -67.59 -19.22 65.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 53.409999999999997 110.864 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.29 -104.82 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.769 -0.729 . . . . 72.120000000000005 112.45 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.24 177.98 0.14 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.782 -0.723 . . . . 64.319999999999993 112.437 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 95.9 m -67.79 97.22 0.62 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.721 0.295 . . . . 74.109999999999999 111.127 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -41.06 116.31 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 72.099999999999994 110.853 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.9 tp -63.26 -39.4 94.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.46 . . . . 74.200000000000003 110.873 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -50.46 -65.29 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 70.230000000000004 110.879 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 15.4 mt -54.02 -55.43 27.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.478 . . . . 74.319999999999993 110.897 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 2.6 m -55.67 -32.22 63.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 111.119 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.31 -48.04 62.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.428 . . . . 71.349999999999994 111.027 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.497 HG22 ' CB ' ' A' ' 137' ' ' ALA . 2.0 t -54.06 -58.44 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 73.540000000000006 111.196 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.492 ' HB2' HG11 ' A' ' 235' ' ' VAL . 1.9 t-80 -64.0 -28.8 70.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 73.219999999999999 110.819 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -62.9 -45.66 91.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 65.25 111.162 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.544 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.6 mt -68.19 -33.95 63.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 74.439999999999998 111.12 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -52.43 -43.13 58.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.834 -0.698 . . . . 51.030000000000001 112.505 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.544 ' O ' ' O ' ' A' ' 185' ' ' PHE . 41.1 m-70 -70.32 -41.36 73.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.815 0.341 . . . . 71.340000000000003 110.833 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 29.5 p -64.95 -20.35 66.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 73.209999999999994 110.903 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 36.5 mt -81.64 -25.79 35.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.134 -0.485 . . . . 75.140000000000001 110.902 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 120.55 11.7 6.49 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.774 -0.726 . . . . 54.100000000000001 112.487 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.415 HD23 HD12 ' A' ' 258' ' ' ILE . 12.4 mt -76.95 158.88 30.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.364 . . . . 65.420000000000002 110.967 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -104.71 -134.49 8.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.806 -0.711 . . . . 63.549999999999997 112.499 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.423 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.7 OUTLIER -129.5 145.1 51.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.338 . . . . 75.319999999999993 110.866 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 27.4 t -108.45 165.56 11.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 72.0 110.811 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.93 -2.99 22.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.495 . . . . 61.340000000000003 110.902 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.2 136.51 95.5 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.579 0.704 . . . . 73.150000000000006 110.845 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -0.44 6.87 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.706 2.271 . . . . 75.519999999999996 112.422 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.81 15.52 1.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 73.310000000000002 110.889 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -84.74 133.48 34.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.269 -0.423 . . . . 75.409999999999997 111.19 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.492 HG11 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -56.78 -37.8 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 74.150000000000006 111.145 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.423 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 47.1 mmm -59.73 -23.21 63.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 74.230000000000004 110.889 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.532 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.7 t80 -54.39 142.72 49.22 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.68 0.753 . . . . 75.329999999999998 110.861 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.532 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.7 Cg_endo -69.69 -1.21 8.02 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.667 2.245 . . . . 74.430000000000007 112.387 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 50.0 m -93.9 141.72 28.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 111.129 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -122.74 141.52 51.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.269 -0.423 . . . . 63.25 110.928 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -161.02 138.79 9.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.494 . . . . 75.439999999999998 110.87 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -62.43 146.67 50.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 75.129999999999995 110.971 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -160.88 132.1 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 75.230000000000004 111.095 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -50.46 133.21 24.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 74.439999999999998 110.902 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 6.4 tt -54.7 -30.39 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 72.340000000000003 111.147 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -75.36 -18.39 59.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 54.32 110.906 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 43.4 p -107.63 -20.25 13.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 73.209999999999994 111.105 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.456 ' C ' ' HG3' ' A' ' 249' ' ' ARG . 10.4 t80 -72.65 120.54 18.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 73.400000000000006 110.886 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.456 ' HG3' ' C ' ' A' ' 248' ' ' PHE . 16.1 mtt180 -152.42 141.92 21.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 75.409999999999997 110.854 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 45.4 mt -59.0 123.44 16.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 75.340000000000003 110.895 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 15.8 m -67.11 162.48 22.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 72.0 110.937 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -48.18 -36.2 13.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 74.340000000000003 111.133 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.04 -47.87 75.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 72.140000000000001 110.837 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -60.45 -51.79 67.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 74.239999999999995 110.824 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 20.6 mt -62.49 -33.48 59.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 75.129999999999995 111.236 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -71.26 -39.81 71.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 75.150000000000006 110.916 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.85 -51.23 7.19 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 73.109999999999999 112.467 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . 0.415 HD12 HD23 ' A' ' 226' ' ' LEU . 2.8 tp -52.65 -35.05 20.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 75.010000000000005 111.198 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 263' ' ' GLY . 71.2 mt-30 -87.02 -16.49 35.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 75.430000000000007 110.929 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.7 t -69.63 -13.98 62.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 73.109999999999999 110.875 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.5 mt -123.72 -17.74 6.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 63.25 110.908 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -115.04 -33.39 5.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 64.329999999999998 110.904 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.289 0 CA-C-O 119.034 -0.87 . . . . 74.25 112.517 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 8.6 p80 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.802 0.334 . . . . 75.150000000000006 110.905 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -139.04 108.9 6.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 74.140000000000001 110.976 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 149' ' ' PHE . 4.6 mp -142.93 162.97 17.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 74.030000000000001 111.172 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.421 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -159.67 163.46 34.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 75.540000000000006 111.136 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.605 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 1.5 p90 -133.13 151.43 51.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 72.340000000000003 110.889 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.434 ' HB3' ' CD1' ' A' ' 160' ' ' LEU . 4.7 tmt_? -141.87 112.66 7.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 75.120000000000005 110.856 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.4 mt -74.4 106.23 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 72.510000000000005 111.125 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -59.14 -48.49 81.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 75.200000000000003 110.858 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . 0.463 HD22 ' N ' ' A' ' 163' ' ' PHE . 0.2 OUTLIER -146.33 171.84 14.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 64.340000000000003 110.818 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -119.72 151.85 38.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 64.230000000000004 110.91 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.514 ' C ' ' H ' ' A' ' 124' ' ' ASP . 36.9 m -103.53 136.17 19.26 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.573 0.702 . . . . 75.010000000000005 111.095 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.468 ' HD2' HG22 ' A' ' 122' ' ' THR . 54.7 Cg_endo -69.72 32.6 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.657 2.238 . . . . 73.519999999999996 112.431 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 122' ' ' THR . 1.6 m-20 -113.99 -23.75 9.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 75.239999999999995 110.851 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.6 166.82 11.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 110.848 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -87.96 141.46 28.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 72.540000000000006 110.931 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.05 -33.5 3.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 74.310000000000002 110.93 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -84.82 -38.64 19.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 74.120000000000005 110.895 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -64.29 -32.87 74.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.177 -0.465 . . . . 62.329999999999998 110.814 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 78.1 t -63.78 -44.99 98.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 54.530000000000001 111.148 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.77 -23.2 39.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 64.549999999999997 110.871 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -76.08 -46.86 26.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 73.420000000000002 110.939 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -72.04 -30.23 64.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 75.329999999999998 111.088 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.3 mp -73.49 -55.62 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 65.150000000000006 111.172 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -48.09 -40.97 24.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 74.310000000000002 110.904 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -76.13 -32.42 59.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 74.129999999999995 110.919 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.505 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -61.23 -49.98 74.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 63.140000000000001 111.09 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.605 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 80.3 m-85 -68.38 -31.14 70.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 72.540000000000006 110.851 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.567 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 3.4 tt0 -63.42 -44.69 93.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 65.319999999999993 110.944 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.424 ' HB ' HG11 ' A' ' 217' ' ' VAL . 55.0 t -49.21 -25.2 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 73.030000000000001 111.146 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.453 ' CD1' HG13 ' A' ' 217' ' ' VAL . 97.8 m95 -98.17 -28.9 13.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 74.200000000000003 110.91 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 p -74.49 -13.32 60.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 73.340000000000003 110.982 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.567 ' ND2' ' O ' ' A' ' 139' ' ' GLN . 57.7 m-20 -91.88 -24.7 19.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.085 -0.507 . . . . 44.130000000000003 110.978 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.7 m -94.86 2.7 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 75.120000000000005 111.222 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.519 ' C ' ' H ' ' A' ' 147' ' ' LEU . 27.4 p -154.71 141.49 13.34 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.611 0.719 . . . . 63.119999999999997 111.152 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 28.33 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.691 2.26 . . . . 74.230000000000004 112.269 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.519 ' H ' ' C ' ' A' ' 145' ' ' THR . 0.4 OUTLIER -84.1 -178.0 6.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.257 -0.429 . . . . 75.319999999999993 110.925 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -142.56 125.8 16.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 75.420000000000002 110.863 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 3.5 m-85 -117.94 137.49 52.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 71.329999999999998 110.847 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 53.9 m -132.34 139.46 48.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.075 -0.511 . . . . 74.230000000000004 110.796 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.3 OUTLIER -91.9 146.48 23.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.059 -0.519 . . . . 71.120000000000005 110.808 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 6.3 pt -150.22 168.13 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 74.510000000000005 111.117 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 75.239999999999995 110.87 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.761 0.315 . . . . 75.420000000000002 111.058 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.8 OUTLIER -86.9 -50.56 6.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 65.150000000000006 110.864 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.473 HG12 HG21 ' A' ' 220' ' ' ILE . 2.6 mp -94.55 97.33 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 74.450000000000003 111.146 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.434 ' CD1' ' HB3' ' A' ' 117' ' ' ARG . 9.2 tp -87.57 110.25 20.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.242 -0.435 . . . . 75.319999999999993 110.93 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.4 t -88.33 117.33 31.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 75.540000000000006 111.075 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.16 102.43 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 74.430000000000007 111.017 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.463 ' N ' HD22 ' A' ' 120' ' ' ASN . 47.0 m-85 -70.49 110.8 5.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.047 -0.524 . . . . 71.420000000000002 110.85 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.54 166.75 20.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 61.039999999999999 111.035 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -114.65 138.57 50.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 74.310000000000002 110.879 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.659 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.89 -154.83 0.16 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.764 -0.731 . . . . 54.140000000000001 112.434 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.816 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.85 116.55 7.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 71.319999999999993 111.098 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.704 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.73 -23.04 11.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.417 . . . . 74.239999999999995 110.878 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.95 29.58 0.51 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.732 . . . . 44.140000000000001 112.488 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.622 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.06 0.39 14.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 74.0 110.85 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 73.93 39.2 0.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 75.140000000000001 110.941 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.704 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -134.55 -41.23 0.78 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 72.219999999999999 110.884 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.816 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.18 99.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 73.430000000000007 111.163 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.659 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -60.3 -168.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 61.329999999999998 110.798 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.33 18.54 3.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 63.200000000000003 110.876 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.581 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.84 -155.64 11.54 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.688 -0.768 . . . . 65.549999999999997 112.509 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -37.5 135.42 0.57 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.803 0.335 . . . . 73.430000000000007 110.902 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.0 164.75 0.1 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.727 -0.749 . . . . 71.239999999999995 112.453 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.86 -142.75 21.83 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.789 -0.72 . . . . 73.230000000000004 112.455 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.32 96.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.785 0.326 . . . . 64.310000000000002 111.099 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 66.7 mt -66.53 -40.44 89.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.306 -0.407 . . . . 73.209999999999994 110.888 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -171.65 168.54 6.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 74.540000000000006 111.061 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.491 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -161.93 140.83 9.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 75.310000000000002 110.854 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.555 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -136.51 173.57 11.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 74.439999999999998 111.013 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 223' ' ' SER . 37.8 m-85 -104.0 -149.91 0.41 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 62.329999999999998 110.869 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -163.78 -81.92 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.754 -0.736 . . . . 52.130000000000003 112.511 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 53.9 1.13 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.689 2.259 . . . . 73.129999999999995 112.351 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.558 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -124.83 147.96 16.63 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.753 -0.737 . . . . 55.329999999999998 112.524 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.9 143.92 32.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 74.450000000000003 110.82 -179.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.5 -63.26 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.733 -0.746 . . . . 73.150000000000006 112.497 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 189' ' ' SER . 4.2 mt -105.4 7.93 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.892 0.377 . . . . 74.329999999999998 111.113 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.558 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -69.78 171.81 40.86 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.77 -0.729 . . . . 74.400000000000006 112.511 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 44.0 19.93 0.14 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 64.120000000000005 112.523 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 192' ' ' GLY . 1.9 m-20 -63.83 107.96 1.34 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.801 0.334 . . . . 74.329999999999998 110.908 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.555 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -82.14 126.16 31.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 73.120000000000005 111.086 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.4 m170 -116.67 130.74 56.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 110.851 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.524 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 46.8 m-85 -115.7 133.71 55.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 75.299999999999997 110.893 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -66.76 109.86 3.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.163 -0.471 . . . . 75.409999999999997 110.814 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -60.36 -37.88 82.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 74.219999999999999 110.82 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.581 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 5.9 m-20 -50.05 -22.15 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 74.109999999999999 110.815 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -81.32 160.67 24.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 75.150000000000006 110.919 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.516 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -98.21 93.43 6.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 73.450000000000003 110.96 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.524 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 34.0 m95 -83.65 123.02 29.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 74.219999999999999 110.95 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.2 p -140.92 -176.25 4.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 74.209999999999994 111.073 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.37 18.11 19.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 73.25 111.147 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.43 -175.82 3.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 74.450000000000003 110.878 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.9 p -67.06 -18.73 65.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 65.299999999999997 110.842 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.95 -108.54 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.788 -0.72 . . . . 73.230000000000004 112.491 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.92 177.52 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.741 -0.742 . . . . 65.299999999999997 112.519 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 97.0 m -65.95 97.74 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 75.129999999999995 111.123 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -41.26 113.38 0.39 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 75.530000000000001 110.855 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 43.1 tp -62.26 -34.47 76.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.263 -0.426 . . . . 74.510000000000005 110.939 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -54.92 -62.05 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 72.150000000000006 110.904 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 12.9 mt -57.18 -53.78 54.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 74.5 110.919 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 2.2 m -54.76 -34.93 63.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 72.349999999999994 111.074 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.38 -49.49 66.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.414 . . . . 64.329999999999998 111.021 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.505 HG22 ' CB ' ' A' ' 137' ' ' ALA . 2.0 t -52.08 -58.77 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 73.319999999999993 111.165 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.529 ' HB2' HG11 ' A' ' 235' ' ' VAL . 2.6 t-80 -62.94 -31.55 72.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 75.219999999999999 110.854 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.14 99.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 51.32 111.062 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.592 HG12 ' CE2' ' A' ' 138' ' ' PHE . 2.5 mt -70.97 -33.46 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 75.409999999999997 111.06 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.05 -43.29 49.68 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.769 -0.729 . . . . 74.140000000000001 112.485 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.436 ' O ' ' O ' ' A' ' 185' ' ' PHE . 50.7 m-70 -68.83 -39.61 79.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.733 0.301 . . . . 71.310000000000002 110.846 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 2.8 m -62.22 -26.66 68.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 73.400000000000006 110.891 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 28.8 mt -77.57 -25.71 50.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 54.32 110.924 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 114.01 14.61 9.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.766 -0.73 . . . . 53.130000000000003 112.53 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 13.3 mt -79.27 148.12 32.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 74.549999999999997 110.924 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -93.95 -160.37 34.73 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.816 -0.707 . . . . 72.209999999999994 112.448 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -103.07 149.2 24.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 73.129999999999995 110.821 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 229' ' ' SER . . . . . 0.404 ' OG ' ' HB2' ' A' ' 236' ' ' MET . 2.5 p -111.53 164.41 13.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.165 -0.471 . . . . 72.319999999999993 110.824 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.43 -0.58 25.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 73.340000000000003 110.913 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.23 132.82 93.38 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.52 0.676 . . . . 74.519999999999996 110.899 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.82 4.95 1.91 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.662 2.241 . . . . 63.32 112.283 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.9 13.46 2.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 63.5 110.925 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -82.51 149.54 27.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 74.099999999999994 111.086 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.529 HG11 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -71.46 -40.07 71.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 75.439999999999998 111.16 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.404 ' HB2' ' OG ' ' A' ' 229' ' ' SER . 38.7 mmm -64.32 -18.97 65.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.515 . . . . 73.349999999999994 110.846 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.595 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.1 t80 -49.26 143.97 8.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.728 0.775 . . . . 65.439999999999998 110.881 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.595 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.8 Cg_endo -69.78 -0.76 7.4 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.709 2.272 . . . . 71.340000000000003 112.388 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 18.6 m -100.16 146.71 26.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 72.040000000000006 111.156 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -125.45 137.22 53.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.203 -0.453 . . . . 73.099999999999994 110.978 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -153.89 139.71 18.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 74.140000000000001 110.849 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -65.24 144.41 57.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 73.430000000000007 110.923 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -162.18 133.98 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.109 -0.496 . . . . 74.219999999999999 111.11 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -60.71 134.34 56.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 75.010000000000005 110.83 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 17.1 tt -52.91 -31.06 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.452 . . . . 74.450000000000003 111.081 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -21.25 64.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 74.340000000000003 110.933 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.9 p -115.95 -6.99 12.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 64.450000000000003 111.213 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . 0.419 ' C ' ' HG3' ' A' ' 249' ' ' ARG . 8.9 t80 -88.05 115.45 25.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 74.049999999999997 110.933 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . 0.419 ' HG3' ' C ' ' A' ' 248' ' ' PHE . 0.1 OUTLIER -144.73 139.72 28.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 74.519999999999996 110.885 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 26.3 mt -53.54 123.42 12.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 72.540000000000006 110.932 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 10.0 p -59.67 160.0 7.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 74.439999999999998 110.833 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -48.8 -33.28 10.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 74.010000000000005 111.208 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -67.14 -44.16 80.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 74.420000000000002 110.845 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.77 -49.51 70.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 74.019999999999996 110.873 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 34.3 mt -63.63 -36.33 76.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 74.140000000000001 111.184 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -70.26 -38.63 75.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 72.099999999999994 110.868 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.37 -50.66 6.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 61.409999999999997 112.458 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 3.3 tp -52.21 -34.82 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 73.219999999999999 111.182 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.404 ' O ' ' N ' ' A' ' 263' ' ' GLY . 66.7 mt-30 -86.48 -17.29 34.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.156 -0.475 . . . . 71.019999999999996 110.889 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.1 t -69.85 -13.62 62.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 55.210000000000001 110.862 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.8 mt -123.81 -18.15 6.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.167 -0.469 . . . . 74.530000000000001 110.95 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -114.85 -33.9 5.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 75.519999999999996 110.888 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 119.105 -0.83 . . . . 45.310000000000002 112.472 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.9 p80 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.831 0.348 . . . . 72.439999999999998 110.86 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -141.34 101.53 4.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 74.109999999999999 110.898 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.43 ' CG2' ' N ' ' A' ' 115' ' ' THR . 4.7 mp -134.73 162.9 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 74.400000000000006 111.152 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.43 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.5 OUTLIER -158.68 161.26 37.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 64.400000000000006 111.109 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.625 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.7 p90 -132.86 148.79 52.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 72.430000000000007 110.92 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.407 ' HB3' ' CD1' ' A' ' 160' ' ' LEU . 4.1 tmt_? -142.67 113.89 7.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.504 . . . . 74.209999999999994 110.956 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.6 mt -74.59 105.29 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 75.129999999999995 111.166 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -58.8 -48.98 79.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 75.319999999999993 110.813 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -140.66 162.63 34.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 64.099999999999994 110.884 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -117.15 142.95 46.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 64.129999999999995 110.895 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.489 ' CG2' ' HD2' ' A' ' 123' ' ' PRO . 24.5 m -94.92 137.51 22.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.632 0.729 . . . . 72.129999999999995 111.134 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.489 ' HD2' ' CG2' ' A' ' 122' ' ' THR . 52.8 Cg_endo -69.82 7.77 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.659 2.239 . . . . 74.400000000000006 112.283 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 122' ' ' THR . 1.6 m-20 -84.89 -29.42 25.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 64.010000000000005 110.849 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.73 166.56 11.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 74.340000000000003 110.899 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -88.93 145.75 25.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.287 -0.415 . . . . 72.200000000000003 110.891 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.1 -34.86 6.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 75.120000000000005 110.943 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -82.38 -37.3 25.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 74.430000000000007 110.886 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -64.58 -32.8 74.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 75.209999999999994 110.839 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 77.9 t -63.43 -47.25 92.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 73.329999999999998 111.078 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.03 -23.45 48.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.101 -0.499 . . . . 73.010000000000005 110.879 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -75.71 -47.23 27.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 74.349999999999994 110.972 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.12 -32.91 71.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 72.239999999999995 111.165 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.3 mp -72.1 -55.07 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 74.439999999999998 111.158 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 139' ' ' GLN . 6.1 ttt180 -48.93 -42.26 36.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 110.932 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -34.76 70.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 74.140000000000001 110.896 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.502 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -60.36 -49.35 77.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 74.329999999999998 111.165 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.625 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.4 m-85 -72.72 -21.84 60.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 74.219999999999999 110.84 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.52 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 3.1 tt0 -77.48 -6.38 53.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 72.519999999999996 110.824 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.2 t -97.71 -16.96 6.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.288 -0.414 . . . . 65.120000000000005 111.212 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.483 ' HA ' HG21 ' A' ' 144' ' ' VAL . 89.2 m95 -105.41 -38.08 6.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 73.420000000000002 110.886 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.8 -12.68 61.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 71.109999999999999 110.876 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.591 ' N ' HD21 ' A' ' 143' ' ' ASN . 1.0 OUTLIER -93.97 -19.58 20.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.511 . . . . 74.25 110.916 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.483 HG21 ' HA ' ' A' ' 141' ' ' TRP . 18.5 m -97.1 1.65 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 74.329999999999998 111.083 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.516 ' C ' ' H ' ' A' ' 147' ' ' LEU . 52.2 p -151.93 147.57 20.14 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.583 0.706 . . . . 74.310000000000002 111.152 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 31.91 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.667 2.245 . . . . 73.239999999999995 112.318 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.516 ' H ' ' C ' ' A' ' 145' ' ' THR . 19.5 mt -95.65 173.83 7.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 70.430000000000007 110.884 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -136.28 126.2 25.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 75.219999999999999 110.882 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.404 ' CD1' ' HB ' ' A' ' 114' ' ' ILE . 3.7 m-30 -114.46 145.96 41.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.405 . . . . 74.109999999999999 110.91 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.8 t -139.44 153.33 47.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 72.329999999999998 110.847 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 1.4 tttt -104.37 142.79 33.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.129 -0.487 . . . . 71.510000000000005 110.897 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 16.4 pt -152.56 159.26 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 71.349999999999994 111.089 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.3 m120 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 74.099999999999994 110.883 179.952 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.809 0.338 . . . . 74.209999999999994 111.06 . . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.4 OUTLIER -84.86 -51.4 6.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 72.329999999999998 110.835 179.932 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.417 HG12 HG21 ' A' ' 220' ' ' ILE . 2.7 mp -92.51 97.3 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 73.340000000000003 111.121 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.407 ' CD1' ' HB3' ' A' ' 117' ' ' ARG . 7.8 tp -88.42 109.13 19.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 74.129999999999995 110.984 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 84.5 t -85.71 121.1 36.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 74.409999999999997 111.089 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.2 p -140.5 103.67 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 73.540000000000006 111.175 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -71.17 110.16 5.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.445 . . . . 71.409999999999997 110.89 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.94 165.83 21.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 74.519999999999996 111.064 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.02 136.9 52.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.151 -0.477 . . . . 73.209999999999994 110.862 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.656 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.43 -155.87 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.758 . . . . 72.549999999999997 112.508 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.81 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.02 116.44 6.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.786 0.327 . . . . 72.439999999999998 111.084 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.694 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.08 -22.44 12.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 71.030000000000001 110.792 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.34 29.51 0.54 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.722 -0.751 . . . . 72.420000000000002 112.521 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.631 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.13 0.45 14.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 74.450000000000003 110.885 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 73.63 39.63 0.55 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 74.129999999999995 110.931 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.694 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.97 -41.65 0.74 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.07 -0.514 . . . . 72.530000000000001 110.839 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.81 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.52 99.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 72.310000000000002 111.097 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.656 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.9 m-85 -60.2 -168.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 74.420000000000002 110.84 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.16 19.03 3.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.029 -0.532 . . . . 74.120000000000005 110.85 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.566 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.34 -157.75 6.1 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 43.0 112.464 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 176' ' ' GLY . 12.0 mmtp -34.64 134.71 0.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 73.439999999999998 110.959 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.0 165.14 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.741 -0.742 . . . . 63.329999999999998 112.459 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.37 -143.35 21.78 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.732 -0.747 . . . . 73.349999999999994 112.472 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.0 97.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.881 0.372 . . . . 70.349999999999994 111.092 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 21.9 mt -66.99 -40.57 87.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 75.420000000000002 110.903 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -171.12 170.21 6.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 71.239999999999995 111.117 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.497 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -164.11 141.17 6.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 74.099999999999994 110.889 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.569 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -135.76 173.64 11.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.307 -0.406 . . . . 71.409999999999997 111.07 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' ' 223' ' ' SER . 47.9 m-85 -101.11 -145.81 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 74.540000000000006 110.829 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -165.09 -86.17 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.768 -0.729 . . . . 64.230000000000004 112.507 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.65 55.6 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.683 2.255 . . . . 74.109999999999999 112.357 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.524 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.53 147.66 16.67 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.718 -0.754 . . . . 72.420000000000002 112.476 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -102.98 142.36 34.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.997 0.427 . . . . 73.049999999999997 110.759 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 64.14 -62.4 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.75 -0.738 . . . . 73.400000000000006 112.526 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.524 ' N ' ' O ' ' A' ' 189' ' ' SER . 2.3 pp -105.99 10.07 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.897 0.38 . . . . 75.120000000000005 111.213 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.524 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -69.47 170.62 42.07 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.797 -0.716 . . . . 74.439999999999998 112.548 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 42.19 22.82 0.13 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.711 -0.757 . . . . 72.299999999999997 112.442 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 192' ' ' GLY . 3.2 m-20 -64.48 103.62 0.68 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.792 0.33 . . . . 73.340000000000003 110.896 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.569 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -76.71 125.75 29.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 74.519999999999996 111.046 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.497 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.3 m170 -115.88 129.68 56.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.116 -0.493 . . . . 75.549999999999997 110.865 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.511 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 50.3 m-85 -113.88 134.26 54.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 75.400000000000006 110.827 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -66.87 108.89 2.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 72.329999999999998 110.923 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -60.09 -37.4 79.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.420000000000002 110.792 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.566 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 11.3 m-20 -50.51 -22.1 1.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 74.109999999999999 110.811 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -81.36 160.83 24.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.165 -0.47 . . . . 61.229999999999997 110.925 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.533 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -98.73 91.47 5.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 75.530000000000001 110.894 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.511 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 33.1 m95 -81.56 124.25 29.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 75.439999999999998 110.896 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.9 p -141.81 -170.45 3.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 75.049999999999997 111.208 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.87 17.42 15.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 70.140000000000001 111.176 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.74 -178.73 4.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 74.010000000000005 110.81 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.4 t -63.41 -19.62 64.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 75.340000000000003 110.926 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.89 -107.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.813 -0.708 . . . . 74.319999999999993 112.386 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.5 177.9 0.18 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.719 -0.753 . . . . 72.120000000000005 112.48 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 95.7 m -68.47 96.86 0.72 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.793 0.33 . . . . 74.310000000000002 111.076 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -40.11 118.46 0.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 73.319999999999993 110.858 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 19.3 tp -64.87 -36.24 83.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 74.030000000000001 110.888 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -54.17 -64.93 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 75.099999999999994 110.915 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 21.0 mt -53.21 -55.32 25.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 75.109999999999999 110.935 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 2.6 m -55.27 -34.87 64.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 62.210000000000001 111.141 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.1 -47.86 72.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 73.219999999999999 111.092 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.502 HG22 ' CB ' ' A' ' 137' ' ' ALA . 2.0 t -53.58 -60.11 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 72.310000000000002 111.079 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.501 ' HB2' HG11 ' A' ' 235' ' ' VAL . 1.8 t-80 -63.31 -28.52 70.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.353 -0.385 . . . . 72.450000000000003 110.8 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -62.96 -44.37 96.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 111.115 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.531 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.5 mt -68.99 -35.24 68.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 75.439999999999998 111.155 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.21 -44.46 51.79 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.806 -0.711 . . . . 72.540000000000006 112.442 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 185' ' ' PHE . 19.6 m-70 -68.03 -38.52 82.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.792 0.329 . . . . 60.420000000000002 110.804 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 13.0 m -64.05 -24.79 67.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 72.409999999999997 110.831 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 44.3 mt -76.29 -27.06 56.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 73.219999999999999 110.952 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 121.03 10.56 6.76 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.722 -0.751 . . . . 44.509999999999998 112.454 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 8.5 mt -76.61 137.7 39.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.864 0.364 . . . . 73.329999999999998 110.939 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -76.8 -135.14 0.64 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.68 -0.771 . . . . 71.310000000000002 112.484 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -131.82 135.31 46.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 71.340000000000003 110.799 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 98.4 p -94.94 160.88 14.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 64.049999999999997 110.863 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.22 0.55 25.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 72.120000000000005 110.835 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.68 132.0 85.64 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.558 0.694 . . . . 72.25 110.831 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 0.93 4.92 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.714 2.276 . . . . 64.030000000000001 112.361 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.8 pttt -136.73 14.06 3.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 73.420000000000002 110.855 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -92.53 128.2 38.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 71.150000000000006 111.088 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.501 HG11 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -52.81 -37.95 26.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 75.430000000000007 111.092 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 70.8 mmm -58.94 -23.69 61.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.263 -0.426 . . . . 75.439999999999998 110.836 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.587 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.5 t80 -52.67 143.36 29.35 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.669 0.747 . . . . 64.540000000000006 110.841 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.587 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.5 Cg_endo -69.78 -9.88 27.19 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.654 2.236 . . . . 65.140000000000001 112.252 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 23.3 m -85.42 150.22 24.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 71.329999999999998 111.157 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -124.78 139.1 54.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.109999999999999 110.919 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -155.26 121.35 5.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.052 -0.522 . . . . 70.430000000000007 110.922 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -52.65 146.78 9.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 73.200000000000003 110.929 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -161.03 130.84 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 75.230000000000004 111.171 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -48.43 138.39 10.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 73.019999999999996 110.865 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 7.6 tt -56.26 -31.28 32.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 74.299999999999997 111.085 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.72 -15.81 58.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 73.019999999999996 110.89 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 33.4 p -105.3 -23.38 12.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 71.310000000000002 111.11 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -70.82 142.27 51.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 71.129999999999995 110.784 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -177.71 132.13 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 73.239999999999995 110.821 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 34.1 mt -49.52 122.8 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 75.310000000000002 110.932 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 32.1 t -64.13 157.81 24.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 73.099999999999994 110.895 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -46.36 -34.77 4.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 75.5 111.106 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.74 -46.26 69.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.325 -0.398 . . . . 75.420000000000002 110.787 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -60.37 -49.94 75.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 72.510000000000005 110.811 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 24.8 mt -66.31 -31.5 53.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.129 -0.487 . . . . 75.129999999999995 111.17 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.63 -39.41 70.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.505 . . . . 65.409999999999997 110.912 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.63 -52.01 6.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 74.310000000000002 112.396 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 7.6 tp -52.55 -34.08 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 75.219999999999999 111.086 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 263' ' ' GLY . 85.8 mt-30 -84.38 -19.2 33.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.115 -0.493 . . . . 75.010000000000005 110.933 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 10.7 t -68.65 -12.91 61.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.454 . . . . 60.310000000000002 110.872 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.1 mt -122.36 -18.1 6.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 74.420000000000002 110.927 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -115.63 -36.12 4.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 73.409999999999997 110.948 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 119.145 -0.808 . . . . 73.230000000000004 112.473 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.6 p80 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.788 0.328 . . . . 72.150000000000006 110.893 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -142.02 91.85 2.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 73.140000000000001 110.876 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 115' ' ' THR . 4.6 mp -122.49 163.94 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 74.129999999999995 111.107 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.438 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.5 OUTLIER -157.88 161.94 38.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 75.549999999999997 111.199 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.573 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 1.4 p90 -136.32 148.7 48.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 70.310000000000002 110.902 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.403 ' HB3' HD13 ' A' ' 160' ' ' LEU . 3.7 tmm_? -141.83 120.01 12.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 71.450000000000003 110.864 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.7 mt -79.82 104.13 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 74.299999999999997 111.192 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -56.44 -46.42 80.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 64.349999999999994 110.932 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -146.82 165.5 29.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 72.420000000000002 110.912 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -114.95 142.09 47.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 71.0 110.944 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.589 HG23 ' HB2' ' A' ' 124' ' ' ASP . 1.0 OUTLIER -88.97 137.99 29.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.602 0.715 . . . . 75.0 111.102 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.71 33.61 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.656 2.237 . . . . 72.319999999999993 112.435 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.589 ' HB2' HG23 ' A' ' 122' ' ' THR . 1.8 m-20 -123.36 -17.44 6.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 71.209999999999994 110.915 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 6.6 mtm -117.28 165.55 13.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 71.519999999999996 110.926 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -92.86 140.57 29.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 71.140000000000001 110.861 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.9 ptt-85 -44.6 -36.91 3.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 74.319999999999993 110.813 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -84.01 -39.27 19.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 71.450000000000003 110.879 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -63.51 -32.1 73.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.103 -0.499 . . . . 75.200000000000003 110.906 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.48 -44.46 94.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.18 -0.464 . . . . 75.349999999999994 111.13 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.45 -22.42 38.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 64.310000000000002 110.924 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -76.15 -47.89 22.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 74.25 110.854 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -72.52 -30.65 64.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 74.109999999999999 111.026 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.2 mp -71.95 -55.37 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.404 . . . . 74.140000000000001 111.124 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -48.0 -40.38 22.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 73.450000000000003 110.919 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -76.47 -33.37 58.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 72.219999999999999 110.873 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.52 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -60.27 -50.93 71.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 62.32 111.137 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.63 ' CZ ' HG12 ' A' ' 220' ' ' ILE . 79.0 m-85 -67.01 -33.55 75.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 74.120000000000005 110.889 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.583 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.8 tt0 -61.92 -43.84 98.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 73.299999999999997 110.905 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.43 ' HB ' HG11 ' A' ' 217' ' ' VAL . 73.2 t -49.56 -25.05 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.163 -0.471 . . . . 71.230000000000004 111.125 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.444 ' CD1' HG13 ' A' ' 217' ' ' VAL . 97.1 m95 -98.33 -29.66 13.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 74.450000000000003 110.891 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 t -73.4 -15.1 61.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.417 . . . . 74.329999999999998 110.896 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.583 ' ND2' ' O ' ' A' ' 139' ' ' GLN . 63.9 m-80 -89.36 -26.14 21.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 75.540000000000006 110.795 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.7 m -93.61 3.71 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 74.519999999999996 111.104 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.519 ' C ' ' H ' ' A' ' 147' ' ' LEU . 59.5 p -153.69 143.1 14.97 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 121.596 0.712 . . . . 73.349999999999994 111.09 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 30.36 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.683 2.256 . . . . 54.049999999999997 112.328 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.519 ' H ' ' C ' ' A' ' 145' ' ' THR . 20.1 mt -91.93 173.1 8.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 70.329999999999998 110.884 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -135.12 126.55 28.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 71.420000000000002 110.927 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -116.41 141.27 48.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 75.030000000000001 110.938 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.7 m -136.73 147.71 46.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 74.310000000000002 110.802 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.435 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 16.4 tptm -98.9 146.45 25.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.501 . . . . 74.25 110.897 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 18.4 pt -150.89 147.02 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 75.140000000000001 111.108 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . 0.41 ' N ' HD21 ' A' ' 153' ' ' ASN . 1.9 m-80 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 74.219999999999999 110.916 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.75 0.309 . . . . 74.129999999999995 111.097 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.65 -51.13 7.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 74.239999999999995 110.822 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 193' ' ' GLY . 3.4 mp -94.16 98.55 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 64.450000000000003 111.163 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . 0.403 HD13 ' HB3' ' A' ' 117' ' ' ARG . 7.0 tp -88.35 110.98 21.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 71.230000000000004 110.934 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 87.7 t -88.24 121.59 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 71.109999999999999 111.139 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.72 106.09 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 64.510000000000005 111.157 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -73.38 109.98 7.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 71.129999999999995 110.859 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.07 166.62 18.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.51 . . . . 75.099999999999994 111.182 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.36 135.06 54.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 74.409999999999997 110.888 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.654 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 44.52 -156.91 0.22 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.739 -0.743 . . . . 74.409999999999997 112.542 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.819 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -63.17 117.67 6.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.338 . . . . 73.439999999999998 111.105 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.715 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -110.59 -22.5 11.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 74.329999999999998 110.945 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.29 30.45 0.51 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.738 -0.744 . . . . 71.439999999999998 112.433 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.624 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -114.28 0.68 14.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.841 0.353 . . . . 75.049999999999997 110.837 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 73.49 39.76 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 71.409999999999997 110.864 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.715 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.26 -40.77 0.73 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.084 -0.507 . . . . 63.240000000000002 110.859 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.819 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.1 99.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 75.010000000000005 111.107 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.654 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.8 m-85 -60.45 -168.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 74.430000000000007 110.892 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.69 18.66 3.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 71.329999999999998 110.872 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.569 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.58 -156.35 9.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.799 -0.715 . . . . 65.430000000000007 112.461 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.74 135.56 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 74.519999999999996 110.859 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.49 165.03 0.14 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 71.209999999999994 112.476 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.97 -142.49 22.46 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.749 -0.738 . . . . 74.540000000000006 112.431 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.42 95.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.8 0.333 . . . . 75.510000000000005 111.214 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -65.1 -46.76 79.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.158 -0.474 . . . . 71.409999999999997 110.894 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . 0.419 ' HB2' ' HA ' ' A' ' 197' ' ' PHE . . . -163.24 174.21 12.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 52.210000000000001 111.048 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.469 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -169.33 139.71 2.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 73.430000000000007 110.823 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.547 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -135.08 174.62 10.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 64.439999999999998 111.007 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.534 ' O ' ' O ' ' A' ' 222' ' ' HIS . 64.3 m-85 -98.51 -134.25 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 74.510000000000005 110.835 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 223' ' ' SER . . . 179.02 -84.87 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.676 -0.774 . . . . 71.329999999999998 112.437 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 50.52 0.83 Allowed 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.727 2.285 . . . . 71.209999999999994 112.367 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.552 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.81 148.78 17.21 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.809 -0.71 . . . . 74.239999999999995 112.544 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.534 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.43 145.9 29.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.941 0.4 . . . . 71.409999999999997 110.856 -179.711 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.33 -64.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.759 . . . . 73.329999999999998 112.551 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.534 ' N ' ' O ' ' A' ' 189' ' ' SER . 14.8 tt -104.22 7.82 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.919 0.39 . . . . 72.0 111.165 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.552 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -69.39 172.92 37.48 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.801 -0.714 . . . . 74.299999999999997 112.497 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 223' ' ' SER . . . 43.2 23.17 0.23 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.683 -0.77 . . . . 73.219999999999999 112.526 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 192' ' ' GLY . 1.6 m-20 -67.0 101.15 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.854 0.359 . . . . 71.109999999999999 110.817 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.547 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -75.09 130.82 39.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 72.230000000000004 111.069 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.469 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.2 m170 -121.21 130.94 53.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 75.439999999999998 110.82 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.448 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 38.0 m-85 -115.44 134.94 54.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 74.430000000000007 110.88 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -67.22 107.02 2.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.506 . . . . 61.119999999999997 110.81 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -57.55 -37.84 73.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.112 -0.495 . . . . 74.349999999999994 111.012 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.569 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 12.9 m-20 -50.64 -20.78 1.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 74.109999999999999 110.889 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -82.42 162.45 22.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.209999999999994 110.882 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.46 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -101.81 87.82 3.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.5 . . . . 72.239999999999995 110.856 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.448 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 23.5 m95 -80.09 120.09 23.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.096 -0.502 . . . . 74.540000000000006 110.995 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.0 p -131.46 -173.84 3.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 71.340000000000003 111.209 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.63 12.85 18.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 70.140000000000001 111.164 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -131.49 -175.74 3.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 65.010000000000005 110.901 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.6 p -51.48 -36.73 45.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 71.349999999999994 110.856 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -63.13 160.71 34.73 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.69 -0.767 . . . . 71.319999999999993 112.524 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . 48.39 -173.17 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.67 -0.776 . . . . 75.310000000000002 112.501 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 51.5 m -86.47 94.11 9.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 74.329999999999998 111.197 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -38.54 113.59 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 73.519999999999996 110.88 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 13.0 tp -62.64 -35.69 80.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 73.109999999999999 110.923 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -53.27 -64.37 0.84 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 74.329999999999998 110.852 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 21.8 mt -56.01 -54.34 46.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 62.009999999999998 110.93 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.7 m -53.73 -37.41 63.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 74.530000000000001 111.112 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . 0.417 ' O ' HG13 ' A' ' 220' ' ' ILE . . . -63.13 -50.56 69.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 62.149999999999999 111.19 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.52 HG22 ' CB ' ' A' ' 137' ' ' ALA . 1.9 t -51.96 -57.76 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 72.340000000000003 111.136 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.575 ' HB2' HG13 ' A' ' 235' ' ' VAL . 3.9 t-80 -65.23 -30.75 71.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 74.439999999999998 110.898 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -62.87 -41.86 99.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 74.200000000000003 111.071 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.63 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.9 mt -71.98 -35.31 53.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 70.540000000000006 111.088 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -51.31 -45.23 52.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.703 -0.761 . . . . 65.439999999999998 112.544 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.534 ' O ' ' O ' ' A' ' 185' ' ' PHE . 37.3 m-70 -68.2 -41.77 80.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.885 0.374 . . . . 74.409999999999997 110.855 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.514 ' OG ' ' HA ' ' A' ' 220' ' ' ILE . 2.1 p -66.45 -18.11 65.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 72.120000000000005 110.885 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 39.9 mt -83.42 -27.19 29.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.239999999999995 110.943 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 119.99 14.06 5.74 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.735 -0.745 . . . . 42.25 112.498 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 221' ' ' GLY . 12.7 mt -81.0 158.32 25.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.895 0.379 . . . . 75.540000000000006 110.943 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -100.11 -133.49 8.14 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.767 -0.73 . . . . 72.319999999999993 112.518 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.02 139.72 51.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.851 0.357 . . . . 74.200000000000003 110.804 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 53.9 m -97.67 162.74 13.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 60.219999999999999 110.906 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.66 -1.44 19.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 72.019999999999996 110.9 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.45 141.91 97.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.58 0.705 . . . . 71.219999999999999 110.824 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -3.88 12.92 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.737 2.291 . . . . 74.239999999999995 112.399 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.5 ptmt -144.27 25.01 1.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 73.219999999999999 110.818 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -86.7 140.22 29.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.327 -0.397 . . . . 73.430000000000007 111.137 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.575 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.0 OUTLIER -62.81 -38.67 82.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.287 -0.415 . . . . 74.340000000000003 111.14 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 54.0 mmm -65.57 -16.97 64.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 74.310000000000002 110.888 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.624 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.2 t80 -55.48 144.81 51.77 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.678 0.751 . . . . 64.209999999999994 110.937 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.624 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.0 Cg_endo -69.73 0.83 5.06 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.779 2.319 . . . . 74.439999999999998 112.359 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.1 m -100.99 139.52 36.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 72.400000000000006 111.103 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -120.44 137.85 54.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 75.349999999999994 110.975 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.6 tptt -156.85 136.87 12.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 72.540000000000006 110.915 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -63.13 146.03 54.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 75.430000000000007 110.905 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -161.79 131.53 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 75.409999999999997 111.068 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -54.6 132.02 44.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 75.510000000000005 110.918 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 15.6 tt -53.65 -30.16 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.432 . . . . 72.400000000000006 111.113 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -20.34 63.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 70.439999999999998 110.874 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 5.0 p -110.95 -20.5 12.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 65.549999999999997 111.254 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -69.5 142.96 53.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.461 . . . . 73.219999999999999 110.849 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -176.07 133.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 72.239999999999995 110.847 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 254' ' ' ASP . 34.7 mt -48.8 137.74 12.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 63.43 110.994 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 23.2 t -80.61 168.06 19.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 71.430000000000007 110.848 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.95 -38.46 56.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.074 -0.512 . . . . 53.25 111.07 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.33 -51.15 67.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.257 -0.429 . . . . 60.439999999999998 110.908 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 7.2 m-20 -57.55 -53.38 58.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 61.229999999999997 110.848 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 2.6 mt -60.12 -36.81 70.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 74.340000000000003 111.105 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -67.61 -39.6 84.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 74.140000000000001 110.861 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.87 -52.59 5.74 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.822 -0.704 . . . . 64.219999999999999 112.416 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 5.6 tp -52.59 -34.5 19.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.832 0.349 . . . . 74.310000000000002 111.194 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 263' ' ' GLY . 70.7 mt-30 -86.33 -17.96 33.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.069 -0.514 . . . . 73.230000000000004 110.94 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.4 t -69.36 -13.97 62.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.452 . . . . 71.299999999999997 110.874 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.2 mt -123.02 -17.51 6.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 73.430000000000007 110.924 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -114.69 -35.51 4.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.108 -0.496 . . . . 75.549999999999997 110.887 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.282 0 CA-C-O 119.118 -0.823 . . . . 72.019999999999996 112.516 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . 0.575 ' HA ' ' CD1' ' A' ' 147' ' ' LEU . 5.3 p80 . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.876 0.37 . . . . 65.439999999999998 110.864 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -130.75 82.69 2.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 74.430000000000007 110.903 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 115' ' ' THR . 5.0 mp -109.99 163.36 7.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 73.25 111.153 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.497 ' OG1' ' CD1' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -160.65 164.71 31.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 73.400000000000006 111.111 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.632 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 5.1 p90 -133.56 145.12 49.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.481 . . . . 73.109999999999999 110.977 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . 0.501 ' HB2' HD12 ' A' ' 152' ' ' ILE . 3.9 tmt_? -136.42 110.06 8.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 74.530000000000001 110.849 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 52.5 mt -70.73 105.83 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 74.530000000000001 111.077 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -60.51 -47.47 86.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 71.400000000000006 110.822 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -141.53 162.9 34.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 110.849 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -116.57 144.29 44.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 75.239999999999995 110.964 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 124' ' ' ASP . 30.4 m -99.12 135.63 20.75 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.572 0.701 . . . . 65.530000000000001 111.133 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.409 ' HD2' ' CG2' ' A' ' 122' ' ' THR . 54.0 Cg_endo -69.74 10.87 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.728 2.285 . . . . 73.420000000000002 112.338 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 122' ' ' THR . 1.6 m-20 -87.89 -26.73 22.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 74.140000000000001 110.861 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -112.76 160.12 18.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 73.120000000000005 110.851 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -86.84 152.02 22.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.150000000000006 110.956 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -45.44 -39.63 7.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 74.329999999999998 110.885 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.01 -38.22 53.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 74.409999999999997 110.939 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -61.39 -35.87 78.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.081 -0.509 . . . . 70.439999999999998 110.89 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 95.0 t -60.9 -44.86 98.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 71.340000000000003 111.122 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 1.0 OUTLIER -83.18 -23.04 33.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 60.130000000000003 110.92 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -76.43 -51.87 10.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 74.400000000000006 110.888 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.59 -30.62 70.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 72.530000000000001 111.161 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.4 mp -77.31 -58.17 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 73.140000000000001 111.094 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 139' ' ' GLN . 6.2 ttm180 -48.06 -47.06 34.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 74.549999999999997 110.884 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -67.62 -33.98 76.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 71.549999999999997 110.879 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.485 ' HA ' ' CG2' ' A' ' 217' ' ' VAL . . . -61.55 -49.47 76.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 71.219999999999999 111.119 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.632 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 96.5 m-85 -73.63 -21.9 60.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 74.349999999999994 110.856 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.475 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.6 tt0 -77.8 -5.21 50.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 75.040000000000006 110.916 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . 0.412 ' HB ' HG11 ' A' ' 217' ' ' VAL . 94.9 t -99.14 -17.59 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 75.530000000000001 111.112 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.494 ' HA ' HG21 ' A' ' 144' ' ' VAL . 97.0 m95 -106.89 -38.23 6.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.1 -0.5 . . . . 74.209999999999994 110.919 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.99 -10.72 59.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.008 0.432 . . . . 61.420000000000002 110.912 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.553 ' N ' HD21 ' A' ' 143' ' ' ASN . 1.1 m-80 -97.24 -17.49 19.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 73.420000000000002 110.873 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.494 HG21 ' HA ' ' A' ' 141' ' ' TRP . 18.1 m -100.2 -3.89 9.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 74.510000000000005 111.087 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.591 ' HB ' ' CD2' ' A' ' 147' ' ' LEU . 44.6 p -142.89 148.4 45.58 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.572 0.701 . . . . 74.329999999999998 111.119 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.82 35.01 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.663 2.242 . . . . 75.349999999999994 112.34 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.591 ' CD2' ' HB ' ' A' ' 145' ' ' THR . 2.8 mm? -104.58 166.28 10.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 75.109999999999999 110.95 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.21 129.36 44.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 74.019999999999996 110.869 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 4.1 m-30 -115.48 137.66 51.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 74.450000000000003 110.909 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 t -125.26 162.77 23.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 51.420000000000002 110.852 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 7.9 tttt -119.5 142.2 48.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 73.540000000000006 110.853 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . 0.501 HD12 ' HB2' ' A' ' 117' ' ' ARG . 0.3 OUTLIER -150.95 166.68 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 72.420000000000002 111.158 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.8 m120 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 73.040000000000006 110.867 179.975 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' A' ' 117' ' ' ARG . . . . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.724 0.297 . . . . 75.099999999999994 111.12 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.4 OUTLIER -85.93 -50.93 6.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 73.340000000000003 110.907 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.423 HG12 ' HB2' ' A' ' 223' ' ' SER . 2.3 mp -92.57 91.59 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 75.239999999999995 111.177 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.4 tp -83.11 109.02 16.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.219 -0.446 . . . . 71.409999999999997 110.902 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.2 t -87.48 119.05 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 62.0 111.178 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 1.8 p -137.75 103.89 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 72.109999999999999 111.114 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . 0.405 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 36.7 m-85 -72.66 110.25 6.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 73.310000000000002 110.871 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.57 166.9 20.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 71.209999999999994 111.115 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.16 137.74 51.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 75.140000000000001 110.837 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.662 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.93 -155.74 0.23 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.716 -0.754 . . . . 63.32 112.512 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.821 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -64.51 116.73 6.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.77 0.319 . . . . 72.299999999999997 111.105 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.706 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.15 -22.22 12.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 73.319999999999993 110.94 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.04 30.35 0.53 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.67 -0.776 . . . . 64.140000000000001 112.456 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.638 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -114.47 1.24 14.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.766 0.317 . . . . 70.519999999999996 110.824 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 73.05 39.75 0.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 72.239999999999995 110.763 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.706 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.25 -41.23 0.73 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 72.409999999999997 110.955 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.821 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.02 100.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 73.400000000000006 111.11 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.662 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -60.56 -168.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 72.209999999999994 110.909 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.87 19.07 3.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 71.099999999999994 110.835 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.577 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.64 -158.22 6.22 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.758 -0.734 . . . . 61.350000000000001 112.559 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 176' ' ' GLY . 5.4 tmtt? -34.69 134.25 0.23 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.878 0.371 . . . . 73.209999999999994 110.908 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.02 164.66 0.16 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.739 -0.743 . . . . 71.030000000000001 112.494 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.97 -142.85 21.8 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 61.539999999999999 112.509 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -50.45 96.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.819 0.343 . . . . 73.230000000000004 111.094 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.94 -42.94 89.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 74.400000000000006 110.92 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -171.09 163.36 7.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 64.310000000000002 111.158 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.474 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.2 p80 -156.06 142.96 18.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 73.510000000000005 110.881 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.584 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -139.01 172.51 12.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 74.25 111.074 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.537 ' O ' ' O ' ' A' ' 222' ' ' HIS . 46.9 m-85 -101.12 -145.51 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 62.229999999999997 110.918 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -168.0 -86.21 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.774 -0.726 . . . . 63.039999999999999 112.456 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.73 54.15 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.755 2.304 . . . . 75.040000000000006 112.305 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . 0.562 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.32 150.64 16.88 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.773 -0.727 . . . . 74.140000000000001 112.47 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 189' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.08 147.01 27.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 72.430000000000007 110.83 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 61.02 -66.21 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.845 -0.693 . . . . 72.109999999999999 112.441 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . 0.546 ' N ' ' O ' ' A' ' 189' ' ' SER . 5.8 mm -102.76 6.89 10.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.777 0.322 . . . . 74.5 111.068 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.562 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -66.96 168.85 36.18 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.748 -0.739 . . . . 75.329999999999998 112.47 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 45.27 18.71 0.18 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 71.430000000000007 112.488 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 192' ' ' GLY . 1.1 m-20 -63.08 102.5 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 73.010000000000005 110.85 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.584 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -76.99 132.22 38.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 74.439999999999998 111.06 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.474 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 4.8 m170 -123.22 129.53 51.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 71.340000000000003 110.868 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.489 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 42.5 m-85 -114.54 135.57 53.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 74.109999999999999 110.846 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -68.43 109.38 3.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 71.120000000000005 110.945 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -61.03 -36.1 78.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 73.439999999999998 110.935 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.577 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 18.0 m-20 -52.18 -20.7 2.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 75.439999999999998 110.849 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -81.57 161.14 23.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.457 . . . . 65.430000000000007 110.823 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.528 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -100.13 90.93 4.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 73.150000000000006 110.801 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.489 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 22.2 m95 -81.26 123.92 28.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 71.319999999999993 110.858 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 43.5 p -140.47 -176.36 4.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 62.109999999999999 111.06 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.28 19.86 18.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 75.5 111.201 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -128.34 -173.24 2.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 73.340000000000003 110.861 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.3 t -71.71 -18.84 62.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 65.209999999999994 110.869 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.06 -106.79 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.686 -0.769 . . . . 52.310000000000002 112.491 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.07 177.01 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.692 -0.766 . . . . 54.130000000000003 112.469 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 89.8 m -66.63 97.54 0.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 75.25 111.249 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -42.14 114.75 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 72.209999999999994 110.947 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 27.1 tp -61.18 -32.46 72.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 72.230000000000004 111.0 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -58.11 -65.23 0.68 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.096 -0.502 . . . . 75.439999999999998 110.98 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 8.9 mp -51.88 -54.43 29.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 74.109999999999999 110.957 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 2.7 m -55.64 -38.93 70.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 74.439999999999998 111.023 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.08 -48.81 77.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 63.43 111.093 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.485 ' CG2' ' HA ' ' A' ' 137' ' ' ALA . 1.9 t -54.83 -57.57 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 73.329999999999998 111.093 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.517 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.3 t-80 -64.87 -28.11 69.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 73.150000000000006 110.989 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -63.8 -46.53 84.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 71.340000000000003 111.067 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.533 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.5 mt -68.02 -35.23 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 72.329999999999998 111.123 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -49.47 -45.91 36.96 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.671 -0.776 . . . . 70.540000000000006 112.474 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' PHE . 4.9 m-70 -68.32 -39.89 81.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.801 0.334 . . . . 73.239999999999995 110.866 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 14.0 m -66.15 -24.66 66.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 71.230000000000004 110.827 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 43.1 mt -75.67 -25.92 57.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 75.450000000000003 110.964 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 124.45 11.16 4.7 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.746 -0.74 . . . . 64.120000000000005 112.454 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 221' ' ' GLY . 14.4 mt -90.03 142.71 27.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 75.299999999999997 110.912 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -93.05 -137.01 8.01 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.71 -0.757 . . . . 71.230000000000004 112.47 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -115.96 144.23 44.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.835 0.35 . . . . 75.25 110.872 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 77.6 p -102.85 167.05 10.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 74.510000000000005 110.836 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 65.6 m -109.54 5.07 22.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 71.040000000000006 110.853 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.75 135.55 80.83 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.524 0.678 . . . . 74.299999999999997 110.88 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -0.41 6.85 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.706 2.271 . . . . 75.5 112.326 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.11 26.39 1.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 75.140000000000001 110.944 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -97.55 144.34 27.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 73.120000000000005 111.042 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.517 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -63.94 -41.54 92.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 71.129999999999995 111.143 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 34.7 mmm -59.86 -18.76 46.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 71.340000000000003 110.83 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.598 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -57.38 144.62 70.69 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.68 0.753 . . . . 74.230000000000004 110.875 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.598 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.1 Cg_endo -69.95 -1.78 9.2 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.709 2.273 . . . . 62.240000000000002 112.34 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.7 m -95.24 137.28 34.5 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.159 -0.473 . . . . 61.450000000000003 111.177 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -118.76 135.88 54.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 75.239999999999995 110.932 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -154.93 131.43 10.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 73.140000000000001 110.926 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -60.15 145.43 46.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.18 -0.464 . . . . 73.400000000000006 110.87 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -159.87 132.51 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 75.409999999999997 111.141 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -50.16 128.17 18.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 75.439999999999998 110.894 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 14.0 tt -51.13 -33.77 13.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.208 -0.451 . . . . 73.140000000000001 111.078 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -69.68 -23.27 63.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 74.5 110.837 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 29.6 p -101.33 -24.42 14.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 75.230000000000004 111.125 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -64.31 144.28 57.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 74.430000000000007 110.834 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -175.04 131.19 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 74.219999999999999 110.846 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 254' ' ' ASP . 33.8 mt -49.81 124.56 10.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 75.439999999999998 110.891 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.34 167.08 15.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 63.509999999999998 110.785 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.61 -39.17 49.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.089 -0.505 . . . . 71.030000000000001 111.159 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.9 -46.92 85.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 74.420000000000002 110.821 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 6.9 m-20 -61.36 -54.49 43.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 65.430000000000007 110.866 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 23.0 mt -60.58 -35.01 60.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 74.010000000000005 111.159 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -68.75 -39.78 80.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.454 . . . . 71.310000000000002 110.861 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.03 -51.19 7.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 73.329999999999998 112.506 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 6.2 tp -53.23 -34.37 21.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.794 0.33 . . . . 72.409999999999997 111.205 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 263' ' ' GLY . 31.2 mt-30 -87.86 -16.13 34.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 71.129999999999995 110.942 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.4 t -69.33 -16.52 63.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 70.329999999999998 110.902 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.1 mt -120.76 -19.42 7.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.509 . . . . 72.0 110.86 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . 0.433 ' HB3' ' CD2' ' A' ' 147' ' ' LEU . 29.7 m-85 -110.17 -37.25 5.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 72.049999999999997 110.908 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.335 0 CA-C-O 119.194 -0.781 . . . . 72.049999999999997 112.475 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.3 p80 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.798 0.333 . . . . 75.129999999999995 110.859 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -125.96 96.41 4.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.187 -0.461 . . . . 73.510000000000005 110.975 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 115' ' ' THR . 4.8 mp -123.29 163.93 21.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 74.420000000000002 111.161 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' THR . . . . . 0.448 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.4 OUTLIER -157.72 163.64 37.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 72.439999999999998 111.226 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' TYR . . . . . 0.593 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.7 p90 -133.53 144.63 49.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 74.140000000000001 110.926 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.84 108.86 6.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.486 . . . . 74.519999999999996 110.83 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 53.2 mt -70.66 106.03 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 75.439999999999998 111.124 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -60.39 -47.43 86.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 71.519999999999996 110.921 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -141.17 162.52 35.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 75.239999999999995 110.96 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -116.35 145.55 43.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.187 -0.46 . . . . 73.329999999999998 110.927 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' THR . . . . . 0.526 ' CG2' ' HD2' ' A' ' 123' ' ' PRO . 3.6 m -93.01 137.9 23.53 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.581 0.705 . . . . 64.329999999999998 111.147 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 123' ' ' PRO . . . . . 0.526 ' HD2' ' CG2' ' A' ' 122' ' ' THR . 54.2 Cg_endo -69.85 0.6 5.48 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.635 2.223 . . . . 75.040000000000006 112.323 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -84.08 -24.23 30.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 71.329999999999998 110.844 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 3.8 mtm -113.12 167.37 10.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 74.319999999999993 110.853 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -92.96 143.41 26.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 73.439999999999998 110.974 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -45.36 -36.22 4.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 73.030000000000001 110.877 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -83.38 -38.23 22.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 74.329999999999998 110.908 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -64.12 -31.8 73.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 75.209999999999994 110.828 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 56.4 t -65.61 -46.21 90.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 74.209999999999994 111.105 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 131' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 0.2 OUTLIER -78.49 -23.53 46.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 72.129999999999995 110.88 179.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -74.93 -48.02 26.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 74.040000000000006 110.955 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.88 -31.18 69.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 73.109999999999999 111.112 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.3 mp -73.8 -53.93 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 74.140000000000001 111.161 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' ARG . . . . . 0.434 ' HB3' ' O ' ' A' ' 131' ' ' ASP . 3.8 ptm180 -49.22 -37.34 22.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 74.200000000000003 110.832 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -76.97 -34.34 57.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 75.129999999999995 110.854 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 137' ' ' ALA . . . . . 0.501 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -60.12 -48.66 80.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 74.530000000000001 111.134 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 138' ' ' PHE . . . . . 0.593 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 96.0 m-85 -72.84 -22.79 60.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 75.340000000000003 110.942 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 139' ' ' GLN . . . . . 0.493 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.4 tt0 -77.78 -5.78 51.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.116 -0.493 . . . . 65.209999999999994 110.917 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 83.8 t -97.94 -16.77 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 71.530000000000001 111.066 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 141' ' ' TRP . . . . . 0.511 ' HA ' HG21 ' A' ' 144' ' ' VAL . 92.1 m95 -107.09 -38.26 6.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.264 -0.426 . . . . 73.430000000000007 110.917 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.95 -11.53 60.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 71.120000000000005 110.814 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 143' ' ' ASN . . . . . 0.599 ' N ' HD21 ' A' ' 143' ' ' ASN . 0.9 OUTLIER -95.53 -17.49 21.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 75.319999999999993 110.849 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 144' ' ' VAL . . . . . 0.511 HG21 ' HA ' ' A' ' 141' ' ' TRP . 22.4 m -99.86 2.72 10.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 75.349999999999994 111.084 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 145' ' ' THR . . . . . 0.52 ' C ' ' H ' ' A' ' 147' ' ' LEU . 44.5 p -150.99 148.69 23.34 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.537 0.684 . . . . 73.409999999999997 111.208 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.71 31.09 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.673 2.249 . . . . 73.239999999999995 112.357 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 147' ' ' LEU . . . . . 0.52 ' H ' ' C ' ' A' ' 145' ' ' THR . 15.4 mt -97.44 175.01 6.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 72.5 110.937 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm -139.05 126.77 22.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 75.540000000000006 110.768 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -115.4 138.36 51.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 75.200000000000003 110.898 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 58.5 m -132.57 149.26 52.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 71.239999999999995 110.919 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 151' ' ' LYS . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 4.4 tttt -99.52 141.05 32.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 65.019999999999996 110.9 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 15.5 pt -150.75 139.26 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 74.25 111.121 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 63.420000000000002 110.896 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.819 0.343 . . . . 74.430000000000007 111.075 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.02 -57.41 2.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 73.109999999999999 110.875 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 159' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 193' ' ' GLY . 2.8 mp -82.52 86.26 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 71.230000000000004 111.139 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.9 tp -79.76 102.78 9.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 70.450000000000003 110.84 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 96.7 t -82.3 123.08 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 73.019999999999996 111.148 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.1 p -140.97 100.05 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 64.510000000000005 111.173 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -67.53 109.39 3.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 75.420000000000002 110.877 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.76 165.76 20.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.112 -0.495 . . . . 62.350000000000001 111.065 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -113.65 134.85 54.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 74.439999999999998 110.847 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 166' ' ' GLY . . . . . 0.645 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.83 -156.98 0.16 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.677 -0.773 . . . . 74.209999999999994 112.509 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 167' ' ' ALA . . . . . 0.819 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -62.76 115.37 4.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.883 0.373 . . . . 74.329999999999998 111.072 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 168' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -108.39 -21.07 12.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 75.450000000000003 110.876 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.89 30.1 0.59 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.684 -0.77 . . . . 64.120000000000005 112.482 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 170' ' ' ASP . . . . . 0.638 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.49 -0.96 14.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.888 0.375 . . . . 45.039999999999999 110.872 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 75.37 38.05 0.42 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 73.420000000000002 110.877 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 172' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -133.95 -41.14 0.83 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 72.439999999999998 110.853 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 173' ' ' ALA . . . . . 0.819 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.26 100.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 75.409999999999997 111.172 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 174' ' ' PHE . . . . . 0.645 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -61.03 -168.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 72.239999999999995 110.862 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.12 17.5 4.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 74.099999999999994 110.883 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 176' ' ' GLY . . . . . 0.571 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.06 -157.41 7.36 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.748 -0.739 . . . . 72.319999999999993 112.5 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 177' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -34.41 134.42 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.905 0.383 . . . . 65.219999999999999 110.868 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.62 165.95 0.12 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.687 -0.768 . . . . 64.430000000000007 112.555 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.56 -143.19 22.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.708 -0.758 . . . . 65.519999999999996 112.488 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.23 96.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.867 0.365 . . . . 74.040000000000006 111.139 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.98 -36.04 81.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 75.049999999999997 110.949 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -174.74 169.0 3.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 63.420000000000002 111.11 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 183' ' ' HIS . . . . . 0.444 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.2 p80 -161.27 142.28 11.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.275 -0.421 . . . . 75.400000000000006 110.881 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 184' ' ' ALA . . . . . 0.526 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -140.75 170.3 16.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 72.430000000000007 111.135 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 185' ' ' PHE . . . . . 0.627 ' O ' ' HA ' ' A' ' 223' ' ' SER . 1.8 m-85 -125.64 167.93 14.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 75.310000000000002 110.93 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 186' ' ' GLY . . . . . 0.739 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -138.18 32.69 2.32 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.787 -0.721 . . . . 74.129999999999995 112.569 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 187' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 186' ' ' GLY . 53.9 Cg_endo -69.75 -23.27 31.05 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 122.694 2.263 . . . . 74.25 112.325 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 90.2 135.41 6.0 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.763 -0.732 . . . . 75.430000000000007 112.5 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.0 t 64.46 148.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.827 0.346 . . . . 75.420000000000002 110.871 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 47.95 -102.07 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.731 -0.747 . . . . 71.040000000000006 112.432 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 40.3 pt -77.84 6.63 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.85 0.357 . . . . 72.120000000000005 111.118 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 192' ' ' GLY . . . . . 0.512 ' HA2' ' HD2' ' A' ' 187' ' ' PRO . . . -74.76 121.54 6.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.766 -0.731 . . . . 65.120000000000005 112.483 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 193' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 75.2 -9.39 13.13 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.75 -0.738 . . . . 54.039999999999999 112.514 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.17 109.51 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.885 0.374 . . . . 72.209999999999994 110.883 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 195' ' ' ALA . . . . . 0.526 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -98.83 138.04 36.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 74.549999999999997 111.151 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 196' ' ' HIS . . . . . 0.444 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 4.9 m170 -125.26 137.62 54.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.316 -0.402 . . . . 73.420000000000002 110.859 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 197' ' ' PHE . . . . . 0.405 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 37.8 m-85 -120.03 142.44 48.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 74.430000000000007 110.869 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -73.8 109.11 7.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 75.400000000000006 110.779 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -62.1 -35.66 79.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 74.239999999999995 110.85 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 200' ' ' ASP . . . . . 0.571 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 12.0 m-20 -51.24 -21.56 2.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 71.519999999999996 110.87 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -81.54 161.29 23.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 74.420000000000002 110.97 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 202' ' ' PHE . . . . . 0.548 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -99.47 88.32 3.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 73.450000000000003 110.917 -179.887 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 203' ' ' TRP . . . . . 0.405 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 33.7 m95 -78.15 123.22 26.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 72.540000000000006 110.887 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 32.6 p -139.64 -176.32 4.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 70.219999999999999 111.146 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.77 17.27 19.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 72.140000000000001 111.112 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 -176.05 3.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 75.450000000000003 110.843 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.8 t -66.69 -18.51 65.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.272 -0.422 . . . . 73.439999999999998 110.86 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.49 -108.3 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 71.219999999999999 112.528 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 209' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.63 176.82 0.13 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.788 -0.72 . . . . 45.43 112.415 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 94.5 m -65.62 97.95 0.35 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.799 0.333 . . . . 72.310000000000002 111.105 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -42.0 117.11 0.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 72.200000000000003 110.95 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 30.4 tp -64.82 -36.72 85.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 73.439999999999998 110.901 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -53.84 -65.45 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 74.0 110.791 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 18.8 mt -53.12 -54.97 27.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.489 . . . . 74.129999999999995 110.894 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 6.2 m -54.81 -38.41 67.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 74.120000000000005 111.099 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.19 -50.04 71.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 62.520000000000003 111.134 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 217' ' ' VAL . . . . . 0.501 HG22 ' CB ' ' A' ' 137' ' ' ALA . 2.1 t -51.67 -59.6 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 74.209999999999994 111.115 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 218' ' ' HIS . . . . . 0.521 ' HB2' HG13 ' A' ' 235' ' ' VAL . 2.1 t-80 -65.07 -28.11 69.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 62.030000000000001 110.856 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -63.81 -46.07 86.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 54.240000000000002 111.112 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 220' ' ' ILE . . . . . 0.531 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.8 mt -66.05 -34.66 71.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 75.299999999999997 111.197 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 221' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -53.69 -44.38 69.34 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.753 -0.736 . . . . 35.43 112.499 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -69.54 -34.92 74.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.724 0.297 . . . . 74.310000000000002 110.811 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 223' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 4.0 p -70.41 -24.85 63.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.275 -0.42 . . . . 72.430000000000007 110.895 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 45.6 mt -76.93 -27.35 54.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 73.319999999999993 110.962 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 120.29 16.32 4.78 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.779 -0.724 . . . . 72.439999999999998 112.553 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 226' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 221' ' ' GLY . 15.3 mt -79.59 162.87 25.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 75.519999999999996 110.937 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -105.38 -133.17 7.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.755 -0.736 . . . . 55.020000000000003 112.411 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 228' ' ' HIS . . . . . 0.415 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.3 OUTLIER -131.2 148.86 52.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 64.519999999999996 110.805 -179.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 86.7 p -108.62 166.44 10.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 73.409999999999997 110.864 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.53 0.46 20.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 74.109999999999999 110.872 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.64 133.9 90.6 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.606 0.717 . . . . 73.040000000000006 110.85 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 0.59 5.44 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.706 2.271 . . . . 73.549999999999997 112.277 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.91 19.07 2.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 72.349999999999994 110.926 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 234' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -91.49 140.26 29.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 65.530000000000001 111.082 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 235' ' ' VAL . . . . . 0.521 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.0 OUTLIER -61.16 -41.18 88.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.235 -0.439 . . . . 75.019999999999996 111.137 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 236' ' ' MET . . . . . 0.415 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 53.9 mmm -58.68 -20.75 51.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 73.239999999999995 110.895 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 237' ' ' PHE . . . . . 0.589 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.0 t80 -55.63 144.03 56.44 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.712 0.768 . . . . 75.319999999999993 110.902 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 238' ' ' PRO . . . . . 0.589 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.8 Cg_endo -69.67 0.79 5.07 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.749 2.299 . . . . 74.420000000000002 112.315 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 30.7 m -97.32 138.91 34.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 65.219999999999999 111.166 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -120.87 137.05 54.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 74.109999999999999 110.937 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -157.4 137.27 12.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 62.530000000000001 110.912 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -61.44 146.91 46.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 72.450000000000003 110.913 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -160.46 132.52 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 75.310000000000002 111.183 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -50.11 132.05 23.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 64.430000000000007 110.874 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 7.3 tt -54.65 -30.63 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 71.209999999999994 111.138 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -76.17 -18.24 59.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 73.25 110.885 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 60.1 p -105.01 -22.77 13.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 73.420000000000002 111.072 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -69.67 142.97 53.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.429 . . . . 65.040000000000006 110.889 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -176.43 131.68 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 73.400000000000006 110.857 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 250' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 254' ' ' ASP . 80.2 mt -49.42 128.85 17.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 74.329999999999998 110.95 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 8.2 m -76.52 169.97 17.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 74.299999999999997 110.899 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.74 -43.24 47.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 73.510000000000005 111.069 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.17 -49.08 79.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 75.510000000000005 110.821 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 254' ' ' ASP . . . . . 0.443 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 16.3 m-20 -57.22 -54.8 42.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 75.530000000000001 110.811 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 2.9 mt -59.73 -39.59 80.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.437 . . . . 74.200000000000003 111.17 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -64.1 -39.84 94.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 75.430000000000007 110.909 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.28 -54.01 5.83 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.766 -0.731 . . . . 71.120000000000005 112.459 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 4.5 tp -53.09 -35.72 23.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.775 0.322 . . . . 70.019999999999996 111.075 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 259' ' ' GLN . . . . . 0.422 ' O ' ' N ' ' A' ' 263' ' ' GLY . 87.0 mt-30 -85.82 -17.22 36.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 60.329999999999998 110.948 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.2 t -69.0 -14.29 62.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 75.219999999999999 110.834 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.7 mt -123.91 -18.4 6.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 75.010000000000005 110.838 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -113.43 -33.98 5.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 71.510000000000005 110.925 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 263' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.429 0 CA-C-O 119.133 -0.815 . . . . 71.299999999999997 112.507 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.4 t80 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.855 0.36 . . . . 74.219999999999999 110.862 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.517 ' H ' ' NE ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -71.29 66.97 0.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 74.319999999999993 110.906 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 175.88 143.23 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 74.340000000000003 110.851 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.6 mmt -52.12 159.46 1.48 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.517 0.675 . . . . 75.430000000000007 110.87 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 78.06 1.04 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.704 2.269 . . . . 71.010000000000005 112.306 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 131.9 -124.1 3.87 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.739 -0.743 . . . . 64.310000000000002 112.48 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -149.86 55.53 0.48 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.726 -0.749 . . . . 74.310000000000002 112.479 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -24.97 29.02 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.694 2.263 . . . . 74.239999999999995 112.364 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.2 m -47.15 137.76 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 75.420000000000002 111.111 179.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 3.4 m0 -63.32 -23.01 67.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 75.400000000000006 110.909 179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 63.9 30.28 14.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 74.340000000000003 110.853 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.33 157.36 33.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 72.420000000000002 110.891 179.97 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 16.0 p80 -99.1 20.45 13.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 74.510000000000005 110.845 179.931 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 0.9 OUTLIER -121.37 110.96 16.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 74.409999999999997 110.921 -179.835 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.422 ' CG2' ' N ' ' A' ' 115' ' ' THR . 4.9 mp -141.06 162.1 22.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 74.530000000000001 111.129 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.422 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.5 OUTLIER -157.58 163.54 38.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 73.099999999999994 111.135 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.622 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 4.2 p90 -134.53 146.91 50.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 73.430000000000007 110.956 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.3 tmt_? -141.63 111.82 6.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 75.040000000000006 110.901 -179.95 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.9 mt -73.83 106.86 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 73.030000000000001 111.137 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -58.89 -50.43 74.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 71.319999999999993 110.893 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 3.3 p-10 -140.17 165.22 27.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 74.439999999999998 110.907 -179.985 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -118.15 138.88 51.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 74.010000000000005 110.896 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.404 HG23 ' HB2' ' A' ' 124' ' ' ASP . 2.5 t -88.11 143.01 32.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.538 0.685 . . . . 74.140000000000001 111.163 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.402 ' HD2' ' OG1' ' A' ' 122' ' ' THR . 53.6 Cg_endo -69.77 -3.11 11.37 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.658 2.239 . . . . 75.400000000000006 112.361 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.404 ' HB2' HG23 ' A' ' 122' ' ' THR . 13.7 m-20 -80.83 -23.27 39.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 73.109999999999999 110.855 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.424 ' HE3' ' HB2' ' A' ' 125' ' ' MET . 16.2 mtm -115.05 166.03 12.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 63.240000000000002 110.869 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -98.17 145.62 26.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 75.099999999999994 110.863 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -45.43 -34.49 3.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 74.209999999999994 110.928 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -82.32 -40.73 21.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 73.549999999999997 110.896 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -63.78 -31.13 72.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 73.200000000000003 110.839 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 59.5 t -63.86 -45.46 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 73.129999999999995 111.158 -179.997 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.3 -23.47 40.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.151 -0.477 . . . . 73.530000000000001 110.879 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -75.26 -47.33 28.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 73.209999999999994 110.941 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.2 -31.07 67.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 74.140000000000001 111.108 179.85 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.3 mp -73.7 -55.23 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 74.129999999999995 111.145 179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -48.56 -42.54 33.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 64.099999999999994 110.896 179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.7 mmpt? -70.87 -35.51 72.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 72.239999999999995 110.905 179.967 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.485 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -60.0 -48.85 80.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 63.329999999999998 111.101 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.622 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 93.3 m-85 -72.6 -22.32 60.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 65.310000000000002 110.814 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.522 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.2 OUTLIER -77.28 -6.24 52.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 75.099999999999994 110.941 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.41 ' HB ' HG13 ' A' ' 217' ' ' VAL . 93.8 t -97.31 -17.56 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 65.340000000000003 111.131 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.496 ' HA ' HG21 ' A' ' 144' ' ' VAL . 95.3 m95 -106.18 -36.39 6.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 74.450000000000003 110.939 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.82 -11.54 61.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 74.099999999999994 110.823 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.617 ' N ' HD21 ' A' ' 143' ' ' ASN . 0.9 OUTLIER -95.61 -18.44 20.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 71.019999999999996 110.933 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.496 HG21 ' HA ' ' A' ' 141' ' ' TRP . 19.9 m -98.42 1.24 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 75.450000000000003 111.108 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.52 ' C ' ' H ' ' A' ' 147' ' ' LEU . 39.0 p -151.96 146.24 18.44 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.606 0.717 . . . . 74.140000000000001 111.14 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 30.59 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.625 2.217 . . . . 64.530000000000001 112.379 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.52 ' H ' ' C ' ' A' ' 145' ' ' THR . 0.2 OUTLIER -91.76 177.48 6.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 74.510000000000005 110.939 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.23 125.59 20.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 73.319999999999993 110.904 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.9 m-30 -114.94 141.56 47.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 72.129999999999995 110.894 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 2.1 t -135.72 153.03 51.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 73.239999999999995 110.857 -179.791 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.479 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 19.8 tttt -104.43 143.18 33.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 74.340000000000003 110.888 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 16.9 pt -152.32 155.52 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 73.409999999999997 111.083 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -122.17 -3.04 9.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 75.129999999999995 110.877 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.9 t -159.78 50.66 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 73.310000000000002 111.118 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -142.19 -153.91 6.03 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 75.120000000000005 112.507 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -107.8 90.63 3.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 74.25 110.856 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -101.46 155.99 17.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 62.0 111.078 179.911 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.15 -52.7 5.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 75.310000000000002 110.86 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.451 HG12 HG21 ' A' ' 220' ' ' ILE . 2.4 mp -90.01 94.21 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 73.329999999999998 111.085 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.9 tp -86.5 107.75 18.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 73.030000000000001 110.895 179.919 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.411 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 88.4 t -84.97 121.63 37.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 75.329999999999998 111.172 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.25 105.43 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 74.219999999999999 111.127 179.971 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -73.31 110.27 7.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 73.019999999999996 110.889 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -126.98 166.83 16.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 74.319999999999993 111.131 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.72 133.1 55.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 75.239999999999995 110.853 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.655 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.36 -158.04 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 63.100000000000001 112.484 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.772 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -50.71 118.81 3.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 74.329999999999998 111.104 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.77 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 4.3 p-80 -137.65 32.5 2.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 75.349999999999994 110.854 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 79.11 53.43 4.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 74.530000000000001 112.478 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.461 ' OD2' ' CE1' ' A' ' 196' ' ' HIS . 23.7 t0 -143.15 9.34 1.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 75.540000000000006 110.88 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 54.16 22.36 3.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 75.439999999999998 110.86 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.77 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 2.1 p-80 -118.62 -38.9 3.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 73.409999999999997 110.848 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.772 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 50.43 99.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 75.430000000000007 111.114 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.655 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.4 m-85 -58.72 -170.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 75.109999999999999 110.862 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.69 21.21 4.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 73.219999999999999 110.862 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.576 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 52.53 -156.05 4.69 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 52.310000000000002 112.477 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.9 OUTLIER -33.77 132.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.829 0.347 . . . . 71.510000000000005 110.911 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.94 163.53 0.13 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.814 -0.708 . . . . 75.340000000000003 112.471 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.18 -142.25 19.64 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 75.540000000000006 112.452 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.2 mt -49.92 97.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 71.230000000000004 111.147 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -66.8 -41.61 87.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 72.230000000000004 110.875 179.968 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -174.74 158.47 2.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 71.209999999999994 111.08 179.8 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.429 ' CE1' ' CD2' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -148.92 134.3 18.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.449 . . . . 61.32 110.847 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.587 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -131.71 175.39 9.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 72.409999999999997 111.134 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.532 ' O ' ' HA ' ' A' ' 223' ' ' SER . 65.7 m-85 -105.6 -152.93 0.48 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 73.420000000000002 110.853 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -160.74 -84.44 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.701 -0.761 . . . . 75.430000000000007 112.463 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 52.33 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.721 2.28 . . . . 74.140000000000001 112.331 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.577 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.56 150.02 17.16 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.781 -0.724 . . . . 70.5 112.499 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -105.54 147.75 28.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 63.509999999999998 110.804 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.27 -64.12 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 51.130000000000003 112.5 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 189' ' ' SER . 2.3 pp -107.15 8.42 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 74.010000000000005 111.119 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.577 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -69.53 169.5 44.27 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.775 -0.726 . . . . 72.439999999999998 112.482 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.43 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 46.78 18.35 0.38 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 60.030000000000001 112.496 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.14 110.4 2.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.333 . . . . 73.239999999999995 110.894 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.587 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -85.01 130.01 34.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 73.519999999999996 111.116 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.461 ' CE1' ' OD2' ' A' ' 170' ' ' ASP . 1.3 m170 -123.32 123.04 39.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 75.209999999999994 110.84 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.546 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 37.1 m-85 -106.5 138.54 42.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 74.120000000000005 110.889 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -68.37 105.37 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 74.5 110.86 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -55.53 -39.09 70.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 75.340000000000003 110.845 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.576 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 15.8 m-20 -48.37 -25.0 1.41 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 65.019999999999996 110.867 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -77.55 163.11 26.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 75.239999999999995 110.894 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.558 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -101.21 86.61 3.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 74.420000000000002 110.872 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.546 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 24.7 m95 -79.53 122.4 26.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 73.519999999999996 110.881 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.6 p -139.94 -172.83 3.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 64.200000000000003 111.148 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.02 19.6 17.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 74.409999999999997 111.155 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -126.93 -175.4 3.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 75.310000000000002 110.894 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 11.4 p -70.44 -18.84 63.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 74.019999999999996 110.891 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.63 -106.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.742 -0.742 . . . . 50.420000000000002 112.47 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.558 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.07 176.54 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.712 -0.756 . . . . 74.409999999999997 112.498 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 55.6 m -66.65 96.93 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 71.430000000000007 111.112 -179.858 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -43.09 116.93 0.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.427 . . . . 73.420000000000002 110.85 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.0 tp -62.83 -37.31 86.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 73.430000000000007 110.924 179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -51.59 -63.9 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 71.140000000000001 110.887 179.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 8.3 mp -54.6 -55.82 25.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 71.400000000000006 110.917 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.5 m -55.45 -32.92 63.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 75.340000000000003 111.157 179.924 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -68.12 -47.99 66.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 74.439999999999998 111.081 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.485 HG22 ' CB ' ' A' ' 137' ' ' ALA . 2.0 t -53.66 -58.01 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 72.019999999999996 111.115 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.544 ' HB2' HG12 ' A' ' 235' ' ' VAL . 1.8 t-80 -64.45 -29.38 70.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 73.010000000000005 110.867 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -62.31 -44.7 95.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 73.129999999999995 111.055 179.978 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.548 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.5 mt -68.95 -35.11 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 70.519999999999996 111.121 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.65 -43.94 46.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.718 -0.753 . . . . 72.209999999999994 112.473 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 185' ' ' PHE . 28.2 m-70 -67.79 -39.06 84.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 74.329999999999998 110.868 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.532 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 3.1 m -63.3 -27.46 69.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 73.010000000000005 110.834 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 44.6 mt -75.52 -27.99 58.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 73.430000000000007 110.902 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 119.9 15.13 5.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.781 -0.723 . . . . 75.409999999999997 112.471 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 14.4 mt -79.02 158.18 27.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 73.439999999999998 110.912 -179.969 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -104.07 -136.4 8.87 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.706 -0.759 . . . . 62.049999999999997 112.487 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.5 m170 -125.94 142.16 51.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.849 0.356 . . . . 72.310000000000002 110.817 -179.906 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 21.7 m -104.7 162.75 13.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 75.219999999999999 110.87 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.0 t -103.86 0.71 30.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 54.439999999999998 110.871 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.24 136.98 95.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.618 0.723 . . . . 72.230000000000004 110.834 179.973 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -0.32 6.76 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.661 2.241 . . . . 74.109999999999999 112.322 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.03 17.36 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.42 . . . . 75.409999999999997 110.884 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.461 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -86.69 134.18 33.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 73.450000000000003 111.133 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.544 HG12 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -58.15 -36.2 56.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 75.209999999999994 111.129 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.415 ' HG2' ' OD2' ' A' ' 254' ' ' ASP . 44.2 mmm -61.56 -21.96 64.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 73.200000000000003 110.912 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.531 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.7 t80 -54.9 142.7 54.63 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.613 0.721 . . . . 74.540000000000006 110.898 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.531 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.3 Cg_endo -69.73 -1.46 8.49 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.695 2.263 . . . . 71.439999999999998 112.345 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 41.8 m -95.32 141.23 29.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 73.409999999999997 111.126 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -118.36 140.33 50.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 74.019999999999996 110.975 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -157.7 138.05 12.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 74.219999999999999 110.858 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 77.9 t80 -68.77 145.4 53.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 73.200000000000003 110.923 -179.951 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -162.27 133.22 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 72.430000000000007 111.081 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -51.37 130.31 26.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 73.430000000000007 110.867 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 16.4 tt -52.26 -30.81 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 74.319999999999993 111.139 179.99 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -67.68 -22.57 65.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 75.219999999999999 110.94 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 28.0 p -109.49 -20.83 12.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 74.420000000000002 111.173 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -69.12 121.28 16.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 72.299999999999997 110.905 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -152.98 143.11 22.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.319999999999993 110.835 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.403 HD11 ' O ' ' A' ' 140' ' ' VAL . 33.2 mt -58.73 123.51 16.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 72.209999999999994 110.927 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 10.3 t -64.32 163.24 13.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 74.099999999999994 110.835 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.2 -37.95 24.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 71.200000000000003 111.101 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -63.81 -45.5 89.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 73.540000000000006 110.87 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . 0.422 ' OD2' ' HB ' ' A' ' 235' ' ' VAL . 5.4 m-20 -61.94 -53.66 52.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 71.540000000000006 110.902 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 23.1 mt -62.03 -34.95 65.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 72.519999999999996 111.112 179.975 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -68.36 -40.5 81.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 74.439999999999998 110.831 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.06 -51.84 6.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 73.209999999999994 112.5 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 5.8 tp -52.51 -35.07 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.775 0.321 . . . . 71.409999999999997 111.1 179.996 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.431 ' O ' ' N ' ' A' ' 263' ' ' GLY . 75.3 mt-30 -87.46 -17.24 32.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 73.140000000000001 110.911 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.5 t -69.75 -13.69 62.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 74.200000000000003 110.851 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.8 mt -123.55 -18.4 6.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 73.239999999999995 110.937 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 39.6 m-85 -114.56 -33.66 5.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 65.129999999999995 110.9 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.431 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.298 0 CA-C-O 119.123 -0.821 . . . . 71.120000000000005 112.505 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.864 0.364 . . . . 71.010000000000005 110.891 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 39.09 38.2 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 73.430000000000007 110.877 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -157.59 123.49 4.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 72.140000000000001 110.876 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -51.45 133.82 33.94 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.615 0.721 . . . . 72.219999999999999 110.874 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 143.6 51.65 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.673 2.249 . . . . 74.349999999999994 112.397 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.52 12.2 63.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.702 -0.761 . . . . 54.109999999999999 112.477 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.489 ' N ' ' CD ' ' A' ' 107' ' ' PRO . . . 42.67 49.92 5.9 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.693 -0.765 . . . . 71.200000000000003 112.458 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 106' ' ' GLY . 54.0 Cg_endo -69.72 -18.82 36.98 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.658 2.239 . . . . 74.120000000000005 112.407 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 57.4 t -47.28 138.33 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 74.140000000000001 111.119 179.886 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.436 ' HB2' ' HG2' ' A' ' 111' ' ' LYS . 4.8 m0 -65.18 -32.0 73.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 73.310000000000002 110.88 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 20.4 mtt-85 64.33 35.23 9.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 75.540000000000006 110.928 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.436 ' HG2' ' HB2' ' A' ' 109' ' ' TRP . 23.4 pttt -122.58 166.29 15.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 75.219999999999999 110.875 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -109.42 35.69 3.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 70.150000000000006 110.848 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.0 m-85 -141.1 106.38 5.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 75.219999999999999 110.995 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.448 ' HB ' ' CD1' ' A' ' 149' ' ' PHE . 4.6 mp -139.77 163.76 24.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 74.439999999999998 111.204 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.436 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.4 OUTLIER -157.91 163.67 37.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 73.299999999999997 111.126 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.61 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.4 p90 -132.67 148.62 52.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.254 -0.43 . . . . 73.150000000000006 110.953 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.7 tmt_? -142.84 113.33 7.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.515 . . . . 74.540000000000006 110.885 -180.0 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.9 mt -74.25 106.54 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 75.140000000000001 111.179 179.929 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -61.34 -45.26 95.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 75.310000000000002 110.914 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.4 p-10 -144.1 161.92 37.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 73.420000000000002 110.931 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -117.23 137.74 52.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 71.239999999999995 110.907 -179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.3 t -88.31 142.51 31.57 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 121.648 0.737 . . . . 75.150000000000006 111.111 -179.966 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 0.86 5.0 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.702 2.268 . . . . 73.109999999999999 112.405 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -82.81 -24.55 33.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.257 -0.429 . . . . 75.409999999999997 110.875 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 5.8 mtm -116.46 165.7 12.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.282 -0.417 . . . . 72.409999999999997 110.838 -179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 4.5 m120 -96.01 145.48 25.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 65.239999999999995 110.893 -179.957 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.89 -34.85 4.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 74.450000000000003 110.909 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -83.04 -37.71 23.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 63.539999999999999 110.902 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -66.57 -29.67 69.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 71.439999999999998 110.894 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 77.6 t -65.36 -46.75 89.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 75.049999999999997 111.154 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.52 -23.85 46.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 70.219999999999999 110.893 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -73.55 -46.39 47.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 73.400000000000006 110.943 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -72.66 -32.75 66.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 74.420000000000002 111.112 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.3 mp -71.62 -53.59 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 75.430000000000007 111.155 179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.6 ttt-85 -49.22 -42.53 40.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 73.209999999999994 110.868 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 9.5 mmtt -71.4 -33.93 69.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 74.209999999999994 110.852 179.982 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.502 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -60.54 -49.32 78.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 70.299999999999997 111.059 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.61 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.9 m-85 -72.13 -23.11 61.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 73.219999999999999 110.917 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.552 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.6 tt0 -77.05 -6.27 52.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 73.239999999999995 110.921 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.43 ' HB ' HG11 ' A' ' 217' ' ' VAL . 92.7 t -97.22 -16.26 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 75.030000000000001 111.249 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.527 ' HA ' HG21 ' A' ' 144' ' ' VAL . 92.7 m95 -106.32 -33.17 7.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 64.530000000000001 110.869 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 142' ' ' SER . . . . . 0.465 ' OG ' ' CD2' ' A' ' 149' ' ' PHE . 6.5 m -70.41 -15.66 62.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 72.329999999999998 110.832 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.553 ' N ' HD21 ' A' ' 143' ' ' ASN . 1.2 m-80 -91.41 -18.69 23.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 75.040000000000006 110.827 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.527 HG21 ' HA ' ' A' ' 141' ' ' TRP . 24.5 m -98.62 1.87 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 74.140000000000001 111.164 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.522 ' C ' ' H ' ' A' ' 147' ' ' LEU . 15.7 p -154.79 145.16 15.91 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.62 0.724 . . . . 65.049999999999997 111.114 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 30.36 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.698 2.266 . . . . 72.420000000000002 112.354 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' A' ' 145' ' ' THR . 2.7 mp -91.54 177.28 6.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 74.420000000000002 110.877 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.08 123.11 14.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 72.420000000000002 110.786 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.465 ' CD2' ' OG ' ' A' ' 142' ' ' SER . 3.3 m-30 -114.55 140.12 49.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 74.430000000000007 110.962 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.0 m -132.78 155.81 48.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 61.43 110.878 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 5.0 tttt -102.72 140.52 36.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.114 -0.494 . . . . 75.530000000000001 110.884 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 18.5 pt -150.74 139.04 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 74.0 111.095 179.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.97 -5.95 15.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 75.319999999999993 110.928 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 23.9 p -153.48 52.96 0.73 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.479 . . . . 65.0 111.129 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -148.13 -155.43 6.64 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.722 -0.752 . . . . 64.329999999999998 112.511 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.82 96.96 6.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.835 0.35 . . . . 73.120000000000005 110.858 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -105.55 155.87 18.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 72.299999999999997 111.103 179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.414 ' HB2' HG22 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -85.76 -51.96 6.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 71.239999999999995 110.884 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.443 HG12 HG21 ' A' ' 220' ' ' ILE . 2.6 mp -90.45 92.98 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 74.329999999999998 111.079 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.9 tp -84.3 109.94 18.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.49 . . . . 73.019999999999996 110.978 179.84 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 92.3 t -87.47 118.57 33.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 73.310000000000002 111.16 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.97 106.09 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.269 -0.423 . . . . 72.349999999999994 111.135 179.871 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 46.7 m-85 -73.3 110.73 7.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 74.519999999999996 110.912 179.954 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -126.58 167.63 15.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 74.329999999999998 111.168 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -120.44 132.22 55.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 74.439999999999998 110.844 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.647 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.4 -157.44 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.743 -0.741 . . . . 73.409999999999997 112.53 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.766 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -51.08 119.04 3.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.773 0.32 . . . . 74.209999999999994 111.114 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.754 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 4.3 p-80 -137.98 31.9 2.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.434 . . . . 73.030000000000001 110.953 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 79.65 53.38 4.34 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.779 -0.724 . . . . 75.019999999999996 112.483 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.478 ' OD2' ' CE1' ' A' ' 196' ' ' HIS . 22.4 t0 -142.85 8.95 1.72 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 74.430000000000007 110.965 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 54.52 22.44 3.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.492 . . . . 73.019999999999996 110.875 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.754 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 2.0 p-80 -119.06 -38.92 2.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 71.420000000000002 110.873 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.766 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 50.45 99.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 64.340000000000003 111.11 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.647 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.4 m-85 -58.22 -171.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 73.310000000000002 110.919 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.21 20.64 4.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 74.540000000000006 110.856 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 53.01 -156.38 5.01 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.68 -0.771 . . . . 75.540000000000006 112.509 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 176' ' ' GLY . 12.7 tptt -33.34 132.02 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.858 0.361 . . . . 74.099999999999994 110.878 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.66 163.81 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.788 -0.72 . . . . 64.219999999999999 112.504 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.92 -142.25 19.84 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.739 -0.743 . . . . 54.32 112.503 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.1 mt -49.89 97.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 74.530000000000001 111.193 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -66.8 -41.27 87.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 71.329999999999998 110.887 179.97 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -174.83 158.25 2.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 73.129999999999995 111.114 179.826 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.45 ' CE1' ' CD2' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -148.96 134.69 18.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 72.430000000000007 110.911 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.595 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -131.92 175.53 9.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 75.439999999999998 111.079 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.524 ' O ' ' HA ' ' A' ' 223' ' ' SER . 39.4 m-85 -104.63 -148.71 0.4 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 73.409999999999997 110.869 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -164.84 -83.58 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.818 -0.706 . . . . 74.219999999999999 112.605 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.405 ' HB3' ' HB2' ' A' ' 107' ' ' PRO . 53.9 Cg_endo -69.79 51.87 0.95 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.732 2.288 . . . . 75.239999999999995 112.321 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.564 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.68 148.92 17.25 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.79 -0.719 . . . . 53.140000000000001 112.485 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -105.13 145.27 30.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 63.329999999999998 110.878 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.56 -62.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.643 -0.789 . . . . 74.099999999999994 112.588 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 189' ' ' SER . 5.8 mm -107.54 8.76 9.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.799 0.333 . . . . 71.120000000000005 111.076 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.564 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -70.84 171.26 45.33 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 73.439999999999998 112.468 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.404 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 45.24 19.67 0.24 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.75 -0.738 . . . . 71.040000000000006 112.478 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 192' ' ' GLY . 2.1 m-20 -65.57 108.45 2.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.772 0.32 . . . . 73.219999999999999 110.886 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.595 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -84.22 129.24 34.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 73.420000000000002 111.108 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.478 ' CE1' ' OD2' ' A' ' 170' ' ' ASP . 1.6 m170 -121.68 123.61 42.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 74.140000000000001 110.867 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.539 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 40.3 m-85 -106.3 137.17 44.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 74.129999999999995 110.925 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -67.17 105.17 1.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 72.340000000000003 110.878 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -55.59 -39.14 70.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 73.540000000000006 110.873 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.564 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 15.5 m-20 -47.92 -25.31 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.497 . . . . 74.25 110.832 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -77.21 162.92 27.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 73.540000000000006 110.907 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.594 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -101.13 85.32 2.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 74.420000000000002 110.811 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.539 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 24.8 m95 -77.61 123.26 26.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.438 . . . . 75.310000000000002 110.903 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 41.0 p -140.21 -173.76 3.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 75.519999999999996 111.102 -179.989 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.83 18.04 18.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.238 -0.437 . . . . 73.540000000000006 111.094 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.8 -177.64 4.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 74.040000000000006 110.849 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.8 p -66.12 -18.99 65.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 75.099999999999994 110.805 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.1 -107.69 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.748 -0.739 . . . . 73.299999999999997 112.449 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.594 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.13 177.29 0.15 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.727 -0.749 . . . . 61.240000000000002 112.523 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 88.1 m -66.78 97.51 0.47 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.755 0.312 . . . . 72.510000000000005 111.17 -179.896 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -42.11 119.25 1.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 75.450000000000003 110.809 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.4 tp -65.53 -37.55 87.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 72.530000000000001 110.851 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -51.15 -64.96 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 74.540000000000006 110.91 179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 22.8 mt -53.53 -55.36 26.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.118 -0.492 . . . . 74.340000000000003 110.954 179.991 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.8 m -55.78 -33.28 64.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 71.150000000000006 111.181 179.915 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -68.05 -47.98 66.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 64.150000000000006 111.092 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.502 HG22 ' CB ' ' A' ' 137' ' ' ALA . 2.0 t -53.61 -57.93 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 72.040000000000006 111.119 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.582 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.7 t-80 -64.66 -28.14 69.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.123 -0.489 . . . . 73.040000000000006 110.907 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -63.86 -45.32 89.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 75.239999999999995 111.087 179.972 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.539 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.5 mt -68.32 -35.89 72.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 72.409999999999997 111.141 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.61 -44.65 47.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.687 -0.768 . . . . 44.32 112.486 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.411 ' O ' ' O ' ' A' ' 185' ' ' PHE . 4.3 m-70 -68.32 -38.06 81.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.706 0.288 . . . . 74.150000000000006 110.809 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.524 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 7.1 m -64.27 -24.69 67.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 74.120000000000005 110.827 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.2 mt -78.07 -27.72 48.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.188 -0.46 . . . . 74.519999999999996 110.885 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 121.11 15.47 4.68 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.65 -0.786 . . . . 53.240000000000002 112.428 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 12.5 mt -80.31 156.12 26.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.906 0.384 . . . . 73.400000000000006 110.846 -179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -99.25 -141.12 11.9 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.759 -0.734 . . . . 74.099999999999994 112.464 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -122.0 139.36 53.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 75.319999999999993 110.904 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.4 t -99.21 163.99 12.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 73.140000000000001 110.884 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.19 -2.86 17.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 74.109999999999999 110.858 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -61.11 141.45 93.79 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.681 0.753 . . . . 64.5 110.839 179.869 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 -3.35 11.83 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.709 2.273 . . . . 64.239999999999995 112.342 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -143.47 19.81 1.87 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 74.25 110.827 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.447 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -82.21 139.03 34.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 71.409999999999997 111.09 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.582 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -63.03 -37.73 80.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.415 . . . . 73.030000000000001 111.055 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 48.5 mmm -66.49 -13.75 61.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 75.439999999999998 110.833 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.619 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.5 t80 -58.64 144.4 79.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.736 0.779 . . . . 73.329999999999998 110.853 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.619 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.2 Cg_endo -69.75 -3.42 11.97 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.753 2.302 . . . . 74.219999999999999 112.314 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 16.9 m -95.7 142.42 28.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 63.200000000000003 111.148 -179.992 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -122.92 134.53 54.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 74.230000000000004 110.94 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -152.67 129.49 10.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.09 -0.504 . . . . 74.420000000000002 110.955 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 85.2 t80 -57.13 143.77 37.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.318 -0.401 . . . . 74.329999999999998 110.876 -179.935 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -158.26 130.34 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 74.140000000000001 111.136 179.841 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -50.84 132.16 26.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 73.239999999999995 110.945 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 14.3 tt -53.98 -29.89 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 53.219999999999999 111.081 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.98 -18.76 61.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 71.319999999999993 110.973 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 38.4 p -109.33 -21.4 12.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 73.349999999999994 111.194 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -71.58 143.1 49.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 75.409999999999997 110.917 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -177.19 133.37 0.18 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 63.310000000000002 110.834 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 52.9 mt -48.0 127.15 11.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 74.340000000000003 110.915 -179.973 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.6 m -67.44 163.49 20.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 71.25 110.829 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.89 -35.09 31.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.478 . . . . 61.43 111.144 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.1 -51.58 52.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 74.019999999999996 110.886 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -56.39 -50.26 72.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 45.439999999999998 110.892 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 21.2 mt -61.4 -39.97 84.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 75.109999999999999 111.07 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -65.44 -39.85 92.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.172 -0.467 . . . . 75.120000000000005 110.948 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -73.73 -52.66 7.99 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.752 -0.737 . . . . 61.039999999999999 112.455 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 3.8 tp -52.54 -34.62 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.783 0.325 . . . . 74.019999999999996 111.124 -179.952 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 263' ' ' GLY . 82.1 mt-30 -86.39 -17.34 34.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 74.219999999999999 110.92 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.7 t -69.49 -13.82 62.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.233 -0.44 . . . . 43.229999999999997 110.851 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.8 mt -123.16 -18.29 6.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 74.409999999999997 110.894 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.425 ' CE1' HD22 ' A' ' 147' ' ' LEU . 36.8 m-85 -114.56 -34.14 5.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.011 0.434 . . . . 74.120000000000005 110.965 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.307 0 CA-C-O 119.099 -0.834 . . . . 62.020000000000003 112.485 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.864 0.364 . . . . 73.549999999999997 110.913 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.539 ' H ' ' NE ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -72.83 66.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 74.219999999999999 110.815 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.8 pp20? 177.75 130.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 72.400000000000006 110.86 -179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 6.3 mmt -50.68 148.08 7.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.555 0.693 . . . . 75.319999999999993 110.884 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -48.58 0.68 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.676 2.251 . . . . 75.230000000000004 112.322 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -122.36 36.96 3.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.788 -0.72 . . . . 71.510000000000005 112.466 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -103.94 97.54 1.44 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.767 -0.73 . . . . 64.019999999999996 112.532 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.89 71.95 1.54 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.697 2.265 . . . . 75.120000000000005 112.297 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 32.6 t -38.6 141.78 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 75.319999999999993 111.17 179.91 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 4.1 m0 -51.14 -28.2 10.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.132 -0.485 . . . . 75.439999999999998 110.942 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 64.2 mtp180 58.25 32.88 22.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 75.400000000000006 110.845 179.992 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -120.46 171.19 8.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 74.310000000000002 110.906 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.2 p80 -111.3 26.75 10.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 75.019999999999996 110.867 179.792 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.1 m-85 -129.48 111.08 12.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 74.129999999999995 110.909 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.425 ' CG2' ' N ' ' A' ' 115' ' ' THR . 4.8 mp -142.33 162.73 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 71.239999999999995 111.14 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.425 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -160.43 163.76 32.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 72.019999999999996 111.074 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.615 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.5 p90 -131.7 152.28 51.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 74.040000000000006 110.953 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -144.35 109.96 5.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 72.530000000000001 110.855 -179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.7 mt -71.58 105.67 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 74.109999999999999 111.114 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -59.57 -45.47 91.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 74.439999999999998 110.827 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -146.12 163.35 35.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 74.319999999999993 110.878 179.976 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.0 m-85 -116.27 140.98 48.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 65.329999999999998 110.873 -179.895 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.418 HG23 ' HB2' ' A' ' 124' ' ' ASP . 2.9 t -90.91 142.67 27.73 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.549 0.69 . . . . 73.349999999999994 111.202 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -2.95 11.04 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.692 2.261 . . . . 65.129999999999995 112.355 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.418 ' HB2' HG23 ' A' ' 122' ' ' THR . 21.9 m-20 -80.4 -23.88 40.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 61.43 110.818 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.419 ' HE2' ' HB2' ' A' ' 125' ' ' MET . 13.3 mtm -115.61 166.25 12.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 75.349999999999994 110.839 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.1 t-20 -96.57 144.63 26.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 64.25 110.961 -179.946 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -45.1 -35.73 3.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.178 -0.465 . . . . 74.319999999999993 110.905 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -83.23 -38.66 21.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 73.239999999999995 110.87 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -65.4 -29.8 70.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 73.319999999999993 110.886 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 73.4 t -66.49 -46.35 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 74.010000000000005 111.156 -179.989 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.13 -23.29 47.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 73.340000000000003 110.827 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -74.43 -47.2 35.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 73.530000000000001 110.917 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.79 -31.51 66.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 71.439999999999998 111.124 179.811 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.4 mp -73.29 -54.13 16.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.218 -0.446 . . . . 74.510000000000005 111.146 179.938 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 3.3 ttm180 -49.06 -41.92 36.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 72.209999999999994 110.832 -179.924 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.8 mmpt? -72.43 -34.24 67.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 73.109999999999999 110.867 179.974 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.503 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -60.5 -48.83 80.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 64.150000000000006 111.168 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.615 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.4 m-85 -72.77 -22.1 60.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 74.310000000000002 110.888 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.523 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.1 OUTLIER -78.64 -5.81 53.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 73.400000000000006 110.937 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.403 ' HB ' HG13 ' A' ' 217' ' ' VAL . 93.4 t -97.1 -16.87 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 72.140000000000001 111.109 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.506 ' HA ' HG21 ' A' ' 144' ' ' VAL . 93.6 m95 -106.48 -35.88 6.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 72.109999999999999 110.878 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.62 -11.47 60.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 70.099999999999994 110.851 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.619 ' N ' HD21 ' A' ' 143' ' ' ASN . 0.9 OUTLIER -95.69 -15.74 22.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.505 . . . . 74.549999999999997 111.018 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.506 HG21 ' HA ' ' A' ' 141' ' ' TRP . 20.9 m -101.51 1.21 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 74.030000000000001 111.079 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.52 ' C ' ' H ' ' A' ' 147' ' ' LEU . 17.1 p -150.31 146.69 20.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.539 0.685 . . . . 63.119999999999997 111.149 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 30.53 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.661 2.241 . . . . 74.120000000000005 112.314 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.52 ' H ' ' C ' ' A' ' 145' ' ' THR . 0.8 OUTLIER -93.32 -178.13 4.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 71.519999999999996 110.914 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -144.34 126.5 15.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 71.310000000000002 110.933 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.405 ' HD2' ' HB3' ' A' ' 138' ' ' PHE . 4.0 m-30 -114.52 142.15 46.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 75.030000000000001 110.906 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.8 m -140.78 137.49 33.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 75.109999999999999 110.893 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.484 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.9 OUTLIER -85.88 142.62 28.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 73.400000000000006 110.941 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 18.2 pt -151.07 135.6 9.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 74.409999999999997 111.114 179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -107.49 -5.73 17.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 74.010000000000005 110.918 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.4 p -153.34 53.25 0.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 71.209999999999994 111.254 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -149.74 -155.56 6.85 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.751 -0.738 . . . . 75.120000000000005 112.457 -179.982 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.2 mpp? -107.69 96.82 6.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.88 0.372 . . . . 74.109999999999999 110.805 -179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -104.78 154.87 19.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 74.140000000000001 111.121 179.863 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.22 -52.55 6.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 75.040000000000006 110.853 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.499 HG12 HG21 ' A' ' 220' ' ' ILE . 1.9 mp -89.53 95.88 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 74.310000000000002 111.139 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.2 tp -86.87 110.08 19.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 75.439999999999998 110.857 -179.996 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 87.8 t -89.83 120.54 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 65.530000000000001 111.14 179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.2 p -139.83 104.97 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 72.329999999999998 111.138 179.96 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -71.87 108.75 5.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 73.409999999999997 110.889 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.11 165.71 20.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 74.450000000000003 111.121 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -114.14 138.29 50.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 74.319999999999993 110.922 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.649 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.74 -154.26 0.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.651 -0.785 . . . . 74.109999999999999 112.496 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.809 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -66.88 116.73 8.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.886 0.374 . . . . 74.219999999999999 111.106 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.695 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.88 -22.7 12.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.204 -0.453 . . . . 74.150000000000006 110.897 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.47 29.39 0.54 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 71.010000000000005 112.498 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.646 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.08 1.43 15.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.389 . . . . 73.299999999999997 110.918 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 72.8 40.34 0.6 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.469 . . . . 74.010000000000005 110.868 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.695 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.72 -41.65 0.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 74.200000000000003 110.888 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.809 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.31 99.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 70.409999999999997 111.074 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.649 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.9 m-85 -60.72 -168.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 75.200000000000003 110.866 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.74 18.66 3.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 70.040000000000006 110.866 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.568 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.2 -157.32 7.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 72.120000000000005 112.526 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 176' ' ' GLY . 11.7 tmtt? -35.29 134.52 0.28 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 74.299999999999997 110.879 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.35 165.49 0.14 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.594 -0.812 . . . . 74.439999999999998 112.496 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.81 -143.23 22.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 73.400000000000006 112.47 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -50.13 96.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.375 . . . . 74.019999999999996 111.174 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 13.4 mt -66.82 -39.48 87.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 73.140000000000001 110.934 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -172.08 167.1 6.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 73.349999999999994 111.142 179.691 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.555 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.6 p80 -159.67 139.72 11.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.428 . . . . 75.040000000000006 110.931 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.573 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -137.64 173.44 11.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 71.430000000000007 111.145 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.519 ' O ' ' O ' ' A' ' 222' ' ' HIS . 23.8 m-85 -99.43 -138.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 61.399999999999999 110.818 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -166.98 -99.64 0.14 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.792 -0.718 . . . . 60.350000000000001 112.578 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 59.54 1.66 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.696 2.264 . . . . 73.200000000000003 112.343 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.588 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.06 154.6 16.43 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.748 -0.739 . . . . 74.430000000000007 112.435 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.572 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.52 148.63 26.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.919 0.39 . . . . 72.209999999999994 110.793 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.68 -67.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.718 -0.753 . . . . 64.310000000000002 112.503 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.572 ' N ' ' O ' ' A' ' 189' ' ' SER . 3.6 mt -103.99 6.33 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 74.109999999999999 111.144 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.588 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -63.69 165.29 29.2 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.685 -0.769 . . . . 74.219999999999999 112.511 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 45.05 20.21 0.23 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.73 -0.748 . . . . 62.140000000000001 112.459 -179.937 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 192' ' ' GLY . 0.8 OUTLIER -64.25 105.77 0.97 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.79 0.329 . . . . 72.519999999999996 110.943 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.573 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -82.15 129.62 34.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 74.120000000000005 111.158 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.555 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 11.2 m170 -119.93 129.93 54.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 75.140000000000001 110.878 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.457 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 47.7 m-85 -114.35 134.22 55.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 75.150000000000006 110.909 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -67.25 109.44 3.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 73.319999999999993 110.916 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -60.22 -37.19 79.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 73.340000000000003 110.861 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.568 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 5.3 m-20 -50.45 -22.89 2.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.233 -0.439 . . . . 73.420000000000002 110.885 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -80.17 163.38 24.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 75.209999999999994 110.835 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.548 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -101.43 89.1 3.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 74.349999999999994 110.843 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.457 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 29.5 m95 -80.59 123.26 27.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.177 -0.465 . . . . 64.230000000000004 110.952 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.3 p -141.26 -174.83 4.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 70.299999999999997 111.183 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.36 20.53 16.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 64.439999999999998 111.104 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -127.74 -173.12 2.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 64.340000000000003 110.903 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.3 p -72.11 -18.87 61.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 71.409999999999997 110.836 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.49 -106.58 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 34.219999999999999 112.502 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.05 176.84 0.1 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.694 -0.765 . . . . 71.310000000000002 112.528 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 89.8 m -66.74 97.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.741 0.305 . . . . 73.439999999999998 111.125 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -42.83 116.93 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 73.519999999999996 110.833 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.8 tp -63.29 -37.94 89.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.083 -0.508 . . . . 75.329999999999998 110.94 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -51.32 -63.91 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 71.329999999999998 110.901 179.919 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 8.0 mp -55.51 -54.99 37.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.119 -0.491 . . . . 75.5 110.895 -179.981 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 2.3 m -55.31 -33.95 63.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 75.219999999999999 111.139 179.948 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -67.69 -48.74 65.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 74.310000000000002 111.009 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.503 HG22 ' CB ' ' A' ' 137' ' ' ALA . 2.0 t -53.43 -58.22 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 73.129999999999995 111.067 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.532 ' HB2' HG11 ' A' ' 235' ' ' VAL . 1.8 t-80 -64.46 -28.13 69.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 74.109999999999999 110.775 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -64.39 -44.07 92.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 75.439999999999998 111.104 179.951 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.525 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.6 mt -70.28 -34.26 57.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 70.439999999999998 111.172 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.442 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -51.79 -45.11 55.53 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.713 -0.756 . . . . 64.319999999999993 112.471 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.519 ' O ' ' O ' ' A' ' 185' ' ' PHE . 4.1 m-70 -68.85 -40.61 79.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.849 0.356 . . . . 73.409999999999997 110.89 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.464 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 32.5 p -65.7 -20.2 66.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.11 -0.495 . . . . 74.430000000000007 110.858 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 52.8 mt -80.84 -25.77 37.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 62.530000000000001 110.897 -179.98 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 122.2 13.18 4.96 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.729 -0.748 . . . . 70.200000000000003 112.441 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.442 ' HB2' ' O ' ' A' ' 221' ' ' GLY . 17.6 mt -84.81 155.65 21.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.337 . . . . 73.439999999999998 110.973 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -102.95 -138.21 9.86 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.767 -0.73 . . . . 71.430000000000007 112.458 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.76 138.76 53.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.918 0.39 . . . . 73.25 110.886 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 69.8 p -97.26 166.97 11.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 74.219999999999999 110.88 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.18 3.09 19.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 73.540000000000006 110.84 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -72.3 135.74 81.87 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.683 0.754 . . . . 74.329999999999998 110.844 179.87 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.62 0.25 5.8 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.713 2.275 . . . . 74.150000000000006 112.331 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.05 25.42 1.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 71.430000000000007 110.908 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.419 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -97.48 143.91 27.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.453 . . . . 63.329999999999998 111.082 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.532 HG11 ' HB2' ' A' ' 218' ' ' HIS . 1.3 t -63.84 -41.75 93.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 73.420000000000002 111.118 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 49.9 mmm -60.33 -17.67 44.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.193 -0.458 . . . . 73.430000000000007 110.904 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.604 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.1 t80 -57.79 144.64 73.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.712 0.768 . . . . 75.5 110.78 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.604 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.5 Cg_endo -69.87 -1.23 8.22 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.552 2.168 . . . . 71.510000000000005 112.385 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 23.3 m -96.32 140.97 30.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 72.409999999999997 111.201 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -122.39 134.48 54.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.185 -0.461 . . . . 72.230000000000004 110.978 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -151.99 135.12 15.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 74.329999999999998 110.9 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 82.1 t80 -64.5 143.52 57.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 75.319999999999993 110.889 -179.943 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -161.18 128.92 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 73.420000000000002 111.105 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -50.37 134.69 23.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 75.239999999999995 110.9 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 8.0 tt -51.31 -33.54 14.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 73.239999999999995 111.222 179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 1.2 p30 -65.73 -23.51 66.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 74.120000000000005 110.907 179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 10.5 p -107.0 -21.81 12.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 71.109999999999999 111.143 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -73.43 134.02 43.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 74.409999999999997 110.852 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 24.3 ptt85 -171.23 134.08 0.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 74.230000000000004 110.91 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.446 ' HB3' ' HB2' ' A' ' 254' ' ' ASP . 54.7 mt -48.06 127.28 12.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 73.400000000000006 110.998 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 30.9 t -72.46 164.43 26.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 73.439999999999998 110.894 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -47.95 -37.98 15.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 74.430000000000007 111.103 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.56 -45.29 91.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 75.549999999999997 110.869 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . 0.446 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 12.7 m-20 -61.03 -55.35 33.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 70.209999999999994 110.889 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 1.3 mp -58.99 -34.55 53.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 74.5 111.153 179.977 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 28.7 mmm-85 -68.08 -40.32 82.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 74.519999999999996 110.908 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.406 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -75.59 -50.62 7.92 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.784 -0.722 . . . . 63.530000000000001 112.562 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 5.6 tp -52.38 -34.53 18.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.772 0.32 . . . . 74.430000000000007 111.159 179.933 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.422 ' O ' ' N ' ' A' ' 263' ' ' GLY . 57.5 mt-30 -86.73 -16.94 34.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 75.230000000000004 110.876 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.406 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 3.2 t -69.47 -13.93 62.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 73.299999999999997 110.853 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.37 -17.71 6.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 74.209999999999994 110.935 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 36.1 m-85 -114.74 -33.28 5.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 75.340000000000003 110.859 -179.953 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.313 0 CA-C-O 119.122 -0.821 . . . . 72.209999999999994 112.454 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 101' ' ' ARG . 31.8 m-85 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.849 0.357 . . . . 74.299999999999997 110.902 . . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 100' ' ' PHE . 8.2 ptt-85 36.59 59.67 0.98 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 74.420000000000002 110.882 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.412 ' C ' ' HA3' ' A' ' 227' ' ' GLY . 14.9 tt0 178.09 132.87 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.175 -0.466 . . . . 65.319999999999993 110.875 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -49.96 150.41 4.06 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.574 0.702 . . . . 71.230000000000004 110.895 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -4.58 14.32 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.624 2.216 . . . . 73.299999999999997 112.347 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.29 -33.87 27.61 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.698 -0.763 . . . . 62.020000000000003 112.42 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 134.04 -150.35 19.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.834 -0.698 . . . . 72.109999999999999 112.529 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.421 ' HA ' ' CD2' ' A' ' 261' ' ' LEU . 53.3 Cg_endo -69.71 139.08 39.54 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.732 2.288 . . . . 70.319999999999993 112.331 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.407 HG23 ' CE1' ' A' ' 262' ' ' TYR . 34.5 m -57.08 -174.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 71.340000000000003 111.166 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.448 ' CH2' ' HB3' ' A' ' 158' ' ' ASP . 7.5 m0 -51.42 -23.97 4.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.212 -0.449 . . . . 75.129999999999995 110.861 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 1.2 mtt-85 70.31 23.04 5.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 74.340000000000003 110.852 -179.979 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -123.15 152.86 40.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 70.209999999999994 110.821 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -97.68 23.84 7.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 71.200000000000003 110.829 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -122.34 113.39 19.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 65.129999999999995 110.906 -179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.433 ' CG2' ' N ' ' A' ' 115' ' ' THR . 5.0 mp -142.96 162.18 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 65.109999999999999 111.141 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.433 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.4 OUTLIER -159.05 164.06 35.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 74.109999999999999 111.157 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.645 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.4 p90 -134.23 145.04 48.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 71.420000000000002 110.879 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.4 tmt_? -137.47 106.9 6.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 73.049999999999997 110.83 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 62.0 mt -70.41 104.93 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 75.540000000000006 111.16 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -55.56 -50.84 68.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 63.240000000000002 110.825 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -143.08 166.6 24.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 74.420000000000002 110.87 179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -116.95 148.89 41.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 64.430000000000007 110.959 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 3.2 t -93.67 141.58 24.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.595 0.712 . . . . 74.420000000000002 111.075 -179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -3.42 11.99 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.711 2.274 . . . . 74.239999999999995 112.296 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.63 -29.91 36.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 75.430000000000007 110.93 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 7.3 mtm -107.97 163.73 12.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 73.140000000000001 110.848 -179.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.4 t-20 -94.25 150.3 20.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 75.540000000000006 110.866 -179.976 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.55 -32.93 8.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 74.400000000000006 110.826 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -82.01 -40.44 22.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 60.229999999999997 110.91 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -65.95 -29.1 69.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 74.450000000000003 110.906 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 59.9 t -64.34 -45.62 95.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 75.120000000000005 111.169 179.966 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.12 -24.46 35.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 74.310000000000002 110.866 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -72.3 -46.8 54.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 74.439999999999998 110.908 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.52 -33.95 69.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 63.420000000000002 111.12 179.872 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.4 mp -72.46 -55.11 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 73.319999999999993 111.126 179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.3 ttm180 -48.58 -45.65 38.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.479 . . . . 64.319999999999993 110.874 179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 12.5 mmtt -68.25 -34.72 76.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 72.439999999999998 110.994 179.993 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.481 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -60.69 -48.94 79.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.504 . . . . 52.130000000000003 111.116 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.645 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 94.4 m-85 -72.82 -22.28 60.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 63.109999999999999 110.921 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.535 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.2 OUTLIER -77.35 -5.93 51.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 74.310000000000002 110.969 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.401 ' HB ' HG13 ' A' ' 217' ' ' VAL . 98.0 t -97.2 -17.14 6.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 71.329999999999998 111.101 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.498 ' HA ' HG21 ' A' ' 144' ' ' VAL . 95.3 m95 -106.05 -35.85 7.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 71.219999999999999 110.876 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.39 -11.39 60.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 62.32 110.822 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.613 ' N ' HD21 ' A' ' 143' ' ' ASN . 0.9 OUTLIER -95.81 -17.71 20.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 75.230000000000004 110.879 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.498 HG21 ' HA ' ' A' ' 141' ' ' TRP . 19.4 m -99.09 1.77 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 72.140000000000001 111.092 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.521 ' C ' ' H ' ' A' ' 147' ' ' LEU . 22.9 p -152.11 146.3 18.41 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.544 0.688 . . . . 75.319999999999993 111.168 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 30.1 0.18 Allowed 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.759 2.306 . . . . 71.109999999999999 112.216 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.521 ' H ' ' C ' ' A' ' 145' ' ' THR . 0.1 OUTLIER -90.0 -176.83 5.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.322 -0.399 . . . . 74.219999999999999 110.894 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -145.49 126.12 14.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 74.319999999999993 110.876 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.42 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 4.1 m-30 -115.35 142.42 46.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 72.030000000000001 110.9 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.5 m -141.05 138.78 33.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.483 . . . . 73.439999999999998 110.815 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.485 ' HG3' ' N ' ' A' ' 152' ' ' ILE . 2.9 tptm -88.45 142.9 27.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 71.200000000000003 110.894 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.485 ' N ' ' HG3' ' A' ' 151' ' ' LYS . 14.6 pt -150.88 132.27 4.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 72.030000000000001 111.138 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -99.17 -9.22 24.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 74.409999999999997 110.854 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.3 t -154.31 61.57 0.69 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 73.019999999999996 111.078 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -154.66 -156.22 7.62 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.816 -0.707 . . . . 42.140000000000001 112.452 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 1.0 OUTLIER -105.02 97.66 7.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.708 0.289 . . . . 74.299999999999997 110.846 -179.913 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -107.13 155.35 19.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 71.310000000000002 111.023 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.448 ' HB3' ' CH2' ' A' ' 109' ' ' TRP . 5.8 m-20 -85.34 -53.58 5.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.427 . . . . 74.120000000000005 110.797 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.444 HG12 HG21 ' A' ' 220' ' ' ILE . 2.4 mp -89.43 94.88 5.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.157 -0.474 . . . . 74.219999999999999 111.109 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.2 tp -85.79 109.18 18.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 74.040000000000006 110.888 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.404 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 87.3 t -89.2 124.13 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 72.530000000000001 111.15 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.4 p -143.59 105.73 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 74.430000000000007 111.199 179.864 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -71.8 109.51 5.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 74.430000000000007 110.911 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -130.38 167.27 18.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 74.219999999999999 111.001 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.51 137.29 52.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 73.319999999999993 110.933 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.66 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.98 -155.64 0.14 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.773 -0.727 . . . . 75.510000000000005 112.454 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.809 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -64.5 115.53 5.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 75.109999999999999 111.083 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.69 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.25 -22.19 12.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 75.5 110.895 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.24 29.11 0.56 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.713 -0.756 . . . . 72.140000000000001 112.4 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.635 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.94 1.23 15.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.904 0.383 . . . . 74.230000000000004 110.864 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 72.8 40.24 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 74.209999999999994 110.78 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.69 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.58 -41.17 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 75.120000000000005 110.913 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.809 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.08 99.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 71.150000000000006 111.075 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.66 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -59.88 -169.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 71.340000000000003 110.911 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.96 17.13 4.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 72.439999999999998 110.927 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.4 -156.81 8.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.797 -0.716 . . . . 61.329999999999998 112.496 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 176' ' ' GLY . 7.6 tttp -34.98 134.8 0.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.815 0.34 . . . . 72.109999999999999 110.926 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.28 163.11 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.711 -0.757 . . . . 73.239999999999995 112.448 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.61 -143.6 20.88 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.766 -0.73 . . . . 74.010000000000005 112.571 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -49.66 97.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 75.420000000000002 111.147 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 76.2 mt -69.53 -36.96 76.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 71.140000000000001 111.027 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -174.39 162.4 3.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 75.530000000000001 111.081 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.525 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.6 p80 -155.27 140.97 18.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 70.510000000000005 110.823 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.587 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -138.85 171.92 13.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 73.519999999999996 111.172 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.512 ' O ' ' HA ' ' A' ' 223' ' ' SER . 17.1 m-85 -100.32 -148.91 0.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.258 -0.428 . . . . 63.340000000000003 110.816 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.404 ' H ' ' HB3' ' A' ' 185' ' ' PHE . . . -159.43 -94.76 0.1 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.637 -0.792 . . . . 53.219999999999999 112.454 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.68 58.69 1.53 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.733 2.289 . . . . 75.310000000000002 112.356 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.599 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.0 153.44 16.97 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.729 -0.748 . . . . 72.010000000000005 112.467 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.597 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.5 150.5 24.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.788 0.328 . . . . 71.150000000000006 110.927 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 59.45 -67.42 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.743 -0.742 . . . . 64.519999999999996 112.423 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.597 ' N ' ' O ' ' A' ' 189' ' ' SER . 26.4 pt -103.66 6.05 10.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.896 0.379 . . . . 71.219999999999999 111.202 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.599 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -64.25 165.25 31.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.656 -0.783 . . . . 73.430000000000007 112.446 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 46.68 17.05 0.23 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.704 -0.76 . . . . 61.409999999999997 112.541 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 192' ' ' GLY . 0.9 OUTLIER -61.82 108.33 0.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.831 0.348 . . . . 70.120000000000005 110.83 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.587 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -83.76 130.56 34.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.121 -0.49 . . . . 64.219999999999999 111.182 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.525 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 11.1 m170 -121.2 128.93 52.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.297 -0.411 . . . . 74.510000000000005 110.86 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.523 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 50.5 m-85 -113.85 131.03 56.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.249 -0.432 . . . . 75.140000000000001 110.85 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . 0.403 ' HB3' ' HG2' ' A' ' 201' ' ' GLU . 63.4 t0 -65.52 114.46 4.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 71.010000000000005 110.945 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -68.06 -33.25 74.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 64.329999999999998 110.83 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.582 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 14.5 m-20 -51.07 -21.6 1.96 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.155 -0.475 . . . . 65.530000000000001 110.823 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . 0.403 ' HG2' ' HB3' ' A' ' 198' ' ' ASP . 0.6 OUTLIER -86.4 164.99 16.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 72.140000000000001 110.882 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.465 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -97.86 98.95 10.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 71.540000000000006 110.926 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.523 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 52.5 m95 -86.46 123.86 32.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.203 -0.453 . . . . 73.420000000000002 110.895 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 39.9 p -145.57 -177.04 5.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 73.510000000000005 111.143 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.34 21.27 16.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 75.319999999999993 111.157 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -128.4 -177.48 4.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 75.349999999999994 110.837 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 207' ' ' SER . . . . . 0.407 ' HA ' ' CD2' ' A' ' 242' ' ' TYR . 4.0 t -67.14 -18.81 65.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 74.040000000000006 110.888 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.21 -106.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.868 -0.682 . . . . 71.239999999999995 112.42 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.465 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.76 178.18 0.2 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.726 -0.75 . . . . 74.439999999999998 112.508 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 99.1 m -66.94 98.09 0.53 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.79 0.329 . . . . 65.25 111.187 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -42.15 116.57 0.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 72.109999999999999 110.953 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 8.1 tp -63.49 -38.74 92.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 75.230000000000004 110.941 179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.9 t80 -51.69 -63.45 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 73.530000000000001 110.903 179.908 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 7.7 mp -56.34 -54.43 45.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 65.329999999999998 110.941 -179.983 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.2 m -56.02 -31.0 62.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 74.049999999999997 111.107 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -70.55 -47.42 60.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 75.439999999999998 111.093 179.879 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.481 HG22 ' CB ' ' A' ' 137' ' ' ALA . 2.0 t -54.56 -58.87 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 74.109999999999999 111.082 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.566 ' HB2' HG12 ' A' ' 235' ' ' VAL . 2.2 t-80 -62.37 -29.94 70.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 73.299999999999997 110.888 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -62.51 -45.52 92.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 74.430000000000007 111.129 179.933 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.56 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.5 mt -69.28 -34.94 65.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.428 . . . . 75.010000000000005 111.079 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.93 -44.84 41.14 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.81 -0.71 . . . . 74.25 112.487 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.478 ' O ' ' O ' ' A' ' 185' ' ' PHE . 45.8 m-70 -67.32 -40.67 85.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.744 0.307 . . . . 75.230000000000004 110.806 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.512 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 2.9 m -62.59 -27.33 69.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.242 -0.436 . . . . 64.230000000000004 110.853 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 62.4 mt -74.57 -28.45 60.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 75.099999999999994 110.907 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 121.11 15.17 4.78 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.75 -0.738 . . . . 63.310000000000002 112.455 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.415 HD21 ' HA ' ' A' ' 258' ' ' ILE . 11.6 mt -83.01 156.03 23.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.338 . . . . 75.310000000000002 110.887 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.412 ' HA3' ' C ' ' A' ' 102' ' ' GLU . . . -102.5 -133.29 7.98 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.694 -0.765 . . . . 64.409999999999997 112.52 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.42 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 1.6 m170 -125.7 142.95 51.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 73.439999999999998 110.882 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 38.1 m -104.19 166.06 10.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 62.140000000000001 110.91 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 42.8 m -108.51 1.87 21.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 75.519999999999996 110.908 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -66.31 140.38 96.74 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.592 0.711 . . . . 75.239999999999995 110.824 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.7 -3.35 11.79 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.758 2.305 . . . . 75.430000000000007 112.35 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.45 24.89 1.55 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 75.349999999999994 110.882 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.448 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -88.85 140.39 29.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 75.109999999999999 111.141 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.566 HG12 ' HB2' ' A' ' 218' ' ' HIS . 1.8 t -63.43 -38.06 81.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 70.030000000000001 111.183 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.42 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 32.1 mmm -66.05 -14.06 61.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 75.140000000000001 110.873 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.596 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.5 t80 -57.91 143.62 76.84 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.635 0.731 . . . . 74.310000000000002 110.866 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.596 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.4 Cg_endo -69.77 -1.62 8.8 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.674 2.249 . . . . 75.420000000000002 112.34 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 6.6 m -100.41 139.66 35.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 75.519999999999996 111.073 -179.882 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -118.75 128.66 54.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 73.349999999999994 110.876 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.22 126.27 12.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.043 -0.526 . . . . 71.420000000000002 110.803 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . 0.407 ' CD2' ' HA ' ' A' ' 207' ' ' SER . 35.9 t80 -57.18 147.39 25.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.147 -0.479 . . . . 75.129999999999995 110.897 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -160.07 132.93 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.514 . . . . 74.409999999999997 111.091 179.915 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -46.77 133.59 10.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 61.119999999999997 110.854 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 5.9 tt -53.32 -34.35 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 75.439999999999998 111.181 179.984 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -72.15 -17.05 61.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 72.510000000000005 110.867 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 24.6 p -107.61 -21.91 12.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 73.450000000000003 111.182 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -72.36 137.82 46.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 73.25 110.829 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -174.48 136.8 0.47 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.147 -0.479 . . . . 72.120000000000005 110.882 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.401 HD11 ' O ' ' A' ' 140' ' ' VAL . 29.2 mt -49.78 129.33 19.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 70.400000000000006 110.921 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 32.5 t -71.3 171.0 11.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 72.200000000000003 110.849 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.16 -37.11 69.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.489 . . . . 75.420000000000002 111.186 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -65.3 -47.49 76.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 75.140000000000001 110.856 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -61.99 -52.04 65.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.194 -0.457 . . . . 74.239999999999995 110.825 179.954 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 30.0 mt -61.36 -35.47 66.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 72.430000000000007 111.107 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -69.68 -39.42 77.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 74.340000000000003 110.892 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.48 -50.1 7.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.791 -0.719 . . . . 63.32 112.459 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.415 ' HA ' HD21 ' A' ' 226' ' ' LEU . 7.0 tp -52.07 -35.25 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.703 0.287 . . . . 74.129999999999995 111.115 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 263' ' ' GLY . 72.1 mt-30 -87.32 -16.68 34.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 74.420000000000002 110.897 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.9 t -70.85 -14.54 62.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 72.209999999999994 110.896 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.421 ' CD2' ' HA ' ' A' ' 107' ' ' PRO . 5.3 mt -121.95 -18.92 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 71.439999999999998 110.868 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.407 ' CE1' HG23 ' A' ' 108' ' ' VAL . 33.6 m-85 -113.12 -34.37 5.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.248 -0.433 . . . . 74.299999999999997 110.951 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.335 0 CA-C-O 119.097 -0.835 . . . . 72.299999999999997 112.545 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.837 0.351 . . . . 73.230000000000004 110.907 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 55.46 51.88 12.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 74.120000000000005 110.86 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER 176.84 146.3 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 70.109999999999999 110.906 -179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.471 ' HG3' ' HD2' ' A' ' 104' ' ' PRO . 0.0 OUTLIER -50.82 146.44 10.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.565 0.698 . . . . 71.319999999999993 110.917 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.471 ' HD2' ' HG3' ' A' ' 103' ' ' MET . 54.0 Cg_endo -69.78 79.43 0.95 Allowed 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 122.685 2.257 . . . . 75.439999999999998 112.371 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 144.79 -119.11 1.2 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.761 -0.733 . . . . 62.229999999999997 112.512 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.527 ' N ' ' CD ' ' A' ' 107' ' ' PRO . . . -159.0 47.83 0.42 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.684 -0.77 . . . . 63.310000000000002 112.431 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 106' ' ' GLY . 54.1 Cg_endo -69.72 -30.19 22.85 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.766 2.311 . . . . 72.439999999999998 112.3 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 21.0 m -44.4 138.94 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 75.519999999999996 111.185 179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 3.0 m0 -64.11 -26.97 68.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 73.430000000000007 110.859 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 47.7 mtp180 61.83 33.65 17.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.408 . . . . 71.120000000000005 110.882 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.76 158.29 30.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 73.530000000000001 110.983 179.978 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -101.69 31.36 3.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 74.129999999999995 110.868 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -134.2 106.71 7.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 73.25 110.939 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.426 ' CG2' ' N ' ' A' ' 115' ' ' THR . 4.7 mp -138.13 162.71 30.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.478 . . . . 74.0 111.179 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.426 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.5 OUTLIER -158.65 163.8 36.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 71.420000000000002 111.113 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.598 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.0 p90 -132.73 149.02 52.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 74.430000000000007 110.928 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -143.93 112.4 6.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.083 -0.508 . . . . 75.019999999999996 110.862 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.0 mt -72.79 106.64 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 74.409999999999997 111.151 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -60.17 -46.38 89.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 75.129999999999995 110.949 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -146.46 166.08 27.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 71.319999999999993 110.892 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -117.47 139.33 51.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 73.150000000000006 110.87 -179.869 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.543 HG21 ' HB2' ' A' ' 124' ' ' ASP . 1.0 OUTLIER -91.22 139.31 25.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.549 0.69 . . . . 71.049999999999997 111.183 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.444 ' HD2' HG23 ' A' ' 122' ' ' THR . 54.2 Cg_endo -69.75 42.16 0.34 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.742 2.295 . . . . 72.230000000000004 112.353 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.543 ' HB2' HG21 ' A' ' 122' ' ' THR . 2.3 m-20 -126.85 -25.61 3.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 63.200000000000003 110.764 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -110.69 165.22 12.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.328 -0.396 . . . . 61.350000000000001 110.861 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -94.45 142.2 27.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 72.430000000000007 110.882 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -44.22 -36.38 2.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 73.099999999999994 110.892 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -83.85 -39.18 20.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 73.400000000000006 110.91 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -63.52 -33.25 75.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.495 . . . . 61.420000000000002 110.888 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 73.8 t -63.38 -46.58 95.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.214 -0.448 . . . . 70.109999999999999 111.16 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.463 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -78.71 -23.62 45.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 74.140000000000001 110.814 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -75.53 -49.42 18.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 75.230000000000004 110.909 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.57 -30.48 69.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.502 . . . . 61.039999999999999 111.124 179.888 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.2 mp -74.15 -54.65 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 72.109999999999999 111.175 179.93 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.463 ' HB3' ' O ' ' A' ' 131' ' ' ASP . 3.3 ptm180 -49.08 -37.39 21.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.264 -0.425 . . . . 75.450000000000003 110.93 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.2 mmpt? -75.48 -36.02 60.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 73.510000000000005 110.942 179.998 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.512 ' HA ' HG21 ' A' ' 217' ' ' VAL . . . -59.87 -49.53 77.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 74.430000000000007 111.091 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.598 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 92.1 m-85 -70.71 -22.7 62.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 74.319999999999993 110.935 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.565 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.9 tt0 -77.4 -7.09 55.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 75.340000000000003 110.867 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.427 ' HB ' HG13 ' A' ' 217' ' ' VAL . 89.6 t -95.75 -17.28 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 72.209999999999994 111.138 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.499 ' HA ' HG21 ' A' ' 144' ' ' VAL . 95.9 m95 -106.11 -36.12 7.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 73.209999999999994 110.958 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -11.37 60.87 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.258 -0.428 . . . . 72.400000000000006 110.867 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.612 ' N ' HD21 ' A' ' 143' ' ' ASN . 0.9 OUTLIER -95.3 -17.68 21.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 72.200000000000003 110.906 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.499 HG21 ' HA ' ' A' ' 141' ' ' TRP . 18.2 m -99.38 1.77 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 72.230000000000004 111.112 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.523 ' C ' ' H ' ' A' ' 147' ' ' LEU . 22.8 p -152.48 146.56 18.42 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.576 0.703 . . . . 75.219999999999999 111.103 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 29.72 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.788 2.325 . . . . 73.439999999999998 112.297 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.523 ' H ' ' C ' ' A' ' 145' ' ' THR . 0.7 OUTLIER -91.15 179.22 5.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 73.109999999999999 110.924 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -141.53 126.17 17.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.430000000000007 110.894 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.7 m-30 -115.41 143.72 44.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 75.219999999999999 110.911 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.9 t -140.23 151.78 45.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 75.109999999999999 110.833 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.44 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 10.2 tttp -101.59 145.21 29.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 74.319999999999993 110.804 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 21.6 pt -151.74 143.54 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 72.0 111.038 179.892 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -105.26 -11.44 16.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 73.340000000000003 110.831 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.1 t -157.73 62.96 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 73.230000000000004 111.068 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -149.8 -155.08 6.64 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.749 -0.738 . . . . 62.140000000000001 112.528 179.885 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 36.3 mmt -106.94 91.7 3.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.773 0.321 . . . . 75.420000000000002 110.836 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -103.15 156.31 17.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 70.140000000000001 111.109 179.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.82 -52.31 5.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 75.310000000000002 110.811 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.503 HG12 HG21 ' A' ' 220' ' ' ILE . 1.9 mp -89.7 94.9 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 71.040000000000006 111.1 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.4 tp -87.17 109.28 19.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 75.239999999999995 110.849 179.957 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 83.9 t -87.33 120.48 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 75.319999999999993 111.157 179.82 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.2 p -139.52 106.51 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 73.430000000000007 111.168 179.982 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.403 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 41.6 m-85 -74.1 112.32 10.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 74.519999999999996 110.952 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.79 168.4 17.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.151 -0.477 . . . . 72.109999999999999 111.084 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.419 ' CG ' ' HB3' ' A' ' 199' ' ' GLU . 37.8 mtp180 -113.07 137.6 51.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 73.239999999999995 110.843 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.641 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 41.18 -151.99 0.13 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.841 -0.695 . . . . 74.209999999999994 112.486 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.813 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -66.41 117.3 8.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.875 0.369 . . . . 74.019999999999996 111.061 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.711 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -109.27 -20.22 13.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 73.230000000000004 110.9 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 129.85 30.03 0.66 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.771 -0.728 . . . . 74.430000000000007 112.478 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.635 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.72 0.21 14.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 71.230000000000004 110.826 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 74.25 38.73 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 71.420000000000002 110.872 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.711 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.3 -41.2 0.81 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 65.349999999999994 110.806 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.813 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.36 99.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 65.329999999999998 111.074 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.641 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.7 m-85 -60.23 -168.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 71.510000000000005 110.8 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.89 19.6 3.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.093 -0.503 . . . . 70.019999999999996 110.898 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.564 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 53.25 -157.8 4.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.773 -0.727 . . . . 42.399999999999999 112.461 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.2 OUTLIER -33.82 134.27 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 73.340000000000003 110.926 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.32 165.66 0.15 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.677 -0.773 . . . . 73.510000000000005 112.508 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.3 -144.06 23.26 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.714 -0.755 . . . . 53.32 112.537 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -49.44 97.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 60.520000000000003 111.177 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.79 -41.28 87.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.097 -0.501 . . . . 73.400000000000006 110.938 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -170.96 169.16 6.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 74.409999999999997 111.123 179.786 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.471 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.2 p80 -163.75 143.48 8.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.254 -0.43 . . . . 74.150000000000006 110.824 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.555 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -138.09 173.23 11.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 73.129999999999995 111.069 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.52 ' O ' ' HA ' ' A' ' 223' ' ' SER . 54.0 m-85 -98.82 -140.88 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 62.409999999999997 110.831 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -171.56 -87.57 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.748 -0.739 . . . . 71.109999999999999 112.493 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 54.21 1.12 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.648 2.232 . . . . 75.439999999999998 112.357 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.566 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.16 149.56 16.83 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 41.149999999999999 112.452 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.64 145.72 29.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.988 0.423 . . . . 74.049999999999997 110.804 -179.766 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.64 -63.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.799 -0.715 . . . . 73.219999999999999 112.479 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.524 ' N ' ' O ' ' A' ' 189' ' ' SER . 5.5 tp -105.29 6.54 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 73.299999999999997 111.14 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.566 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -67.82 169.78 37.7 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.803 -0.713 . . . . 61.299999999999997 112.442 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 45.32 18.9 0.2 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 64.109999999999999 112.561 -179.886 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 192' ' ' GLY . 0.9 OUTLIER -63.15 103.41 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 71.099999999999994 110.913 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.555 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -77.76 131.15 37.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.223 -0.444 . . . . 63.450000000000003 111.067 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.471 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.7 m170 -121.37 130.23 53.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.45 . . . . 73.299999999999997 110.856 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.476 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 41.8 m-85 -115.13 134.22 55.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 73.430000000000007 110.88 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -67.52 104.69 1.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 71.329999999999998 110.886 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.419 ' HB3' ' CG ' ' A' ' 165' ' ' ARG . 4.2 tm-20 -57.24 -36.7 71.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 75.109999999999999 110.875 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.564 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 14.3 m-20 -50.41 -22.18 1.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 73.310000000000002 110.839 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -82.12 164.21 21.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 74.549999999999997 110.816 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.533 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -100.73 91.77 4.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 75.340000000000003 110.892 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.476 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 33.1 m95 -82.64 123.54 29.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.155 -0.475 . . . . 73.549999999999997 110.887 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.7 p -140.3 -172.4 3.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 74.430000000000007 111.164 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.6 17.34 17.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 71.5 111.098 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.26 -176.59 3.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 74.510000000000005 110.782 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.2 p -66.06 -18.54 65.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 72.430000000000007 110.951 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.91 -108.85 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.799 -0.715 . . . . 52.140000000000001 112.496 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.38 178.26 0.15 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.76 -0.733 . . . . 73.329999999999998 112.495 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 90.0 m -66.52 97.69 0.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.83 0.347 . . . . 72.439999999999998 111.185 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -41.65 116.83 0.83 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.446 . . . . 72.319999999999993 110.908 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 17.4 tp -63.88 -36.01 82.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 75.430000000000007 110.894 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -53.68 -64.27 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 71.150000000000006 110.855 179.986 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 19.3 mt -54.81 -54.32 43.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 71.239999999999995 110.913 179.99 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 2.5 m -54.53 -34.64 62.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 72.239999999999995 111.212 179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.77 -48.98 70.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 72.340000000000003 111.159 179.771 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.512 HG21 ' HA ' ' A' ' 137' ' ' ALA . 0.8 OUTLIER -52.5 -58.89 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 71.019999999999996 111.127 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.574 ' HB2' HG12 ' A' ' 235' ' ' VAL . 3.4 t-80 -63.29 -29.38 70.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 70.310000000000002 110.932 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -63.84 -44.5 92.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 75.209999999999994 111.111 179.963 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.565 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.4 mt -71.03 -34.23 54.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 64.450000000000003 111.108 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.428 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -52.63 -44.81 60.16 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.76 -0.734 . . . . 71.5 112.392 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.508 ' O ' ' O ' ' A' ' 185' ' ' PHE . 3.4 m-70 -69.46 -40.85 76.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 74.239999999999995 110.913 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.52 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 43.9 p -64.38 -20.55 66.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 75.129999999999995 110.842 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 61.3 mt -81.74 -26.03 34.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 74.299999999999997 110.886 -179.92 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 121.97 10.49 6.27 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.784 -0.722 . . . . 71.310000000000002 112.454 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.428 ' HB2' ' O ' ' A' ' 221' ' ' GLY . 46.0 mt -79.77 149.41 31.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.865 0.364 . . . . 75.329999999999998 110.935 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -95.35 -141.35 11.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.737 -0.745 . . . . 62.43 112.558 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -119.08 142.6 47.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.801 0.334 . . . . 74.540000000000006 110.86 179.997 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 49.3 m -103.5 163.65 12.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 74.430000000000007 110.913 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.4 t -108.51 0.74 21.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.489 . . . . 65.310000000000002 110.891 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.14 141.57 98.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.601 0.715 . . . . 71.239999999999995 110.883 179.966 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 -3.84 12.88 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.695 2.263 . . . . 70.299999999999997 112.352 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -144.27 25.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 70.400000000000006 110.806 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.444 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -89.28 139.21 30.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 71.209999999999994 111.025 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.574 HG12 ' HB2' ' A' ' 218' ' ' HIS . 1.7 t -62.42 -37.92 79.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 74.340000000000003 111.126 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 37.1 mmm -65.79 -14.41 61.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 75.310000000000002 110.899 179.89 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.606 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.4 t80 -58.69 143.93 81.19 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.61 0.719 . . . . 72.040000000000006 110.91 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.606 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.1 Cg_endo -69.71 -0.99 7.67 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.689 2.259 . . . . 64.030000000000001 112.405 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 17.0 m -98.52 139.65 33.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.127 -0.488 . . . . 74.129999999999995 111.249 179.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -122.1 133.34 54.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 71.409999999999997 110.96 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -151.87 134.43 15.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 75.430000000000007 110.927 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 83.2 t80 -59.62 144.8 46.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.45 . . . . 74.340000000000003 110.947 -179.958 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -160.33 131.66 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 73.120000000000005 111.114 179.956 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -53.95 134.8 43.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 53.109999999999999 110.912 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 7.2 tt -54.2 -29.74 19.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 75.299999999999997 111.104 -179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -70.96 -19.47 62.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 74.340000000000003 110.933 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.9 p -111.21 -20.28 12.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 75.340000000000003 111.145 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 10.2 t80 -74.44 133.91 42.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 74.409999999999997 110.88 179.996 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.1 136.13 1.42 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 73.310000000000002 110.931 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.401 ' HB3' ' HB2' ' A' ' 254' ' ' ASP . 36.5 mt -48.65 127.38 13.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 72.340000000000003 110.927 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.6 p -69.77 164.6 23.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 74.129999999999995 110.866 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.14 -34.77 32.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 74.25 111.093 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.52 -48.02 68.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 74.209999999999994 110.864 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . 0.401 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 8.9 m-20 -61.27 -50.87 71.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 73.319999999999993 110.878 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 31.5 mt -61.83 -35.1 65.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 74.430000000000007 111.155 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -69.5 -39.23 77.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 74.129999999999995 110.908 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.32 -50.27 8.51 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.737 -0.744 . . . . 71.010000000000005 112.536 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 5.6 tp -52.56 -35.29 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.812 0.339 . . . . 74.349999999999994 111.091 -179.923 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.422 ' O ' ' N ' ' A' ' 263' ' ' GLY . 74.7 mt-30 -86.77 -16.45 36.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 74.409999999999997 110.882 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.0 t -70.31 -13.77 62.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 65.010000000000005 110.845 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.1 mt -123.59 -18.06 6.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 73.140000000000001 110.961 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 37.3 m-85 -115.31 -33.56 5.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 75.25 110.861 -179.959 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.453 -0.227 0 CA-C-O 119.13 -0.817 . . . . 71.230000000000004 112.419 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 18.1 p90 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.914 0.388 . . . . 74.239999999999995 110.952 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 176.72 -175.59 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 74.420000000000002 110.879 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -39.79 148.69 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 74.430000000000007 110.883 -179.948 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.82 161.17 0.7 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.536 0.684 . . . . 70.510000000000005 110.884 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -7.1 20.18 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.701 2.267 . . . . 75.129999999999995 112.359 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -160.33 45.35 0.42 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.734 -0.746 . . . . 61.520000000000003 112.51 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -108.74 87.32 0.48 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.753 -0.736 . . . . 71.200000000000003 112.501 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 84.48 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.664 2.242 . . . . 74.150000000000006 112.326 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.1 p -46.77 160.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 64.299999999999997 111.174 179.832 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 4.1 m0 -68.02 -22.33 64.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 75.099999999999994 110.908 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 66.03 27.78 10.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.301 -0.409 . . . . 72.319999999999993 110.925 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.64 149.29 44.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 74.430000000000007 110.923 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.2 p80 -96.91 19.35 12.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.317 -0.401 . . . . 75.329999999999998 110.892 179.837 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -121.62 101.18 7.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.458 . . . . 73.439999999999998 110.87 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.449 ' CG2' ' N ' ' A' ' 115' ' ' THR . 5.1 mp -126.77 162.25 31.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 73.310000000000002 111.156 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.449 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -155.9 166.91 32.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 74.319999999999993 111.188 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.634 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.5 p90 -137.16 146.27 44.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 73.400000000000006 110.909 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.4 ' HB3' HD13 ' A' ' 160' ' ' LEU . 3.7 tmm_? -139.2 112.46 8.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 75.299999999999997 110.945 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.1 mt -74.08 105.7 3.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.202 -0.454 . . . . 74.450000000000003 111.108 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -57.75 -47.57 82.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 73.549999999999997 110.919 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -144.82 163.81 32.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.116 -0.493 . . . . 74.150000000000006 110.914 179.953 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.4 m-85 -116.01 139.63 50.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 63.310000000000002 110.902 -179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.417 HG21 ' HB2' ' A' ' 124' ' ' ASP . 2.5 t -89.95 142.62 29.04 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.608 0.718 . . . . 75.319999999999993 111.138 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -3.99 13.16 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.638 2.225 . . . . 74.549999999999997 112.344 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.417 ' HB2' HG21 ' A' ' 122' ' ' THR . 21.8 m-20 -79.28 -23.28 43.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 75.329999999999998 110.901 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.427 ' HE2' ' HB2' ' A' ' 125' ' ' MET . 12.9 mtm -115.99 166.15 12.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 71.439999999999998 110.878 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -97.23 145.03 26.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 74.040000000000006 110.836 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -45.58 -35.39 3.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 72.140000000000001 110.864 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -82.47 -38.84 23.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 74.329999999999998 110.891 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -65.31 -29.44 70.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 62.420000000000002 110.903 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.48 ' HA ' ' CD2' ' A' ' 212' ' ' LEU . 65.4 t -66.04 -45.34 90.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 73.340000000000003 111.153 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.69 -23.29 42.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 74.230000000000004 110.842 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -74.55 -46.81 36.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.447 . . . . 75.209999999999994 110.958 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -72.34 -31.12 65.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.099 -0.501 . . . . 75.409999999999997 111.118 179.868 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.3 mp -72.71 -54.97 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 73.120000000000005 111.172 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.3 ttt180 -48.66 -43.2 36.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 72.030000000000001 110.868 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.9 mmpt? -70.64 -34.57 72.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 74.349999999999994 110.991 179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.501 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -60.41 -49.24 78.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 65.439999999999998 111.103 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.634 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.9 m-85 -72.29 -22.82 61.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 74.450000000000003 110.884 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.496 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.8 tt0 -76.87 -5.57 48.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 72.109999999999999 110.937 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 85.9 t -98.83 -16.82 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 74.329999999999998 111.19 179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.484 ' HA ' HG21 ' A' ' 144' ' ' VAL . 94.9 m95 -107.37 -37.16 6.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.174 -0.466 . . . . 74.219999999999999 110.9 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.67 -11.92 60.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 73.230000000000004 110.775 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.579 ' N ' HD21 ' A' ' 143' ' ' ASN . 1.0 OUTLIER -95.21 -16.3 22.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 72.420000000000002 110.974 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.484 HG21 ' HA ' ' A' ' 141' ' ' TRP . 19.5 m -98.8 0.67 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 74.030000000000001 111.182 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.511 ' C ' ' H ' ' A' ' 147' ' ' LEU . 62.6 p -150.19 149.14 26.34 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.637 0.732 . . . . 74.140000000000001 111.204 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 32.84 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.675 2.25 . . . . 74.200000000000003 112.357 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.511 ' H ' ' C ' ' A' ' 145' ' ' THR . 13.8 mt -97.98 177.62 5.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 75.400000000000006 110.884 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.42 126.18 18.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 72.129999999999995 110.862 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.414 ' CD1' ' HB ' ' A' ' 114' ' ' ILE . 3.6 m-30 -114.44 143.78 44.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.425 . . . . 74.010000000000005 110.878 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.38 152.51 49.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.483 . . . . 74.409999999999997 110.856 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.3 OUTLIER -100.08 148.27 24.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.489 . . . . 73.409999999999997 110.879 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 3.9 pt -152.12 168.87 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.146 -0.479 . . . . 74.120000000000005 111.07 179.897 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.51 15.88 2.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 75.140000000000001 110.892 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.3 p -93.55 -54.34 3.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 74.200000000000003 111.192 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 146.38 7.29 0.32 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.804 -0.713 . . . . 73.540000000000006 112.52 179.942 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 36.9 mmt -106.98 76.52 1.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.828 0.347 . . . . 73.310000000000002 110.862 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -145.85 162.97 36.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 50.310000000000002 111.131 179.935 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.8 -53.36 5.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 75.219999999999999 110.864 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.455 HG12 HG21 ' A' ' 220' ' ' ILE . 2.6 mp -90.51 96.22 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.228 -0.442 . . . . 74.049999999999997 111.075 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.4 HD13 ' HB3' ' A' ' 117' ' ' ARG . 8.0 tp -87.03 109.57 19.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 73.319999999999993 110.861 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 93.9 t -89.09 120.07 37.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 75.319999999999993 111.145 179.814 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.4 p -139.76 105.21 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 72.430000000000007 111.066 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -72.69 108.22 5.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 74.030000000000001 110.886 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.05 166.08 19.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 72.140000000000001 111.207 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.99 137.98 50.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.262 -0.426 . . . . 73.299999999999997 110.893 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.652 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.09 -156.03 0.14 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.721 -0.752 . . . . 74.430000000000007 112.453 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.807 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -64.58 116.55 6.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.769 0.319 . . . . 64.340000000000003 111.101 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.13 -21.48 12.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 74.040000000000006 110.849 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.32 29.38 0.6 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.683 -0.77 . . . . 62.009999999999998 112.507 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.647 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.33 1.36 15.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 64.430000000000007 110.945 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 72.63 40.22 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 73.319999999999993 110.956 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.51 -41.64 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 72.109999999999999 110.819 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.807 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.52 100.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 74.299999999999997 111.079 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.652 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.9 m-85 -60.87 -168.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 70.140000000000001 110.865 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.87 19.43 3.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 51.210000000000001 110.918 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.573 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.43 -156.63 8.93 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.783 -0.722 . . . . 72.150000000000006 112.475 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -37.67 136.54 0.52 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.855 0.359 . . . . 64.129999999999995 110.864 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.97 163.98 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 72.450000000000003 112.48 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.92 -142.28 21.46 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.813 -0.708 . . . . 63.420000000000002 112.479 -179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.56 95.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 63.420000000000002 111.104 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.9 mm? -65.86 -43.56 88.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 75.530000000000001 110.904 179.946 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -169.99 162.62 9.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 61.310000000000002 111.063 179.787 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.529 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.5 p80 -154.37 140.9 18.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.235 -0.439 . . . . 72.329999999999998 110.81 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.587 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -138.46 172.92 12.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.174 -0.466 . . . . 74.400000000000006 111.133 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 223' ' ' SER . 13.0 m-85 -101.53 -148.46 0.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 64.319999999999993 110.891 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -159.0 -96.31 0.11 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.789 -0.719 . . . . 52.229999999999997 112.531 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 59.31 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.799 2.333 . . . . 74.519999999999996 112.301 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.591 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.98 153.51 16.78 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.772 -0.728 . . . . 70.019999999999996 112.531 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.575 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.18 148.39 26.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.887 0.375 . . . . 74.519999999999996 110.862 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.55 -66.94 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.746 -0.74 . . . . 72.319999999999993 112.416 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 189' ' ' SER . 1.1 mp -103.58 6.08 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.807 0.337 . . . . 74.120000000000005 111.135 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.591 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -63.93 165.29 30.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.697 -0.763 . . . . 63.329999999999998 112.481 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 45.51 19.07 0.24 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.789 -0.719 . . . . 71.310000000000002 112.473 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 192' ' ' GLY . 0.8 OUTLIER -63.67 107.65 1.22 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.88 0.371 . . . . 72.430000000000007 110.795 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.587 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -82.71 128.95 34.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 71.140000000000001 111.089 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.529 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 9.2 m170 -120.04 130.16 54.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 74.25 110.886 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.501 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 44.2 m-85 -115.29 133.72 55.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 75.109999999999999 110.849 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -66.92 110.15 3.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 74.099999999999994 110.857 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.25 -37.67 81.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 62.119999999999997 110.878 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.573 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 5.5 m-20 -50.62 -21.48 1.59 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 74.400000000000006 110.807 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -81.52 162.47 23.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.308 -0.406 . . . . 73.430000000000007 110.879 -179.918 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.535 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.4 OUTLIER -100.54 90.0 4.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 71.450000000000003 110.85 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.501 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 27.0 m95 -81.6 121.72 26.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 74.540000000000006 110.951 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 40.6 p -140.21 -175.72 4.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.434 . . . . 73.329999999999998 111.112 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.93 20.79 17.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.455 . . . . 73.010000000000005 111.201 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -127.91 -176.45 3.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 75.239999999999995 110.766 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.2 p -68.96 -19.18 64.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 63.299999999999997 110.882 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.48 -107.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 72.239999999999995 112.39 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.535 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -51.9 175.89 0.12 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.718 -0.753 . . . . 54.219999999999999 112.432 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 43.7 m -64.3 98.81 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.786 0.327 . . . . 74.329999999999998 111.173 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -44.96 115.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 74.040000000000006 110.834 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.48 ' CD2' ' HA ' ' A' ' 130' ' ' VAL . 12.5 tp -60.33 -39.12 85.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 74.109999999999999 110.834 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -51.67 -63.66 1.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 75.219999999999999 110.935 179.949 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 8.6 mp -54.43 -55.46 28.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 72.109999999999999 110.929 -180.0 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.3 m -54.81 -36.15 64.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 73.510000000000005 111.197 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.32 -48.55 72.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 52.119999999999997 111.152 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.501 HG22 ' CB ' ' A' ' 137' ' ' ALA . 2.1 t -53.8 -57.93 4.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.166 -0.47 . . . . 70.450000000000003 111.201 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.518 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.8 t-80 -64.48 -28.16 69.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 73.019999999999996 110.847 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -64.68 -45.42 86.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 73.340000000000003 111.071 179.906 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.532 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.4 mt -69.5 -35.78 68.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 74.219999999999999 111.094 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.67 -44.74 38.66 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.848 -0.692 . . . . 72.140000000000001 112.402 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.461 ' O ' ' O ' ' A' ' 185' ' ' PHE . 3.8 m-70 -68.85 -39.37 79.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 75.329999999999998 110.851 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.523 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 5.0 m -63.05 -25.61 68.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 73.299999999999997 110.814 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 40.3 mt -77.29 -26.1 51.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 73.439999999999998 110.912 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 122.21 15.23 4.26 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.773 -0.727 . . . . 70.099999999999994 112.466 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 40.4 mt -82.18 155.66 24.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.779 0.324 . . . . 71.310000000000002 110.944 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -104.89 -140.68 10.48 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.699 -0.762 . . . . 70.340000000000003 112.473 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -120.97 149.45 42.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.754 0.311 . . . . 74.409999999999997 110.87 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.515 ' N ' ' HB3' ' A' ' 236' ' ' MET . 43.8 m -116.66 164.14 15.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 72.530000000000001 110.781 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.26 4.38 33.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.038 -0.528 . . . . 74.310000000000002 110.881 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -69.68 135.77 88.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.49 0.662 . . . . 75.099999999999994 110.978 179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.57 -1.34 8.15 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.759 2.306 . . . . 72.310000000000002 112.356 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.8 23.95 1.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 75.209999999999994 110.89 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.466 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -99.19 130.36 45.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 75.019999999999996 111.098 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.518 HG13 ' HB2' ' A' ' 218' ' ' HIS . 2.0 t -54.59 -31.49 23.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 74.209999999999994 111.164 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.515 ' HB3' ' N ' ' A' ' 229' ' ' SER . 0.0 OUTLIER -65.61 -14.24 60.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 71.340000000000003 110.883 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.574 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.4 t80 -64.06 143.06 98.27 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.623 0.725 . . . . 75.329999999999998 110.866 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.574 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.7 Cg_endo -69.77 -7.53 21.3 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.688 2.259 . . . . 64.230000000000004 112.381 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.1 m -92.87 149.81 21.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 75.230000000000004 111.048 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -125.82 137.39 53.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 74.329999999999998 110.905 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -152.63 128.94 10.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 71.530000000000001 110.877 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -58.4 145.82 37.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 73.040000000000006 110.926 -179.928 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -160.35 132.21 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 72.120000000000005 111.082 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -46.86 135.2 9.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 71.109999999999999 110.892 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 7.3 tt -53.97 -33.49 24.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.479 . . . . 73.030000000000001 111.154 179.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -73.49 -17.19 61.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 73.209999999999994 110.905 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 24.5 p -106.01 -23.2 12.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 72.200000000000003 111.185 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -73.06 130.59 40.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 73.150000000000006 110.881 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -166.37 136.6 3.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 74.230000000000004 110.84 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.407 ' HB3' ' HB2' ' A' ' 254' ' ' ASP . 50.8 mt -50.41 124.91 11.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 74.340000000000003 110.99 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.73 170.37 12.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 73.230000000000004 110.858 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.85 -40.96 61.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 74.150000000000006 111.075 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.31 -47.6 85.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.29 -0.414 . . . . 70.420000000000002 110.844 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . 0.407 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 31.0 m-20 -61.3 -54.76 39.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 74.129999999999995 110.846 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 22.7 mt -60.73 -32.84 52.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 73.540000000000006 111.123 179.992 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -68.97 -41.31 78.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 75.209999999999994 110.845 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.5 -49.66 8.96 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.744 -0.741 . . . . 70.109999999999999 112.418 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 8.3 tp -53.34 -34.34 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.359 . . . . 75.409999999999997 111.107 -179.929 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.426 ' O ' ' N ' ' A' ' 263' ' ' GLY . 49.2 mt-30 -87.67 -16.25 34.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.464 . . . . 74.140000000000001 110.919 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.4 t -69.63 -14.73 62.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 74.540000000000006 110.83 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.22 -18.68 6.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 72.299999999999997 110.879 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 40.6 m-85 -114.22 -33.06 5.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 74.120000000000005 110.942 179.977 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.426 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.347 0 CA-C-O 119.085 -0.842 . . . . 72.230000000000004 112.552 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 15.9 p90 . . . . . 0 CA--C 1.527 0.064 0 CA-C-O 120.84 0.352 . . . . 75.099999999999994 110.873 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 175.94 -175.89 0.11 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 70.439999999999998 110.856 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.1 pp20? -39.57 146.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.186 -0.461 . . . . 74.400000000000006 110.887 -179.916 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 12.4 tpp -56.14 136.28 74.49 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.547 0.689 . . . . 71.549999999999997 110.908 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 78.39 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.651 2.234 . . . . 65.129999999999995 112.389 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 126.46 14.81 2.84 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 60.43 112.461 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -109.33 85.54 0.41 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.719 -0.753 . . . . 64.409999999999997 112.397 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.83 95.99 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.726 2.284 . . . . 62.5 112.346 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.5 m -51.86 171.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.162 -0.472 . . . . 75.420000000000002 111.129 179.957 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 5.7 m0 -64.31 -29.67 70.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 75.239999999999995 110.949 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 44.3 mtm-85 65.72 33.29 8.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 72.329999999999998 110.9 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -121.62 171.07 9.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 73.120000000000005 110.957 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.426 ' HA ' ' HG ' ' A' ' 147' ' ' LEU . 1.7 p80 -114.4 30.14 7.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.353 -0.385 . . . . 65.439999999999998 110.891 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -136.47 108.38 7.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 74.230000000000004 110.955 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.423 ' CG2' ' N ' ' A' ' 115' ' ' THR . 5.1 mp -136.97 161.26 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 74.439999999999998 111.176 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.423 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.5 OUTLIER -158.41 163.5 37.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 74.040000000000006 111.108 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.634 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.9 p90 -133.04 145.85 51.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 73.319999999999993 110.924 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.56 115.2 10.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 73.329999999999998 110.863 -179.965 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 62.8 mt -76.58 107.78 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 75.019999999999996 111.128 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -60.49 -49.4 77.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 73.329999999999998 110.863 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -142.1 167.56 21.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 63.399999999999999 110.902 -179.976 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -118.4 148.93 42.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 110.933 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.515 ' C ' ' H ' ' A' ' 124' ' ' ASP . 87.7 m -100.21 135.48 20.3 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.551 0.691 . . . . 72.409999999999997 111.187 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.73 21.22 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.611 2.207 . . . . 72.409999999999997 112.347 179.936 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.515 ' H ' ' C ' ' A' ' 122' ' ' THR . 1.6 m-20 -101.12 -24.75 14.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.224 -0.444 . . . . 74.420000000000002 110.879 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.403 ' HE3' HG21 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -116.19 166.2 12.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 73.430000000000007 110.835 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -89.56 147.93 23.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 74.219999999999999 110.86 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -47.87 -35.27 10.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 74.329999999999998 110.92 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -81.88 -37.21 27.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 74.329999999999998 110.891 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 76.1 m-20 -64.86 -31.41 72.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 74.310000000000002 110.841 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.403 HG21 ' HE3' ' A' ' 125' ' ' MET . 62.4 t -64.65 -44.85 96.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 73.519999999999996 111.048 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.2 -23.19 38.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 73.420000000000002 110.803 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -75.54 -46.67 30.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 71.019999999999996 110.839 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.43 -35.69 75.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 75.040000000000006 111.14 179.891 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.4 mp -70.59 -55.17 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 74.120000000000005 111.134 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.6 OUTLIER -48.34 -44.15 34.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.081 -0.509 . . . . 62.520000000000003 110.929 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.9 mmpt? -69.88 -35.14 74.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 74.340000000000003 110.889 179.882 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.453 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -59.84 -49.35 78.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.411 . . . . 71.439999999999998 111.116 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.634 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.8 m-85 -72.47 -22.16 61.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 70.150000000000006 110.848 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.499 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.6 OUTLIER -77.89 -5.87 52.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 74.450000000000003 110.936 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.414 ' HB ' HG11 ' A' ' 217' ' ' VAL . 87.4 t -97.23 -18.65 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 71.409999999999997 111.185 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.444 ' CD1' HG13 ' A' ' 217' ' ' VAL . 95.7 m95 -103.73 -40.19 6.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 71.230000000000004 110.962 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -13.57 62.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 75.510000000000005 110.817 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.589 ' N ' HD21 ' A' ' 143' ' ' ASN . 1.0 OUTLIER -94.07 -4.04 50.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 71.319999999999993 110.876 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.422 HG21 ' HA ' ' A' ' 141' ' ' TRP . 31.3 m -120.96 3.59 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 61.530000000000001 111.047 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.531 HG23 ' HD2' ' A' ' 146' ' ' PRO . 3.2 m -145.98 141.66 16.89 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.675 0.75 . . . . 71.439999999999998 111.077 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . 0.531 ' HD2' HG23 ' A' ' 145' ' ' THR . 54.1 Cg_endo -69.78 35.64 0.22 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.695 2.264 . . . . 73.530000000000001 112.328 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.482 ' H ' ' C ' ' A' ' 145' ' ' THR . 3.1 mp -103.22 -177.34 3.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 74.430000000000007 110.88 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -141.64 126.91 18.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 64.0 110.854 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -114.06 146.45 40.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 74.400000000000006 110.887 179.919 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.8 t -142.27 151.51 42.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 72.319999999999993 110.877 -179.799 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 7.2 tttp -102.54 143.13 32.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 75.230000000000004 110.925 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 21.8 pt -151.94 142.02 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 74.310000000000002 111.144 179.903 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.517 ' N ' HD21 ' A' ' 153' ' ' ASN . 1.3 m-80 -101.42 -19.79 15.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 64.439999999999998 110.828 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.1 t -150.5 66.07 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 72.409999999999997 111.116 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -152.12 -155.61 7.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.741 . . . . 60.049999999999997 112.473 179.94 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.82 94.17 5.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.747 0.308 . . . . 72.299999999999997 110.911 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -106.96 155.16 20.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 75.430000000000007 111.151 179.946 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.26 -53.33 5.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.42 . . . . 73.510000000000005 110.918 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.457 HG12 HG21 ' A' ' 220' ' ' ILE . 2.5 mp -88.68 94.1 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 72.5 111.078 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.5 tp -85.76 108.87 18.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.479 . . . . 74.150000000000006 110.904 179.905 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.2 t -86.96 119.11 34.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 74.409999999999997 111.152 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 1.9 p -138.24 104.91 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 74.049999999999997 111.081 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.404 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 39.6 m-85 -73.22 111.68 8.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.195 -0.457 . . . . 71.340000000000003 110.862 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.92 166.41 21.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 75.319999999999993 111.131 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -114.41 136.16 53.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 75.319999999999993 110.987 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.657 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 44.57 -157.78 0.19 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.773 -0.727 . . . . 72.430000000000007 112.499 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.826 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -62.53 116.45 5.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.832 0.348 . . . . 73.530000000000001 110.999 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.25 -22.12 12.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 74.230000000000004 110.884 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.71 30.35 0.54 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.708 -0.758 . . . . 72.310000000000002 112.515 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.633 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.97 0.1 14.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.912 0.387 . . . . 73.120000000000005 110.899 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 74.33 39.04 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 75.319999999999993 110.954 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.96 -41.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 74.109999999999999 110.853 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.826 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.2 100.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 72.439999999999998 111.102 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.657 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.1 m-85 -61.18 -168.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 74.209999999999994 110.898 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.17 18.84 3.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 72.030000000000001 110.825 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.579 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.07 -158.04 5.57 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 62.43 112.477 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.8 OUTLIER -33.76 133.94 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 75.430000000000007 110.884 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.45 165.44 0.15 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.715 -0.755 . . . . 62.039999999999999 112.541 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.64 -143.56 22.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.692 -0.766 . . . . 71.409999999999997 112.486 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.02 96.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.83 0.348 . . . . 75.329999999999998 111.169 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 13.3 mt -66.32 -44.0 84.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 75.430000000000007 110.9 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -170.09 163.09 9.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 73.239999999999995 111.08 179.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.483 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -155.62 142.66 19.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 75.319999999999993 110.81 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.575 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -139.02 172.26 13.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 73.030000000000001 111.101 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.457 ' O ' ' HA ' ' A' ' 223' ' ' SER . 48.4 m-85 -100.7 -151.39 0.41 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 64.340000000000003 110.858 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -154.99 -97.07 0.13 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.74 -0.743 . . . . 74.230000000000004 112.481 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 61.31 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.685 2.256 . . . . 73.420000000000002 112.329 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.606 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.65 153.76 17.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 53.240000000000002 112.473 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.58 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.75 149.71 25.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.396 . . . . 62.509999999999998 110.829 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.23 -66.77 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.739 . . . . 71.340000000000003 112.475 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.58 ' N ' ' O ' ' A' ' 189' ' ' SER . 1.1 mp -104.78 6.61 10.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.809 0.338 . . . . 74.019999999999996 111.098 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.606 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -65.33 164.33 37.45 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.763 -0.732 . . . . 40.149999999999999 112.482 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.505 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 47.21 16.73 0.29 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 72.450000000000003 112.457 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 192' ' ' GLY . 1.1 m-20 -63.31 111.77 2.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.78 0.324 . . . . 73.5 110.898 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.575 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -85.49 128.76 34.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 74.349999999999994 111.076 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.483 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.8 m170 -119.29 128.65 54.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 71.120000000000005 110.846 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.516 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 47.8 m-85 -114.27 134.23 55.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.208 -0.451 . . . . 72.209999999999994 110.89 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -67.19 108.91 2.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 71.409999999999997 110.871 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.94 -36.91 78.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 74.439999999999998 110.843 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.579 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 16.8 m-20 -51.38 -21.06 2.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 75.219999999999999 110.854 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -82.61 162.72 21.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 73.140000000000001 110.885 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.51 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -100.66 92.46 5.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 74.409999999999997 110.887 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.516 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 30.0 m95 -82.7 122.47 28.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.02 -0.536 . . . . 75.439999999999998 110.948 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.2 p -139.42 -170.85 2.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 74.099999999999994 111.204 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.09 17.24 15.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.278 -0.419 . . . . 73.140000000000001 111.151 -179.954 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.58 -177.55 4.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 73.109999999999999 110.804 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.3 p -64.95 -18.66 65.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 72.439999999999998 110.831 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.31 -108.3 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.744 -0.741 . . . . 43.200000000000003 112.452 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.51 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.09 177.45 0.14 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.698 -0.763 . . . . 72.310000000000002 112.474 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 96.3 m -66.76 94.55 0.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.8 0.334 . . . . 74.439999999999998 111.187 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -38.12 117.09 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 73.439999999999998 110.875 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 25.0 tp -63.66 -36.59 84.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 73.019999999999996 110.921 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 3.2 t80 -52.82 -64.63 0.75 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 75.420000000000002 110.932 179.925 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 15.2 mt -53.53 -55.54 24.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 73.540000000000006 110.902 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.7 m -55.52 -32.99 63.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.468 . . . . 63.43 111.065 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -68.0 -46.24 71.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 75.340000000000003 111.026 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.453 HG22 ' CB ' ' A' ' 137' ' ' ALA . 1.9 t -55.96 -59.4 2.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.279 -0.419 . . . . 73.200000000000003 111.104 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.514 ' HB2' ' CG1' ' A' ' 235' ' ' VAL . 1.1 t-80 -60.6 -31.7 70.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 75.040000000000006 110.925 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -60.25 -46.75 88.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 70.409999999999997 111.075 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.569 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.3 mt -68.75 -34.54 65.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 72.239999999999995 111.167 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.01 -42.69 48.42 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.788 -0.72 . . . . 64.340000000000003 112.418 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.44 ' O ' ' O ' ' A' ' 185' ' ' PHE . 24.1 m-70 -67.62 -39.94 84.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 74.310000000000002 110.89 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.505 ' HB3' ' HA3' ' A' ' 193' ' ' GLY . 2.1 m -60.76 -28.87 69.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 72.219999999999999 110.877 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 52.3 mt -76.21 -26.42 56.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 72.140000000000001 110.88 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 117.67 16.53 5.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.803 -0.713 . . . . 72.329999999999998 112.458 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 53.4 mt -77.45 159.25 29.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 65.310000000000002 110.894 -179.85 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -103.71 -140.14 10.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.702 -0.761 . . . . 74.340000000000003 112.504 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.3 m170 -123.35 136.19 54.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.814 0.34 . . . . 73.209999999999994 110.934 -179.992 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 29.8 t -104.92 162.56 13.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 73.5 110.89 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.6 t -107.75 5.85 27.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 74.549999999999997 110.751 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.53 140.45 92.31 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-O 121.673 0.749 . . . . 71.150000000000006 110.806 179.982 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 0.55 5.47 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.757 2.305 . . . . 75.430000000000007 112.365 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -143.62 14.66 1.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 75.150000000000006 110.813 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.417 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -77.33 140.3 39.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 73.200000000000003 111.129 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.514 ' CG1' ' HB2' ' A' ' 218' ' ' HIS . 51.6 t -69.8 -26.18 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 73.209999999999994 111.138 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 55.6 mmm -81.92 -7.03 59.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 63.119999999999997 110.955 179.834 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.477 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 2.4 t80 -50.9 138.28 24.48 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.681 0.753 . . . . 73.230000000000004 110.882 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.477 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 53.6 Cg_endo -69.75 -7.87 22.15 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.622 2.215 . . . . 64.540000000000006 112.335 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 239' ' ' THR . . . . . 0.401 ' HB ' ' CD2' ' A' ' 237' ' ' PHE . 22.3 m -110.91 130.99 55.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 63.25 111.18 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -92.24 146.82 23.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.958 0.409 . . . . 73.430000000000007 110.953 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -161.87 132.02 4.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 53.25 110.848 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 65.0 t80 -61.89 149.06 41.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 74.510000000000005 110.915 -179.959 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -160.76 137.48 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 74.329999999999998 111.12 179.886 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -60.76 127.39 31.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 73.109999999999999 110.825 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 14.4 tt -54.0 -29.48 18.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 75.430000000000007 111.152 179.948 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.08 -21.26 64.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 74.239999999999995 110.849 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.8 p -111.89 -18.2 12.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 71.25 111.119 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 36.8 t80 -62.72 142.2 58.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 73.299999999999997 110.903 179.967 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -177.11 136.25 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 75.349999999999994 110.831 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.418 ' HB3' ' HB2' ' A' ' 254' ' ' ASP . 8.7 mt -51.57 127.71 21.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 72.319999999999993 110.914 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 35.8 t -66.89 161.68 23.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 74.109999999999999 110.863 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.27 -30.17 11.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 72.049999999999997 111.128 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -71.75 -45.87 60.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 64.129999999999995 110.9 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . 0.418 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 2.1 m-20 -62.36 -50.57 71.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 74.010000000000005 110.82 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 24.2 mt -62.29 -35.63 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 71.239999999999995 111.158 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 29.1 mmt-85 -71.08 -38.04 72.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 74.5 110.848 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.13 -49.93 7.17 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.673 -0.775 . . . . 72.209999999999994 112.523 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 8.4 tp -52.4 -34.84 19.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.786 0.327 . . . . 75.25 111.141 -179.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 263' ' ' GLY . 30.5 mt-30 -87.81 -16.18 34.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 72.530000000000001 110.925 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.6 t -70.16 -14.25 62.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 73.25 110.809 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.37 -19.33 6.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 74.530000000000001 110.923 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.423 ' CG ' HD23 ' A' ' 147' ' ' LEU . 37.6 m-85 -113.8 -35.06 5.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.448 . . . . 74.010000000000005 110.955 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.325 0 CA-C-O 119.157 -0.801 . . . . 50.310000000000002 112.498 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.894 0.378 . . . . 74.219999999999999 110.884 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 50.88 49.5 20.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 74.25 110.833 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.44 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 1.7 tt0 176.44 136.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 64.239999999999995 110.904 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.504 ' HG3' ' HD2' ' A' ' 104' ' ' PRO . 1.1 tpt -52.51 137.75 41.26 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.632 0.729 . . . . 72.430000000000007 110.873 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.504 ' HD2' ' HG3' ' A' ' 103' ' ' MET . 54.8 Cg_endo -69.71 87.12 0.55 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.656 2.237 . . . . 75.549999999999997 112.415 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 141.75 -136.67 7.5 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.698 -0.763 . . . . 75.409999999999997 112.511 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.719 ' N ' ' CD ' ' A' ' 107' ' ' PRO . . . -136.27 34.93 2.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.74 -0.743 . . . . 54.409999999999997 112.514 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.719 ' CD ' ' N ' ' A' ' 106' ' ' GLY . 54.4 Cg_endo -69.69 -8.92 24.84 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.701 2.267 . . . . 72.5 112.375 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.448 ' HB ' ' HA3' ' A' ' 225' ' ' GLY . 2.2 p -96.87 103.68 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 72.239999999999995 111.157 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -50.97 108.03 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 64.209999999999994 110.881 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -75.06 56.17 0.76 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 70.409999999999997 110.806 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -121.8 151.28 40.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.253 -0.431 . . . . 74.409999999999997 110.963 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 9.9 p80 -95.65 39.5 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 70.239999999999995 110.854 179.953 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -141.92 98.67 3.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.149 -0.478 . . . . 73.329999999999998 110.904 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.424 ' O ' ' HA ' ' A' ' 149' ' ' PHE . 4.6 mp -132.12 163.19 38.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.097 -0.501 . . . . 63.409999999999997 111.136 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.42 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -160.26 163.44 33.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 75.040000000000006 111.238 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.595 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.7 p90 -133.72 155.71 49.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 75.040000000000006 110.854 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.8 tmt_? -144.87 111.56 5.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 73.299999999999997 110.923 -179.938 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.0 mt -73.37 104.18 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.31 -0.405 . . . . 74.430000000000007 111.206 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -57.82 -45.72 85.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 62.340000000000003 110.896 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -146.92 164.24 33.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 74.400000000000006 110.862 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -116.5 144.82 43.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 75.409999999999997 110.923 -179.954 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.406 HG22 ' HB2' ' A' ' 124' ' ' ASP . 3.0 t -94.33 142.15 24.48 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.564 0.697 . . . . 72.049999999999997 111.17 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.87 -3.17 11.54 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.643 2.229 . . . . 73.019999999999996 112.339 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.406 ' HB2' HG22 ' A' ' 122' ' ' THR . 22.8 m-20 -79.96 -23.38 41.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 60.32 110.933 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.409 ' HE3' ' HB2' ' A' ' 125' ' ' MET . 16.6 mtm -115.94 166.63 11.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 73.030000000000001 110.858 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 46.7 t30 -96.32 143.95 26.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 73.030000000000001 110.909 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.88 -32.83 1.73 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 73.219999999999999 110.911 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -85.73 -40.44 16.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 75.319999999999993 110.9 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -64.88 -29.24 70.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 73.200000000000003 110.906 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.428 ' HA ' ' CD2' ' A' ' 212' ' ' LEU . 78.9 t -67.39 -45.36 85.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 75.409999999999997 111.168 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -80.12 -22.72 41.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 73.540000000000006 110.878 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -73.75 -47.02 42.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 73.239999999999995 110.955 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -73.84 -30.01 62.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.5 . . . . 74.319999999999993 111.094 179.885 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.4 mp -73.84 -55.85 11.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 75.420000000000002 111.202 179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 2.1 ttt180 -48.02 -42.12 27.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 64.530000000000001 110.868 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.88 -33.35 59.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 75.340000000000003 110.902 179.94 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.462 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -60.35 -50.78 72.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 71.109999999999999 111.145 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.595 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 80.7 m-85 -67.37 -32.55 73.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 73.299999999999997 110.832 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.581 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.7 tt0 -63.42 -44.2 95.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 64.219999999999999 110.991 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.406 ' HB ' HG12 ' A' ' 217' ' ' VAL . 79.3 t -49.35 -24.81 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 73.319999999999993 111.077 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.434 ' CD1' HG11 ' A' ' 217' ' ' VAL . 97.6 m95 -98.99 -28.36 13.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.253 -0.43 . . . . 75.200000000000003 110.867 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.2 p -76.14 -12.54 60.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.282 -0.417 . . . . 63.43 110.842 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 139' ' ' GLN . 57.8 m-20 -92.73 -24.75 18.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 74.420000000000002 110.867 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.4 m -93.28 0.8 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 73.120000000000005 111.079 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.522 ' C ' ' H ' ' A' ' 147' ' ' LEU . 77.6 p -152.93 143.98 16.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.642 0.734 . . . . 74.530000000000001 111.146 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 29.33 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.604 2.202 . . . . 74.019999999999996 112.333 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.522 ' H ' ' C ' ' A' ' 145' ' ' THR . 29.4 mt -87.71 175.59 7.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.444 . . . . 74.25 110.937 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -137.67 126.47 23.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 73.530000000000001 110.983 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.424 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 3.4 m-85 -116.6 140.28 49.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 74.109999999999999 110.83 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.9 m -136.09 145.94 46.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 72.120000000000005 110.847 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.425 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 5.5 tttt -94.22 144.87 25.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 73.420000000000002 110.893 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 14.8 pt -151.25 132.85 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 73.349999999999994 111.081 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.33 -0.17 28.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.155 -0.475 . . . . 73.439999999999998 110.866 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.7 t -160.54 55.61 0.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 72.150000000000006 111.126 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -151.06 -155.46 6.94 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.652 -0.785 . . . . 75.140000000000001 112.454 179.963 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.65 96.63 6.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.7 0.286 . . . . 71.310000000000002 110.914 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -105.27 157.03 17.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.414 . . . . 73.209999999999994 111.104 179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.94 -50.95 7.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 72.519999999999996 110.849 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.454 HG12 HG21 ' A' ' 220' ' ' ILE . 2.6 mp -93.14 98.95 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 75.099999999999994 111.203 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.4 tp -88.67 109.89 20.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 75.150000000000006 110.995 179.892 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.3 t -89.07 121.44 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 73.319999999999993 111.144 179.863 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.98 106.43 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 75.140000000000001 111.175 179.898 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -73.66 108.57 6.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 74.319999999999993 110.819 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.91 165.61 20.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.029 -0.532 . . . . 64.030000000000001 111.163 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.08 137.69 51.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 64.129999999999995 110.879 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.658 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.82 -155.48 0.23 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.772 -0.728 . . . . 53.450000000000003 112.473 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.815 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.45 117.07 7.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 73.409999999999997 111.113 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.28 -22.51 12.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 75.439999999999998 110.831 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.32 29.68 0.54 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.805 -0.712 . . . . 75.019999999999996 112.518 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.624 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.1 -0.45 14.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.824 0.345 . . . . 60.210000000000001 110.882 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 74.77 39.39 0.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 74.140000000000001 110.946 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -135.02 -41.28 0.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 74.120000000000005 110.82 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.815 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.19 99.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.43 . . . . 74.5 111.093 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.658 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -60.4 -168.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 71.510000000000005 110.911 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.69 19.12 3.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 72.420000000000002 110.798 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.568 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.5 -157.99 6.18 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.789 -0.72 . . . . 72.319999999999993 112.508 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 176' ' ' GLY . 9.6 ptpt -34.59 134.05 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 73.519999999999996 110.966 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.84 165.42 0.18 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.777 -0.725 . . . . 75.200000000000003 112.491 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.69 -142.9 22.1 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.775 -0.726 . . . . 73.140000000000001 112.488 -179.85 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.47 96.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.953 0.406 . . . . 72.439999999999998 111.145 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.56 -42.71 91.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 73.409999999999997 110.903 179.906 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -171.25 163.55 7.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 72.140000000000001 111.163 179.84 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.485 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -156.11 142.13 18.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 72.010000000000005 110.88 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.576 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -137.79 172.93 12.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 62.109999999999999 111.123 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.494 ' O ' ' HA ' ' A' ' 223' ' ' SER . 12.2 m-85 -101.7 -148.48 0.37 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.24 -0.436 . . . . 75.019999999999996 110.796 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -164.03 -86.85 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.739 -0.744 . . . . 74.239999999999995 112.483 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.82 55.51 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.564 2.176 . . . . 74.120000000000005 112.374 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.569 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.82 149.79 16.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 63.210000000000001 112.502 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.13 146.48 28.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.388 . . . . 74.329999999999998 110.805 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.03 -64.77 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.796 -0.716 . . . . 64.329999999999998 112.512 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' A' ' 189' ' ' SER . 8.2 pt -105.25 8.86 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.871 0.367 . . . . 73.510000000000005 111.214 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.569 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -68.91 169.75 41.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.701 -0.761 . . . . 75.230000000000004 112.433 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.429 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 44.67 20.78 0.23 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.727 -0.749 . . . . 74.239999999999995 112.542 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 192' ' ' GLY . 2.3 m-20 -64.98 107.34 1.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.784 0.326 . . . . 72.420000000000002 110.892 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.576 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -81.4 129.06 34.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 71.140000000000001 111.094 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.485 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.8 m170 -119.86 129.82 54.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.312 -0.403 . . . . 71.030000000000001 110.805 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.478 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 47.7 m-85 -114.47 133.9 55.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 70.120000000000005 110.876 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -66.76 107.3 2.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.128 -0.487 . . . . 75.129999999999995 110.769 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -58.4 -37.51 75.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 75.430000000000007 110.794 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.568 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 14.6 m-20 -50.48 -22.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 62.509999999999998 110.875 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -80.79 162.96 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 64.450000000000003 110.853 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.557 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -101.22 88.53 3.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 71.420000000000002 110.853 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.478 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 31.1 m95 -79.54 123.9 28.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 75.420000000000002 110.913 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 25.1 p -142.7 -175.96 4.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.457 . . . . 73.129999999999995 111.086 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.12 21.45 16.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 73.540000000000006 111.158 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -128.29 -174.86 3.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 73.420000000000002 110.884 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.4 p -70.87 -19.2 62.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 65.450000000000003 110.758 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.76 -105.23 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.717 -0.754 . . . . 72.030000000000001 112.519 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.557 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.5 177.23 0.11 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.735 -0.745 . . . . 74.319999999999993 112.503 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 68.7 m -66.93 98.14 0.53 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.819 0.342 . . . . 72.319999999999993 111.107 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -42.13 115.72 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 75.140000000000001 110.85 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.428 ' CD2' ' HA ' ' A' ' 130' ' ' VAL . 5.8 tp -63.93 -36.62 84.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 73.349999999999994 110.957 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -51.93 -64.05 0.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 74.439999999999998 110.874 179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 18.2 mt -56.1 -54.84 40.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 74.510000000000005 110.855 -179.923 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 2.5 m -54.5 -34.52 61.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 74.25 111.155 179.983 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.83 -49.35 66.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 71.319999999999993 111.069 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.462 HG22 ' CB ' ' A' ' 137' ' ' ALA . 2.0 t -52.81 -58.03 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.326 -0.397 . . . . 74.540000000000006 111.17 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.514 ' HB2' HG12 ' A' ' 235' ' ' VAL . 4.3 t-80 -63.36 -30.81 71.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 73.299999999999997 110.799 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -62.48 -43.27 99.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 75.530000000000001 111.087 -179.981 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.57 HG12 ' CE2' ' A' ' 138' ' ' PHE . 2.5 mt -71.65 -35.42 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 73.439999999999998 111.053 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.24 -43.95 43.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.644 -0.789 . . . . 74.209999999999994 112.515 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 185' ' ' PHE . 31.5 m-70 -68.52 -39.52 81.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 74.340000000000003 110.915 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.494 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 5.0 m -62.15 -27.39 68.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 73.439999999999998 110.843 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 68.2 mt -76.8 -27.23 55.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 75.439999999999998 110.911 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . 0.448 ' HA3' ' HB ' ' A' ' 108' ' ' VAL . . . 117.05 16.76 6.08 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.752 -0.737 . . . . 52.409999999999997 112.468 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 32.3 mt -78.85 149.08 32.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.9 0.381 . . . . 72.400000000000006 110.874 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . 0.44 ' H ' ' HA ' ' A' ' 102' ' ' GLU . . . -90.94 -142.65 10.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.733 -0.746 . . . . 71.140000000000001 112.487 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.414 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 0.4 OUTLIER -122.31 142.07 50.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.337 . . . . 73.439999999999998 110.833 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 28.7 t -103.49 161.58 13.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 65.109999999999999 110.824 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.25 -1.7 23.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 74.319999999999993 110.875 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.3 140.91 96.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.564 0.697 . . . . 73.299999999999997 110.907 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.71 -2.78 10.71 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.703 2.269 . . . . 70.200000000000003 112.367 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 3.6 ptmt -143.85 21.07 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 72.340000000000003 110.898 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.432 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -85.19 135.56 33.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 71.310000000000002 111.062 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.514 HG12 ' HB2' ' A' ' 218' ' ' HIS . 1.3 t -60.56 -35.68 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 75.140000000000001 111.105 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.414 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 41.1 mmm -65.44 -17.99 64.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 73.310000000000002 110.95 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.56 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.2 t80 -56.78 142.72 71.57 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.729 0.776 . . . . 72.319999999999993 110.896 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.56 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.6 Cg_endo -69.7 -1.4 8.36 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.669 2.246 . . . . 75.510000000000005 112.387 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.5 m -96.77 144.33 26.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 51.329999999999998 111.163 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -123.88 140.29 53.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 72.409999999999997 110.899 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -160.42 135.31 7.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 70.540000000000006 110.899 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 70.8 t80 -59.04 148.69 29.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 73.510000000000005 110.976 -179.984 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -161.2 133.09 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 75.239999999999995 111.183 179.926 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -49.47 131.55 20.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 71.400000000000006 110.811 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 4.3 tt -54.44 -30.86 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 72.129999999999995 111.103 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -77.41 -17.62 57.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 74.25 110.928 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 50.9 p -104.14 -23.06 13.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 74.400000000000006 111.107 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -67.9 140.92 56.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 74.010000000000005 110.86 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.4 ptt85 -175.59 132.24 0.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.074 -0.512 . . . . 73.219999999999999 110.819 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.409 ' HB3' ' HB2' ' A' ' 254' ' ' ASP . 26.9 mt -48.24 125.48 9.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 74.230000000000004 110.998 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.1 p -68.34 166.15 17.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 72.230000000000004 110.806 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.32 -38.46 41.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 63.409999999999997 111.085 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -63.34 -46.69 85.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 72.209999999999994 110.947 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . 0.409 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 4.9 m-20 -62.22 -53.53 53.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 72.329999999999998 110.867 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 26.3 mt -59.99 -36.06 64.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 72.310000000000002 111.136 -179.975 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -68.23 -39.75 82.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 73.209999999999994 110.901 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.3 -53.17 5.74 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 53.299999999999997 112.514 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 6.4 tp -52.21 -35.5 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.673 0.273 . . . . 74.540000000000006 111.083 179.998 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.435 ' O ' ' N ' ' A' ' 263' ' ' GLY . 70.0 mt-30 -85.81 -17.51 35.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 71.230000000000004 110.894 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 10.4 t -70.6 -13.63 62.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 75.299999999999997 110.817 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.443 ' HB3' HG13 ' A' ' 108' ' ' VAL . 4.7 mt -122.35 -17.74 6.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 75.430000000000007 110.883 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 33.3 m-85 -115.75 -34.77 4.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 73.230000000000004 110.987 179.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.435 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.279 0 CA-C-O 119.156 -0.802 . . . . 64.450000000000003 112.464 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.462 ' C ' ' HG2' ' A' ' 101' ' ' ARG . 10.6 m-85 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.954 0.407 . . . . 74.349999999999994 110.939 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.462 ' HG2' ' C ' ' A' ' 100' ' ' PHE . 14.6 ptt180 34.25 48.53 0.27 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 75.340000000000003 110.784 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . 0.436 ' HB3' ' O ' ' A' ' 101' ' ' ARG . 2.0 pp20? 179.1 135.2 0.09 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.166 -0.47 . . . . 75.239999999999995 110.808 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.9 mmm -50.9 143.93 14.41 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.544 0.688 . . . . 74.319999999999993 110.893 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 -23.7 30.87 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.714 2.276 . . . . 70.420000000000002 112.407 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -150.11 35.61 0.98 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.795 -0.717 . . . . 73.040000000000006 112.521 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -107.42 91.38 0.69 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.821 -0.704 . . . . 55.240000000000002 112.497 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 108' ' ' VAL . 53.0 Cg_endo -69.74 77.68 1.05 Allowed 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.627 2.218 . . . . 73.420000000000002 112.299 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.406 ' C ' ' O ' ' A' ' 107' ' ' PRO . 61.2 t -36.9 144.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.273 -0.421 . . . . 74.430000000000007 111.121 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -52.3 -31.02 31.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 75.209999999999994 110.866 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 16.1 mtp180 63.45 30.72 15.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 73.219999999999999 110.872 -179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.92 138.0 54.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 75.340000000000003 110.915 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.543 ' HA ' ' CD1' ' A' ' 147' ' ' LEU . 0.5 OUTLIER -84.09 43.55 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 72.430000000000007 110.843 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -143.73 82.69 1.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 74.439999999999998 110.963 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.401 ' CG2' ' N ' ' A' ' 115' ' ' THR . 4.2 mp -115.63 164.0 12.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 73.109999999999999 111.12 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.401 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -159.51 162.21 35.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.198 -0.456 . . . . 75.310000000000002 111.112 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.605 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.5 p90 -133.13 148.79 52.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.436 . . . . 74.450000000000003 110.904 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.7 tmm_? -142.51 113.37 7.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 73.450000000000003 110.875 -179.997 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.4 mt -73.93 106.03 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 75.219999999999999 111.164 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -59.24 -47.25 86.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 74.510000000000005 110.902 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.1 p-10 -143.29 162.88 34.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 74.150000000000006 110.857 179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.2 m-85 -117.25 137.66 52.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 54.32 110.955 -179.919 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.409 ' OG1' ' HD2' ' A' ' 123' ' ' PRO . 2.6 t -87.43 143.23 33.91 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.639 0.733 . . . . 72.200000000000003 111.128 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.409 ' HD2' ' OG1' ' A' ' 122' ' ' THR . 53.2 Cg_endo -69.88 -3.62 12.45 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.588 2.192 . . . . 73.519999999999996 112.338 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.402 ' HB2' HG23 ' A' ' 122' ' ' THR . 15.7 m-20 -80.02 -23.74 41.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 65.25 110.875 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.431 ' HE1' ' HB2' ' A' ' 125' ' ' MET . 15.6 mtm -115.67 166.73 11.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 74.519999999999996 110.916 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -97.69 143.93 27.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.429 . . . . 72.120000000000005 110.92 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.47 -35.09 3.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 72.450000000000003 110.869 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -83.36 -38.65 21.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 73.219999999999999 110.914 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -65.26 -30.48 71.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.22 -0.445 . . . . 62.240000000000002 110.776 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 60.8 t -65.31 -47.37 87.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 71.340000000000003 111.22 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.99 -23.18 48.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 75.549999999999997 110.845 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -74.26 -46.71 39.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.233 -0.439 . . . . 73.420000000000002 110.95 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -72.8 -31.48 64.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 73.530000000000001 111.116 179.796 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.4 mp -71.95 -53.79 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 74.209999999999994 111.152 179.931 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -48.92 -41.88 35.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 74.129999999999995 110.897 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 8.0 mmpt? -70.97 -36.29 72.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 71.450000000000003 110.94 179.914 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.487 ' HA ' HG21 ' A' ' 217' ' ' VAL . . . -59.05 -50.83 72.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 63.229999999999997 111.11 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.605 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 93.4 m-85 -69.92 -22.96 63.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 75.030000000000001 110.926 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.477 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.7 tt0 -77.52 -6.87 55.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.119 -0.491 . . . . 73.010000000000005 110.905 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.453 ' HB ' HG12 ' A' ' 217' ' ' VAL . 91.5 t -96.08 -18.34 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 65.340000000000003 111.086 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.482 ' CD1' HG11 ' A' ' 217' ' ' VAL . 96.1 m95 -106.02 -39.82 5.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 74.329999999999998 110.933 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -9.79 58.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 72.310000000000002 110.859 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.553 ' N ' HD21 ' A' ' 143' ' ' ASN . 1.1 m-80 -99.87 -7.92 24.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 74.420000000000002 110.888 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.477 HG21 ' HA ' ' A' ' 141' ' ' TRP . 19.8 m -110.61 -5.24 11.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 74.450000000000003 111.152 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.554 ' HB ' ' CD2' ' A' ' 147' ' ' LEU . 44.8 p -141.36 149.62 55.3 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.555 0.693 . . . . 75.099999999999994 111.132 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 34.85 0.21 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.726 2.284 . . . . 74.25 112.27 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.554 ' CD2' ' HB ' ' A' ' 145' ' ' THR . 2.9 mm? -104.98 167.09 9.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 74.140000000000001 110.924 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -131.12 127.93 39.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 64.129999999999995 110.932 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.3 m-30 -114.6 146.52 40.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 64.099999999999994 110.871 179.956 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.3 m -137.14 155.33 49.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 72.430000000000007 110.781 -179.72 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.478 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.4 OUTLIER -106.78 142.36 36.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 72.319999999999993 110.83 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 20.3 pt -151.26 147.97 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 71.319999999999993 111.197 179.789 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.81 12.67 11.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 72.150000000000006 110.924 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.8 t -173.53 49.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.488 . . . . 74.420000000000002 111.094 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -146.27 -149.63 5.03 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.718 -0.753 . . . . 32.130000000000003 112.502 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.89 92.76 4.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.729 0.3 . . . . 75.439999999999998 110.93 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -103.31 154.79 19.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 74.129999999999995 111.097 179.96 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.25 -54.67 4.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 74.219999999999999 110.863 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.451 HG12 HG21 ' A' ' 220' ' ' ILE . 2.5 mp -87.34 92.8 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.483 . . . . 72.409999999999997 111.123 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.4 tp -84.83 108.61 17.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 73.230000000000004 110.959 179.849 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 90.3 t -87.14 120.6 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.429 . . . . 71.450000000000003 111.091 179.857 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.2 p -139.45 105.61 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 72.409999999999997 111.124 179.902 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -73.23 108.17 5.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 73.120000000000005 110.908 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.64 165.79 20.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 73.010000000000005 111.064 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.91 137.65 51.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 74.340000000000003 110.851 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.658 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.49 -155.67 0.19 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.705 -0.76 . . . . 64.420000000000002 112.565 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.817 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -64.88 116.9 6.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.908 0.385 . . . . 74.540000000000006 111.126 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.696 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.17 -23.09 11.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.289 -0.414 . . . . 64.439999999999998 110.839 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.92 29.7 0.51 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.723 -0.751 . . . . 71.230000000000004 112.486 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.627 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.28 -0.17 14.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.804 0.335 . . . . 73.239999999999995 110.877 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 74.26 39.72 0.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 62.109999999999999 110.924 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.696 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.24 -41.29 0.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.042 -0.526 . . . . 73.150000000000006 110.869 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.817 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.2 100.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 72.140000000000001 111.224 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.658 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.2 m-85 -60.71 -168.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 74.219999999999999 110.84 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.8 18.95 3.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.118 -0.492 . . . . 72.409999999999997 110.827 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.641 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.46 -157.17 6.61 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.789 -0.72 . . . . 72.450000000000003 112.482 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 176' ' ' GLY . 5.7 tmtt? -34.42 133.86 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 74.230000000000004 110.893 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.41 166.5 0.18 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.681 -0.771 . . . . 65.430000000000007 112.565 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.18 -143.71 23.15 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.712 -0.756 . . . . 74.109999999999999 112.496 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -49.99 96.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.896 0.379 . . . . 74.519999999999996 111.101 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 25.0 mt -65.51 -42.7 91.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 74.430000000000007 110.869 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -171.32 162.74 6.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.248 -0.433 . . . . 75.019999999999996 111.2 179.873 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.467 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.3 p80 -155.64 143.11 19.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.289 -0.414 . . . . 64.25 110.879 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.585 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -139.3 171.59 14.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 73.0 111.068 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 222' ' ' HIS . 50.2 m-85 -98.67 -146.79 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 75.420000000000002 110.834 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -157.41 -101.44 0.18 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.797 -0.716 . . . . 63.140000000000001 112.552 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.66 63.14 1.73 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.709 2.273 . . . . 73.329999999999998 112.361 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.608 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.06 155.66 17.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 71.25 112.553 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.94 150.19 24.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.859 0.361 . . . . 71.310000000000002 110.881 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 59.35 -67.6 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.7 -0.762 . . . . 73.239999999999995 112.492 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.589 ' N ' ' O ' ' A' ' 189' ' ' SER . 24.3 pt -104.48 7.84 9.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.816 0.341 . . . . 75.420000000000002 111.174 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.608 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -64.32 162.37 36.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 73.420000000000002 112.532 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.459 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 46.58 17.7 0.28 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.736 -0.745 . . . . 62.329999999999998 112.528 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 192' ' ' GLY . 1.7 m-20 -63.09 111.13 2.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 71.219999999999999 110.859 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.585 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -84.31 129.39 34.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 65.299999999999997 111.124 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.467 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.0 m170 -120.16 129.31 54.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 71.200000000000003 110.875 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.48 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 42.5 m-85 -114.52 133.71 55.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 74.230000000000004 110.88 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -66.14 107.09 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 74.430000000000007 110.883 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -58.38 -37.41 75.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.147 -0.479 . . . . 75.0 110.868 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.641 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 9.9 m-20 -50.2 -23.62 2.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 71.219999999999999 110.81 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -80.17 162.95 24.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 72.209999999999994 110.868 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.563 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -100.67 89.91 4.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 72.510000000000005 110.819 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.48 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 33.0 m95 -80.94 123.51 28.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 73.120000000000005 111.007 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.0 p -141.18 -175.08 4.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.225 -0.443 . . . . 75.430000000000007 111.118 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.2 18.39 18.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 65.200000000000003 111.148 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.87 -177.98 4.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 73.200000000000003 110.847 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 17.4 p -65.07 -19.15 65.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 74.109999999999999 110.814 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.02 -108.53 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.706 -0.759 . . . . 73.209999999999994 112.446 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.563 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.92 177.5 0.12 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.795 -0.717 . . . . 74.450000000000003 112.525 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 91.6 m -65.86 97.32 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.851 0.358 . . . . 75.140000000000001 111.156 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -42.11 116.81 0.87 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 75.420000000000002 110.903 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 11.8 tp -63.89 -38.46 91.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 72.200000000000003 110.964 179.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.3 t80 -49.25 -64.93 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 73.439999999999998 110.888 179.891 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 21.8 mt -55.3 -54.95 37.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.238 -0.437 . . . . 73.329999999999998 110.873 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 2.1 m -54.51 -31.75 56.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 74.430000000000007 111.082 -179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.31 -48.88 60.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.429 . . . . 72.340000000000003 111.169 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.487 HG21 ' HA ' ' A' ' 137' ' ' ALA . 0.6 OUTLIER -52.61 -57.85 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 72.530000000000001 111.051 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.536 ' HB2' HG13 ' A' ' 235' ' ' VAL . 2.0 t-80 -64.16 -30.21 71.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 71.349999999999994 110.889 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -62.3 -43.95 97.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 73.310000000000002 111.082 179.889 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.572 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.4 mt -70.59 -35.34 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 75.530000000000001 111.148 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.91 -44.61 40.76 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.708 -0.758 . . . . 73.450000000000003 112.533 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 185' ' ' PHE . 34.1 m-70 -67.21 -40.19 86.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.832 0.349 . . . . 72.030000000000001 110.894 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.461 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 2.7 m -62.35 -26.25 68.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 71.5 110.885 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 72.9 mt -76.66 -27.87 55.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 72.310000000000002 110.911 -179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 120.44 18.57 4.05 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.673 -0.775 . . . . 71.030000000000001 112.51 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 13.3 mt -82.84 159.74 22.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.795 0.331 . . . . 75.420000000000002 110.948 -179.918 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -106.57 -135.23 7.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 74.239999999999995 112.477 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.6 m170 -127.64 143.83 51.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.83 0.348 . . . . 73.450000000000003 110.821 -179.953 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 62.2 m -108.95 163.52 13.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 74.140000000000001 110.86 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.03 0.69 30.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 73.099999999999994 110.845 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -65.18 136.57 96.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.629 0.728 . . . . 75.400000000000006 110.836 179.966 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 -0.46 6.99 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.699 2.266 . . . . 71.230000000000004 112.346 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.15 19.57 1.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 71.540000000000006 110.956 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.495 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -91.07 129.93 37.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 72.319999999999993 111.088 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.536 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.2 t -54.11 -34.93 27.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 70.109999999999999 111.163 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 39.7 mmm -62.16 -21.14 64.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 73.439999999999998 110.885 179.959 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.532 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -56.22 142.53 67.02 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.681 0.753 . . . . 72.5 110.831 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.532 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.1 Cg_endo -69.73 -1.28 8.18 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.691 2.26 . . . . 71.319999999999993 112.343 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.8 m -95.55 140.35 30.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 71.219999999999999 111.191 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -120.32 137.14 54.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 75.120000000000005 110.854 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -154.57 132.14 11.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.071 -0.513 . . . . 74.5 110.86 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 88.4 t80 -59.65 142.85 52.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 110.93 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.8 OUTLIER -158.46 128.85 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 74.409999999999997 111.185 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -51.29 134.37 27.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 72.530000000000001 110.876 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 10.8 tt -54.58 -30.13 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 71.349999999999994 111.183 179.952 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.81 -18.1 60.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 71.510000000000005 110.924 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 28.1 p -107.56 -23.31 12.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 74.439999999999998 111.115 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -68.64 146.43 53.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 73.510000000000005 110.833 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -176.28 129.58 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 73.400000000000006 110.802 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 15.1 mt -48.99 131.99 18.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 75.329999999999998 110.955 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 47.0 t -77.35 166.31 23.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 73.409999999999997 110.818 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.03 -37.99 35.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.059 -0.519 . . . . 75.319999999999993 111.074 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.31 -45.01 89.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.219 -0.446 . . . . 72.349999999999994 110.852 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -61.37 -54.8 39.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 72.439999999999998 110.875 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 2.6 mp -60.76 -37.07 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 73.430000000000007 111.052 179.973 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -68.36 -37.77 80.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 73.010000000000005 110.881 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.414 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -78.23 -51.23 5.81 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.682 -0.771 . . . . 44.509999999999998 112.456 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 6.3 tp -52.8 -33.72 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.763 0.316 . . . . 74.310000000000002 111.159 -179.998 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 263' ' ' GLY . 30.8 mt-30 -87.66 -16.49 34.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 73.120000000000005 110.855 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.414 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 2.6 t -68.98 -16.24 63.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 74.420000000000002 110.856 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.13 -19.23 7.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 75.129999999999995 110.893 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.45 ' HB3' ' CD2' ' A' ' 147' ' ' LEU . 31.2 m-85 -110.45 -36.67 5.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.157 -0.474 . . . . 74.109999999999999 110.971 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.638 -0.791 . . . . 51.329999999999998 112.479 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.847 0.356 . . . . 72.319999999999993 110.911 . . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.92 99.39 1.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 73.219999999999999 110.924 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 2.6 pp20? -100.34 147.83 25.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 65.239999999999995 110.898 -179.876 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 4.5 mtt -48.48 151.98 1.78 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.516 0.674 . . . . 72.120000000000005 110.899 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 135.42 30.25 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.686 2.258 . . . . 70.239999999999995 112.299 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 106' ' ' GLY . . . 86.22 19.98 56.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.759 -0.734 . . . . 71.0 112.577 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.41 ' N ' ' CD ' ' A' ' 107' ' ' PRO . . . 38.32 54.61 2.1 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.719 -0.753 . . . . 74.310000000000002 112.423 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.41 ' CD ' ' N ' ' A' ' 106' ' ' GLY . 54.2 Cg_endo -69.82 -22.54 31.68 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.64 2.227 . . . . 75.030000000000001 112.339 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.8 p -46.81 122.78 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 74.530000000000001 111.105 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.424 ' HB3' ' HG2' ' A' ' 111' ' ' LYS . 3.0 m0 -57.02 -32.19 65.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 75.540000000000006 110.911 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 11.7 mtt-85 62.92 35.55 13.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 65.519999999999996 110.894 -179.965 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.424 ' HG2' ' HB3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -121.76 168.02 12.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 74.310000000000002 110.96 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -107.55 36.05 2.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 70.200000000000003 110.822 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -140.59 108.95 5.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 65.5 110.881 -179.835 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.433 ' CG2' ' N ' ' A' ' 115' ' ' THR . 4.7 mp -142.48 164.01 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 74.109999999999999 111.111 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.433 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -160.37 163.13 33.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 75.439999999999998 111.155 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.572 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.2 p90 -134.2 153.97 51.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.41 . . . . 73.200000000000003 110.888 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -145.88 110.65 5.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 74.549999999999997 110.838 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 59.5 mt -73.14 106.0 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 74.239999999999995 111.072 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -59.42 -51.03 71.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 74.230000000000004 110.933 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -138.41 166.28 24.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.319999999999993 110.884 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -116.05 154.36 30.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 75.120000000000005 110.919 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.493 ' CG2' ' HD2' ' A' ' 123' ' ' PRO . 11.0 m -102.67 137.42 19.34 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.571 0.7 . . . . 75.340000000000003 111.149 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.493 ' HD2' ' CG2' ' A' ' 122' ' ' THR . 53.3 Cg_endo -69.67 3.45 2.72 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.688 2.258 . . . . 71.120000000000005 112.362 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -87.6 -28.59 21.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 74.310000000000002 110.797 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 5.8 mtm -110.19 167.01 10.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 74.329999999999998 110.861 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -90.14 142.58 27.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 73.430000000000007 110.878 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.36 -37.07 4.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 75.030000000000001 110.898 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -82.53 -36.88 25.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 71.420000000000002 110.887 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -64.84 -32.0 73.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.148 -0.478 . . . . 64.129999999999995 110.868 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 62.4 t -64.78 -43.86 96.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 74.349999999999994 111.124 179.983 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.4 -23.27 35.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 75.340000000000003 110.926 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -75.33 -48.1 24.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 73.439999999999998 110.865 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.41 -30.67 66.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 75.450000000000003 111.088 179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.3 mp -73.09 -55.58 12.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 75.310000000000002 111.112 -179.917 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 7.0 ttt180 -48.2 -41.75 28.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.214 -0.448 . . . . 75.099999999999994 110.835 179.921 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.6 mmtt -75.66 -31.75 59.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.213 -0.449 . . . . 74.549999999999997 110.873 179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.488 ' HA ' HG21 ' A' ' 217' ' ' VAL . . . -61.9 -50.83 70.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 61.420000000000002 111.119 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.591 ' CE2' HG12 ' A' ' 220' ' ' ILE . 75.5 m-85 -66.21 -30.89 71.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 75.120000000000005 110.972 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.593 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 3.7 tt0 -63.99 -42.62 97.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 72.140000000000001 110.87 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.42 ' HB ' HG12 ' A' ' 217' ' ' VAL . 74.1 t -50.23 -24.43 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 71.400000000000006 111.088 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.419 ' CD1' HG11 ' A' ' 217' ' ' VAL . 98.1 m95 -98.1 -30.35 12.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.185 -0.461 . . . . 75.439999999999998 110.967 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 12.8 t -72.52 -14.74 61.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 70.349999999999994 110.863 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.593 ' ND2' ' O ' ' A' ' 139' ' ' GLN . 63.7 m-80 -89.32 -25.71 21.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.51 . . . . 72.530000000000001 110.914 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 7.0 m -94.74 2.82 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 73.420000000000002 111.132 179.882 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.513 ' C ' ' H ' ' A' ' 147' ' ' LEU . 23.6 p -154.45 142.61 14.26 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.502 0.667 . . . . 62.350000000000001 111.191 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 19.26 0.18 Allowed 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.685 2.257 . . . . 71.430000000000007 112.414 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.513 ' H ' ' C ' ' A' ' 145' ' ' THR . 0.6 OUTLIER -74.27 -177.57 3.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 75.530000000000001 110.903 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -144.4 124.52 13.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 73.129999999999995 110.91 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.414 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 2.4 m-85 -116.79 140.2 49.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 74.310000000000002 110.815 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.5 t -136.21 145.33 45.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 73.129999999999995 110.821 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.468 ' HG3' ' N ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -93.7 144.25 25.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 74.030000000000001 110.857 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.468 ' N ' ' HG3' ' A' ' 151' ' ' LYS . 11.4 pt -150.65 130.49 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 74.319999999999993 111.127 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -98.12 -7.5 29.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 73.209999999999994 110.893 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.9 t -157.13 60.19 0.51 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 65.329999999999998 111.111 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -151.81 -155.79 7.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.752 -0.737 . . . . 52.219999999999999 112.482 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.19 97.67 7.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.794 0.331 . . . . 74.409999999999997 110.919 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -107.23 157.7 17.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 74.439999999999998 111.075 179.915 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.92 -50.87 7.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 74.439999999999998 110.92 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.463 HG12 HG21 ' A' ' 220' ' ' ILE . 2.9 mp -92.65 96.52 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 72.420000000000002 111.098 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.3 tp -87.26 110.49 20.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 75.319999999999993 110.961 179.793 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . 0.449 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 88.2 t -88.54 119.07 35.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.112 -0.494 . . . . 75.439999999999998 111.139 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.1 p -138.38 106.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 74.510000000000005 111.125 179.945 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.432 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 34.4 m-85 -75.88 111.78 11.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 74.129999999999995 110.901 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -130.93 172.7 11.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 63.520000000000003 111.106 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.419 ' CG ' ' HB3' ' A' ' 199' ' ' GLU . 9.1 mtt180 -115.54 139.57 49.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 74.430000000000007 110.912 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.64 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 39.28 -149.05 0.11 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.773 -0.727 . . . . 74.140000000000001 112.476 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.812 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -69.4 117.02 10.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 74.510000000000005 111.125 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.43 -20.65 13.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 73.109999999999999 110.91 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.12 29.79 0.65 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.783 -0.722 . . . . 74.439999999999998 112.496 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.636 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.2 0.28 14.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.82 0.343 . . . . 75.510000000000005 110.812 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 74.1 38.73 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 75.400000000000006 110.895 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.2 -41.74 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 73.150000000000006 110.876 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.812 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.52 99.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 74.010000000000005 111.046 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.64 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -60.5 -168.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.325 -0.398 . . . . 73.549999999999997 110.865 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.15 19.88 3.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 71.239999999999995 110.907 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.563 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 53.74 -157.94 5.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 71.129999999999995 112.536 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 176' ' ' GLY . 9.9 tttt -34.58 134.43 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.339 . . . . 71.540000000000006 110.937 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.55 165.77 0.17 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.663 -0.78 . . . . 61.229999999999997 112.508 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.3 -143.45 22.84 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.734 -0.746 . . . . 73.219999999999999 112.553 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -49.66 96.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.875 0.369 . . . . 71.129999999999995 111.154 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 84.4 mt -65.96 -42.49 89.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 65.420000000000002 110.962 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -171.11 166.69 7.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.288 -0.414 . . . . 65.340000000000003 111.091 179.769 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.508 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -159.68 140.74 12.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.134 -0.485 . . . . 63.43 110.831 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.552 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -135.94 173.14 12.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 71.519999999999996 111.086 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.567 ' O ' ' HA ' ' A' ' 223' ' ' SER . 10.4 m-85 -104.66 -151.82 0.45 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 74.420000000000002 110.837 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -161.29 -81.74 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.745 -0.74 . . . . 70.420000000000002 112.531 179.989 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.409 ' HG3' ' HB3' ' A' ' 107' ' ' PRO . 52.3 Cg_endo -69.87 53.92 1.17 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.639 2.226 . . . . 65.420000000000002 112.333 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.554 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -124.15 147.37 16.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.775 -0.726 . . . . 54.039999999999999 112.487 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.63 144.2 31.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 74.310000000000002 110.81 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.46 -63.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.721 -0.752 . . . . 74.219999999999999 112.506 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 189' ' ' SER . 2.2 pp -106.2 9.54 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.924 0.392 . . . . 75.519999999999996 111.133 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.554 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -70.72 171.43 44.65 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.734 -0.746 . . . . 70.420000000000002 112.45 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.43 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 44.24 20.44 0.18 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.734 -0.745 . . . . 75.230000000000004 112.476 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 192' ' ' GLY . 4.1 m-20 -64.24 108.59 1.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.776 0.322 . . . . 72.430000000000007 110.954 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.552 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -82.14 121.7 26.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 74.239999999999995 111.1 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.508 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.7 m170 -112.13 130.42 55.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 75.319999999999993 110.893 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.471 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 46.6 m-85 -115.23 136.12 53.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 71.209999999999994 110.897 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -69.29 104.03 2.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 73.109999999999999 110.827 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.434 ' HG2' HG21 ' A' ' 122' ' ' THR . 4.2 tm-20 -55.87 -37.99 69.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 73.239999999999995 110.863 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.563 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 12.7 m-20 -49.26 -22.72 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 71.209999999999994 110.836 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -81.05 161.13 24.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 73.430000000000007 110.867 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.477 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -97.95 89.83 4.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 75.120000000000005 110.919 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.471 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 28.3 m95 -81.54 123.11 28.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 73.349999999999994 110.905 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.9 p -135.56 -174.23 3.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 70.239999999999995 111.225 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.53 12.78 18.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.279 -0.419 . . . . 70.129999999999995 111.167 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -131.04 -176.0 3.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 75.540000000000006 110.897 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.2 p -51.25 -36.06 40.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.433 . . . . 74.239999999999995 110.835 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -64.08 159.64 39.95 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.704 -0.76 . . . . 70.409999999999997 112.451 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.477 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . 49.15 -173.71 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.707 -0.759 . . . . 63.240000000000002 112.597 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.7 m -85.66 93.44 8.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.76 0.314 . . . . 75.450000000000003 111.122 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -38.91 111.47 0.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 72.219999999999999 110.822 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.0 tp -60.18 -36.78 78.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 74.140000000000001 110.869 179.957 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -51.97 -62.8 1.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.462 . . . . 73.209999999999994 110.935 179.926 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 31.6 mt -57.52 -52.4 65.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 74.150000000000006 110.93 -179.988 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.7 m -53.64 -38.07 63.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 63.119999999999997 111.137 179.913 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -61.74 -51.92 66.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 65.319999999999993 111.09 179.879 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.488 HG21 ' HA ' ' A' ' 137' ' ' ALA . 1.4 t -50.21 -58.87 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.458 . . . . 73.400000000000006 111.154 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.571 ' HB2' HG11 ' A' ' 235' ' ' VAL . 2.8 t-80 -62.86 -31.81 72.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 73.310000000000002 110.854 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -62.37 -43.29 99.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 61.350000000000001 111.121 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.591 HG12 ' CE2' ' A' ' 138' ' ' PHE . 2.4 mt -70.51 -33.43 53.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 75.510000000000005 111.093 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.92 -43.45 48.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.738 -0.744 . . . . 52.32 112.474 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.428 ' O ' ' O ' ' A' ' 185' ' ' PHE . 47.8 m-70 -68.37 -39.73 81.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.734 0.302 . . . . 74.439999999999998 110.814 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.567 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 2.0 m -62.16 -26.7 68.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 74.329999999999998 110.902 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 79.5 mt -77.25 -26.55 52.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 75.349999999999994 110.934 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 112.16 22.05 6.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.731 . . . . 54.420000000000002 112.487 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -87.66 146.86 25.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.9 0.381 . . . . 74.109999999999999 110.887 -179.833 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -88.04 -160.12 35.4 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.731 -0.747 . . . . 73.299999999999997 112.546 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -102.57 125.97 49.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 71.219999999999999 110.872 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.4 m -80.55 162.77 24.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 71.230000000000004 110.836 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.82 -1.1 19.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 70.5 110.894 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.44 142.75 97.9 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.582 0.706 . . . . 75.540000000000006 110.88 179.927 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -4.24 13.66 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.637 2.224 . . . . 63.109999999999999 112.344 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.68 23.61 1.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 74.519999999999996 110.867 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.407 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -81.54 143.0 32.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 71.329999999999998 111.068 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.571 HG11 ' HB2' ' A' ' 218' ' ' HIS . 1.3 t -65.78 -38.91 83.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.219 -0.446 . . . . 74.150000000000006 111.146 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 83.1 mmm -68.57 -12.27 61.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 72.329999999999998 110.878 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.644 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.5 t80 -57.8 145.1 72.28 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.582 0.706 . . . . 70.439999999999998 110.892 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.644 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.8 Cg_endo -69.77 0.89 5.0 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.666 2.244 . . . . 75.430000000000007 112.372 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 24.6 m -101.72 143.91 31.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 73.129999999999995 111.101 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -123.11 138.31 54.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 74.349999999999994 110.915 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -157.13 129.61 7.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 74.219999999999999 110.854 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 86.3 t80 -59.66 145.83 43.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 74.230000000000004 110.949 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -161.21 131.27 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 65.409999999999997 111.143 179.911 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -52.72 133.67 36.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.053 -0.521 . . . . 75.109999999999999 110.924 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.2 tt -53.69 -30.19 18.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.289 -0.414 . . . . 74.219999999999999 111.151 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.84 -20.26 63.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 74.040000000000006 110.96 179.847 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 6.3 p -110.45 -21.24 12.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 64.150000000000006 111.175 -179.972 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -69.4 142.13 53.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 73.140000000000001 110.905 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -176.5 133.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 72.340000000000003 110.927 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 40.0 mt -47.52 123.58 5.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 75.010000000000005 110.987 -179.981 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 7.1 t -58.3 158.36 7.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 62.329999999999998 110.954 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.52 -30.49 8.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 74.540000000000006 111.07 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -72.89 -45.69 56.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 75.239999999999995 110.846 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.12 -41.26 98.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 64.409999999999997 110.845 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 42.8 mt -69.6 -43.36 80.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 75.329999999999998 111.145 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . 0.406 ' HG3' ' N ' ' A' ' 257' ' ' GLY . 0.0 OUTLIER -69.07 -28.99 67.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 74.099999999999994 110.919 179.9 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . 0.413 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -85.06 -49.77 4.36 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.648 -0.787 . . . . 60.340000000000003 112.527 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 4.4 tp -54.22 -32.06 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.734 0.302 . . . . 74.019999999999996 111.123 179.964 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 263' ' ' GLY . 69.6 mt-30 -86.72 -17.58 33.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 74.519999999999996 110.942 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 260' ' ' SER . . . . . 0.413 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 2.4 t -67.79 -14.35 62.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 75.150000000000006 110.896 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.5 mt -121.8 -19.68 6.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 64.099999999999994 110.932 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 42.5 m-85 -113.41 -35.19 5.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 74.530000000000001 110.871 -179.941 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 C--O 1.229 -0.218 0 CA-C-O 119.199 -0.778 . . . . 62.420000000000002 112.471 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.1 t80 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.881 0.372 . . . . 74.430000000000007 110.914 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 177.6 -174.19 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 55.43 110.898 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -39.23 147.81 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 75.310000000000002 110.944 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.28 158.97 0.9 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.548 0.689 . . . . 73.299999999999997 110.85 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.87 68.95 1.73 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.629 2.219 . . . . 62.439999999999998 112.273 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 111.04 30.93 3.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.774 -0.727 . . . . 71.340000000000003 112.457 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -112.73 75.32 0.23 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.777 -0.725 . . . . 72.349999999999994 112.442 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 107.79 1.93 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.68 2.254 . . . . 61.420000000000002 112.373 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 18.5 m -50.83 170.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 73.140000000000001 111.115 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 2.7 m-90 -56.32 -19.77 15.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 75.329999999999998 111.006 179.918 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.7 mtt180 66.0 28.4 10.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 74.510000000000005 110.862 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 4.2 mtmm -121.53 146.1 47.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 75.439999999999998 110.899 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 14.2 p80 -94.04 19.82 8.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 72.400000000000006 110.939 179.842 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -123.77 95.23 4.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 73.310000000000002 110.892 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 115' ' ' THR . 4.8 mp -121.93 162.53 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 75.040000000000006 111.144 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.438 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -156.87 164.77 37.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 73.409999999999997 111.073 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.594 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.4 p90 -134.81 148.57 50.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 74.409999999999997 110.835 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.2 tmt_? -140.72 110.71 6.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.02 -0.536 . . . . 72.519999999999996 110.908 179.958 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 57.0 mt -73.11 104.8 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 73.200000000000003 111.049 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -56.41 -48.97 75.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 70.420000000000002 110.836 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.8 p-10 -143.54 163.57 32.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 75.219999999999999 110.876 -179.943 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -116.38 138.47 51.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 71.519999999999996 110.903 -179.964 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 9.1 t -87.86 141.95 32.0 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.55 0.69 . . . . 74.439999999999998 111.154 179.955 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -3.77 12.69 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.638 2.226 . . . . 75.25 112.363 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -78.43 -23.3 46.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 74.140000000000001 110.93 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 12.7 mtm -116.79 166.78 11.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 72.0 110.9 179.983 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 23.9 t-20 -94.46 144.01 25.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 63.310000000000002 110.867 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -45.42 -36.92 4.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 75.5 110.86 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -82.57 -36.14 26.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 72.430000000000007 110.919 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -66.99 -30.17 70.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 73.400000000000006 110.828 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 82.0 t -66.57 -46.35 86.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 74.530000000000001 111.142 -179.907 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.433 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 0.4 OUTLIER -77.54 -24.72 49.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.187 -0.46 . . . . 71.430000000000007 110.796 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -73.22 -47.84 40.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 75.109999999999999 110.856 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.36 -31.42 69.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.175 -0.466 . . . . 64.439999999999998 111.122 179.906 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.3 mp -74.26 -53.46 17.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 73.25 111.102 -179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.433 ' HB3' ' O ' ' A' ' 131' ' ' ASP . 7.0 ptp180 -49.22 -37.2 22.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 74.120000000000005 110.806 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 7.3 mmtt -76.88 -34.47 57.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 74.430000000000007 110.869 -179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.499 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -59.98 -48.66 80.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 72.219999999999999 111.082 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.594 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 94.1 m-85 -72.5 -22.69 61.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 72.040000000000006 110.899 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.487 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.2 OUTLIER -77.13 -5.5 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 72.409999999999997 110.89 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 84.1 t -98.74 -17.05 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 74.5 111.125 179.922 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.484 ' HA ' HG21 ' A' ' 144' ' ' VAL . 94.1 m95 -107.01 -37.03 6.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 73.299999999999997 110.906 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.78 -11.81 60.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.427 . . . . 75.230000000000004 110.88 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.602 ' N ' HD21 ' A' ' 143' ' ' ASN . 0.9 OUTLIER -94.99 -17.09 22.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 75.519999999999996 110.912 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.484 HG21 ' HA ' ' A' ' 141' ' ' TRP . 21.2 m -98.76 2.19 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 65.430000000000007 111.098 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.516 ' C ' ' H ' ' A' ' 147' ' ' LEU . 51.4 p -151.66 149.49 24.13 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.525 0.679 . . . . 64.120000000000005 111.219 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 32.01 0.19 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.698 2.265 . . . . 65.230000000000004 112.386 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.516 ' H ' ' C ' ' A' ' 145' ' ' THR . 13.2 mt -97.8 175.92 5.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 75.239999999999995 110.929 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -140.1 125.53 19.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.172 -0.467 . . . . 74.099999999999994 110.954 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.424 ' CD1' ' HB ' ' A' ' 114' ' ' ILE . 3.2 m-30 -114.39 139.88 49.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 72.239999999999995 110.864 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.1 m -134.94 149.4 50.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 65.540000000000006 110.906 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.476 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 1.8 tttt -95.58 148.22 22.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 74.530000000000001 110.883 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.413 HD13 ' CB ' ' A' ' 157' ' ' ALA . 3.6 pt -152.46 165.06 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 74.109999999999999 111.153 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.45 17.94 2.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 60.340000000000003 110.99 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.1 p -94.63 -49.62 5.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 74.299999999999997 111.235 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 139.6 8.2 0.97 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.765 -0.731 . . . . 73.540000000000006 112.49 179.865 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 23.7 mtm -108.17 75.78 1.01 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.766 0.317 . . . . 64.310000000000002 110.907 179.974 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.413 ' CB ' HD13 ' A' ' 152' ' ' ILE . . . -145.69 163.78 33.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 73.5 111.118 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.67 -53.12 5.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 75.420000000000002 110.846 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.493 HG12 HG21 ' A' ' 220' ' ' ILE . 2.3 mp -90.53 97.61 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 74.310000000000002 111.165 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 8.5 tp -89.29 109.3 20.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 75.25 110.875 179.99 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 95.7 t -89.06 123.49 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 71.530000000000001 111.122 179.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 p -142.64 107.8 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 72.319999999999993 111.144 179.98 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -77.18 109.3 10.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 74.310000000000002 110.87 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -130.56 169.76 15.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 42.200000000000003 111.09 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . 0.491 ' HG3' ' HB3' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -112.88 139.22 48.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 74.420000000000002 110.826 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.644 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 41.43 -150.87 0.2 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.667 -0.778 . . . . 64.530000000000001 112.457 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.809 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -68.04 117.93 10.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.723 0.297 . . . . 55.43 111.163 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.706 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.79 -21.56 12.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 55.310000000000002 110.906 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.08 29.54 0.61 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.738 -0.744 . . . . 62.039999999999999 112.499 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.621 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.73 -0.32 15.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.88 0.372 . . . . 71.329999999999998 110.825 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 74.76 38.67 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 74.230000000000004 110.87 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.706 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -134.29 -41.24 0.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 73.329999999999998 110.898 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.809 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 55.04 99.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 72.140000000000001 111.106 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.644 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.7 m-85 -60.73 -166.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 72.129999999999995 110.829 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.59 19.5 2.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.056 -0.52 . . . . 75.120000000000005 110.862 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.579 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.7 -157.53 6.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 62.25 112.453 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 176' ' ' GLY . 12.4 mmtm -36.7 135.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 75.310000000000002 110.917 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.76 162.85 0.15 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.7 -0.762 . . . . 74.549999999999997 112.521 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.53 -140.01 20.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.68 -0.772 . . . . 64.329999999999998 112.513 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.6 mt -49.92 93.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.819 0.342 . . . . 74.349999999999994 111.206 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 1.7 tm? -67.44 -33.34 74.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 74.409999999999997 110.944 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -178.89 169.31 1.6 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 63.350000000000001 111.06 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.501 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.3 p80 -165.28 139.43 4.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 74.200000000000003 110.855 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.579 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -137.93 173.47 11.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.267 -0.424 . . . . 72.530000000000001 111.125 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.488 ' O ' ' O ' ' A' ' 222' ' ' HIS . 10.2 m-85 -98.85 -141.98 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.006 0.432 . . . . 74.329999999999998 110.809 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -164.42 -101.13 0.15 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.736 -0.745 . . . . 73.310000000000002 112.507 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 61.42 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.66 2.24 . . . . 73.329999999999998 112.349 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.586 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.94 154.66 16.74 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.736 -0.745 . . . . 74.140000000000001 112.442 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.569 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.05 147.95 26.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.938 0.399 . . . . 63.520000000000003 110.821 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.66 -67.2 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 53.32 112.545 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.569 ' N ' ' O ' ' A' ' 189' ' ' SER . 5.2 mm -103.39 6.58 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 75.329999999999998 111.118 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.586 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -64.14 165.43 30.81 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.8 -0.714 . . . . 71.519999999999996 112.483 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 45.35 19.17 0.22 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.735 -0.745 . . . . 73.450000000000003 112.471 -179.925 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.417 ' N ' ' O ' ' A' ' 192' ' ' GLY . 0.8 OUTLIER -63.5 105.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.885 0.374 . . . . 72.510000000000005 110.846 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.579 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -81.84 131.65 35.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 72.420000000000002 111.127 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.501 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 7.7 m170 -122.82 129.77 52.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 75.299999999999997 110.884 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.568 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 34.1 m-85 -115.5 135.5 54.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.292 -0.413 . . . . 75.329999999999998 110.963 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -69.36 106.82 3.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 71.109999999999999 110.961 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.491 ' HB3' ' HG3' ' A' ' 165' ' ' ARG . 3.9 tm-20 -58.35 -37.53 75.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 75.510000000000005 110.916 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.579 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 14.9 m-20 -49.18 -23.22 1.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.506 . . . . 64.510000000000005 110.852 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.75 163.4 24.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 72.430000000000007 110.88 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.482 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.2 OUTLIER -96.9 96.35 8.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 74.519999999999996 110.855 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.568 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 34.0 m95 -87.89 123.89 33.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.475 . . . . 64.219999999999999 110.891 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.8 p -143.73 -179.13 6.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 72.010000000000005 111.127 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.24 18.64 20.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 72.439999999999998 111.128 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.85 -175.51 3.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 74.219999999999999 110.796 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 24.1 p -66.91 -18.11 65.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 64.420000000000002 110.835 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.95 -108.7 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.61 -0.805 . . . . 42.229999999999997 112.538 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.482 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.04 178.18 0.12 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.818 -0.706 . . . . 73.340000000000003 112.492 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 210' ' ' THR . . . . . 0.452 ' N ' ' O ' ' A' ' 202' ' ' PHE . 96.3 m -66.08 97.42 0.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.338 . . . . 72.25 111.044 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -41.48 111.93 0.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 75.209999999999994 110.843 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.6 tp -58.8 -38.08 77.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 75.439999999999998 110.869 179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -52.5 -64.28 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 72.420000000000002 110.845 179.989 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 19.3 mt -52.45 -56.22 16.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 75.040000000000006 110.92 -179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.0 m -54.87 -37.93 66.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 74.549999999999997 111.164 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.06 -48.28 79.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 72.200000000000003 111.059 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.499 HG22 ' CB ' ' A' ' 137' ' ' ALA . 2.1 t -53.84 -58.52 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 72.010000000000005 111.182 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.548 ' HB2' HG12 ' A' ' 235' ' ' VAL . 1.7 t-80 -64.78 -27.65 69.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 71.239999999999995 110.931 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -64.14 -44.77 91.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 73.109999999999999 111.074 179.87 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.54 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.6 mt -69.33 -34.54 63.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 73.120000000000005 111.16 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.458 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -52.43 -45.25 58.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.698 -0.763 . . . . 74.519999999999996 112.494 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.488 ' O ' ' O ' ' A' ' 185' ' ' PHE . 3.8 m-70 -68.49 -40.22 81.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.784 0.326 . . . . 73.420000000000002 110.847 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.478 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 29.8 p -65.39 -21.29 66.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 75.120000000000005 110.84 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 59.6 mt -79.81 -26.84 40.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 63.420000000000002 110.941 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 122.35 12.88 5.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.699 -0.762 . . . . 65.040000000000006 112.447 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.458 ' HB2' ' O ' ' A' ' 221' ' ' GLY . 11.3 mt -81.71 156.09 25.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.83 0.348 . . . . 73.109999999999999 110.933 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -99.89 -140.5 11.43 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.797 -0.716 . . . . 65.510000000000005 112.493 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -120.91 141.98 50.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.359 . . . . 74.409999999999997 110.808 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 60.9 p -99.16 163.05 12.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 75.430000000000007 110.904 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.67 1.22 21.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 62.329999999999998 110.824 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.17 132.35 73.69 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.553 0.692 . . . . 74.5 110.864 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 52.8 Cg_endo -69.87 4.15 2.4 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.638 2.225 . . . . 74.150000000000006 112.321 -179.928 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.01 11.12 3.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 74.030000000000001 110.884 179.891 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -88.82 150.22 23.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 73.150000000000006 111.151 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.548 HG12 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -71.73 -39.67 69.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 74.340000000000003 111.136 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 48.0 mmm -61.73 -15.12 37.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 74.140000000000001 110.861 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.608 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -56.53 144.49 63.66 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.649 0.738 . . . . 75.430000000000007 110.9 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.608 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.0 Cg_endo -69.84 -1.75 9.06 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.582 2.188 . . . . 74.430000000000007 112.313 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 22.0 m -97.88 141.07 31.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.419 . . . . 75.230000000000004 111.19 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -122.64 135.36 54.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 72.25 110.932 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -156.27 137.04 13.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 73.030000000000001 110.905 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 66.4 t80 -59.2 146.28 39.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 73.140000000000001 110.997 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.6 OUTLIER -158.96 133.01 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 75.319999999999993 111.082 179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -51.13 129.32 23.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 71.439999999999998 110.835 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 9.7 tt -53.84 -30.88 19.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 74.430000000000007 111.157 179.946 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -73.43 -21.15 60.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 71.519999999999996 110.926 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 69.8 p -104.05 -22.41 13.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 72.049999999999997 111.176 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -67.03 141.86 57.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 74.150000000000006 110.91 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -175.41 132.41 0.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 74.540000000000006 110.83 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 55.5 mt -49.89 122.78 7.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 75.319999999999993 110.907 179.939 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 8.6 t -65.96 167.21 10.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 73.510000000000005 110.898 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.01 -38.05 35.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 64.150000000000006 111.048 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -61.86 -49.12 77.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 65.530000000000001 110.826 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . 0.431 ' OD2' ' HB ' ' A' ' 235' ' ' VAL . 2.0 m-20 -59.25 -55.79 30.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.244 -0.435 . . . . 73.439999999999998 110.813 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 18.3 mt -59.68 -33.46 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 72.420000000000002 111.201 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -69.2 -41.06 77.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 74.019999999999996 110.874 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.84 -49.87 7.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.75 -0.738 . . . . 73.340000000000003 112.542 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.4 ' HA ' HD21 ' A' ' 226' ' ' LEU . 7.5 tp -53.08 -33.67 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.72 0.295 . . . . 75.530000000000001 111.098 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.421 ' O ' ' N ' ' A' ' 263' ' ' GLY . 52.8 mt-30 -88.21 -16.21 33.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.485 . . . . 75.329999999999998 110.933 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.7 t -69.54 -14.16 62.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 73.200000000000003 110.826 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.99 -18.65 5.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.144 -0.48 . . . . 75.439999999999998 110.934 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 41.1 m-85 -114.3 -32.88 5.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 74.349999999999994 110.896 -179.979 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.421 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.369 0 CA-C-O 119.22 -0.767 . . . . 64.120000000000005 112.468 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.808 0.337 . . . . 70.239999999999995 110.902 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.38 69.85 1.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 74.519999999999996 110.905 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 176.86 126.79 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 75.140000000000001 110.968 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 34.1 ttm -50.88 130.6 29.2 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.594 0.712 . . . . 73.099999999999994 110.855 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 67.1 1.77 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.661 2.241 . . . . 71.109999999999999 112.414 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -160.97 21.9 0.23 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.805 -0.712 . . . . 75.319999999999993 112.507 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.97 -156.3 24.32 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.682 -0.77 . . . . 74.340000000000003 112.431 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.85 137.67 35.74 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.692 2.261 . . . . 73.319999999999993 112.344 -179.903 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.421 ' CG2' ' H ' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -44.0 -84.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 72.510000000000005 111.116 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.421 ' H ' ' CG2' ' A' ' 108' ' ' VAL . 30.5 m0 -133.22 -31.43 1.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 73.319999999999993 110.824 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 72.29 19.84 4.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.295 -0.412 . . . . 71.040000000000006 110.911 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.402 ' O ' HD12 ' A' ' 147' ' ' LEU . 20.2 pttt -122.63 138.23 54.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 65.439999999999998 110.841 -179.993 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.509 ' HA ' ' CD1' ' A' ' 147' ' ' LEU . 2.1 p80 -93.79 42.38 1.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 75.310000000000002 110.894 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -144.62 90.94 2.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 74.409999999999997 110.972 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.445 ' CG2' ' N ' ' A' ' 115' ' ' THR . 5.0 mp -121.09 162.49 19.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 75.5 111.216 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.445 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.2 OUTLIER -160.09 162.71 34.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 63.119999999999997 111.102 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.594 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.1 p90 -133.4 149.71 51.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.496 . . . . 74.420000000000002 110.952 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 3.9 tmt_? -142.5 115.06 8.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 73.329999999999998 110.823 -179.927 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 52.7 mt -75.35 103.43 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 71.409999999999997 111.128 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -57.15 -45.72 83.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 74.209999999999994 110.933 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -145.01 161.38 39.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.431 . . . . 72.030000000000001 110.914 179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -115.53 134.05 55.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 74.129999999999995 110.906 -179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.405 HG23 ' HB2' ' A' ' 124' ' ' ASP . 2.3 t -82.41 142.05 46.32 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.55 0.691 . . . . 75.439999999999998 111.195 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.89 -5.78 17.11 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.646 2.231 . . . . 64.25 112.308 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.405 ' HB2' HG23 ' A' ' 122' ' ' THR . 40.3 m-20 -77.07 -22.15 53.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.439 . . . . 73.140000000000001 110.876 179.902 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 18.2 mtm -117.74 167.15 11.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 72.5 110.884 -179.991 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 45.6 t30 -94.09 143.17 26.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 74.349999999999994 110.934 -179.959 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -44.72 -35.23 2.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.226 -0.443 . . . . 74.519999999999996 110.853 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -84.26 -38.35 20.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 74.129999999999995 110.932 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -65.7 -30.02 70.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 63.240000000000002 110.783 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . 0.411 ' HA ' ' CD2' ' A' ' 212' ' ' LEU . 79.7 t -66.79 -46.78 84.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 71.200000000000003 111.07 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.449 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -77.22 -24.29 51.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 61.25 110.894 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -73.89 -47.01 41.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 64.409999999999997 110.91 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.93 -32.19 71.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 63.140000000000001 111.134 179.778 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.3 mp -74.72 -53.65 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 74.400000000000006 111.161 179.981 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.449 ' HB3' ' O ' ' A' ' 131' ' ' ASP . 6.8 ptp180 -49.18 -38.07 24.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 72.329999999999998 110.937 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 1.6 mmtp -77.18 -31.93 55.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 75.450000000000003 110.916 179.928 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.527 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -61.58 -49.14 77.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 55.149999999999999 111.066 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.594 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.6 m-85 -72.82 -22.09 60.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 75.530000000000001 110.844 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.49 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.6 OUTLIER -77.4 -5.54 50.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 61.140000000000001 110.888 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.46 ' HB ' HG11 ' A' ' 217' ' ' VAL . 97.8 t -98.11 -17.21 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 73.230000000000004 111.152 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.494 ' CD1' HG13 ' A' ' 217' ' ' VAL . 95.9 m95 -106.87 -37.19 6.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 73.510000000000005 110.906 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.25 -10.84 60.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 73.129999999999995 110.815 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.591 ' N ' HD21 ' A' ' 143' ' ' ASN . 0.9 OUTLIER -97.07 -19.4 18.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 65.109999999999999 110.939 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.486 HG21 ' HA ' ' A' ' 141' ' ' TRP . 18.3 m -100.23 -2.27 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.47 . . . . 71.219999999999999 111.075 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.555 ' HB ' ' CD2' ' A' ' 147' ' ' LEU . 34.3 p -142.39 147.45 43.36 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.517 0.675 . . . . 73.230000000000004 111.212 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.79 34.72 0.21 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.649 2.233 . . . . 73.040000000000006 112.336 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.555 ' CD2' ' HB ' ' A' ' 145' ' ' THR . 3.0 mm? -104.57 166.47 10.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 70.310000000000002 110.883 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -128.99 125.69 37.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 71.230000000000004 110.926 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.403 ' CD1' ' HB ' ' A' ' 114' ' ' ILE . 3.3 m-30 -114.55 143.49 44.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 70.010000000000005 110.909 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 44.4 m -140.75 148.24 40.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 75.099999999999994 110.821 -179.755 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.412 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 12.4 tptm -97.36 146.13 25.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 75.5 110.813 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 16.3 pt -150.31 142.85 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 73.219999999999999 111.076 179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -112.02 3.31 17.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 74.329999999999998 111.007 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.3 t -166.5 52.29 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 75.329999999999998 111.167 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -145.87 -156.19 6.79 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.726 -0.749 . . . . 74.129999999999995 112.436 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 30.9 mmt -106.18 88.74 2.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.761 0.315 . . . . 74.400000000000006 110.907 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -96.37 153.26 17.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 61.310000000000002 111.141 179.905 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.51 -52.87 6.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 65.099999999999994 110.813 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.516 ' HA ' ' O ' ' A' ' 193' ' ' GLY . 2.4 mp -91.52 97.96 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 75.239999999999995 111.151 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 6.9 tp -88.8 110.69 21.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.176 -0.466 . . . . 73.420000000000002 110.947 179.887 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 90.6 t -88.81 119.51 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 71.239999999999995 111.16 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 p -138.82 104.52 2.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.174 -0.467 . . . . 72.120000000000005 111.238 179.889 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -70.98 110.48 5.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 64.030000000000001 110.891 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -130.32 166.38 20.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 51.409999999999997 111.054 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 21.3 ptt-85 -114.7 140.0 49.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 72.129999999999995 110.82 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.645 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 41.39 -150.85 0.2 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.761 -0.733 . . . . 71.230000000000004 112.471 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.812 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -70.21 117.33 11.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.773 0.32 . . . . 71.099999999999994 111.122 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.698 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.99 -21.09 12.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 75.129999999999995 110.778 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.29 29.4 0.66 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 73.239999999999995 112.587 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.646 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.46 0.03 15.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.78 0.324 . . . . 74.209999999999994 110.863 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 74.32 38.95 0.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 75.329999999999998 110.916 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.698 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.74 -41.02 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 72.140000000000001 110.849 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.812 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 53.44 99.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 74.019999999999996 111.098 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.645 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.9 m-85 -59.88 -168.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 75.099999999999994 110.861 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.59 19.11 3.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.195 -0.457 . . . . 74.409999999999997 110.96 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.579 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.62 -157.09 6.88 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 74.200000000000003 112.48 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -35.23 134.46 0.27 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.836 0.351 . . . . 74.219999999999999 110.89 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.45 165.44 0.15 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.659 -0.781 . . . . 70.219999999999999 112.467 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.96 -143.34 22.13 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.749 . . . . 53.420000000000002 112.447 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -49.95 97.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.869 0.366 . . . . 75.109999999999999 111.166 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.9 mt -67.75 -38.65 83.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 73.299999999999997 110.946 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -172.72 167.87 5.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 64.239999999999995 111.047 179.721 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.514 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -161.13 143.04 12.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 74.340000000000003 110.89 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.421 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -134.94 176.44 8.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.304 -0.407 . . . . 74.099999999999994 111.048 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.436 ' O ' ' O ' ' A' ' 222' ' ' HIS . 7.9 m-85 -100.77 -120.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 72.010000000000005 110.947 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.555 ' HA2' ' O ' ' A' ' 223' ' ' SER . . . 166.75 -92.74 0.1 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.715 -0.755 . . . . 75.209999999999994 112.501 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.91 55.37 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.615 2.21 . . . . 64.420000000000002 112.369 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.558 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.32 151.52 16.93 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 53.509999999999998 112.401 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.82 145.1 30.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.898 0.38 . . . . 72.209999999999994 110.82 -179.719 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.63 -65.18 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.7 -0.762 . . . . 73.109999999999999 112.37 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 189' ' ' SER . 1.9 mp -103.63 6.81 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.855 0.36 . . . . 72.340000000000003 111.126 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.558 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -66.82 170.43 32.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.782 -0.723 . . . . 71.219999999999999 112.485 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 42.66 24.74 0.26 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.722 -0.751 . . . . 74.049999999999997 112.455 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.87 102.23 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.775 0.321 . . . . 74.239999999999995 110.911 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.421 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -77.21 128.78 34.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 63.409999999999997 111.073 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.514 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 8.5 m170 -118.53 131.15 56.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 73.510000000000005 110.827 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.454 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 51.4 m-85 -115.23 134.74 54.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 75.319999999999993 110.858 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -67.57 109.07 3.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.089 -0.505 . . . . 63.43 110.802 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.55 -37.19 80.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 74.340000000000003 111.005 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.579 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 5.0 m-20 -50.41 -22.68 1.97 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 72.140000000000001 110.825 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -79.84 163.17 24.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 74.109999999999999 110.889 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.55 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -100.64 88.23 3.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 73.219999999999999 110.938 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.454 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 33.6 m95 -79.48 124.71 28.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.457 . . . . 74.329999999999998 110.944 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 22.7 p -142.6 -177.79 5.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.252 -0.431 . . . . 74.430000000000007 111.178 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.07 19.76 18.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 74.519999999999996 111.219 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.11 -175.62 3.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 74.439999999999998 110.914 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.9 p -68.77 -18.31 64.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 74.439999999999998 110.826 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.18 -107.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.667 -0.777 . . . . 74.200000000000003 112.515 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.55 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.42 176.87 0.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.763 -0.732 . . . . 72.129999999999995 112.428 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 94.3 m -64.89 97.37 0.22 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.757 0.313 . . . . 74.439999999999998 111.2 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -41.45 116.42 0.76 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 74.040000000000006 110.888 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . 0.411 ' CD2' ' HA ' ' A' ' 130' ' ' VAL . 8.6 tp -64.12 -38.39 90.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 72.340000000000003 110.916 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 4.1 t80 -51.97 -66.9 0.3 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 73.219999999999999 110.939 179.949 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 21.9 mt -52.84 -54.96 26.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.141 -0.482 . . . . 61.25 110.879 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 215' ' ' THR . . . . . 0.452 ' O ' ' CB ' ' A' ' 219' ' ' ALA . 5.1 m -54.8 -37.19 65.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 74.409999999999997 111.092 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.81 -50.57 64.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 75.439999999999998 111.115 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.527 HG22 ' CB ' ' A' ' 137' ' ' ALA . 1.8 t -52.42 -56.61 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 74.0 111.106 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . . . . . . . . . 1.8 t-80 -69.12 -26.49 64.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 63.32 110.904 179.904 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . 0.452 ' CB ' ' O ' ' A' ' 215' ' ' THR . . . -64.83 -45.22 87.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 72.409999999999997 111.126 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.529 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 3.1 mt -67.68 -37.41 78.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.254 -0.43 . . . . 73.439999999999998 111.149 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.492 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -52.57 -46.39 58.84 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.804 -0.712 . . . . 74.5 112.428 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.436 ' O ' ' O ' ' A' ' 185' ' ' PHE . 2.5 m-70 -69.39 -38.64 78.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.332 . . . . 75.439999999999998 110.824 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.555 ' O ' ' HA2' ' A' ' 186' ' ' GLY . 0.3 OUTLIER -74.8 -9.77 58.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.005 0.431 . . . . 65.140000000000001 110.934 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 13.5 mt -90.1 -25.9 20.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 72.450000000000003 110.923 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 124.48 12.94 4.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.785 -0.722 . . . . 63.32 112.529 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.492 ' HB2' ' O ' ' A' ' 221' ' ' GLY . 0.2 OUTLIER -85.61 160.99 19.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.829 0.347 . . . . 73.129999999999995 110.964 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -105.89 -144.92 12.63 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.754 -0.736 . . . . 74.420000000000002 112.487 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -115.86 146.94 41.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.775 0.321 . . . . 74.5 110.862 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 37.3 m -103.08 162.56 12.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.179 -0.464 . . . . 72.209999999999994 110.846 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.2 t -107.07 1.26 24.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 72.239999999999995 110.852 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.05 141.29 94.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.6 0.714 . . . . 74.219999999999999 110.801 -179.986 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 -3.36 11.79 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.634 2.222 . . . . 73.230000000000004 112.384 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.72 17.16 1.99 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 63.310000000000002 110.922 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.41 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -78.06 137.94 38.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 61.340000000000003 111.024 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . . . . . . . . . 6.9 p -63.99 -29.59 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 71.319999999999993 111.108 179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 61.2 mmm -73.81 -12.61 60.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 74.519999999999996 110.89 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.65 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -59.09 146.27 78.1 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.59 0.71 . . . . 72.040000000000006 110.831 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.65 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.8 Cg_endo -69.75 1.2 4.64 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.739 2.293 . . . . 75.219999999999999 112.33 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 53.2 m -102.89 129.02 49.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 71.549999999999997 111.152 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -110.4 136.33 49.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 74.040000000000006 110.921 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -155.69 133.86 11.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 74.329999999999998 110.851 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 71.1 t80 -59.24 147.77 34.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 74.450000000000003 110.983 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER -159.64 133.24 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 75.439999999999998 111.091 179.886 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -49.94 133.26 22.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 64.420000000000002 110.768 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 8.4 tt -55.17 -30.89 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 72.329999999999998 111.063 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -77.3 -17.43 58.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 74.340000000000003 110.836 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 66.6 p -103.21 -24.43 13.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 63.210000000000001 111.195 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -65.7 144.31 56.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 72.239999999999995 110.891 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -176.8 128.65 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 74.319999999999993 110.909 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 54.7 mt -48.66 127.14 13.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 75.430000000000007 110.875 -179.94 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 38.9 m -72.05 167.27 20.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.140000000000001 110.897 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.4 -38.93 60.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.089 -0.505 . . . . 75.239999999999995 111.11 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -46.67 84.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 74.340000000000003 110.868 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -61.92 -52.12 65.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.237 -0.438 . . . . 73.5 110.848 -179.938 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 21.1 mt -62.99 -34.66 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 74.299999999999997 111.102 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -69.51 -40.04 77.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 74.540000000000006 110.922 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.3 -49.26 7.53 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.811 -0.709 . . . . 64.430000000000007 112.525 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 3.8 tp -53.01 -32.84 18.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.78 0.324 . . . . 74.420000000000002 111.142 -179.996 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 263' ' ' GLY . 47.6 mt-30 -88.08 -17.38 31.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 64.219999999999999 110.889 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.4 t -69.17 -16.51 63.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 73.310000000000002 110.792 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.7 mt -118.81 -23.03 7.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 73.219999999999999 110.857 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.47 ' HB3' ' CD2' ' A' ' 147' ' ' LEU . 27.7 m-85 -106.3 -38.33 6.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 74.329999999999998 110.951 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.32 0 CA-C-O 119.149 -0.806 . . . . 73.510000000000005 112.446 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.434 ' O ' ' C ' ' A' ' 101' ' ' ARG . 2.6 t80 . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.871 0.367 . . . . 71.030000000000001 110.909 . . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.439 ' H ' ' NE ' ' A' ' 101' ' ' ARG . 0.5 OUTLIER -35.36 138.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 65.519999999999996 110.903 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -177.04 145.59 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 72.409999999999997 110.854 -179.894 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.53 152.71 3.12 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.562 0.696 . . . . 63.020000000000003 110.888 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.65 64.47 1.74 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.784 2.323 . . . . 74.120000000000005 112.317 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -159.23 -84.2 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.687 -0.768 . . . . 72.530000000000001 112.419 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.412 ' N ' ' HD2' ' A' ' 107' ' ' PRO . . . 144.91 -62.01 0.48 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.704 -0.76 . . . . 62.229999999999997 112.452 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.412 ' HD2' ' N ' ' A' ' 106' ' ' GLY . 53.4 Cg_endo -69.83 79.13 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.619 2.213 . . . . 72.129999999999995 112.401 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.437 ' O ' ' C ' ' A' ' 109' ' ' TRP . 16.6 m -94.94 34.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 74.040000000000006 111.109 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.437 ' C ' ' O ' ' A' ' 108' ' ' VAL . 0.5 OUTLIER 34.14 88.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 73.030000000000001 110.917 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -75.83 57.65 1.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.269 -0.423 . . . . 74.209999999999994 110.85 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 19.8 mtmt -98.92 141.44 31.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 64.239999999999995 110.889 179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -91.46 19.1 6.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 75.239999999999995 110.905 179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -128.74 92.47 3.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 75.420000000000002 110.926 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.424 ' CG2' ' N ' ' A' ' 115' ' ' THR . 3.9 mp -121.22 165.71 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 72.430000000000007 111.078 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.424 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.3 OUTLIER -159.29 160.36 35.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 72.109999999999999 111.139 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.592 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 1.9 p90 -132.33 144.32 50.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.267 -0.424 . . . . 75.129999999999995 110.994 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -136.23 113.34 10.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 74.430000000000007 110.842 -179.965 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 63.0 mt -76.04 105.4 4.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 74.420000000000002 111.086 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -56.2 -51.28 68.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 75.010000000000005 110.971 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.8 p-10 -141.97 166.52 24.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 62.229999999999997 110.86 179.965 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -117.07 146.22 43.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 75.430000000000007 110.923 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.404 HG23 ' HB2' ' A' ' 124' ' ' ASP . 3.5 t -93.58 142.67 25.47 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 121.634 0.73 . . . . 72.409999999999997 111.125 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.89 -1.79 9.18 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.643 2.229 . . . . 73.420000000000002 112.291 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.404 ' HB2' HG23 ' A' ' 122' ' ' THR . 15.7 m-20 -81.82 -23.07 36.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 71.010000000000005 110.887 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.424 ' HE2' ' HB2' ' A' ' 125' ' ' MET . 13.2 mtm -116.5 166.51 12.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 74.310000000000002 110.892 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -96.22 145.92 25.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 75.519999999999996 110.816 -179.873 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -45.52 -34.91 3.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 75.519999999999996 110.887 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -83.29 -38.96 21.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 74.219999999999999 110.941 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -65.67 -29.77 70.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 61.140000000000001 110.812 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 79.5 t -65.79 -45.86 90.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.282 -0.417 . . . . 75.25 111.132 179.995 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.75 -23.07 42.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 71.209999999999994 110.925 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -74.83 -47.78 28.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.477 . . . . 73.140000000000001 110.924 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -71.39 -31.32 67.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 71.519999999999996 110.99 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.3 mp -73.87 -55.57 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.432 . . . . 71.019999999999996 111.106 -179.973 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 13.3 ttt180 -48.67 -42.91 36.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 71.209999999999994 110.85 179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.3 mmpt? -70.56 -34.46 72.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.43 . . . . 72.109999999999999 110.855 -179.996 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.495 ' HA ' HG21 ' A' ' 217' ' ' VAL . . . -60.99 -50.48 73.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 72.140000000000001 111.001 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.592 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.2 m-85 -70.97 -21.82 62.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 72.209999999999994 110.94 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.574 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.5 tt0 -78.71 -5.93 54.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 75.530000000000001 110.916 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.496 ' HB ' HG11 ' A' ' 217' ' ' VAL . 95.3 t -95.59 -17.41 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 73.450000000000003 111.096 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.481 ' CD1' HG13 ' A' ' 217' ' ' VAL . 95.8 m95 -105.47 -36.73 7.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.211 -0.449 . . . . 73.340000000000003 110.896 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.98 -11.94 61.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 72.439999999999998 110.846 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.61 ' N ' HD21 ' A' ' 143' ' ' ASN . 0.9 OUTLIER -94.5 -18.57 21.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 75.129999999999995 110.909 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.478 HG21 ' HA ' ' A' ' 141' ' ' TRP . 16.9 m -98.03 2.5 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 65.219999999999999 111.189 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.516 ' C ' ' H ' ' A' ' 147' ' ' LEU . 49.9 p -151.2 149.11 23.93 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.619 0.723 . . . . 51.240000000000002 111.146 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 31.57 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.665 2.244 . . . . 64.430000000000007 112.345 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.516 ' H ' ' C ' ' A' ' 145' ' ' THR . 14.4 mt -98.46 173.41 6.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 74.329999999999998 110.895 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -137.59 127.33 25.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 75.439999999999998 110.893 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.5 m-30 -114.47 143.8 44.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 73.219999999999999 110.851 179.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.2 t -138.85 147.87 43.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.12 -0.491 . . . . 72.310000000000002 110.845 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.472 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 2.6 tptm -97.42 141.84 30.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.494 . . . . 71.120000000000005 110.922 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.449 ' N ' ' HG3' ' A' ' 151' ' ' LYS . 17.2 pt -150.07 133.23 7.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 72.450000000000003 111.13 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -100.63 -6.82 24.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 74.400000000000006 110.915 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.2 t -155.61 58.48 0.62 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 73.430000000000007 111.167 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -151.57 -156.62 7.51 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.755 -0.736 . . . . 62.109999999999999 112.512 179.95 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 33.4 mmt -105.44 97.4 7.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 72.439999999999998 110.915 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -107.21 154.39 21.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 73.349999999999994 111.116 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -82.88 -53.03 6.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.226 -0.443 . . . . 73.530000000000001 110.799 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.504 ' HA ' ' O ' ' A' ' 193' ' ' GLY . 2.8 mp -91.06 97.91 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.26 -0.427 . . . . 71.409999999999997 111.145 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.1 tp -87.4 109.92 19.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.133 -0.485 . . . . 74.349999999999994 111.009 179.857 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 95.9 t -88.01 123.22 40.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 75.140000000000001 111.109 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 p -142.1 105.56 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 74.120000000000005 111.143 179.949 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -71.61 108.22 4.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 70.109999999999999 110.845 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.1 166.19 18.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 75.310000000000002 111.089 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 -114.25 137.25 52.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 75.409999999999997 110.831 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.657 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.3 -154.92 0.2 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.761 -0.733 . . . . 73.349999999999994 112.458 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.815 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.64 116.96 7.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 75.340000000000003 111.094 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.704 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.96 -22.69 12.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 73.329999999999998 110.855 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.76 28.86 0.55 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.675 -0.774 . . . . 64.040000000000006 112.527 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.624 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.43 0.14 15.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.778 0.323 . . . . 72.409999999999997 110.837 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 74.04 39.08 0.53 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 71.310000000000002 110.927 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.704 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.38 -40.94 0.8 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 72.409999999999997 110.861 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.815 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 53.8 99.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 55.310000000000002 111.131 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.657 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.1 m-85 -60.63 -168.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 72.420000000000002 110.903 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.75 19.03 3.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 75.209999999999994 110.837 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.573 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.5 -158.1 6.1 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.766 -0.73 . . . . 70.430000000000007 112.492 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 176' ' ' GLY . 2.1 ttmm -34.25 134.22 0.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.351 . . . . 74.299999999999997 110.828 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.4 165.55 0.15 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.826 -0.702 . . . . 73.439999999999998 112.524 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.37 -144.01 23.16 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.81 -0.71 . . . . 73.319999999999993 112.533 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -49.51 97.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 75.150000000000006 111.152 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.9 mt -67.04 -41.88 85.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 73.349999999999994 110.953 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -169.52 169.34 8.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 71.150000000000006 111.138 179.729 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.486 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -163.24 143.54 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 75.450000000000003 110.884 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.461 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -135.44 174.79 10.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 71.230000000000004 111.159 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.534 ' O ' ' O ' ' A' ' 222' ' ' HIS . 94.9 m-85 -96.93 -122.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 72.349999999999994 110.905 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.477 ' HA2' ' O ' ' A' ' 223' ' ' SER . . . 172.21 -98.34 0.13 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.721 -0.752 . . . . 42.030000000000001 112.431 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 57.13 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.686 2.257 . . . . 72.310000000000002 112.321 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.554 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -122.16 153.12 16.82 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.772 -0.728 . . . . 71.129999999999995 112.557 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.63 145.92 29.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 63.210000000000001 110.841 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.67 -64.71 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.742 -0.742 . . . . 72.120000000000005 112.554 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 189' ' ' SER . 1.2 mp -104.88 6.18 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.805 0.336 . . . . 71.200000000000003 111.099 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.554 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -64.66 168.14 27.96 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.702 -0.761 . . . . 71.209999999999994 112.486 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.504 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 42.77 23.2 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.757 -0.735 . . . . 72.439999999999998 112.43 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 192' ' ' GLY . 0.9 OUTLIER -66.52 99.34 0.57 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.806 0.336 . . . . 75.109999999999999 110.856 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.461 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -74.0 132.87 42.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 73.329999999999998 111.069 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.486 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.8 m170 -123.41 131.27 53.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 71.299999999999997 110.923 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.435 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 40.9 m-85 -115.5 135.07 54.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 73.25 110.866 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -68.03 107.48 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 70.439999999999998 110.827 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.54 -35.93 75.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 71.0 110.904 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.573 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 15.6 m-20 -51.47 -21.59 2.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 73.129999999999995 110.83 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -81.39 163.29 22.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 73.219999999999999 110.893 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.562 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -101.75 85.96 2.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 75.120000000000005 110.917 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.435 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 30.9 m95 -76.62 123.58 26.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.107 -0.497 . . . . 72.519999999999996 110.862 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 35.8 p -141.54 -178.01 5.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 73.25 111.151 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.45 20.94 17.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 75.129999999999995 111.129 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -127.81 -172.97 2.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.432 . . . . 74.409999999999997 110.903 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.1 p -73.14 -18.84 61.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 73.299999999999997 110.856 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -61.24 -104.91 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.751 -0.737 . . . . 72.310000000000002 112.427 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.562 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -51.77 176.18 0.1 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 70.420000000000002 112.462 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 73.1 m -65.9 97.62 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 73.109999999999999 111.14 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -41.88 116.46 0.8 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 73.420000000000002 110.885 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 7.0 tp -65.44 -36.74 84.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 74.340000000000003 110.945 179.935 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 3.6 t80 -51.88 -64.85 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 73.150000000000006 110.87 179.936 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 15.1 mt -56.47 -52.98 62.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.22 -0.445 . . . . 72.430000000000007 110.911 179.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 8.0 m -53.69 -38.01 63.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 70.540000000000006 111.184 179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -62.97 -50.89 68.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 52.340000000000003 111.14 179.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.496 HG11 ' HB ' ' A' ' 140' ' ' VAL . 0.3 OUTLIER -52.16 -57.58 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 74.299999999999997 111.17 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.603 ' HB2' HG13 ' A' ' 235' ' ' VAL . 4.3 t-80 -65.29 -29.09 69.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.112 -0.494 . . . . 72.010000000000005 110.891 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -64.42 -46.66 82.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 63.439999999999998 111.059 179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.582 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.4 mt -69.2 -35.5 68.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.285 -0.416 . . . . 75.319999999999993 111.126 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.473 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -51.98 -46.34 55.68 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.845 -0.693 . . . . 60.520000000000003 112.396 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.534 ' O ' ' O ' ' A' ' 185' ' ' PHE . 3.0 m-70 -69.54 -40.11 77.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.835 0.35 . . . . 74.540000000000006 110.824 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.477 ' O ' ' HA2' ' A' ' 186' ' ' GLY . 0.0 OUTLIER -72.23 -11.37 60.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.17 -0.468 . . . . 73.450000000000003 110.881 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . 0.4 ' HG ' HG23 ' A' ' 220' ' ' ILE . 21.4 mt -88.88 -25.11 22.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 75.439999999999998 110.872 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 122.66 11.19 5.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.741 . . . . 73.109999999999999 112.515 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.473 ' HB2' ' O ' ' A' ' 221' ' ' GLY . 0.2 OUTLIER -88.52 152.4 21.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.37 . . . . 74.340000000000003 110.891 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -98.02 -141.25 12.02 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.788 -0.72 . . . . 75.439999999999998 112.52 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.95 141.94 46.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.846 0.355 . . . . 74.310000000000002 110.844 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.419 ' HB2' ' HB2' ' A' ' 234' ' ' ALA . 49.4 m -92.23 160.55 15.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 74.310000000000002 110.801 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.2 t -109.68 9.75 24.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 74.010000000000005 110.874 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . 0.41 ' O ' ' CD1' ' A' ' 237' ' ' PHE . 0.1 OUTLIER -80.95 143.32 53.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.562 0.696 . . . . 62.140000000000001 110.929 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -3.87 12.92 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.765 2.31 . . . . 72.109999999999999 112.289 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.27 30.8 1.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 72.430000000000007 110.836 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.419 ' HB2' ' HB2' ' A' ' 229' ' ' SER . . . -92.59 145.54 24.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 62.340000000000003 111.162 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.603 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.5 t -65.46 -42.2 92.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 75.319999999999993 111.226 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 54.0 mmm -64.74 -14.66 59.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 73.420000000000002 110.902 179.862 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.653 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.0 t80 -57.72 146.24 66.95 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.621 0.724 . . . . 71.540000000000006 110.874 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.653 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.1 Cg_endo -69.77 1.0 4.83 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.662 2.241 . . . . 71.319999999999993 112.42 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 38.6 m -102.17 130.0 48.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 74.140000000000001 111.144 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -113.78 135.85 53.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 74.109999999999999 110.922 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -155.51 137.39 14.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 71.239999999999995 110.825 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 65.9 t80 -62.0 145.21 53.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 65.120000000000005 110.939 -179.998 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -160.29 133.31 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.5 . . . . 71.409999999999997 111.077 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -57.47 131.32 49.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 74.129999999999995 110.903 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 16.7 tt -53.2 -30.25 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 74.510000000000005 111.161 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.95 -21.85 65.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 73.219999999999999 110.859 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.8 p -110.84 -19.63 12.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 72.010000000000005 111.173 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -67.44 142.78 56.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 73.540000000000006 110.911 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -176.32 132.36 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 73.209999999999994 110.919 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 43.9 mt -49.26 132.64 19.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.452 . . . . 74.219999999999999 110.999 179.952 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 32.9 t -74.15 172.8 11.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 64.25 110.853 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.1 -37.61 72.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.115 -0.493 . . . . 73.439999999999998 111.112 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -64.33 -50.56 67.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 60.340000000000003 110.928 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 5.0 m-20 -59.06 -50.91 72.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 73.299999999999997 110.917 179.98 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 20.5 mt -63.46 -34.07 65.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 75.239999999999995 111.214 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -69.65 -40.19 76.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 75.040000000000006 110.872 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.65 -50.0 7.52 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.731 -0.747 . . . . 74.329999999999998 112.486 -179.961 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 3.8 tp -53.5 -33.63 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.299 . . . . 72.540000000000006 111.061 -179.931 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.432 ' O ' ' N ' ' A' ' 263' ' ' GLY . 70.8 mt-30 -88.16 -16.1 34.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 75.239999999999995 110.903 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.5 t -69.23 -15.25 63.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 61.049999999999997 110.849 -179.794 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . 0.427 ' HB3' ' CG2' ' A' ' 108' ' ' VAL . 2.6 mt -122.83 -18.61 6.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.085 -0.507 . . . . 75.230000000000004 110.915 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 38.4 m-85 -113.77 -33.9 5.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 75.409999999999997 110.931 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.432 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.362 0 CA-C-O 119.155 -0.803 . . . . 61.149999999999999 112.481 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.895 0.379 . . . . 73.219999999999999 110.953 . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 59.94 -170.38 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 72.010000000000005 110.933 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 3.9 pm0 -38.21 147.86 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 72.030000000000001 110.945 -179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -49.29 161.77 0.45 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.603 0.716 . . . . 75.310000000000002 110.865 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.8 95.72 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.65 2.233 . . . . 71.319999999999993 112.317 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 130.49 -131.62 6.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 63.329999999999998 112.416 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -146.37 58.94 0.49 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.745 -0.74 . . . . 54.229999999999997 112.45 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 -19.33 36.62 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.669 2.246 . . . . 74.120000000000005 112.421 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 9.3 p -62.91 148.7 10.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 72.329999999999998 111.143 179.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.423 ' HB2' ' HG2' ' A' ' 111' ' ' LYS . 4.8 m0 -75.08 -28.24 60.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.176 -0.466 . . . . 74.439999999999998 110.863 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 23.5 mtt180 68.54 28.35 5.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 74.120000000000005 110.877 -179.907 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.423 ' HG2' ' HB2' ' A' ' 109' ' ' TRP . 32.9 pttt -122.62 155.65 35.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 74.310000000000002 110.905 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.556 ' HA ' ' CD1' ' A' ' 147' ' ' LEU . 1.8 p80 -102.51 42.78 1.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 74.239999999999995 110.897 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -146.21 92.87 2.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.204 -0.453 . . . . 73.510000000000005 110.93 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.429 ' CG2' ' N ' ' A' ' 115' ' ' THR . 4.9 mp -122.66 162.61 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 75.409999999999997 111.086 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.429 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.4 OUTLIER -158.66 163.32 37.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 72.200000000000003 111.18 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.608 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.7 p90 -133.68 148.29 51.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.239 -0.437 . . . . 74.319999999999993 110.915 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.413 ' HB3' ' CD1' ' A' ' 160' ' ' LEU . 0.0 OUTLIER -140.37 112.61 7.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 74.099999999999994 110.912 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.2 mt -74.16 105.31 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 73.099999999999994 111.172 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -56.59 -45.96 81.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 72.299999999999997 110.81 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.413 ' N ' HD21 ' A' ' 120' ' ' ASN . 0.1 OUTLIER -150.1 169.12 22.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 75.109999999999999 110.872 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.6 m-85 -117.09 157.83 25.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 73.239999999999995 110.916 -179.983 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -107.95 146.7 34.02 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.634 0.73 . . . . 74.209999999999994 111.204 -179.987 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 -2.49 10.29 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.711 2.274 . . . . 72.030000000000001 112.25 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -83.64 -25.82 30.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.314 -0.403 . . . . 72.230000000000004 110.936 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' MET . . . . . 0.402 ' HE2' ' CZ ' ' A' ' 163' ' ' PHE . 6.9 mtm -114.66 164.14 14.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 72.140000000000001 110.77 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -96.43 143.76 27.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 71.140000000000001 110.974 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -45.09 -37.05 3.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.443 . . . . 75.209999999999994 110.836 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -82.92 -36.11 25.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 75.549999999999997 110.792 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -67.69 -29.46 68.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 71.019999999999996 110.871 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 94.9 t -66.56 -46.58 85.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.219 -0.446 . . . . 75.409999999999997 111.148 179.982 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.445 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 10.1 t0 -77.13 -25.82 52.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 65.129999999999995 110.866 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -72.72 -49.26 32.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 72.109999999999999 110.931 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -69.44 -30.42 68.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 75.200000000000003 111.09 179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.2 mp -74.64 -53.77 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 72.140000000000001 111.128 179.959 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.445 ' HB3' ' O ' ' A' ' 131' ' ' ASP . 7.2 ptp180 -49.45 -35.4 19.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 71.200000000000003 110.911 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 6.8 mmtp -78.85 -34.1 45.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 74.109999999999999 110.873 179.981 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.467 ' HA ' HG21 ' A' ' 217' ' ' VAL . . . -61.07 -49.16 78.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 72.010000000000005 111.059 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.608 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 89.4 m-85 -70.39 -23.54 62.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.419 . . . . 74.439999999999998 110.966 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.464 ' O ' ' HB3' ' A' ' 143' ' ' ASN . 0.2 OUTLIER -75.4 -15.11 60.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 72.120000000000005 110.936 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 93.6 t -85.03 -19.62 8.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.459 . . . . 74.329999999999998 111.147 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.439 ' CD1' HG13 ' A' ' 217' ' ' VAL . 96.9 m95 -104.74 -27.0 12.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 74.510000000000005 110.916 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.63 -7.59 59.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 73.129999999999995 110.846 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.464 ' HB3' ' O ' ' A' ' 139' ' ' GLN . 0.1 OUTLIER -99.15 -18.39 17.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 73.140000000000001 110.867 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 28.9 m -100.14 -7.9 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 73.519999999999996 111.139 179.934 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.514 ' C ' ' H ' ' A' ' 147' ' ' LEU . 32.5 p -141.97 147.21 43.75 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.642 0.734 . . . . 74.230000000000004 111.096 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 32.43 0.19 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.718 2.279 . . . . 74.540000000000006 112.27 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.556 ' CD1' ' HA ' ' A' ' 112' ' ' HIS . 3.8 mm? -94.49 170.07 9.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.307 -0.406 . . . . 74.129999999999995 111.004 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.24 126.35 29.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 74.519999999999996 110.92 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.4 m-85 -117.53 144.04 45.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 74.450000000000003 110.796 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.1 t -137.66 153.03 49.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 74.030000000000001 110.844 -179.796 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 10.7 tttt -103.37 146.31 28.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 75.420000000000002 110.928 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 24.7 pt -152.12 143.89 15.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 71.409999999999997 111.167 179.835 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -104.34 -18.14 14.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 71.540000000000006 110.829 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.0 t -151.55 63.22 0.87 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 72.109999999999999 111.162 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -149.94 -156.31 7.2 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.676 -0.774 . . . . 73.200000000000003 112.409 -179.97 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 30.1 mmt -106.85 94.11 4.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.783 0.325 . . . . 74.450000000000003 110.914 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -104.67 159.05 16.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 74.209999999999994 111.077 179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.63 -52.82 5.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 70.439999999999998 110.795 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.461 HG12 HG21 ' A' ' 220' ' ' ILE . 2.6 mp -90.4 95.86 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 73.129999999999995 111.042 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.413 ' CD1' ' HB3' ' A' ' 117' ' ' ARG . 8.4 tp -86.75 108.92 18.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 74.219999999999999 110.865 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 96.7 t -87.85 120.02 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 74.150000000000006 111.142 179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 p -138.72 104.31 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 63.049999999999997 111.169 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.403 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 35.5 m-85 -73.73 106.49 5.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 75.150000000000006 110.926 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.03 164.13 23.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 75.219999999999999 111.103 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -110.87 140.72 45.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 74.540000000000006 110.885 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.677 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.67 -151.56 0.31 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.732 -0.747 . . . . 34.210000000000001 112.542 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.812 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -68.74 119.24 12.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.79 0.329 . . . . 74.510000000000005 111.084 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.705 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -111.17 -21.55 11.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 74.030000000000001 110.842 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.16 30.67 0.56 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.724 -0.751 . . . . 54.009999999999998 112.466 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.634 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -114.26 0.23 14.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.87 0.367 . . . . 74.239999999999995 110.835 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 74.13 38.91 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 75.040000000000006 110.796 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.705 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -134.71 -41.04 0.77 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.164 -0.471 . . . . 73.409999999999997 110.842 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.812 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 52.94 100.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 63.43 111.153 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.677 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.6 m-85 -60.72 -169.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 73.420000000000002 110.883 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . 0.438 ' OD2' ' HA3' ' A' ' 179' ' ' GLY . 40.9 p30 -134.07 18.92 3.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 73.219999999999999 110.945 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.565 ' HA2' ' CB ' ' A' ' 200' ' ' ASP . . . 57.81 -162.12 9.43 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.743 -0.741 . . . . 73.420000000000002 112.519 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -35.3 136.94 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 74.400000000000006 110.963 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.76 155.56 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.734 -0.746 . . . . 73.510000000000005 112.469 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . 0.438 ' HA3' ' OD2' ' A' ' 175' ' ' ASP . . . 86.04 -142.68 19.22 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.647 -0.787 . . . . 73.019999999999996 112.366 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.0 mt -48.68 98.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.81 0.338 . . . . 72.420000000000002 111.213 -179.979 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 33.8 mt -71.4 -42.96 67.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 74.129999999999995 110.952 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -170.03 154.35 5.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 73.140000000000001 111.145 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.486 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.1 p80 -148.36 141.65 25.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 74.230000000000004 110.857 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.577 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -137.97 172.78 12.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 54.450000000000003 111.145 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.511 ' O ' ' HA ' ' A' ' 223' ' ' SER . 37.5 m-85 -102.85 -149.65 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 73.439999999999998 110.853 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -162.66 -86.6 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.84 -0.695 . . . . 73.010000000000005 112.593 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 55.8 1.31 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.661 2.241 . . . . 70.219999999999999 112.346 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.572 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -124.31 150.39 17.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.79 -0.719 . . . . 63.439999999999998 112.427 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.46 147.28 27.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 74.109999999999999 110.884 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.17 -64.73 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.715 -0.755 . . . . 65.219999999999999 112.525 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.537 ' N ' ' O ' ' A' ' 189' ' ' SER . 21.9 pt -105.81 7.69 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.873 0.368 . . . . 74.430000000000007 111.112 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.572 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -67.55 168.04 39.81 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.777 -0.725 . . . . 73.299999999999997 112.502 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.426 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 46.35 18.41 0.32 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.743 -0.741 . . . . 73.200000000000003 112.523 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.09 108.72 1.61 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.881 0.372 . . . . 73.120000000000005 110.789 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.577 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -83.32 127.69 33.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 74.340000000000003 111.114 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.486 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.2 m170 -118.37 127.0 53.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 73.420000000000002 110.866 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.522 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 37.9 m-85 -111.09 132.04 54.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 73.450000000000003 110.848 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -65.08 107.75 1.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 72.349999999999994 110.902 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . 0.408 ' O ' ' CD ' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -58.72 -38.41 78.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.187 -0.461 . . . . 75.540000000000006 110.905 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.565 ' CB ' ' HA2' ' A' ' 176' ' ' GLY . 19.3 m-20 -49.92 -21.32 1.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 63.030000000000001 110.835 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -81.31 164.39 22.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 73.230000000000004 110.903 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.484 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.4 OUTLIER -100.94 89.75 3.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 75.549999999999997 110.862 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.522 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 31.1 m95 -81.87 122.33 27.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 73.540000000000006 110.904 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.8 p -137.35 -175.27 4.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 75.299999999999997 111.147 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.35 15.68 19.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 74.420000000000002 111.138 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -129.73 -174.81 3.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 72.109999999999999 110.917 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.7 p -54.79 -34.91 63.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 73.310000000000002 110.855 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -65.8 162.54 41.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.759 -0.734 . . . . 62.119999999999997 112.483 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.484 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . 48.65 -172.38 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.748 . . . . 61.409999999999997 112.571 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 29.8 m -87.3 93.53 9.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.85 0.357 . . . . 71.430000000000007 111.125 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -40.06 110.85 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 55.420000000000002 110.921 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 6.9 tp -57.28 -40.86 78.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 70.150000000000006 110.948 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.6 t80 -48.23 -64.27 0.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 74.450000000000003 110.923 179.888 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 17.4 mt -55.81 -52.3 64.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.135 -0.484 . . . . 70.519999999999996 110.865 179.99 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -54.12 -37.31 64.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 75.450000000000003 111.134 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.8 -51.57 64.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 73.310000000000002 111.04 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.467 HG21 ' HA ' ' A' ' 137' ' ' ALA . 0.9 OUTLIER -49.96 -57.5 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 72.049999999999997 111.106 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.523 ' HB2' HG12 ' A' ' 235' ' ' VAL . 3.6 t-80 -66.32 -29.37 69.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.278 -0.419 . . . . 73.409999999999997 110.9 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -63.5 -42.76 98.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 75.109999999999999 111.069 179.855 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.583 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.2 mt -71.57 -35.0 54.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.263 -0.426 . . . . 71.430000000000007 111.232 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.45 -43.34 44.5 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.623 -0.798 . . . . 75.299999999999997 112.495 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 185' ' ' PHE . 32.7 m-70 -69.27 -39.9 78.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.797 0.332 . . . . 71.209999999999994 110.86 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.511 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 3.4 m -62.54 -27.03 68.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 50.229999999999997 110.807 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 74.2 mt -75.72 -27.39 58.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.244 -0.435 . . . . 71.409999999999997 110.988 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 118.0 16.16 5.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.691 -0.766 . . . . 71.430000000000007 112.521 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 29.3 mt -80.78 155.06 26.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.874 0.369 . . . . 73.409999999999997 110.856 -179.822 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -98.43 -137.09 9.56 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.7 -0.762 . . . . 60.229999999999997 112.513 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.439 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 1.1 m170 -125.34 149.78 47.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.861 0.362 . . . . 72.310000000000002 110.848 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 67.7 m -110.87 163.88 13.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 75.040000000000006 110.886 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.66 -3.01 25.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 63.140000000000001 110.892 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -67.75 137.23 92.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.598 0.713 . . . . 71.420000000000002 110.872 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -3.86 12.91 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.694 2.262 . . . . 72.239999999999995 112.311 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.21 3.07 3.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 74.129999999999995 110.852 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.473 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -74.98 128.51 35.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 73.349999999999994 111.109 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.523 HG12 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -55.33 -34.53 33.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 74.010000000000005 111.187 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.439 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 41.9 mmm -62.21 -21.18 64.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 74.010000000000005 110.937 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.531 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -56.72 142.65 71.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.582 0.706 . . . . 73.409999999999997 110.895 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.531 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.9 Cg_endo -69.74 -2.24 9.82 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.647 2.231 . . . . 73.140000000000001 112.382 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 42.1 m -93.7 143.14 26.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 64.129999999999995 111.066 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -123.68 140.48 52.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 74.030000000000001 110.918 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.32 128.01 3.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 73.420000000000002 110.917 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 84.3 t80 -54.01 144.55 18.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 73.219999999999999 110.94 -179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 1.1 m -158.27 130.78 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 72.099999999999994 111.223 179.954 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -52.33 133.01 34.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 74.400000000000006 110.925 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 9.2 tt -53.57 -29.46 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 72.209999999999994 111.171 179.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.16 -21.12 63.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 64.109999999999999 110.909 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 44.3 p -109.95 -20.66 12.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 75.530000000000001 111.201 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -72.47 130.69 41.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 75.439999999999998 110.863 179.987 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -166.87 137.33 3.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.482 . . . . 74.239999999999995 110.877 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 64.5 mt -49.36 124.19 8.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.247 -0.433 . . . . 74.319999999999993 110.881 -179.965 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 8.4 t -70.26 166.62 19.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 74.299999999999997 110.87 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.63 -40.75 40.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 73.140000000000001 111.063 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.8 -45.76 93.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 75.329999999999998 110.948 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . 0.417 ' OD2' ' HB ' ' A' ' 235' ' ' VAL . 5.2 m-20 -62.99 -54.62 35.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.11 -0.496 . . . . 71.549999999999997 110.827 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 18.7 mt -61.87 -28.08 43.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 75.299999999999997 111.144 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -75.26 -41.47 57.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 74.010000000000005 110.848 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.92 -50.46 6.92 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.732 -0.746 . . . . 64.219999999999999 112.491 -179.977 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 3.3 tp -54.55 -32.9 25.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.748 0.308 . . . . 73.409999999999997 111.097 179.973 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.457 ' O ' ' N ' ' A' ' 263' ' ' GLY . 36.8 mt-30 -87.84 -16.78 33.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 75.409999999999997 110.885 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.5 t -68.21 -15.51 63.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 74.150000000000006 110.783 -179.802 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 5.8 mt -120.34 -20.68 7.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 75.450000000000003 110.917 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.524 ' CD1' HD11 ' A' ' 147' ' ' LEU . 34.8 m-85 -111.56 -36.45 5.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 72.030000000000001 110.991 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.355 0 CA-C-O 119.147 -0.807 . . . . 54.399999999999999 112.555 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.8 0.333 . . . . 72.420000000000002 110.908 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 50.65 55.84 8.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 73.049999999999997 110.86 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.2 pp20? 178.72 132.41 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 75.030000000000001 110.848 -179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.409 ' CG ' ' HD2' ' A' ' 104' ' ' PRO . 0.2 OUTLIER -51.93 143.98 21.47 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.585 0.707 . . . . 75.530000000000001 110.86 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.409 ' HD2' ' CG ' ' A' ' 103' ' ' MET . 52.9 Cg_endo -69.81 136.18 32.22 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.751 2.3 . . . . 73.510000000000005 112.289 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 95.52 -12.19 67.93 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.702 -0.761 . . . . 54.520000000000003 112.376 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.704 ' N ' ' CD ' ' A' ' 107' ' ' PRO . . . 70.44 35.27 68.53 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.775 -0.726 . . . . 71.140000000000001 112.436 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 106' ' ' GLY . 53.6 Cg_endo -69.74 59.1 1.59 Allowed 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.671 2.247 . . . . 65.239999999999995 112.281 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 11.6 m -130.24 151.09 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 63.310000000000002 111.124 179.9 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -91.11 107.44 19.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.214 -0.448 . . . . 74.099999999999994 110.92 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 30.5 mtt180 -70.56 56.79 0.18 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 74.430000000000007 110.888 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -124.04 166.11 16.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 75.099999999999994 110.845 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -114.99 34.24 4.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 72.510000000000005 110.861 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -137.9 103.26 4.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.472 . . . . 75.0 110.948 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.44 ' CG2' ' N ' ' A' ' 115' ' ' THR . 5.4 mp -132.2 160.66 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 72.519999999999996 111.156 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.44 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.4 OUTLIER -157.98 164.46 36.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.227 -0.442 . . . . 75.299999999999997 111.059 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.607 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.9 p90 -134.53 149.14 50.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 72.219999999999999 110.938 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 4.1 tmt_? -142.44 113.84 7.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 75.129999999999995 110.943 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 48.4 mt -74.87 106.24 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 74.439999999999998 111.075 -179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -59.41 -47.03 87.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 75.340000000000003 110.932 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.0 p-10 -142.71 161.84 37.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 72.530000000000001 110.96 179.98 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.7 m-85 -117.4 146.75 43.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.454 . . . . 71.439999999999998 110.926 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' THR . . . . . . . . . . . . . 2.1 t -93.39 141.28 23.74 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.536 0.684 . . . . 65.409999999999997 111.167 -179.998 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -1.66 8.87 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.732 2.288 . . . . 62.439999999999998 112.289 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.11 -30.26 31.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.268 -0.424 . . . . 74.219999999999999 110.868 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 8.1 mtm -108.06 163.63 12.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 74.319999999999993 110.918 179.901 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -95.02 146.42 24.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 71.239999999999995 110.842 -179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.33 -32.52 3.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 71.319999999999993 110.919 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -83.73 -38.94 20.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 74.340000000000003 110.917 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -66.0 -30.26 70.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 64.129999999999995 110.853 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 84.7 t -65.2 -47.01 89.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 74.010000000000005 111.158 179.995 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.12 -24.1 47.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 74.329999999999998 110.806 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -73.12 -47.02 47.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 72.439999999999998 110.887 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -72.31 -31.21 65.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 75.129999999999995 111.065 179.923 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.3 mp -73.93 -54.15 15.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 75.540000000000006 111.148 -179.981 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 4.2 ttm180 -48.88 -43.03 38.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 73.25 110.812 179.968 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.1 mmpt? -70.79 -34.64 71.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 74.439999999999998 110.939 179.955 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.497 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -60.07 -49.36 77.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 74.129999999999995 111.128 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.607 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.8 m-85 -72.68 -22.19 60.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 73.400000000000006 110.883 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.529 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.6 tt0 -78.0 -6.34 54.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.068 -0.514 . . . . 72.450000000000003 110.927 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.405 ' HB ' HG13 ' A' ' 217' ' ' VAL . 99.1 t -97.65 -16.93 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 72.420000000000002 111.056 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.48 ' HA ' HG21 ' A' ' 144' ' ' VAL . 89.9 m95 -106.33 -37.74 6.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 75.230000000000004 110.921 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.18 -12.54 61.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 73.25 110.831 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.606 ' N ' HD21 ' A' ' 143' ' ' ASN . 0.9 OUTLIER -93.6 -19.47 21.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 74.409999999999997 110.866 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.48 HG21 ' HA ' ' A' ' 141' ' ' TRP . 17.8 m -98.91 3.19 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 74.129999999999995 111.214 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.518 ' C ' ' H ' ' A' ' 147' ' ' LEU . 23.4 p -149.46 145.04 18.53 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.603 0.716 . . . . 75.25 111.097 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.75 29.96 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.711 2.274 . . . . 73.430000000000007 112.344 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.518 ' H ' ' C ' ' A' ' 145' ' ' THR . 5.0 mp -96.88 176.91 5.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 72.239999999999995 110.94 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -137.51 126.58 24.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 72.519999999999996 110.923 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.8 m-30 -112.76 145.29 40.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 73.530000000000001 110.88 179.941 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 3.1 t -139.34 155.2 47.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 72.450000000000003 110.789 -179.812 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.464 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.5 OUTLIER -106.02 141.0 38.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 73.549999999999997 110.836 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 20.5 pt -150.82 144.74 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 60.439999999999998 111.056 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.9 8.46 13.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 55.32 110.892 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.1 t -167.81 50.9 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 74.319999999999993 111.158 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -148.47 -152.74 5.78 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.71 -0.757 . . . . 74.230000000000004 112.461 179.958 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 30.1 mmt -107.11 96.76 6.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.35 . . . . 61.439999999999998 110.915 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -105.94 155.15 19.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 74.200000000000003 111.144 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.61 -51.07 7.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 73.25 110.85 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.488 HG12 HG21 ' A' ' 220' ' ' ILE . 2.0 mp -92.85 97.41 7.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 74.329999999999998 111.18 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.5 tp -88.58 109.56 20.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 72.340000000000003 110.873 179.987 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 85.8 t -87.49 123.39 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 74.299999999999997 111.225 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 p -142.2 106.11 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 71.510000000000005 111.125 179.974 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -73.18 107.59 5.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 74.450000000000003 110.913 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.5 164.26 23.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 74.209999999999994 111.093 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.82 138.26 48.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 74.219999999999999 110.902 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.662 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 41.83 -154.16 0.12 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.793 -0.718 . . . . 64.030000000000001 112.402 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.813 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.41 117.06 7.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 51.310000000000002 111.025 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.691 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -109.5 -22.34 12.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.25 -0.432 . . . . 71.439999999999998 110.818 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.01 29.68 0.55 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.746 -0.74 . . . . 72.439999999999998 112.534 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.639 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.97 0.18 14.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.861 0.362 . . . . 75.430000000000007 110.859 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 73.96 39.54 0.51 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 74.230000000000004 110.901 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.691 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.16 -41.53 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 73.450000000000003 110.851 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.813 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.26 99.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 72.150000000000006 111.058 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.662 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.1 m-85 -59.73 -169.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.279 -0.418 . . . . 65.420000000000002 110.842 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.68 19.41 3.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 74.129999999999995 110.884 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.563 ' HA2' ' CB ' ' A' ' 200' ' ' ASP . . . 55.26 -162.72 4.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.707 -0.759 . . . . 72.230000000000004 112.517 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 176' ' ' GLY . 1.7 ptpp? -33.42 136.0 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 71.420000000000002 110.904 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 61.02 160.84 0.1 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.74 -0.743 . . . . 62.0 112.552 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.06 -141.41 20.0 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.817 -0.706 . . . . 73.239999999999995 112.444 -179.897 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.6 97.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.861 0.362 . . . . 74.200000000000003 111.103 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.8 mm? -68.63 -36.97 79.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 71.450000000000003 110.868 179.918 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -174.08 169.96 3.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 71.310000000000002 111.097 179.773 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.488 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.3 p80 -163.79 142.12 7.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 73.340000000000003 110.867 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.562 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -136.28 173.37 11.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.299 -0.409 . . . . 65.209999999999994 111.174 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.544 ' O ' ' O ' ' A' ' 222' ' ' HIS . 16.7 m-85 -98.69 -141.15 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 71.040000000000006 110.774 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -174.89 -81.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.799 -0.715 . . . . 64.530000000000001 112.541 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.4 ' HG3' ' HB2' ' A' ' 107' ' ' PRO . 54.1 Cg_endo -69.73 47.46 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.706 2.271 . . . . 75.420000000000002 112.369 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.547 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -119.71 147.47 18.1 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.71 -0.757 . . . . 72.439999999999998 112.508 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.88 144.96 30.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.347 . . . . 74.049999999999997 110.816 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.56 -64.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.725 -0.75 . . . . 64.530000000000001 112.481 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 189' ' ' SER . 14.6 tt -104.43 8.84 9.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 74.349999999999994 111.183 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.547 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -70.76 174.21 40.0 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.672 -0.775 . . . . 63.450000000000003 112.467 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 223' ' ' SER . . . 42.76 23.19 0.18 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 71.549999999999997 112.486 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 192' ' ' GLY . 1.9 m-20 -65.49 101.2 0.56 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.903 0.383 . . . . 74.209999999999994 110.917 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.562 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -74.72 130.36 39.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 75.209999999999994 111.124 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.488 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.2 m170 -121.05 130.19 53.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 71.129999999999995 110.837 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.523 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 47.6 m-85 -114.91 133.7 55.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 73.129999999999995 110.847 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -64.72 112.84 3.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 72.549999999999997 110.823 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -68.2 -18.99 64.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 73.209999999999994 110.961 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.563 ' CB ' ' HA2' ' A' ' 176' ' ' GLY . 14.4 m-20 -68.89 -8.57 45.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 74.030000000000001 110.841 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 50.4 mm-40 -97.27 162.17 13.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 75.519999999999996 110.891 -179.926 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.503 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.2 OUTLIER -95.94 94.18 7.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 75.400000000000006 110.942 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.523 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 45.4 m95 -82.95 124.69 30.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 73.219999999999999 110.926 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 36.0 p -145.97 -177.6 5.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 72.329999999999998 111.159 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.59 21.08 17.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 73.450000000000003 111.192 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -128.13 -177.72 4.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 73.540000000000006 110.875 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.7 t -67.59 -19.22 65.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 53.409999999999997 110.864 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.29 -104.82 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.769 -0.729 . . . . 72.120000000000005 112.45 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.503 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.24 177.98 0.14 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.782 -0.723 . . . . 64.319999999999993 112.437 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 95.9 m -67.79 97.22 0.62 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.721 0.295 . . . . 74.109999999999999 111.127 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -41.06 116.31 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 72.099999999999994 110.853 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 9.9 tp -63.26 -39.4 94.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.46 . . . . 74.200000000000003 110.873 179.985 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.7 t80 -50.46 -65.29 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 70.230000000000004 110.879 179.89 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 15.4 mt -54.02 -55.43 27.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.478 . . . . 74.319999999999993 110.897 -179.894 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 2.6 m -55.67 -32.22 63.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 74.439999999999998 111.119 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.31 -48.04 62.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.428 . . . . 71.349999999999994 111.027 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.497 HG22 ' CB ' ' A' ' 137' ' ' ALA . 2.0 t -54.06 -58.44 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 73.540000000000006 111.196 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.492 ' HB2' HG11 ' A' ' 235' ' ' VAL . 1.9 t-80 -64.0 -28.8 70.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 73.219999999999999 110.819 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -62.9 -45.66 91.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 65.25 111.162 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.544 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.6 mt -68.19 -33.95 63.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 74.439999999999998 111.12 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -52.43 -43.13 58.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.834 -0.698 . . . . 51.030000000000001 112.505 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.544 ' O ' ' O ' ' A' ' 185' ' ' PHE . 41.1 m-70 -70.32 -41.36 73.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.815 0.341 . . . . 71.340000000000003 110.833 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.519 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 29.5 p -64.95 -20.35 66.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 73.209999999999994 110.903 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 36.5 mt -81.64 -25.79 35.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.134 -0.485 . . . . 75.140000000000001 110.902 179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 120.55 11.7 6.49 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.774 -0.726 . . . . 54.100000000000001 112.487 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.415 HD23 HD12 ' A' ' 258' ' ' ILE . 12.4 mt -76.95 158.88 30.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.364 . . . . 65.420000000000002 110.967 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -104.71 -134.49 8.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.806 -0.711 . . . . 63.549999999999997 112.499 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.423 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.7 OUTLIER -129.5 145.1 51.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.338 . . . . 75.319999999999993 110.866 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 27.4 t -108.45 165.56 11.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 72.0 110.811 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.93 -2.99 22.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.495 . . . . 61.340000000000003 110.902 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -62.2 136.51 95.5 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.579 0.704 . . . . 73.150000000000006 110.845 179.921 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -0.44 6.87 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.706 2.271 . . . . 75.519999999999996 112.422 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.81 15.52 1.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 73.310000000000002 110.889 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.471 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -84.74 133.48 34.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.269 -0.423 . . . . 75.409999999999997 111.19 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.492 HG11 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -56.78 -37.8 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 74.150000000000006 111.145 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.423 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 47.1 mmm -59.73 -23.21 63.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 74.230000000000004 110.889 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.532 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.7 t80 -54.39 142.72 49.22 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.68 0.753 . . . . 75.329999999999998 110.861 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.532 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.7 Cg_endo -69.69 -1.21 8.02 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.667 2.245 . . . . 74.430000000000007 112.387 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 50.0 m -93.9 141.72 28.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 73.109999999999999 111.129 179.997 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -122.74 141.52 51.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.269 -0.423 . . . . 63.25 110.928 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -161.02 138.79 9.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.494 . . . . 75.439999999999998 110.87 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 66.8 t80 -62.43 146.67 50.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 75.129999999999995 110.971 -179.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -160.88 132.1 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 75.230000000000004 111.095 179.92 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -50.46 133.21 24.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 74.439999999999998 110.902 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 6.4 tt -54.7 -30.39 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 72.340000000000003 111.147 179.95 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -75.36 -18.39 59.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 54.32 110.906 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 43.4 p -107.63 -20.25 13.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 73.209999999999994 111.105 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.456 ' C ' ' HG3' ' A' ' 249' ' ' ARG . 10.4 t80 -72.65 120.54 18.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 73.400000000000006 110.886 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.456 ' HG3' ' C ' ' A' ' 248' ' ' PHE . 16.1 mtt180 -152.42 141.92 21.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 75.409999999999997 110.854 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 45.4 mt -59.0 123.44 16.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 75.340000000000003 110.895 -179.962 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 15.8 m -67.11 162.48 22.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 72.0 110.937 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -48.18 -36.2 13.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 74.340000000000003 111.133 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.04 -47.87 75.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 72.140000000000001 110.837 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 9.4 m-20 -60.45 -51.79 67.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 74.239999999999995 110.824 -179.93 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 20.6 mt -62.49 -33.48 59.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 75.129999999999995 111.236 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -71.26 -39.81 71.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 75.150000000000006 110.916 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.85 -51.23 7.19 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 73.109999999999999 112.467 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.415 HD12 HD23 ' A' ' 226' ' ' LEU . 2.8 tp -52.65 -35.05 20.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 75.010000000000005 111.198 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.434 ' O ' ' N ' ' A' ' 263' ' ' GLY . 71.2 mt-30 -87.02 -16.49 35.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 75.430000000000007 110.929 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.7 t -69.63 -13.98 62.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 73.109999999999999 110.875 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.5 mt -123.72 -17.74 6.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 63.25 110.908 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 35.1 m-85 -115.04 -33.39 5.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 64.329999999999998 110.904 -179.99 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.434 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.289 0 CA-C-O 119.034 -0.87 . . . . 74.25 112.517 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 42.9 p90 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.8 0.333 . . . . 74.420000000000002 110.899 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.573 HH21 ' N ' ' A' ' 258' ' ' ILE . 0.0 OUTLIER -50.43 99.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 74.019999999999996 110.87 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -159.42 129.2 5.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.504 . . . . 75.409999999999997 110.861 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.9 tpp -52.02 134.32 39.35 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.604 0.716 . . . . 72.439999999999998 110.767 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 139.54 40.39 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.719 2.279 . . . . 73.230000000000004 112.407 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.99 13.61 54.23 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.688 -0.767 . . . . 70.340000000000003 112.443 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.446 ' N ' ' CD ' ' A' ' 107' ' ' PRO . . . 39.95 52.68 3.27 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.68 -0.771 . . . . 71.140000000000001 112.525 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 106' ' ' GLY . 53.5 Cg_endo -69.8 -24.58 29.34 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.63 2.22 . . . . 70.219999999999999 112.344 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 40.7 t -48.89 130.65 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 75.109999999999999 111.146 179.905 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.409 ' HB3' ' HG2' ' A' ' 111' ' ' LYS . 2.8 m-90 -60.94 -29.11 69.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.284 -0.416 . . . . 75.209999999999994 110.829 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 27.9 mtm180 64.21 32.55 12.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 73.140000000000001 110.895 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . 0.409 ' HG2' ' HB3' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -123.11 165.7 16.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 74.409999999999997 110.919 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -104.96 36.67 2.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 75.150000000000006 110.905 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.7 m-85 -139.04 108.9 6.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 74.140000000000001 110.976 -179.793 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.426 ' O ' ' HA ' ' A' ' 149' ' ' PHE . 4.6 mp -142.93 162.97 17.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 74.030000000000001 111.172 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.421 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.1 OUTLIER -159.67 163.46 34.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 75.540000000000006 111.136 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.605 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 1.5 p90 -133.13 151.43 51.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 72.340000000000003 110.889 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.434 ' HB3' ' CD1' ' A' ' 160' ' ' LEU . 4.7 tmt_? -141.87 112.66 7.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 75.120000000000005 110.856 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.4 mt -74.4 106.23 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 72.510000000000005 111.125 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -59.14 -48.49 81.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 75.200000000000003 110.858 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . 0.463 HD22 ' N ' ' A' ' 163' ' ' PHE . 0.2 OUTLIER -146.33 171.84 14.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 64.340000000000003 110.818 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.5 m-85 -119.72 151.85 38.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 64.230000000000004 110.91 -179.82 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.514 ' C ' ' H ' ' A' ' 124' ' ' ASP . 36.9 m -103.53 136.17 19.26 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.573 0.702 . . . . 75.010000000000005 111.095 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.468 ' HD2' HG22 ' A' ' 122' ' ' THR . 54.7 Cg_endo -69.72 32.6 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.657 2.238 . . . . 73.519999999999996 112.431 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.514 ' H ' ' C ' ' A' ' 122' ' ' THR . 1.6 m-20 -113.99 -23.75 9.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 75.239999999999995 110.851 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -117.6 166.82 11.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 110.848 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -87.96 141.46 28.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 72.540000000000006 110.931 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.05 -33.5 3.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 74.310000000000002 110.93 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -84.82 -38.64 19.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 74.120000000000005 110.895 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -64.29 -32.87 74.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.177 -0.465 . . . . 62.329999999999998 110.814 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 78.1 t -63.78 -44.99 98.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 54.530000000000001 111.148 179.992 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.77 -23.2 39.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 64.549999999999997 110.871 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -76.08 -46.86 26.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 73.420000000000002 110.939 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -72.04 -30.23 64.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 75.329999999999998 111.088 179.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.3 mp -73.49 -55.62 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 65.150000000000006 111.172 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 1.1 ttt85 -48.09 -40.97 24.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 74.310000000000002 110.904 179.894 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 3.3 mmpt? -76.13 -32.42 59.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 74.129999999999995 110.919 179.933 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.505 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -61.23 -49.98 74.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 63.140000000000001 111.09 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.605 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 80.3 m-85 -68.38 -31.14 70.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 72.540000000000006 110.851 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.567 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 3.4 tt0 -63.42 -44.69 93.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 65.319999999999993 110.944 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.424 ' HB ' HG11 ' A' ' 217' ' ' VAL . 55.0 t -49.21 -25.2 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 73.030000000000001 111.146 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.453 ' CD1' HG13 ' A' ' 217' ' ' VAL . 97.8 m95 -98.17 -28.9 13.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 74.200000000000003 110.91 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 p -74.49 -13.32 60.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 73.340000000000003 110.982 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.567 ' ND2' ' O ' ' A' ' 139' ' ' GLN . 57.7 m-20 -91.88 -24.7 19.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.085 -0.507 . . . . 44.130000000000003 110.978 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 5.7 m -94.86 2.7 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 75.120000000000005 111.222 179.821 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.519 ' C ' ' H ' ' A' ' 147' ' ' LEU . 27.4 p -154.71 141.49 13.34 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.611 0.719 . . . . 63.119999999999997 111.152 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 28.33 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.691 2.26 . . . . 74.230000000000004 112.269 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.519 ' H ' ' C ' ' A' ' 145' ' ' THR . 0.4 OUTLIER -84.1 -178.0 6.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.257 -0.429 . . . . 75.319999999999993 110.925 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -142.56 125.8 16.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 75.420000000000002 110.863 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.426 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 3.5 m-85 -117.94 137.49 52.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 71.329999999999998 110.847 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 53.9 m -132.34 139.46 48.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.075 -0.511 . . . . 74.230000000000004 110.796 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.454 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.3 OUTLIER -91.9 146.48 23.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.059 -0.519 . . . . 71.120000000000005 110.808 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 6.3 pt -150.22 168.13 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 74.510000000000005 111.117 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.77 13.56 4.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 75.239999999999995 110.87 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.6 p -90.79 -58.48 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 75.209999999999994 111.092 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 143.22 12.33 0.37 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.717 -0.754 . . . . 71.109999999999999 112.443 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 9.9 mtm -108.05 72.71 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.822 0.344 . . . . 72.129999999999995 110.863 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -143.53 170.07 16.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 75.420000000000002 111.058 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.9 -50.56 6.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 65.150000000000006 110.864 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.473 HG12 HG21 ' A' ' 220' ' ' ILE . 2.6 mp -94.55 97.33 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 74.450000000000003 111.146 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.434 ' CD1' ' HB3' ' A' ' 117' ' ' ARG . 9.2 tp -87.57 110.25 20.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.242 -0.435 . . . . 75.319999999999993 110.93 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.4 t -88.33 117.33 31.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 75.540000000000006 111.075 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 p -137.16 102.43 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 74.430000000000007 111.017 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.463 ' N ' HD22 ' A' ' 120' ' ' ASN . 47.0 m-85 -70.49 110.8 5.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.047 -0.524 . . . . 71.420000000000002 110.85 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.54 166.75 20.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 61.039999999999999 111.035 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -114.65 138.57 50.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 74.310000000000002 110.879 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.659 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.89 -154.83 0.16 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.764 -0.731 . . . . 54.140000000000001 112.434 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.816 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.85 116.55 7.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 71.319999999999993 111.098 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.704 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.73 -23.04 11.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.417 . . . . 74.239999999999995 110.878 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.95 29.58 0.51 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.732 . . . . 44.140000000000001 112.488 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.622 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.06 0.39 14.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 74.0 110.85 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 73.93 39.2 0.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 75.140000000000001 110.941 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.704 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -134.55 -41.23 0.78 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 72.219999999999999 110.884 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.816 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.18 99.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 73.430000000000007 111.163 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.659 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -60.3 -168.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 61.329999999999998 110.798 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.33 18.54 3.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 63.200000000000003 110.876 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.581 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.84 -155.64 11.54 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.688 -0.768 . . . . 65.549999999999997 112.509 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -37.5 135.42 0.57 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.803 0.335 . . . . 73.430000000000007 110.902 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.0 164.75 0.1 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.727 -0.749 . . . . 71.239999999999995 112.453 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.86 -142.75 21.83 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.789 -0.72 . . . . 73.230000000000004 112.455 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.32 96.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.785 0.326 . . . . 64.310000000000002 111.099 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 66.7 mt -66.53 -40.44 89.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.306 -0.407 . . . . 73.209999999999994 110.888 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -171.65 168.54 6.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 74.540000000000006 111.061 179.825 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.491 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -161.93 140.83 9.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 75.310000000000002 110.854 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.555 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -136.51 173.57 11.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 74.439999999999998 111.013 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.527 ' O ' ' HA ' ' A' ' 223' ' ' SER . 37.8 m-85 -104.0 -149.91 0.41 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 62.329999999999998 110.869 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -163.78 -81.92 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.754 -0.736 . . . . 52.130000000000003 112.511 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.402 ' HG3' ' HB3' ' A' ' 107' ' ' PRO . 53.9 Cg_endo -69.76 53.9 1.13 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.689 2.259 . . . . 73.129999999999995 112.351 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.558 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -124.83 147.96 16.63 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.753 -0.737 . . . . 55.329999999999998 112.524 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.9 143.92 32.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 74.450000000000003 110.82 -179.668 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.5 -63.26 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.733 -0.746 . . . . 73.150000000000006 112.497 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 189' ' ' SER . 4.2 mt -105.4 7.93 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.892 0.377 . . . . 74.329999999999998 111.113 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.558 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -69.78 171.81 40.86 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.77 -0.729 . . . . 74.400000000000006 112.511 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.436 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 44.0 19.93 0.14 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 64.120000000000005 112.523 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.438 ' N ' ' O ' ' A' ' 192' ' ' GLY . 1.9 m-20 -63.83 107.96 1.34 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.801 0.334 . . . . 74.329999999999998 110.908 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.555 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -82.14 126.16 31.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 73.120000000000005 111.086 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.4 m170 -116.67 130.74 56.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 74.439999999999998 110.851 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.524 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 46.8 m-85 -115.7 133.71 55.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 75.299999999999997 110.893 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -66.76 109.86 3.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.163 -0.471 . . . . 75.409999999999997 110.814 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -60.36 -37.88 82.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 74.219999999999999 110.82 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.581 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 5.9 m-20 -50.05 -22.15 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 74.109999999999999 110.815 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -81.32 160.67 24.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 75.150000000000006 110.919 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.516 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -98.21 93.43 6.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 73.450000000000003 110.96 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.524 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 34.0 m95 -83.65 123.02 29.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 74.219999999999999 110.95 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.2 p -140.92 -176.25 4.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 74.209999999999994 111.073 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.37 18.11 19.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 73.25 111.147 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.43 -175.82 3.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 74.450000000000003 110.878 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.9 p -67.06 -18.73 65.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 65.299999999999997 110.842 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.95 -108.54 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.788 -0.72 . . . . 73.230000000000004 112.491 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.516 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.92 177.52 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.741 -0.742 . . . . 65.299999999999997 112.519 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 97.0 m -65.95 97.74 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 75.129999999999995 111.123 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -41.26 113.38 0.39 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 75.530000000000001 110.855 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 43.1 tp -62.26 -34.47 76.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.263 -0.426 . . . . 74.510000000000005 110.939 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 3.3 t80 -54.92 -62.05 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 72.150000000000006 110.904 179.9 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 12.9 mt -57.18 -53.78 54.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 74.5 110.919 -179.973 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 2.2 m -54.76 -34.93 63.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 72.349999999999994 111.074 179.924 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.38 -49.49 66.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.414 . . . . 64.329999999999998 111.021 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.505 HG22 ' CB ' ' A' ' 137' ' ' ALA . 2.0 t -52.08 -58.77 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 73.319999999999993 111.165 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.529 ' HB2' HG11 ' A' ' 235' ' ' VAL . 2.6 t-80 -62.94 -31.55 72.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 75.219999999999999 110.854 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -61.73 -43.14 99.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 51.32 111.062 -179.969 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.592 HG12 ' CE2' ' A' ' 138' ' ' PHE . 2.5 mt -70.97 -33.46 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 75.409999999999997 111.06 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.05 -43.29 49.68 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.769 -0.729 . . . . 74.140000000000001 112.485 179.974 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.436 ' O ' ' O ' ' A' ' 185' ' ' PHE . 50.7 m-70 -68.83 -39.61 79.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.733 0.301 . . . . 71.310000000000002 110.846 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 2.8 m -62.22 -26.66 68.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 73.400000000000006 110.891 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 28.8 mt -77.57 -25.71 50.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 54.32 110.924 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 114.01 14.61 9.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.766 -0.73 . . . . 53.130000000000003 112.53 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 13.3 mt -79.27 148.12 32.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 74.549999999999997 110.924 -179.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -93.95 -160.37 34.73 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.816 -0.707 . . . . 72.209999999999994 112.448 179.94 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.1 m170 -103.07 149.2 24.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 73.129999999999995 110.821 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 229' ' ' SER . . . . . 0.434 ' HA ' ' HB3' ' A' ' 101' ' ' ARG . 2.5 p -111.53 164.41 13.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.165 -0.471 . . . . 72.319999999999993 110.824 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.43 -0.58 25.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 73.340000000000003 110.913 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -67.23 132.82 93.38 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.52 0.676 . . . . 74.519999999999996 110.899 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.82 4.95 1.91 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.662 2.241 . . . . 63.32 112.283 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.9 13.46 2.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 63.5 110.925 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -82.51 149.54 27.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 74.099999999999994 111.086 179.884 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.529 HG11 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -71.46 -40.07 71.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 75.439999999999998 111.16 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.404 ' HB2' ' OG ' ' A' ' 229' ' ' SER . 38.7 mmm -64.32 -18.97 65.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.515 . . . . 73.349999999999994 110.846 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.595 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.1 t80 -49.26 143.97 8.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.728 0.775 . . . . 65.439999999999998 110.881 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.595 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.8 Cg_endo -69.78 -0.76 7.4 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.709 2.272 . . . . 71.340000000000003 112.388 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 18.6 m -100.16 146.71 26.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 72.040000000000006 111.156 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -125.45 137.22 53.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.203 -0.453 . . . . 73.099999999999994 110.978 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -153.89 139.71 18.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 74.140000000000001 110.849 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 72.2 t80 -65.24 144.41 57.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 73.430000000000007 110.923 179.958 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.1 OUTLIER -162.18 133.98 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.109 -0.496 . . . . 74.219999999999999 111.11 179.848 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -60.71 134.34 56.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 75.010000000000005 110.83 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 17.1 tt -52.91 -31.06 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.452 . . . . 74.450000000000003 111.081 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.14 -21.25 64.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 74.340000000000003 110.933 179.918 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.9 p -115.95 -6.99 12.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 64.450000000000003 111.213 179.964 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . 0.419 ' C ' ' HG3' ' A' ' 249' ' ' ARG . 8.9 t80 -88.05 115.45 25.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 74.049999999999997 110.933 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . 0.419 ' HG3' ' C ' ' A' ' 248' ' ' PHE . 0.1 OUTLIER -144.73 139.72 28.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 74.519999999999996 110.885 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 26.3 mt -53.54 123.42 12.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 72.540000000000006 110.932 -179.925 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 10.0 p -59.67 160.0 7.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 74.439999999999998 110.833 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -48.8 -33.28 10.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 74.010000000000005 111.208 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -67.14 -44.16 80.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 74.420000000000002 110.845 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.77 -49.51 70.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 74.019999999999996 110.873 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 34.3 mt -63.63 -36.33 76.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 74.140000000000001 111.184 179.966 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -70.26 -38.63 75.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 72.099999999999994 110.868 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.37 -50.66 6.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 61.409999999999997 112.458 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . 0.573 ' N ' HH21 ' A' ' 101' ' ' ARG . 3.3 tp -52.21 -34.82 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 73.219999999999999 111.182 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.404 ' O ' ' N ' ' A' ' 263' ' ' GLY . 66.7 mt-30 -86.48 -17.29 34.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.156 -0.475 . . . . 71.019999999999996 110.889 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.1 t -69.85 -13.62 62.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 55.210000000000001 110.862 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.8 mt -123.81 -18.15 6.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.167 -0.469 . . . . 74.530000000000001 110.95 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 42.1 m-85 -114.85 -33.9 5.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 75.519999999999996 110.888 179.945 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 119.105 -0.83 . . . . 45.310000000000002 112.472 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 101' ' ' ARG . 36.3 p90 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.826 0.346 . . . . 74.150000000000006 110.855 . . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 100' ' ' PHE . 0.2 OUTLIER 35.08 61.51 0.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 74.200000000000003 110.835 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER 176.47 111.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 74.430000000000007 110.877 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.418 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . 33.9 tpp -51.38 134.83 32.78 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.664 0.745 . . . . 73.129999999999995 110.828 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.411 ' HD2' ' HG3' ' A' ' 103' ' ' MET . 53.6 Cg_endo -69.77 139.46 40.23 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.674 2.249 . . . . 72.430000000000007 112.45 179.929 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.7 7.01 63.41 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 65.010000000000005 112.577 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.55 ' N ' ' CD ' ' A' ' 107' ' ' PRO . . . 49.29 45.68 35.32 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.729 -0.748 . . . . 75.400000000000006 112.439 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 106' ' ' GLY . 54.0 Cg_endo -69.79 -5.31 15.92 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.617 2.211 . . . . 71.450000000000003 112.342 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 1.8 p -80.08 99.9 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 74.310000000000002 111.104 179.921 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -45.08 107.55 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 72.540000000000006 110.922 179.895 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.79 56.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.337 -0.392 . . . . 72.420000000000002 110.946 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 5.5 pttt -122.78 149.58 43.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 74.150000000000006 110.919 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -93.66 40.42 1.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 72.439999999999998 110.86 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -141.34 101.53 4.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 74.109999999999999 110.898 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.43 ' CG2' ' N ' ' A' ' 115' ' ' THR . 4.7 mp -134.73 162.9 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 74.400000000000006 111.152 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.43 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.5 OUTLIER -158.68 161.26 37.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 64.400000000000006 111.109 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.625 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.7 p90 -132.86 148.79 52.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 72.430000000000007 110.92 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.407 ' HB3' ' CD1' ' A' ' 160' ' ' LEU . 4.1 tmt_? -142.67 113.89 7.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.504 . . . . 74.209999999999994 110.956 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.6 mt -74.59 105.29 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 75.129999999999995 111.166 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -58.8 -48.98 79.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 75.319999999999993 110.813 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 1.7 p-10 -140.66 162.63 34.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 64.099999999999994 110.884 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.3 m-85 -117.15 142.95 46.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 64.129999999999995 110.895 -179.885 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.489 ' CG2' ' HD2' ' A' ' 123' ' ' PRO . 24.5 m -94.92 137.51 22.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.632 0.729 . . . . 72.129999999999995 111.134 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.489 ' HD2' ' CG2' ' A' ' 122' ' ' THR . 52.8 Cg_endo -69.82 7.77 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.659 2.239 . . . . 74.400000000000006 112.283 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.412 ' H ' ' C ' ' A' ' 122' ' ' THR . 1.6 m-20 -84.89 -29.42 25.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 64.010000000000005 110.849 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -112.73 166.56 11.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 74.340000000000003 110.899 179.961 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -88.93 145.75 25.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.287 -0.415 . . . . 72.200000000000003 110.891 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.1 -34.86 6.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 75.120000000000005 110.943 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -82.38 -37.3 25.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 74.430000000000007 110.886 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -64.58 -32.8 74.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 75.209999999999994 110.839 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 77.9 t -63.43 -47.25 92.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 73.329999999999998 111.078 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.03 -23.45 48.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.101 -0.499 . . . . 73.010000000000005 110.879 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -75.71 -47.23 27.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 74.349999999999994 110.972 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -70.12 -32.91 71.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 72.239999999999995 111.165 179.759 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.3 mp -72.1 -55.07 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 74.439999999999998 111.158 179.926 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.401 ' O ' ' HB2' ' A' ' 139' ' ' GLN . 6.1 ttt180 -48.93 -42.26 36.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 74.409999999999997 110.932 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -71.32 -34.76 70.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 74.140000000000001 110.896 179.925 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.502 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -60.36 -49.35 77.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 74.329999999999998 111.165 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.625 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.4 m-85 -72.72 -21.84 60.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 74.219999999999999 110.84 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.52 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 3.1 tt0 -77.48 -6.38 53.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 72.519999999999996 110.824 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 96.2 t -97.71 -16.96 6.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.288 -0.414 . . . . 65.120000000000005 111.212 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.483 ' HA ' HG21 ' A' ' 144' ' ' VAL . 89.2 m95 -105.41 -38.08 6.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 73.420000000000002 110.886 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.8 -12.68 61.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 71.109999999999999 110.876 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.591 ' N ' HD21 ' A' ' 143' ' ' ASN . 1.0 OUTLIER -93.97 -19.58 20.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.511 . . . . 74.25 110.916 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.483 HG21 ' HA ' ' A' ' 141' ' ' TRP . 18.5 m -97.1 1.65 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 74.329999999999998 111.083 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.516 ' C ' ' H ' ' A' ' 147' ' ' LEU . 52.2 p -151.93 147.57 20.14 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.583 0.706 . . . . 74.310000000000002 111.152 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 31.91 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.667 2.245 . . . . 73.239999999999995 112.318 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.516 ' H ' ' C ' ' A' ' 145' ' ' THR . 19.5 mt -95.65 173.83 7.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 70.430000000000007 110.884 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -136.28 126.2 25.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 75.219999999999999 110.882 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.404 ' CD1' ' HB ' ' A' ' 114' ' ' ILE . 3.7 m-30 -114.46 145.96 41.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.405 . . . . 74.109999999999999 110.91 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.8 t -139.44 153.33 47.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 72.329999999999998 110.847 -179.799 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 1.4 tttt -104.37 142.79 33.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.129 -0.487 . . . . 71.510000000000005 110.897 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 16.4 pt -152.56 159.26 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 71.349999999999994 111.089 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -119.34 -21.65 7.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 74.099999999999994 110.883 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.6 t -144.02 53.24 1.29 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.441 . . . . 70.200000000000003 111.148 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -139.34 -155.31 6.6 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.709 -0.758 . . . . 74.519999999999996 112.514 179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 34.3 mmt -107.73 89.58 3.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.34 . . . . 61.240000000000002 110.914 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -101.01 154.63 18.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 74.209999999999994 111.06 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.86 -51.4 6.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 72.329999999999998 110.835 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.417 HG12 HG21 ' A' ' 220' ' ' ILE . 2.7 mp -92.51 97.3 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 73.340000000000003 111.121 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.407 ' CD1' ' HB3' ' A' ' 117' ' ' ARG . 7.8 tp -88.42 109.13 19.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 74.129999999999995 110.984 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 84.5 t -85.71 121.1 36.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 74.409999999999997 111.089 179.919 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.2 p -140.5 103.67 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 73.540000000000006 111.175 179.856 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -71.17 110.16 5.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.445 . . . . 71.409999999999997 110.89 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.94 165.83 21.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 74.519999999999996 111.064 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.02 136.9 52.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.151 -0.477 . . . . 73.209999999999994 110.862 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.656 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.43 -155.87 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.758 . . . . 72.549999999999997 112.508 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.81 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.02 116.44 6.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.786 0.327 . . . . 72.439999999999998 111.084 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.694 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.08 -22.44 12.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 71.030000000000001 110.792 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.34 29.51 0.54 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.722 -0.751 . . . . 72.420000000000002 112.521 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.631 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.13 0.45 14.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 74.450000000000003 110.885 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 73.63 39.63 0.55 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 74.129999999999995 110.931 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.694 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.97 -41.65 0.74 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.07 -0.514 . . . . 72.530000000000001 110.839 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.81 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.52 99.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 72.310000000000002 111.097 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.656 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.9 m-85 -60.2 -168.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 74.420000000000002 110.84 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.16 19.03 3.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.029 -0.532 . . . . 74.120000000000005 110.85 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.566 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.34 -157.75 6.1 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 43.0 112.464 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 176' ' ' GLY . 12.0 mmtp -34.64 134.71 0.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 73.439999999999998 110.959 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.0 165.14 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.741 -0.742 . . . . 63.329999999999998 112.459 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.37 -143.35 21.78 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.732 -0.747 . . . . 73.349999999999994 112.472 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.0 97.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.881 0.372 . . . . 70.349999999999994 111.092 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 21.9 mt -66.99 -40.57 87.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 75.420000000000002 110.903 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -171.12 170.21 6.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 71.239999999999995 111.117 179.836 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.497 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -164.11 141.17 6.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 74.099999999999994 110.889 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.569 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -135.76 173.64 11.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.307 -0.406 . . . . 71.409999999999997 111.07 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.518 ' O ' ' HA ' ' A' ' 223' ' ' SER . 47.9 m-85 -101.11 -145.81 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 74.540000000000006 110.829 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -165.09 -86.17 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.768 -0.729 . . . . 64.230000000000004 112.507 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.4 ' HB3' ' HB2' ' A' ' 107' ' ' PRO . 54.3 Cg_endo -69.65 55.6 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.683 2.255 . . . . 74.109999999999999 112.357 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.524 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.53 147.66 16.67 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.718 -0.754 . . . . 72.420000000000002 112.476 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -102.98 142.36 34.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.997 0.427 . . . . 73.049999999999997 110.759 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 64.14 -62.4 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.75 -0.738 . . . . 73.400000000000006 112.526 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.524 ' N ' ' O ' ' A' ' 189' ' ' SER . 2.3 pp -105.99 10.07 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.897 0.38 . . . . 75.120000000000005 111.213 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.524 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -69.47 170.62 42.07 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.797 -0.716 . . . . 74.439999999999998 112.548 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 42.19 22.82 0.13 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.711 -0.757 . . . . 72.299999999999997 112.442 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 192' ' ' GLY . 3.2 m-20 -64.48 103.62 0.68 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.792 0.33 . . . . 73.340000000000003 110.896 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.569 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -76.71 125.75 29.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 74.519999999999996 111.046 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.497 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.3 m170 -115.88 129.68 56.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.116 -0.493 . . . . 75.549999999999997 110.865 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.511 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 50.3 m-85 -113.88 134.26 54.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 75.400000000000006 110.827 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -66.87 108.89 2.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 72.329999999999998 110.923 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -60.09 -37.4 79.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.420000000000002 110.792 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.566 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 11.3 m-20 -50.51 -22.1 1.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 74.109999999999999 110.811 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -81.36 160.83 24.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.165 -0.47 . . . . 61.229999999999997 110.925 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.533 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -98.73 91.47 5.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 75.530000000000001 110.894 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.511 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 33.1 m95 -81.56 124.25 29.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 75.439999999999998 110.896 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.9 p -141.81 -170.45 3.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 75.049999999999997 111.208 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.87 17.42 15.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 70.140000000000001 111.176 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.74 -178.73 4.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 74.010000000000005 110.81 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.4 t -63.41 -19.62 64.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 75.340000000000003 110.926 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.89 -107.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.813 -0.708 . . . . 74.319999999999993 112.386 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.533 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.5 177.9 0.18 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.719 -0.753 . . . . 72.120000000000005 112.48 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 95.7 m -68.47 96.86 0.72 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.793 0.33 . . . . 74.310000000000002 111.076 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -40.11 118.46 0.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 73.319999999999993 110.858 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 19.3 tp -64.87 -36.24 83.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 74.030000000000001 110.888 179.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -54.17 -64.93 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 75.099999999999994 110.915 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 21.0 mt -53.21 -55.32 25.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 75.109999999999999 110.935 179.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 2.6 m -55.27 -34.87 64.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 62.210000000000001 111.141 179.958 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.1 -47.86 72.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 73.219999999999999 111.092 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.502 HG22 ' CB ' ' A' ' 137' ' ' ALA . 2.0 t -53.58 -60.11 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 72.310000000000002 111.079 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.501 ' HB2' HG11 ' A' ' 235' ' ' VAL . 1.8 t-80 -63.31 -28.52 70.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.353 -0.385 . . . . 72.450000000000003 110.8 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -62.96 -44.37 96.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 74.430000000000007 111.115 179.917 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.531 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.5 mt -68.99 -35.24 68.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 75.439999999999998 111.155 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.21 -44.46 51.79 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.806 -0.711 . . . . 72.540000000000006 112.442 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 185' ' ' PHE . 19.6 m-70 -68.03 -38.52 82.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.792 0.329 . . . . 60.420000000000002 110.804 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.518 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 13.0 m -64.05 -24.79 67.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 72.409999999999997 110.831 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 44.3 mt -76.29 -27.06 56.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 73.219999999999999 110.952 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 121.03 10.56 6.76 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.722 -0.751 . . . . 44.509999999999998 112.454 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . . . . . . . . . 8.5 mt -76.61 137.7 39.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.864 0.364 . . . . 73.329999999999998 110.939 -179.872 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -76.8 -135.14 0.64 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.68 -0.771 . . . . 71.310000000000002 112.484 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -131.82 135.31 46.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 71.340000000000003 110.799 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 98.4 p -94.94 160.88 14.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 64.049999999999997 110.863 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.22 0.55 25.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 72.120000000000005 110.835 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -71.68 132.0 85.64 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.558 0.694 . . . . 72.25 110.831 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 0.93 4.92 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.714 2.276 . . . . 64.030000000000001 112.361 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.8 pttt -136.73 14.06 3.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 73.420000000000002 110.855 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.489 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -92.53 128.2 38.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 71.150000000000006 111.088 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.501 HG11 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -52.81 -37.95 26.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 75.430000000000007 111.092 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 70.8 mmm -58.94 -23.69 61.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.263 -0.426 . . . . 75.439999999999998 110.836 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.587 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.5 t80 -52.67 143.36 29.35 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.669 0.747 . . . . 64.540000000000006 110.841 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.587 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.5 Cg_endo -69.78 -9.88 27.19 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.654 2.236 . . . . 65.140000000000001 112.252 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 23.3 m -85.42 150.22 24.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 71.329999999999998 111.157 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -124.78 139.1 54.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.109999999999999 110.919 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -155.26 121.35 5.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.052 -0.522 . . . . 70.430000000000007 110.922 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 87.3 t80 -52.65 146.78 9.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 73.200000000000003 110.929 -179.97 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.5 OUTLIER -161.03 130.84 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 75.230000000000004 111.171 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -48.43 138.39 10.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 73.019999999999996 110.865 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 7.6 tt -56.26 -31.28 32.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 74.299999999999997 111.085 -179.941 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -77.72 -15.81 58.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 73.019999999999996 110.89 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 33.4 p -105.3 -23.38 12.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 71.310000000000002 111.11 179.981 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -70.82 142.27 51.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 71.129999999999995 110.784 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -177.71 132.13 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 73.239999999999995 110.821 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . . . . . . . . . 34.1 mt -49.52 122.8 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 75.310000000000002 110.932 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 32.1 t -64.13 157.81 24.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 73.099999999999994 110.895 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -46.36 -34.77 4.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 75.5 111.106 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.74 -46.26 69.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.325 -0.398 . . . . 75.420000000000002 110.787 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 28.6 m-20 -60.37 -49.94 75.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 72.510000000000005 110.811 -179.861 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 24.8 mt -66.31 -31.5 53.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.129 -0.487 . . . . 75.129999999999995 111.17 -179.987 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.63 -39.41 70.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.505 . . . . 65.409999999999997 110.912 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.63 -52.01 6.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 74.310000000000002 112.396 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 7.6 tp -52.55 -34.08 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 75.219999999999999 111.086 -179.931 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.473 ' O ' ' N ' ' A' ' 263' ' ' GLY . 85.8 mt-30 -84.38 -19.2 33.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.115 -0.493 . . . . 75.010000000000005 110.933 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 10.7 t -68.65 -12.91 61.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.454 . . . . 60.310000000000002 110.872 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.1 mt -122.36 -18.1 6.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 74.420000000000002 110.927 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 38.1 m-85 -115.63 -36.12 4.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 73.409999999999997 110.948 179.977 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.473 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 119.145 -0.808 . . . . 73.230000000000004 112.473 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 18.3 p90 . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.846 0.355 . . . . 73.200000000000003 110.84 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.74 66.2 2.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 74.209999999999994 110.863 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? 178.35 126.01 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 71.049999999999997 110.884 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.442 ' HG3' ' HD2' ' A' ' 104' ' ' PRO . 3.0 tpt -51.07 135.72 28.99 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.535 0.683 . . . . 73.109999999999999 110.837 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.442 ' HD2' ' HG3' ' A' ' 103' ' ' MET . 52.7 Cg_endo -69.81 136.13 32.09 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.733 2.289 . . . . 75.420000000000002 112.301 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 96.22 -9.46 67.46 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.779 -0.724 . . . . 73.530000000000001 112.46 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . 0.712 ' N ' ' CD ' ' A' ' 107' ' ' PRO . . . 69.41 35.58 76.17 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.745 -0.74 . . . . 73.400000000000006 112.496 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.712 ' CD ' ' N ' ' A' ' 106' ' ' GLY . 53.1 Cg_endo -69.73 34.02 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.691 2.26 . . . . 74.430000000000007 112.381 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.491 ' H ' ' C ' ' A' ' 106' ' ' GLY . 7.5 p -116.03 137.89 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 74.409999999999997 111.066 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -79.62 107.32 12.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.088 -0.505 . . . . 74.340000000000003 110.876 179.95 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -73.59 56.85 0.54 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 74.329999999999998 110.919 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.18 145.07 48.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 74.209999999999994 110.917 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -94.05 37.59 1.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 72.150000000000006 110.893 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -142.02 91.85 2.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 73.140000000000001 110.876 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.438 ' CG2' ' N ' ' A' ' 115' ' ' THR . 4.6 mp -122.49 163.94 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 74.129999999999995 111.107 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.438 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.5 OUTLIER -157.88 161.94 38.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 75.549999999999997 111.199 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.573 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 1.4 p90 -136.32 148.7 48.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 70.310000000000002 110.902 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.403 ' HB3' HD13 ' A' ' 160' ' ' LEU . 3.7 tmm_? -141.83 120.01 12.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 71.450000000000003 110.864 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.7 mt -79.82 104.13 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 74.299999999999997 111.192 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -56.44 -46.42 80.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 64.349999999999994 110.932 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.5 p-10 -146.82 165.5 29.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 72.420000000000002 110.912 179.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.3 m-85 -114.95 142.09 47.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 71.0 110.944 -179.921 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.589 HG23 ' HB2' ' A' ' 124' ' ' ASP . 1.0 OUTLIER -88.97 137.99 29.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.602 0.715 . . . . 75.0 111.102 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.71 33.61 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.656 2.237 . . . . 72.319999999999993 112.435 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.589 ' HB2' HG23 ' A' ' 122' ' ' THR . 1.8 m-20 -123.36 -17.44 6.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 71.209999999999994 110.915 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 6.6 mtm -117.28 165.55 13.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 71.519999999999996 110.926 179.914 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -92.86 140.57 29.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 71.140000000000001 110.861 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.9 ptt-85 -44.6 -36.91 3.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 74.319999999999993 110.813 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -84.01 -39.27 19.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 71.450000000000003 110.879 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -63.51 -32.1 73.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.103 -0.499 . . . . 75.200000000000003 110.906 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 58.3 t -65.48 -44.46 94.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.18 -0.464 . . . . 75.349999999999994 111.13 179.948 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.45 -22.42 38.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 64.310000000000002 110.924 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -76.15 -47.89 22.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 74.25 110.854 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -72.52 -30.65 64.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 74.109999999999999 111.026 179.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.2 mp -71.95 -55.37 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.404 . . . . 74.140000000000001 111.124 -179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . . . . . . . . . 5.1 ttt180 -48.0 -40.38 22.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 73.450000000000003 110.919 179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 4.8 mmtp -76.47 -33.37 58.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 72.219999999999999 110.873 179.998 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.52 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -60.27 -50.93 71.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 62.32 111.137 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.63 ' CZ ' HG12 ' A' ' 220' ' ' ILE . 79.0 m-85 -67.01 -33.55 75.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 74.120000000000005 110.889 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.583 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.8 tt0 -61.92 -43.84 98.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 73.299999999999997 110.905 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.43 ' HB ' HG11 ' A' ' 217' ' ' VAL . 73.2 t -49.56 -25.05 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.163 -0.471 . . . . 71.230000000000004 111.125 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.444 ' CD1' HG13 ' A' ' 217' ' ' VAL . 97.1 m95 -98.33 -29.66 13.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 74.450000000000003 110.891 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 t -73.4 -15.1 61.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.417 . . . . 74.329999999999998 110.896 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.583 ' ND2' ' O ' ' A' ' 139' ' ' GLN . 63.9 m-80 -89.36 -26.14 21.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 75.540000000000006 110.795 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . . . . . . . . . 4.7 m -93.61 3.71 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 74.519999999999996 111.104 -179.985 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.519 ' C ' ' H ' ' A' ' 147' ' ' LEU . 59.5 p -153.69 143.1 14.97 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 121.596 0.712 . . . . 73.349999999999994 111.09 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 30.36 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.683 2.256 . . . . 54.049999999999997 112.328 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.519 ' H ' ' C ' ' A' ' 145' ' ' THR . 20.1 mt -91.93 173.1 8.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 70.329999999999998 110.884 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -135.12 126.55 28.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 71.420000000000002 110.927 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 2.7 m-85 -116.41 141.27 48.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 75.030000000000001 110.938 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.7 m -136.73 147.71 46.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 74.310000000000002 110.802 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.435 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 16.4 tptm -98.9 146.45 25.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.501 . . . . 74.25 110.897 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 18.4 pt -150.89 147.02 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 75.140000000000001 111.108 179.911 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . 0.41 ' N ' HD21 ' A' ' 153' ' ' ASN . 1.9 m-80 -113.07 4.54 16.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 74.219999999999999 110.916 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.1 t -169.98 58.3 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.135 -0.484 . . . . 71.200000000000003 111.169 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -150.53 -154.23 6.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.743 . . . . 55.409999999999997 112.505 -179.997 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.0 96.21 6.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.339 . . . . 70.030000000000001 110.906 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -106.72 156.14 18.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 74.129999999999995 111.097 179.971 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.65 -51.13 7.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 74.239999999999995 110.822 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.451 ' HA ' ' O ' ' A' ' 193' ' ' GLY . 3.4 mp -94.16 98.55 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 64.450000000000003 111.163 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . 0.403 HD13 ' HB3' ' A' ' 117' ' ' ARG . 7.0 tp -88.35 110.98 21.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 71.230000000000004 110.934 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 87.7 t -88.24 121.59 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 71.109999999999999 111.139 179.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 p -140.72 106.09 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 64.510000000000005 111.157 179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 46.8 m-85 -73.38 109.98 7.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 71.129999999999995 110.859 -179.896 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.07 166.62 18.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.51 . . . . 75.099999999999994 111.182 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.36 135.06 54.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 74.409999999999997 110.888 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.654 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 44.52 -156.91 0.22 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.739 -0.743 . . . . 74.409999999999997 112.542 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.819 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -63.17 117.67 6.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.338 . . . . 73.439999999999998 111.105 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.715 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -110.59 -22.5 11.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 74.329999999999998 110.945 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.29 30.45 0.51 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.738 -0.744 . . . . 71.439999999999998 112.433 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.624 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -114.28 0.68 14.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.841 0.353 . . . . 75.049999999999997 110.837 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 73.49 39.76 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 71.409999999999997 110.864 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.715 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.26 -40.77 0.73 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.084 -0.507 . . . . 63.240000000000002 110.859 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.819 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.1 99.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 75.010000000000005 111.107 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.654 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.8 m-85 -60.45 -168.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 74.430000000000007 110.892 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.69 18.66 3.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 71.329999999999998 110.872 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.569 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.58 -156.35 9.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.799 -0.715 . . . . 65.430000000000007 112.461 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.74 135.56 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 74.519999999999996 110.859 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.49 165.03 0.14 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 71.209999999999994 112.476 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 81.97 -142.49 22.46 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.749 -0.738 . . . . 74.540000000000006 112.431 -179.912 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.42 95.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.8 0.333 . . . . 75.510000000000005 111.214 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.1 mm? -65.1 -46.76 79.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.158 -0.474 . . . . 71.409999999999997 110.894 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . 0.419 ' HB2' ' HA ' ' A' ' 197' ' ' PHE . . . -163.24 174.21 12.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 52.210000000000001 111.048 179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.469 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -169.33 139.71 2.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 73.430000000000007 110.823 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.547 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -135.08 174.62 10.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 64.439999999999998 111.007 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.534 ' O ' ' O ' ' A' ' 222' ' ' HIS . 64.3 m-85 -98.51 -134.25 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 74.510000000000005 110.835 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.431 ' HA2' ' O ' ' A' ' 223' ' ' SER . . . 179.02 -84.87 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.676 -0.774 . . . . 71.329999999999998 112.437 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 50.52 0.83 Allowed 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.727 2.285 . . . . 71.209999999999994 112.367 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.552 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.81 148.78 17.21 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.809 -0.71 . . . . 74.239999999999995 112.544 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.534 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.43 145.9 29.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.941 0.4 . . . . 71.409999999999997 110.856 -179.711 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.33 -64.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.759 . . . . 73.329999999999998 112.551 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.534 ' N ' ' O ' ' A' ' 189' ' ' SER . 14.8 tt -104.22 7.82 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.919 0.39 . . . . 72.0 111.165 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.552 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -69.39 172.92 37.48 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.801 -0.714 . . . . 74.299999999999997 112.497 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.48 ' O ' ' HB3' ' A' ' 223' ' ' SER . . . 43.2 23.17 0.23 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.683 -0.77 . . . . 73.219999999999999 112.526 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 192' ' ' GLY . 1.6 m-20 -67.0 101.15 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.854 0.359 . . . . 71.109999999999999 110.817 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.547 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -75.09 130.82 39.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 72.230000000000004 111.069 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.469 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.2 m170 -121.21 130.94 53.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 75.439999999999998 110.82 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.448 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 38.0 m-85 -115.44 134.94 54.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 74.430000000000007 110.88 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -67.22 107.02 2.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.506 . . . . 61.119999999999997 110.81 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -57.55 -37.84 73.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.112 -0.495 . . . . 74.349999999999994 111.012 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.569 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 12.9 m-20 -50.64 -20.78 1.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 74.109999999999999 110.889 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -82.42 162.45 22.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.209999999999994 110.882 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.46 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -101.81 87.82 3.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.5 . . . . 72.239999999999995 110.856 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.448 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 23.5 m95 -80.09 120.09 23.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.096 -0.502 . . . . 74.540000000000006 110.995 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.0 p -131.46 -173.84 3.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 71.340000000000003 111.209 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.63 12.85 18.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 70.140000000000001 111.164 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -131.49 -175.74 3.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 65.010000000000005 110.901 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.6 p -51.48 -36.73 45.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 71.349999999999994 110.856 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -63.13 160.71 34.73 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.69 -0.767 . . . . 71.319999999999993 112.524 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.46 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . 48.39 -173.17 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.67 -0.776 . . . . 75.310000000000002 112.501 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 51.5 m -86.47 94.11 9.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 74.329999999999998 111.197 -179.932 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -38.54 113.59 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 73.519999999999996 110.88 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 13.0 tp -62.64 -35.69 80.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 73.109999999999999 110.923 179.94 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 3.5 t80 -53.27 -64.37 0.84 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 74.329999999999998 110.852 -179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 21.8 mt -56.01 -54.34 46.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 62.009999999999998 110.93 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 3.7 m -53.73 -37.41 63.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 74.530000000000001 111.112 179.931 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . 0.417 ' O ' HG13 ' A' ' 220' ' ' ILE . . . -63.13 -50.56 69.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 62.149999999999999 111.19 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.52 HG22 ' CB ' ' A' ' 137' ' ' ALA . 1.9 t -51.96 -57.76 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 72.340000000000003 111.136 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.575 ' HB2' HG13 ' A' ' 235' ' ' VAL . 3.9 t-80 -65.23 -30.75 71.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 74.439999999999998 110.898 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -62.87 -41.86 99.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 74.200000000000003 111.071 -179.958 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.63 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.9 mt -71.98 -35.31 53.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 70.540000000000006 111.088 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.438 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -51.31 -45.23 52.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.703 -0.761 . . . . 65.439999999999998 112.544 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.534 ' O ' ' O ' ' A' ' 185' ' ' PHE . 37.3 m-70 -68.2 -41.77 80.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.885 0.374 . . . . 74.409999999999997 110.855 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.514 ' OG ' ' HA ' ' A' ' 220' ' ' ILE . 2.1 p -66.45 -18.11 65.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 72.120000000000005 110.885 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 39.9 mt -83.42 -27.19 29.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.239999999999995 110.943 179.937 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 119.99 14.06 5.74 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.735 -0.745 . . . . 42.25 112.498 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.438 ' HB2' ' O ' ' A' ' 221' ' ' GLY . 12.7 mt -81.0 158.32 25.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.895 0.379 . . . . 75.540000000000006 110.943 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -100.11 -133.49 8.14 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.767 -0.73 . . . . 72.319999999999993 112.518 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -129.02 139.72 51.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.851 0.357 . . . . 74.200000000000003 110.804 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 53.9 m -97.67 162.74 13.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 60.219999999999999 110.906 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.66 -1.44 19.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 72.019999999999996 110.9 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -63.45 141.91 97.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.58 0.705 . . . . 71.219999999999999 110.824 179.965 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -3.88 12.92 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.737 2.291 . . . . 74.239999999999995 112.399 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.5 ptmt -144.27 25.01 1.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 73.219999999999999 110.818 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.44 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -86.7 140.22 29.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.327 -0.397 . . . . 73.430000000000007 111.137 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.575 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.0 OUTLIER -62.81 -38.67 82.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.287 -0.415 . . . . 74.340000000000003 111.14 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 54.0 mmm -65.57 -16.97 64.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 74.310000000000002 110.888 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.624 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.2 t80 -55.48 144.81 51.77 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.678 0.751 . . . . 64.209999999999994 110.937 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.624 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.0 Cg_endo -69.73 0.83 5.06 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.779 2.319 . . . . 74.439999999999998 112.359 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.1 m -100.99 139.52 36.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 72.400000000000006 111.103 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -120.44 137.85 54.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 75.349999999999994 110.975 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.6 tptt -156.85 136.87 12.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 72.540000000000006 110.915 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 80.0 t80 -63.13 146.03 54.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 75.430000000000007 110.905 -179.902 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.2 OUTLIER -161.79 131.53 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 75.409999999999997 111.068 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -54.6 132.02 44.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 75.510000000000005 110.918 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 15.6 tt -53.65 -30.16 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.432 . . . . 72.400000000000006 111.113 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.0 OUTLIER -69.5 -20.34 63.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 70.439999999999998 110.874 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 5.0 p -110.95 -20.5 12.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 65.549999999999997 111.254 179.969 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -69.5 142.96 53.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.461 . . . . 73.219999999999999 110.849 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -176.07 133.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 72.239999999999995 110.847 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.4 ' HB3' ' HB2' ' A' ' 254' ' ' ASP . 34.7 mt -48.8 137.74 12.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 63.43 110.994 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 23.2 t -80.61 168.06 19.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 71.430000000000007 110.848 -179.905 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.95 -38.46 56.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.074 -0.512 . . . . 53.25 111.07 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.33 -51.15 67.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.257 -0.429 . . . . 60.439999999999998 110.908 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . 0.4 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 7.2 m-20 -57.55 -53.38 58.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 61.229999999999997 110.848 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 2.6 mt -60.12 -36.81 70.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 74.340000000000003 111.105 -179.946 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -67.61 -39.6 84.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 74.140000000000001 110.861 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.87 -52.59 5.74 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.822 -0.704 . . . . 64.219999999999999 112.416 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 5.6 tp -52.59 -34.5 19.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.832 0.349 . . . . 74.310000000000002 111.194 -179.91 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.437 ' O ' ' N ' ' A' ' 263' ' ' GLY . 70.7 mt-30 -86.33 -17.96 33.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.069 -0.514 . . . . 73.230000000000004 110.94 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.4 t -69.36 -13.97 62.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.452 . . . . 71.299999999999997 110.874 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.2 mt -123.02 -17.51 6.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 73.430000000000007 110.924 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 35.9 m-85 -114.69 -35.51 4.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.108 -0.496 . . . . 75.549999999999997 110.887 -179.974 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.437 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.282 0 CA-C-O 119.118 -0.823 . . . . 72.019999999999996 112.516 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 101' ' ' ARG . 98.1 m-85 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.82 0.343 . . . . 71.219999999999999 110.906 . . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 100' ' ' PHE . 23.3 ptt180 36.13 68.36 0.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 73.230000000000004 110.893 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.6 mt-10 -175.22 131.54 0.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 75.219999999999999 110.916 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' MET . . . . . 0.403 ' HB3' ' HD2' ' A' ' 104' ' ' PRO . 16.6 mmt -51.37 159.51 1.13 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.547 0.689 . . . . 73.409999999999997 110.86 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . 0.403 ' HD2' ' HB3' ' A' ' 103' ' ' MET . 53.6 Cg_endo -69.82 -4.52 14.24 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.714 2.276 . . . . 70.549999999999997 112.311 -179.966 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.6 -56.15 3.03 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 74.319999999999993 112.523 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 144.21 -131.49 4.41 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.666 -0.778 . . . . 63.119999999999997 112.433 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.65 130.18 19.01 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.641 2.228 . . . . 65.230000000000004 112.315 -179.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 10.0 p -49.66 166.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 74.340000000000003 111.174 179.842 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 5.5 m0 -47.44 -24.52 0.83 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.196 -0.457 . . . . 75.329999999999998 110.958 179.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 7.3 mtt180 70.82 26.3 3.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.234 -0.439 . . . . 74.140000000000001 110.866 -179.955 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -121.74 145.46 48.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 75.450000000000003 110.935 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . 0.575 ' HA ' ' CD1' ' A' ' 147' ' ' LEU . 5.3 p80 -100.51 29.39 4.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.414 . . . . 65.439999999999998 110.864 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -130.75 82.69 2.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 74.430000000000007 110.903 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.443 ' CG2' ' N ' ' A' ' 115' ' ' THR . 5.0 mp -109.99 163.36 7.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 73.25 111.153 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.497 ' OG1' ' CD1' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -160.65 164.71 31.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 73.400000000000006 111.111 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.632 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 5.1 p90 -133.56 145.12 49.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.481 . . . . 73.109999999999999 110.977 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . 0.501 ' HB2' HD12 ' A' ' 152' ' ' ILE . 3.9 tmt_? -136.42 110.06 8.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 74.530000000000001 110.849 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 52.5 mt -70.73 105.83 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 74.530000000000001 111.077 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -60.51 -47.47 86.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 71.400000000000006 110.822 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.2 p-10 -141.53 162.9 34.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 74.400000000000006 110.849 -179.941 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 4.1 m-85 -116.57 144.29 44.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 75.239999999999995 110.964 -179.971 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.444 ' C ' ' H ' ' A' ' 124' ' ' ASP . 30.4 m -99.12 135.63 20.75 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.572 0.701 . . . . 65.530000000000001 111.133 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.409 ' HD2' ' CG2' ' A' ' 122' ' ' THR . 54.0 Cg_endo -69.74 10.87 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.728 2.285 . . . . 73.420000000000002 112.338 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . 0.444 ' H ' ' C ' ' A' ' 122' ' ' THR . 1.6 m-20 -87.89 -26.73 22.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 74.140000000000001 110.861 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -112.76 160.12 18.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 73.120000000000005 110.851 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -86.84 152.02 22.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.150000000000006 110.956 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -45.44 -39.63 7.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 74.329999999999998 110.885 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.01 -38.22 53.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 74.409999999999997 110.939 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.8 t0 -61.39 -35.87 78.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.081 -0.509 . . . . 70.439999999999998 110.89 179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 95.0 t -60.9 -44.86 98.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 71.340000000000003 111.122 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.426 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 1.0 OUTLIER -83.18 -23.04 33.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 60.130000000000003 110.92 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -76.43 -51.87 10.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 74.400000000000006 110.888 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -66.59 -30.62 70.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 72.530000000000001 111.161 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.4 mp -77.31 -58.17 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 73.140000000000001 111.094 -179.996 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.427 ' O ' ' HB2' ' A' ' 139' ' ' GLN . 6.2 ttm180 -48.06 -47.06 34.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 74.549999999999997 110.884 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.8 mmpt? -67.62 -33.98 76.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 71.549999999999997 110.879 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.485 ' HA ' ' CG2' ' A' ' 217' ' ' VAL . . . -61.55 -49.47 76.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 71.219999999999999 111.119 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.632 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 96.5 m-85 -73.63 -21.9 60.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 74.349999999999994 110.856 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.475 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.6 tt0 -77.8 -5.21 50.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 75.040000000000006 110.916 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . 0.412 ' HB ' HG11 ' A' ' 217' ' ' VAL . 94.9 t -99.14 -17.59 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 75.530000000000001 111.112 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.494 ' HA ' HG21 ' A' ' 144' ' ' VAL . 97.0 m95 -106.89 -38.23 6.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.1 -0.5 . . . . 74.209999999999994 110.919 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.99 -10.72 59.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.008 0.432 . . . . 61.420000000000002 110.912 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.553 ' N ' HD21 ' A' ' 143' ' ' ASN . 1.1 m-80 -97.24 -17.49 19.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 73.420000000000002 110.873 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.494 HG21 ' HA ' ' A' ' 141' ' ' TRP . 18.1 m -100.2 -3.89 9.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 74.510000000000005 111.087 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.591 ' HB ' ' CD2' ' A' ' 147' ' ' LEU . 44.6 p -142.89 148.4 45.58 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.572 0.701 . . . . 74.329999999999998 111.119 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.82 35.01 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.663 2.242 . . . . 75.349999999999994 112.34 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.591 ' CD2' ' HB ' ' A' ' 145' ' ' THR . 2.8 mm? -104.58 166.28 10.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 75.109999999999999 110.95 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -129.21 129.36 44.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 74.019999999999996 110.869 179.885 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . 0.413 ' HA ' ' O ' ' A' ' 114' ' ' ILE . 4.1 m-30 -115.48 137.66 51.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 74.450000000000003 110.909 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.3 t -125.26 162.77 23.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 51.420000000000002 110.852 -179.785 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 7.9 tttt -119.5 142.2 48.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 73.540000000000006 110.853 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . 0.501 HD12 ' HB2' ' A' ' 117' ' ' ARG . 0.3 OUTLIER -150.95 166.68 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 72.420000000000002 111.158 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -131.36 18.55 4.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 73.040000000000006 110.867 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 10.1 t -95.3 -42.6 8.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 75.239999999999995 111.209 -179.976 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 133.53 7.17 2.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 70.340000000000003 112.482 179.892 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 156' ' ' MET . . . . . 0.431 ' HE1' ' HB3' ' A' ' 156' ' ' MET . 2.9 ttp -103.62 80.98 1.85 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.884 0.373 . . . . 62.420000000000002 110.913 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . 0.419 ' HB3' ' HB2' ' A' ' 117' ' ' ARG . . . -151.13 163.37 38.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 75.099999999999994 111.12 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.4 OUTLIER -85.93 -50.93 6.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 73.340000000000003 110.907 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.423 HG12 ' HB2' ' A' ' 223' ' ' SER . 2.3 mp -92.57 91.59 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 75.239999999999995 111.177 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.4 tp -83.11 109.02 16.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.219 -0.446 . . . . 71.409999999999997 110.902 179.922 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 97.2 t -87.48 119.05 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 62.0 111.178 179.817 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 1.8 p -137.75 103.89 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 72.109999999999999 111.114 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . 0.405 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 36.7 m-85 -72.66 110.25 6.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 73.310000000000002 110.871 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.57 166.9 20.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 71.209999999999994 111.115 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.16 137.74 51.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 75.140000000000001 110.837 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.662 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.93 -155.74 0.23 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.716 -0.754 . . . . 63.32 112.512 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.821 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -64.51 116.73 6.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.77 0.319 . . . . 72.299999999999997 111.105 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.706 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.15 -22.22 12.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 73.319999999999993 110.94 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.04 30.35 0.53 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.67 -0.776 . . . . 64.140000000000001 112.456 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.638 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -114.47 1.24 14.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.766 0.317 . . . . 70.519999999999996 110.824 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 73.05 39.75 0.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 72.239999999999995 110.763 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.706 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.25 -41.23 0.73 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 72.409999999999997 110.955 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.821 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.02 100.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 73.400000000000006 111.11 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.662 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -60.56 -168.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 72.209999999999994 110.909 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.87 19.07 3.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 71.099999999999994 110.835 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.577 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.64 -158.22 6.22 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.758 -0.734 . . . . 61.350000000000001 112.559 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 176' ' ' GLY . 5.4 tmtt? -34.69 134.25 0.23 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.878 0.371 . . . . 73.209999999999994 110.908 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.02 164.66 0.16 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.739 -0.743 . . . . 71.030000000000001 112.494 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.97 -142.85 21.8 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 61.539999999999999 112.509 -179.929 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -50.45 96.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.819 0.343 . . . . 73.230000000000004 111.094 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 3.0 mm? -65.94 -42.94 89.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 74.400000000000006 110.92 179.87 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -171.09 163.36 7.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 64.310000000000002 111.158 179.76 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.474 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.2 p80 -156.06 142.96 18.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 73.510000000000005 110.881 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.584 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -139.01 172.51 12.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 74.25 111.074 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.537 ' O ' ' O ' ' A' ' 222' ' ' HIS . 46.9 m-85 -101.12 -145.51 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 62.229999999999997 110.918 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -168.0 -86.21 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.774 -0.726 . . . . 63.039999999999999 112.456 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.73 54.15 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.755 2.304 . . . . 75.040000000000006 112.305 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . 0.562 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.32 150.64 16.88 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.773 -0.727 . . . . 74.140000000000001 112.47 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 189' ' ' SER . . . . . 0.546 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.08 147.01 27.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 72.430000000000007 110.83 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 61.02 -66.21 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.845 -0.693 . . . . 72.109999999999999 112.441 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . 0.546 ' N ' ' O ' ' A' ' 189' ' ' SER . 5.8 mm -102.76 6.89 10.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.777 0.322 . . . . 74.5 111.068 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.562 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -66.96 168.85 36.18 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.748 -0.739 . . . . 75.329999999999998 112.47 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 45.27 18.71 0.18 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 71.430000000000007 112.488 -179.834 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . 0.424 ' N ' ' O ' ' A' ' 192' ' ' GLY . 1.1 m-20 -63.08 102.5 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 73.010000000000005 110.85 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.584 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -76.99 132.22 38.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 74.439999999999998 111.06 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.474 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 4.8 m170 -123.22 129.53 51.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 71.340000000000003 110.868 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.489 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 42.5 m-85 -114.54 135.57 53.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 74.109999999999999 110.846 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -68.43 109.38 3.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 71.120000000000005 110.945 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -61.03 -36.1 78.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 73.439999999999998 110.935 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.577 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 18.0 m-20 -52.18 -20.7 2.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 75.439999999999998 110.849 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -81.57 161.14 23.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.457 . . . . 65.430000000000007 110.823 -179.89 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.528 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -100.13 90.93 4.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 73.150000000000006 110.801 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.489 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 22.2 m95 -81.26 123.92 28.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 71.319999999999993 110.858 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 43.5 p -140.47 -176.36 4.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 62.109999999999999 111.06 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -110.28 19.86 18.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 75.5 111.201 -179.998 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -128.34 -173.24 2.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 73.340000000000003 110.861 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.3 t -71.71 -18.84 62.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 65.209999999999994 110.869 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.06 -106.79 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.686 -0.769 . . . . 52.310000000000002 112.491 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.528 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.07 177.01 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.692 -0.766 . . . . 54.130000000000003 112.469 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 89.8 m -66.63 97.54 0.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 75.25 111.249 -179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -42.14 114.75 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 72.209999999999994 110.947 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 27.1 tp -61.18 -32.46 72.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 72.230000000000004 111.0 179.946 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 3.0 t80 -58.11 -65.23 0.68 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.096 -0.502 . . . . 75.439999999999998 110.98 179.914 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 8.9 mp -51.88 -54.43 29.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 74.109999999999999 110.957 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 2.7 m -55.64 -38.93 70.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 74.439999999999998 111.023 179.949 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.08 -48.81 77.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 63.43 111.093 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.485 ' CG2' ' HA ' ' A' ' 137' ' ' ALA . 1.9 t -54.83 -57.57 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 73.329999999999998 111.093 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.517 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.3 t-80 -64.87 -28.11 69.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 73.150000000000006 110.989 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -63.8 -46.53 84.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 71.340000000000003 111.067 179.891 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.533 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.5 mt -68.02 -35.23 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 72.329999999999998 111.123 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.411 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -49.47 -45.91 36.96 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.671 -0.776 . . . . 70.540000000000006 112.474 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' PHE . 4.9 m-70 -68.32 -39.89 81.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.801 0.334 . . . . 73.239999999999995 110.866 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.526 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 14.0 m -66.15 -24.66 66.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 71.230000000000004 110.827 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 43.1 mt -75.67 -25.92 57.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 75.450000000000003 110.964 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 124.45 11.16 4.7 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.746 -0.74 . . . . 64.120000000000005 112.454 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.411 ' HB2' ' O ' ' A' ' 221' ' ' GLY . 14.4 mt -90.03 142.71 27.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 75.299999999999997 110.912 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -93.05 -137.01 8.01 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.71 -0.757 . . . . 71.230000000000004 112.47 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -115.96 144.23 44.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.835 0.35 . . . . 75.25 110.872 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 77.6 p -102.85 167.05 10.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 74.510000000000005 110.836 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 65.6 m -109.54 5.07 22.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 71.040000000000006 110.853 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -72.75 135.55 80.83 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.524 0.678 . . . . 74.299999999999997 110.88 179.953 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -0.41 6.85 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.706 2.271 . . . . 75.5 112.326 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.11 26.39 1.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 75.140000000000001 110.944 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -97.55 144.34 27.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 73.120000000000005 111.042 179.867 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.517 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -63.94 -41.54 92.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 71.129999999999995 111.143 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 34.7 mmm -59.86 -18.76 46.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 71.340000000000003 110.83 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.598 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -57.38 144.62 70.69 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.68 0.753 . . . . 74.230000000000004 110.875 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.598 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.1 Cg_endo -69.95 -1.78 9.2 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.709 2.273 . . . . 62.240000000000002 112.34 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.7 m -95.24 137.28 34.5 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.159 -0.473 . . . . 61.450000000000003 111.177 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -118.76 135.88 54.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 75.239999999999995 110.932 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -154.93 131.43 10.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 73.140000000000001 110.926 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 80.1 t80 -60.15 145.43 46.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.18 -0.464 . . . . 73.400000000000006 110.87 -179.876 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -159.87 132.51 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 75.409999999999997 111.141 179.902 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -50.16 128.17 18.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 75.439999999999998 110.894 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 14.0 tt -51.13 -33.77 13.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.208 -0.451 . . . . 73.140000000000001 111.078 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -69.68 -23.27 63.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 74.5 110.837 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 29.6 p -101.33 -24.42 14.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 75.230000000000004 111.125 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -64.31 144.28 57.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 74.430000000000007 110.834 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -175.04 131.19 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 74.219999999999999 110.846 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.405 ' HB3' ' HB2' ' A' ' 254' ' ' ASP . 33.8 mt -49.81 124.56 10.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 75.439999999999998 110.891 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.34 167.08 15.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 63.509999999999998 110.785 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.61 -39.17 49.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.089 -0.505 . . . . 71.030000000000001 111.159 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.9 -46.92 85.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 74.420000000000002 110.821 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . 0.405 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 6.9 m-20 -61.36 -54.49 43.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 65.430000000000007 110.866 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 23.0 mt -60.58 -35.01 60.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 74.010000000000005 111.159 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -68.75 -39.78 80.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.454 . . . . 71.310000000000002 110.861 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.03 -51.19 7.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 73.329999999999998 112.506 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 6.2 tp -53.23 -34.37 21.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.794 0.33 . . . . 72.409999999999997 111.205 -179.97 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 263' ' ' GLY . 31.2 mt-30 -87.86 -16.13 34.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 71.129999999999995 110.942 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.4 t -69.33 -16.52 63.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 70.329999999999998 110.902 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.1 mt -120.76 -19.42 7.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.509 . . . . 72.0 110.86 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . 0.433 ' HB3' ' CD2' ' A' ' 147' ' ' LEU . 29.7 m-85 -110.17 -37.25 5.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 72.049999999999997 110.908 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.335 0 CA-C-O 119.194 -0.781 . . . . 72.049999999999997 112.475 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.827 0.346 . . . . 75.209999999999994 110.848 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 50.09 59.95 4.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 73.530000000000001 110.874 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 4.6 pt-20 -178.66 135.83 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.123 -0.489 . . . . 72.230000000000004 110.867 -179.89 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.4 tpt -51.76 135.35 36.16 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.557 0.694 . . . . 71.140000000000001 110.869 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 73.95 1.3 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.639 2.226 . . . . 74.109999999999999 112.394 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 110.38 25.88 5.08 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.714 -0.755 . . . . 73.129999999999995 112.46 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.83 111.53 2.54 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.78 -0.724 . . . . 53.329999999999998 112.428 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' PRO . . . . . 0.477 ' O ' ' CG2' ' A' ' 108' ' ' VAL . 54.1 Cg_endo -69.78 4.2 2.34 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.665 2.243 . . . . 73.430000000000007 112.299 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.477 ' CG2' ' O ' ' A' ' 107' ' ' PRO . 17.7 m 45.16 30.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.305 -0.407 . . . . 74.319999999999993 111.14 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' TRP . . . . . 0.432 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 10.4 m0 76.22 -40.67 0.4 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.137 -0.483 . . . . 74.420000000000002 110.828 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' ARG . . . . . 0.428 ' H ' ' C ' ' A' ' 108' ' ' VAL . 4.7 mtt-85 70.9 31.94 2.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 74.329999999999998 110.906 -179.959 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -122.34 161.44 23.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 74.150000000000006 110.895 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -109.63 20.64 17.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 75.129999999999995 110.859 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -125.96 96.41 4.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.187 -0.461 . . . . 73.510000000000005 110.975 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ILE . . . . . 0.448 ' CG2' ' N ' ' A' ' 115' ' ' THR . 4.8 mp -123.29 163.93 21.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 74.420000000000002 111.161 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' THR . . . . . 0.448 ' N ' ' CG2' ' A' ' 114' ' ' ILE . 0.4 OUTLIER -157.72 163.64 37.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 72.439999999999998 111.226 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' TYR . . . . . 0.593 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.7 p90 -133.53 144.63 49.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 74.140000000000001 110.926 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -138.84 108.86 6.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.486 . . . . 74.519999999999996 110.83 -179.967 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 53.2 mt -70.66 106.03 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 75.439999999999998 111.124 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -60.39 -47.43 86.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 71.519999999999996 110.921 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 2.3 p-10 -141.17 162.52 35.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 75.239999999999995 110.96 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 5.1 m-85 -116.35 145.55 43.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.187 -0.46 . . . . 73.329999999999998 110.927 -179.932 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' THR . . . . . 0.526 ' CG2' ' HD2' ' A' ' 123' ' ' PRO . 3.6 m -93.01 137.9 23.53 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.581 0.705 . . . . 64.329999999999998 111.147 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' PRO . . . . . 0.526 ' HD2' ' CG2' ' A' ' 122' ' ' THR . 54.2 Cg_endo -69.85 0.6 5.48 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.635 2.223 . . . . 75.040000000000006 112.323 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -84.08 -24.23 30.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 71.329999999999998 110.844 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' MET . . . . . . . . . . . . . 3.8 mtm -113.12 167.37 10.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 74.319999999999993 110.853 179.994 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -92.96 143.41 26.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 73.439999999999998 110.974 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -45.36 -36.22 4.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 73.030000000000001 110.877 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -83.38 -38.23 22.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 74.329999999999998 110.908 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -64.12 -31.8 73.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 75.209999999999994 110.828 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' VAL . . . . . . . . . . . . . 56.4 t -65.61 -46.21 90.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 74.209999999999994 111.105 -179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' ASP . . . . . 0.434 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 0.2 OUTLIER -78.49 -23.53 46.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 72.129999999999995 110.88 179.902 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -74.93 -48.02 26.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 74.040000000000006 110.955 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' ALA . . . . . . . . . . . . . . . -68.88 -31.18 69.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 73.109999999999999 111.112 179.835 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' ILE . . . . . . . . . . . . . 1.3 mp -73.8 -53.93 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 74.140000000000001 111.161 179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' ARG . . . . . 0.434 ' HB3' ' O ' ' A' ' 131' ' ' ASP . 3.8 ptm180 -49.22 -37.34 22.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 74.200000000000003 110.832 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' LYS . . . . . . . . . . . . . 5.6 mmpt? -76.97 -34.34 57.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 75.129999999999995 110.854 -179.988 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 137' ' ' ALA . . . . . 0.501 ' CB ' HG22 ' A' ' 217' ' ' VAL . . . -60.12 -48.66 80.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 74.530000000000001 111.134 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 138' ' ' PHE . . . . . 0.593 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 96.0 m-85 -72.84 -22.79 60.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 75.340000000000003 110.942 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 139' ' ' GLN . . . . . 0.493 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.4 tt0 -77.78 -5.78 51.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.116 -0.493 . . . . 65.209999999999994 110.917 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 140' ' ' VAL . . . . . . . . . . . . . 83.8 t -97.94 -16.77 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 71.530000000000001 111.066 179.959 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 141' ' ' TRP . . . . . 0.511 ' HA ' HG21 ' A' ' 144' ' ' VAL . 92.1 m95 -107.09 -38.26 6.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.264 -0.426 . . . . 73.430000000000007 110.917 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.95 -11.53 60.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 71.120000000000005 110.814 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 143' ' ' ASN . . . . . 0.599 ' N ' HD21 ' A' ' 143' ' ' ASN . 0.9 OUTLIER -95.53 -17.49 21.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 75.319999999999993 110.849 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 144' ' ' VAL . . . . . 0.511 HG21 ' HA ' ' A' ' 141' ' ' TRP . 22.4 m -99.86 2.72 10.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 75.349999999999994 111.084 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 145' ' ' THR . . . . . 0.52 ' C ' ' H ' ' A' ' 147' ' ' LEU . 44.5 p -150.99 148.69 23.34 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.537 0.684 . . . . 73.409999999999997 111.208 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.71 31.09 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.673 2.249 . . . . 73.239999999999995 112.357 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 147' ' ' LEU . . . . . 0.52 ' H ' ' C ' ' A' ' 145' ' ' THR . 15.4 mt -97.44 175.01 6.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 72.5 110.937 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm -139.05 126.77 22.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 75.540000000000006 110.768 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 149' ' ' PHE . . . . . . . . . . . . . 3.7 m-85 -115.4 138.36 51.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 75.200000000000003 110.898 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 58.5 m -132.57 149.26 52.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 71.239999999999995 110.919 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 151' ' ' LYS . . . . . 0.485 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 4.4 tttt -99.52 141.05 32.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 65.019999999999996 110.9 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 15.5 pt -150.75 139.26 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 74.25 111.121 179.95 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.41 5.35 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 63.420000000000002 110.896 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 10.0 t -163.5 47.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 74.109999999999999 111.16 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . -144.4 -153.19 5.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.702 -0.761 . . . . 60.329999999999998 112.431 179.992 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 38.9 mmt -107.61 95.63 5.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.823 0.344 . . . . 75.010000000000005 110.862 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 157' ' ' ALA . . . . . . . . . . . . . . . -105.64 158.23 16.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 74.430000000000007 111.075 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.02 -57.41 2.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 73.109999999999999 110.875 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 159' ' ' ILE . . . . . 0.564 ' HA ' ' O ' ' A' ' 193' ' ' GLY . 2.8 mp -82.52 86.26 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 71.230000000000004 111.139 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 160' ' ' LEU . . . . . . . . . . . . . 7.9 tp -79.76 102.78 9.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 70.450000000000003 110.84 179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 96.7 t -82.3 123.08 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 73.019999999999996 111.148 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.1 p -140.97 100.05 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 64.510000000000005 111.173 179.875 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -67.53 109.39 3.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 75.420000000000002 110.877 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.76 165.76 20.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.112 -0.495 . . . . 62.350000000000001 111.065 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -113.65 134.85 54.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 74.439999999999998 110.847 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 166' ' ' GLY . . . . . 0.645 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.83 -156.98 0.16 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.677 -0.773 . . . . 74.209999999999994 112.509 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 167' ' ' ALA . . . . . 0.819 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -62.76 115.37 4.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.883 0.373 . . . . 74.329999999999998 111.072 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 168' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -108.39 -21.07 12.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 75.450000000000003 110.876 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.89 30.1 0.59 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.684 -0.77 . . . . 64.120000000000005 112.482 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 170' ' ' ASP . . . . . 0.638 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.49 -0.96 14.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.888 0.375 . . . . 45.039999999999999 110.872 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 75.37 38.05 0.42 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 73.420000000000002 110.877 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 172' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -133.95 -41.14 0.83 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 72.439999999999998 110.853 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 173' ' ' ALA . . . . . 0.819 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.26 100.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 75.409999999999997 111.172 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 174' ' ' PHE . . . . . 0.645 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -61.03 -168.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 72.239999999999995 110.862 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.12 17.5 4.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 74.099999999999994 110.883 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 176' ' ' GLY . . . . . 0.571 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.06 -157.41 7.36 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.748 -0.739 . . . . 72.319999999999993 112.5 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 177' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -34.41 134.42 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.905 0.383 . . . . 65.219999999999999 110.868 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.62 165.95 0.12 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.687 -0.768 . . . . 64.430000000000007 112.555 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.56 -143.19 22.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.708 -0.758 . . . . 65.519999999999996 112.488 -179.878 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.23 96.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.867 0.365 . . . . 74.040000000000006 111.139 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -66.98 -36.04 81.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 75.049999999999997 110.949 179.894 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -174.74 169.0 3.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 63.420000000000002 111.11 179.724 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 183' ' ' HIS . . . . . 0.444 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.2 p80 -161.27 142.28 11.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.275 -0.421 . . . . 75.400000000000006 110.881 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 184' ' ' ALA . . . . . 0.526 ' CB ' ' HA ' ' A' ' 195' ' ' ALA . . . -140.75 170.3 16.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 72.430000000000007 111.135 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 185' ' ' PHE . . . . . 0.627 ' O ' ' HA ' ' A' ' 223' ' ' SER . 1.8 m-85 -125.64 167.93 14.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 75.310000000000002 110.93 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 186' ' ' GLY . . . . . 0.739 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -138.18 32.69 2.32 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.787 -0.721 . . . . 74.129999999999995 112.569 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 187' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 186' ' ' GLY . 53.9 Cg_endo -69.75 -23.27 31.05 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 122.694 2.263 . . . . 74.25 112.325 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 188' ' ' GLY . . . . . . . . . . . . . . . 90.2 135.41 6.0 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.763 -0.732 . . . . 75.430000000000007 112.5 -179.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.0 t 64.46 148.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.827 0.346 . . . . 75.420000000000002 110.871 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 47.95 -102.07 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.731 -0.747 . . . . 71.040000000000006 112.432 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 40.3 pt -77.84 6.63 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.85 0.357 . . . . 72.120000000000005 111.118 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 192' ' ' GLY . . . . . 0.512 ' HA2' ' HD2' ' A' ' 187' ' ' PRO . . . -74.76 121.54 6.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.766 -0.731 . . . . 65.120000000000005 112.483 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 193' ' ' GLY . . . . . 0.564 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 75.2 -9.39 13.13 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.75 -0.738 . . . . 54.039999999999999 112.514 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.17 109.51 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.885 0.374 . . . . 72.209999999999994 110.883 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 195' ' ' ALA . . . . . 0.526 ' HA ' ' CB ' ' A' ' 184' ' ' ALA . . . -98.83 138.04 36.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 74.549999999999997 111.151 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 196' ' ' HIS . . . . . 0.444 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 4.9 m170 -125.26 137.62 54.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.316 -0.402 . . . . 73.420000000000002 110.859 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 197' ' ' PHE . . . . . 0.405 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 37.8 m-85 -120.03 142.44 48.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 74.430000000000007 110.869 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -73.8 109.11 7.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 75.400000000000006 110.779 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -62.1 -35.66 79.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 74.239999999999995 110.85 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 200' ' ' ASP . . . . . 0.571 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 12.0 m-20 -51.24 -21.56 2.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 71.519999999999996 110.87 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.8 mm-40 -81.54 161.29 23.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 74.420000000000002 110.97 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 202' ' ' PHE . . . . . 0.548 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -99.47 88.32 3.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 73.450000000000003 110.917 -179.887 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 203' ' ' TRP . . . . . 0.405 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 33.7 m95 -78.15 123.22 26.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 72.540000000000006 110.887 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 32.6 p -139.64 -176.32 4.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 70.219999999999999 111.146 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.77 17.27 19.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 72.140000000000001 111.112 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 -176.05 3.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 75.450000000000003 110.843 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.8 t -66.69 -18.51 65.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.272 -0.422 . . . . 73.439999999999998 110.86 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.49 -108.3 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 71.219999999999999 112.528 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 209' ' ' GLY . . . . . 0.548 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.63 176.82 0.13 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.788 -0.72 . . . . 45.43 112.415 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 94.5 m -65.62 97.95 0.35 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.799 0.333 . . . . 72.310000000000002 111.105 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -42.0 117.11 0.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 72.200000000000003 110.95 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 212' ' ' LEU . . . . . . . . . . . . . 30.4 tp -64.82 -36.72 85.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 73.439999999999998 110.901 -179.952 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 213' ' ' PHE . . . . . . . . . . . . . 2.4 t80 -53.84 -65.45 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 74.0 110.791 179.989 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 214' ' ' LEU . . . . . . . . . . . . . 18.8 mt -53.12 -54.97 27.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.489 . . . . 74.129999999999995 110.894 -179.872 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 215' ' ' THR . . . . . . . . . . . . . 6.2 m -54.81 -38.41 67.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 74.120000000000005 111.099 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.19 -50.04 71.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 62.520000000000003 111.134 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 217' ' ' VAL . . . . . 0.501 HG22 ' CB ' ' A' ' 137' ' ' ALA . 2.1 t -51.67 -59.6 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 74.209999999999994 111.115 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 218' ' ' HIS . . . . . 0.521 ' HB2' HG13 ' A' ' 235' ' ' VAL . 2.1 t-80 -65.07 -28.11 69.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 62.030000000000001 110.856 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -63.81 -46.07 86.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 54.240000000000002 111.112 179.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 220' ' ' ILE . . . . . 0.531 HG12 ' CZ ' ' A' ' 138' ' ' PHE . 2.8 mt -66.05 -34.66 71.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 75.299999999999997 111.197 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 221' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -53.69 -44.38 69.34 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.753 -0.736 . . . . 35.43 112.499 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -69.54 -34.92 74.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.724 0.297 . . . . 74.310000000000002 110.811 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 223' ' ' SER . . . . . 0.627 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 4.0 p -70.41 -24.85 63.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.275 -0.42 . . . . 72.430000000000007 110.895 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 45.6 mt -76.93 -27.35 54.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 73.319999999999993 110.962 179.949 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 120.29 16.32 4.78 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.779 -0.724 . . . . 72.439999999999998 112.553 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 226' ' ' LEU . . . . . 0.454 ' HB2' ' O ' ' A' ' 221' ' ' GLY . 15.3 mt -79.59 162.87 25.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 75.519999999999996 110.937 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -105.38 -133.17 7.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.755 -0.736 . . . . 55.020000000000003 112.411 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 228' ' ' HIS . . . . . 0.415 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.3 OUTLIER -131.2 148.86 52.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 64.519999999999996 110.805 -179.851 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 86.7 p -108.62 166.44 10.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 73.409999999999997 110.864 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.53 0.46 20.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 74.109999999999999 110.872 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.64 133.9 90.6 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.606 0.717 . . . . 73.040000000000006 110.85 179.872 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 0.59 5.44 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.706 2.271 . . . . 73.549999999999997 112.277 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.91 19.07 2.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 72.349999999999994 110.926 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 234' ' ' ALA . . . . . 0.445 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -91.49 140.26 29.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 65.530000000000001 111.082 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 235' ' ' VAL . . . . . 0.521 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.0 OUTLIER -61.16 -41.18 88.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.235 -0.439 . . . . 75.019999999999996 111.137 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 236' ' ' MET . . . . . 0.415 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 53.9 mmm -58.68 -20.75 51.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 73.239999999999995 110.895 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 237' ' ' PHE . . . . . 0.589 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.0 t80 -55.63 144.03 56.44 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.712 0.768 . . . . 75.319999999999993 110.902 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 238' ' ' PRO . . . . . 0.589 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.8 Cg_endo -69.67 0.79 5.07 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.749 2.299 . . . . 74.420000000000002 112.315 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 30.7 m -97.32 138.91 34.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 65.219999999999999 111.166 -179.955 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -120.87 137.05 54.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 74.109999999999999 110.937 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -157.4 137.27 12.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 62.530000000000001 110.912 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 242' ' ' TYR . . . . . . . . . . . . . 73.9 t80 -61.44 146.91 46.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 72.450000000000003 110.913 -179.954 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 243' ' ' VAL . . . . . . . . . . . . . 0.3 OUTLIER -160.46 132.52 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 75.310000000000002 111.183 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -50.11 132.05 23.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 64.430000000000007 110.874 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 7.3 tt -54.65 -30.63 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 71.209999999999994 111.138 179.971 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -76.17 -18.24 59.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 73.25 110.885 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 60.1 p -105.01 -22.77 13.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 73.420000000000002 111.072 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -69.67 142.97 53.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.429 . . . . 65.040000000000006 110.889 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -176.43 131.68 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 73.400000000000006 110.857 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 250' ' ' LEU . . . . . 0.443 ' HB3' ' HB2' ' A' ' 254' ' ' ASP . 80.2 mt -49.42 128.85 17.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 74.329999999999998 110.95 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 8.2 m -76.52 169.97 17.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 74.299999999999997 110.899 -179.96 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.74 -43.24 47.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 73.510000000000005 111.069 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.17 -49.08 79.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 75.510000000000005 110.821 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 254' ' ' ASP . . . . . 0.443 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 16.3 m-20 -57.22 -54.8 42.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 75.530000000000001 110.811 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 2.9 mt -59.73 -39.59 80.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.437 . . . . 74.200000000000003 111.17 179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -64.1 -39.84 94.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 75.430000000000007 110.909 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.28 -54.01 5.83 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.766 -0.731 . . . . 71.120000000000005 112.459 -179.933 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 258' ' ' ILE . . . . . . . . . . . . . 4.5 tp -53.09 -35.72 23.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.775 0.322 . . . . 70.019999999999996 111.075 -179.964 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 259' ' ' GLN . . . . . 0.422 ' O ' ' N ' ' A' ' 263' ' ' GLY . 87.0 mt-30 -85.82 -17.22 36.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 60.329999999999998 110.948 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.2 t -69.0 -14.29 62.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 75.219999999999999 110.834 -179.804 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.7 mt -123.91 -18.4 6.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 75.010000000000005 110.838 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 262' ' ' TYR . . . . . . . . . . . . . 36.8 m-85 -113.43 -33.98 5.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 71.510000000000005 110.925 -179.961 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 263' ' ' GLY . . . . . 0.422 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.429 0 CA-C-O 119.133 -0.815 . . . . 71.299999999999997 112.507 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.402 ' HA ' ' HG ' ' A' ' 147' ' ' LEU . 16.0 p80 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.801 0.334 . . . . 74.51 110.845 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.405 ' C ' HD12 ' A' ' 114' ' ' ILE . 0.9 OUTLIER -121.37 110.96 16.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 64.11 110.921 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 115' ' ' THR . 4.9 mp -141.06 162.1 22.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 74.12 111.129 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.574 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -157.58 163.54 38.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 73.1 111.135 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.622 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 4.2 p90 -134.53 146.91 50.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 73.43 110.956 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.466 ' HD2' HD11 ' A' ' 160' ' ' LEU . 4.3 tmt_? -141.63 111.82 6.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 72.24 110.901 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.9 mt -73.83 106.86 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 72.01 111.137 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -58.89 -50.43 74.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 71.32 110.893 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.62 ' OD1' HG23 ' A' ' 162' ' ' VAL . 3.3 p-10 -140.17 165.22 27.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 43.44 110.907 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -118.15 138.88 51.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 74.01 110.896 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.754 HG22 ' HE2' ' A' ' 125' ' ' MET . 2.5 t -88.11 143.01 32.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.538 0.685 . . . . 74.14 111.163 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.408 ' HD2' ' OG1' ' A' ' 122' ' ' THR . 53.6 Cg_endo -69.77 -3.11 11.37 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.658 2.239 . . . . 75.4 112.361 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.462 ' H ' HG23 ' A' ' 122' ' ' THR . 13.7 m-20 -80.83 -23.27 39.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 65.01 110.855 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.754 ' HE2' HG22 ' A' ' 122' ' ' THR . 16.2 mtm -115.05 166.03 12.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 43.43 110.869 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -98.17 145.62 26.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 75.1 110.863 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -45.43 -34.49 3.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 74.21 110.928 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -82.32 -40.73 21.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 73.55 110.896 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -63.78 -31.13 72.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 73.2 110.839 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.47 ' O ' HD13 ' A' ' 134' ' ' ILE . 59.5 t -63.86 -45.46 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 71.13 111.158 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.3 -23.47 40.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.151 -0.477 . . . . 73.53 110.879 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -75.26 -47.33 28.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 64.34 110.941 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.754 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -71.2 -31.07 67.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 74.14 111.108 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.625 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -73.7 -55.23 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 74.13 111.145 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.53 ' N ' HG22 ' A' ' 134' ' ' ILE . 5.3 ttt180 -48.56 -42.54 33.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 63.51 110.896 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.614 ' O ' HG23 ' A' ' 140' ' ' VAL . 8.7 mmpt? -70.87 -35.51 72.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 72.24 110.905 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.91 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.0 -48.85 80.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 42.4 111.101 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.622 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 93.3 m-85 -72.6 -22.32 60.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 63.33 110.814 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.28 -6.24 52.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 75.1 110.941 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 136' ' ' LYS . 93.8 t -97.31 -17.56 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 12.35 111.131 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.796 ' NE1' HG12 ' A' ' 217' ' ' VAL . 95.3 m95 -106.18 -36.39 6.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 73.3 110.939 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.82 -11.54 61.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 74.1 110.823 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -95.61 -18.44 20.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 71.02 110.933 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.844 HG11 HD12 ' A' ' 250' ' ' LEU . 19.9 m -98.42 1.24 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 75.2 111.108 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.568 HG21 HG13 ' A' ' 258' ' ' ILE . 39.0 p -151.96 146.24 18.44 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.606 0.717 . . . . 74.14 111.14 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 30.59 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.625 2.217 . . . . 64.53 112.379 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.838 HD21 ' CG ' ' A' ' 262' ' ' TYR . 0.2 OUTLIER -91.76 177.48 6.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 53.5 110.939 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.23 125.59 20.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 73.32 110.904 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.549 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.9 m-30 -114.94 141.56 47.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 71.03 110.894 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.403 ' H ' ' HA ' ' A' ' 115' ' ' THR . 2.1 t -135.72 153.03 51.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 44.33 110.857 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.478 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 19.8 tttt -104.43 143.18 33.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 72.52 110.888 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.477 HD11 ' HB2' ' A' ' 157' ' ' ALA . 16.9 pt -152.32 155.52 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 73.31 111.083 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 75.13 110.877 179.932 . . . . . . . . 0 0 . 1 . 001 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.477 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.835 0.35 . . . . 62.0 111.078 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.5 OUTLIER -86.15 -52.7 5.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 75.31 110.86 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.668 HG12 HG23 ' A' ' 220' ' ' ILE . 2.4 mp -90.01 94.21 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 62.2 111.085 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.466 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.9 tp -86.5 107.75 18.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 73.03 110.895 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 88.4 t -84.97 121.63 37.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 75.33 111.172 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.62 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -140.25 105.43 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 74.22 111.127 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -73.31 110.27 7.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 73.02 110.889 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.545 ' HB3' ' CD2' ' A' ' 168' ' ' HIS . . . -126.98 166.83 16.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 72.23 111.131 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.72 133.1 55.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 75.24 110.853 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.676 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.36 -158.04 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 62.14 112.484 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.766 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -50.71 118.81 3.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 73.02 111.104 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.569 ' NE2' ' CE1' ' A' ' 172' ' ' HIS . 12.4 p80 -137.65 32.5 2.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 75.35 110.854 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 79.11 53.43 4.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 60.31 112.478 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.461 ' OD2' ' CE1' ' A' ' 196' ' ' HIS . 23.7 t0 -143.15 9.34 1.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 75.54 110.88 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 54.16 22.36 3.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 74.11 110.86 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.569 ' CE1' ' NE2' ' A' ' 168' ' ' HIS . 2.1 p-80 -118.62 -38.9 3.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 73.41 110.848 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.766 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 50.43 99.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 72.3 111.114 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.676 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.4 m-85 -58.72 -170.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 74.43 110.862 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.69 21.21 4.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 61.41 110.862 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.583 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 52.53 -156.05 4.69 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 44.31 112.477 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.9 OUTLIER -33.77 132.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.829 0.347 . . . . 64.22 110.911 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.94 163.53 0.13 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.814 -0.708 . . . . 75.34 112.471 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.18 -142.25 19.64 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 74.33 112.452 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.2 mt -49.92 97.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 71.23 111.147 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.467 HD12 HG21 ' A' ' 210' ' ' THR . 2.9 mm? -66.8 -41.61 87.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 71.41 110.875 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 197' ' ' PHE . . . -174.74 158.47 2.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 71.21 111.08 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.433 ' CE1' ' OD2' ' A' ' 170' ' ' ASP . 0.3 OUTLIER -148.92 134.3 18.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.449 . . . . 61.32 110.847 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.781 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -131.71 175.39 9.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 72.24 111.134 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.534 ' O ' ' HA ' ' A' ' 223' ' ' SER . 65.7 m-85 -105.6 -152.93 0.48 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 73.42 110.853 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -160.74 -84.44 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.701 -0.761 . . . . 61.32 112.463 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 52.33 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.721 2.28 . . . . 61.44 112.331 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.59 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.56 150.02 17.16 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.781 -0.724 . . . . 41.13 112.499 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -105.54 147.75 28.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 55.33 110.804 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.27 -64.12 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 44.22 112.5 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 189' ' ' SER . 2.3 pp -107.15 8.42 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 73.31 111.119 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.59 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -69.53 169.5 44.27 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.775 -0.726 . . . . 72.44 112.482 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 46.78 18.35 0.38 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 40.34 112.496 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.14 110.4 2.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.333 . . . . 73.24 110.894 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.781 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -85.01 130.01 34.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 73.52 111.116 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.461 ' CE1' ' OD2' ' A' ' 170' ' ' ASP . 1.3 m170 -123.32 123.04 39.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 71.23 110.84 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.557 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 37.1 m-85 -106.5 138.54 42.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 74.12 110.889 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -68.37 105.37 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 73.32 110.86 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -55.53 -39.09 70.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 75.34 110.845 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.583 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 15.8 m-20 -48.37 -25.0 1.41 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 50.02 110.867 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -77.55 163.11 26.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 74.24 110.894 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.571 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -101.21 86.61 3.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 74.42 110.872 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.557 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 24.7 m95 -79.53 122.4 26.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 73.52 110.881 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.6 p -139.94 -172.83 3.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 64.2 111.148 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.02 19.6 17.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 72.31 111.155 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -126.93 -175.4 3.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 75.31 110.894 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 11.4 p -70.44 -18.84 63.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 54.45 110.891 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.63 -106.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.742 -0.742 . . . . 50.42 112.47 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.07 176.54 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.712 -0.756 . . . . 74.41 112.498 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.467 HG21 HD12 ' A' ' 181' ' ' LEU . 55.6 m -66.65 96.93 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 71.43 111.112 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -43.09 116.93 0.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.427 . . . . 73.42 110.85 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.754 HD23 ' HB3' ' A' ' 133' ' ' ALA . 9.0 tp -62.83 -37.31 86.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 61.42 110.924 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.737 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.6 t80 -51.59 -63.9 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 71.14 110.887 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.56 HD21 ' CG2' ' A' ' 243' ' ' VAL . 8.3 mp -54.6 -55.82 25.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 65.21 110.917 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.505 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 1.5 m -55.45 -32.92 63.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 73.53 111.157 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -68.12 -47.99 66.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 71.2 111.081 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.91 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -53.66 -58.01 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 55.14 111.115 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.744 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.8 t-80 -64.45 -29.38 70.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 73.01 110.867 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.31 -44.7 95.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 65.42 111.055 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.668 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -68.95 -35.11 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 70.52 111.121 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.65 -43.94 46.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.718 -0.753 . . . . 72.21 112.473 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 185' ' ' PHE . 28.2 m-70 -67.79 -39.06 84.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 71.3 110.868 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.655 ' OG ' HG23 ' A' ' 159' ' ' ILE . 3.1 m -63.3 -27.46 69.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 62.4 110.834 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 44.6 mt -75.52 -27.99 58.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 73.3 110.902 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 119.9 15.13 5.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.781 -0.723 . . . . 75.41 112.471 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.704 HD21 ' HA ' ' A' ' 258' ' ' ILE . 14.4 mt -79.02 158.18 27.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 64.14 110.912 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -104.07 -136.4 8.87 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.706 -0.759 . . . . 62.05 112.487 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 0.0 OUTLIER -125.94 142.16 51.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.849 0.356 . . . . 72.31 110.817 -179.906 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 21.7 m -104.7 162.75 13.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 75.22 110.87 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.0 t -103.86 0.71 30.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 54.44 110.871 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.598 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -66.24 136.98 95.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.618 0.723 . . . . 72.23 110.834 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -0.32 6.76 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.661 2.241 . . . . 72.14 112.322 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.03 17.36 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.42 . . . . 75.41 110.884 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.598 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -86.69 134.18 33.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 73.45 111.133 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.744 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -58.15 -36.2 56.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 74.41 111.129 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.428 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 44.2 mmm -61.56 -21.96 64.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 73.2 110.912 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.543 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.7 t80 -54.9 142.7 54.63 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.613 0.721 . . . . 74.54 110.898 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.543 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.3 Cg_endo -69.73 -1.46 8.49 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.695 2.263 . . . . 71.44 112.345 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 41.8 m -95.32 141.23 29.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 64.41 111.126 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -118.36 140.33 50.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 61.32 110.975 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -157.7 138.05 12.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 62.44 110.858 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.57 ' O ' HG13 ' A' ' 243' ' ' VAL . 77.9 t80 -68.77 145.4 53.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 72.44 110.923 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -162.27 133.22 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 72.43 111.081 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -51.37 130.31 26.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 73.43 110.867 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.49 HD11 ' HD3' ' A' ' 136' ' ' LYS . 16.4 tt -52.26 -30.81 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 74.32 111.139 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.68 -22.57 65.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 75.22 110.94 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 28.0 p -109.49 -20.83 12.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 74.42 111.173 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -69.12 121.28 16.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 72.3 110.905 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -152.98 143.11 22.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.32 110.835 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.844 HD12 HG11 ' A' ' 144' ' ' VAL . 33.2 mt -58.73 123.51 16.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 72.21 110.927 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 10.3 t -64.32 163.24 13.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 74.1 110.835 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.2 -37.95 24.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 33.53 111.101 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -63.81 -45.5 89.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 73.54 110.87 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.424 ' OD2' ' HB ' ' A' ' 235' ' ' VAL . 5.4 m-20 -61.94 -53.66 52.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 71.54 110.902 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.414 ' HA ' HG22 ' A' ' 258' ' ' ILE . 23.1 mt -62.03 -34.95 65.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 45.54 111.112 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -68.36 -40.5 81.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 73.44 110.831 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.06 -51.84 6.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 73.21 112.5 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.704 ' HA ' HD21 ' A' ' 226' ' ' LEU . 5.8 tp -52.51 -35.07 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.775 0.321 . . . . 62.33 111.1 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 263' ' ' GLY . 75.3 mt-30 -87.46 -17.24 32.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 73.14 110.911 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.5 t -69.75 -13.69 62.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 74.2 110.851 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.8 mt -123.55 -18.4 6.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 53.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.838 ' CG ' HD21 ' A' ' 147' ' ' LEU . 39.6 m-85 -114.56 -33.66 5.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 63.32 110.9 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.298 0 CA-C-O 119.123 -0.821 . . . . 71.12 112.505 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 4.5 p80 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.791 0.329 . . . . 65.11 110.848 . . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.413 ' C ' HD12 ' A' ' 114' ' ' ILE . 4.0 m-85 -141.1 106.38 5.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 75.22 110.995 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.675 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.6 mp -139.77 163.76 24.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 74.44 111.204 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.603 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -157.91 163.67 37.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 71.52 111.126 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.61 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.4 p90 -132.67 148.62 52.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.254 -0.43 . . . . 70.42 110.953 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.667 ' HD2' HD11 ' A' ' 160' ' ' LEU . 3.7 tmt_? -142.84 113.33 7.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.515 . . . . 64.14 110.885 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.424 HD12 ' OH ' ' A' ' 121' ' ' TYR . 45.9 mt -74.25 106.54 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 75.14 111.179 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -61.34 -45.26 95.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 75.31 110.914 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.71 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.4 p-10 -144.1 161.92 37.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 73.42 110.931 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.642 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.1 m-85 -117.23 137.74 52.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 71.22 110.907 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.756 HG22 ' HE1' ' A' ' 125' ' ' MET . 9.3 t -88.31 142.51 31.57 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 121.648 0.737 . . . . 75.15 111.111 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 0.86 5.0 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.702 2.268 . . . . 64.42 112.405 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -82.81 -24.55 33.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.257 -0.429 . . . . 71.13 110.875 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.756 ' HE1' HG22 ' A' ' 122' ' ' THR . 5.8 mtm -116.46 165.7 12.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.282 -0.417 . . . . 53.04 110.838 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.474 ' O ' HG23 ' A' ' 130' ' ' VAL . 4.5 m120 -96.01 145.48 25.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 65.24 110.893 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.89 -34.85 4.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 73.13 110.909 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -83.04 -37.71 23.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 55.42 110.902 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -66.57 -29.67 69.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 62.33 110.894 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.662 HG22 ' CE ' ' A' ' 125' ' ' MET . 77.6 t -65.36 -46.75 89.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 65.52 111.154 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.52 -23.85 46.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 65.1 110.893 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -73.55 -46.39 47.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 72.52 110.943 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.697 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -72.66 -32.75 66.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 72.32 111.112 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.59 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -71.62 -53.59 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 75.43 111.155 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.533 ' N ' HG22 ' A' ' 134' ' ' ILE . 4.6 ttt-85 -49.22 -42.53 40.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 73.04 110.868 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.717 ' O ' HG23 ' A' ' 140' ' ' VAL . 9.5 mmtt -71.4 -33.93 69.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 74.12 110.852 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.884 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.54 -49.32 78.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 65.43 111.059 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.61 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.9 m-85 -72.13 -23.11 61.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 73.22 110.917 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -77.05 -6.27 52.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 73.24 110.921 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 136' ' ' LYS . 92.7 t -97.22 -16.26 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 64.34 111.249 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.806 ' NE1' HG12 ' A' ' 217' ' ' VAL . 92.7 m95 -106.32 -33.17 7.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 64.31 110.869 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 142' ' ' SER . . . . . 0.455 ' OG ' ' CD2' ' A' ' 149' ' ' PHE . 6.5 m -70.41 -15.66 62.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 72.33 110.832 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -91.41 -18.69 23.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 75.04 110.827 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.747 HG11 HD12 ' A' ' 250' ' ' LEU . 24.5 m -98.62 1.87 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 74.14 111.164 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 147' ' ' LEU . 15.7 p -154.79 145.16 15.91 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.62 0.724 . . . . 65.05 111.114 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 30.36 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.698 2.266 . . . . 63.14 112.354 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.727 HD21 ' CD1' ' A' ' 262' ' ' TYR . 2.7 mp -91.54 177.28 6.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 74.42 110.877 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.08 123.11 14.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 71.11 110.786 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.675 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.3 m-30 -114.55 140.12 49.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 74.43 110.962 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.0 m -132.78 155.81 48.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 53.31 110.878 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 5.0 tttt -102.72 140.52 36.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.114 -0.494 . . . . 71.23 110.884 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.54 HD11 ' N ' ' A' ' 157' ' ' ALA . 18.5 pt -150.74 139.04 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 74.0 111.095 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.2 m120 . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 75.32 110.928 179.881 . . . . . . . . 0 0 . 1 . 002 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.54 ' N ' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.785 0.326 . . . . 52.34 111.103 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.435 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.4 OUTLIER -85.76 -51.96 6.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 71.24 110.884 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.646 HG12 HG23 ' A' ' 220' ' ' ILE . 2.6 mp -90.45 92.98 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 74.33 111.079 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.667 HD11 ' HD2' ' A' ' 117' ' ' ARG . 6.9 tp -84.3 109.94 18.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.49 . . . . 73.02 110.978 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 92.3 t -87.47 118.57 33.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 73.31 111.16 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.71 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -137.97 106.09 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.269 -0.423 . . . . 65.33 111.135 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.406 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 46.7 m-85 -73.3 110.73 7.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 72.22 110.912 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.537 ' CB ' ' CD2' ' A' ' 168' ' ' HIS . . . -126.58 167.63 15.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 74.33 111.168 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -120.44 132.22 55.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 73.42 110.844 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.668 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.4 -157.44 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.743 -0.741 . . . . 73.41 112.53 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.762 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -51.08 119.04 3.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.773 0.32 . . . . 71.12 111.114 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.554 ' NE2' ' CE1' ' A' ' 172' ' ' HIS . 12.4 p80 -137.98 31.9 2.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.434 . . . . 73.03 110.953 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 79.65 53.38 4.34 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.779 -0.724 . . . . 62.43 112.483 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.478 ' OD2' ' CE1' ' A' ' 196' ' ' HIS . 22.4 t0 -142.85 8.95 1.72 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 74.43 110.965 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 54.52 22.44 3.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.492 . . . . 73.02 110.875 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.554 ' CE1' ' NE2' ' A' ' 168' ' ' HIS . 2.0 p-80 -119.06 -38.92 2.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 64.11 110.873 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.762 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 50.45 99.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 64.34 111.11 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.668 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.4 m-85 -58.22 -171.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 51.11 110.919 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.21 20.64 4.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 71.23 110.856 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.573 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 53.01 -156.38 5.01 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.68 -0.771 . . . . 75.54 112.509 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 176' ' ' GLY . 12.7 tptt -33.34 132.02 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.858 0.361 . . . . 73.4 110.878 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.66 163.81 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.788 -0.72 . . . . 64.22 112.504 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.92 -142.25 19.84 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.739 -0.743 . . . . 50.04 112.503 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.1 mt -49.89 97.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 74.53 111.193 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.456 HD12 HG21 ' A' ' 210' ' ' THR . 2.8 mm? -66.8 -41.27 87.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 71.33 110.887 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 197' ' ' PHE . . . -174.83 158.25 2.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 23.44 111.114 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.45 ' CE1' ' CD2' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -148.96 134.69 18.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 72.43 110.911 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.815 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -131.92 175.53 9.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 75.44 111.079 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' ' 223' ' ' SER . 39.4 m-85 -104.63 -148.71 0.4 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 65.23 110.869 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -164.84 -83.58 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.818 -0.706 . . . . 64.44 112.605 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 51.87 0.95 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.732 2.288 . . . . 75.24 112.321 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.575 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.68 148.92 17.25 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.79 -0.719 . . . . 44.23 112.485 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -105.13 145.27 30.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 35.3 110.878 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.56 -62.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.643 -0.789 . . . . 74.1 112.588 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 189' ' ' SER . 5.8 mm -107.54 8.76 9.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.799 0.333 . . . . 71.12 111.076 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.575 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -70.84 171.26 45.33 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 73.44 112.468 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 45.24 19.67 0.24 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.75 -0.738 . . . . 63.54 112.478 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 192' ' ' GLY . 2.1 m-20 -65.57 108.45 2.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.772 0.32 . . . . 73.22 110.886 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.815 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -84.22 129.24 34.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 53.41 111.108 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.478 ' CE1' ' OD2' ' A' ' 170' ' ' ASP . 1.6 m170 -121.68 123.61 42.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 74.14 110.867 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.55 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 40.3 m-85 -106.3 137.17 44.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.925 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -67.17 105.17 1.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 65.14 110.878 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -55.59 -39.14 70.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 73.54 110.873 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.573 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 15.5 m-20 -47.92 -25.31 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.497 . . . . 74.25 110.832 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -77.21 162.92 27.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 73.54 110.907 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.607 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -101.13 85.32 2.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 74.42 110.811 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.55 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 24.8 m95 -77.61 123.26 26.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.438 . . . . 75.31 110.903 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 204' ' ' THR . . . . . 0.412 HG23 ' HD1' ' A' ' 202' ' ' PHE . 41.0 p -140.21 -173.76 3.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 75.22 111.102 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.83 18.04 18.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.238 -0.437 . . . . 73.22 111.094 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.8 -177.64 4.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 74.04 110.849 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.8 p -66.12 -18.99 65.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 64.42 110.805 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.1 -107.69 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.748 -0.739 . . . . 73.3 112.449 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.13 177.29 0.15 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.727 -0.749 . . . . 53.12 112.523 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.456 HG21 HD12 ' A' ' 181' ' ' LEU . 88.1 m -66.78 97.51 0.47 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.755 0.312 . . . . 65.01 111.17 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -42.11 119.25 1.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 71.13 110.809 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.638 HD23 ' HB3' ' A' ' 133' ' ' ALA . 9.4 tp -65.53 -37.55 87.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 72.53 110.851 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.729 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.7 t80 -51.15 -64.96 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 72.11 110.91 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.533 HD11 ' H ' ' A' ' 243' ' ' VAL . 22.8 mt -53.53 -55.36 26.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.118 -0.492 . . . . 71.11 110.954 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.522 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 1.8 m -55.78 -33.28 64.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 71.15 111.181 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -68.05 -47.98 66.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 64.15 111.092 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.884 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -53.61 -57.93 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 71.25 111.119 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.76 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.7 t-80 -64.66 -28.14 69.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.123 -0.489 . . . . 72.01 110.907 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -63.86 -45.32 89.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 75.24 111.087 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.646 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -68.32 -35.89 72.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 72.04 111.141 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.61 -44.65 47.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.687 -0.768 . . . . 44.32 112.486 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.411 ' O ' ' O ' ' A' ' 185' ' ' PHE . 4.3 m-70 -68.32 -38.06 81.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.706 0.288 . . . . 74.15 110.809 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.606 ' OG ' HG23 ' A' ' 159' ' ' ILE . 7.1 m -64.27 -24.69 67.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 64.52 110.827 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.2 mt -78.07 -27.72 48.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.188 -0.46 . . . . 74.52 110.885 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 121.11 15.47 4.68 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.65 -0.786 . . . . 53.24 112.428 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.755 HD21 ' HA ' ' A' ' 258' ' ' ILE . 12.5 mt -80.31 156.12 26.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.906 0.384 . . . . 73.4 110.846 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -99.25 -141.12 11.9 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.759 -0.734 . . . . 74.1 112.464 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -122.0 139.36 53.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 74.15 110.904 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.4 t -99.21 163.99 12.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.884 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.19 -2.86 17.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 74.11 110.858 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.643 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -61.11 141.45 93.79 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.681 0.753 . . . . 64.5 110.839 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 -3.35 11.83 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.709 2.273 . . . . 63.05 112.342 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -143.47 19.81 1.87 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 74.25 110.827 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.643 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -82.21 139.03 34.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 71.41 111.09 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.76 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -63.03 -37.73 80.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.415 . . . . 73.03 111.055 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 48.5 mmm -66.49 -13.75 61.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 75.44 110.833 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.63 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.5 t80 -58.64 144.4 79.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.736 0.779 . . . . 73.33 110.853 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.63 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.2 Cg_endo -69.75 -3.42 11.97 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.753 2.302 . . . . 74.22 112.314 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.4 ' HG1' ' HD2' ' A' ' 237' ' ' PHE . 16.9 m -95.7 142.42 28.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 62.11 111.148 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -122.92 134.53 54.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 73.5 110.94 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -152.67 129.49 10.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.09 -0.504 . . . . 74.42 110.955 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.496 ' O ' HG13 ' A' ' 243' ' ' VAL . 85.2 t80 -57.13 143.77 37.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.318 -0.401 . . . . 74.33 110.876 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.533 ' H ' HD11 ' A' ' 214' ' ' LEU . 0.9 OUTLIER -158.26 130.34 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 71.5 111.136 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -50.84 132.16 26.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 73.24 110.945 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 14.3 tt -53.98 -29.89 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 53.22 111.081 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.98 -18.76 61.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 70.12 110.973 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 38.4 p -109.33 -21.4 12.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 71.11 111.194 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -71.58 143.1 49.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 75.34 110.917 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -177.19 133.37 0.18 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 63.31 110.834 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.747 HD12 HG11 ' A' ' 144' ' ' VAL . 52.9 mt -48.0 127.15 11.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 74.25 110.915 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.6 m -67.44 163.49 20.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 71.25 110.829 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.89 -35.09 31.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.478 . . . . 53.12 111.144 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.1 -51.58 52.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 74.02 110.886 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -56.39 -50.26 72.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 45.44 110.892 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 21.2 mt -61.4 -39.97 84.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 73.23 111.07 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -65.44 -39.85 92.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.172 -0.467 . . . . 65.14 110.948 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -73.73 -52.66 7.99 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.752 -0.737 . . . . 61.04 112.455 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.755 ' HA ' HD21 ' A' ' 226' ' ' LEU . 3.8 tp -52.54 -34.62 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.783 0.325 . . . . 74.02 111.124 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 263' ' ' GLY . 82.1 mt-30 -86.39 -17.34 34.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 61.25 110.92 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.7 t -69.49 -13.82 62.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.233 -0.44 . . . . 33.13 110.851 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.8 mt -123.16 -18.29 6.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 63.43 110.894 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.727 ' CD1' HD21 ' A' ' 147' ' ' LEU . 36.8 m-85 -114.56 -34.14 5.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.011 0.434 . . . . 74.12 110.965 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.307 0 CA-C-O 119.099 -0.834 . . . . 61.31 112.485 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.401 ' HA ' ' HG ' ' A' ' 147' ' ' LEU . 6.2 p80 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.791 0.329 . . . . 75.02 110.867 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.409 ' C ' HD12 ' A' ' 114' ' ' ILE . 2.1 m-85 -129.48 111.08 12.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 74.13 110.909 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.584 HG22 ' N ' ' A' ' 115' ' ' THR . 4.8 mp -142.33 162.73 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 71.24 111.14 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.584 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -160.43 163.76 32.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 52.52 111.074 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.615 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.5 p90 -131.7 152.28 51.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 74.04 110.953 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.693 ' HD2' HD11 ' A' ' 160' ' ' LEU . 3.9 tmt_? -144.35 109.96 5.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 72.53 110.855 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.7 mt -71.58 105.67 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 63.41 111.114 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -59.57 -45.47 91.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 62.54 110.827 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.729 ' OD1' HG23 ' A' ' 162' ' ' VAL . 1.7 p-10 -146.12 163.35 35.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 72.13 110.878 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.61 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.0 m-85 -116.27 140.98 48.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 65.33 110.873 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.725 HG22 ' CE ' ' A' ' 125' ' ' MET . 2.9 t -90.91 142.67 27.73 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.549 0.69 . . . . 73.23 111.202 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -2.95 11.04 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.692 2.261 . . . . 65.02 112.355 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.422 ' H ' HG23 ' A' ' 122' ' ' THR . 21.9 m-20 -80.4 -23.88 40.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 54.22 110.818 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.725 ' CE ' HG22 ' A' ' 122' ' ' THR . 13.3 mtm -115.61 166.25 12.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 75.35 110.839 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.407 ' O ' HG23 ' A' ' 130' ' ' VAL . 7.1 t-20 -96.57 144.63 26.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 63.21 110.961 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -45.1 -35.73 3.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.178 -0.465 . . . . 74.04 110.905 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -83.23 -38.66 21.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 73.24 110.87 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -65.4 -29.8 70.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 73.32 110.886 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.61 HG11 ' CE2' ' A' ' 121' ' ' TYR . 73.4 t -66.49 -46.35 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 61.23 111.156 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.13 -23.29 47.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 73.34 110.827 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -74.43 -47.2 35.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 71.41 110.917 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.715 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -71.79 -31.51 66.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 71.44 111.124 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.631 HD13 HD21 ' A' ' 212' ' ' LEU . 1.4 mp -73.29 -54.13 16.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.218 -0.446 . . . . 72.11 111.146 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.538 ' N ' HG22 ' A' ' 134' ' ' ILE . 3.3 ttm180 -49.06 -41.92 36.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 71.15 110.832 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.739 ' O ' HG23 ' A' ' 140' ' ' VAL . 7.8 mmpt? -72.43 -34.24 67.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 70.02 110.867 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.9 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.5 -48.83 80.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 64.15 111.168 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.639 ' HE1' HD13 ' A' ' 159' ' ' ILE . 95.4 m-85 -72.77 -22.1 60.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 71.31 110.888 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.64 -5.81 53.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 73.4 110.937 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 136' ' ' LYS . 93.4 t -97.1 -16.87 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 72.14 111.109 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.807 ' NE1' HG12 ' A' ' 217' ' ' VAL . 93.6 m95 -106.48 -35.88 6.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 72.11 110.878 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.62 -11.47 60.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 52.13 110.851 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -95.69 -15.74 22.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.505 . . . . 74.55 111.018 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.686 HG11 HD12 ' A' ' 250' ' ' LEU . 20.9 m -101.51 1.21 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 74.03 111.079 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.693 HG21 HG13 ' A' ' 258' ' ' ILE . 17.1 p -150.31 146.69 20.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.539 0.685 . . . . 63.12 111.149 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 30.53 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.661 2.241 . . . . 64.44 112.314 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.713 HD21 ' CD1' ' A' ' 262' ' ' TYR . 0.8 OUTLIER -93.32 -178.13 4.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 64.34 110.914 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -144.34 126.5 15.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 71.31 110.933 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.501 ' HE1' HD13 ' A' ' 114' ' ' ILE . 4.0 m-30 -114.52 142.15 46.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 74.31 110.906 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.8 m -140.78 137.49 33.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 71.33 110.893 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.9 OUTLIER -85.88 142.62 28.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 64.13 110.941 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.649 HD11 ' N ' ' A' ' 157' ' ' ALA . 18.2 pt -151.07 135.6 9.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 73.51 111.114 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.1 m120 . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 74.01 110.918 179.946 . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.649 ' N ' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.78 0.324 . . . . 71.53 111.121 . . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.6 OUTLIER -83.22 -52.55 6.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 75.04 110.853 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.726 HG12 HG23 ' A' ' 220' ' ' ILE . 1.9 mp -89.53 95.88 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 63.24 111.139 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.693 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.2 tp -86.87 110.08 19.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 62.23 110.857 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.427 HG13 ' CE1' ' A' ' 197' ' ' PHE . 87.8 t -89.83 120.54 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 44.11 111.14 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.729 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.2 p -139.83 104.97 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 72.33 111.138 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -71.87 108.75 5.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 73.41 110.889 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.465 ' CB ' ' CD2' ' A' ' 168' ' ' HIS . . . -129.11 165.71 20.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 74.45 111.121 179.893 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -114.14 138.29 50.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 74.32 110.922 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.67 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.74 -154.26 0.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.651 -0.785 . . . . 74.11 112.496 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.802 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -66.88 116.73 8.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.886 0.374 . . . . 74.22 111.106 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.495 ' NE2' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.88 -22.7 12.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.204 -0.453 . . . . 64.3 110.897 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.47 29.39 0.54 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 71.01 112.498 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.646 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.08 1.43 15.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.389 . . . . 73.3 110.918 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 72.8 40.34 0.6 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.469 . . . . 64.43 110.868 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.579 ' ND1' ' N ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -135.72 -41.65 0.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 74.14 110.888 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.802 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.31 99.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 70.41 111.074 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.67 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.9 m-85 -60.72 -168.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 75.2 110.866 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.74 18.66 3.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 70.04 110.866 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.578 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.2 -157.32 7.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 72.12 112.526 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 176' ' ' GLY . 11.7 tmtt? -35.29 134.52 0.28 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 74.3 110.879 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.35 165.49 0.14 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.594 -0.812 . . . . 74.44 112.496 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.81 -143.23 22.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 73.4 112.47 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -50.13 96.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.375 . . . . 71.02 111.174 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 13.4 mt -66.82 -39.48 87.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 52.34 110.934 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -172.08 167.1 6.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 73.35 111.142 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.561 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.6 p80 -159.67 139.72 11.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.428 . . . . 74.31 110.931 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.761 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -137.64 173.44 11.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 51.13 111.145 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.519 ' O ' ' O ' ' A' ' 222' ' ' HIS . 23.8 m-85 -99.43 -138.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 61.4 110.818 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -166.98 -99.64 0.14 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.792 -0.718 . . . . 60.35 112.578 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 59.54 1.66 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.696 2.264 . . . . 64.54 112.343 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.598 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.06 154.6 16.43 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.748 -0.739 . . . . 70.35 112.435 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.572 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.52 148.63 26.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.919 0.39 . . . . 72.21 110.793 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.68 -67.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.718 -0.753 . . . . 64.31 112.503 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.572 ' N ' ' O ' ' A' ' 189' ' ' SER . 3.6 mt -103.99 6.33 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 74.11 111.144 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.598 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -63.69 165.29 29.2 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.685 -0.769 . . . . 74.22 112.511 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 45.05 20.21 0.23 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.73 -0.748 . . . . 62.14 112.459 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 192' ' ' GLY . 0.8 OUTLIER -64.25 105.77 0.97 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.79 0.329 . . . . 63.2 110.943 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.761 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -82.15 129.62 34.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 64.42 111.158 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.561 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 11.2 m170 -119.93 129.93 54.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 75.14 110.878 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.465 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 47.7 m-85 -114.35 134.22 55.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 75.15 110.909 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -67.25 109.44 3.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 73.32 110.916 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -60.22 -37.19 79.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 73.34 110.861 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.578 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 5.3 m-20 -50.45 -22.89 2.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.233 -0.439 . . . . 73.42 110.885 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -80.17 163.38 24.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 75.21 110.835 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.561 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -101.43 89.1 3.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 74.35 110.843 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.513 ' CZ3' HG21 ' A' ' 215' ' ' THR . 29.5 m95 -80.59 123.26 27.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.177 -0.465 . . . . 60.22 110.952 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.3 p -141.26 -174.83 4.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 70.3 111.183 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.36 20.53 16.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 64.44 111.104 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -127.74 -173.12 2.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 64.34 110.903 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.3 p -72.11 -18.87 61.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 71.41 110.836 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.49 -106.58 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 31.23 112.502 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.05 176.84 0.1 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.694 -0.765 . . . . 71.31 112.528 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 89.8 m -66.74 97.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.741 0.305 . . . . 73.44 111.125 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -42.83 116.93 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 73.52 110.833 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.661 HD23 ' HB3' ' A' ' 133' ' ' ALA . 9.8 tp -63.29 -37.94 89.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.083 -0.508 . . . . 74.52 110.94 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.762 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.6 t80 -51.32 -63.91 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 50.51 110.901 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.566 HD21 ' CG2' ' A' ' 243' ' ' VAL . 8.0 mp -55.51 -54.99 37.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.119 -0.491 . . . . 75.5 110.895 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.513 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.3 m -55.31 -33.95 63.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 73.2 111.139 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -67.69 -48.74 65.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 74.31 111.009 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.9 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -53.43 -58.22 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 71.45 111.067 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.767 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.8 t-80 -64.46 -28.13 69.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 74.11 110.775 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -64.39 -44.07 92.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 73.4 111.104 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.726 HG23 HG12 ' A' ' 159' ' ' ILE . 2.6 mt -70.28 -34.26 57.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 64.44 111.172 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -51.79 -45.11 55.53 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.713 -0.756 . . . . 61.24 112.471 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.519 ' O ' ' O ' ' A' ' 185' ' ' PHE . 4.1 m-70 -68.85 -40.61 79.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.849 0.356 . . . . 73.41 110.89 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.488 ' OG ' HG12 ' A' ' 159' ' ' ILE . 32.5 p -65.7 -20.2 66.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.11 -0.495 . . . . 74.43 110.858 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.422 HD21 HG21 ' A' ' 114' ' ' ILE . 52.8 mt -80.84 -25.77 37.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 33.33 110.897 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 122.2 13.18 4.96 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.729 -0.748 . . . . 70.2 112.441 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.871 HD21 ' HA ' ' A' ' 258' ' ' ILE . 17.6 mt -84.81 155.65 21.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.337 . . . . 61.45 110.973 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -102.95 -138.21 9.86 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.767 -0.73 . . . . 65.31 112.458 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -120.76 138.76 53.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.918 0.39 . . . . 73.25 110.886 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 69.8 p -97.26 166.97 11.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.88 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.18 3.09 19.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 73.54 110.84 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 234' ' ' ALA . 0.4 OUTLIER -72.3 135.74 81.87 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.683 0.754 . . . . 74.33 110.844 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.62 0.25 5.8 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.713 2.275 . . . . 61.13 112.331 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.05 25.42 1.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 71.43 110.908 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 231' ' ' ASP . . . -97.48 143.91 27.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.453 . . . . 63.33 111.082 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.767 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.3 t -63.84 -41.75 93.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 72.45 111.118 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 49.9 mmm -60.33 -17.67 44.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.193 -0.458 . . . . 72.22 110.904 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.615 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.1 t80 -57.79 144.64 73.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.712 0.768 . . . . 75.5 110.78 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.615 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.5 Cg_endo -69.87 -1.23 8.22 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.552 2.168 . . . . 71.51 112.385 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 23.3 m -96.32 140.97 30.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 63.4 111.201 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -122.39 134.48 54.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.185 -0.461 . . . . 72.23 110.978 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -151.99 135.12 15.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 72.13 110.9 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.553 ' O ' HG13 ' A' ' 243' ' ' VAL . 82.1 t80 -64.5 143.52 57.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 74.31 110.889 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.566 ' CG2' HD21 ' A' ' 214' ' ' LEU . 0.2 OUTLIER -161.18 128.92 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 62.12 111.105 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -50.37 134.69 23.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 75.24 110.9 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.508 HD12 ' CE2' ' A' ' 213' ' ' PHE . 8.0 tt -51.31 -33.54 14.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 73.24 111.222 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.54 ' OD1' HG23 ' A' ' 247' ' ' THR . 1.2 p30 -65.73 -23.51 66.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 74.12 110.907 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.54 HG23 ' OD1' ' A' ' 246' ' ' ASN . 10.5 p -107.0 -21.81 12.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 61.15 111.143 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -73.43 134.02 43.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 71.01 110.852 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 24.3 ptt85 -171.23 134.08 0.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 74.23 110.91 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.686 HD12 HG11 ' A' ' 144' ' ' VAL . 54.7 mt -48.06 127.28 12.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 71.24 110.998 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 30.9 t -72.46 164.43 26.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 43.11 110.894 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -47.95 -37.98 15.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 74.43 111.103 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.56 -45.29 91.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 75.55 110.869 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 12.7 m-20 -61.03 -55.35 33.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 70.21 110.889 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.429 ' HA ' HG22 ' A' ' 258' ' ' ILE . 1.3 mp -58.99 -34.55 53.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 71.02 111.153 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 28.7 mmm-85 -68.08 -40.32 82.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 54.53 110.908 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -75.59 -50.62 7.92 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.784 -0.722 . . . . 63.53 112.562 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.871 ' HA ' HD21 ' A' ' 226' ' ' LEU . 5.6 tp -52.38 -34.53 18.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.772 0.32 . . . . 74.43 111.159 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' A' ' 263' ' ' GLY . 57.5 mt-30 -86.73 -16.94 34.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 75.23 110.876 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 3.2 t -69.47 -13.93 62.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 52.24 110.853 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.37 -17.71 6.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 70.43 110.935 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.713 ' CD1' HD21 ' A' ' 147' ' ' LEU . 36.1 m-85 -114.74 -33.28 5.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 74.41 110.859 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.313 0 CA-C-O 119.122 -0.821 . . . . 63.24 112.454 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.4 p80 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.813 0.34 . . . . 60.34 110.829 . . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.453 ' C ' HD12 ' A' ' 114' ' ' ILE . 1.7 m-85 -122.34 113.39 19.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 65.13 110.906 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.577 HG22 ' N ' ' A' ' 115' ' ' THR . 5.0 mp -142.96 162.18 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 64.24 111.141 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.577 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -159.05 164.06 35.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 74.11 111.157 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.645 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.4 p90 -134.23 145.04 48.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 64.21 110.879 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.711 ' HD2' HD11 ' A' ' 160' ' ' LEU . 3.4 tmt_? -137.47 106.9 6.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 71.25 110.83 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 62.0 mt -70.41 104.93 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 71.44 111.16 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -55.56 -50.84 68.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 63.24 110.825 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.651 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.0 p-10 -143.08 166.6 24.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 63.33 110.87 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -116.95 148.89 41.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 64.43 110.959 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.475 HG23 ' HG3' ' A' ' 125' ' ' MET . 3.2 t -93.67 141.58 24.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.595 0.712 . . . . 74.42 111.075 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -3.42 11.99 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.711 2.274 . . . . 52.42 112.296 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.63 -29.91 36.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 75.43 110.93 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.601 ' HE3' HG22 ' A' ' 130' ' ' VAL . 7.3 mtm -107.97 163.73 12.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 73.14 110.848 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.752 ' O ' HG23 ' A' ' 130' ' ' VAL . 2.4 t-20 -94.25 150.3 20.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 75.54 110.866 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.55 -32.93 8.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 74.4 110.826 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -82.01 -40.44 22.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 60.23 110.91 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -65.95 -29.1 69.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 74.13 110.906 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 126' ' ' ASN . 59.9 t -64.34 -45.62 95.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 75.12 111.169 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.12 -24.46 35.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 74.31 110.866 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -72.3 -46.8 54.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 72.14 110.908 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.993 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -71.52 -33.95 69.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 63.42 111.12 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.604 HD13 HD21 ' A' ' 212' ' ' LEU . 1.4 mp -72.46 -55.11 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 73.32 111.126 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.547 ' N ' HG22 ' A' ' 134' ' ' ILE . 5.3 ttm180 -48.58 -45.65 38.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.479 . . . . 63.21 110.874 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.646 ' O ' HG23 ' A' ' 140' ' ' VAL . 12.5 mmtt -68.25 -34.72 76.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 72.44 110.994 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.901 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.69 -48.94 79.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.504 . . . . 41.4 111.116 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.645 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 94.4 m-85 -72.82 -22.28 60.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 62.24 110.921 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.35 -5.93 51.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 74.31 110.969 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 136' ' ' LYS . 98.0 t -97.2 -17.14 6.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 71.33 111.101 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.806 ' NE1' HG12 ' A' ' 217' ' ' VAL . 95.3 m95 -106.05 -35.85 7.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 71.22 110.876 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.39 -11.39 60.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 62.32 110.822 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -95.81 -17.71 20.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 73.33 110.879 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.914 HG11 HD12 ' A' ' 250' ' ' LEU . 19.4 m -99.09 1.77 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 72.14 111.092 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.53 HG21 HG13 ' A' ' 258' ' ' ILE . 22.9 p -152.11 146.3 18.41 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.544 0.688 . . . . 75.32 111.168 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 30.1 0.18 Allowed 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.759 2.306 . . . . 64.31 112.216 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.821 HD21 ' CG ' ' A' ' 262' ' ' TYR . 0.1 OUTLIER -90.0 -176.83 5.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.322 -0.399 . . . . 74.22 110.894 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -145.49 126.12 14.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 73.42 110.876 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.468 ' HE1' HD13 ' A' ' 114' ' ' ILE . 4.1 m-30 -115.35 142.42 46.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 72.03 110.9 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.5 m -141.05 138.78 33.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.483 . . . . 73.44 110.815 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.488 ' HG3' ' N ' ' A' ' 152' ' ' ILE . 2.9 tptm -88.45 142.9 27.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 64.03 110.894 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.555 HD11 ' N ' ' A' ' 157' ' ' ALA . 14.6 pt -150.88 132.27 4.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 52.02 111.138 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 74.41 110.854 -179.975 . . . . . . . . 0 0 . 1 . 004 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.555 ' N ' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.837 0.351 . . . . 61.03 111.023 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -85.34 -53.58 5.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.427 . . . . 73.05 110.797 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.65 HG12 HG23 ' A' ' 220' ' ' ILE . 2.4 mp -89.43 94.88 5.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.157 -0.474 . . . . 72.44 111.109 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.711 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.2 tp -85.79 109.18 18.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 72.23 110.888 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.46 HG13 ' CE1' ' A' ' 197' ' ' PHE . 87.3 t -89.2 124.13 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 54.32 111.15 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.651 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.4 p -143.59 105.73 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 74.43 111.199 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -71.8 109.51 5.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 74.43 110.911 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.479 ' HB3' ' CD2' ' A' ' 168' ' ' HIS . . . -130.38 167.27 18.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 72.01 111.001 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.51 137.29 52.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 73.32 110.933 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.683 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.98 -155.64 0.14 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.773 -0.727 . . . . 75.51 112.454 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.8 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -64.5 115.53 5.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 75.11 111.083 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.49 ' NE2' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.25 -22.19 12.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 74.43 110.895 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.24 29.11 0.56 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.713 -0.756 . . . . 71.34 112.4 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.635 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.94 1.23 15.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.904 0.383 . . . . 54.11 110.864 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 72.8 40.24 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 74.21 110.78 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.574 ' ND1' ' N ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -135.58 -41.17 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 75.12 110.913 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.8 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.08 99.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 52.34 111.075 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.683 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -59.88 -169.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 63.44 110.911 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.96 17.13 4.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 72.44 110.927 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.593 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.4 -156.81 8.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.797 -0.716 . . . . 61.33 112.496 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 176' ' ' GLY . 7.6 tttp -34.98 134.8 0.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.815 0.34 . . . . 41.52 110.926 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.28 163.11 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.711 -0.757 . . . . 65.25 112.448 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.61 -143.6 20.88 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.766 -0.73 . . . . 74.01 112.571 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -49.66 97.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 64.03 111.147 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 76.2 mt -69.53 -36.96 76.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 71.14 111.027 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -174.39 162.4 3.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 75.53 111.081 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.53 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.6 p80 -155.27 140.97 18.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 70.51 110.823 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.75 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -138.85 171.92 13.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 73.43 111.172 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 223' ' ' SER . 17.1 m-85 -100.32 -148.91 0.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.258 -0.428 . . . . 63.34 110.816 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -159.43 -94.76 0.1 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.637 -0.792 . . . . 43.21 112.454 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.68 58.69 1.53 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.733 2.289 . . . . 51.34 112.356 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.611 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.0 153.44 16.97 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.729 -0.748 . . . . 72.01 112.467 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.597 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.5 150.5 24.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.788 0.328 . . . . 51.55 110.927 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 59.45 -67.42 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.743 -0.742 . . . . 64.52 112.423 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.597 ' N ' ' O ' ' A' ' 189' ' ' SER . 26.4 pt -103.66 6.05 10.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.896 0.379 . . . . 45.41 111.202 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.611 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -64.25 165.25 31.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.656 -0.783 . . . . 73.43 112.446 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 46.68 17.05 0.23 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.704 -0.76 . . . . 61.41 112.541 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 192' ' ' GLY . 0.9 OUTLIER -61.82 108.33 0.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.831 0.348 . . . . 70.12 110.83 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.75 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -83.76 130.56 34.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.121 -0.49 . . . . 62.32 111.182 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.53 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 11.1 m170 -121.2 128.93 52.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.297 -0.411 . . . . 74.51 110.86 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.535 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 50.5 m-85 -113.85 131.03 56.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.249 -0.432 . . . . 72.23 110.85 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 198' ' ' ASP . . . . . 0.409 ' HB3' ' HG2' ' A' ' 201' ' ' GLU . 63.4 t0 -65.52 114.46 4.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 71.01 110.945 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -68.06 -33.25 74.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 64.33 110.83 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.593 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 14.5 m-20 -51.07 -21.6 1.96 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.155 -0.475 . . . . 65.53 110.823 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.409 ' HG2' ' HB3' ' A' ' 198' ' ' ASP . 0.6 OUTLIER -86.4 164.99 16.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 60.23 110.882 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.478 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -97.86 98.95 10.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 71.54 110.926 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.535 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 52.5 m95 -86.46 123.86 32.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.203 -0.453 . . . . 73.42 110.895 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 39.9 p -145.57 -177.04 5.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 72.25 111.143 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.34 21.27 16.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 75.32 111.157 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -128.4 -177.48 4.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 75.35 110.837 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 207' ' ' SER . . . . . 0.415 ' HA ' ' CD2' ' A' ' 242' ' ' TYR . 4.0 t -67.14 -18.81 65.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 73.43 110.888 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.21 -106.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.868 -0.682 . . . . 71.24 112.42 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.76 178.18 0.2 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.726 -0.75 . . . . 74.32 112.508 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 99.1 m -66.94 98.09 0.53 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.79 0.329 . . . . 65.25 111.187 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -42.15 116.57 0.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 63.22 110.953 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.993 HD23 ' HB3' ' A' ' 133' ' ' ALA . 8.1 tp -63.49 -38.74 92.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 74.13 110.941 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.734 ' N ' ' HB1' ' A' ' 133' ' ' ALA . 2.9 t80 -51.69 -63.45 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 73.53 110.903 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.559 HD21 ' CG2' ' A' ' 243' ' ' VAL . 7.7 mp -56.34 -54.43 45.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 65.33 110.941 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 219' ' ' ALA . 3.2 m -56.02 -31.0 62.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 53.13 111.107 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 137' ' ' ALA . . . -70.55 -47.42 60.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 75.44 111.093 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.901 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -54.56 -58.87 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 71.31 111.082 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.743 ' HB2' HG13 ' A' ' 235' ' ' VAL . 2.2 t-80 -62.37 -29.94 70.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 73.3 110.888 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.51 -45.52 92.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 74.43 111.129 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.65 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -69.28 -34.94 65.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.428 . . . . 75.01 111.079 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.93 -44.84 41.14 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.81 -0.71 . . . . 61.23 112.487 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.478 ' O ' ' O ' ' A' ' 185' ' ' PHE . 45.8 m-70 -67.32 -40.67 85.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.744 0.307 . . . . 75.23 110.806 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.644 ' OG ' HG23 ' A' ' 159' ' ' ILE . 2.9 m -62.59 -27.33 69.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.242 -0.436 . . . . 64.13 110.853 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 62.4 mt -74.57 -28.45 60.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 75.1 110.907 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 121.11 15.17 4.78 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.75 -0.738 . . . . 63.31 112.455 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.677 HD21 ' HA ' ' A' ' 258' ' ' ILE . 11.6 mt -83.01 156.03 23.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.338 . . . . 75.31 110.887 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.439 ' O ' ' HE2' ' A' ' 236' ' ' MET . . . -102.5 -133.29 7.98 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.694 -0.765 . . . . 55.04 112.52 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.451 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 0.0 OUTLIER -125.7 142.95 51.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 61.3 110.882 -179.936 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 38.1 m -104.19 166.06 10.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 52.41 110.91 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 42.8 m -108.51 1.87 21.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 75.52 110.908 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.615 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -66.31 140.38 96.74 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.592 0.711 . . . . 75.24 110.824 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.7 -3.35 11.79 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.758 2.305 . . . . 64.14 112.35 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.45 24.89 1.55 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 75.35 110.882 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.615 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -88.85 140.39 29.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 71.53 111.141 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.743 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.8 t -63.43 -38.06 81.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 62.43 111.183 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.458 ' HE3' ' HA ' ' A' ' 236' ' ' MET . 32.1 mmm -66.05 -14.06 61.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 74.41 110.873 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.606 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.5 t80 -57.91 143.62 76.84 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.635 0.731 . . . . 74.31 110.866 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.606 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.4 Cg_endo -69.77 -1.62 8.8 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.674 2.249 . . . . 75.42 112.34 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.401 ' HG1' ' HD2' ' A' ' 237' ' ' PHE . 6.6 m -100.41 139.66 35.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 75.52 111.073 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -118.75 128.66 54.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 73.35 110.876 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.22 126.27 12.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.043 -0.526 . . . . 71.42 110.803 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.55 ' O ' HG13 ' A' ' 243' ' ' VAL . 35.9 t80 -57.18 147.39 25.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.147 -0.479 . . . . 75.13 110.897 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.559 ' CG2' HD21 ' A' ' 214' ' ' LEU . 0.6 OUTLIER -160.07 132.93 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.514 . . . . 64.44 111.091 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 244' ' ' ASP . . . . . 0.516 ' CG ' HD22 ' A' ' 246' ' ' ASN . 13.2 t0 -46.77 133.59 10.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 61.12 110.854 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.424 HD12 ' CE2' ' A' ' 213' ' ' PHE . 5.9 tt -53.32 -34.35 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 75.44 111.181 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.516 HD22 ' CG ' ' A' ' 244' ' ' ASP . 5.0 p30 -72.15 -17.05 61.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 72.51 110.867 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.453 HG23 ' OD1' ' A' ' 246' ' ' ASN . 24.6 p -107.61 -21.91 12.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 73.45 111.182 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -72.36 137.82 46.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 73.25 110.829 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -174.48 136.8 0.47 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.147 -0.479 . . . . 72.12 110.882 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.914 HD12 HG11 ' A' ' 144' ' ' VAL . 29.2 mt -49.78 129.33 19.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 65.11 110.921 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 32.5 t -71.3 171.0 11.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 63.43 110.849 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.16 -37.11 69.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.489 . . . . 71.44 111.186 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -65.3 -47.49 76.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.856 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.6 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 4.8 m-20 -61.99 -52.04 65.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.194 -0.457 . . . . 74.24 110.825 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 30.0 mt -61.36 -35.47 66.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 71.53 111.107 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -69.68 -39.42 77.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 73.55 110.892 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.48 -50.1 7.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.791 -0.719 . . . . 43.32 112.459 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.677 ' HA ' HD21 ' A' ' 226' ' ' LEU . 7.0 tp -52.07 -35.25 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.703 0.287 . . . . 62.21 111.115 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 263' ' ' GLY . 72.1 mt-30 -87.32 -16.68 34.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 74.23 110.897 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.9 t -70.85 -14.54 62.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 72.21 110.896 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 5.3 mt -121.95 -18.92 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 71.44 110.868 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.821 ' CG ' HD21 ' A' ' 147' ' ' LEU . 33.6 m-85 -113.12 -34.37 5.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.248 -0.433 . . . . 74.3 110.951 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.335 0 CA-C-O 119.097 -0.835 . . . . 44.24 112.545 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 9.1 p80 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.839 0.352 . . . . 74.12 110.868 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -134.2 106.71 7.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 73.25 110.939 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.585 HG22 ' N ' ' A' ' 115' ' ' THR . 4.7 mp -138.13 162.71 30.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.478 . . . . 62.54 111.179 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.59 ' O ' HD12 ' A' ' 159' ' ' ILE . 0.5 OUTLIER -158.65 163.8 36.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 64.44 111.113 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.598 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.0 p90 -132.73 149.02 52.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 74.43 110.928 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.458 ' HD2' HD11 ' A' ' 160' ' ' LEU . 4.2 tmt_? -143.93 112.4 6.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.083 -0.508 . . . . 70.34 110.862 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.0 mt -72.79 106.64 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 65.55 111.151 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.17 -46.38 89.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 75.13 110.949 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.738 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.0 p-10 -146.46 166.08 27.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 71.32 110.892 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.708 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.1 m-85 -117.47 139.33 51.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 73.15 110.87 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.49 HG22 ' HB2' ' A' ' 124' ' ' ASP . 1.0 OUTLIER -91.22 139.31 25.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.549 0.69 . . . . 71.05 111.183 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.404 ' HD2' HG23 ' A' ' 122' ' ' THR . 54.2 Cg_endo -69.75 42.16 0.34 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.742 2.295 . . . . 51.3 112.353 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.49 ' HB2' HG22 ' A' ' 122' ' ' THR . 2.3 m-20 -126.85 -25.61 3.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 53.23 110.764 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.491 ' CE ' HG22 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -110.69 165.22 12.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.328 -0.396 . . . . 61.35 110.861 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -94.45 142.2 27.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 72.43 110.882 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -44.22 -36.38 2.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 73.1 110.892 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -83.85 -39.18 20.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 61.12 110.91 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -63.52 -33.25 75.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.495 . . . . 30.01 110.888 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.708 HG11 ' CE2' ' A' ' 121' ' ' TYR . 73.8 t -63.38 -46.58 95.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.214 -0.448 . . . . 70.11 111.16 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -78.71 -23.62 45.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 63.01 110.814 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -75.53 -49.42 18.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 75.23 110.909 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.71 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -68.57 -30.48 69.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.502 . . . . 61.04 111.124 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.2 mp -74.15 -54.65 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 71.53 111.175 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.526 ' N ' HG22 ' A' ' 134' ' ' ILE . 3.3 ptm180 -49.08 -37.39 21.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.264 -0.425 . . . . 73.14 110.93 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.63 ' O ' HG23 ' A' ' 140' ' ' VAL . 7.2 mmpt? -75.48 -36.02 60.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 73.51 110.942 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.686 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -59.87 -49.53 77.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 74.43 111.091 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.626 ' HE2' HD13 ' A' ' 159' ' ' ILE . 92.1 m-85 -70.71 -22.7 62.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 74.32 110.935 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.415 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 2.9 tt0 -77.4 -7.09 55.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 65.11 110.867 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 136' ' ' LYS . 89.6 t -95.75 -17.28 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 43.45 111.138 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.85 ' NE1' HG12 ' A' ' 217' ' ' VAL . 95.9 m95 -106.11 -36.12 7.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 73.21 110.958 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -11.37 60.87 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.258 -0.428 . . . . 64.32 110.867 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 139' ' ' GLN . 2.5 m120 -95.3 -17.68 21.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 72.2 110.906 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.816 HG11 HD12 ' A' ' 250' ' ' LEU . 18.2 m -99.38 1.77 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 72.23 111.112 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.653 HG21 HG13 ' A' ' 258' ' ' ILE . 22.8 p -152.48 146.56 18.42 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.576 0.703 . . . . 61.02 111.103 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 29.72 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.788 2.325 . . . . 64.14 112.297 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.728 HD21 ' CG ' ' A' ' 262' ' ' TYR . 0.7 OUTLIER -91.15 179.22 5.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 65.11 110.924 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -141.53 126.17 17.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.43 110.894 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.575 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.7 m-30 -115.41 143.72 44.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 52.51 110.911 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.9 t -140.23 151.78 45.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 71.12 110.833 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 10.2 tttp -101.59 145.21 29.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 74.32 110.804 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.518 HD11 ' HB2' ' A' ' 157' ' ' ALA . 21.6 pt -151.74 143.54 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 61.52 111.038 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 73.22 110.831 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.518 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.789 0.328 . . . . 70.14 111.109 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.5 OUTLIER -85.82 -52.31 5.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 75.31 110.811 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.783 HG12 HG23 ' A' ' 220' ' ' ILE . 1.9 mp -89.7 94.9 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 63.41 111.1 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.458 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.4 tp -87.17 109.28 19.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 75.24 110.849 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.406 HG13 ' CE1' ' A' ' 197' ' ' PHE . 83.9 t -87.33 120.48 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 63.33 111.157 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.738 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.2 p -139.52 106.51 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 73.43 111.168 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.42 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 41.6 m-85 -74.1 112.32 10.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 73.41 110.952 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.497 ' HB3' ' CD2' ' A' ' 168' ' ' HIS . . . -131.79 168.4 17.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.151 -0.477 . . . . 72.11 111.084 179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.427 ' CG ' ' HB3' ' A' ' 199' ' ' GLU . 37.8 mtp180 -113.07 137.6 51.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 73.24 110.843 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.663 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 41.18 -151.99 0.13 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.841 -0.695 . . . . 74.21 112.486 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.804 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -66.41 117.3 8.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.875 0.369 . . . . 64.11 111.061 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.511 ' NE2' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -109.27 -20.22 13.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 73.23 110.9 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 129.85 30.03 0.66 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.771 -0.728 . . . . 74.43 112.478 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.635 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.72 0.21 14.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 71.23 110.826 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 74.25 38.73 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 71.33 110.872 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.571 ' ND1' ' N ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -134.3 -41.2 0.81 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 54.35 110.806 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.804 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.36 99.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 65.33 111.074 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.663 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.7 m-85 -60.23 -168.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 53.02 110.8 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.89 19.6 3.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.093 -0.503 . . . . 64.13 110.898 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.574 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 53.25 -157.8 4.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.773 -0.727 . . . . 32.21 112.461 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.2 OUTLIER -33.82 134.27 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 73.13 110.926 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.32 165.66 0.15 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.677 -0.773 . . . . 44.02 112.508 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.3 -144.06 23.26 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.714 -0.755 . . . . 42.43 112.537 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -49.44 97.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 60.44 111.177 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.79 -41.28 87.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.097 -0.501 . . . . 73.4 110.938 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -170.96 169.16 6.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 74.41 111.123 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.476 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.2 p80 -163.75 143.48 8.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.254 -0.43 . . . . 74.15 110.824 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.745 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -138.09 173.23 11.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 73.13 111.069 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' ' 223' ' ' SER . 54.0 m-85 -98.82 -140.88 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 62.41 110.831 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -171.56 -87.57 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.748 -0.739 . . . . 71.11 112.493 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 54.21 1.12 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.648 2.232 . . . . 65.3 112.357 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.579 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.16 149.56 16.83 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 33.41 112.452 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.64 145.72 29.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.988 0.423 . . . . 74.05 110.804 -179.766 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.64 -63.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.799 -0.715 . . . . 53.11 112.479 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.524 ' N ' ' O ' ' A' ' 189' ' ' SER . 5.5 tp -105.29 6.54 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 73.3 111.14 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.579 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -67.82 169.78 37.7 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.803 -0.713 . . . . 61.3 112.442 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 45.32 18.9 0.2 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 51.32 112.561 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 192' ' ' GLY . 0.9 OUTLIER -63.15 103.41 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 50.32 110.913 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.745 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -77.76 131.15 37.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.223 -0.444 . . . . 63.31 111.067 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.476 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.7 m170 -121.37 130.23 53.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.45 . . . . 73.3 110.856 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.483 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 41.8 m-85 -115.13 134.22 55.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 63.51 110.88 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -67.52 104.69 1.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 55.33 110.886 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.427 ' HB3' ' CG ' ' A' ' 165' ' ' ARG . 4.2 tm-20 -57.24 -36.7 71.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 72.21 110.875 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.574 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 14.3 m-20 -50.41 -22.18 1.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 73.31 110.839 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -82.12 164.21 21.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 74.15 110.816 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.544 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -100.73 91.77 4.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 75.34 110.892 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.549 ' CZ3' HG21 ' A' ' 215' ' ' THR . 33.1 m95 -82.64 123.54 29.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.155 -0.475 . . . . 73.55 110.887 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.7 p -140.3 -172.4 3.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 63.4 111.164 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.6 17.34 17.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 71.5 111.098 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.26 -176.59 3.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 74.51 110.782 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.2 p -66.06 -18.54 65.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 72.43 110.951 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.91 -108.85 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.799 -0.715 . . . . 44.15 112.496 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.38 178.26 0.15 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.76 -0.733 . . . . 63.45 112.495 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 90.0 m -66.52 97.69 0.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.83 0.347 . . . . 72.11 111.185 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -41.65 116.83 0.83 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.446 . . . . 70.04 110.908 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 130' ' ' VAL . 17.4 tp -63.88 -36.01 82.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 62.11 110.894 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.71 ' CA ' ' HB1' ' A' ' 133' ' ' ALA . 2.4 t80 -53.68 -64.27 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 71.15 110.855 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.549 HD11 ' H ' ' A' ' 243' ' ' VAL . 19.3 mt -54.81 -54.32 43.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 52.42 110.913 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.549 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.5 m -54.53 -34.64 62.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 72.11 111.212 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.409 ' HB3' ' HB2' ' A' ' 137' ' ' ALA . . . -65.77 -48.98 70.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 71.3 111.159 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.85 HG12 ' NE1' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -52.5 -58.89 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 53.51 111.127 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.736 ' HB2' HG13 ' A' ' 235' ' ' VAL . 3.4 t-80 -63.29 -29.38 70.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 70.31 110.932 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -63.84 -44.5 92.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 71.43 111.111 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.783 HG23 HG12 ' A' ' 159' ' ' ILE . 2.4 mt -71.03 -34.23 54.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 64.45 111.108 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -52.63 -44.81 60.16 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.76 -0.734 . . . . 71.5 112.392 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.508 ' O ' ' O ' ' A' ' 185' ' ' PHE . 3.4 m-70 -69.46 -40.85 76.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 74.24 110.913 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 43.9 p -64.38 -20.55 66.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 64.23 110.842 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.401 HD21 HG21 ' A' ' 114' ' ' ILE . 61.3 mt -81.74 -26.03 34.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 62.14 110.886 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 121.97 10.49 6.27 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.784 -0.722 . . . . 64.43 112.454 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.89 HD21 ' HA ' ' A' ' 258' ' ' ILE . 46.0 mt -79.77 149.41 31.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.865 0.364 . . . . 75.33 110.935 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -95.35 -141.35 11.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.737 -0.745 . . . . 62.43 112.558 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.423 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 0.2 OUTLIER -119.08 142.6 47.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.801 0.334 . . . . 74.54 110.86 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 49.3 m -103.5 163.65 12.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 74.43 110.913 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.4 t -108.51 0.74 21.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.489 . . . . 65.31 110.891 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.61 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -65.14 141.57 98.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.601 0.715 . . . . 71.24 110.883 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 -3.84 12.88 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.695 2.263 . . . . 41.43 112.352 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -144.27 25.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 63.44 110.806 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.61 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -89.28 139.21 30.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 71.21 111.025 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.736 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.7 t -62.42 -37.92 79.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 74.34 111.126 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.423 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 37.1 mmm -65.79 -14.41 61.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 65.14 110.899 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.617 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.4 t80 -58.69 143.93 81.19 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.61 0.719 . . . . 71.55 110.91 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.617 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.1 Cg_endo -69.71 -0.99 7.67 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.689 2.259 . . . . 64.03 112.405 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.411 ' HG1' ' HD2' ' A' ' 237' ' ' PHE . 17.0 m -98.52 139.65 33.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.127 -0.488 . . . . 65.44 111.249 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -122.1 133.34 54.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 71.41 110.96 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -151.87 134.43 15.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 62.22 110.927 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.542 ' O ' HG13 ' A' ' 243' ' ' VAL . 83.2 t80 -59.62 144.8 46.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.45 . . . . 74.34 110.947 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.549 ' H ' HD11 ' A' ' 214' ' ' LEU . 0.4 OUTLIER -160.33 131.66 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 54.31 111.114 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -53.95 134.8 43.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 50.13 110.912 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.458 HD12 ' CE2' ' A' ' 213' ' ' PHE . 7.2 tt -54.2 -29.74 19.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 62.0 111.104 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.96 -19.47 62.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 74.34 110.933 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.9 p -111.21 -20.28 12.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 75.34 111.145 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.425 ' CD2' HD22 ' A' ' 214' ' ' LEU . 10.2 t80 -74.44 133.91 42.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 74.41 110.88 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.1 136.13 1.42 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 73.31 110.931 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.816 HD12 HG11 ' A' ' 144' ' ' VAL . 36.5 mt -48.65 127.38 13.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 65.41 110.927 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.6 p -69.77 164.6 23.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 74.13 110.866 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.14 -34.77 32.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 74.25 111.093 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.52 -48.02 68.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 73.04 110.864 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.496 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 8.9 m-20 -61.27 -50.87 71.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 73.32 110.878 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 31.5 mt -61.83 -35.1 65.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 74.43 111.155 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -69.5 -39.23 77.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 63.15 110.908 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.32 -50.27 8.51 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.737 -0.744 . . . . 71.01 112.536 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.89 ' HA ' HD21 ' A' ' 226' ' ' LEU . 5.6 tp -52.56 -35.29 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.812 0.339 . . . . 74.35 111.091 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 263' ' ' GLY . 74.7 mt-30 -86.77 -16.45 36.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 74.41 110.882 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.0 t -70.31 -13.77 62.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 65.01 110.845 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.1 mt -123.59 -18.06 6.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 73.14 110.961 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.728 ' CG ' HD21 ' A' ' 147' ' ' LEU . 37.3 m-85 -115.31 -33.56 5.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 74.53 110.861 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.453 -0.227 0 CA-C-O 119.13 -0.817 . . . . 71.23 112.419 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.567 ' HA ' HD22 ' A' ' 147' ' ' LEU . 12.2 p80 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.836 0.35 . . . . 61.44 110.892 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -121.62 101.18 7.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.458 . . . . 65.32 110.87 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.579 HG22 ' N ' ' A' ' 115' ' ' THR . 5.1 mp -126.77 162.25 31.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 53.24 111.156 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.579 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -155.9 166.91 32.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 61.54 111.188 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.634 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.5 p90 -137.16 146.27 44.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 72.2 110.909 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.547 ' NE ' HD11 ' A' ' 160' ' ' LEU . 3.7 tmm_? -139.2 112.46 8.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 55.1 110.945 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.1 mt -74.08 105.7 3.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.202 -0.454 . . . . 74.45 111.108 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -57.75 -47.57 82.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 72.01 110.919 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.758 ' OD1' HG23 ' A' ' 162' ' ' VAL . 1.4 p-10 -144.82 163.81 32.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.116 -0.493 . . . . 74.15 110.914 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.66 ' CE2' HG11 ' A' ' 130' ' ' VAL . 4.4 m-85 -116.01 139.63 50.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 55.34 110.902 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.732 HG22 ' CE ' ' A' ' 125' ' ' MET . 2.5 t -89.95 142.62 29.04 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.608 0.718 . . . . 72.33 111.138 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -3.99 13.16 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.638 2.225 . . . . 52.04 112.344 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.422 ' H ' HG23 ' A' ' 122' ' ' THR . 21.8 m-20 -79.28 -23.28 43.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 75.33 110.901 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.732 ' CE ' HG22 ' A' ' 122' ' ' THR . 12.9 mtm -115.99 166.15 12.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 63.04 110.878 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -97.23 145.03 26.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 74.04 110.836 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -45.58 -35.39 3.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 65.44 110.864 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -82.47 -38.84 23.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 43.14 110.891 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -65.31 -29.44 70.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 61.21 110.903 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.66 HG11 ' CE2' ' A' ' 121' ' ' TYR . 65.4 t -66.04 -45.34 90.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 73.34 111.153 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.69 -23.29 42.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 73.21 110.842 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -74.55 -46.81 36.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.447 . . . . 73.42 110.958 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.737 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -72.34 -31.12 65.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.099 -0.501 . . . . 70.24 111.118 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.541 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -72.71 -54.97 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 72.21 111.172 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.541 ' N ' HG22 ' A' ' 134' ' ' ILE . 5.3 ttt180 -48.66 -43.2 36.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 41.42 110.868 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.657 ' O ' HG23 ' A' ' 140' ' ' VAL . 6.9 mmpt? -70.64 -34.57 72.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 74.35 110.991 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.943 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.41 -49.24 78.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 65.44 111.103 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.634 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.9 m-85 -72.29 -22.82 61.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 74.45 110.884 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -76.87 -5.57 48.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 65.15 110.937 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 136' ' ' LYS . 85.9 t -98.83 -16.82 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 71.31 111.19 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.796 ' NE1' HG12 ' A' ' 217' ' ' VAL . 94.9 m95 -107.37 -37.16 6.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.174 -0.466 . . . . 74.22 110.9 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.67 -11.92 60.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 73.23 110.775 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -95.21 -16.3 22.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 72.42 110.974 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.709 HG11 HD12 ' A' ' 250' ' ' LEU . 19.5 m -98.8 0.67 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 74.03 111.182 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.604 HG21 HG13 ' A' ' 258' ' ' ILE . 62.6 p -150.19 149.14 26.34 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.637 0.732 . . . . 72.54 111.204 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 32.84 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.675 2.25 . . . . 61.32 112.357 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.807 HD11 ' CD2' ' A' ' 262' ' ' TYR . 13.8 mt -97.98 177.62 5.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 74.42 110.884 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.42 126.18 18.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 70.34 110.862 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.569 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.6 m-30 -114.44 143.78 44.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.425 . . . . 74.01 110.878 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.38 152.51 49.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.483 . . . . 62.4 110.856 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.487 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.3 OUTLIER -100.08 148.27 24.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.489 . . . . 73.41 110.879 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.492 HD11 ' HB2' ' A' ' 157' ' ' ALA . 3.9 pt -152.12 168.87 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.146 -0.479 . . . . 62.5 111.07 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 75.14 110.892 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.492 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.787 0.327 . . . . 32.43 111.131 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.412 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.8 OUTLIER -85.8 -53.36 5.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 65.5 110.864 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.658 HG12 HG23 ' A' ' 220' ' ' ILE . 2.6 mp -90.51 96.22 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.228 -0.442 . . . . 74.05 111.075 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.547 HD11 ' NE ' ' A' ' 117' ' ' ARG . 8.0 tp -87.03 109.57 19.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 60.45 110.861 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.409 HG13 ' CE1' ' A' ' 197' ' ' PHE . 93.9 t -89.09 120.07 37.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 75.32 111.145 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.758 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.4 p -139.76 105.21 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 72.43 111.066 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -72.69 108.22 5.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 74.03 110.886 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.49 ' HB3' ' CD2' ' A' ' 168' ' ' HIS . . . -129.05 166.08 19.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 72.14 111.207 179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.99 137.98 50.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.262 -0.426 . . . . 73.3 110.893 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.677 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.09 -156.03 0.14 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.721 -0.752 . . . . 73.25 112.453 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.798 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -64.58 116.55 6.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.769 0.319 . . . . 64.34 111.101 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.503 ' NE2' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.13 -21.48 12.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 74.04 110.849 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.32 29.38 0.6 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.683 -0.77 . . . . 61.0 112.507 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.647 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.33 1.36 15.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 64.43 110.945 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 72.63 40.22 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 73.21 110.956 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.581 ' ND1' ' N ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -135.51 -41.64 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 71.54 110.819 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.798 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.52 100.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 52.24 111.079 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.677 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.9 m-85 -60.87 -168.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 63.23 110.865 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.87 19.43 3.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 51.21 110.918 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.581 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.43 -156.63 8.93 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.783 -0.722 . . . . 53.12 112.475 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -37.67 136.54 0.52 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.855 0.359 . . . . 64.13 110.864 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.97 163.98 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 72.45 112.48 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.411 ' O ' HD22 ' A' ' 181' ' ' LEU . . . 82.92 -142.28 21.46 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.813 -0.708 . . . . 63.42 112.479 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.56 95.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 63.32 111.104 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 181' ' ' LEU . 2.9 mm? -65.86 -43.56 88.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 74.53 110.904 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -169.99 162.62 9.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 33.41 111.063 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.533 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.5 p80 -154.37 140.9 18.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.235 -0.439 . . . . 72.33 110.81 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.757 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -138.46 172.92 12.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.174 -0.466 . . . . 71.13 111.133 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 223' ' ' SER . 13.0 m-85 -101.53 -148.46 0.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 64.04 110.891 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -159.0 -96.31 0.11 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.789 -0.719 . . . . 52.23 112.531 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 59.31 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.799 2.333 . . . . 72.14 112.301 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.605 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.98 153.51 16.78 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.772 -0.728 . . . . 53.54 112.531 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.575 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.18 148.39 26.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.887 0.375 . . . . 35.01 110.862 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.55 -66.94 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.746 -0.74 . . . . 24.13 112.416 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 189' ' ' SER . 1.1 mp -103.58 6.08 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.807 0.337 . . . . 44.52 111.135 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.605 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -63.93 165.29 30.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.697 -0.763 . . . . 63.33 112.481 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 45.51 19.07 0.24 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.789 -0.719 . . . . 71.31 112.473 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.413 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 0.8 OUTLIER -63.67 107.65 1.22 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.88 0.371 . . . . 72.43 110.795 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.757 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -82.71 128.95 34.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 70.34 111.089 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.533 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 9.2 m170 -120.04 130.16 54.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 74.25 110.886 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.509 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 44.2 m-85 -115.29 133.72 55.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 74.33 110.849 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -66.92 110.15 3.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 73.23 110.857 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.25 -37.67 81.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 62.12 110.878 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.581 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 5.5 m-20 -50.62 -21.48 1.59 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 74.4 110.807 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.41 ' HG3' HD13 ' A' ' 181' ' ' LEU . 6.3 mm-40 -81.52 162.47 23.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.308 -0.406 . . . . 71.4 110.879 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.547 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.4 OUTLIER -100.54 90.0 4.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 70.43 110.85 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.521 ' HZ3' HG21 ' A' ' 215' ' ' THR . 27.0 m95 -81.6 121.72 26.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 74.54 110.951 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 40.6 p -140.21 -175.72 4.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.434 . . . . 73.33 111.112 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.93 20.79 17.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.455 . . . . 72.32 111.201 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -127.91 -176.45 3.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 75.24 110.766 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.2 p -68.96 -19.18 64.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 63.3 110.882 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.48 -107.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 72.24 112.39 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -51.9 175.89 0.12 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.718 -0.753 . . . . 54.22 112.432 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 43.7 m -64.3 98.81 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.786 0.327 . . . . 72.04 111.173 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -44.96 115.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 50.31 110.834 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.654 HD23 ' HB3' ' A' ' 133' ' ' ALA . 12.5 tp -60.33 -39.12 85.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 71.12 110.834 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.772 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.4 t80 -51.67 -63.66 1.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 72.41 110.935 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.548 HD21 ' CG2' ' A' ' 243' ' ' VAL . 8.6 mp -54.43 -55.46 28.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 63.42 110.929 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.521 HG21 ' HZ3' ' A' ' 203' ' ' TRP . 1.3 m -54.81 -36.15 64.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 73.51 111.197 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.32 -48.55 72.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 35.24 111.152 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.943 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.1 t -53.8 -57.93 4.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.166 -0.47 . . . . 64.44 111.201 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.75 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.8 t-80 -64.48 -28.16 69.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 73.02 110.847 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -64.68 -45.42 86.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 64.43 111.071 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.658 HG23 HG12 ' A' ' 159' ' ' ILE . 2.4 mt -69.5 -35.78 68.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 72.34 111.094 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.67 -44.74 38.66 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.848 -0.692 . . . . 65.43 112.402 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.461 ' O ' ' O ' ' A' ' 185' ' ' PHE . 3.8 m-70 -68.85 -39.37 79.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 75.33 110.851 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.572 ' OG ' HG23 ' A' ' 159' ' ' ILE . 5.0 m -63.05 -25.61 68.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 55.22 110.814 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 40.3 mt -77.29 -26.1 51.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 73.44 110.912 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 122.21 15.23 4.26 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.773 -0.727 . . . . 60.13 112.466 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.877 HD21 ' HA ' ' A' ' 258' ' ' ILE . 40.4 mt -82.18 155.66 24.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.779 0.324 . . . . 71.31 110.944 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -104.89 -140.68 10.48 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.699 -0.762 . . . . 70.34 112.473 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.97 149.45 42.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.754 0.311 . . . . 74.41 110.87 -179.966 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.535 ' N ' ' HB3' ' A' ' 236' ' ' MET . 43.8 m -116.66 164.14 15.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 61.43 110.781 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.26 4.38 33.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.038 -0.528 . . . . 74.31 110.881 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.536 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.3 OUTLIER -69.68 135.77 88.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.49 0.662 . . . . 75.1 110.978 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.57 -1.34 8.15 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.759 2.306 . . . . 70.41 112.356 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.8 23.95 1.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 72.24 110.89 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.536 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -99.19 130.36 45.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 52.12 111.098 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.75 HG13 ' HB2' ' A' ' 218' ' ' HIS . 2.0 t -54.59 -31.49 23.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 74.21 111.164 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.535 ' HB3' ' N ' ' A' ' 229' ' ' SER . 0.0 OUTLIER -65.61 -14.24 60.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 64.14 110.883 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.582 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.4 t80 -64.06 143.06 98.27 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.623 0.725 . . . . 75.33 110.866 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.582 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.7 Cg_endo -69.77 -7.53 21.3 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.688 2.259 . . . . 64.23 112.381 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.1 m -92.87 149.81 21.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 55.42 111.048 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -125.82 137.39 53.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 62.23 110.905 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -152.63 128.94 10.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 71.53 110.877 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.547 ' O ' HG13 ' A' ' 243' ' ' VAL . 80.1 t80 -58.4 145.82 37.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 70.03 110.926 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.548 ' CG2' HD21 ' A' ' 214' ' ' LEU . 0.4 OUTLIER -160.35 132.21 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 71.13 111.082 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 244' ' ' ASP . . . . . 0.505 ' CG ' HD22 ' A' ' 246' ' ' ASN . 14.6 t0 -46.86 135.2 9.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 71.11 110.892 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.648 HD11 ' HD3' ' A' ' 136' ' ' LYS . 7.3 tt -53.97 -33.49 24.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.479 . . . . 72.42 111.154 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.505 HD22 ' CG ' ' A' ' 244' ' ' ASP . 5.4 p30 -73.49 -17.19 61.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 73.21 110.905 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.447 HG23 ' OD1' ' A' ' 246' ' ' ASN . 24.5 p -106.01 -23.2 12.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 51.21 111.185 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -73.06 130.59 40.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 73.15 110.881 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -166.37 136.6 3.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 74.23 110.84 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.709 HD12 HG11 ' A' ' 144' ' ' VAL . 50.8 mt -50.41 124.91 11.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 74.34 110.99 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.73 170.37 12.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 45.12 110.858 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.85 -40.96 61.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 62.03 111.075 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.31 -47.6 85.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.29 -0.414 . . . . 65.11 110.844 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 31.0 m-20 -61.3 -54.76 39.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 72.23 110.846 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.406 ' HA ' HG22 ' A' ' 258' ' ' ILE . 22.7 mt -60.73 -32.84 52.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 73.54 111.123 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -68.97 -41.31 78.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 75.21 110.845 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.5 -49.66 8.96 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.744 -0.741 . . . . 62.54 112.418 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.877 ' HA ' HD21 ' A' ' 226' ' ' LEU . 8.3 tp -53.34 -34.34 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.359 . . . . 75.41 111.107 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.42 ' O ' ' N ' ' A' ' 263' ' ' GLY . 49.2 mt-30 -87.67 -16.25 34.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.464 . . . . 74.14 110.919 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.4 t -69.63 -14.73 62.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 74.54 110.83 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.22 -18.68 6.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 72.3 110.879 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.807 ' CD2' HD11 ' A' ' 147' ' ' LEU . 40.6 m-85 -114.22 -33.06 5.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 74.12 110.942 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.347 0 CA-C-O 119.085 -0.842 . . . . 72.23 112.552 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.441 ' HA ' ' HG ' ' A' ' 147' ' ' LEU . 1.7 p80 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.739 0.304 . . . . 65.44 110.891 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -136.47 108.38 7.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 74.23 110.955 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.569 HG22 ' N ' ' A' ' 115' ' ' THR . 5.1 mp -136.97 161.26 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 62.35 111.176 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.569 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -158.41 163.5 37.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 53.22 111.108 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.634 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.9 p90 -133.04 145.85 51.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 72.01 110.924 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.568 ' HD2' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -139.56 115.2 10.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 71.52 110.863 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 62.8 mt -76.58 107.78 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 75.02 111.128 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -60.49 -49.4 77.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 73.33 110.863 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.658 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.0 p-10 -142.1 167.56 21.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 63.4 110.902 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -118.4 148.93 42.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 74.34 110.933 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.501 HG23 ' HD2' ' A' ' 123' ' ' PRO . 87.7 m -100.21 135.48 20.3 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.551 0.691 . . . . 72.31 111.187 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.501 ' HD2' HG23 ' A' ' 122' ' ' THR . 54.2 Cg_endo -69.73 21.22 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.611 2.207 . . . . 72.41 112.347 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 122' ' ' THR . 1.6 m-20 -101.12 -24.75 14.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.224 -0.444 . . . . 74.42 110.879 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.405 ' HE3' HG22 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -116.19 166.2 12.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 72.34 110.835 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -89.56 147.93 23.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 74.22 110.86 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -47.87 -35.27 10.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 70.22 110.92 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -81.88 -37.21 27.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 74.33 110.891 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.406 ' HB3' HG23 ' A' ' 205' ' ' THR . 76.1 m-20 -64.86 -31.41 72.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 74.31 110.841 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.405 HG22 ' HE3' ' A' ' 125' ' ' MET . 62.4 t -64.65 -44.85 96.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 73.52 111.048 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.2 -23.19 38.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 72.34 110.803 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -75.54 -46.67 30.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 61.43 110.839 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.71 ' HB1' ' N ' ' A' ' 213' ' ' PHE . . . -69.43 -35.69 75.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 75.04 111.14 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.542 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.4 mp -70.59 -55.17 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 74.11 111.134 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.542 ' N ' HG22 ' A' ' 134' ' ' ILE . 0.6 OUTLIER -48.34 -44.15 34.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.081 -0.509 . . . . 62.44 110.929 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.634 ' O ' HG23 ' A' ' 140' ' ' VAL . 5.9 mmpt? -69.88 -35.14 74.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 72.12 110.889 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.916 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -59.84 -49.35 78.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.411 . . . . 71.44 111.116 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.634 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.8 m-85 -72.47 -22.16 61.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 70.15 110.848 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -77.89 -5.87 52.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 74.45 110.936 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.76 ' O ' HD11 ' A' ' 250' ' ' LEU . 87.4 t -97.23 -18.65 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 65.34 111.185 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.805 ' NE1' HG12 ' A' ' 217' ' ' VAL . 95.7 m95 -103.73 -40.19 6.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 62.05 110.962 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -13.57 62.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 75.51 110.817 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -94.07 -4.04 50.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 71.13 110.876 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.822 HG11 HD12 ' A' ' 250' ' ' LEU . 31.3 m -120.96 3.59 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 61.23 111.047 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.717 HG23 ' HD2' ' A' ' 146' ' ' PRO . 3.2 m -145.98 141.66 16.89 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.675 0.75 . . . . 71.44 111.077 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 146' ' ' PRO . . . . . 0.717 ' HD2' HG23 ' A' ' 145' ' ' THR . 54.1 Cg_endo -69.78 35.64 0.22 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.695 2.264 . . . . 72.44 112.328 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.785 HD21 ' CE1' ' A' ' 262' ' ' TYR . 3.1 mp -103.22 -177.34 3.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 71.23 110.88 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -141.64 126.91 18.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 64.0 110.854 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.418 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.8 m-30 -114.06 146.45 40.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 74.24 110.887 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.455 ' H ' ' HA ' ' A' ' 115' ' ' THR . 5.8 t -142.27 151.51 42.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 72.02 110.877 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 7.2 tttp -102.54 143.13 32.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 74.43 110.925 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.52 HD11 ' HB2' ' A' ' 157' ' ' ALA . 21.8 pt -151.94 142.02 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 72.1 111.144 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.3 m120 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 64.44 110.828 179.981 . . . . . . . . 0 0 . 1 . 007 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.52 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.774 0.321 . . . . 73.01 111.151 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.26 -53.33 5.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.42 . . . . 73.51 110.918 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.659 HG12 HG23 ' A' ' 220' ' ' ILE . 2.5 mp -88.68 94.1 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 72.5 111.078 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.568 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.5 tp -85.76 108.87 18.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.479 . . . . 74.15 110.904 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.2 t -86.96 119.11 34.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 73.01 111.152 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.658 HG23 ' OD1' ' A' ' 120' ' ' ASN . 1.9 p -138.24 104.91 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 74.05 111.081 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.419 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 39.6 m-85 -73.22 111.68 8.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.195 -0.457 . . . . 71.34 110.862 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.49 ' HB3' ' CD2' ' A' ' 168' ' ' HIS . . . -131.92 166.41 21.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 75.32 111.131 179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -114.41 136.16 53.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 62.33 110.987 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.679 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 44.57 -157.78 0.19 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.773 -0.727 . . . . 72.43 112.499 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.819 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -62.53 116.45 5.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.832 0.348 . . . . 62.24 110.999 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.501 ' NE2' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -109.25 -22.12 12.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 74.23 110.884 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.71 30.35 0.54 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.708 -0.758 . . . . 53.53 112.515 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.633 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.97 0.1 14.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.912 0.387 . . . . 73.12 110.899 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 74.33 39.04 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 75.32 110.954 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.575 ' ND1' ' N ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -134.96 -41.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 71.51 110.853 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.819 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.2 100.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 65.32 111.102 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.679 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.1 m-85 -61.18 -168.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 74.01 110.898 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.17 18.84 3.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 71.22 110.825 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.587 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.07 -158.04 5.57 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 62.43 112.477 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.8 OUTLIER -33.76 133.94 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 75.43 110.884 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.45 165.44 0.15 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.715 -0.755 . . . . 62.04 112.541 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.64 -143.56 22.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.692 -0.766 . . . . 71.41 112.486 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.02 96.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.83 0.348 . . . . 75.23 111.169 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 13.3 mt -66.32 -44.0 84.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 71.22 110.9 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -170.09 163.09 9.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 73.24 111.08 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.488 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -155.62 142.66 19.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 75.23 110.81 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.744 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -139.02 172.26 13.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 72.41 111.101 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 223' ' ' SER . 48.4 m-85 -100.7 -151.39 0.41 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 62.1 110.858 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -154.99 -97.07 0.13 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.74 -0.743 . . . . 74.23 112.481 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 61.31 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.685 2.256 . . . . 73.42 112.329 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.617 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.65 153.76 17.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 53.24 112.473 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.58 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.75 149.71 25.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.396 . . . . 62.51 110.829 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.23 -66.77 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.739 . . . . 71.34 112.475 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.58 ' N ' ' O ' ' A' ' 189' ' ' SER . 1.1 mp -104.78 6.61 10.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.809 0.338 . . . . 62.33 111.098 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.617 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -65.33 164.33 37.45 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.763 -0.732 . . . . 40.15 112.482 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 47.21 16.73 0.29 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 54.23 112.457 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.409 ' CG ' ' HB3' ' A' ' 160' ' ' LEU . 1.1 m-20 -63.31 111.77 2.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.78 0.324 . . . . 65.23 110.898 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.744 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -85.49 128.76 34.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 74.35 111.076 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.488 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.8 m170 -119.29 128.65 54.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 71.12 110.846 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.525 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 47.8 m-85 -114.27 134.23 55.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.208 -0.451 . . . . 71.1 110.89 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -67.19 108.91 2.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 71.41 110.871 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.94 -36.91 78.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 65.32 110.843 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.587 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 16.8 m-20 -51.38 -21.06 2.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 74.33 110.854 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -82.61 162.72 21.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 71.42 110.885 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.522 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -100.66 92.46 5.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 70.25 110.887 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.525 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 30.0 m95 -82.7 122.47 28.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.02 -0.536 . . . . 63.1 110.948 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.2 p -139.42 -170.85 2.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 74.1 111.204 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.406 HG23 ' HB3' ' A' ' 129' ' ' ASP . 0.2 OUTLIER -116.09 17.24 15.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.278 -0.419 . . . . 61.02 111.151 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.58 -177.55 4.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 73.11 110.804 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.3 p -64.95 -18.66 65.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 72.44 110.831 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.31 -108.3 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.744 -0.741 . . . . 43.2 112.452 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.09 177.45 0.14 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.698 -0.763 . . . . 72.31 112.474 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 96.3 m -66.76 94.55 0.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.8 0.334 . . . . 70.31 111.187 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -38.12 117.09 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 73.44 110.875 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.502 HD23 ' HB3' ' A' ' 133' ' ' ALA . 25.0 tp -63.66 -36.59 84.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 73.02 110.921 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.71 ' N ' ' HB1' ' A' ' 133' ' ' ALA . 3.2 t80 -52.82 -64.63 0.75 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 75.42 110.932 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.44 HD11 ' H ' ' A' ' 243' ' ' VAL . 15.2 mt -53.53 -55.54 24.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 73.54 110.902 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.523 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 1.7 m -55.52 -32.99 63.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.468 . . . . 63.43 111.065 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.415 ' HB3' ' HB2' ' A' ' 137' ' ' ALA . . . -68.0 -46.24 71.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 75.34 111.026 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.916 HG22 ' HA ' ' A' ' 137' ' ' ALA . 1.9 t -55.96 -59.4 2.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.279 -0.419 . . . . 71.32 111.104 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.526 ' HB2' ' CG1' ' A' ' 235' ' ' VAL . 1.1 t-80 -60.6 -31.7 70.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 63.1 110.925 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -60.25 -46.75 88.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 70.41 111.075 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.659 HG23 HG12 ' A' ' 159' ' ' ILE . 2.3 mt -68.75 -34.54 65.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 72.24 111.167 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.01 -42.69 48.42 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.788 -0.72 . . . . 64.34 112.418 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.44 ' O ' ' O ' ' A' ' 185' ' ' PHE . 24.1 m-70 -67.62 -39.94 84.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 64.04 110.89 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.586 ' OG ' HG23 ' A' ' 159' ' ' ILE . 2.1 m -60.76 -28.87 69.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 72.22 110.877 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 52.3 mt -76.21 -26.42 56.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 72.14 110.88 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 117.67 16.53 5.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.803 -0.713 . . . . 65.42 112.458 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.945 HD11 HD13 ' A' ' 258' ' ' ILE . 53.4 mt -77.45 159.25 29.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 62.11 110.894 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -103.71 -140.14 10.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.702 -0.761 . . . . 73.45 112.504 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.405 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 0.1 OUTLIER -123.35 136.19 54.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.814 0.34 . . . . 63.14 110.934 -179.992 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 29.8 t -104.92 162.56 13.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 73.5 110.89 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.6 t -107.75 5.85 27.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 74.55 110.751 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.553 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -68.53 140.45 92.31 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-O 121.673 0.749 . . . . 71.15 110.806 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 0.55 5.47 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.757 2.305 . . . . 75.43 112.365 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -143.62 14.66 1.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 51.12 110.813 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.553 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -77.33 140.3 39.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 73.2 111.129 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.565 HG21 HD23 ' A' ' 250' ' ' LEU . 51.6 t -69.8 -26.18 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 62.41 111.138 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.405 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 55.6 mmm -81.92 -7.03 59.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 62.41 110.955 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.496 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 2.4 t80 -50.9 138.28 24.48 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.681 0.753 . . . . 64.34 110.882 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.496 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 53.6 Cg_endo -69.75 -7.87 22.15 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.622 2.215 . . . . 64.54 112.335 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.41 ' HB ' ' CD2' ' A' ' 237' ' ' PHE . 22.3 m -110.91 130.99 55.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 53.31 111.18 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -92.24 146.82 23.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.958 0.409 . . . . 73.43 110.953 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -161.87 132.02 4.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 42.01 110.848 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.536 ' O ' HG13 ' A' ' 243' ' ' VAL . 65.0 t80 -61.89 149.06 41.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 74.13 110.915 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -160.76 137.48 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 74.33 111.12 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -60.76 127.39 31.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 51.33 110.825 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.559 HD11 ' HD3' ' A' ' 136' ' ' LYS . 14.4 tt -54.0 -29.48 18.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 75.24 111.152 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.08 -21.26 64.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 74.24 110.849 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.8 p -111.89 -18.2 12.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 63.14 111.119 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.567 ' HE2' HG21 ' A' ' 140' ' ' VAL . 36.8 t80 -62.72 142.2 58.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 73.3 110.903 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -177.11 136.25 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 74.01 110.831 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.822 HD12 HG11 ' A' ' 144' ' ' VAL . 8.7 mt -51.57 127.71 21.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 64.22 110.914 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 35.8 t -66.89 161.68 23.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 74.11 110.863 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.27 -30.17 11.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 72.05 111.128 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -71.75 -45.87 60.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 64.13 110.9 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.447 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 2.1 m-20 -62.36 -50.57 71.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 74.01 110.82 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 24.2 mt -62.29 -35.63 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 54.25 111.158 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 29.1 mmt-85 -71.08 -38.04 72.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 74.5 110.848 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.13 -49.93 7.17 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.673 -0.775 . . . . 63.24 112.523 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.945 HD13 HD11 ' A' ' 226' ' ' LEU . 8.4 tp -52.4 -34.84 19.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.786 0.327 . . . . 72.42 111.141 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.409 ' O ' ' N ' ' A' ' 263' ' ' GLY . 30.5 mt-30 -87.81 -16.18 34.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 72.53 110.925 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.6 t -70.16 -14.25 62.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 73.25 110.809 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.37 -19.33 6.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 63.34 110.923 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.785 ' CE1' HD21 ' A' ' 147' ' ' LEU . 37.6 m-85 -113.8 -35.06 5.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.448 . . . . 74.01 110.955 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.325 0 CA-C-O 119.157 -0.801 . . . . 43.21 112.498 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.464 ' HA ' HD22 ' A' ' 147' ' ' LEU . 9.9 p80 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.729 0.299 . . . . 70.24 110.854 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -141.92 98.67 3.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.149 -0.478 . . . . 73.25 110.904 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.652 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.6 mp -132.12 163.19 38.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.097 -0.501 . . . . 60.23 111.136 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.589 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -160.26 163.44 33.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 72.41 111.238 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.595 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.7 p90 -133.72 155.71 49.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 75.04 110.854 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.709 ' HD2' HD11 ' A' ' 160' ' ' LEU . 3.8 tmt_? -144.87 111.56 5.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 73.3 110.923 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.0 mt -73.37 104.18 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.31 -0.405 . . . . 74.43 111.206 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -57.82 -45.72 85.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 55.52 110.896 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.743 ' OD1' HG23 ' A' ' 162' ' ' VAL . 1.6 p-10 -146.92 164.24 33.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 74.4 110.862 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.592 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.3 m-85 -116.5 144.82 43.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 75.41 110.923 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.715 HG22 ' CE ' ' A' ' 125' ' ' MET . 3.0 t -94.33 142.15 24.48 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.564 0.697 . . . . 72.05 111.17 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.87 -3.17 11.54 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.643 2.229 . . . . 62.2 112.339 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.401 ' H ' HG23 ' A' ' 122' ' ' THR . 22.8 m-20 -79.96 -23.38 41.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 43.1 110.933 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.715 ' CE ' HG22 ' A' ' 122' ' ' THR . 16.6 mtm -115.94 166.63 11.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 72.51 110.858 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.409 ' O ' HG23 ' A' ' 130' ' ' VAL . 46.7 t30 -96.32 143.95 26.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 70.35 110.909 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.88 -32.83 1.73 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 73.22 110.911 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -85.73 -40.44 16.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 70.41 110.9 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -64.88 -29.24 70.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 73.2 110.906 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.62 ' O ' HD13 ' A' ' 134' ' ' ILE . 78.9 t -67.39 -45.36 85.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 71.4 111.168 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -80.12 -22.72 41.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 73.54 110.878 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -73.75 -47.02 42.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 72.14 110.955 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.774 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -73.84 -30.01 62.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.5 . . . . 74.32 111.094 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.656 HD13 HD21 ' A' ' 212' ' ' LEU . 1.4 mp -73.84 -55.85 11.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 73.53 111.202 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.558 ' N ' HG22 ' A' ' 134' ' ' ILE . 2.1 ttt180 -48.02 -42.12 27.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 64.53 110.868 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.551 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -75.88 -33.35 59.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 64.12 110.902 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.848 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.35 -50.78 72.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 71.11 111.145 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.616 ' HE2' HD13 ' A' ' 159' ' ' ILE . 80.7 m-85 -67.37 -32.55 73.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 61.43 110.832 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.442 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 2.7 tt0 -63.42 -44.2 95.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 50.45 110.991 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 136' ' ' LYS . 79.3 t -49.35 -24.81 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 73.32 111.077 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.791 ' NE1' HG12 ' A' ' 217' ' ' VAL . 97.6 m95 -98.99 -28.36 13.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.253 -0.43 . . . . 75.2 110.867 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.2 p -76.14 -12.54 60.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.282 -0.417 . . . . 63.43 110.842 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 139' ' ' GLN . 21.3 m120 -92.73 -24.75 18.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 62.14 110.867 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.64 HG11 HD12 ' A' ' 250' ' ' LEU . 4.4 m -93.28 0.8 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 62.33 111.079 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.559 HG21 HG13 ' A' ' 258' ' ' ILE . 77.6 p -152.93 143.98 16.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.642 0.734 . . . . 74.53 111.146 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 29.33 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.604 2.202 . . . . 74.02 112.333 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.751 HD11 ' CD2' ' A' ' 262' ' ' TYR . 29.4 mt -87.71 175.59 7.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.444 . . . . 70.14 110.937 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -137.67 126.47 23.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 73.53 110.983 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.652 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.4 m-85 -116.6 140.28 49.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 74.11 110.83 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.9 m -136.09 145.94 46.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 64.55 110.847 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.424 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 5.5 tttt -94.22 144.87 25.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 64.23 110.893 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.627 HD11 ' HB2' ' A' ' 157' ' ' ALA . 14.8 pt -151.25 132.85 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 72.52 111.081 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.155 -0.475 . . . . 73.44 110.866 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.627 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 N--CA 1.458 -0.057 0 CA-C-O 120.788 0.327 . . . . 73.21 111.104 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.94 -50.95 7.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 72.52 110.849 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.65 HG23 ' OG ' ' A' ' 223' ' ' SER . 2.6 mp -93.14 98.95 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 75.1 111.203 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.709 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.4 tp -88.67 109.89 20.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 71.04 110.995 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.442 HG13 ' CE1' ' A' ' 197' ' ' PHE . 98.3 t -89.07 121.44 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 72.42 111.144 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.743 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -140.98 106.43 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 75.11 111.175 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -73.66 108.57 6.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 72.41 110.819 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.469 ' HB3' ' CD2' ' A' ' 168' ' ' HIS . . . -128.91 165.61 20.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.029 -0.532 . . . . 64.03 111.163 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.08 137.69 51.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 63.34 110.879 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.68 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.82 -155.48 0.23 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.772 -0.728 . . . . 53.45 112.473 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.805 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.45 117.07 7.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 73.41 111.113 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.501 ' NE2' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.28 -22.51 12.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 75.44 110.831 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.32 29.68 0.54 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.805 -0.712 . . . . 33.52 112.518 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.624 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.1 -0.45 14.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.824 0.345 . . . . 50.03 110.882 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 74.77 39.39 0.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 74.14 110.946 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.578 ' ND1' ' N ' ' A' ' 173' ' ' ALA . 0.4 OUTLIER -135.02 -41.28 0.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 74.12 110.82 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.805 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.19 99.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.43 . . . . 74.5 111.093 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.68 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -60.4 -168.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 71.51 110.911 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.69 19.12 3.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 72.42 110.798 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.575 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.5 -157.99 6.18 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.789 -0.72 . . . . 63.45 112.508 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 176' ' ' GLY . 9.6 ptpt -34.59 134.05 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 73.52 110.966 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.84 165.42 0.18 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.777 -0.725 . . . . 75.2 112.491 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.441 ' O ' HD22 ' A' ' 181' ' ' LEU . . . 82.69 -142.9 22.1 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.775 -0.726 . . . . 41.51 112.488 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.47 96.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.953 0.406 . . . . 72.44 111.145 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.441 HD22 ' O ' ' A' ' 179' ' ' GLY . 3.0 mm? -65.56 -42.71 91.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 63.43 110.903 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -171.25 163.55 7.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 62.3 111.163 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.493 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -156.11 142.13 18.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 60.12 110.88 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.742 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -137.79 172.93 12.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 40.12 111.123 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 223' ' ' SER . 12.2 m-85 -101.7 -148.48 0.37 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.24 -0.436 . . . . 75.02 110.796 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -164.03 -86.85 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.739 -0.744 . . . . 63.4 112.483 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.82 55.51 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.564 2.176 . . . . 74.12 112.374 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.582 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.82 149.79 16.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 63.21 112.502 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.13 146.48 28.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.388 . . . . 71.41 110.805 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.03 -64.77 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.796 -0.716 . . . . 64.33 112.512 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' A' ' 189' ' ' SER . 8.2 pt -105.25 8.86 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.871 0.367 . . . . 73.51 111.214 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.582 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -68.91 169.75 41.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.701 -0.761 . . . . 75.23 112.433 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 44.67 20.78 0.23 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.727 -0.749 . . . . 74.24 112.542 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 192' ' ' GLY . 2.3 m-20 -64.98 107.34 1.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.784 0.326 . . . . 72.42 110.892 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.742 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -81.4 129.06 34.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 71.14 111.094 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.493 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.8 m170 -119.86 129.82 54.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.312 -0.403 . . . . 65.12 110.805 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.484 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 47.7 m-85 -114.47 133.9 55.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 55.21 110.876 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -66.76 107.3 2.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.128 -0.487 . . . . 75.13 110.769 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -58.4 -37.51 75.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 75.22 110.794 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.575 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 14.6 m-20 -50.48 -22.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 62.51 110.875 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -80.79 162.96 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 62.31 110.853 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.571 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -101.22 88.53 3.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 71.42 110.853 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.553 ' CZ3' HG21 ' A' ' 215' ' ' THR . 31.1 m95 -79.54 123.9 28.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 75.21 110.913 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 25.1 p -142.7 -175.96 4.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.457 . . . . 73.13 111.086 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.12 21.45 16.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 73.54 111.158 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -128.29 -174.86 3.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 51.15 110.884 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.4 p -70.87 -19.2 62.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 65.45 110.758 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.76 -105.23 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.717 -0.754 . . . . 72.03 112.519 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.5 177.23 0.11 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.735 -0.745 . . . . 42.14 112.503 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 68.7 m -66.93 98.14 0.53 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.819 0.342 . . . . 72.32 111.107 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -42.13 115.72 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.85 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.774 HD23 ' HB3' ' A' ' 133' ' ' ALA . 5.8 tp -63.93 -36.62 84.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 53.35 110.957 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.718 ' O ' HG23 ' A' ' 217' ' ' VAL . 4.5 t80 -51.93 -64.05 0.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 74.44 110.874 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.434 HD11 ' H ' ' A' ' 243' ' ' VAL . 18.2 mt -56.1 -54.84 40.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 74.51 110.855 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.553 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.5 m -54.5 -34.52 61.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 74.25 111.155 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.83 -49.35 66.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 54.45 111.069 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.848 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -52.81 -58.03 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.326 -0.397 . . . . 74.54 111.17 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.64 ' HB2' HG13 ' A' ' 235' ' ' VAL . 4.3 t-80 -63.36 -30.81 71.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 73.3 110.799 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.48 -43.27 99.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 75.4 111.087 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.636 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -71.65 -35.42 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 64.34 111.053 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.24 -43.95 43.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.644 -0.789 . . . . 74.21 112.515 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 185' ' ' PHE . 31.5 m-70 -68.52 -39.52 81.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 74.34 110.915 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.65 ' OG ' HG23 ' A' ' 159' ' ' ILE . 5.0 m -62.15 -27.39 68.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 73.44 110.843 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 68.2 mt -76.8 -27.23 55.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 73.55 110.911 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 117.05 16.76 6.08 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.752 -0.737 . . . . 51.33 112.468 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.899 HD11 HD13 ' A' ' 258' ' ' ILE . 32.3 mt -78.85 149.08 32.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.9 0.381 . . . . 62.42 110.874 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -90.94 -142.65 10.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.733 -0.746 . . . . 65.31 112.487 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 0.0 OUTLIER -122.31 142.07 50.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.337 . . . . 72.41 110.833 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 28.7 t -103.49 161.58 13.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 65.11 110.824 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.25 -1.7 23.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 74.32 110.875 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.621 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -62.3 140.91 96.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.564 0.697 . . . . 73.3 110.907 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.71 -2.78 10.71 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.703 2.269 . . . . 70.2 112.367 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 3.6 ptmt -143.85 21.07 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 71.42 110.898 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.621 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -85.19 135.56 33.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 62.02 111.062 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.64 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.3 t -60.56 -35.68 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 54.04 111.105 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.445 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 41.1 mmm -65.44 -17.99 64.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 73.31 110.95 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.569 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.2 t80 -56.78 142.72 71.57 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.729 0.776 . . . . 72.32 110.896 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.569 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.6 Cg_endo -69.7 -1.4 8.36 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.669 2.246 . . . . 72.34 112.387 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.5 m -96.77 144.33 26.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 51.33 111.163 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -123.88 140.29 53.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 72.41 110.899 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -160.42 135.31 7.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 70.54 110.899 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.564 ' O ' HG13 ' A' ' 243' ' ' VAL . 70.8 t80 -59.04 148.69 29.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 73.51 110.976 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.3 OUTLIER -161.2 133.09 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 65.22 111.183 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -49.47 131.55 20.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 70.02 110.811 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 4.3 tt -54.44 -30.86 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 72.13 111.103 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -77.41 -17.62 57.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 74.25 110.928 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 50.9 p -104.14 -23.06 13.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 74.4 111.107 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -67.9 140.92 56.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 74.01 110.86 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.4 ptt85 -175.59 132.24 0.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.074 -0.512 . . . . 70.44 110.819 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.64 HD12 HG11 ' A' ' 144' ' ' VAL . 26.9 mt -48.24 125.48 9.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 74.23 110.998 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.1 p -68.34 166.15 17.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 72.23 110.806 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.32 -38.46 41.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 63.41 111.085 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -63.34 -46.69 85.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 72.21 110.947 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 4.9 m-20 -62.22 -53.53 53.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 53.2 110.867 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.419 ' HA ' HG22 ' A' ' 258' ' ' ILE . 26.3 mt -59.99 -36.06 64.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 72.31 111.136 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -68.23 -39.75 82.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 65.35 110.901 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.3 -53.17 5.74 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 53.3 112.514 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.899 HD13 HD11 ' A' ' 226' ' ' LEU . 6.4 tp -52.21 -35.5 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.673 0.273 . . . . 74.54 111.083 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 263' ' ' GLY . 70.0 mt-30 -85.81 -17.51 35.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 71.23 110.894 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 10.4 t -70.6 -13.63 62.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 75.3 110.817 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.7 mt -122.35 -17.74 6.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 71.14 110.883 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.751 ' CD2' HD11 ' A' ' 147' ' ' LEU . 33.3 m-85 -115.75 -34.77 4.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 73.23 110.987 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.279 0 CA-C-O 119.156 -0.802 . . . . 64.45 112.464 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.634 ' HA ' HD12 ' A' ' 147' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.815 0.341 . . . . 64.42 110.843 . . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -143.73 82.69 1.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 72.12 110.963 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.632 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.2 mp -115.63 164.0 12.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 73.11 111.12 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.584 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -159.51 162.21 35.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.198 -0.456 . . . . 75.31 111.112 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.605 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.5 p90 -133.13 148.79 52.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.436 . . . . 74.45 110.904 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.674 ' HE ' HD11 ' A' ' 160' ' ' LEU . 3.7 tmm_? -142.51 113.37 7.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 73.43 110.875 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.4 mt -73.93 106.03 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 75.22 111.164 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -59.24 -47.25 86.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 53.22 110.902 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.728 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.1 p-10 -143.29 162.88 34.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 74.15 110.857 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.602 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.2 m-85 -117.25 137.66 52.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 54.32 110.955 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.731 HG22 ' CE ' ' A' ' 125' ' ' MET . 2.6 t -87.43 143.23 33.91 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.639 0.733 . . . . 72.2 111.128 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.414 ' HD2' ' OG1' ' A' ' 122' ' ' THR . 53.2 Cg_endo -69.88 -3.62 12.45 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.588 2.192 . . . . 73.52 112.338 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.44 ' H ' HG23 ' A' ' 122' ' ' THR . 15.7 m-20 -80.02 -23.74 41.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 65.25 110.875 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.731 ' CE ' HG22 ' A' ' 122' ' ' THR . 15.6 mtm -115.67 166.73 11.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 72.33 110.916 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -97.69 143.93 27.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.429 . . . . 72.12 110.92 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.47 -35.09 3.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 72.45 110.869 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -83.36 -38.65 21.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 73.2 110.914 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -65.26 -30.48 71.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.22 -0.445 . . . . 62.24 110.776 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.602 HG11 ' CE2' ' A' ' 121' ' ' TYR . 60.8 t -65.31 -47.37 87.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 50.21 111.22 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.99 -23.18 48.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 64.4 110.845 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -74.26 -46.71 39.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.233 -0.439 . . . . 73.42 110.95 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.706 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -72.8 -31.48 64.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 71.1 111.116 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.55 HD13 ' O ' ' A' ' 130' ' ' VAL . 1.4 mp -71.95 -53.79 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 74.21 111.152 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.537 ' N ' HG22 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -48.92 -41.88 35.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 73.13 110.897 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.662 ' O ' HG23 ' A' ' 140' ' ' VAL . 8.0 mmpt? -70.97 -36.29 72.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 53.01 110.94 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.654 ' O ' HG13 ' A' ' 217' ' ' VAL . . . -59.05 -50.83 72.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 63.23 111.11 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.605 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 93.4 m-85 -69.92 -22.96 63.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 74.24 110.926 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -77.52 -6.87 55.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.119 -0.491 . . . . 72.22 110.905 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.719 ' O ' HD11 ' A' ' 250' ' ' LEU . 91.5 t -96.08 -18.34 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 65.34 111.086 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.874 ' NE1' HG12 ' A' ' 217' ' ' VAL . 96.1 m95 -106.02 -39.82 5.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 72.33 110.933 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -9.79 58.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 72.31 110.859 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -99.87 -7.92 24.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 72.43 110.888 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.893 HG11 HD12 ' A' ' 250' ' ' LEU . 19.8 m -110.61 -5.24 11.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 74.45 111.152 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.744 ' CB ' HD23 ' A' ' 147' ' ' LEU . 44.8 p -141.36 149.62 55.3 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.555 0.693 . . . . 74.2 111.132 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 34.85 0.21 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.726 2.284 . . . . 70.32 112.27 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.928 HD21 ' HB3' ' A' ' 262' ' ' TYR . 2.9 mm? -104.98 167.09 9.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 54.14 110.924 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -131.12 127.93 39.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 54.21 110.932 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.632 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.3 m-30 -114.6 146.52 40.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 64.1 110.871 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 115' ' ' THR . 49.3 m -137.14 155.33 49.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 72.13 110.781 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.4 OUTLIER -106.78 142.36 36.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 61.55 110.83 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 157' ' ' ALA . 20.3 pt -151.26 147.97 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 71.13 111.197 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 63.4 110.924 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.6 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.77 0.319 . . . . 43.0 111.097 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.416 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.8 OUTLIER -84.25 -54.67 4.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 74.22 110.863 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.663 HG12 HG23 ' A' ' 220' ' ' ILE . 2.5 mp -87.34 92.8 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.483 . . . . 72.41 111.123 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.674 HD11 ' HE ' ' A' ' 117' ' ' ARG . 7.4 tp -84.83 108.61 17.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 73.23 110.959 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.419 HG13 ' CE1' ' A' ' 197' ' ' PHE . 90.3 t -87.14 120.6 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.429 . . . . 71.45 111.091 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.728 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.2 p -139.45 105.61 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 72.41 111.124 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -73.23 108.17 5.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 63.43 110.908 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.48 ' HB3' ' CD2' ' A' ' 168' ' ' HIS . . . -128.64 165.79 20.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 73.01 111.064 179.989 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.91 137.65 51.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 74.03 110.851 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.68 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.49 -155.67 0.19 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.705 -0.76 . . . . 63.55 112.565 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.808 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -64.88 116.9 6.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.908 0.385 . . . . 74.54 111.126 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.496 ' NE2' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -109.17 -23.09 11.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.289 -0.414 . . . . 64.44 110.839 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.92 29.7 0.51 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.723 -0.751 . . . . 42.41 112.486 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.627 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.28 -0.17 14.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.804 0.335 . . . . 64.34 110.877 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 74.26 39.72 0.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 62.11 110.924 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.571 ' ND1' ' N ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -135.24 -41.29 0.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.042 -0.526 . . . . 73.15 110.869 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.808 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.2 100.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 24.23 111.224 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.68 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.2 m-85 -60.71 -168.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 62.41 110.84 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.8 18.95 3.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.118 -0.492 . . . . 72.41 110.827 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.65 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.46 -157.17 6.61 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.789 -0.72 . . . . 72.45 112.482 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.451 ' N ' ' HB3' ' A' ' 200' ' ' ASP . 5.7 tmtt? -34.42 133.86 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 74.23 110.893 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.41 166.5 0.18 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.681 -0.771 . . . . 65.43 112.565 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.18 -143.71 23.15 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.712 -0.756 . . . . 74.11 112.496 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -49.99 96.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.896 0.379 . . . . 73.31 111.101 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 25.0 mt -65.51 -42.7 91.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 44.43 110.869 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -171.32 162.74 6.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.248 -0.433 . . . . 63.55 111.2 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.472 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.3 p80 -155.64 143.11 19.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.289 -0.414 . . . . 64.25 110.879 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.753 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -139.3 171.59 14.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 73.0 111.068 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 222' ' ' HIS . 50.2 m-85 -98.67 -146.79 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 75.42 110.834 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -157.41 -101.44 0.18 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.797 -0.716 . . . . 63.14 112.552 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.66 63.14 1.73 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.709 2.273 . . . . 73.33 112.361 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.619 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.06 155.66 17.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 71.25 112.553 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.94 150.19 24.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.859 0.361 . . . . 71.31 110.881 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 59.35 -67.6 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.7 -0.762 . . . . 63.35 112.492 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.589 ' N ' ' O ' ' A' ' 189' ' ' SER . 24.3 pt -104.48 7.84 9.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.816 0.341 . . . . 74.2 111.174 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.619 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -64.32 162.37 36.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 40.42 112.532 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 46.58 17.7 0.28 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.736 -0.745 . . . . 54.21 112.528 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 192' ' ' GLY . 1.7 m-20 -63.09 111.13 2.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 61.2 110.859 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.753 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -84.31 129.39 34.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 65.3 111.124 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.472 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.0 m170 -120.16 129.31 54.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 63.45 110.875 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.488 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 42.5 m-85 -114.52 133.71 55.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 74.23 110.88 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -66.14 107.09 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 74.43 110.883 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -58.38 -37.41 75.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.147 -0.479 . . . . 75.0 110.868 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.65 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 9.9 m-20 -50.2 -23.62 2.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 65.41 110.81 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -80.17 162.95 24.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 72.21 110.868 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.572 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -100.67 89.91 4.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 72.51 110.819 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.534 ' CZ3' HG21 ' A' ' 215' ' ' THR . 33.0 m95 -80.94 123.51 28.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 72.21 111.007 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.0 p -141.18 -175.08 4.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.225 -0.443 . . . . 75.43 111.118 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.2 18.39 18.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 53.03 111.148 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.87 -177.98 4.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 73.2 110.847 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 17.4 p -65.07 -19.15 65.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 74.11 110.814 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.02 -108.53 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.706 -0.759 . . . . 73.21 112.446 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.92 177.5 0.12 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.795 -0.717 . . . . 74.45 112.525 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 91.6 m -65.86 97.32 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.851 0.358 . . . . 75.14 111.156 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -42.11 116.81 0.87 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 75.42 110.903 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.57 HD22 ' SD ' ' A' ' 125' ' ' MET . 11.8 tp -63.89 -38.46 91.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 43.51 110.964 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.706 ' CA ' ' HB1' ' A' ' 133' ' ' ALA . 2.3 t80 -49.25 -64.93 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.888 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.562 HD11 ' H ' ' A' ' 243' ' ' VAL . 21.8 mt -55.3 -54.95 37.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.238 -0.437 . . . . 73.33 110.873 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.534 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.1 m -54.51 -31.75 56.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 74.43 111.082 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.31 -48.88 60.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.429 . . . . 72.34 111.169 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.874 HG12 ' NE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -52.61 -57.85 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 72.53 111.051 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.743 ' HB2' HG13 ' A' ' 235' ' ' VAL . 2.0 t-80 -64.16 -30.21 71.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 71.35 110.889 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.3 -43.95 97.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 73.31 111.082 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.663 HG23 HG12 ' A' ' 159' ' ' ILE . 2.4 mt -70.59 -35.34 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 71.4 111.148 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.91 -44.61 40.76 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.708 -0.758 . . . . 73.45 112.533 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 185' ' ' PHE . 34.1 m-70 -67.21 -40.19 86.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.832 0.349 . . . . 72.03 110.894 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.584 ' OG ' HG23 ' A' ' 159' ' ' ILE . 2.7 m -62.35 -26.25 68.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 71.5 110.885 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.508 HD22 ' OH ' ' A' ' 262' ' ' TYR . 72.9 mt -76.66 -27.87 55.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 72.31 110.911 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 120.44 18.57 4.05 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.673 -0.775 . . . . 71.03 112.51 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.848 HD21 ' HA ' ' A' ' 258' ' ' ILE . 13.3 mt -82.84 159.74 22.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.795 0.331 . . . . 75.42 110.948 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -106.57 -135.23 7.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 72.13 112.477 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 0.1 OUTLIER -127.64 143.83 51.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.83 0.348 . . . . 73.45 110.821 -179.953 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 62.2 m -108.95 163.52 13.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 74.14 110.86 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.03 0.69 30.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 73.1 110.845 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.571 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -65.18 136.57 96.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.629 0.728 . . . . 64.35 110.836 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 -0.46 6.99 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.699 2.266 . . . . 71.1 112.346 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.15 19.57 1.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 71.54 110.956 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.571 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -91.07 129.93 37.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 65.43 111.088 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.743 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.2 t -54.11 -34.93 27.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 62.4 111.163 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.427 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 39.7 mmm -62.16 -21.14 64.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 62.31 110.885 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.545 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -56.22 142.53 67.02 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.681 0.753 . . . . 72.5 110.831 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.545 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.1 Cg_endo -69.73 -1.28 8.18 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.691 2.26 . . . . 61.24 112.343 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.8 m -95.55 140.35 30.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 71.22 111.191 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -120.32 137.14 54.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 75.12 110.854 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -154.57 132.14 11.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.071 -0.513 . . . . 73.13 110.86 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.503 ' O ' HG13 ' A' ' 243' ' ' VAL . 88.4 t80 -59.65 142.85 52.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.93 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.562 ' H ' HD11 ' A' ' 214' ' ' LEU . 0.8 OUTLIER -158.46 128.85 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 72.12 111.185 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -51.29 134.37 27.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 72.53 110.876 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.449 HD11 ' HD3' ' A' ' 136' ' ' LYS . 10.8 tt -54.58 -30.13 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 71.35 111.183 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.81 -18.1 60.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 71.51 110.924 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 28.1 p -107.56 -23.31 12.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 74.44 111.115 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -68.64 146.43 53.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 73.51 110.833 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -176.28 129.58 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 73.4 110.802 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.893 HD12 HG11 ' A' ' 144' ' ' VAL . 15.1 mt -48.99 131.99 18.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 75.33 110.955 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.475 ' O ' HD12 ' A' ' 255' ' ' ILE . 47.0 t -77.35 166.31 23.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 72.14 110.818 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.03 -37.99 35.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.059 -0.519 . . . . 71.13 111.074 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.31 -45.01 89.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.219 -0.446 . . . . 72.35 110.852 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -61.37 -54.8 39.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 72.44 110.875 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.475 HD12 ' O ' ' A' ' 251' ' ' SER . 2.6 mp -60.76 -37.07 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 71.3 111.052 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -68.36 -37.77 80.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 73.01 110.881 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -78.23 -51.23 5.81 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.682 -0.771 . . . . 44.51 112.456 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.848 ' HA ' HD21 ' A' ' 226' ' ' LEU . 6.3 tp -52.8 -33.72 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.763 0.316 . . . . 61.54 111.159 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 263' ' ' GLY . 30.8 mt-30 -87.66 -16.49 34.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 73.12 110.855 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 2.6 t -68.98 -16.24 63.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.856 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.13 -19.23 7.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 75.13 110.893 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.928 ' HB3' HD21 ' A' ' 147' ' ' LEU . 31.2 m-85 -110.45 -36.67 5.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.157 -0.474 . . . . 72.13 110.971 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.638 -0.791 . . . . 51.33 112.479 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.6 p80 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.829 0.347 . . . . 60.35 110.822 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.401 ' C ' HD12 ' A' ' 114' ' ' ILE . 3.2 m-85 -140.59 108.95 5.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 62.01 110.881 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.634 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.7 mp -142.48 164.01 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 73.33 111.111 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.605 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -160.37 163.13 33.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 64.21 111.155 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.572 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.2 p90 -134.2 153.97 51.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.41 . . . . 70.24 110.888 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.603 ' HD2' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -145.88 110.65 5.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 73.54 110.838 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 59.5 mt -73.14 106.0 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 63.32 111.072 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -59.42 -51.03 71.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 74.23 110.933 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.682 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.7 p-10 -138.41 166.28 24.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.32 110.884 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -116.05 154.36 30.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 75.12 110.919 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.496 ' CG2' ' HD2' ' A' ' 123' ' ' PRO . 11.0 m -102.67 137.42 19.34 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.571 0.7 . . . . 74.11 111.149 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.496 ' HD2' ' CG2' ' A' ' 122' ' ' THR . 53.3 Cg_endo -69.67 3.45 2.72 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.688 2.258 . . . . 65.01 112.362 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.47 ' H ' HG22 ' A' ' 122' ' ' THR . 2.1 m-20 -87.6 -28.59 21.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 74.31 110.797 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.595 ' SD ' HD22 ' A' ' 212' ' ' LEU . 5.8 mtm -110.19 167.01 10.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 74.33 110.861 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -90.14 142.58 27.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 73.43 110.878 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.36 -37.07 4.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 75.03 110.898 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -82.53 -36.88 25.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 71.42 110.887 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -64.84 -32.0 73.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.148 -0.478 . . . . 62.4 110.868 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.569 HG22 ' HE3' ' A' ' 125' ' ' MET . 62.4 t -64.78 -43.86 96.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 70.05 111.124 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.4 -23.27 35.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 75.34 110.926 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -75.33 -48.1 24.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 73.44 110.865 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.594 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -71.41 -30.67 66.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 62.12 111.088 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.62 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -73.09 -55.58 12.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 75.31 111.112 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.531 ' N ' HG22 ' A' ' 134' ' ' ILE . 7.0 ttt180 -48.2 -41.75 28.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.835 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 140' ' ' VAL . 7.6 mmtt -75.66 -31.75 59.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.213 -0.449 . . . . 72.31 110.873 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.656 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -61.9 -50.83 70.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 61.42 111.119 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.655 ' HE2' HD13 ' A' ' 159' ' ' ILE . 75.5 m-85 -66.21 -30.89 71.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 75.12 110.972 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.445 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 3.7 tt0 -63.99 -42.62 97.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 72.14 110.87 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 136' ' ' LYS . 74.1 t -50.23 -24.43 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 54.11 111.088 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.806 ' NE1' HG12 ' A' ' 217' ' ' VAL . 98.1 m95 -98.1 -30.35 12.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.185 -0.461 . . . . 75.44 110.967 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 12.8 t -72.52 -14.74 61.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 63.44 110.863 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 139' ' ' GLN . 29.2 m120 -89.32 -25.71 21.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.51 . . . . 41.23 110.914 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.6 HG21 ' CD1' ' A' ' 250' ' ' LEU . 7.0 m -94.74 2.82 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 71.11 111.132 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.472 ' C ' ' H ' ' A' ' 147' ' ' LEU . 23.6 p -154.45 142.61 14.26 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.502 0.667 . . . . 61.44 111.191 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 19.26 0.18 Allowed 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.685 2.257 . . . . 71.43 112.414 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.794 HD21 ' CG ' ' A' ' 262' ' ' TYR . 0.6 OUTLIER -74.27 -177.57 3.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 75.53 110.903 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -144.4 124.52 13.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 71.34 110.91 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.634 ' HE1' HD13 ' A' ' 114' ' ' ILE . 2.4 m-85 -116.79 140.2 49.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 72.43 110.815 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.5 t -136.21 145.33 45.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 64.52 110.821 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.478 ' HG3' ' N ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -93.7 144.25 25.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 64.01 110.857 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.605 HD11 ' HB2' ' A' ' 157' ' ' ALA . 11.4 pt -150.65 130.49 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 43.11 111.127 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 73.21 110.893 179.946 . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.605 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.819 0.343 . . . . 74.44 111.075 . . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.92 -50.87 7.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 64.11 110.92 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.694 HG12 HG23 ' A' ' 220' ' ' ILE . 2.9 mp -92.65 96.52 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 72.42 111.098 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.603 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.3 tp -87.26 110.49 20.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 75.32 110.961 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 88.2 t -88.54 119.07 35.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.112 -0.494 . . . . 74.24 111.139 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.682 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.1 p -138.38 106.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 74.34 111.125 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.448 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 34.4 m-85 -75.88 111.78 11.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 74.13 110.901 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.522 ' HB3' ' CD2' ' A' ' 168' ' ' HIS . . . -130.93 172.7 11.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 63.52 111.106 179.885 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.431 ' CG ' ' HB3' ' A' ' 199' ' ' GLU . 9.1 mtt180 -115.54 139.57 49.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 62.23 110.912 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.664 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 39.28 -149.05 0.11 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.773 -0.727 . . . . 74.14 112.476 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.802 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -69.4 117.02 10.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 74.51 111.125 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.522 ' CD2' ' HB3' ' A' ' 164' ' ' ALA . 0.3 OUTLIER -108.43 -20.65 13.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 64.13 110.91 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.12 29.79 0.65 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.783 -0.722 . . . . 74.44 112.496 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.636 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.2 0.28 14.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.82 0.343 . . . . 74.41 110.812 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 74.1 38.73 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 75.21 110.895 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.582 ' ND1' ' N ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -134.2 -41.74 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 73.15 110.876 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.802 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.52 99.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 74.01 111.046 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.664 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -60.5 -168.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.325 -0.398 . . . . 71.3 110.865 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.15 19.88 3.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 71.24 110.907 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.571 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 53.74 -157.94 5.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 71.13 112.536 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 176' ' ' GLY . 9.9 tttt -34.58 134.43 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.339 . . . . 71.54 110.937 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.55 165.77 0.17 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.663 -0.78 . . . . 40.41 112.508 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.3 -143.45 22.84 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.734 -0.746 . . . . 73.22 112.553 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -49.66 96.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.875 0.369 . . . . 71.13 111.154 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 84.4 mt -65.96 -42.49 89.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 64.42 110.962 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -171.11 166.69 7.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.288 -0.414 . . . . 45.1 111.091 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.516 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -159.68 140.74 12.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.134 -0.485 . . . . 63.43 110.831 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.759 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -135.94 173.14 12.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 71.52 111.086 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 223' ' ' SER . 10.4 m-85 -104.66 -151.82 0.45 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 64.04 110.837 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.412 ' H ' ' HB3' ' A' ' 185' ' ' PHE . . . -161.29 -81.74 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.745 -0.74 . . . . 53.31 112.531 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.87 53.92 1.17 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.639 2.226 . . . . 65.42 112.333 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.567 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -124.15 147.37 16.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.775 -0.726 . . . . 54.04 112.487 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.63 144.2 31.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 74.24 110.81 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.46 -63.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.721 -0.752 . . . . 74.22 112.506 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 189' ' ' SER . 2.2 pp -106.2 9.54 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.924 0.392 . . . . 75.52 111.133 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.567 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -70.72 171.43 44.65 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.734 -0.746 . . . . 70.11 112.45 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.44 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 44.24 20.44 0.18 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.734 -0.745 . . . . 75.23 112.476 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 192' ' ' GLY . 4.1 m-20 -64.24 108.59 1.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.776 0.322 . . . . 72.43 110.954 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.759 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -82.14 121.7 26.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 64.31 111.1 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.516 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.7 m170 -112.13 130.42 55.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 75.32 110.893 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.48 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 46.6 m-85 -115.23 136.12 53.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 62.01 110.897 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -69.29 104.03 2.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 73.11 110.827 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.431 ' HB3' ' CG ' ' A' ' 165' ' ' ARG . 4.2 tm-20 -55.87 -37.99 69.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 73.24 110.863 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.571 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 12.7 m-20 -49.26 -22.72 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 54.25 110.836 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -81.05 161.13 24.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 73.43 110.867 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.491 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -97.95 89.83 4.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 74.21 110.919 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.537 ' CZ3' HG21 ' A' ' 215' ' ' THR . 28.3 m95 -81.54 123.11 28.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 73.35 110.905 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.9 p -135.56 -174.23 3.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 70.24 111.225 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.53 12.78 18.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.279 -0.419 . . . . 64.12 111.167 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -131.04 -176.0 3.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 75.24 110.897 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.2 p -51.25 -36.06 40.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.433 . . . . 63.31 110.835 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -64.08 159.64 39.95 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.704 -0.76 . . . . 70.41 112.451 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . 49.15 -173.71 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.707 -0.759 . . . . 54.43 112.597 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.7 m -85.66 93.44 8.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.76 0.314 . . . . 75.45 111.122 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -38.91 111.47 0.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 72.22 110.822 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.62 HD21 HD13 ' A' ' 134' ' ' ILE . 9.0 tp -60.18 -36.78 78.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 74.14 110.869 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.594 ' CA ' ' HB1' ' A' ' 133' ' ' ALA . 3.6 t80 -51.97 -62.8 1.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.462 . . . . 71.45 110.935 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.547 HD11 ' H ' ' A' ' 243' ' ' VAL . 31.6 mt -57.52 -52.4 65.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 71.22 110.93 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.537 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 1.7 m -53.64 -38.07 63.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 53.34 111.137 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.429 ' HB3' ' CB ' ' A' ' 137' ' ' ALA . . . -61.74 -51.92 66.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 65.32 111.09 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.806 HG12 ' NE1' ' A' ' 141' ' ' TRP . 1.4 t -50.21 -58.87 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.458 . . . . 61.41 111.154 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.65 ' HB2' HG13 ' A' ' 235' ' ' VAL . 2.8 t-80 -62.86 -31.81 72.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 73.31 110.854 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -62.37 -43.29 99.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 42.34 111.121 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.694 HG23 HG12 ' A' ' 159' ' ' ILE . 2.4 mt -70.51 -33.43 53.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 75.51 111.093 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.92 -43.45 48.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.738 -0.744 . . . . 34.52 112.474 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.428 ' O ' ' O ' ' A' ' 185' ' ' PHE . 47.8 m-70 -68.37 -39.73 81.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.734 0.302 . . . . 74.31 110.814 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.601 ' OG ' HG23 ' A' ' 159' ' ' ILE . 2.0 m -62.16 -26.7 68.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 74.33 110.902 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 79.5 mt -77.25 -26.55 52.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 75.01 110.934 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 112.16 22.05 6.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.731 . . . . 54.42 112.487 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.742 HD11 ' HA ' ' A' ' 258' ' ' ILE . 0.1 OUTLIER -87.66 146.86 25.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.9 0.381 . . . . 74.11 110.887 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -88.04 -160.12 35.4 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.731 -0.747 . . . . 73.3 112.546 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -102.57 125.97 49.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 71.22 110.872 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.4 m -80.55 162.77 24.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 71.23 110.836 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.82 -1.1 19.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 70.5 110.894 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.638 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -63.44 142.75 97.9 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.582 0.706 . . . . 54.22 110.88 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -4.24 13.66 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.637 2.224 . . . . 63.11 112.344 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.68 23.61 1.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 64.42 110.867 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.638 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -81.54 143.0 32.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 71.21 111.068 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.65 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.3 t -65.78 -38.91 83.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.219 -0.446 . . . . 74.15 111.146 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 83.1 mmm -68.57 -12.27 61.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 65.23 110.878 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.657 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.5 t80 -57.8 145.1 72.28 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.582 0.706 . . . . 70.44 110.892 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.657 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.8 Cg_endo -69.77 0.89 5.0 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.666 2.244 . . . . 75.43 112.372 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 24.6 m -101.72 143.91 31.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 73.13 111.101 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -123.11 138.31 54.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 74.35 110.915 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -157.13 129.61 7.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 74.22 110.854 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.576 ' O ' HG13 ' A' ' 243' ' ' VAL . 86.3 t80 -59.66 145.83 43.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 74.23 110.949 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.3 OUTLIER -161.21 131.27 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 65.41 111.143 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -52.72 133.67 36.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.053 -0.521 . . . . 75.11 110.924 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.2 tt -53.69 -30.19 18.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.289 -0.414 . . . . 74.22 111.151 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.517 ' OD1' HG23 ' A' ' 247' ' ' THR . 0.1 OUTLIER -69.84 -20.26 63.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 73.24 110.96 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.517 HG23 ' OD1' ' A' ' 246' ' ' ASN . 6.3 p -110.45 -21.24 12.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 63.24 111.175 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -69.4 142.13 53.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 73.14 110.905 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -176.5 133.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 72.3 110.927 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.6 ' CD1' HG21 ' A' ' 144' ' ' VAL . 40.0 mt -47.52 123.58 5.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 74.11 110.987 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 7.1 t -58.3 158.36 7.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 62.33 110.954 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.52 -30.49 8.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 74.54 111.07 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -72.89 -45.69 56.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 75.24 110.846 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.12 -41.26 98.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 64.41 110.845 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.463 HG12 HG11 ' A' ' 144' ' ' VAL . 42.8 mt -69.6 -43.36 80.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 75.33 111.145 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.07 -28.99 67.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 74.1 110.919 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -85.06 -49.77 4.36 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.648 -0.787 . . . . 60.34 112.527 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.742 ' HA ' HD11 ' A' ' 226' ' ' LEU . 4.4 tp -54.22 -32.06 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.734 0.302 . . . . 74.02 111.123 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 263' ' ' GLY . 69.6 mt-30 -86.72 -17.58 33.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 74.52 110.942 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 2.4 t -67.79 -14.35 62.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 75.15 110.896 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.5 mt -121.8 -19.68 6.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 53.32 110.932 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.794 ' CG ' HD21 ' A' ' 147' ' ' LEU . 42.5 m-85 -113.41 -35.19 5.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 74.24 110.871 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 C--O 1.229 -0.218 0 CA-C-O 119.199 -0.778 . . . . 43.4 112.471 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.536 ' HA ' HD22 ' A' ' 147' ' ' LEU . 14.2 p80 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.931 0.396 . . . . 64.01 110.939 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -123.77 95.23 4.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 73.31 110.892 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.636 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.8 mp -121.93 162.53 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 53.12 111.144 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.591 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -156.87 164.77 37.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 73.04 111.073 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.594 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.4 p90 -134.81 148.57 50.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 74.41 110.835 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.438 ' HB3' HD12 ' A' ' 160' ' ' LEU . 4.2 tmt_? -140.72 110.71 6.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.02 -0.536 . . . . 72.52 110.908 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 57.0 mt -73.11 104.8 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 52.31 111.049 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -56.41 -48.97 75.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 70.42 110.836 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.74 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.8 p-10 -143.54 163.57 32.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 75.22 110.876 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.569 ' CE2' HG11 ' A' ' 130' ' ' VAL . 4.9 m-85 -116.38 138.47 51.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 71.52 110.903 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.646 HG22 ' CE ' ' A' ' 125' ' ' MET . 9.1 t -87.86 141.95 32.0 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.55 0.69 . . . . 74.44 111.154 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -3.77 12.69 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.638 2.226 . . . . 61.2 112.363 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -78.43 -23.3 46.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 74.14 110.93 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.659 ' CE ' HG22 ' A' ' 130' ' ' VAL . 12.7 mtm -116.79 166.78 11.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 71.11 110.9 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.461 ' O ' HG23 ' A' ' 130' ' ' VAL . 23.9 t-20 -94.46 144.01 25.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 62.14 110.867 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -45.42 -36.92 4.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 44.02 110.86 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -82.57 -36.14 26.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 72.43 110.919 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -66.99 -30.17 70.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 73.4 110.828 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.659 HG22 ' CE ' ' A' ' 125' ' ' MET . 82.0 t -66.57 -46.35 86.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 65.43 111.142 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.428 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 0.4 OUTLIER -77.54 -24.72 49.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.187 -0.46 . . . . 71.43 110.796 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -73.22 -47.84 40.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 73.42 110.856 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.747 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -69.36 -31.42 69.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.175 -0.466 . . . . 51.24 111.122 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.626 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -74.26 -53.46 17.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 71.01 111.102 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.509 ' N ' HG22 ' A' ' 134' ' ' ILE . 7.0 ptp180 -49.22 -37.2 22.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 73.35 110.806 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.641 ' O ' HG23 ' A' ' 140' ' ' VAL . 7.3 mmtt -76.88 -34.47 57.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 74.03 110.869 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.931 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -59.98 -48.66 80.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 72.22 111.082 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.623 ' HE2' HD13 ' A' ' 159' ' ' ILE . 94.1 m-85 -72.5 -22.69 61.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 72.04 110.899 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.13 -5.5 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 71.4 110.89 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 136' ' ' LYS . 84.1 t -98.74 -17.05 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 74.33 111.125 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.808 ' NE1' HG12 ' A' ' 217' ' ' VAL . 94.1 m95 -107.01 -37.03 6.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 73.3 110.906 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.78 -11.81 60.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.427 . . . . 62.42 110.88 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -94.99 -17.09 22.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 75.52 110.912 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.684 HG11 HD12 ' A' ' 250' ' ' LEU . 21.2 m -98.76 2.19 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 65.43 111.098 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.548 HG21 HG13 ' A' ' 258' ' ' ILE . 51.4 p -151.66 149.49 24.13 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.525 0.679 . . . . 23.03 111.219 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 32.01 0.19 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.698 2.265 . . . . 61.33 112.386 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.788 HD11 ' CD2' ' A' ' 262' ' ' TYR . 13.2 mt -97.8 175.92 5.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 75.03 110.929 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -140.1 125.53 19.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.172 -0.467 . . . . 74.1 110.954 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.636 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.2 m-30 -114.39 139.88 49.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 71.45 110.864 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.1 m -134.94 149.4 50.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 65.54 110.906 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 1.8 tttt -95.58 148.22 22.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 61.34 110.883 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 157' ' ' ALA . 3.6 pt -152.46 165.06 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 74.11 111.153 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 43.51 110.99 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.543 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.81 0.338 . . . . 53.23 111.118 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.5 OUTLIER -84.67 -53.12 5.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 75.42 110.846 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.771 HG12 HG23 ' A' ' 220' ' ' ILE . 2.3 mp -90.53 97.61 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 71.23 111.165 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 117' ' ' ARG . 8.5 tp -89.29 109.3 20.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 64.35 110.875 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.428 HG13 ' CE1' ' A' ' 197' ' ' PHE . 95.7 t -89.06 123.49 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 71.53 111.122 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.74 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -142.64 107.8 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 72.32 111.144 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -77.18 109.3 10.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 71.03 110.87 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.526 ' HB3' ' CD2' ' A' ' 168' ' ' HIS . . . -130.56 169.76 15.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 41.24 111.09 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 165' ' ' ARG . . . . . 0.498 ' HG3' ' HB3' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -112.88 139.22 48.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 74.42 110.826 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.664 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 41.43 -150.87 0.2 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.667 -0.778 . . . . 64.53 112.457 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.8 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -68.04 117.93 10.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.723 0.297 . . . . 55.43 111.163 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.526 ' CD2' ' HB3' ' A' ' 164' ' ' ALA . 0.4 OUTLIER -108.79 -21.56 12.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 55.31 110.906 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.08 29.54 0.61 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.738 -0.744 . . . . 62.04 112.499 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.621 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.73 -0.32 15.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.88 0.372 . . . . 54.52 110.825 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 74.76 38.67 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 74.23 110.87 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.577 ' ND1' ' N ' ' A' ' 173' ' ' ALA . 0.4 OUTLIER -134.29 -41.24 0.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 73.33 110.898 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.8 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 55.04 99.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 63.22 111.106 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.664 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.7 m-85 -60.73 -166.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 72.13 110.829 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.59 19.5 2.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.056 -0.52 . . . . 65.42 110.862 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.585 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.7 -157.53 6.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 62.25 112.453 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 176' ' ' GLY . 12.4 mmtm -36.7 135.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 75.23 110.917 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.76 162.85 0.15 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.7 -0.762 . . . . 33.23 112.521 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.53 -140.01 20.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.68 -0.772 . . . . 54.0 112.513 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.6 mt -49.92 93.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.819 0.342 . . . . 71.03 111.206 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.665 HD11 HG21 ' A' ' 210' ' ' THR . 1.7 tm? -67.44 -33.34 74.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.944 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -178.89 169.31 1.6 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 35.14 111.06 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.505 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.3 p80 -165.28 139.43 4.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 74.2 110.855 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.726 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -137.93 173.47 11.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.267 -0.424 . . . . 32.44 111.125 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.488 ' O ' ' O ' ' A' ' 222' ' ' HIS . 10.2 m-85 -98.85 -141.98 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.006 0.432 . . . . 74.33 110.809 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -164.42 -101.13 0.15 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.736 -0.745 . . . . 72.4 112.507 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 61.42 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.66 2.24 . . . . 63.14 112.349 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.601 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.94 154.66 16.74 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.736 -0.745 . . . . 64.02 112.442 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.569 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.05 147.95 26.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.938 0.399 . . . . 63.52 110.821 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.66 -67.2 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 53.13 112.545 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.569 ' N ' ' O ' ' A' ' 189' ' ' SER . 5.2 mm -103.39 6.58 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 70.11 111.118 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.601 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -64.14 165.43 30.81 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.8 -0.714 . . . . 71.52 112.483 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 45.35 19.17 0.22 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.735 -0.745 . . . . 73.45 112.471 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.423 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 0.8 OUTLIER -63.5 105.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.885 0.374 . . . . 62.24 110.846 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.726 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -81.84 131.65 35.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 72.42 111.127 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.505 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 7.7 m170 -122.82 129.77 52.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 75.3 110.884 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.58 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 34.1 m-85 -115.5 135.5 54.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.292 -0.413 . . . . 75.33 110.963 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -69.36 106.82 3.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 71.11 110.961 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.498 ' HB3' ' HG3' ' A' ' 165' ' ' ARG . 3.9 tm-20 -58.35 -37.53 75.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 75.51 110.916 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.585 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 14.9 m-20 -49.18 -23.22 1.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.506 . . . . 64.51 110.852 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.75 163.4 24.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 64.3 110.88 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.493 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.2 OUTLIER -96.9 96.35 8.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 73.42 110.855 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.58 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 34.0 m95 -87.89 123.89 33.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.475 . . . . 64.22 110.891 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.8 p -143.73 -179.13 6.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 54.32 111.127 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.24 18.64 20.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 54.32 111.128 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.85 -175.51 3.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 63.44 110.796 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 24.1 p -66.91 -18.11 65.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 62.54 110.835 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.95 -108.7 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.61 -0.805 . . . . 42.23 112.538 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.04 178.18 0.12 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.818 -0.706 . . . . 73.34 112.492 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.665 HG21 HD11 ' A' ' 181' ' ' LEU . 96.3 m -66.08 97.42 0.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.338 . . . . 72.25 111.044 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -41.48 111.93 0.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 75.21 110.843 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.747 HD23 ' HB3' ' A' ' 133' ' ' ALA . 9.6 tp -58.8 -38.08 77.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 73.32 110.869 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.771 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.7 t80 -52.5 -64.28 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 61.41 110.845 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.458 HD11 ' H ' ' A' ' 243' ' ' VAL . 19.3 mt -52.45 -56.22 16.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 75.04 110.92 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 219' ' ' ALA . 3.0 m -54.87 -37.93 66.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 74.55 111.164 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.06 -48.28 79.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 32.45 111.059 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.931 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.1 t -53.84 -58.52 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 54.41 111.182 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.753 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.7 t-80 -64.78 -27.65 69.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 71.24 110.931 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -64.14 -44.77 91.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 73.11 111.074 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.771 HG23 HG12 ' A' ' 159' ' ' ILE . 2.6 mt -69.33 -34.54 63.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 70.55 111.16 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -52.43 -45.25 58.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.698 -0.763 . . . . 64.22 112.494 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.488 ' O ' ' O ' ' A' ' 185' ' ' PHE . 3.8 m-70 -68.49 -40.22 81.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.784 0.326 . . . . 73.42 110.847 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 29.8 p -65.39 -21.29 66.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 75.12 110.84 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 59.6 mt -79.81 -26.84 40.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 61.51 110.941 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 122.35 12.88 5.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.699 -0.762 . . . . 54.04 112.447 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.509 HD21 ' HA ' ' A' ' 258' ' ' ILE . 11.3 mt -81.71 156.09 25.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.83 0.348 . . . . 72.11 110.933 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -99.89 -140.5 11.43 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.797 -0.716 . . . . 65.51 112.493 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -120.91 141.98 50.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.359 . . . . 70.41 110.808 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 60.9 p -99.16 163.05 12.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 72.2 110.904 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.67 1.22 21.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 55.32 110.824 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.17 132.35 73.69 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.553 0.692 . . . . 74.5 110.864 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 232' ' ' PRO . . . . . 0.403 ' HG2' ' HE2' ' A' ' 233' ' ' LYS . 52.8 Cg_endo -69.87 4.15 2.4 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.638 2.225 . . . . 51.22 112.321 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 233' ' ' LYS . . . . . 0.403 ' HE2' ' HG2' ' A' ' 232' ' ' PRO . 0.0 OUTLIER -136.01 11.12 3.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 74.03 110.884 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -88.82 150.22 23.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 73.15 111.151 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.753 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -71.73 -39.67 69.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 71.11 111.136 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.464 ' HE2' ' HB3' ' A' ' 226' ' ' LEU . 48.0 mmm -61.73 -15.12 37.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 74.14 110.861 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.618 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -56.53 144.49 63.66 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.649 0.738 . . . . 75.43 110.9 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.618 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.0 Cg_endo -69.84 -1.75 9.06 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.582 2.188 . . . . 63.2 112.313 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 22.0 m -97.88 141.07 31.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.419 . . . . 75.23 111.19 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -122.64 135.36 54.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 54.53 110.932 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -156.27 137.04 13.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 60.44 110.905 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.504 ' O ' HG13 ' A' ' 243' ' ' VAL . 66.4 t80 -59.2 146.28 39.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 73.14 110.997 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.6 OUTLIER -158.96 133.01 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 75.32 111.082 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -51.13 129.32 23.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 71.44 110.835 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.42 HD12 ' CE2' ' A' ' 213' ' ' PHE . 9.7 tt -53.84 -30.88 19.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 74.43 111.157 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -73.43 -21.15 60.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 71.52 110.926 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 69.8 p -104.05 -22.41 13.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 61.43 111.176 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -67.03 141.86 57.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 74.14 110.91 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -175.41 132.41 0.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 74.54 110.83 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.684 HD12 HG11 ' A' ' 144' ' ' VAL . 55.5 mt -49.89 122.78 7.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 75.32 110.907 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 8.6 t -65.96 167.21 10.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 73.51 110.898 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.01 -38.05 35.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 53.51 111.048 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -61.86 -49.12 77.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 65.53 110.826 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.436 ' OD2' ' HB ' ' A' ' 235' ' ' VAL . 2.0 m-20 -59.25 -55.79 30.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.244 -0.435 . . . . 73.44 110.813 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 18.3 mt -59.68 -33.46 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 61.01 111.201 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -69.2 -41.06 77.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 71.24 110.874 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.84 -49.87 7.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.75 -0.738 . . . . 73.34 112.542 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.548 HG13 HG21 ' A' ' 145' ' ' THR . 7.5 tp -53.08 -33.67 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.72 0.295 . . . . 73.43 111.098 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.412 ' O ' ' N ' ' A' ' 263' ' ' GLY . 52.8 mt-30 -88.21 -16.21 33.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.485 . . . . 75.33 110.933 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.7 t -69.54 -14.16 62.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 73.2 110.826 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.99 -18.65 5.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.144 -0.48 . . . . 75.44 110.934 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.788 ' CD2' HD11 ' A' ' 147' ' ' LEU . 41.1 m-85 -114.3 -32.88 5.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 74.35 110.896 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.369 0 CA-C-O 119.22 -0.767 . . . . 64.12 112.468 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.615 ' HA ' HD12 ' A' ' 147' ' ' LEU . 2.1 p80 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.876 0.369 . . . . 71.13 110.894 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -144.62 90.94 2.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 74.41 110.972 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.587 HG22 ' N ' ' A' ' 115' ' ' THR . 5.0 mp -121.09 162.49 19.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 75.5 111.216 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.587 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -160.09 162.71 34.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 62.34 111.102 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.594 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.1 p90 -133.4 149.71 51.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.496 . . . . 74.42 110.952 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.688 ' HD2' HD11 ' A' ' 160' ' ' LEU . 3.9 tmt_? -142.5 115.06 8.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 72.35 110.823 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 52.7 mt -75.35 103.43 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 70.43 111.128 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -57.15 -45.72 83.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 74.21 110.933 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.736 ' OD1' HG23 ' A' ' 162' ' ' VAL . 1.7 p-10 -145.01 161.38 39.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.431 . . . . 65.24 110.914 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.57 ' CD2' HG11 ' A' ' 130' ' ' VAL . 4.7 m-85 -115.53 134.05 55.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 62.0 110.906 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.708 HG22 ' CE ' ' A' ' 125' ' ' MET . 2.3 t -82.41 142.05 46.32 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.55 0.691 . . . . 72.55 111.195 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.89 -5.78 17.11 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.646 2.231 . . . . 64.25 112.308 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -77.07 -22.15 53.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.439 . . . . 62.43 110.876 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.708 ' CE ' HG22 ' A' ' 122' ' ' THR . 18.2 mtm -117.74 167.15 11.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 71.12 110.884 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.41 ' O ' HG23 ' A' ' 130' ' ' VAL . 45.6 t30 -94.09 143.17 26.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 74.35 110.934 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -44.72 -35.23 2.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.226 -0.443 . . . . 70.44 110.853 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -84.26 -38.35 20.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 74.13 110.932 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -65.7 -30.02 70.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 63.24 110.783 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.612 HG22 ' CE ' ' A' ' 125' ' ' MET . 79.7 t -66.79 -46.78 84.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 32.13 111.07 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -77.22 -24.29 51.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 61.25 110.894 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -73.89 -47.01 41.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 64.11 110.91 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.886 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -68.93 -32.19 71.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 63.14 111.134 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.616 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -74.72 -53.65 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 71.04 111.161 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.526 ' N ' HG22 ' A' ' 134' ' ' ILE . 6.8 ptp180 -49.18 -38.07 24.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 72.33 110.937 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.652 ' O ' HG23 ' A' ' 140' ' ' VAL . 1.6 mmtp -77.18 -31.93 55.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 74.35 110.916 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.917 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -61.58 -49.14 77.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 43.15 111.066 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.665 ' HE2' HD13 ' A' ' 159' ' ' ILE . 95.6 m-85 -72.82 -22.09 60.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 74.01 110.844 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -77.4 -5.54 50.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 61.14 110.888 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 136' ' ' LYS . 97.8 t -98.11 -17.21 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 73.23 111.152 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.855 ' NE1' HG12 ' A' ' 217' ' ' VAL . 95.9 m95 -106.87 -37.19 6.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 73.51 110.906 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.25 -10.84 60.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 73.13 110.815 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -97.07 -19.4 18.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 65.1 110.939 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.81 HG11 HD12 ' A' ' 250' ' ' LEU . 18.3 m -100.23 -2.27 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.47 . . . . 71.22 111.075 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.739 ' CB ' HD23 ' A' ' 147' ' ' LEU . 34.3 p -142.39 147.45 43.36 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.517 0.675 . . . . 72.43 111.212 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.79 34.72 0.21 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.649 2.233 . . . . 60.25 112.336 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.909 HD21 ' HB3' ' A' ' 262' ' ' TYR . 3.0 mm? -104.57 166.47 10.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 61.43 110.883 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -128.99 125.69 37.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 50.43 110.926 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.46 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.3 m-30 -114.55 143.49 44.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 70.01 110.909 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.405 ' H ' ' HA ' ' A' ' 115' ' ' THR . 44.4 m -140.75 148.24 40.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 75.1 110.821 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.424 ' HD2' ' CD2' ' A' ' 116' ' ' TYR . 12.4 tptm -97.36 146.13 25.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 75.42 110.813 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.614 HD11 ' N ' ' A' ' 157' ' ' ALA . 16.3 pt -150.31 142.85 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 62.15 111.076 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 65.41 111.007 179.801 . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.614 ' N ' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.825 0.345 . . . . 61.31 111.141 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.409 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.3 OUTLIER -82.51 -52.87 6.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 65.1 110.813 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.724 HG12 HG23 ' A' ' 220' ' ' ILE . 2.4 mp -91.52 97.96 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 75.05 111.151 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.688 HD11 ' HD2' ' A' ' 117' ' ' ARG . 6.9 tp -88.8 110.69 21.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.176 -0.466 . . . . 73.42 110.947 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 90.6 t -88.81 119.51 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 70.51 111.16 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.736 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -138.82 104.52 2.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.174 -0.467 . . . . 72.12 111.238 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -70.98 110.48 5.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 64.03 110.891 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.464 ' CB ' ' CD2' ' A' ' 168' ' ' HIS . . . -130.32 166.38 20.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 51.41 111.054 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 21.3 ptt-85 -114.7 140.0 49.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 55.32 110.82 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.664 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 41.39 -150.85 0.2 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.761 -0.733 . . . . 63.4 112.471 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.804 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -70.21 117.33 11.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.773 0.32 . . . . 71.1 111.122 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.498 ' NE2' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.99 -21.09 12.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 75.13 110.778 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.29 29.4 0.66 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 64.33 112.587 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.646 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.46 0.03 15.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.78 0.324 . . . . 74.21 110.863 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 74.32 38.95 0.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 75.33 110.916 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.58 ' ND1' ' N ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -134.74 -41.02 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 70.42 110.849 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.804 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 53.44 99.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 61.24 111.098 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.664 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.9 m-85 -59.88 -168.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 53.3 110.861 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.59 19.11 3.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.195 -0.457 . . . . 74.41 110.96 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.591 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.62 -157.09 6.88 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 74.2 112.48 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -35.23 134.46 0.27 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.836 0.351 . . . . 61.51 110.89 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.45 165.44 0.15 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.659 -0.781 . . . . 54.32 112.467 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.96 -143.34 22.13 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.749 . . . . 53.42 112.447 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -49.95 97.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.869 0.366 . . . . 73.43 111.166 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.9 mt -67.75 -38.65 83.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 73.3 110.946 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.431 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -172.72 167.87 5.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 54.01 111.047 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.522 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -161.13 143.04 12.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 74.34 110.89 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.667 ' HB1' ' HB2' ' A' ' 223' ' ' SER . . . -134.94 176.44 8.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.304 -0.407 . . . . 74.1 111.048 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.436 ' O ' ' O ' ' A' ' 222' ' ' HIS . 7.9 m-85 -100.77 -120.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 71.41 110.947 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 223' ' ' SER . . . 166.75 -92.74 0.1 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.715 -0.755 . . . . 44.51 112.501 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.91 55.37 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.615 2.21 . . . . 62.13 112.369 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.57 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.32 151.52 16.93 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 53.51 112.401 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.82 145.1 30.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.898 0.38 . . . . 72.21 110.82 -179.719 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.63 -65.18 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.7 -0.762 . . . . 64.03 112.37 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 189' ' ' SER . 1.9 mp -103.63 6.81 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.855 0.36 . . . . 70.42 111.126 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.57 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -66.82 170.43 32.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.782 -0.723 . . . . 34.21 112.485 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 42.66 24.74 0.26 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.722 -0.751 . . . . 74.05 112.455 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.87 102.23 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.775 0.321 . . . . 65.4 110.911 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.582 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -77.21 128.78 34.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 54.42 111.073 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.522 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 8.5 m170 -118.53 131.15 56.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 73.51 110.827 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.459 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 51.4 m-85 -115.23 134.74 54.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 75.32 110.858 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -67.57 109.07 3.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.089 -0.505 . . . . 63.43 110.802 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.55 -37.19 80.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 73.33 111.005 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.591 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 5.0 m-20 -50.41 -22.68 1.97 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 72.14 110.825 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -79.84 163.17 24.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 74.11 110.889 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.565 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -100.64 88.23 3.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 72.32 110.938 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.533 ' HZ3' HG21 ' A' ' 215' ' ' THR . 33.6 m95 -79.48 124.71 28.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.457 . . . . 72.51 110.944 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 22.7 p -142.6 -177.79 5.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.252 -0.431 . . . . 74.43 111.178 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.07 19.76 18.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 72.52 111.219 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.11 -175.62 3.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 74.44 110.914 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.9 p -68.77 -18.31 64.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 74.44 110.826 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.18 -107.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.667 -0.777 . . . . 72.23 112.515 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.42 176.87 0.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.763 -0.732 . . . . 72.13 112.428 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 94.3 m -64.89 97.37 0.22 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.757 0.313 . . . . 74.44 111.2 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -41.45 116.42 0.76 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 74.04 110.888 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.886 HD23 ' HB3' ' A' ' 133' ' ' ALA . 8.6 tp -64.12 -38.39 90.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 51.33 110.916 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.801 ' O ' HG23 ' A' ' 217' ' ' VAL . 4.1 t80 -51.97 -66.9 0.3 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 73.22 110.939 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.477 HD11 ' H ' ' A' ' 243' ' ' VAL . 21.9 mt -52.84 -54.96 26.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.141 -0.482 . . . . 54.24 110.879 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.618 ' O ' ' HB2' ' A' ' 219' ' ' ALA . 5.1 m -54.8 -37.19 65.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 63.2 111.092 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.81 -50.57 64.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 74.14 111.115 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.917 HG22 ' HA ' ' A' ' 137' ' ' ALA . 1.8 t -52.42 -56.61 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 74.0 111.106 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.792 ' HB2' HG22 ' A' ' 235' ' ' VAL . 1.8 t-80 -69.12 -26.49 64.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 63.32 110.904 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -64.83 -45.22 87.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 71.14 111.126 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.724 HG23 HG12 ' A' ' 159' ' ' ILE . 3.1 mt -67.68 -37.41 78.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.254 -0.43 . . . . 65.31 111.149 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -52.57 -46.39 58.84 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.804 -0.712 . . . . 74.5 112.428 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.436 ' O ' ' O ' ' A' ' 185' ' ' PHE . 2.5 m-70 -69.39 -38.64 78.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.332 . . . . 70.4 110.824 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.667 ' HB2' ' HB1' ' A' ' 184' ' ' ALA . 0.3 OUTLIER -74.8 -9.77 58.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.005 0.431 . . . . 55.43 110.934 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.546 ' CD1' HG22 ' A' ' 220' ' ' ILE . 13.5 mt -90.1 -25.9 20.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 72.45 110.923 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 124.48 12.94 4.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.785 -0.722 . . . . 63.32 112.529 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.847 HD11 ' HA ' ' A' ' 258' ' ' ILE . 0.2 OUTLIER -85.61 160.99 19.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.829 0.347 . . . . 71.41 110.964 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -105.89 -144.92 12.63 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.754 -0.736 . . . . 74.42 112.487 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -115.86 146.94 41.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.775 0.321 . . . . 74.5 110.862 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 37.3 m -103.08 162.56 12.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.179 -0.464 . . . . 52.24 110.846 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.2 t -107.07 1.26 24.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 72.24 110.852 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.655 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -68.05 141.29 94.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.6 0.714 . . . . 74.22 110.801 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 -3.36 11.79 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.634 2.222 . . . . 73.23 112.384 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.72 17.16 1.99 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 63.31 110.922 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.655 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -78.06 137.94 38.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 61.34 111.024 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.792 HG22 ' HB2' ' A' ' 218' ' ' HIS . 6.9 p -63.99 -29.59 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 64.52 111.108 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 61.2 mmm -73.81 -12.61 60.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 73.53 110.89 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.664 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -59.09 146.27 78.1 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.59 0.71 . . . . 72.04 110.831 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.664 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.8 Cg_endo -69.75 1.2 4.64 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.739 2.293 . . . . 75.22 112.33 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 53.2 m -102.89 129.02 49.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 71.55 111.152 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -110.4 136.33 49.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 74.04 110.921 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -155.69 133.86 11.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 74.33 110.851 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.525 ' O ' HG13 ' A' ' 243' ' ' VAL . 71.1 t80 -59.24 147.77 34.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 74.45 110.983 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.4 OUTLIER -159.64 133.24 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 75.44 111.091 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -49.94 133.26 22.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 53.43 110.768 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 8.4 tt -55.17 -30.89 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 72.33 111.063 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -77.3 -17.43 58.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 74.24 110.836 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 66.6 p -103.21 -24.43 13.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 63.21 111.195 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -65.7 144.31 56.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 72.24 110.891 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -176.8 128.65 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 74.32 110.909 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.81 HD12 HG11 ' A' ' 144' ' ' VAL . 54.7 mt -48.66 127.14 13.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 62.35 110.875 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 38.9 m -72.05 167.27 20.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.14 110.897 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.4 -38.93 60.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.089 -0.505 . . . . 73.21 111.11 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -46.67 84.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.868 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.591 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 7.0 m-20 -61.92 -52.12 65.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.237 -0.438 . . . . 73.5 110.848 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 21.1 mt -62.99 -34.66 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 74.3 111.102 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -69.51 -40.04 77.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 71.3 110.922 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.3 -49.26 7.53 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.811 -0.709 . . . . 33.22 112.525 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.847 ' HA ' HD11 ' A' ' 226' ' ' LEU . 3.8 tp -53.01 -32.84 18.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.78 0.324 . . . . 74.42 111.142 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 263' ' ' GLY . 47.6 mt-30 -88.08 -17.38 31.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 64.22 110.889 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.4 t -69.17 -16.51 63.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 73.31 110.792 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.7 mt -118.81 -23.03 7.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 73.22 110.857 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.909 ' HB3' HD21 ' A' ' 147' ' ' LEU . 27.7 m-85 -106.3 -38.33 6.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 74.33 110.951 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.32 0 CA-C-O 119.149 -0.806 . . . . 73.51 112.446 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.429 ' HA ' HD22 ' A' ' 147' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.855 0.359 . . . . 75.24 110.905 . . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -128.74 92.47 3.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 75.42 110.926 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.67 HD13 ' HE1' ' A' ' 149' ' ' PHE . 3.9 mp -121.22 165.71 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 71.31 111.078 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.612 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -159.29 160.36 35.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 64.41 111.139 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.592 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 1.9 p90 -132.33 144.32 50.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.267 -0.424 . . . . 75.13 110.994 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.72 ' HD2' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -136.23 113.34 10.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 73.22 110.842 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 63.0 mt -76.04 105.4 4.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 74.42 111.086 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -56.2 -51.28 68.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 44.54 110.971 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.636 ' OD1' HG23 ' A' ' 162' ' ' VAL . 1.8 p-10 -141.97 166.52 24.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 60.41 110.86 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -117.07 146.22 43.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 72.04 110.923 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.717 HG22 ' CE ' ' A' ' 125' ' ' MET . 3.5 t -93.58 142.67 25.47 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 121.634 0.73 . . . . 72.41 111.125 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.89 -1.79 9.18 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.643 2.229 . . . . 73.42 112.291 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.416 ' H ' HG23 ' A' ' 122' ' ' THR . 15.7 m-20 -81.82 -23.07 36.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 71.01 110.887 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.717 ' CE ' HG22 ' A' ' 122' ' ' THR . 13.2 mtm -116.5 166.51 12.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 74.31 110.892 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.433 ' O ' HG23 ' A' ' 130' ' ' VAL . 7.4 t-20 -96.22 145.92 25.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 75.52 110.816 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -45.52 -34.91 3.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 75.52 110.887 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -83.29 -38.96 21.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 74.22 110.941 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -65.67 -29.77 70.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 61.14 110.812 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.585 HG22 ' CE ' ' A' ' 125' ' ' MET . 79.5 t -65.79 -45.86 90.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.282 -0.417 . . . . 75.25 111.132 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.75 -23.07 42.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 71.21 110.925 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -74.83 -47.78 28.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.477 . . . . 64.2 110.924 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.881 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -71.39 -31.32 67.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 65.13 110.99 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.754 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -73.87 -55.57 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.432 . . . . 64.32 111.106 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.544 ' N ' HG22 ' A' ' 134' ' ' ILE . 13.3 ttt180 -48.67 -42.91 36.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 62.41 110.85 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.688 ' O ' HG23 ' A' ' 140' ' ' VAL . 4.3 mmpt? -70.56 -34.46 72.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.43 . . . . 70.41 110.855 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.687 ' O ' HG13 ' A' ' 217' ' ' VAL . . . -60.99 -50.48 73.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 72.14 111.001 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.592 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.2 m-85 -70.97 -21.82 62.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 72.21 110.94 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.424 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 2.5 tt0 -78.71 -5.93 54.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 74.01 110.916 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 136' ' ' LYS . 95.3 t -95.59 -17.41 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 54.22 111.096 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.886 ' NE1' HG12 ' A' ' 217' ' ' VAL . 95.8 m95 -105.47 -36.73 7.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.211 -0.449 . . . . 64.13 110.896 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.98 -11.94 61.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 72.44 110.846 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 139' ' ' GLN . 2.5 m120 -94.5 -18.57 21.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 74.33 110.909 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.808 HG11 HD12 ' A' ' 250' ' ' LEU . 16.9 m -98.03 2.5 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 64.22 111.189 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.487 ' C ' ' H ' ' A' ' 147' ' ' LEU . 49.9 p -151.2 149.11 23.93 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.619 0.723 . . . . 44.32 111.146 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 31.57 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.665 2.244 . . . . 62.02 112.345 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.801 HD11 ' CG ' ' A' ' 262' ' ' TYR . 14.4 mt -98.46 173.41 6.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 65.43 110.895 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -137.59 127.33 25.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 75.44 110.893 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.67 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.5 m-30 -114.47 143.8 44.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 70.14 110.851 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.2 t -138.85 147.87 43.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.12 -0.491 . . . . 72.31 110.845 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.47 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 2.6 tptm -97.42 141.84 30.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.494 . . . . 71.12 110.922 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.533 HD11 ' N ' ' A' ' 157' ' ' ALA . 17.2 pt -150.07 133.23 7.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 72.45 111.13 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.2 m120 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 74.4 110.915 179.991 . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.533 ' N ' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.773 0.32 . . . . 73.35 111.116 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 192' ' ' GLY . 1.1 t0 -82.88 -53.03 6.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.226 -0.443 . . . . 73.53 110.799 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.618 HG12 HG23 ' A' ' 220' ' ' ILE . 2.8 mp -91.06 97.91 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.26 -0.427 . . . . 71.41 111.145 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.72 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.1 tp -87.4 109.92 19.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.133 -0.485 . . . . 74.35 111.009 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.459 HG13 ' CE1' ' A' ' 197' ' ' PHE . 95.9 t -88.01 123.22 40.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 64.03 111.109 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.636 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -142.1 105.56 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 64.43 111.143 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -71.61 108.22 4.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 60.54 110.845 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.476 ' HB3' ' CD2' ' A' ' 168' ' ' HIS . . . -128.1 166.19 18.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 75.31 111.089 179.916 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 -114.25 137.25 52.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 75.41 110.831 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.68 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.3 -154.92 0.2 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.761 -0.733 . . . . 71.41 112.458 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.806 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.64 116.96 7.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 52.23 111.094 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.504 ' NE2' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.96 -22.69 12.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 73.33 110.855 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.76 28.86 0.55 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.675 -0.774 . . . . 64.04 112.527 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.624 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.43 0.14 15.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.778 0.323 . . . . 72.41 110.837 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 74.04 39.08 0.53 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 71.31 110.927 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.576 ' ND1' ' N ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -134.38 -40.94 0.8 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 64.3 110.861 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.806 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 53.8 99.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 55.31 111.131 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.68 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.1 m-85 -60.63 -168.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 72.42 110.903 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.75 19.03 3.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 75.21 110.837 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.5 -158.1 6.1 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.766 -0.73 . . . . 42.42 112.492 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 176' ' ' GLY . 2.1 ttmm -34.25 134.22 0.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.351 . . . . 74.3 110.828 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.4 165.55 0.15 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.826 -0.702 . . . . 73.44 112.524 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.37 -144.01 23.16 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.81 -0.71 . . . . 73.32 112.533 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -49.51 97.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 72.41 111.152 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.9 mt -67.04 -41.88 85.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 73.35 110.953 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -169.52 169.34 8.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 71.15 111.138 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.491 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -163.24 143.54 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 75.45 110.884 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.669 ' HB1' ' HB3' ' A' ' 223' ' ' SER . . . -135.44 174.79 10.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 71.23 111.159 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.534 ' O ' ' O ' ' A' ' 222' ' ' HIS . 94.9 m-85 -96.93 -122.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 64.02 110.905 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 223' ' ' SER . . . 172.21 -98.34 0.13 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.721 -0.752 . . . . 32.13 112.431 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 57.13 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.686 2.257 . . . . 71.44 112.321 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.568 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -122.16 153.12 16.82 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.772 -0.728 . . . . 71.13 112.557 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.63 145.92 29.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 63.21 110.841 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.67 -64.71 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.742 -0.742 . . . . 63.25 112.554 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 189' ' ' SER . 1.2 mp -104.88 6.18 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.805 0.336 . . . . 70.14 111.099 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.568 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -64.66 168.14 27.96 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.702 -0.761 . . . . 71.21 112.486 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 42.77 23.2 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.757 -0.735 . . . . 72.44 112.43 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.422 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 0.9 OUTLIER -66.52 99.34 0.57 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.806 0.336 . . . . 75.11 110.856 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.625 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -74.0 132.87 42.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 73.33 111.069 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.8 m170 -123.41 131.27 53.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 71.3 110.923 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.459 ' CE1' HG13 ' A' ' 161' ' ' VAL . 40.9 m-85 -115.5 135.07 54.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 71.34 110.866 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -68.03 107.48 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 64.14 110.827 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.54 -35.93 75.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 71.0 110.904 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.582 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 15.6 m-20 -51.47 -21.59 2.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 73.13 110.83 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -81.39 163.29 22.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 72.03 110.893 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.577 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -101.75 85.96 2.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 75.12 110.917 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.634 ' CZ3' HG21 ' A' ' 215' ' ' THR . 30.9 m95 -76.62 123.58 26.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.107 -0.497 . . . . 72.33 110.862 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 35.8 p -141.54 -178.01 5.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 73.22 111.151 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.45 20.94 17.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 72.25 111.129 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -127.81 -172.97 2.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.432 . . . . 74.41 110.903 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.1 p -73.14 -18.84 61.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 73.3 110.856 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -61.24 -104.91 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.751 -0.737 . . . . 71.52 112.427 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.577 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -51.77 176.18 0.1 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 70.42 112.462 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 73.1 m -65.9 97.62 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 73.11 111.14 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -41.88 116.46 0.8 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 65.15 110.885 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.881 HD23 ' HB3' ' A' ' 133' ' ' ALA . 7.0 tp -65.44 -36.74 84.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 74.34 110.945 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.636 ' CA ' ' HB1' ' A' ' 133' ' ' ALA . 3.6 t80 -51.88 -64.85 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 73.15 110.87 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.485 HD11 ' H ' ' A' ' 243' ' ' VAL . 15.1 mt -56.47 -52.98 62.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.22 -0.445 . . . . 54.43 110.911 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.634 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 8.0 m -53.69 -38.01 63.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 63.4 111.184 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 137' ' ' ALA . . . -62.97 -50.89 68.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 43.12 111.14 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.886 HG12 ' NE1' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -52.16 -57.58 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 73.35 111.17 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.706 ' HB2' HG13 ' A' ' 235' ' ' VAL . 4.3 t-80 -65.29 -29.09 69.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.112 -0.494 . . . . 55.11 110.891 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -64.42 -46.66 82.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 53.44 111.059 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.618 HG23 HG12 ' A' ' 159' ' ' ILE . 2.4 mt -69.2 -35.5 68.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.285 -0.416 . . . . 74.45 111.126 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -51.98 -46.34 55.68 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.845 -0.693 . . . . 53.32 112.396 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.534 ' O ' ' O ' ' A' ' 185' ' ' PHE . 3.0 m-70 -69.54 -40.11 77.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.835 0.35 . . . . 52.33 110.824 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.669 ' HB3' ' HB1' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -72.23 -11.37 60.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.17 -0.468 . . . . 72.11 110.881 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 21.4 mt -88.88 -25.11 22.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 75.44 110.872 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 122.66 11.19 5.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.741 . . . . 73.11 112.515 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.879 HD11 ' HA ' ' A' ' 258' ' ' ILE . 0.2 OUTLIER -88.52 152.4 21.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.37 . . . . 74.34 110.891 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -98.02 -141.25 12.02 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.788 -0.72 . . . . 75.44 112.52 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -112.95 141.94 46.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.846 0.355 . . . . 74.31 110.844 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 49.4 m -92.23 160.55 15.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 74.31 110.801 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.2 t -109.68 9.75 24.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 61.11 110.874 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 234' ' ' ALA . 0.1 OUTLIER -80.95 143.32 53.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.562 0.696 . . . . 62.14 110.929 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -3.87 12.92 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.765 2.31 . . . . 71.11 112.289 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.27 30.8 1.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 72.43 110.836 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.693 ' HB1' ' OD1' ' A' ' 254' ' ' ASP . . . -92.59 145.54 24.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 62.34 111.162 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.706 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.5 t -65.46 -42.2 92.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 75.32 111.226 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.428 ' HE3' ' CE1' ' A' ' 222' ' ' HIS . 54.0 mmm -64.74 -14.66 59.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 73.23 110.902 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.67 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.0 t80 -57.72 146.24 66.95 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.621 0.724 . . . . 62.34 110.874 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.67 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.1 Cg_endo -69.77 1.0 4.83 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.662 2.241 . . . . 71.32 112.42 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 38.6 m -102.17 130.0 48.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 74.14 111.144 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -113.78 135.85 53.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 74.11 110.922 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -155.51 137.39 14.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 64.22 110.825 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.534 ' O ' HG13 ' A' ' 243' ' ' VAL . 65.9 t80 -62.0 145.21 53.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 65.12 110.939 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -160.29 133.31 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.5 . . . . 71.14 111.077 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -57.47 131.32 49.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 74.13 110.903 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.532 HD11 ' HD3' ' A' ' 136' ' ' LYS . 16.7 tt -53.2 -30.25 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 73.42 111.161 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.95 -21.85 65.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 73.22 110.859 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.8 p -110.84 -19.63 12.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 44.52 111.173 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -67.44 142.78 56.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 73.54 110.911 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -176.32 132.36 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 73.21 110.919 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.808 HD12 HG11 ' A' ' 144' ' ' VAL . 43.9 mt -49.26 132.64 19.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.452 . . . . 65.15 110.999 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 32.9 t -74.15 172.8 11.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 64.25 110.853 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.1 -37.61 72.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.115 -0.493 . . . . 73.44 111.112 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -64.33 -50.56 67.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 60.34 110.928 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.693 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 5.0 m-20 -59.06 -50.91 72.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 71.34 110.917 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 20.5 mt -63.46 -34.07 65.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 75.24 111.214 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -69.65 -40.19 76.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 72.21 110.872 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -76.65 -50.0 7.52 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.731 -0.747 . . . . 74.33 112.486 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.879 ' HA ' HD11 ' A' ' 226' ' ' LEU . 3.8 tp -53.5 -33.63 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.299 . . . . 64.13 111.061 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' A' ' 263' ' ' GLY . 70.8 mt-30 -88.16 -16.1 34.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 75.24 110.903 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 2.5 t -69.23 -15.25 63.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 61.05 110.849 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.6 mt -122.83 -18.61 6.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.085 -0.507 . . . . 64.51 110.915 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.801 ' CG ' HD11 ' A' ' 147' ' ' LEU . 38.4 m-85 -113.77 -33.9 5.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 74.21 110.931 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.362 0 CA-C-O 119.155 -0.803 . . . . 61.15 112.481 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.564 ' HA ' ' CD1' ' A' ' 147' ' ' LEU . 1.8 p80 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.779 0.323 . . . . 61.43 110.897 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -146.21 92.87 2.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.204 -0.453 . . . . 73.51 110.93 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.577 HG22 ' N ' ' A' ' 115' ' ' THR . 4.9 mp -122.66 162.61 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 75.41 111.086 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.577 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -158.66 163.32 37.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 63.25 111.18 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.608 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.7 p90 -133.68 148.29 51.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.239 -0.437 . . . . 74.32 110.915 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.57 ' HD2' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -140.37 112.61 7.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 74.1 110.912 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.2 mt -74.16 105.31 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 73.1 111.172 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -56.59 -45.96 81.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 72.3 110.81 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -150.1 169.12 22.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 75.11 110.872 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.595 ' CE2' HG11 ' A' ' 130' ' ' VAL . 4.6 m-85 -117.09 157.83 25.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 73.24 110.916 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.509 HG23 ' HG3' ' A' ' 125' ' ' MET . 0.1 OUTLIER -107.95 146.7 34.02 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.634 0.73 . . . . 65.31 111.204 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 -2.49 10.29 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.711 2.274 . . . . 72.03 112.25 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -83.64 -25.82 30.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.314 -0.403 . . . . 72.23 110.936 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.689 ' CE ' HG22 ' A' ' 130' ' ' VAL . 6.9 mtm -114.66 164.14 14.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 72.14 110.77 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.529 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.9 OUTLIER -96.43 143.76 27.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 71.14 110.974 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -45.09 -37.05 3.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.443 . . . . 75.21 110.836 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -82.92 -36.11 25.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 75.55 110.792 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -67.69 -29.46 68.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 55.23 110.871 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.689 HG22 ' CE ' ' A' ' 125' ' ' MET . 94.9 t -66.56 -46.58 85.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.219 -0.446 . . . . 54.24 111.148 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.447 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 10.1 t0 -77.13 -25.82 52.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 65.13 110.866 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -72.72 -49.26 32.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 72.11 110.931 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.627 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -69.44 -30.42 68.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 75.2 111.09 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.693 HD13 HD21 ' A' ' 212' ' ' LEU . 1.2 mp -74.64 -53.77 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 61.31 111.128 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.507 ' N ' HG22 ' A' ' 134' ' ' ILE . 7.2 ptp180 -49.45 -35.4 19.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 71.2 110.911 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.614 ' O ' HG23 ' A' ' 140' ' ' VAL . 6.8 mmtp -78.85 -34.1 45.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 64.42 110.873 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.653 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -61.07 -49.16 78.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 72.01 111.059 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.608 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 89.4 m-85 -70.39 -23.54 62.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.419 . . . . 65.3 110.966 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.47 ' O ' ' HB3' ' A' ' 143' ' ' ASN . 0.2 OUTLIER -75.4 -15.11 60.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 55.44 110.936 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 136' ' ' LYS . 93.6 t -85.03 -19.62 8.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.459 . . . . 71.03 111.147 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.844 ' NE1' HG12 ' A' ' 217' ' ' VAL . 96.9 m95 -104.74 -27.0 12.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 74.51 110.916 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.63 -7.59 59.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 72.33 110.846 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 139' ' ' GLN . 0.1 OUTLIER -99.15 -18.39 17.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 73.14 110.867 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.773 HG23 HG23 ' A' ' 145' ' ' THR . 28.9 m -100.14 -7.9 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 73.52 111.139 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.773 HG23 HG23 ' A' ' 144' ' ' VAL . 32.5 p -141.97 147.21 43.75 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.642 0.734 . . . . 74.23 111.096 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 32.43 0.19 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.718 2.279 . . . . 74.54 112.27 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.768 HD21 ' HB3' ' A' ' 262' ' ' TYR . 3.8 mm? -94.49 170.07 9.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.307 -0.406 . . . . 71.31 111.004 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.24 126.35 29.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 63.42 110.92 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.441 ' HE1' HD13 ' A' ' 114' ' ' ILE . 2.4 m-85 -117.53 144.04 45.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 74.45 110.796 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.403 ' H ' ' HA ' ' A' ' 115' ' ' THR . 6.1 t -137.66 153.03 49.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 74.03 110.844 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 10.7 tttt -103.37 146.31 28.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 75.42 110.928 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 157' ' ' ALA . 24.7 pt -152.12 143.89 15.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 63.33 111.167 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 64.54 110.829 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.526 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.733 0.301 . . . . 61.43 111.077 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.412 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.7 OUTLIER -86.63 -52.82 5.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 70.44 110.795 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.674 HG12 HG23 ' A' ' 220' ' ' ILE . 2.6 mp -90.4 95.86 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 73.13 111.042 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.57 HD11 ' HD2' ' A' ' 117' ' ' ARG . 8.4 tp -86.75 108.92 18.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 73.14 110.865 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.464 HG13 ' CE1' ' A' ' 197' ' ' PHE . 96.7 t -87.85 120.02 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 74.15 111.142 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 p -138.72 104.31 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 61.45 111.169 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.448 ' CZ ' ' HE1' ' A' ' 125' ' ' MET . 35.5 m-85 -73.73 106.49 5.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 74.13 110.926 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.519 ' HB3' ' CD2' ' A' ' 168' ' ' HIS . . . -129.03 164.13 23.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 75.22 111.103 179.976 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -110.87 140.72 45.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 64.31 110.885 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.7 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.67 -151.56 0.31 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.732 -0.747 . . . . 34.21 112.542 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.806 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -68.74 119.24 12.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.79 0.329 . . . . 74.51 111.084 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.519 ' CD2' ' HB3' ' A' ' 164' ' ' ALA . 0.4 OUTLIER -111.17 -21.55 11.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 72.24 110.842 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.16 30.67 0.56 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.724 -0.751 . . . . 40.22 112.466 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.634 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -114.26 0.23 14.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.87 0.367 . . . . 62.14 110.835 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 74.13 38.91 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 75.04 110.796 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.586 ' ND1' ' N ' ' A' ' 173' ' ' ALA . 0.4 OUTLIER -134.71 -41.04 0.77 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.164 -0.471 . . . . 73.34 110.842 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.806 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 52.94 100.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 63.11 111.153 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.7 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.6 m-85 -60.72 -169.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 73.42 110.883 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 175' ' ' ASP . . . . . 0.442 ' OD2' ' HA3' ' A' ' 179' ' ' GLY . 40.9 p30 -134.07 18.92 3.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 73.22 110.945 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.578 ' HA2' ' CB ' ' A' ' 200' ' ' ASP . . . 57.81 -162.12 9.43 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.743 -0.741 . . . . 73.42 112.519 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -35.3 136.94 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 70.24 110.963 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.76 155.56 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.734 -0.746 . . . . 73.51 112.469 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.442 ' HA3' ' OD2' ' A' ' 175' ' ' ASP . . . 86.04 -142.68 19.22 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.647 -0.787 . . . . 73.02 112.366 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 180' ' ' ILE . . . . . 0.415 HG22 ' HE1' ' A' ' 174' ' ' PHE . 2.0 mt -48.68 98.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.81 0.338 . . . . 72.42 111.213 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 33.8 mt -71.4 -42.96 67.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 74.13 110.952 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -170.03 154.35 5.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 73.14 111.145 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.491 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.1 p80 -148.36 141.65 25.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 74.23 110.857 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.744 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -137.97 172.78 12.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 24.24 111.145 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 223' ' ' SER . 37.5 m-85 -102.85 -149.65 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 73.44 110.853 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -162.66 -86.6 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.84 -0.695 . . . . 73.01 112.593 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 55.8 1.31 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.661 2.241 . . . . 70.22 112.346 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.585 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -124.31 150.39 17.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.79 -0.719 . . . . 51.13 112.427 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.46 147.28 27.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 74.11 110.884 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.17 -64.73 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.715 -0.755 . . . . 65.22 112.525 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.537 ' N ' ' O ' ' A' ' 189' ' ' SER . 21.9 pt -105.81 7.69 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.873 0.368 . . . . 74.43 111.112 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.585 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -67.55 168.04 39.81 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.777 -0.725 . . . . 73.3 112.502 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 46.35 18.41 0.32 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.743 -0.741 . . . . 73.2 112.523 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.09 108.72 1.61 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.881 0.372 . . . . 65.01 110.789 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.744 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -83.32 127.69 33.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 45.42 111.114 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.2 m170 -118.37 127.0 53.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 73.42 110.866 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.531 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 37.9 m-85 -111.09 132.04 54.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 72.31 110.848 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -65.08 107.75 1.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 72.35 110.902 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 199' ' ' GLU . . . . . 0.408 ' O ' ' CD ' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -58.72 -38.41 78.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.187 -0.461 . . . . 71.33 110.905 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.578 ' CB ' ' HA2' ' A' ' 176' ' ' GLY . 19.3 m-20 -49.92 -21.32 1.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 63.03 110.835 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -81.31 164.39 22.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 63.41 110.903 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.499 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.4 OUTLIER -100.94 89.75 3.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 75.55 110.862 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.531 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 31.1 m95 -81.87 122.33 27.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 64.45 110.904 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.8 p -137.35 -175.27 4.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 75.3 111.147 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.35 15.68 19.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 74.42 111.138 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -129.73 -174.81 3.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 63.35 110.917 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.7 p -54.79 -34.91 63.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 73.31 110.855 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -65.8 162.54 41.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.759 -0.734 . . . . 62.12 112.483 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . 48.65 -172.38 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.748 . . . . 61.41 112.571 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 29.8 m -87.3 93.53 9.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.85 0.357 . . . . 71.43 111.125 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -40.06 110.85 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 54.43 110.921 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.693 HD21 HD13 ' A' ' 134' ' ' ILE . 6.9 tp -57.28 -40.86 78.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 65.21 110.948 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.627 ' CA ' ' HB1' ' A' ' 133' ' ' ALA . 2.6 t80 -48.23 -64.27 0.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 63.43 110.923 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.517 HD11 ' H ' ' A' ' 243' ' ' VAL . 17.4 mt -55.81 -52.3 64.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.135 -0.484 . . . . 70.52 110.865 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.515 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 1.0 OUTLIER -54.12 -37.31 64.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 75.45 111.134 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.8 -51.57 64.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 73.31 111.04 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.844 HG12 ' NE1' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -49.96 -57.5 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 72.05 111.106 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.713 ' HB2' HG13 ' A' ' 235' ' ' VAL . 3.6 t-80 -66.32 -29.37 69.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.278 -0.419 . . . . 70.25 110.9 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -63.5 -42.76 98.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 75.11 111.069 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.674 HG23 HG12 ' A' ' 159' ' ' ILE . 2.2 mt -71.57 -35.0 54.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.263 -0.426 . . . . 71.43 111.232 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.45 -43.34 44.5 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.623 -0.798 . . . . 53.24 112.495 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 185' ' ' PHE . 32.7 m-70 -69.27 -39.9 78.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.797 0.332 . . . . 71.2 110.86 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.625 ' OG ' HG23 ' A' ' 159' ' ' ILE . 3.4 m -62.54 -27.03 68.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 44.43 110.807 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 74.2 mt -75.72 -27.39 58.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.244 -0.435 . . . . 62.24 110.988 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 118.0 16.16 5.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.691 -0.766 . . . . 63.45 112.521 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.842 HD11 ' CD1' ' A' ' 258' ' ' ILE . 29.3 mt -80.78 155.06 26.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.874 0.369 . . . . 72.35 110.856 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -98.43 -137.09 9.56 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.7 -0.762 . . . . 60.23 112.513 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.471 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 0.0 OUTLIER -125.34 149.78 47.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.861 0.362 . . . . 72.31 110.848 -179.916 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 67.7 m -110.87 163.88 13.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 74.15 110.886 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.66 -3.01 25.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 63.14 110.892 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.533 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -67.75 137.23 92.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.598 0.713 . . . . 71.42 110.872 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -3.86 12.91 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.694 2.262 . . . . 61.53 112.311 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.21 3.07 3.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 74.13 110.852 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.533 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -74.98 128.51 35.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 73.35 111.109 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.713 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -55.33 -34.53 33.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 74.01 111.187 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.471 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 41.9 mmm -62.21 -21.18 64.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 74.01 110.937 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.541 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -56.72 142.65 71.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.582 0.706 . . . . 73.21 110.895 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.541 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.9 Cg_endo -69.74 -2.24 9.82 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.647 2.231 . . . . 71.51 112.382 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 42.1 m -93.7 143.14 26.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 53.03 111.066 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -123.68 140.48 52.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 74.03 110.918 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.32 128.01 3.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 71.11 110.917 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.502 ' O ' HG13 ' A' ' 243' ' ' VAL . 84.3 t80 -54.01 144.55 18.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 63.34 110.94 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.517 ' H ' HD11 ' A' ' 214' ' ' LEU . 1.1 m -158.27 130.78 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 54.22 111.223 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -52.33 133.01 34.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 74.4 110.925 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.414 HD12 ' CE2' ' A' ' 213' ' ' PHE . 9.2 tt -53.57 -29.46 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 72.21 111.171 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.16 -21.12 63.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 64.11 110.909 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 44.3 p -109.95 -20.66 12.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 75.53 111.201 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.444 ' HE2' HG21 ' A' ' 217' ' ' VAL . 9.9 t80 -72.47 130.69 41.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 64.33 110.863 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -166.87 137.33 3.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.482 . . . . 74.24 110.877 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.631 HD12 HG11 ' A' ' 144' ' ' VAL . 64.5 mt -49.36 124.19 8.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.247 -0.433 . . . . 61.33 110.881 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 8.4 t -70.26 166.62 19.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 52.2 110.87 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.63 -40.75 40.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 73.14 111.063 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.8 -45.76 93.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 75.33 110.948 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.592 ' O ' HG22 ' A' ' 258' ' ' ILE . 5.2 m-20 -62.99 -54.62 35.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.11 -0.496 . . . . 64.22 110.827 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 18.7 mt -61.87 -28.08 43.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 75.3 111.144 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -75.26 -41.47 57.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 65.15 110.848 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -76.92 -50.46 6.92 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.732 -0.746 . . . . 64.22 112.491 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.842 ' CD1' HD11 ' A' ' 226' ' ' LEU . 3.3 tp -54.55 -32.9 25.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.748 0.308 . . . . 71.32 111.097 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.457 ' O ' ' N ' ' A' ' 263' ' ' GLY . 36.8 mt-30 -87.84 -16.78 33.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 75.41 110.885 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 2.5 t -68.21 -15.51 63.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 74.15 110.783 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 5.8 mt -120.34 -20.68 7.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 75.45 110.917 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.768 ' HB3' HD21 ' A' ' 147' ' ' LEU . 34.8 m-85 -111.56 -36.45 5.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 72.03 110.991 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.355 0 CA-C-O 119.147 -0.807 . . . . 54.4 112.555 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.7 p80 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.853 0.359 . . . . 72.51 110.861 . . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -137.9 103.26 4.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.472 . . . . 71.41 110.948 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.566 HG22 ' N ' ' A' ' 115' ' ' THR . 5.4 mp -132.2 160.66 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 71.41 111.156 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.566 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -157.98 164.46 36.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.227 -0.442 . . . . 75.3 111.059 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.607 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.9 p90 -134.53 149.14 50.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 72.22 110.938 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.544 ' HD2' HD11 ' A' ' 160' ' ' LEU . 4.1 tmt_? -142.44 113.84 7.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 62.31 110.943 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' ILE . . . . . 0.421 HD12 ' OH ' ' A' ' 121' ' ' TYR . 48.4 mt -74.87 106.24 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 53.33 111.075 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -59.41 -47.03 87.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 75.34 110.932 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.735 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.0 p-10 -142.71 161.84 37.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 72.53 110.96 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.695 ' CE2' HG11 ' A' ' 130' ' ' VAL . 4.7 m-85 -117.4 146.75 43.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.454 . . . . 71.44 110.926 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.505 HG22 ' HE1' ' A' ' 125' ' ' MET . 2.1 t -93.39 141.28 23.74 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.536 0.684 . . . . 63.25 111.167 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -1.66 8.87 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.732 2.288 . . . . 61.3 112.289 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.11 -30.26 31.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.268 -0.424 . . . . 74.22 110.868 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.706 ' HE3' HG22 ' A' ' 130' ' ' VAL . 8.1 mtm -108.06 163.63 12.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 74.32 110.918 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 126' ' ' ASN . . . . . 0.527 ' O ' HG23 ' A' ' 130' ' ' VAL . 2.8 m120 -95.02 146.42 24.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 71.24 110.842 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.33 -32.52 3.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 71.32 110.919 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -83.73 -38.94 20.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 74.34 110.917 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -66.0 -30.26 70.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 64.13 110.853 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.706 HG22 ' HE3' ' A' ' 125' ' ' MET . 84.7 t -65.2 -47.01 89.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 55.31 111.158 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.12 -24.1 47.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 74.33 110.806 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -73.12 -47.02 47.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 63.32 110.887 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.75 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -72.31 -31.21 65.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 75.13 111.065 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.669 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -73.93 -54.15 15.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 64.21 111.148 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.526 ' N ' HG22 ' A' ' 134' ' ' ILE . 4.2 ttm180 -48.88 -43.03 38.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 72.31 110.812 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.686 ' O ' HG23 ' A' ' 140' ' ' VAL . 5.1 mmpt? -70.79 -34.64 71.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 55.31 110.939 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.918 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.07 -49.36 77.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 74.13 111.128 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.639 ' HE1' HD13 ' A' ' 159' ' ' ILE . 95.8 m-85 -72.68 -22.19 60.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 64.5 110.883 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -78.0 -6.34 54.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.068 -0.514 . . . . 72.12 110.927 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 136' ' ' LYS . 99.1 t -97.65 -16.93 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 71.22 111.056 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.829 ' NE1' HG12 ' A' ' 217' ' ' VAL . 89.9 m95 -106.33 -37.74 6.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 72.3 110.921 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.18 -12.54 61.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 42.1 110.831 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -93.6 -19.47 21.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 74.41 110.866 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.782 HG11 HD12 ' A' ' 250' ' ' LEU . 17.8 m -98.91 3.19 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 63.3 111.214 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.514 HG21 HG13 ' A' ' 258' ' ' ILE . 23.4 p -149.46 145.04 18.53 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.603 0.716 . . . . 75.25 111.097 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.75 29.96 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.711 2.274 . . . . 73.43 112.344 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.729 HD21 ' CD1' ' A' ' 262' ' ' TYR . 5.0 mp -96.88 176.91 5.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 71.55 110.94 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -137.51 126.58 24.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 71.23 110.923 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.414 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.8 m-30 -112.76 145.29 40.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 73.53 110.88 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.431 ' H ' ' HA ' ' A' ' 115' ' ' THR . 3.1 t -139.34 155.2 47.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 72.45 110.789 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.5 OUTLIER -106.02 141.0 38.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 73.55 110.836 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 157' ' ' ALA . 20.5 pt -150.82 144.74 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 60.44 111.056 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.3 m120 . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 53.42 110.892 179.916 . . . . . . . . 0 0 . 1 . 015 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.48 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.763 0.316 . . . . 74.2 111.144 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.3 OUTLIER -84.61 -51.07 7.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 73.25 110.85 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.728 HG12 HG23 ' A' ' 220' ' ' ILE . 2.0 mp -92.85 97.41 7.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 65.53 111.18 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.544 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.5 tp -88.58 109.56 20.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 72.34 110.873 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.443 HG13 ' CE1' ' A' ' 197' ' ' PHE . 85.8 t -87.49 123.39 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 63.22 111.225 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.735 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -142.2 106.11 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 71.51 111.125 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -73.18 107.59 5.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 72.33 110.913 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.485 ' HB3' ' CD2' ' A' ' 168' ' ' HIS . . . -128.5 164.26 23.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 44.33 111.093 179.879 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.82 138.26 48.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 72.11 110.902 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.684 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 41.83 -154.16 0.12 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.793 -0.718 . . . . 60.24 112.402 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.807 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.41 117.06 7.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 51.31 111.025 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.491 ' NE2' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -109.5 -22.34 12.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.25 -0.432 . . . . 71.44 110.818 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.01 29.68 0.55 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.746 -0.74 . . . . 72.44 112.534 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.639 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.97 0.18 14.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.861 0.362 . . . . 71.44 110.859 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 73.96 39.54 0.51 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 73.21 110.901 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.573 ' ND1' ' N ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -135.16 -41.53 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 73.32 110.851 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.807 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.26 99.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 72.15 111.058 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.684 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.1 m-85 -59.73 -169.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.279 -0.418 . . . . 65.42 110.842 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.68 19.41 3.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 64.22 110.884 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.574 ' HA2' ' CB ' ' A' ' 200' ' ' ASP . . . 55.26 -162.72 4.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.707 -0.759 . . . . 70.22 112.517 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 176' ' ' GLY . 1.7 ptpp? -33.42 136.0 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 71.42 110.904 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 61.02 160.84 0.1 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.74 -0.743 . . . . 62.0 112.552 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.515 ' O ' HD22 ' A' ' 181' ' ' LEU . . . 84.06 -141.41 20.0 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.817 -0.706 . . . . 73.24 112.444 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.6 97.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.861 0.362 . . . . 74.2 111.103 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.57 HD13 ' HG3' ' A' ' 201' ' ' GLU . 2.8 mm? -68.63 -36.97 79.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 71.34 110.868 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -174.08 169.96 3.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 51.43 111.097 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.493 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.3 p80 -163.79 142.12 7.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 73.34 110.867 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.744 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -136.28 173.37 11.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.299 -0.409 . . . . 65.21 111.174 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.544 ' O ' ' O ' ' A' ' 222' ' ' HIS . 16.7 m-85 -98.69 -141.15 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 65.41 110.774 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -174.89 -81.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.799 -0.715 . . . . 64.53 112.541 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 47.46 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.706 2.271 . . . . 75.42 112.369 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.558 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -119.71 147.47 18.1 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.71 -0.757 . . . . 72.44 112.508 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.88 144.96 30.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.347 . . . . 74.05 110.816 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.56 -64.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.725 -0.75 . . . . 64.53 112.481 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 189' ' ' SER . 14.6 tt -104.43 8.84 9.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 74.35 111.183 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.558 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -70.76 174.21 40.0 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.672 -0.775 . . . . 52.04 112.467 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 223' ' ' SER . . . 42.76 23.19 0.18 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 71.11 112.486 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 192' ' ' GLY . 1.9 m-20 -65.49 101.2 0.56 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.903 0.383 . . . . 74.21 110.917 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.744 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -74.72 130.36 39.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 62.32 111.124 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.493 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.2 m170 -121.05 130.19 53.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 71.13 110.837 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.532 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 47.6 m-85 -114.91 133.7 55.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 73.13 110.847 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -64.72 112.84 3.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 72.41 110.823 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -68.2 -18.99 64.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 73.21 110.961 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.574 ' CB ' ' HA2' ' A' ' 176' ' ' GLY . 14.4 m-20 -68.89 -8.57 45.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 74.03 110.841 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.57 ' HG3' HD13 ' A' ' 181' ' ' LEU . 50.4 mm-40 -97.27 162.17 13.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 72.43 110.891 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.514 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.2 OUTLIER -95.94 94.18 7.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 75.4 110.942 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.532 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 45.4 m95 -82.95 124.69 30.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 72.12 110.926 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 36.0 p -145.97 -177.6 5.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 60.52 111.159 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.59 21.08 17.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 73.45 111.192 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -128.13 -177.72 4.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 73.54 110.875 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.7 t -67.59 -19.22 65.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 44.44 110.864 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.29 -104.82 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.769 -0.729 . . . . 72.12 112.45 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.24 177.98 0.14 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.782 -0.723 . . . . 51.45 112.437 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 95.9 m -67.79 97.22 0.62 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.721 0.295 . . . . 74.11 111.127 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -41.06 116.31 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 72.1 110.853 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.75 HD23 ' HB3' ' A' ' 133' ' ' ALA . 9.9 tp -63.26 -39.4 94.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.46 . . . . 74.2 110.873 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.732 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.7 t80 -50.46 -65.29 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 70.23 110.879 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.469 HD11 ' H ' ' A' ' 243' ' ' VAL . 15.4 mt -54.02 -55.43 27.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.478 . . . . 73.32 110.897 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.514 ' O ' ' HB2' ' A' ' 219' ' ' ALA . 2.6 m -55.67 -32.22 63.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 74.44 111.119 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.31 -48.04 62.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.428 . . . . 71.35 111.027 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.918 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -54.06 -58.44 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 73.54 111.196 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.717 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.9 t-80 -64.0 -28.8 70.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 73.22 110.819 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.9 -45.66 91.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 65.25 111.162 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.728 HG23 HG12 ' A' ' 159' ' ' ILE . 2.6 mt -68.19 -33.95 63.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 52.21 111.12 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -52.43 -43.13 58.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.834 -0.698 . . . . 51.03 112.505 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.544 ' O ' ' O ' ' A' ' 185' ' ' PHE . 41.1 m-70 -70.32 -41.36 73.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.815 0.341 . . . . 71.34 110.833 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 29.5 p -64.95 -20.35 66.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 73.21 110.903 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.428 HD21 HG21 ' A' ' 114' ' ' ILE . 36.5 mt -81.64 -25.79 35.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.134 -0.485 . . . . 75.14 110.902 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 120.55 11.7 6.49 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.774 -0.726 . . . . 43.22 112.487 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.803 HD11 ' CD1' ' A' ' 258' ' ' ILE . 12.4 mt -76.95 158.88 30.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.364 . . . . 65.42 110.967 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -104.71 -134.49 8.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.806 -0.711 . . . . 63.55 112.499 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 0.0 OUTLIER -129.5 145.1 51.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.338 . . . . 72.5 110.866 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 27.4 t -108.45 165.56 11.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 72.0 110.811 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.93 -2.99 22.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.495 . . . . 61.34 110.902 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.623 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -62.2 136.51 95.5 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.579 0.704 . . . . 73.15 110.845 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -0.44 6.87 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.706 2.271 . . . . 75.52 112.422 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.81 15.52 1.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 73.14 110.889 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.623 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -84.74 133.48 34.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.269 -0.423 . . . . 75.41 111.19 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.717 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -56.78 -37.8 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 74.15 111.145 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.441 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 47.1 mmm -59.73 -23.21 63.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 74.23 110.889 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.542 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.7 t80 -54.39 142.72 49.22 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.68 0.753 . . . . 75.33 110.861 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.542 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.7 Cg_endo -69.69 -1.21 8.02 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.667 2.245 . . . . 74.43 112.387 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.409 ' HG1' ' HD2' ' A' ' 237' ' ' PHE . 50.0 m -93.9 141.72 28.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 63.34 111.129 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -122.74 141.52 51.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.269 -0.423 . . . . 62.14 110.928 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -161.02 138.79 9.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.494 . . . . 75.44 110.87 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.55 ' O ' HG13 ' A' ' 243' ' ' VAL . 66.8 t80 -62.43 146.67 50.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 75.13 110.971 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -160.88 132.1 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 60.43 111.095 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -50.46 133.21 24.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 74.11 110.902 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.625 HD11 ' HD3' ' A' ' 136' ' ' LYS . 6.4 tt -54.7 -30.39 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 72.34 111.147 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -75.36 -18.39 59.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 44.31 110.906 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 43.4 p -107.63 -20.25 13.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 73.21 111.105 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.467 ' C ' ' HG3' ' A' ' 249' ' ' ARG . 10.4 t80 -72.65 120.54 18.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 72.35 110.886 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.467 ' HG3' ' C ' ' A' ' 248' ' ' PHE . 16.1 mtt180 -152.42 141.92 21.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 64.41 110.854 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.782 HD12 HG11 ' A' ' 144' ' ' VAL . 45.4 mt -59.0 123.44 16.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 73.43 110.895 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 15.8 m -67.11 162.48 22.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 71.04 110.937 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -48.18 -36.2 13.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 50.34 111.133 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.04 -47.87 75.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 72.14 110.837 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.419 ' O ' HG22 ' A' ' 258' ' ' ILE . 9.4 m-20 -60.45 -51.79 67.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 74.24 110.824 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 20.6 mt -62.49 -33.48 59.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 75.13 111.236 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -71.26 -39.81 71.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 75.15 110.916 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.85 -51.23 7.19 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 73.11 112.467 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.803 ' CD1' HD11 ' A' ' 226' ' ' LEU . 2.8 tp -52.65 -35.05 20.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 75.01 111.198 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.419 ' O ' ' N ' ' A' ' 263' ' ' GLY . 71.2 mt-30 -87.02 -16.49 35.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 70.0 110.929 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.7 t -69.63 -13.98 62.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 73.11 110.875 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.5 mt -123.72 -17.74 6.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 63.25 110.908 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.729 ' CD1' HD21 ' A' ' 147' ' ' LEU . 35.1 m-85 -115.04 -33.39 5.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 64.33 110.904 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.289 0 CA-C-O 119.034 -0.87 . . . . 61.41 112.517 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 8.6 p80 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.802 0.334 . . . . 60.12 110.905 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 113' ' ' TYR . . . . . 0.434 ' C ' HD12 ' A' ' 114' ' ' ILE . 2.7 m-85 -139.04 108.9 6.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 74.14 110.976 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.614 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.6 mp -142.93 162.97 17.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 72.2 111.172 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.588 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -159.67 163.46 34.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 75.54 111.136 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.605 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 1.5 p90 -133.13 151.43 51.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 72.34 110.889 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.538 ' HD2' HD11 ' A' ' 160' ' ' LEU . 4.7 tmt_? -141.87 112.66 7.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 73.3 110.856 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.4 mt -74.4 106.23 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 72.22 111.125 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -59.14 -48.49 81.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 75.2 110.858 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -146.33 171.84 14.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 64.22 110.818 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.603 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.5 m-85 -119.72 151.85 38.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 64.13 110.91 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.554 HG23 ' HD2' ' A' ' 123' ' ' PRO . 36.9 m -103.53 136.17 19.26 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.573 0.702 . . . . 75.01 111.095 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.554 ' HD2' HG23 ' A' ' 122' ' ' THR . 54.7 Cg_endo -69.72 32.6 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.657 2.238 . . . . 70.32 112.431 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 122' ' ' THR . 1.6 m-20 -113.99 -23.75 9.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 75.24 110.851 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.663 ' SD ' HD22 ' A' ' 212' ' ' LEU . 0.0 OUTLIER -117.6 166.82 11.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.848 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -87.96 141.46 28.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 72.54 110.931 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.05 -33.5 3.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 63.12 110.93 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -84.82 -38.64 19.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 74.12 110.895 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -64.29 -32.87 74.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.177 -0.465 . . . . 61.11 110.814 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.603 HG11 ' CE2' ' A' ' 121' ' ' TYR . 78.1 t -63.78 -44.99 98.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 43.2 111.148 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.77 -23.2 39.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 64.55 110.871 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -76.08 -46.86 26.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 73.42 110.939 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.636 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -72.04 -30.23 64.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 65.53 111.088 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.535 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.3 mp -73.49 -55.62 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 65.15 111.172 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.535 ' N ' HG22 ' A' ' 134' ' ' ILE . 1.1 ttt85 -48.09 -40.97 24.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 74.31 110.904 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.413 ' O ' HG23 ' A' ' 140' ' ' VAL . 3.3 mmpt? -76.13 -32.42 59.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 74.13 110.919 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.843 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -61.23 -49.98 74.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 63.14 111.09 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.619 ' HE2' HD13 ' A' ' 159' ' ' ILE . 80.3 m-85 -68.38 -31.14 70.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 71.15 110.851 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.425 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 3.4 tt0 -63.42 -44.69 93.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 65.32 110.944 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 136' ' ' LYS . 55.0 t -49.21 -25.2 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 73.03 111.146 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.788 ' NE1' HG12 ' A' ' 217' ' ' VAL . 97.8 m95 -98.17 -28.9 13.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 71.11 110.91 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 p -74.49 -13.32 60.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 42.52 110.982 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 139' ' ' GLN . 22.4 m120 -91.88 -24.7 19.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.085 -0.507 . . . . 43.55 110.978 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.585 HG21 ' CD1' ' A' ' 250' ' ' LEU . 5.7 m -94.86 2.7 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 75.12 111.222 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 147' ' ' LEU . 27.4 p -154.71 141.49 13.34 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.611 0.719 . . . . 63.12 111.152 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 28.33 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.691 2.26 . . . . 74.23 112.269 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.843 HD21 ' CG ' ' A' ' 262' ' ' TYR . 0.4 OUTLIER -84.1 -178.0 6.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.257 -0.429 . . . . 70.24 110.925 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -142.56 125.8 16.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 75.42 110.863 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.614 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.5 m-85 -117.94 137.49 52.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 71.33 110.847 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 53.9 m -132.34 139.46 48.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.075 -0.511 . . . . 55.01 110.796 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.3 OUTLIER -91.9 146.48 23.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.059 -0.519 . . . . 71.12 110.808 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 6.3 pt -150.22 168.13 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 74.51 111.117 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 75.24 110.87 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.569 ' HA ' HG23 ' A' ' 115' ' ' THR . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.761 0.315 . . . . 75.42 111.058 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.8 OUTLIER -86.9 -50.56 6.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 65.15 110.864 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.7 HG12 HG23 ' A' ' 220' ' ' ILE . 2.6 mp -94.55 97.33 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 74.45 111.146 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.538 HD11 ' HD2' ' A' ' 117' ' ' ARG . 9.2 tp -87.57 110.25 20.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.242 -0.435 . . . . 75.32 110.93 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.4 t -88.33 117.33 31.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 75.54 111.075 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 162' ' ' VAL . 2.3 p -137.16 102.43 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 74.43 111.017 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.4 ' CB ' ' HG1' ' A' ' 122' ' ' THR . 47.0 m-85 -70.49 110.8 5.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.047 -0.524 . . . . 71.42 110.85 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.488 ' HB3' ' CD2' ' A' ' 168' ' ' HIS . . . -131.54 166.75 20.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 61.04 111.035 179.955 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -114.65 138.57 50.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 73.43 110.879 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.681 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.89 -154.83 0.16 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.764 -0.731 . . . . 54.14 112.434 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.805 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.85 116.55 7.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 71.32 111.098 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.504 ' NE2' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.73 -23.04 11.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.417 . . . . 74.04 110.878 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.95 29.58 0.51 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.732 . . . . 42.13 112.488 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.622 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.06 0.39 14.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 44.0 110.85 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 73.93 39.2 0.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 75.14 110.941 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.576 ' ND1' ' N ' ' A' ' 173' ' ' ALA . 0.4 OUTLIER -134.55 -41.23 0.78 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 72.22 110.884 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.805 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.18 99.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 45.44 111.163 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.681 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -60.3 -168.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 61.33 110.798 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.33 18.54 3.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 63.2 110.876 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.593 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.84 -155.64 11.54 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.688 -0.768 . . . . 61.11 112.509 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -37.5 135.42 0.57 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.803 0.335 . . . . 54.42 110.902 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.0 164.75 0.1 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.727 -0.749 . . . . 71.24 112.453 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.86 -142.75 21.83 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.789 -0.72 . . . . 73.23 112.455 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.32 96.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.785 0.326 . . . . 64.23 111.099 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 66.7 mt -66.53 -40.44 89.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.306 -0.407 . . . . 61.04 110.888 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -171.65 168.54 6.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 72.43 111.061 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.497 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -161.93 140.83 9.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 75.31 110.854 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.742 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -136.51 173.57 11.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 74.44 111.013 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 223' ' ' SER . 37.8 m-85 -104.0 -149.91 0.41 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 62.33 110.869 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -163.78 -81.92 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.754 -0.736 . . . . 52.13 112.511 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 53.9 1.13 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.689 2.259 . . . . 70.05 112.351 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.57 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -124.83 147.96 16.63 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.753 -0.737 . . . . 55.33 112.524 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.9 143.92 32.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 63.1 110.82 -179.668 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.5 -63.26 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.733 -0.746 . . . . 51.04 112.497 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 189' ' ' SER . 4.2 mt -105.4 7.93 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.892 0.377 . . . . 74.33 111.113 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.57 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -69.78 171.81 40.86 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.77 -0.729 . . . . 62.43 112.511 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 44.0 19.93 0.14 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 53.11 112.523 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.438 ' CG ' ' HB3' ' A' ' 160' ' ' LEU . 1.9 m-20 -63.83 107.96 1.34 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.801 0.334 . . . . 74.33 110.908 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.742 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -82.14 126.16 31.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 73.12 111.086 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.497 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.4 m170 -116.67 130.74 56.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 73.41 110.851 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.531 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 46.8 m-85 -115.7 133.71 55.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 74.4 110.893 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -66.76 109.86 3.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.163 -0.471 . . . . 75.41 110.814 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -60.36 -37.88 82.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 74.04 110.82 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.593 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 5.9 m-20 -50.05 -22.15 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 53.41 110.815 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -81.32 160.67 24.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 72.4 110.919 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.526 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -98.21 93.43 6.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 73.45 110.96 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.531 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 34.0 m95 -83.65 123.02 29.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 74.01 110.95 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.2 p -140.92 -176.25 4.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 73.24 111.073 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.37 18.11 19.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 73.25 111.147 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.43 -175.82 3.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 74.45 110.878 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.9 p -67.06 -18.73 65.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 65.3 110.842 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.95 -108.54 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.788 -0.72 . . . . 73.23 112.491 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.92 177.52 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.741 -0.742 . . . . 65.3 112.519 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 97.0 m -65.95 97.74 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 75.13 111.123 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -41.26 113.38 0.39 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 72.22 110.855 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.663 HD22 ' SD ' ' A' ' 125' ' ' MET . 43.1 tp -62.26 -34.47 76.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.263 -0.426 . . . . 74.51 110.939 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.702 ' O ' HG23 ' A' ' 217' ' ' VAL . 3.3 t80 -54.92 -62.05 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 72.15 110.904 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.572 HD11 ' H ' ' A' ' 243' ' ' VAL . 12.9 mt -57.18 -53.78 54.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 64.22 110.919 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.489 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.2 m -54.76 -34.93 63.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 61.14 111.074 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.38 -49.49 66.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.414 . . . . 62.13 111.021 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.843 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -52.08 -58.77 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 44.25 111.165 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.67 ' HB2' HG13 ' A' ' 235' ' ' VAL . 2.6 t-80 -62.94 -31.55 72.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 75.22 110.854 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -61.73 -43.14 99.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 41.35 111.062 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.7 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -70.97 -33.46 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 73.53 111.06 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.521 ' CA ' HD12 ' A' ' 226' ' ' LEU . . . -51.05 -43.29 49.68 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.769 -0.729 . . . . 74.14 112.485 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.436 ' O ' ' O ' ' A' ' 185' ' ' PHE . 50.7 m-70 -68.83 -39.61 79.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.733 0.301 . . . . 65.0 110.846 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.617 ' OG ' HG23 ' A' ' 159' ' ' ILE . 2.8 m -62.22 -26.66 68.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 64.12 110.891 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 28.8 mt -77.57 -25.71 50.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 54.32 110.924 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 114.01 14.61 9.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.766 -0.73 . . . . 53.13 112.53 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.781 HD21 HD12 ' A' ' 258' ' ' ILE . 13.3 mt -79.27 148.12 32.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 74.55 110.924 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 227' ' ' GLY . . . . . 0.418 ' O ' ' HE2' ' A' ' 236' ' ' MET . . . -93.95 -160.37 34.73 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.816 -0.707 . . . . 72.21 112.448 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 0.0 OUTLIER -103.07 149.2 24.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 65.51 110.821 -179.886 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 229' ' ' SER . . . . . 0.402 ' OG ' ' HB2' ' A' ' 236' ' ' MET . 2.5 p -111.53 164.41 13.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.165 -0.471 . . . . 72.32 110.824 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.43 -0.58 25.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 73.34 110.913 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.429 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.3 OUTLIER -67.23 132.82 93.38 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.52 0.676 . . . . 64.31 110.899 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.82 4.95 1.91 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.662 2.241 . . . . 63.32 112.283 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.9 13.46 2.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 62.44 110.925 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.429 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -82.51 149.54 27.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 64.34 111.086 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.67 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -71.46 -40.07 71.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 75.12 111.16 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.418 ' HE2' ' O ' ' A' ' 227' ' ' GLY . 38.7 mmm -64.32 -18.97 65.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.515 . . . . 73.35 110.846 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.605 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.1 t80 -49.26 143.97 8.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.728 0.775 . . . . 54.12 110.881 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.605 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.8 Cg_endo -69.78 -0.76 7.4 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.709 2.272 . . . . 71.34 112.388 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 18.6 m -100.16 146.71 26.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 72.04 111.156 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -125.45 137.22 53.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.203 -0.453 . . . . 72.12 110.978 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -153.89 139.71 18.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 70.44 110.849 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.582 ' O ' HG13 ' A' ' 243' ' ' VAL . 72.2 t80 -65.24 144.41 57.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 73.43 110.923 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -162.18 133.98 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.109 -0.496 . . . . 73.33 111.11 179.848 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -60.71 134.34 56.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 74.24 110.83 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 17.1 tt -52.91 -31.06 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.452 . . . . 74.45 111.081 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.509 ' OD1' HG23 ' A' ' 247' ' ' THR . 0.1 OUTLIER -69.14 -21.25 64.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 72.33 110.933 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.509 HG23 ' OD1' ' A' ' 246' ' ' ASN . 11.9 p -115.95 -6.99 12.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 64.45 111.213 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 248' ' ' PHE . . . . . 0.468 ' CD2' HD22 ' A' ' 214' ' ' LEU . 8.9 t80 -88.05 115.45 25.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 74.05 110.933 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 249' ' ' ARG . . . . . 0.404 ' HG3' ' C ' ' A' ' 248' ' ' PHE . 0.1 OUTLIER -144.73 139.72 28.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 74.52 110.885 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.585 ' CD1' HG21 ' A' ' 144' ' ' VAL . 26.3 mt -53.54 123.42 12.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 55.4 110.932 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 10.0 p -59.67 160.0 7.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 74.43 110.833 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -48.8 -33.28 10.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 74.01 111.208 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -67.14 -44.16 80.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 74.42 110.845 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.77 -49.51 70.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 74.02 110.873 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.451 HG12 HG11 ' A' ' 144' ' ' VAL . 34.3 mt -63.63 -36.33 76.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 74.14 111.184 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -70.26 -38.63 75.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 72.1 110.868 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.37 -50.66 6.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 41.11 112.458 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.781 HD12 HD21 ' A' ' 226' ' ' LEU . 3.3 tp -52.21 -34.82 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 73.22 111.182 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.404 ' O ' ' N ' ' A' ' 263' ' ' GLY . 66.7 mt-30 -86.48 -17.29 34.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.156 -0.475 . . . . 71.02 110.889 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.1 t -69.85 -13.62 62.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 50.51 110.862 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.8 mt -123.81 -18.15 6.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.167 -0.469 . . . . 65.5 110.95 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.843 ' CG ' HD21 ' A' ' 147' ' ' LEU . 42.1 m-85 -114.85 -33.9 5.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 74.22 110.888 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 119.105 -0.83 . . . . 35.1 112.472 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.9 p80 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.831 0.348 . . . . 72.44 110.86 . . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -141.34 101.53 4.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 74.11 110.898 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.61 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.7 mp -134.73 162.9 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 70.4 111.152 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.586 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -158.68 161.26 37.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 51.34 111.109 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.625 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.7 p90 -132.86 148.79 52.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 71.2 110.92 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.424 ' HB3' HD12 ' A' ' 160' ' ' LEU . 4.1 tmt_? -142.67 113.89 7.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.504 . . . . 62.44 110.956 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.6 mt -74.59 105.29 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 75.13 111.166 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -58.8 -48.98 79.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 70.21 110.813 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.73 ' OD1' HG23 ' A' ' 162' ' ' VAL . 1.7 p-10 -140.66 162.63 34.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 64.1 110.884 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.661 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.3 m-85 -117.15 142.95 46.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 64.13 110.895 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.515 HG23 ' HD2' ' A' ' 123' ' ' PRO . 24.5 m -94.92 137.51 22.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.632 0.729 . . . . 70.21 111.134 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.515 ' HD2' HG23 ' A' ' 122' ' ' THR . 52.8 Cg_endo -69.82 7.77 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.659 2.239 . . . . 74.4 112.283 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.498 ' H ' HG22 ' A' ' 122' ' ' THR . 1.6 m-20 -84.89 -29.42 25.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 64.01 110.849 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.656 ' SD ' HD22 ' A' ' 212' ' ' LEU . 0.0 OUTLIER -112.73 166.56 11.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 72.52 110.899 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -88.93 145.75 25.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.287 -0.415 . . . . 71.31 110.891 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.1 -34.86 6.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 72.1 110.943 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -82.38 -37.3 25.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 74.43 110.886 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -64.58 -32.8 74.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 75.21 110.839 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.661 HG11 ' CE2' ' A' ' 121' ' ' TYR . 77.9 t -63.43 -47.25 92.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 73.33 111.078 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.03 -23.45 48.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.101 -0.499 . . . . 73.01 110.879 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -75.71 -47.23 27.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 62.21 110.972 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.729 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -70.12 -32.91 71.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 63.33 111.165 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.534 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.3 mp -72.1 -55.07 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 74.35 111.158 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.534 ' N ' HG22 ' A' ' 134' ' ' ILE . 6.1 ttt180 -48.93 -42.26 36.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 72.45 110.932 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.622 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -71.32 -34.76 70.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 72.41 110.896 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.903 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.36 -49.35 77.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 72.05 111.165 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.625 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.4 m-85 -72.72 -21.84 60.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 70.2 110.84 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 135' ' ' ARG . 3.1 tt0 -77.48 -6.38 53.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 63.02 110.824 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 136' ' ' LYS . 96.2 t -97.71 -16.96 6.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.288 -0.414 . . . . 63.43 111.212 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.783 ' NE1' HG12 ' A' ' 217' ' ' VAL . 89.2 m95 -105.41 -38.08 6.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 70.35 110.886 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.8 -12.68 61.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 54.42 110.876 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -93.97 -19.58 20.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.511 . . . . 61.33 110.916 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.859 HG11 HD12 ' A' ' 250' ' ' LEU . 18.5 m -97.1 1.65 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 74.33 111.083 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.584 HG21 HG13 ' A' ' 258' ' ' ILE . 52.2 p -151.93 147.57 20.14 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.583 0.706 . . . . 74.31 111.152 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 31.91 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.667 2.245 . . . . 64.15 112.318 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.76 HD11 ' CG ' ' A' ' 262' ' ' TYR . 19.5 mt -95.65 173.83 7.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 63.31 110.884 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -136.28 126.2 25.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 72.22 110.882 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.61 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.7 m-30 -114.46 145.96 41.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.405 . . . . 54.15 110.91 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.401 ' H ' ' HA ' ' A' ' 115' ' ' THR . 5.8 t -139.44 153.33 47.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 72.33 110.847 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 1.4 tttt -104.37 142.79 33.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.129 -0.487 . . . . 41.42 110.897 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.467 HD11 ' HB2' ' A' ' 157' ' ' ALA . 16.4 pt -152.56 159.26 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 64.45 111.089 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 74.1 110.883 179.952 . . . . . . . . 0 0 . 1 . 017 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.809 0.338 . . . . 74.21 111.06 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.4 OUTLIER -84.86 -51.4 6.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 53.03 110.835 179.932 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.623 HG12 HG23 ' A' ' 220' ' ' ILE . 2.7 mp -92.51 97.3 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 54.41 111.121 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.424 HD12 ' HB3' ' A' ' 117' ' ' ARG . 7.8 tp -88.42 109.13 19.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 74.04 110.984 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.428 HG13 ' CE1' ' A' ' 197' ' ' PHE . 84.5 t -85.71 121.1 36.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 72.31 111.089 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.73 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.2 p -140.5 103.67 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 73.54 111.175 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -71.17 110.16 5.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.445 . . . . 71.41 110.89 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.457 ' CB ' ' CD2' ' A' ' 168' ' ' HIS . . . -129.94 165.83 21.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 74.52 111.064 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.02 136.9 52.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.151 -0.477 . . . . 73.21 110.862 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.675 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.43 -155.87 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.758 . . . . 72.55 112.508 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.799 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.02 116.44 6.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.786 0.327 . . . . 72.44 111.084 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.493 ' NE2' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.08 -22.44 12.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 62.11 110.792 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.34 29.51 0.54 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.722 -0.751 . . . . 72.42 112.521 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.631 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.13 0.45 14.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 74.45 110.885 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 73.63 39.63 0.55 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 74.13 110.931 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.574 ' ND1' ' N ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -134.97 -41.65 0.74 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.07 -0.514 . . . . 44.51 110.839 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.799 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.52 99.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 52.1 111.097 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.675 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.9 m-85 -60.2 -168.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 72.44 110.84 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.16 19.03 3.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.029 -0.532 . . . . 74.12 110.85 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.574 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.34 -157.75 6.1 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 41.42 112.464 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 176' ' ' GLY . 12.0 mmtp -34.64 134.71 0.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 64.03 110.959 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.0 165.14 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.741 -0.742 . . . . 63.33 112.459 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.37 -143.35 21.78 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.732 -0.747 . . . . 73.35 112.472 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.0 97.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.881 0.372 . . . . 64.34 111.092 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 21.9 mt -66.99 -40.57 87.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 75.42 110.903 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -171.12 170.21 6.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 45.11 111.117 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.503 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -164.11 141.17 6.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 74.1 110.889 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.781 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -135.76 173.64 11.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.307 -0.406 . . . . 71.41 111.07 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 223' ' ' SER . 47.9 m-85 -101.11 -145.81 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 74.54 110.829 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -165.09 -86.17 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.768 -0.729 . . . . 60.13 112.507 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.65 55.6 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.683 2.255 . . . . 73.51 112.357 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.536 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.53 147.66 16.67 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.718 -0.754 . . . . 52.32 112.476 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -102.98 142.36 34.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.997 0.427 . . . . 73.05 110.759 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 64.14 -62.4 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.75 -0.738 . . . . 73.4 112.526 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.524 ' N ' ' O ' ' A' ' 189' ' ' SER . 2.3 pp -105.99 10.07 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.897 0.38 . . . . 75.12 111.213 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.536 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -69.47 170.62 42.07 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.797 -0.716 . . . . 74.44 112.548 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 42.19 22.82 0.13 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.711 -0.757 . . . . 65.34 112.442 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 192' ' ' GLY . 3.2 m-20 -64.48 103.62 0.68 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.792 0.33 . . . . 73.34 110.896 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.781 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -76.71 125.75 29.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 74.52 111.046 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.503 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.3 m170 -115.88 129.68 56.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.116 -0.493 . . . . 75.55 110.865 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.519 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 50.3 m-85 -113.88 134.26 54.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 74.23 110.827 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -66.87 108.89 2.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 72.33 110.923 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -60.09 -37.4 79.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.42 110.792 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.574 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 11.3 m-20 -50.51 -22.1 1.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 74.03 110.811 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -81.36 160.83 24.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.165 -0.47 . . . . 61.23 110.925 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.544 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -98.73 91.47 5.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 75.53 110.894 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.519 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 33.1 m95 -81.56 124.25 29.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 75.44 110.896 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.9 p -141.81 -170.45 3.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 75.05 111.208 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.87 17.42 15.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 70.1 111.176 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.74 -178.73 4.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 70.25 110.81 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.4 t -63.41 -19.62 64.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 75.34 110.926 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.89 -107.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.813 -0.708 . . . . 72.5 112.386 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.5 177.9 0.18 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.719 -0.753 . . . . 72.12 112.48 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 95.7 m -68.47 96.86 0.72 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.793 0.33 . . . . 74.21 111.076 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -40.11 118.46 0.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 73.32 110.858 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.656 HD22 ' SD ' ' A' ' 125' ' ' MET . 19.3 tp -64.87 -36.24 83.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 50.23 110.888 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.729 ' CA ' ' HB1' ' A' ' 133' ' ' ALA . 2.4 t80 -54.17 -64.93 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 75.1 110.915 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.515 HD11 ' H ' ' A' ' 243' ' ' VAL . 21.0 mt -53.21 -55.32 25.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 55.31 110.935 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.495 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.6 m -55.27 -34.87 64.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 62.21 111.141 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.1 -47.86 72.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 54.23 111.092 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.903 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -53.58 -60.11 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 34.35 111.079 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.624 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.8 t-80 -63.31 -28.52 70.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.353 -0.385 . . . . 72.45 110.8 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.96 -44.37 96.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 74.43 111.115 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.623 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -68.99 -35.24 68.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 74.11 111.155 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.21 -44.46 51.79 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.806 -0.711 . . . . 72.54 112.442 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 185' ' ' PHE . 19.6 m-70 -68.03 -38.52 82.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.792 0.329 . . . . 60.35 110.804 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.619 ' OG ' HG23 ' A' ' 159' ' ' ILE . 13.0 m -64.05 -24.79 67.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 72.41 110.831 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 44.3 mt -76.29 -27.06 56.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 73.22 110.952 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 121.03 10.56 6.76 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.722 -0.751 . . . . 44.51 112.454 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.489 HD11 HD13 ' A' ' 258' ' ' ILE . 8.5 mt -76.61 137.7 39.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.864 0.364 . . . . 63.05 110.939 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -76.8 -135.14 0.64 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.68 -0.771 . . . . 52.42 112.484 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -131.82 135.31 46.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 71.34 110.799 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 98.4 p -94.94 160.88 14.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 61.22 110.863 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.22 0.55 25.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 72.12 110.835 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' A' ' 234' ' ' ALA . 0.3 OUTLIER -71.68 132.0 85.64 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.558 0.694 . . . . 71.5 110.831 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 0.93 4.92 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.714 2.276 . . . . 61.53 112.361 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.8 pttt -136.73 14.06 3.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 71.41 110.855 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -92.53 128.2 38.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 70.33 111.088 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.624 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -52.81 -37.95 26.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 64.42 111.092 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 70.8 mmm -58.94 -23.69 61.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.263 -0.426 . . . . 73.02 110.836 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.594 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.5 t80 -52.67 143.36 29.35 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.669 0.747 . . . . 64.54 110.841 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.594 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.5 Cg_endo -69.78 -9.88 27.19 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.654 2.236 . . . . 52.1 112.252 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 23.3 m -85.42 150.22 24.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 62.52 111.157 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -124.78 139.1 54.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.11 110.919 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -155.26 121.35 5.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.052 -0.522 . . . . 65.31 110.922 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.567 ' O ' HG13 ' A' ' 243' ' ' VAL . 87.3 t80 -52.65 146.78 9.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 73.2 110.929 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.5 OUTLIER -161.03 130.84 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 74.13 111.171 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 244' ' ' ASP . . . . . 0.432 ' CG ' HD22 ' A' ' 246' ' ' ASN . 18.7 t0 -48.43 138.39 10.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 73.02 110.865 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.585 HD11 ' HD3' ' A' ' 136' ' ' LYS . 7.6 tt -56.26 -31.28 32.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 53.33 111.085 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.483 ' OD1' HG23 ' A' ' 247' ' ' THR . 5.2 p30 -77.72 -15.81 58.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 73.02 110.89 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.483 HG23 ' OD1' ' A' ' 246' ' ' ASN . 33.4 p -105.3 -23.38 12.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 71.31 111.11 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -70.82 142.27 51.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 71.13 110.784 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -177.71 132.13 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 72.12 110.821 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.859 HD12 HG11 ' A' ' 144' ' ' VAL . 34.1 mt -49.52 122.8 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 73.24 110.932 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 32.1 t -64.13 157.81 24.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 73.1 110.895 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -46.36 -34.77 4.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 75.5 111.106 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.74 -46.26 69.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.325 -0.398 . . . . 75.42 110.787 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.418 ' O ' HG22 ' A' ' 258' ' ' ILE . 28.6 m-20 -60.37 -49.94 75.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 72.51 110.811 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.41 ' HA ' HG22 ' A' ' 258' ' ' ILE . 24.8 mt -66.31 -31.5 53.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.129 -0.487 . . . . 74.44 111.17 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.63 -39.41 70.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.505 . . . . 52.5 110.912 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.63 -52.01 6.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 74.31 112.396 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.584 HG13 HG21 ' A' ' 145' ' ' THR . 7.6 tp -52.55 -34.08 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 75.22 111.086 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.457 ' O ' ' N ' ' A' ' 263' ' ' GLY . 85.8 mt-30 -84.38 -19.2 33.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.115 -0.493 . . . . 75.01 110.933 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 10.7 t -68.65 -12.91 61.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.454 . . . . 60.31 110.872 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.1 mt -122.36 -18.1 6.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 74.42 110.927 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.76 ' CG ' HD11 ' A' ' 147' ' ' LEU . 38.1 m-85 -115.63 -36.12 4.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 73.41 110.948 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 119.145 -0.808 . . . . 70.1 112.473 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.6 p80 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.788 0.328 . . . . 72.15 110.893 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -142.02 91.85 2.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 73.14 110.876 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.656 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.6 mp -122.49 163.94 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 74.13 111.107 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.606 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -157.88 161.94 38.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 75.55 111.199 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.573 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 1.4 p90 -136.32 148.7 48.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 65.22 110.902 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.733 ' NE ' HD11 ' A' ' 160' ' ' LEU . 3.7 tmm_? -141.83 120.01 12.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 61.44 110.864 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.7 mt -79.82 104.13 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 73.15 111.192 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -56.44 -46.42 80.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 63.43 110.932 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.735 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.5 p-10 -146.82 165.5 29.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 64.3 110.912 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.544 ' CE2' HG11 ' A' ' 130' ' ' VAL . 4.3 m-85 -114.95 142.09 47.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 71.0 110.944 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.632 HG22 ' H ' ' A' ' 124' ' ' ASP . 1.0 OUTLIER -88.97 137.99 29.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.602 0.715 . . . . 65.14 111.102 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.71 33.61 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.656 2.237 . . . . 63.43 112.435 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.632 ' H ' HG22 ' A' ' 122' ' ' THR . 1.8 m-20 -123.36 -17.44 6.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 71.21 110.915 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.599 ' SD ' HD22 ' A' ' 212' ' ' LEU . 6.6 mtm -117.28 165.55 13.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 71.42 110.926 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -92.86 140.57 29.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 71.14 110.861 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.9 ptt-85 -44.6 -36.91 3.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 74.03 110.813 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -84.01 -39.27 19.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 71.45 110.879 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -63.51 -32.1 73.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.103 -0.499 . . . . 74.32 110.906 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.544 HG11 ' CE2' ' A' ' 121' ' ' TYR . 58.3 t -65.48 -44.46 94.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.18 -0.464 . . . . 75.35 111.13 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.45 -22.42 38.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 63.13 110.924 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -76.15 -47.89 22.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 74.25 110.854 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.552 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -72.52 -30.65 64.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 74.11 111.026 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.2 mp -71.95 -55.37 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.404 . . . . 74.14 111.124 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.526 ' N ' HG22 ' A' ' 134' ' ' ILE . 5.1 ttt180 -48.0 -40.38 22.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 73.45 110.919 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 140' ' ' VAL . 4.8 mmtp -76.47 -33.37 58.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 72.22 110.873 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.823 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.27 -50.93 71.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 62.32 111.137 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.627 ' CZ ' HG12 ' A' ' 220' ' ' ILE . 79.0 m-85 -67.01 -33.55 75.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 74.12 110.889 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.432 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 2.8 tt0 -61.92 -43.84 98.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 73.3 110.905 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 136' ' ' LYS . 73.2 t -49.56 -25.05 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.163 -0.471 . . . . 71.23 111.125 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.799 ' NE1' HG12 ' A' ' 217' ' ' VAL . 97.1 m95 -98.33 -29.66 13.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 74.45 110.891 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 t -73.4 -15.1 61.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.417 . . . . 74.33 110.896 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 143' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 139' ' ' GLN . 28.2 m120 -89.36 -26.14 21.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 75.54 110.795 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.551 HG21 ' CD1' ' A' ' 250' ' ' LEU . 4.7 m -93.61 3.71 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 74.31 111.104 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 147' ' ' LEU . 59.5 p -153.69 143.1 14.97 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 121.596 0.712 . . . . 52.32 111.09 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 30.36 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.683 2.256 . . . . 54.05 112.328 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.797 HD11 ' CG ' ' A' ' 262' ' ' TYR . 20.1 mt -91.93 173.1 8.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 70.33 110.884 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -135.12 126.55 28.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 71.42 110.927 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.656 ' HE1' HD13 ' A' ' 114' ' ' ILE . 2.7 m-85 -116.41 141.27 48.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 74.15 110.938 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.7 m -136.73 147.71 46.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 63.11 110.802 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.432 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 16.4 tptm -98.9 146.45 25.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.501 . . . . 74.25 110.897 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 157' ' ' ALA . 18.4 pt -150.89 147.02 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 74.33 111.108 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.3 m120 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 74.02 110.916 179.918 . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.416 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.75 0.309 . . . . 63.12 111.097 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.65 -51.13 7.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 74.24 110.822 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.636 HG12 HG23 ' A' ' 220' ' ' ILE . 3.4 mp -94.16 98.55 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 64.32 111.163 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.733 HD11 ' NE ' ' A' ' 117' ' ' ARG . 7.0 tp -88.35 110.98 21.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 71.23 110.934 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.413 HG13 ' CE1' ' A' ' 197' ' ' PHE . 87.7 t -88.24 121.59 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 71.11 111.139 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.735 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -140.72 106.09 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 51.1 111.157 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.414 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 46.8 m-85 -73.38 109.98 7.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 70.11 110.859 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.461 ' HB3' ' CD2' ' A' ' 168' ' ' HIS . . . -129.07 166.62 18.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.51 . . . . 75.1 111.182 179.913 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.36 135.06 54.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 74.41 110.888 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.674 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 44.52 -156.91 0.22 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.739 -0.743 . . . . 74.41 112.542 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.811 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -63.17 117.67 6.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.338 . . . . 73.44 111.105 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.515 ' NE2' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -110.59 -22.5 11.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 62.05 110.945 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.29 30.45 0.51 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.738 -0.744 . . . . 51.32 112.433 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.624 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -114.28 0.68 14.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.841 0.353 . . . . 75.05 110.837 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 73.49 39.76 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 71.24 110.864 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.573 ' ND1' ' N ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -135.26 -40.77 0.73 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.084 -0.507 . . . . 60.43 110.859 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.811 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.1 99.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 64.51 111.107 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.674 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.8 m-85 -60.45 -168.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 74.43 110.892 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.69 18.66 3.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 71.2 110.872 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.573 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.58 -156.35 9.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.799 -0.715 . . . . 65.43 112.461 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.74 135.56 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 70.42 110.859 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.49 165.03 0.14 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 71.21 112.476 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.495 ' O ' HD22 ' A' ' 181' ' ' LEU . . . 81.97 -142.49 22.46 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.749 -0.738 . . . . 74.54 112.431 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.42 95.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.8 0.333 . . . . 75.51 111.214 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.495 HD22 ' O ' ' A' ' 179' ' ' GLY . 3.1 mm? -65.1 -46.76 79.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.158 -0.474 . . . . 71.2 110.894 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -163.24 174.21 12.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 51.44 111.048 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.473 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -169.33 139.71 2.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 73.25 110.823 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.727 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -135.08 174.62 10.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 61.12 111.007 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.534 ' O ' ' O ' ' A' ' 222' ' ' HIS . 64.3 m-85 -98.51 -134.25 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 71.24 110.835 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 223' ' ' SER . . . 179.02 -84.87 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.676 -0.774 . . . . 62.1 112.437 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 50.52 0.83 Allowed 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.727 2.285 . . . . 71.21 112.367 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.564 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.81 148.78 17.21 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.809 -0.71 . . . . 72.23 112.544 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.534 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.43 145.9 29.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.941 0.4 . . . . 71.41 110.856 -179.711 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.33 -64.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.759 . . . . 72.31 112.551 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.534 ' N ' ' O ' ' A' ' 189' ' ' SER . 14.8 tt -104.22 7.82 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.919 0.39 . . . . 72.0 111.165 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.564 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -69.39 172.92 37.48 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.801 -0.714 . . . . 74.3 112.497 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.504 ' O ' ' HB3' ' A' ' 223' ' ' SER . . . 43.2 23.17 0.23 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.683 -0.77 . . . . 50.13 112.526 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 192' ' ' GLY . 1.6 m-20 -67.0 101.15 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.854 0.359 . . . . 41.43 110.817 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.727 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -75.09 130.82 39.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 72.23 111.069 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.473 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.2 m170 -121.21 130.94 53.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 75.22 110.82 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.452 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 38.0 m-85 -115.44 134.94 54.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 74.43 110.88 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -67.22 107.02 2.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.506 . . . . 61.12 110.81 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -57.55 -37.84 73.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.112 -0.495 . . . . 74.14 111.012 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.573 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 12.9 m-20 -50.64 -20.78 1.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 74.11 110.889 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -82.42 162.45 22.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.21 110.882 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.472 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -101.81 87.82 3.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.5 . . . . 64.33 110.856 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.572 ' CZ3' HG21 ' A' ' 215' ' ' THR . 23.5 m95 -80.09 120.09 23.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.096 -0.502 . . . . 74.54 110.995 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.0 p -131.46 -173.84 3.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 71.34 111.209 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.63 12.85 18.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 70.14 111.164 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -131.49 -175.74 3.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 65.01 110.901 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.6 p -51.48 -36.73 45.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 33.42 110.856 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -63.13 160.71 34.73 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.69 -0.767 . . . . 71.32 112.524 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . 48.39 -173.17 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.67 -0.776 . . . . 75.31 112.501 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.418 HG21 HD12 ' A' ' 181' ' ' LEU . 51.5 m -86.47 94.11 9.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 74.24 111.197 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -38.54 113.59 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 73.52 110.88 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.599 HD22 ' SD ' ' A' ' 125' ' ' MET . 13.0 tp -62.64 -35.69 80.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 73.11 110.923 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.663 ' O ' HG23 ' A' ' 217' ' ' VAL . 3.5 t80 -53.27 -64.37 0.84 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 74.33 110.852 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.524 HD11 ' H ' ' A' ' 243' ' ' VAL . 21.8 mt -56.01 -54.34 46.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 52.32 110.93 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.572 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 3.7 m -53.73 -37.41 63.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 74.53 111.112 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 216' ' ' ALA . . . . . 0.401 ' O ' HG13 ' A' ' 220' ' ' ILE . . . -63.13 -50.56 69.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 62.15 111.19 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.823 HG22 ' HA ' ' A' ' 137' ' ' ALA . 1.9 t -51.96 -57.76 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 64.14 111.136 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.699 ' HB2' HG13 ' A' ' 235' ' ' VAL . 3.9 t-80 -65.23 -30.75 71.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.898 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.87 -41.86 99.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 74.2 111.071 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.636 HG23 HG12 ' A' ' 159' ' ' ILE . 2.9 mt -71.98 -35.31 53.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 70.54 111.088 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -51.31 -45.23 52.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.703 -0.761 . . . . 63.34 112.544 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.534 ' O ' ' O ' ' A' ' 185' ' ' PHE . 37.3 m-70 -68.2 -41.77 80.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.885 0.374 . . . . 74.41 110.855 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.519 ' OG ' ' HA ' ' A' ' 220' ' ' ILE . 2.1 p -66.45 -18.11 65.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 54.33 110.885 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.489 HD21 HG21 ' A' ' 114' ' ' ILE . 39.9 mt -83.42 -27.19 29.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.24 110.943 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 119.99 14.06 5.74 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.735 -0.745 . . . . 42.25 112.498 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.776 HD21 ' HA ' ' A' ' 258' ' ' ILE . 12.7 mt -81.0 158.32 25.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.895 0.379 . . . . 75.54 110.943 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -100.11 -133.49 8.14 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.767 -0.73 . . . . 72.32 112.518 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 228' ' ' HIS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 0.0 OUTLIER -129.02 139.72 51.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.851 0.357 . . . . 74.2 110.804 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 53.9 m -97.67 162.74 13.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 60.22 110.906 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.66 -1.44 19.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 72.02 110.9 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.604 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -63.45 141.91 97.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.58 0.705 . . . . 71.22 110.824 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -3.88 12.92 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.737 2.291 . . . . 72.22 112.399 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.5 ptmt -144.27 25.01 1.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 73.22 110.818 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.604 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -86.7 140.22 29.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.327 -0.397 . . . . 30.4 111.137 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.699 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.0 OUTLIER -62.81 -38.67 82.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.287 -0.415 . . . . 70.24 111.14 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 236' ' ' MET . . . . . 0.4 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 54.0 mmm -65.57 -16.97 64.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 74.31 110.888 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.633 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.2 t80 -55.48 144.81 51.77 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.678 0.751 . . . . 62.11 110.937 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.633 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.0 Cg_endo -69.73 0.83 5.06 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.779 2.319 . . . . 74.44 112.359 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.1 m -100.99 139.52 36.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 71.22 111.103 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -120.44 137.85 54.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 75.35 110.975 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.6 tptt -156.85 136.87 12.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 71.04 110.915 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.578 ' O ' HG13 ' A' ' 243' ' ' VAL . 80.0 t80 -63.13 146.03 54.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 75.43 110.905 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -161.79 131.53 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 64.22 111.068 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -54.6 132.02 44.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 72.33 110.918 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 15.6 tt -53.65 -30.16 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.432 . . . . 72.14 111.113 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 246' ' ' ASN . . . . . 0.498 ' OD1' HG23 ' A' ' 247' ' ' THR . 0.1 OUTLIER -69.5 -20.34 63.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 70.44 110.874 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 247' ' ' THR . . . . . 0.498 HG23 ' OD1' ' A' ' 246' ' ' ASN . 5.0 p -110.95 -20.5 12.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 62.21 111.254 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -69.5 142.96 53.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.461 . . . . 73.22 110.849 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -176.07 133.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 64.32 110.847 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.551 ' CD1' HG21 ' A' ' 144' ' ' VAL . 34.7 mt -48.8 137.74 12.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 54.32 110.994 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.576 ' O ' HD12 ' A' ' 255' ' ' ILE . 23.2 t -80.61 168.06 19.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 71.43 110.848 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.95 -38.46 56.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.074 -0.512 . . . . 53.25 111.07 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.33 -51.15 67.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.257 -0.429 . . . . 60.44 110.908 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.514 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 7.2 m-20 -57.55 -53.38 58.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 61.23 110.848 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.576 HD12 ' O ' ' A' ' 251' ' ' SER . 2.6 mt -60.12 -36.81 70.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 71.43 111.105 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -67.61 -39.6 84.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 74.14 110.861 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.87 -52.59 5.74 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.822 -0.704 . . . . 64.2 112.416 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.776 ' HA ' HD21 ' A' ' 226' ' ' LEU . 5.6 tp -52.59 -34.5 19.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.832 0.349 . . . . 74.31 111.194 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.424 ' O ' ' N ' ' A' ' 263' ' ' GLY . 70.7 mt-30 -86.33 -17.96 33.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.069 -0.514 . . . . 73.23 110.94 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.4 t -69.36 -13.97 62.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.452 . . . . 71.3 110.874 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.2 mt -123.02 -17.51 6.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 73.43 110.924 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.797 ' CG ' HD11 ' A' ' 147' ' ' LEU . 35.9 m-85 -114.69 -35.51 4.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.108 -0.496 . . . . 75.55 110.887 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.282 0 CA-C-O 119.118 -0.823 . . . . 72.02 112.516 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.814 ' HA ' HD12 ' A' ' 147' ' ' LEU . 5.3 p80 . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.876 0.37 . . . . 65.04 110.864 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -130.75 82.69 2.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 74.43 110.903 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.585 HG22 ' N ' ' A' ' 115' ' ' THR . 5.0 mp -109.99 163.36 7.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 73.25 111.153 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.699 HG23 ' HA ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -160.65 164.71 31.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 73.4 111.111 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.632 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 5.1 p90 -133.56 145.12 49.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.481 . . . . 72.22 110.977 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.665 ' HD2' HD11 ' A' ' 160' ' ' LEU . 3.9 tmt_? -136.42 110.06 8.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 71.13 110.849 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 52.5 mt -70.73 105.83 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 74.53 111.077 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -60.51 -47.47 86.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 62.3 110.822 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.669 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.2 p-10 -141.53 162.9 34.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 74.4 110.849 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.835 ' CE2' HG11 ' A' ' 130' ' ' VAL . 4.1 m-85 -116.57 144.29 44.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 75.24 110.964 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 124' ' ' ASP . 30.4 m -99.12 135.63 20.75 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.572 0.701 . . . . 65.53 111.133 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.471 ' HD2' HG23 ' A' ' 122' ' ' THR . 54.0 Cg_endo -69.74 10.87 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.728 2.285 . . . . 63.12 112.338 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 124' ' ' ASP . . . . . 0.507 ' H ' HG22 ' A' ' 122' ' ' THR . 1.6 m-20 -87.89 -26.73 22.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 62.25 110.861 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.697 ' HE2' HD22 ' A' ' 212' ' ' LEU . 0.1 OUTLIER -112.76 160.12 18.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 71.11 110.851 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -86.84 152.02 22.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.15 110.956 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -45.44 -39.63 7.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 74.13 110.885 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.01 -38.22 53.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 74.41 110.939 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 129' ' ' ASP . . . . . 0.775 ' OD1' HG23 ' A' ' 205' ' ' THR . 38.8 t0 -61.39 -35.87 78.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.081 -0.509 . . . . 70.44 110.89 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.835 HG11 ' CE2' ' A' ' 121' ' ' TYR . 95.0 t -60.9 -44.86 98.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 70.2 111.122 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 1.0 OUTLIER -83.18 -23.04 33.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 60.13 110.92 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -76.43 -51.87 10.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 74.4 110.888 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.721 ' HB1' ' N ' ' A' ' 213' ' ' PHE . . . -66.59 -30.62 70.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 72.53 111.161 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.538 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.4 mp -77.31 -58.17 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 64.44 111.094 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.538 ' N ' HG22 ' A' ' 134' ' ' ILE . 6.2 ttm180 -48.06 -47.06 34.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 73.53 110.884 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.689 ' O ' HG23 ' A' ' 140' ' ' VAL . 5.8 mmpt? -67.62 -33.98 76.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 71.04 110.879 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.972 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -61.55 -49.47 76.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 71.22 111.119 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.632 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 96.5 m-85 -73.63 -21.9 60.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 64.12 110.856 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 135' ' ' ARG . 2.6 tt0 -77.8 -5.21 50.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 75.04 110.916 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 136' ' ' LYS . 94.9 t -99.14 -17.59 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 62.31 111.112 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.821 ' NE1' HG12 ' A' ' 217' ' ' VAL . 97.0 m95 -106.89 -38.23 6.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.1 -0.5 . . . . 74.21 110.919 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.99 -10.72 59.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.008 0.432 . . . . 61.42 110.912 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -97.24 -17.49 19.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 73.42 110.873 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.803 HG11 HD12 ' A' ' 250' ' ' LEU . 18.1 m -100.2 -3.89 9.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 64.24 111.087 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.779 ' CB ' HD23 ' A' ' 147' ' ' LEU . 44.6 p -142.89 148.4 45.58 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.572 0.701 . . . . 73.21 111.119 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.82 35.01 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.663 2.242 . . . . 71.33 112.34 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.916 HD21 ' HB3' ' A' ' 262' ' ' TYR . 2.8 mm? -104.58 166.28 10.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 65.21 110.95 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 148' ' ' LYS . . . . . 0.416 ' HD2' ' HB2' ' A' ' 112' ' ' HIS . 0.5 OUTLIER -129.21 129.36 44.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 74.02 110.869 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.453 ' HE1' HD13 ' A' ' 114' ' ' ILE . 4.1 m-30 -115.48 137.66 51.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 74.45 110.909 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 150' ' ' SER . . . . . 0.455 ' H ' ' HA ' ' A' ' 115' ' ' THR . 6.3 t -125.26 162.77 23.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 42.21 110.852 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 7.9 tttt -119.5 142.2 48.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 73.22 110.853 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.917 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 0.3 OUTLIER -150.95 166.68 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 72.42 111.158 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 73.04 110.867 179.975 . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.917 ' HB2' ' CD1' ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.724 0.297 . . . . 74.21 111.12 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 158' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.4 OUTLIER -85.93 -50.93 6.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 73.34 110.907 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.612 HG12 HG23 ' A' ' 220' ' ' ILE . 2.3 mp -92.57 91.59 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 73.12 111.177 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.665 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.4 tp -83.11 109.02 16.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.219 -0.446 . . . . 71.41 110.902 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 161' ' ' VAL . . . . . 0.443 HG13 ' CE1' ' A' ' 197' ' ' PHE . 97.2 t -87.48 119.05 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 61.32 111.178 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.669 HG23 ' OD1' ' A' ' 120' ' ' ASN . 1.8 p -137.75 103.89 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 72.11 111.114 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 163' ' ' PHE . . . . . 0.418 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 36.7 m-85 -72.66 110.25 6.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 63.11 110.871 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.499 ' HB3' ' CD2' ' A' ' 168' ' ' HIS . . . -131.57 166.9 20.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 71.21 111.115 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.16 137.74 51.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 72.35 110.837 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.684 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.93 -155.74 0.23 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.716 -0.754 . . . . 63.32 112.512 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.811 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -64.51 116.73 6.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.77 0.319 . . . . 64.34 111.105 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.506 ' NE2' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -109.15 -22.22 12.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 73.32 110.94 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.04 30.35 0.53 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.67 -0.776 . . . . 62.32 112.456 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.638 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -114.47 1.24 14.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.766 0.317 . . . . 70.52 110.824 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 73.05 39.75 0.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 72.24 110.763 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.581 ' ND1' ' N ' ' A' ' 173' ' ' ALA . 0.3 OUTLIER -135.25 -41.23 0.73 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 71.14 110.955 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.811 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.02 100.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 73.4 111.11 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.684 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -60.56 -168.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 64.24 110.909 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.87 19.07 3.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 71.1 110.835 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.589 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.64 -158.22 6.22 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.758 -0.734 . . . . 61.35 112.559 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 176' ' ' GLY . 5.4 tmtt? -34.69 134.25 0.23 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.878 0.371 . . . . 72.01 110.908 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.02 164.66 0.16 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.739 -0.743 . . . . 71.03 112.494 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.469 ' O ' HD22 ' A' ' 181' ' ' LEU . . . 82.97 -142.85 21.8 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 61.54 112.509 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -50.45 96.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.819 0.343 . . . . 53.42 111.094 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.469 HD22 ' O ' ' A' ' 179' ' ' GLY . 3.0 mm? -65.94 -42.94 89.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 74.4 110.92 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -171.09 163.36 7.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 64.31 111.158 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.48 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.2 p80 -156.06 142.96 18.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 72.34 110.881 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.734 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -139.01 172.51 12.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 74.25 111.074 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.537 ' O ' ' O ' ' A' ' 222' ' ' HIS . 46.9 m-85 -101.12 -145.51 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 61.03 110.918 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -168.0 -86.21 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.774 -0.726 . . . . 63.04 112.456 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.73 54.15 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.755 2.304 . . . . 75.04 112.305 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.574 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.32 150.64 16.88 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.773 -0.727 . . . . 71.33 112.47 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 189' ' ' SER . . . . . 0.565 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.08 147.01 27.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 43.31 110.83 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 61.02 -66.21 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.845 -0.693 . . . . 60.44 112.441 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 191' ' ' ILE . . . . . 0.565 ' N ' ' O ' ' A' ' 189' ' ' SER . 5.8 mm -102.76 6.89 10.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.777 0.322 . . . . 74.5 111.068 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.574 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -66.96 168.85 36.18 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.748 -0.739 . . . . 75.33 112.47 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 45.27 18.71 0.18 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 70.41 112.488 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 194' ' ' ASP . . . . . 0.425 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 1.1 m-20 -63.08 102.5 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 73.01 110.85 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.734 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -76.99 132.22 38.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 74.44 111.06 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.48 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 4.8 m170 -123.22 129.53 51.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 71.34 110.868 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.499 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 42.5 m-85 -114.54 135.57 53.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 73.41 110.846 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -68.43 109.38 3.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 71.12 110.945 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -61.03 -36.1 78.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 73.44 110.935 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.589 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 18.0 m-20 -52.18 -20.7 2.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 53.33 110.849 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.4 ' HG3' HD13 ' A' ' 181' ' ' LEU . 6.5 mm-40 -81.57 161.14 23.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.457 . . . . 51.32 110.823 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.542 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -100.13 90.93 4.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 73.15 110.801 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.499 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 22.2 m95 -81.26 123.92 28.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 71.32 110.858 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 43.5 p -140.47 -176.36 4.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 62.11 111.06 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 205' ' ' THR . . . . . 0.775 HG23 ' OD1' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -110.28 19.86 18.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 74.22 111.201 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -128.34 -173.24 2.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 73.34 110.861 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.3 t -71.71 -18.84 62.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 65.21 110.869 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.06 -106.79 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.686 -0.769 . . . . 52.31 112.491 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.07 177.01 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.692 -0.766 . . . . 54.13 112.469 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 210' ' ' THR . . . . . 0.404 HG21 HD12 ' A' ' 181' ' ' LEU . 89.8 m -66.63 97.54 0.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 75.14 111.249 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -42.14 114.75 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 72.21 110.947 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.697 HD22 ' HE2' ' A' ' 125' ' ' MET . 27.1 tp -61.18 -32.46 72.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 62.24 111.0 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.782 ' O ' HG23 ' A' ' 217' ' ' VAL . 3.0 t80 -58.11 -65.23 0.68 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.096 -0.502 . . . . 75.44 110.98 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.581 HD21 ' CG2' ' A' ' 243' ' ' VAL . 8.9 mp -51.88 -54.43 29.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 74.11 110.957 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.49 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.7 m -55.64 -38.93 70.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 74.44 111.023 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.08 -48.81 77.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 63.43 111.093 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.972 HG22 ' HA ' ' A' ' 137' ' ' ALA . 1.9 t -54.83 -57.57 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 63.01 111.093 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.775 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.3 t-80 -64.87 -28.11 69.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 73.15 110.989 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -63.8 -46.53 84.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 61.53 111.067 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.612 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -68.02 -35.23 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 72.33 111.123 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -49.47 -45.91 36.96 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.671 -0.776 . . . . 62.32 112.474 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 222' ' ' HIS . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' PHE . 4.9 m-70 -68.32 -39.89 81.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.801 0.334 . . . . 73.24 110.866 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.563 ' OG ' HG23 ' A' ' 159' ' ' ILE . 14.0 m -66.15 -24.66 66.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 62.11 110.827 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 43.1 mt -75.67 -25.92 57.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 62.41 110.964 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 124.45 11.16 4.7 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.746 -0.74 . . . . 64.12 112.454 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 258' ' ' ILE . 14.4 mt -90.03 142.71 27.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 75.3 110.912 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -93.05 -137.01 8.01 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.71 -0.757 . . . . 41.43 112.47 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -115.96 144.23 44.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.835 0.35 . . . . 75.25 110.872 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 77.6 p -102.85 167.05 10.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 60.13 110.836 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 65.6 m -109.54 5.07 22.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 71.04 110.853 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.527 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -72.75 135.55 80.83 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.524 0.678 . . . . 74.3 110.88 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -0.41 6.85 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.706 2.271 . . . . 75.5 112.326 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.11 26.39 1.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 75.14 110.944 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.527 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -97.55 144.34 27.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 73.12 111.042 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.775 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -63.94 -41.54 92.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 71.13 111.143 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 34.7 mmm -59.86 -18.76 46.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 71.24 110.83 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.604 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -57.38 144.62 70.69 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.68 0.753 . . . . 74.21 110.875 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.604 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.1 Cg_endo -69.95 -1.78 9.2 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.709 2.273 . . . . 51.53 112.34 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.7 m -95.24 137.28 34.5 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.159 -0.473 . . . . 53.35 111.177 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -118.76 135.88 54.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 75.24 110.932 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -154.93 131.43 10.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 61.22 110.926 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.53 ' O ' HG13 ' A' ' 243' ' ' VAL . 80.1 t80 -60.15 145.43 46.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.18 -0.464 . . . . 71.04 110.87 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.581 ' CG2' HD21 ' A' ' 214' ' ' LEU . 0.3 OUTLIER -159.87 132.51 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 73.43 111.141 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -50.16 128.17 18.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 75.44 110.894 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.618 HD11 ' HD3' ' A' ' 136' ' ' LYS . 14.0 tt -51.13 -33.77 13.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.208 -0.451 . . . . 73.14 111.078 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -69.68 -23.27 63.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 74.5 110.837 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 29.6 p -101.33 -24.42 14.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 74.1 111.125 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -64.31 144.28 57.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 63.33 110.834 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -175.04 131.19 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 74.22 110.846 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.803 HD12 HG11 ' A' ' 144' ' ' VAL . 33.8 mt -49.81 124.56 10.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 75.44 110.891 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.34 167.08 15.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 54.21 110.785 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.61 -39.17 49.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.089 -0.505 . . . . 71.03 111.159 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.9 -46.92 85.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 74.42 110.821 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.433 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 6.9 m-20 -61.36 -54.49 43.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 65.43 110.866 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 23.0 mt -60.58 -35.01 60.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 74.01 111.159 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -68.75 -39.78 80.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.454 . . . . 71.11 110.861 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.03 -51.19 7.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 73.33 112.506 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.663 HG13 HG21 ' A' ' 145' ' ' THR . 6.2 tp -53.23 -34.37 21.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.794 0.33 . . . . 72.14 111.205 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 263' ' ' GLY . 31.2 mt-30 -87.86 -16.13 34.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 71.13 110.942 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.4 t -69.33 -16.52 63.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 70.21 110.902 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.1 mt -120.76 -19.42 7.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.509 . . . . 72.0 110.86 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.916 ' HB3' HD21 ' A' ' 147' ' ' LEU . 29.7 m-85 -110.17 -37.25 5.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 62.15 110.908 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.335 0 CA-C-O 119.194 -0.781 . . . . 72.05 112.475 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' HIS . . . . . 0.464 ' HA ' HD22 ' A' ' 147' ' ' LEU . 3.3 p80 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.798 0.333 . . . . 62.04 110.859 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -125.96 96.41 4.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.187 -0.461 . . . . 73.51 110.975 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ILE . . . . . 0.613 HG22 ' N ' ' A' ' 115' ' ' THR . 4.8 mp -123.29 163.93 21.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 71.24 111.161 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' THR . . . . . 0.613 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -157.72 163.64 37.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 72.44 111.226 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' TYR . . . . . 0.593 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.7 p90 -133.53 144.63 49.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 64.53 110.926 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' ARG . . . . . 0.646 ' HD2' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -138.84 108.86 6.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.486 . . . . 53.35 110.83 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 53.2 mt -70.66 106.03 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 74.12 111.124 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -60.39 -47.43 86.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 71.52 110.921 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ASN . . . . . 0.701 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.3 p-10 -141.17 162.52 35.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 75.24 110.96 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' TYR . . . . . 0.575 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.1 m-85 -116.35 145.55 43.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.187 -0.46 . . . . 73.33 110.927 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' THR . . . . . 0.522 ' CG2' ' HD2' ' A' ' 123' ' ' PRO . 3.6 m -93.01 137.9 23.53 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.581 0.705 . . . . 51.24 111.147 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 123' ' ' PRO . . . . . 0.522 ' HD2' ' CG2' ' A' ' 122' ' ' THR . 54.2 Cg_endo -69.85 0.6 5.48 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.635 2.223 . . . . 75.04 112.323 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -84.08 -24.23 30.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 71.33 110.844 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 125' ' ' MET . . . . . 0.67 ' SD ' HD22 ' A' ' 212' ' ' LEU . 3.8 mtm -113.12 167.37 10.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 74.32 110.853 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -92.96 143.41 26.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 73.44 110.974 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -45.36 -36.22 4.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 71.3 110.877 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -83.38 -38.23 22.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 74.33 110.908 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -64.12 -31.8 73.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 75.21 110.828 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 130' ' ' VAL . . . . . 0.575 HG11 ' CE2' ' A' ' 121' ' ' TYR . 56.4 t -65.61 -46.21 90.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 74.21 111.105 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 131' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 0.2 OUTLIER -78.49 -23.53 46.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 51.43 110.88 179.902 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -74.93 -48.02 26.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 74.04 110.955 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 133' ' ' ALA . . . . . 0.672 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -68.88 -31.18 69.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 35.41 111.112 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' ILE . . . . . 0.518 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.3 mp -73.8 -53.93 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 62.13 111.161 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 135' ' ' ARG . . . . . 0.518 ' N ' HG22 ' A' ' 134' ' ' ILE . 3.8 ptm180 -49.22 -37.34 22.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 74.2 110.832 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 136' ' ' LYS . . . . . 0.731 ' O ' HG23 ' A' ' 140' ' ' VAL . 5.6 mmpt? -76.97 -34.34 57.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 73.14 110.854 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 137' ' ' ALA . . . . . 0.911 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.12 -48.66 80.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 60.41 111.134 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 138' ' ' PHE . . . . . 0.623 ' HE1' HD13 ' A' ' 159' ' ' ILE . 96.0 m-85 -72.84 -22.79 60.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 75.34 110.942 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 139' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 135' ' ' ARG . 2.4 tt0 -77.78 -5.78 51.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.116 -0.493 . . . . 65.21 110.917 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 140' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 136' ' ' LYS . 83.8 t -97.94 -16.77 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 71.53 111.066 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 141' ' ' TRP . . . . . 0.813 ' NE1' HG12 ' A' ' 217' ' ' VAL . 92.1 m95 -107.09 -38.26 6.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.264 -0.426 . . . . 72.41 110.917 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.95 -11.53 60.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 51.03 110.814 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -95.53 -17.49 21.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 72.41 110.849 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 144' ' ' VAL . . . . . 0.685 HG11 HD12 ' A' ' 250' ' ' LEU . 22.4 m -99.86 2.72 10.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 75.34 111.084 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 145' ' ' THR . . . . . 0.587 HG21 HG13 ' A' ' 258' ' ' ILE . 44.5 p -150.99 148.69 23.34 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.537 0.684 . . . . 73.41 111.208 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.71 31.09 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.673 2.249 . . . . 72.12 112.357 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 147' ' ' LEU . . . . . 0.772 HD11 ' CD2' ' A' ' 262' ' ' TYR . 15.4 mt -97.44 175.01 6.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 71.42 110.937 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm -139.05 126.77 22.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 74.41 110.768 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 149' ' ' PHE . . . . . 0.57 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.7 m-85 -115.4 138.36 51.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 75.2 110.898 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 58.5 m -132.57 149.26 52.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 71.24 110.919 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 151' ' ' LYS . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 4.4 tttt -99.52 141.05 32.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 64.23 110.9 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 152' ' ' ILE . . . . . 0.597 HD11 ' N ' ' A' ' 157' ' ' ALA . 15.5 pt -150.75 139.26 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 72.34 111.121 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 55.32 110.896 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 157' ' ' ALA . . . . . 0.597 ' N ' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.819 0.343 . . . . 51.44 111.075 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.02 -57.41 2.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 73.11 110.875 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 159' ' ' ILE . . . . . 0.683 HG12 HG23 ' A' ' 220' ' ' ILE . 2.8 mp -82.52 86.26 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 64.12 111.139 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 160' ' ' LEU . . . . . 0.646 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.9 tp -79.76 102.78 9.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 70.45 110.84 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 96.7 t -82.3 123.08 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 63.45 111.148 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 162' ' ' VAL . . . . . 0.701 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.1 p -140.97 100.05 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 64.51 111.173 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -67.53 109.39 3.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 75.01 110.877 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 164' ' ' ALA . . . . . 0.488 ' HB3' ' CD2' ' A' ' 168' ' ' HIS . . . -128.76 165.76 20.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.112 -0.495 . . . . 60.41 111.065 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -113.65 134.85 54.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 74.24 110.847 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 166' ' ' GLY . . . . . 0.665 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.83 -156.98 0.16 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.677 -0.773 . . . . 55.13 112.509 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 167' ' ' ALA . . . . . 0.81 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -62.76 115.37 4.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.883 0.373 . . . . 72.03 111.072 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 168' ' ' HIS . . . . . 0.501 ' NE2' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -108.39 -21.07 12.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 75.45 110.876 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.89 30.1 0.59 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.684 -0.77 . . . . 42.31 112.482 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 170' ' ' ASP . . . . . 0.638 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.49 -0.96 14.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.888 0.375 . . . . 45.04 110.872 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 75.37 38.05 0.42 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 73.42 110.877 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 172' ' ' HIS . . . . . 0.576 ' ND1' ' N ' ' A' ' 173' ' ' ALA . 0.4 OUTLIER -133.95 -41.14 0.83 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 71.04 110.853 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 173' ' ' ALA . . . . . 0.81 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.26 100.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 74.43 111.172 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 174' ' ' PHE . . . . . 0.665 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -61.03 -168.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 72.15 110.862 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.12 17.5 4.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 54.45 110.883 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 176' ' ' GLY . . . . . 0.577 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.06 -157.41 7.36 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.748 -0.739 . . . . 54.14 112.5 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 177' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -34.41 134.42 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.905 0.383 . . . . 65.22 110.868 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.62 165.95 0.12 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.687 -0.768 . . . . 62.54 112.555 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 179' ' ' GLY . . . . . 0.422 ' O ' HD22 ' A' ' 181' ' ' LEU . . . 82.56 -143.19 22.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.708 -0.758 . . . . 64.33 112.488 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.23 96.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.867 0.365 . . . . 73.5 111.139 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 181' ' ' LEU . . . . . 0.499 HD13 ' HG3' ' A' ' 201' ' ' GLU . 2.7 mm? -66.98 -36.04 81.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 60.45 110.949 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 182' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -174.74 169.0 3.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 52.34 111.11 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 183' ' ' HIS . . . . . 0.45 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.2 p80 -161.27 142.28 11.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.275 -0.421 . . . . 75.4 110.881 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 184' ' ' ALA . . . . . 0.607 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -140.75 170.3 16.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 71.45 111.135 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 185' ' ' PHE . . . . . 0.641 ' O ' ' HA ' ' A' ' 223' ' ' SER . 1.8 m-85 -125.64 167.93 14.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 74.44 110.93 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 186' ' ' GLY . . . . . 0.739 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -138.18 32.69 2.32 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.787 -0.721 . . . . 74.02 112.569 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 187' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 186' ' ' GLY . 53.9 Cg_endo -69.75 -23.27 31.05 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 122.694 2.263 . . . . 72.21 112.325 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 188' ' ' GLY . . . . . 0.423 ' H ' ' CA ' ' A' ' 192' ' ' GLY . . . 90.2 135.41 6.0 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.763 -0.732 . . . . 75.24 112.5 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.0 t 64.46 148.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.827 0.346 . . . . 75.42 110.871 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 47.95 -102.07 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.731 -0.747 . . . . 71.04 112.432 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 40.3 pt -77.84 6.63 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.85 0.357 . . . . 64.23 111.118 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 192' ' ' GLY . . . . . 0.483 ' HA2' ' HD2' ' A' ' 187' ' ' PRO . . . -74.76 121.54 6.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.766 -0.731 . . . . 63.23 112.483 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 193' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 75.2 -9.39 13.13 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.75 -0.738 . . . . 45.01 112.514 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.17 109.51 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.885 0.374 . . . . 72.21 110.883 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 195' ' ' ALA . . . . . 0.607 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -98.83 138.04 36.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 74.55 111.151 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 196' ' ' HIS . . . . . 0.455 ' O ' ' HB1' ' A' ' 182' ' ' ALA . 4.9 m170 -125.26 137.62 54.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.316 -0.402 . . . . 73.42 110.859 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 197' ' ' PHE . . . . . 0.415 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 37.8 m-85 -120.03 142.44 48.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 74.43 110.869 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -73.8 109.11 7.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 75.4 110.779 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -62.1 -35.66 79.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 74.24 110.85 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 200' ' ' ASP . . . . . 0.577 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 12.0 m-20 -51.24 -21.56 2.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 71.52 110.87 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 201' ' ' GLU . . . . . 0.499 ' HG3' HD13 ' A' ' 181' ' ' LEU . 5.8 mm-40 -81.54 161.29 23.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 74.42 110.97 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 202' ' ' PHE . . . . . 0.564 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -99.47 88.32 3.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 73.45 110.917 -179.887 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 203' ' ' TRP . . . . . 0.491 ' CZ3' HG21 ' A' ' 215' ' ' THR . 33.7 m95 -78.15 123.22 26.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 71.42 110.887 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 32.6 p -139.64 -176.32 4.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 70.22 111.146 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.77 17.27 19.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 72.14 111.112 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 -176.05 3.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 54.54 110.843 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.8 t -66.69 -18.51 65.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.272 -0.422 . . . . 73.44 110.86 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.49 -108.3 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 71.22 112.528 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 209' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.63 176.82 0.13 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.788 -0.72 . . . . 43.45 112.415 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 94.5 m -65.62 97.95 0.35 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.799 0.333 . . . . 72.31 111.105 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -42.0 117.11 0.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 72.2 110.95 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 212' ' ' LEU . . . . . 0.67 HD22 ' SD ' ' A' ' 125' ' ' MET . 30.4 tp -64.82 -36.72 85.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 61.51 110.901 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 213' ' ' PHE . . . . . 0.761 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.4 t80 -53.84 -65.45 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 44.25 110.791 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 214' ' ' LEU . . . . . 0.511 HD11 ' H ' ' A' ' 243' ' ' VAL . 18.8 mt -53.12 -54.97 27.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.489 . . . . 74.13 110.894 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 215' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 219' ' ' ALA . 6.2 m -54.81 -38.41 67.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 74.12 111.099 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.19 -50.04 71.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 61.41 111.134 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 217' ' ' VAL . . . . . 0.911 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.1 t -51.67 -59.6 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 60.12 111.115 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 218' ' ' HIS . . . . . 0.741 ' HB2' HG13 ' A' ' 235' ' ' VAL . 2.1 t-80 -65.07 -28.11 69.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 62.0 110.856 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 219' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -63.81 -46.07 86.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 42.42 111.112 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 220' ' ' ILE . . . . . 0.683 HG23 HG12 ' A' ' 159' ' ' ILE . 2.8 mt -66.05 -34.66 71.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 73.33 111.197 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 221' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -53.69 -44.38 69.34 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.753 -0.736 . . . . 32.44 112.499 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -69.54 -34.92 74.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.724 0.297 . . . . 70.41 110.811 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 223' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 4.0 p -70.41 -24.85 63.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.275 -0.42 . . . . 71.33 110.895 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 224' ' ' LEU . . . . . 0.461 HD21 HG21 ' A' ' 114' ' ' ILE . 45.6 mt -76.93 -27.35 54.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 71.22 110.962 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 120.29 16.32 4.78 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.779 -0.724 . . . . 72.44 112.553 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 226' ' ' LEU . . . . . 0.888 HD21 ' HA ' ' A' ' 258' ' ' ILE . 15.3 mt -79.59 162.87 25.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 75.52 110.937 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -105.38 -133.17 7.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.755 -0.736 . . . . 43.31 112.411 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -131.2 148.86 52.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 64.12 110.805 -179.851 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 86.7 p -108.62 166.44 10.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 73.41 110.864 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.53 0.46 20.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 64.21 110.872 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 231' ' ' ASP . . . . . 0.532 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -68.64 133.9 90.6 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.606 0.717 . . . . 73.04 110.85 179.872 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 0.59 5.44 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.706 2.271 . . . . 73.55 112.277 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.91 19.07 2.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 72.35 110.926 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 234' ' ' ALA . . . . . 0.532 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -91.49 140.26 29.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 55.14 111.082 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 235' ' ' VAL . . . . . 0.741 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.0 OUTLIER -61.16 -41.18 88.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.235 -0.439 . . . . 75.02 111.137 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 53.9 mmm -58.68 -20.75 51.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 73.24 110.895 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 237' ' ' PHE . . . . . 0.6 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.0 t80 -55.63 144.03 56.44 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.712 0.768 . . . . 62.5 110.902 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 238' ' ' PRO . . . . . 0.6 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.8 Cg_endo -69.67 0.79 5.07 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.749 2.299 . . . . 74.42 112.315 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 239' ' ' THR . . . . . 0.434 ' HG1' ' HD2' ' A' ' 237' ' ' PHE . 30.7 m -97.32 138.91 34.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 65.22 111.166 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -120.87 137.05 54.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 71.13 110.937 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -157.4 137.27 12.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 61.31 110.912 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 242' ' ' TYR . . . . . 0.548 ' O ' HG13 ' A' ' 243' ' ' VAL . 73.9 t80 -61.44 146.91 46.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 72.45 110.913 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 243' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.3 OUTLIER -160.46 132.52 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 75.31 111.183 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -50.11 132.05 23.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 64.43 110.874 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 245' ' ' ILE . . . . . 0.458 HD11 ' HD3' ' A' ' 136' ' ' LYS . 7.3 tt -54.65 -30.63 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 71.21 111.138 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -76.17 -18.24 59.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 73.25 110.885 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 60.1 p -105.01 -22.77 13.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 73.42 111.072 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -69.67 142.97 53.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.429 . . . . 61.23 110.889 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -176.43 131.68 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 73.2 110.857 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 250' ' ' LEU . . . . . 0.685 HD12 HG11 ' A' ' 144' ' ' VAL . 80.2 mt -49.42 128.85 17.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 74.33 110.95 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 251' ' ' SER . . . . . 0.448 ' O ' HD12 ' A' ' 255' ' ' ILE . 8.2 m -76.52 169.97 17.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 74.3 110.899 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.74 -43.24 47.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 70.31 111.069 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.17 -49.08 79.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 75.51 110.821 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 254' ' ' ASP . . . . . 0.464 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 16.3 m-20 -57.22 -54.8 42.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 71.34 110.811 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 255' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 251' ' ' SER . 2.9 mt -59.73 -39.59 80.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.437 . . . . 73.51 111.17 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -64.1 -39.84 94.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 75.43 110.909 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 257' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -75.28 -54.01 5.83 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.766 -0.731 . . . . 54.33 112.459 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 258' ' ' ILE . . . . . 0.888 ' HA ' HD21 ' A' ' 226' ' ' LEU . 4.5 tp -53.09 -35.72 23.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.775 0.322 . . . . 65.15 111.075 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 259' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 263' ' ' GLY . 87.0 mt-30 -85.82 -17.22 36.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 53.14 110.948 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 260' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 3.2 t -69.0 -14.29 62.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 72.4 110.834 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.7 mt -123.91 -18.4 6.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 63.24 110.838 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 262' ' ' TYR . . . . . 0.772 ' CD2' HD11 ' A' ' 147' ' ' LEU . 36.8 m-85 -113.43 -33.98 5.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 64.42 110.925 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 263' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.429 0 CA-C-O 119.133 -0.815 . . . . 71.3 112.507 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.4 t80 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.855 0.36 . . . . 74.22 110.862 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.572 ' H ' ' NE ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -71.29 66.97 0.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 74.32 110.906 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 175.88 143.23 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 74.34 110.851 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.6 mmt -52.12 159.46 1.48 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.517 0.675 . . . . 75.43 110.87 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 78.06 1.04 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.704 2.269 . . . . 62.22 112.306 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 131.9 -124.1 3.87 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.739 -0.743 . . . . 64.31 112.48 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -149.86 55.53 0.48 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.726 -0.749 . . . . 52.11 112.479 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -24.97 29.02 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.694 2.263 . . . . 74.24 112.364 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.855 HG21 ' HB3' ' A' ' 261' ' ' LEU . 5.2 m -47.15 137.76 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 51.24 111.111 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.419 ' HB3' ' HG2' ' A' ' 111' ' ' LYS . 3.4 m0 -63.32 -23.01 67.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 75.4 110.909 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 63.9 30.28 14.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 74.34 110.853 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.419 ' HG2' ' HB3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -123.33 157.36 33.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 71.24 110.891 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.402 ' HA ' ' HG ' ' A' ' 147' ' ' LEU . 16.0 p80 -99.1 20.45 13.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 74.51 110.845 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.405 ' C ' HD12 ' A' ' 114' ' ' ILE . 0.9 OUTLIER -121.37 110.96 16.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 64.11 110.921 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 115' ' ' THR . 4.9 mp -141.06 162.1 22.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 74.12 111.129 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.574 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -157.58 163.54 38.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 73.1 111.135 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.622 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 4.2 p90 -134.53 146.91 50.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 73.43 110.956 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.466 ' HD2' HD11 ' A' ' 160' ' ' LEU . 4.3 tmt_? -141.63 111.82 6.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 72.24 110.901 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.9 mt -73.83 106.86 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 72.01 111.137 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -58.89 -50.43 74.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 71.32 110.893 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.62 ' OD1' HG23 ' A' ' 162' ' ' VAL . 3.3 p-10 -140.17 165.22 27.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 43.44 110.907 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -118.15 138.88 51.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 74.01 110.896 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.754 HG22 ' HE2' ' A' ' 125' ' ' MET . 2.5 t -88.11 143.01 32.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.538 0.685 . . . . 74.14 111.163 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.408 ' HD2' ' OG1' ' A' ' 122' ' ' THR . 53.6 Cg_endo -69.77 -3.11 11.37 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.658 2.239 . . . . 75.4 112.361 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.462 ' H ' HG23 ' A' ' 122' ' ' THR . 13.7 m-20 -80.83 -23.27 39.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 65.01 110.855 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.754 ' HE2' HG22 ' A' ' 122' ' ' THR . 16.2 mtm -115.05 166.03 12.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 43.43 110.869 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -98.17 145.62 26.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 75.1 110.863 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -45.43 -34.49 3.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 74.21 110.928 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -82.32 -40.73 21.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 73.55 110.896 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -63.78 -31.13 72.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 73.2 110.839 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.47 ' O ' HD13 ' A' ' 134' ' ' ILE . 59.5 t -63.86 -45.46 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 71.13 111.158 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.3 -23.47 40.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.151 -0.477 . . . . 73.53 110.879 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -75.26 -47.33 28.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 64.34 110.941 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.754 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -71.2 -31.07 67.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 74.14 111.108 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.625 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -73.7 -55.23 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 74.13 111.145 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.53 ' N ' HG22 ' A' ' 134' ' ' ILE . 5.3 ttt180 -48.56 -42.54 33.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 63.51 110.896 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.614 ' O ' HG23 ' A' ' 140' ' ' VAL . 8.7 mmpt? -70.87 -35.51 72.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 72.24 110.905 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.91 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.0 -48.85 80.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 42.4 111.101 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.622 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 93.3 m-85 -72.6 -22.32 60.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 63.33 110.814 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.28 -6.24 52.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 75.1 110.941 -179.952 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 136' ' ' LYS . 93.8 t -97.31 -17.56 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 12.35 111.131 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.796 ' NE1' HG12 ' A' ' 217' ' ' VAL . 95.3 m95 -106.18 -36.39 6.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 73.3 110.939 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.82 -11.54 61.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 74.1 110.823 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -95.61 -18.44 20.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 71.02 110.933 -179.988 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.844 HG11 HD12 ' A' ' 250' ' ' LEU . 19.9 m -98.42 1.24 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 75.2 111.108 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.568 HG21 HG13 ' A' ' 258' ' ' ILE . 39.0 p -151.96 146.24 18.44 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.606 0.717 . . . . 74.14 111.14 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 30.59 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.625 2.217 . . . . 64.53 112.379 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.838 HD21 ' CG ' ' A' ' 262' ' ' TYR . 0.2 OUTLIER -91.76 177.48 6.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 53.5 110.939 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.23 125.59 20.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 73.32 110.904 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.549 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.9 m-30 -114.94 141.56 47.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 71.03 110.894 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.403 ' H ' ' HA ' ' A' ' 115' ' ' THR . 2.1 t -135.72 153.03 51.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 44.33 110.857 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.478 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 19.8 tttt -104.43 143.18 33.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 72.52 110.888 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.581 HD12 ' CA ' ' A' ' 155' ' ' GLY . 16.9 pt -152.32 155.52 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 73.31 111.083 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 38.9 m-20 -122.17 -3.04 9.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 75.13 110.877 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.9 t -159.78 50.66 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 73.31 111.118 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.581 ' CA ' HD12 ' A' ' 152' ' ' ILE . . . -142.19 -153.91 6.03 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 71.1 112.507 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -107.8 90.63 3.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 74.25 110.856 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.477 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -101.46 155.99 17.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 62.0 111.078 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.15 -52.7 5.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 75.31 110.86 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.668 HG12 HG23 ' A' ' 220' ' ' ILE . 2.4 mp -90.01 94.21 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 62.2 111.085 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.466 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.9 tp -86.5 107.75 18.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 73.03 110.895 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 88.4 t -84.97 121.63 37.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 75.33 111.172 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.62 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -140.25 105.43 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 74.22 111.127 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -73.31 110.27 7.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 73.02 110.889 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -126.98 166.83 16.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 72.23 111.131 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.72 133.1 55.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 75.24 110.853 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.676 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.36 -158.04 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 62.14 112.484 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.766 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -50.71 118.81 3.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 73.02 111.104 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.77 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 4.3 p-80 -137.65 32.5 2.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 75.35 110.854 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 79.11 53.43 4.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 60.31 112.478 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.461 ' OD2' ' CE1' ' A' ' 196' ' ' HIS . 23.7 t0 -143.15 9.34 1.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 75.54 110.88 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 54.16 22.36 3.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 74.11 110.86 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.77 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 2.1 p-80 -118.62 -38.9 3.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 73.41 110.848 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.766 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 50.43 99.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 72.3 111.114 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.676 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.4 m-85 -58.72 -170.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 74.43 110.862 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.69 21.21 4.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 61.41 110.862 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.583 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 52.53 -156.05 4.69 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 44.31 112.477 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.9 OUTLIER -33.77 132.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.829 0.347 . . . . 64.22 110.911 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.94 163.53 0.13 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.814 -0.708 . . . . 75.34 112.471 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.18 -142.25 19.64 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 74.33 112.452 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.2 mt -49.92 97.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 71.23 111.147 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.467 HD12 HG21 ' A' ' 210' ' ' THR . 2.9 mm? -66.8 -41.61 87.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 71.41 110.875 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 197' ' ' PHE . . . -174.74 158.47 2.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 71.21 111.08 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.429 ' CE1' ' CD2' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -148.92 134.3 18.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.449 . . . . 61.32 110.847 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.781 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -131.71 175.39 9.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 72.24 111.134 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.534 ' O ' ' HA ' ' A' ' 223' ' ' SER . 65.7 m-85 -105.6 -152.93 0.48 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 73.42 110.853 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -160.74 -84.44 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.701 -0.761 . . . . 61.32 112.463 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 52.33 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.721 2.28 . . . . 61.44 112.331 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.59 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.56 150.02 17.16 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.781 -0.724 . . . . 41.13 112.499 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -105.54 147.75 28.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 55.33 110.804 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.27 -64.12 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 44.22 112.5 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 189' ' ' SER . 2.3 pp -107.15 8.42 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 73.31 111.119 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.59 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -69.53 169.5 44.27 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.775 -0.726 . . . . 72.44 112.482 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 46.78 18.35 0.38 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 40.34 112.496 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.14 110.4 2.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.333 . . . . 73.24 110.894 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.781 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -85.01 130.01 34.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 73.52 111.116 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.461 ' CE1' ' OD2' ' A' ' 170' ' ' ASP . 1.3 m170 -123.32 123.04 39.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 71.23 110.84 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.557 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 37.1 m-85 -106.5 138.54 42.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 74.12 110.889 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -68.37 105.37 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 73.32 110.86 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -55.53 -39.09 70.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 75.34 110.845 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.583 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 15.8 m-20 -48.37 -25.0 1.41 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 50.02 110.867 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -77.55 163.11 26.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 74.24 110.894 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.571 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -101.21 86.61 3.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 74.42 110.872 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.557 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 24.7 m95 -79.53 122.4 26.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 73.52 110.881 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.6 p -139.94 -172.83 3.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 64.2 111.148 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.02 19.6 17.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 72.31 111.155 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -126.93 -175.4 3.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 75.31 110.894 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 11.4 p -70.44 -18.84 63.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 54.45 110.891 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.63 -106.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.742 -0.742 . . . . 50.42 112.47 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.07 176.54 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.712 -0.756 . . . . 74.41 112.498 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.467 HG21 HD12 ' A' ' 181' ' ' LEU . 55.6 m -66.65 96.93 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 71.43 111.112 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -43.09 116.93 0.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.427 . . . . 73.42 110.85 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.754 HD23 ' HB3' ' A' ' 133' ' ' ALA . 9.0 tp -62.83 -37.31 86.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 61.42 110.924 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.737 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.6 t80 -51.59 -63.9 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 71.14 110.887 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.56 HD21 ' CG2' ' A' ' 243' ' ' VAL . 8.3 mp -54.6 -55.82 25.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 65.21 110.917 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.505 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 1.5 m -55.45 -32.92 63.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 73.53 111.157 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -68.12 -47.99 66.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 71.2 111.081 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.91 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -53.66 -58.01 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 55.14 111.115 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.744 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.8 t-80 -64.45 -29.38 70.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 73.01 110.867 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.31 -44.7 95.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 65.42 111.055 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.668 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -68.95 -35.11 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 70.52 111.121 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.65 -43.94 46.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.718 -0.753 . . . . 72.21 112.473 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 185' ' ' PHE . 28.2 m-70 -67.79 -39.06 84.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 71.3 110.868 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.655 ' OG ' HG23 ' A' ' 159' ' ' ILE . 3.1 m -63.3 -27.46 69.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 62.4 110.834 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 44.6 mt -75.52 -27.99 58.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 73.3 110.902 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 119.9 15.13 5.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.781 -0.723 . . . . 75.41 112.471 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.704 HD21 ' HA ' ' A' ' 258' ' ' ILE . 14.4 mt -79.02 158.18 27.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 64.14 110.912 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -104.07 -136.4 8.87 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.706 -0.759 . . . . 62.05 112.487 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 1.5 m170 -125.94 142.16 51.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.849 0.356 . . . . 72.31 110.817 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 21.7 m -104.7 162.75 13.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 75.22 110.87 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.0 t -103.86 0.71 30.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 54.44 110.871 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.598 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -66.24 136.98 95.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.618 0.723 . . . . 72.23 110.834 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -0.32 6.76 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.661 2.241 . . . . 72.14 112.322 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.03 17.36 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.42 . . . . 75.41 110.884 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.598 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -86.69 134.18 33.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 73.45 111.133 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.744 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -58.15 -36.2 56.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 74.41 111.129 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.428 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 44.2 mmm -61.56 -21.96 64.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 73.2 110.912 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.543 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.7 t80 -54.9 142.7 54.63 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.613 0.721 . . . . 74.54 110.898 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.543 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.3 Cg_endo -69.73 -1.46 8.49 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.695 2.263 . . . . 71.44 112.345 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 41.8 m -95.32 141.23 29.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 64.41 111.126 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -118.36 140.33 50.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 61.32 110.975 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -157.7 138.05 12.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 62.44 110.858 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.57 ' O ' HG13 ' A' ' 243' ' ' VAL . 77.9 t80 -68.77 145.4 53.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 72.44 110.923 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -162.27 133.22 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 72.43 111.081 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -51.37 130.31 26.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 73.43 110.867 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.49 HD11 ' HD3' ' A' ' 136' ' ' LYS . 16.4 tt -52.26 -30.81 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 74.32 111.139 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -67.68 -22.57 65.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 75.22 110.94 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 28.0 p -109.49 -20.83 12.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 74.42 111.173 -179.995 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -69.12 121.28 16.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 72.3 110.905 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -152.98 143.11 22.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.32 110.835 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.844 HD12 HG11 ' A' ' 144' ' ' VAL . 33.2 mt -58.73 123.51 16.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 72.21 110.927 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 10.3 t -64.32 163.24 13.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 74.1 110.835 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.2 -37.95 24.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 33.53 111.101 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -63.81 -45.5 89.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 73.54 110.87 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.424 ' OD2' ' HB ' ' A' ' 235' ' ' VAL . 5.4 m-20 -61.94 -53.66 52.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 71.54 110.902 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.414 ' HA ' HG22 ' A' ' 258' ' ' ILE . 23.1 mt -62.03 -34.95 65.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 45.54 111.112 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -68.36 -40.5 81.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 73.44 110.831 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.06 -51.84 6.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 73.21 112.5 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.704 ' HA ' HD21 ' A' ' 226' ' ' LEU . 5.8 tp -52.51 -35.07 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.775 0.321 . . . . 62.33 111.1 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 263' ' ' GLY . 75.3 mt-30 -87.46 -17.24 32.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 73.14 110.911 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.5 t -69.75 -13.69 62.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 74.2 110.851 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.855 ' HB3' HG21 ' A' ' 108' ' ' VAL . 3.8 mt -123.55 -18.4 6.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 53.0 110.937 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.838 ' CG ' HD21 ' A' ' 147' ' ' LEU . 39.6 m-85 -114.56 -33.66 5.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 63.32 110.9 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.298 0 CA-C-O 119.123 -0.821 . . . . 71.12 112.505 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.864 0.364 . . . . 71.01 110.891 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 39.09 38.2 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 73.43 110.877 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -157.59 123.49 4.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 55.04 110.876 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -51.45 133.82 33.94 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.615 0.721 . . . . 72.22 110.874 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 143.6 51.65 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.673 2.249 . . . . 74.35 112.397 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.52 12.2 63.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.702 -0.761 . . . . 54.11 112.477 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.489 ' N ' ' CD ' ' A' ' 107' ' ' PRO . . . 42.67 49.92 5.9 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.693 -0.765 . . . . 52.23 112.458 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 106' ' ' GLY . 54.0 Cg_endo -69.72 -18.82 36.98 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.658 2.239 . . . . 74.1 112.407 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.075 HG21 HD13 ' A' ' 261' ' ' LEU . 57.4 t -47.28 138.33 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 70.42 111.119 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.504 ' CZ3' HD23 ' A' ' 224' ' ' LEU . 4.8 m0 -65.18 -32.0 73.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 73.31 110.88 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.714 ' H ' HG12 ' A' ' 108' ' ' VAL . 20.4 mtt-85 64.33 35.23 9.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 75.34 110.928 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.473 ' HG2' ' HB2' ' A' ' 109' ' ' TRP . 23.4 pttt -122.58 166.29 15.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 70.04 110.875 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -109.42 35.69 3.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 65.11 110.848 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.413 ' C ' HD12 ' A' ' 114' ' ' ILE . 4.0 m-85 -141.1 106.38 5.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 75.22 110.995 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.675 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.6 mp -139.77 163.76 24.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 74.44 111.204 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.603 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -157.91 163.67 37.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 71.52 111.126 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.61 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.4 p90 -132.67 148.62 52.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.254 -0.43 . . . . 70.42 110.953 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.667 ' HD2' HD11 ' A' ' 160' ' ' LEU . 3.7 tmt_? -142.84 113.33 7.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.515 . . . . 64.14 110.885 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.424 HD12 ' OH ' ' A' ' 121' ' ' TYR . 45.9 mt -74.25 106.54 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 75.14 111.179 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -61.34 -45.26 95.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 75.31 110.914 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.71 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.4 p-10 -144.1 161.92 37.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 73.42 110.931 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.642 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.1 m-85 -117.23 137.74 52.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 71.22 110.907 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.756 HG22 ' HE1' ' A' ' 125' ' ' MET . 9.3 t -88.31 142.51 31.57 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 121.648 0.737 . . . . 75.15 111.111 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 0.86 5.0 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.702 2.268 . . . . 64.42 112.405 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -82.81 -24.55 33.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.257 -0.429 . . . . 71.13 110.875 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.756 ' HE1' HG22 ' A' ' 122' ' ' THR . 5.8 mtm -116.46 165.7 12.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.282 -0.417 . . . . 53.04 110.838 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.474 ' O ' HG23 ' A' ' 130' ' ' VAL . 4.5 m120 -96.01 145.48 25.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 65.24 110.893 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.89 -34.85 4.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 73.13 110.909 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -83.04 -37.71 23.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 55.42 110.902 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -66.57 -29.67 69.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 62.33 110.894 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.662 HG22 ' CE ' ' A' ' 125' ' ' MET . 77.6 t -65.36 -46.75 89.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 65.52 111.154 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.52 -23.85 46.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 65.1 110.893 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -73.55 -46.39 47.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 72.52 110.943 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.697 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -72.66 -32.75 66.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 72.32 111.112 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.59 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -71.62 -53.59 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 75.43 111.155 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.533 ' N ' HG22 ' A' ' 134' ' ' ILE . 4.6 ttt-85 -49.22 -42.53 40.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 73.04 110.868 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.717 ' O ' HG23 ' A' ' 140' ' ' VAL . 9.5 mmtt -71.4 -33.93 69.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 74.12 110.852 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.884 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.54 -49.32 78.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 65.43 111.059 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.61 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.9 m-85 -72.13 -23.11 61.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 73.22 110.917 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -77.05 -6.27 52.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 73.24 110.921 -179.915 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 136' ' ' LYS . 92.7 t -97.22 -16.26 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 64.34 111.249 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.806 ' NE1' HG12 ' A' ' 217' ' ' VAL . 92.7 m95 -106.32 -33.17 7.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 64.31 110.869 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 142' ' ' SER . . . . . 0.455 ' OG ' ' CD2' ' A' ' 149' ' ' PHE . 6.5 m -70.41 -15.66 62.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 72.33 110.832 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -91.41 -18.69 23.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 75.04 110.827 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.747 HG11 HD12 ' A' ' 250' ' ' LEU . 24.5 m -98.62 1.87 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 74.14 111.164 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 147' ' ' LEU . 15.7 p -154.79 145.16 15.91 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.62 0.724 . . . . 65.05 111.114 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 30.36 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.698 2.266 . . . . 63.14 112.354 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.727 HD21 ' CD1' ' A' ' 262' ' ' TYR . 2.7 mp -91.54 177.28 6.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 74.42 110.877 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.08 123.11 14.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 71.11 110.786 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.675 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.3 m-30 -114.55 140.12 49.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 74.43 110.962 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.0 m -132.78 155.81 48.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 53.31 110.878 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 5.0 tttt -102.72 140.52 36.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.114 -0.494 . . . . 71.23 110.884 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.54 HD11 ' N ' ' A' ' 157' ' ' ALA . 18.5 pt -150.74 139.04 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 74.0 111.095 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.2 m120 -108.97 -5.95 15.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 75.32 110.928 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 23.9 p -153.48 52.96 0.73 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.479 . . . . 63.44 111.129 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.505 ' CA ' HD12 ' A' ' 152' ' ' ILE . . . -148.13 -155.43 6.64 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.722 -0.752 . . . . 41.34 112.511 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.82 96.96 6.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.835 0.35 . . . . 73.12 110.858 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.54 ' N ' HD11 ' A' ' 152' ' ' ILE . . . -105.55 155.87 18.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 52.34 111.103 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.76 -51.96 6.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 71.24 110.884 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.646 HG12 HG23 ' A' ' 220' ' ' ILE . 2.6 mp -90.45 92.98 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 74.33 111.079 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.667 HD11 ' HD2' ' A' ' 117' ' ' ARG . 6.9 tp -84.3 109.94 18.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.49 . . . . 73.02 110.978 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 92.3 t -87.47 118.57 33.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 73.31 111.16 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.71 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -137.97 106.09 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.269 -0.423 . . . . 65.33 111.135 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.406 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 46.7 m-85 -73.3 110.73 7.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 72.22 110.912 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -126.58 167.63 15.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 74.33 111.168 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -120.44 132.22 55.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 73.42 110.844 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.668 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.4 -157.44 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.743 -0.741 . . . . 73.41 112.53 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.762 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -51.08 119.04 3.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.773 0.32 . . . . 71.12 111.114 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.754 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 4.3 p-80 -137.98 31.9 2.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.434 . . . . 73.03 110.953 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 79.65 53.38 4.34 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.779 -0.724 . . . . 62.43 112.483 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.478 ' OD2' ' CE1' ' A' ' 196' ' ' HIS . 22.4 t0 -142.85 8.95 1.72 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 74.43 110.965 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 54.52 22.44 3.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.492 . . . . 73.02 110.875 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.754 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 2.0 p-80 -119.06 -38.92 2.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 64.11 110.873 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.762 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 50.45 99.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 64.34 111.11 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.668 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.4 m-85 -58.22 -171.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 51.11 110.919 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.21 20.64 4.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 71.23 110.856 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.573 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 53.01 -156.38 5.01 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.68 -0.771 . . . . 75.54 112.509 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 176' ' ' GLY . 12.7 tptt -33.34 132.02 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.858 0.361 . . . . 73.4 110.878 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.66 163.81 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.788 -0.72 . . . . 64.22 112.504 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.92 -142.25 19.84 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.739 -0.743 . . . . 50.04 112.503 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.1 mt -49.89 97.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 74.53 111.193 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.456 HD12 HG21 ' A' ' 210' ' ' THR . 2.8 mm? -66.8 -41.27 87.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 71.33 110.887 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 197' ' ' PHE . . . -174.83 158.25 2.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 23.44 111.114 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.45 ' CE1' ' CD2' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -148.96 134.69 18.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 72.43 110.911 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.815 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -131.92 175.53 9.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 75.44 111.079 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' ' 223' ' ' SER . 39.4 m-85 -104.63 -148.71 0.4 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 65.23 110.869 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -164.84 -83.58 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.818 -0.706 . . . . 64.44 112.605 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.409 ' HB3' ' HB2' ' A' ' 107' ' ' PRO . 53.9 Cg_endo -69.79 51.87 0.95 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.732 2.288 . . . . 75.24 112.321 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.575 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.68 148.92 17.25 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.79 -0.719 . . . . 44.23 112.485 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -105.13 145.27 30.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 35.3 110.878 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.56 -62.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.643 -0.789 . . . . 74.1 112.588 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 189' ' ' SER . 5.8 mm -107.54 8.76 9.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.799 0.333 . . . . 71.12 111.076 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.575 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -70.84 171.26 45.33 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 73.44 112.468 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 45.24 19.67 0.24 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.75 -0.738 . . . . 63.54 112.478 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 192' ' ' GLY . 2.1 m-20 -65.57 108.45 2.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.772 0.32 . . . . 73.22 110.886 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.815 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -84.22 129.24 34.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 53.41 111.108 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.478 ' CE1' ' OD2' ' A' ' 170' ' ' ASP . 1.6 m170 -121.68 123.61 42.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 74.14 110.867 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.55 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 40.3 m-85 -106.3 137.17 44.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.925 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -67.17 105.17 1.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 65.14 110.878 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -55.59 -39.14 70.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 73.54 110.873 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.573 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 15.5 m-20 -47.92 -25.31 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.497 . . . . 74.25 110.832 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -77.21 162.92 27.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 73.54 110.907 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.607 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -101.13 85.32 2.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 74.42 110.811 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.55 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 24.8 m95 -77.61 123.26 26.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.438 . . . . 75.31 110.903 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 204' ' ' THR . . . . . 0.412 HG23 ' HD1' ' A' ' 202' ' ' PHE . 41.0 p -140.21 -173.76 3.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 75.22 111.102 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.83 18.04 18.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.238 -0.437 . . . . 73.22 111.094 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.8 -177.64 4.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 74.04 110.849 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.8 p -66.12 -18.99 65.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 64.42 110.805 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.1 -107.69 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.748 -0.739 . . . . 73.3 112.449 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.13 177.29 0.15 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.727 -0.749 . . . . 53.12 112.523 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.456 HG21 HD12 ' A' ' 181' ' ' LEU . 88.1 m -66.78 97.51 0.47 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.755 0.312 . . . . 65.01 111.17 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -42.11 119.25 1.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 71.13 110.809 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.638 HD23 ' HB3' ' A' ' 133' ' ' ALA . 9.4 tp -65.53 -37.55 87.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 72.53 110.851 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.729 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.7 t80 -51.15 -64.96 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 72.11 110.91 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.533 HD11 ' H ' ' A' ' 243' ' ' VAL . 22.8 mt -53.53 -55.36 26.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.118 -0.492 . . . . 71.11 110.954 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.522 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 1.8 m -55.78 -33.28 64.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 71.15 111.181 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -68.05 -47.98 66.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 64.15 111.092 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.884 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -53.61 -57.93 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 71.25 111.119 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.76 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.7 t-80 -64.66 -28.14 69.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.123 -0.489 . . . . 72.01 110.907 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -63.86 -45.32 89.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 75.24 111.087 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.646 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -68.32 -35.89 72.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 72.04 111.141 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.61 -44.65 47.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.687 -0.768 . . . . 44.32 112.486 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.411 ' O ' ' O ' ' A' ' 185' ' ' PHE . 4.3 m-70 -68.32 -38.06 81.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.706 0.288 . . . . 74.15 110.809 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.606 ' OG ' HG23 ' A' ' 159' ' ' ILE . 7.1 m -64.27 -24.69 67.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 64.52 110.827 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.504 HD23 ' CZ3' ' A' ' 109' ' ' TRP . 70.2 mt -78.07 -27.72 48.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.188 -0.46 . . . . 74.52 110.885 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 121.11 15.47 4.68 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.65 -0.786 . . . . 53.24 112.428 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.755 HD21 ' HA ' ' A' ' 258' ' ' ILE . 12.5 mt -80.31 156.12 26.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.906 0.384 . . . . 73.4 110.846 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -99.25 -141.12 11.9 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.759 -0.734 . . . . 74.1 112.464 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -122.0 139.36 53.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 74.15 110.904 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.4 t -99.21 163.99 12.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.884 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.19 -2.86 17.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 74.11 110.858 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.643 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -61.11 141.45 93.79 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.681 0.753 . . . . 64.5 110.839 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 -3.35 11.83 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.709 2.273 . . . . 63.05 112.342 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -143.47 19.81 1.87 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 74.25 110.827 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.643 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -82.21 139.03 34.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 71.41 111.09 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.76 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -63.03 -37.73 80.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.415 . . . . 73.03 111.055 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 48.5 mmm -66.49 -13.75 61.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 75.44 110.833 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.63 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.5 t80 -58.64 144.4 79.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.736 0.779 . . . . 73.33 110.853 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.63 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.2 Cg_endo -69.75 -3.42 11.97 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.753 2.302 . . . . 74.22 112.314 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.4 ' HG1' ' HD2' ' A' ' 237' ' ' PHE . 16.9 m -95.7 142.42 28.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 62.11 111.148 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -122.92 134.53 54.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 73.5 110.94 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -152.67 129.49 10.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.09 -0.504 . . . . 74.42 110.955 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.496 ' O ' HG13 ' A' ' 243' ' ' VAL . 85.2 t80 -57.13 143.77 37.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.318 -0.401 . . . . 74.33 110.876 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.533 ' H ' HD11 ' A' ' 214' ' ' LEU . 0.9 OUTLIER -158.26 130.34 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 71.5 111.136 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -50.84 132.16 26.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 73.24 110.945 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 14.3 tt -53.98 -29.89 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 53.22 111.081 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -72.98 -18.76 61.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 70.12 110.973 179.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 38.4 p -109.33 -21.4 12.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 71.11 111.194 179.936 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -71.58 143.1 49.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 75.34 110.917 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -177.19 133.37 0.18 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 63.31 110.834 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.747 HD12 HG11 ' A' ' 144' ' ' VAL . 52.9 mt -48.0 127.15 11.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 74.25 110.915 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.6 m -67.44 163.49 20.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 71.25 110.829 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.89 -35.09 31.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.478 . . . . 53.12 111.144 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.1 -51.58 52.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 74.02 110.886 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -56.39 -50.26 72.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 45.44 110.892 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 21.2 mt -61.4 -39.97 84.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 73.23 111.07 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -65.44 -39.85 92.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.172 -0.467 . . . . 65.14 110.948 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -73.73 -52.66 7.99 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.752 -0.737 . . . . 61.04 112.455 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.755 ' HA ' HD21 ' A' ' 226' ' ' LEU . 3.8 tp -52.54 -34.62 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.783 0.325 . . . . 74.02 111.124 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 263' ' ' GLY . 82.1 mt-30 -86.39 -17.34 34.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 61.25 110.92 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.7 t -69.49 -13.82 62.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.233 -0.44 . . . . 33.13 110.851 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 1.075 HD13 HG21 ' A' ' 108' ' ' VAL . 2.8 mt -123.16 -18.29 6.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 63.43 110.894 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.727 ' CD1' HD21 ' A' ' 147' ' ' LEU . 36.8 m-85 -114.56 -34.14 5.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.011 0.434 . . . . 74.12 110.965 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.307 0 CA-C-O 119.099 -0.834 . . . . 61.31 112.485 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.864 0.364 . . . . 70.32 110.913 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.58 ' H ' ' NE ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -72.83 66.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 74.22 110.815 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.41 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 2.8 pp20? 177.75 130.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 72.4 110.86 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 6.3 mmt -50.68 148.08 7.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.555 0.693 . . . . 74.14 110.884 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -48.58 0.68 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.676 2.251 . . . . 74.3 112.322 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -122.36 36.96 3.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.788 -0.72 . . . . 71.51 112.466 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -103.94 97.54 1.44 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.767 -0.73 . . . . 64.02 112.532 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.89 71.95 1.54 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.697 2.265 . . . . 75.12 112.297 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.713 ' CG2' HD22 ' A' ' 261' ' ' LEU . 32.6 t -38.6 141.78 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 75.32 111.17 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 4.1 m0 -51.14 -28.2 10.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.132 -0.485 . . . . 65.25 110.942 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.617 ' H ' HG12 ' A' ' 108' ' ' VAL . 64.2 mtp180 58.25 32.88 22.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 75.4 110.845 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -120.46 171.19 8.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 72.21 110.906 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.401 ' HA ' ' HG ' ' A' ' 147' ' ' LEU . 6.2 p80 -111.3 26.75 10.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 75.02 110.867 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.409 ' C ' HD12 ' A' ' 114' ' ' ILE . 2.1 m-85 -129.48 111.08 12.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 74.13 110.909 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.584 HG22 ' N ' ' A' ' 115' ' ' THR . 4.8 mp -142.33 162.73 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 71.24 111.14 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.584 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -160.43 163.76 32.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 52.52 111.074 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.615 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.5 p90 -131.7 152.28 51.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 74.04 110.953 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.693 ' HD2' HD11 ' A' ' 160' ' ' LEU . 3.9 tmt_? -144.35 109.96 5.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 72.53 110.855 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.7 mt -71.58 105.67 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 63.41 111.114 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -59.57 -45.47 91.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 62.54 110.827 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.729 ' OD1' HG23 ' A' ' 162' ' ' VAL . 1.7 p-10 -146.12 163.35 35.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 72.13 110.878 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.61 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.0 m-85 -116.27 140.98 48.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 65.33 110.873 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.725 HG22 ' CE ' ' A' ' 125' ' ' MET . 2.9 t -90.91 142.67 27.73 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.549 0.69 . . . . 73.23 111.202 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -2.95 11.04 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.692 2.261 . . . . 65.02 112.355 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.422 ' H ' HG23 ' A' ' 122' ' ' THR . 21.9 m-20 -80.4 -23.88 40.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 54.22 110.818 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.725 ' CE ' HG22 ' A' ' 122' ' ' THR . 13.3 mtm -115.61 166.25 12.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 75.35 110.839 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.407 ' O ' HG23 ' A' ' 130' ' ' VAL . 7.1 t-20 -96.57 144.63 26.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 63.21 110.961 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -45.1 -35.73 3.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.178 -0.465 . . . . 74.04 110.905 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -83.23 -38.66 21.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 73.24 110.87 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -65.4 -29.8 70.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 73.32 110.886 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.61 HG11 ' CE2' ' A' ' 121' ' ' TYR . 73.4 t -66.49 -46.35 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 61.23 111.156 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.13 -23.29 47.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 73.34 110.827 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -74.43 -47.2 35.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 71.41 110.917 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.715 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -71.79 -31.51 66.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 71.44 111.124 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.631 HD13 HD21 ' A' ' 212' ' ' LEU . 1.4 mp -73.29 -54.13 16.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.218 -0.446 . . . . 72.11 111.146 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.538 ' N ' HG22 ' A' ' 134' ' ' ILE . 3.3 ttm180 -49.06 -41.92 36.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 71.15 110.832 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.739 ' O ' HG23 ' A' ' 140' ' ' VAL . 7.8 mmpt? -72.43 -34.24 67.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 70.02 110.867 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.9 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.5 -48.83 80.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 64.15 111.168 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.639 ' HE1' HD13 ' A' ' 159' ' ' ILE . 95.4 m-85 -72.77 -22.1 60.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 71.31 110.888 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -78.64 -5.81 53.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 73.4 110.937 -179.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 136' ' ' LYS . 93.4 t -97.1 -16.87 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 72.14 111.109 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.807 ' NE1' HG12 ' A' ' 217' ' ' VAL . 93.6 m95 -106.48 -35.88 6.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 72.11 110.878 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.62 -11.47 60.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 52.13 110.851 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -95.69 -15.74 22.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.505 . . . . 74.55 111.018 179.934 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.686 HG11 HD12 ' A' ' 250' ' ' LEU . 20.9 m -101.51 1.21 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 74.03 111.079 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.693 HG21 HG13 ' A' ' 258' ' ' ILE . 17.1 p -150.31 146.69 20.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.539 0.685 . . . . 63.12 111.149 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 30.53 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.661 2.241 . . . . 64.44 112.314 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.713 HD21 ' CD1' ' A' ' 262' ' ' TYR . 0.8 OUTLIER -93.32 -178.13 4.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 64.34 110.914 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -144.34 126.5 15.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 71.31 110.933 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.501 ' HE1' HD13 ' A' ' 114' ' ' ILE . 4.0 m-30 -114.52 142.15 46.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 74.31 110.906 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.8 m -140.78 137.49 33.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 71.33 110.893 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.9 OUTLIER -85.88 142.62 28.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 64.13 110.941 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.649 HD11 ' N ' ' A' ' 157' ' ' ALA . 18.2 pt -151.07 135.6 9.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 73.51 111.114 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -107.49 -5.73 17.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 74.01 110.918 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.4 p -153.34 53.25 0.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 71.21 111.254 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.44 ' C ' HD12 ' A' ' 152' ' ' ILE . . . -149.74 -155.56 6.85 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.751 -0.738 . . . . 42.43 112.457 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.421 ' HB2' ' HE2' ' A' ' 156' ' ' MET . 1.2 mpp? -107.69 96.82 6.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.88 0.372 . . . . 74.04 110.805 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.649 ' N ' HD11 ' A' ' 152' ' ' ILE . . . -104.78 154.87 19.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 71.53 111.121 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.22 -52.55 6.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 75.04 110.853 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.726 HG12 HG23 ' A' ' 220' ' ' ILE . 1.9 mp -89.53 95.88 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 63.24 111.139 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.693 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.2 tp -86.87 110.08 19.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 62.23 110.857 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.427 HG13 ' CE1' ' A' ' 197' ' ' PHE . 87.8 t -89.83 120.54 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 44.11 111.14 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.729 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.2 p -139.83 104.97 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 72.33 111.138 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -71.87 108.75 5.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 73.41 110.889 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.11 165.71 20.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 74.45 111.121 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -114.14 138.29 50.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 74.32 110.922 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.67 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.74 -154.26 0.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.651 -0.785 . . . . 74.11 112.496 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.802 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -66.88 116.73 8.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.886 0.374 . . . . 74.22 111.106 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.695 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.88 -22.7 12.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.204 -0.453 . . . . 64.3 110.897 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.47 29.39 0.54 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 71.01 112.498 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.646 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.08 1.43 15.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.389 . . . . 73.3 110.918 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 72.8 40.34 0.6 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.469 . . . . 64.43 110.868 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.695 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.72 -41.65 0.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 74.14 110.888 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.802 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.31 99.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 70.41 111.074 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.67 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.9 m-85 -60.72 -168.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 75.2 110.866 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.74 18.66 3.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 70.04 110.866 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.578 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.2 -157.32 7.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 72.12 112.526 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 176' ' ' GLY . 11.7 tmtt? -35.29 134.52 0.28 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 74.3 110.879 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.35 165.49 0.14 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.594 -0.812 . . . . 74.44 112.496 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.81 -143.23 22.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 73.4 112.47 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -50.13 96.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.375 . . . . 71.02 111.174 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 13.4 mt -66.82 -39.48 87.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 52.34 110.934 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -172.08 167.1 6.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 73.35 111.142 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.561 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.6 p80 -159.67 139.72 11.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.428 . . . . 74.31 110.931 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.761 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -137.64 173.44 11.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 51.13 111.145 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.519 ' O ' ' O ' ' A' ' 222' ' ' HIS . 23.8 m-85 -99.43 -138.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 61.4 110.818 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -166.98 -99.64 0.14 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.792 -0.718 . . . . 60.35 112.578 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 59.54 1.66 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.696 2.264 . . . . 64.54 112.343 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.598 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.06 154.6 16.43 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.748 -0.739 . . . . 70.35 112.435 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.572 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.52 148.63 26.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.919 0.39 . . . . 72.21 110.793 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.68 -67.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.718 -0.753 . . . . 64.31 112.503 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.572 ' N ' ' O ' ' A' ' 189' ' ' SER . 3.6 mt -103.99 6.33 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 74.11 111.144 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.598 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -63.69 165.29 29.2 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.685 -0.769 . . . . 74.22 112.511 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 45.05 20.21 0.23 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.73 -0.748 . . . . 62.14 112.459 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 192' ' ' GLY . 0.8 OUTLIER -64.25 105.77 0.97 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.79 0.329 . . . . 63.2 110.943 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.761 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -82.15 129.62 34.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 64.42 111.158 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.561 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 11.2 m170 -119.93 129.93 54.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 75.14 110.878 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.465 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 47.7 m-85 -114.35 134.22 55.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 75.15 110.909 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -67.25 109.44 3.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 73.32 110.916 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -60.22 -37.19 79.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 73.34 110.861 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.578 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 5.3 m-20 -50.45 -22.89 2.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.233 -0.439 . . . . 73.42 110.885 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -80.17 163.38 24.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 75.21 110.835 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.561 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -101.43 89.1 3.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 74.35 110.843 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.513 ' CZ3' HG21 ' A' ' 215' ' ' THR . 29.5 m95 -80.59 123.26 27.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.177 -0.465 . . . . 60.22 110.952 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.3 p -141.26 -174.83 4.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 70.3 111.183 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.36 20.53 16.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 64.44 111.104 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -127.74 -173.12 2.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 64.34 110.903 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.3 p -72.11 -18.87 61.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 71.41 110.836 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.49 -106.58 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 31.23 112.502 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.05 176.84 0.1 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.694 -0.765 . . . . 71.31 112.528 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 89.8 m -66.74 97.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.741 0.305 . . . . 73.44 111.125 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -42.83 116.93 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 73.52 110.833 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.661 HD23 ' HB3' ' A' ' 133' ' ' ALA . 9.8 tp -63.29 -37.94 89.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.083 -0.508 . . . . 74.52 110.94 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.762 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.6 t80 -51.32 -63.91 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 50.51 110.901 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.566 HD21 ' CG2' ' A' ' 243' ' ' VAL . 8.0 mp -55.51 -54.99 37.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.119 -0.491 . . . . 75.5 110.895 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.513 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.3 m -55.31 -33.95 63.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 73.2 111.139 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -67.69 -48.74 65.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 74.31 111.009 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.9 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -53.43 -58.22 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 71.45 111.067 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.767 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.8 t-80 -64.46 -28.13 69.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 74.11 110.775 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -64.39 -44.07 92.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 73.4 111.104 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.726 HG23 HG12 ' A' ' 159' ' ' ILE . 2.6 mt -70.28 -34.26 57.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 64.44 111.172 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -51.79 -45.11 55.53 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.713 -0.756 . . . . 61.24 112.471 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.519 ' O ' ' O ' ' A' ' 185' ' ' PHE . 4.1 m-70 -68.85 -40.61 79.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.849 0.356 . . . . 73.41 110.89 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.488 ' OG ' HG12 ' A' ' 159' ' ' ILE . 32.5 p -65.7 -20.2 66.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.11 -0.495 . . . . 74.43 110.858 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.465 ' O ' HG13 ' A' ' 108' ' ' VAL . 52.8 mt -80.84 -25.77 37.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 33.33 110.897 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.464 ' HA3' HG22 ' A' ' 108' ' ' VAL . . . 122.2 13.18 4.96 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.729 -0.748 . . . . 70.2 112.441 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.871 HD21 ' HA ' ' A' ' 258' ' ' ILE . 17.6 mt -84.81 155.65 21.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.337 . . . . 61.45 110.973 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.41 ' H ' ' HA ' ' A' ' 102' ' ' GLU . . . -102.95 -138.21 9.86 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.767 -0.73 . . . . 65.31 112.458 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.76 138.76 53.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.918 0.39 . . . . 73.25 110.886 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 69.8 p -97.26 166.97 11.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.88 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.18 3.09 19.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 73.54 110.84 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 234' ' ' ALA . 0.4 OUTLIER -72.3 135.74 81.87 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.683 0.754 . . . . 74.33 110.844 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.62 0.25 5.8 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.713 2.275 . . . . 61.13 112.331 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.05 25.42 1.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 71.43 110.908 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 231' ' ' ASP . . . -97.48 143.91 27.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.453 . . . . 63.33 111.082 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.767 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.3 t -63.84 -41.75 93.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 72.45 111.118 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 49.9 mmm -60.33 -17.67 44.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.193 -0.458 . . . . 72.22 110.904 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.615 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.1 t80 -57.79 144.64 73.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.712 0.768 . . . . 75.5 110.78 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.615 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.5 Cg_endo -69.87 -1.23 8.22 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.552 2.168 . . . . 71.51 112.385 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 23.3 m -96.32 140.97 30.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 63.4 111.201 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -122.39 134.48 54.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.185 -0.461 . . . . 72.23 110.978 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -151.99 135.12 15.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 72.13 110.9 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.553 ' O ' HG13 ' A' ' 243' ' ' VAL . 82.1 t80 -64.5 143.52 57.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 74.31 110.889 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.566 ' CG2' HD21 ' A' ' 214' ' ' LEU . 0.2 OUTLIER -161.18 128.92 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 62.12 111.105 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -50.37 134.69 23.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 75.24 110.9 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.508 HD12 ' CE2' ' A' ' 213' ' ' PHE . 8.0 tt -51.31 -33.54 14.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 73.24 111.222 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.54 ' OD1' HG23 ' A' ' 247' ' ' THR . 1.2 p30 -65.73 -23.51 66.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 74.12 110.907 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.54 HG23 ' OD1' ' A' ' 246' ' ' ASN . 10.5 p -107.0 -21.81 12.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 61.15 111.143 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -73.43 134.02 43.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 71.01 110.852 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 24.3 ptt85 -171.23 134.08 0.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 74.23 110.91 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.686 HD12 HG11 ' A' ' 144' ' ' VAL . 54.7 mt -48.06 127.28 12.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 71.24 110.998 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 30.9 t -72.46 164.43 26.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 43.11 110.894 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -47.95 -37.98 15.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 74.43 111.103 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.56 -45.29 91.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 75.55 110.869 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 12.7 m-20 -61.03 -55.35 33.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 70.21 110.889 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.429 ' HA ' HG22 ' A' ' 258' ' ' ILE . 1.3 mp -58.99 -34.55 53.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 71.02 111.153 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 28.7 mmm-85 -68.08 -40.32 82.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 54.53 110.908 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.417 ' HA3' ' HB2' ' A' ' 101' ' ' ARG . . . -75.59 -50.62 7.92 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.784 -0.722 . . . . 63.53 112.562 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.871 ' HA ' HD21 ' A' ' 226' ' ' LEU . 5.6 tp -52.38 -34.53 18.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.772 0.32 . . . . 74.43 111.159 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' A' ' 263' ' ' GLY . 57.5 mt-30 -86.73 -16.94 34.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 75.23 110.876 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 3.2 t -69.47 -13.93 62.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 52.24 110.853 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.713 HD22 ' CG2' ' A' ' 108' ' ' VAL . 0.8 OUTLIER -124.37 -17.71 6.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 70.43 110.935 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.713 ' CD1' HD21 ' A' ' 147' ' ' LEU . 36.1 m-85 -114.74 -33.28 5.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 74.41 110.859 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.313 0 CA-C-O 119.122 -0.821 . . . . 63.24 112.454 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 101' ' ' ARG . 31.8 m-85 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.849 0.357 . . . . 54.22 110.902 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 100' ' ' PHE . 8.2 ptt-85 36.59 59.67 0.98 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 63.44 110.882 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.558 ' CD ' HD21 ' A' ' 261' ' ' LEU . 14.9 tt0 178.09 132.87 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.175 -0.466 . . . . 65.32 110.875 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -49.96 150.41 4.06 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.574 0.702 . . . . 70.34 110.895 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -4.58 14.32 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.624 2.216 . . . . 54.24 112.347 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.29 -33.87 27.61 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.698 -0.763 . . . . 62.02 112.42 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 134.04 -150.35 19.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.834 -0.698 . . . . 72.11 112.529 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.853 ' HA ' HD22 ' A' ' 261' ' ' LEU . 53.3 Cg_endo -69.71 139.08 39.54 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.732 2.288 . . . . 60.01 112.331 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.826 HG12 ' HA3' ' A' ' 225' ' ' GLY . 34.5 m -57.08 -174.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 63.3 111.166 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.463 ' CH2' ' HB3' ' A' ' 158' ' ' ASP . 7.5 m0 -51.42 -23.97 4.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.212 -0.449 . . . . 75.13 110.861 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.754 ' H ' HG23 ' A' ' 108' ' ' VAL . 1.2 mtt-85 70.31 23.04 5.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 62.14 110.852 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -123.15 152.86 40.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 70.21 110.821 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -97.68 23.84 7.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 60.34 110.829 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.453 ' C ' HD12 ' A' ' 114' ' ' ILE . 1.7 m-85 -122.34 113.39 19.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 65.13 110.906 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.577 HG22 ' N ' ' A' ' 115' ' ' THR . 5.0 mp -142.96 162.18 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 64.24 111.141 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.577 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -159.05 164.06 35.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 74.11 111.157 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.645 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.4 p90 -134.23 145.04 48.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 64.21 110.879 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.711 ' HD2' HD11 ' A' ' 160' ' ' LEU . 3.4 tmt_? -137.47 106.9 6.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 71.25 110.83 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 62.0 mt -70.41 104.93 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 71.44 111.16 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -55.56 -50.84 68.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 63.24 110.825 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.651 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.0 p-10 -143.08 166.6 24.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 63.33 110.87 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -116.95 148.89 41.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 64.43 110.959 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.475 HG23 ' HG3' ' A' ' 125' ' ' MET . 3.2 t -93.67 141.58 24.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.595 0.712 . . . . 74.42 111.075 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -3.42 11.99 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.711 2.274 . . . . 52.42 112.296 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.63 -29.91 36.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 75.43 110.93 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.601 ' HE3' HG22 ' A' ' 130' ' ' VAL . 7.3 mtm -107.97 163.73 12.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 73.14 110.848 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.752 ' O ' HG23 ' A' ' 130' ' ' VAL . 2.4 t-20 -94.25 150.3 20.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 75.54 110.866 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.55 -32.93 8.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 74.4 110.826 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -82.01 -40.44 22.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 60.23 110.91 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -65.95 -29.1 69.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 74.13 110.906 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 126' ' ' ASN . 59.9 t -64.34 -45.62 95.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 75.12 111.169 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.12 -24.46 35.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 74.31 110.866 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -72.3 -46.8 54.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 72.14 110.908 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.993 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -71.52 -33.95 69.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 63.42 111.12 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.604 HD13 HD21 ' A' ' 212' ' ' LEU . 1.4 mp -72.46 -55.11 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 73.32 111.126 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.547 ' N ' HG22 ' A' ' 134' ' ' ILE . 5.3 ttm180 -48.58 -45.65 38.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.479 . . . . 63.21 110.874 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.646 ' O ' HG23 ' A' ' 140' ' ' VAL . 12.5 mmtt -68.25 -34.72 76.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 72.44 110.994 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.901 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.69 -48.94 79.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.504 . . . . 41.4 111.116 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.645 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 94.4 m-85 -72.82 -22.28 60.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 62.24 110.921 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.35 -5.93 51.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 74.31 110.969 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 136' ' ' LYS . 98.0 t -97.2 -17.14 6.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 71.33 111.101 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.806 ' NE1' HG12 ' A' ' 217' ' ' VAL . 95.3 m95 -106.05 -35.85 7.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 71.22 110.876 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.39 -11.39 60.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 62.32 110.822 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -95.81 -17.71 20.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 73.33 110.879 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.914 HG11 HD12 ' A' ' 250' ' ' LEU . 19.4 m -99.09 1.77 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 72.14 111.092 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.53 HG21 HG13 ' A' ' 258' ' ' ILE . 22.9 p -152.11 146.3 18.41 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.544 0.688 . . . . 75.32 111.168 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 30.1 0.18 Allowed 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.759 2.306 . . . . 64.31 112.216 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.821 HD21 ' CG ' ' A' ' 262' ' ' TYR . 0.1 OUTLIER -90.0 -176.83 5.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.322 -0.399 . . . . 74.22 110.894 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -145.49 126.12 14.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 73.42 110.876 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.468 ' HE1' HD13 ' A' ' 114' ' ' ILE . 4.1 m-30 -115.35 142.42 46.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 72.03 110.9 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.5 m -141.05 138.78 33.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.483 . . . . 73.44 110.815 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.488 ' HG3' ' N ' ' A' ' 152' ' ' ILE . 2.9 tptm -88.45 142.9 27.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 64.03 110.894 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.555 HD11 ' N ' ' A' ' 157' ' ' ALA . 14.6 pt -150.88 132.27 4.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 52.02 111.138 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.3 m-20 -99.17 -9.22 24.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 74.41 110.854 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.3 t -154.31 61.57 0.69 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 73.02 111.078 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.492 ' C ' HD12 ' A' ' 152' ' ' ILE . . . -154.66 -156.22 7.62 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.816 -0.707 . . . . 42.14 112.452 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.438 ' HB2' ' HE2' ' A' ' 156' ' ' MET . 1.0 OUTLIER -105.02 97.66 7.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.708 0.289 . . . . 73.41 110.846 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.555 ' N ' HD11 ' A' ' 152' ' ' ILE . . . -107.13 155.35 19.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 61.03 111.023 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.463 ' HB3' ' CH2' ' A' ' 109' ' ' TRP . 5.8 m-20 -85.34 -53.58 5.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.427 . . . . 73.05 110.797 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.65 HG12 HG23 ' A' ' 220' ' ' ILE . 2.4 mp -89.43 94.88 5.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.157 -0.474 . . . . 72.44 111.109 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.711 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.2 tp -85.79 109.18 18.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 72.23 110.888 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.46 HG13 ' CE1' ' A' ' 197' ' ' PHE . 87.3 t -89.2 124.13 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 54.32 111.15 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.651 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.4 p -143.59 105.73 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 74.43 111.199 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -71.8 109.51 5.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 74.43 110.911 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -130.38 167.27 18.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 72.01 111.001 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.51 137.29 52.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 73.32 110.933 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.683 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.98 -155.64 0.14 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.773 -0.727 . . . . 75.51 112.454 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.8 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -64.5 115.53 5.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 75.11 111.083 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.69 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.25 -22.19 12.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 74.43 110.895 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.24 29.11 0.56 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.713 -0.756 . . . . 71.34 112.4 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.635 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.94 1.23 15.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.904 0.383 . . . . 54.11 110.864 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 72.8 40.24 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 74.21 110.78 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.69 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.58 -41.17 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 75.12 110.913 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.8 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.08 99.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 52.34 111.075 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.683 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -59.88 -169.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 63.44 110.911 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.96 17.13 4.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 72.44 110.927 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.593 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.4 -156.81 8.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.797 -0.716 . . . . 61.33 112.496 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 176' ' ' GLY . 7.6 tttp -34.98 134.8 0.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.815 0.34 . . . . 41.52 110.926 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.28 163.11 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.711 -0.757 . . . . 65.25 112.448 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.61 -143.6 20.88 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.766 -0.73 . . . . 74.01 112.571 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -49.66 97.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 64.03 111.147 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 76.2 mt -69.53 -36.96 76.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 71.14 111.027 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -174.39 162.4 3.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 75.53 111.081 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.53 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.6 p80 -155.27 140.97 18.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 70.51 110.823 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.75 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -138.85 171.92 13.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 73.43 111.172 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 223' ' ' SER . 17.1 m-85 -100.32 -148.91 0.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.258 -0.428 . . . . 63.34 110.816 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -159.43 -94.76 0.1 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.637 -0.792 . . . . 43.21 112.454 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.68 58.69 1.53 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.733 2.289 . . . . 51.34 112.356 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.611 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.0 153.44 16.97 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.729 -0.748 . . . . 72.01 112.467 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.597 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.5 150.5 24.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.788 0.328 . . . . 51.55 110.927 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 59.45 -67.42 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.743 -0.742 . . . . 64.52 112.423 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.597 ' N ' ' O ' ' A' ' 189' ' ' SER . 26.4 pt -103.66 6.05 10.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.896 0.379 . . . . 45.41 111.202 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.611 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -64.25 165.25 31.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.656 -0.783 . . . . 73.43 112.446 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 46.68 17.05 0.23 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.704 -0.76 . . . . 61.41 112.541 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 192' ' ' GLY . 0.9 OUTLIER -61.82 108.33 0.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.831 0.348 . . . . 70.12 110.83 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.75 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -83.76 130.56 34.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.121 -0.49 . . . . 62.32 111.182 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.53 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 11.1 m170 -121.2 128.93 52.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.297 -0.411 . . . . 74.51 110.86 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.535 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 50.5 m-85 -113.85 131.03 56.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.249 -0.432 . . . . 72.23 110.85 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 198' ' ' ASP . . . . . 0.409 ' HB3' ' HG2' ' A' ' 201' ' ' GLU . 63.4 t0 -65.52 114.46 4.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 71.01 110.945 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -68.06 -33.25 74.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 64.33 110.83 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.593 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 14.5 m-20 -51.07 -21.6 1.96 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.155 -0.475 . . . . 65.53 110.823 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.409 ' HG2' ' HB3' ' A' ' 198' ' ' ASP . 0.6 OUTLIER -86.4 164.99 16.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 60.23 110.882 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.478 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -97.86 98.95 10.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 71.54 110.926 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.535 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 52.5 m95 -86.46 123.86 32.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.203 -0.453 . . . . 73.42 110.895 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 39.9 p -145.57 -177.04 5.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 72.25 111.143 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.34 21.27 16.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 75.32 111.157 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -128.4 -177.48 4.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 75.35 110.837 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 207' ' ' SER . . . . . 0.415 ' HA ' ' CD2' ' A' ' 242' ' ' TYR . 4.0 t -67.14 -18.81 65.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 73.43 110.888 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.21 -106.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.868 -0.682 . . . . 71.24 112.42 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.76 178.18 0.2 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.726 -0.75 . . . . 74.32 112.508 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 99.1 m -66.94 98.09 0.53 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.79 0.329 . . . . 65.25 111.187 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -42.15 116.57 0.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 63.22 110.953 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.993 HD23 ' HB3' ' A' ' 133' ' ' ALA . 8.1 tp -63.49 -38.74 92.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 74.13 110.941 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.734 ' N ' ' HB1' ' A' ' 133' ' ' ALA . 2.9 t80 -51.69 -63.45 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 73.53 110.903 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.559 HD21 ' CG2' ' A' ' 243' ' ' VAL . 7.7 mp -56.34 -54.43 45.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 65.33 110.941 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 219' ' ' ALA . 3.2 m -56.02 -31.0 62.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 53.13 111.107 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 137' ' ' ALA . . . -70.55 -47.42 60.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 75.44 111.093 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.901 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -54.56 -58.87 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 71.31 111.082 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.743 ' HB2' HG13 ' A' ' 235' ' ' VAL . 2.2 t-80 -62.37 -29.94 70.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 73.3 110.888 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.51 -45.52 92.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 74.43 111.129 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.65 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -69.28 -34.94 65.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.428 . . . . 75.01 111.079 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.93 -44.84 41.14 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.81 -0.71 . . . . 61.23 112.487 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.478 ' O ' ' O ' ' A' ' 185' ' ' PHE . 45.8 m-70 -67.32 -40.67 85.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.744 0.307 . . . . 75.23 110.806 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.644 ' OG ' HG23 ' A' ' 159' ' ' ILE . 2.9 m -62.59 -27.33 69.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.242 -0.436 . . . . 64.13 110.853 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 62.4 mt -74.57 -28.45 60.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 75.1 110.907 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.826 ' HA3' HG12 ' A' ' 108' ' ' VAL . . . 121.11 15.17 4.78 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.75 -0.738 . . . . 63.31 112.455 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.677 HD21 ' HA ' ' A' ' 258' ' ' ILE . 11.6 mt -83.01 156.03 23.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.338 . . . . 75.31 110.887 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.439 ' O ' ' HE2' ' A' ' 236' ' ' MET . . . -102.5 -133.29 7.98 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.694 -0.765 . . . . 55.04 112.52 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.451 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 1.6 m170 -125.7 142.95 51.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 61.3 110.882 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 38.1 m -104.19 166.06 10.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 52.41 110.91 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 42.8 m -108.51 1.87 21.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 75.52 110.908 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.615 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -66.31 140.38 96.74 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.592 0.711 . . . . 75.24 110.824 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.7 -3.35 11.79 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.758 2.305 . . . . 64.14 112.35 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.45 24.89 1.55 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 75.35 110.882 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.615 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -88.85 140.39 29.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 71.53 111.141 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.743 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.8 t -63.43 -38.06 81.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 62.43 111.183 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.458 ' HE3' ' HA ' ' A' ' 236' ' ' MET . 32.1 mmm -66.05 -14.06 61.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 74.41 110.873 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.606 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.5 t80 -57.91 143.62 76.84 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.635 0.731 . . . . 74.31 110.866 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.606 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.4 Cg_endo -69.77 -1.62 8.8 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.674 2.249 . . . . 75.42 112.34 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.401 ' HG1' ' HD2' ' A' ' 237' ' ' PHE . 6.6 m -100.41 139.66 35.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 75.52 111.073 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -118.75 128.66 54.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 73.35 110.876 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.22 126.27 12.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.043 -0.526 . . . . 71.42 110.803 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.55 ' O ' HG13 ' A' ' 243' ' ' VAL . 35.9 t80 -57.18 147.39 25.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.147 -0.479 . . . . 75.13 110.897 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.559 ' CG2' HD21 ' A' ' 214' ' ' LEU . 0.6 OUTLIER -160.07 132.93 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.514 . . . . 64.44 111.091 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.516 ' CG ' HD22 ' A' ' 246' ' ' ASN . 13.2 t0 -46.77 133.59 10.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 61.12 110.854 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.424 HD12 ' CE2' ' A' ' 213' ' ' PHE . 5.9 tt -53.32 -34.35 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 75.44 111.181 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.516 HD22 ' CG ' ' A' ' 244' ' ' ASP . 5.0 p30 -72.15 -17.05 61.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 72.51 110.867 179.928 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.453 HG23 ' OD1' ' A' ' 246' ' ' ASN . 24.6 p -107.61 -21.91 12.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 73.45 111.182 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -72.36 137.82 46.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 73.25 110.829 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -174.48 136.8 0.47 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.147 -0.479 . . . . 72.12 110.882 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.914 HD12 HG11 ' A' ' 144' ' ' VAL . 29.2 mt -49.78 129.33 19.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 65.11 110.921 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 32.5 t -71.3 171.0 11.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 63.43 110.849 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.16 -37.11 69.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.489 . . . . 71.44 111.186 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -65.3 -47.49 76.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.856 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.6 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 4.8 m-20 -61.99 -52.04 65.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.194 -0.457 . . . . 74.24 110.825 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 30.0 mt -61.36 -35.47 66.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 71.53 111.107 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -69.68 -39.42 77.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 73.55 110.892 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.48 -50.1 7.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.791 -0.719 . . . . 43.32 112.459 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.677 ' HA ' HD21 ' A' ' 226' ' ' LEU . 7.0 tp -52.07 -35.25 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.703 0.287 . . . . 62.21 111.115 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 263' ' ' GLY . 72.1 mt-30 -87.32 -16.68 34.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 74.23 110.897 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.9 t -70.85 -14.54 62.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 72.21 110.896 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.853 HD22 ' HA ' ' A' ' 107' ' ' PRO . 5.3 mt -121.95 -18.92 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 71.44 110.868 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.821 ' CG ' HD21 ' A' ' 147' ' ' LEU . 33.6 m-85 -113.12 -34.37 5.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.248 -0.433 . . . . 74.3 110.951 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.335 0 CA-C-O 119.097 -0.835 . . . . 44.24 112.545 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.837 0.351 . . . . 53.1 110.907 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 55.46 51.88 12.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 73.2 110.86 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.478 ' HB2' HD11 ' A' ' 261' ' ' LEU . 0.0 OUTLIER 176.84 146.3 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 70.11 110.906 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.487 ' HG3' ' HD2' ' A' ' 104' ' ' PRO . 0.0 OUTLIER -50.82 146.44 10.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.565 0.698 . . . . 64.42 110.917 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.487 ' HD2' ' HG3' ' A' ' 103' ' ' MET . 54.0 Cg_endo -69.78 79.43 0.95 Allowed 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 122.685 2.257 . . . . 73.15 112.371 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 144.79 -119.11 1.2 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.761 -0.733 . . . . 54.32 112.512 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.527 ' N ' ' CD ' ' A' ' 107' ' ' PRO . . . -159.0 47.83 0.42 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.684 -0.77 . . . . 63.31 112.431 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 106' ' ' GLY . 54.1 Cg_endo -69.72 -30.19 22.85 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.766 2.311 . . . . 72.44 112.3 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.878 HG11 HD13 ' A' ' 261' ' ' LEU . 21.0 m -44.4 138.94 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 75.52 111.185 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.449 ' CZ3' HD23 ' A' ' 224' ' ' LEU . 3.0 m0 -64.11 -26.97 68.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 70.22 110.859 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.701 ' HG3' HG23 ' A' ' 108' ' ' VAL . 47.7 mtp180 61.83 33.65 17.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.408 . . . . 71.12 110.882 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.441 ' HG2' ' HB3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -122.76 158.29 30.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 73.53 110.983 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -101.69 31.36 3.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 74.12 110.868 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -134.2 106.71 7.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 73.25 110.939 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.585 HG22 ' N ' ' A' ' 115' ' ' THR . 4.7 mp -138.13 162.71 30.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.478 . . . . 62.54 111.179 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.59 ' O ' HD12 ' A' ' 159' ' ' ILE . 0.5 OUTLIER -158.65 163.8 36.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 64.44 111.113 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.598 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.0 p90 -132.73 149.02 52.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 74.43 110.928 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.458 ' HD2' HD11 ' A' ' 160' ' ' LEU . 4.2 tmt_? -143.93 112.4 6.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.083 -0.508 . . . . 70.34 110.862 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.0 mt -72.79 106.64 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 65.55 111.151 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -60.17 -46.38 89.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 75.13 110.949 179.916 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.738 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.0 p-10 -146.46 166.08 27.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 71.32 110.892 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.708 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.1 m-85 -117.47 139.33 51.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 73.15 110.87 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.49 HG22 ' HB2' ' A' ' 124' ' ' ASP . 1.0 OUTLIER -91.22 139.31 25.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.549 0.69 . . . . 71.05 111.183 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.404 ' HD2' HG23 ' A' ' 122' ' ' THR . 54.2 Cg_endo -69.75 42.16 0.34 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.742 2.295 . . . . 51.3 112.353 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.49 ' HB2' HG22 ' A' ' 122' ' ' THR . 2.3 m-20 -126.85 -25.61 3.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 53.23 110.764 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.491 ' CE ' HG22 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -110.69 165.22 12.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.328 -0.396 . . . . 61.35 110.861 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -94.45 142.2 27.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 72.43 110.882 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -44.22 -36.38 2.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 73.1 110.892 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -83.85 -39.18 20.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 61.12 110.91 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -63.52 -33.25 75.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.495 . . . . 30.01 110.888 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.708 HG11 ' CE2' ' A' ' 121' ' ' TYR . 73.8 t -63.38 -46.58 95.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.214 -0.448 . . . . 70.11 111.16 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -78.71 -23.62 45.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 63.01 110.814 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -75.53 -49.42 18.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 75.23 110.909 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.71 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -68.57 -30.48 69.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.502 . . . . 61.04 111.124 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.2 mp -74.15 -54.65 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 71.53 111.175 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.526 ' N ' HG22 ' A' ' 134' ' ' ILE . 3.3 ptm180 -49.08 -37.39 21.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.264 -0.425 . . . . 73.14 110.93 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.63 ' O ' HG23 ' A' ' 140' ' ' VAL . 7.2 mmpt? -75.48 -36.02 60.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 73.51 110.942 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.686 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -59.87 -49.53 77.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 74.43 111.091 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.626 ' HE2' HD13 ' A' ' 159' ' ' ILE . 92.1 m-85 -70.71 -22.7 62.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 74.32 110.935 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.415 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 2.9 tt0 -77.4 -7.09 55.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 65.11 110.867 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 136' ' ' LYS . 89.6 t -95.75 -17.28 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 43.45 111.138 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.85 ' NE1' HG12 ' A' ' 217' ' ' VAL . 95.9 m95 -106.11 -36.12 7.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 73.21 110.958 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -11.37 60.87 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.258 -0.428 . . . . 64.32 110.867 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.415 ' OD1' ' O ' ' A' ' 139' ' ' GLN . 2.5 m120 -95.3 -17.68 21.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 72.2 110.906 -179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.816 HG11 HD12 ' A' ' 250' ' ' LEU . 18.2 m -99.38 1.77 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 72.23 111.112 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.653 HG21 HG13 ' A' ' 258' ' ' ILE . 22.8 p -152.48 146.56 18.42 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.576 0.703 . . . . 61.02 111.103 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 29.72 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.788 2.325 . . . . 64.14 112.297 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.728 HD21 ' CG ' ' A' ' 262' ' ' TYR . 0.7 OUTLIER -91.15 179.22 5.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 65.11 110.924 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -141.53 126.17 17.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.43 110.894 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.575 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.7 m-30 -115.41 143.72 44.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 52.51 110.911 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.9 t -140.23 151.78 45.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 71.12 110.833 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 10.2 tttp -101.59 145.21 29.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 74.32 110.804 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.583 HD12 ' CA ' ' A' ' 155' ' ' GLY . 21.6 pt -151.74 143.54 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 61.52 111.038 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.5 m-20 -105.26 -11.44 16.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 73.22 110.831 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.1 t -157.73 62.96 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 72.25 111.068 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.583 ' CA ' HD12 ' A' ' 152' ' ' ILE . . . -149.8 -155.08 6.64 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.749 -0.738 . . . . 41.01 112.528 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 36.3 mmt -106.94 91.7 3.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.773 0.321 . . . . 75.42 110.836 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.518 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -103.15 156.31 17.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 70.14 111.109 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.82 -52.31 5.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 75.31 110.811 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.783 HG12 HG23 ' A' ' 220' ' ' ILE . 1.9 mp -89.7 94.9 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 63.41 111.1 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.458 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.4 tp -87.17 109.28 19.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 75.24 110.849 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.406 HG13 ' CE1' ' A' ' 197' ' ' PHE . 83.9 t -87.33 120.48 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 63.33 111.157 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.738 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.2 p -139.52 106.51 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 73.43 111.168 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.42 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 41.6 m-85 -74.1 112.32 10.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 73.41 110.952 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.79 168.4 17.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.151 -0.477 . . . . 72.11 111.084 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.427 ' CG ' ' HB3' ' A' ' 199' ' ' GLU . 37.8 mtp180 -113.07 137.6 51.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 73.24 110.843 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.663 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 41.18 -151.99 0.13 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.841 -0.695 . . . . 74.21 112.486 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.804 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -66.41 117.3 8.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.875 0.369 . . . . 64.11 111.061 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.711 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -109.27 -20.22 13.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 73.23 110.9 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 129.85 30.03 0.66 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.771 -0.728 . . . . 74.43 112.478 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.635 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.72 0.21 14.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 71.23 110.826 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 74.25 38.73 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 71.33 110.872 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.711 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.3 -41.2 0.81 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 54.35 110.806 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.804 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.36 99.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 65.33 111.074 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.663 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.7 m-85 -60.23 -168.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 53.02 110.8 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.89 19.6 3.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.093 -0.503 . . . . 64.13 110.898 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.574 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 53.25 -157.8 4.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.773 -0.727 . . . . 32.21 112.461 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.2 OUTLIER -33.82 134.27 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 73.13 110.926 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.32 165.66 0.15 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.677 -0.773 . . . . 44.02 112.508 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.3 -144.06 23.26 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.714 -0.755 . . . . 42.43 112.537 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -49.44 97.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 60.44 111.177 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.79 -41.28 87.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.097 -0.501 . . . . 73.4 110.938 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -170.96 169.16 6.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 74.41 111.123 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.476 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.2 p80 -163.75 143.48 8.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.254 -0.43 . . . . 74.15 110.824 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.745 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -138.09 173.23 11.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 73.13 111.069 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' ' 223' ' ' SER . 54.0 m-85 -98.82 -140.88 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 62.41 110.831 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -171.56 -87.57 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.748 -0.739 . . . . 71.11 112.493 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 54.21 1.12 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.648 2.232 . . . . 65.3 112.357 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.579 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.16 149.56 16.83 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 33.41 112.452 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.64 145.72 29.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.988 0.423 . . . . 74.05 110.804 -179.766 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.64 -63.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.799 -0.715 . . . . 53.11 112.479 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.524 ' N ' ' O ' ' A' ' 189' ' ' SER . 5.5 tp -105.29 6.54 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 73.3 111.14 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.579 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -67.82 169.78 37.7 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.803 -0.713 . . . . 61.3 112.442 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 45.32 18.9 0.2 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 51.32 112.561 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 192' ' ' GLY . 0.9 OUTLIER -63.15 103.41 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 50.32 110.913 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.745 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -77.76 131.15 37.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.223 -0.444 . . . . 63.31 111.067 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.476 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.7 m170 -121.37 130.23 53.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.45 . . . . 73.3 110.856 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.483 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 41.8 m-85 -115.13 134.22 55.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 63.51 110.88 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -67.52 104.69 1.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 55.33 110.886 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.427 ' HB3' ' CG ' ' A' ' 165' ' ' ARG . 4.2 tm-20 -57.24 -36.7 71.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 72.21 110.875 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.574 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 14.3 m-20 -50.41 -22.18 1.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 73.31 110.839 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -82.12 164.21 21.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 74.15 110.816 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.544 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -100.73 91.77 4.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 75.34 110.892 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.549 ' CZ3' HG21 ' A' ' 215' ' ' THR . 33.1 m95 -82.64 123.54 29.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.155 -0.475 . . . . 73.55 110.887 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.7 p -140.3 -172.4 3.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 63.4 111.164 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.6 17.34 17.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 71.5 111.098 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.26 -176.59 3.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 74.51 110.782 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.2 p -66.06 -18.54 65.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 72.43 110.951 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.91 -108.85 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.799 -0.715 . . . . 44.15 112.496 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.38 178.26 0.15 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.76 -0.733 . . . . 63.45 112.495 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 90.0 m -66.52 97.69 0.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.83 0.347 . . . . 72.11 111.185 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -41.65 116.83 0.83 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.446 . . . . 70.04 110.908 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 130' ' ' VAL . 17.4 tp -63.88 -36.01 82.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 62.11 110.894 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.71 ' CA ' ' HB1' ' A' ' 133' ' ' ALA . 2.4 t80 -53.68 -64.27 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 71.15 110.855 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.549 HD11 ' H ' ' A' ' 243' ' ' VAL . 19.3 mt -54.81 -54.32 43.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 52.42 110.913 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.549 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.5 m -54.53 -34.64 62.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 72.11 111.212 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.409 ' HB3' ' HB2' ' A' ' 137' ' ' ALA . . . -65.77 -48.98 70.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 71.3 111.159 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.85 HG12 ' NE1' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -52.5 -58.89 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 53.51 111.127 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.736 ' HB2' HG13 ' A' ' 235' ' ' VAL . 3.4 t-80 -63.29 -29.38 70.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 70.31 110.932 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -63.84 -44.5 92.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 71.43 111.111 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.783 HG23 HG12 ' A' ' 159' ' ' ILE . 2.4 mt -71.03 -34.23 54.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 64.45 111.108 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -52.63 -44.81 60.16 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.76 -0.734 . . . . 71.5 112.392 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.508 ' O ' ' O ' ' A' ' 185' ' ' PHE . 3.4 m-70 -69.46 -40.85 76.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 74.24 110.913 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 43.9 p -64.38 -20.55 66.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 64.23 110.842 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.449 HD23 ' CZ3' ' A' ' 109' ' ' TRP . 61.3 mt -81.74 -26.03 34.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 62.14 110.886 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 121.97 10.49 6.27 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.784 -0.722 . . . . 64.43 112.454 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.89 HD21 ' HA ' ' A' ' 258' ' ' ILE . 46.0 mt -79.77 149.41 31.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.865 0.364 . . . . 75.33 110.935 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.449 ' H ' ' HA ' ' A' ' 102' ' ' GLU . . . -95.35 -141.35 11.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.737 -0.745 . . . . 62.43 112.558 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.423 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 0.2 OUTLIER -119.08 142.6 47.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.801 0.334 . . . . 74.54 110.86 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 49.3 m -103.5 163.65 12.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 74.43 110.913 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.4 t -108.51 0.74 21.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.489 . . . . 65.31 110.891 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.61 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -65.14 141.57 98.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.601 0.715 . . . . 71.24 110.883 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 -3.84 12.88 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.695 2.263 . . . . 41.43 112.352 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -144.27 25.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 63.44 110.806 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.61 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -89.28 139.21 30.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 71.21 111.025 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.736 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.7 t -62.42 -37.92 79.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 74.34 111.126 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.423 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 37.1 mmm -65.79 -14.41 61.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 65.14 110.899 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.617 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.4 t80 -58.69 143.93 81.19 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.61 0.719 . . . . 71.55 110.91 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.617 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.1 Cg_endo -69.71 -0.99 7.67 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.689 2.259 . . . . 64.03 112.405 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.411 ' HG1' ' HD2' ' A' ' 237' ' ' PHE . 17.0 m -98.52 139.65 33.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.127 -0.488 . . . . 65.44 111.249 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -122.1 133.34 54.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 71.41 110.96 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -151.87 134.43 15.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 62.22 110.927 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.542 ' O ' HG13 ' A' ' 243' ' ' VAL . 83.2 t80 -59.62 144.8 46.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.45 . . . . 74.34 110.947 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.549 ' H ' HD11 ' A' ' 214' ' ' LEU . 0.4 OUTLIER -160.33 131.66 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 54.31 111.114 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -53.95 134.8 43.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 50.13 110.912 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.458 HD12 ' CE2' ' A' ' 213' ' ' PHE . 7.2 tt -54.2 -29.74 19.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 62.0 111.104 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.96 -19.47 62.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 74.34 110.933 179.921 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 11.9 p -111.21 -20.28 12.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 75.34 111.145 -179.987 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.425 ' CD2' HD22 ' A' ' 214' ' ' LEU . 10.2 t80 -74.44 133.91 42.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 74.41 110.88 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.1 136.13 1.42 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 73.31 110.931 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.816 HD12 HG11 ' A' ' 144' ' ' VAL . 36.5 mt -48.65 127.38 13.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 65.41 110.927 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.6 p -69.77 164.6 23.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 74.13 110.866 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.14 -34.77 32.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 74.25 111.093 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.52 -48.02 68.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 73.04 110.864 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.496 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 8.9 m-20 -61.27 -50.87 71.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 73.32 110.878 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 31.5 mt -61.83 -35.1 65.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 74.43 111.155 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -69.5 -39.23 77.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 63.15 110.908 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.32 -50.27 8.51 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.737 -0.744 . . . . 71.01 112.536 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.89 ' HA ' HD21 ' A' ' 226' ' ' LEU . 5.6 tp -52.56 -35.29 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.812 0.339 . . . . 74.35 111.091 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 263' ' ' GLY . 74.7 mt-30 -86.77 -16.45 36.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 74.41 110.882 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.0 t -70.31 -13.77 62.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 65.01 110.845 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.878 HD13 HG11 ' A' ' 108' ' ' VAL . 3.1 mt -123.59 -18.06 6.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 73.14 110.961 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.728 ' CG ' HD21 ' A' ' 147' ' ' LEU . 37.3 m-85 -115.31 -33.56 5.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 74.53 110.861 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.453 -0.227 0 CA-C-O 119.13 -0.817 . . . . 71.23 112.419 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 229' ' ' SER . 18.1 p90 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.914 0.388 . . . . 74.24 110.952 . . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 176.72 -175.59 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 54.33 110.879 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.786 ' CB ' HD11 ' A' ' 261' ' ' LEU . 0.4 OUTLIER -39.79 148.69 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.883 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.431 ' HG3' ' HA2' ' A' ' 227' ' ' GLY . 0.0 OUTLIER -50.82 161.17 0.7 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.536 0.684 . . . . 70.51 110.884 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -7.1 20.18 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.701 2.267 . . . . 73.22 112.359 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -160.33 45.35 0.42 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.734 -0.746 . . . . 61.52 112.51 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -108.74 87.32 0.48 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.753 -0.736 . . . . 55.44 112.501 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 84.48 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.664 2.242 . . . . 74.15 112.326 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 224' ' ' LEU . 9.1 p -46.77 160.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 54.44 111.174 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.432 ' N ' HG22 ' A' ' 108' ' ' VAL . 4.1 m0 -68.02 -22.33 64.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 75.1 110.908 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 66.03 27.78 10.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.301 -0.409 . . . . 51.42 110.925 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.64 149.29 44.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 74.43 110.923 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.567 ' HA ' HD22 ' A' ' 147' ' ' LEU . 12.2 p80 -96.91 19.35 12.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.317 -0.401 . . . . 61.44 110.892 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -121.62 101.18 7.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.458 . . . . 65.32 110.87 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.579 HG22 ' N ' ' A' ' 115' ' ' THR . 5.1 mp -126.77 162.25 31.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 53.24 111.156 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.579 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -155.9 166.91 32.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 61.54 111.188 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.634 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.5 p90 -137.16 146.27 44.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 72.2 110.909 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.547 ' NE ' HD11 ' A' ' 160' ' ' LEU . 3.7 tmm_? -139.2 112.46 8.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 55.1 110.945 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.1 mt -74.08 105.7 3.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.202 -0.454 . . . . 74.45 111.108 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -57.75 -47.57 82.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 72.01 110.919 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.758 ' OD1' HG23 ' A' ' 162' ' ' VAL . 1.4 p-10 -144.82 163.81 32.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.116 -0.493 . . . . 74.15 110.914 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.66 ' CE2' HG11 ' A' ' 130' ' ' VAL . 4.4 m-85 -116.01 139.63 50.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 55.34 110.902 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.732 HG22 ' CE ' ' A' ' 125' ' ' MET . 2.5 t -89.95 142.62 29.04 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.608 0.718 . . . . 72.33 111.138 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -3.99 13.16 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.638 2.225 . . . . 52.04 112.344 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.422 ' H ' HG23 ' A' ' 122' ' ' THR . 21.8 m-20 -79.28 -23.28 43.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 75.33 110.901 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.732 ' CE ' HG22 ' A' ' 122' ' ' THR . 12.9 mtm -115.99 166.15 12.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 63.04 110.878 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -97.23 145.03 26.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 74.04 110.836 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -45.58 -35.39 3.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 65.44 110.864 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -82.47 -38.84 23.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 43.14 110.891 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -65.31 -29.44 70.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 61.21 110.903 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.66 HG11 ' CE2' ' A' ' 121' ' ' TYR . 65.4 t -66.04 -45.34 90.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 73.34 111.153 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.69 -23.29 42.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 73.21 110.842 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -74.55 -46.81 36.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.447 . . . . 73.42 110.958 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.737 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -72.34 -31.12 65.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.099 -0.501 . . . . 70.24 111.118 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.541 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -72.71 -54.97 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 72.21 111.172 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.541 ' N ' HG22 ' A' ' 134' ' ' ILE . 5.3 ttt180 -48.66 -43.2 36.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 41.42 110.868 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.657 ' O ' HG23 ' A' ' 140' ' ' VAL . 6.9 mmpt? -70.64 -34.57 72.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 74.35 110.991 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.943 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.41 -49.24 78.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 65.44 111.103 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.634 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.9 m-85 -72.29 -22.82 61.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 74.45 110.884 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.8 tt0 -76.87 -5.57 48.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 65.15 110.937 -179.938 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 136' ' ' LYS . 85.9 t -98.83 -16.82 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 71.31 111.19 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.796 ' NE1' HG12 ' A' ' 217' ' ' VAL . 94.9 m95 -107.37 -37.16 6.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.174 -0.466 . . . . 74.22 110.9 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.67 -11.92 60.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 73.23 110.775 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -95.21 -16.3 22.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 72.42 110.974 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.709 HG11 HD12 ' A' ' 250' ' ' LEU . 19.5 m -98.8 0.67 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 74.03 111.182 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.604 HG21 HG13 ' A' ' 258' ' ' ILE . 62.6 p -150.19 149.14 26.34 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.637 0.732 . . . . 72.54 111.204 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 32.84 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.675 2.25 . . . . 61.32 112.357 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.807 HD11 ' CD2' ' A' ' 262' ' ' TYR . 13.8 mt -97.98 177.62 5.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 74.42 110.884 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.42 126.18 18.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 70.34 110.862 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.569 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.6 m-30 -114.44 143.78 44.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.425 . . . . 74.01 110.878 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.38 152.51 49.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.483 . . . . 62.4 110.856 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.487 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.3 OUTLIER -100.08 148.27 24.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.489 . . . . 73.41 110.879 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.492 HD11 ' HB2' ' A' ' 157' ' ' ALA . 3.9 pt -152.12 168.87 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.146 -0.479 . . . . 62.5 111.07 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.51 15.88 2.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 75.14 110.892 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.3 p -93.55 -54.34 3.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 73.31 111.192 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.416 ' H ' HD12 ' A' ' 152' ' ' ILE . . . 146.38 7.29 0.32 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.804 -0.713 . . . . 73.54 112.52 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 36.9 mmt -106.98 76.52 1.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.828 0.347 . . . . 63.23 110.862 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.492 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -145.85 162.97 36.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 32.43 111.131 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.8 -53.36 5.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 65.5 110.864 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.658 HG12 HG23 ' A' ' 220' ' ' ILE . 2.6 mp -90.51 96.22 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.228 -0.442 . . . . 74.05 111.075 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.547 HD11 ' NE ' ' A' ' 117' ' ' ARG . 8.0 tp -87.03 109.57 19.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 60.45 110.861 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.409 HG13 ' CE1' ' A' ' 197' ' ' PHE . 93.9 t -89.09 120.07 37.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 75.32 111.145 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.758 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.4 p -139.76 105.21 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 72.43 111.066 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -72.69 108.22 5.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 74.03 110.886 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.05 166.08 19.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 72.14 111.207 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.99 137.98 50.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.262 -0.426 . . . . 73.3 110.893 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.677 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.09 -156.03 0.14 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.721 -0.752 . . . . 73.25 112.453 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.798 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -64.58 116.55 6.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.769 0.319 . . . . 64.34 111.101 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.13 -21.48 12.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 74.04 110.849 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.32 29.38 0.6 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.683 -0.77 . . . . 61.0 112.507 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.647 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.33 1.36 15.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 64.43 110.945 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 72.63 40.22 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 73.21 110.956 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.51 -41.64 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 71.54 110.819 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.798 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.52 100.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 52.24 111.079 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.677 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.9 m-85 -60.87 -168.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 63.23 110.865 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.87 19.43 3.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 51.21 110.918 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.581 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.43 -156.63 8.93 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.783 -0.722 . . . . 53.12 112.475 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -37.67 136.54 0.52 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.855 0.359 . . . . 64.13 110.864 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.97 163.98 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 72.45 112.48 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.411 ' O ' HD22 ' A' ' 181' ' ' LEU . . . 82.92 -142.28 21.46 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.813 -0.708 . . . . 63.42 112.479 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.56 95.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 63.32 111.104 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 181' ' ' LEU . 2.9 mm? -65.86 -43.56 88.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 74.53 110.904 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -169.99 162.62 9.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 33.41 111.063 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.533 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.5 p80 -154.37 140.9 18.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.235 -0.439 . . . . 72.33 110.81 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.757 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -138.46 172.92 12.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.174 -0.466 . . . . 71.13 111.133 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 223' ' ' SER . 13.0 m-85 -101.53 -148.46 0.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 64.04 110.891 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -159.0 -96.31 0.11 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.789 -0.719 . . . . 52.23 112.531 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 59.31 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.799 2.333 . . . . 72.14 112.301 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.605 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.98 153.51 16.78 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.772 -0.728 . . . . 53.54 112.531 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.575 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.18 148.39 26.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.887 0.375 . . . . 35.01 110.862 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.55 -66.94 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.746 -0.74 . . . . 24.13 112.416 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 189' ' ' SER . 1.1 mp -103.58 6.08 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.807 0.337 . . . . 44.52 111.135 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.605 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -63.93 165.29 30.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.697 -0.763 . . . . 63.33 112.481 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 45.51 19.07 0.24 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.789 -0.719 . . . . 71.31 112.473 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.413 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 0.8 OUTLIER -63.67 107.65 1.22 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.88 0.371 . . . . 72.43 110.795 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.757 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -82.71 128.95 34.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 70.34 111.089 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.533 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 9.2 m170 -120.04 130.16 54.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 74.25 110.886 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.509 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 44.2 m-85 -115.29 133.72 55.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 74.33 110.849 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -66.92 110.15 3.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 73.23 110.857 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.25 -37.67 81.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 62.12 110.878 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.581 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 5.5 m-20 -50.62 -21.48 1.59 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 74.4 110.807 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.41 ' HG3' HD13 ' A' ' 181' ' ' LEU . 6.3 mm-40 -81.52 162.47 23.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.308 -0.406 . . . . 71.4 110.879 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.547 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.4 OUTLIER -100.54 90.0 4.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 70.43 110.85 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.521 ' HZ3' HG21 ' A' ' 215' ' ' THR . 27.0 m95 -81.6 121.72 26.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 74.54 110.951 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 40.6 p -140.21 -175.72 4.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.434 . . . . 73.33 111.112 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.93 20.79 17.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.455 . . . . 72.32 111.201 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -127.91 -176.45 3.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 75.24 110.766 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.2 p -68.96 -19.18 64.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 63.3 110.882 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.48 -107.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 72.24 112.39 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -51.9 175.89 0.12 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.718 -0.753 . . . . 54.22 112.432 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 43.7 m -64.3 98.81 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.786 0.327 . . . . 72.04 111.173 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -44.96 115.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 50.31 110.834 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.654 HD23 ' HB3' ' A' ' 133' ' ' ALA . 12.5 tp -60.33 -39.12 85.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 71.12 110.834 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.772 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.4 t80 -51.67 -63.66 1.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 72.41 110.935 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.548 HD21 ' CG2' ' A' ' 243' ' ' VAL . 8.6 mp -54.43 -55.46 28.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 63.42 110.929 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.521 HG21 ' HZ3' ' A' ' 203' ' ' TRP . 1.3 m -54.81 -36.15 64.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 73.51 111.197 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.32 -48.55 72.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 35.24 111.152 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.943 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.1 t -53.8 -57.93 4.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.166 -0.47 . . . . 64.44 111.201 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.75 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.8 t-80 -64.48 -28.16 69.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 73.02 110.847 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -64.68 -45.42 86.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 64.43 111.071 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.658 HG23 HG12 ' A' ' 159' ' ' ILE . 2.4 mt -69.5 -35.78 68.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 72.34 111.094 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.67 -44.74 38.66 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.848 -0.692 . . . . 65.43 112.402 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.461 ' O ' ' O ' ' A' ' 185' ' ' PHE . 3.8 m-70 -68.85 -39.37 79.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 75.33 110.851 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.572 ' OG ' HG23 ' A' ' 159' ' ' ILE . 5.0 m -63.05 -25.61 68.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 55.22 110.814 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.719 ' O ' HG23 ' A' ' 108' ' ' VAL . 40.3 mt -77.29 -26.1 51.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 73.44 110.912 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 122.21 15.23 4.26 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.773 -0.727 . . . . 60.13 112.466 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.877 HD21 ' HA ' ' A' ' 258' ' ' ILE . 40.4 mt -82.18 155.66 24.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.779 0.324 . . . . 71.31 110.944 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.431 ' HA2' ' HG3' ' A' ' 103' ' ' MET . . . -104.89 -140.68 10.48 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.699 -0.762 . . . . 70.34 112.473 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -120.97 149.45 42.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.754 0.311 . . . . 74.41 110.87 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.535 ' N ' ' HB3' ' A' ' 236' ' ' MET . 43.8 m -116.66 164.14 15.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 61.43 110.781 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.26 4.38 33.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.038 -0.528 . . . . 74.31 110.881 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.536 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.3 OUTLIER -69.68 135.77 88.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.49 0.662 . . . . 75.1 110.978 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.57 -1.34 8.15 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.759 2.306 . . . . 70.41 112.356 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.8 23.95 1.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 72.24 110.89 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.536 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -99.19 130.36 45.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 52.12 111.098 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.75 HG13 ' HB2' ' A' ' 218' ' ' HIS . 2.0 t -54.59 -31.49 23.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 74.21 111.164 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.535 ' HB3' ' N ' ' A' ' 229' ' ' SER . 0.0 OUTLIER -65.61 -14.24 60.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 64.14 110.883 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.582 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.4 t80 -64.06 143.06 98.27 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.623 0.725 . . . . 75.33 110.866 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.582 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.7 Cg_endo -69.77 -7.53 21.3 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.688 2.259 . . . . 64.23 112.381 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.1 m -92.87 149.81 21.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 55.42 111.048 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -125.82 137.39 53.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 62.23 110.905 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -152.63 128.94 10.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 71.53 110.877 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.547 ' O ' HG13 ' A' ' 243' ' ' VAL . 80.1 t80 -58.4 145.82 37.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 70.03 110.926 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.548 ' CG2' HD21 ' A' ' 214' ' ' LEU . 0.4 OUTLIER -160.35 132.21 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 71.13 111.082 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.505 ' CG ' HD22 ' A' ' 246' ' ' ASN . 14.6 t0 -46.86 135.2 9.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 71.11 110.892 179.843 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.648 HD11 ' HD3' ' A' ' 136' ' ' LYS . 7.3 tt -53.97 -33.49 24.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.479 . . . . 72.42 111.154 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.505 HD22 ' CG ' ' A' ' 244' ' ' ASP . 5.4 p30 -73.49 -17.19 61.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 73.21 110.905 179.916 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.447 HG23 ' OD1' ' A' ' 246' ' ' ASN . 24.5 p -106.01 -23.2 12.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 51.21 111.185 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -73.06 130.59 40.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 73.15 110.881 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -166.37 136.6 3.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 74.23 110.84 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.709 HD12 HG11 ' A' ' 144' ' ' VAL . 50.8 mt -50.41 124.91 11.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 74.34 110.99 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.73 170.37 12.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 45.12 110.858 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.85 -40.96 61.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 62.03 111.075 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.31 -47.6 85.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.29 -0.414 . . . . 65.11 110.844 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 31.0 m-20 -61.3 -54.76 39.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 72.23 110.846 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.406 ' HA ' HG22 ' A' ' 258' ' ' ILE . 22.7 mt -60.73 -32.84 52.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 73.54 111.123 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -68.97 -41.31 78.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 75.21 110.845 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.5 -49.66 8.96 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.744 -0.741 . . . . 62.54 112.418 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.877 ' HA ' HD21 ' A' ' 226' ' ' LEU . 8.3 tp -53.34 -34.34 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.359 . . . . 75.41 111.107 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.42 ' O ' ' N ' ' A' ' 263' ' ' GLY . 49.2 mt-30 -87.67 -16.25 34.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.464 . . . . 74.14 110.919 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.4 t -69.63 -14.73 62.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 74.54 110.83 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.786 HD11 ' CB ' ' A' ' 102' ' ' GLU . 1.0 OUTLIER -123.22 -18.68 6.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 72.3 110.879 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.807 ' CD2' HD11 ' A' ' 147' ' ' LEU . 40.6 m-85 -114.22 -33.06 5.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 74.12 110.942 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.347 0 CA-C-O 119.085 -0.842 . . . . 72.23 112.552 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 15.9 p90 . . . . . 0 CA--C 1.527 0.064 0 CA-C-O 120.84 0.352 . . . . 75.1 110.873 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 175.94 -175.89 0.11 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 70.13 110.856 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.787 ' HB3' HD11 ' A' ' 261' ' ' LEU . 2.1 pp20? -39.57 146.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.186 -0.461 . . . . 74.4 110.887 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 12.4 tpp -56.14 136.28 74.49 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.547 0.689 . . . . 71.55 110.908 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 78.39 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.651 2.234 . . . . 63.25 112.389 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 126.46 14.81 2.84 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 51.51 112.461 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -109.33 85.54 0.41 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.719 -0.753 . . . . 64.24 112.397 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.83 95.99 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.726 2.284 . . . . 62.5 112.346 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.82 HG12 ' HA3' ' A' ' 225' ' ' GLY . 18.5 m -51.86 171.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.162 -0.472 . . . . 71.4 111.129 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.412 ' CZ3' HD23 ' A' ' 224' ' ' LEU . 5.7 m0 -64.31 -29.67 70.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 72.43 110.949 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 44.3 mtm-85 65.72 33.29 8.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 72.1 110.9 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -121.62 171.07 9.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 73.12 110.957 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.441 ' HA ' ' HG ' ' A' ' 147' ' ' LEU . 1.7 p80 -114.4 30.14 7.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.353 -0.385 . . . . 65.44 110.891 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -136.47 108.38 7.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 74.23 110.955 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.569 HG22 ' N ' ' A' ' 115' ' ' THR . 5.1 mp -136.97 161.26 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 62.35 111.176 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.569 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -158.41 163.5 37.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 53.22 111.108 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.634 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.9 p90 -133.04 145.85 51.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 72.01 110.924 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.568 ' HD2' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -139.56 115.2 10.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 71.52 110.863 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 62.8 mt -76.58 107.78 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 75.02 111.128 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -60.49 -49.4 77.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 73.33 110.863 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.658 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.0 p-10 -142.1 167.56 21.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 63.4 110.902 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -118.4 148.93 42.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 74.34 110.933 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.501 HG23 ' HD2' ' A' ' 123' ' ' PRO . 87.7 m -100.21 135.48 20.3 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.551 0.691 . . . . 72.31 111.187 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.501 ' HD2' HG23 ' A' ' 122' ' ' THR . 54.2 Cg_endo -69.73 21.22 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.611 2.207 . . . . 72.41 112.347 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 122' ' ' THR . 1.6 m-20 -101.12 -24.75 14.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.224 -0.444 . . . . 74.42 110.879 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.405 ' HE3' HG22 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -116.19 166.2 12.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 72.34 110.835 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -89.56 147.93 23.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 74.22 110.86 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -47.87 -35.27 10.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 70.22 110.92 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -81.88 -37.21 27.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 74.33 110.891 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.406 ' HB3' HG23 ' A' ' 205' ' ' THR . 76.1 m-20 -64.86 -31.41 72.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 74.31 110.841 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.405 HG22 ' HE3' ' A' ' 125' ' ' MET . 62.4 t -64.65 -44.85 96.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 73.52 111.048 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.2 -23.19 38.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 72.34 110.803 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -75.54 -46.67 30.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 61.43 110.839 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.71 ' HB1' ' N ' ' A' ' 213' ' ' PHE . . . -69.43 -35.69 75.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 75.04 111.14 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.542 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.4 mp -70.59 -55.17 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 74.11 111.134 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.542 ' N ' HG22 ' A' ' 134' ' ' ILE . 0.6 OUTLIER -48.34 -44.15 34.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.081 -0.509 . . . . 62.44 110.929 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.634 ' O ' HG23 ' A' ' 140' ' ' VAL . 5.9 mmpt? -69.88 -35.14 74.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 72.12 110.889 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.916 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -59.84 -49.35 78.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.411 . . . . 71.44 111.116 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.634 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.8 m-85 -72.47 -22.16 61.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 70.15 110.848 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 3.6 tp60 -77.89 -5.87 52.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 74.45 110.936 -179.988 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.76 ' O ' HD11 ' A' ' 250' ' ' LEU . 87.4 t -97.23 -18.65 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 65.34 111.185 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.805 ' NE1' HG12 ' A' ' 217' ' ' VAL . 95.7 m95 -103.73 -40.19 6.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 62.05 110.962 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -13.57 62.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 75.51 110.817 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -94.07 -4.04 50.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 71.13 110.876 -179.951 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.822 HG11 HD12 ' A' ' 250' ' ' LEU . 31.3 m -120.96 3.59 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 61.23 111.047 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.717 HG23 ' HD2' ' A' ' 146' ' ' PRO . 3.2 m -145.98 141.66 16.89 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.675 0.75 . . . . 71.44 111.077 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 146' ' ' PRO . . . . . 0.717 ' HD2' HG23 ' A' ' 145' ' ' THR . 54.1 Cg_endo -69.78 35.64 0.22 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.695 2.264 . . . . 72.44 112.328 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.785 HD21 ' CE1' ' A' ' 262' ' ' TYR . 3.1 mp -103.22 -177.34 3.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 71.23 110.88 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -141.64 126.91 18.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 64.0 110.854 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.418 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.8 m-30 -114.06 146.45 40.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 74.24 110.887 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.455 ' H ' ' HA ' ' A' ' 115' ' ' THR . 5.8 t -142.27 151.51 42.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 72.02 110.877 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 7.2 tttp -102.54 143.13 32.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 74.43 110.925 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.573 HD12 ' CA ' ' A' ' 155' ' ' GLY . 21.8 pt -151.94 142.02 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 72.1 111.144 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.3 m120 -101.42 -19.79 15.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 64.44 110.828 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.1 t -150.5 66.07 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 64.41 111.116 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.573 ' CA ' HD12 ' A' ' 152' ' ' ILE . . . -152.12 -155.61 7.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.741 . . . . 53.31 112.473 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.82 94.17 5.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.747 0.308 . . . . 53.43 110.911 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.52 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -106.96 155.16 20.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 73.01 111.151 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.26 -53.33 5.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.42 . . . . 73.51 110.918 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.659 HG12 HG23 ' A' ' 220' ' ' ILE . 2.5 mp -88.68 94.1 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 72.5 111.078 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.568 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.5 tp -85.76 108.87 18.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.479 . . . . 74.15 110.904 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.2 t -86.96 119.11 34.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 73.01 111.152 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.658 HG23 ' OD1' ' A' ' 120' ' ' ASN . 1.9 p -138.24 104.91 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 74.05 111.081 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.419 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 39.6 m-85 -73.22 111.68 8.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.195 -0.457 . . . . 71.34 110.862 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.92 166.41 21.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 75.32 111.131 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -114.41 136.16 53.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 62.33 110.987 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.679 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 44.57 -157.78 0.19 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.773 -0.727 . . . . 72.43 112.499 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.819 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -62.53 116.45 5.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.832 0.348 . . . . 62.24 110.999 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.25 -22.12 12.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 74.23 110.884 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.71 30.35 0.54 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.708 -0.758 . . . . 53.53 112.515 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.633 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.97 0.1 14.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.912 0.387 . . . . 73.12 110.899 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 74.33 39.04 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 75.32 110.954 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.96 -41.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 71.51 110.853 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.819 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.2 100.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 65.32 111.102 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.679 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.1 m-85 -61.18 -168.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 74.01 110.898 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.17 18.84 3.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 71.22 110.825 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.587 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.07 -158.04 5.57 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 62.43 112.477 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.8 OUTLIER -33.76 133.94 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 75.43 110.884 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.45 165.44 0.15 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.715 -0.755 . . . . 62.04 112.541 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.64 -143.56 22.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.692 -0.766 . . . . 71.41 112.486 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.02 96.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.83 0.348 . . . . 75.23 111.169 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 13.3 mt -66.32 -44.0 84.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 71.22 110.9 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -170.09 163.09 9.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 73.24 111.08 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.488 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -155.62 142.66 19.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 75.23 110.81 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.744 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -139.02 172.26 13.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 72.41 111.101 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 223' ' ' SER . 48.4 m-85 -100.7 -151.39 0.41 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 62.1 110.858 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -154.99 -97.07 0.13 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.74 -0.743 . . . . 74.23 112.481 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 61.31 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.685 2.256 . . . . 73.42 112.329 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.617 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.65 153.76 17.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 53.24 112.473 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.58 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.75 149.71 25.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.396 . . . . 62.51 110.829 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.23 -66.77 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.739 . . . . 71.34 112.475 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.58 ' N ' ' O ' ' A' ' 189' ' ' SER . 1.1 mp -104.78 6.61 10.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.809 0.338 . . . . 62.33 111.098 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.617 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -65.33 164.33 37.45 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.763 -0.732 . . . . 40.15 112.482 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 47.21 16.73 0.29 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 54.23 112.457 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.409 ' CG ' ' HB3' ' A' ' 160' ' ' LEU . 1.1 m-20 -63.31 111.77 2.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.78 0.324 . . . . 65.23 110.898 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.744 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -85.49 128.76 34.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 74.35 111.076 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.488 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.8 m170 -119.29 128.65 54.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 71.12 110.846 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.525 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 47.8 m-85 -114.27 134.23 55.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.208 -0.451 . . . . 71.1 110.89 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -67.19 108.91 2.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 71.41 110.871 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.94 -36.91 78.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 65.32 110.843 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.587 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 16.8 m-20 -51.38 -21.06 2.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 74.33 110.854 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -82.61 162.72 21.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 71.42 110.885 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.522 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -100.66 92.46 5.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 70.25 110.887 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.525 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 30.0 m95 -82.7 122.47 28.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.02 -0.536 . . . . 63.1 110.948 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.2 p -139.42 -170.85 2.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 74.1 111.204 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.406 HG23 ' HB3' ' A' ' 129' ' ' ASP . 0.2 OUTLIER -116.09 17.24 15.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.278 -0.419 . . . . 61.02 111.151 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.58 -177.55 4.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 73.11 110.804 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.3 p -64.95 -18.66 65.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 72.44 110.831 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.31 -108.3 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.744 -0.741 . . . . 43.2 112.452 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.09 177.45 0.14 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.698 -0.763 . . . . 72.31 112.474 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 96.3 m -66.76 94.55 0.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.8 0.334 . . . . 70.31 111.187 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -38.12 117.09 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 73.44 110.875 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.502 HD23 ' HB3' ' A' ' 133' ' ' ALA . 25.0 tp -63.66 -36.59 84.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 73.02 110.921 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.71 ' N ' ' HB1' ' A' ' 133' ' ' ALA . 3.2 t80 -52.82 -64.63 0.75 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 75.42 110.932 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.44 HD11 ' H ' ' A' ' 243' ' ' VAL . 15.2 mt -53.53 -55.54 24.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 73.54 110.902 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.523 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 1.7 m -55.52 -32.99 63.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.468 . . . . 63.43 111.065 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.415 ' HB3' ' HB2' ' A' ' 137' ' ' ALA . . . -68.0 -46.24 71.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 75.34 111.026 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.916 HG22 ' HA ' ' A' ' 137' ' ' ALA . 1.9 t -55.96 -59.4 2.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.279 -0.419 . . . . 71.32 111.104 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.526 ' HB2' ' CG1' ' A' ' 235' ' ' VAL . 1.1 t-80 -60.6 -31.7 70.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 63.1 110.925 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -60.25 -46.75 88.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 70.41 111.075 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.659 HG23 HG12 ' A' ' 159' ' ' ILE . 2.3 mt -68.75 -34.54 65.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 72.24 111.167 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.01 -42.69 48.42 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.788 -0.72 . . . . 64.34 112.418 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.44 ' O ' ' O ' ' A' ' 185' ' ' PHE . 24.1 m-70 -67.62 -39.94 84.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 64.04 110.89 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.586 ' OG ' HG23 ' A' ' 159' ' ' ILE . 2.1 m -60.76 -28.87 69.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 72.22 110.877 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.412 HD23 ' CZ3' ' A' ' 109' ' ' TRP . 52.3 mt -76.21 -26.42 56.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 72.14 110.88 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.82 ' HA3' HG12 ' A' ' 108' ' ' VAL . . . 117.67 16.53 5.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.803 -0.713 . . . . 65.42 112.458 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.945 HD11 HD13 ' A' ' 258' ' ' ILE . 53.4 mt -77.45 159.25 29.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 62.11 110.894 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -103.71 -140.14 10.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.702 -0.761 . . . . 73.45 112.504 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.405 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 1.3 m170 -123.35 136.19 54.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.814 0.34 . . . . 63.14 110.934 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 29.8 t -104.92 162.56 13.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 73.5 110.89 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.6 t -107.75 5.85 27.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 74.55 110.751 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.553 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -68.53 140.45 92.31 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-O 121.673 0.749 . . . . 71.15 110.806 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 0.55 5.47 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.757 2.305 . . . . 75.43 112.365 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -143.62 14.66 1.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 51.12 110.813 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.553 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -77.33 140.3 39.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 73.2 111.129 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.565 HG21 HD23 ' A' ' 250' ' ' LEU . 51.6 t -69.8 -26.18 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 62.41 111.138 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.405 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 55.6 mmm -81.92 -7.03 59.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 62.41 110.955 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.496 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 2.4 t80 -50.9 138.28 24.48 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.681 0.753 . . . . 64.34 110.882 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.496 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 53.6 Cg_endo -69.75 -7.87 22.15 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.622 2.215 . . . . 64.54 112.335 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.41 ' HB ' ' CD2' ' A' ' 237' ' ' PHE . 22.3 m -110.91 130.99 55.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 53.31 111.18 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -92.24 146.82 23.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.958 0.409 . . . . 73.43 110.953 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -161.87 132.02 4.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 42.01 110.848 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.536 ' O ' HG13 ' A' ' 243' ' ' VAL . 65.0 t80 -61.89 149.06 41.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 74.13 110.915 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -160.76 137.48 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 74.33 111.12 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -60.76 127.39 31.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 51.33 110.825 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.559 HD11 ' HD3' ' A' ' 136' ' ' LYS . 14.4 tt -54.0 -29.48 18.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 75.24 111.152 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -69.08 -21.26 64.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 74.24 110.849 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.8 p -111.89 -18.2 12.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 63.14 111.119 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.567 ' HE2' HG21 ' A' ' 140' ' ' VAL . 36.8 t80 -62.72 142.2 58.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 73.3 110.903 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -177.11 136.25 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 74.01 110.831 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.822 HD12 HG11 ' A' ' 144' ' ' VAL . 8.7 mt -51.57 127.71 21.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 64.22 110.914 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 35.8 t -66.89 161.68 23.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 74.11 110.863 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.27 -30.17 11.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 72.05 111.128 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -71.75 -45.87 60.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 64.13 110.9 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.447 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 2.1 m-20 -62.36 -50.57 71.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 74.01 110.82 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 24.2 mt -62.29 -35.63 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 54.25 111.158 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 29.1 mmt-85 -71.08 -38.04 72.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 74.5 110.848 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.13 -49.93 7.17 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.673 -0.775 . . . . 63.24 112.523 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.945 HD13 HD11 ' A' ' 226' ' ' LEU . 8.4 tp -52.4 -34.84 19.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.786 0.327 . . . . 72.42 111.141 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.409 ' O ' ' N ' ' A' ' 263' ' ' GLY . 30.5 mt-30 -87.81 -16.18 34.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 72.53 110.925 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.6 t -70.16 -14.25 62.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 73.25 110.809 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.787 HD11 ' HB3' ' A' ' 102' ' ' GLU . 0.4 OUTLIER -122.37 -19.33 6.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 63.34 110.923 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.785 ' CE1' HD21 ' A' ' 147' ' ' LEU . 37.6 m-85 -113.8 -35.06 5.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.448 . . . . 74.01 110.955 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.325 0 CA-C-O 119.157 -0.801 . . . . 43.21 112.498 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.894 0.378 . . . . 74.22 110.884 . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 50.88 49.5 20.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 74.25 110.833 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.531 ' CD ' HD21 ' A' ' 261' ' ' LEU . 1.7 tt0 176.44 136.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 62.1 110.904 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.48 ' HG3' ' HD2' ' A' ' 104' ' ' PRO . 1.1 tpt -52.51 137.75 41.26 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.632 0.729 . . . . 72.43 110.873 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.48 ' HD2' ' HG3' ' A' ' 103' ' ' MET . 54.8 Cg_endo -69.71 87.12 0.55 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.656 2.237 . . . . 75.55 112.415 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 141.75 -136.67 7.5 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.698 -0.763 . . . . 70.24 112.511 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.719 ' N ' ' CD ' ' A' ' 107' ' ' PRO . . . -136.27 34.93 2.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.74 -0.743 . . . . 54.41 112.514 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.719 ' CD ' ' N ' ' A' ' 106' ' ' GLY . 54.4 Cg_endo -69.69 -8.92 24.84 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.701 2.267 . . . . 72.5 112.375 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.048 HG11 HD13 ' A' ' 261' ' ' LEU . 2.2 p -96.87 103.68 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 52.0 111.157 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.45 ' CZ3' HD23 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -50.97 108.03 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 64.21 110.881 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -75.06 56.17 0.76 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 70.41 110.806 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -121.8 151.28 40.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.253 -0.431 . . . . 74.41 110.963 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.464 ' HA ' HD22 ' A' ' 147' ' ' LEU . 9.9 p80 -95.65 39.5 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 70.24 110.854 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -141.92 98.67 3.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.149 -0.478 . . . . 73.25 110.904 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.652 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.6 mp -132.12 163.19 38.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.097 -0.501 . . . . 60.23 111.136 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.589 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -160.26 163.44 33.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 72.41 111.238 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.595 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.7 p90 -133.72 155.71 49.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 75.04 110.854 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.709 ' HD2' HD11 ' A' ' 160' ' ' LEU . 3.8 tmt_? -144.87 111.56 5.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 73.3 110.923 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.0 mt -73.37 104.18 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.31 -0.405 . . . . 74.43 111.206 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -57.82 -45.72 85.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 55.52 110.896 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.743 ' OD1' HG23 ' A' ' 162' ' ' VAL . 1.6 p-10 -146.92 164.24 33.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 74.4 110.862 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.592 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.3 m-85 -116.5 144.82 43.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 75.41 110.923 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.715 HG22 ' CE ' ' A' ' 125' ' ' MET . 3.0 t -94.33 142.15 24.48 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.564 0.697 . . . . 72.05 111.17 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.87 -3.17 11.54 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.643 2.229 . . . . 62.2 112.339 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.401 ' H ' HG23 ' A' ' 122' ' ' THR . 22.8 m-20 -79.96 -23.38 41.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 43.1 110.933 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.715 ' CE ' HG22 ' A' ' 122' ' ' THR . 16.6 mtm -115.94 166.63 11.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 72.51 110.858 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.409 ' O ' HG23 ' A' ' 130' ' ' VAL . 46.7 t30 -96.32 143.95 26.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 70.35 110.909 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.88 -32.83 1.73 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 73.22 110.911 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -85.73 -40.44 16.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 70.41 110.9 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -64.88 -29.24 70.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 73.2 110.906 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.62 ' O ' HD13 ' A' ' 134' ' ' ILE . 78.9 t -67.39 -45.36 85.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 71.4 111.168 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -80.12 -22.72 41.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 73.54 110.878 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -73.75 -47.02 42.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 72.14 110.955 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.774 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -73.84 -30.01 62.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.5 . . . . 74.32 111.094 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.656 HD13 HD21 ' A' ' 212' ' ' LEU . 1.4 mp -73.84 -55.85 11.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 73.53 111.202 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.558 ' N ' HG22 ' A' ' 134' ' ' ILE . 2.1 ttt180 -48.02 -42.12 27.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 64.53 110.868 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.551 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -75.88 -33.35 59.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 64.12 110.902 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.848 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.35 -50.78 72.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 71.11 111.145 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.616 ' HE2' HD13 ' A' ' 159' ' ' ILE . 80.7 m-85 -67.37 -32.55 73.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 61.43 110.832 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.442 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 2.7 tt0 -63.42 -44.2 95.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 50.45 110.991 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 136' ' ' LYS . 79.3 t -49.35 -24.81 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 73.32 111.077 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.791 ' NE1' HG12 ' A' ' 217' ' ' VAL . 97.6 m95 -98.99 -28.36 13.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.253 -0.43 . . . . 75.2 110.867 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.2 p -76.14 -12.54 60.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.282 -0.417 . . . . 63.43 110.842 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.442 ' OD1' ' O ' ' A' ' 139' ' ' GLN . 21.3 m120 -92.73 -24.75 18.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 62.14 110.867 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.64 HG11 HD12 ' A' ' 250' ' ' LEU . 4.4 m -93.28 0.8 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 62.33 111.079 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.559 HG21 HG13 ' A' ' 258' ' ' ILE . 77.6 p -152.93 143.98 16.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.642 0.734 . . . . 74.53 111.146 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 29.33 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.604 2.202 . . . . 74.02 112.333 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.751 HD11 ' CD2' ' A' ' 262' ' ' TYR . 29.4 mt -87.71 175.59 7.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.444 . . . . 70.14 110.937 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -137.67 126.47 23.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 73.53 110.983 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.652 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.4 m-85 -116.6 140.28 49.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 74.11 110.83 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.9 m -136.09 145.94 46.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 64.55 110.847 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.424 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 5.5 tttt -94.22 144.87 25.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 64.23 110.893 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.627 HD11 ' HB2' ' A' ' 157' ' ' ALA . 14.8 pt -151.25 132.85 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 72.52 111.081 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.33 -0.17 28.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.155 -0.475 . . . . 73.44 110.866 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.7 t -160.54 55.61 0.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 62.12 111.126 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.405 ' C ' HD12 ' A' ' 152' ' ' ILE . . . -151.06 -155.46 6.94 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.652 -0.785 . . . . 75.14 112.454 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.65 96.63 6.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.7 0.286 . . . . 65.25 110.914 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.627 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -105.27 157.03 17.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.414 . . . . 73.21 111.104 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.94 -50.95 7.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 72.52 110.849 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.65 HG23 ' OG ' ' A' ' 223' ' ' SER . 2.6 mp -93.14 98.95 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 75.1 111.203 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.709 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.4 tp -88.67 109.89 20.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 71.04 110.995 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.442 HG13 ' CE1' ' A' ' 197' ' ' PHE . 98.3 t -89.07 121.44 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 72.42 111.144 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.743 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -140.98 106.43 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 75.11 111.175 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -73.66 108.57 6.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 72.41 110.819 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.91 165.61 20.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.029 -0.532 . . . . 64.03 111.163 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.08 137.69 51.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 63.34 110.879 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.68 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.82 -155.48 0.23 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.772 -0.728 . . . . 53.45 112.473 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.805 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.45 117.07 7.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 73.41 111.113 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.28 -22.51 12.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 75.44 110.831 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.32 29.68 0.54 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.805 -0.712 . . . . 33.52 112.518 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.624 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.1 -0.45 14.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.824 0.345 . . . . 50.03 110.882 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 74.77 39.39 0.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 74.14 110.946 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -135.02 -41.28 0.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 74.12 110.82 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.805 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.19 99.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.43 . . . . 74.5 111.093 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.68 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -60.4 -168.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 71.51 110.911 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.69 19.12 3.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 72.42 110.798 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.575 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.5 -157.99 6.18 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.789 -0.72 . . . . 63.45 112.508 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 176' ' ' GLY . 9.6 ptpt -34.59 134.05 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 73.52 110.966 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.84 165.42 0.18 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.777 -0.725 . . . . 75.2 112.491 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.441 ' O ' HD22 ' A' ' 181' ' ' LEU . . . 82.69 -142.9 22.1 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.775 -0.726 . . . . 41.51 112.488 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.47 96.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.953 0.406 . . . . 72.44 111.145 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.441 HD22 ' O ' ' A' ' 179' ' ' GLY . 3.0 mm? -65.56 -42.71 91.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 63.43 110.903 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -171.25 163.55 7.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 62.3 111.163 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.493 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -156.11 142.13 18.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 60.12 110.88 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.742 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -137.79 172.93 12.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 40.12 111.123 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 223' ' ' SER . 12.2 m-85 -101.7 -148.48 0.37 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.24 -0.436 . . . . 75.02 110.796 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -164.03 -86.85 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.739 -0.744 . . . . 63.4 112.483 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.82 55.51 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.564 2.176 . . . . 74.12 112.374 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.582 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.82 149.79 16.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 63.21 112.502 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.13 146.48 28.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.388 . . . . 71.41 110.805 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.03 -64.77 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.796 -0.716 . . . . 64.33 112.512 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' A' ' 189' ' ' SER . 8.2 pt -105.25 8.86 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.871 0.367 . . . . 73.51 111.214 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.582 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -68.91 169.75 41.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.701 -0.761 . . . . 75.23 112.433 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 44.67 20.78 0.23 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.727 -0.749 . . . . 74.24 112.542 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 192' ' ' GLY . 2.3 m-20 -64.98 107.34 1.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.784 0.326 . . . . 72.42 110.892 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.742 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -81.4 129.06 34.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 71.14 111.094 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.493 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.8 m170 -119.86 129.82 54.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.312 -0.403 . . . . 65.12 110.805 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.484 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 47.7 m-85 -114.47 133.9 55.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 55.21 110.876 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -66.76 107.3 2.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.128 -0.487 . . . . 75.13 110.769 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -58.4 -37.51 75.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 75.22 110.794 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.575 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 14.6 m-20 -50.48 -22.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 62.51 110.875 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -80.79 162.96 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 62.31 110.853 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.571 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -101.22 88.53 3.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 71.42 110.853 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.553 ' CZ3' HG21 ' A' ' 215' ' ' THR . 31.1 m95 -79.54 123.9 28.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 75.21 110.913 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 25.1 p -142.7 -175.96 4.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.457 . . . . 73.13 111.086 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.12 21.45 16.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 73.54 111.158 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -128.29 -174.86 3.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 51.15 110.884 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.4 p -70.87 -19.2 62.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 65.45 110.758 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.76 -105.23 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.717 -0.754 . . . . 72.03 112.519 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.5 177.23 0.11 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.735 -0.745 . . . . 42.14 112.503 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 68.7 m -66.93 98.14 0.53 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.819 0.342 . . . . 72.32 111.107 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -42.13 115.72 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.85 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.774 HD23 ' HB3' ' A' ' 133' ' ' ALA . 5.8 tp -63.93 -36.62 84.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 53.35 110.957 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.718 ' O ' HG23 ' A' ' 217' ' ' VAL . 4.5 t80 -51.93 -64.05 0.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 74.44 110.874 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.434 HD11 ' H ' ' A' ' 243' ' ' VAL . 18.2 mt -56.1 -54.84 40.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 74.51 110.855 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.553 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.5 m -54.5 -34.52 61.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 74.25 111.155 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.83 -49.35 66.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 54.45 111.069 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.848 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -52.81 -58.03 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.326 -0.397 . . . . 74.54 111.17 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.64 ' HB2' HG13 ' A' ' 235' ' ' VAL . 4.3 t-80 -63.36 -30.81 71.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 73.3 110.799 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.48 -43.27 99.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 75.4 111.087 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.636 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -71.65 -35.42 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 64.34 111.053 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.24 -43.95 43.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.644 -0.789 . . . . 74.21 112.515 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 185' ' ' PHE . 31.5 m-70 -68.52 -39.52 81.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 74.34 110.915 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.65 ' OG ' HG23 ' A' ' 159' ' ' ILE . 5.0 m -62.15 -27.39 68.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 73.44 110.843 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.62 ' O ' HG23 ' A' ' 108' ' ' VAL . 68.2 mt -76.8 -27.23 55.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 73.55 110.911 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.446 ' HA3' ' HB ' ' A' ' 108' ' ' VAL . . . 117.05 16.76 6.08 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.752 -0.737 . . . . 51.33 112.468 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.899 HD11 HD13 ' A' ' 258' ' ' ILE . 32.3 mt -78.85 149.08 32.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.9 0.381 . . . . 62.42 110.874 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.494 ' H ' ' HA ' ' A' ' 102' ' ' GLU . . . -90.94 -142.65 10.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.733 -0.746 . . . . 65.31 112.487 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 0.4 OUTLIER -122.31 142.07 50.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.337 . . . . 72.41 110.833 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 28.7 t -103.49 161.58 13.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 65.11 110.824 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.25 -1.7 23.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 74.32 110.875 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.621 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -62.3 140.91 96.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.564 0.697 . . . . 73.3 110.907 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.71 -2.78 10.71 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.703 2.269 . . . . 70.2 112.367 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 3.6 ptmt -143.85 21.07 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 71.42 110.898 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.621 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -85.19 135.56 33.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 62.02 111.062 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.64 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.3 t -60.56 -35.68 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 54.04 111.105 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.445 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 41.1 mmm -65.44 -17.99 64.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 73.31 110.95 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.569 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.2 t80 -56.78 142.72 71.57 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.729 0.776 . . . . 72.32 110.896 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.569 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.6 Cg_endo -69.7 -1.4 8.36 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.669 2.246 . . . . 72.34 112.387 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.5 m -96.77 144.33 26.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 51.33 111.163 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -123.88 140.29 53.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 72.41 110.899 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -160.42 135.31 7.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 70.54 110.899 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.564 ' O ' HG13 ' A' ' 243' ' ' VAL . 70.8 t80 -59.04 148.69 29.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 73.51 110.976 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.3 OUTLIER -161.2 133.09 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 65.22 111.183 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -49.47 131.55 20.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 70.02 110.811 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 4.3 tt -54.44 -30.86 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 72.13 111.103 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -77.41 -17.62 57.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 74.25 110.928 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 50.9 p -104.14 -23.06 13.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 74.4 111.107 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -67.9 140.92 56.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 74.01 110.86 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.4 ptt85 -175.59 132.24 0.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.074 -0.512 . . . . 70.44 110.819 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.64 HD12 HG11 ' A' ' 144' ' ' VAL . 26.9 mt -48.24 125.48 9.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 74.23 110.998 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.1 p -68.34 166.15 17.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 72.23 110.806 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.32 -38.46 41.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 63.41 111.085 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -63.34 -46.69 85.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 72.21 110.947 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 4.9 m-20 -62.22 -53.53 53.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 53.2 110.867 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.419 ' HA ' HG22 ' A' ' 258' ' ' ILE . 26.3 mt -59.99 -36.06 64.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 72.31 111.136 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -68.23 -39.75 82.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 65.35 110.901 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.3 -53.17 5.74 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 53.3 112.514 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.899 HD13 HD11 ' A' ' 226' ' ' LEU . 6.4 tp -52.21 -35.5 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.673 0.273 . . . . 74.54 111.083 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 263' ' ' GLY . 70.0 mt-30 -85.81 -17.51 35.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 71.23 110.894 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 10.4 t -70.6 -13.63 62.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 75.3 110.817 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 1.048 HD13 HG11 ' A' ' 108' ' ' VAL . 4.7 mt -122.35 -17.74 6.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 71.14 110.883 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.751 ' CD2' HD11 ' A' ' 147' ' ' LEU . 33.3 m-85 -115.75 -34.77 4.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 73.23 110.987 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.279 0 CA-C-O 119.156 -0.802 . . . . 64.45 112.464 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.472 ' C ' ' HG2' ' A' ' 101' ' ' ARG . 10.6 m-85 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.954 0.407 . . . . 74.35 110.939 . . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.472 ' HG2' ' C ' ' A' ' 100' ' ' PHE . 14.6 ptt180 34.25 48.53 0.27 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 75.34 110.784 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 101' ' ' ARG . 2.0 pp20? 179.1 135.2 0.09 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.166 -0.47 . . . . 75.24 110.808 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.9 mmm -50.9 143.93 14.41 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.544 0.688 . . . . 74.32 110.893 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 -23.7 30.87 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.714 2.276 . . . . 70.42 112.407 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -150.11 35.61 0.98 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.795 -0.717 . . . . 71.41 112.521 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -107.42 91.38 0.69 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.821 -0.704 . . . . 55.24 112.497 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 108' ' ' VAL . 53.0 Cg_endo -69.74 77.68 1.05 Allowed 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.627 2.218 . . . . 73.42 112.299 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.763 HG22 ' HA3' ' A' ' 225' ' ' GLY . 61.2 t -36.9 144.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.273 -0.421 . . . . 74.43 111.121 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -52.3 -31.02 31.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 75.21 110.866 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.736 ' H ' HG12 ' A' ' 108' ' ' VAL . 16.1 mtp180 63.45 30.72 15.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 71.11 110.872 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.92 138.0 54.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 71.12 110.915 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.634 ' HA ' HD12 ' A' ' 147' ' ' LEU . 0.5 OUTLIER -84.09 43.55 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 64.42 110.843 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -143.73 82.69 1.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 72.12 110.963 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.632 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.2 mp -115.63 164.0 12.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 73.11 111.12 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.584 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -159.51 162.21 35.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.198 -0.456 . . . . 75.31 111.112 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.605 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.5 p90 -133.13 148.79 52.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.436 . . . . 74.45 110.904 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.674 ' HE ' HD11 ' A' ' 160' ' ' LEU . 3.7 tmm_? -142.51 113.37 7.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 73.43 110.875 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.4 mt -73.93 106.03 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 75.22 111.164 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -59.24 -47.25 86.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 53.22 110.902 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.728 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.1 p-10 -143.29 162.88 34.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 74.15 110.857 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.602 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.2 m-85 -117.25 137.66 52.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 54.32 110.955 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.731 HG22 ' CE ' ' A' ' 125' ' ' MET . 2.6 t -87.43 143.23 33.91 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.639 0.733 . . . . 72.2 111.128 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.414 ' HD2' ' OG1' ' A' ' 122' ' ' THR . 53.2 Cg_endo -69.88 -3.62 12.45 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.588 2.192 . . . . 73.52 112.338 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.44 ' H ' HG23 ' A' ' 122' ' ' THR . 15.7 m-20 -80.02 -23.74 41.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 65.25 110.875 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.731 ' CE ' HG22 ' A' ' 122' ' ' THR . 15.6 mtm -115.67 166.73 11.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 72.33 110.916 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -97.69 143.93 27.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.429 . . . . 72.12 110.92 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.47 -35.09 3.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 72.45 110.869 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -83.36 -38.65 21.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 73.2 110.914 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -65.26 -30.48 71.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.22 -0.445 . . . . 62.24 110.776 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.602 HG11 ' CE2' ' A' ' 121' ' ' TYR . 60.8 t -65.31 -47.37 87.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 50.21 111.22 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.99 -23.18 48.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 64.4 110.845 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -74.26 -46.71 39.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.233 -0.439 . . . . 73.42 110.95 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.706 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -72.8 -31.48 64.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 71.1 111.116 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.55 HD13 ' O ' ' A' ' 130' ' ' VAL . 1.4 mp -71.95 -53.79 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 74.21 111.152 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.537 ' N ' HG22 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -48.92 -41.88 35.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 73.13 110.897 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.662 ' O ' HG23 ' A' ' 140' ' ' VAL . 8.0 mmpt? -70.97 -36.29 72.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 53.01 110.94 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.654 ' O ' HG13 ' A' ' 217' ' ' VAL . . . -59.05 -50.83 72.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 63.23 111.11 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.605 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 93.4 m-85 -69.92 -22.96 63.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 74.24 110.926 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.7 tt0 -77.52 -6.87 55.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.119 -0.491 . . . . 72.22 110.905 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.719 ' O ' HD11 ' A' ' 250' ' ' LEU . 91.5 t -96.08 -18.34 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 65.34 111.086 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.874 ' NE1' HG12 ' A' ' 217' ' ' VAL . 96.1 m95 -106.02 -39.82 5.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 72.33 110.933 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -9.79 58.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 72.31 110.859 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -99.87 -7.92 24.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 72.43 110.888 -179.984 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.893 HG11 HD12 ' A' ' 250' ' ' LEU . 19.8 m -110.61 -5.24 11.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 74.45 111.152 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.744 ' CB ' HD23 ' A' ' 147' ' ' LEU . 44.8 p -141.36 149.62 55.3 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.555 0.693 . . . . 74.2 111.132 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 34.85 0.21 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.726 2.284 . . . . 70.32 112.27 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.928 HD21 ' HB3' ' A' ' 262' ' ' TYR . 2.9 mm? -104.98 167.09 9.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 54.14 110.924 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -131.12 127.93 39.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 54.21 110.932 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.632 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.3 m-30 -114.6 146.52 40.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 64.1 110.871 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 115' ' ' THR . 49.3 m -137.14 155.33 49.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 72.13 110.781 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.4 OUTLIER -106.78 142.36 36.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 61.55 110.83 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 157' ' ' ALA . 20.3 pt -151.26 147.97 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 71.13 111.197 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -120.81 12.67 11.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 63.4 110.924 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.8 t -173.53 49.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.488 . . . . 74.42 111.094 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.423 ' CA ' HD12 ' A' ' 152' ' ' ILE . . . -146.27 -149.63 5.03 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.718 -0.753 . . . . 32.13 112.502 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.89 92.76 4.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.729 0.3 . . . . 74.43 110.93 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.6 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -103.31 154.79 19.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 43.0 111.097 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.25 -54.67 4.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 74.22 110.863 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.663 HG12 HG23 ' A' ' 220' ' ' ILE . 2.5 mp -87.34 92.8 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.483 . . . . 72.41 111.123 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.674 HD11 ' HE ' ' A' ' 117' ' ' ARG . 7.4 tp -84.83 108.61 17.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 73.23 110.959 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.419 HG13 ' CE1' ' A' ' 197' ' ' PHE . 90.3 t -87.14 120.6 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.429 . . . . 71.45 111.091 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.728 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.2 p -139.45 105.61 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 72.41 111.124 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -73.23 108.17 5.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 63.43 110.908 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.64 165.79 20.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 73.01 111.064 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.91 137.65 51.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 74.03 110.851 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.68 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.49 -155.67 0.19 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.705 -0.76 . . . . 63.55 112.565 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.808 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -64.88 116.9 6.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.908 0.385 . . . . 74.54 111.126 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.696 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.17 -23.09 11.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.289 -0.414 . . . . 64.44 110.839 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.92 29.7 0.51 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.723 -0.751 . . . . 42.41 112.486 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.627 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.28 -0.17 14.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.804 0.335 . . . . 64.34 110.877 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 74.26 39.72 0.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 62.11 110.924 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.696 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.24 -41.29 0.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.042 -0.526 . . . . 73.15 110.869 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.808 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.2 100.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 24.23 111.224 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.68 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.2 m-85 -60.71 -168.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 62.41 110.84 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.8 18.95 3.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.118 -0.492 . . . . 72.41 110.827 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.65 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.46 -157.17 6.61 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.789 -0.72 . . . . 72.45 112.482 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.451 ' N ' ' HB3' ' A' ' 200' ' ' ASP . 5.7 tmtt? -34.42 133.86 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 74.23 110.893 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.41 166.5 0.18 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.681 -0.771 . . . . 65.43 112.565 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.18 -143.71 23.15 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.712 -0.756 . . . . 74.11 112.496 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -49.99 96.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.896 0.379 . . . . 73.31 111.101 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 25.0 mt -65.51 -42.7 91.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 44.43 110.869 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -171.32 162.74 6.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.248 -0.433 . . . . 63.55 111.2 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.472 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.3 p80 -155.64 143.11 19.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.289 -0.414 . . . . 64.25 110.879 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.753 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -139.3 171.59 14.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 73.0 111.068 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 222' ' ' HIS . 50.2 m-85 -98.67 -146.79 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 75.42 110.834 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -157.41 -101.44 0.18 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.797 -0.716 . . . . 63.14 112.552 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.66 63.14 1.73 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.709 2.273 . . . . 73.33 112.361 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.619 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.06 155.66 17.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 71.25 112.553 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.94 150.19 24.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.859 0.361 . . . . 71.31 110.881 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 59.35 -67.6 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.7 -0.762 . . . . 63.35 112.492 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.589 ' N ' ' O ' ' A' ' 189' ' ' SER . 24.3 pt -104.48 7.84 9.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.816 0.341 . . . . 74.2 111.174 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.619 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -64.32 162.37 36.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 40.42 112.532 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 46.58 17.7 0.28 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.736 -0.745 . . . . 54.21 112.528 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 192' ' ' GLY . 1.7 m-20 -63.09 111.13 2.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 61.2 110.859 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.753 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -84.31 129.39 34.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 65.3 111.124 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.472 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.0 m170 -120.16 129.31 54.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 63.45 110.875 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.488 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 42.5 m-85 -114.52 133.71 55.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 74.23 110.88 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -66.14 107.09 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 74.43 110.883 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -58.38 -37.41 75.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.147 -0.479 . . . . 75.0 110.868 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.65 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 9.9 m-20 -50.2 -23.62 2.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 65.41 110.81 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -80.17 162.95 24.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 72.21 110.868 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.572 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -100.67 89.91 4.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 72.51 110.819 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.534 ' CZ3' HG21 ' A' ' 215' ' ' THR . 33.0 m95 -80.94 123.51 28.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 72.21 111.007 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.0 p -141.18 -175.08 4.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.225 -0.443 . . . . 75.43 111.118 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.2 18.39 18.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 53.03 111.148 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.87 -177.98 4.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 73.2 110.847 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 17.4 p -65.07 -19.15 65.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 74.11 110.814 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.02 -108.53 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.706 -0.759 . . . . 73.21 112.446 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.92 177.5 0.12 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.795 -0.717 . . . . 74.45 112.525 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 91.6 m -65.86 97.32 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.851 0.358 . . . . 75.14 111.156 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -42.11 116.81 0.87 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 75.42 110.903 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.57 HD22 ' SD ' ' A' ' 125' ' ' MET . 11.8 tp -63.89 -38.46 91.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 43.51 110.964 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.706 ' CA ' ' HB1' ' A' ' 133' ' ' ALA . 2.3 t80 -49.25 -64.93 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.888 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.562 HD11 ' H ' ' A' ' 243' ' ' VAL . 21.8 mt -55.3 -54.95 37.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.238 -0.437 . . . . 73.33 110.873 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.534 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.1 m -54.51 -31.75 56.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 74.43 111.082 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.31 -48.88 60.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.429 . . . . 72.34 111.169 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.874 HG12 ' NE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -52.61 -57.85 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 72.53 111.051 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.743 ' HB2' HG13 ' A' ' 235' ' ' VAL . 2.0 t-80 -64.16 -30.21 71.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 71.35 110.889 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.3 -43.95 97.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 73.31 111.082 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.663 HG23 HG12 ' A' ' 159' ' ' ILE . 2.4 mt -70.59 -35.34 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 71.4 111.148 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.91 -44.61 40.76 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.708 -0.758 . . . . 73.45 112.533 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 185' ' ' PHE . 34.1 m-70 -67.21 -40.19 86.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.832 0.349 . . . . 72.03 110.894 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.584 ' OG ' HG23 ' A' ' 159' ' ' ILE . 2.7 m -62.35 -26.25 68.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 71.5 110.885 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.722 ' O ' HG13 ' A' ' 108' ' ' VAL . 72.9 mt -76.66 -27.87 55.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 72.31 110.911 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.763 ' HA3' HG22 ' A' ' 108' ' ' VAL . . . 120.44 18.57 4.05 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.673 -0.775 . . . . 71.03 112.51 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.848 HD21 ' HA ' ' A' ' 258' ' ' ILE . 13.3 mt -82.84 159.74 22.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.795 0.331 . . . . 75.42 110.948 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -106.57 -135.23 7.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 72.13 112.477 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 1.6 m170 -127.64 143.83 51.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.83 0.348 . . . . 73.45 110.821 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 62.2 m -108.95 163.52 13.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 74.14 110.86 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.03 0.69 30.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 73.1 110.845 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.571 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -65.18 136.57 96.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.629 0.728 . . . . 64.35 110.836 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 -0.46 6.99 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.699 2.266 . . . . 71.1 112.346 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.15 19.57 1.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 71.54 110.956 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.571 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -91.07 129.93 37.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 65.43 111.088 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.743 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.2 t -54.11 -34.93 27.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 62.4 111.163 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.427 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 39.7 mmm -62.16 -21.14 64.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 62.31 110.885 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.545 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -56.22 142.53 67.02 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.681 0.753 . . . . 72.5 110.831 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.545 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.1 Cg_endo -69.73 -1.28 8.18 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.691 2.26 . . . . 61.24 112.343 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.8 m -95.55 140.35 30.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 71.22 111.191 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -120.32 137.14 54.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 75.12 110.854 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -154.57 132.14 11.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.071 -0.513 . . . . 73.13 110.86 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.503 ' O ' HG13 ' A' ' 243' ' ' VAL . 88.4 t80 -59.65 142.85 52.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.93 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.562 ' H ' HD11 ' A' ' 214' ' ' LEU . 0.8 OUTLIER -158.46 128.85 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 72.12 111.185 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -51.29 134.37 27.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 72.53 110.876 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.449 HD11 ' HD3' ' A' ' 136' ' ' LYS . 10.8 tt -54.58 -30.13 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 71.35 111.183 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -73.81 -18.1 60.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 71.51 110.924 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 28.1 p -107.56 -23.31 12.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 74.44 111.115 -179.935 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -68.64 146.43 53.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 73.51 110.833 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -176.28 129.58 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 73.4 110.802 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.893 HD12 HG11 ' A' ' 144' ' ' VAL . 15.1 mt -48.99 131.99 18.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 75.33 110.955 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.475 ' O ' HD12 ' A' ' 255' ' ' ILE . 47.0 t -77.35 166.31 23.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 72.14 110.818 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.03 -37.99 35.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.059 -0.519 . . . . 71.13 111.074 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.31 -45.01 89.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.219 -0.446 . . . . 72.35 110.852 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -61.37 -54.8 39.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 72.44 110.875 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.475 HD12 ' O ' ' A' ' 251' ' ' SER . 2.6 mp -60.76 -37.07 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 71.3 111.052 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -68.36 -37.77 80.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 73.01 110.881 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -78.23 -51.23 5.81 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.682 -0.771 . . . . 44.51 112.456 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.848 ' HA ' HD21 ' A' ' 226' ' ' LEU . 6.3 tp -52.8 -33.72 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.763 0.316 . . . . 61.54 111.159 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 263' ' ' GLY . 30.8 mt-30 -87.66 -16.49 34.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 73.12 110.855 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 2.6 t -68.98 -16.24 63.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.856 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.491 HD22 HG23 ' A' ' 108' ' ' VAL . 1.3 mt -121.13 -19.23 7.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 75.13 110.893 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.928 ' HB3' HD21 ' A' ' 147' ' ' LEU . 31.2 m-85 -110.45 -36.67 5.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.157 -0.474 . . . . 72.13 110.971 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.638 -0.791 . . . . 51.33 112.479 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.847 0.356 . . . . 71.13 110.911 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.92 99.39 1.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 73.22 110.924 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.595 ' HB3' HD11 ' A' ' 261' ' ' LEU . 2.6 pp20? -100.34 147.83 25.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 65.24 110.898 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.417 ' HB3' ' HG3' ' A' ' 107' ' ' PRO . 4.5 mtt -48.48 151.98 1.78 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.516 0.674 . . . . 72.12 110.899 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 135.42 30.25 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.686 2.258 . . . . 70.24 112.299 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 106' ' ' GLY . . . 86.22 19.98 56.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.759 -0.734 . . . . 42.23 112.577 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.41 ' N ' ' CD ' ' A' ' 107' ' ' PRO . . . 38.32 54.61 2.1 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.719 -0.753 . . . . 74.31 112.423 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.419 ' HB3' ' HG3' ' A' ' 187' ' ' PRO . 54.2 Cg_endo -69.82 -22.54 31.68 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.64 2.227 . . . . 75.03 112.339 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.856 HG11 HD22 ' A' ' 261' ' ' LEU . 5.8 p -46.81 122.78 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 74.53 111.105 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.576 ' CZ3' HD23 ' A' ' 224' ' ' LEU . 3.0 m0 -57.02 -32.19 65.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 75.54 110.911 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.549 ' HG3' HG13 ' A' ' 108' ' ' VAL . 11.7 mtt-85 62.92 35.55 13.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 64.01 110.894 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.469 ' HG2' ' HB3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -121.76 168.02 12.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 74.31 110.96 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -107.55 36.05 2.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 60.35 110.822 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.401 ' C ' HD12 ' A' ' 114' ' ' ILE . 3.2 m-85 -140.59 108.95 5.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 62.01 110.881 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.634 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.7 mp -142.48 164.01 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 73.33 111.111 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.605 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -160.37 163.13 33.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 64.21 111.155 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.572 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.2 p90 -134.2 153.97 51.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.41 . . . . 70.24 110.888 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.603 ' HD2' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -145.88 110.65 5.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 73.54 110.838 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 59.5 mt -73.14 106.0 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 63.32 111.072 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -59.42 -51.03 71.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 74.23 110.933 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.682 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.7 p-10 -138.41 166.28 24.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.32 110.884 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -116.05 154.36 30.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 75.12 110.919 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.496 ' CG2' ' HD2' ' A' ' 123' ' ' PRO . 11.0 m -102.67 137.42 19.34 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.571 0.7 . . . . 74.11 111.149 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.496 ' HD2' ' CG2' ' A' ' 122' ' ' THR . 53.3 Cg_endo -69.67 3.45 2.72 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.688 2.258 . . . . 65.01 112.362 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.47 ' H ' HG22 ' A' ' 122' ' ' THR . 2.1 m-20 -87.6 -28.59 21.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 74.31 110.797 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.595 ' SD ' HD22 ' A' ' 212' ' ' LEU . 5.8 mtm -110.19 167.01 10.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 74.33 110.861 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -90.14 142.58 27.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 73.43 110.878 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.36 -37.07 4.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 75.03 110.898 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -82.53 -36.88 25.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 71.42 110.887 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -64.84 -32.0 73.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.148 -0.478 . . . . 62.4 110.868 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.569 HG22 ' HE3' ' A' ' 125' ' ' MET . 62.4 t -64.78 -43.86 96.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 70.05 111.124 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.4 -23.27 35.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 75.34 110.926 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -75.33 -48.1 24.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 73.44 110.865 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.594 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -71.41 -30.67 66.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 62.12 111.088 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.62 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -73.09 -55.58 12.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 75.31 111.112 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.531 ' N ' HG22 ' A' ' 134' ' ' ILE . 7.0 ttt180 -48.2 -41.75 28.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.835 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 140' ' ' VAL . 7.6 mmtt -75.66 -31.75 59.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.213 -0.449 . . . . 72.31 110.873 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.656 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -61.9 -50.83 70.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 61.42 111.119 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.655 ' HE2' HD13 ' A' ' 159' ' ' ILE . 75.5 m-85 -66.21 -30.89 71.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 75.12 110.972 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.445 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 3.7 tt0 -63.99 -42.62 97.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 72.14 110.87 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 136' ' ' LYS . 74.1 t -50.23 -24.43 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 54.11 111.088 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.806 ' NE1' HG12 ' A' ' 217' ' ' VAL . 98.1 m95 -98.1 -30.35 12.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.185 -0.461 . . . . 75.44 110.967 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 12.8 t -72.52 -14.74 61.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 63.44 110.863 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.445 ' OD1' ' O ' ' A' ' 139' ' ' GLN . 29.2 m120 -89.32 -25.71 21.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.51 . . . . 41.23 110.914 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.6 HG21 ' CD1' ' A' ' 250' ' ' LEU . 7.0 m -94.74 2.82 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 71.11 111.132 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.472 ' C ' ' H ' ' A' ' 147' ' ' LEU . 23.6 p -154.45 142.61 14.26 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.502 0.667 . . . . 61.44 111.191 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 19.26 0.18 Allowed 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.685 2.257 . . . . 71.43 112.414 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.794 HD21 ' CG ' ' A' ' 262' ' ' TYR . 0.6 OUTLIER -74.27 -177.57 3.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 75.53 110.903 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -144.4 124.52 13.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 71.34 110.91 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.634 ' HE1' HD13 ' A' ' 114' ' ' ILE . 2.4 m-85 -116.79 140.2 49.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 72.43 110.815 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.5 t -136.21 145.33 45.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 64.52 110.821 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.478 ' HG3' ' N ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -93.7 144.25 25.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 64.01 110.857 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.605 HD11 ' HB2' ' A' ' 157' ' ' ALA . 11.4 pt -150.65 130.49 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 43.11 111.127 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 8.2 m-20 -98.12 -7.5 29.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 73.21 110.893 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.9 t -157.13 60.19 0.51 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 65.33 111.111 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.434 ' C ' HD12 ' A' ' 152' ' ' ILE . . . -151.81 -155.79 7.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.752 -0.737 . . . . 50.05 112.482 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.19 97.67 7.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.794 0.331 . . . . 74.41 110.919 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.605 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -107.23 157.7 17.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 74.44 111.075 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.92 -50.87 7.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 64.11 110.92 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.694 HG12 HG23 ' A' ' 220' ' ' ILE . 2.9 mp -92.65 96.52 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 72.42 111.098 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.603 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.3 tp -87.26 110.49 20.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 75.32 110.961 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 88.2 t -88.54 119.07 35.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.112 -0.494 . . . . 74.24 111.139 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.682 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.1 p -138.38 106.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 74.34 111.125 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.448 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 34.4 m-85 -75.88 111.78 11.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 74.13 110.901 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -130.93 172.7 11.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 63.52 111.106 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.431 ' CG ' ' HB3' ' A' ' 199' ' ' GLU . 9.1 mtt180 -115.54 139.57 49.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 62.23 110.912 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.664 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 39.28 -149.05 0.11 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.773 -0.727 . . . . 74.14 112.476 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.802 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -69.4 117.02 10.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 74.51 111.125 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.43 -20.65 13.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 64.13 110.91 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.12 29.79 0.65 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.783 -0.722 . . . . 74.44 112.496 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.636 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.2 0.28 14.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.82 0.343 . . . . 74.41 110.812 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 74.1 38.73 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 75.21 110.895 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.2 -41.74 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 73.15 110.876 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.802 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.52 99.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 74.01 111.046 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.664 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -60.5 -168.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.325 -0.398 . . . . 71.3 110.865 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.15 19.88 3.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 71.24 110.907 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.571 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 53.74 -157.94 5.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 71.13 112.536 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 176' ' ' GLY . 9.9 tttt -34.58 134.43 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.339 . . . . 71.54 110.937 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.55 165.77 0.17 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.663 -0.78 . . . . 40.41 112.508 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.3 -143.45 22.84 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.734 -0.746 . . . . 73.22 112.553 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -49.66 96.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.875 0.369 . . . . 71.13 111.154 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 84.4 mt -65.96 -42.49 89.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 64.42 110.962 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -171.11 166.69 7.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.288 -0.414 . . . . 45.1 111.091 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.516 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -159.68 140.74 12.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.134 -0.485 . . . . 63.43 110.831 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.759 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -135.94 173.14 12.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 71.52 111.086 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 223' ' ' SER . 10.4 m-85 -104.66 -151.82 0.45 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 64.04 110.837 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.412 ' H ' ' HB3' ' A' ' 185' ' ' PHE . . . -161.29 -81.74 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.745 -0.74 . . . . 53.31 112.531 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.419 ' HG3' ' HB3' ' A' ' 107' ' ' PRO . 52.3 Cg_endo -69.87 53.92 1.17 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.639 2.226 . . . . 65.42 112.333 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.567 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -124.15 147.37 16.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.775 -0.726 . . . . 54.04 112.487 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.63 144.2 31.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 74.24 110.81 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.46 -63.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.721 -0.752 . . . . 74.22 112.506 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 189' ' ' SER . 2.2 pp -106.2 9.54 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.924 0.392 . . . . 75.52 111.133 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.567 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -70.72 171.43 44.65 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.734 -0.746 . . . . 70.11 112.45 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.44 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 44.24 20.44 0.18 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.734 -0.745 . . . . 75.23 112.476 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 192' ' ' GLY . 4.1 m-20 -64.24 108.59 1.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.776 0.322 . . . . 72.43 110.954 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.759 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -82.14 121.7 26.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 64.31 111.1 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.516 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.7 m170 -112.13 130.42 55.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 75.32 110.893 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.48 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 46.6 m-85 -115.23 136.12 53.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 62.01 110.897 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -69.29 104.03 2.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 73.11 110.827 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.431 ' HB3' ' CG ' ' A' ' 165' ' ' ARG . 4.2 tm-20 -55.87 -37.99 69.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 73.24 110.863 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.571 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 12.7 m-20 -49.26 -22.72 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 54.25 110.836 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -81.05 161.13 24.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 73.43 110.867 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.491 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -97.95 89.83 4.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 74.21 110.919 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.537 ' CZ3' HG21 ' A' ' 215' ' ' THR . 28.3 m95 -81.54 123.11 28.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 73.35 110.905 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.9 p -135.56 -174.23 3.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 70.24 111.225 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.53 12.78 18.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.279 -0.419 . . . . 64.12 111.167 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 3.2 p80 -131.04 -176.0 3.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 75.24 110.897 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.2 p -51.25 -36.06 40.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.433 . . . . 63.31 110.835 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -64.08 159.64 39.95 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.704 -0.76 . . . . 70.41 112.451 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . 49.15 -173.71 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.707 -0.759 . . . . 54.43 112.597 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.7 m -85.66 93.44 8.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.76 0.314 . . . . 75.45 111.122 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -38.91 111.47 0.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 72.22 110.822 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.62 HD21 HD13 ' A' ' 134' ' ' ILE . 9.0 tp -60.18 -36.78 78.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 74.14 110.869 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.594 ' CA ' ' HB1' ' A' ' 133' ' ' ALA . 3.6 t80 -51.97 -62.8 1.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.462 . . . . 71.45 110.935 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.547 HD11 ' H ' ' A' ' 243' ' ' VAL . 31.6 mt -57.52 -52.4 65.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 71.22 110.93 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.537 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 1.7 m -53.64 -38.07 63.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 53.34 111.137 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.429 ' HB3' ' CB ' ' A' ' 137' ' ' ALA . . . -61.74 -51.92 66.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 65.32 111.09 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.806 HG12 ' NE1' ' A' ' 141' ' ' TRP . 1.4 t -50.21 -58.87 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.458 . . . . 61.41 111.154 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.65 ' HB2' HG13 ' A' ' 235' ' ' VAL . 2.8 t-80 -62.86 -31.81 72.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 73.31 110.854 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -62.37 -43.29 99.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 42.34 111.121 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.694 HG23 HG12 ' A' ' 159' ' ' ILE . 2.4 mt -70.51 -33.43 53.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 75.51 111.093 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.92 -43.45 48.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.738 -0.744 . . . . 34.52 112.474 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.428 ' O ' ' O ' ' A' ' 185' ' ' PHE . 47.8 m-70 -68.37 -39.73 81.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.734 0.302 . . . . 74.31 110.814 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.601 ' OG ' HG23 ' A' ' 159' ' ' ILE . 2.0 m -62.16 -26.7 68.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 74.33 110.902 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.576 HD23 ' CZ3' ' A' ' 109' ' ' TRP . 79.5 mt -77.25 -26.55 52.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 75.01 110.934 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 112.16 22.05 6.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.731 . . . . 54.42 112.487 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.742 HD11 ' HA ' ' A' ' 258' ' ' ILE . 0.1 OUTLIER -87.66 146.86 25.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.9 0.381 . . . . 74.11 110.887 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.417 ' H ' ' HA ' ' A' ' 102' ' ' GLU . . . -88.04 -160.12 35.4 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.731 -0.747 . . . . 73.3 112.546 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -102.57 125.97 49.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 71.22 110.872 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.4 m -80.55 162.77 24.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 71.23 110.836 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.82 -1.1 19.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 70.5 110.894 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.638 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -63.44 142.75 97.9 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.582 0.706 . . . . 54.22 110.88 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -4.24 13.66 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.637 2.224 . . . . 63.11 112.344 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.68 23.61 1.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 64.42 110.867 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.638 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -81.54 143.0 32.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 71.21 111.068 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.65 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.3 t -65.78 -38.91 83.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.219 -0.446 . . . . 74.15 111.146 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 83.1 mmm -68.57 -12.27 61.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 65.23 110.878 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.657 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.5 t80 -57.8 145.1 72.28 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.582 0.706 . . . . 70.44 110.892 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.657 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.8 Cg_endo -69.77 0.89 5.0 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.666 2.244 . . . . 75.43 112.372 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 24.6 m -101.72 143.91 31.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 73.13 111.101 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -123.11 138.31 54.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 74.35 110.915 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -157.13 129.61 7.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 74.22 110.854 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.576 ' O ' HG13 ' A' ' 243' ' ' VAL . 86.3 t80 -59.66 145.83 43.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 74.23 110.949 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.3 OUTLIER -161.21 131.27 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 65.41 111.143 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -52.72 133.67 36.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.053 -0.521 . . . . 75.11 110.924 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.2 tt -53.69 -30.19 18.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.289 -0.414 . . . . 74.22 111.151 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.517 ' OD1' HG23 ' A' ' 247' ' ' THR . 0.1 OUTLIER -69.84 -20.26 63.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 73.24 110.96 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.517 HG23 ' OD1' ' A' ' 246' ' ' ASN . 6.3 p -110.45 -21.24 12.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 63.24 111.175 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -69.4 142.13 53.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 73.14 110.905 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -176.5 133.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 72.3 110.927 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.6 ' CD1' HG21 ' A' ' 144' ' ' VAL . 40.0 mt -47.52 123.58 5.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 74.11 110.987 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 7.1 t -58.3 158.36 7.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 62.33 110.954 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.52 -30.49 8.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 74.54 111.07 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -72.89 -45.69 56.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 75.24 110.846 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.12 -41.26 98.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 64.41 110.845 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.463 HG12 HG11 ' A' ' 144' ' ' VAL . 42.8 mt -69.6 -43.36 80.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 75.33 111.145 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.07 -28.99 67.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 74.1 110.919 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -85.06 -49.77 4.36 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.648 -0.787 . . . . 60.34 112.527 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.742 ' HA ' HD11 ' A' ' 226' ' ' LEU . 4.4 tp -54.22 -32.06 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.734 0.302 . . . . 74.02 111.123 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 263' ' ' GLY . 69.6 mt-30 -86.72 -17.58 33.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 74.52 110.942 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 2.4 t -67.79 -14.35 62.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 75.15 110.896 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.856 HD22 HG11 ' A' ' 108' ' ' VAL . 4.5 mt -121.8 -19.68 6.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 53.32 110.932 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.794 ' CG ' HD21 ' A' ' 147' ' ' LEU . 42.5 m-85 -113.41 -35.19 5.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 74.24 110.871 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 C--O 1.229 -0.218 0 CA-C-O 119.199 -0.778 . . . . 43.4 112.471 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.1 t80 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.881 0.372 . . . . 74.43 110.914 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 177.6 -174.19 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 52.52 110.898 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.811 ' HB3' HD11 ' A' ' 261' ' ' LEU . 0.0 OUTLIER -39.23 147.81 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 65.23 110.944 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.28 158.97 0.9 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.548 0.689 . . . . 61.11 110.85 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.87 68.95 1.73 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.629 2.219 . . . . 62.44 112.273 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 111.04 30.93 3.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.774 -0.727 . . . . 71.34 112.457 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -112.73 75.32 0.23 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.777 -0.725 . . . . 72.35 112.442 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 107.79 1.93 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.68 2.254 . . . . 52.33 112.373 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.763 HG12 ' HA3' ' A' ' 225' ' ' GLY . 18.5 m -50.83 170.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 73.14 111.115 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.467 ' CZ3' HD23 ' A' ' 224' ' ' LEU . 2.7 m-90 -56.32 -19.77 15.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 75.33 111.006 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.72 ' H ' HG23 ' A' ' 108' ' ' VAL . 6.7 mtt180 66.0 28.4 10.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 74.51 110.862 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 4.2 mtmm -121.53 146.1 47.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 72.21 110.899 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.536 ' HA ' HD22 ' A' ' 147' ' ' LEU . 14.2 p80 -94.04 19.82 8.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 64.01 110.939 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -123.77 95.23 4.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 73.31 110.892 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.636 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.8 mp -121.93 162.53 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 53.12 111.144 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.591 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -156.87 164.77 37.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 73.04 111.073 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.594 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.4 p90 -134.81 148.57 50.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 74.41 110.835 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.438 ' HB3' HD12 ' A' ' 160' ' ' LEU . 4.2 tmt_? -140.72 110.71 6.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.02 -0.536 . . . . 72.52 110.908 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 57.0 mt -73.11 104.8 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 52.31 111.049 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -56.41 -48.97 75.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 70.42 110.836 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.74 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.8 p-10 -143.54 163.57 32.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 75.22 110.876 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.569 ' CE2' HG11 ' A' ' 130' ' ' VAL . 4.9 m-85 -116.38 138.47 51.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 71.52 110.903 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.646 HG22 ' CE ' ' A' ' 125' ' ' MET . 9.1 t -87.86 141.95 32.0 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.55 0.69 . . . . 74.44 111.154 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -3.77 12.69 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.638 2.226 . . . . 61.2 112.363 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -78.43 -23.3 46.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 74.14 110.93 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.659 ' CE ' HG22 ' A' ' 130' ' ' VAL . 12.7 mtm -116.79 166.78 11.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 71.11 110.9 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.461 ' O ' HG23 ' A' ' 130' ' ' VAL . 23.9 t-20 -94.46 144.01 25.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 62.14 110.867 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -45.42 -36.92 4.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 44.02 110.86 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -82.57 -36.14 26.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 72.43 110.919 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -66.99 -30.17 70.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 73.4 110.828 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.659 HG22 ' CE ' ' A' ' 125' ' ' MET . 82.0 t -66.57 -46.35 86.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 65.43 111.142 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.428 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 0.4 OUTLIER -77.54 -24.72 49.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.187 -0.46 . . . . 71.43 110.796 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -73.22 -47.84 40.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 73.42 110.856 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.747 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -69.36 -31.42 69.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.175 -0.466 . . . . 51.24 111.122 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.626 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -74.26 -53.46 17.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 71.01 111.102 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.509 ' N ' HG22 ' A' ' 134' ' ' ILE . 7.0 ptp180 -49.22 -37.2 22.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 73.35 110.806 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.641 ' O ' HG23 ' A' ' 140' ' ' VAL . 7.3 mmtt -76.88 -34.47 57.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 74.03 110.869 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.931 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -59.98 -48.66 80.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 72.22 111.082 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.623 ' HE2' HD13 ' A' ' 159' ' ' ILE . 94.1 m-85 -72.5 -22.69 61.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 72.04 110.899 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -77.13 -5.5 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 71.4 110.89 -179.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 136' ' ' LYS . 84.1 t -98.74 -17.05 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 74.33 111.125 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.808 ' NE1' HG12 ' A' ' 217' ' ' VAL . 94.1 m95 -107.01 -37.03 6.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 73.3 110.906 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.78 -11.81 60.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.427 . . . . 62.42 110.88 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -94.99 -17.09 22.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 75.52 110.912 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.684 HG11 HD12 ' A' ' 250' ' ' LEU . 21.2 m -98.76 2.19 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 65.43 111.098 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.548 HG21 HG13 ' A' ' 258' ' ' ILE . 51.4 p -151.66 149.49 24.13 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.525 0.679 . . . . 23.03 111.219 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 32.01 0.19 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.698 2.265 . . . . 61.33 112.386 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.788 HD11 ' CD2' ' A' ' 262' ' ' TYR . 13.2 mt -97.8 175.92 5.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 75.03 110.929 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -140.1 125.53 19.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.172 -0.467 . . . . 74.1 110.954 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.636 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.2 m-30 -114.39 139.88 49.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 71.45 110.864 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.1 m -134.94 149.4 50.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 65.54 110.906 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 1.8 tttt -95.58 148.22 22.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 61.34 110.883 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 157' ' ' ALA . 3.6 pt -152.46 165.06 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 74.11 111.153 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.45 17.94 2.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 43.51 110.99 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.1 p -94.63 -49.62 5.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 64.11 111.235 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.432 ' H ' HD12 ' A' ' 152' ' ' ILE . . . 139.6 8.2 0.97 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.765 -0.731 . . . . 65.2 112.49 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.405 ' O ' HD13 ' A' ' 152' ' ' ILE . 23.7 mtm -108.17 75.78 1.01 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.766 0.317 . . . . 64.31 110.907 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.543 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -145.69 163.78 33.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 53.23 111.118 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.67 -53.12 5.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 75.42 110.846 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.771 HG12 HG23 ' A' ' 220' ' ' ILE . 2.3 mp -90.53 97.61 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 71.23 111.165 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 117' ' ' ARG . 8.5 tp -89.29 109.3 20.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 64.35 110.875 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.428 HG13 ' CE1' ' A' ' 197' ' ' PHE . 95.7 t -89.06 123.49 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 71.53 111.122 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.74 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -142.64 107.8 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 72.32 111.144 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -77.18 109.3 10.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 71.03 110.87 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -130.56 169.76 15.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 41.24 111.09 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 165' ' ' ARG . . . . . 0.498 ' HG3' ' HB3' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -112.88 139.22 48.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 74.42 110.826 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.664 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 41.43 -150.87 0.2 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.667 -0.778 . . . . 64.53 112.457 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.8 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -68.04 117.93 10.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.723 0.297 . . . . 55.43 111.163 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.706 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.79 -21.56 12.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 55.31 110.906 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.08 29.54 0.61 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.738 -0.744 . . . . 62.04 112.499 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.621 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.73 -0.32 15.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.88 0.372 . . . . 54.52 110.825 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 74.76 38.67 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 74.23 110.87 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.706 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -134.29 -41.24 0.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 73.33 110.898 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.8 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 55.04 99.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 63.22 111.106 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.664 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.7 m-85 -60.73 -166.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 72.13 110.829 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.59 19.5 2.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.056 -0.52 . . . . 65.42 110.862 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.585 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.7 -157.53 6.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 62.25 112.453 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 176' ' ' GLY . 12.4 mmtm -36.7 135.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 75.23 110.917 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.76 162.85 0.15 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.7 -0.762 . . . . 33.23 112.521 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.53 -140.01 20.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.68 -0.772 . . . . 54.0 112.513 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.6 mt -49.92 93.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.819 0.342 . . . . 71.03 111.206 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.665 HD11 HG21 ' A' ' 210' ' ' THR . 1.7 tm? -67.44 -33.34 74.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.944 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -178.89 169.31 1.6 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 35.14 111.06 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.505 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.3 p80 -165.28 139.43 4.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 74.2 110.855 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.726 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -137.93 173.47 11.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.267 -0.424 . . . . 32.44 111.125 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.488 ' O ' ' O ' ' A' ' 222' ' ' HIS . 10.2 m-85 -98.85 -141.98 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.006 0.432 . . . . 74.33 110.809 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -164.42 -101.13 0.15 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.736 -0.745 . . . . 72.4 112.507 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 61.42 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.66 2.24 . . . . 63.14 112.349 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.601 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.94 154.66 16.74 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.736 -0.745 . . . . 64.02 112.442 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.569 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.05 147.95 26.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.938 0.399 . . . . 63.52 110.821 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.66 -67.2 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 53.13 112.545 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.569 ' N ' ' O ' ' A' ' 189' ' ' SER . 5.2 mm -103.39 6.58 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 70.11 111.118 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.601 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -64.14 165.43 30.81 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.8 -0.714 . . . . 71.52 112.483 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 45.35 19.17 0.22 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.735 -0.745 . . . . 73.45 112.471 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.423 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 0.8 OUTLIER -63.5 105.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.885 0.374 . . . . 62.24 110.846 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.726 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -81.84 131.65 35.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 72.42 111.127 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.505 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 7.7 m170 -122.82 129.77 52.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 75.3 110.884 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.58 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 34.1 m-85 -115.5 135.5 54.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.292 -0.413 . . . . 75.33 110.963 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -69.36 106.82 3.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 71.11 110.961 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.498 ' HB3' ' HG3' ' A' ' 165' ' ' ARG . 3.9 tm-20 -58.35 -37.53 75.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 75.51 110.916 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.585 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 14.9 m-20 -49.18 -23.22 1.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.506 . . . . 64.51 110.852 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.75 163.4 24.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 64.3 110.88 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.493 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.2 OUTLIER -96.9 96.35 8.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 73.42 110.855 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.58 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 34.0 m95 -87.89 123.89 33.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.475 . . . . 64.22 110.891 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.8 p -143.73 -179.13 6.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 54.32 111.127 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.24 18.64 20.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 54.32 111.128 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.85 -175.51 3.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 63.44 110.796 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 24.1 p -66.91 -18.11 65.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 62.54 110.835 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.95 -108.7 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.61 -0.805 . . . . 42.23 112.538 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.04 178.18 0.12 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.818 -0.706 . . . . 73.34 112.492 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.665 HG21 HD11 ' A' ' 181' ' ' LEU . 96.3 m -66.08 97.42 0.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.338 . . . . 72.25 111.044 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -41.48 111.93 0.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 75.21 110.843 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.747 HD23 ' HB3' ' A' ' 133' ' ' ALA . 9.6 tp -58.8 -38.08 77.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 73.32 110.869 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.771 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.7 t80 -52.5 -64.28 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 61.41 110.845 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.458 HD11 ' H ' ' A' ' 243' ' ' VAL . 19.3 mt -52.45 -56.22 16.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 75.04 110.92 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 219' ' ' ALA . 3.0 m -54.87 -37.93 66.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 74.55 111.164 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.06 -48.28 79.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 32.45 111.059 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.931 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.1 t -53.84 -58.52 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 54.41 111.182 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.753 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.7 t-80 -64.78 -27.65 69.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 71.24 110.931 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -64.14 -44.77 91.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 73.11 111.074 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.771 HG23 HG12 ' A' ' 159' ' ' ILE . 2.6 mt -69.33 -34.54 63.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 70.55 111.16 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -52.43 -45.25 58.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.698 -0.763 . . . . 64.22 112.494 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.488 ' O ' ' O ' ' A' ' 185' ' ' PHE . 3.8 m-70 -68.49 -40.22 81.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.784 0.326 . . . . 73.42 110.847 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 29.8 p -65.39 -21.29 66.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 75.12 110.84 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.467 HD23 ' CZ3' ' A' ' 109' ' ' TRP . 59.6 mt -79.81 -26.84 40.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 61.51 110.941 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.763 ' HA3' HG12 ' A' ' 108' ' ' VAL . . . 122.35 12.88 5.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.699 -0.762 . . . . 54.04 112.447 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.509 HD21 ' HA ' ' A' ' 258' ' ' ILE . 11.3 mt -81.71 156.09 25.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.83 0.348 . . . . 72.11 110.933 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -99.89 -140.5 11.43 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.797 -0.716 . . . . 65.51 112.493 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -120.91 141.98 50.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.359 . . . . 70.41 110.808 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 60.9 p -99.16 163.05 12.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 72.2 110.904 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.67 1.22 21.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 55.32 110.824 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.17 132.35 73.69 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.553 0.692 . . . . 74.5 110.864 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 232' ' ' PRO . . . . . 0.403 ' HG2' ' HE2' ' A' ' 233' ' ' LYS . 52.8 Cg_endo -69.87 4.15 2.4 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.638 2.225 . . . . 51.22 112.321 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 233' ' ' LYS . . . . . 0.403 ' HE2' ' HG2' ' A' ' 232' ' ' PRO . 0.0 OUTLIER -136.01 11.12 3.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 74.03 110.884 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -88.82 150.22 23.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 73.15 111.151 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.753 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -71.73 -39.67 69.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 71.11 111.136 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 48.0 mmm -61.73 -15.12 37.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 74.14 110.861 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.618 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -56.53 144.49 63.66 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.649 0.738 . . . . 75.43 110.9 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.618 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.0 Cg_endo -69.84 -1.75 9.06 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.582 2.188 . . . . 63.2 112.313 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 22.0 m -97.88 141.07 31.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.419 . . . . 75.23 111.19 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -122.64 135.36 54.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 54.53 110.932 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -156.27 137.04 13.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 60.44 110.905 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.504 ' O ' HG13 ' A' ' 243' ' ' VAL . 66.4 t80 -59.2 146.28 39.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 73.14 110.997 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.6 OUTLIER -158.96 133.01 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 75.32 111.082 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -51.13 129.32 23.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 71.44 110.835 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.42 HD12 ' CE2' ' A' ' 213' ' ' PHE . 9.7 tt -53.84 -30.88 19.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 74.43 111.157 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -73.43 -21.15 60.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 71.52 110.926 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 69.8 p -104.05 -22.41 13.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 61.43 111.176 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -67.03 141.86 57.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 74.14 110.91 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -175.41 132.41 0.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 74.54 110.83 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.684 HD12 HG11 ' A' ' 144' ' ' VAL . 55.5 mt -49.89 122.78 7.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 75.32 110.907 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 8.6 t -65.96 167.21 10.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 73.51 110.898 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.01 -38.05 35.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 53.51 111.048 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -61.86 -49.12 77.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 65.53 110.826 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.436 ' OD2' ' HB ' ' A' ' 235' ' ' VAL . 2.0 m-20 -59.25 -55.79 30.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.244 -0.435 . . . . 73.44 110.813 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 18.3 mt -59.68 -33.46 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 61.01 111.201 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -69.2 -41.06 77.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 71.24 110.874 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.84 -49.87 7.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.75 -0.738 . . . . 73.34 112.542 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.548 HG13 HG21 ' A' ' 145' ' ' THR . 7.5 tp -53.08 -33.67 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.72 0.295 . . . . 73.43 111.098 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.412 ' O ' ' N ' ' A' ' 263' ' ' GLY . 52.8 mt-30 -88.21 -16.21 33.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.485 . . . . 75.33 110.933 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.7 t -69.54 -14.16 62.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 73.2 110.826 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.811 HD11 ' HB3' ' A' ' 102' ' ' GLU . 0.8 OUTLIER -123.99 -18.65 5.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.144 -0.48 . . . . 75.44 110.934 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.788 ' CD2' HD11 ' A' ' 147' ' ' LEU . 41.1 m-85 -114.3 -32.88 5.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 74.35 110.896 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.369 0 CA-C-O 119.22 -0.767 . . . . 64.12 112.468 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.808 0.337 . . . . 70.24 110.902 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.38 69.85 1.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 73.31 110.905 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 176.86 126.79 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 74.45 110.968 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 34.1 ttm -50.88 130.6 29.2 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.594 0.712 . . . . 63.3 110.855 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 67.1 1.77 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.661 2.241 . . . . 61.31 112.414 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -160.97 21.9 0.23 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.805 -0.712 . . . . 75.32 112.507 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.97 -156.3 24.32 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.682 -0.77 . . . . 60.14 112.431 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.487 ' HA ' HD22 ' A' ' 261' ' ' LEU . 53.5 Cg_endo -69.85 137.67 35.74 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.692 2.261 . . . . 73.32 112.344 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.868 HG12 ' HA3' ' A' ' 225' ' ' GLY . 0.0 OUTLIER -44.0 -84.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 72.51 111.116 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.706 ' CZ3' HD23 ' A' ' 224' ' ' LEU . 30.5 m0 -133.22 -31.43 1.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 72.14 110.824 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 72.29 19.84 4.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.295 -0.412 . . . . 70.12 110.911 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.2 pttt -122.63 138.23 54.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 64.21 110.841 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.615 ' HA ' HD12 ' A' ' 147' ' ' LEU . 2.1 p80 -93.79 42.38 1.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 71.13 110.894 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -144.62 90.94 2.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 74.41 110.972 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.587 HG22 ' N ' ' A' ' 115' ' ' THR . 5.0 mp -121.09 162.49 19.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 75.5 111.216 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.587 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -160.09 162.71 34.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 62.34 111.102 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.594 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.1 p90 -133.4 149.71 51.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.496 . . . . 74.42 110.952 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.688 ' HD2' HD11 ' A' ' 160' ' ' LEU . 3.9 tmt_? -142.5 115.06 8.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 72.35 110.823 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 52.7 mt -75.35 103.43 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 70.43 111.128 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -57.15 -45.72 83.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 74.21 110.933 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.736 ' OD1' HG23 ' A' ' 162' ' ' VAL . 1.7 p-10 -145.01 161.38 39.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.431 . . . . 65.24 110.914 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.57 ' CD2' HG11 ' A' ' 130' ' ' VAL . 4.7 m-85 -115.53 134.05 55.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 62.0 110.906 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.708 HG22 ' CE ' ' A' ' 125' ' ' MET . 2.3 t -82.41 142.05 46.32 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.55 0.691 . . . . 72.55 111.195 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.89 -5.78 17.11 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.646 2.231 . . . . 64.25 112.308 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -77.07 -22.15 53.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.439 . . . . 62.43 110.876 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.708 ' CE ' HG22 ' A' ' 122' ' ' THR . 18.2 mtm -117.74 167.15 11.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 71.12 110.884 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.41 ' O ' HG23 ' A' ' 130' ' ' VAL . 45.6 t30 -94.09 143.17 26.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 74.35 110.934 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -44.72 -35.23 2.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.226 -0.443 . . . . 70.44 110.853 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -84.26 -38.35 20.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 74.13 110.932 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -65.7 -30.02 70.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 63.24 110.783 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.612 HG22 ' CE ' ' A' ' 125' ' ' MET . 79.7 t -66.79 -46.78 84.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 32.13 111.07 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -77.22 -24.29 51.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 61.25 110.894 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -73.89 -47.01 41.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 64.11 110.91 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.886 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -68.93 -32.19 71.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 63.14 111.134 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.616 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -74.72 -53.65 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 71.04 111.161 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.526 ' N ' HG22 ' A' ' 134' ' ' ILE . 6.8 ptp180 -49.18 -38.07 24.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 72.33 110.937 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.652 ' O ' HG23 ' A' ' 140' ' ' VAL . 1.6 mmtp -77.18 -31.93 55.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 74.35 110.916 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.917 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -61.58 -49.14 77.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 43.15 111.066 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.665 ' HE2' HD13 ' A' ' 159' ' ' ILE . 95.6 m-85 -72.82 -22.09 60.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 74.01 110.844 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.408 ' HB2' ' O ' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -77.4 -5.54 50.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 61.14 110.888 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 136' ' ' LYS . 97.8 t -98.11 -17.21 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 73.23 111.152 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.855 ' NE1' HG12 ' A' ' 217' ' ' VAL . 95.9 m95 -106.87 -37.19 6.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 73.51 110.906 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.25 -10.84 60.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 73.13 110.815 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.7 m120 -97.07 -19.4 18.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 65.1 110.939 -179.975 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.81 HG11 HD12 ' A' ' 250' ' ' LEU . 18.3 m -100.23 -2.27 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.47 . . . . 71.22 111.075 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.739 ' CB ' HD23 ' A' ' 147' ' ' LEU . 34.3 p -142.39 147.45 43.36 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.517 0.675 . . . . 72.43 111.212 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.79 34.72 0.21 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.649 2.233 . . . . 60.25 112.336 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.909 HD21 ' HB3' ' A' ' 262' ' ' TYR . 3.0 mm? -104.57 166.47 10.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 61.43 110.883 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -128.99 125.69 37.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 50.43 110.926 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.46 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.3 m-30 -114.55 143.49 44.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 70.01 110.909 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.405 ' H ' ' HA ' ' A' ' 115' ' ' THR . 44.4 m -140.75 148.24 40.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 75.1 110.821 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.424 ' HD2' ' CD2' ' A' ' 116' ' ' TYR . 12.4 tptm -97.36 146.13 25.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 75.42 110.813 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.614 HD11 ' N ' ' A' ' 157' ' ' ALA . 16.3 pt -150.31 142.85 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 62.15 111.076 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 5.4 m-20 -112.02 3.31 17.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 65.41 111.007 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.3 t -166.5 52.29 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 73.14 111.167 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.494 ' CA ' HD12 ' A' ' 152' ' ' ILE . . . -145.87 -156.19 6.79 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.726 -0.749 . . . . 60.24 112.436 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 30.9 mmt -106.18 88.74 2.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.761 0.315 . . . . 71.05 110.907 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.614 ' N ' HD11 ' A' ' 152' ' ' ILE . . . -96.37 153.26 17.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 61.31 111.141 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.51 -52.87 6.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 65.1 110.813 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.724 HG12 HG23 ' A' ' 220' ' ' ILE . 2.4 mp -91.52 97.96 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 75.05 111.151 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.688 HD11 ' HD2' ' A' ' 117' ' ' ARG . 6.9 tp -88.8 110.69 21.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.176 -0.466 . . . . 73.42 110.947 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 90.6 t -88.81 119.51 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 70.51 111.16 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.736 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -138.82 104.52 2.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.174 -0.467 . . . . 72.12 111.238 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -70.98 110.48 5.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 64.03 110.891 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -130.32 166.38 20.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 51.41 111.054 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 21.3 ptt-85 -114.7 140.0 49.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 55.32 110.82 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.664 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 41.39 -150.85 0.2 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.761 -0.733 . . . . 63.4 112.471 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.804 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -70.21 117.33 11.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.773 0.32 . . . . 71.1 111.122 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.698 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.99 -21.09 12.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 75.13 110.778 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.29 29.4 0.66 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 64.33 112.587 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.646 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.46 0.03 15.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.78 0.324 . . . . 74.21 110.863 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 74.32 38.95 0.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 75.33 110.916 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.698 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.74 -41.02 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 70.42 110.849 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.804 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 53.44 99.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 61.24 111.098 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.664 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.9 m-85 -59.88 -168.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 53.3 110.861 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.59 19.11 3.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.195 -0.457 . . . . 74.41 110.96 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.591 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.62 -157.09 6.88 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 74.2 112.48 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -35.23 134.46 0.27 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.836 0.351 . . . . 61.51 110.89 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.45 165.44 0.15 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.659 -0.781 . . . . 54.32 112.467 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.96 -143.34 22.13 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.749 . . . . 53.42 112.447 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -49.95 97.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.869 0.366 . . . . 73.43 111.166 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.9 mt -67.75 -38.65 83.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 73.3 110.946 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.431 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -172.72 167.87 5.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 54.01 111.047 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.522 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -161.13 143.04 12.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 74.34 110.89 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.667 ' HB1' ' HB2' ' A' ' 223' ' ' SER . . . -134.94 176.44 8.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.304 -0.407 . . . . 74.1 111.048 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.436 ' O ' ' O ' ' A' ' 222' ' ' HIS . 7.9 m-85 -100.77 -120.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 71.41 110.947 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 223' ' ' SER . . . 166.75 -92.74 0.1 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.715 -0.755 . . . . 44.51 112.501 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.91 55.37 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.615 2.21 . . . . 62.13 112.369 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.57 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.32 151.52 16.93 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 53.51 112.401 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.82 145.1 30.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.898 0.38 . . . . 72.21 110.82 -179.719 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.63 -65.18 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.7 -0.762 . . . . 64.03 112.37 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 189' ' ' SER . 1.9 mp -103.63 6.81 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.855 0.36 . . . . 70.42 111.126 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.57 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -66.82 170.43 32.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.782 -0.723 . . . . 34.21 112.485 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 42.66 24.74 0.26 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.722 -0.751 . . . . 74.05 112.455 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.87 102.23 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.775 0.321 . . . . 65.4 110.911 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.582 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -77.21 128.78 34.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 54.42 111.073 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.522 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 8.5 m170 -118.53 131.15 56.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 73.51 110.827 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.459 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 51.4 m-85 -115.23 134.74 54.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 75.32 110.858 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -67.57 109.07 3.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.089 -0.505 . . . . 63.43 110.802 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.55 -37.19 80.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 73.33 111.005 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.591 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 5.0 m-20 -50.41 -22.68 1.97 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 72.14 110.825 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -79.84 163.17 24.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 74.11 110.889 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.565 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -100.64 88.23 3.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 72.32 110.938 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.533 ' HZ3' HG21 ' A' ' 215' ' ' THR . 33.6 m95 -79.48 124.71 28.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.457 . . . . 72.51 110.944 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 22.7 p -142.6 -177.79 5.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.252 -0.431 . . . . 74.43 111.178 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.07 19.76 18.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 72.52 111.219 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.11 -175.62 3.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 74.44 110.914 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.9 p -68.77 -18.31 64.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 74.44 110.826 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.18 -107.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.667 -0.777 . . . . 72.23 112.515 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.42 176.87 0.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.763 -0.732 . . . . 72.13 112.428 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 94.3 m -64.89 97.37 0.22 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.757 0.313 . . . . 74.44 111.2 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -41.45 116.42 0.76 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 74.04 110.888 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.886 HD23 ' HB3' ' A' ' 133' ' ' ALA . 8.6 tp -64.12 -38.39 90.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 51.33 110.916 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.801 ' O ' HG23 ' A' ' 217' ' ' VAL . 4.1 t80 -51.97 -66.9 0.3 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 73.22 110.939 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.477 HD11 ' H ' ' A' ' 243' ' ' VAL . 21.9 mt -52.84 -54.96 26.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.141 -0.482 . . . . 54.24 110.879 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.618 ' O ' ' HB2' ' A' ' 219' ' ' ALA . 5.1 m -54.8 -37.19 65.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 63.2 111.092 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.81 -50.57 64.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 74.14 111.115 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.917 HG22 ' HA ' ' A' ' 137' ' ' ALA . 1.8 t -52.42 -56.61 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 74.0 111.106 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.792 ' HB2' HG22 ' A' ' 235' ' ' VAL . 1.8 t-80 -69.12 -26.49 64.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 63.32 110.904 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -64.83 -45.22 87.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 71.14 111.126 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.724 HG23 HG12 ' A' ' 159' ' ' ILE . 3.1 mt -67.68 -37.41 78.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.254 -0.43 . . . . 65.31 111.149 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -52.57 -46.39 58.84 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.804 -0.712 . . . . 74.5 112.428 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.436 ' O ' ' O ' ' A' ' 185' ' ' PHE . 2.5 m-70 -69.39 -38.64 78.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.332 . . . . 70.4 110.824 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.667 ' HB2' ' HB1' ' A' ' 184' ' ' ALA . 0.3 OUTLIER -74.8 -9.77 58.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.005 0.431 . . . . 55.43 110.934 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.706 HD23 ' CZ3' ' A' ' 109' ' ' TRP . 13.5 mt -90.1 -25.9 20.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 72.45 110.923 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.868 ' HA3' HG12 ' A' ' 108' ' ' VAL . . . 124.48 12.94 4.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.785 -0.722 . . . . 63.32 112.529 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.847 HD11 ' HA ' ' A' ' 258' ' ' ILE . 0.2 OUTLIER -85.61 160.99 19.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.829 0.347 . . . . 71.41 110.964 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -105.89 -144.92 12.63 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.754 -0.736 . . . . 74.42 112.487 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -115.86 146.94 41.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.775 0.321 . . . . 74.5 110.862 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 37.3 m -103.08 162.56 12.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.179 -0.464 . . . . 52.24 110.846 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.2 t -107.07 1.26 24.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 72.24 110.852 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.655 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -68.05 141.29 94.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.6 0.714 . . . . 74.22 110.801 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 -3.36 11.79 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.634 2.222 . . . . 73.23 112.384 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.72 17.16 1.99 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 63.31 110.922 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.655 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -78.06 137.94 38.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 61.34 111.024 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.792 HG22 ' HB2' ' A' ' 218' ' ' HIS . 6.9 p -63.99 -29.59 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 64.52 111.108 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 61.2 mmm -73.81 -12.61 60.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 73.53 110.89 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.664 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -59.09 146.27 78.1 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.59 0.71 . . . . 72.04 110.831 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.664 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.8 Cg_endo -69.75 1.2 4.64 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.739 2.293 . . . . 75.22 112.33 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 53.2 m -102.89 129.02 49.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 71.55 111.152 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -110.4 136.33 49.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 74.04 110.921 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -155.69 133.86 11.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 74.33 110.851 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.525 ' O ' HG13 ' A' ' 243' ' ' VAL . 71.1 t80 -59.24 147.77 34.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 74.45 110.983 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.4 OUTLIER -159.64 133.24 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 75.44 111.091 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -49.94 133.26 22.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 53.43 110.768 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 8.4 tt -55.17 -30.89 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 72.33 111.063 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.4 m120 -77.3 -17.43 58.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 74.24 110.836 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 66.6 p -103.21 -24.43 13.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 63.21 111.195 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -65.7 144.31 56.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 72.24 110.891 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -176.8 128.65 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 74.32 110.909 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.81 HD12 HG11 ' A' ' 144' ' ' VAL . 54.7 mt -48.66 127.14 13.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 62.35 110.875 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 38.9 m -72.05 167.27 20.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.14 110.897 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.4 -38.93 60.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.089 -0.505 . . . . 73.21 111.11 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -46.67 84.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.868 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.591 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 7.0 m-20 -61.92 -52.12 65.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.237 -0.438 . . . . 73.5 110.848 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 21.1 mt -62.99 -34.66 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 74.3 111.102 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -69.51 -40.04 77.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 71.3 110.922 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.3 -49.26 7.53 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.811 -0.709 . . . . 33.22 112.525 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.847 ' HA ' HD11 ' A' ' 226' ' ' LEU . 3.8 tp -53.01 -32.84 18.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.78 0.324 . . . . 74.42 111.142 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 263' ' ' GLY . 47.6 mt-30 -88.08 -17.38 31.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 64.22 110.889 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.4 t -69.17 -16.51 63.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 73.31 110.792 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.716 ' HB3' HG22 ' A' ' 108' ' ' VAL . 4.7 mt -118.81 -23.03 7.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 73.22 110.857 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.909 ' HB3' HD21 ' A' ' 147' ' ' LEU . 27.7 m-85 -106.3 -38.33 6.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 74.33 110.951 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.32 0 CA-C-O 119.149 -0.806 . . . . 73.51 112.446 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.434 ' O ' ' C ' ' A' ' 101' ' ' ARG . 2.6 t80 . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.871 0.367 . . . . 71.03 110.909 . . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.477 ' H ' ' NE ' ' A' ' 101' ' ' ARG . 0.5 OUTLIER -35.36 138.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 65.52 110.903 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.432 ' HB2' HD11 ' A' ' 261' ' ' LEU . 0.0 OUTLIER -177.04 145.59 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 61.4 110.854 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.53 152.71 3.12 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.562 0.696 . . . . 63.02 110.888 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.65 64.47 1.74 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.784 2.323 . . . . 62.23 112.317 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -159.23 -84.2 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.687 -0.768 . . . . 72.53 112.419 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.43 ' N ' ' HD2' ' A' ' 107' ' ' PRO . . . 144.91 -62.01 0.48 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.704 -0.76 . . . . 62.14 112.452 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 106' ' ' GLY . 53.4 Cg_endo -69.83 79.13 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.619 2.213 . . . . 63.03 112.401 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.509 HG21 HD13 ' A' ' 261' ' ' LEU . 16.6 m -94.94 34.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 74.03 111.109 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.437 ' C ' ' O ' ' A' ' 108' ' ' VAL . 0.5 OUTLIER 34.14 88.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 71.42 110.917 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -75.83 57.65 1.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.269 -0.423 . . . . 72.33 110.85 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.471 ' O ' HD11 ' A' ' 114' ' ' ILE . 19.8 mtmt -98.92 141.44 31.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 62.41 110.889 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.429 ' HA ' HD22 ' A' ' 147' ' ' LEU . 0.0 OUTLIER -91.46 19.1 6.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 75.24 110.905 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -128.74 92.47 3.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 75.42 110.926 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.67 HD13 ' HE1' ' A' ' 149' ' ' PHE . 3.9 mp -121.22 165.71 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 71.31 111.078 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.612 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -159.29 160.36 35.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 64.41 111.139 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.592 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 1.9 p90 -132.33 144.32 50.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.267 -0.424 . . . . 75.13 110.994 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.72 ' HD2' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -136.23 113.34 10.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 73.22 110.842 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 63.0 mt -76.04 105.4 4.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 74.42 111.086 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -56.2 -51.28 68.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 44.54 110.971 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.636 ' OD1' HG23 ' A' ' 162' ' ' VAL . 1.8 p-10 -141.97 166.52 24.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 60.41 110.86 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -117.07 146.22 43.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 72.04 110.923 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.717 HG22 ' CE ' ' A' ' 125' ' ' MET . 3.5 t -93.58 142.67 25.47 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 121.634 0.73 . . . . 72.41 111.125 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.89 -1.79 9.18 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.643 2.229 . . . . 73.42 112.291 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.416 ' H ' HG23 ' A' ' 122' ' ' THR . 15.7 m-20 -81.82 -23.07 36.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 71.01 110.887 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.717 ' CE ' HG22 ' A' ' 122' ' ' THR . 13.2 mtm -116.5 166.51 12.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 74.31 110.892 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.433 ' O ' HG23 ' A' ' 130' ' ' VAL . 7.4 t-20 -96.22 145.92 25.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 75.52 110.816 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -45.52 -34.91 3.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 75.52 110.887 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -83.29 -38.96 21.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 74.22 110.941 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -65.67 -29.77 70.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 61.14 110.812 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.585 HG22 ' CE ' ' A' ' 125' ' ' MET . 79.5 t -65.79 -45.86 90.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.282 -0.417 . . . . 75.25 111.132 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.75 -23.07 42.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 71.21 110.925 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -74.83 -47.78 28.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.477 . . . . 64.2 110.924 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.881 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -71.39 -31.32 67.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 65.13 110.99 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.754 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -73.87 -55.57 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.432 . . . . 64.32 111.106 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.544 ' N ' HG22 ' A' ' 134' ' ' ILE . 13.3 ttt180 -48.67 -42.91 36.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 62.41 110.85 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.688 ' O ' HG23 ' A' ' 140' ' ' VAL . 4.3 mmpt? -70.56 -34.46 72.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.43 . . . . 70.41 110.855 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.687 ' O ' HG13 ' A' ' 217' ' ' VAL . . . -60.99 -50.48 73.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 72.14 111.001 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.592 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.2 m-85 -70.97 -21.82 62.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 72.21 110.94 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.424 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 2.5 tt0 -78.71 -5.93 54.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 74.01 110.916 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 136' ' ' LYS . 95.3 t -95.59 -17.41 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 54.22 111.096 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.886 ' NE1' HG12 ' A' ' 217' ' ' VAL . 95.8 m95 -105.47 -36.73 7.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.211 -0.449 . . . . 64.13 110.896 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.98 -11.94 61.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 72.44 110.846 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.424 ' OD1' ' O ' ' A' ' 139' ' ' GLN . 2.5 m120 -94.5 -18.57 21.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 74.33 110.909 -179.96 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.808 HG11 HD12 ' A' ' 250' ' ' LEU . 16.9 m -98.03 2.5 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 64.22 111.189 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.487 ' C ' ' H ' ' A' ' 147' ' ' LEU . 49.9 p -151.2 149.11 23.93 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.619 0.723 . . . . 44.32 111.146 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 31.57 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.665 2.244 . . . . 62.02 112.345 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.801 HD11 ' CG ' ' A' ' 262' ' ' TYR . 14.4 mt -98.46 173.41 6.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 65.43 110.895 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -137.59 127.33 25.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 75.44 110.893 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.67 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.5 m-30 -114.47 143.8 44.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 70.14 110.851 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.2 t -138.85 147.87 43.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.12 -0.491 . . . . 72.31 110.845 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.47 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 2.6 tptm -97.42 141.84 30.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.494 . . . . 71.12 110.922 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.533 HD11 ' N ' ' A' ' 157' ' ' ALA . 17.2 pt -150.07 133.23 7.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 72.45 111.13 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.2 m120 -100.63 -6.82 24.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 74.4 110.915 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.2 t -155.61 58.48 0.62 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 73.15 111.167 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.49 ' C ' HD12 ' A' ' 152' ' ' ILE . . . -151.57 -156.62 7.51 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.755 -0.736 . . . . 62.11 112.512 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 33.4 mmt -105.44 97.4 7.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 70.24 110.915 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.533 ' N ' HD11 ' A' ' 152' ' ' ILE . . . -107.21 154.39 21.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 73.35 111.116 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -82.88 -53.03 6.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.226 -0.443 . . . . 73.53 110.799 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.618 HG12 HG23 ' A' ' 220' ' ' ILE . 2.8 mp -91.06 97.91 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.26 -0.427 . . . . 71.41 111.145 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.72 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.1 tp -87.4 109.92 19.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.133 -0.485 . . . . 74.35 111.009 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.459 HG13 ' CE1' ' A' ' 197' ' ' PHE . 95.9 t -88.01 123.22 40.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 64.03 111.109 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.636 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -142.1 105.56 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 64.43 111.143 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -71.61 108.22 4.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 60.54 110.845 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.1 166.19 18.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 75.31 111.089 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 -114.25 137.25 52.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 75.41 110.831 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.68 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.3 -154.92 0.2 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.761 -0.733 . . . . 71.41 112.458 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.806 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.64 116.96 7.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 52.23 111.094 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.704 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.96 -22.69 12.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 73.33 110.855 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.76 28.86 0.55 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.675 -0.774 . . . . 64.04 112.527 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.624 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.43 0.14 15.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.778 0.323 . . . . 72.41 110.837 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 74.04 39.08 0.53 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 71.31 110.927 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.704 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.38 -40.94 0.8 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 64.3 110.861 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.806 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 53.8 99.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 55.31 111.131 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.68 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.1 m-85 -60.63 -168.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 72.42 110.903 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.75 19.03 3.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 75.21 110.837 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.5 -158.1 6.1 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.766 -0.73 . . . . 42.42 112.492 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 176' ' ' GLY . 2.1 ttmm -34.25 134.22 0.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.351 . . . . 74.3 110.828 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.4 165.55 0.15 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.826 -0.702 . . . . 73.44 112.524 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.37 -144.01 23.16 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.81 -0.71 . . . . 73.32 112.533 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -49.51 97.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 72.41 111.152 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.9 mt -67.04 -41.88 85.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 73.35 110.953 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -169.52 169.34 8.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 71.15 111.138 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.491 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -163.24 143.54 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 75.45 110.884 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.669 ' HB1' ' HB3' ' A' ' 223' ' ' SER . . . -135.44 174.79 10.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 71.23 111.159 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.534 ' O ' ' O ' ' A' ' 222' ' ' HIS . 94.9 m-85 -96.93 -122.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 64.02 110.905 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 223' ' ' SER . . . 172.21 -98.34 0.13 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.721 -0.752 . . . . 32.13 112.431 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 57.13 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.686 2.257 . . . . 71.44 112.321 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.568 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -122.16 153.12 16.82 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.772 -0.728 . . . . 71.13 112.557 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.63 145.92 29.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 63.21 110.841 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.67 -64.71 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.742 -0.742 . . . . 63.25 112.554 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 189' ' ' SER . 1.2 mp -104.88 6.18 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.805 0.336 . . . . 70.14 111.099 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.568 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -64.66 168.14 27.96 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.702 -0.761 . . . . 71.21 112.486 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 42.77 23.2 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.757 -0.735 . . . . 72.44 112.43 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.422 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 0.9 OUTLIER -66.52 99.34 0.57 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.806 0.336 . . . . 75.11 110.856 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.625 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -74.0 132.87 42.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 73.33 111.069 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.8 m170 -123.41 131.27 53.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 71.3 110.923 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.459 ' CE1' HG13 ' A' ' 161' ' ' VAL . 40.9 m-85 -115.5 135.07 54.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 71.34 110.866 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -68.03 107.48 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 64.14 110.827 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.54 -35.93 75.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 71.0 110.904 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.582 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 15.6 m-20 -51.47 -21.59 2.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 73.13 110.83 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -81.39 163.29 22.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 72.03 110.893 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.577 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -101.75 85.96 2.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 75.12 110.917 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.634 ' CZ3' HG21 ' A' ' 215' ' ' THR . 30.9 m95 -76.62 123.58 26.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.107 -0.497 . . . . 72.33 110.862 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 35.8 p -141.54 -178.01 5.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 73.22 111.151 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.45 20.94 17.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 72.25 111.129 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -127.81 -172.97 2.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.432 . . . . 74.41 110.903 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.1 p -73.14 -18.84 61.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 73.3 110.856 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -61.24 -104.91 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.751 -0.737 . . . . 71.52 112.427 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.577 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -51.77 176.18 0.1 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 70.42 112.462 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 73.1 m -65.9 97.62 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 73.11 111.14 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -41.88 116.46 0.8 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 65.15 110.885 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.881 HD23 ' HB3' ' A' ' 133' ' ' ALA . 7.0 tp -65.44 -36.74 84.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 74.34 110.945 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.636 ' CA ' ' HB1' ' A' ' 133' ' ' ALA . 3.6 t80 -51.88 -64.85 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 73.15 110.87 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.485 HD11 ' H ' ' A' ' 243' ' ' VAL . 15.1 mt -56.47 -52.98 62.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.22 -0.445 . . . . 54.43 110.911 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.634 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 8.0 m -53.69 -38.01 63.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 63.4 111.184 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 137' ' ' ALA . . . -62.97 -50.89 68.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 43.12 111.14 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.886 HG12 ' NE1' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -52.16 -57.58 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 73.35 111.17 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.706 ' HB2' HG13 ' A' ' 235' ' ' VAL . 4.3 t-80 -65.29 -29.09 69.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.112 -0.494 . . . . 55.11 110.891 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -64.42 -46.66 82.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 53.44 111.059 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.618 HG23 HG12 ' A' ' 159' ' ' ILE . 2.4 mt -69.2 -35.5 68.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.285 -0.416 . . . . 74.45 111.126 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -51.98 -46.34 55.68 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.845 -0.693 . . . . 53.32 112.396 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.534 ' O ' ' O ' ' A' ' 185' ' ' PHE . 3.0 m-70 -69.54 -40.11 77.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.835 0.35 . . . . 52.33 110.824 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.669 ' HB3' ' HB1' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -72.23 -11.37 60.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.17 -0.468 . . . . 72.11 110.881 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.414 HD23 ' CH2' ' A' ' 109' ' ' TRP . 21.4 mt -88.88 -25.11 22.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 75.44 110.872 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.434 ' O ' HG11 ' A' ' 108' ' ' VAL . . . 122.66 11.19 5.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.741 . . . . 73.11 112.515 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.879 HD11 ' HA ' ' A' ' 258' ' ' ILE . 0.2 OUTLIER -88.52 152.4 21.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.37 . . . . 74.34 110.891 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -98.02 -141.25 12.02 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.788 -0.72 . . . . 75.44 112.52 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.95 141.94 46.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.846 0.355 . . . . 74.31 110.844 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.421 ' HA ' ' HD2' ' A' ' 101' ' ' ARG . 49.4 m -92.23 160.55 15.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 74.31 110.801 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.2 t -109.68 9.75 24.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 61.11 110.874 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 234' ' ' ALA . 0.1 OUTLIER -80.95 143.32 53.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.562 0.696 . . . . 62.14 110.929 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -3.87 12.92 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.765 2.31 . . . . 71.11 112.289 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.27 30.8 1.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 72.43 110.836 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.693 ' HB1' ' OD1' ' A' ' 254' ' ' ASP . . . -92.59 145.54 24.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 62.34 111.162 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.706 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.5 t -65.46 -42.2 92.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 75.32 111.226 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.44 ' HE3' ' CE1' ' A' ' 222' ' ' HIS . 54.0 mmm -64.74 -14.66 59.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 73.23 110.902 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.67 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.0 t80 -57.72 146.24 66.95 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.621 0.724 . . . . 62.34 110.874 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.67 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.1 Cg_endo -69.77 1.0 4.83 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.662 2.241 . . . . 71.32 112.42 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 38.6 m -102.17 130.0 48.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 74.14 111.144 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -113.78 135.85 53.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 74.11 110.922 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -155.51 137.39 14.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 64.22 110.825 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.534 ' O ' HG13 ' A' ' 243' ' ' VAL . 65.9 t80 -62.0 145.21 53.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 65.12 110.939 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -160.29 133.31 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.5 . . . . 71.14 111.077 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -57.47 131.32 49.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 74.13 110.903 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.532 HD11 ' HD3' ' A' ' 136' ' ' LYS . 16.7 tt -53.2 -30.25 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 73.42 111.161 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -67.95 -21.85 65.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 73.22 110.859 179.969 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 3.8 p -110.84 -19.63 12.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 44.52 111.173 -179.991 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -67.44 142.78 56.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 73.54 110.911 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -176.32 132.36 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 73.21 110.919 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.808 HD12 HG11 ' A' ' 144' ' ' VAL . 43.9 mt -49.26 132.64 19.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.452 . . . . 65.15 110.999 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 32.9 t -74.15 172.8 11.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 64.25 110.853 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.1 -37.61 72.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.115 -0.493 . . . . 73.44 111.112 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -64.33 -50.56 67.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 60.34 110.928 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.693 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 5.0 m-20 -59.06 -50.91 72.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 71.34 110.917 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 20.5 mt -63.46 -34.07 65.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 75.24 111.214 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -69.65 -40.19 76.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 72.21 110.872 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -76.65 -50.0 7.52 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.731 -0.747 . . . . 74.33 112.486 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.879 ' HA ' HD11 ' A' ' 226' ' ' LEU . 3.8 tp -53.5 -33.63 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.299 . . . . 64.13 111.061 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' A' ' 263' ' ' GLY . 70.8 mt-30 -88.16 -16.1 34.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 75.24 110.903 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 2.5 t -69.23 -15.25 63.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 61.05 110.849 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.509 HD13 HG21 ' A' ' 108' ' ' VAL . 2.6 mt -122.83 -18.61 6.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.085 -0.507 . . . . 64.51 110.915 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.801 ' CG ' HD11 ' A' ' 147' ' ' LEU . 38.4 m-85 -113.77 -33.9 5.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 74.21 110.931 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.362 0 CA-C-O 119.155 -0.803 . . . . 61.15 112.481 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.895 0.379 . . . . 61.24 110.953 . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 59.94 -170.38 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 72.01 110.933 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.837 ' HB2' HD11 ' A' ' 261' ' ' LEU . 3.9 pm0 -38.21 147.86 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 62.21 110.945 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -49.29 161.77 0.45 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.603 0.716 . . . . 75.31 110.865 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.8 95.72 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.65 2.233 . . . . 71.32 112.317 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 130.49 -131.62 6.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 63.33 112.416 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -146.37 58.94 0.49 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.745 -0.74 . . . . 53.23 112.45 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 -19.33 36.62 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.669 2.246 . . . . 74.12 112.421 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.82 HG11 ' HB3' ' A' ' 261' ' ' LEU . 9.3 p -62.91 148.7 10.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 72.21 111.143 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.501 ' CZ3' HD23 ' A' ' 224' ' ' LEU . 4.8 m0 -75.08 -28.24 60.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.176 -0.466 . . . . 65.42 110.863 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.645 ' H ' HG22 ' A' ' 108' ' ' VAL . 23.5 mtt180 68.54 28.35 5.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 73.43 110.877 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.451 ' HG2' ' HB2' ' A' ' 109' ' ' TRP . 32.9 pttt -122.62 155.65 35.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 74.15 110.905 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.564 ' HA ' ' CD1' ' A' ' 147' ' ' LEU . 1.8 p80 -102.51 42.78 1.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 61.43 110.897 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -146.21 92.87 2.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.204 -0.453 . . . . 73.51 110.93 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.577 HG22 ' N ' ' A' ' 115' ' ' THR . 4.9 mp -122.66 162.61 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 75.41 111.086 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.577 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -158.66 163.32 37.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 63.25 111.18 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.608 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.7 p90 -133.68 148.29 51.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.239 -0.437 . . . . 74.32 110.915 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.57 ' HD2' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -140.37 112.61 7.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 74.1 110.912 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.2 mt -74.16 105.31 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 73.1 111.172 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -56.59 -45.96 81.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 72.3 110.81 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 13.2 p-10 -150.1 169.12 22.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 75.11 110.872 -179.927 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.595 ' CE2' HG11 ' A' ' 130' ' ' VAL . 4.6 m-85 -117.09 157.83 25.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 73.24 110.916 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.509 HG23 ' HG3' ' A' ' 125' ' ' MET . 0.1 OUTLIER -107.95 146.7 34.02 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.634 0.73 . . . . 65.31 111.204 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 -2.49 10.29 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.711 2.274 . . . . 72.03 112.25 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -83.64 -25.82 30.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.314 -0.403 . . . . 72.23 110.936 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.689 ' CE ' HG22 ' A' ' 130' ' ' VAL . 6.9 mtm -114.66 164.14 14.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 72.14 110.77 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.529 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.9 OUTLIER -96.43 143.76 27.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 71.14 110.974 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -45.09 -37.05 3.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.443 . . . . 75.21 110.836 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -82.92 -36.11 25.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 75.55 110.792 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -67.69 -29.46 68.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 55.23 110.871 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.689 HG22 ' CE ' ' A' ' 125' ' ' MET . 94.9 t -66.56 -46.58 85.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.219 -0.446 . . . . 54.24 111.148 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.447 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 10.1 t0 -77.13 -25.82 52.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 65.13 110.866 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -72.72 -49.26 32.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 72.11 110.931 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.627 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -69.44 -30.42 68.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 75.2 111.09 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.693 HD13 HD21 ' A' ' 212' ' ' LEU . 1.2 mp -74.64 -53.77 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 61.31 111.128 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.507 ' N ' HG22 ' A' ' 134' ' ' ILE . 7.2 ptp180 -49.45 -35.4 19.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 71.2 110.911 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.614 ' O ' HG23 ' A' ' 140' ' ' VAL . 6.8 mmtp -78.85 -34.1 45.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 64.42 110.873 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.653 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -61.07 -49.16 78.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 72.01 111.059 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.608 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 89.4 m-85 -70.39 -23.54 62.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.419 . . . . 65.3 110.966 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.47 ' O ' ' HB3' ' A' ' 143' ' ' ASN . 0.2 OUTLIER -75.4 -15.11 60.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 55.44 110.936 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 136' ' ' LYS . 93.6 t -85.03 -19.62 8.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.459 . . . . 71.03 111.147 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.844 ' NE1' HG12 ' A' ' 217' ' ' VAL . 96.9 m95 -104.74 -27.0 12.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 74.51 110.916 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.63 -7.59 59.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 72.33 110.846 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 139' ' ' GLN . 0.1 OUTLIER -99.15 -18.39 17.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 73.14 110.867 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.773 HG23 HG23 ' A' ' 145' ' ' THR . 28.9 m -100.14 -7.9 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 73.52 111.139 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.773 HG23 HG23 ' A' ' 144' ' ' VAL . 32.5 p -141.97 147.21 43.75 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.642 0.734 . . . . 74.23 111.096 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 32.43 0.19 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.718 2.279 . . . . 74.54 112.27 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.768 HD21 ' HB3' ' A' ' 262' ' ' TYR . 3.8 mm? -94.49 170.07 9.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.307 -0.406 . . . . 71.31 111.004 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.24 126.35 29.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 63.42 110.92 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.441 ' HE1' HD13 ' A' ' 114' ' ' ILE . 2.4 m-85 -117.53 144.04 45.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 74.45 110.796 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.403 ' H ' ' HA ' ' A' ' 115' ' ' THR . 6.1 t -137.66 153.03 49.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 74.03 110.844 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 10.7 tttt -103.37 146.31 28.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 75.42 110.928 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.563 HD12 ' CA ' ' A' ' 155' ' ' GLY . 24.7 pt -152.12 143.89 15.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 63.33 111.167 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.8 m-20 -104.34 -18.14 14.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 64.54 110.829 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.0 t -151.55 63.22 0.87 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 64.53 111.162 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.563 ' CA ' HD12 ' A' ' 152' ' ' ILE . . . -149.94 -156.31 7.2 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.676 -0.774 . . . . 73.2 112.409 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 30.1 mmt -106.85 94.11 4.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.783 0.325 . . . . 73.2 110.914 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.526 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -104.67 159.05 16.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 61.43 111.077 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.63 -52.82 5.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 70.44 110.795 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.674 HG12 HG23 ' A' ' 220' ' ' ILE . 2.6 mp -90.4 95.86 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 73.13 111.042 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.57 HD11 ' HD2' ' A' ' 117' ' ' ARG . 8.4 tp -86.75 108.92 18.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 73.14 110.865 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.464 HG13 ' CE1' ' A' ' 197' ' ' PHE . 96.7 t -87.85 120.02 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 74.15 111.142 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 p -138.72 104.31 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 61.45 111.169 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.448 ' CZ ' ' HE1' ' A' ' 125' ' ' MET . 35.5 m-85 -73.73 106.49 5.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 74.13 110.926 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.03 164.13 23.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 75.22 111.103 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -110.87 140.72 45.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 64.31 110.885 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.7 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.67 -151.56 0.31 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.732 -0.747 . . . . 34.21 112.542 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.806 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -68.74 119.24 12.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.79 0.329 . . . . 74.51 111.084 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.705 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -111.17 -21.55 11.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 72.24 110.842 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.16 30.67 0.56 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.724 -0.751 . . . . 40.22 112.466 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.634 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -114.26 0.23 14.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.87 0.367 . . . . 62.14 110.835 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 74.13 38.91 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 75.04 110.796 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.705 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -134.71 -41.04 0.77 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.164 -0.471 . . . . 73.34 110.842 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.806 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 52.94 100.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 63.11 111.153 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.7 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.6 m-85 -60.72 -169.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 73.42 110.883 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 175' ' ' ASP . . . . . 0.442 ' OD2' ' HA3' ' A' ' 179' ' ' GLY . 40.9 p30 -134.07 18.92 3.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 73.22 110.945 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.578 ' HA2' ' CB ' ' A' ' 200' ' ' ASP . . . 57.81 -162.12 9.43 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.743 -0.741 . . . . 73.42 112.519 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -35.3 136.94 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 70.24 110.963 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.76 155.56 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.734 -0.746 . . . . 73.51 112.469 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.442 ' HA3' ' OD2' ' A' ' 175' ' ' ASP . . . 86.04 -142.68 19.22 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.647 -0.787 . . . . 73.02 112.366 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 180' ' ' ILE . . . . . 0.415 HG22 ' HE1' ' A' ' 174' ' ' PHE . 2.0 mt -48.68 98.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.81 0.338 . . . . 72.42 111.213 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 33.8 mt -71.4 -42.96 67.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 74.13 110.952 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -170.03 154.35 5.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 73.14 111.145 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.491 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.1 p80 -148.36 141.65 25.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 74.23 110.857 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.744 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -137.97 172.78 12.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 24.24 111.145 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 223' ' ' SER . 37.5 m-85 -102.85 -149.65 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 73.44 110.853 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -162.66 -86.6 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.84 -0.695 . . . . 73.01 112.593 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 55.8 1.31 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.661 2.241 . . . . 70.22 112.346 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.585 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -124.31 150.39 17.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.79 -0.719 . . . . 51.13 112.427 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.46 147.28 27.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 74.11 110.884 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.17 -64.73 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.715 -0.755 . . . . 65.22 112.525 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.537 ' N ' ' O ' ' A' ' 189' ' ' SER . 21.9 pt -105.81 7.69 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.873 0.368 . . . . 74.43 111.112 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.585 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -67.55 168.04 39.81 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.777 -0.725 . . . . 73.3 112.502 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 46.35 18.41 0.32 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.743 -0.741 . . . . 73.2 112.523 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.09 108.72 1.61 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.881 0.372 . . . . 65.01 110.789 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.744 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -83.32 127.69 33.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 45.42 111.114 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.2 m170 -118.37 127.0 53.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 73.42 110.866 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.531 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 37.9 m-85 -111.09 132.04 54.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 72.31 110.848 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -65.08 107.75 1.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 72.35 110.902 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 199' ' ' GLU . . . . . 0.408 ' O ' ' CD ' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -58.72 -38.41 78.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.187 -0.461 . . . . 71.33 110.905 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.578 ' CB ' ' HA2' ' A' ' 176' ' ' GLY . 19.3 m-20 -49.92 -21.32 1.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 63.03 110.835 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -81.31 164.39 22.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 63.41 110.903 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.499 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.4 OUTLIER -100.94 89.75 3.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 75.55 110.862 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.531 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 31.1 m95 -81.87 122.33 27.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 64.45 110.904 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.8 p -137.35 -175.27 4.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 75.3 111.147 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.35 15.68 19.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 74.42 111.138 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -129.73 -174.81 3.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 63.35 110.917 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.7 p -54.79 -34.91 63.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 73.31 110.855 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -65.8 162.54 41.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.759 -0.734 . . . . 62.12 112.483 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . 48.65 -172.38 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.748 . . . . 61.41 112.571 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 29.8 m -87.3 93.53 9.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.85 0.357 . . . . 71.43 111.125 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -40.06 110.85 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 54.43 110.921 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.693 HD21 HD13 ' A' ' 134' ' ' ILE . 6.9 tp -57.28 -40.86 78.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 65.21 110.948 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.627 ' CA ' ' HB1' ' A' ' 133' ' ' ALA . 2.6 t80 -48.23 -64.27 0.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 63.43 110.923 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.517 HD11 ' H ' ' A' ' 243' ' ' VAL . 17.4 mt -55.81 -52.3 64.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.135 -0.484 . . . . 70.52 110.865 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.515 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 1.0 OUTLIER -54.12 -37.31 64.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 75.45 111.134 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.8 -51.57 64.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 73.31 111.04 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.844 HG12 ' NE1' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -49.96 -57.5 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 72.05 111.106 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.713 ' HB2' HG13 ' A' ' 235' ' ' VAL . 3.6 t-80 -66.32 -29.37 69.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.278 -0.419 . . . . 70.25 110.9 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -63.5 -42.76 98.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 75.11 111.069 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.674 HG23 HG12 ' A' ' 159' ' ' ILE . 2.2 mt -71.57 -35.0 54.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.263 -0.426 . . . . 71.43 111.232 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.45 -43.34 44.5 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.623 -0.798 . . . . 53.24 112.495 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 185' ' ' PHE . 32.7 m-70 -69.27 -39.9 78.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.797 0.332 . . . . 71.2 110.86 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.625 ' OG ' HG23 ' A' ' 159' ' ' ILE . 3.4 m -62.54 -27.03 68.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 44.43 110.807 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.501 HD23 ' CZ3' ' A' ' 109' ' ' TRP . 74.2 mt -75.72 -27.39 58.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.244 -0.435 . . . . 62.24 110.988 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 118.0 16.16 5.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.691 -0.766 . . . . 63.45 112.521 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.842 HD11 ' CD1' ' A' ' 258' ' ' ILE . 29.3 mt -80.78 155.06 26.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.874 0.369 . . . . 72.35 110.856 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.403 ' H ' ' HA ' ' A' ' 102' ' ' GLU . . . -98.43 -137.09 9.56 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.7 -0.762 . . . . 60.23 112.513 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.471 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 1.1 m170 -125.34 149.78 47.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.861 0.362 . . . . 72.31 110.848 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 67.7 m -110.87 163.88 13.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 74.15 110.886 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.66 -3.01 25.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 63.14 110.892 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.533 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -67.75 137.23 92.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.598 0.713 . . . . 71.42 110.872 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -3.86 12.91 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.694 2.262 . . . . 61.53 112.311 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.21 3.07 3.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 74.13 110.852 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.533 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -74.98 128.51 35.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 73.35 111.109 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.713 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -55.33 -34.53 33.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 74.01 111.187 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.471 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 41.9 mmm -62.21 -21.18 64.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 74.01 110.937 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.541 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -56.72 142.65 71.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.582 0.706 . . . . 73.21 110.895 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.541 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.9 Cg_endo -69.74 -2.24 9.82 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.647 2.231 . . . . 71.51 112.382 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 42.1 m -93.7 143.14 26.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 53.03 111.066 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -123.68 140.48 52.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 74.03 110.918 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.32 128.01 3.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 71.11 110.917 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.502 ' O ' HG13 ' A' ' 243' ' ' VAL . 84.3 t80 -54.01 144.55 18.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 63.34 110.94 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.517 ' H ' HD11 ' A' ' 214' ' ' LEU . 1.1 m -158.27 130.78 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 54.22 111.223 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -52.33 133.01 34.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 74.4 110.925 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.414 HD12 ' CE2' ' A' ' 213' ' ' PHE . 9.2 tt -53.57 -29.46 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 72.21 111.171 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -70.16 -21.12 63.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 64.11 110.909 179.914 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 44.3 p -109.95 -20.66 12.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 75.53 111.201 -179.967 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.444 ' HE2' HG21 ' A' ' 217' ' ' VAL . 9.9 t80 -72.47 130.69 41.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 64.33 110.863 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -166.87 137.33 3.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.482 . . . . 74.24 110.877 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.631 HD12 HG11 ' A' ' 144' ' ' VAL . 64.5 mt -49.36 124.19 8.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.247 -0.433 . . . . 61.33 110.881 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 8.4 t -70.26 166.62 19.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 52.2 110.87 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.63 -40.75 40.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 73.14 111.063 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.8 -45.76 93.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 75.33 110.948 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.592 ' O ' HG22 ' A' ' 258' ' ' ILE . 5.2 m-20 -62.99 -54.62 35.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.11 -0.496 . . . . 64.22 110.827 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 18.7 mt -61.87 -28.08 43.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 75.3 111.144 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -75.26 -41.47 57.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 65.15 110.848 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -76.92 -50.46 6.92 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.732 -0.746 . . . . 64.22 112.491 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.842 ' CD1' HD11 ' A' ' 226' ' ' LEU . 3.3 tp -54.55 -32.9 25.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.748 0.308 . . . . 71.32 111.097 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.457 ' O ' ' N ' ' A' ' 263' ' ' GLY . 36.8 mt-30 -87.84 -16.78 33.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 75.41 110.885 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 2.5 t -68.21 -15.51 63.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 74.15 110.783 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.837 HD11 ' HB2' ' A' ' 102' ' ' GLU . 5.8 mt -120.34 -20.68 7.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 75.45 110.917 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.768 ' HB3' HD21 ' A' ' 147' ' ' LEU . 34.8 m-85 -111.56 -36.45 5.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 72.03 110.991 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.355 0 CA-C-O 119.147 -0.807 . . . . 54.4 112.555 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.8 0.333 . . . . 52.32 110.908 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 50.65 55.84 8.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 73.05 110.86 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.61 ' HB2' HD11 ' A' ' 261' ' ' LEU . 1.2 pp20? 178.72 132.41 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 75.03 110.848 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.423 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . 0.2 OUTLIER -51.93 143.98 21.47 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.585 0.707 . . . . 75.53 110.86 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 103' ' ' MET . 52.9 Cg_endo -69.81 136.18 32.22 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.751 2.3 . . . . 73.51 112.289 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 95.52 -12.19 67.93 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.702 -0.761 . . . . 54.52 112.376 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.704 ' N ' ' CD ' ' A' ' 107' ' ' PRO . . . 70.44 35.27 68.53 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.775 -0.726 . . . . 53.24 112.436 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 106' ' ' GLY . 53.6 Cg_endo -69.74 59.1 1.59 Allowed 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.671 2.247 . . . . 65.24 112.281 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.948 HG21 ' HB3' ' A' ' 261' ' ' LEU . 11.6 m -130.24 151.09 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 63.31 111.124 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -91.11 107.44 19.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.214 -0.448 . . . . 74.1 110.92 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 30.5 mtt180 -70.56 56.79 0.18 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 74.43 110.888 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -124.04 166.11 16.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 75.1 110.845 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -114.99 34.24 4.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 72.51 110.861 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -137.9 103.26 4.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.472 . . . . 71.41 110.948 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.566 HG22 ' N ' ' A' ' 115' ' ' THR . 5.4 mp -132.2 160.66 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 71.41 111.156 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.566 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -157.98 164.46 36.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.227 -0.442 . . . . 75.3 111.059 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.607 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.9 p90 -134.53 149.14 50.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 72.22 110.938 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.544 ' HD2' HD11 ' A' ' 160' ' ' LEU . 4.1 tmt_? -142.44 113.84 7.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 62.31 110.943 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' ILE . . . . . 0.421 HD12 ' OH ' ' A' ' 121' ' ' TYR . 48.4 mt -74.87 106.24 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 53.33 111.075 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -59.41 -47.03 87.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 75.34 110.932 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.735 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.0 p-10 -142.71 161.84 37.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 72.53 110.96 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.695 ' CE2' HG11 ' A' ' 130' ' ' VAL . 4.7 m-85 -117.4 146.75 43.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.454 . . . . 71.44 110.926 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.505 HG22 ' HE1' ' A' ' 125' ' ' MET . 2.1 t -93.39 141.28 23.74 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.536 0.684 . . . . 63.25 111.167 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -1.66 8.87 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.732 2.288 . . . . 61.3 112.289 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.11 -30.26 31.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.268 -0.424 . . . . 74.22 110.868 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.706 ' HE3' HG22 ' A' ' 130' ' ' VAL . 8.1 mtm -108.06 163.63 12.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 74.32 110.918 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 126' ' ' ASN . . . . . 0.527 ' O ' HG23 ' A' ' 130' ' ' VAL . 2.8 m120 -95.02 146.42 24.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 71.24 110.842 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.33 -32.52 3.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 71.32 110.919 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -83.73 -38.94 20.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 74.34 110.917 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -66.0 -30.26 70.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 64.13 110.853 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.706 HG22 ' HE3' ' A' ' 125' ' ' MET . 84.7 t -65.2 -47.01 89.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 55.31 111.158 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.12 -24.1 47.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 74.33 110.806 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -73.12 -47.02 47.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 63.32 110.887 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.75 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -72.31 -31.21 65.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 75.13 111.065 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.669 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -73.93 -54.15 15.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 64.21 111.148 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.526 ' N ' HG22 ' A' ' 134' ' ' ILE . 4.2 ttm180 -48.88 -43.03 38.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 72.31 110.812 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.686 ' O ' HG23 ' A' ' 140' ' ' VAL . 5.1 mmpt? -70.79 -34.64 71.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 55.31 110.939 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.918 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.07 -49.36 77.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 74.13 111.128 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.639 ' HE1' HD13 ' A' ' 159' ' ' ILE . 95.8 m-85 -72.68 -22.19 60.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 64.5 110.883 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 139' ' ' GLN . . . . . . . . . . . . . 2.6 tt0 -78.0 -6.34 54.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.068 -0.514 . . . . 72.12 110.927 -179.862 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 136' ' ' LYS . 99.1 t -97.65 -16.93 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 71.22 111.056 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.829 ' NE1' HG12 ' A' ' 217' ' ' VAL . 89.9 m95 -106.33 -37.74 6.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 72.3 110.921 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.18 -12.54 61.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 42.1 110.831 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -93.6 -19.47 21.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 74.41 110.866 -179.931 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.782 HG11 HD12 ' A' ' 250' ' ' LEU . 17.8 m -98.91 3.19 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 63.3 111.214 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.514 HG21 HG13 ' A' ' 258' ' ' ILE . 23.4 p -149.46 145.04 18.53 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.603 0.716 . . . . 75.25 111.097 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.75 29.96 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.711 2.274 . . . . 73.43 112.344 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.729 HD21 ' CD1' ' A' ' 262' ' ' TYR . 5.0 mp -96.88 176.91 5.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 71.55 110.94 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -137.51 126.58 24.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 71.23 110.923 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.414 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.8 m-30 -112.76 145.29 40.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 73.53 110.88 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.431 ' H ' ' HA ' ' A' ' 115' ' ' THR . 3.1 t -139.34 155.2 47.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 72.45 110.789 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.5 OUTLIER -106.02 141.0 38.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 73.55 110.836 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.481 HD12 ' CA ' ' A' ' 155' ' ' GLY . 20.5 pt -150.82 144.74 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 60.44 111.056 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -116.9 8.46 13.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 53.42 110.892 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.1 t -167.81 50.9 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 74.32 111.158 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.481 ' CA ' HD12 ' A' ' 152' ' ' ILE . . . -148.47 -152.74 5.78 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.71 -0.757 . . . . 61.41 112.461 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 30.1 mmt -107.11 96.76 6.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.35 . . . . 61.44 110.915 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.48 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -105.94 155.15 19.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 74.2 111.144 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.61 -51.07 7.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 73.25 110.85 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.728 HG12 HG23 ' A' ' 220' ' ' ILE . 2.0 mp -92.85 97.41 7.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 65.53 111.18 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.544 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.5 tp -88.58 109.56 20.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 72.34 110.873 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.443 HG13 ' CE1' ' A' ' 197' ' ' PHE . 85.8 t -87.49 123.39 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 63.22 111.225 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.735 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -142.2 106.11 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 71.51 111.125 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -73.18 107.59 5.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 72.33 110.913 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.5 164.26 23.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 44.33 111.093 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.82 138.26 48.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 72.11 110.902 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.684 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 41.83 -154.16 0.12 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.793 -0.718 . . . . 60.24 112.402 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.807 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.41 117.06 7.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 51.31 111.025 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.691 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -109.5 -22.34 12.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.25 -0.432 . . . . 71.44 110.818 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.01 29.68 0.55 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.746 -0.74 . . . . 72.44 112.534 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.639 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.97 0.18 14.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.861 0.362 . . . . 71.44 110.859 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 73.96 39.54 0.51 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 73.21 110.901 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.691 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.16 -41.53 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 73.32 110.851 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.807 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.26 99.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 72.15 111.058 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.684 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.1 m-85 -59.73 -169.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.279 -0.418 . . . . 65.42 110.842 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.68 19.41 3.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 64.22 110.884 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.574 ' HA2' ' CB ' ' A' ' 200' ' ' ASP . . . 55.26 -162.72 4.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.707 -0.759 . . . . 70.22 112.517 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 176' ' ' GLY . 1.7 ptpp? -33.42 136.0 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 71.42 110.904 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 61.02 160.84 0.1 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.74 -0.743 . . . . 62.0 112.552 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.515 ' O ' HD22 ' A' ' 181' ' ' LEU . . . 84.06 -141.41 20.0 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.817 -0.706 . . . . 73.24 112.444 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.6 97.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.861 0.362 . . . . 74.2 111.103 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.57 HD13 ' HG3' ' A' ' 201' ' ' GLU . 2.8 mm? -68.63 -36.97 79.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 71.34 110.868 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -174.08 169.96 3.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 51.43 111.097 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.493 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.3 p80 -163.79 142.12 7.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 73.34 110.867 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.744 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -136.28 173.37 11.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.299 -0.409 . . . . 65.21 111.174 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.544 ' O ' ' O ' ' A' ' 222' ' ' HIS . 16.7 m-85 -98.69 -141.15 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 65.41 110.774 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -174.89 -81.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.799 -0.715 . . . . 64.53 112.541 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.405 ' HG3' ' HB2' ' A' ' 107' ' ' PRO . 54.1 Cg_endo -69.73 47.46 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.706 2.271 . . . . 75.42 112.369 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.558 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -119.71 147.47 18.1 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.71 -0.757 . . . . 72.44 112.508 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.88 144.96 30.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.347 . . . . 74.05 110.816 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.56 -64.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.725 -0.75 . . . . 64.53 112.481 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 189' ' ' SER . 14.6 tt -104.43 8.84 9.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 74.35 111.183 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.558 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -70.76 174.21 40.0 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.672 -0.775 . . . . 52.04 112.467 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 223' ' ' SER . . . 42.76 23.19 0.18 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 71.11 112.486 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 192' ' ' GLY . 1.9 m-20 -65.49 101.2 0.56 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.903 0.383 . . . . 74.21 110.917 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.744 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -74.72 130.36 39.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 62.32 111.124 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.493 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.2 m170 -121.05 130.19 53.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 71.13 110.837 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.532 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 47.6 m-85 -114.91 133.7 55.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 73.13 110.847 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -64.72 112.84 3.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 72.41 110.823 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -68.2 -18.99 64.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 73.21 110.961 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.574 ' CB ' ' HA2' ' A' ' 176' ' ' GLY . 14.4 m-20 -68.89 -8.57 45.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 74.03 110.841 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.57 ' HG3' HD13 ' A' ' 181' ' ' LEU . 50.4 mm-40 -97.27 162.17 13.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 72.43 110.891 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.514 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.2 OUTLIER -95.94 94.18 7.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 75.4 110.942 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.532 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 45.4 m95 -82.95 124.69 30.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 72.12 110.926 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 36.0 p -145.97 -177.6 5.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 60.52 111.159 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.59 21.08 17.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 73.45 111.192 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -128.13 -177.72 4.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 73.54 110.875 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.7 t -67.59 -19.22 65.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 44.44 110.864 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.29 -104.82 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.769 -0.729 . . . . 72.12 112.45 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.24 177.98 0.14 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.782 -0.723 . . . . 51.45 112.437 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 95.9 m -67.79 97.22 0.62 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.721 0.295 . . . . 74.11 111.127 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -41.06 116.31 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 72.1 110.853 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.75 HD23 ' HB3' ' A' ' 133' ' ' ALA . 9.9 tp -63.26 -39.4 94.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.46 . . . . 74.2 110.873 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.732 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.7 t80 -50.46 -65.29 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 70.23 110.879 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.469 HD11 ' H ' ' A' ' 243' ' ' VAL . 15.4 mt -54.02 -55.43 27.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.478 . . . . 73.32 110.897 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.514 ' O ' ' HB2' ' A' ' 219' ' ' ALA . 2.6 m -55.67 -32.22 63.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 74.44 111.119 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.31 -48.04 62.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.428 . . . . 71.35 111.027 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.918 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -54.06 -58.44 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 73.54 111.196 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.717 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.9 t-80 -64.0 -28.8 70.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 73.22 110.819 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.9 -45.66 91.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 65.25 111.162 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.728 HG23 HG12 ' A' ' 159' ' ' ILE . 2.6 mt -68.19 -33.95 63.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 52.21 111.12 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -52.43 -43.13 58.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.834 -0.698 . . . . 51.03 112.505 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.544 ' O ' ' O ' ' A' ' 185' ' ' PHE . 41.1 m-70 -70.32 -41.36 73.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.815 0.341 . . . . 71.34 110.833 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 29.5 p -64.95 -20.35 66.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 73.21 110.903 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.428 HD21 HG21 ' A' ' 114' ' ' ILE . 36.5 mt -81.64 -25.79 35.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.134 -0.485 . . . . 75.14 110.902 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.881 ' HA3' HG12 ' A' ' 108' ' ' VAL . . . 120.55 11.7 6.49 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.774 -0.726 . . . . 43.22 112.487 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.803 HD11 ' CD1' ' A' ' 258' ' ' ILE . 12.4 mt -76.95 158.88 30.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.364 . . . . 65.42 110.967 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -104.71 -134.49 8.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.806 -0.711 . . . . 63.55 112.499 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 0.7 OUTLIER -129.5 145.1 51.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.338 . . . . 72.5 110.866 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 27.4 t -108.45 165.56 11.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 72.0 110.811 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.93 -2.99 22.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.495 . . . . 61.34 110.902 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.623 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -62.2 136.51 95.5 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.579 0.704 . . . . 73.15 110.845 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -0.44 6.87 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.706 2.271 . . . . 75.52 112.422 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.81 15.52 1.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 73.14 110.889 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.623 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -84.74 133.48 34.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.269 -0.423 . . . . 75.41 111.19 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.717 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -56.78 -37.8 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 74.15 111.145 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.441 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 47.1 mmm -59.73 -23.21 63.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 74.23 110.889 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.542 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.7 t80 -54.39 142.72 49.22 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.68 0.753 . . . . 75.33 110.861 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.542 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.7 Cg_endo -69.69 -1.21 8.02 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.667 2.245 . . . . 74.43 112.387 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.409 ' HG1' ' HD2' ' A' ' 237' ' ' PHE . 50.0 m -93.9 141.72 28.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 63.34 111.129 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -122.74 141.52 51.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.269 -0.423 . . . . 62.14 110.928 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -161.02 138.79 9.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.494 . . . . 75.44 110.87 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.55 ' O ' HG13 ' A' ' 243' ' ' VAL . 66.8 t80 -62.43 146.67 50.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 75.13 110.971 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -160.88 132.1 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 60.43 111.095 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -50.46 133.21 24.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 74.11 110.902 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.625 HD11 ' HD3' ' A' ' 136' ' ' LYS . 6.4 tt -54.7 -30.39 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 72.34 111.147 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 9.4 m120 -75.36 -18.39 59.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 44.31 110.906 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 43.4 p -107.63 -20.25 13.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 73.21 111.105 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.467 ' C ' ' HG3' ' A' ' 249' ' ' ARG . 10.4 t80 -72.65 120.54 18.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 72.35 110.886 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.467 ' HG3' ' C ' ' A' ' 248' ' ' PHE . 16.1 mtt180 -152.42 141.92 21.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 64.41 110.854 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.782 HD12 HG11 ' A' ' 144' ' ' VAL . 45.4 mt -59.0 123.44 16.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 73.43 110.895 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 15.8 m -67.11 162.48 22.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 71.04 110.937 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -48.18 -36.2 13.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 50.34 111.133 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.04 -47.87 75.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 72.14 110.837 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.419 ' O ' HG22 ' A' ' 258' ' ' ILE . 9.4 m-20 -60.45 -51.79 67.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 74.24 110.824 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 20.6 mt -62.49 -33.48 59.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 75.13 111.236 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -71.26 -39.81 71.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 75.15 110.916 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.85 -51.23 7.19 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 73.11 112.467 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.803 ' CD1' HD11 ' A' ' 226' ' ' LEU . 2.8 tp -52.65 -35.05 20.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 75.01 111.198 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.419 ' O ' ' N ' ' A' ' 263' ' ' GLY . 71.2 mt-30 -87.02 -16.49 35.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 70.0 110.929 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.7 t -69.63 -13.98 62.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 73.11 110.875 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.948 ' HB3' HG21 ' A' ' 108' ' ' VAL . 3.5 mt -123.72 -17.74 6.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 63.25 110.908 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.729 ' CD1' HD21 ' A' ' 147' ' ' LEU . 35.1 m-85 -115.04 -33.39 5.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 64.33 110.904 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.289 0 CA-C-O 119.034 -0.87 . . . . 61.41 112.517 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.508 ' HZ ' ' HG ' ' A' ' 230' ' ' SER . 42.9 p90 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.8 0.333 . . . . 74.42 110.899 . . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.613 HH22 HD22 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -50.43 99.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 74.02 110.87 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -159.42 129.2 5.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.504 . . . . 75.41 110.861 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.9 tpp -52.02 134.32 39.35 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.604 0.716 . . . . 72.44 110.767 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 139.54 40.39 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.719 2.279 . . . . 72.33 112.407 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.99 13.61 54.23 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.688 -0.767 . . . . 33.12 112.443 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.446 ' N ' ' CD ' ' A' ' 107' ' ' PRO . . . 39.95 52.68 3.27 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.68 -0.771 . . . . 62.34 112.525 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 106' ' ' GLY . 53.5 Cg_endo -69.8 -24.58 29.34 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.63 2.22 . . . . 70.22 112.344 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 1.026 HG21 HD13 ' A' ' 261' ' ' LEU . 40.7 t -48.89 130.65 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 73.14 111.146 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.627 ' HZ3' HD23 ' A' ' 224' ' ' LEU . 2.8 m-90 -60.94 -29.11 69.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.284 -0.416 . . . . 75.21 110.829 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.692 ' H ' HG12 ' A' ' 108' ' ' VAL . 27.9 mtm180 64.21 32.55 12.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 73.14 110.895 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.453 ' HG2' ' HB3' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -123.11 165.7 16.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 72.41 110.919 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -104.96 36.67 2.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 60.12 110.905 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 113' ' ' TYR . . . . . 0.434 ' C ' HD12 ' A' ' 114' ' ' ILE . 2.7 m-85 -139.04 108.9 6.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 74.14 110.976 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.614 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.6 mp -142.93 162.97 17.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 72.2 111.172 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.588 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -159.67 163.46 34.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 75.54 111.136 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.605 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 1.5 p90 -133.13 151.43 51.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 72.34 110.889 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.538 ' HD2' HD11 ' A' ' 160' ' ' LEU . 4.7 tmt_? -141.87 112.66 7.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 73.3 110.856 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.4 mt -74.4 106.23 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 72.22 111.125 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -59.14 -48.49 81.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 75.2 110.858 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ASN . . . . . . . . . . . . . 11.4 p-10 -146.33 171.84 14.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 64.22 110.818 -179.949 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.603 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.5 m-85 -119.72 151.85 38.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 64.13 110.91 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.554 HG23 ' HD2' ' A' ' 123' ' ' PRO . 36.9 m -103.53 136.17 19.26 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.573 0.702 . . . . 75.01 111.095 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.554 ' HD2' HG23 ' A' ' 122' ' ' THR . 54.7 Cg_endo -69.72 32.6 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.657 2.238 . . . . 70.32 112.431 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 122' ' ' THR . 1.6 m-20 -113.99 -23.75 9.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 75.24 110.851 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.663 ' SD ' HD22 ' A' ' 212' ' ' LEU . 0.0 OUTLIER -117.6 166.82 11.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.848 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -87.96 141.46 28.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 72.54 110.931 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.05 -33.5 3.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 63.12 110.93 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -84.82 -38.64 19.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 74.12 110.895 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -64.29 -32.87 74.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.177 -0.465 . . . . 61.11 110.814 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.603 HG11 ' CE2' ' A' ' 121' ' ' TYR . 78.1 t -63.78 -44.99 98.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 43.2 111.148 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.77 -23.2 39.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 64.55 110.871 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -76.08 -46.86 26.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 73.42 110.939 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.636 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -72.04 -30.23 64.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 65.53 111.088 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.535 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.3 mp -73.49 -55.62 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 65.15 111.172 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.535 ' N ' HG22 ' A' ' 134' ' ' ILE . 1.1 ttt85 -48.09 -40.97 24.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 74.31 110.904 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.413 ' O ' HG23 ' A' ' 140' ' ' VAL . 3.3 mmpt? -76.13 -32.42 59.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 74.13 110.919 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.843 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -61.23 -49.98 74.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 63.14 111.09 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.619 ' HE2' HD13 ' A' ' 159' ' ' ILE . 80.3 m-85 -68.38 -31.14 70.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 71.15 110.851 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.425 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 3.4 tt0 -63.42 -44.69 93.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 65.32 110.944 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 136' ' ' LYS . 55.0 t -49.21 -25.2 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 73.03 111.146 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.788 ' NE1' HG12 ' A' ' 217' ' ' VAL . 97.8 m95 -98.17 -28.9 13.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 71.11 110.91 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 p -74.49 -13.32 60.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 42.52 110.982 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.425 ' OD1' ' O ' ' A' ' 139' ' ' GLN . 22.4 m120 -91.88 -24.7 19.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.085 -0.507 . . . . 43.55 110.978 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.585 HG21 ' CD1' ' A' ' 250' ' ' LEU . 5.7 m -94.86 2.7 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 75.12 111.222 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 147' ' ' LEU . 27.4 p -154.71 141.49 13.34 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.611 0.719 . . . . 63.12 111.152 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 28.33 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.691 2.26 . . . . 74.23 112.269 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.843 HD21 ' CG ' ' A' ' 262' ' ' TYR . 0.4 OUTLIER -84.1 -178.0 6.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.257 -0.429 . . . . 70.24 110.925 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -142.56 125.8 16.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 75.42 110.863 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.614 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.5 m-85 -117.94 137.49 52.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 71.33 110.847 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 53.9 m -132.34 139.46 48.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.075 -0.511 . . . . 55.01 110.796 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.3 OUTLIER -91.9 146.48 23.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.059 -0.519 . . . . 71.12 110.808 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 6.3 pt -150.22 168.13 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 74.51 111.117 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -132.77 13.56 4.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 75.24 110.87 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.6 p -90.79 -58.48 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 75.21 111.092 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 143.22 12.33 0.37 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.717 -0.754 . . . . 71.11 112.443 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 9.9 mtm -108.05 72.71 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.822 0.344 . . . . 72.13 110.863 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.569 ' HA ' HG23 ' A' ' 115' ' ' THR . . . -143.53 170.07 16.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 75.42 111.058 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.9 -50.56 6.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 65.15 110.864 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.7 HG12 HG23 ' A' ' 220' ' ' ILE . 2.6 mp -94.55 97.33 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 74.45 111.146 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.538 HD11 ' HD2' ' A' ' 117' ' ' ARG . 9.2 tp -87.57 110.25 20.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.242 -0.435 . . . . 75.32 110.93 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.4 t -88.33 117.33 31.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 75.54 111.075 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 162' ' ' VAL . 2.3 p -137.16 102.43 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 74.43 111.017 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.4 ' CB ' ' HG1' ' A' ' 122' ' ' THR . 47.0 m-85 -70.49 110.8 5.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.047 -0.524 . . . . 71.42 110.85 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.54 166.75 20.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 61.04 111.035 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -114.65 138.57 50.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 73.43 110.879 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.681 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.89 -154.83 0.16 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.764 -0.731 . . . . 54.14 112.434 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.805 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.85 116.55 7.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 71.32 111.098 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.704 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.73 -23.04 11.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.417 . . . . 74.04 110.878 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.95 29.58 0.51 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.732 . . . . 42.13 112.488 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.622 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.06 0.39 14.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 44.0 110.85 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 73.93 39.2 0.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 75.14 110.941 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.704 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -134.55 -41.23 0.78 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 72.22 110.884 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.805 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.18 99.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 45.44 111.163 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.681 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -60.3 -168.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 61.33 110.798 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.33 18.54 3.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 63.2 110.876 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.593 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.84 -155.64 11.54 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.688 -0.768 . . . . 61.11 112.509 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -37.5 135.42 0.57 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.803 0.335 . . . . 54.42 110.902 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.0 164.75 0.1 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.727 -0.749 . . . . 71.24 112.453 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.86 -142.75 21.83 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.789 -0.72 . . . . 73.23 112.455 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.32 96.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.785 0.326 . . . . 64.23 111.099 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 66.7 mt -66.53 -40.44 89.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.306 -0.407 . . . . 61.04 110.888 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -171.65 168.54 6.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 72.43 111.061 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.497 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -161.93 140.83 9.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 75.31 110.854 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.742 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -136.51 173.57 11.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 74.44 111.013 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 223' ' ' SER . 37.8 m-85 -104.0 -149.91 0.41 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 62.33 110.869 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -163.78 -81.92 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.754 -0.736 . . . . 52.13 112.511 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.41 ' HG3' ' HB3' ' A' ' 107' ' ' PRO . 53.9 Cg_endo -69.76 53.9 1.13 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.689 2.259 . . . . 70.05 112.351 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.57 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -124.83 147.96 16.63 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.753 -0.737 . . . . 55.33 112.524 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.9 143.92 32.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 63.1 110.82 -179.668 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.5 -63.26 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.733 -0.746 . . . . 51.04 112.497 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 189' ' ' SER . 4.2 mt -105.4 7.93 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.892 0.377 . . . . 74.33 111.113 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.57 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -69.78 171.81 40.86 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.77 -0.729 . . . . 62.43 112.511 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 44.0 19.93 0.14 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 53.11 112.523 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.438 ' CG ' ' HB3' ' A' ' 160' ' ' LEU . 1.9 m-20 -63.83 107.96 1.34 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.801 0.334 . . . . 74.33 110.908 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.742 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -82.14 126.16 31.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 73.12 111.086 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.497 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.4 m170 -116.67 130.74 56.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 73.41 110.851 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.531 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 46.8 m-85 -115.7 133.71 55.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 74.4 110.893 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -66.76 109.86 3.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.163 -0.471 . . . . 75.41 110.814 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -60.36 -37.88 82.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 74.04 110.82 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.593 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 5.9 m-20 -50.05 -22.15 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 53.41 110.815 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -81.32 160.67 24.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 72.4 110.919 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.526 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -98.21 93.43 6.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 73.45 110.96 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.531 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 34.0 m95 -83.65 123.02 29.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 74.01 110.95 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.2 p -140.92 -176.25 4.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 73.24 111.073 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.37 18.11 19.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 73.25 111.147 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.43 -175.82 3.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 74.45 110.878 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.9 p -67.06 -18.73 65.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 65.3 110.842 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.95 -108.54 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.788 -0.72 . . . . 73.23 112.491 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.92 177.52 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.741 -0.742 . . . . 65.3 112.519 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 97.0 m -65.95 97.74 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 75.13 111.123 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -41.26 113.38 0.39 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 72.22 110.855 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.663 HD22 ' SD ' ' A' ' 125' ' ' MET . 43.1 tp -62.26 -34.47 76.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.263 -0.426 . . . . 74.51 110.939 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.702 ' O ' HG23 ' A' ' 217' ' ' VAL . 3.3 t80 -54.92 -62.05 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 72.15 110.904 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.572 HD11 ' H ' ' A' ' 243' ' ' VAL . 12.9 mt -57.18 -53.78 54.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 64.22 110.919 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.489 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.2 m -54.76 -34.93 63.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 61.14 111.074 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.38 -49.49 66.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.414 . . . . 62.13 111.021 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.843 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -52.08 -58.77 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 44.25 111.165 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.67 ' HB2' HG13 ' A' ' 235' ' ' VAL . 2.6 t-80 -62.94 -31.55 72.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 75.22 110.854 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -61.73 -43.14 99.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 41.35 111.062 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.7 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -70.97 -33.46 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 73.53 111.06 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.521 ' CA ' HD12 ' A' ' 226' ' ' LEU . . . -51.05 -43.29 49.68 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.769 -0.729 . . . . 74.14 112.485 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.436 ' O ' ' O ' ' A' ' 185' ' ' PHE . 50.7 m-70 -68.83 -39.61 79.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.733 0.301 . . . . 65.0 110.846 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.617 ' OG ' HG23 ' A' ' 159' ' ' ILE . 2.8 m -62.22 -26.66 68.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 64.12 110.891 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.627 HD23 ' HZ3' ' A' ' 109' ' ' TRP . 28.8 mt -77.57 -25.71 50.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 54.32 110.924 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 114.01 14.61 9.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.766 -0.73 . . . . 53.13 112.53 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.781 HD21 HD12 ' A' ' 258' ' ' ILE . 13.3 mt -79.27 148.12 32.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 74.55 110.924 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.418 ' O ' ' HE2' ' A' ' 236' ' ' MET . . . -93.95 -160.37 34.73 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.816 -0.707 . . . . 72.21 112.448 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 1.1 m170 -103.07 149.2 24.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 65.51 110.821 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.454 ' HA ' ' HB3' ' A' ' 101' ' ' ARG . 2.5 p -111.53 164.41 13.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.165 -0.471 . . . . 72.32 110.824 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 230' ' ' SER . . . . . 0.508 ' HG ' ' HZ ' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -105.43 -0.58 25.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 73.34 110.913 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.429 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.3 OUTLIER -67.23 132.82 93.38 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.52 0.676 . . . . 64.31 110.899 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.82 4.95 1.91 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.662 2.241 . . . . 63.32 112.283 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.9 13.46 2.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 62.44 110.925 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.429 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -82.51 149.54 27.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 64.34 111.086 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.67 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -71.46 -40.07 71.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 75.12 111.16 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.418 ' HE2' ' O ' ' A' ' 227' ' ' GLY . 38.7 mmm -64.32 -18.97 65.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.515 . . . . 73.35 110.846 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.605 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.1 t80 -49.26 143.97 8.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.728 0.775 . . . . 54.12 110.881 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.605 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.8 Cg_endo -69.78 -0.76 7.4 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.709 2.272 . . . . 71.34 112.388 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 18.6 m -100.16 146.71 26.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 72.04 111.156 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -125.45 137.22 53.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.203 -0.453 . . . . 72.12 110.978 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -153.89 139.71 18.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 70.44 110.849 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.582 ' O ' HG13 ' A' ' 243' ' ' VAL . 72.2 t80 -65.24 144.41 57.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 73.43 110.923 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -162.18 133.98 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.109 -0.496 . . . . 73.33 111.11 179.848 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -60.71 134.34 56.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 74.24 110.83 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 17.1 tt -52.91 -31.06 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.452 . . . . 74.45 111.081 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.509 ' OD1' HG23 ' A' ' 247' ' ' THR . 0.1 OUTLIER -69.14 -21.25 64.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 72.33 110.933 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.509 HG23 ' OD1' ' A' ' 246' ' ' ASN . 11.9 p -115.95 -6.99 12.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 64.45 111.213 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 248' ' ' PHE . . . . . 0.468 ' CD2' HD22 ' A' ' 214' ' ' LEU . 8.9 t80 -88.05 115.45 25.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 74.05 110.933 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 249' ' ' ARG . . . . . 0.404 ' HG3' ' C ' ' A' ' 248' ' ' PHE . 0.1 OUTLIER -144.73 139.72 28.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 74.52 110.885 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.585 ' CD1' HG21 ' A' ' 144' ' ' VAL . 26.3 mt -53.54 123.42 12.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 55.4 110.932 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 10.0 p -59.67 160.0 7.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 74.43 110.833 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -48.8 -33.28 10.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 74.01 111.208 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -67.14 -44.16 80.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 74.42 110.845 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.77 -49.51 70.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 74.02 110.873 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.451 HG12 HG11 ' A' ' 144' ' ' VAL . 34.3 mt -63.63 -36.33 76.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 74.14 111.184 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -70.26 -38.63 75.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 72.1 110.868 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.37 -50.66 6.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 41.11 112.458 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.781 HD12 HD21 ' A' ' 226' ' ' LEU . 3.3 tp -52.21 -34.82 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 73.22 111.182 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.404 ' O ' ' N ' ' A' ' 263' ' ' GLY . 66.7 mt-30 -86.48 -17.29 34.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.156 -0.475 . . . . 71.02 110.889 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.1 t -69.85 -13.62 62.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 50.51 110.862 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 1.026 HD13 HG21 ' A' ' 108' ' ' VAL . 1.8 mt -123.81 -18.15 6.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.167 -0.469 . . . . 65.5 110.95 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.843 ' CG ' HD21 ' A' ' 147' ' ' LEU . 42.1 m-85 -114.85 -33.9 5.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 74.22 110.888 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 119.105 -0.83 . . . . 35.1 112.472 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 101' ' ' ARG . 36.3 p90 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.826 0.346 . . . . 74.15 110.855 . . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 100' ' ' PHE . 0.2 OUTLIER 35.08 61.51 0.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 54.13 110.835 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.769 ' HG2' HD11 ' A' ' 261' ' ' LEU . 0.3 OUTLIER 176.47 111.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 74.43 110.877 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.444 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . 33.9 tpp -51.38 134.83 32.78 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.664 0.745 . . . . 73.13 110.828 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 139.46 40.23 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.674 2.249 . . . . 72.43 112.45 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.7 7.01 63.41 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 65.01 112.577 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.55 ' N ' ' CD ' ' A' ' 107' ' ' PRO . . . 49.29 45.68 35.32 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.729 -0.748 . . . . 75.4 112.439 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 106' ' ' GLY . 54.0 Cg_endo -69.79 -5.31 15.92 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.617 2.211 . . . . 52.43 112.342 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.855 HG11 HD13 ' A' ' 261' ' ' LEU . 1.8 p -80.08 99.9 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 74.31 111.104 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.471 ' CZ3' HD23 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -45.08 107.55 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 72.54 110.922 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.79 56.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.337 -0.392 . . . . 71.21 110.946 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' LYS . . . . . 0.406 ' HG2' ' HB2' ' A' ' 109' ' ' TRP . 5.5 pttt -122.78 149.58 43.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 63.43 110.919 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -93.66 40.42 1.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 72.44 110.86 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -141.34 101.53 4.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 74.11 110.898 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.61 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.7 mp -134.73 162.9 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 70.4 111.152 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.586 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -158.68 161.26 37.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 51.34 111.109 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.625 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.7 p90 -132.86 148.79 52.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 71.2 110.92 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.424 ' HB3' HD12 ' A' ' 160' ' ' LEU . 4.1 tmt_? -142.67 113.89 7.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.504 . . . . 62.44 110.956 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.6 mt -74.59 105.29 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 75.13 111.166 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -58.8 -48.98 79.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 70.21 110.813 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.73 ' OD1' HG23 ' A' ' 162' ' ' VAL . 1.7 p-10 -140.66 162.63 34.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 64.1 110.884 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.661 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.3 m-85 -117.15 142.95 46.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 64.13 110.895 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.515 HG23 ' HD2' ' A' ' 123' ' ' PRO . 24.5 m -94.92 137.51 22.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.632 0.729 . . . . 70.21 111.134 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.515 ' HD2' HG23 ' A' ' 122' ' ' THR . 52.8 Cg_endo -69.82 7.77 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.659 2.239 . . . . 74.4 112.283 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.498 ' H ' HG22 ' A' ' 122' ' ' THR . 1.6 m-20 -84.89 -29.42 25.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 64.01 110.849 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.656 ' SD ' HD22 ' A' ' 212' ' ' LEU . 0.0 OUTLIER -112.73 166.56 11.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 72.52 110.899 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -88.93 145.75 25.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.287 -0.415 . . . . 71.31 110.891 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.1 -34.86 6.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 72.1 110.943 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -82.38 -37.3 25.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 74.43 110.886 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -64.58 -32.8 74.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 75.21 110.839 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.661 HG11 ' CE2' ' A' ' 121' ' ' TYR . 77.9 t -63.43 -47.25 92.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 73.33 111.078 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.03 -23.45 48.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.101 -0.499 . . . . 73.01 110.879 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -75.71 -47.23 27.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 62.21 110.972 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.729 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -70.12 -32.91 71.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 63.33 111.165 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.534 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.3 mp -72.1 -55.07 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 74.35 111.158 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.534 ' N ' HG22 ' A' ' 134' ' ' ILE . 6.1 ttt180 -48.93 -42.26 36.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 72.45 110.932 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.622 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -71.32 -34.76 70.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 72.41 110.896 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.903 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.36 -49.35 77.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 72.05 111.165 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.625 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.4 m-85 -72.72 -21.84 60.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 70.2 110.84 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.415 ' HB2' ' O ' ' A' ' 135' ' ' ARG . 3.1 tt0 -77.48 -6.38 53.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 63.02 110.824 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 136' ' ' LYS . 96.2 t -97.71 -16.96 6.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.288 -0.414 . . . . 63.43 111.212 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.783 ' NE1' HG12 ' A' ' 217' ' ' VAL . 89.2 m95 -105.41 -38.08 6.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 70.35 110.886 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.8 -12.68 61.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 54.42 110.876 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -93.97 -19.58 20.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.511 . . . . 61.33 110.916 -179.992 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.859 HG11 HD12 ' A' ' 250' ' ' LEU . 18.5 m -97.1 1.65 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 74.33 111.083 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.584 HG21 HG13 ' A' ' 258' ' ' ILE . 52.2 p -151.93 147.57 20.14 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.583 0.706 . . . . 74.31 111.152 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 31.91 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.667 2.245 . . . . 64.15 112.318 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.76 HD11 ' CG ' ' A' ' 262' ' ' TYR . 19.5 mt -95.65 173.83 7.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 63.31 110.884 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -136.28 126.2 25.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 72.22 110.882 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.61 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.7 m-30 -114.46 145.96 41.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.405 . . . . 54.15 110.91 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.401 ' H ' ' HA ' ' A' ' 115' ' ' THR . 5.8 t -139.44 153.33 47.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 72.33 110.847 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 1.4 tttt -104.37 142.79 33.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.129 -0.487 . . . . 41.42 110.897 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.592 HD12 ' CA ' ' A' ' 155' ' ' GLY . 16.4 pt -152.56 159.26 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 64.45 111.089 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 52.1 m-20 -119.34 -21.65 7.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 74.1 110.883 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.6 t -144.02 53.24 1.29 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.441 . . . . 52.04 111.148 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.592 ' CA ' HD12 ' A' ' 152' ' ' ILE . . . -139.34 -155.31 6.6 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.709 -0.758 . . . . 74.52 112.514 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 34.3 mmt -107.73 89.58 3.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.34 . . . . 60.0 110.914 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -101.01 154.63 18.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 74.21 111.06 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.86 -51.4 6.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 53.03 110.835 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.623 HG12 HG23 ' A' ' 220' ' ' ILE . 2.7 mp -92.51 97.3 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 54.41 111.121 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.424 HD12 ' HB3' ' A' ' 117' ' ' ARG . 7.8 tp -88.42 109.13 19.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 74.04 110.984 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.428 HG13 ' CE1' ' A' ' 197' ' ' PHE . 84.5 t -85.71 121.1 36.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 72.31 111.089 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.73 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.2 p -140.5 103.67 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 73.54 111.175 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -71.17 110.16 5.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.445 . . . . 71.41 110.89 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.94 165.83 21.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 74.52 111.064 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.02 136.9 52.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.151 -0.477 . . . . 73.21 110.862 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.675 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.43 -155.87 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.758 . . . . 72.55 112.508 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.799 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.02 116.44 6.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.786 0.327 . . . . 72.44 111.084 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.694 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.08 -22.44 12.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 62.11 110.792 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.34 29.51 0.54 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.722 -0.751 . . . . 72.42 112.521 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.631 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.13 0.45 14.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 74.45 110.885 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 73.63 39.63 0.55 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 74.13 110.931 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.694 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.97 -41.65 0.74 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.07 -0.514 . . . . 44.51 110.839 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.799 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.52 99.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 52.1 111.097 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.675 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.9 m-85 -60.2 -168.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 72.44 110.84 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.16 19.03 3.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.029 -0.532 . . . . 74.12 110.85 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.574 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.34 -157.75 6.1 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 41.42 112.464 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 176' ' ' GLY . 12.0 mmtp -34.64 134.71 0.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 64.03 110.959 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.0 165.14 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.741 -0.742 . . . . 63.33 112.459 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.37 -143.35 21.78 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.732 -0.747 . . . . 73.35 112.472 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.0 97.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.881 0.372 . . . . 64.34 111.092 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 21.9 mt -66.99 -40.57 87.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 75.42 110.903 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -171.12 170.21 6.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 45.11 111.117 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.503 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -164.11 141.17 6.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 74.1 110.889 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.781 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -135.76 173.64 11.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.307 -0.406 . . . . 71.41 111.07 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 223' ' ' SER . 47.9 m-85 -101.11 -145.81 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 74.54 110.829 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -165.09 -86.17 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.768 -0.729 . . . . 60.13 112.507 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.407 ' HB3' ' HB2' ' A' ' 107' ' ' PRO . 54.3 Cg_endo -69.65 55.6 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.683 2.255 . . . . 73.51 112.357 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.536 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.53 147.66 16.67 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.718 -0.754 . . . . 52.32 112.476 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -102.98 142.36 34.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.997 0.427 . . . . 73.05 110.759 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 64.14 -62.4 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.75 -0.738 . . . . 73.4 112.526 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.524 ' N ' ' O ' ' A' ' 189' ' ' SER . 2.3 pp -105.99 10.07 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.897 0.38 . . . . 75.12 111.213 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.536 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -69.47 170.62 42.07 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.797 -0.716 . . . . 74.44 112.548 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 42.19 22.82 0.13 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.711 -0.757 . . . . 65.34 112.442 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 192' ' ' GLY . 3.2 m-20 -64.48 103.62 0.68 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.792 0.33 . . . . 73.34 110.896 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.781 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -76.71 125.75 29.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 74.52 111.046 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.503 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.3 m170 -115.88 129.68 56.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.116 -0.493 . . . . 75.55 110.865 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.519 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 50.3 m-85 -113.88 134.26 54.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 74.23 110.827 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -66.87 108.89 2.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 72.33 110.923 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -60.09 -37.4 79.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.42 110.792 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.574 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 11.3 m-20 -50.51 -22.1 1.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 74.03 110.811 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -81.36 160.83 24.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.165 -0.47 . . . . 61.23 110.925 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.544 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -98.73 91.47 5.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 75.53 110.894 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.519 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 33.1 m95 -81.56 124.25 29.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 75.44 110.896 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.9 p -141.81 -170.45 3.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 75.05 111.208 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.87 17.42 15.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 70.1 111.176 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.74 -178.73 4.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 70.25 110.81 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.4 t -63.41 -19.62 64.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 75.34 110.926 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.89 -107.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.813 -0.708 . . . . 72.5 112.386 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.5 177.9 0.18 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.719 -0.753 . . . . 72.12 112.48 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 95.7 m -68.47 96.86 0.72 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.793 0.33 . . . . 74.21 111.076 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -40.11 118.46 0.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 73.32 110.858 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.656 HD22 ' SD ' ' A' ' 125' ' ' MET . 19.3 tp -64.87 -36.24 83.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 50.23 110.888 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.729 ' CA ' ' HB1' ' A' ' 133' ' ' ALA . 2.4 t80 -54.17 -64.93 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 75.1 110.915 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.515 HD11 ' H ' ' A' ' 243' ' ' VAL . 21.0 mt -53.21 -55.32 25.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 55.31 110.935 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.495 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.6 m -55.27 -34.87 64.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 62.21 111.141 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.1 -47.86 72.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 54.23 111.092 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.903 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -53.58 -60.11 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 34.35 111.079 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.624 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.8 t-80 -63.31 -28.52 70.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.353 -0.385 . . . . 72.45 110.8 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.96 -44.37 96.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 74.43 111.115 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.623 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -68.99 -35.24 68.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 74.11 111.155 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.21 -44.46 51.79 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.806 -0.711 . . . . 72.54 112.442 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 185' ' ' PHE . 19.6 m-70 -68.03 -38.52 82.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.792 0.329 . . . . 60.35 110.804 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.619 ' OG ' HG23 ' A' ' 159' ' ' ILE . 13.0 m -64.05 -24.79 67.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 72.41 110.831 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.522 ' O ' HG23 ' A' ' 108' ' ' VAL . 44.3 mt -76.29 -27.06 56.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 73.22 110.952 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 121.03 10.56 6.76 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.722 -0.751 . . . . 44.51 112.454 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.489 HD11 HD13 ' A' ' 258' ' ' ILE . 8.5 mt -76.61 137.7 39.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.864 0.364 . . . . 63.05 110.939 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 227' ' ' GLY . . . . . 0.432 ' H ' ' HA ' ' A' ' 102' ' ' GLU . . . -76.8 -135.14 0.64 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.68 -0.771 . . . . 52.42 112.484 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 3.0 m-70 -131.82 135.31 46.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 71.34 110.799 -179.904 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 98.4 p -94.94 160.88 14.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 61.22 110.863 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.22 0.55 25.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 72.12 110.835 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' A' ' 234' ' ' ALA . 0.3 OUTLIER -71.68 132.0 85.64 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.558 0.694 . . . . 71.5 110.831 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 0.93 4.92 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.714 2.276 . . . . 61.53 112.361 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.8 pttt -136.73 14.06 3.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 71.41 110.855 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -92.53 128.2 38.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 70.33 111.088 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.624 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -52.81 -37.95 26.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 64.42 111.092 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 70.8 mmm -58.94 -23.69 61.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.263 -0.426 . . . . 73.02 110.836 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.594 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.5 t80 -52.67 143.36 29.35 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.669 0.747 . . . . 64.54 110.841 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.594 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.5 Cg_endo -69.78 -9.88 27.19 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.654 2.236 . . . . 52.1 112.252 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 23.3 m -85.42 150.22 24.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 62.52 111.157 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -124.78 139.1 54.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.11 110.919 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -155.26 121.35 5.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.052 -0.522 . . . . 65.31 110.922 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.567 ' O ' HG13 ' A' ' 243' ' ' VAL . 87.3 t80 -52.65 146.78 9.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 73.2 110.929 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.5 OUTLIER -161.03 130.84 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 74.13 111.171 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 244' ' ' ASP . . . . . 0.432 ' CG ' HD22 ' A' ' 246' ' ' ASN . 18.7 t0 -48.43 138.39 10.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 73.02 110.865 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.585 HD11 ' HD3' ' A' ' 136' ' ' LYS . 7.6 tt -56.26 -31.28 32.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 53.33 111.085 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.483 ' OD1' HG23 ' A' ' 247' ' ' THR . 5.2 p30 -77.72 -15.81 58.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 73.02 110.89 179.888 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.483 HG23 ' OD1' ' A' ' 246' ' ' ASN . 33.4 p -105.3 -23.38 12.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 71.31 111.11 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -70.82 142.27 51.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 71.13 110.784 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -177.71 132.13 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 72.12 110.821 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.859 HD12 HG11 ' A' ' 144' ' ' VAL . 34.1 mt -49.52 122.8 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 73.24 110.932 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 32.1 t -64.13 157.81 24.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 73.1 110.895 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -46.36 -34.77 4.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 75.5 111.106 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.74 -46.26 69.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.325 -0.398 . . . . 75.42 110.787 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.418 ' O ' HG22 ' A' ' 258' ' ' ILE . 28.6 m-20 -60.37 -49.94 75.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 72.51 110.811 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.41 ' HA ' HG22 ' A' ' 258' ' ' ILE . 24.8 mt -66.31 -31.5 53.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.129 -0.487 . . . . 74.44 111.17 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.63 -39.41 70.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.505 . . . . 52.5 110.912 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.63 -52.01 6.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 74.31 112.396 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.584 HG13 HG21 ' A' ' 145' ' ' THR . 7.6 tp -52.55 -34.08 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 75.22 111.086 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.457 ' O ' ' N ' ' A' ' 263' ' ' GLY . 85.8 mt-30 -84.38 -19.2 33.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.115 -0.493 . . . . 75.01 110.933 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 10.7 t -68.65 -12.91 61.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.454 . . . . 60.31 110.872 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.855 HD13 HG11 ' A' ' 108' ' ' VAL . 2.1 mt -122.36 -18.1 6.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 74.42 110.927 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.76 ' CG ' HD11 ' A' ' 147' ' ' LEU . 38.1 m-85 -115.63 -36.12 4.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 73.41 110.948 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 119.145 -0.808 . . . . 70.1 112.473 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 18.3 p90 . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.846 0.355 . . . . 54.34 110.84 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.74 66.2 2.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 74.21 110.863 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? 178.35 126.01 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 71.04 110.884 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' MET . . . . . 0.414 ' HG3' ' HD2' ' A' ' 104' ' ' PRO . 3.0 tpt -51.07 135.72 28.99 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.535 0.683 . . . . 73.11 110.837 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 104' ' ' PRO . . . . . 0.414 ' HD2' ' HG3' ' A' ' 103' ' ' MET . 52.7 Cg_endo -69.81 136.13 32.09 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.733 2.289 . . . . 51.3 112.301 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 96.22 -9.46 67.46 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.779 -0.724 . . . . 41.41 112.46 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.712 ' N ' ' CD ' ' A' ' 107' ' ' PRO . . . 69.41 35.58 76.17 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.745 -0.74 . . . . 73.4 112.496 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.712 ' CD ' ' N ' ' A' ' 106' ' ' GLY . 53.1 Cg_endo -69.73 34.02 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.691 2.26 . . . . 52.53 112.381 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 224' ' ' LEU . 7.5 p -116.03 137.89 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 63.31 111.066 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.456 ' CZ3' HD23 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -79.62 107.32 12.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.088 -0.505 . . . . 74.34 110.876 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -73.59 56.85 0.54 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 71.35 110.919 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.18 145.07 48.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 74.21 110.917 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -94.05 37.59 1.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 72.15 110.893 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -142.02 91.85 2.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 73.14 110.876 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.656 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.6 mp -122.49 163.94 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 74.13 111.107 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.606 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -157.88 161.94 38.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 75.55 111.199 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.573 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 1.4 p90 -136.32 148.7 48.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 65.22 110.902 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.733 ' NE ' HD11 ' A' ' 160' ' ' LEU . 3.7 tmm_? -141.83 120.01 12.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 61.44 110.864 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.7 mt -79.82 104.13 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 73.15 111.192 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -56.44 -46.42 80.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 63.43 110.932 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.735 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.5 p-10 -146.82 165.5 29.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 64.3 110.912 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.544 ' CE2' HG11 ' A' ' 130' ' ' VAL . 4.3 m-85 -114.95 142.09 47.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 71.0 110.944 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.632 HG22 ' H ' ' A' ' 124' ' ' ASP . 1.0 OUTLIER -88.97 137.99 29.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.602 0.715 . . . . 65.14 111.102 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.71 33.61 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.656 2.237 . . . . 63.43 112.435 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.632 ' H ' HG22 ' A' ' 122' ' ' THR . 1.8 m-20 -123.36 -17.44 6.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 71.21 110.915 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.599 ' SD ' HD22 ' A' ' 212' ' ' LEU . 6.6 mtm -117.28 165.55 13.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 71.42 110.926 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -92.86 140.57 29.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 71.14 110.861 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.9 ptt-85 -44.6 -36.91 3.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 74.03 110.813 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -84.01 -39.27 19.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 71.45 110.879 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -63.51 -32.1 73.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.103 -0.499 . . . . 74.32 110.906 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.544 HG11 ' CE2' ' A' ' 121' ' ' TYR . 58.3 t -65.48 -44.46 94.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.18 -0.464 . . . . 75.35 111.13 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.45 -22.42 38.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 63.13 110.924 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -76.15 -47.89 22.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 74.25 110.854 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.552 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -72.52 -30.65 64.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 74.11 111.026 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.2 mp -71.95 -55.37 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.404 . . . . 74.14 111.124 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.526 ' N ' HG22 ' A' ' 134' ' ' ILE . 5.1 ttt180 -48.0 -40.38 22.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 73.45 110.919 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 140' ' ' VAL . 4.8 mmtp -76.47 -33.37 58.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 72.22 110.873 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.823 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.27 -50.93 71.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 62.32 111.137 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.627 ' CZ ' HG12 ' A' ' 220' ' ' ILE . 79.0 m-85 -67.01 -33.55 75.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 74.12 110.889 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.432 ' O ' ' OD1' ' A' ' 143' ' ' ASN . 2.8 tt0 -61.92 -43.84 98.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 73.3 110.905 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 136' ' ' LYS . 73.2 t -49.56 -25.05 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.163 -0.471 . . . . 71.23 111.125 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.799 ' NE1' HG12 ' A' ' 217' ' ' VAL . 97.1 m95 -98.33 -29.66 13.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 74.45 110.891 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 t -73.4 -15.1 61.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.417 . . . . 74.33 110.896 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 143' ' ' ASN . . . . . 0.432 ' OD1' ' O ' ' A' ' 139' ' ' GLN . 28.2 m120 -89.36 -26.14 21.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 75.54 110.795 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.551 HG21 ' CD1' ' A' ' 250' ' ' LEU . 4.7 m -93.61 3.71 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 74.31 111.104 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 147' ' ' LEU . 59.5 p -153.69 143.1 14.97 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 121.596 0.712 . . . . 52.32 111.09 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 30.36 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.683 2.256 . . . . 54.05 112.328 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.797 HD11 ' CG ' ' A' ' 262' ' ' TYR . 20.1 mt -91.93 173.1 8.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 70.33 110.884 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -135.12 126.55 28.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 71.42 110.927 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.656 ' HE1' HD13 ' A' ' 114' ' ' ILE . 2.7 m-85 -116.41 141.27 48.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 74.15 110.938 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.7 m -136.73 147.71 46.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 63.11 110.802 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.432 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 16.4 tptm -98.9 146.45 25.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.501 . . . . 74.25 110.897 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.578 HD12 ' CA ' ' A' ' 155' ' ' GLY . 18.4 pt -150.89 147.02 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 74.33 111.108 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 4.3 m120 -113.07 4.54 16.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 74.02 110.916 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.1 t -169.98 58.3 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.135 -0.484 . . . . 71.2 111.169 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.578 ' CA ' HD12 ' A' ' 152' ' ' ILE . . . -150.53 -154.23 6.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.743 . . . . 55.41 112.505 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.0 96.21 6.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.339 . . . . 64.53 110.906 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.416 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -106.72 156.14 18.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 63.12 111.097 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.65 -51.13 7.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 74.24 110.822 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.636 HG12 HG23 ' A' ' 220' ' ' ILE . 3.4 mp -94.16 98.55 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 64.32 111.163 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.733 HD11 ' NE ' ' A' ' 117' ' ' ARG . 7.0 tp -88.35 110.98 21.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 71.23 110.934 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.413 HG13 ' CE1' ' A' ' 197' ' ' PHE . 87.7 t -88.24 121.59 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 71.11 111.139 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.735 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -140.72 106.09 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 51.1 111.157 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.414 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 46.8 m-85 -73.38 109.98 7.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 70.11 110.859 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.07 166.62 18.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.51 . . . . 75.1 111.182 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.36 135.06 54.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 74.41 110.888 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.674 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 44.52 -156.91 0.22 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.739 -0.743 . . . . 74.41 112.542 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.811 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -63.17 117.67 6.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.338 . . . . 73.44 111.105 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.715 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -110.59 -22.5 11.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 62.05 110.945 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.29 30.45 0.51 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.738 -0.744 . . . . 51.32 112.433 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.624 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -114.28 0.68 14.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.841 0.353 . . . . 75.05 110.837 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 73.49 39.76 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 71.24 110.864 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.715 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.26 -40.77 0.73 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.084 -0.507 . . . . 60.43 110.859 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.811 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.1 99.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 64.51 111.107 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.674 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.8 m-85 -60.45 -168.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 74.43 110.892 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.69 18.66 3.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 71.2 110.872 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.573 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.58 -156.35 9.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.799 -0.715 . . . . 65.43 112.461 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.74 135.56 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 70.42 110.859 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.49 165.03 0.14 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 71.21 112.476 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.495 ' O ' HD22 ' A' ' 181' ' ' LEU . . . 81.97 -142.49 22.46 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.749 -0.738 . . . . 74.54 112.431 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.42 95.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.8 0.333 . . . . 75.51 111.214 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.495 HD22 ' O ' ' A' ' 179' ' ' GLY . 3.1 mm? -65.1 -46.76 79.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.158 -0.474 . . . . 71.2 110.894 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -163.24 174.21 12.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 51.44 111.048 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.473 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -169.33 139.71 2.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 73.25 110.823 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.727 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -135.08 174.62 10.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 61.12 111.007 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.534 ' O ' ' O ' ' A' ' 222' ' ' HIS . 64.3 m-85 -98.51 -134.25 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 71.24 110.835 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 223' ' ' SER . . . 179.02 -84.87 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.676 -0.774 . . . . 62.1 112.437 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 50.52 0.83 Allowed 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.727 2.285 . . . . 71.21 112.367 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.564 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.81 148.78 17.21 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.809 -0.71 . . . . 72.23 112.544 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.534 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.43 145.9 29.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.941 0.4 . . . . 71.41 110.856 -179.711 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.33 -64.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.759 . . . . 72.31 112.551 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.534 ' N ' ' O ' ' A' ' 189' ' ' SER . 14.8 tt -104.22 7.82 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.919 0.39 . . . . 72.0 111.165 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.564 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -69.39 172.92 37.48 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.801 -0.714 . . . . 74.3 112.497 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.504 ' O ' ' HB3' ' A' ' 223' ' ' SER . . . 43.2 23.17 0.23 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.683 -0.77 . . . . 50.13 112.526 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 192' ' ' GLY . 1.6 m-20 -67.0 101.15 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.854 0.359 . . . . 41.43 110.817 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.727 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -75.09 130.82 39.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 72.23 111.069 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.473 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.2 m170 -121.21 130.94 53.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 75.22 110.82 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.452 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 38.0 m-85 -115.44 134.94 54.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 74.43 110.88 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -67.22 107.02 2.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.506 . . . . 61.12 110.81 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -57.55 -37.84 73.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.112 -0.495 . . . . 74.14 111.012 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.573 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 12.9 m-20 -50.64 -20.78 1.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 74.11 110.889 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -82.42 162.45 22.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.21 110.882 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.472 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -101.81 87.82 3.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.5 . . . . 64.33 110.856 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.572 ' CZ3' HG21 ' A' ' 215' ' ' THR . 23.5 m95 -80.09 120.09 23.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.096 -0.502 . . . . 74.54 110.995 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.0 p -131.46 -173.84 3.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 71.34 111.209 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.63 12.85 18.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 70.14 111.164 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 3.3 p80 -131.49 -175.74 3.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 65.01 110.901 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.6 p -51.48 -36.73 45.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 33.42 110.856 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -63.13 160.71 34.73 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.69 -0.767 . . . . 71.32 112.524 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . 48.39 -173.17 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.67 -0.776 . . . . 75.31 112.501 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.418 HG21 HD12 ' A' ' 181' ' ' LEU . 51.5 m -86.47 94.11 9.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 74.24 111.197 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -38.54 113.59 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 73.52 110.88 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.599 HD22 ' SD ' ' A' ' 125' ' ' MET . 13.0 tp -62.64 -35.69 80.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 73.11 110.923 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.663 ' O ' HG23 ' A' ' 217' ' ' VAL . 3.5 t80 -53.27 -64.37 0.84 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 74.33 110.852 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.524 HD11 ' H ' ' A' ' 243' ' ' VAL . 21.8 mt -56.01 -54.34 46.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 52.32 110.93 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.572 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 3.7 m -53.73 -37.41 63.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 74.53 111.112 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 216' ' ' ALA . . . . . 0.401 ' O ' HG13 ' A' ' 220' ' ' ILE . . . -63.13 -50.56 69.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 62.15 111.19 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.823 HG22 ' HA ' ' A' ' 137' ' ' ALA . 1.9 t -51.96 -57.76 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 64.14 111.136 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.699 ' HB2' HG13 ' A' ' 235' ' ' VAL . 3.9 t-80 -65.23 -30.75 71.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.898 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.87 -41.86 99.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 74.2 111.071 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.636 HG23 HG12 ' A' ' 159' ' ' ILE . 2.9 mt -71.98 -35.31 53.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 70.54 111.088 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -51.31 -45.23 52.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.703 -0.761 . . . . 63.34 112.544 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.534 ' O ' ' O ' ' A' ' 185' ' ' PHE . 37.3 m-70 -68.2 -41.77 80.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.885 0.374 . . . . 74.41 110.855 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.519 ' OG ' ' HA ' ' A' ' 220' ' ' ILE . 2.1 p -66.45 -18.11 65.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 54.33 110.885 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.795 ' O ' HG23 ' A' ' 108' ' ' VAL . 39.9 mt -83.42 -27.19 29.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.24 110.943 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 119.99 14.06 5.74 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.735 -0.745 . . . . 42.25 112.498 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.776 HD21 ' HA ' ' A' ' 258' ' ' ILE . 12.7 mt -81.0 158.32 25.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.895 0.379 . . . . 75.54 110.943 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -100.11 -133.49 8.14 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.767 -0.73 . . . . 72.32 112.518 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 0.3 OUTLIER -129.02 139.72 51.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.851 0.357 . . . . 74.2 110.804 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 53.9 m -97.67 162.74 13.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 60.22 110.906 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.66 -1.44 19.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 72.02 110.9 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.604 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -63.45 141.91 97.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.58 0.705 . . . . 71.22 110.824 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -3.88 12.92 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.737 2.291 . . . . 72.22 112.399 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.5 ptmt -144.27 25.01 1.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 73.22 110.818 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.604 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -86.7 140.22 29.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.327 -0.397 . . . . 30.4 111.137 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.699 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.0 OUTLIER -62.81 -38.67 82.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.287 -0.415 . . . . 70.24 111.14 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.4 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 54.0 mmm -65.57 -16.97 64.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 74.31 110.888 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.633 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.2 t80 -55.48 144.81 51.77 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.678 0.751 . . . . 62.11 110.937 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.633 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.0 Cg_endo -69.73 0.83 5.06 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.779 2.319 . . . . 74.44 112.359 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.1 m -100.99 139.52 36.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 71.22 111.103 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -120.44 137.85 54.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 75.35 110.975 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.6 tptt -156.85 136.87 12.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 71.04 110.915 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.578 ' O ' HG13 ' A' ' 243' ' ' VAL . 80.0 t80 -63.13 146.03 54.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 75.43 110.905 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -161.79 131.53 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 64.22 111.068 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -54.6 132.02 44.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 72.33 110.918 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 15.6 tt -53.65 -30.16 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.432 . . . . 72.14 111.113 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 246' ' ' ASN . . . . . 0.498 ' OD1' HG23 ' A' ' 247' ' ' THR . 0.1 OUTLIER -69.5 -20.34 63.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 70.44 110.874 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 247' ' ' THR . . . . . 0.498 HG23 ' OD1' ' A' ' 246' ' ' ASN . 5.0 p -110.95 -20.5 12.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 62.21 111.254 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -69.5 142.96 53.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.461 . . . . 73.22 110.849 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -176.07 133.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 64.32 110.847 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.551 ' CD1' HG21 ' A' ' 144' ' ' VAL . 34.7 mt -48.8 137.74 12.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 54.32 110.994 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.576 ' O ' HD12 ' A' ' 255' ' ' ILE . 23.2 t -80.61 168.06 19.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 71.43 110.848 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.95 -38.46 56.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.074 -0.512 . . . . 53.25 111.07 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.33 -51.15 67.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.257 -0.429 . . . . 60.44 110.908 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.514 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 7.2 m-20 -57.55 -53.38 58.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 61.23 110.848 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.576 HD12 ' O ' ' A' ' 251' ' ' SER . 2.6 mt -60.12 -36.81 70.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 71.43 111.105 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -67.61 -39.6 84.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 74.14 110.861 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.87 -52.59 5.74 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.822 -0.704 . . . . 64.2 112.416 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.776 ' HA ' HD21 ' A' ' 226' ' ' LEU . 5.6 tp -52.59 -34.5 19.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.832 0.349 . . . . 74.31 111.194 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.424 ' O ' ' N ' ' A' ' 263' ' ' GLY . 70.7 mt-30 -86.33 -17.96 33.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.069 -0.514 . . . . 73.23 110.94 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.4 t -69.36 -13.97 62.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.452 . . . . 71.3 110.874 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.577 ' HB3' HG11 ' A' ' 108' ' ' VAL . 3.2 mt -123.02 -17.51 6.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 73.43 110.924 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.797 ' CG ' HD11 ' A' ' 147' ' ' LEU . 35.9 m-85 -114.69 -35.51 4.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.108 -0.496 . . . . 75.55 110.887 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.282 0 CA-C-O 119.118 -0.823 . . . . 72.02 112.516 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 100' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 101' ' ' ARG . 98.1 m-85 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.82 0.343 . . . . 71.22 110.906 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 100' ' ' PHE . 23.3 ptt180 36.13 68.36 0.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 65.42 110.893 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.795 ' HG2' HD11 ' A' ' 261' ' ' LEU . 1.6 mt-10 -175.22 131.54 0.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 75.22 110.916 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 16.6 mmt -51.37 159.51 1.13 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.547 0.689 . . . . 73.41 110.86 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -4.52 14.24 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.714 2.276 . . . . 70.55 112.311 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.6 -56.15 3.03 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 61.44 112.523 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' GLY . . . . . 0.41 ' HA3' ' HD2' ' A' ' 107' ' ' PRO . . . 144.21 -131.49 4.41 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.666 -0.778 . . . . 34.0 112.433 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.41 ' HD2' ' HA3' ' A' ' 106' ' ' GLY . 54.1 Cg_endo -69.65 130.18 19.01 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.641 2.228 . . . . 65.23 112.315 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.82 HG13 ' H ' ' A' ' 110' ' ' ARG . 10.0 p -49.66 166.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 74.34 111.174 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.538 ' N ' HG22 ' A' ' 108' ' ' VAL . 5.5 m0 -47.44 -24.52 0.83 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.196 -0.457 . . . . 63.24 110.958 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' ARG . . . . . 0.82 ' H ' HG13 ' A' ' 108' ' ' VAL . 7.3 mtt180 70.82 26.3 3.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.234 -0.439 . . . . 73.44 110.866 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -121.74 145.46 48.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 75.45 110.935 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.814 ' HA ' HD12 ' A' ' 147' ' ' LEU . 5.3 p80 -100.51 29.39 4.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.414 . . . . 65.04 110.864 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -130.75 82.69 2.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 74.43 110.903 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.585 HG22 ' N ' ' A' ' 115' ' ' THR . 5.0 mp -109.99 163.36 7.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 73.25 111.153 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.699 HG23 ' HA ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -160.65 164.71 31.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 73.4 111.111 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.632 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 5.1 p90 -133.56 145.12 49.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.481 . . . . 72.22 110.977 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.665 ' HD2' HD11 ' A' ' 160' ' ' LEU . 3.9 tmt_? -136.42 110.06 8.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 71.13 110.849 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 52.5 mt -70.73 105.83 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 74.53 111.077 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -60.51 -47.47 86.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 62.3 110.822 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.669 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.2 p-10 -141.53 162.9 34.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 74.4 110.849 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.835 ' CE2' HG11 ' A' ' 130' ' ' VAL . 4.1 m-85 -116.57 144.29 44.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 75.24 110.964 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 124' ' ' ASP . 30.4 m -99.12 135.63 20.75 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.572 0.701 . . . . 65.53 111.133 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.471 ' HD2' HG23 ' A' ' 122' ' ' THR . 54.0 Cg_endo -69.74 10.87 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.728 2.285 . . . . 63.12 112.338 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' ASP . . . . . 0.507 ' H ' HG22 ' A' ' 122' ' ' THR . 1.6 m-20 -87.89 -26.73 22.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 62.25 110.861 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.697 ' HE2' HD22 ' A' ' 212' ' ' LEU . 0.1 OUTLIER -112.76 160.12 18.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 71.11 110.851 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -86.84 152.02 22.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.15 110.956 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -45.44 -39.63 7.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 74.13 110.885 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.01 -38.22 53.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 74.41 110.939 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' ASP . . . . . 0.775 ' OD1' HG23 ' A' ' 205' ' ' THR . 38.8 t0 -61.39 -35.87 78.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.081 -0.509 . . . . 70.44 110.89 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.835 HG11 ' CE2' ' A' ' 121' ' ' TYR . 95.0 t -60.9 -44.86 98.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 70.2 111.122 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 1.0 OUTLIER -83.18 -23.04 33.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 60.13 110.92 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -76.43 -51.87 10.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 74.4 110.888 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.721 ' HB1' ' N ' ' A' ' 213' ' ' PHE . . . -66.59 -30.62 70.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 72.53 111.161 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.538 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.4 mp -77.31 -58.17 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 64.44 111.094 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.538 ' N ' HG22 ' A' ' 134' ' ' ILE . 6.2 ttm180 -48.06 -47.06 34.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 73.53 110.884 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.689 ' O ' HG23 ' A' ' 140' ' ' VAL . 5.8 mmpt? -67.62 -33.98 76.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 71.04 110.879 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.972 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -61.55 -49.47 76.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 71.22 111.119 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.632 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 96.5 m-85 -73.63 -21.9 60.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 64.12 110.856 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.442 ' HB2' ' O ' ' A' ' 135' ' ' ARG . 2.6 tt0 -77.8 -5.21 50.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 75.04 110.916 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 136' ' ' LYS . 94.9 t -99.14 -17.59 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 62.31 111.112 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.821 ' NE1' HG12 ' A' ' 217' ' ' VAL . 97.0 m95 -106.89 -38.23 6.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.1 -0.5 . . . . 74.21 110.919 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.99 -10.72 59.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.008 0.432 . . . . 61.42 110.912 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -97.24 -17.49 19.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 73.42 110.873 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.803 HG11 HD12 ' A' ' 250' ' ' LEU . 18.1 m -100.2 -3.89 9.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 64.24 111.087 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.779 ' CB ' HD23 ' A' ' 147' ' ' LEU . 44.6 p -142.89 148.4 45.58 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.572 0.701 . . . . 73.21 111.119 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.82 35.01 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.663 2.242 . . . . 71.33 112.34 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.916 HD21 ' HB3' ' A' ' 262' ' ' TYR . 2.8 mm? -104.58 166.28 10.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 65.21 110.95 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 148' ' ' LYS . . . . . 0.416 ' HD2' ' HB2' ' A' ' 112' ' ' HIS . 0.5 OUTLIER -129.21 129.36 44.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 74.02 110.869 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.453 ' HE1' HD13 ' A' ' 114' ' ' ILE . 4.1 m-30 -115.48 137.66 51.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 74.45 110.909 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 150' ' ' SER . . . . . 0.455 ' H ' ' HA ' ' A' ' 115' ' ' THR . 6.3 t -125.26 162.77 23.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 42.21 110.852 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 7.9 tttt -119.5 142.2 48.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 73.22 110.853 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.917 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 0.3 OUTLIER -150.95 166.68 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 72.42 111.158 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 47.2 m-20 -131.36 18.55 4.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 73.04 110.867 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 154' ' ' THR . . . . . 0.447 HG23 ' N ' ' A' ' 155' ' ' GLY . 10.1 t -95.3 -42.6 8.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 71.24 111.209 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.447 ' N ' HG23 ' A' ' 154' ' ' THR . . . 133.53 7.17 2.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 41.41 112.482 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 156' ' ' MET . . . . . 0.41 ' H ' HG23 ' A' ' 154' ' ' THR . 2.9 ttp -103.62 80.98 1.85 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.884 0.373 . . . . 62.42 110.913 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.917 ' HB2' ' CD1' ' A' ' 152' ' ' ILE . . . -151.13 163.37 38.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 74.21 111.12 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 158' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.4 OUTLIER -85.93 -50.93 6.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 73.34 110.907 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.612 HG12 HG23 ' A' ' 220' ' ' ILE . 2.3 mp -92.57 91.59 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 73.12 111.177 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.665 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.4 tp -83.11 109.02 16.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.219 -0.446 . . . . 71.41 110.902 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 161' ' ' VAL . . . . . 0.443 HG13 ' CE1' ' A' ' 197' ' ' PHE . 97.2 t -87.48 119.05 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 61.32 111.178 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.669 HG23 ' OD1' ' A' ' 120' ' ' ASN . 1.8 p -137.75 103.89 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 72.11 111.114 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 163' ' ' PHE . . . . . 0.418 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 36.7 m-85 -72.66 110.25 6.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 63.11 110.871 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.57 166.9 20.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 71.21 111.115 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.16 137.74 51.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 72.35 110.837 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.684 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.93 -155.74 0.23 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.716 -0.754 . . . . 63.32 112.512 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.811 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -64.51 116.73 6.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.77 0.319 . . . . 64.34 111.105 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.706 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.15 -22.22 12.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 73.32 110.94 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.04 30.35 0.53 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.67 -0.776 . . . . 62.32 112.456 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.638 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -114.47 1.24 14.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.766 0.317 . . . . 70.52 110.824 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 73.05 39.75 0.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 72.24 110.763 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.706 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.25 -41.23 0.73 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 71.14 110.955 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.811 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.02 100.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 73.4 111.11 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.684 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -60.56 -168.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 64.24 110.909 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.87 19.07 3.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 71.1 110.835 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.589 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.64 -158.22 6.22 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.758 -0.734 . . . . 61.35 112.559 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 176' ' ' GLY . 5.4 tmtt? -34.69 134.25 0.23 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.878 0.371 . . . . 72.01 110.908 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.02 164.66 0.16 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.739 -0.743 . . . . 71.03 112.494 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.469 ' O ' HD22 ' A' ' 181' ' ' LEU . . . 82.97 -142.85 21.8 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 61.54 112.509 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -50.45 96.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.819 0.343 . . . . 53.42 111.094 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.469 HD22 ' O ' ' A' ' 179' ' ' GLY . 3.0 mm? -65.94 -42.94 89.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 74.4 110.92 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -171.09 163.36 7.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 64.31 111.158 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.48 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.2 p80 -156.06 142.96 18.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 72.34 110.881 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.734 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -139.01 172.51 12.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 74.25 111.074 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.537 ' O ' ' O ' ' A' ' 222' ' ' HIS . 46.9 m-85 -101.12 -145.51 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 61.03 110.918 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -168.0 -86.21 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.774 -0.726 . . . . 63.04 112.456 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.73 54.15 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.755 2.304 . . . . 75.04 112.305 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.574 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.32 150.64 16.88 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.773 -0.727 . . . . 71.33 112.47 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 189' ' ' SER . . . . . 0.565 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.08 147.01 27.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 43.31 110.83 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 61.02 -66.21 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.845 -0.693 . . . . 60.44 112.441 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 191' ' ' ILE . . . . . 0.565 ' N ' ' O ' ' A' ' 189' ' ' SER . 5.8 mm -102.76 6.89 10.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.777 0.322 . . . . 74.5 111.068 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.574 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -66.96 168.85 36.18 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.748 -0.739 . . . . 75.33 112.47 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 45.27 18.71 0.18 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 70.41 112.488 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 194' ' ' ASP . . . . . 0.425 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 1.1 m-20 -63.08 102.5 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 73.01 110.85 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.734 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -76.99 132.22 38.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 74.44 111.06 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.48 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 4.8 m170 -123.22 129.53 51.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 71.34 110.868 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.499 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 42.5 m-85 -114.54 135.57 53.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 73.41 110.846 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -68.43 109.38 3.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 71.12 110.945 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -61.03 -36.1 78.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 73.44 110.935 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.589 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 18.0 m-20 -52.18 -20.7 2.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 53.33 110.849 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.4 ' HG3' HD13 ' A' ' 181' ' ' LEU . 6.5 mm-40 -81.57 161.14 23.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.457 . . . . 51.32 110.823 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.542 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -100.13 90.93 4.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 73.15 110.801 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.499 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 22.2 m95 -81.26 123.92 28.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 71.32 110.858 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 43.5 p -140.47 -176.36 4.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 62.11 111.06 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 205' ' ' THR . . . . . 0.775 HG23 ' OD1' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -110.28 19.86 18.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 74.22 111.201 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -128.34 -173.24 2.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 73.34 110.861 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.3 t -71.71 -18.84 62.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 65.21 110.869 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.06 -106.79 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.686 -0.769 . . . . 52.31 112.491 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.07 177.01 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.692 -0.766 . . . . 54.13 112.469 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 210' ' ' THR . . . . . 0.404 HG21 HD12 ' A' ' 181' ' ' LEU . 89.8 m -66.63 97.54 0.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 75.14 111.249 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -42.14 114.75 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 72.21 110.947 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.697 HD22 ' HE2' ' A' ' 125' ' ' MET . 27.1 tp -61.18 -32.46 72.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 62.24 111.0 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.782 ' O ' HG23 ' A' ' 217' ' ' VAL . 3.0 t80 -58.11 -65.23 0.68 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.096 -0.502 . . . . 75.44 110.98 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.581 HD21 ' CG2' ' A' ' 243' ' ' VAL . 8.9 mp -51.88 -54.43 29.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 74.11 110.957 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.49 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.7 m -55.64 -38.93 70.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 74.44 111.023 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.08 -48.81 77.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 63.43 111.093 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.972 HG22 ' HA ' ' A' ' 137' ' ' ALA . 1.9 t -54.83 -57.57 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 63.01 111.093 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.775 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.3 t-80 -64.87 -28.11 69.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 73.15 110.989 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -63.8 -46.53 84.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 61.53 111.067 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.612 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -68.02 -35.23 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 72.33 111.123 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -49.47 -45.91 36.96 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.671 -0.776 . . . . 62.32 112.474 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 222' ' ' HIS . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' PHE . 4.9 m-70 -68.32 -39.89 81.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.801 0.334 . . . . 73.24 110.866 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.563 ' OG ' HG23 ' A' ' 159' ' ' ILE . 14.0 m -66.15 -24.66 66.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 62.11 110.827 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.734 ' O ' HG23 ' A' ' 108' ' ' VAL . 43.1 mt -75.67 -25.92 57.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 62.41 110.964 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 124.45 11.16 4.7 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.746 -0.74 . . . . 64.12 112.454 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 258' ' ' ILE . 14.4 mt -90.03 142.71 27.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 75.3 110.912 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -93.05 -137.01 8.01 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.71 -0.757 . . . . 41.43 112.47 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -115.96 144.23 44.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.835 0.35 . . . . 75.25 110.872 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 77.6 p -102.85 167.05 10.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 60.13 110.836 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 65.6 m -109.54 5.07 22.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 71.04 110.853 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.527 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -72.75 135.55 80.83 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.524 0.678 . . . . 74.3 110.88 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -0.41 6.85 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.706 2.271 . . . . 75.5 112.326 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.11 26.39 1.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 75.14 110.944 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.527 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -97.55 144.34 27.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 73.12 111.042 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.775 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -63.94 -41.54 92.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 71.13 111.143 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 34.7 mmm -59.86 -18.76 46.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 71.24 110.83 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.604 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -57.38 144.62 70.69 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.68 0.753 . . . . 74.21 110.875 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.604 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.1 Cg_endo -69.95 -1.78 9.2 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.709 2.273 . . . . 51.53 112.34 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.7 m -95.24 137.28 34.5 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.159 -0.473 . . . . 53.35 111.177 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -118.76 135.88 54.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 75.24 110.932 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -154.93 131.43 10.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 61.22 110.926 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.53 ' O ' HG13 ' A' ' 243' ' ' VAL . 80.1 t80 -60.15 145.43 46.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.18 -0.464 . . . . 71.04 110.87 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.581 ' CG2' HD21 ' A' ' 214' ' ' LEU . 0.3 OUTLIER -159.87 132.51 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 73.43 111.141 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -50.16 128.17 18.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 75.44 110.894 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.618 HD11 ' HD3' ' A' ' 136' ' ' LYS . 14.0 tt -51.13 -33.77 13.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.208 -0.451 . . . . 73.14 111.078 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 10.6 m120 -69.68 -23.27 63.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 74.5 110.837 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 29.6 p -101.33 -24.42 14.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 74.1 111.125 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -64.31 144.28 57.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 63.33 110.834 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -175.04 131.19 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 74.22 110.846 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.803 HD12 HG11 ' A' ' 144' ' ' VAL . 33.8 mt -49.81 124.56 10.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 75.44 110.891 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.34 167.08 15.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 54.21 110.785 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.61 -39.17 49.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.089 -0.505 . . . . 71.03 111.159 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.9 -46.92 85.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 74.42 110.821 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.433 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 6.9 m-20 -61.36 -54.49 43.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 65.43 110.866 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 23.0 mt -60.58 -35.01 60.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 74.01 111.159 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -68.75 -39.78 80.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.454 . . . . 71.11 110.861 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.03 -51.19 7.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 73.33 112.506 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.663 HG13 HG21 ' A' ' 145' ' ' THR . 6.2 tp -53.23 -34.37 21.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.794 0.33 . . . . 72.14 111.205 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 263' ' ' GLY . 31.2 mt-30 -87.86 -16.13 34.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 71.13 110.942 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.4 t -69.33 -16.52 63.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 70.21 110.902 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.795 HD11 ' HG2' ' A' ' 102' ' ' GLU . 2.1 mt -120.76 -19.42 7.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.509 . . . . 72.0 110.86 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.916 ' HB3' HD21 ' A' ' 147' ' ' LEU . 29.7 m-85 -110.17 -37.25 5.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 62.15 110.908 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.335 0 CA-C-O 119.194 -0.781 . . . . 72.05 112.475 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.827 0.346 . . . . 75.21 110.848 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 101' ' ' ARG . . . . . 0.402 ' HG2' ' HB3' ' A' ' 229' ' ' SER . 0.0 OUTLIER 50.09 59.95 4.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 71.31 110.874 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 102' ' ' GLU . . . . . 0.655 ' HB2' HD11 ' A' ' 261' ' ' LEU . 4.6 pt-20 -178.66 135.83 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.123 -0.489 . . . . 72.23 110.867 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.4 tpt -51.76 135.35 36.16 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.557 0.694 . . . . 71.14 110.869 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 73.95 1.3 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.639 2.226 . . . . 74.11 112.394 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 110.38 25.88 5.08 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.714 -0.755 . . . . 72.52 112.46 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.83 111.53 2.54 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.78 -0.724 . . . . 53.33 112.428 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 107' ' ' PRO . . . . . 0.601 ' O ' HG22 ' A' ' 108' ' ' VAL . 54.1 Cg_endo -69.78 4.2 2.34 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.665 2.243 . . . . 62.32 112.299 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.73 HG11 HD13 ' A' ' 261' ' ' LEU . 17.7 m 45.16 30.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.305 -0.407 . . . . 74.32 111.14 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' TRP . . . . . 0.417 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 10.4 m0 76.22 -40.67 0.4 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.137 -0.483 . . . . 74.15 110.828 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.7 mtt-85 70.9 31.94 2.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 74.33 110.906 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -122.34 161.44 23.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 64.55 110.895 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 112' ' ' HIS . . . . . 0.464 ' HA ' HD22 ' A' ' 147' ' ' LEU . 3.3 p80 -109.63 20.64 17.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 62.04 110.859 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -125.96 96.41 4.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.187 -0.461 . . . . 73.51 110.975 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ILE . . . . . 0.613 HG22 ' N ' ' A' ' 115' ' ' THR . 4.8 mp -123.29 163.93 21.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 71.24 111.161 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' THR . . . . . 0.613 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -157.72 163.64 37.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 72.44 111.226 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' TYR . . . . . 0.593 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.7 p90 -133.53 144.63 49.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 64.53 110.926 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' ARG . . . . . 0.646 ' HD2' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -138.84 108.86 6.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.486 . . . . 53.35 110.83 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 53.2 mt -70.66 106.03 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 74.12 111.124 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 3.9 t30 -60.39 -47.43 86.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 71.52 110.921 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ASN . . . . . 0.701 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.3 p-10 -141.17 162.52 35.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 75.24 110.96 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' TYR . . . . . 0.575 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.1 m-85 -116.35 145.55 43.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.187 -0.46 . . . . 73.33 110.927 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' THR . . . . . 0.522 ' CG2' ' HD2' ' A' ' 123' ' ' PRO . 3.6 m -93.01 137.9 23.53 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.581 0.705 . . . . 51.24 111.147 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' PRO . . . . . 0.522 ' HD2' ' CG2' ' A' ' 122' ' ' THR . 54.2 Cg_endo -69.85 0.6 5.48 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.635 2.223 . . . . 75.04 112.323 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -84.08 -24.23 30.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 71.33 110.844 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 125' ' ' MET . . . . . 0.67 ' SD ' HD22 ' A' ' 212' ' ' LEU . 3.8 mtm -113.12 167.37 10.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 74.32 110.853 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -92.96 143.41 26.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 73.44 110.974 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -45.36 -36.22 4.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 71.3 110.877 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -83.38 -38.23 22.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 74.33 110.908 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -64.12 -31.8 73.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 75.21 110.828 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' VAL . . . . . 0.575 HG11 ' CE2' ' A' ' 121' ' ' TYR . 56.4 t -65.61 -46.21 90.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 74.21 111.105 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 0.2 OUTLIER -78.49 -23.53 46.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 51.43 110.88 179.902 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -74.93 -48.02 26.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 74.04 110.955 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' ALA . . . . . 0.672 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -68.88 -31.18 69.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 35.41 111.112 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' ILE . . . . . 0.518 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.3 mp -73.8 -53.93 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 62.13 111.161 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 135' ' ' ARG . . . . . 0.518 ' N ' HG22 ' A' ' 134' ' ' ILE . 3.8 ptm180 -49.22 -37.34 22.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 74.2 110.832 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 136' ' ' LYS . . . . . 0.731 ' O ' HG23 ' A' ' 140' ' ' VAL . 5.6 mmpt? -76.97 -34.34 57.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 73.14 110.854 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 137' ' ' ALA . . . . . 0.911 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.12 -48.66 80.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 60.41 111.134 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 138' ' ' PHE . . . . . 0.623 ' HE1' HD13 ' A' ' 159' ' ' ILE . 96.0 m-85 -72.84 -22.79 60.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 75.34 110.942 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 139' ' ' GLN . . . . . 0.436 ' HB2' ' O ' ' A' ' 135' ' ' ARG . 2.4 tt0 -77.78 -5.78 51.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.116 -0.493 . . . . 65.21 110.917 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 140' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 136' ' ' LYS . 83.8 t -97.94 -16.77 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 71.53 111.066 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 141' ' ' TRP . . . . . 0.813 ' NE1' HG12 ' A' ' 217' ' ' VAL . 92.1 m95 -107.09 -38.26 6.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.264 -0.426 . . . . 72.41 110.917 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.95 -11.53 60.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 51.03 110.814 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 143' ' ' ASN . . . . . . . . . . . . . 2.6 m120 -95.53 -17.49 21.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 72.41 110.849 -179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 144' ' ' VAL . . . . . 0.685 HG11 HD12 ' A' ' 250' ' ' LEU . 22.4 m -99.86 2.72 10.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 75.34 111.084 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 145' ' ' THR . . . . . 0.587 HG21 HG13 ' A' ' 258' ' ' ILE . 44.5 p -150.99 148.69 23.34 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.537 0.684 . . . . 73.41 111.208 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.71 31.09 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.673 2.249 . . . . 72.12 112.357 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 147' ' ' LEU . . . . . 0.772 HD11 ' CD2' ' A' ' 262' ' ' TYR . 15.4 mt -97.44 175.01 6.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 71.42 110.937 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm -139.05 126.77 22.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 74.41 110.768 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 149' ' ' PHE . . . . . 0.57 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.7 m-85 -115.4 138.36 51.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 75.2 110.898 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 58.5 m -132.57 149.26 52.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 71.24 110.919 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 151' ' ' LYS . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 4.4 tttt -99.52 141.05 32.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 64.23 110.9 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 152' ' ' ILE . . . . . 0.597 HD11 ' N ' ' A' ' 157' ' ' ALA . 15.5 pt -150.75 139.26 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 72.34 111.121 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.41 5.35 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 55.32 110.896 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 10.0 t -163.5 47.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 70.1 111.16 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 155' ' ' GLY . . . . . 0.507 ' CA ' HD12 ' A' ' 152' ' ' ILE . . . -144.4 -153.19 5.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.702 -0.761 . . . . 51.33 112.431 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 38.9 mmt -107.61 95.63 5.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.823 0.344 . . . . 75.01 110.862 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 157' ' ' ALA . . . . . 0.597 ' N ' HD11 ' A' ' 152' ' ' ILE . . . -105.64 158.23 16.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 51.44 111.075 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.02 -57.41 2.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 73.11 110.875 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 159' ' ' ILE . . . . . 0.683 HG12 HG23 ' A' ' 220' ' ' ILE . 2.8 mp -82.52 86.26 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 64.12 111.139 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 160' ' ' LEU . . . . . 0.646 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.9 tp -79.76 102.78 9.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 70.45 110.84 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 96.7 t -82.3 123.08 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 63.45 111.148 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 162' ' ' VAL . . . . . 0.701 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.1 p -140.97 100.05 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 64.51 111.173 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -67.53 109.39 3.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 75.01 110.877 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.76 165.76 20.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.112 -0.495 . . . . 60.41 111.065 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -113.65 134.85 54.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 74.24 110.847 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 166' ' ' GLY . . . . . 0.665 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.83 -156.98 0.16 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.677 -0.773 . . . . 55.13 112.509 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 167' ' ' ALA . . . . . 0.81 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -62.76 115.37 4.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.883 0.373 . . . . 72.03 111.072 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 168' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -108.39 -21.07 12.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 75.45 110.876 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.89 30.1 0.59 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.684 -0.77 . . . . 42.31 112.482 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 170' ' ' ASP . . . . . 0.638 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.49 -0.96 14.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.888 0.375 . . . . 45.04 110.872 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 75.37 38.05 0.42 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 73.42 110.877 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 172' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -133.95 -41.14 0.83 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 71.04 110.853 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 173' ' ' ALA . . . . . 0.81 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.26 100.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 74.43 111.172 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 174' ' ' PHE . . . . . 0.665 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -61.03 -168.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 72.15 110.862 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.12 17.5 4.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 54.45 110.883 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 176' ' ' GLY . . . . . 0.577 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.06 -157.41 7.36 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.748 -0.739 . . . . 54.14 112.5 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 177' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -34.41 134.42 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.905 0.383 . . . . 65.22 110.868 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.62 165.95 0.12 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.687 -0.768 . . . . 62.54 112.555 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 179' ' ' GLY . . . . . 0.422 ' O ' HD22 ' A' ' 181' ' ' LEU . . . 82.56 -143.19 22.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.708 -0.758 . . . . 64.33 112.488 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.23 96.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.867 0.365 . . . . 73.5 111.139 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 181' ' ' LEU . . . . . 0.499 HD13 ' HG3' ' A' ' 201' ' ' GLU . 2.7 mm? -66.98 -36.04 81.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 60.45 110.949 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 182' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -174.74 169.0 3.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 52.34 111.11 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 183' ' ' HIS . . . . . 0.45 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.2 p80 -161.27 142.28 11.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.275 -0.421 . . . . 75.4 110.881 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 184' ' ' ALA . . . . . 0.607 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -140.75 170.3 16.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 71.45 111.135 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 185' ' ' PHE . . . . . 0.641 ' O ' ' HA ' ' A' ' 223' ' ' SER . 1.8 m-85 -125.64 167.93 14.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 74.44 110.93 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 186' ' ' GLY . . . . . 0.739 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -138.18 32.69 2.32 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.787 -0.721 . . . . 74.02 112.569 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 187' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 186' ' ' GLY . 53.9 Cg_endo -69.75 -23.27 31.05 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 122.694 2.263 . . . . 72.21 112.325 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 188' ' ' GLY . . . . . 0.423 ' H ' ' CA ' ' A' ' 192' ' ' GLY . . . 90.2 135.41 6.0 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.763 -0.732 . . . . 75.24 112.5 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.0 t 64.46 148.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.827 0.346 . . . . 75.42 110.871 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 47.95 -102.07 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.731 -0.747 . . . . 71.04 112.432 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 40.3 pt -77.84 6.63 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.85 0.357 . . . . 64.23 111.118 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 192' ' ' GLY . . . . . 0.483 ' HA2' ' HD2' ' A' ' 187' ' ' PRO . . . -74.76 121.54 6.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.766 -0.731 . . . . 63.23 112.483 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 193' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 75.2 -9.39 13.13 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.75 -0.738 . . . . 45.01 112.514 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.17 109.51 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.885 0.374 . . . . 72.21 110.883 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 195' ' ' ALA . . . . . 0.607 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -98.83 138.04 36.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 74.55 111.151 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 196' ' ' HIS . . . . . 0.455 ' O ' ' HB1' ' A' ' 182' ' ' ALA . 4.9 m170 -125.26 137.62 54.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.316 -0.402 . . . . 73.42 110.859 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 197' ' ' PHE . . . . . 0.415 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 37.8 m-85 -120.03 142.44 48.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 74.43 110.869 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -73.8 109.11 7.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 75.4 110.779 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -62.1 -35.66 79.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 74.24 110.85 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 200' ' ' ASP . . . . . 0.577 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 12.0 m-20 -51.24 -21.56 2.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 71.52 110.87 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 201' ' ' GLU . . . . . 0.499 ' HG3' HD13 ' A' ' 181' ' ' LEU . 5.8 mm-40 -81.54 161.29 23.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 74.42 110.97 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 202' ' ' PHE . . . . . 0.564 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -99.47 88.32 3.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 73.45 110.917 -179.887 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 203' ' ' TRP . . . . . 0.491 ' CZ3' HG21 ' A' ' 215' ' ' THR . 33.7 m95 -78.15 123.22 26.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 71.42 110.887 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 32.6 p -139.64 -176.32 4.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 70.22 111.146 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.77 17.27 19.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 72.14 111.112 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 -176.05 3.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 54.54 110.843 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.8 t -66.69 -18.51 65.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.272 -0.422 . . . . 73.44 110.86 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.49 -108.3 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 71.22 112.528 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 209' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.63 176.82 0.13 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.788 -0.72 . . . . 43.45 112.415 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 94.5 m -65.62 97.95 0.35 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.799 0.333 . . . . 72.31 111.105 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -42.0 117.11 0.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 72.2 110.95 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 212' ' ' LEU . . . . . 0.67 HD22 ' SD ' ' A' ' 125' ' ' MET . 30.4 tp -64.82 -36.72 85.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 61.51 110.901 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 213' ' ' PHE . . . . . 0.761 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.4 t80 -53.84 -65.45 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 44.25 110.791 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 214' ' ' LEU . . . . . 0.511 HD11 ' H ' ' A' ' 243' ' ' VAL . 18.8 mt -53.12 -54.97 27.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.489 . . . . 74.13 110.894 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 215' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 219' ' ' ALA . 6.2 m -54.81 -38.41 67.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 74.12 111.099 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.19 -50.04 71.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 61.41 111.134 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 217' ' ' VAL . . . . . 0.911 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.1 t -51.67 -59.6 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 60.12 111.115 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 218' ' ' HIS . . . . . 0.741 ' HB2' HG13 ' A' ' 235' ' ' VAL . 2.1 t-80 -65.07 -28.11 69.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 62.0 110.856 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 219' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -63.81 -46.07 86.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 42.42 111.112 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 220' ' ' ILE . . . . . 0.683 HG23 HG12 ' A' ' 159' ' ' ILE . 2.8 mt -66.05 -34.66 71.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 73.33 111.197 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 221' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -53.69 -44.38 69.34 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.753 -0.736 . . . . 32.44 112.499 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -69.54 -34.92 74.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.724 0.297 . . . . 70.41 110.811 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 223' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 4.0 p -70.41 -24.85 63.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.275 -0.42 . . . . 71.33 110.895 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 224' ' ' LEU . . . . . 0.461 HD21 HG21 ' A' ' 114' ' ' ILE . 45.6 mt -76.93 -27.35 54.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 71.22 110.962 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 225' ' ' GLY . . . . . 0.547 ' HA3' HG12 ' A' ' 108' ' ' VAL . . . 120.29 16.32 4.78 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.779 -0.724 . . . . 72.44 112.553 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 226' ' ' LEU . . . . . 0.888 HD21 ' HA ' ' A' ' 258' ' ' ILE . 15.3 mt -79.59 162.87 25.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 75.52 110.937 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -105.38 -133.17 7.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.755 -0.736 . . . . 43.31 112.411 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 228' ' ' HIS . . . . . 0.415 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.3 OUTLIER -131.2 148.86 52.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 64.12 110.805 -179.851 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 229' ' ' SER . . . . . 0.402 ' HB3' ' HG2' ' A' ' 101' ' ' ARG . 86.7 p -108.62 166.44 10.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 73.41 110.864 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.53 0.46 20.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 64.21 110.872 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 231' ' ' ASP . . . . . 0.532 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -68.64 133.9 90.6 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.606 0.717 . . . . 73.04 110.85 179.872 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 0.59 5.44 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.706 2.271 . . . . 73.55 112.277 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.91 19.07 2.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 72.35 110.926 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 234' ' ' ALA . . . . . 0.532 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -91.49 140.26 29.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 55.14 111.082 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 235' ' ' VAL . . . . . 0.741 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.0 OUTLIER -61.16 -41.18 88.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.235 -0.439 . . . . 75.02 111.137 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 236' ' ' MET . . . . . 0.415 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 53.9 mmm -58.68 -20.75 51.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 73.24 110.895 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 237' ' ' PHE . . . . . 0.6 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.0 t80 -55.63 144.03 56.44 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.712 0.768 . . . . 62.5 110.902 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 238' ' ' PRO . . . . . 0.6 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.8 Cg_endo -69.67 0.79 5.07 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.749 2.299 . . . . 74.42 112.315 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 239' ' ' THR . . . . . 0.434 ' HG1' ' HD2' ' A' ' 237' ' ' PHE . 30.7 m -97.32 138.91 34.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 65.22 111.166 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -120.87 137.05 54.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 71.13 110.937 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -157.4 137.27 12.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 61.31 110.912 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 242' ' ' TYR . . . . . 0.548 ' O ' HG13 ' A' ' 243' ' ' VAL . 73.9 t80 -61.44 146.91 46.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 72.45 110.913 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 243' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.3 OUTLIER -160.46 132.52 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 75.31 111.183 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -50.11 132.05 23.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 64.43 110.874 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 245' ' ' ILE . . . . . 0.458 HD11 ' HD3' ' A' ' 136' ' ' LYS . 7.3 tt -54.65 -30.63 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 71.21 111.138 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -76.17 -18.24 59.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 73.25 110.885 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 60.1 p -105.01 -22.77 13.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 73.42 111.072 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -69.67 142.97 53.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.429 . . . . 61.23 110.889 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -176.43 131.68 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 73.2 110.857 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 250' ' ' LEU . . . . . 0.685 HD12 HG11 ' A' ' 144' ' ' VAL . 80.2 mt -49.42 128.85 17.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 74.33 110.95 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 251' ' ' SER . . . . . 0.448 ' O ' HD12 ' A' ' 255' ' ' ILE . 8.2 m -76.52 169.97 17.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 74.3 110.899 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.74 -43.24 47.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 70.31 111.069 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.17 -49.08 79.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 75.51 110.821 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 254' ' ' ASP . . . . . 0.464 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 16.3 m-20 -57.22 -54.8 42.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 71.34 110.811 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 255' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 251' ' ' SER . 2.9 mt -59.73 -39.59 80.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.437 . . . . 73.51 111.17 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -64.1 -39.84 94.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 75.43 110.909 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 257' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -75.28 -54.01 5.83 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.766 -0.731 . . . . 54.33 112.459 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 258' ' ' ILE . . . . . 0.888 ' HA ' HD21 ' A' ' 226' ' ' LEU . 4.5 tp -53.09 -35.72 23.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.775 0.322 . . . . 65.15 111.075 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 259' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 263' ' ' GLY . 87.0 mt-30 -85.82 -17.22 36.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 53.14 110.948 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 260' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 3.2 t -69.0 -14.29 62.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 72.4 110.834 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 261' ' ' LEU . . . . . 0.73 HD13 HG11 ' A' ' 108' ' ' VAL . 2.7 mt -123.91 -18.4 6.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 63.24 110.838 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 262' ' ' TYR . . . . . 0.772 ' CD2' HD11 ' A' ' 147' ' ' LEU . 36.8 m-85 -113.43 -33.98 5.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 64.42 110.925 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 263' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.429 0 CA-C-O 119.133 -0.815 . . . . 71.3 112.507 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.402 ' HA ' ' HG ' ' A' ' 147' ' ' LEU . 16.0 p80 . . . . . 0 C--O 1.231 0.096 0 CA-C-O 120.801 0.334 . . . . 74.51 110.845 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.405 ' C ' HD12 ' A' ' 114' ' ' ILE . 0.9 OUTLIER -121.37 110.96 16.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 64.11 110.921 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 115' ' ' THR . 4.9 mp -141.06 162.1 22.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 74.12 111.129 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.574 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -157.58 163.54 38.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 73.1 111.135 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.622 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 4.2 p90 -134.53 146.91 50.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 73.43 110.956 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.466 ' HD2' HD11 ' A' ' 160' ' ' LEU . 4.3 tmt_? -141.63 111.82 6.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 72.24 110.901 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.9 mt -73.83 106.86 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 72.01 111.137 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -58.89 -50.43 74.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 71.32 110.893 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.62 ' OD1' HG23 ' A' ' 162' ' ' VAL . 3.3 p-10 -140.17 165.22 27.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 43.44 110.907 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -118.15 138.88 51.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 74.01 110.896 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.754 HG22 ' HE2' ' A' ' 125' ' ' MET . 2.5 t -88.11 143.01 32.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.538 0.685 . . . . 74.14 111.163 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.408 ' HD2' ' OG1' ' A' ' 122' ' ' THR . 53.6 Cg_endo -69.77 -3.11 11.37 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.658 2.239 . . . . 75.4 112.361 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.462 ' H ' HG23 ' A' ' 122' ' ' THR . 13.7 m-20 -80.83 -23.27 39.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 65.01 110.855 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.754 ' HE2' HG22 ' A' ' 122' ' ' THR . 16.2 mtm -115.05 166.03 12.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 43.43 110.869 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -98.17 145.62 26.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 75.1 110.863 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -45.43 -34.49 3.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 74.21 110.928 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -82.32 -40.73 21.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 73.55 110.896 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -63.78 -31.13 72.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 73.2 110.839 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.47 ' O ' HD13 ' A' ' 134' ' ' ILE . 59.5 t -63.86 -45.46 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 71.13 111.158 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.3 -23.47 40.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.151 -0.477 . . . . 73.53 110.879 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -75.26 -47.33 28.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 64.34 110.941 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.754 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -71.2 -31.07 67.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 74.14 111.108 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.625 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -73.7 -55.23 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 74.13 111.145 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.53 ' N ' HG22 ' A' ' 134' ' ' ILE . 5.3 ttt180 -48.56 -42.54 33.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 63.51 110.896 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.614 ' O ' HG23 ' A' ' 140' ' ' VAL . 8.7 mmpt? -70.87 -35.51 72.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 72.24 110.905 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.91 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.0 -48.85 80.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 42.4 111.101 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.622 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 93.3 m-85 -72.6 -22.32 60.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 63.33 110.814 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.522 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.2 OUTLIER -77.28 -6.24 52.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 75.1 110.941 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 136' ' ' LYS . 93.8 t -97.31 -17.56 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 12.35 111.131 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.796 ' NE1' HG12 ' A' ' 217' ' ' VAL . 95.3 m95 -106.18 -36.39 6.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 73.3 110.939 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.82 -11.54 61.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 74.1 110.823 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.621 HD22 ' N ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER -95.61 -18.44 20.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 71.02 110.933 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.844 HG11 HD12 ' A' ' 250' ' ' LEU . 19.9 m -98.42 1.24 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 75.2 111.108 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.568 HG21 HG13 ' A' ' 258' ' ' ILE . 39.0 p -151.96 146.24 18.44 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.606 0.717 . . . . 74.14 111.14 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 30.59 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.625 2.217 . . . . 64.53 112.379 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.838 HD21 ' CG ' ' A' ' 262' ' ' TYR . 0.2 OUTLIER -91.76 177.48 6.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 53.5 110.939 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.23 125.59 20.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 73.32 110.904 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.549 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.9 m-30 -114.94 141.56 47.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 71.03 110.894 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.403 ' H ' ' HA ' ' A' ' 115' ' ' THR . 2.1 t -135.72 153.03 51.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 44.33 110.857 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.478 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 19.8 tttt -104.43 143.18 33.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 72.52 110.888 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.477 HD11 ' HB2' ' A' ' 157' ' ' ALA . 16.9 pt -152.32 155.52 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 73.31 111.083 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 8.5 m120 . . . . . 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 75.13 110.877 179.932 . . . . . . . . 0 0 . 1 . 001 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.477 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.231 0.11 0 CA-C-O 120.835 0.35 . . . . 62.0 111.078 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.5 OUTLIER -86.15 -52.7 5.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 75.31 110.86 179.969 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.668 HG12 HG23 ' A' ' 220' ' ' ILE . 2.4 mp -90.01 94.21 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 62.2 111.085 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.466 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.9 tp -86.5 107.75 18.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 73.03 110.895 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 88.4 t -84.97 121.63 37.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 75.33 111.172 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.62 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -140.25 105.43 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 74.22 111.127 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -73.31 110.27 7.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 73.02 110.889 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -126.98 166.83 16.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 72.23 111.131 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.72 133.1 55.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 75.24 110.853 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.676 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.36 -158.04 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 62.14 112.484 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.766 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -50.71 118.81 3.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 73.02 111.104 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.77 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 4.3 p-80 -137.65 32.5 2.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 75.35 110.854 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 79.11 53.43 4.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 60.31 112.478 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.461 ' OD2' ' CE1' ' A' ' 196' ' ' HIS . 23.7 t0 -143.15 9.34 1.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 75.54 110.88 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 54.16 22.36 3.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 74.11 110.86 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.77 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 2.1 p-80 -118.62 -38.9 3.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 73.41 110.848 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.766 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 50.43 99.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 72.3 111.114 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.676 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.4 m-85 -58.72 -170.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 74.43 110.862 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.69 21.21 4.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 61.41 110.862 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.583 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 52.53 -156.05 4.69 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 44.31 112.477 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.9 OUTLIER -33.77 132.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.829 0.347 . . . . 64.22 110.911 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.94 163.53 0.13 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.814 -0.708 . . . . 75.34 112.471 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.18 -142.25 19.64 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 74.33 112.452 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.2 mt -49.92 97.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 71.23 111.147 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.467 HD12 HG21 ' A' ' 210' ' ' THR . 2.9 mm? -66.8 -41.61 87.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 71.41 110.875 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 197' ' ' PHE . . . -174.74 158.47 2.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 71.21 111.08 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.433 ' CE1' ' OD2' ' A' ' 170' ' ' ASP . 0.3 OUTLIER -148.92 134.3 18.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.449 . . . . 61.32 110.847 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.781 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -131.71 175.39 9.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 72.24 111.134 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.534 ' O ' ' HA ' ' A' ' 223' ' ' SER . 65.7 m-85 -105.6 -152.93 0.48 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 73.42 110.853 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -160.74 -84.44 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.701 -0.761 . . . . 61.32 112.463 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 52.33 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.721 2.28 . . . . 61.44 112.331 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.59 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.56 150.02 17.16 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.781 -0.724 . . . . 41.13 112.499 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -105.54 147.75 28.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 55.33 110.804 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.27 -64.12 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 44.22 112.5 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 189' ' ' SER . 2.3 pp -107.15 8.42 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 73.31 111.119 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.59 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -69.53 169.5 44.27 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.775 -0.726 . . . . 72.44 112.482 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 46.78 18.35 0.38 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 40.34 112.496 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.14 110.4 2.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.333 . . . . 73.24 110.894 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.781 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -85.01 130.01 34.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 73.52 111.116 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.461 ' CE1' ' OD2' ' A' ' 170' ' ' ASP . 1.3 m170 -123.32 123.04 39.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 71.23 110.84 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.557 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 37.1 m-85 -106.5 138.54 42.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 74.12 110.889 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -68.37 105.37 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 73.32 110.86 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -55.53 -39.09 70.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 75.34 110.845 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.583 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 15.8 m-20 -48.37 -25.0 1.41 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 50.02 110.867 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -77.55 163.11 26.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 74.24 110.894 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.571 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -101.21 86.61 3.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 74.42 110.872 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.557 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 24.7 m95 -79.53 122.4 26.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 73.52 110.881 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.6 p -139.94 -172.83 3.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 64.2 111.148 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.02 19.6 17.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 72.31 111.155 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -126.93 -175.4 3.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 75.31 110.894 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 11.4 p -70.44 -18.84 63.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 54.45 110.891 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.63 -106.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.742 -0.742 . . . . 50.42 112.47 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.07 176.54 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.712 -0.756 . . . . 74.41 112.498 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.467 HG21 HD12 ' A' ' 181' ' ' LEU . 55.6 m -66.65 96.93 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 71.43 111.112 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -43.09 116.93 0.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.427 . . . . 73.42 110.85 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.754 HD23 ' HB3' ' A' ' 133' ' ' ALA . 9.0 tp -62.83 -37.31 86.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 61.42 110.924 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.737 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.6 t80 -51.59 -63.9 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 71.14 110.887 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.56 HD21 ' CG2' ' A' ' 243' ' ' VAL . 8.3 mp -54.6 -55.82 25.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 65.21 110.917 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.505 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 1.5 m -55.45 -32.92 63.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 73.53 111.157 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -68.12 -47.99 66.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 71.2 111.081 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.91 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -53.66 -58.01 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 55.14 111.115 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.744 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.8 t-80 -64.45 -29.38 70.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 73.01 110.867 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.31 -44.7 95.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 65.42 111.055 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.668 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -68.95 -35.11 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 70.52 111.121 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.65 -43.94 46.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.718 -0.753 . . . . 72.21 112.473 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 185' ' ' PHE . 28.2 m-70 -67.79 -39.06 84.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 71.3 110.868 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.655 ' OG ' HG23 ' A' ' 159' ' ' ILE . 3.1 m -63.3 -27.46 69.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 62.4 110.834 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 44.6 mt -75.52 -27.99 58.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 73.3 110.902 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 119.9 15.13 5.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.781 -0.723 . . . . 75.41 112.471 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.704 HD21 ' HA ' ' A' ' 258' ' ' ILE . 14.4 mt -79.02 158.18 27.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 64.14 110.912 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -104.07 -136.4 8.87 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.706 -0.759 . . . . 62.05 112.487 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 1.5 m170 -125.94 142.16 51.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.849 0.356 . . . . 72.31 110.817 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 21.7 m -104.7 162.75 13.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 75.22 110.87 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.0 t -103.86 0.71 30.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 54.44 110.871 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.598 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -66.24 136.98 95.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.618 0.723 . . . . 72.23 110.834 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -0.32 6.76 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.661 2.241 . . . . 72.14 112.322 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.03 17.36 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.42 . . . . 75.41 110.884 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.598 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -86.69 134.18 33.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 73.45 111.133 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.744 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -58.15 -36.2 56.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 74.41 111.129 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.428 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 44.2 mmm -61.56 -21.96 64.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 73.2 110.912 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.543 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.7 t80 -54.9 142.7 54.63 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.613 0.721 . . . . 74.54 110.898 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.543 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.3 Cg_endo -69.73 -1.46 8.49 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.695 2.263 . . . . 71.44 112.345 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 41.8 m -95.32 141.23 29.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 64.41 111.126 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -118.36 140.33 50.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 61.32 110.975 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -157.7 138.05 12.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 62.44 110.858 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.57 ' O ' HG13 ' A' ' 243' ' ' VAL . 77.9 t80 -68.77 145.4 53.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 72.44 110.923 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -162.27 133.22 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 72.43 111.081 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -51.37 130.31 26.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 73.43 110.867 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.49 HD11 ' HD3' ' A' ' 136' ' ' LYS . 16.4 tt -52.26 -30.81 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 74.32 111.139 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.439 HD22 HG23 ' A' ' 247' ' ' THR . 0.4 OUTLIER -67.68 -22.57 65.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 75.22 110.94 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.439 HG23 HD22 ' A' ' 246' ' ' ASN . 28.0 p -109.49 -20.83 12.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 74.42 111.173 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -69.12 121.28 16.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 72.3 110.905 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -152.98 143.11 22.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.32 110.835 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.844 HD12 HG11 ' A' ' 144' ' ' VAL . 33.2 mt -58.73 123.51 16.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 72.21 110.927 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 10.3 t -64.32 163.24 13.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 74.1 110.835 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.2 -37.95 24.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 33.53 111.101 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -63.81 -45.5 89.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 73.54 110.87 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.424 ' OD2' ' HB ' ' A' ' 235' ' ' VAL . 5.4 m-20 -61.94 -53.66 52.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 71.54 110.902 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.414 ' HA ' HG22 ' A' ' 258' ' ' ILE . 23.1 mt -62.03 -34.95 65.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 45.54 111.112 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -68.36 -40.5 81.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 73.44 110.831 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.06 -51.84 6.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 73.21 112.5 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.704 ' HA ' HD21 ' A' ' 226' ' ' LEU . 5.8 tp -52.51 -35.07 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.775 0.321 . . . . 62.33 111.1 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 263' ' ' GLY . 75.3 mt-30 -87.46 -17.24 32.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 73.14 110.911 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.5 t -69.75 -13.69 62.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 74.2 110.851 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.8 mt -123.55 -18.4 6.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 53.0 110.937 179.972 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.838 ' CG ' HD21 ' A' ' 147' ' ' LEU . 39.6 m-85 -114.56 -33.66 5.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 63.32 110.9 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.298 0 CA-C-O 119.123 -0.821 . . . . 71.12 112.505 179.961 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 4.5 p80 . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.791 0.329 . . . . 65.11 110.848 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.413 ' C ' HD12 ' A' ' 114' ' ' ILE . 4.0 m-85 -141.1 106.38 5.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 75.22 110.995 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.675 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.6 mp -139.77 163.76 24.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 74.44 111.204 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.603 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -157.91 163.67 37.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 71.52 111.126 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.61 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.4 p90 -132.67 148.62 52.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.254 -0.43 . . . . 70.42 110.953 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.667 ' HD2' HD11 ' A' ' 160' ' ' LEU . 3.7 tmt_? -142.84 113.33 7.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.515 . . . . 64.14 110.885 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.424 HD12 ' OH ' ' A' ' 121' ' ' TYR . 45.9 mt -74.25 106.54 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 75.14 111.179 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -61.34 -45.26 95.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 75.31 110.914 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.71 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.4 p-10 -144.1 161.92 37.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 73.42 110.931 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.642 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.1 m-85 -117.23 137.74 52.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 71.22 110.907 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.756 HG22 ' HE1' ' A' ' 125' ' ' MET . 9.3 t -88.31 142.51 31.57 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 121.648 0.737 . . . . 75.15 111.111 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 0.86 5.0 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.702 2.268 . . . . 64.42 112.405 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -82.81 -24.55 33.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.257 -0.429 . . . . 71.13 110.875 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.756 ' HE1' HG22 ' A' ' 122' ' ' THR . 5.8 mtm -116.46 165.7 12.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.282 -0.417 . . . . 53.04 110.838 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.474 ' O ' HG23 ' A' ' 130' ' ' VAL . 4.5 m120 -96.01 145.48 25.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 65.24 110.893 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.89 -34.85 4.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 73.13 110.909 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -83.04 -37.71 23.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 55.42 110.902 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -66.57 -29.67 69.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 62.33 110.894 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.662 HG22 ' CE ' ' A' ' 125' ' ' MET . 77.6 t -65.36 -46.75 89.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 65.52 111.154 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.52 -23.85 46.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 65.1 110.893 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -73.55 -46.39 47.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 72.52 110.943 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.697 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -72.66 -32.75 66.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 72.32 111.112 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.59 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -71.62 -53.59 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 75.43 111.155 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.533 ' N ' HG22 ' A' ' 134' ' ' ILE . 4.6 ttt-85 -49.22 -42.53 40.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 73.04 110.868 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.717 ' O ' HG23 ' A' ' 140' ' ' VAL . 9.5 mmtt -71.4 -33.93 69.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 74.12 110.852 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.884 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.54 -49.32 78.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 65.43 111.059 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.61 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.9 m-85 -72.13 -23.11 61.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 73.22 110.917 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.552 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.6 tt0 -77.05 -6.27 52.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 73.24 110.921 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 136' ' ' LYS . 92.7 t -97.22 -16.26 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 64.34 111.249 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.806 ' NE1' HG12 ' A' ' 217' ' ' VAL . 92.7 m95 -106.32 -33.17 7.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 64.31 110.869 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . 0.455 ' OG ' ' CD2' ' A' ' 149' ' ' PHE . 6.5 m -70.41 -15.66 62.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 72.33 110.832 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.557 HD22 ' N ' ' A' ' 143' ' ' ASN . 1.2 m-80 -91.41 -18.69 23.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 75.04 110.827 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.747 HG11 HD12 ' A' ' 250' ' ' LEU . 24.5 m -98.62 1.87 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 74.14 111.164 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 147' ' ' LEU . 15.7 p -154.79 145.16 15.91 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.62 0.724 . . . . 65.05 111.114 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 30.36 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.698 2.266 . . . . 63.14 112.354 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.727 HD21 ' CD1' ' A' ' 262' ' ' TYR . 2.7 mp -91.54 177.28 6.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 74.42 110.877 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.08 123.11 14.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 71.11 110.786 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.675 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.3 m-30 -114.55 140.12 49.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 74.43 110.962 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.0 m -132.78 155.81 48.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 53.31 110.878 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 5.0 tttt -102.72 140.52 36.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.114 -0.494 . . . . 71.23 110.884 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.54 HD11 ' N ' ' A' ' 157' ' ' ALA . 18.5 pt -150.74 139.04 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 74.0 111.095 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 75.32 110.928 179.881 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.54 ' N ' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.231 0.112 0 CA-C-O 120.785 0.326 . . . . 52.34 111.103 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.435 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.4 OUTLIER -85.76 -51.96 6.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 71.24 110.884 179.937 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.646 HG12 HG23 ' A' ' 220' ' ' ILE . 2.6 mp -90.45 92.98 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 74.33 111.079 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.667 HD11 ' HD2' ' A' ' 117' ' ' ARG . 6.9 tp -84.3 109.94 18.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.49 . . . . 73.02 110.978 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 92.3 t -87.47 118.57 33.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 73.31 111.16 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.71 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -137.97 106.09 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.269 -0.423 . . . . 65.33 111.135 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.406 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 46.7 m-85 -73.3 110.73 7.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 72.22 110.912 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -126.58 167.63 15.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 74.33 111.168 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -120.44 132.22 55.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 73.42 110.844 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.668 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.4 -157.44 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.743 -0.741 . . . . 73.41 112.53 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.762 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -51.08 119.04 3.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.773 0.32 . . . . 71.12 111.114 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.754 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 4.3 p-80 -137.98 31.9 2.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.434 . . . . 73.03 110.953 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 79.65 53.38 4.34 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.779 -0.724 . . . . 62.43 112.483 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.478 ' OD2' ' CE1' ' A' ' 196' ' ' HIS . 22.4 t0 -142.85 8.95 1.72 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 74.43 110.965 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 54.52 22.44 3.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.492 . . . . 73.02 110.875 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.754 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 2.0 p-80 -119.06 -38.92 2.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 64.11 110.873 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.762 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 50.45 99.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 64.34 111.11 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.668 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.4 m-85 -58.22 -171.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 51.11 110.919 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.21 20.64 4.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 71.23 110.856 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.573 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 53.01 -156.38 5.01 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.68 -0.771 . . . . 75.54 112.509 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 176' ' ' GLY . 12.7 tptt -33.34 132.02 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.858 0.361 . . . . 73.4 110.878 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.66 163.81 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.788 -0.72 . . . . 64.22 112.504 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.92 -142.25 19.84 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.739 -0.743 . . . . 50.04 112.503 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.1 mt -49.89 97.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 74.53 111.193 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.456 HD12 HG21 ' A' ' 210' ' ' THR . 2.8 mm? -66.8 -41.27 87.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 71.33 110.887 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 197' ' ' PHE . . . -174.83 158.25 2.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 23.44 111.114 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.45 ' CE1' ' CD2' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -148.96 134.69 18.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 72.43 110.911 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.815 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -131.92 175.53 9.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 75.44 111.079 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' ' 223' ' ' SER . 39.4 m-85 -104.63 -148.71 0.4 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 65.23 110.869 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -164.84 -83.58 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.818 -0.706 . . . . 64.44 112.605 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.79 51.87 0.95 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.732 2.288 . . . . 75.24 112.321 179.974 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.575 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.68 148.92 17.25 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.79 -0.719 . . . . 44.23 112.485 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -105.13 145.27 30.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 35.3 110.878 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.56 -62.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.643 -0.789 . . . . 74.1 112.588 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 189' ' ' SER . 5.8 mm -107.54 8.76 9.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.799 0.333 . . . . 71.12 111.076 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.575 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -70.84 171.26 45.33 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 73.44 112.468 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 45.24 19.67 0.24 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.75 -0.738 . . . . 63.54 112.478 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 192' ' ' GLY . 2.1 m-20 -65.57 108.45 2.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.772 0.32 . . . . 73.22 110.886 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.815 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -84.22 129.24 34.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 53.41 111.108 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.478 ' CE1' ' OD2' ' A' ' 170' ' ' ASP . 1.6 m170 -121.68 123.61 42.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 74.14 110.867 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.55 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 40.3 m-85 -106.3 137.17 44.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.925 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -67.17 105.17 1.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 65.14 110.878 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -55.59 -39.14 70.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 73.54 110.873 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.573 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 15.5 m-20 -47.92 -25.31 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.497 . . . . 74.25 110.832 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -77.21 162.92 27.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 73.54 110.907 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.607 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -101.13 85.32 2.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 74.42 110.811 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.55 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 24.8 m95 -77.61 123.26 26.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.438 . . . . 75.31 110.903 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . 0.412 HG23 ' HD1' ' A' ' 202' ' ' PHE . 41.0 p -140.21 -173.76 3.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 75.22 111.102 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.83 18.04 18.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.238 -0.437 . . . . 73.22 111.094 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.8 -177.64 4.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 74.04 110.849 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.8 p -66.12 -18.99 65.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 64.42 110.805 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.1 -107.69 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.748 -0.739 . . . . 73.3 112.449 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.13 177.29 0.15 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.727 -0.749 . . . . 53.12 112.523 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.456 HG21 HD12 ' A' ' 181' ' ' LEU . 88.1 m -66.78 97.51 0.47 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.755 0.312 . . . . 65.01 111.17 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -42.11 119.25 1.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 71.13 110.809 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.638 HD23 ' HB3' ' A' ' 133' ' ' ALA . 9.4 tp -65.53 -37.55 87.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 72.53 110.851 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.729 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.7 t80 -51.15 -64.96 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 72.11 110.91 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.533 HD11 ' H ' ' A' ' 243' ' ' VAL . 22.8 mt -53.53 -55.36 26.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.118 -0.492 . . . . 71.11 110.954 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.522 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 1.8 m -55.78 -33.28 64.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 71.15 111.181 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -68.05 -47.98 66.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 64.15 111.092 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.884 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -53.61 -57.93 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 71.25 111.119 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.76 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.7 t-80 -64.66 -28.14 69.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.123 -0.489 . . . . 72.01 110.907 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -63.86 -45.32 89.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 75.24 111.087 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.646 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -68.32 -35.89 72.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 72.04 111.141 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.61 -44.65 47.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.687 -0.768 . . . . 44.32 112.486 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.411 ' O ' ' O ' ' A' ' 185' ' ' PHE . 4.3 m-70 -68.32 -38.06 81.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.706 0.288 . . . . 74.15 110.809 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.606 ' OG ' HG23 ' A' ' 159' ' ' ILE . 7.1 m -64.27 -24.69 67.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 64.52 110.827 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 70.2 mt -78.07 -27.72 48.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.188 -0.46 . . . . 74.52 110.885 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 121.11 15.47 4.68 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.65 -0.786 . . . . 53.24 112.428 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.755 HD21 ' HA ' ' A' ' 258' ' ' ILE . 12.5 mt -80.31 156.12 26.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.906 0.384 . . . . 73.4 110.846 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -99.25 -141.12 11.9 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.759 -0.734 . . . . 74.1 112.464 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -122.0 139.36 53.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 74.15 110.904 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.4 t -99.21 163.99 12.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.884 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.19 -2.86 17.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 74.11 110.858 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.643 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -61.11 141.45 93.79 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.681 0.753 . . . . 64.5 110.839 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 -3.35 11.83 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.709 2.273 . . . . 63.05 112.342 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -143.47 19.81 1.87 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 74.25 110.827 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.643 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -82.21 139.03 34.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 71.41 111.09 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.76 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -63.03 -37.73 80.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.415 . . . . 73.03 111.055 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 48.5 mmm -66.49 -13.75 61.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 75.44 110.833 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.63 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.5 t80 -58.64 144.4 79.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.736 0.779 . . . . 73.33 110.853 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.63 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.2 Cg_endo -69.75 -3.42 11.97 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.753 2.302 . . . . 74.22 112.314 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.4 ' HG1' ' HD2' ' A' ' 237' ' ' PHE . 16.9 m -95.7 142.42 28.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 62.11 111.148 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -122.92 134.53 54.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 73.5 110.94 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -152.67 129.49 10.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.09 -0.504 . . . . 74.42 110.955 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.496 ' O ' HG13 ' A' ' 243' ' ' VAL . 85.2 t80 -57.13 143.77 37.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.318 -0.401 . . . . 74.33 110.876 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.533 ' H ' HD11 ' A' ' 214' ' ' LEU . 0.9 OUTLIER -158.26 130.34 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 71.5 111.136 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -50.84 132.16 26.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 73.24 110.945 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 14.3 tt -53.98 -29.89 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 53.22 111.081 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.456 HD22 HG23 ' A' ' 247' ' ' THR . 0.3 OUTLIER -72.98 -18.76 61.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 70.12 110.973 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.456 HG23 HD22 ' A' ' 246' ' ' ASN . 38.4 p -109.33 -21.4 12.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 71.11 111.194 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -71.58 143.1 49.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 75.34 110.917 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -177.19 133.37 0.18 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 63.31 110.834 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.747 HD12 HG11 ' A' ' 144' ' ' VAL . 52.9 mt -48.0 127.15 11.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 74.25 110.915 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.6 m -67.44 163.49 20.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 71.25 110.829 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.89 -35.09 31.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.478 . . . . 53.12 111.144 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.1 -51.58 52.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 74.02 110.886 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -56.39 -50.26 72.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 45.44 110.892 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 21.2 mt -61.4 -39.97 84.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 73.23 111.07 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -65.44 -39.85 92.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.172 -0.467 . . . . 65.14 110.948 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -73.73 -52.66 7.99 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.752 -0.737 . . . . 61.04 112.455 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.755 ' HA ' HD21 ' A' ' 226' ' ' LEU . 3.8 tp -52.54 -34.62 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.783 0.325 . . . . 74.02 111.124 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 263' ' ' GLY . 82.1 mt-30 -86.39 -17.34 34.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 61.25 110.92 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.7 t -69.49 -13.82 62.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.233 -0.44 . . . . 33.13 110.851 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.8 mt -123.16 -18.29 6.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 63.43 110.894 179.918 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.727 ' CD1' HD21 ' A' ' 147' ' ' LEU . 36.8 m-85 -114.56 -34.14 5.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.011 0.434 . . . . 74.12 110.965 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.307 0 CA-C-O 119.099 -0.834 . . . . 61.31 112.485 179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.401 ' HA ' ' HG ' ' A' ' 147' ' ' LEU . 6.2 p80 . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.791 0.329 . . . . 75.02 110.867 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.409 ' C ' HD12 ' A' ' 114' ' ' ILE . 2.1 m-85 -129.48 111.08 12.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 74.13 110.909 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.584 HG22 ' N ' ' A' ' 115' ' ' THR . 4.8 mp -142.33 162.73 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 71.24 111.14 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.584 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -160.43 163.76 32.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 52.52 111.074 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.615 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.5 p90 -131.7 152.28 51.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 74.04 110.953 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.693 ' HD2' HD11 ' A' ' 160' ' ' LEU . 3.9 tmt_? -144.35 109.96 5.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 72.53 110.855 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.7 mt -71.58 105.67 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 63.41 111.114 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -59.57 -45.47 91.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 62.54 110.827 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.729 ' OD1' HG23 ' A' ' 162' ' ' VAL . 1.7 p-10 -146.12 163.35 35.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 72.13 110.878 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.61 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.0 m-85 -116.27 140.98 48.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 65.33 110.873 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.725 HG22 ' CE ' ' A' ' 125' ' ' MET . 2.9 t -90.91 142.67 27.73 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.549 0.69 . . . . 73.23 111.202 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -2.95 11.04 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.692 2.261 . . . . 65.02 112.355 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.422 ' H ' HG23 ' A' ' 122' ' ' THR . 21.9 m-20 -80.4 -23.88 40.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 54.22 110.818 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.725 ' CE ' HG22 ' A' ' 122' ' ' THR . 13.3 mtm -115.61 166.25 12.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 75.35 110.839 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.407 ' O ' HG23 ' A' ' 130' ' ' VAL . 7.1 t-20 -96.57 144.63 26.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 63.21 110.961 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -45.1 -35.73 3.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.178 -0.465 . . . . 74.04 110.905 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -83.23 -38.66 21.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 73.24 110.87 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -65.4 -29.8 70.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 73.32 110.886 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.61 HG11 ' CE2' ' A' ' 121' ' ' TYR . 73.4 t -66.49 -46.35 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 61.23 111.156 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.13 -23.29 47.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 73.34 110.827 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -74.43 -47.2 35.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 71.41 110.917 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.715 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -71.79 -31.51 66.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 71.44 111.124 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.631 HD13 HD21 ' A' ' 212' ' ' LEU . 1.4 mp -73.29 -54.13 16.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.218 -0.446 . . . . 72.11 111.146 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.538 ' N ' HG22 ' A' ' 134' ' ' ILE . 3.3 ttm180 -49.06 -41.92 36.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 71.15 110.832 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.739 ' O ' HG23 ' A' ' 140' ' ' VAL . 7.8 mmpt? -72.43 -34.24 67.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 70.02 110.867 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.9 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.5 -48.83 80.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 64.15 111.168 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.639 ' HE1' HD13 ' A' ' 159' ' ' ILE . 95.4 m-85 -72.77 -22.1 60.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 71.31 110.888 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.523 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.1 OUTLIER -78.64 -5.81 53.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 73.4 110.937 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 136' ' ' LYS . 93.4 t -97.1 -16.87 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 72.14 111.109 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.807 ' NE1' HG12 ' A' ' 217' ' ' VAL . 93.6 m95 -106.48 -35.88 6.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 72.11 110.878 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.62 -11.47 60.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 52.13 110.851 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.624 HD22 ' N ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER -95.69 -15.74 22.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.505 . . . . 74.55 111.018 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.686 HG11 HD12 ' A' ' 250' ' ' LEU . 20.9 m -101.51 1.21 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 74.03 111.079 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.693 HG21 HG13 ' A' ' 258' ' ' ILE . 17.1 p -150.31 146.69 20.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.539 0.685 . . . . 63.12 111.149 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 30.53 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.661 2.241 . . . . 64.44 112.314 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.713 HD21 ' CD1' ' A' ' 262' ' ' TYR . 0.8 OUTLIER -93.32 -178.13 4.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 64.34 110.914 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -144.34 126.5 15.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 71.31 110.933 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.501 ' HE1' HD13 ' A' ' 114' ' ' ILE . 4.0 m-30 -114.52 142.15 46.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 74.31 110.906 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.8 m -140.78 137.49 33.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 71.33 110.893 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.9 OUTLIER -85.88 142.62 28.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 64.13 110.941 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.649 HD11 ' N ' ' A' ' 157' ' ' ALA . 18.2 pt -151.07 135.6 9.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 73.51 111.114 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 74.01 110.918 179.946 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.649 ' N ' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.78 0.324 . . . . 71.53 111.121 . . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.426 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.6 OUTLIER -83.22 -52.55 6.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 75.04 110.853 -179.977 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.726 HG12 HG23 ' A' ' 220' ' ' ILE . 1.9 mp -89.53 95.88 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 63.24 111.139 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.693 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.2 tp -86.87 110.08 19.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 62.23 110.857 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.427 HG13 ' CE1' ' A' ' 197' ' ' PHE . 87.8 t -89.83 120.54 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 44.11 111.14 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.729 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.2 p -139.83 104.97 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 72.33 111.138 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -71.87 108.75 5.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 73.41 110.889 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.11 165.71 20.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 74.45 111.121 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -114.14 138.29 50.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 74.32 110.922 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.67 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.74 -154.26 0.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.651 -0.785 . . . . 74.11 112.496 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.802 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -66.88 116.73 8.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.886 0.374 . . . . 74.22 111.106 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.695 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.88 -22.7 12.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.204 -0.453 . . . . 64.3 110.897 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.47 29.39 0.54 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 71.01 112.498 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.646 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.08 1.43 15.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.389 . . . . 73.3 110.918 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 72.8 40.34 0.6 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.469 . . . . 64.43 110.868 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.695 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.72 -41.65 0.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 74.14 110.888 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.802 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.31 99.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 70.41 111.074 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.67 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.9 m-85 -60.72 -168.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 75.2 110.866 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.74 18.66 3.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 70.04 110.866 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.578 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.2 -157.32 7.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 72.12 112.526 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 176' ' ' GLY . 11.7 tmtt? -35.29 134.52 0.28 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 74.3 110.879 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.35 165.49 0.14 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.594 -0.812 . . . . 74.44 112.496 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.81 -143.23 22.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 73.4 112.47 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -50.13 96.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.375 . . . . 71.02 111.174 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 13.4 mt -66.82 -39.48 87.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 52.34 110.934 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -172.08 167.1 6.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 73.35 111.142 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.561 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.6 p80 -159.67 139.72 11.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.428 . . . . 74.31 110.931 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.761 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -137.64 173.44 11.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 51.13 111.145 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.519 ' O ' ' O ' ' A' ' 222' ' ' HIS . 23.8 m-85 -99.43 -138.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 61.4 110.818 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -166.98 -99.64 0.14 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.792 -0.718 . . . . 60.35 112.578 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 59.54 1.66 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.696 2.264 . . . . 64.54 112.343 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.598 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.06 154.6 16.43 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.748 -0.739 . . . . 70.35 112.435 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.572 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.52 148.63 26.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.919 0.39 . . . . 72.21 110.793 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.68 -67.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.718 -0.753 . . . . 64.31 112.503 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.572 ' N ' ' O ' ' A' ' 189' ' ' SER . 3.6 mt -103.99 6.33 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 74.11 111.144 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.598 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -63.69 165.29 29.2 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.685 -0.769 . . . . 74.22 112.511 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 45.05 20.21 0.23 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.73 -0.748 . . . . 62.14 112.459 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 192' ' ' GLY . 0.8 OUTLIER -64.25 105.77 0.97 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.79 0.329 . . . . 63.2 110.943 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.761 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -82.15 129.62 34.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 64.42 111.158 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.561 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 11.2 m170 -119.93 129.93 54.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 75.14 110.878 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.465 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 47.7 m-85 -114.35 134.22 55.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 75.15 110.909 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -67.25 109.44 3.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 73.32 110.916 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -60.22 -37.19 79.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 73.34 110.861 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.578 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 5.3 m-20 -50.45 -22.89 2.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.233 -0.439 . . . . 73.42 110.885 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -80.17 163.38 24.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 75.21 110.835 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.561 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -101.43 89.1 3.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 74.35 110.843 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.513 ' CZ3' HG21 ' A' ' 215' ' ' THR . 29.5 m95 -80.59 123.26 27.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.177 -0.465 . . . . 60.22 110.952 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.3 p -141.26 -174.83 4.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 70.3 111.183 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.36 20.53 16.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 64.44 111.104 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -127.74 -173.12 2.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 64.34 110.903 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.3 p -72.11 -18.87 61.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 71.41 110.836 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.49 -106.58 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 31.23 112.502 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.05 176.84 0.1 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.694 -0.765 . . . . 71.31 112.528 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 89.8 m -66.74 97.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.741 0.305 . . . . 73.44 111.125 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -42.83 116.93 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 73.52 110.833 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.661 HD23 ' HB3' ' A' ' 133' ' ' ALA . 9.8 tp -63.29 -37.94 89.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.083 -0.508 . . . . 74.52 110.94 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.762 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.6 t80 -51.32 -63.91 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 50.51 110.901 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.566 HD21 ' CG2' ' A' ' 243' ' ' VAL . 8.0 mp -55.51 -54.99 37.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.119 -0.491 . . . . 75.5 110.895 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.513 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.3 m -55.31 -33.95 63.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 73.2 111.139 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -67.69 -48.74 65.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 74.31 111.009 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.9 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -53.43 -58.22 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 71.45 111.067 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.767 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.8 t-80 -64.46 -28.13 69.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 74.11 110.775 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -64.39 -44.07 92.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 73.4 111.104 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.726 HG23 HG12 ' A' ' 159' ' ' ILE . 2.6 mt -70.28 -34.26 57.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 64.44 111.172 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -51.79 -45.11 55.53 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.713 -0.756 . . . . 61.24 112.471 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.519 ' O ' ' O ' ' A' ' 185' ' ' PHE . 4.1 m-70 -68.85 -40.61 79.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.849 0.356 . . . . 73.41 110.89 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.488 ' OG ' HG12 ' A' ' 159' ' ' ILE . 32.5 p -65.7 -20.2 66.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.11 -0.495 . . . . 74.43 110.858 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.422 HD21 HG21 ' A' ' 114' ' ' ILE . 52.8 mt -80.84 -25.77 37.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 33.33 110.897 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 122.2 13.18 4.96 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.729 -0.748 . . . . 70.2 112.441 179.922 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.871 HD21 ' HA ' ' A' ' 258' ' ' ILE . 17.6 mt -84.81 155.65 21.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.337 . . . . 61.45 110.973 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -102.95 -138.21 9.86 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.767 -0.73 . . . . 65.31 112.458 179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.76 138.76 53.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.918 0.39 . . . . 73.25 110.886 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 69.8 p -97.26 166.97 11.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.88 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.18 3.09 19.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 73.54 110.84 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 234' ' ' ALA . 0.4 OUTLIER -72.3 135.74 81.87 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.683 0.754 . . . . 74.33 110.844 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.62 0.25 5.8 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.713 2.275 . . . . 61.13 112.331 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.05 25.42 1.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 71.43 110.908 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 231' ' ' ASP . . . -97.48 143.91 27.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.453 . . . . 63.33 111.082 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.767 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.3 t -63.84 -41.75 93.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 72.45 111.118 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 49.9 mmm -60.33 -17.67 44.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.193 -0.458 . . . . 72.22 110.904 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.615 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.1 t80 -57.79 144.64 73.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.712 0.768 . . . . 75.5 110.78 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.615 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.5 Cg_endo -69.87 -1.23 8.22 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.552 2.168 . . . . 71.51 112.385 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 23.3 m -96.32 140.97 30.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 63.4 111.201 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -122.39 134.48 54.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.185 -0.461 . . . . 72.23 110.978 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -151.99 135.12 15.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 72.13 110.9 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.553 ' O ' HG13 ' A' ' 243' ' ' VAL . 82.1 t80 -64.5 143.52 57.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 74.31 110.889 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.566 ' CG2' HD21 ' A' ' 214' ' ' LEU . 0.2 OUTLIER -161.18 128.92 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 62.12 111.105 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -50.37 134.69 23.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 75.24 110.9 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.508 HD12 ' CE2' ' A' ' 213' ' ' PHE . 8.0 tt -51.31 -33.54 14.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 73.24 111.222 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.54 ' OD1' HG23 ' A' ' 247' ' ' THR . 1.2 p30 -65.73 -23.51 66.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 74.12 110.907 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.54 HG23 ' OD1' ' A' ' 246' ' ' ASN . 10.5 p -107.0 -21.81 12.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 61.15 111.143 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -73.43 134.02 43.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 71.01 110.852 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 24.3 ptt85 -171.23 134.08 0.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 74.23 110.91 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.686 HD12 HG11 ' A' ' 144' ' ' VAL . 54.7 mt -48.06 127.28 12.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 71.24 110.998 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 30.9 t -72.46 164.43 26.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 43.11 110.894 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -47.95 -37.98 15.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 74.43 111.103 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.56 -45.29 91.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 75.55 110.869 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 12.7 m-20 -61.03 -55.35 33.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 70.21 110.889 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.429 ' HA ' HG22 ' A' ' 258' ' ' ILE . 1.3 mp -58.99 -34.55 53.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 71.02 111.153 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 28.7 mmm-85 -68.08 -40.32 82.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 54.53 110.908 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.409 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -75.59 -50.62 7.92 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.784 -0.722 . . . . 63.53 112.562 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.871 ' HA ' HD21 ' A' ' 226' ' ' LEU . 5.6 tp -52.38 -34.53 18.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.772 0.32 . . . . 74.43 111.159 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' A' ' 263' ' ' GLY . 57.5 mt-30 -86.73 -16.94 34.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 75.23 110.876 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 3.2 t -69.47 -13.93 62.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 52.24 110.853 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -124.37 -17.71 6.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 70.43 110.935 -179.942 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.713 ' CD1' HD21 ' A' ' 147' ' ' LEU . 36.1 m-85 -114.74 -33.28 5.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 74.41 110.859 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.313 0 CA-C-O 119.122 -0.821 . . . . 63.24 112.454 -179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.4 p80 . . . . . 0 C--O 1.231 0.095 0 CA-C-O 120.813 0.34 . . . . 60.34 110.829 . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.453 ' C ' HD12 ' A' ' 114' ' ' ILE . 1.7 m-85 -122.34 113.39 19.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 65.13 110.906 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.577 HG22 ' N ' ' A' ' 115' ' ' THR . 5.0 mp -142.96 162.18 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 64.24 111.141 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.577 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -159.05 164.06 35.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 74.11 111.157 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.645 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.4 p90 -134.23 145.04 48.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 64.21 110.879 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.711 ' HD2' HD11 ' A' ' 160' ' ' LEU . 3.4 tmt_? -137.47 106.9 6.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 71.25 110.83 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 62.0 mt -70.41 104.93 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 71.44 111.16 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -55.56 -50.84 68.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 63.24 110.825 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.651 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.0 p-10 -143.08 166.6 24.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 63.33 110.87 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -116.95 148.89 41.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 64.43 110.959 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.475 HG23 ' HG3' ' A' ' 125' ' ' MET . 3.2 t -93.67 141.58 24.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.595 0.712 . . . . 74.42 111.075 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -3.42 11.99 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.711 2.274 . . . . 52.42 112.296 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.63 -29.91 36.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 75.43 110.93 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.601 ' HE3' HG22 ' A' ' 130' ' ' VAL . 7.3 mtm -107.97 163.73 12.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 73.14 110.848 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.752 ' O ' HG23 ' A' ' 130' ' ' VAL . 2.4 t-20 -94.25 150.3 20.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 75.54 110.866 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.55 -32.93 8.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 74.4 110.826 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -82.01 -40.44 22.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 60.23 110.91 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -65.95 -29.1 69.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 74.13 110.906 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 126' ' ' ASN . 59.9 t -64.34 -45.62 95.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 75.12 111.169 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.12 -24.46 35.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 74.31 110.866 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -72.3 -46.8 54.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 72.14 110.908 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.993 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -71.52 -33.95 69.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 63.42 111.12 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.604 HD13 HD21 ' A' ' 212' ' ' LEU . 1.4 mp -72.46 -55.11 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 73.32 111.126 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.547 ' N ' HG22 ' A' ' 134' ' ' ILE . 5.3 ttm180 -48.58 -45.65 38.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.479 . . . . 63.21 110.874 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.646 ' O ' HG23 ' A' ' 140' ' ' VAL . 12.5 mmtt -68.25 -34.72 76.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 72.44 110.994 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.901 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.69 -48.94 79.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.504 . . . . 41.4 111.116 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.645 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 94.4 m-85 -72.82 -22.28 60.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 62.24 110.921 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.535 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.2 OUTLIER -77.35 -5.93 51.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 74.31 110.969 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 136' ' ' LYS . 98.0 t -97.2 -17.14 6.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 71.33 111.101 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.806 ' NE1' HG12 ' A' ' 217' ' ' VAL . 95.3 m95 -106.05 -35.85 7.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 71.22 110.876 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.39 -11.39 60.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 62.32 110.822 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.618 HD22 ' N ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER -95.81 -17.71 20.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 73.33 110.879 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.914 HG11 HD12 ' A' ' 250' ' ' LEU . 19.4 m -99.09 1.77 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 72.14 111.092 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.53 HG21 HG13 ' A' ' 258' ' ' ILE . 22.9 p -152.11 146.3 18.41 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.544 0.688 . . . . 75.32 111.168 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 30.1 0.18 Allowed 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.759 2.306 . . . . 64.31 112.216 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.821 HD21 ' CG ' ' A' ' 262' ' ' TYR . 0.1 OUTLIER -90.0 -176.83 5.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.322 -0.399 . . . . 74.22 110.894 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -145.49 126.12 14.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 73.42 110.876 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.468 ' HE1' HD13 ' A' ' 114' ' ' ILE . 4.1 m-30 -115.35 142.42 46.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 72.03 110.9 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.5 m -141.05 138.78 33.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.483 . . . . 73.44 110.815 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.488 ' HG3' ' N ' ' A' ' 152' ' ' ILE . 2.9 tptm -88.45 142.9 27.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 64.03 110.894 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.555 HD11 ' N ' ' A' ' 157' ' ' ALA . 14.6 pt -150.88 132.27 4.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 52.02 111.138 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.2 m120 . . . . . 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 74.41 110.854 -179.975 . . . . . . . . 0 0 . 1 . 004 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.555 ' N ' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.232 0.15 0 CA-C-O 120.837 0.351 . . . . 61.03 111.023 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 5.8 m-20 -85.34 -53.58 5.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.427 . . . . 73.05 110.797 179.997 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.65 HG12 HG23 ' A' ' 220' ' ' ILE . 2.4 mp -89.43 94.88 5.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.157 -0.474 . . . . 72.44 111.109 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.711 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.2 tp -85.79 109.18 18.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 72.23 110.888 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.46 HG13 ' CE1' ' A' ' 197' ' ' PHE . 87.3 t -89.2 124.13 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 54.32 111.15 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.651 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.4 p -143.59 105.73 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 74.43 111.199 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -71.8 109.51 5.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 74.43 110.911 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -130.38 167.27 18.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 72.01 111.001 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.51 137.29 52.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 73.32 110.933 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.683 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.98 -155.64 0.14 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.773 -0.727 . . . . 75.51 112.454 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.8 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -64.5 115.53 5.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 75.11 111.083 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.69 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.25 -22.19 12.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 74.43 110.895 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.24 29.11 0.56 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.713 -0.756 . . . . 71.34 112.4 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.635 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.94 1.23 15.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.904 0.383 . . . . 54.11 110.864 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 72.8 40.24 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 74.21 110.78 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.69 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.58 -41.17 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 75.12 110.913 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.8 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.08 99.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 52.34 111.075 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.683 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -59.88 -169.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 63.44 110.911 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.96 17.13 4.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 72.44 110.927 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.593 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.4 -156.81 8.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.797 -0.716 . . . . 61.33 112.496 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 176' ' ' GLY . 7.6 tttp -34.98 134.8 0.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.815 0.34 . . . . 41.52 110.926 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.28 163.11 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.711 -0.757 . . . . 65.25 112.448 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.61 -143.6 20.88 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.766 -0.73 . . . . 74.01 112.571 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -49.66 97.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 64.03 111.147 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 76.2 mt -69.53 -36.96 76.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 71.14 111.027 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -174.39 162.4 3.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 75.53 111.081 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.53 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.6 p80 -155.27 140.97 18.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 70.51 110.823 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.75 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -138.85 171.92 13.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 73.43 111.172 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 223' ' ' SER . 17.1 m-85 -100.32 -148.91 0.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.258 -0.428 . . . . 63.34 110.816 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -159.43 -94.76 0.1 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.637 -0.792 . . . . 43.21 112.454 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.68 58.69 1.53 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.733 2.289 . . . . 51.34 112.356 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.611 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.0 153.44 16.97 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.729 -0.748 . . . . 72.01 112.467 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.597 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.5 150.5 24.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.788 0.328 . . . . 51.55 110.927 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 59.45 -67.42 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.743 -0.742 . . . . 64.52 112.423 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.597 ' N ' ' O ' ' A' ' 189' ' ' SER . 26.4 pt -103.66 6.05 10.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.896 0.379 . . . . 45.41 111.202 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.611 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -64.25 165.25 31.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.656 -0.783 . . . . 73.43 112.446 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 46.68 17.05 0.23 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.704 -0.76 . . . . 61.41 112.541 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 192' ' ' GLY . 0.9 OUTLIER -61.82 108.33 0.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.831 0.348 . . . . 70.12 110.83 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.75 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -83.76 130.56 34.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.121 -0.49 . . . . 62.32 111.182 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.53 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 11.1 m170 -121.2 128.93 52.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.297 -0.411 . . . . 74.51 110.86 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.535 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 50.5 m-85 -113.85 131.03 56.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.249 -0.432 . . . . 72.23 110.85 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . 0.409 ' HB3' ' HG2' ' A' ' 201' ' ' GLU . 63.4 t0 -65.52 114.46 4.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 71.01 110.945 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -68.06 -33.25 74.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 64.33 110.83 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.593 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 14.5 m-20 -51.07 -21.6 1.96 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.155 -0.475 . . . . 65.53 110.823 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.409 ' HG2' ' HB3' ' A' ' 198' ' ' ASP . 0.6 OUTLIER -86.4 164.99 16.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 60.23 110.882 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.478 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -97.86 98.95 10.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 71.54 110.926 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.535 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 52.5 m95 -86.46 123.86 32.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.203 -0.453 . . . . 73.42 110.895 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 39.9 p -145.57 -177.04 5.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 72.25 111.143 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.34 21.27 16.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 75.32 111.157 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -128.4 -177.48 4.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 75.35 110.837 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . 0.415 ' HA ' ' CD2' ' A' ' 242' ' ' TYR . 4.0 t -67.14 -18.81 65.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 73.43 110.888 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.21 -106.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.868 -0.682 . . . . 71.24 112.42 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.76 178.18 0.2 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.726 -0.75 . . . . 74.32 112.508 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 99.1 m -66.94 98.09 0.53 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.79 0.329 . . . . 65.25 111.187 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -42.15 116.57 0.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 63.22 110.953 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.993 HD23 ' HB3' ' A' ' 133' ' ' ALA . 8.1 tp -63.49 -38.74 92.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 74.13 110.941 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.734 ' N ' ' HB1' ' A' ' 133' ' ' ALA . 2.9 t80 -51.69 -63.45 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 73.53 110.903 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.559 HD21 ' CG2' ' A' ' 243' ' ' VAL . 7.7 mp -56.34 -54.43 45.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 65.33 110.941 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 219' ' ' ALA . 3.2 m -56.02 -31.0 62.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 53.13 111.107 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 137' ' ' ALA . . . -70.55 -47.42 60.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 75.44 111.093 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.901 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -54.56 -58.87 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 71.31 111.082 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.743 ' HB2' HG13 ' A' ' 235' ' ' VAL . 2.2 t-80 -62.37 -29.94 70.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 73.3 110.888 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.51 -45.52 92.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 74.43 111.129 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.65 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -69.28 -34.94 65.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.428 . . . . 75.01 111.079 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.93 -44.84 41.14 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.81 -0.71 . . . . 61.23 112.487 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.478 ' O ' ' O ' ' A' ' 185' ' ' PHE . 45.8 m-70 -67.32 -40.67 85.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.744 0.307 . . . . 75.23 110.806 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.644 ' OG ' HG23 ' A' ' 159' ' ' ILE . 2.9 m -62.59 -27.33 69.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.242 -0.436 . . . . 64.13 110.853 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 62.4 mt -74.57 -28.45 60.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 75.1 110.907 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 121.11 15.17 4.78 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.75 -0.738 . . . . 63.31 112.455 179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.677 HD21 ' HA ' ' A' ' 258' ' ' ILE . 11.6 mt -83.01 156.03 23.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.338 . . . . 75.31 110.887 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.439 ' O ' ' HE2' ' A' ' 236' ' ' MET . . . -102.5 -133.29 7.98 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.694 -0.765 . . . . 55.04 112.52 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.451 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 1.6 m170 -125.7 142.95 51.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 61.3 110.882 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 38.1 m -104.19 166.06 10.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 52.41 110.91 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 42.8 m -108.51 1.87 21.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 75.52 110.908 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.615 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -66.31 140.38 96.74 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.592 0.711 . . . . 75.24 110.824 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.7 -3.35 11.79 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.758 2.305 . . . . 64.14 112.35 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.45 24.89 1.55 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 75.35 110.882 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.615 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -88.85 140.39 29.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 71.53 111.141 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.743 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.8 t -63.43 -38.06 81.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 62.43 111.183 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.458 ' HE3' ' HA ' ' A' ' 236' ' ' MET . 32.1 mmm -66.05 -14.06 61.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 74.41 110.873 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.606 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.5 t80 -57.91 143.62 76.84 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.635 0.731 . . . . 74.31 110.866 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.606 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.4 Cg_endo -69.77 -1.62 8.8 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.674 2.249 . . . . 75.42 112.34 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.401 ' HG1' ' HD2' ' A' ' 237' ' ' PHE . 6.6 m -100.41 139.66 35.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 75.52 111.073 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -118.75 128.66 54.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 73.35 110.876 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.22 126.27 12.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.043 -0.526 . . . . 71.42 110.803 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.55 ' O ' HG13 ' A' ' 243' ' ' VAL . 35.9 t80 -57.18 147.39 25.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.147 -0.479 . . . . 75.13 110.897 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.559 ' CG2' HD21 ' A' ' 214' ' ' LEU . 0.6 OUTLIER -160.07 132.93 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.514 . . . . 64.44 111.091 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -46.77 133.59 10.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 61.12 110.854 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.424 HD12 ' CE2' ' A' ' 213' ' ' PHE . 5.9 tt -53.32 -34.35 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 75.44 111.181 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.701 HD22 HG23 ' A' ' 247' ' ' THR . 0.5 OUTLIER -72.15 -17.05 61.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 72.51 110.867 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.701 HG23 HD22 ' A' ' 246' ' ' ASN . 24.6 p -107.61 -21.91 12.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 73.45 111.182 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -72.36 137.82 46.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 73.25 110.829 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -174.48 136.8 0.47 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.147 -0.479 . . . . 72.12 110.882 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.914 HD12 HG11 ' A' ' 144' ' ' VAL . 29.2 mt -49.78 129.33 19.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 65.11 110.921 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 32.5 t -71.3 171.0 11.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 63.43 110.849 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.16 -37.11 69.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.489 . . . . 71.44 111.186 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -65.3 -47.49 76.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.856 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.6 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 4.8 m-20 -61.99 -52.04 65.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.194 -0.457 . . . . 74.24 110.825 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 30.0 mt -61.36 -35.47 66.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 71.53 111.107 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -69.68 -39.42 77.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 73.55 110.892 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.48 -50.1 7.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.791 -0.719 . . . . 43.32 112.459 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.677 ' HA ' HD21 ' A' ' 226' ' ' LEU . 7.0 tp -52.07 -35.25 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.703 0.287 . . . . 62.21 111.115 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 263' ' ' GLY . 72.1 mt-30 -87.32 -16.68 34.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 74.23 110.897 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.9 t -70.85 -14.54 62.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 72.21 110.896 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 5.3 mt -121.95 -18.92 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 71.44 110.868 -179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.821 ' CG ' HD21 ' A' ' 147' ' ' LEU . 33.6 m-85 -113.12 -34.37 5.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.248 -0.433 . . . . 74.3 110.951 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.335 0 CA-C-O 119.097 -0.835 . . . . 44.24 112.545 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 9.1 p80 . . . . . 0 C--O 1.232 0.14 0 CA-C-O 120.839 0.352 . . . . 74.12 110.868 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -134.2 106.71 7.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 73.25 110.939 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.585 HG22 ' N ' ' A' ' 115' ' ' THR . 4.7 mp -138.13 162.71 30.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.478 . . . . 62.54 111.179 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.59 ' O ' HD12 ' A' ' 159' ' ' ILE . 0.5 OUTLIER -158.65 163.8 36.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 64.44 111.113 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.598 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.0 p90 -132.73 149.02 52.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 74.43 110.928 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.458 ' HD2' HD11 ' A' ' 160' ' ' LEU . 4.2 tmt_? -143.93 112.4 6.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.083 -0.508 . . . . 70.34 110.862 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.0 mt -72.79 106.64 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 65.55 111.151 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -60.17 -46.38 89.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 75.13 110.949 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.738 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.0 p-10 -146.46 166.08 27.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 71.32 110.892 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.708 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.1 m-85 -117.47 139.33 51.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 73.15 110.87 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.49 HG22 ' HB2' ' A' ' 124' ' ' ASP . 1.0 OUTLIER -91.22 139.31 25.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.549 0.69 . . . . 71.05 111.183 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.404 ' HD2' HG23 ' A' ' 122' ' ' THR . 54.2 Cg_endo -69.75 42.16 0.34 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.742 2.295 . . . . 51.3 112.353 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.49 ' HB2' HG22 ' A' ' 122' ' ' THR . 2.3 m-20 -126.85 -25.61 3.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 53.23 110.764 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.491 ' CE ' HG22 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -110.69 165.22 12.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.328 -0.396 . . . . 61.35 110.861 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -94.45 142.2 27.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 72.43 110.882 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -44.22 -36.38 2.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 73.1 110.892 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -83.85 -39.18 20.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 61.12 110.91 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -63.52 -33.25 75.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.495 . . . . 30.01 110.888 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.708 HG11 ' CE2' ' A' ' 121' ' ' TYR . 73.8 t -63.38 -46.58 95.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.214 -0.448 . . . . 70.11 111.16 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -78.71 -23.62 45.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 63.01 110.814 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -75.53 -49.42 18.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 75.23 110.909 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.71 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -68.57 -30.48 69.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.502 . . . . 61.04 111.124 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.2 mp -74.15 -54.65 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 71.53 111.175 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.526 ' N ' HG22 ' A' ' 134' ' ' ILE . 3.3 ptm180 -49.08 -37.39 21.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.264 -0.425 . . . . 73.14 110.93 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.63 ' O ' HG23 ' A' ' 140' ' ' VAL . 7.2 mmpt? -75.48 -36.02 60.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 73.51 110.942 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.686 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -59.87 -49.53 77.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 74.43 111.091 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.626 ' HE2' HD13 ' A' ' 159' ' ' ILE . 92.1 m-85 -70.71 -22.7 62.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 74.32 110.935 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.565 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.9 tt0 -77.4 -7.09 55.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 65.11 110.867 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 136' ' ' LYS . 89.6 t -95.75 -17.28 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 43.45 111.138 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.85 ' NE1' HG12 ' A' ' 217' ' ' VAL . 95.9 m95 -106.11 -36.12 7.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 73.21 110.958 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -11.37 60.87 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.258 -0.428 . . . . 64.32 110.867 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.617 HD22 ' N ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER -95.3 -17.68 21.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 72.2 110.906 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.816 HG11 HD12 ' A' ' 250' ' ' LEU . 18.2 m -99.38 1.77 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 72.23 111.112 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.653 HG21 HG13 ' A' ' 258' ' ' ILE . 22.8 p -152.48 146.56 18.42 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.576 0.703 . . . . 61.02 111.103 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 29.72 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.788 2.325 . . . . 64.14 112.297 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.728 HD21 ' CG ' ' A' ' 262' ' ' TYR . 0.7 OUTLIER -91.15 179.22 5.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 65.11 110.924 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -141.53 126.17 17.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.43 110.894 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.575 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.7 m-30 -115.41 143.72 44.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 52.51 110.911 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.9 t -140.23 151.78 45.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 71.12 110.833 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 10.2 tttp -101.59 145.21 29.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 74.32 110.804 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.518 HD11 ' HB2' ' A' ' 157' ' ' ALA . 21.6 pt -151.74 143.54 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 61.52 111.038 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.1 m120 . . . . . 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 73.22 110.831 179.954 . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.518 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 N--CA 1.457 -0.11 0 CA-C-O 120.789 0.328 . . . . 70.14 111.109 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.428 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.5 OUTLIER -85.82 -52.31 5.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 75.31 110.811 -179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.783 HG12 HG23 ' A' ' 220' ' ' ILE . 1.9 mp -89.7 94.9 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 63.41 111.1 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.458 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.4 tp -87.17 109.28 19.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 75.24 110.849 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.406 HG13 ' CE1' ' A' ' 197' ' ' PHE . 83.9 t -87.33 120.48 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 63.33 111.157 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.738 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.2 p -139.52 106.51 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 73.43 111.168 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.42 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 41.6 m-85 -74.1 112.32 10.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 73.41 110.952 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.79 168.4 17.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.151 -0.477 . . . . 72.11 111.084 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.427 ' CG ' ' HB3' ' A' ' 199' ' ' GLU . 37.8 mtp180 -113.07 137.6 51.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 73.24 110.843 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.663 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 41.18 -151.99 0.13 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.841 -0.695 . . . . 74.21 112.486 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.804 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -66.41 117.3 8.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.875 0.369 . . . . 64.11 111.061 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.711 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -109.27 -20.22 13.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 73.23 110.9 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 129.85 30.03 0.66 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.771 -0.728 . . . . 74.43 112.478 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.635 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.72 0.21 14.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 71.23 110.826 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 74.25 38.73 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 71.33 110.872 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.711 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.3 -41.2 0.81 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 54.35 110.806 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.804 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.36 99.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 65.33 111.074 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.663 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.7 m-85 -60.23 -168.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 53.02 110.8 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.89 19.6 3.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.093 -0.503 . . . . 64.13 110.898 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.574 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 53.25 -157.8 4.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.773 -0.727 . . . . 32.21 112.461 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.2 OUTLIER -33.82 134.27 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 73.13 110.926 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.32 165.66 0.15 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.677 -0.773 . . . . 44.02 112.508 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.3 -144.06 23.26 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.714 -0.755 . . . . 42.43 112.537 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -49.44 97.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 60.44 111.177 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.79 -41.28 87.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.097 -0.501 . . . . 73.4 110.938 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -170.96 169.16 6.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 74.41 111.123 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.476 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.2 p80 -163.75 143.48 8.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.254 -0.43 . . . . 74.15 110.824 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.745 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -138.09 173.23 11.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 73.13 111.069 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' ' 223' ' ' SER . 54.0 m-85 -98.82 -140.88 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 62.41 110.831 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -171.56 -87.57 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.748 -0.739 . . . . 71.11 112.493 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 54.21 1.12 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.648 2.232 . . . . 65.3 112.357 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.579 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.16 149.56 16.83 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 33.41 112.452 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.64 145.72 29.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.988 0.423 . . . . 74.05 110.804 -179.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.64 -63.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.799 -0.715 . . . . 53.11 112.479 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.524 ' N ' ' O ' ' A' ' 189' ' ' SER . 5.5 tp -105.29 6.54 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 73.3 111.14 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.579 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -67.82 169.78 37.7 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.803 -0.713 . . . . 61.3 112.442 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 45.32 18.9 0.2 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 51.32 112.561 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 192' ' ' GLY . 0.9 OUTLIER -63.15 103.41 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 50.32 110.913 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.745 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -77.76 131.15 37.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.223 -0.444 . . . . 63.31 111.067 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.476 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.7 m170 -121.37 130.23 53.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.45 . . . . 73.3 110.856 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.483 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 41.8 m-85 -115.13 134.22 55.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 63.51 110.88 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -67.52 104.69 1.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 55.33 110.886 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.427 ' HB3' ' CG ' ' A' ' 165' ' ' ARG . 4.2 tm-20 -57.24 -36.7 71.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 72.21 110.875 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.574 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 14.3 m-20 -50.41 -22.18 1.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 73.31 110.839 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -82.12 164.21 21.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 74.15 110.816 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.544 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -100.73 91.77 4.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 75.34 110.892 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.549 ' CZ3' HG21 ' A' ' 215' ' ' THR . 33.1 m95 -82.64 123.54 29.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.155 -0.475 . . . . 73.55 110.887 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.7 p -140.3 -172.4 3.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 63.4 111.164 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.6 17.34 17.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 71.5 111.098 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.26 -176.59 3.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 74.51 110.782 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.2 p -66.06 -18.54 65.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 72.43 110.951 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.91 -108.85 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.799 -0.715 . . . . 44.15 112.496 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.38 178.26 0.15 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.76 -0.733 . . . . 63.45 112.495 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 90.0 m -66.52 97.69 0.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.83 0.347 . . . . 72.11 111.185 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -41.65 116.83 0.83 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.446 . . . . 70.04 110.908 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 130' ' ' VAL . 17.4 tp -63.88 -36.01 82.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 62.11 110.894 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.71 ' CA ' ' HB1' ' A' ' 133' ' ' ALA . 2.4 t80 -53.68 -64.27 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 71.15 110.855 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.549 HD11 ' H ' ' A' ' 243' ' ' VAL . 19.3 mt -54.81 -54.32 43.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 52.42 110.913 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.549 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.5 m -54.53 -34.64 62.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 72.11 111.212 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.409 ' HB3' ' HB2' ' A' ' 137' ' ' ALA . . . -65.77 -48.98 70.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 71.3 111.159 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.85 HG12 ' NE1' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -52.5 -58.89 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 53.51 111.127 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.736 ' HB2' HG13 ' A' ' 235' ' ' VAL . 3.4 t-80 -63.29 -29.38 70.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 70.31 110.932 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -63.84 -44.5 92.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 71.43 111.111 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.783 HG23 HG12 ' A' ' 159' ' ' ILE . 2.4 mt -71.03 -34.23 54.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 64.45 111.108 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -52.63 -44.81 60.16 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.76 -0.734 . . . . 71.5 112.392 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.508 ' O ' ' O ' ' A' ' 185' ' ' PHE . 3.4 m-70 -69.46 -40.85 76.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 74.24 110.913 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 43.9 p -64.38 -20.55 66.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 64.23 110.842 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.401 HD21 HG21 ' A' ' 114' ' ' ILE . 61.3 mt -81.74 -26.03 34.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 62.14 110.886 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 121.97 10.49 6.27 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.784 -0.722 . . . . 64.43 112.454 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.89 HD21 ' HA ' ' A' ' 258' ' ' ILE . 46.0 mt -79.77 149.41 31.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.865 0.364 . . . . 75.33 110.935 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -95.35 -141.35 11.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.737 -0.745 . . . . 62.43 112.558 179.877 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.423 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 0.2 OUTLIER -119.08 142.6 47.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.801 0.334 . . . . 74.54 110.86 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 49.3 m -103.5 163.65 12.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 74.43 110.913 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.4 t -108.51 0.74 21.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.489 . . . . 65.31 110.891 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.61 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -65.14 141.57 98.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.601 0.715 . . . . 71.24 110.883 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 -3.84 12.88 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.695 2.263 . . . . 41.43 112.352 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -144.27 25.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 63.44 110.806 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.61 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -89.28 139.21 30.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 71.21 111.025 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.736 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.7 t -62.42 -37.92 79.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 74.34 111.126 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.423 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 37.1 mmm -65.79 -14.41 61.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 65.14 110.899 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.617 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.4 t80 -58.69 143.93 81.19 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.61 0.719 . . . . 71.55 110.91 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.617 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.1 Cg_endo -69.71 -0.99 7.67 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.689 2.259 . . . . 64.03 112.405 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.411 ' HG1' ' HD2' ' A' ' 237' ' ' PHE . 17.0 m -98.52 139.65 33.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.127 -0.488 . . . . 65.44 111.249 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -122.1 133.34 54.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 71.41 110.96 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -151.87 134.43 15.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 62.22 110.927 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.542 ' O ' HG13 ' A' ' 243' ' ' VAL . 83.2 t80 -59.62 144.8 46.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.45 . . . . 74.34 110.947 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.549 ' H ' HD11 ' A' ' 214' ' ' LEU . 0.4 OUTLIER -160.33 131.66 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 54.31 111.114 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -53.95 134.8 43.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 50.13 110.912 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.458 HD12 ' CE2' ' A' ' 213' ' ' PHE . 7.2 tt -54.2 -29.74 19.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 62.0 111.104 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.456 ' ND2' HG23 ' A' ' 247' ' ' THR . 0.2 OUTLIER -70.96 -19.47 62.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 74.34 110.933 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.456 HG23 ' ND2' ' A' ' 246' ' ' ASN . 11.9 p -111.21 -20.28 12.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 75.34 111.145 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.425 ' CD2' HD22 ' A' ' 214' ' ' LEU . 10.2 t80 -74.44 133.91 42.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 74.41 110.88 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.1 136.13 1.42 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 73.31 110.931 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.816 HD12 HG11 ' A' ' 144' ' ' VAL . 36.5 mt -48.65 127.38 13.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 65.41 110.927 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.6 p -69.77 164.6 23.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 74.13 110.866 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.14 -34.77 32.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 74.25 111.093 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.52 -48.02 68.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 73.04 110.864 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.496 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 8.9 m-20 -61.27 -50.87 71.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 73.32 110.878 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 31.5 mt -61.83 -35.1 65.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 74.43 111.155 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -69.5 -39.23 77.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 63.15 110.908 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.32 -50.27 8.51 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.737 -0.744 . . . . 71.01 112.536 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.89 ' HA ' HD21 ' A' ' 226' ' ' LEU . 5.6 tp -52.56 -35.29 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.812 0.339 . . . . 74.35 111.091 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 263' ' ' GLY . 74.7 mt-30 -86.77 -16.45 36.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 74.41 110.882 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.0 t -70.31 -13.77 62.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 65.01 110.845 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.1 mt -123.59 -18.06 6.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 73.14 110.961 -179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.728 ' CG ' HD21 ' A' ' 147' ' ' LEU . 37.3 m-85 -115.31 -33.56 5.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 74.53 110.861 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.453 -0.227 0 CA-C-O 119.13 -0.817 . . . . 71.23 112.419 -179.975 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.567 ' HA ' HD22 ' A' ' 147' ' ' LEU . 12.2 p80 . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.836 0.35 . . . . 61.44 110.892 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -121.62 101.18 7.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.458 . . . . 65.32 110.87 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.579 HG22 ' N ' ' A' ' 115' ' ' THR . 5.1 mp -126.77 162.25 31.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 53.24 111.156 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.579 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -155.9 166.91 32.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 61.54 111.188 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.634 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.5 p90 -137.16 146.27 44.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 72.2 110.909 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.547 ' NE ' HD11 ' A' ' 160' ' ' LEU . 3.7 tmm_? -139.2 112.46 8.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 55.1 110.945 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.1 mt -74.08 105.7 3.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.202 -0.454 . . . . 74.45 111.108 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -57.75 -47.57 82.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 72.01 110.919 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.758 ' OD1' HG23 ' A' ' 162' ' ' VAL . 1.4 p-10 -144.82 163.81 32.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.116 -0.493 . . . . 74.15 110.914 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.66 ' CE2' HG11 ' A' ' 130' ' ' VAL . 4.4 m-85 -116.01 139.63 50.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 55.34 110.902 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.732 HG22 ' CE ' ' A' ' 125' ' ' MET . 2.5 t -89.95 142.62 29.04 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.608 0.718 . . . . 72.33 111.138 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -3.99 13.16 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.638 2.225 . . . . 52.04 112.344 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.422 ' H ' HG23 ' A' ' 122' ' ' THR . 21.8 m-20 -79.28 -23.28 43.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 75.33 110.901 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.732 ' CE ' HG22 ' A' ' 122' ' ' THR . 12.9 mtm -115.99 166.15 12.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 63.04 110.878 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -97.23 145.03 26.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 74.04 110.836 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -45.58 -35.39 3.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 65.44 110.864 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -82.47 -38.84 23.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 43.14 110.891 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -65.31 -29.44 70.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 61.21 110.903 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.66 HG11 ' CE2' ' A' ' 121' ' ' TYR . 65.4 t -66.04 -45.34 90.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 73.34 111.153 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.69 -23.29 42.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 73.21 110.842 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -74.55 -46.81 36.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.447 . . . . 73.42 110.958 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.737 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -72.34 -31.12 65.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.099 -0.501 . . . . 70.24 111.118 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.541 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -72.71 -54.97 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 72.21 111.172 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.541 ' N ' HG22 ' A' ' 134' ' ' ILE . 5.3 ttt180 -48.66 -43.2 36.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 41.42 110.868 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.657 ' O ' HG23 ' A' ' 140' ' ' VAL . 6.9 mmpt? -70.64 -34.57 72.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 74.35 110.991 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.943 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.41 -49.24 78.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 65.44 111.103 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.634 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.9 m-85 -72.29 -22.82 61.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 74.45 110.884 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.496 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.8 tt0 -76.87 -5.57 48.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 65.15 110.937 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 136' ' ' LYS . 85.9 t -98.83 -16.82 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 71.31 111.19 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.796 ' NE1' HG12 ' A' ' 217' ' ' VAL . 94.9 m95 -107.37 -37.16 6.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.174 -0.466 . . . . 74.22 110.9 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.67 -11.92 60.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 73.23 110.775 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.582 HD22 ' N ' ' A' ' 143' ' ' ASN . 1.0 OUTLIER -95.21 -16.3 22.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 72.42 110.974 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.709 HG11 HD12 ' A' ' 250' ' ' LEU . 19.5 m -98.8 0.67 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 74.03 111.182 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.604 HG21 HG13 ' A' ' 258' ' ' ILE . 62.6 p -150.19 149.14 26.34 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.637 0.732 . . . . 72.54 111.204 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 32.84 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.675 2.25 . . . . 61.32 112.357 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.807 HD11 ' CD2' ' A' ' 262' ' ' TYR . 13.8 mt -97.98 177.62 5.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 74.42 110.884 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.42 126.18 18.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 70.34 110.862 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.569 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.6 m-30 -114.44 143.78 44.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.425 . . . . 74.01 110.878 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.38 152.51 49.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.483 . . . . 62.4 110.856 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.487 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.3 OUTLIER -100.08 148.27 24.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.489 . . . . 73.41 110.879 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.492 HD11 ' HB2' ' A' ' 157' ' ' ALA . 3.9 pt -152.12 168.87 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.146 -0.479 . . . . 62.5 111.07 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 75.14 110.892 179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.492 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.231 0.131 0 CA-C-O 120.787 0.327 . . . . 32.43 111.131 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.412 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.8 OUTLIER -85.8 -53.36 5.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 65.5 110.864 179.975 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.658 HG12 HG23 ' A' ' 220' ' ' ILE . 2.6 mp -90.51 96.22 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.228 -0.442 . . . . 74.05 111.075 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.547 HD11 ' NE ' ' A' ' 117' ' ' ARG . 8.0 tp -87.03 109.57 19.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 60.45 110.861 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.409 HG13 ' CE1' ' A' ' 197' ' ' PHE . 93.9 t -89.09 120.07 37.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 75.32 111.145 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.758 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.4 p -139.76 105.21 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 72.43 111.066 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -72.69 108.22 5.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 74.03 110.886 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.05 166.08 19.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 72.14 111.207 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.99 137.98 50.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.262 -0.426 . . . . 73.3 110.893 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.677 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.09 -156.03 0.14 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.721 -0.752 . . . . 73.25 112.453 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.798 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -64.58 116.55 6.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.769 0.319 . . . . 64.34 111.101 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.13 -21.48 12.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 74.04 110.849 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.32 29.38 0.6 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.683 -0.77 . . . . 61.0 112.507 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.647 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.33 1.36 15.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 64.43 110.945 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 72.63 40.22 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 73.21 110.956 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.51 -41.64 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 71.54 110.819 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.798 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.52 100.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 52.24 111.079 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.677 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.9 m-85 -60.87 -168.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 63.23 110.865 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.87 19.43 3.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 51.21 110.918 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.581 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.43 -156.63 8.93 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.783 -0.722 . . . . 53.12 112.475 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -37.67 136.54 0.52 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.855 0.359 . . . . 64.13 110.864 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.97 163.98 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 72.45 112.48 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.411 ' O ' HD22 ' A' ' 181' ' ' LEU . . . 82.92 -142.28 21.46 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.813 -0.708 . . . . 63.42 112.479 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.56 95.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 63.32 111.104 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 181' ' ' LEU . 2.9 mm? -65.86 -43.56 88.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 74.53 110.904 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -169.99 162.62 9.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 33.41 111.063 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.533 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.5 p80 -154.37 140.9 18.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.235 -0.439 . . . . 72.33 110.81 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.757 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -138.46 172.92 12.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.174 -0.466 . . . . 71.13 111.133 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 223' ' ' SER . 13.0 m-85 -101.53 -148.46 0.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 64.04 110.891 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -159.0 -96.31 0.11 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.789 -0.719 . . . . 52.23 112.531 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 59.31 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.799 2.333 . . . . 72.14 112.301 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.605 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.98 153.51 16.78 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.772 -0.728 . . . . 53.54 112.531 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.575 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.18 148.39 26.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.887 0.375 . . . . 35.01 110.862 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.55 -66.94 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.746 -0.74 . . . . 24.13 112.416 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 189' ' ' SER . 1.1 mp -103.58 6.08 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.807 0.337 . . . . 44.52 111.135 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.605 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -63.93 165.29 30.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.697 -0.763 . . . . 63.33 112.481 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 45.51 19.07 0.24 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.789 -0.719 . . . . 71.31 112.473 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.413 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 0.8 OUTLIER -63.67 107.65 1.22 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.88 0.371 . . . . 72.43 110.795 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.757 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -82.71 128.95 34.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 70.34 111.089 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.533 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 9.2 m170 -120.04 130.16 54.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 74.25 110.886 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.509 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 44.2 m-85 -115.29 133.72 55.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 74.33 110.849 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -66.92 110.15 3.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 73.23 110.857 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.25 -37.67 81.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 62.12 110.878 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.581 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 5.5 m-20 -50.62 -21.48 1.59 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 74.4 110.807 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.41 ' HG3' HD13 ' A' ' 181' ' ' LEU . 6.3 mm-40 -81.52 162.47 23.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.308 -0.406 . . . . 71.4 110.879 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.547 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.4 OUTLIER -100.54 90.0 4.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 70.43 110.85 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.521 ' HZ3' HG21 ' A' ' 215' ' ' THR . 27.0 m95 -81.6 121.72 26.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 74.54 110.951 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 40.6 p -140.21 -175.72 4.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.434 . . . . 73.33 111.112 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.93 20.79 17.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.455 . . . . 72.32 111.201 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -127.91 -176.45 3.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 75.24 110.766 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.2 p -68.96 -19.18 64.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 63.3 110.882 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.48 -107.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 72.24 112.39 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -51.9 175.89 0.12 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.718 -0.753 . . . . 54.22 112.432 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 43.7 m -64.3 98.81 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.786 0.327 . . . . 72.04 111.173 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -44.96 115.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 50.31 110.834 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.654 HD23 ' HB3' ' A' ' 133' ' ' ALA . 12.5 tp -60.33 -39.12 85.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 71.12 110.834 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.772 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.4 t80 -51.67 -63.66 1.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 72.41 110.935 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.548 HD21 ' CG2' ' A' ' 243' ' ' VAL . 8.6 mp -54.43 -55.46 28.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 63.42 110.929 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.521 HG21 ' HZ3' ' A' ' 203' ' ' TRP . 1.3 m -54.81 -36.15 64.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 73.51 111.197 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.32 -48.55 72.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 35.24 111.152 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.943 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.1 t -53.8 -57.93 4.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.166 -0.47 . . . . 64.44 111.201 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.75 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.8 t-80 -64.48 -28.16 69.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 73.02 110.847 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -64.68 -45.42 86.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 64.43 111.071 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.658 HG23 HG12 ' A' ' 159' ' ' ILE . 2.4 mt -69.5 -35.78 68.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 72.34 111.094 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.67 -44.74 38.66 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.848 -0.692 . . . . 65.43 112.402 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.461 ' O ' ' O ' ' A' ' 185' ' ' PHE . 3.8 m-70 -68.85 -39.37 79.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 75.33 110.851 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.572 ' OG ' HG23 ' A' ' 159' ' ' ILE . 5.0 m -63.05 -25.61 68.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 55.22 110.814 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 40.3 mt -77.29 -26.1 51.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 73.44 110.912 179.986 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 122.21 15.23 4.26 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.773 -0.727 . . . . 60.13 112.466 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.877 HD21 ' HA ' ' A' ' 258' ' ' ILE . 40.4 mt -82.18 155.66 24.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.779 0.324 . . . . 71.31 110.944 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -104.89 -140.68 10.48 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.699 -0.762 . . . . 70.34 112.473 179.924 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -120.97 149.45 42.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.754 0.311 . . . . 74.41 110.87 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.535 ' N ' ' HB3' ' A' ' 236' ' ' MET . 43.8 m -116.66 164.14 15.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 61.43 110.781 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.26 4.38 33.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.038 -0.528 . . . . 74.31 110.881 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.536 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.3 OUTLIER -69.68 135.77 88.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.49 0.662 . . . . 75.1 110.978 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.57 -1.34 8.15 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.759 2.306 . . . . 70.41 112.356 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.8 23.95 1.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 72.24 110.89 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.536 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -99.19 130.36 45.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 52.12 111.098 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.75 HG13 ' HB2' ' A' ' 218' ' ' HIS . 2.0 t -54.59 -31.49 23.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 74.21 111.164 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.535 ' HB3' ' N ' ' A' ' 229' ' ' SER . 0.0 OUTLIER -65.61 -14.24 60.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 64.14 110.883 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.582 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.4 t80 -64.06 143.06 98.27 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.623 0.725 . . . . 75.33 110.866 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.582 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.7 Cg_endo -69.77 -7.53 21.3 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.688 2.259 . . . . 64.23 112.381 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.1 m -92.87 149.81 21.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 55.42 111.048 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -125.82 137.39 53.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 62.23 110.905 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -152.63 128.94 10.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 71.53 110.877 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.547 ' O ' HG13 ' A' ' 243' ' ' VAL . 80.1 t80 -58.4 145.82 37.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 70.03 110.926 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.548 ' CG2' HD21 ' A' ' 214' ' ' LEU . 0.4 OUTLIER -160.35 132.21 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 71.13 111.082 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -46.86 135.2 9.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 71.11 110.892 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.648 HD11 ' HD3' ' A' ' 136' ' ' LYS . 7.3 tt -53.97 -33.49 24.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.479 . . . . 72.42 111.154 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.677 HD22 HG23 ' A' ' 247' ' ' THR . 0.5 OUTLIER -73.49 -17.19 61.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 73.21 110.905 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.677 HG23 HD22 ' A' ' 246' ' ' ASN . 24.5 p -106.01 -23.2 12.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 51.21 111.185 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -73.06 130.59 40.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 73.15 110.881 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -166.37 136.6 3.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 74.23 110.84 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.709 HD12 HG11 ' A' ' 144' ' ' VAL . 50.8 mt -50.41 124.91 11.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 74.34 110.99 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.73 170.37 12.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 45.12 110.858 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.85 -40.96 61.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 62.03 111.075 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.31 -47.6 85.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.29 -0.414 . . . . 65.11 110.844 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 31.0 m-20 -61.3 -54.76 39.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 72.23 110.846 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.406 ' HA ' HG22 ' A' ' 258' ' ' ILE . 22.7 mt -60.73 -32.84 52.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 73.54 111.123 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -68.97 -41.31 78.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 75.21 110.845 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.5 -49.66 8.96 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.744 -0.741 . . . . 62.54 112.418 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.877 ' HA ' HD21 ' A' ' 226' ' ' LEU . 8.3 tp -53.34 -34.34 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.359 . . . . 75.41 111.107 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.42 ' O ' ' N ' ' A' ' 263' ' ' GLY . 49.2 mt-30 -87.67 -16.25 34.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.464 . . . . 74.14 110.919 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.4 t -69.63 -14.73 62.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 74.54 110.83 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -123.22 -18.68 6.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 72.3 110.879 -179.982 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.807 ' CD2' HD11 ' A' ' 147' ' ' LEU . 40.6 m-85 -114.22 -33.06 5.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 74.12 110.942 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.347 0 CA-C-O 119.085 -0.842 . . . . 72.23 112.552 179.978 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.441 ' HA ' ' HG ' ' A' ' 147' ' ' LEU . 1.7 p80 . . . . . 0 C--O 1.231 0.101 0 CA-C-O 120.739 0.304 . . . . 65.44 110.891 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -136.47 108.38 7.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 74.23 110.955 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.569 HG22 ' N ' ' A' ' 115' ' ' THR . 5.1 mp -136.97 161.26 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 62.35 111.176 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.569 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -158.41 163.5 37.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 53.22 111.108 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.634 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.9 p90 -133.04 145.85 51.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 72.01 110.924 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.568 ' HD2' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -139.56 115.2 10.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 71.52 110.863 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 62.8 mt -76.58 107.78 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 75.02 111.128 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -60.49 -49.4 77.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 73.33 110.863 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.658 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.0 p-10 -142.1 167.56 21.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 63.4 110.902 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -118.4 148.93 42.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 74.34 110.933 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.501 HG23 ' HD2' ' A' ' 123' ' ' PRO . 87.7 m -100.21 135.48 20.3 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.551 0.691 . . . . 72.31 111.187 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.501 ' HD2' HG23 ' A' ' 122' ' ' THR . 54.2 Cg_endo -69.73 21.22 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.611 2.207 . . . . 72.41 112.347 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 122' ' ' THR . 1.6 m-20 -101.12 -24.75 14.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.224 -0.444 . . . . 74.42 110.879 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.405 ' HE3' HG22 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -116.19 166.2 12.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 72.34 110.835 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -89.56 147.93 23.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 74.22 110.86 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -47.87 -35.27 10.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 70.22 110.92 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -81.88 -37.21 27.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 74.33 110.891 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.406 ' HB3' HG23 ' A' ' 205' ' ' THR . 76.1 m-20 -64.86 -31.41 72.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 74.31 110.841 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.405 HG22 ' HE3' ' A' ' 125' ' ' MET . 62.4 t -64.65 -44.85 96.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 73.52 111.048 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.2 -23.19 38.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 72.34 110.803 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -75.54 -46.67 30.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 61.43 110.839 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.71 ' HB1' ' N ' ' A' ' 213' ' ' PHE . . . -69.43 -35.69 75.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 75.04 111.14 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.542 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.4 mp -70.59 -55.17 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 74.11 111.134 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.542 ' N ' HG22 ' A' ' 134' ' ' ILE . 0.6 OUTLIER -48.34 -44.15 34.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.081 -0.509 . . . . 62.44 110.929 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.634 ' O ' HG23 ' A' ' 140' ' ' VAL . 5.9 mmpt? -69.88 -35.14 74.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 72.12 110.889 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.916 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -59.84 -49.35 78.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.411 . . . . 71.44 111.116 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.634 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.8 m-85 -72.47 -22.16 61.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 70.15 110.848 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.499 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.6 OUTLIER -77.89 -5.87 52.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 74.45 110.936 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.76 ' O ' HD11 ' A' ' 250' ' ' LEU . 87.4 t -97.23 -18.65 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 65.34 111.185 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.805 ' NE1' HG12 ' A' ' 217' ' ' VAL . 95.7 m95 -103.73 -40.19 6.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 62.05 110.962 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -13.57 62.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 75.51 110.817 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.592 HD22 ' N ' ' A' ' 143' ' ' ASN . 1.0 OUTLIER -94.07 -4.04 50.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 71.13 110.876 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.822 HG11 HD12 ' A' ' 250' ' ' LEU . 31.3 m -120.96 3.59 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 61.23 111.047 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.717 HG23 ' HD2' ' A' ' 146' ' ' PRO . 3.2 m -145.98 141.66 16.89 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.675 0.75 . . . . 71.44 111.077 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . 0.717 ' HD2' HG23 ' A' ' 145' ' ' THR . 54.1 Cg_endo -69.78 35.64 0.22 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.695 2.264 . . . . 72.44 112.328 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.785 HD21 ' CE1' ' A' ' 262' ' ' TYR . 3.1 mp -103.22 -177.34 3.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 71.23 110.88 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -141.64 126.91 18.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 64.0 110.854 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.418 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.8 m-30 -114.06 146.45 40.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 74.24 110.887 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.455 ' H ' ' HA ' ' A' ' 115' ' ' THR . 5.8 t -142.27 151.51 42.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 72.02 110.877 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 7.2 tttp -102.54 143.13 32.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 74.43 110.925 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.52 HD11 ' HB2' ' A' ' 157' ' ' ALA . 21.8 pt -151.94 142.02 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 72.1 111.144 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.518 HD22 ' N ' ' A' ' 153' ' ' ASN . 1.3 m-80 . . . . . 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 64.44 110.828 179.981 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.52 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.231 0.116 0 CA-C-O 120.774 0.321 . . . . 73.01 111.151 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.26 -53.33 5.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.42 . . . . 73.51 110.918 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.659 HG12 HG23 ' A' ' 220' ' ' ILE . 2.5 mp -88.68 94.1 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 72.5 111.078 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.568 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.5 tp -85.76 108.87 18.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.479 . . . . 74.15 110.904 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.2 t -86.96 119.11 34.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 73.01 111.152 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.658 HG23 ' OD1' ' A' ' 120' ' ' ASN . 1.9 p -138.24 104.91 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 74.05 111.081 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.419 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 39.6 m-85 -73.22 111.68 8.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.195 -0.457 . . . . 71.34 110.862 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.92 166.41 21.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 75.32 111.131 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -114.41 136.16 53.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 62.33 110.987 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.679 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 44.57 -157.78 0.19 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.773 -0.727 . . . . 72.43 112.499 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.819 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -62.53 116.45 5.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.832 0.348 . . . . 62.24 110.999 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.25 -22.12 12.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 74.23 110.884 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.71 30.35 0.54 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.708 -0.758 . . . . 53.53 112.515 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.633 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.97 0.1 14.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.912 0.387 . . . . 73.12 110.899 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 74.33 39.04 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 75.32 110.954 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.96 -41.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 71.51 110.853 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.819 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.2 100.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 65.32 111.102 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.679 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.1 m-85 -61.18 -168.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 74.01 110.898 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.17 18.84 3.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 71.22 110.825 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.587 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.07 -158.04 5.57 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 62.43 112.477 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.8 OUTLIER -33.76 133.94 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 75.43 110.884 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.45 165.44 0.15 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.715 -0.755 . . . . 62.04 112.541 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.64 -143.56 22.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.692 -0.766 . . . . 71.41 112.486 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.02 96.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.83 0.348 . . . . 75.23 111.169 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 13.3 mt -66.32 -44.0 84.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 71.22 110.9 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -170.09 163.09 9.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 73.24 111.08 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.488 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -155.62 142.66 19.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 75.23 110.81 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.744 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -139.02 172.26 13.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 72.41 111.101 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 223' ' ' SER . 48.4 m-85 -100.7 -151.39 0.41 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 62.1 110.858 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -154.99 -97.07 0.13 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.74 -0.743 . . . . 74.23 112.481 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 61.31 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.685 2.256 . . . . 73.42 112.329 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.617 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.65 153.76 17.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 53.24 112.473 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.58 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.75 149.71 25.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.396 . . . . 62.51 110.829 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.23 -66.77 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.739 . . . . 71.34 112.475 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.58 ' N ' ' O ' ' A' ' 189' ' ' SER . 1.1 mp -104.78 6.61 10.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.809 0.338 . . . . 62.33 111.098 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.617 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -65.33 164.33 37.45 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.763 -0.732 . . . . 40.15 112.482 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 47.21 16.73 0.29 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 54.23 112.457 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.409 ' CG ' ' HB3' ' A' ' 160' ' ' LEU . 1.1 m-20 -63.31 111.77 2.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.78 0.324 . . . . 65.23 110.898 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.744 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -85.49 128.76 34.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 74.35 111.076 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.488 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.8 m170 -119.29 128.65 54.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 71.12 110.846 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.525 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 47.8 m-85 -114.27 134.23 55.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.208 -0.451 . . . . 71.1 110.89 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -67.19 108.91 2.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 71.41 110.871 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.94 -36.91 78.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 65.32 110.843 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.587 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 16.8 m-20 -51.38 -21.06 2.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 74.33 110.854 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -82.61 162.72 21.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 71.42 110.885 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.522 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -100.66 92.46 5.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 70.25 110.887 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.525 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 30.0 m95 -82.7 122.47 28.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.02 -0.536 . . . . 63.1 110.948 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.2 p -139.42 -170.85 2.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 74.1 111.204 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.406 HG23 ' HB3' ' A' ' 129' ' ' ASP . 0.2 OUTLIER -116.09 17.24 15.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.278 -0.419 . . . . 61.02 111.151 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.58 -177.55 4.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 73.11 110.804 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.3 p -64.95 -18.66 65.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 72.44 110.831 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.31 -108.3 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.744 -0.741 . . . . 43.2 112.452 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.09 177.45 0.14 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.698 -0.763 . . . . 72.31 112.474 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 96.3 m -66.76 94.55 0.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.8 0.334 . . . . 70.31 111.187 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -38.12 117.09 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 73.44 110.875 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.502 HD23 ' HB3' ' A' ' 133' ' ' ALA . 25.0 tp -63.66 -36.59 84.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 73.02 110.921 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.71 ' N ' ' HB1' ' A' ' 133' ' ' ALA . 3.2 t80 -52.82 -64.63 0.75 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 75.42 110.932 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.44 HD11 ' H ' ' A' ' 243' ' ' VAL . 15.2 mt -53.53 -55.54 24.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 73.54 110.902 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.523 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 1.7 m -55.52 -32.99 63.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.468 . . . . 63.43 111.065 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.415 ' HB3' ' HB2' ' A' ' 137' ' ' ALA . . . -68.0 -46.24 71.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 75.34 111.026 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.916 HG22 ' HA ' ' A' ' 137' ' ' ALA . 1.9 t -55.96 -59.4 2.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.279 -0.419 . . . . 71.32 111.104 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.526 ' HB2' ' CG1' ' A' ' 235' ' ' VAL . 1.1 t-80 -60.6 -31.7 70.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 63.1 110.925 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -60.25 -46.75 88.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 70.41 111.075 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.659 HG23 HG12 ' A' ' 159' ' ' ILE . 2.3 mt -68.75 -34.54 65.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 72.24 111.167 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.01 -42.69 48.42 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.788 -0.72 . . . . 64.34 112.418 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.44 ' O ' ' O ' ' A' ' 185' ' ' PHE . 24.1 m-70 -67.62 -39.94 84.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 64.04 110.89 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.586 ' OG ' HG23 ' A' ' 159' ' ' ILE . 2.1 m -60.76 -28.87 69.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 72.22 110.877 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 52.3 mt -76.21 -26.42 56.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 72.14 110.88 179.961 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 117.67 16.53 5.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.803 -0.713 . . . . 65.42 112.458 179.899 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.945 HD11 HD13 ' A' ' 258' ' ' ILE . 53.4 mt -77.45 159.25 29.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 62.11 110.894 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -103.71 -140.14 10.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.702 -0.761 . . . . 73.45 112.504 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.405 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 1.3 m170 -123.35 136.19 54.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.814 0.34 . . . . 63.14 110.934 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 29.8 t -104.92 162.56 13.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 73.5 110.89 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.6 t -107.75 5.85 27.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 74.55 110.751 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.553 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -68.53 140.45 92.31 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-O 121.673 0.749 . . . . 71.15 110.806 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 0.55 5.47 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.757 2.305 . . . . 75.43 112.365 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -143.62 14.66 1.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 51.12 110.813 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.553 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -77.33 140.3 39.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 73.2 111.129 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.565 HG21 HD23 ' A' ' 250' ' ' LEU . 51.6 t -69.8 -26.18 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 62.41 111.138 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.405 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 55.6 mmm -81.92 -7.03 59.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 62.41 110.955 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.496 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 2.4 t80 -50.9 138.28 24.48 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.681 0.753 . . . . 64.34 110.882 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.496 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 53.6 Cg_endo -69.75 -7.87 22.15 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.622 2.215 . . . . 64.54 112.335 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.41 ' HB ' ' CD2' ' A' ' 237' ' ' PHE . 22.3 m -110.91 130.99 55.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 53.31 111.18 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -92.24 146.82 23.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.958 0.409 . . . . 73.43 110.953 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -161.87 132.02 4.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 42.01 110.848 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.536 ' O ' HG13 ' A' ' 243' ' ' VAL . 65.0 t80 -61.89 149.06 41.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 74.13 110.915 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -160.76 137.48 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 74.33 111.12 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -60.76 127.39 31.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 51.33 110.825 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.559 HD11 ' HD3' ' A' ' 136' ' ' LYS . 14.4 tt -54.0 -29.48 18.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 75.24 111.152 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.08 -21.26 64.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 74.24 110.849 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.8 p -111.89 -18.2 12.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 63.14 111.119 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.567 ' HE2' HG21 ' A' ' 140' ' ' VAL . 36.8 t80 -62.72 142.2 58.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 73.3 110.903 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -177.11 136.25 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 74.01 110.831 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.822 HD12 HG11 ' A' ' 144' ' ' VAL . 8.7 mt -51.57 127.71 21.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 64.22 110.914 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 35.8 t -66.89 161.68 23.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 74.11 110.863 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.27 -30.17 11.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 72.05 111.128 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -71.75 -45.87 60.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 64.13 110.9 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.447 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 2.1 m-20 -62.36 -50.57 71.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 74.01 110.82 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 24.2 mt -62.29 -35.63 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 54.25 111.158 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 29.1 mmt-85 -71.08 -38.04 72.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 74.5 110.848 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.13 -49.93 7.17 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.673 -0.775 . . . . 63.24 112.523 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.945 HD13 HD11 ' A' ' 226' ' ' LEU . 8.4 tp -52.4 -34.84 19.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.786 0.327 . . . . 72.42 111.141 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.409 ' O ' ' N ' ' A' ' 263' ' ' GLY . 30.5 mt-30 -87.81 -16.18 34.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 72.53 110.925 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.6 t -70.16 -14.25 62.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 73.25 110.809 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -122.37 -19.33 6.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 63.34 110.923 179.958 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.785 ' CE1' HD21 ' A' ' 147' ' ' LEU . 37.6 m-85 -113.8 -35.06 5.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.448 . . . . 74.01 110.955 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.325 0 CA-C-O 119.157 -0.801 . . . . 43.21 112.498 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.464 ' HA ' HD22 ' A' ' 147' ' ' LEU . 9.9 p80 . . . . . 0 C--O 1.231 0.085 0 CA-C-O 120.729 0.299 . . . . 70.24 110.854 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -141.92 98.67 3.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.149 -0.478 . . . . 73.25 110.904 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.652 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.6 mp -132.12 163.19 38.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.097 -0.501 . . . . 60.23 111.136 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.589 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -160.26 163.44 33.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 72.41 111.238 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.595 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.7 p90 -133.72 155.71 49.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 75.04 110.854 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.709 ' HD2' HD11 ' A' ' 160' ' ' LEU . 3.8 tmt_? -144.87 111.56 5.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 73.3 110.923 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.0 mt -73.37 104.18 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.31 -0.405 . . . . 74.43 111.206 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -57.82 -45.72 85.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 55.52 110.896 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.743 ' OD1' HG23 ' A' ' 162' ' ' VAL . 1.6 p-10 -146.92 164.24 33.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 74.4 110.862 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.592 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.3 m-85 -116.5 144.82 43.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 75.41 110.923 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.715 HG22 ' CE ' ' A' ' 125' ' ' MET . 3.0 t -94.33 142.15 24.48 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.564 0.697 . . . . 72.05 111.17 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.87 -3.17 11.54 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.643 2.229 . . . . 62.2 112.339 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.401 ' H ' HG23 ' A' ' 122' ' ' THR . 22.8 m-20 -79.96 -23.38 41.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 43.1 110.933 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.715 ' CE ' HG22 ' A' ' 122' ' ' THR . 16.6 mtm -115.94 166.63 11.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 72.51 110.858 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.409 ' O ' HG23 ' A' ' 130' ' ' VAL . 46.7 t30 -96.32 143.95 26.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 70.35 110.909 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.88 -32.83 1.73 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 73.22 110.911 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -85.73 -40.44 16.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 70.41 110.9 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -64.88 -29.24 70.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 73.2 110.906 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.62 ' O ' HD13 ' A' ' 134' ' ' ILE . 78.9 t -67.39 -45.36 85.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 71.4 111.168 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -80.12 -22.72 41.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 73.54 110.878 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -73.75 -47.02 42.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 72.14 110.955 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.774 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -73.84 -30.01 62.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.5 . . . . 74.32 111.094 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.656 HD13 HD21 ' A' ' 212' ' ' LEU . 1.4 mp -73.84 -55.85 11.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 73.53 111.202 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.558 ' N ' HG22 ' A' ' 134' ' ' ILE . 2.1 ttt180 -48.02 -42.12 27.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 64.53 110.868 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.551 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -75.88 -33.35 59.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 64.12 110.902 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.848 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.35 -50.78 72.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 71.11 111.145 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.616 ' HE2' HD13 ' A' ' 159' ' ' ILE . 80.7 m-85 -67.37 -32.55 73.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 61.43 110.832 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.581 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.7 tt0 -63.42 -44.2 95.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 50.45 110.991 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 136' ' ' LYS . 79.3 t -49.35 -24.81 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 73.32 111.077 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.791 ' NE1' HG12 ' A' ' 217' ' ' VAL . 97.6 m95 -98.99 -28.36 13.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.253 -0.43 . . . . 75.2 110.867 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.2 p -76.14 -12.54 60.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.282 -0.417 . . . . 63.43 110.842 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 139' ' ' GLN . 57.8 m-20 -92.73 -24.75 18.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 62.14 110.867 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.64 HG11 HD12 ' A' ' 250' ' ' LEU . 4.4 m -93.28 0.8 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 62.33 111.079 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.559 HG21 HG13 ' A' ' 258' ' ' ILE . 77.6 p -152.93 143.98 16.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.642 0.734 . . . . 74.53 111.146 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 29.33 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.604 2.202 . . . . 74.02 112.333 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.751 HD11 ' CD2' ' A' ' 262' ' ' TYR . 29.4 mt -87.71 175.59 7.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.444 . . . . 70.14 110.937 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -137.67 126.47 23.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 73.53 110.983 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.652 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.4 m-85 -116.6 140.28 49.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 74.11 110.83 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.9 m -136.09 145.94 46.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 64.55 110.847 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.424 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 5.5 tttt -94.22 144.87 25.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 64.23 110.893 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.627 HD11 ' HB2' ' A' ' 157' ' ' ALA . 14.8 pt -151.25 132.85 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 72.52 111.081 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 C--N 1.33 -0.248 0 CA-C-N 116.155 -0.475 . . . . 73.44 110.866 179.968 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.627 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 N--CA 1.458 -0.057 0 CA-C-O 120.788 0.327 . . . . 73.21 111.104 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.94 -50.95 7.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 72.52 110.849 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.65 HG23 ' OG ' ' A' ' 223' ' ' SER . 2.6 mp -93.14 98.95 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 75.1 111.203 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.709 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.4 tp -88.67 109.89 20.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 71.04 110.995 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.442 HG13 ' CE1' ' A' ' 197' ' ' PHE . 98.3 t -89.07 121.44 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 72.42 111.144 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.743 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -140.98 106.43 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 75.11 111.175 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -73.66 108.57 6.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 72.41 110.819 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.91 165.61 20.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.029 -0.532 . . . . 64.03 111.163 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.08 137.69 51.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 63.34 110.879 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.68 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.82 -155.48 0.23 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.772 -0.728 . . . . 53.45 112.473 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.805 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.45 117.07 7.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 73.41 111.113 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.28 -22.51 12.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 75.44 110.831 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.32 29.68 0.54 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.805 -0.712 . . . . 33.52 112.518 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.624 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.1 -0.45 14.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.824 0.345 . . . . 50.03 110.882 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 74.77 39.39 0.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 74.14 110.946 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -135.02 -41.28 0.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 74.12 110.82 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.805 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.19 99.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.43 . . . . 74.5 111.093 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.68 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -60.4 -168.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 71.51 110.911 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.69 19.12 3.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 72.42 110.798 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.575 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.5 -157.99 6.18 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.789 -0.72 . . . . 63.45 112.508 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 176' ' ' GLY . 9.6 ptpt -34.59 134.05 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 73.52 110.966 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.84 165.42 0.18 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.777 -0.725 . . . . 75.2 112.491 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.441 ' O ' HD22 ' A' ' 181' ' ' LEU . . . 82.69 -142.9 22.1 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.775 -0.726 . . . . 41.51 112.488 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.47 96.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.953 0.406 . . . . 72.44 111.145 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.441 HD22 ' O ' ' A' ' 179' ' ' GLY . 3.0 mm? -65.56 -42.71 91.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 63.43 110.903 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -171.25 163.55 7.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 62.3 111.163 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.493 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -156.11 142.13 18.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 60.12 110.88 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.742 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -137.79 172.93 12.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 40.12 111.123 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 223' ' ' SER . 12.2 m-85 -101.7 -148.48 0.37 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.24 -0.436 . . . . 75.02 110.796 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -164.03 -86.85 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.739 -0.744 . . . . 63.4 112.483 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.82 55.51 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.564 2.176 . . . . 74.12 112.374 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.582 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.82 149.79 16.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 63.21 112.502 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.13 146.48 28.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.388 . . . . 71.41 110.805 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.03 -64.77 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.796 -0.716 . . . . 64.33 112.512 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' A' ' 189' ' ' SER . 8.2 pt -105.25 8.86 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.871 0.367 . . . . 73.51 111.214 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.582 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -68.91 169.75 41.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.701 -0.761 . . . . 75.23 112.433 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 44.67 20.78 0.23 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.727 -0.749 . . . . 74.24 112.542 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 192' ' ' GLY . 2.3 m-20 -64.98 107.34 1.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.784 0.326 . . . . 72.42 110.892 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.742 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -81.4 129.06 34.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 71.14 111.094 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.493 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.8 m170 -119.86 129.82 54.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.312 -0.403 . . . . 65.12 110.805 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.484 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 47.7 m-85 -114.47 133.9 55.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 55.21 110.876 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -66.76 107.3 2.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.128 -0.487 . . . . 75.13 110.769 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -58.4 -37.51 75.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 75.22 110.794 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.575 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 14.6 m-20 -50.48 -22.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 62.51 110.875 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -80.79 162.96 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 62.31 110.853 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.571 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -101.22 88.53 3.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 71.42 110.853 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.553 ' CZ3' HG21 ' A' ' 215' ' ' THR . 31.1 m95 -79.54 123.9 28.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 75.21 110.913 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 25.1 p -142.7 -175.96 4.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.457 . . . . 73.13 111.086 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.12 21.45 16.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 73.54 111.158 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -128.29 -174.86 3.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 51.15 110.884 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.4 p -70.87 -19.2 62.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 65.45 110.758 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.76 -105.23 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.717 -0.754 . . . . 72.03 112.519 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.5 177.23 0.11 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.735 -0.745 . . . . 42.14 112.503 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 68.7 m -66.93 98.14 0.53 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.819 0.342 . . . . 72.32 111.107 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -42.13 115.72 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.85 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.774 HD23 ' HB3' ' A' ' 133' ' ' ALA . 5.8 tp -63.93 -36.62 84.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 53.35 110.957 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.718 ' O ' HG23 ' A' ' 217' ' ' VAL . 4.5 t80 -51.93 -64.05 0.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 74.44 110.874 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.434 HD11 ' H ' ' A' ' 243' ' ' VAL . 18.2 mt -56.1 -54.84 40.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 74.51 110.855 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.553 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.5 m -54.5 -34.52 61.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 74.25 111.155 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.83 -49.35 66.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 54.45 111.069 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.848 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -52.81 -58.03 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.326 -0.397 . . . . 74.54 111.17 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.64 ' HB2' HG13 ' A' ' 235' ' ' VAL . 4.3 t-80 -63.36 -30.81 71.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 73.3 110.799 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.48 -43.27 99.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 75.4 111.087 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.636 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -71.65 -35.42 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 64.34 111.053 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.24 -43.95 43.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.644 -0.789 . . . . 74.21 112.515 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 185' ' ' PHE . 31.5 m-70 -68.52 -39.52 81.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 74.34 110.915 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.65 ' OG ' HG23 ' A' ' 159' ' ' ILE . 5.0 m -62.15 -27.39 68.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 73.44 110.843 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 68.2 mt -76.8 -27.23 55.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 73.55 110.911 -179.966 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 117.05 16.76 6.08 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.752 -0.737 . . . . 51.33 112.468 179.984 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.899 HD11 HD13 ' A' ' 258' ' ' ILE . 32.3 mt -78.85 149.08 32.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.9 0.381 . . . . 62.42 110.874 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -90.94 -142.65 10.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.733 -0.746 . . . . 65.31 112.487 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 0.4 OUTLIER -122.31 142.07 50.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.337 . . . . 72.41 110.833 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 28.7 t -103.49 161.58 13.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 65.11 110.824 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.25 -1.7 23.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 74.32 110.875 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.621 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -62.3 140.91 96.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.564 0.697 . . . . 73.3 110.907 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.71 -2.78 10.71 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.703 2.269 . . . . 70.2 112.367 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 3.6 ptmt -143.85 21.07 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 71.42 110.898 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.621 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -85.19 135.56 33.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 62.02 111.062 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.64 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.3 t -60.56 -35.68 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 54.04 111.105 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.445 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 41.1 mmm -65.44 -17.99 64.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 73.31 110.95 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.569 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.2 t80 -56.78 142.72 71.57 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.729 0.776 . . . . 72.32 110.896 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.569 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.6 Cg_endo -69.7 -1.4 8.36 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.669 2.246 . . . . 72.34 112.387 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.5 m -96.77 144.33 26.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 51.33 111.163 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -123.88 140.29 53.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 72.41 110.899 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -160.42 135.31 7.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 70.54 110.899 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.564 ' O ' HG13 ' A' ' 243' ' ' VAL . 70.8 t80 -59.04 148.69 29.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 73.51 110.976 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.3 OUTLIER -161.2 133.09 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 65.22 111.183 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -49.47 131.55 20.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 70.02 110.811 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 4.3 tt -54.44 -30.86 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 72.13 111.103 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -77.41 -17.62 57.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 74.25 110.928 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 50.9 p -104.14 -23.06 13.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 74.4 111.107 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -67.9 140.92 56.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 74.01 110.86 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.4 ptt85 -175.59 132.24 0.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.074 -0.512 . . . . 70.44 110.819 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.64 HD12 HG11 ' A' ' 144' ' ' VAL . 26.9 mt -48.24 125.48 9.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 74.23 110.998 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.1 p -68.34 166.15 17.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 72.23 110.806 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.32 -38.46 41.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 63.41 111.085 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -63.34 -46.69 85.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 72.21 110.947 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 4.9 m-20 -62.22 -53.53 53.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 53.2 110.867 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.419 ' HA ' HG22 ' A' ' 258' ' ' ILE . 26.3 mt -59.99 -36.06 64.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 72.31 111.136 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -68.23 -39.75 82.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 65.35 110.901 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.3 -53.17 5.74 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 53.3 112.514 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.899 HD13 HD11 ' A' ' 226' ' ' LEU . 6.4 tp -52.21 -35.5 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.673 0.273 . . . . 74.54 111.083 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 263' ' ' GLY . 70.0 mt-30 -85.81 -17.51 35.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 71.23 110.894 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 10.4 t -70.6 -13.63 62.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 75.3 110.817 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.7 mt -122.35 -17.74 6.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 71.14 110.883 -179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.751 ' CD2' HD11 ' A' ' 147' ' ' LEU . 33.3 m-85 -115.75 -34.77 4.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 73.23 110.987 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.279 0 CA-C-O 119.156 -0.802 . . . . 64.45 112.464 179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.634 ' HA ' HD12 ' A' ' 147' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.232 0.135 0 CA-C-O 120.815 0.341 . . . . 64.42 110.843 . . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -143.73 82.69 1.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 72.12 110.963 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.632 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.2 mp -115.63 164.0 12.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 73.11 111.12 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.584 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -159.51 162.21 35.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.198 -0.456 . . . . 75.31 111.112 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.605 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.5 p90 -133.13 148.79 52.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.436 . . . . 74.45 110.904 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.674 ' HE ' HD11 ' A' ' 160' ' ' LEU . 3.7 tmm_? -142.51 113.37 7.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 73.43 110.875 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.4 mt -73.93 106.03 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 75.22 111.164 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -59.24 -47.25 86.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 53.22 110.902 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.728 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.1 p-10 -143.29 162.88 34.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 74.15 110.857 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.602 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.2 m-85 -117.25 137.66 52.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 54.32 110.955 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.731 HG22 ' CE ' ' A' ' 125' ' ' MET . 2.6 t -87.43 143.23 33.91 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.639 0.733 . . . . 72.2 111.128 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.414 ' HD2' ' OG1' ' A' ' 122' ' ' THR . 53.2 Cg_endo -69.88 -3.62 12.45 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.588 2.192 . . . . 73.52 112.338 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.44 ' H ' HG23 ' A' ' 122' ' ' THR . 15.7 m-20 -80.02 -23.74 41.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 65.25 110.875 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.731 ' CE ' HG22 ' A' ' 122' ' ' THR . 15.6 mtm -115.67 166.73 11.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 72.33 110.916 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -97.69 143.93 27.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.429 . . . . 72.12 110.92 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.47 -35.09 3.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 72.45 110.869 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -83.36 -38.65 21.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 73.2 110.914 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -65.26 -30.48 71.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.22 -0.445 . . . . 62.24 110.776 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.602 HG11 ' CE2' ' A' ' 121' ' ' TYR . 60.8 t -65.31 -47.37 87.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 50.21 111.22 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.99 -23.18 48.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 64.4 110.845 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -74.26 -46.71 39.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.233 -0.439 . . . . 73.42 110.95 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.706 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -72.8 -31.48 64.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 71.1 111.116 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.55 HD13 ' O ' ' A' ' 130' ' ' VAL . 1.4 mp -71.95 -53.79 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 74.21 111.152 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.537 ' N ' HG22 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -48.92 -41.88 35.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 73.13 110.897 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.662 ' O ' HG23 ' A' ' 140' ' ' VAL . 8.0 mmpt? -70.97 -36.29 72.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 53.01 110.94 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.654 ' O ' HG13 ' A' ' 217' ' ' VAL . . . -59.05 -50.83 72.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 63.23 111.11 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.605 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 93.4 m-85 -69.92 -22.96 63.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 74.24 110.926 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.477 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.7 tt0 -77.52 -6.87 55.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.119 -0.491 . . . . 72.22 110.905 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.719 ' O ' HD11 ' A' ' 250' ' ' LEU . 91.5 t -96.08 -18.34 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 65.34 111.086 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.874 ' NE1' HG12 ' A' ' 217' ' ' VAL . 96.1 m95 -106.02 -39.82 5.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 72.33 110.933 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -9.79 58.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 72.31 110.859 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.556 HD22 ' N ' ' A' ' 143' ' ' ASN . 1.1 m-80 -99.87 -7.92 24.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 72.43 110.888 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.893 HG11 HD12 ' A' ' 250' ' ' LEU . 19.8 m -110.61 -5.24 11.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 74.45 111.152 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.744 ' CB ' HD23 ' A' ' 147' ' ' LEU . 44.8 p -141.36 149.62 55.3 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.555 0.693 . . . . 74.2 111.132 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 34.85 0.21 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.726 2.284 . . . . 70.32 112.27 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.928 HD21 ' HB3' ' A' ' 262' ' ' TYR . 2.9 mm? -104.98 167.09 9.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 54.14 110.924 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -131.12 127.93 39.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 54.21 110.932 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.632 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.3 m-30 -114.6 146.52 40.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 64.1 110.871 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 115' ' ' THR . 49.3 m -137.14 155.33 49.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 72.13 110.781 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.4 OUTLIER -106.78 142.36 36.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 61.55 110.83 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 157' ' ' ALA . 20.3 pt -151.26 147.97 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 71.13 111.197 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 63.4 110.924 179.924 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.6 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 N--CA 1.457 -0.095 0 CA-C-O 120.77 0.319 . . . . 43.0 111.097 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.416 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.8 OUTLIER -84.25 -54.67 4.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 74.22 110.863 -179.961 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.663 HG12 HG23 ' A' ' 220' ' ' ILE . 2.5 mp -87.34 92.8 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.483 . . . . 72.41 111.123 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.674 HD11 ' HE ' ' A' ' 117' ' ' ARG . 7.4 tp -84.83 108.61 17.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 73.23 110.959 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.419 HG13 ' CE1' ' A' ' 197' ' ' PHE . 90.3 t -87.14 120.6 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.429 . . . . 71.45 111.091 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.728 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.2 p -139.45 105.61 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 72.41 111.124 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -73.23 108.17 5.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 63.43 110.908 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.64 165.79 20.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 73.01 111.064 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.91 137.65 51.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 74.03 110.851 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.68 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.49 -155.67 0.19 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.705 -0.76 . . . . 63.55 112.565 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.808 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -64.88 116.9 6.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.908 0.385 . . . . 74.54 111.126 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.696 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.17 -23.09 11.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.289 -0.414 . . . . 64.44 110.839 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.92 29.7 0.51 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.723 -0.751 . . . . 42.41 112.486 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.627 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.28 -0.17 14.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.804 0.335 . . . . 64.34 110.877 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 74.26 39.72 0.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 62.11 110.924 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.696 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.24 -41.29 0.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.042 -0.526 . . . . 73.15 110.869 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.808 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.2 100.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 24.23 111.224 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.68 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.2 m-85 -60.71 -168.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 62.41 110.84 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.8 18.95 3.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.118 -0.492 . . . . 72.41 110.827 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.65 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.46 -157.17 6.61 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.789 -0.72 . . . . 72.45 112.482 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.451 ' N ' ' HB3' ' A' ' 200' ' ' ASP . 5.7 tmtt? -34.42 133.86 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 74.23 110.893 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.41 166.5 0.18 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.681 -0.771 . . . . 65.43 112.565 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.18 -143.71 23.15 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.712 -0.756 . . . . 74.11 112.496 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -49.99 96.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.896 0.379 . . . . 73.31 111.101 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 25.0 mt -65.51 -42.7 91.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 44.43 110.869 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -171.32 162.74 6.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.248 -0.433 . . . . 63.55 111.2 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.472 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.3 p80 -155.64 143.11 19.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.289 -0.414 . . . . 64.25 110.879 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.753 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -139.3 171.59 14.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 73.0 111.068 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 222' ' ' HIS . 50.2 m-85 -98.67 -146.79 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 75.42 110.834 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -157.41 -101.44 0.18 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.797 -0.716 . . . . 63.14 112.552 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.66 63.14 1.73 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.709 2.273 . . . . 73.33 112.361 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.619 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.06 155.66 17.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 71.25 112.553 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.94 150.19 24.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.859 0.361 . . . . 71.31 110.881 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 59.35 -67.6 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.7 -0.762 . . . . 63.35 112.492 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.589 ' N ' ' O ' ' A' ' 189' ' ' SER . 24.3 pt -104.48 7.84 9.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.816 0.341 . . . . 74.2 111.174 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.619 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -64.32 162.37 36.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 40.42 112.532 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 46.58 17.7 0.28 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.736 -0.745 . . . . 54.21 112.528 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 192' ' ' GLY . 1.7 m-20 -63.09 111.13 2.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 61.2 110.859 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.753 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -84.31 129.39 34.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 65.3 111.124 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.472 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.0 m170 -120.16 129.31 54.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 63.45 110.875 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.488 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 42.5 m-85 -114.52 133.71 55.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 74.23 110.88 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -66.14 107.09 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 74.43 110.883 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -58.38 -37.41 75.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.147 -0.479 . . . . 75.0 110.868 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.65 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 9.9 m-20 -50.2 -23.62 2.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 65.41 110.81 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -80.17 162.95 24.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 72.21 110.868 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.572 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -100.67 89.91 4.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 72.51 110.819 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.534 ' CZ3' HG21 ' A' ' 215' ' ' THR . 33.0 m95 -80.94 123.51 28.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 72.21 111.007 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.0 p -141.18 -175.08 4.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.225 -0.443 . . . . 75.43 111.118 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.2 18.39 18.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 53.03 111.148 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.87 -177.98 4.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 73.2 110.847 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 17.4 p -65.07 -19.15 65.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 74.11 110.814 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.02 -108.53 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.706 -0.759 . . . . 73.21 112.446 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.92 177.5 0.12 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.795 -0.717 . . . . 74.45 112.525 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 91.6 m -65.86 97.32 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.851 0.358 . . . . 75.14 111.156 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -42.11 116.81 0.87 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 75.42 110.903 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.57 HD22 ' SD ' ' A' ' 125' ' ' MET . 11.8 tp -63.89 -38.46 91.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 43.51 110.964 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.706 ' CA ' ' HB1' ' A' ' 133' ' ' ALA . 2.3 t80 -49.25 -64.93 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.888 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.562 HD11 ' H ' ' A' ' 243' ' ' VAL . 21.8 mt -55.3 -54.95 37.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.238 -0.437 . . . . 73.33 110.873 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.534 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.1 m -54.51 -31.75 56.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 74.43 111.082 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.31 -48.88 60.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.429 . . . . 72.34 111.169 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.874 HG12 ' NE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -52.61 -57.85 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 72.53 111.051 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.743 ' HB2' HG13 ' A' ' 235' ' ' VAL . 2.0 t-80 -64.16 -30.21 71.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 71.35 110.889 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.3 -43.95 97.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 73.31 111.082 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.663 HG23 HG12 ' A' ' 159' ' ' ILE . 2.4 mt -70.59 -35.34 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 71.4 111.148 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.91 -44.61 40.76 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.708 -0.758 . . . . 73.45 112.533 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 185' ' ' PHE . 34.1 m-70 -67.21 -40.19 86.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.832 0.349 . . . . 72.03 110.894 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.584 ' OG ' HG23 ' A' ' 159' ' ' ILE . 2.7 m -62.35 -26.25 68.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 71.5 110.885 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.508 HD22 ' OH ' ' A' ' 262' ' ' TYR . 72.9 mt -76.66 -27.87 55.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 72.31 110.911 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 120.44 18.57 4.05 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.673 -0.775 . . . . 71.03 112.51 179.861 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.848 HD21 ' HA ' ' A' ' 258' ' ' ILE . 13.3 mt -82.84 159.74 22.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.795 0.331 . . . . 75.42 110.948 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -106.57 -135.23 7.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 72.13 112.477 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 1.6 m170 -127.64 143.83 51.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.83 0.348 . . . . 73.45 110.821 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 62.2 m -108.95 163.52 13.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 74.14 110.86 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.03 0.69 30.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 73.1 110.845 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.571 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -65.18 136.57 96.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.629 0.728 . . . . 64.35 110.836 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 -0.46 6.99 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.699 2.266 . . . . 71.1 112.346 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.15 19.57 1.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 71.54 110.956 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.571 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -91.07 129.93 37.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 65.43 111.088 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.743 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.2 t -54.11 -34.93 27.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 62.4 111.163 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.427 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 39.7 mmm -62.16 -21.14 64.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 62.31 110.885 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.545 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -56.22 142.53 67.02 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.681 0.753 . . . . 72.5 110.831 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.545 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.1 Cg_endo -69.73 -1.28 8.18 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.691 2.26 . . . . 61.24 112.343 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.8 m -95.55 140.35 30.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 71.22 111.191 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -120.32 137.14 54.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 75.12 110.854 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -154.57 132.14 11.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.071 -0.513 . . . . 73.13 110.86 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.503 ' O ' HG13 ' A' ' 243' ' ' VAL . 88.4 t80 -59.65 142.85 52.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.93 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.562 ' H ' HD11 ' A' ' 214' ' ' LEU . 0.8 OUTLIER -158.46 128.85 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 72.12 111.185 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -51.29 134.37 27.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 72.53 110.876 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.449 HD11 ' HD3' ' A' ' 136' ' ' LYS . 10.8 tt -54.58 -30.13 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 71.35 111.183 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.426 HD22 HG23 ' A' ' 247' ' ' THR . 0.3 OUTLIER -73.81 -18.1 60.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 71.51 110.924 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.426 HG23 HD22 ' A' ' 246' ' ' ASN . 28.1 p -107.56 -23.31 12.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 74.44 111.115 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -68.64 146.43 53.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 73.51 110.833 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -176.28 129.58 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 73.4 110.802 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.893 HD12 HG11 ' A' ' 144' ' ' VAL . 15.1 mt -48.99 131.99 18.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 75.33 110.955 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.475 ' O ' HD12 ' A' ' 255' ' ' ILE . 47.0 t -77.35 166.31 23.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 72.14 110.818 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.03 -37.99 35.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.059 -0.519 . . . . 71.13 111.074 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.31 -45.01 89.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.219 -0.446 . . . . 72.35 110.852 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -61.37 -54.8 39.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 72.44 110.875 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.475 HD12 ' O ' ' A' ' 251' ' ' SER . 2.6 mp -60.76 -37.07 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 71.3 111.052 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -68.36 -37.77 80.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 73.01 110.881 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -78.23 -51.23 5.81 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.682 -0.771 . . . . 44.51 112.456 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.848 ' HA ' HD21 ' A' ' 226' ' ' LEU . 6.3 tp -52.8 -33.72 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.763 0.316 . . . . 61.54 111.159 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 263' ' ' GLY . 30.8 mt-30 -87.66 -16.49 34.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 73.12 110.855 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 2.6 t -68.98 -16.24 63.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.856 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.3 mt -121.13 -19.23 7.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 75.13 110.893 179.975 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.928 ' HB3' HD21 ' A' ' 147' ' ' LEU . 31.2 m-85 -110.45 -36.67 5.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.157 -0.474 . . . . 72.13 110.971 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.638 -0.791 . . . . 51.33 112.479 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.6 p80 . . . . . 0 C--O 1.231 0.106 0 CA-C-O 120.829 0.347 . . . . 60.35 110.822 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.401 ' C ' HD12 ' A' ' 114' ' ' ILE . 3.2 m-85 -140.59 108.95 5.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 62.01 110.881 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.634 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.7 mp -142.48 164.01 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 73.33 111.111 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.605 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -160.37 163.13 33.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 64.21 111.155 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.572 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.2 p90 -134.2 153.97 51.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.41 . . . . 70.24 110.888 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.603 ' HD2' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -145.88 110.65 5.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 73.54 110.838 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 59.5 mt -73.14 106.0 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 63.32 111.072 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -59.42 -51.03 71.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 74.23 110.933 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.682 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.7 p-10 -138.41 166.28 24.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.32 110.884 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -116.05 154.36 30.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 75.12 110.919 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.496 ' CG2' ' HD2' ' A' ' 123' ' ' PRO . 11.0 m -102.67 137.42 19.34 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.571 0.7 . . . . 74.11 111.149 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.496 ' HD2' ' CG2' ' A' ' 122' ' ' THR . 53.3 Cg_endo -69.67 3.45 2.72 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.688 2.258 . . . . 65.01 112.362 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.47 ' H ' HG22 ' A' ' 122' ' ' THR . 2.1 m-20 -87.6 -28.59 21.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 74.31 110.797 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.595 ' SD ' HD22 ' A' ' 212' ' ' LEU . 5.8 mtm -110.19 167.01 10.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 74.33 110.861 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -90.14 142.58 27.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 73.43 110.878 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.36 -37.07 4.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 75.03 110.898 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -82.53 -36.88 25.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 71.42 110.887 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -64.84 -32.0 73.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.148 -0.478 . . . . 62.4 110.868 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.569 HG22 ' HE3' ' A' ' 125' ' ' MET . 62.4 t -64.78 -43.86 96.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 70.05 111.124 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.4 -23.27 35.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 75.34 110.926 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -75.33 -48.1 24.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 73.44 110.865 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.594 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -71.41 -30.67 66.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 62.12 111.088 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.62 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -73.09 -55.58 12.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 75.31 111.112 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.531 ' N ' HG22 ' A' ' 134' ' ' ILE . 7.0 ttt180 -48.2 -41.75 28.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.835 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 140' ' ' VAL . 7.6 mmtt -75.66 -31.75 59.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.213 -0.449 . . . . 72.31 110.873 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.656 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -61.9 -50.83 70.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 61.42 111.119 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.655 ' HE2' HD13 ' A' ' 159' ' ' ILE . 75.5 m-85 -66.21 -30.89 71.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 75.12 110.972 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.593 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 3.7 tt0 -63.99 -42.62 97.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 72.14 110.87 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 136' ' ' LYS . 74.1 t -50.23 -24.43 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 54.11 111.088 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.806 ' NE1' HG12 ' A' ' 217' ' ' VAL . 98.1 m95 -98.1 -30.35 12.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.185 -0.461 . . . . 75.44 110.967 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 12.8 t -72.52 -14.74 61.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 63.44 110.863 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.593 ' ND2' ' O ' ' A' ' 139' ' ' GLN . 63.7 m-80 -89.32 -25.71 21.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.51 . . . . 41.23 110.914 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.6 HG21 ' CD1' ' A' ' 250' ' ' LEU . 7.0 m -94.74 2.82 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 71.11 111.132 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.472 ' C ' ' H ' ' A' ' 147' ' ' LEU . 23.6 p -154.45 142.61 14.26 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.502 0.667 . . . . 61.44 111.191 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 19.26 0.18 Allowed 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.685 2.257 . . . . 71.43 112.414 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.794 HD21 ' CG ' ' A' ' 262' ' ' TYR . 0.6 OUTLIER -74.27 -177.57 3.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 75.53 110.903 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -144.4 124.52 13.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 71.34 110.91 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.634 ' HE1' HD13 ' A' ' 114' ' ' ILE . 2.4 m-85 -116.79 140.2 49.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 72.43 110.815 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.5 t -136.21 145.33 45.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 64.52 110.821 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.478 ' HG3' ' N ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -93.7 144.25 25.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 64.01 110.857 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.605 HD11 ' HB2' ' A' ' 157' ' ' ALA . 11.4 pt -150.65 130.49 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 43.11 111.127 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.1 m120 . . . . . 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 73.21 110.893 179.946 . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.605 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.23 0.046 0 CA-C-O 120.819 0.343 . . . . 74.44 111.075 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.92 -50.87 7.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 64.11 110.92 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.694 HG12 HG23 ' A' ' 220' ' ' ILE . 2.9 mp -92.65 96.52 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 72.42 111.098 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.603 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.3 tp -87.26 110.49 20.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 75.32 110.961 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 88.2 t -88.54 119.07 35.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.112 -0.494 . . . . 74.24 111.139 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.682 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.1 p -138.38 106.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 74.34 111.125 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.448 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 34.4 m-85 -75.88 111.78 11.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 74.13 110.901 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -130.93 172.7 11.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 63.52 111.106 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.431 ' CG ' ' HB3' ' A' ' 199' ' ' GLU . 9.1 mtt180 -115.54 139.57 49.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 62.23 110.912 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.664 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 39.28 -149.05 0.11 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.773 -0.727 . . . . 74.14 112.476 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.802 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -69.4 117.02 10.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 74.51 111.125 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.43 -20.65 13.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 64.13 110.91 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.12 29.79 0.65 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.783 -0.722 . . . . 74.44 112.496 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.636 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.2 0.28 14.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.82 0.343 . . . . 74.41 110.812 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 74.1 38.73 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 75.21 110.895 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.2 -41.74 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 73.15 110.876 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.802 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.52 99.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 74.01 111.046 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.664 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -60.5 -168.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.325 -0.398 . . . . 71.3 110.865 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.15 19.88 3.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 71.24 110.907 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.571 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 53.74 -157.94 5.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 71.13 112.536 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 176' ' ' GLY . 9.9 tttt -34.58 134.43 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.339 . . . . 71.54 110.937 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.55 165.77 0.17 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.663 -0.78 . . . . 40.41 112.508 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.3 -143.45 22.84 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.734 -0.746 . . . . 73.22 112.553 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -49.66 96.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.875 0.369 . . . . 71.13 111.154 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 84.4 mt -65.96 -42.49 89.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 64.42 110.962 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -171.11 166.69 7.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.288 -0.414 . . . . 45.1 111.091 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.516 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -159.68 140.74 12.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.134 -0.485 . . . . 63.43 110.831 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.759 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -135.94 173.14 12.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 71.52 111.086 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 223' ' ' SER . 10.4 m-85 -104.66 -151.82 0.45 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 64.04 110.837 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.412 ' H ' ' HB3' ' A' ' 185' ' ' PHE . . . -161.29 -81.74 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.745 -0.74 . . . . 53.31 112.531 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.3 Cg_endo -69.87 53.92 1.17 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.639 2.226 . . . . 65.42 112.333 -179.899 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.567 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -124.15 147.37 16.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.775 -0.726 . . . . 54.04 112.487 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.63 144.2 31.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 74.24 110.81 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.46 -63.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.721 -0.752 . . . . 74.22 112.506 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 189' ' ' SER . 2.2 pp -106.2 9.54 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.924 0.392 . . . . 75.52 111.133 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.567 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -70.72 171.43 44.65 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.734 -0.746 . . . . 70.11 112.45 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.44 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 44.24 20.44 0.18 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.734 -0.745 . . . . 75.23 112.476 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 192' ' ' GLY . 4.1 m-20 -64.24 108.59 1.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.776 0.322 . . . . 72.43 110.954 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.759 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -82.14 121.7 26.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 64.31 111.1 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.516 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.7 m170 -112.13 130.42 55.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 75.32 110.893 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.48 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 46.6 m-85 -115.23 136.12 53.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 62.01 110.897 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -69.29 104.03 2.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 73.11 110.827 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.431 ' HB3' ' CG ' ' A' ' 165' ' ' ARG . 4.2 tm-20 -55.87 -37.99 69.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 73.24 110.863 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.571 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 12.7 m-20 -49.26 -22.72 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 54.25 110.836 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -81.05 161.13 24.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 73.43 110.867 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.491 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -97.95 89.83 4.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 74.21 110.919 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.537 ' CZ3' HG21 ' A' ' 215' ' ' THR . 28.3 m95 -81.54 123.11 28.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 73.35 110.905 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.9 p -135.56 -174.23 3.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 70.24 111.225 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.53 12.78 18.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.279 -0.419 . . . . 64.12 111.167 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -131.04 -176.0 3.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 75.24 110.897 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.2 p -51.25 -36.06 40.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.433 . . . . 63.31 110.835 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -64.08 159.64 39.95 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.704 -0.76 . . . . 70.41 112.451 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . 49.15 -173.71 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.707 -0.759 . . . . 54.43 112.597 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.7 m -85.66 93.44 8.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.76 0.314 . . . . 75.45 111.122 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -38.91 111.47 0.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 72.22 110.822 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.62 HD21 HD13 ' A' ' 134' ' ' ILE . 9.0 tp -60.18 -36.78 78.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 74.14 110.869 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.594 ' CA ' ' HB1' ' A' ' 133' ' ' ALA . 3.6 t80 -51.97 -62.8 1.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.462 . . . . 71.45 110.935 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.547 HD11 ' H ' ' A' ' 243' ' ' VAL . 31.6 mt -57.52 -52.4 65.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 71.22 110.93 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.537 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 1.7 m -53.64 -38.07 63.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 53.34 111.137 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.429 ' HB3' ' CB ' ' A' ' 137' ' ' ALA . . . -61.74 -51.92 66.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 65.32 111.09 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.806 HG12 ' NE1' ' A' ' 141' ' ' TRP . 1.4 t -50.21 -58.87 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.458 . . . . 61.41 111.154 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.65 ' HB2' HG13 ' A' ' 235' ' ' VAL . 2.8 t-80 -62.86 -31.81 72.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 73.31 110.854 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -62.37 -43.29 99.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 42.34 111.121 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.694 HG23 HG12 ' A' ' 159' ' ' ILE . 2.4 mt -70.51 -33.43 53.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 75.51 111.093 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.92 -43.45 48.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.738 -0.744 . . . . 34.52 112.474 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.428 ' O ' ' O ' ' A' ' 185' ' ' PHE . 47.8 m-70 -68.37 -39.73 81.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.734 0.302 . . . . 74.31 110.814 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.601 ' OG ' HG23 ' A' ' 159' ' ' ILE . 2.0 m -62.16 -26.7 68.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 74.33 110.902 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 79.5 mt -77.25 -26.55 52.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 75.01 110.934 179.981 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 112.16 22.05 6.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.731 . . . . 54.42 112.487 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.742 HD11 ' HA ' ' A' ' 258' ' ' ILE . 0.1 OUTLIER -87.66 146.86 25.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.9 0.381 . . . . 74.11 110.887 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -88.04 -160.12 35.4 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.731 -0.747 . . . . 73.3 112.546 179.873 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -102.57 125.97 49.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 71.22 110.872 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.4 m -80.55 162.77 24.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 71.23 110.836 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.82 -1.1 19.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 70.5 110.894 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.638 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -63.44 142.75 97.9 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.582 0.706 . . . . 54.22 110.88 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -4.24 13.66 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.637 2.224 . . . . 63.11 112.344 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.68 23.61 1.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 64.42 110.867 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.638 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -81.54 143.0 32.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 71.21 111.068 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.65 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.3 t -65.78 -38.91 83.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.219 -0.446 . . . . 74.15 111.146 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 83.1 mmm -68.57 -12.27 61.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 65.23 110.878 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.657 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.5 t80 -57.8 145.1 72.28 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.582 0.706 . . . . 70.44 110.892 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.657 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.8 Cg_endo -69.77 0.89 5.0 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.666 2.244 . . . . 75.43 112.372 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 24.6 m -101.72 143.91 31.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 73.13 111.101 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -123.11 138.31 54.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 74.35 110.915 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -157.13 129.61 7.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 74.22 110.854 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.576 ' O ' HG13 ' A' ' 243' ' ' VAL . 86.3 t80 -59.66 145.83 43.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 74.23 110.949 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.3 OUTLIER -161.21 131.27 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 65.41 111.143 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -52.72 133.67 36.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.053 -0.521 . . . . 75.11 110.924 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.2 tt -53.69 -30.19 18.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.289 -0.414 . . . . 74.22 111.151 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.667 ' ND2' HG23 ' A' ' 247' ' ' THR . 0.0 OUTLIER -69.84 -20.26 63.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 73.24 110.96 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.667 HG23 ' ND2' ' A' ' 246' ' ' ASN . 6.3 p -110.45 -21.24 12.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 63.24 111.175 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -69.4 142.13 53.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 73.14 110.905 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -176.5 133.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 72.3 110.927 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.6 ' CD1' HG21 ' A' ' 144' ' ' VAL . 40.0 mt -47.52 123.58 5.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 74.11 110.987 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 7.1 t -58.3 158.36 7.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 62.33 110.954 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.52 -30.49 8.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 74.54 111.07 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -72.89 -45.69 56.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 75.24 110.846 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.12 -41.26 98.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 64.41 110.845 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.463 HG12 HG11 ' A' ' 144' ' ' VAL . 42.8 mt -69.6 -43.36 80.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 75.33 111.145 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.07 -28.99 67.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 74.1 110.919 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -85.06 -49.77 4.36 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.648 -0.787 . . . . 60.34 112.527 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.742 ' HA ' HD11 ' A' ' 226' ' ' LEU . 4.4 tp -54.22 -32.06 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.734 0.302 . . . . 74.02 111.123 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 263' ' ' GLY . 69.6 mt-30 -86.72 -17.58 33.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 74.52 110.942 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 2.4 t -67.79 -14.35 62.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 75.15 110.896 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.5 mt -121.8 -19.68 6.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 53.32 110.932 -179.985 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.794 ' CG ' HD21 ' A' ' 147' ' ' LEU . 42.5 m-85 -113.41 -35.19 5.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 74.24 110.871 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 C--O 1.229 -0.218 0 CA-C-O 119.199 -0.778 . . . . 43.4 112.471 179.976 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.536 ' HA ' HD22 ' A' ' 147' ' ' LEU . 14.2 p80 . . . . . 0 C--O 1.231 0.102 0 CA-C-O 120.931 0.396 . . . . 64.01 110.939 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -123.77 95.23 4.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 73.31 110.892 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.636 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.8 mp -121.93 162.53 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 53.12 111.144 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.591 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -156.87 164.77 37.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 73.04 111.073 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.594 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.4 p90 -134.81 148.57 50.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 74.41 110.835 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.438 ' HB3' HD12 ' A' ' 160' ' ' LEU . 4.2 tmt_? -140.72 110.71 6.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.02 -0.536 . . . . 72.52 110.908 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 57.0 mt -73.11 104.8 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 52.31 111.049 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -56.41 -48.97 75.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 70.42 110.836 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.74 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.8 p-10 -143.54 163.57 32.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 75.22 110.876 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.569 ' CE2' HG11 ' A' ' 130' ' ' VAL . 4.9 m-85 -116.38 138.47 51.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 71.52 110.903 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.646 HG22 ' CE ' ' A' ' 125' ' ' MET . 9.1 t -87.86 141.95 32.0 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.55 0.69 . . . . 74.44 111.154 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -3.77 12.69 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.638 2.226 . . . . 61.2 112.363 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -78.43 -23.3 46.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 74.14 110.93 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.659 ' CE ' HG22 ' A' ' 130' ' ' VAL . 12.7 mtm -116.79 166.78 11.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 71.11 110.9 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.461 ' O ' HG23 ' A' ' 130' ' ' VAL . 23.9 t-20 -94.46 144.01 25.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 62.14 110.867 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -45.42 -36.92 4.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 44.02 110.86 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -82.57 -36.14 26.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 72.43 110.919 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -66.99 -30.17 70.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 73.4 110.828 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.659 HG22 ' CE ' ' A' ' 125' ' ' MET . 82.0 t -66.57 -46.35 86.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 65.43 111.142 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.428 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 0.4 OUTLIER -77.54 -24.72 49.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.187 -0.46 . . . . 71.43 110.796 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -73.22 -47.84 40.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 73.42 110.856 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.747 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -69.36 -31.42 69.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.175 -0.466 . . . . 51.24 111.122 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.626 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -74.26 -53.46 17.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 71.01 111.102 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.509 ' N ' HG22 ' A' ' 134' ' ' ILE . 7.0 ptp180 -49.22 -37.2 22.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 73.35 110.806 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.641 ' O ' HG23 ' A' ' 140' ' ' VAL . 7.3 mmtt -76.88 -34.47 57.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 74.03 110.869 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.931 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -59.98 -48.66 80.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 72.22 111.082 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.623 ' HE2' HD13 ' A' ' 159' ' ' ILE . 94.1 m-85 -72.5 -22.69 61.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 72.04 110.899 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.487 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.2 OUTLIER -77.13 -5.5 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 71.4 110.89 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 136' ' ' LYS . 84.1 t -98.74 -17.05 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 74.33 111.125 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.808 ' NE1' HG12 ' A' ' 217' ' ' VAL . 94.1 m95 -107.01 -37.03 6.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 73.3 110.906 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.78 -11.81 60.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.427 . . . . 62.42 110.88 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.604 HD22 ' N ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER -94.99 -17.09 22.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 75.52 110.912 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.684 HG11 HD12 ' A' ' 250' ' ' LEU . 21.2 m -98.76 2.19 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 65.43 111.098 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.548 HG21 HG13 ' A' ' 258' ' ' ILE . 51.4 p -151.66 149.49 24.13 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.525 0.679 . . . . 23.03 111.219 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 32.01 0.19 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.698 2.265 . . . . 61.33 112.386 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.788 HD11 ' CD2' ' A' ' 262' ' ' TYR . 13.2 mt -97.8 175.92 5.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 75.03 110.929 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -140.1 125.53 19.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.172 -0.467 . . . . 74.1 110.954 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.636 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.2 m-30 -114.39 139.88 49.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 71.45 110.864 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.1 m -134.94 149.4 50.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 65.54 110.906 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 1.8 tttt -95.58 148.22 22.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 61.34 110.883 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 157' ' ' ALA . 3.6 pt -152.46 165.06 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 74.11 111.153 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER . . . . . 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 43.51 110.99 179.899 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.543 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.23 0.067 0 CA-C-O 120.81 0.338 . . . . 53.23 111.118 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.447 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.5 OUTLIER -84.67 -53.12 5.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 75.42 110.846 179.989 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.771 HG12 HG23 ' A' ' 220' ' ' ILE . 2.3 mp -90.53 97.61 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 71.23 111.165 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 117' ' ' ARG . 8.5 tp -89.29 109.3 20.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 64.35 110.875 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.428 HG13 ' CE1' ' A' ' 197' ' ' PHE . 95.7 t -89.06 123.49 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 71.53 111.122 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.74 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -142.64 107.8 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 72.32 111.144 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -77.18 109.3 10.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 71.03 110.87 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -130.56 169.76 15.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 41.24 111.09 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . 0.498 ' HG3' ' HB3' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -112.88 139.22 48.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 74.42 110.826 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.664 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 41.43 -150.87 0.2 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.667 -0.778 . . . . 64.53 112.457 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.8 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -68.04 117.93 10.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.723 0.297 . . . . 55.43 111.163 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.706 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.79 -21.56 12.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 55.31 110.906 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.08 29.54 0.61 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.738 -0.744 . . . . 62.04 112.499 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.621 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.73 -0.32 15.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.88 0.372 . . . . 54.52 110.825 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 74.76 38.67 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 74.23 110.87 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.706 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -134.29 -41.24 0.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 73.33 110.898 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.8 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 55.04 99.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 63.22 111.106 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.664 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.7 m-85 -60.73 -166.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 72.13 110.829 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.59 19.5 2.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.056 -0.52 . . . . 65.42 110.862 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.585 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.7 -157.53 6.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 62.25 112.453 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 176' ' ' GLY . 12.4 mmtm -36.7 135.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 75.23 110.917 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.76 162.85 0.15 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.7 -0.762 . . . . 33.23 112.521 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.53 -140.01 20.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.68 -0.772 . . . . 54.0 112.513 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.6 mt -49.92 93.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.819 0.342 . . . . 71.03 111.206 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.665 HD11 HG21 ' A' ' 210' ' ' THR . 1.7 tm? -67.44 -33.34 74.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.944 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -178.89 169.31 1.6 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 35.14 111.06 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.505 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.3 p80 -165.28 139.43 4.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 74.2 110.855 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.726 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -137.93 173.47 11.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.267 -0.424 . . . . 32.44 111.125 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.488 ' O ' ' O ' ' A' ' 222' ' ' HIS . 10.2 m-85 -98.85 -141.98 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.006 0.432 . . . . 74.33 110.809 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -164.42 -101.13 0.15 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.736 -0.745 . . . . 72.4 112.507 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 61.42 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.66 2.24 . . . . 63.14 112.349 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.601 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.94 154.66 16.74 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.736 -0.745 . . . . 64.02 112.442 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.569 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.05 147.95 26.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.938 0.399 . . . . 63.52 110.821 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.66 -67.2 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 53.13 112.545 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.569 ' N ' ' O ' ' A' ' 189' ' ' SER . 5.2 mm -103.39 6.58 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 70.11 111.118 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.601 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -64.14 165.43 30.81 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.8 -0.714 . . . . 71.52 112.483 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 45.35 19.17 0.22 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.735 -0.745 . . . . 73.45 112.471 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.423 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 0.8 OUTLIER -63.5 105.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.885 0.374 . . . . 62.24 110.846 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.726 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -81.84 131.65 35.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 72.42 111.127 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.505 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 7.7 m170 -122.82 129.77 52.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 75.3 110.884 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.58 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 34.1 m-85 -115.5 135.5 54.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.292 -0.413 . . . . 75.33 110.963 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -69.36 106.82 3.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 71.11 110.961 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.498 ' HB3' ' HG3' ' A' ' 165' ' ' ARG . 3.9 tm-20 -58.35 -37.53 75.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 75.51 110.916 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.585 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 14.9 m-20 -49.18 -23.22 1.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.506 . . . . 64.51 110.852 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.75 163.4 24.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 64.3 110.88 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.493 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.2 OUTLIER -96.9 96.35 8.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 73.42 110.855 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.58 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 34.0 m95 -87.89 123.89 33.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.475 . . . . 64.22 110.891 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.8 p -143.73 -179.13 6.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 54.32 111.127 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.24 18.64 20.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 54.32 111.128 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.85 -175.51 3.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 63.44 110.796 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 24.1 p -66.91 -18.11 65.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 62.54 110.835 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.95 -108.7 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.61 -0.805 . . . . 42.23 112.538 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.04 178.18 0.12 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.818 -0.706 . . . . 73.34 112.492 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.665 HG21 HD11 ' A' ' 181' ' ' LEU . 96.3 m -66.08 97.42 0.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.338 . . . . 72.25 111.044 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -41.48 111.93 0.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 75.21 110.843 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.747 HD23 ' HB3' ' A' ' 133' ' ' ALA . 9.6 tp -58.8 -38.08 77.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 73.32 110.869 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.771 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.7 t80 -52.5 -64.28 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 61.41 110.845 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.458 HD11 ' H ' ' A' ' 243' ' ' VAL . 19.3 mt -52.45 -56.22 16.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 75.04 110.92 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 219' ' ' ALA . 3.0 m -54.87 -37.93 66.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 74.55 111.164 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.06 -48.28 79.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 32.45 111.059 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.931 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.1 t -53.84 -58.52 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 54.41 111.182 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.753 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.7 t-80 -64.78 -27.65 69.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 71.24 110.931 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -64.14 -44.77 91.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 73.11 111.074 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.771 HG23 HG12 ' A' ' 159' ' ' ILE . 2.6 mt -69.33 -34.54 63.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 70.55 111.16 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -52.43 -45.25 58.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.698 -0.763 . . . . 64.22 112.494 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.488 ' O ' ' O ' ' A' ' 185' ' ' PHE . 3.8 m-70 -68.49 -40.22 81.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.784 0.326 . . . . 73.42 110.847 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 29.8 p -65.39 -21.29 66.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 75.12 110.84 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 59.6 mt -79.81 -26.84 40.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 61.51 110.941 179.981 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 122.35 12.88 5.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.699 -0.762 . . . . 54.04 112.447 179.951 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.509 HD21 ' HA ' ' A' ' 258' ' ' ILE . 11.3 mt -81.71 156.09 25.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.83 0.348 . . . . 72.11 110.933 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -99.89 -140.5 11.43 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.797 -0.716 . . . . 65.51 112.493 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -120.91 141.98 50.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.359 . . . . 70.41 110.808 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 60.9 p -99.16 163.05 12.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 72.2 110.904 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.67 1.22 21.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 55.32 110.824 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.17 132.35 73.69 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.553 0.692 . . . . 74.5 110.864 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . 0.403 ' HG2' ' HE2' ' A' ' 233' ' ' LYS . 52.8 Cg_endo -69.87 4.15 2.4 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.638 2.225 . . . . 51.22 112.321 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . 0.403 ' HE2' ' HG2' ' A' ' 232' ' ' PRO . 0.0 OUTLIER -136.01 11.12 3.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 74.03 110.884 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -88.82 150.22 23.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 73.15 111.151 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.753 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -71.73 -39.67 69.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 71.11 111.136 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.464 ' HE2' ' HB3' ' A' ' 226' ' ' LEU . 48.0 mmm -61.73 -15.12 37.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 74.14 110.861 179.933 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.618 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -56.53 144.49 63.66 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.649 0.738 . . . . 75.43 110.9 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.618 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.0 Cg_endo -69.84 -1.75 9.06 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.582 2.188 . . . . 63.2 112.313 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 22.0 m -97.88 141.07 31.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.419 . . . . 75.23 111.19 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -122.64 135.36 54.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 54.53 110.932 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -156.27 137.04 13.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 60.44 110.905 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.504 ' O ' HG13 ' A' ' 243' ' ' VAL . 66.4 t80 -59.2 146.28 39.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 73.14 110.997 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.6 OUTLIER -158.96 133.01 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 75.32 111.082 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -51.13 129.32 23.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 71.44 110.835 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.42 HD12 ' CE2' ' A' ' 213' ' ' PHE . 9.7 tt -53.84 -30.88 19.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 74.43 111.157 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -73.43 -21.15 60.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 71.52 110.926 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 69.8 p -104.05 -22.41 13.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 61.43 111.176 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -67.03 141.86 57.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 74.14 110.91 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -175.41 132.41 0.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 74.54 110.83 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.684 HD12 HG11 ' A' ' 144' ' ' VAL . 55.5 mt -49.89 122.78 7.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 75.32 110.907 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 8.6 t -65.96 167.21 10.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 73.51 110.898 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.01 -38.05 35.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 53.51 111.048 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -61.86 -49.12 77.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 65.53 110.826 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.436 ' OD2' ' HB ' ' A' ' 235' ' ' VAL . 2.0 m-20 -59.25 -55.79 30.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.244 -0.435 . . . . 73.44 110.813 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 18.3 mt -59.68 -33.46 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 61.01 111.201 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -69.2 -41.06 77.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 71.24 110.874 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.84 -49.87 7.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.75 -0.738 . . . . 73.34 112.542 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.548 HG13 HG21 ' A' ' 145' ' ' THR . 7.5 tp -53.08 -33.67 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.72 0.295 . . . . 73.43 111.098 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.412 ' O ' ' N ' ' A' ' 263' ' ' GLY . 52.8 mt-30 -88.21 -16.21 33.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.485 . . . . 75.33 110.933 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.7 t -69.54 -14.16 62.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 73.2 110.826 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -123.99 -18.65 5.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.144 -0.48 . . . . 75.44 110.934 179.96 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.788 ' CD2' HD11 ' A' ' 147' ' ' LEU . 41.1 m-85 -114.3 -32.88 5.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 74.35 110.896 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.369 0 CA-C-O 119.22 -0.767 . . . . 64.12 112.468 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.615 ' HA ' HD12 ' A' ' 147' ' ' LEU . 2.1 p80 . . . . . 0 C--O 1.231 0.113 0 CA-C-O 120.876 0.369 . . . . 71.13 110.894 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -144.62 90.94 2.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 74.41 110.972 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.587 HG22 ' N ' ' A' ' 115' ' ' THR . 5.0 mp -121.09 162.49 19.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 75.5 111.216 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.587 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -160.09 162.71 34.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 62.34 111.102 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.594 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.1 p90 -133.4 149.71 51.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.496 . . . . 74.42 110.952 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.688 ' HD2' HD11 ' A' ' 160' ' ' LEU . 3.9 tmt_? -142.5 115.06 8.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 72.35 110.823 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 52.7 mt -75.35 103.43 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 70.43 111.128 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -57.15 -45.72 83.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 74.21 110.933 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.736 ' OD1' HG23 ' A' ' 162' ' ' VAL . 1.7 p-10 -145.01 161.38 39.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.431 . . . . 65.24 110.914 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.57 ' CD2' HG11 ' A' ' 130' ' ' VAL . 4.7 m-85 -115.53 134.05 55.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 62.0 110.906 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.708 HG22 ' CE ' ' A' ' 125' ' ' MET . 2.3 t -82.41 142.05 46.32 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.55 0.691 . . . . 72.55 111.195 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.89 -5.78 17.11 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.646 2.231 . . . . 64.25 112.308 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -77.07 -22.15 53.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.439 . . . . 62.43 110.876 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.708 ' CE ' HG22 ' A' ' 122' ' ' THR . 18.2 mtm -117.74 167.15 11.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 71.12 110.884 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.41 ' O ' HG23 ' A' ' 130' ' ' VAL . 45.6 t30 -94.09 143.17 26.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 74.35 110.934 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -44.72 -35.23 2.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.226 -0.443 . . . . 70.44 110.853 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -84.26 -38.35 20.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 74.13 110.932 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -65.7 -30.02 70.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 63.24 110.783 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.612 HG22 ' CE ' ' A' ' 125' ' ' MET . 79.7 t -66.79 -46.78 84.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 32.13 111.07 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -77.22 -24.29 51.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 61.25 110.894 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -73.89 -47.01 41.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 64.11 110.91 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.886 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -68.93 -32.19 71.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 63.14 111.134 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.616 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -74.72 -53.65 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 71.04 111.161 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.526 ' N ' HG22 ' A' ' 134' ' ' ILE . 6.8 ptp180 -49.18 -38.07 24.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 72.33 110.937 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.652 ' O ' HG23 ' A' ' 140' ' ' VAL . 1.6 mmtp -77.18 -31.93 55.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 74.35 110.916 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.917 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -61.58 -49.14 77.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 43.15 111.066 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.665 ' HE2' HD13 ' A' ' 159' ' ' ILE . 95.6 m-85 -72.82 -22.09 60.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 74.01 110.844 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.49 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.6 OUTLIER -77.4 -5.54 50.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 61.14 110.888 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 136' ' ' LYS . 97.8 t -98.11 -17.21 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 73.23 111.152 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.855 ' NE1' HG12 ' A' ' 217' ' ' VAL . 95.9 m95 -106.87 -37.19 6.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 73.51 110.906 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.25 -10.84 60.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 73.13 110.815 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.59 HD22 ' N ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER -97.07 -19.4 18.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 65.1 110.939 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.81 HG11 HD12 ' A' ' 250' ' ' LEU . 18.3 m -100.23 -2.27 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.47 . . . . 71.22 111.075 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.739 ' CB ' HD23 ' A' ' 147' ' ' LEU . 34.3 p -142.39 147.45 43.36 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.517 0.675 . . . . 72.43 111.212 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.79 34.72 0.21 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.649 2.233 . . . . 60.25 112.336 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.909 HD21 ' HB3' ' A' ' 262' ' ' TYR . 3.0 mm? -104.57 166.47 10.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 61.43 110.883 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -128.99 125.69 37.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 50.43 110.926 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.46 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.3 m-30 -114.55 143.49 44.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 70.01 110.909 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.405 ' H ' ' HA ' ' A' ' 115' ' ' THR . 44.4 m -140.75 148.24 40.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 75.1 110.821 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.424 ' HD2' ' CD2' ' A' ' 116' ' ' TYR . 12.4 tptm -97.36 146.13 25.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 75.42 110.813 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.614 HD11 ' N ' ' A' ' 157' ' ' ALA . 16.3 pt -150.31 142.85 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 62.15 111.076 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.5 m120 . . . . . 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 65.41 111.007 179.801 . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.614 ' N ' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.825 0.345 . . . . 61.31 111.141 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.409 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.3 OUTLIER -82.51 -52.87 6.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 65.1 110.813 -179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.724 HG12 HG23 ' A' ' 220' ' ' ILE . 2.4 mp -91.52 97.96 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 75.05 111.151 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.688 HD11 ' HD2' ' A' ' 117' ' ' ARG . 6.9 tp -88.8 110.69 21.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.176 -0.466 . . . . 73.42 110.947 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 90.6 t -88.81 119.51 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 70.51 111.16 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.736 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -138.82 104.52 2.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.174 -0.467 . . . . 72.12 111.238 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -70.98 110.48 5.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 64.03 110.891 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -130.32 166.38 20.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 51.41 111.054 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 21.3 ptt-85 -114.7 140.0 49.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 55.32 110.82 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.664 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 41.39 -150.85 0.2 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.761 -0.733 . . . . 63.4 112.471 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.804 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -70.21 117.33 11.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.773 0.32 . . . . 71.1 111.122 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.698 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.99 -21.09 12.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 75.13 110.778 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.29 29.4 0.66 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 64.33 112.587 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.646 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.46 0.03 15.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.78 0.324 . . . . 74.21 110.863 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 74.32 38.95 0.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 75.33 110.916 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.698 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.74 -41.02 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 70.42 110.849 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.804 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 53.44 99.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 61.24 111.098 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.664 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.9 m-85 -59.88 -168.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 53.3 110.861 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.59 19.11 3.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.195 -0.457 . . . . 74.41 110.96 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.591 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.62 -157.09 6.88 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 74.2 112.48 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -35.23 134.46 0.27 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.836 0.351 . . . . 61.51 110.89 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.45 165.44 0.15 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.659 -0.781 . . . . 54.32 112.467 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.96 -143.34 22.13 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.749 . . . . 53.42 112.447 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -49.95 97.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.869 0.366 . . . . 73.43 111.166 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.9 mt -67.75 -38.65 83.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 73.3 110.946 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.431 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -172.72 167.87 5.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 54.01 111.047 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.522 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -161.13 143.04 12.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 74.34 110.89 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.667 ' HB1' ' HB2' ' A' ' 223' ' ' SER . . . -134.94 176.44 8.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.304 -0.407 . . . . 74.1 111.048 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.436 ' O ' ' O ' ' A' ' 222' ' ' HIS . 7.9 m-85 -100.77 -120.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 71.41 110.947 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 223' ' ' SER . . . 166.75 -92.74 0.1 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.715 -0.755 . . . . 44.51 112.501 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.91 55.37 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.615 2.21 . . . . 62.13 112.369 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.57 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.32 151.52 16.93 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 53.51 112.401 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.82 145.1 30.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.898 0.38 . . . . 72.21 110.82 -179.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.63 -65.18 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.7 -0.762 . . . . 64.03 112.37 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 189' ' ' SER . 1.9 mp -103.63 6.81 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.855 0.36 . . . . 70.42 111.126 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.57 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -66.82 170.43 32.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.782 -0.723 . . . . 34.21 112.485 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 42.66 24.74 0.26 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.722 -0.751 . . . . 74.05 112.455 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.87 102.23 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.775 0.321 . . . . 65.4 110.911 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.582 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -77.21 128.78 34.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 54.42 111.073 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.522 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 8.5 m170 -118.53 131.15 56.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 73.51 110.827 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.459 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 51.4 m-85 -115.23 134.74 54.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 75.32 110.858 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -67.57 109.07 3.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.089 -0.505 . . . . 63.43 110.802 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.55 -37.19 80.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 73.33 111.005 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.591 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 5.0 m-20 -50.41 -22.68 1.97 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 72.14 110.825 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -79.84 163.17 24.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 74.11 110.889 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.565 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -100.64 88.23 3.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 72.32 110.938 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.533 ' HZ3' HG21 ' A' ' 215' ' ' THR . 33.6 m95 -79.48 124.71 28.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.457 . . . . 72.51 110.944 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 22.7 p -142.6 -177.79 5.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.252 -0.431 . . . . 74.43 111.178 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.07 19.76 18.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 72.52 111.219 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.11 -175.62 3.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 74.44 110.914 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.9 p -68.77 -18.31 64.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 74.44 110.826 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.18 -107.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.667 -0.777 . . . . 72.23 112.515 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.42 176.87 0.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.763 -0.732 . . . . 72.13 112.428 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 94.3 m -64.89 97.37 0.22 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.757 0.313 . . . . 74.44 111.2 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -41.45 116.42 0.76 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 74.04 110.888 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.886 HD23 ' HB3' ' A' ' 133' ' ' ALA . 8.6 tp -64.12 -38.39 90.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 51.33 110.916 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.801 ' O ' HG23 ' A' ' 217' ' ' VAL . 4.1 t80 -51.97 -66.9 0.3 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 73.22 110.939 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.477 HD11 ' H ' ' A' ' 243' ' ' VAL . 21.9 mt -52.84 -54.96 26.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.141 -0.482 . . . . 54.24 110.879 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.618 ' O ' ' HB2' ' A' ' 219' ' ' ALA . 5.1 m -54.8 -37.19 65.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 63.2 111.092 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.81 -50.57 64.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 74.14 111.115 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.917 HG22 ' HA ' ' A' ' 137' ' ' ALA . 1.8 t -52.42 -56.61 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 74.0 111.106 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.792 ' HB2' HG22 ' A' ' 235' ' ' VAL . 1.8 t-80 -69.12 -26.49 64.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 63.32 110.904 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -64.83 -45.22 87.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 71.14 111.126 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.724 HG23 HG12 ' A' ' 159' ' ' ILE . 3.1 mt -67.68 -37.41 78.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.254 -0.43 . . . . 65.31 111.149 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -52.57 -46.39 58.84 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.804 -0.712 . . . . 74.5 112.428 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.436 ' O ' ' O ' ' A' ' 185' ' ' PHE . 2.5 m-70 -69.39 -38.64 78.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.332 . . . . 70.4 110.824 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.667 ' HB2' ' HB1' ' A' ' 184' ' ' ALA . 0.3 OUTLIER -74.8 -9.77 58.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.005 0.431 . . . . 55.43 110.934 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.546 ' CD1' HG22 ' A' ' 220' ' ' ILE . 13.5 mt -90.1 -25.9 20.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 72.45 110.923 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 124.48 12.94 4.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.785 -0.722 . . . . 63.32 112.529 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.847 HD11 ' HA ' ' A' ' 258' ' ' ILE . 0.2 OUTLIER -85.61 160.99 19.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.829 0.347 . . . . 71.41 110.964 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -105.89 -144.92 12.63 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.754 -0.736 . . . . 74.42 112.487 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -115.86 146.94 41.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.775 0.321 . . . . 74.5 110.862 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 37.3 m -103.08 162.56 12.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.179 -0.464 . . . . 52.24 110.846 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.2 t -107.07 1.26 24.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 72.24 110.852 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.655 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -68.05 141.29 94.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.6 0.714 . . . . 74.22 110.801 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 -3.36 11.79 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.634 2.222 . . . . 73.23 112.384 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.72 17.16 1.99 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 63.31 110.922 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.655 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -78.06 137.94 38.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 61.34 111.024 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.792 HG22 ' HB2' ' A' ' 218' ' ' HIS . 6.9 p -63.99 -29.59 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 64.52 111.108 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 61.2 mmm -73.81 -12.61 60.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 73.53 110.89 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.664 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -59.09 146.27 78.1 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.59 0.71 . . . . 72.04 110.831 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.664 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.8 Cg_endo -69.75 1.2 4.64 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.739 2.293 . . . . 75.22 112.33 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 53.2 m -102.89 129.02 49.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 71.55 111.152 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -110.4 136.33 49.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 74.04 110.921 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -155.69 133.86 11.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 74.33 110.851 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.525 ' O ' HG13 ' A' ' 243' ' ' VAL . 71.1 t80 -59.24 147.77 34.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 74.45 110.983 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.4 OUTLIER -159.64 133.24 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 75.44 111.091 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -49.94 133.26 22.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 53.43 110.768 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 8.4 tt -55.17 -30.89 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 72.33 111.063 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -77.3 -17.43 58.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 74.24 110.836 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 66.6 p -103.21 -24.43 13.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 63.21 111.195 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -65.7 144.31 56.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 72.24 110.891 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -176.8 128.65 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 74.32 110.909 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.81 HD12 HG11 ' A' ' 144' ' ' VAL . 54.7 mt -48.66 127.14 13.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 62.35 110.875 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 38.9 m -72.05 167.27 20.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.14 110.897 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.4 -38.93 60.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.089 -0.505 . . . . 73.21 111.11 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -46.67 84.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.868 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.591 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 7.0 m-20 -61.92 -52.12 65.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.237 -0.438 . . . . 73.5 110.848 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 21.1 mt -62.99 -34.66 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 74.3 111.102 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -69.51 -40.04 77.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 71.3 110.922 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.3 -49.26 7.53 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.811 -0.709 . . . . 33.22 112.525 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.847 ' HA ' HD11 ' A' ' 226' ' ' LEU . 3.8 tp -53.01 -32.84 18.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.78 0.324 . . . . 74.42 111.142 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 263' ' ' GLY . 47.6 mt-30 -88.08 -17.38 31.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 64.22 110.889 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.4 t -69.17 -16.51 63.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 73.31 110.792 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 4.7 mt -118.81 -23.03 7.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 73.22 110.857 -179.923 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.909 ' HB3' HD21 ' A' ' 147' ' ' LEU . 27.7 m-85 -106.3 -38.33 6.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 74.33 110.951 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.32 0 CA-C-O 119.149 -0.806 . . . . 73.51 112.446 179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.429 ' HA ' HD22 ' A' ' 147' ' ' LEU . 0.5 OUTLIER . . . . . 0 C--O 1.231 0.126 0 CA-C-O 120.855 0.359 . . . . 75.24 110.905 . . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -128.74 92.47 3.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 75.42 110.926 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.67 HD13 ' HE1' ' A' ' 149' ' ' PHE . 3.9 mp -121.22 165.71 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 71.31 111.078 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.612 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -159.29 160.36 35.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 64.41 111.139 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.592 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 1.9 p90 -132.33 144.32 50.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.267 -0.424 . . . . 75.13 110.994 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.72 ' HD2' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -136.23 113.34 10.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 73.22 110.842 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 63.0 mt -76.04 105.4 4.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 74.42 111.086 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -56.2 -51.28 68.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 44.54 110.971 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.636 ' OD1' HG23 ' A' ' 162' ' ' VAL . 1.8 p-10 -141.97 166.52 24.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 60.41 110.86 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -117.07 146.22 43.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 72.04 110.923 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.717 HG22 ' CE ' ' A' ' 125' ' ' MET . 3.5 t -93.58 142.67 25.47 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 121.634 0.73 . . . . 72.41 111.125 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.89 -1.79 9.18 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.643 2.229 . . . . 73.42 112.291 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.416 ' H ' HG23 ' A' ' 122' ' ' THR . 15.7 m-20 -81.82 -23.07 36.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 71.01 110.887 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.717 ' CE ' HG22 ' A' ' 122' ' ' THR . 13.2 mtm -116.5 166.51 12.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 74.31 110.892 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.433 ' O ' HG23 ' A' ' 130' ' ' VAL . 7.4 t-20 -96.22 145.92 25.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 75.52 110.816 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -45.52 -34.91 3.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 75.52 110.887 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -83.29 -38.96 21.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 74.22 110.941 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -65.67 -29.77 70.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 61.14 110.812 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.585 HG22 ' CE ' ' A' ' 125' ' ' MET . 79.5 t -65.79 -45.86 90.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.282 -0.417 . . . . 75.25 111.132 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.75 -23.07 42.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 71.21 110.925 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -74.83 -47.78 28.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.477 . . . . 64.2 110.924 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.881 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -71.39 -31.32 67.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 65.13 110.99 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.754 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -73.87 -55.57 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.432 . . . . 64.32 111.106 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.544 ' N ' HG22 ' A' ' 134' ' ' ILE . 13.3 ttt180 -48.67 -42.91 36.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 62.41 110.85 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.688 ' O ' HG23 ' A' ' 140' ' ' VAL . 4.3 mmpt? -70.56 -34.46 72.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.43 . . . . 70.41 110.855 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.687 ' O ' HG13 ' A' ' 217' ' ' VAL . . . -60.99 -50.48 73.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 72.14 111.001 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.592 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.2 m-85 -70.97 -21.82 62.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 72.21 110.94 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.574 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.5 tt0 -78.71 -5.93 54.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 74.01 110.916 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 136' ' ' LYS . 95.3 t -95.59 -17.41 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 54.22 111.096 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.886 ' NE1' HG12 ' A' ' 217' ' ' VAL . 95.8 m95 -105.47 -36.73 7.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.211 -0.449 . . . . 64.13 110.896 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.98 -11.94 61.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 72.44 110.846 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.619 HD22 ' N ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER -94.5 -18.57 21.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 74.33 110.909 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.808 HG11 HD12 ' A' ' 250' ' ' LEU . 16.9 m -98.03 2.5 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 64.22 111.189 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.487 ' C ' ' H ' ' A' ' 147' ' ' LEU . 49.9 p -151.2 149.11 23.93 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.619 0.723 . . . . 44.32 111.146 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 31.57 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.665 2.244 . . . . 62.02 112.345 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.801 HD11 ' CG ' ' A' ' 262' ' ' TYR . 14.4 mt -98.46 173.41 6.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 65.43 110.895 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -137.59 127.33 25.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 75.44 110.893 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.67 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.5 m-30 -114.47 143.8 44.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 70.14 110.851 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.2 t -138.85 147.87 43.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.12 -0.491 . . . . 72.31 110.845 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.47 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 2.6 tptm -97.42 141.84 30.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.494 . . . . 71.12 110.922 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.533 HD11 ' N ' ' A' ' 157' ' ' ALA . 17.2 pt -150.07 133.23 7.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 72.45 111.13 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 . . . . . 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 74.4 110.915 179.991 . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.533 ' N ' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.23 0.069 0 CA-C-O 120.773 0.32 . . . . 73.35 111.116 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.4 ' O ' ' O ' ' A' ' 192' ' ' GLY . 1.1 t0 -82.88 -53.03 6.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.226 -0.443 . . . . 73.53 110.799 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.618 HG12 HG23 ' A' ' 220' ' ' ILE . 2.8 mp -91.06 97.91 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.26 -0.427 . . . . 71.41 111.145 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.72 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.1 tp -87.4 109.92 19.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.133 -0.485 . . . . 74.35 111.009 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.459 HG13 ' CE1' ' A' ' 197' ' ' PHE . 95.9 t -88.01 123.22 40.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 64.03 111.109 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.636 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -142.1 105.56 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 64.43 111.143 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -71.61 108.22 4.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 60.54 110.845 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.1 166.19 18.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 75.31 111.089 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 -114.25 137.25 52.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 75.41 110.831 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.68 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.3 -154.92 0.2 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.761 -0.733 . . . . 71.41 112.458 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.806 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.64 116.96 7.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 52.23 111.094 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.704 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.96 -22.69 12.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 73.33 110.855 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.76 28.86 0.55 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.675 -0.774 . . . . 64.04 112.527 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.624 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.43 0.14 15.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.778 0.323 . . . . 72.41 110.837 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 74.04 39.08 0.53 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 71.31 110.927 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.704 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.38 -40.94 0.8 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 64.3 110.861 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.806 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 53.8 99.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 55.31 111.131 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.68 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.1 m-85 -60.63 -168.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 72.42 110.903 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.75 19.03 3.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 75.21 110.837 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.5 -158.1 6.1 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.766 -0.73 . . . . 42.42 112.492 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 176' ' ' GLY . 2.1 ttmm -34.25 134.22 0.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.351 . . . . 74.3 110.828 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.4 165.55 0.15 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.826 -0.702 . . . . 73.44 112.524 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.37 -144.01 23.16 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.81 -0.71 . . . . 73.32 112.533 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -49.51 97.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 72.41 111.152 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.9 mt -67.04 -41.88 85.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 73.35 110.953 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -169.52 169.34 8.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 71.15 111.138 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.491 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -163.24 143.54 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 75.45 110.884 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.669 ' HB1' ' HB3' ' A' ' 223' ' ' SER . . . -135.44 174.79 10.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 71.23 111.159 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.534 ' O ' ' O ' ' A' ' 222' ' ' HIS . 94.9 m-85 -96.93 -122.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 64.02 110.905 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 223' ' ' SER . . . 172.21 -98.34 0.13 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.721 -0.752 . . . . 32.13 112.431 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 57.13 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.686 2.257 . . . . 71.44 112.321 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.568 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -122.16 153.12 16.82 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.772 -0.728 . . . . 71.13 112.557 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.63 145.92 29.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 63.21 110.841 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.67 -64.71 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.742 -0.742 . . . . 63.25 112.554 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 189' ' ' SER . 1.2 mp -104.88 6.18 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.805 0.336 . . . . 70.14 111.099 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.568 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -64.66 168.14 27.96 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.702 -0.761 . . . . 71.21 112.486 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 42.77 23.2 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.757 -0.735 . . . . 72.44 112.43 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.422 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 0.9 OUTLIER -66.52 99.34 0.57 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.806 0.336 . . . . 75.11 110.856 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.625 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -74.0 132.87 42.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 73.33 111.069 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.8 m170 -123.41 131.27 53.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 71.3 110.923 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.459 ' CE1' HG13 ' A' ' 161' ' ' VAL . 40.9 m-85 -115.5 135.07 54.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 71.34 110.866 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -68.03 107.48 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 64.14 110.827 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.54 -35.93 75.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 71.0 110.904 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.582 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 15.6 m-20 -51.47 -21.59 2.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 73.13 110.83 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -81.39 163.29 22.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 72.03 110.893 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.577 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -101.75 85.96 2.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 75.12 110.917 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.634 ' CZ3' HG21 ' A' ' 215' ' ' THR . 30.9 m95 -76.62 123.58 26.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.107 -0.497 . . . . 72.33 110.862 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 35.8 p -141.54 -178.01 5.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 73.22 111.151 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.45 20.94 17.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 72.25 111.129 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -127.81 -172.97 2.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.432 . . . . 74.41 110.903 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.1 p -73.14 -18.84 61.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 73.3 110.856 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -61.24 -104.91 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.751 -0.737 . . . . 71.52 112.427 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.577 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -51.77 176.18 0.1 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 70.42 112.462 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 73.1 m -65.9 97.62 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 73.11 111.14 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -41.88 116.46 0.8 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 65.15 110.885 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.881 HD23 ' HB3' ' A' ' 133' ' ' ALA . 7.0 tp -65.44 -36.74 84.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 74.34 110.945 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.636 ' CA ' ' HB1' ' A' ' 133' ' ' ALA . 3.6 t80 -51.88 -64.85 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 73.15 110.87 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.485 HD11 ' H ' ' A' ' 243' ' ' VAL . 15.1 mt -56.47 -52.98 62.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.22 -0.445 . . . . 54.43 110.911 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.634 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 8.0 m -53.69 -38.01 63.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 63.4 111.184 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 137' ' ' ALA . . . -62.97 -50.89 68.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 43.12 111.14 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.886 HG12 ' NE1' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -52.16 -57.58 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 73.35 111.17 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.706 ' HB2' HG13 ' A' ' 235' ' ' VAL . 4.3 t-80 -65.29 -29.09 69.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.112 -0.494 . . . . 55.11 110.891 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -64.42 -46.66 82.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 53.44 111.059 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.618 HG23 HG12 ' A' ' 159' ' ' ILE . 2.4 mt -69.2 -35.5 68.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.285 -0.416 . . . . 74.45 111.126 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -51.98 -46.34 55.68 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.845 -0.693 . . . . 53.32 112.396 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.534 ' O ' ' O ' ' A' ' 185' ' ' PHE . 3.0 m-70 -69.54 -40.11 77.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.835 0.35 . . . . 52.33 110.824 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.669 ' HB3' ' HB1' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -72.23 -11.37 60.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.17 -0.468 . . . . 72.11 110.881 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 21.4 mt -88.88 -25.11 22.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 75.44 110.872 179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 122.66 11.19 5.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.741 . . . . 73.11 112.515 179.906 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.879 HD11 ' HA ' ' A' ' 258' ' ' ILE . 0.2 OUTLIER -88.52 152.4 21.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.37 . . . . 74.34 110.891 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -98.02 -141.25 12.02 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.788 -0.72 . . . . 75.44 112.52 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.95 141.94 46.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.846 0.355 . . . . 74.31 110.844 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 49.4 m -92.23 160.55 15.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 74.31 110.801 -179.745 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.2 t -109.68 9.75 24.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 61.11 110.874 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 234' ' ' ALA . 0.1 OUTLIER -80.95 143.32 53.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.562 0.696 . . . . 62.14 110.929 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -3.87 12.92 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.765 2.31 . . . . 71.11 112.289 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.27 30.8 1.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 72.43 110.836 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.693 ' HB1' ' OD1' ' A' ' 254' ' ' ASP . . . -92.59 145.54 24.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 62.34 111.162 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.706 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.5 t -65.46 -42.2 92.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 75.32 111.226 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.428 ' HE3' ' CE1' ' A' ' 222' ' ' HIS . 54.0 mmm -64.74 -14.66 59.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 73.23 110.902 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.67 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.0 t80 -57.72 146.24 66.95 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.621 0.724 . . . . 62.34 110.874 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.67 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.1 Cg_endo -69.77 1.0 4.83 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.662 2.241 . . . . 71.32 112.42 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 38.6 m -102.17 130.0 48.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 74.14 111.144 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -113.78 135.85 53.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 74.11 110.922 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -155.51 137.39 14.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 64.22 110.825 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.534 ' O ' HG13 ' A' ' 243' ' ' VAL . 65.9 t80 -62.0 145.21 53.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 65.12 110.939 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -160.29 133.31 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.5 . . . . 71.14 111.077 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -57.47 131.32 49.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 74.13 110.903 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.532 HD11 ' HD3' ' A' ' 136' ' ' LYS . 16.7 tt -53.2 -30.25 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 73.42 111.161 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.511 ' ND2' HG23 ' A' ' 247' ' ' THR . 0.2 OUTLIER -67.95 -21.85 65.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 73.22 110.859 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.511 HG23 ' ND2' ' A' ' 246' ' ' ASN . 3.8 p -110.84 -19.63 12.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 44.52 111.173 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -67.44 142.78 56.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 73.54 110.911 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -176.32 132.36 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 73.21 110.919 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.808 HD12 HG11 ' A' ' 144' ' ' VAL . 43.9 mt -49.26 132.64 19.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.452 . . . . 65.15 110.999 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 32.9 t -74.15 172.8 11.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 64.25 110.853 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.1 -37.61 72.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.115 -0.493 . . . . 73.44 111.112 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -64.33 -50.56 67.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 60.34 110.928 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.693 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 5.0 m-20 -59.06 -50.91 72.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 71.34 110.917 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 20.5 mt -63.46 -34.07 65.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 75.24 111.214 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -69.65 -40.19 76.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 72.21 110.872 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -76.65 -50.0 7.52 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.731 -0.747 . . . . 74.33 112.486 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.879 ' HA ' HD11 ' A' ' 226' ' ' LEU . 3.8 tp -53.5 -33.63 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.299 . . . . 64.13 111.061 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' A' ' 263' ' ' GLY . 70.8 mt-30 -88.16 -16.1 34.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 75.24 110.903 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 2.5 t -69.23 -15.25 63.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 61.05 110.849 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.6 mt -122.83 -18.61 6.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.085 -0.507 . . . . 64.51 110.915 -179.982 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.801 ' CG ' HD11 ' A' ' 147' ' ' LEU . 38.4 m-85 -113.77 -33.9 5.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 74.21 110.931 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.362 0 CA-C-O 119.155 -0.803 . . . . 61.15 112.481 179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.564 ' HA ' ' CD1' ' A' ' 147' ' ' LEU . 1.8 p80 . . . . . 0 C--O 1.231 0.091 0 CA-C-O 120.779 0.323 . . . . 61.43 110.897 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -146.21 92.87 2.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.204 -0.453 . . . . 73.51 110.93 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.577 HG22 ' N ' ' A' ' 115' ' ' THR . 4.9 mp -122.66 162.61 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 75.41 111.086 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.577 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -158.66 163.32 37.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 63.25 111.18 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.608 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.7 p90 -133.68 148.29 51.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.239 -0.437 . . . . 74.32 110.915 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.57 ' HD2' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -140.37 112.61 7.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 74.1 110.912 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.2 mt -74.16 105.31 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 73.1 111.172 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -56.59 -45.96 81.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 72.3 110.81 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.437 HD21 ' N ' ' A' ' 163' ' ' PHE . 0.1 OUTLIER -150.1 169.12 22.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 75.11 110.872 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.595 ' CE2' HG11 ' A' ' 130' ' ' VAL . 4.6 m-85 -117.09 157.83 25.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 73.24 110.916 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.509 HG23 ' HG3' ' A' ' 125' ' ' MET . 0.1 OUTLIER -107.95 146.7 34.02 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.634 0.73 . . . . 65.31 111.204 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 -2.49 10.29 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.711 2.274 . . . . 72.03 112.25 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -83.64 -25.82 30.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.314 -0.403 . . . . 72.23 110.936 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.689 ' CE ' HG22 ' A' ' 130' ' ' VAL . 6.9 mtm -114.66 164.14 14.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 72.14 110.77 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.529 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.2 OUTLIER -96.43 143.76 27.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 71.14 110.974 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -45.09 -37.05 3.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.443 . . . . 75.21 110.836 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -82.92 -36.11 25.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 75.55 110.792 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -67.69 -29.46 68.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 55.23 110.871 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.689 HG22 ' CE ' ' A' ' 125' ' ' MET . 94.9 t -66.56 -46.58 85.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.219 -0.446 . . . . 54.24 111.148 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.447 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 10.1 t0 -77.13 -25.82 52.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 65.13 110.866 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -72.72 -49.26 32.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 72.11 110.931 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.627 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -69.44 -30.42 68.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 75.2 111.09 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.693 HD13 HD21 ' A' ' 212' ' ' LEU . 1.2 mp -74.64 -53.77 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 61.31 111.128 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.507 ' N ' HG22 ' A' ' 134' ' ' ILE . 7.2 ptp180 -49.45 -35.4 19.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 71.2 110.911 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.614 ' O ' HG23 ' A' ' 140' ' ' VAL . 6.8 mmtp -78.85 -34.1 45.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 64.42 110.873 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.653 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -61.07 -49.16 78.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 72.01 111.059 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.608 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 89.4 m-85 -70.39 -23.54 62.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.419 . . . . 65.3 110.966 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.47 ' O ' ' HB3' ' A' ' 143' ' ' ASN . 0.2 OUTLIER -75.4 -15.11 60.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 55.44 110.936 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 136' ' ' LYS . 93.6 t -85.03 -19.62 8.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.459 . . . . 71.03 111.147 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.844 ' NE1' HG12 ' A' ' 217' ' ' VAL . 96.9 m95 -104.74 -27.0 12.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 74.51 110.916 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.63 -7.59 59.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 72.33 110.846 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 139' ' ' GLN . 0.1 OUTLIER -99.15 -18.39 17.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 73.14 110.867 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.773 HG23 HG23 ' A' ' 145' ' ' THR . 28.9 m -100.14 -7.9 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 73.52 111.139 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.773 HG23 HG23 ' A' ' 144' ' ' VAL . 32.5 p -141.97 147.21 43.75 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.642 0.734 . . . . 74.23 111.096 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 32.43 0.19 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.718 2.279 . . . . 74.54 112.27 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.768 HD21 ' HB3' ' A' ' 262' ' ' TYR . 3.8 mm? -94.49 170.07 9.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.307 -0.406 . . . . 71.31 111.004 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.24 126.35 29.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 63.42 110.92 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.441 ' HE1' HD13 ' A' ' 114' ' ' ILE . 2.4 m-85 -117.53 144.04 45.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 74.45 110.796 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.403 ' H ' ' HA ' ' A' ' 115' ' ' THR . 6.1 t -137.66 153.03 49.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 74.03 110.844 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 10.7 tttt -103.37 146.31 28.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 75.42 110.928 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.526 HD11 ' HB2' ' A' ' 157' ' ' ALA . 24.7 pt -152.12 143.89 15.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 63.33 111.167 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.3 m120 . . . . . 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 64.54 110.829 -179.994 . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.526 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.231 0.114 0 CA-C-O 120.733 0.301 . . . . 61.43 111.077 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.412 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.7 OUTLIER -86.63 -52.82 5.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 70.44 110.795 179.952 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.674 HG12 HG23 ' A' ' 220' ' ' ILE . 2.6 mp -90.4 95.86 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 73.13 111.042 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.57 HD11 ' HD2' ' A' ' 117' ' ' ARG . 8.4 tp -86.75 108.92 18.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 73.14 110.865 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.464 HG13 ' CE1' ' A' ' 197' ' ' PHE . 96.7 t -87.85 120.02 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 74.15 111.142 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 p -138.72 104.31 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 61.45 111.169 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.448 ' CZ ' ' HE1' ' A' ' 125' ' ' MET . 35.5 m-85 -73.73 106.49 5.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 74.13 110.926 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.03 164.13 23.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 75.22 111.103 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -110.87 140.72 45.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 64.31 110.885 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.7 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.67 -151.56 0.31 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.732 -0.747 . . . . 34.21 112.542 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.806 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -68.74 119.24 12.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.79 0.329 . . . . 74.51 111.084 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.705 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -111.17 -21.55 11.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 72.24 110.842 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.16 30.67 0.56 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.724 -0.751 . . . . 40.22 112.466 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.634 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -114.26 0.23 14.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.87 0.367 . . . . 62.14 110.835 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 74.13 38.91 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 75.04 110.796 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.705 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -134.71 -41.04 0.77 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.164 -0.471 . . . . 73.34 110.842 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.806 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 52.94 100.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 63.11 111.153 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.7 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.6 m-85 -60.72 -169.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 73.42 110.883 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . 0.442 ' OD2' ' HA3' ' A' ' 179' ' ' GLY . 40.9 p30 -134.07 18.92 3.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 73.22 110.945 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.578 ' HA2' ' CB ' ' A' ' 200' ' ' ASP . . . 57.81 -162.12 9.43 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.743 -0.741 . . . . 73.42 112.519 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -35.3 136.94 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 70.24 110.963 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.76 155.56 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.734 -0.746 . . . . 73.51 112.469 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.442 ' HA3' ' OD2' ' A' ' 175' ' ' ASP . . . 86.04 -142.68 19.22 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.647 -0.787 . . . . 73.02 112.366 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . 0.415 HG22 ' HE1' ' A' ' 174' ' ' PHE . 2.0 mt -48.68 98.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.81 0.338 . . . . 72.42 111.213 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 33.8 mt -71.4 -42.96 67.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 74.13 110.952 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -170.03 154.35 5.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 73.14 111.145 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.491 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.1 p80 -148.36 141.65 25.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 74.23 110.857 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.744 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -137.97 172.78 12.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 24.24 111.145 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 223' ' ' SER . 37.5 m-85 -102.85 -149.65 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 73.44 110.853 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -162.66 -86.6 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.84 -0.695 . . . . 73.01 112.593 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 55.8 1.31 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.661 2.241 . . . . 70.22 112.346 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.585 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -124.31 150.39 17.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.79 -0.719 . . . . 51.13 112.427 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.46 147.28 27.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 74.11 110.884 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.17 -64.73 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.715 -0.755 . . . . 65.22 112.525 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.537 ' N ' ' O ' ' A' ' 189' ' ' SER . 21.9 pt -105.81 7.69 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.873 0.368 . . . . 74.43 111.112 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.585 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -67.55 168.04 39.81 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.777 -0.725 . . . . 73.3 112.502 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 46.35 18.41 0.32 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.743 -0.741 . . . . 73.2 112.523 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.09 108.72 1.61 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.881 0.372 . . . . 65.01 110.789 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.744 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -83.32 127.69 33.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 45.42 111.114 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.2 m170 -118.37 127.0 53.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 73.42 110.866 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.531 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 37.9 m-85 -111.09 132.04 54.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 72.31 110.848 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -65.08 107.75 1.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 72.35 110.902 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . 0.408 ' O ' ' CD ' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -58.72 -38.41 78.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.187 -0.461 . . . . 71.33 110.905 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.578 ' CB ' ' HA2' ' A' ' 176' ' ' GLY . 19.3 m-20 -49.92 -21.32 1.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 63.03 110.835 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -81.31 164.39 22.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 63.41 110.903 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.499 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.4 OUTLIER -100.94 89.75 3.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 75.55 110.862 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.531 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 31.1 m95 -81.87 122.33 27.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 64.45 110.904 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.8 p -137.35 -175.27 4.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 75.3 111.147 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.35 15.68 19.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 74.42 111.138 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -129.73 -174.81 3.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 63.35 110.917 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.7 p -54.79 -34.91 63.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 73.31 110.855 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -65.8 162.54 41.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.759 -0.734 . . . . 62.12 112.483 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . 48.65 -172.38 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.748 . . . . 61.41 112.571 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 29.8 m -87.3 93.53 9.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.85 0.357 . . . . 71.43 111.125 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -40.06 110.85 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 54.43 110.921 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.693 HD21 HD13 ' A' ' 134' ' ' ILE . 6.9 tp -57.28 -40.86 78.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 65.21 110.948 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.627 ' CA ' ' HB1' ' A' ' 133' ' ' ALA . 2.6 t80 -48.23 -64.27 0.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 63.43 110.923 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.517 HD11 ' H ' ' A' ' 243' ' ' VAL . 17.4 mt -55.81 -52.3 64.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.135 -0.484 . . . . 70.52 110.865 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.515 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 1.0 OUTLIER -54.12 -37.31 64.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 75.45 111.134 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.8 -51.57 64.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 73.31 111.04 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.844 HG12 ' NE1' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -49.96 -57.5 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 72.05 111.106 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.713 ' HB2' HG13 ' A' ' 235' ' ' VAL . 3.6 t-80 -66.32 -29.37 69.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.278 -0.419 . . . . 70.25 110.9 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -63.5 -42.76 98.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 75.11 111.069 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.674 HG23 HG12 ' A' ' 159' ' ' ILE . 2.2 mt -71.57 -35.0 54.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.263 -0.426 . . . . 71.43 111.232 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.45 -43.34 44.5 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.623 -0.798 . . . . 53.24 112.495 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 185' ' ' PHE . 32.7 m-70 -69.27 -39.9 78.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.797 0.332 . . . . 71.2 110.86 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.625 ' OG ' HG23 ' A' ' 159' ' ' ILE . 3.4 m -62.54 -27.03 68.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 44.43 110.807 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 74.2 mt -75.72 -27.39 58.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.244 -0.435 . . . . 62.24 110.988 179.9 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 118.0 16.16 5.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.691 -0.766 . . . . 63.45 112.521 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.842 HD11 ' CD1' ' A' ' 258' ' ' ILE . 29.3 mt -80.78 155.06 26.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.874 0.369 . . . . 72.35 110.856 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -98.43 -137.09 9.56 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.7 -0.762 . . . . 60.23 112.513 179.847 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.471 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 1.1 m170 -125.34 149.78 47.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.861 0.362 . . . . 72.31 110.848 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 67.7 m -110.87 163.88 13.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 74.15 110.886 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.66 -3.01 25.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 63.14 110.892 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.533 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -67.75 137.23 92.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.598 0.713 . . . . 71.42 110.872 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -3.86 12.91 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.694 2.262 . . . . 61.53 112.311 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.21 3.07 3.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 74.13 110.852 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.533 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -74.98 128.51 35.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 73.35 111.109 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.713 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -55.33 -34.53 33.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 74.01 111.187 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.471 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 41.9 mmm -62.21 -21.18 64.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 74.01 110.937 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.541 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -56.72 142.65 71.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.582 0.706 . . . . 73.21 110.895 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.541 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.9 Cg_endo -69.74 -2.24 9.82 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.647 2.231 . . . . 71.51 112.382 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 42.1 m -93.7 143.14 26.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 53.03 111.066 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -123.68 140.48 52.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 74.03 110.918 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.32 128.01 3.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 71.11 110.917 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.502 ' O ' HG13 ' A' ' 243' ' ' VAL . 84.3 t80 -54.01 144.55 18.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 63.34 110.94 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.517 ' H ' HD11 ' A' ' 214' ' ' LEU . 1.1 m -158.27 130.78 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 54.22 111.223 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -52.33 133.01 34.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 74.4 110.925 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.414 HD12 ' CE2' ' A' ' 213' ' ' PHE . 9.2 tt -53.57 -29.46 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 72.21 111.171 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.522 HD22 HG23 ' A' ' 247' ' ' THR . 0.3 OUTLIER -70.16 -21.12 63.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 64.11 110.909 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.522 HG23 HD22 ' A' ' 246' ' ' ASN . 44.3 p -109.95 -20.66 12.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 75.53 111.201 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.444 ' HE2' HG21 ' A' ' 217' ' ' VAL . 9.9 t80 -72.47 130.69 41.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 64.33 110.863 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -166.87 137.33 3.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.482 . . . . 74.24 110.877 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.631 HD12 HG11 ' A' ' 144' ' ' VAL . 64.5 mt -49.36 124.19 8.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.247 -0.433 . . . . 61.33 110.881 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 8.4 t -70.26 166.62 19.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 52.2 110.87 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.63 -40.75 40.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 73.14 111.063 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.8 -45.76 93.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 75.33 110.948 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.592 ' O ' HG22 ' A' ' 258' ' ' ILE . 5.2 m-20 -62.99 -54.62 35.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.11 -0.496 . . . . 64.22 110.827 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 18.7 mt -61.87 -28.08 43.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 75.3 111.144 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -75.26 -41.47 57.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 65.15 110.848 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -76.92 -50.46 6.92 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.732 -0.746 . . . . 64.22 112.491 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.842 ' CD1' HD11 ' A' ' 226' ' ' LEU . 3.3 tp -54.55 -32.9 25.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.748 0.308 . . . . 71.32 111.097 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.457 ' O ' ' N ' ' A' ' 263' ' ' GLY . 36.8 mt-30 -87.84 -16.78 33.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 75.41 110.885 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 2.5 t -68.21 -15.51 63.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 74.15 110.783 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 5.8 mt -120.34 -20.68 7.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 75.45 110.917 179.963 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.768 ' HB3' HD21 ' A' ' 147' ' ' LEU . 34.8 m-85 -111.56 -36.45 5.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 72.03 110.991 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.355 0 CA-C-O 119.147 -0.807 . . . . 54.4 112.555 179.913 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.7 p80 . . . . . 0 C--O 1.23 0.077 0 CA-C-O 120.853 0.359 . . . . 72.51 110.861 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -137.9 103.26 4.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.472 . . . . 71.41 110.948 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.566 HG22 ' N ' ' A' ' 115' ' ' THR . 5.4 mp -132.2 160.66 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 71.41 111.156 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.566 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -157.98 164.46 36.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.227 -0.442 . . . . 75.3 111.059 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.607 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.9 p90 -134.53 149.14 50.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 72.22 110.938 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.544 ' HD2' HD11 ' A' ' 160' ' ' LEU . 4.1 tmt_? -142.44 113.84 7.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 62.31 110.943 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . 0.421 HD12 ' OH ' ' A' ' 121' ' ' TYR . 48.4 mt -74.87 106.24 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 53.33 111.075 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -59.41 -47.03 87.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 75.34 110.932 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.735 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.0 p-10 -142.71 161.84 37.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 72.53 110.96 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.695 ' CE2' HG11 ' A' ' 130' ' ' VAL . 4.7 m-85 -117.4 146.75 43.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.454 . . . . 71.44 110.926 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.505 HG22 ' HE1' ' A' ' 125' ' ' MET . 2.1 t -93.39 141.28 23.74 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.536 0.684 . . . . 63.25 111.167 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -1.66 8.87 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.732 2.288 . . . . 61.3 112.289 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.11 -30.26 31.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.268 -0.424 . . . . 74.22 110.868 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.706 ' HE3' HG22 ' A' ' 130' ' ' VAL . 8.1 mtm -108.06 163.63 12.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 74.32 110.918 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . 0.527 ' O ' HG23 ' A' ' 130' ' ' VAL . 2.8 m120 -95.02 146.42 24.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 71.24 110.842 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.33 -32.52 3.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 71.32 110.919 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -83.73 -38.94 20.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 74.34 110.917 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -66.0 -30.26 70.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 64.13 110.853 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.706 HG22 ' HE3' ' A' ' 125' ' ' MET . 84.7 t -65.2 -47.01 89.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 55.31 111.158 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.12 -24.1 47.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 74.33 110.806 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -73.12 -47.02 47.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 63.32 110.887 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.75 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -72.31 -31.21 65.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 75.13 111.065 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.669 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -73.93 -54.15 15.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 64.21 111.148 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.526 ' N ' HG22 ' A' ' 134' ' ' ILE . 4.2 ttm180 -48.88 -43.03 38.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 72.31 110.812 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.686 ' O ' HG23 ' A' ' 140' ' ' VAL . 5.1 mmpt? -70.79 -34.64 71.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 55.31 110.939 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.918 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.07 -49.36 77.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 74.13 111.128 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.639 ' HE1' HD13 ' A' ' 159' ' ' ILE . 95.8 m-85 -72.68 -22.19 60.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 64.5 110.883 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.529 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.6 tt0 -78.0 -6.34 54.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.068 -0.514 . . . . 72.12 110.927 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 136' ' ' LYS . 99.1 t -97.65 -16.93 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 71.22 111.056 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.829 ' NE1' HG12 ' A' ' 217' ' ' VAL . 89.9 m95 -106.33 -37.74 6.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 72.3 110.921 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.18 -12.54 61.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 42.1 110.831 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.61 HD22 ' N ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER -93.6 -19.47 21.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 74.41 110.866 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.782 HG11 HD12 ' A' ' 250' ' ' LEU . 17.8 m -98.91 3.19 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 63.3 111.214 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.514 HG21 HG13 ' A' ' 258' ' ' ILE . 23.4 p -149.46 145.04 18.53 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.603 0.716 . . . . 75.25 111.097 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.75 29.96 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.711 2.274 . . . . 73.43 112.344 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.729 HD21 ' CD1' ' A' ' 262' ' ' TYR . 5.0 mp -96.88 176.91 5.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 71.55 110.94 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -137.51 126.58 24.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 71.23 110.923 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.414 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.8 m-30 -112.76 145.29 40.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 73.53 110.88 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.431 ' H ' ' HA ' ' A' ' 115' ' ' THR . 3.1 t -139.34 155.2 47.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 72.45 110.789 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.5 OUTLIER -106.02 141.0 38.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 73.55 110.836 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.48 HD11 ' HB2' ' A' ' 157' ' ' ALA . 20.5 pt -150.82 144.74 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 60.44 111.056 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 53.42 110.892 179.916 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.48 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.231 0.092 0 CA-C-O 120.763 0.316 . . . . 74.2 111.144 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.401 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.3 OUTLIER -84.61 -51.07 7.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 73.25 110.85 179.93 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.728 HG12 HG23 ' A' ' 220' ' ' ILE . 2.0 mp -92.85 97.41 7.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 65.53 111.18 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.544 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.5 tp -88.58 109.56 20.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 72.34 110.873 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.443 HG13 ' CE1' ' A' ' 197' ' ' PHE . 85.8 t -87.49 123.39 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 63.22 111.225 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.735 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -142.2 106.11 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 71.51 111.125 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -73.18 107.59 5.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 72.33 110.913 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.5 164.26 23.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 44.33 111.093 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.82 138.26 48.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 72.11 110.902 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.684 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 41.83 -154.16 0.12 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.793 -0.718 . . . . 60.24 112.402 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.807 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.41 117.06 7.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 51.31 111.025 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.691 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -109.5 -22.34 12.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.25 -0.432 . . . . 71.44 110.818 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.01 29.68 0.55 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.746 -0.74 . . . . 72.44 112.534 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.639 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.97 0.18 14.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.861 0.362 . . . . 71.44 110.859 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 73.96 39.54 0.51 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 73.21 110.901 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.691 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.16 -41.53 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 73.32 110.851 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.807 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.26 99.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 72.15 111.058 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.684 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.1 m-85 -59.73 -169.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.279 -0.418 . . . . 65.42 110.842 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.68 19.41 3.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 64.22 110.884 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.574 ' HA2' ' CB ' ' A' ' 200' ' ' ASP . . . 55.26 -162.72 4.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.707 -0.759 . . . . 70.22 112.517 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 176' ' ' GLY . 1.7 ptpp? -33.42 136.0 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 71.42 110.904 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 61.02 160.84 0.1 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.74 -0.743 . . . . 62.0 112.552 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.515 ' O ' HD22 ' A' ' 181' ' ' LEU . . . 84.06 -141.41 20.0 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.817 -0.706 . . . . 73.24 112.444 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.6 97.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.861 0.362 . . . . 74.2 111.103 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.57 HD13 ' HG3' ' A' ' 201' ' ' GLU . 2.8 mm? -68.63 -36.97 79.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 71.34 110.868 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -174.08 169.96 3.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 51.43 111.097 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.493 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.3 p80 -163.79 142.12 7.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 73.34 110.867 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.744 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -136.28 173.37 11.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.299 -0.409 . . . . 65.21 111.174 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.544 ' O ' ' O ' ' A' ' 222' ' ' HIS . 16.7 m-85 -98.69 -141.15 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 65.41 110.774 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -174.89 -81.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.799 -0.715 . . . . 64.53 112.541 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.73 47.46 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.706 2.271 . . . . 75.42 112.369 -180.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.558 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -119.71 147.47 18.1 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.71 -0.757 . . . . 72.44 112.508 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.88 144.96 30.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.347 . . . . 74.05 110.816 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.56 -64.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.725 -0.75 . . . . 64.53 112.481 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 189' ' ' SER . 14.6 tt -104.43 8.84 9.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 74.35 111.183 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.558 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -70.76 174.21 40.0 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.672 -0.775 . . . . 52.04 112.467 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 223' ' ' SER . . . 42.76 23.19 0.18 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 71.11 112.486 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 192' ' ' GLY . 1.9 m-20 -65.49 101.2 0.56 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.903 0.383 . . . . 74.21 110.917 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.744 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -74.72 130.36 39.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 62.32 111.124 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.493 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.2 m170 -121.05 130.19 53.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 71.13 110.837 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.532 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 47.6 m-85 -114.91 133.7 55.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 73.13 110.847 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -64.72 112.84 3.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 72.41 110.823 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -68.2 -18.99 64.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 73.21 110.961 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.574 ' CB ' ' HA2' ' A' ' 176' ' ' GLY . 14.4 m-20 -68.89 -8.57 45.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 74.03 110.841 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.57 ' HG3' HD13 ' A' ' 181' ' ' LEU . 50.4 mm-40 -97.27 162.17 13.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 72.43 110.891 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.514 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.2 OUTLIER -95.94 94.18 7.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 75.4 110.942 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.532 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 45.4 m95 -82.95 124.69 30.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 72.12 110.926 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 36.0 p -145.97 -177.6 5.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 60.52 111.159 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.59 21.08 17.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 73.45 111.192 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -128.13 -177.72 4.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 73.54 110.875 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.7 t -67.59 -19.22 65.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 44.44 110.864 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.29 -104.82 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.769 -0.729 . . . . 72.12 112.45 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.24 177.98 0.14 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.782 -0.723 . . . . 51.45 112.437 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 95.9 m -67.79 97.22 0.62 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.721 0.295 . . . . 74.11 111.127 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -41.06 116.31 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 72.1 110.853 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.75 HD23 ' HB3' ' A' ' 133' ' ' ALA . 9.9 tp -63.26 -39.4 94.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.46 . . . . 74.2 110.873 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.732 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.7 t80 -50.46 -65.29 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 70.23 110.879 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.469 HD11 ' H ' ' A' ' 243' ' ' VAL . 15.4 mt -54.02 -55.43 27.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.478 . . . . 73.32 110.897 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.514 ' O ' ' HB2' ' A' ' 219' ' ' ALA . 2.6 m -55.67 -32.22 63.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 74.44 111.119 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.31 -48.04 62.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.428 . . . . 71.35 111.027 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.918 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -54.06 -58.44 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 73.54 111.196 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.717 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.9 t-80 -64.0 -28.8 70.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 73.22 110.819 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.9 -45.66 91.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 65.25 111.162 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.728 HG23 HG12 ' A' ' 159' ' ' ILE . 2.6 mt -68.19 -33.95 63.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 52.21 111.12 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -52.43 -43.13 58.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.834 -0.698 . . . . 51.03 112.505 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.544 ' O ' ' O ' ' A' ' 185' ' ' PHE . 41.1 m-70 -70.32 -41.36 73.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.815 0.341 . . . . 71.34 110.833 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 29.5 p -64.95 -20.35 66.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 73.21 110.903 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.428 HD21 HG21 ' A' ' 114' ' ' ILE . 36.5 mt -81.64 -25.79 35.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.134 -0.485 . . . . 75.14 110.902 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 120.55 11.7 6.49 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.774 -0.726 . . . . 43.22 112.487 179.874 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.803 HD11 ' CD1' ' A' ' 258' ' ' ILE . 12.4 mt -76.95 158.88 30.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.364 . . . . 65.42 110.967 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -104.71 -134.49 8.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.806 -0.711 . . . . 63.55 112.499 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 0.7 OUTLIER -129.5 145.1 51.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.338 . . . . 72.5 110.866 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 27.4 t -108.45 165.56 11.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 72.0 110.811 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.93 -2.99 22.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.495 . . . . 61.34 110.902 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.623 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -62.2 136.51 95.5 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.579 0.704 . . . . 73.15 110.845 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -0.44 6.87 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.706 2.271 . . . . 75.52 112.422 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.81 15.52 1.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 73.14 110.889 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.623 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -84.74 133.48 34.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.269 -0.423 . . . . 75.41 111.19 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.717 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -56.78 -37.8 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 74.15 111.145 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.441 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 47.1 mmm -59.73 -23.21 63.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 74.23 110.889 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.542 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.7 t80 -54.39 142.72 49.22 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.68 0.753 . . . . 75.33 110.861 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.542 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.7 Cg_endo -69.69 -1.21 8.02 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.667 2.245 . . . . 74.43 112.387 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.409 ' HG1' ' HD2' ' A' ' 237' ' ' PHE . 50.0 m -93.9 141.72 28.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 63.34 111.129 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -122.74 141.52 51.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.269 -0.423 . . . . 62.14 110.928 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -161.02 138.79 9.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.494 . . . . 75.44 110.87 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.55 ' O ' HG13 ' A' ' 243' ' ' VAL . 66.8 t80 -62.43 146.67 50.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 75.13 110.971 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -160.88 132.1 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 60.43 111.095 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -50.46 133.21 24.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 74.11 110.902 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.625 HD11 ' HD3' ' A' ' 136' ' ' LYS . 6.4 tt -54.7 -30.39 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 72.34 111.147 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -75.36 -18.39 59.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 44.31 110.906 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 43.4 p -107.63 -20.25 13.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 73.21 111.105 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.467 ' C ' ' HG3' ' A' ' 249' ' ' ARG . 10.4 t80 -72.65 120.54 18.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 72.35 110.886 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.467 ' HG3' ' C ' ' A' ' 248' ' ' PHE . 16.1 mtt180 -152.42 141.92 21.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 64.41 110.854 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.782 HD12 HG11 ' A' ' 144' ' ' VAL . 45.4 mt -59.0 123.44 16.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 73.43 110.895 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 15.8 m -67.11 162.48 22.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 71.04 110.937 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -48.18 -36.2 13.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 50.34 111.133 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.04 -47.87 75.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 72.14 110.837 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.419 ' O ' HG22 ' A' ' 258' ' ' ILE . 9.4 m-20 -60.45 -51.79 67.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 74.24 110.824 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 20.6 mt -62.49 -33.48 59.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 75.13 111.236 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -71.26 -39.81 71.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 75.15 110.916 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.85 -51.23 7.19 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 73.11 112.467 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.803 ' CD1' HD11 ' A' ' 226' ' ' LEU . 2.8 tp -52.65 -35.05 20.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 75.01 111.198 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.419 ' O ' ' N ' ' A' ' 263' ' ' GLY . 71.2 mt-30 -87.02 -16.49 35.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 70.0 110.929 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.7 t -69.63 -13.98 62.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 73.11 110.875 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.5 mt -123.72 -17.74 6.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 63.25 110.908 179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.729 ' CD1' HD21 ' A' ' 147' ' ' LEU . 35.1 m-85 -115.04 -33.39 5.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 64.33 110.904 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.289 0 CA-C-O 119.034 -0.87 . . . . 61.41 112.517 -179.978 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 8.6 p80 . . . . . 0 C--O 1.231 0.1 0 CA-C-O 120.802 0.334 . . . . 60.12 110.905 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . 0.434 ' C ' HD12 ' A' ' 114' ' ' ILE . 2.7 m-85 -139.04 108.9 6.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 74.14 110.976 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.614 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.6 mp -142.93 162.97 17.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 72.2 111.172 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.588 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -159.67 163.46 34.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 75.54 111.136 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.605 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 1.5 p90 -133.13 151.43 51.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 72.34 110.889 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.538 ' HD2' HD11 ' A' ' 160' ' ' LEU . 4.7 tmt_? -141.87 112.66 7.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 73.3 110.856 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.4 mt -74.4 106.23 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 72.22 111.125 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -59.14 -48.49 81.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 75.2 110.858 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.503 HD21 ' N ' ' A' ' 163' ' ' PHE . 0.2 OUTLIER -146.33 171.84 14.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 64.22 110.818 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.603 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.5 m-85 -119.72 151.85 38.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 64.13 110.91 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.554 HG23 ' HD2' ' A' ' 123' ' ' PRO . 36.9 m -103.53 136.17 19.26 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.573 0.702 . . . . 75.01 111.095 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.554 ' HD2' HG23 ' A' ' 122' ' ' THR . 54.7 Cg_endo -69.72 32.6 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.657 2.238 . . . . 70.32 112.431 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 122' ' ' THR . 1.6 m-20 -113.99 -23.75 9.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 75.24 110.851 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.663 ' SD ' HD22 ' A' ' 212' ' ' LEU . 0.0 OUTLIER -117.6 166.82 11.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.848 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -87.96 141.46 28.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 72.54 110.931 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.05 -33.5 3.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 63.12 110.93 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -84.82 -38.64 19.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 74.12 110.895 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -64.29 -32.87 74.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.177 -0.465 . . . . 61.11 110.814 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.603 HG11 ' CE2' ' A' ' 121' ' ' TYR . 78.1 t -63.78 -44.99 98.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 43.2 111.148 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.77 -23.2 39.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 64.55 110.871 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -76.08 -46.86 26.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 73.42 110.939 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.636 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -72.04 -30.23 64.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 65.53 111.088 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.535 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.3 mp -73.49 -55.62 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 65.15 111.172 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.535 ' N ' HG22 ' A' ' 134' ' ' ILE . 1.1 ttt85 -48.09 -40.97 24.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 74.31 110.904 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.413 ' O ' HG23 ' A' ' 140' ' ' VAL . 3.3 mmpt? -76.13 -32.42 59.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 74.13 110.919 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.843 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -61.23 -49.98 74.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 63.14 111.09 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.619 ' HE2' HD13 ' A' ' 159' ' ' ILE . 80.3 m-85 -68.38 -31.14 70.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 71.15 110.851 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.567 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 3.4 tt0 -63.42 -44.69 93.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 65.32 110.944 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 136' ' ' LYS . 55.0 t -49.21 -25.2 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 73.03 111.146 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.788 ' NE1' HG12 ' A' ' 217' ' ' VAL . 97.8 m95 -98.17 -28.9 13.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 71.11 110.91 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 p -74.49 -13.32 60.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 42.52 110.982 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.567 ' ND2' ' O ' ' A' ' 139' ' ' GLN . 57.7 m-20 -91.88 -24.7 19.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.085 -0.507 . . . . 43.55 110.978 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.585 HG21 ' CD1' ' A' ' 250' ' ' LEU . 5.7 m -94.86 2.7 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 75.12 111.222 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 147' ' ' LEU . 27.4 p -154.71 141.49 13.34 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.611 0.719 . . . . 63.12 111.152 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 28.33 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.691 2.26 . . . . 74.23 112.269 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.843 HD21 ' CG ' ' A' ' 262' ' ' TYR . 0.4 OUTLIER -84.1 -178.0 6.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.257 -0.429 . . . . 70.24 110.925 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -142.56 125.8 16.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 75.42 110.863 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.614 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.5 m-85 -117.94 137.49 52.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 71.33 110.847 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 53.9 m -132.34 139.46 48.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.075 -0.511 . . . . 55.01 110.796 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.3 OUTLIER -91.9 146.48 23.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.059 -0.519 . . . . 71.12 110.808 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 6.3 pt -150.22 168.13 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 74.51 111.117 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 75.24 110.87 179.916 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.569 ' HA ' HG23 ' A' ' 115' ' ' THR . . . . . . . . 0 C--O 1.231 0.127 0 CA-C-O 120.761 0.315 . . . . 75.42 111.058 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.8 OUTLIER -86.9 -50.56 6.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 65.15 110.864 179.986 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.7 HG12 HG23 ' A' ' 220' ' ' ILE . 2.6 mp -94.55 97.33 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 74.45 111.146 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.538 HD11 ' HD2' ' A' ' 117' ' ' ARG . 9.2 tp -87.57 110.25 20.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.242 -0.435 . . . . 75.32 110.93 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.4 t -88.33 117.33 31.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 75.54 111.075 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 162' ' ' VAL . 2.3 p -137.16 102.43 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 74.43 111.017 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.503 ' N ' HD21 ' A' ' 120' ' ' ASN . 47.0 m-85 -70.49 110.8 5.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.047 -0.524 . . . . 71.42 110.85 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.54 166.75 20.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 61.04 111.035 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -114.65 138.57 50.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 73.43 110.879 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.681 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.89 -154.83 0.16 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.764 -0.731 . . . . 54.14 112.434 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.805 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.85 116.55 7.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 71.32 111.098 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.704 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.73 -23.04 11.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.417 . . . . 74.04 110.878 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.95 29.58 0.51 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.732 . . . . 42.13 112.488 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.622 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.06 0.39 14.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 44.0 110.85 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 73.93 39.2 0.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 75.14 110.941 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.704 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -134.55 -41.23 0.78 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 72.22 110.884 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.805 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.18 99.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 45.44 111.163 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.681 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -60.3 -168.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 61.33 110.798 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.33 18.54 3.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 63.2 110.876 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.593 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.84 -155.64 11.54 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.688 -0.768 . . . . 61.11 112.509 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -37.5 135.42 0.57 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.803 0.335 . . . . 54.42 110.902 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.0 164.75 0.1 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.727 -0.749 . . . . 71.24 112.453 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.86 -142.75 21.83 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.789 -0.72 . . . . 73.23 112.455 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.32 96.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.785 0.326 . . . . 64.23 111.099 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 66.7 mt -66.53 -40.44 89.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.306 -0.407 . . . . 61.04 110.888 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -171.65 168.54 6.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 72.43 111.061 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.497 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -161.93 140.83 9.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 75.31 110.854 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.742 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -136.51 173.57 11.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 74.44 111.013 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 223' ' ' SER . 37.8 m-85 -104.0 -149.91 0.41 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 62.33 110.869 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -163.78 -81.92 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.754 -0.736 . . . . 52.13 112.511 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.76 53.9 1.13 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.689 2.259 . . . . 70.05 112.351 -179.957 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.57 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -124.83 147.96 16.63 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.753 -0.737 . . . . 55.33 112.524 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.9 143.92 32.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 63.1 110.82 -179.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.5 -63.26 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.733 -0.746 . . . . 51.04 112.497 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 189' ' ' SER . 4.2 mt -105.4 7.93 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.892 0.377 . . . . 74.33 111.113 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.57 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -69.78 171.81 40.86 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.77 -0.729 . . . . 62.43 112.511 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 44.0 19.93 0.14 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 53.11 112.523 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.438 ' CG ' ' HB3' ' A' ' 160' ' ' LEU . 1.9 m-20 -63.83 107.96 1.34 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.801 0.334 . . . . 74.33 110.908 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.742 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -82.14 126.16 31.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 73.12 111.086 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.497 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.4 m170 -116.67 130.74 56.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 73.41 110.851 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.531 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 46.8 m-85 -115.7 133.71 55.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 74.4 110.893 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -66.76 109.86 3.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.163 -0.471 . . . . 75.41 110.814 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -60.36 -37.88 82.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 74.04 110.82 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.593 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 5.9 m-20 -50.05 -22.15 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 53.41 110.815 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -81.32 160.67 24.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 72.4 110.919 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.526 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -98.21 93.43 6.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 73.45 110.96 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.531 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 34.0 m95 -83.65 123.02 29.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 74.01 110.95 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.2 p -140.92 -176.25 4.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 73.24 111.073 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.37 18.11 19.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 73.25 111.147 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.43 -175.82 3.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 74.45 110.878 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.9 p -67.06 -18.73 65.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 65.3 110.842 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.95 -108.54 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.788 -0.72 . . . . 73.23 112.491 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.92 177.52 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.741 -0.742 . . . . 65.3 112.519 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 97.0 m -65.95 97.74 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 75.13 111.123 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -41.26 113.38 0.39 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 72.22 110.855 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.663 HD22 ' SD ' ' A' ' 125' ' ' MET . 43.1 tp -62.26 -34.47 76.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.263 -0.426 . . . . 74.51 110.939 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.702 ' O ' HG23 ' A' ' 217' ' ' VAL . 3.3 t80 -54.92 -62.05 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 72.15 110.904 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.572 HD11 ' H ' ' A' ' 243' ' ' VAL . 12.9 mt -57.18 -53.78 54.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 64.22 110.919 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.489 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.2 m -54.76 -34.93 63.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 61.14 111.074 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.38 -49.49 66.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.414 . . . . 62.13 111.021 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.843 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -52.08 -58.77 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 44.25 111.165 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.67 ' HB2' HG13 ' A' ' 235' ' ' VAL . 2.6 t-80 -62.94 -31.55 72.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 75.22 110.854 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -61.73 -43.14 99.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 41.35 111.062 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.7 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -70.97 -33.46 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 73.53 111.06 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.521 ' CA ' HD12 ' A' ' 226' ' ' LEU . . . -51.05 -43.29 49.68 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.769 -0.729 . . . . 74.14 112.485 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.436 ' O ' ' O ' ' A' ' 185' ' ' PHE . 50.7 m-70 -68.83 -39.61 79.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.733 0.301 . . . . 65.0 110.846 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.617 ' OG ' HG23 ' A' ' 159' ' ' ILE . 2.8 m -62.22 -26.66 68.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 64.12 110.891 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 28.8 mt -77.57 -25.71 50.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 54.32 110.924 179.931 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 114.01 14.61 9.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.766 -0.73 . . . . 53.13 112.53 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.781 HD21 HD12 ' A' ' 258' ' ' ILE . 13.3 mt -79.27 148.12 32.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 74.55 110.924 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . 0.418 ' O ' ' HE2' ' A' ' 236' ' ' MET . . . -93.95 -160.37 34.73 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.816 -0.707 . . . . 72.21 112.448 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 1.1 m170 -103.07 149.2 24.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 65.51 110.821 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . 0.402 ' OG ' ' HB2' ' A' ' 236' ' ' MET . 2.5 p -111.53 164.41 13.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.165 -0.471 . . . . 72.32 110.824 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -105.43 -0.58 25.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 73.34 110.913 -179.906 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.429 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.3 OUTLIER -67.23 132.82 93.38 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.52 0.676 . . . . 64.31 110.899 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.82 4.95 1.91 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.662 2.241 . . . . 63.32 112.283 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.9 13.46 2.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 62.44 110.925 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.429 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -82.51 149.54 27.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 64.34 111.086 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.67 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -71.46 -40.07 71.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 75.12 111.16 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.418 ' HE2' ' O ' ' A' ' 227' ' ' GLY . 38.7 mmm -64.32 -18.97 65.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.515 . . . . 73.35 110.846 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.605 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.1 t80 -49.26 143.97 8.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.728 0.775 . . . . 54.12 110.881 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.605 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.8 Cg_endo -69.78 -0.76 7.4 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.709 2.272 . . . . 71.34 112.388 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 18.6 m -100.16 146.71 26.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 72.04 111.156 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -125.45 137.22 53.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.203 -0.453 . . . . 72.12 110.978 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -153.89 139.71 18.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 70.44 110.849 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.582 ' O ' HG13 ' A' ' 243' ' ' VAL . 72.2 t80 -65.24 144.41 57.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 73.43 110.923 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -162.18 133.98 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.109 -0.496 . . . . 73.33 111.11 179.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -60.71 134.34 56.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 74.24 110.83 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 17.1 tt -52.91 -31.06 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.452 . . . . 74.45 111.081 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.663 ' ND2' HG23 ' A' ' 247' ' ' THR . 0.0 OUTLIER -69.14 -21.25 64.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 72.33 110.933 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.663 HG23 ' ND2' ' A' ' 246' ' ' ASN . 11.9 p -115.95 -6.99 12.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 64.45 111.213 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . 0.468 ' CD2' HD22 ' A' ' 214' ' ' LEU . 8.9 t80 -88.05 115.45 25.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 74.05 110.933 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . 0.404 ' HG3' ' C ' ' A' ' 248' ' ' PHE . 0.1 OUTLIER -144.73 139.72 28.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 74.52 110.885 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.585 ' CD1' HG21 ' A' ' 144' ' ' VAL . 26.3 mt -53.54 123.42 12.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 55.4 110.932 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 10.0 p -59.67 160.0 7.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 74.43 110.833 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -48.8 -33.28 10.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 74.01 111.208 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -67.14 -44.16 80.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 74.42 110.845 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.77 -49.51 70.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 74.02 110.873 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.451 HG12 HG11 ' A' ' 144' ' ' VAL . 34.3 mt -63.63 -36.33 76.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 74.14 111.184 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -70.26 -38.63 75.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 72.1 110.868 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.37 -50.66 6.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 41.11 112.458 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.781 HD12 HD21 ' A' ' 226' ' ' LEU . 3.3 tp -52.21 -34.82 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 73.22 111.182 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.404 ' O ' ' N ' ' A' ' 263' ' ' GLY . 66.7 mt-30 -86.48 -17.29 34.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.156 -0.475 . . . . 71.02 110.889 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.1 t -69.85 -13.62 62.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 50.51 110.862 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 1.8 mt -123.81 -18.15 6.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.167 -0.469 . . . . 65.5 110.95 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.843 ' CG ' HD21 ' A' ' 147' ' ' LEU . 42.1 m-85 -114.85 -33.9 5.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 74.22 110.888 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 119.105 -0.83 . . . . 35.1 112.472 -179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.9 p80 . . . . . 0 C--O 1.231 0.13 0 CA-C-O 120.831 0.348 . . . . 72.44 110.86 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -141.34 101.53 4.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 74.11 110.898 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.61 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.7 mp -134.73 162.9 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 70.4 111.152 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.586 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -158.68 161.26 37.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 51.34 111.109 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.625 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.7 p90 -132.86 148.79 52.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 71.2 110.92 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.424 ' HB3' HD12 ' A' ' 160' ' ' LEU . 4.1 tmt_? -142.67 113.89 7.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.504 . . . . 62.44 110.956 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.6 mt -74.59 105.29 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 75.13 111.166 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -58.8 -48.98 79.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 70.21 110.813 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.73 ' OD1' HG23 ' A' ' 162' ' ' VAL . 1.7 p-10 -140.66 162.63 34.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 64.1 110.884 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.661 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.3 m-85 -117.15 142.95 46.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 64.13 110.895 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.515 HG23 ' HD2' ' A' ' 123' ' ' PRO . 24.5 m -94.92 137.51 22.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.632 0.729 . . . . 70.21 111.134 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.515 ' HD2' HG23 ' A' ' 122' ' ' THR . 52.8 Cg_endo -69.82 7.77 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.659 2.239 . . . . 74.4 112.283 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.498 ' H ' HG22 ' A' ' 122' ' ' THR . 1.6 m-20 -84.89 -29.42 25.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 64.01 110.849 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.656 ' SD ' HD22 ' A' ' 212' ' ' LEU . 0.0 OUTLIER -112.73 166.56 11.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 72.52 110.899 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -88.93 145.75 25.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.287 -0.415 . . . . 71.31 110.891 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.1 -34.86 6.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 72.1 110.943 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -82.38 -37.3 25.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 74.43 110.886 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -64.58 -32.8 74.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 75.21 110.839 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.661 HG11 ' CE2' ' A' ' 121' ' ' TYR . 77.9 t -63.43 -47.25 92.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 73.33 111.078 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.03 -23.45 48.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.101 -0.499 . . . . 73.01 110.879 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -75.71 -47.23 27.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 62.21 110.972 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.729 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -70.12 -32.91 71.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 63.33 111.165 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.534 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.3 mp -72.1 -55.07 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 74.35 111.158 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.534 ' N ' HG22 ' A' ' 134' ' ' ILE . 6.1 ttt180 -48.93 -42.26 36.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 72.45 110.932 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.622 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -71.32 -34.76 70.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 72.41 110.896 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.903 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.36 -49.35 77.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 72.05 111.165 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.625 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.4 m-85 -72.72 -21.84 60.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 70.2 110.84 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.52 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 3.1 tt0 -77.48 -6.38 53.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 63.02 110.824 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 136' ' ' LYS . 96.2 t -97.71 -16.96 6.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.288 -0.414 . . . . 63.43 111.212 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.783 ' NE1' HG12 ' A' ' 217' ' ' VAL . 89.2 m95 -105.41 -38.08 6.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 70.35 110.886 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.8 -12.68 61.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 54.42 110.876 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.596 HD22 ' N ' ' A' ' 143' ' ' ASN . 1.0 OUTLIER -93.97 -19.58 20.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.511 . . . . 61.33 110.916 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.859 HG11 HD12 ' A' ' 250' ' ' LEU . 18.5 m -97.1 1.65 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 74.33 111.083 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.584 HG21 HG13 ' A' ' 258' ' ' ILE . 52.2 p -151.93 147.57 20.14 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.583 0.706 . . . . 74.31 111.152 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 31.91 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.667 2.245 . . . . 64.15 112.318 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.76 HD11 ' CG ' ' A' ' 262' ' ' TYR . 19.5 mt -95.65 173.83 7.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 63.31 110.884 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -136.28 126.2 25.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 72.22 110.882 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.61 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.7 m-30 -114.46 145.96 41.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.405 . . . . 54.15 110.91 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.401 ' H ' ' HA ' ' A' ' 115' ' ' THR . 5.8 t -139.44 153.33 47.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 72.33 110.847 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 1.4 tttt -104.37 142.79 33.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.129 -0.487 . . . . 41.42 110.897 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.467 HD11 ' HB2' ' A' ' 157' ' ' ALA . 16.4 pt -152.56 159.26 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 64.45 111.089 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.3 m120 . . . . . 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 74.1 110.883 179.952 . . . . . . . . 0 0 . 1 . 017 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 N--CA 1.458 -0.068 0 CA-C-O 120.809 0.338 . . . . 74.21 111.06 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.421 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.4 OUTLIER -84.86 -51.4 6.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 53.03 110.835 179.932 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.623 HG12 HG23 ' A' ' 220' ' ' ILE . 2.7 mp -92.51 97.3 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 54.41 111.121 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.424 HD12 ' HB3' ' A' ' 117' ' ' ARG . 7.8 tp -88.42 109.13 19.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 74.04 110.984 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.428 HG13 ' CE1' ' A' ' 197' ' ' PHE . 84.5 t -85.71 121.1 36.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 72.31 111.089 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.73 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.2 p -140.5 103.67 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 73.54 111.175 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -71.17 110.16 5.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.445 . . . . 71.41 110.89 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.94 165.83 21.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 74.52 111.064 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.02 136.9 52.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.151 -0.477 . . . . 73.21 110.862 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.675 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.43 -155.87 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.758 . . . . 72.55 112.508 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.799 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.02 116.44 6.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.786 0.327 . . . . 72.44 111.084 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.694 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.08 -22.44 12.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 62.11 110.792 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.34 29.51 0.54 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.722 -0.751 . . . . 72.42 112.521 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.631 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.13 0.45 14.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 74.45 110.885 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 73.63 39.63 0.55 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 74.13 110.931 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.694 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.97 -41.65 0.74 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.07 -0.514 . . . . 44.51 110.839 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.799 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.52 99.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 52.1 111.097 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.675 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.9 m-85 -60.2 -168.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 72.44 110.84 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.16 19.03 3.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.029 -0.532 . . . . 74.12 110.85 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.574 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.34 -157.75 6.1 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 41.42 112.464 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 176' ' ' GLY . 12.0 mmtp -34.64 134.71 0.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 64.03 110.959 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.0 165.14 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.741 -0.742 . . . . 63.33 112.459 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.37 -143.35 21.78 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.732 -0.747 . . . . 73.35 112.472 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.0 97.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.881 0.372 . . . . 64.34 111.092 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 21.9 mt -66.99 -40.57 87.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 75.42 110.903 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -171.12 170.21 6.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 45.11 111.117 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.503 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -164.11 141.17 6.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 74.1 110.889 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.781 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -135.76 173.64 11.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.307 -0.406 . . . . 71.41 111.07 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 223' ' ' SER . 47.9 m-85 -101.11 -145.81 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 74.54 110.829 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -165.09 -86.17 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.768 -0.729 . . . . 60.13 112.507 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.65 55.6 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.683 2.255 . . . . 73.51 112.357 -179.976 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.536 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.53 147.66 16.67 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.718 -0.754 . . . . 52.32 112.476 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -102.98 142.36 34.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.997 0.427 . . . . 73.05 110.759 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 64.14 -62.4 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.75 -0.738 . . . . 73.4 112.526 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.524 ' N ' ' O ' ' A' ' 189' ' ' SER . 2.3 pp -105.99 10.07 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.897 0.38 . . . . 75.12 111.213 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.536 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -69.47 170.62 42.07 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.797 -0.716 . . . . 74.44 112.548 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 42.19 22.82 0.13 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.711 -0.757 . . . . 65.34 112.442 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 192' ' ' GLY . 3.2 m-20 -64.48 103.62 0.68 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.792 0.33 . . . . 73.34 110.896 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.781 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -76.71 125.75 29.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 74.52 111.046 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.503 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.3 m170 -115.88 129.68 56.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.116 -0.493 . . . . 75.55 110.865 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.519 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 50.3 m-85 -113.88 134.26 54.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 74.23 110.827 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -66.87 108.89 2.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 72.33 110.923 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -60.09 -37.4 79.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.42 110.792 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.574 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 11.3 m-20 -50.51 -22.1 1.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 74.03 110.811 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -81.36 160.83 24.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.165 -0.47 . . . . 61.23 110.925 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.544 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -98.73 91.47 5.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 75.53 110.894 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.519 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 33.1 m95 -81.56 124.25 29.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 75.44 110.896 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.9 p -141.81 -170.45 3.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 75.05 111.208 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.87 17.42 15.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 70.1 111.176 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.74 -178.73 4.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 70.25 110.81 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.4 t -63.41 -19.62 64.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 75.34 110.926 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.89 -107.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.813 -0.708 . . . . 72.5 112.386 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.5 177.9 0.18 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.719 -0.753 . . . . 72.12 112.48 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 95.7 m -68.47 96.86 0.72 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.793 0.33 . . . . 74.21 111.076 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -40.11 118.46 0.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 73.32 110.858 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.656 HD22 ' SD ' ' A' ' 125' ' ' MET . 19.3 tp -64.87 -36.24 83.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 50.23 110.888 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.729 ' CA ' ' HB1' ' A' ' 133' ' ' ALA . 2.4 t80 -54.17 -64.93 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 75.1 110.915 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.515 HD11 ' H ' ' A' ' 243' ' ' VAL . 21.0 mt -53.21 -55.32 25.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 55.31 110.935 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.495 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.6 m -55.27 -34.87 64.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 62.21 111.141 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.1 -47.86 72.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 54.23 111.092 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.903 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -53.58 -60.11 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 34.35 111.079 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.624 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.8 t-80 -63.31 -28.52 70.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.353 -0.385 . . . . 72.45 110.8 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.96 -44.37 96.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 74.43 111.115 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.623 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -68.99 -35.24 68.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 74.11 111.155 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.21 -44.46 51.79 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.806 -0.711 . . . . 72.54 112.442 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 185' ' ' PHE . 19.6 m-70 -68.03 -38.52 82.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.792 0.329 . . . . 60.35 110.804 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.619 ' OG ' HG23 ' A' ' 159' ' ' ILE . 13.0 m -64.05 -24.79 67.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 72.41 110.831 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 44.3 mt -76.29 -27.06 56.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 73.22 110.952 179.99 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 121.03 10.56 6.76 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.722 -0.751 . . . . 44.51 112.454 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.489 HD11 HD13 ' A' ' 258' ' ' ILE . 8.5 mt -76.61 137.7 39.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.864 0.364 . . . . 63.05 110.939 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -76.8 -135.14 0.64 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.68 -0.771 . . . . 52.42 112.484 179.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -131.82 135.31 46.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 71.34 110.799 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 98.4 p -94.94 160.88 14.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 61.22 110.863 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.22 0.55 25.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 72.12 110.835 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' A' ' 234' ' ' ALA . 0.3 OUTLIER -71.68 132.0 85.64 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.558 0.694 . . . . 71.5 110.831 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 0.93 4.92 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.714 2.276 . . . . 61.53 112.361 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.8 pttt -136.73 14.06 3.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 71.41 110.855 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -92.53 128.2 38.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 70.33 111.088 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.624 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -52.81 -37.95 26.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 64.42 111.092 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 70.8 mmm -58.94 -23.69 61.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.263 -0.426 . . . . 73.02 110.836 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.594 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.5 t80 -52.67 143.36 29.35 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.669 0.747 . . . . 64.54 110.841 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.594 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.5 Cg_endo -69.78 -9.88 27.19 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.654 2.236 . . . . 52.1 112.252 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 23.3 m -85.42 150.22 24.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 62.52 111.157 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -124.78 139.1 54.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.11 110.919 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -155.26 121.35 5.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.052 -0.522 . . . . 65.31 110.922 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.567 ' O ' HG13 ' A' ' 243' ' ' VAL . 87.3 t80 -52.65 146.78 9.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 73.2 110.929 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.5 OUTLIER -161.03 130.84 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 74.13 111.171 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -48.43 138.39 10.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 73.02 110.865 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.585 HD11 ' HD3' ' A' ' 136' ' ' LYS . 7.6 tt -56.26 -31.28 32.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 53.33 111.085 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.651 HD22 HG23 ' A' ' 247' ' ' THR . 0.5 OUTLIER -77.72 -15.81 58.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 73.02 110.89 179.888 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.651 HG23 HD22 ' A' ' 246' ' ' ASN . 33.4 p -105.3 -23.38 12.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 71.31 111.11 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -70.82 142.27 51.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 71.13 110.784 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -177.71 132.13 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 72.12 110.821 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.859 HD12 HG11 ' A' ' 144' ' ' VAL . 34.1 mt -49.52 122.8 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 73.24 110.932 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 32.1 t -64.13 157.81 24.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 73.1 110.895 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -46.36 -34.77 4.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 75.5 111.106 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.74 -46.26 69.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.325 -0.398 . . . . 75.42 110.787 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.418 ' O ' HG22 ' A' ' 258' ' ' ILE . 28.6 m-20 -60.37 -49.94 75.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 72.51 110.811 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.41 ' HA ' HG22 ' A' ' 258' ' ' ILE . 24.8 mt -66.31 -31.5 53.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.129 -0.487 . . . . 74.44 111.17 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.63 -39.41 70.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.505 . . . . 52.5 110.912 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.63 -52.01 6.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 74.31 112.396 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.584 HG13 HG21 ' A' ' 145' ' ' THR . 7.6 tp -52.55 -34.08 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 75.22 111.086 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.457 ' O ' ' N ' ' A' ' 263' ' ' GLY . 85.8 mt-30 -84.38 -19.2 33.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.115 -0.493 . . . . 75.01 110.933 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 10.7 t -68.65 -12.91 61.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.454 . . . . 60.31 110.872 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.1 mt -122.36 -18.1 6.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 74.42 110.927 -179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.76 ' CG ' HD11 ' A' ' 147' ' ' LEU . 38.1 m-85 -115.63 -36.12 4.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 73.41 110.948 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 119.145 -0.808 . . . . 70.1 112.473 179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.6 p80 . . . . . 0 C--O 1.23 0.062 0 CA-C-O 120.788 0.328 . . . . 72.15 110.893 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -142.02 91.85 2.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 73.14 110.876 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.656 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.6 mp -122.49 163.94 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 74.13 111.107 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.606 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -157.88 161.94 38.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 75.55 111.199 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.573 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 1.4 p90 -136.32 148.7 48.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 65.22 110.902 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.733 ' NE ' HD11 ' A' ' 160' ' ' LEU . 3.7 tmm_? -141.83 120.01 12.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 61.44 110.864 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.7 mt -79.82 104.13 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 73.15 111.192 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -56.44 -46.42 80.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 63.43 110.932 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.735 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.5 p-10 -146.82 165.5 29.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 64.3 110.912 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.544 ' CE2' HG11 ' A' ' 130' ' ' VAL . 4.3 m-85 -114.95 142.09 47.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 71.0 110.944 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.632 HG22 ' H ' ' A' ' 124' ' ' ASP . 1.0 OUTLIER -88.97 137.99 29.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.602 0.715 . . . . 65.14 111.102 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.71 33.61 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.656 2.237 . . . . 63.43 112.435 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.632 ' H ' HG22 ' A' ' 122' ' ' THR . 1.8 m-20 -123.36 -17.44 6.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 71.21 110.915 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.599 ' SD ' HD22 ' A' ' 212' ' ' LEU . 6.6 mtm -117.28 165.55 13.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 71.42 110.926 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -92.86 140.57 29.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 71.14 110.861 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.9 ptt-85 -44.6 -36.91 3.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 74.03 110.813 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -84.01 -39.27 19.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 71.45 110.879 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -63.51 -32.1 73.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.103 -0.499 . . . . 74.32 110.906 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.544 HG11 ' CE2' ' A' ' 121' ' ' TYR . 58.3 t -65.48 -44.46 94.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.18 -0.464 . . . . 75.35 111.13 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.45 -22.42 38.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 63.13 110.924 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -76.15 -47.89 22.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 74.25 110.854 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.552 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -72.52 -30.65 64.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 74.11 111.026 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.2 mp -71.95 -55.37 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.404 . . . . 74.14 111.124 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.526 ' N ' HG22 ' A' ' 134' ' ' ILE . 5.1 ttt180 -48.0 -40.38 22.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 73.45 110.919 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 140' ' ' VAL . 4.8 mmtp -76.47 -33.37 58.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 72.22 110.873 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.823 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.27 -50.93 71.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 62.32 111.137 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.627 ' CZ ' HG12 ' A' ' 220' ' ' ILE . 79.0 m-85 -67.01 -33.55 75.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 74.12 110.889 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.583 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.8 tt0 -61.92 -43.84 98.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 73.3 110.905 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 136' ' ' LYS . 73.2 t -49.56 -25.05 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.163 -0.471 . . . . 71.23 111.125 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.799 ' NE1' HG12 ' A' ' 217' ' ' VAL . 97.1 m95 -98.33 -29.66 13.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 74.45 110.891 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 t -73.4 -15.1 61.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.417 . . . . 74.33 110.896 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.583 ' ND2' ' O ' ' A' ' 139' ' ' GLN . 63.9 m-80 -89.36 -26.14 21.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 75.54 110.795 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.551 HG21 ' CD1' ' A' ' 250' ' ' LEU . 4.7 m -93.61 3.71 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 74.31 111.104 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 147' ' ' LEU . 59.5 p -153.69 143.1 14.97 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 121.596 0.712 . . . . 52.32 111.09 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 30.36 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.683 2.256 . . . . 54.05 112.328 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.797 HD11 ' CG ' ' A' ' 262' ' ' TYR . 20.1 mt -91.93 173.1 8.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 70.33 110.884 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -135.12 126.55 28.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 71.42 110.927 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.656 ' HE1' HD13 ' A' ' 114' ' ' ILE . 2.7 m-85 -116.41 141.27 48.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 74.15 110.938 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.7 m -136.73 147.71 46.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 63.11 110.802 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.432 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 16.4 tptm -98.9 146.45 25.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.501 . . . . 74.25 110.897 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.416 HD11 ' HB2' ' A' ' 157' ' ' ALA . 18.4 pt -150.89 147.02 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 74.33 111.108 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . 0.411 ' N ' HD22 ' A' ' 153' ' ' ASN . 1.9 m-80 . . . . . 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 74.02 110.916 179.918 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.416 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.75 0.309 . . . . 63.12 111.097 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.65 -51.13 7.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 74.24 110.822 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.636 HG12 HG23 ' A' ' 220' ' ' ILE . 3.4 mp -94.16 98.55 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 64.32 111.163 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.733 HD11 ' NE ' ' A' ' 117' ' ' ARG . 7.0 tp -88.35 110.98 21.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 71.23 110.934 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.413 HG13 ' CE1' ' A' ' 197' ' ' PHE . 87.7 t -88.24 121.59 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 71.11 111.139 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.735 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -140.72 106.09 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 51.1 111.157 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.414 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 46.8 m-85 -73.38 109.98 7.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 70.11 110.859 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.07 166.62 18.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.51 . . . . 75.1 111.182 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.36 135.06 54.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 74.41 110.888 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.674 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 44.52 -156.91 0.22 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.739 -0.743 . . . . 74.41 112.542 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.811 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -63.17 117.67 6.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.338 . . . . 73.44 111.105 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.715 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -110.59 -22.5 11.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 62.05 110.945 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.29 30.45 0.51 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.738 -0.744 . . . . 51.32 112.433 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.624 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -114.28 0.68 14.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.841 0.353 . . . . 75.05 110.837 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 73.49 39.76 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 71.24 110.864 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.715 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.26 -40.77 0.73 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.084 -0.507 . . . . 60.43 110.859 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.811 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.1 99.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 64.51 111.107 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.674 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.8 m-85 -60.45 -168.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 74.43 110.892 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.69 18.66 3.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 71.2 110.872 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.573 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.58 -156.35 9.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.799 -0.715 . . . . 65.43 112.461 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.74 135.56 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 70.42 110.859 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.49 165.03 0.14 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 71.21 112.476 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.495 ' O ' HD22 ' A' ' 181' ' ' LEU . . . 81.97 -142.49 22.46 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.749 -0.738 . . . . 74.54 112.431 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.42 95.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.8 0.333 . . . . 75.51 111.214 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.495 HD22 ' O ' ' A' ' 179' ' ' GLY . 3.1 mm? -65.1 -46.76 79.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.158 -0.474 . . . . 71.2 110.894 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -163.24 174.21 12.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 51.44 111.048 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.473 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -169.33 139.71 2.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 73.25 110.823 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.727 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -135.08 174.62 10.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 61.12 111.007 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.534 ' O ' ' O ' ' A' ' 222' ' ' HIS . 64.3 m-85 -98.51 -134.25 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 71.24 110.835 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 223' ' ' SER . . . 179.02 -84.87 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.676 -0.774 . . . . 62.1 112.437 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 50.52 0.83 Allowed 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.727 2.285 . . . . 71.21 112.367 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.564 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.81 148.78 17.21 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.809 -0.71 . . . . 72.23 112.544 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.534 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.43 145.9 29.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.941 0.4 . . . . 71.41 110.856 -179.711 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.33 -64.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.759 . . . . 72.31 112.551 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.534 ' N ' ' O ' ' A' ' 189' ' ' SER . 14.8 tt -104.22 7.82 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.919 0.39 . . . . 72.0 111.165 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.564 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -69.39 172.92 37.48 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.801 -0.714 . . . . 74.3 112.497 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.504 ' O ' ' HB3' ' A' ' 223' ' ' SER . . . 43.2 23.17 0.23 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.683 -0.77 . . . . 50.13 112.526 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 192' ' ' GLY . 1.6 m-20 -67.0 101.15 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.854 0.359 . . . . 41.43 110.817 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.727 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -75.09 130.82 39.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 72.23 111.069 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.473 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.2 m170 -121.21 130.94 53.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 75.22 110.82 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.452 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 38.0 m-85 -115.44 134.94 54.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 74.43 110.88 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -67.22 107.02 2.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.506 . . . . 61.12 110.81 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -57.55 -37.84 73.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.112 -0.495 . . . . 74.14 111.012 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.573 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 12.9 m-20 -50.64 -20.78 1.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 74.11 110.889 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -82.42 162.45 22.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.21 110.882 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.472 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -101.81 87.82 3.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.5 . . . . 64.33 110.856 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.572 ' CZ3' HG21 ' A' ' 215' ' ' THR . 23.5 m95 -80.09 120.09 23.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.096 -0.502 . . . . 74.54 110.995 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.0 p -131.46 -173.84 3.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 71.34 111.209 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.63 12.85 18.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 70.14 111.164 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -131.49 -175.74 3.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 65.01 110.901 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.6 p -51.48 -36.73 45.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 33.42 110.856 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -63.13 160.71 34.73 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.69 -0.767 . . . . 71.32 112.524 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . 48.39 -173.17 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.67 -0.776 . . . . 75.31 112.501 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.418 HG21 HD12 ' A' ' 181' ' ' LEU . 51.5 m -86.47 94.11 9.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 74.24 111.197 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -38.54 113.59 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 73.52 110.88 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.599 HD22 ' SD ' ' A' ' 125' ' ' MET . 13.0 tp -62.64 -35.69 80.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 73.11 110.923 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.663 ' O ' HG23 ' A' ' 217' ' ' VAL . 3.5 t80 -53.27 -64.37 0.84 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 74.33 110.852 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.524 HD11 ' H ' ' A' ' 243' ' ' VAL . 21.8 mt -56.01 -54.34 46.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 52.32 110.93 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.572 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 3.7 m -53.73 -37.41 63.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 74.53 111.112 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . 0.401 ' O ' HG13 ' A' ' 220' ' ' ILE . . . -63.13 -50.56 69.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 62.15 111.19 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.823 HG22 ' HA ' ' A' ' 137' ' ' ALA . 1.9 t -51.96 -57.76 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 64.14 111.136 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.699 ' HB2' HG13 ' A' ' 235' ' ' VAL . 3.9 t-80 -65.23 -30.75 71.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.898 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.87 -41.86 99.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 74.2 111.071 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.636 HG23 HG12 ' A' ' 159' ' ' ILE . 2.9 mt -71.98 -35.31 53.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 70.54 111.088 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -51.31 -45.23 52.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.703 -0.761 . . . . 63.34 112.544 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.534 ' O ' ' O ' ' A' ' 185' ' ' PHE . 37.3 m-70 -68.2 -41.77 80.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.885 0.374 . . . . 74.41 110.855 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.519 ' OG ' ' HA ' ' A' ' 220' ' ' ILE . 2.1 p -66.45 -18.11 65.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 54.33 110.885 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.489 HD21 HG21 ' A' ' 114' ' ' ILE . 39.9 mt -83.42 -27.19 29.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.24 110.943 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 119.99 14.06 5.74 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.735 -0.745 . . . . 42.25 112.498 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.776 HD21 ' HA ' ' A' ' 258' ' ' ILE . 12.7 mt -81.0 158.32 25.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.895 0.379 . . . . 75.54 110.943 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -100.11 -133.49 8.14 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.767 -0.73 . . . . 72.32 112.518 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 0.3 OUTLIER -129.02 139.72 51.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.851 0.357 . . . . 74.2 110.804 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 53.9 m -97.67 162.74 13.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 60.22 110.906 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.66 -1.44 19.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 72.02 110.9 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.604 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -63.45 141.91 97.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.58 0.705 . . . . 71.22 110.824 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -3.88 12.92 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.737 2.291 . . . . 72.22 112.399 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.5 ptmt -144.27 25.01 1.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 73.22 110.818 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.604 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -86.7 140.22 29.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.327 -0.397 . . . . 30.4 111.137 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.699 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.0 OUTLIER -62.81 -38.67 82.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.287 -0.415 . . . . 70.24 111.14 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.4 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 54.0 mmm -65.57 -16.97 64.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 74.31 110.888 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.633 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.2 t80 -55.48 144.81 51.77 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.678 0.751 . . . . 62.11 110.937 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.633 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.0 Cg_endo -69.73 0.83 5.06 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.779 2.319 . . . . 74.44 112.359 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.1 m -100.99 139.52 36.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 71.22 111.103 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -120.44 137.85 54.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 75.35 110.975 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.6 tptt -156.85 136.87 12.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 71.04 110.915 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.578 ' O ' HG13 ' A' ' 243' ' ' VAL . 80.0 t80 -63.13 146.03 54.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 75.43 110.905 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -161.79 131.53 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 64.22 111.068 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -54.6 132.02 44.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 72.33 110.918 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 15.6 tt -53.65 -30.16 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.432 . . . . 72.14 111.113 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . 0.661 HD21 HG23 ' A' ' 247' ' ' THR . 0.0 OUTLIER -69.5 -20.34 63.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 70.44 110.874 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . 0.661 HG23 HD21 ' A' ' 246' ' ' ASN . 5.0 p -110.95 -20.5 12.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 62.21 111.254 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -69.5 142.96 53.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.461 . . . . 73.22 110.849 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -176.07 133.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 64.32 110.847 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.551 ' CD1' HG21 ' A' ' 144' ' ' VAL . 34.7 mt -48.8 137.74 12.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 54.32 110.994 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.576 ' O ' HD12 ' A' ' 255' ' ' ILE . 23.2 t -80.61 168.06 19.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 71.43 110.848 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.95 -38.46 56.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.074 -0.512 . . . . 53.25 111.07 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.33 -51.15 67.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.257 -0.429 . . . . 60.44 110.908 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.514 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 7.2 m-20 -57.55 -53.38 58.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 61.23 110.848 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.576 HD12 ' O ' ' A' ' 251' ' ' SER . 2.6 mt -60.12 -36.81 70.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 71.43 111.105 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -67.61 -39.6 84.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 74.14 110.861 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.87 -52.59 5.74 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.822 -0.704 . . . . 64.2 112.416 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.776 ' HA ' HD21 ' A' ' 226' ' ' LEU . 5.6 tp -52.59 -34.5 19.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.832 0.349 . . . . 74.31 111.194 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.424 ' O ' ' N ' ' A' ' 263' ' ' GLY . 70.7 mt-30 -86.33 -17.96 33.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.069 -0.514 . . . . 73.23 110.94 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.4 t -69.36 -13.97 62.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.452 . . . . 71.3 110.874 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 3.2 mt -123.02 -17.51 6.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 73.43 110.924 -179.988 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.797 ' CG ' HD11 ' A' ' 147' ' ' LEU . 35.9 m-85 -114.69 -35.51 4.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.108 -0.496 . . . . 75.55 110.887 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.282 0 CA-C-O 119.118 -0.823 . . . . 72.02 112.516 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.814 ' HA ' HD12 ' A' ' 147' ' ' LEU . 5.3 p80 . . . . . 0 N--CA 1.458 -0.07 0 CA-C-O 120.876 0.37 . . . . 65.04 110.864 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -130.75 82.69 2.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 74.43 110.903 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.585 HG22 ' N ' ' A' ' 115' ' ' THR . 5.0 mp -109.99 163.36 7.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 73.25 111.153 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.699 HG23 ' HA ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -160.65 164.71 31.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 73.4 111.111 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.632 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 5.1 p90 -133.56 145.12 49.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.481 . . . . 72.22 110.977 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.665 ' HD2' HD11 ' A' ' 160' ' ' LEU . 3.9 tmt_? -136.42 110.06 8.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 71.13 110.849 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 52.5 mt -70.73 105.83 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 74.53 111.077 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -60.51 -47.47 86.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 62.3 110.822 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.669 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.2 p-10 -141.53 162.9 34.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 74.4 110.849 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.835 ' CE2' HG11 ' A' ' 130' ' ' VAL . 4.1 m-85 -116.57 144.29 44.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 75.24 110.964 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 124' ' ' ASP . 30.4 m -99.12 135.63 20.75 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.572 0.701 . . . . 65.53 111.133 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.471 ' HD2' HG23 ' A' ' 122' ' ' THR . 54.0 Cg_endo -69.74 10.87 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.728 2.285 . . . . 63.12 112.338 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . 0.507 ' H ' HG22 ' A' ' 122' ' ' THR . 1.6 m-20 -87.89 -26.73 22.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 62.25 110.861 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.697 ' HE2' HD22 ' A' ' 212' ' ' LEU . 0.1 OUTLIER -112.76 160.12 18.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 71.11 110.851 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -86.84 152.02 22.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.15 110.956 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -45.44 -39.63 7.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 74.13 110.885 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.01 -38.22 53.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 74.41 110.939 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . 0.775 ' OD1' HG23 ' A' ' 205' ' ' THR . 38.8 t0 -61.39 -35.87 78.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.081 -0.509 . . . . 70.44 110.89 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.835 HG11 ' CE2' ' A' ' 121' ' ' TYR . 95.0 t -60.9 -44.86 98.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 70.2 111.122 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 1.0 OUTLIER -83.18 -23.04 33.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 60.13 110.92 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -76.43 -51.87 10.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 74.4 110.888 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.721 ' HB1' ' N ' ' A' ' 213' ' ' PHE . . . -66.59 -30.62 70.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 72.53 111.161 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.538 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.4 mp -77.31 -58.17 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 64.44 111.094 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.538 ' N ' HG22 ' A' ' 134' ' ' ILE . 6.2 ttm180 -48.06 -47.06 34.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 73.53 110.884 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.689 ' O ' HG23 ' A' ' 140' ' ' VAL . 5.8 mmpt? -67.62 -33.98 76.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 71.04 110.879 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.972 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -61.55 -49.47 76.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 71.22 111.119 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.632 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 96.5 m-85 -73.63 -21.9 60.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 64.12 110.856 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.475 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.6 tt0 -77.8 -5.21 50.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 75.04 110.916 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 136' ' ' LYS . 94.9 t -99.14 -17.59 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 62.31 111.112 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.821 ' NE1' HG12 ' A' ' 217' ' ' VAL . 97.0 m95 -106.89 -38.23 6.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.1 -0.5 . . . . 74.21 110.919 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.99 -10.72 59.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.008 0.432 . . . . 61.42 110.912 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.561 HD22 ' N ' ' A' ' 143' ' ' ASN . 1.1 m-80 -97.24 -17.49 19.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 73.42 110.873 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.803 HG11 HD12 ' A' ' 250' ' ' LEU . 18.1 m -100.2 -3.89 9.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 64.24 111.087 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.779 ' CB ' HD23 ' A' ' 147' ' ' LEU . 44.6 p -142.89 148.4 45.58 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.572 0.701 . . . . 73.21 111.119 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.82 35.01 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.663 2.242 . . . . 71.33 112.34 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.916 HD21 ' HB3' ' A' ' 262' ' ' TYR . 2.8 mm? -104.58 166.28 10.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 65.21 110.95 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . 0.416 ' HD2' ' HB2' ' A' ' 112' ' ' HIS . 0.5 OUTLIER -129.21 129.36 44.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 74.02 110.869 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.453 ' HE1' HD13 ' A' ' 114' ' ' ILE . 4.1 m-30 -115.48 137.66 51.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 74.45 110.909 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . 0.455 ' H ' ' HA ' ' A' ' 115' ' ' THR . 6.3 t -125.26 162.77 23.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 42.21 110.852 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 7.9 tttt -119.5 142.2 48.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 73.22 110.853 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.917 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 0.3 OUTLIER -150.95 166.68 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 72.42 111.158 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.8 m120 . . . . . 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 73.04 110.867 179.975 . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.917 ' HB2' ' CD1' ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.232 0.133 0 CA-C-O 120.724 0.297 . . . . 74.21 111.12 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.4 OUTLIER -85.93 -50.93 6.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 73.34 110.907 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.612 HG12 HG23 ' A' ' 220' ' ' ILE . 2.3 mp -92.57 91.59 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 73.12 111.177 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.665 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.4 tp -83.11 109.02 16.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.219 -0.446 . . . . 71.41 110.902 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . 0.443 HG13 ' CE1' ' A' ' 197' ' ' PHE . 97.2 t -87.48 119.05 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 61.32 111.178 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.669 HG23 ' OD1' ' A' ' 120' ' ' ASN . 1.8 p -137.75 103.89 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 72.11 111.114 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . 0.418 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 36.7 m-85 -72.66 110.25 6.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 63.11 110.871 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.57 166.9 20.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 71.21 111.115 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.16 137.74 51.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 72.35 110.837 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.684 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.93 -155.74 0.23 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.716 -0.754 . . . . 63.32 112.512 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.811 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -64.51 116.73 6.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.77 0.319 . . . . 64.34 111.105 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.706 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.15 -22.22 12.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 73.32 110.94 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.04 30.35 0.53 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.67 -0.776 . . . . 62.32 112.456 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.638 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -114.47 1.24 14.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.766 0.317 . . . . 70.52 110.824 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 73.05 39.75 0.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 72.24 110.763 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.706 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.25 -41.23 0.73 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 71.14 110.955 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.811 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.02 100.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 73.4 111.11 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.684 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -60.56 -168.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 64.24 110.909 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.87 19.07 3.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 71.1 110.835 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.589 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.64 -158.22 6.22 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.758 -0.734 . . . . 61.35 112.559 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 176' ' ' GLY . 5.4 tmtt? -34.69 134.25 0.23 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.878 0.371 . . . . 72.01 110.908 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.02 164.66 0.16 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.739 -0.743 . . . . 71.03 112.494 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.469 ' O ' HD22 ' A' ' 181' ' ' LEU . . . 82.97 -142.85 21.8 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 61.54 112.509 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -50.45 96.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.819 0.343 . . . . 53.42 111.094 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.469 HD22 ' O ' ' A' ' 179' ' ' GLY . 3.0 mm? -65.94 -42.94 89.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 74.4 110.92 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -171.09 163.36 7.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 64.31 111.158 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.48 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.2 p80 -156.06 142.96 18.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 72.34 110.881 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.734 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -139.01 172.51 12.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 74.25 111.074 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.537 ' O ' ' O ' ' A' ' 222' ' ' HIS . 46.9 m-85 -101.12 -145.51 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 61.03 110.918 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -168.0 -86.21 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.774 -0.726 . . . . 63.04 112.456 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.73 54.15 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.755 2.304 . . . . 75.04 112.305 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.574 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.32 150.64 16.88 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.773 -0.727 . . . . 71.33 112.47 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . 0.565 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.08 147.01 27.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 43.31 110.83 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 61.02 -66.21 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.845 -0.693 . . . . 60.44 112.441 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . 0.565 ' N ' ' O ' ' A' ' 189' ' ' SER . 5.8 mm -102.76 6.89 10.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.777 0.322 . . . . 74.5 111.068 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.574 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -66.96 168.85 36.18 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.748 -0.739 . . . . 75.33 112.47 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 45.27 18.71 0.18 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 70.41 112.488 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . 0.425 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 1.1 m-20 -63.08 102.5 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 73.01 110.85 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.734 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -76.99 132.22 38.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 74.44 111.06 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.48 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 4.8 m170 -123.22 129.53 51.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 71.34 110.868 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.499 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 42.5 m-85 -114.54 135.57 53.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 73.41 110.846 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -68.43 109.38 3.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 71.12 110.945 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -61.03 -36.1 78.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 73.44 110.935 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.589 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 18.0 m-20 -52.18 -20.7 2.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 53.33 110.849 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.4 ' HG3' HD13 ' A' ' 181' ' ' LEU . 6.5 mm-40 -81.57 161.14 23.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.457 . . . . 51.32 110.823 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.542 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -100.13 90.93 4.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 73.15 110.801 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.499 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 22.2 m95 -81.26 123.92 28.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 71.32 110.858 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 43.5 p -140.47 -176.36 4.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 62.11 111.06 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . 0.775 HG23 ' OD1' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -110.28 19.86 18.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 74.22 111.201 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -128.34 -173.24 2.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 73.34 110.861 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.3 t -71.71 -18.84 62.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 65.21 110.869 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.06 -106.79 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.686 -0.769 . . . . 52.31 112.491 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.07 177.01 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.692 -0.766 . . . . 54.13 112.469 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . 0.404 HG21 HD12 ' A' ' 181' ' ' LEU . 89.8 m -66.63 97.54 0.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 75.14 111.249 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -42.14 114.75 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 72.21 110.947 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.697 HD22 ' HE2' ' A' ' 125' ' ' MET . 27.1 tp -61.18 -32.46 72.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 62.24 111.0 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.782 ' O ' HG23 ' A' ' 217' ' ' VAL . 3.0 t80 -58.11 -65.23 0.68 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.096 -0.502 . . . . 75.44 110.98 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.581 HD21 ' CG2' ' A' ' 243' ' ' VAL . 8.9 mp -51.88 -54.43 29.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 74.11 110.957 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.49 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.7 m -55.64 -38.93 70.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 74.44 111.023 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.08 -48.81 77.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 63.43 111.093 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.972 HG22 ' HA ' ' A' ' 137' ' ' ALA . 1.9 t -54.83 -57.57 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 63.01 111.093 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.775 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.3 t-80 -64.87 -28.11 69.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 73.15 110.989 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -63.8 -46.53 84.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 61.53 111.067 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.612 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -68.02 -35.23 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 72.33 111.123 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -49.47 -45.91 36.96 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.671 -0.776 . . . . 62.32 112.474 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' PHE . 4.9 m-70 -68.32 -39.89 81.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.801 0.334 . . . . 73.24 110.866 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.563 ' OG ' HG23 ' A' ' 159' ' ' ILE . 14.0 m -66.15 -24.66 66.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 62.11 110.827 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 43.1 mt -75.67 -25.92 57.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 62.41 110.964 -179.993 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 124.45 11.16 4.7 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.746 -0.74 . . . . 64.12 112.454 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 258' ' ' ILE . 14.4 mt -90.03 142.71 27.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 75.3 110.912 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -93.05 -137.01 8.01 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.71 -0.757 . . . . 41.43 112.47 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -115.96 144.23 44.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.835 0.35 . . . . 75.25 110.872 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 77.6 p -102.85 167.05 10.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 60.13 110.836 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 65.6 m -109.54 5.07 22.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 71.04 110.853 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.527 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -72.75 135.55 80.83 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.524 0.678 . . . . 74.3 110.88 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -0.41 6.85 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.706 2.271 . . . . 75.5 112.326 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.11 26.39 1.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 75.14 110.944 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.527 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -97.55 144.34 27.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 73.12 111.042 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.775 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -63.94 -41.54 92.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 71.13 111.143 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 34.7 mmm -59.86 -18.76 46.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 71.24 110.83 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.604 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -57.38 144.62 70.69 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.68 0.753 . . . . 74.21 110.875 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.604 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.1 Cg_endo -69.95 -1.78 9.2 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.709 2.273 . . . . 51.53 112.34 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.7 m -95.24 137.28 34.5 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.159 -0.473 . . . . 53.35 111.177 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -118.76 135.88 54.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 75.24 110.932 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -154.93 131.43 10.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 61.22 110.926 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.53 ' O ' HG13 ' A' ' 243' ' ' VAL . 80.1 t80 -60.15 145.43 46.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.18 -0.464 . . . . 71.04 110.87 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.581 ' CG2' HD21 ' A' ' 214' ' ' LEU . 0.3 OUTLIER -159.87 132.51 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 73.43 111.141 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -50.16 128.17 18.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 75.44 110.894 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.618 HD11 ' HD3' ' A' ' 136' ' ' LYS . 14.0 tt -51.13 -33.77 13.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.208 -0.451 . . . . 73.14 111.078 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -69.68 -23.27 63.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 74.5 110.837 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 29.6 p -101.33 -24.42 14.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 74.1 111.125 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -64.31 144.28 57.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 63.33 110.834 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -175.04 131.19 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 74.22 110.846 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.803 HD12 HG11 ' A' ' 144' ' ' VAL . 33.8 mt -49.81 124.56 10.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 75.44 110.891 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.34 167.08 15.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 54.21 110.785 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.61 -39.17 49.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.089 -0.505 . . . . 71.03 111.159 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.9 -46.92 85.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 74.42 110.821 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.433 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 6.9 m-20 -61.36 -54.49 43.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 65.43 110.866 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 23.0 mt -60.58 -35.01 60.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 74.01 111.159 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -68.75 -39.78 80.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.454 . . . . 71.11 110.861 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.03 -51.19 7.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 73.33 112.506 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.663 HG13 HG21 ' A' ' 145' ' ' THR . 6.2 tp -53.23 -34.37 21.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.794 0.33 . . . . 72.14 111.205 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 263' ' ' GLY . 31.2 mt-30 -87.86 -16.13 34.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 71.13 110.942 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.4 t -69.33 -16.52 63.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 70.21 110.902 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.1 mt -120.76 -19.42 7.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.509 . . . . 72.0 110.86 -179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.916 ' HB3' HD21 ' A' ' 147' ' ' LEU . 29.7 m-85 -110.17 -37.25 5.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 62.15 110.908 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.335 0 CA-C-O 119.194 -0.781 . . . . 72.05 112.475 179.895 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' HIS . . . . . 0.464 ' HA ' HD22 ' A' ' 147' ' ' LEU . 3.3 p80 . . . . . 0 C--O 1.232 0.143 0 CA-C-O 120.798 0.333 . . . . 62.04 110.859 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -125.96 96.41 4.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.187 -0.461 . . . . 73.51 110.975 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ILE . . . . . 0.613 HG22 ' N ' ' A' ' 115' ' ' THR . 4.8 mp -123.29 163.93 21.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 71.24 111.161 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' THR . . . . . 0.613 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -157.72 163.64 37.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 72.44 111.226 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' TYR . . . . . 0.593 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.7 p90 -133.53 144.63 49.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 64.53 110.926 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' ARG . . . . . 0.646 ' HD2' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -138.84 108.86 6.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.486 . . . . 53.35 110.83 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 53.2 mt -70.66 106.03 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 74.12 111.124 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -60.39 -47.43 86.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 71.52 110.921 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ASN . . . . . 0.701 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.3 p-10 -141.17 162.52 35.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 75.24 110.96 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' TYR . . . . . 0.575 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.1 m-85 -116.35 145.55 43.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.187 -0.46 . . . . 73.33 110.927 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' THR . . . . . 0.522 ' CG2' ' HD2' ' A' ' 123' ' ' PRO . 3.6 m -93.01 137.9 23.53 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.581 0.705 . . . . 51.24 111.147 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 123' ' ' PRO . . . . . 0.522 ' HD2' ' CG2' ' A' ' 122' ' ' THR . 54.2 Cg_endo -69.85 0.6 5.48 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.635 2.223 . . . . 75.04 112.323 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -84.08 -24.23 30.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 71.33 110.844 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 125' ' ' MET . . . . . 0.67 ' SD ' HD22 ' A' ' 212' ' ' LEU . 3.8 mtm -113.12 167.37 10.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 74.32 110.853 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -92.96 143.41 26.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 73.44 110.974 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -45.36 -36.22 4.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 71.3 110.877 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -83.38 -38.23 22.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 74.33 110.908 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -64.12 -31.8 73.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 75.21 110.828 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 130' ' ' VAL . . . . . 0.575 HG11 ' CE2' ' A' ' 121' ' ' TYR . 56.4 t -65.61 -46.21 90.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 74.21 111.105 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 131' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 0.2 OUTLIER -78.49 -23.53 46.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 51.43 110.88 179.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -74.93 -48.02 26.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 74.04 110.955 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' ALA . . . . . 0.672 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -68.88 -31.18 69.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 35.41 111.112 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' ILE . . . . . 0.518 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.3 mp -73.8 -53.93 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 62.13 111.161 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' ARG . . . . . 0.518 ' N ' HG22 ' A' ' 134' ' ' ILE . 3.8 ptm180 -49.22 -37.34 22.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 74.2 110.832 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' LYS . . . . . 0.731 ' O ' HG23 ' A' ' 140' ' ' VAL . 5.6 mmpt? -76.97 -34.34 57.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 73.14 110.854 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 137' ' ' ALA . . . . . 0.911 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.12 -48.66 80.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 60.41 111.134 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 138' ' ' PHE . . . . . 0.623 ' HE1' HD13 ' A' ' 159' ' ' ILE . 96.0 m-85 -72.84 -22.79 60.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 75.34 110.942 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 139' ' ' GLN . . . . . 0.493 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.4 tt0 -77.78 -5.78 51.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.116 -0.493 . . . . 65.21 110.917 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 140' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 136' ' ' LYS . 83.8 t -97.94 -16.77 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 71.53 111.066 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 141' ' ' TRP . . . . . 0.813 ' NE1' HG12 ' A' ' 217' ' ' VAL . 92.1 m95 -107.09 -38.26 6.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.264 -0.426 . . . . 72.41 110.917 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.95 -11.53 60.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 51.03 110.814 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 143' ' ' ASN . . . . . 0.604 HD22 ' N ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER -95.53 -17.49 21.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 72.41 110.849 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 144' ' ' VAL . . . . . 0.685 HG11 HD12 ' A' ' 250' ' ' LEU . 22.4 m -99.86 2.72 10.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 75.34 111.084 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 145' ' ' THR . . . . . 0.587 HG21 HG13 ' A' ' 258' ' ' ILE . 44.5 p -150.99 148.69 23.34 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.537 0.684 . . . . 73.41 111.208 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.71 31.09 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.673 2.249 . . . . 72.12 112.357 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 147' ' ' LEU . . . . . 0.772 HD11 ' CD2' ' A' ' 262' ' ' TYR . 15.4 mt -97.44 175.01 6.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 71.42 110.937 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm -139.05 126.77 22.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 74.41 110.768 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 149' ' ' PHE . . . . . 0.57 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.7 m-85 -115.4 138.36 51.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 75.2 110.898 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 58.5 m -132.57 149.26 52.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 71.24 110.919 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 151' ' ' LYS . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 4.4 tttt -99.52 141.05 32.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 64.23 110.9 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 152' ' ' ILE . . . . . 0.597 HD11 ' N ' ' A' ' 157' ' ' ALA . 15.5 pt -150.75 139.26 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 72.34 111.121 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER . . . . . 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 55.32 110.896 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 157' ' ' ALA . . . . . 0.597 ' N ' HD11 ' A' ' 152' ' ' ILE . . . . . . . . 0 C--O 1.231 0.09 0 CA-C-O 120.819 0.343 . . . . 51.44 111.075 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.02 -57.41 2.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 73.11 110.875 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 159' ' ' ILE . . . . . 0.683 HG12 HG23 ' A' ' 220' ' ' ILE . 2.8 mp -82.52 86.26 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 64.12 111.139 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 160' ' ' LEU . . . . . 0.646 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.9 tp -79.76 102.78 9.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 70.45 110.84 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 96.7 t -82.3 123.08 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 63.45 111.148 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 162' ' ' VAL . . . . . 0.701 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.1 p -140.97 100.05 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 64.51 111.173 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -67.53 109.39 3.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 75.01 110.877 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.76 165.76 20.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.112 -0.495 . . . . 60.41 111.065 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -113.65 134.85 54.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 74.24 110.847 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 166' ' ' GLY . . . . . 0.665 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.83 -156.98 0.16 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.677 -0.773 . . . . 55.13 112.509 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 167' ' ' ALA . . . . . 0.81 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -62.76 115.37 4.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.883 0.373 . . . . 72.03 111.072 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 168' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -108.39 -21.07 12.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 75.45 110.876 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.89 30.1 0.59 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.684 -0.77 . . . . 42.31 112.482 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 170' ' ' ASP . . . . . 0.638 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.49 -0.96 14.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.888 0.375 . . . . 45.04 110.872 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 75.37 38.05 0.42 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 73.42 110.877 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 172' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -133.95 -41.14 0.83 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 71.04 110.853 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 173' ' ' ALA . . . . . 0.81 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.26 100.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 74.43 111.172 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 174' ' ' PHE . . . . . 0.665 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -61.03 -168.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 72.15 110.862 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.12 17.5 4.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 54.45 110.883 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 176' ' ' GLY . . . . . 0.577 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.06 -157.41 7.36 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.748 -0.739 . . . . 54.14 112.5 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 177' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -34.41 134.42 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.905 0.383 . . . . 65.22 110.868 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.62 165.95 0.12 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.687 -0.768 . . . . 62.54 112.555 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 179' ' ' GLY . . . . . 0.422 ' O ' HD22 ' A' ' 181' ' ' LEU . . . 82.56 -143.19 22.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.708 -0.758 . . . . 64.33 112.488 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.23 96.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.867 0.365 . . . . 73.5 111.139 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 181' ' ' LEU . . . . . 0.499 HD13 ' HG3' ' A' ' 201' ' ' GLU . 2.7 mm? -66.98 -36.04 81.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 60.45 110.949 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 182' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -174.74 169.0 3.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 52.34 111.11 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 183' ' ' HIS . . . . . 0.45 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.2 p80 -161.27 142.28 11.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.275 -0.421 . . . . 75.4 110.881 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 184' ' ' ALA . . . . . 0.607 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -140.75 170.3 16.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 71.45 111.135 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 185' ' ' PHE . . . . . 0.641 ' O ' ' HA ' ' A' ' 223' ' ' SER . 1.8 m-85 -125.64 167.93 14.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 74.44 110.93 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 186' ' ' GLY . . . . . 0.739 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -138.18 32.69 2.32 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.787 -0.721 . . . . 74.02 112.569 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 187' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 186' ' ' GLY . 53.9 Cg_endo -69.75 -23.27 31.05 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 122.694 2.263 . . . . 72.21 112.325 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 188' ' ' GLY . . . . . 0.423 ' H ' ' CA ' ' A' ' 192' ' ' GLY . . . 90.2 135.41 6.0 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.763 -0.732 . . . . 75.24 112.5 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.0 t 64.46 148.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.827 0.346 . . . . 75.42 110.871 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 47.95 -102.07 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.731 -0.747 . . . . 71.04 112.432 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 40.3 pt -77.84 6.63 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.85 0.357 . . . . 64.23 111.118 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 192' ' ' GLY . . . . . 0.483 ' HA2' ' HD2' ' A' ' 187' ' ' PRO . . . -74.76 121.54 6.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.766 -0.731 . . . . 63.23 112.483 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 193' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 75.2 -9.39 13.13 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.75 -0.738 . . . . 45.01 112.514 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.17 109.51 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.885 0.374 . . . . 72.21 110.883 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 195' ' ' ALA . . . . . 0.607 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -98.83 138.04 36.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 74.55 111.151 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 196' ' ' HIS . . . . . 0.455 ' O ' ' HB1' ' A' ' 182' ' ' ALA . 4.9 m170 -125.26 137.62 54.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.316 -0.402 . . . . 73.42 110.859 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 197' ' ' PHE . . . . . 0.415 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 37.8 m-85 -120.03 142.44 48.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 74.43 110.869 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -73.8 109.11 7.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 75.4 110.779 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -62.1 -35.66 79.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 74.24 110.85 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 200' ' ' ASP . . . . . 0.577 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 12.0 m-20 -51.24 -21.56 2.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 71.52 110.87 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 201' ' ' GLU . . . . . 0.499 ' HG3' HD13 ' A' ' 181' ' ' LEU . 5.8 mm-40 -81.54 161.29 23.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 74.42 110.97 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 202' ' ' PHE . . . . . 0.564 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -99.47 88.32 3.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 73.45 110.917 -179.887 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 203' ' ' TRP . . . . . 0.491 ' CZ3' HG21 ' A' ' 215' ' ' THR . 33.7 m95 -78.15 123.22 26.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 71.42 110.887 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 32.6 p -139.64 -176.32 4.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 70.22 111.146 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.77 17.27 19.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 72.14 111.112 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 -176.05 3.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 54.54 110.843 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.8 t -66.69 -18.51 65.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.272 -0.422 . . . . 73.44 110.86 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.49 -108.3 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 71.22 112.528 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 209' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.63 176.82 0.13 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.788 -0.72 . . . . 43.45 112.415 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 94.5 m -65.62 97.95 0.35 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.799 0.333 . . . . 72.31 111.105 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -42.0 117.11 0.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 72.2 110.95 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 212' ' ' LEU . . . . . 0.67 HD22 ' SD ' ' A' ' 125' ' ' MET . 30.4 tp -64.82 -36.72 85.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 61.51 110.901 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 213' ' ' PHE . . . . . 0.761 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.4 t80 -53.84 -65.45 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 44.25 110.791 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 214' ' ' LEU . . . . . 0.511 HD11 ' H ' ' A' ' 243' ' ' VAL . 18.8 mt -53.12 -54.97 27.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.489 . . . . 74.13 110.894 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 215' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 219' ' ' ALA . 6.2 m -54.81 -38.41 67.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 74.12 111.099 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.19 -50.04 71.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 61.41 111.134 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 217' ' ' VAL . . . . . 0.911 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.1 t -51.67 -59.6 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 60.12 111.115 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 218' ' ' HIS . . . . . 0.741 ' HB2' HG13 ' A' ' 235' ' ' VAL . 2.1 t-80 -65.07 -28.11 69.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 62.0 110.856 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 219' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -63.81 -46.07 86.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 42.42 111.112 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 220' ' ' ILE . . . . . 0.683 HG23 HG12 ' A' ' 159' ' ' ILE . 2.8 mt -66.05 -34.66 71.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 73.33 111.197 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 221' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -53.69 -44.38 69.34 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.753 -0.736 . . . . 32.44 112.499 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -69.54 -34.92 74.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.724 0.297 . . . . 70.41 110.811 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 223' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 4.0 p -70.41 -24.85 63.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.275 -0.42 . . . . 71.33 110.895 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 224' ' ' LEU . . . . . 0.461 HD21 HG21 ' A' ' 114' ' ' ILE . 45.6 mt -76.93 -27.35 54.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 71.22 110.962 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 120.29 16.32 4.78 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.779 -0.724 . . . . 72.44 112.553 179.873 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 226' ' ' LEU . . . . . 0.888 HD21 ' HA ' ' A' ' 258' ' ' ILE . 15.3 mt -79.59 162.87 25.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 75.52 110.937 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -105.38 -133.17 7.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.755 -0.736 . . . . 43.31 112.411 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 228' ' ' HIS . . . . . 0.415 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.3 OUTLIER -131.2 148.86 52.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 64.12 110.805 -179.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 86.7 p -108.62 166.44 10.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 73.41 110.864 -179.846 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.53 0.46 20.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 64.21 110.872 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 231' ' ' ASP . . . . . 0.532 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -68.64 133.9 90.6 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.606 0.717 . . . . 73.04 110.85 179.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 0.59 5.44 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.706 2.271 . . . . 73.55 112.277 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.91 19.07 2.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 72.35 110.926 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 234' ' ' ALA . . . . . 0.532 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -91.49 140.26 29.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 55.14 111.082 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 235' ' ' VAL . . . . . 0.741 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.0 OUTLIER -61.16 -41.18 88.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.235 -0.439 . . . . 75.02 111.137 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 236' ' ' MET . . . . . 0.415 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 53.9 mmm -58.68 -20.75 51.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 73.24 110.895 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 237' ' ' PHE . . . . . 0.6 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.0 t80 -55.63 144.03 56.44 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.712 0.768 . . . . 62.5 110.902 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 238' ' ' PRO . . . . . 0.6 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.8 Cg_endo -69.67 0.79 5.07 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.749 2.299 . . . . 74.42 112.315 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 239' ' ' THR . . . . . 0.434 ' HG1' ' HD2' ' A' ' 237' ' ' PHE . 30.7 m -97.32 138.91 34.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 65.22 111.166 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -120.87 137.05 54.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 71.13 110.937 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -157.4 137.27 12.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 61.31 110.912 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 242' ' ' TYR . . . . . 0.548 ' O ' HG13 ' A' ' 243' ' ' VAL . 73.9 t80 -61.44 146.91 46.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 72.45 110.913 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 243' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.3 OUTLIER -160.46 132.52 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 75.31 111.183 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -50.11 132.05 23.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 64.43 110.874 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 245' ' ' ILE . . . . . 0.458 HD11 ' HD3' ' A' ' 136' ' ' LYS . 7.3 tt -54.65 -30.63 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 71.21 111.138 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -76.17 -18.24 59.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 73.25 110.885 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 60.1 p -105.01 -22.77 13.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 73.42 111.072 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -69.67 142.97 53.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.429 . . . . 61.23 110.889 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -176.43 131.68 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 73.2 110.857 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 250' ' ' LEU . . . . . 0.685 HD12 HG11 ' A' ' 144' ' ' VAL . 80.2 mt -49.42 128.85 17.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 74.33 110.95 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 251' ' ' SER . . . . . 0.448 ' O ' HD12 ' A' ' 255' ' ' ILE . 8.2 m -76.52 169.97 17.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 74.3 110.899 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.74 -43.24 47.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 70.31 111.069 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.17 -49.08 79.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 75.51 110.821 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 254' ' ' ASP . . . . . 0.464 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 16.3 m-20 -57.22 -54.8 42.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 71.34 110.811 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 255' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 251' ' ' SER . 2.9 mt -59.73 -39.59 80.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.437 . . . . 73.51 111.17 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -64.1 -39.84 94.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 75.43 110.909 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 257' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -75.28 -54.01 5.83 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.766 -0.731 . . . . 54.33 112.459 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 258' ' ' ILE . . . . . 0.888 ' HA ' HD21 ' A' ' 226' ' ' LEU . 4.5 tp -53.09 -35.72 23.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.775 0.322 . . . . 65.15 111.075 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 259' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 263' ' ' GLY . 87.0 mt-30 -85.82 -17.22 36.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 53.14 110.948 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 260' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 3.2 t -69.0 -14.29 62.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 72.4 110.834 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 261' ' ' LEU . . . . . . . . . . . . . 2.7 mt -123.91 -18.4 6.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 63.24 110.838 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 262' ' ' TYR . . . . . 0.772 ' CD2' HD11 ' A' ' 147' ' ' LEU . 36.8 m-85 -113.43 -33.98 5.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 64.42 110.925 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 263' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.429 0 CA-C-O 119.133 -0.815 . . . . 71.3 112.507 179.997 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.4 t80 . . . . . 0 C--O 1.232 0.151 0 CA-C-O 120.855 0.36 . . . . 74.22 110.862 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.572 ' H ' ' NE ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -71.29 66.97 0.46 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.138 -0.483 . . . . 74.32 110.906 -179.936 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER 175.88 143.23 0.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.176 -0.465 . . . . 74.34 110.851 -179.912 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.6 mmt -52.12 159.46 1.48 Allowed Pre-proline 0 C--N 1.329 -0.325 0 CA-C-O 121.517 0.675 . . . . 75.43 110.87 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.79 78.06 1.04 Allowed 'Trans proline' 0 C--O 1.231 0.154 0 C-N-CA 122.704 2.269 . . . . 62.22 112.306 -179.984 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 131.9 -124.1 3.87 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.739 -0.743 . . . . 64.31 112.48 179.979 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -149.86 55.53 0.48 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.726 -0.749 . . . . 52.11 112.479 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.77 -24.97 29.02 Favored 'Trans proline' 0 C--O 1.231 0.17 0 C-N-CA 122.694 2.263 . . . . 74.24 112.364 -179.971 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.855 HG21 ' HB3' ' A' ' 261' ' ' LEU . 5.2 m -47.15 137.76 2.51 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.221 -0.445 . . . . 51.24 111.111 179.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.419 ' HB3' ' HG2' ' A' ' 111' ' ' LYS . 3.4 m0 -63.32 -23.01 67.23 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.141 -0.481 . . . . 75.4 110.909 179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 26.7 mtm180 63.9 30.28 14.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.232 -0.44 . . . . 74.34 110.853 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.419 ' HG2' ' HB3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -123.33 157.36 33.43 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.192 -0.458 . . . . 71.24 110.891 179.97 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.402 ' HA ' ' HG ' ' A' ' 147' ' ' LEU . 16.0 p80 -99.1 20.45 13.37 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.204 -0.453 . . . . 74.51 110.845 179.931 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.405 ' C ' HD12 ' A' ' 114' ' ' ILE . 0.9 OUTLIER -121.37 110.96 16.73 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 64.11 110.921 -179.835 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.574 HG22 ' N ' ' A' ' 115' ' ' THR . 4.9 mp -141.06 162.1 22.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 74.12 111.129 179.926 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.574 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -157.58 163.54 38.22 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.161 -0.472 . . . . 73.1 111.135 179.958 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.622 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 4.2 p90 -134.53 146.91 50.14 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.196 -0.456 . . . . 73.43 110.956 -179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.466 ' HD2' HD11 ' A' ' 160' ' ' LEU . 4.3 tmt_? -141.63 111.82 6.87 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.123 -0.489 . . . . 72.24 110.901 -179.95 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.9 mt -73.83 106.86 3.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.197 -0.456 . . . . 72.01 111.137 -179.989 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -58.89 -50.43 74.06 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 71.32 110.893 179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.62 ' OD1' HG23 ' A' ' 162' ' ' VAL . 3.3 p-10 -140.17 165.22 27.97 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.148 -0.478 . . . . 43.44 110.907 -179.985 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -118.15 138.88 51.98 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.206 -0.452 . . . . 74.01 110.896 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.754 HG22 ' HE2' ' A' ' 125' ' ' MET . 2.5 t -88.11 143.01 32.32 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.538 0.685 . . . . 74.14 111.163 -179.98 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.408 ' HD2' ' OG1' ' A' ' 122' ' ' THR . 53.6 Cg_endo -69.77 -3.11 11.37 Favored 'Trans proline' 0 C--N 1.341 0.175 0 C-N-CA 122.658 2.239 . . . . 75.4 112.361 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.462 ' H ' HG23 ' A' ' 122' ' ' THR . 13.7 m-20 -80.83 -23.27 39.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.247 -0.433 . . . . 65.01 110.855 179.921 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.754 ' HE2' HG22 ' A' ' 122' ' ' THR . 16.2 mtm -115.05 166.03 12.25 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.185 -0.461 . . . . 43.43 110.869 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.2 m120 -98.17 145.62 26.42 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.203 -0.453 . . . . 75.1 110.863 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 9.6 ptm180 -45.43 -34.49 3.16 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.16 -0.473 . . . . 74.21 110.928 179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 1.1 pp20? -82.32 -40.73 21.04 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.172 -0.467 . . . . 73.55 110.896 -180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 71.1 m-20 -63.78 -31.13 72.2 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.179 -0.464 . . . . 73.2 110.839 179.999 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.47 ' O ' HD13 ' A' ' 134' ' ' ILE . 59.5 t -63.86 -45.46 96.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.232 -0.44 . . . . 71.13 111.158 -179.997 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -80.3 -23.47 40.65 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.151 -0.477 . . . . 73.53 110.879 179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -75.26 -47.33 28.5 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.185 -0.461 . . . . 64.34 110.941 -179.845 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.754 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -71.2 -31.07 67.18 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.092 -0.504 . . . . 74.14 111.108 179.85 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.625 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -73.7 -55.23 13.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.231 -0.441 . . . . 74.13 111.145 179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.53 ' N ' HG22 ' A' ' 134' ' ' ILE . 5.3 ttt180 -48.56 -42.54 33.87 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.19 -0.459 . . . . 63.51 110.896 179.939 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.614 ' O ' HG23 ' A' ' 140' ' ' VAL . 8.7 mmpt? -70.87 -35.51 72.41 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.139 -0.482 . . . . 72.24 110.905 179.967 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.91 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.0 -48.85 80.01 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.229 -0.441 . . . . 42.4 111.101 179.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.622 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 93.3 m-85 -72.6 -22.32 60.99 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.217 -0.447 . . . . 63.33 110.814 -179.886 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.522 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.2 OUTLIER -77.28 -6.24 52.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.218 -0.446 . . . . 75.1 110.941 -179.952 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 136' ' ' LYS . 93.8 t -97.31 -17.56 6.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.455 . . . . 12.35 111.131 179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.796 ' NE1' HG12 ' A' ' 217' ' ' VAL . 95.3 m95 -106.18 -36.39 6.91 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 73.3 110.939 179.987 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -70.82 -11.54 61.02 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.228 -0.442 . . . . 74.1 110.823 -179.808 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.621 HD22 ' N ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER -95.61 -18.44 20.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.143 -0.48 . . . . 71.02 110.933 -179.988 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.844 HG11 HD12 ' A' ' 250' ' ' LEU . 19.9 m -98.42 1.24 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.141 -0.481 . . . . 75.2 111.108 179.917 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.568 HG21 HG13 ' A' ' 258' ' ' ILE . 39.0 p -151.96 146.24 18.44 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.606 0.717 . . . . 74.14 111.14 179.981 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.78 30.59 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.198 0 C-N-CA 122.625 2.217 . . . . 64.53 112.379 179.926 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.838 HD21 ' CG ' ' A' ' 262' ' ' TYR . 0.2 OUTLIER -91.76 177.48 6.19 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 53.5 110.939 179.957 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.23 125.59 20.3 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.187 -0.46 . . . . 73.32 110.904 179.891 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.549 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.9 m-30 -114.94 141.56 47.79 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.258 -0.428 . . . . 71.03 110.894 179.998 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.403 ' H ' ' HA ' ' A' ' 115' ' ' THR . 2.1 t -135.72 153.03 51.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.175 -0.466 . . . . 44.33 110.857 -179.791 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.478 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 19.8 tttt -104.43 143.18 33.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.113 -0.494 . . . . 72.52 110.888 179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.581 HD12 ' CA ' ' A' ' 155' ' ' GLY . 16.9 pt -152.32 155.52 6.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.299 0 CA-C-N 116.202 -0.454 . . . . 73.31 111.083 179.916 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 8.5 m120 -122.17 -3.04 9.04 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.139 -0.482 . . . . 75.13 110.877 179.932 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.9 t -159.78 50.66 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.204 -0.453 . . . . 73.31 111.118 -179.993 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.581 ' CA ' HD12 ' A' ' 152' ' ' ILE . . . -142.19 -153.91 6.03 Favored Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.758 -0.734 . . . . 71.1 112.507 179.927 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -107.8 90.63 3.36 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.793 0.33 . . . . 74.25 110.856 -179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.477 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -101.46 155.99 17.74 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.228 -0.442 . . . . 62.0 111.078 179.911 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.15 -52.7 5.5 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.21 -0.45 . . . . 75.31 110.86 179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.668 HG12 HG23 ' A' ' 220' ' ' ILE . 2.4 mp -90.01 94.21 4.75 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.25 -0.432 . . . . 62.2 111.085 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.466 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.9 tp -86.5 107.75 18.23 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.161 -0.472 . . . . 73.03 110.895 179.919 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.421 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 88.4 t -84.97 121.63 37.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.199 -0.455 . . . . 75.33 111.172 179.822 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.62 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -140.25 105.43 1.99 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.168 -0.469 . . . . 74.22 111.127 179.971 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 47.3 m-85 -73.31 110.27 7.47 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.149 -0.478 . . . . 73.02 110.889 -179.968 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -126.98 166.83 16.8 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.147 -0.479 . . . . 72.23 111.131 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -119.72 133.1 55.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.203 -0.453 . . . . 75.24 110.853 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.676 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.36 -158.04 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.729 -0.748 . . . . 62.14 112.484 -179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.766 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -50.71 118.81 3.34 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.8 0.333 . . . . 73.02 111.104 179.947 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.77 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 4.3 p-80 -137.65 32.5 2.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.25 -0.432 . . . . 75.35 110.854 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 79.11 53.43 4.48 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.737 -0.744 . . . . 60.31 112.478 -179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.461 ' OD2' ' CE1' ' A' ' 196' ' ' HIS . 23.7 t0 -143.15 9.34 1.67 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.819 0.342 . . . . 75.54 110.88 -179.994 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 23.2 m-85 54.16 22.36 3.53 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.185 -0.461 . . . . 74.11 110.86 -179.874 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.77 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 2.1 p-80 -118.62 -38.9 3.05 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.15 -0.477 . . . . 73.41 110.848 179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.766 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 50.43 99.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.233 -0.44 . . . . 72.3 111.114 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.676 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.4 m-85 -58.72 -170.91 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.222 -0.444 . . . . 74.43 110.862 -179.903 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.69 21.21 4.24 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.117 -0.492 . . . . 61.41 110.862 -179.999 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.583 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 52.53 -156.05 4.69 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.744 -0.741 . . . . 44.31 112.477 -179.901 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.448 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.9 OUTLIER -33.77 132.85 0.21 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.829 0.347 . . . . 64.22 110.911 -179.944 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.94 163.53 0.13 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.814 -0.708 . . . . 75.34 112.471 179.953 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 85.18 -142.25 19.64 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.748 -0.739 . . . . 74.33 112.452 -179.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.2 mt -49.92 97.64 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.884 0.373 . . . . 71.23 111.147 -179.97 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.467 HD12 HG21 ' A' ' 210' ' ' THR . 2.9 mm? -66.8 -41.61 87.28 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 71.41 110.875 179.968 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 197' ' ' PHE . . . -174.74 158.47 2.66 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.195 -0.457 . . . . 71.21 111.08 179.8 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.429 ' CE1' ' CD2' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -148.92 134.3 18.48 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.449 . . . . 61.32 110.847 -179.967 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.781 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -131.71 175.39 9.23 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.235 -0.439 . . . . 72.24 111.134 179.913 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.534 ' O ' ' HA ' ' A' ' 223' ' ' SER . 65.7 m-85 -105.6 -152.93 0.48 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.223 -0.444 . . . . 73.42 110.853 -179.89 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -160.74 -84.44 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.701 -0.761 . . . . 61.32 112.463 -179.927 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 52.33 0.99 Allowed 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.721 2.28 . . . . 61.44 112.331 -179.92 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.59 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.56 150.02 17.16 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.781 -0.724 . . . . 41.13 112.499 -179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.538 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -105.54 147.75 28.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.919 0.39 . . . . 55.33 110.804 -179.724 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.27 -64.12 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.734 -0.746 . . . . 44.22 112.5 -179.998 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.538 ' N ' ' O ' ' A' ' 189' ' ' SER . 2.3 pp -107.15 8.42 9.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-O 120.888 0.375 . . . . 73.31 111.119 -179.948 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.59 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -69.53 169.5 44.27 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.775 -0.726 . . . . 72.44 112.482 179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.459 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 46.78 18.35 0.38 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 40.34 112.496 -179.94 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 4.2 m-20 -65.14 110.4 2.52 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.798 0.333 . . . . 73.24 110.894 -179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.781 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -85.01 130.01 34.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 73.52 111.116 179.953 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.461 ' CE1' ' OD2' ' A' ' 170' ' ' ASP . 1.3 m170 -123.32 123.04 39.82 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.275 -0.421 . . . . 71.23 110.84 -179.984 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.557 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 37.1 m-85 -106.5 138.54 42.5 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 74.12 110.889 -179.898 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 25.3 t0 -68.37 105.37 2.15 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.175 -0.466 . . . . 73.32 110.86 180.0 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -55.53 -39.09 70.11 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.212 -0.449 . . . . 75.34 110.845 -179.904 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.583 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 15.8 m-20 -48.37 -25.0 1.41 Allowed 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.172 -0.467 . . . . 50.02 110.867 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -77.55 163.11 26.58 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.23 -0.441 . . . . 74.24 110.894 -179.913 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.571 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -101.21 86.61 3.05 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.17 -0.468 . . . . 74.42 110.872 -179.909 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.557 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 24.7 m95 -79.53 122.4 26.43 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.156 -0.475 . . . . 73.52 110.881 -179.915 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 24.6 p -139.94 -172.83 3.48 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.274 -0.421 . . . . 64.2 111.148 -179.956 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -113.02 19.6 17.09 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.19 -0.459 . . . . 72.31 111.155 -179.977 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -126.93 -175.4 3.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.455 . . . . 75.31 110.894 179.925 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 11.4 p -70.44 -18.84 63.01 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.195 -0.457 . . . . 54.45 110.891 -179.833 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.63 -106.34 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.742 -0.742 . . . . 50.42 112.47 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.07 176.54 0.11 Allowed Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.712 -0.756 . . . . 74.41 112.498 -179.894 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.467 HG21 HD12 ' A' ' 181' ' ' LEU . 55.6 m -66.65 96.93 0.42 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.76 0.314 . . . . 71.43 111.112 -179.858 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -43.09 116.93 0.98 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.262 -0.427 . . . . 73.42 110.85 -179.99 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.754 HD23 ' HB3' ' A' ' 133' ' ' ALA . 9.0 tp -62.83 -37.31 86.28 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.188 -0.46 . . . . 61.42 110.924 179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.737 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.6 t80 -51.59 -63.9 0.98 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.18 -0.464 . . . . 71.14 110.887 179.949 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.56 HD21 ' CG2' ' A' ' 243' ' ' VAL . 8.3 mp -54.6 -55.82 25.43 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.156 -0.475 . . . . 65.21 110.917 -179.988 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.505 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 1.5 m -55.45 -32.92 63.16 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.166 -0.47 . . . . 73.53 111.157 179.924 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -68.12 -47.99 66.63 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.248 -0.433 . . . . 71.2 111.081 179.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.91 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -53.66 -58.01 4.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 55.14 111.115 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.744 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.8 t-80 -64.45 -29.38 70.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.152 -0.476 . . . . 73.01 110.867 179.93 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.463 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.31 -44.7 95.91 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.203 -0.453 . . . . 65.42 111.055 179.978 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.668 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -68.95 -35.11 67.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.22 -0.445 . . . . 70.52 111.121 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.65 -43.94 46.91 Favored Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.718 -0.753 . . . . 72.21 112.473 179.916 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.409 ' O ' ' O ' ' A' ' 185' ' ' PHE . 28.2 m-70 -67.79 -39.06 84.09 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.784 0.326 . . . . 71.3 110.868 -179.946 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.655 ' OG ' HG23 ' A' ' 159' ' ' ILE . 3.1 m -63.3 -27.46 69.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.216 -0.447 . . . . 62.4 110.834 -179.775 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 44.6 mt -75.52 -27.99 58.94 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.116 -0.493 . . . . 73.3 110.902 -179.963 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 119.9 15.13 5.35 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.781 -0.723 . . . . 75.41 112.471 179.883 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.704 HD21 ' HA ' ' A' ' 258' ' ' ILE . 14.4 mt -79.02 158.18 27.95 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.875 0.369 . . . . 64.14 110.912 -179.969 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -104.07 -136.4 8.87 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.706 -0.759 . . . . 62.05 112.487 179.855 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.428 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 1.5 m170 -125.94 142.16 51.64 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.849 0.356 . . . . 72.31 110.817 -179.906 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 21.7 m -104.7 162.75 13.02 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.222 -0.445 . . . . 75.22 110.87 -179.812 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 4.0 t -103.86 0.71 30.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.123 -0.49 . . . . 54.44 110.871 -179.813 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.598 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -66.24 136.98 95.42 Favored Pre-proline 0 C--N 1.329 -0.307 0 CA-C-O 121.618 0.723 . . . . 72.23 110.834 179.973 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.79 -0.32 6.76 Favored 'Trans proline' 0 C--N 1.342 0.213 0 C-N-CA 122.661 2.241 . . . . 72.14 112.322 -179.973 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.03 17.36 1.93 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.277 -0.42 . . . . 75.41 110.884 179.902 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.598 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -86.69 134.18 33.62 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.192 -0.458 . . . . 73.45 111.133 179.812 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.744 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -58.15 -36.2 56.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.294 -0.412 . . . . 74.41 111.129 179.981 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.428 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 44.2 mmm -61.56 -21.96 64.75 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 73.2 110.912 179.935 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.543 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.7 t80 -54.9 142.7 54.63 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.613 0.721 . . . . 74.54 110.898 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.543 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.3 Cg_endo -69.73 -1.46 8.49 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.695 2.263 . . . . 71.44 112.345 180.0 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 41.8 m -95.32 141.23 29.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.197 -0.456 . . . . 64.41 111.126 -179.975 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 55.7 t80 -118.36 140.33 50.01 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.218 -0.446 . . . . 61.32 110.975 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 16.0 ttmt -157.7 138.05 12.74 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.136 -0.484 . . . . 62.44 110.858 179.938 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.57 ' O ' HG13 ' A' ' 243' ' ' VAL . 77.9 t80 -68.77 145.4 53.82 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.187 -0.461 . . . . 72.44 110.923 -179.951 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.57 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -162.27 133.22 0.87 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.069 -0.514 . . . . 72.43 111.081 179.937 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 54.0 t0 -51.37 130.31 26.86 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.15 -0.477 . . . . 73.43 110.867 179.888 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.49 HD11 ' HD3' ' A' ' 136' ' ' LYS . 16.4 tt -52.26 -30.81 14.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 74.32 111.139 179.99 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.439 HD22 HG23 ' A' ' 247' ' ' THR . 0.4 OUTLIER -67.68 -22.57 65.28 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 75.22 110.94 179.924 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.439 HG23 HD22 ' A' ' 246' ' ' ASN . 28.0 p -109.49 -20.83 12.74 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.144 -0.48 . . . . 74.42 111.173 -179.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -69.12 121.28 16.42 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.196 -0.456 . . . . 72.3 110.905 -179.977 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 49.6 mtp180 -152.98 143.11 22.36 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.185 -0.461 . . . . 74.32 110.835 -179.896 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.844 HD12 HG11 ' A' ' 144' ' ' VAL . 33.2 mt -58.73 123.51 16.62 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.203 -0.453 . . . . 72.21 110.927 179.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 10.3 t -64.32 163.24 13.37 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.226 -0.443 . . . . 74.1 110.835 -179.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.2 -37.95 24.5 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.144 -0.48 . . . . 33.53 111.101 179.918 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 4.8 m-20 -63.81 -45.5 89.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.214 -0.448 . . . . 73.54 110.87 179.962 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.424 ' OD2' ' HB ' ' A' ' 235' ' ' VAL . 5.4 m-20 -61.94 -53.66 52.66 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.179 -0.464 . . . . 71.54 110.902 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.414 ' HA ' HG22 ' A' ' 258' ' ' ILE . 23.1 mt -62.03 -34.95 65.81 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.206 -0.452 . . . . 45.54 111.112 179.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 15.6 mmm180 -68.36 -40.5 81.47 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.176 -0.466 . . . . 73.44 110.831 -179.991 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.06 -51.84 6.66 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.744 -0.741 . . . . 73.21 112.5 -179.948 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.704 ' HA ' HD21 ' A' ' 226' ' ' LEU . 5.8 tp -52.51 -35.07 19.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.775 0.321 . . . . 62.33 111.1 179.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.41 ' O ' ' N ' ' A' ' 263' ' ' GLY . 75.3 mt-30 -87.46 -17.24 32.64 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.206 -0.452 . . . . 73.14 110.911 179.941 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.5 t -69.75 -13.69 62.41 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.198 -0.455 . . . . 74.2 110.851 -179.793 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.855 ' HB3' HG21 ' A' ' 108' ' ' VAL . 3.8 mt -123.55 -18.4 6.17 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.165 -0.471 . . . . 53.0 110.937 179.972 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.838 ' CG ' HD21 ' A' ' 147' ' ' LEU . 39.6 m-85 -114.56 -33.66 5.48 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.18 -0.464 . . . . 63.32 110.9 -179.989 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.41 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.298 0 CA-C-O 119.123 -0.821 . . . . 71.12 112.505 179.961 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 34.5 m-85 . . . . . 0 C--O 1.232 0.158 0 CA-C-O 120.864 0.364 . . . . 71.01 110.891 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 39.09 38.2 0.29 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.199 -0.455 . . . . 73.43 110.877 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 50.8 mt-10 -157.59 123.49 4.71 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 55.04 110.876 -179.902 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.4 OUTLIER -51.45 133.82 33.94 Favored Pre-proline 0 C--N 1.329 -0.312 0 CA-C-O 121.615 0.721 . . . . 72.22 110.874 -179.99 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.7 143.6 51.65 Favored 'Trans proline' 0 C--N 1.341 0.176 0 C-N-CA 122.673 2.249 . . . . 74.35 112.397 179.962 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 89.52 12.2 63.13 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.702 -0.761 . . . . 54.11 112.477 179.928 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.489 ' N ' ' CD ' ' A' ' 107' ' ' PRO . . . 42.67 49.92 5.9 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.693 -0.765 . . . . 52.23 112.458 -179.928 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.489 ' CD ' ' N ' ' A' ' 106' ' ' GLY . 54.0 Cg_endo -69.72 -18.82 36.98 Favored 'Trans proline' 0 C--N 1.341 0.141 0 C-N-CA 122.658 2.239 . . . . 74.1 112.407 179.978 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.075 HG21 HD13 ' A' ' 261' ' ' LEU . 57.4 t -47.28 138.33 2.4 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.271 0 CA-C-N 116.205 -0.452 . . . . 70.42 111.119 179.886 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.504 ' CZ3' HD23 ' A' ' 224' ' ' LEU . 4.8 m0 -65.18 -32.0 73.46 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.268 -0.424 . . . . 73.31 110.88 179.977 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.714 ' H ' HG12 ' A' ' 108' ' ' VAL . 20.4 mtt-85 64.33 35.23 9.97 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.23 -0.441 . . . . 75.34 110.928 -179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.473 ' HG2' ' HB2' ' A' ' 109' ' ' TRP . 23.4 pttt -122.58 166.29 15.07 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.122 -0.49 . . . . 70.04 110.875 -179.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 4.5 p80 -109.42 35.69 3.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.206 -0.452 . . . . 65.11 110.848 179.911 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.413 ' C ' HD12 ' A' ' 114' ' ' ILE . 4.0 m-85 -141.1 106.38 5.02 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.198 -0.455 . . . . 75.22 110.995 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.675 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.6 mp -139.77 163.76 24.46 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.198 -0.456 . . . . 74.44 111.204 179.899 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.603 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -157.91 163.67 37.65 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.238 -0.437 . . . . 71.52 111.126 179.953 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.61 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.4 p90 -132.67 148.62 52.35 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.254 -0.43 . . . . 70.42 110.953 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.667 ' HD2' HD11 ' A' ' 160' ' ' LEU . 3.7 tmt_? -142.84 113.33 7.34 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.068 -0.515 . . . . 64.14 110.885 -180.0 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.424 HD12 ' OH ' ' A' ' 121' ' ' TYR . 45.9 mt -74.25 106.54 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.21 -0.45 . . . . 75.14 111.179 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 8.0 t-20 -61.34 -45.26 95.16 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.243 -0.435 . . . . 75.31 110.914 179.942 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.71 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.4 p-10 -144.1 161.92 37.57 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.207 -0.452 . . . . 73.42 110.931 179.942 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.642 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.1 m-85 -117.23 137.74 52.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.178 -0.465 . . . . 71.22 110.907 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.756 HG22 ' HE1' ' A' ' 125' ' ' MET . 9.3 t -88.31 142.51 31.57 Favored Pre-proline 0 C--N 1.331 -0.219 0 CA-C-O 121.648 0.737 . . . . 75.15 111.111 -179.966 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 0.86 5.0 Favored 'Trans proline' 0 C--O 1.232 0.201 0 C-N-CA 122.702 2.268 . . . . 64.42 112.405 179.937 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -82.81 -24.55 33.3 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.257 -0.429 . . . . 71.13 110.875 179.85 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.756 ' HE1' HG22 ' A' ' 122' ' ' THR . 5.8 mtm -116.46 165.7 12.93 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.282 -0.417 . . . . 53.04 110.838 -179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.474 ' O ' HG23 ' A' ' 130' ' ' VAL . 4.5 m120 -96.01 145.48 25.4 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.227 -0.442 . . . . 65.24 110.893 -179.957 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.89 -34.85 4.11 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.142 -0.481 . . . . 73.13 110.909 -179.968 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.2 mt-10 -83.04 -37.71 23.55 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.186 -0.461 . . . . 55.42 110.902 -179.956 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 50.1 m-20 -66.57 -29.67 69.79 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.204 -0.453 . . . . 62.33 110.894 179.925 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.662 HG22 ' CE ' ' A' ' 125' ' ' MET . 77.6 t -65.36 -46.75 89.39 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.264 0 CA-C-N 116.245 -0.434 . . . . 65.52 111.154 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -78.52 -23.85 46.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.258 -0.428 . . . . 65.1 110.893 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -73.55 -46.39 47.84 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.194 -0.457 . . . . 72.52 110.943 -179.87 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.697 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -72.66 -32.75 66.08 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.14 -0.482 . . . . 72.32 111.112 179.879 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.59 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -71.62 -53.59 20.07 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.162 -0.472 . . . . 75.43 111.155 179.998 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.533 ' N ' HG22 ' A' ' 134' ' ' ILE . 4.6 ttt-85 -49.22 -42.53 40.65 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 73.04 110.868 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.717 ' O ' HG23 ' A' ' 140' ' ' VAL . 9.5 mmtt -71.4 -33.93 69.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.161 -0.472 . . . . 74.12 110.852 179.982 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.884 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.54 -49.32 78.03 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.238 -0.437 . . . . 65.43 111.059 179.852 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.61 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.9 m-85 -72.13 -23.11 61.26 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.273 -0.421 . . . . 73.22 110.917 -179.958 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.552 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.6 tt0 -77.05 -6.27 52.05 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.115 -0.493 . . . . 73.24 110.921 -179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.717 HG23 ' O ' ' A' ' 136' ' ' LYS . 92.7 t -97.22 -16.26 7.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.181 -0.463 . . . . 64.34 111.249 179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.806 ' NE1' HG12 ' A' ' 217' ' ' VAL . 92.7 m95 -106.32 -33.17 7.86 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.105 -0.498 . . . . 64.31 110.869 -179.964 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . 0.455 ' OG ' ' CD2' ' A' ' 149' ' ' PHE . 6.5 m -70.41 -15.66 62.86 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.136 -0.484 . . . . 72.33 110.832 -179.799 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.557 HD22 ' N ' ' A' ' 143' ' ' ASN . 1.2 m-80 -91.41 -18.69 23.85 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.103 -0.498 . . . . 75.04 110.827 -179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.747 HG11 HD12 ' A' ' 250' ' ' LEU . 24.5 m -98.62 1.87 10.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.239 -0.437 . . . . 74.14 111.164 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 147' ' ' LEU . 15.7 p -154.79 145.16 15.91 Favored Pre-proline 0 C--N 1.33 -0.269 0 CA-C-O 121.62 0.724 . . . . 65.05 111.114 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.76 30.36 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.698 2.266 . . . . 63.14 112.354 179.938 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.727 HD21 ' CD1' ' A' ' 262' ' ' TYR . 2.7 mp -91.54 177.28 6.26 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.233 -0.44 . . . . 74.42 110.877 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.08 123.11 14.55 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.14 -0.482 . . . . 71.11 110.786 179.797 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.675 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.3 m-30 -114.55 140.12 49.03 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.167 -0.47 . . . . 74.43 110.962 179.835 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.0 m -132.78 155.81 48.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.169 -0.468 . . . . 53.31 110.878 -179.777 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.481 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 5.0 tttt -102.72 140.52 36.89 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.114 -0.494 . . . . 71.23 110.884 179.948 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.54 HD11 ' N ' ' A' ' 157' ' ' ALA . 18.5 pt -150.74 139.04 14.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.248 -0.433 . . . . 74.0 111.095 179.822 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -108.97 -5.95 15.89 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.148 -0.478 . . . . 75.32 110.928 179.881 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 23.9 p -153.48 52.96 0.73 Allowed 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.145 -0.479 . . . . 63.44 111.129 -179.959 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.505 ' CA ' HD12 ' A' ' 152' ' ' ILE . . . -148.13 -155.43 6.64 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.722 -0.752 . . . . 41.34 112.511 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -106.82 96.96 6.81 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.835 0.35 . . . . 73.12 110.858 -179.949 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.54 ' N ' HD11 ' A' ' 152' ' ' ILE . . . -105.55 155.87 18.78 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.253 -0.43 . . . . 52.34 111.103 179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.76 -51.96 6.08 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.214 -0.448 . . . . 71.24 110.884 179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.646 HG12 HG23 ' A' ' 220' ' ' ILE . 2.6 mp -90.45 92.98 4.13 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.213 -0.449 . . . . 74.33 111.079 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.667 HD11 ' HD2' ' A' ' 117' ' ' ARG . 6.9 tp -84.3 109.94 18.2 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.121 -0.49 . . . . 73.02 110.978 179.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.412 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 92.3 t -87.47 118.57 33.6 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.242 -0.435 . . . . 73.31 111.16 179.846 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.71 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -137.97 106.09 3.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.269 -0.423 . . . . 65.33 111.135 179.871 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.406 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 46.7 m-85 -73.3 110.73 7.8 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.15 -0.477 . . . . 72.22 110.912 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -126.58 167.63 15.39 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.127 -0.488 . . . . 74.33 111.168 179.879 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -120.44 132.22 55.13 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.201 -0.454 . . . . 73.42 110.844 -179.862 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.668 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.4 -157.44 0.08 OUTLIER Glycine 0 N--CA 1.45 -0.423 0 C-N-CA 120.743 -0.741 . . . . 73.41 112.53 179.999 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.762 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -51.08 119.04 3.61 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-O 120.773 0.32 . . . . 71.12 111.114 179.96 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.754 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 4.3 p-80 -137.98 31.9 2.44 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.244 -0.434 . . . . 73.03 110.953 179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 79.65 53.38 4.34 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.779 -0.724 . . . . 62.43 112.483 -179.904 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.478 ' OD2' ' CE1' ' A' ' 196' ' ' HIS . 22.4 t0 -142.85 8.95 1.72 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.866 0.365 . . . . 74.43 110.965 179.946 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 21.5 m-85 54.52 22.44 3.92 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.119 -0.492 . . . . 73.02 110.875 -179.872 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.754 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 2.0 p-80 -119.06 -38.92 2.98 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.17 -0.468 . . . . 64.11 110.873 179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.762 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 50.45 99.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 64.34 111.11 179.976 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.668 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.4 m-85 -58.22 -171.23 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.166 -0.47 . . . . 51.11 110.919 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -132.21 20.64 4.43 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 71.23 110.856 -179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.573 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 53.01 -156.38 5.01 Favored Glycine 0 N--CA 1.452 -0.248 0 C-N-CA 120.68 -0.771 . . . . 75.54 112.509 -179.882 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.453 ' C ' ' O ' ' A' ' 176' ' ' GLY . 12.7 tptt -33.34 132.02 0.19 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.858 0.361 . . . . 73.4 110.878 179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.66 163.81 0.18 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.788 -0.72 . . . . 64.22 112.504 179.926 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.92 -142.25 19.84 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.739 -0.743 . . . . 50.04 112.503 -179.858 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.1 mt -49.89 97.66 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-O 120.886 0.374 . . . . 74.53 111.193 -179.967 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.456 HD12 HG21 ' A' ' 210' ' ' THR . 2.8 mm? -66.8 -41.27 87.84 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.141 -0.481 . . . . 71.33 110.887 179.97 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.4 ' HB2' ' HA ' ' A' ' 197' ' ' PHE . . . -174.83 158.25 2.57 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.214 -0.448 . . . . 23.44 111.114 179.826 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.45 ' CE1' ' CD2' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -148.96 134.69 18.8 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.198 -0.456 . . . . 72.43 110.911 179.963 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.815 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -131.92 175.53 9.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.187 -0.46 . . . . 75.44 111.079 179.997 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.53 ' O ' ' HA ' ' A' ' 223' ' ' SER . 39.4 m-85 -104.63 -148.71 0.4 Allowed 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.267 -0.424 . . . . 65.23 110.869 -179.937 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -164.84 -83.58 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.35 0 C-N-CA 120.818 -0.706 . . . . 64.44 112.605 -179.963 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.409 ' HB3' ' HB2' ' A' ' 107' ' ' PRO . 53.9 Cg_endo -69.79 51.87 0.95 Allowed 'Trans proline' 0 C--O 1.231 0.167 0 C-N-CA 122.732 2.288 . . . . 75.24 112.321 179.974 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.575 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.68 148.92 17.25 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.79 -0.719 . . . . 44.23 112.485 -179.98 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.516 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -105.13 145.27 30.78 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-O 120.905 0.383 . . . . 35.3 110.878 -179.738 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.56 -62.7 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.643 -0.789 . . . . 74.1 112.588 -179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.516 ' N ' ' O ' ' A' ' 189' ' ' SER . 5.8 mm -107.54 8.76 9.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.799 0.333 . . . . 71.12 111.076 179.996 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.575 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -70.84 171.26 45.33 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.753 -0.737 . . . . 73.44 112.468 179.889 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.418 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 45.24 19.67 0.24 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.75 -0.738 . . . . 63.54 112.478 -179.954 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.409 ' N ' ' O ' ' A' ' 192' ' ' GLY . 2.1 m-20 -65.57 108.45 2.04 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.772 0.32 . . . . 73.22 110.886 179.963 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.815 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -84.22 129.24 34.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 53.41 111.108 179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.478 ' CE1' ' OD2' ' A' ' 170' ' ' ASP . 1.6 m170 -121.68 123.61 42.29 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.189 -0.46 . . . . 74.14 110.867 179.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.55 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 40.3 m-85 -106.3 137.17 44.73 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 74.13 110.925 -179.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 24.4 t0 -67.17 105.17 1.63 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.139 -0.482 . . . . 65.14 110.878 179.971 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.8 tm-20 -55.59 -39.14 70.32 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.165 -0.471 . . . . 73.54 110.873 -179.923 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.573 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 15.5 m-20 -47.92 -25.31 1.29 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.108 -0.497 . . . . 74.25 110.832 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -77.21 162.92 27.01 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 73.54 110.907 -179.906 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.607 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -101.13 85.32 2.8 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.19 -0.459 . . . . 74.42 110.811 -179.827 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.55 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 24.8 m95 -77.61 123.26 26.4 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.235 -0.438 . . . . 75.31 110.903 -179.981 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . 0.412 HG23 ' HD1' ' A' ' 202' ' ' PHE . 41.0 p -140.21 -173.76 3.75 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.215 -0.448 . . . . 75.22 111.102 -179.989 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -112.83 18.04 18.51 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.238 -0.437 . . . . 73.22 111.094 -179.87 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.8 -177.64 4.28 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.177 -0.465 . . . . 74.04 110.849 179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 23.8 p -66.12 -18.99 65.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.224 -0.444 . . . . 64.42 110.805 -179.731 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.1 -107.69 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.748 -0.739 . . . . 73.3 112.449 -179.998 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.607 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.13 177.29 0.15 Allowed Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.727 -0.749 . . . . 53.12 112.523 -179.904 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.456 HG21 HD12 ' A' ' 181' ' ' LEU . 88.1 m -66.78 97.51 0.47 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.755 0.312 . . . . 65.01 111.17 -179.896 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -42.11 119.25 1.3 Allowed 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.279 -0.419 . . . . 71.13 110.809 -179.93 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.638 HD23 ' HB3' ' A' ' 133' ' ' ALA . 9.4 tp -65.53 -37.55 87.09 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.204 -0.453 . . . . 72.53 110.851 -179.983 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.729 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.7 t80 -51.15 -64.96 0.64 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.11 -0.495 . . . . 72.11 110.91 179.909 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.533 HD11 ' H ' ' A' ' 243' ' ' VAL . 22.8 mt -53.53 -55.36 26.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.118 -0.492 . . . . 71.11 110.954 179.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.522 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 1.8 m -55.78 -33.28 64.22 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.221 -0.445 . . . . 71.15 111.181 179.915 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -68.05 -47.98 66.87 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.181 -0.463 . . . . 64.15 111.092 179.839 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.884 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -53.61 -57.93 4.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.222 -0.444 . . . . 71.25 111.119 179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.76 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.7 t-80 -64.66 -28.14 69.41 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.123 -0.489 . . . . 72.01 110.907 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.46 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -63.86 -45.32 89.99 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.188 -0.46 . . . . 75.24 111.087 179.972 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.646 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -68.32 -35.89 72.82 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.22 -0.445 . . . . 72.04 111.141 -179.993 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.61 -44.65 47.21 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.687 -0.768 . . . . 44.32 112.486 179.952 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.411 ' O ' ' O ' ' A' ' 185' ' ' PHE . 4.3 m-70 -68.32 -38.06 81.2 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-O 120.706 0.288 . . . . 74.15 110.809 -179.926 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.606 ' OG ' HG23 ' A' ' 159' ' ' ILE . 7.1 m -64.27 -24.69 67.75 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.223 -0.444 . . . . 64.52 110.827 -179.743 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.504 HD23 ' CZ3' ' A' ' 109' ' ' TRP . 70.2 mt -78.07 -27.72 48.68 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.188 -0.46 . . . . 74.52 110.885 -179.995 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 121.11 15.47 4.68 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.65 -0.786 . . . . 53.24 112.428 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.755 HD21 ' HA ' ' A' ' 258' ' ' ILE . 12.5 mt -80.31 156.12 26.93 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.906 0.384 . . . . 73.4 110.846 -179.869 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -99.25 -141.12 11.9 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.759 -0.734 . . . . 74.1 112.464 179.927 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -122.0 139.36 53.77 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.839 0.352 . . . . 74.15 110.904 -179.933 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 6.4 t -99.21 163.99 12.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.21 -0.45 . . . . 72.21 110.884 -179.745 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -109.19 -2.86 17.7 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 74.11 110.858 -179.82 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.643 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -61.11 141.45 93.79 Favored Pre-proline 0 C--N 1.329 -0.326 0 CA-C-O 121.681 0.753 . . . . 64.5 110.839 179.869 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.76 -3.35 11.83 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.709 2.273 . . . . 63.05 112.342 179.997 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 1.4 ptmt -143.47 19.81 1.87 Allowed 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.175 -0.466 . . . . 74.25 110.827 179.986 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.643 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -82.21 139.03 34.5 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 71.41 111.09 179.868 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.76 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -63.03 -37.73 80.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.288 -0.415 . . . . 73.03 111.055 179.995 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 48.5 mmm -66.49 -13.75 61.3 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.199 -0.455 . . . . 75.44 110.833 179.931 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.63 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.5 t80 -58.64 144.4 79.96 Favored Pre-proline 0 C--N 1.329 -0.318 0 CA-C-O 121.736 0.779 . . . . 73.33 110.853 -179.865 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.63 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.2 Cg_endo -69.75 -3.42 11.97 Favored 'Trans proline' 0 C--N 1.341 0.183 0 C-N-CA 122.753 2.302 . . . . 74.22 112.314 -179.987 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.4 ' HG1' ' HD2' ' A' ' 237' ' ' PHE . 16.9 m -95.7 142.42 28.02 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.24 -0.436 . . . . 62.11 111.148 -179.992 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 51.4 t80 -122.92 134.53 54.36 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.181 -0.463 . . . . 73.5 110.94 -179.908 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.3 ptmt -152.67 129.49 10.93 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.09 -0.504 . . . . 74.42 110.955 179.969 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.496 ' O ' HG13 ' A' ' 243' ' ' VAL . 85.2 t80 -57.13 143.77 37.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.318 -0.401 . . . . 74.33 110.876 -179.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.533 ' H ' HD11 ' A' ' 214' ' ' LEU . 0.9 OUTLIER -158.26 130.34 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.218 -0.446 . . . . 71.5 111.136 179.841 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 49.8 t0 -50.84 132.16 26.56 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.16 -0.473 . . . . 73.24 110.945 179.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 14.3 tt -53.98 -29.89 19.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.307 0 CA-C-N 116.188 -0.46 . . . . 53.22 111.081 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.456 HD22 HG23 ' A' ' 247' ' ' THR . 0.3 OUTLIER -72.98 -18.76 61.33 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.216 -0.447 . . . . 70.12 110.973 179.925 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.456 HG23 HD22 ' A' ' 246' ' ' ASN . 38.4 p -109.33 -21.4 12.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.158 -0.474 . . . . 71.11 111.194 179.936 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 44.3 t80 -71.58 143.1 49.99 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.222 -0.445 . . . . 75.34 110.917 -179.984 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 2.0 ptp85 -177.19 133.37 0.18 Allowed 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.206 -0.452 . . . . 63.31 110.834 -179.916 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.747 HD12 HG11 ' A' ' 144' ' ' VAL . 52.9 mt -48.0 127.15 11.81 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.127 -0.488 . . . . 74.25 110.915 -179.973 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 3.6 m -67.44 163.49 20.81 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.228 -0.442 . . . . 71.25 110.829 -179.89 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.89 -35.09 31.11 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.147 -0.478 . . . . 53.12 111.144 179.865 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -67.1 -51.58 52.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.219 -0.446 . . . . 74.02 110.886 179.945 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -56.39 -50.26 72.11 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.207 -0.451 . . . . 45.44 110.892 -179.995 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 21.2 mt -61.4 -39.97 84.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.121 -0.49 . . . . 73.23 111.07 -179.909 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 2.2 mpt_? -65.44 -39.85 92.57 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.172 -0.467 . . . . 65.14 110.948 179.941 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -73.73 -52.66 7.99 Favored Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.752 -0.737 . . . . 61.04 112.455 -179.983 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.755 ' HA ' HD21 ' A' ' 226' ' ' LEU . 3.8 tp -52.54 -34.62 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-O 120.783 0.325 . . . . 74.02 111.124 -179.952 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.429 ' O ' ' N ' ' A' ' 263' ' ' GLY . 82.1 mt-30 -86.39 -17.34 34.64 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.195 -0.457 . . . . 61.25 110.92 179.929 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.7 t -69.49 -13.82 62.54 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.233 -0.44 . . . . 33.13 110.851 -179.833 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 1.075 HD13 HG21 ' A' ' 108' ' ' VAL . 2.8 mt -123.16 -18.29 6.38 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.151 -0.477 . . . . 63.43 110.894 179.918 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.727 ' CD1' HD21 ' A' ' 147' ' ' LEU . 36.8 m-85 -114.56 -34.14 5.32 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-O 121.011 0.434 . . . . 74.12 110.965 -179.955 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.429 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.307 0 CA-C-O 119.099 -0.834 . . . . 61.31 112.485 179.985 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 27.2 m-85 . . . . . 0 C--O 1.231 0.081 0 CA-C-O 120.864 0.364 . . . . 70.32 110.913 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.58 ' H ' ' NE ' ' A' ' 101' ' ' ARG . 0.0 OUTLIER -72.83 66.67 0.78 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 74.22 110.815 -179.861 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.41 ' HA ' ' H ' ' A' ' 227' ' ' GLY . 2.8 pp20? 177.75 130.24 0.06 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.448 . . . . 72.4 110.86 -179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 6.3 mmt -50.68 148.08 7.52 Favored Pre-proline 0 C--N 1.328 -0.335 0 CA-C-O 121.555 0.693 . . . . 74.14 110.884 179.907 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.81 -48.58 0.68 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.676 2.251 . . . . 74.3 112.322 179.973 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -122.36 36.96 3.0 Favored Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.788 -0.72 . . . . 71.51 112.466 -179.948 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -103.94 97.54 1.44 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.767 -0.73 . . . . 64.02 112.532 -179.964 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.89 71.95 1.54 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.697 2.265 . . . . 75.12 112.297 -179.909 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.713 ' CG2' HD22 ' A' ' 261' ' ' LEU . 32.6 t -38.6 141.78 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.139 -0.482 . . . . 75.32 111.17 179.91 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 4.1 m0 -51.14 -28.2 10.35 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.132 -0.485 . . . . 65.25 110.942 -179.905 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.617 ' H ' HG12 ' A' ' 108' ' ' VAL . 64.2 mtp180 58.25 32.88 22.59 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.214 -0.448 . . . . 75.4 110.845 179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 3.5 mtmt -120.46 171.19 8.72 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.267 -0.424 . . . . 72.21 110.906 179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.401 ' HA ' ' HG ' ' A' ' 147' ' ' LEU . 6.2 p80 -111.3 26.75 10.35 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.226 -0.443 . . . . 75.02 110.867 179.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.409 ' C ' HD12 ' A' ' 114' ' ' ILE . 2.1 m-85 -129.48 111.08 12.41 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.199 -0.455 . . . . 74.13 110.909 -179.868 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.584 HG22 ' N ' ' A' ' 115' ' ' THR . 4.8 mp -142.33 162.73 18.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.131 -0.486 . . . . 71.24 111.14 179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.584 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -160.43 163.76 32.8 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.117 -0.492 . . . . 52.52 111.074 179.987 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.615 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.5 p90 -131.7 152.28 51.01 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.168 -0.469 . . . . 74.04 110.953 179.962 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.693 ' HD2' HD11 ' A' ' 160' ' ' LEU . 3.9 tmt_? -144.35 109.96 5.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.194 -0.457 . . . . 72.53 110.855 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 44.7 mt -71.58 105.67 1.92 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.278 -0.419 . . . . 63.41 111.114 179.911 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 41.2 t30 -59.57 -45.47 91.74 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.143 -0.481 . . . . 62.54 110.827 179.949 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.729 ' OD1' HG23 ' A' ' 162' ' ' VAL . 1.7 p-10 -146.12 163.35 35.61 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.191 -0.459 . . . . 72.13 110.878 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.61 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.0 m-85 -116.27 140.98 48.75 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.117 -0.492 . . . . 65.33 110.873 -179.895 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.725 HG22 ' CE ' ' A' ' 125' ' ' MET . 2.9 t -90.91 142.67 27.73 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.549 0.69 . . . . 73.23 111.202 179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.75 -2.95 11.04 Favored 'Trans proline' 0 C--N 1.341 0.139 0 C-N-CA 122.692 2.261 . . . . 65.02 112.355 179.975 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.422 ' H ' HG23 ' A' ' 122' ' ' THR . 21.9 m-20 -80.4 -23.88 40.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 54.22 110.818 179.958 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.725 ' CE ' HG22 ' A' ' 122' ' ' THR . 13.3 mtm -115.61 166.25 12.12 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.233 -0.439 . . . . 75.35 110.839 -179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.407 ' O ' HG23 ' A' ' 130' ' ' VAL . 7.1 t-20 -96.57 144.63 26.45 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.203 -0.453 . . . . 63.21 110.961 -179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 28.8 ptt180 -45.1 -35.73 3.25 Favored 'General case' 0 C--N 1.327 -0.38 0 CA-C-N 116.178 -0.465 . . . . 74.04 110.905 -179.965 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 17.9 mt-10 -83.23 -38.66 21.95 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.102 -0.499 . . . . 73.24 110.87 -179.897 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 38.2 m-20 -65.4 -29.8 70.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.066 -0.515 . . . . 73.32 110.886 179.996 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.61 HG11 ' CE2' ' A' ' 121' ' ' TYR . 73.4 t -66.49 -46.35 86.71 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.173 -0.467 . . . . 61.23 111.156 -179.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.13 -23.29 47.86 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.197 -0.456 . . . . 73.34 110.827 179.955 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -74.43 -47.2 35.13 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.232 -0.44 . . . . 71.41 110.917 -179.797 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.715 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -71.79 -31.51 66.67 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.124 -0.489 . . . . 71.44 111.124 179.811 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.631 HD13 HD21 ' A' ' 212' ' ' LEU . 1.4 mp -73.29 -54.13 16.39 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.218 -0.446 . . . . 72.11 111.146 179.938 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.538 ' N ' HG22 ' A' ' 134' ' ' ILE . 3.3 ttm180 -49.06 -41.92 36.89 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.12 -0.491 . . . . 71.15 110.832 -179.924 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.739 ' O ' HG23 ' A' ' 140' ' ' VAL . 7.8 mmpt? -72.43 -34.24 67.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.192 -0.458 . . . . 70.02 110.867 179.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.9 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.5 -48.83 80.03 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.221 -0.445 . . . . 64.15 111.168 179.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.639 ' HE1' HD13 ' A' ' 159' ' ' ILE . 95.4 m-85 -72.77 -22.1 60.89 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.12 -0.491 . . . . 71.31 110.888 -179.961 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.523 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.1 OUTLIER -78.64 -5.81 53.98 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.16 -0.473 . . . . 73.4 110.937 -179.958 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.739 HG23 ' O ' ' A' ' 136' ' ' LYS . 93.4 t -97.1 -16.87 6.98 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.199 -0.455 . . . . 72.14 111.109 179.969 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.807 ' NE1' HG12 ' A' ' 217' ' ' VAL . 93.6 m95 -106.48 -35.88 6.96 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.222 -0.445 . . . . 72.11 110.878 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.62 -11.47 60.96 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.221 -0.445 . . . . 52.13 110.851 -179.778 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.624 HD22 ' N ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER -95.69 -15.74 22.47 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.088 -0.505 . . . . 74.55 111.018 179.934 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.686 HG11 HD12 ' A' ' 250' ' ' LEU . 20.9 m -101.51 1.21 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.148 -0.478 . . . . 74.03 111.079 179.929 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.693 HG21 HG13 ' A' ' 258' ' ' ILE . 17.1 p -150.31 146.69 20.32 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.539 0.685 . . . . 63.12 111.149 -179.949 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.78 30.53 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.186 0 C-N-CA 122.661 2.241 . . . . 64.44 112.314 179.898 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.713 HD21 ' CD1' ' A' ' 262' ' ' TYR . 0.8 OUTLIER -93.32 -178.13 4.65 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.252 -0.431 . . . . 64.34 110.914 179.952 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 6.0 mtmm -144.34 126.5 15.61 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.181 -0.463 . . . . 71.31 110.933 179.813 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.501 ' HE1' HD13 ' A' ' 114' ' ' ILE . 4.0 m-30 -114.52 142.15 46.78 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.211 -0.449 . . . . 74.31 110.906 -179.976 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.8 m -140.78 137.49 33.41 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.136 -0.484 . . . . 71.33 110.893 -179.705 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.482 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.9 OUTLIER -85.88 142.62 28.74 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 64.13 110.941 179.936 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.649 HD11 ' N ' ' A' ' 157' ' ' ALA . 18.2 pt -151.07 135.6 9.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.206 -0.452 . . . . 73.51 111.114 179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -107.49 -5.73 17.45 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.176 -0.465 . . . . 74.01 110.918 179.946 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 24.4 p -153.34 53.25 0.74 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 71.21 111.254 -179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.44 ' C ' HD12 ' A' ' 152' ' ' ILE . . . -149.74 -155.56 6.85 Favored Glycine 0 N--CA 1.451 -0.338 0 C-N-CA 120.751 -0.738 . . . . 42.43 112.457 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.421 ' HB2' ' HE2' ' A' ' 156' ' ' MET . 1.2 mpp? -107.69 96.82 6.66 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-O 120.88 0.372 . . . . 74.04 110.805 -179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.649 ' N ' HD11 ' A' ' 152' ' ' ILE . . . -104.78 154.87 19.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 71.53 111.121 179.863 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.22 -52.55 6.49 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.474 . . . . 75.04 110.853 -179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.726 HG12 HG23 ' A' ' 220' ' ' ILE . 1.9 mp -89.53 95.88 5.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.112 -0.495 . . . . 63.24 111.139 -179.931 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.693 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.2 tp -86.87 110.08 19.74 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.168 -0.469 . . . . 62.23 110.857 -179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.427 HG13 ' CE1' ' A' ' 197' ' ' PHE . 87.8 t -89.83 120.54 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.209 -0.451 . . . . 44.11 111.14 179.807 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.729 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.2 p -139.83 104.97 2.05 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.117 -0.492 . . . . 72.33 111.138 179.96 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 45.9 m-85 -71.87 108.75 5.31 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.232 -0.44 . . . . 73.41 110.889 179.993 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.11 165.71 20.71 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.174 -0.466 . . . . 74.45 111.121 179.893 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 8.8 ptm180 -114.14 138.29 50.62 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.205 -0.452 . . . . 74.32 110.922 -179.985 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.67 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.74 -154.26 0.17 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.651 -0.785 . . . . 74.11 112.496 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.802 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -66.88 116.73 8.06 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.886 0.374 . . . . 74.22 111.106 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.695 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.88 -22.7 12.07 Favored 'General case' 0 C--N 1.331 -0.227 0 CA-C-N 116.204 -0.453 . . . . 64.3 110.897 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.47 29.39 0.54 Allowed Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.741 -0.742 . . . . 71.01 112.498 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.646 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.08 1.43 15.32 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.916 0.389 . . . . 73.3 110.918 -179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 15.1 m-85 72.8 40.34 0.6 Allowed 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.167 -0.469 . . . . 64.43 110.868 -179.908 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.695 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.72 -41.65 0.69 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 74.14 110.888 179.99 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.802 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.31 99.93 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.187 -0.46 . . . . 70.41 111.074 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.67 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.9 m-85 -60.72 -168.27 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.226 -0.443 . . . . 75.2 110.866 -179.9 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.74 18.66 3.54 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.149 -0.478 . . . . 70.04 110.866 179.939 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.578 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.2 -157.32 7.73 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.704 -0.76 . . . . 72.12 112.526 -179.927 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 176' ' ' GLY . 11.7 tmtt? -35.29 134.52 0.28 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.835 0.35 . . . . 74.3 110.879 179.994 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.35 165.49 0.14 Allowed Glycine 0 N--CA 1.452 -0.287 0 C-N-CA 120.594 -0.812 . . . . 74.44 112.496 179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.81 -143.23 22.2 Favored Glycine 0 N--CA 1.451 -0.345 0 C-N-CA 120.749 -0.739 . . . . 73.4 112.47 -179.987 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -50.13 96.27 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.886 0.375 . . . . 71.02 111.174 -179.956 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 13.4 mt -66.82 -39.48 87.7 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.2 -0.454 . . . . 52.34 110.934 179.94 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.439 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -172.08 167.1 6.09 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.21 -0.45 . . . . 73.35 111.142 179.691 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.561 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.6 p80 -159.67 139.72 11.74 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.257 -0.428 . . . . 74.31 110.931 -179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.761 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -137.64 173.44 11.65 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.242 -0.436 . . . . 51.13 111.145 179.909 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.519 ' O ' ' O ' ' A' ' 222' ' ' HIS . 23.8 m-85 -99.43 -138.93 0.32 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.174 -0.466 . . . . 61.4 110.818 -179.877 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -166.98 -99.64 0.14 Allowed Glycine 0 N--CA 1.453 -0.232 0 C-N-CA 120.792 -0.718 . . . . 60.35 112.578 -179.999 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.83 59.54 1.66 Allowed 'Trans proline' 0 C--N 1.341 0.164 0 C-N-CA 122.696 2.264 . . . . 64.54 112.343 -179.977 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.598 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.06 154.6 16.43 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.748 -0.739 . . . . 70.35 112.435 -179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.572 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.52 148.63 26.27 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-O 120.919 0.39 . . . . 72.21 110.793 -179.739 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.68 -67.01 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.718 -0.753 . . . . 64.31 112.503 179.947 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.572 ' N ' ' O ' ' A' ' 189' ' ' SER . 3.6 mt -103.99 6.33 10.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.867 0.365 . . . . 74.11 111.144 179.996 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.598 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -63.69 165.29 29.2 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.685 -0.769 . . . . 74.22 112.511 179.892 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.415 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 45.05 20.21 0.23 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.73 -0.748 . . . . 62.14 112.459 -179.937 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 192' ' ' GLY . 0.8 OUTLIER -64.25 105.77 0.97 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-O 120.79 0.329 . . . . 63.2 110.943 179.971 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.761 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -82.15 129.62 34.87 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.163 -0.471 . . . . 64.42 111.158 179.959 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.561 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 11.2 m170 -119.93 129.93 54.57 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.221 -0.445 . . . . 75.14 110.878 -179.947 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.465 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 47.7 m-85 -114.35 134.22 55.13 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.218 -0.446 . . . . 75.15 110.909 -179.896 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -67.25 109.44 3.1 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.184 -0.462 . . . . 73.32 110.916 179.962 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -60.22 -37.19 79.55 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.274 -0.421 . . . . 73.34 110.861 -179.929 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.578 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 5.3 m-20 -50.45 -22.89 2.1 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.233 -0.439 . . . . 73.42 110.885 179.997 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 5.9 mm-40 -80.17 163.38 24.12 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.122 -0.49 . . . . 75.21 110.835 -179.866 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.561 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -101.43 89.1 3.63 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.102 -0.499 . . . . 74.35 110.843 -179.877 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.513 ' CZ3' HG21 ' A' ' 215' ' ' THR . 29.5 m95 -80.59 123.26 27.98 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.177 -0.465 . . . . 60.22 110.952 179.972 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.3 p -141.26 -174.83 4.13 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.177 -0.465 . . . . 70.3 111.183 -179.951 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -112.36 20.53 16.64 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.19 -0.459 . . . . 64.44 111.104 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -127.74 -173.12 2.84 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.267 -0.424 . . . . 64.34 110.903 179.912 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.3 p -72.11 -18.87 61.87 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.215 -0.448 . . . . 71.41 110.836 -179.773 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.49 -106.58 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.746 -0.74 . . . . 31.23 112.502 179.945 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.561 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.05 176.84 0.1 Allowed Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.694 -0.765 . . . . 71.31 112.528 -179.94 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 89.8 m -66.74 97.43 0.46 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.741 0.305 . . . . 73.44 111.125 -179.857 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -42.83 116.93 0.95 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 73.52 110.833 -179.959 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.661 HD23 ' HB3' ' A' ' 133' ' ' ALA . 9.8 tp -63.29 -37.94 89.2 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.083 -0.508 . . . . 74.52 110.94 179.975 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.762 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.6 t80 -51.32 -63.91 0.98 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.182 -0.463 . . . . 50.51 110.901 179.919 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.566 HD21 ' CG2' ' A' ' 243' ' ' VAL . 8.0 mp -55.51 -54.99 37.02 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.119 -0.491 . . . . 75.5 110.895 -179.981 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.513 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.3 m -55.31 -33.95 63.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.27 -0.423 . . . . 73.2 111.139 179.948 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -67.69 -48.74 65.73 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.221 -0.445 . . . . 74.31 111.009 179.942 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.9 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -53.43 -58.22 3.58 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.249 -0.432 . . . . 71.45 111.067 -179.982 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.767 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.8 t-80 -64.46 -28.13 69.46 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.191 -0.459 . . . . 74.11 110.775 -179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -64.39 -44.07 92.49 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.231 -0.44 . . . . 73.4 111.104 179.951 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.726 HG23 HG12 ' A' ' 159' ' ' ILE . 2.6 mt -70.28 -34.26 57.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-N 116.265 -0.425 . . . . 64.44 111.172 179.941 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.443 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -51.79 -45.11 55.53 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.713 -0.756 . . . . 61.24 112.471 179.908 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.519 ' O ' ' O ' ' A' ' 185' ' ' PHE . 4.1 m-70 -68.85 -40.61 79.29 Favored 'General case' 0 C--N 1.331 -0.232 0 CA-C-O 120.849 0.356 . . . . 73.41 110.89 -179.935 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.488 ' OG ' HG12 ' A' ' 159' ' ' ILE . 32.5 p -65.7 -20.2 66.19 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.11 -0.495 . . . . 74.43 110.858 -179.749 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.465 ' O ' HG13 ' A' ' 108' ' ' VAL . 52.8 mt -80.84 -25.77 37.5 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.142 -0.481 . . . . 33.33 110.897 -179.98 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.464 ' HA3' HG22 ' A' ' 108' ' ' VAL . . . 122.2 13.18 4.96 Favored Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.729 -0.748 . . . . 70.2 112.441 179.922 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.871 HD21 ' HA ' ' A' ' 258' ' ' ILE . 17.6 mt -84.81 155.65 21.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.809 0.337 . . . . 61.45 110.973 -179.903 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.41 ' H ' ' HA ' ' A' ' 102' ' ' GLU . . . -102.95 -138.21 9.86 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.767 -0.73 . . . . 65.31 112.458 179.883 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -120.76 138.76 53.84 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.918 0.39 . . . . 73.25 110.886 -179.966 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 69.8 p -97.26 166.97 11.31 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.17 -0.468 . . . . 74.22 110.88 -179.807 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -110.18 3.09 19.79 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.1 -0.5 . . . . 73.54 110.84 -179.852 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.524 ' HB3' ' HB2' ' A' ' 234' ' ' ALA . 0.4 OUTLIER -72.3 135.74 81.87 Favored Pre-proline 0 C--N 1.328 -0.33 0 CA-C-O 121.683 0.754 . . . . 74.33 110.844 179.87 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.62 0.25 5.8 Favored 'Trans proline' 0 C--N 1.342 0.207 0 C-N-CA 122.713 2.275 . . . . 61.13 112.331 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.05 25.42 1.76 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.226 -0.443 . . . . 71.43 110.908 -179.992 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.524 ' HB2' ' HB3' ' A' ' 231' ' ' ASP . . . -97.48 143.91 27.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.202 -0.453 . . . . 63.33 111.082 179.876 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.767 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.3 t -63.84 -41.75 93.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.192 -0.458 . . . . 72.45 111.118 179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 49.9 mmm -60.33 -17.67 44.59 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.193 -0.458 . . . . 72.22 110.904 179.875 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.615 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.1 t80 -57.79 144.64 73.53 Favored Pre-proline 0 C--N 1.329 -0.283 0 CA-C-O 121.712 0.768 . . . . 75.5 110.78 -179.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.615 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.5 Cg_endo -69.87 -1.23 8.22 Favored 'Trans proline' 0 C--O 1.232 0.199 0 C-N-CA 122.552 2.168 . . . . 71.51 112.385 -179.991 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 23.3 m -96.32 140.97 30.22 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.221 -0.445 . . . . 63.4 111.201 179.915 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 57.6 t80 -122.39 134.48 54.62 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.185 -0.461 . . . . 72.23 110.978 -179.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.9 ptpp? -151.99 135.12 15.8 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.1 -0.5 . . . . 72.13 110.9 179.901 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.553 ' O ' HG13 ' A' ' 243' ' ' VAL . 82.1 t80 -64.5 143.52 57.85 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.128 -0.487 . . . . 74.31 110.889 -179.943 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.566 ' CG2' HD21 ' A' ' 214' ' ' LEU . 0.2 OUTLIER -161.18 128.92 0.62 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.041 -0.527 . . . . 62.12 111.105 179.939 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 6.0 t70 -50.37 134.69 23.03 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 75.24 110.9 179.955 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.508 HD12 ' CE2' ' A' ' 213' ' ' PHE . 8.0 tt -51.31 -33.54 14.06 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.195 -0.457 . . . . 73.24 111.222 179.936 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.54 ' OD1' HG23 ' A' ' 247' ' ' THR . 1.2 p30 -65.73 -23.51 66.76 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.126 -0.488 . . . . 74.12 110.907 179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.54 HG23 ' OD1' ' A' ' 246' ' ' ASN . 10.5 p -107.0 -21.81 12.88 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.457 . . . . 61.15 111.143 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 10.3 t80 -73.43 134.02 43.86 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.177 -0.465 . . . . 71.01 110.852 -179.936 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 24.3 ptt85 -171.23 134.08 0.89 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.146 -0.479 . . . . 74.23 110.91 -179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.686 HD12 HG11 ' A' ' 144' ' ' VAL . 54.7 mt -48.06 127.28 12.11 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.185 -0.461 . . . . 71.24 110.998 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 30.9 t -72.46 164.43 26.39 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.15 -0.477 . . . . 43.11 110.894 -179.868 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -47.95 -37.98 15.68 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.194 -0.457 . . . . 74.43 111.103 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -63.56 -45.29 91.16 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.218 -0.447 . . . . 75.55 110.869 -179.954 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.474 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 12.7 m-20 -61.03 -55.35 33.76 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 70.21 110.889 179.923 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.429 ' HA ' HG22 ' A' ' 258' ' ' ILE . 1.3 mp -58.99 -34.55 53.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.185 -0.461 . . . . 71.02 111.153 179.977 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 28.7 mmm-85 -68.08 -40.32 82.71 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.116 -0.493 . . . . 54.53 110.908 -179.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.417 ' HA3' ' HB2' ' A' ' 101' ' ' ARG . . . -75.59 -50.62 7.92 Favored Glycine 0 N--CA 1.45 -0.383 0 C-N-CA 120.784 -0.722 . . . . 63.53 112.562 179.926 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.871 ' HA ' HD21 ' A' ' 226' ' ' LEU . 5.6 tp -52.38 -34.53 18.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.772 0.32 . . . . 74.43 111.159 179.933 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.406 ' O ' ' N ' ' A' ' 263' ' ' GLY . 57.5 mt-30 -86.73 -16.94 34.9 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.122 -0.49 . . . . 75.23 110.876 179.985 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.409 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 3.2 t -69.47 -13.93 62.61 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.17 -0.468 . . . . 52.24 110.853 -179.813 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.713 HD22 ' CG2' ' A' ' 108' ' ' VAL . 0.8 OUTLIER -124.37 -17.71 6.0 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.126 -0.488 . . . . 70.43 110.935 -179.942 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.713 ' CD1' HD21 ' A' ' 147' ' ' LEU . 36.1 m-85 -114.74 -33.28 5.55 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.15 -0.477 . . . . 74.41 110.859 -179.953 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.406 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.313 0 CA-C-O 119.122 -0.821 . . . . 63.24 112.454 -179.963 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 101' ' ' ARG . 31.8 m-85 . . . . . 0 C--O 1.23 0.076 0 CA-C-O 120.849 0.357 . . . . 54.22 110.902 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 100' ' ' PHE . 8.2 ptt-85 36.59 59.67 0.98 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.12 -0.491 . . . . 63.44 110.882 -179.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.558 ' CD ' HD21 ' A' ' 261' ' ' LEU . 14.9 tt0 178.09 132.87 0.07 Allowed 'General case' 0 C--N 1.331 -0.215 0 CA-C-N 116.175 -0.466 . . . . 65.32 110.875 -179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.5 OUTLIER -49.96 150.41 4.06 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.574 0.702 . . . . 70.34 110.895 179.92 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 -4.58 14.32 Favored 'Trans proline' 0 C--N 1.342 0.198 0 C-N-CA 122.624 2.216 . . . . 54.24 112.347 179.995 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.29 -33.87 27.61 Favored Glycine 0 N--CA 1.452 -0.247 0 C-N-CA 120.698 -0.763 . . . . 62.02 112.42 -179.938 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 134.04 -150.35 19.96 Favored Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.834 -0.698 . . . . 72.11 112.529 -179.904 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.853 ' HA ' HD22 ' A' ' 261' ' ' LEU . 53.3 Cg_endo -69.71 139.08 39.54 Favored 'Trans proline' 0 C--N 1.342 0.189 0 C-N-CA 122.732 2.288 . . . . 60.01 112.331 -179.922 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.826 HG12 ' HA3' ' A' ' 225' ' ' GLY . 34.5 m -57.08 -174.38 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.185 -0.461 . . . . 63.3 111.166 179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.463 ' CH2' ' HB3' ' A' ' 158' ' ' ASP . 7.5 m0 -51.42 -23.97 4.44 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.212 -0.449 . . . . 75.13 110.861 -179.974 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.754 ' H ' HG23 ' A' ' 108' ' ' VAL . 1.2 mtt-85 70.31 23.04 5.17 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.254 -0.43 . . . . 62.14 110.852 -179.979 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.4 mtmt -123.15 152.86 40.74 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.191 -0.459 . . . . 70.21 110.821 179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 12.4 p80 -97.68 23.84 7.41 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.183 -0.462 . . . . 60.34 110.829 179.892 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.453 ' C ' HD12 ' A' ' 114' ' ' ILE . 1.7 m-85 -122.34 113.39 19.34 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.192 -0.458 . . . . 65.13 110.906 -179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.577 HG22 ' N ' ' A' ' 115' ' ' THR . 5.0 mp -142.96 162.18 17.54 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.184 -0.462 . . . . 64.24 111.141 179.819 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.577 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -159.05 164.06 35.76 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.159 -0.473 . . . . 74.11 111.157 179.967 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.645 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.4 p90 -134.23 145.04 48.79 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.227 -0.442 . . . . 64.21 110.879 -179.842 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.711 ' HD2' HD11 ' A' ' 160' ' ' LEU . 3.4 tmt_? -137.47 106.9 6.11 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.162 -0.472 . . . . 71.25 110.83 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 62.0 mt -70.41 104.93 1.29 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.332 0 CA-C-N 116.209 -0.451 . . . . 71.44 111.16 179.93 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -55.56 -50.84 68.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.246 -0.434 . . . . 63.24 110.825 179.994 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.651 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.0 p-10 -143.08 166.6 24.22 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.193 -0.458 . . . . 63.33 110.87 179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 1.8 m-85 -116.95 148.89 41.01 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.146 -0.479 . . . . 64.43 110.959 -179.919 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.475 HG23 ' HG3' ' A' ' 125' ' ' MET . 3.2 t -93.67 141.58 24.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.595 0.712 . . . . 74.42 111.075 -179.964 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.8 -3.42 11.99 Favored 'Trans proline' 0 C--N 1.341 0.166 0 C-N-CA 122.711 2.274 . . . . 52.42 112.296 179.909 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 3.9 m-20 -80.63 -29.91 36.75 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.224 -0.444 . . . . 75.43 110.93 179.859 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.601 ' HE3' HG22 ' A' ' 130' ' ' VAL . 7.3 mtm -107.97 163.73 12.88 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.186 -0.461 . . . . 73.14 110.848 -179.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.752 ' O ' HG23 ' A' ' 130' ' ' VAL . 2.4 t-20 -94.25 150.3 20.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.209 -0.451 . . . . 75.54 110.866 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.55 -32.93 8.74 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.113 -0.494 . . . . 74.4 110.826 -179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 7.6 pt-20 -82.01 -40.44 22.12 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.164 -0.471 . . . . 60.23 110.91 -179.889 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.0 m-20 -65.95 -29.1 69.44 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.155 -0.475 . . . . 74.13 110.906 179.951 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.752 HG23 ' O ' ' A' ' 126' ' ' ASN . 59.9 t -64.34 -45.62 95.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.208 -0.451 . . . . 75.12 111.169 179.966 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.12 -24.46 35.11 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.177 -0.465 . . . . 74.31 110.866 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -72.3 -46.8 54.11 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.214 -0.448 . . . . 72.14 110.908 -179.83 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.993 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -71.52 -33.95 69.65 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.117 -0.492 . . . . 63.42 111.12 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.604 HD13 HD21 ' A' ' 212' ' ' LEU . 1.4 mp -72.46 -55.11 14.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-N 116.258 -0.428 . . . . 73.32 111.126 179.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.547 ' N ' HG22 ' A' ' 134' ' ' ILE . 5.3 ttm180 -48.58 -45.65 38.19 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.145 -0.479 . . . . 63.21 110.874 179.953 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.646 ' O ' HG23 ' A' ' 140' ' ' VAL . 12.5 mmtt -68.25 -34.72 76.72 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.189 -0.46 . . . . 72.44 110.994 179.993 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.901 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.69 -48.94 79.54 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.092 -0.504 . . . . 41.4 111.116 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.645 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 94.4 m-85 -72.82 -22.28 60.83 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.461 . . . . 62.24 110.921 -179.889 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.535 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.2 OUTLIER -77.35 -5.93 51.43 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.1 -0.5 . . . . 74.31 110.969 -179.983 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.646 HG23 ' O ' ' A' ' 136' ' ' LYS . 98.0 t -97.2 -17.14 6.88 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.203 -0.453 . . . . 71.33 111.101 179.992 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.806 ' NE1' HG12 ' A' ' 217' ' ' VAL . 95.3 m95 -106.05 -35.85 7.13 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.162 -0.472 . . . . 71.22 110.876 179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -71.39 -11.39 60.87 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.196 -0.456 . . . . 62.32 110.822 -179.806 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.618 HD22 ' N ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER -95.81 -17.71 20.96 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.17 -0.468 . . . . 73.33 110.879 -179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.914 HG11 HD12 ' A' ' 250' ' ' LEU . 19.4 m -99.09 1.77 10.52 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.157 -0.474 . . . . 72.14 111.092 179.963 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.53 HG21 HG13 ' A' ' 258' ' ' ILE . 22.9 p -152.11 146.3 18.41 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.544 0.688 . . . . 75.32 111.168 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.78 30.1 0.18 Allowed 'Trans proline' 0 C--O 1.233 0.241 0 C-N-CA 122.759 2.306 . . . . 64.31 112.216 179.971 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.821 HD21 ' CG ' ' A' ' 262' ' ' TYR . 0.1 OUTLIER -90.0 -176.83 5.02 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.322 -0.399 . . . . 74.22 110.894 179.971 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 17.5 mttm -145.49 126.12 14.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.197 -0.456 . . . . 73.42 110.876 179.877 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.468 ' HE1' HD13 ' A' ' 114' ' ' ILE . 4.1 m-30 -115.35 142.42 46.72 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.223 -0.444 . . . . 72.03 110.9 179.951 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 48.5 m -141.05 138.78 33.86 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.136 -0.483 . . . . 73.44 110.815 -179.712 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.488 ' HG3' ' N ' ' A' ' 152' ' ' ILE . 2.9 tptm -88.45 142.9 27.34 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.137 -0.483 . . . . 64.03 110.894 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.555 HD11 ' N ' ' A' ' 157' ' ' ALA . 14.6 pt -150.88 132.27 4.95 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.269 0 CA-C-N 116.21 -0.45 . . . . 52.02 111.138 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.2 m120 -99.17 -9.22 24.03 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.257 -0.429 . . . . 74.41 110.854 -179.975 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.3 t -154.31 61.57 0.69 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.182 -0.463 . . . . 73.02 111.078 179.996 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.492 ' C ' HD12 ' A' ' 152' ' ' ILE . . . -154.66 -156.22 7.62 Favored Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.816 -0.707 . . . . 42.14 112.452 179.968 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.438 ' HB2' ' HE2' ' A' ' 156' ' ' MET . 1.0 OUTLIER -105.02 97.66 7.48 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.708 0.289 . . . . 73.41 110.846 -179.913 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.555 ' N ' HD11 ' A' ' 152' ' ' ILE . . . -107.13 155.35 19.96 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.248 -0.433 . . . . 61.03 111.023 -179.985 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.463 ' HB3' ' CH2' ' A' ' 109' ' ' TRP . 5.8 m-20 -85.34 -53.58 5.13 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.262 -0.427 . . . . 73.05 110.797 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.65 HG12 HG23 ' A' ' 220' ' ' ILE . 2.4 mp -89.43 94.88 5.05 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.378 0 CA-C-N 116.157 -0.474 . . . . 72.44 111.109 -179.931 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.711 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.2 tp -85.79 109.18 18.48 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.199 -0.455 . . . . 72.23 110.888 179.947 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.46 HG13 ' CE1' ' A' ' 197' ' ' PHE . 87.3 t -89.2 124.13 41.79 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.187 -0.46 . . . . 54.32 111.15 179.817 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.651 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.4 p -143.59 105.73 1.02 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.182 -0.463 . . . . 74.43 111.199 179.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 52.2 m-85 -71.8 109.51 5.72 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.195 -0.457 . . . . 74.43 110.911 -179.962 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -130.38 167.27 18.83 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.156 -0.475 . . . . 72.01 111.001 179.961 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.51 137.29 52.21 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.113 -0.494 . . . . 73.32 110.933 -179.957 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.683 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.98 -155.64 0.14 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.773 -0.727 . . . . 75.51 112.454 -179.971 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.8 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -64.5 115.53 5.24 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.755 0.312 . . . . 75.11 111.083 -179.975 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.69 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.25 -22.19 12.46 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.247 -0.433 . . . . 74.43 110.895 179.948 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.24 29.11 0.56 Allowed Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.713 -0.756 . . . . 71.34 112.4 -179.953 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.635 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.94 1.23 15.36 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-O 120.904 0.383 . . . . 54.11 110.864 179.996 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 14.6 m-85 72.8 40.24 0.61 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.187 -0.46 . . . . 74.21 110.78 -179.999 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.69 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.58 -41.17 0.7 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.2 -0.454 . . . . 75.12 110.913 179.914 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.8 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.08 99.71 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.243 -0.435 . . . . 52.34 111.075 179.907 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.683 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -59.88 -169.22 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.206 -0.452 . . . . 63.44 110.911 -179.935 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -132.96 17.13 4.18 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.16 -0.473 . . . . 72.44 110.927 179.872 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.593 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.4 -156.81 8.63 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.797 -0.716 . . . . 61.33 112.496 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.428 ' C ' ' O ' ' A' ' 176' ' ' GLY . 7.6 tttp -34.98 134.8 0.22 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-O 120.815 0.34 . . . . 41.52 110.926 -179.955 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.28 163.11 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.711 -0.757 . . . . 65.25 112.448 179.963 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 84.61 -143.6 20.88 Favored Glycine 0 N--CA 1.452 -0.254 0 C-N-CA 120.766 -0.73 . . . . 74.01 112.571 -179.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -49.66 97.91 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-O 120.915 0.388 . . . . 64.03 111.147 179.964 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 76.2 mt -69.53 -36.96 76.88 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.201 -0.454 . . . . 71.14 111.027 179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.412 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -174.39 162.4 3.55 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.076 -0.511 . . . . 75.53 111.081 179.877 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.53 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.6 p80 -155.27 140.97 18.02 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.256 -0.429 . . . . 70.51 110.823 -179.969 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.75 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -138.85 171.92 13.63 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.246 -0.434 . . . . 73.43 111.172 179.924 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 223' ' ' SER . 17.1 m-85 -100.32 -148.91 0.36 Allowed 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.258 -0.428 . . . . 63.34 110.816 -179.878 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -159.43 -94.76 0.1 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.637 -0.792 . . . . 43.21 112.454 -179.97 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.68 58.69 1.53 Allowed 'Trans proline' 0 C--N 1.341 0.144 0 C-N-CA 122.733 2.289 . . . . 51.34 112.356 -179.99 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.611 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.0 153.44 16.97 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.729 -0.748 . . . . 72.01 112.467 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.597 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.5 150.5 24.53 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.788 0.328 . . . . 51.55 110.927 -179.736 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 59.45 -67.42 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.743 -0.742 . . . . 64.52 112.423 179.973 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.597 ' N ' ' O ' ' A' ' 189' ' ' SER . 26.4 pt -103.66 6.05 10.31 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-O 120.896 0.379 . . . . 45.41 111.202 -179.945 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.611 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -64.25 165.25 31.58 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.656 -0.783 . . . . 73.43 112.446 179.982 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.454 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 46.68 17.05 0.23 Allowed Glycine 0 N--CA 1.451 -0.346 0 C-N-CA 120.704 -0.76 . . . . 61.41 112.541 -179.84 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.41 ' N ' ' O ' ' A' ' 192' ' ' GLY . 0.9 OUTLIER -61.82 108.33 0.99 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.831 0.348 . . . . 70.12 110.83 -179.921 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.75 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -83.76 130.56 34.95 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.121 -0.49 . . . . 62.32 111.182 179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.53 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 11.1 m170 -121.2 128.93 52.93 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.297 -0.411 . . . . 74.51 110.86 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.535 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 50.5 m-85 -113.85 131.03 56.41 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.249 -0.432 . . . . 72.23 110.85 -179.934 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . 0.409 ' HB3' ' HG2' ' A' ' 201' ' ' GLU . 63.4 t0 -65.52 114.46 4.9 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.078 -0.51 . . . . 71.01 110.945 179.902 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -68.06 -33.25 74.2 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.223 -0.444 . . . . 64.33 110.83 -179.843 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.593 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 14.5 m-20 -51.07 -21.6 1.96 Allowed 'General case' 0 C--N 1.328 -0.37 0 CA-C-N 116.155 -0.475 . . . . 65.53 110.823 179.973 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.409 ' HG2' ' HB3' ' A' ' 198' ' ' ASP . 0.6 OUTLIER -86.4 164.99 16.71 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.279 -0.419 . . . . 60.23 110.882 -179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.478 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -97.86 98.95 10.26 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.133 -0.485 . . . . 71.54 110.926 -179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.535 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 52.5 m95 -86.46 123.86 32.15 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.203 -0.453 . . . . 73.42 110.895 -179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 39.9 p -145.57 -177.04 5.36 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.25 -0.432 . . . . 72.25 111.143 -179.978 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -111.34 21.27 16.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 75.32 111.157 -179.927 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -128.4 -177.48 4.18 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.207 -0.451 . . . . 75.35 110.837 179.98 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . 0.415 ' HA ' ' CD2' ' A' ' 242' ' ' TYR . 4.0 t -67.14 -18.81 65.45 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 73.43 110.888 -179.821 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.21 -106.06 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.868 -0.682 . . . . 71.24 112.42 -179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.478 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.76 178.18 0.2 Allowed Glycine 0 N--CA 1.452 -0.25 0 C-N-CA 120.726 -0.75 . . . . 74.32 112.508 -179.921 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 99.1 m -66.94 98.09 0.53 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.79 0.329 . . . . 65.25 111.187 -179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 1.6 t-20 -42.15 116.57 0.84 Allowed 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.171 -0.468 . . . . 63.22 110.953 179.968 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.993 HD23 ' HB3' ' A' ' 133' ' ' ALA . 8.1 tp -63.49 -38.74 92.31 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.131 -0.486 . . . . 74.13 110.941 179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.734 ' N ' ' HB1' ' A' ' 133' ' ' ALA . 2.9 t80 -51.69 -63.45 1.13 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.155 -0.475 . . . . 73.53 110.903 179.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.559 HD21 ' CG2' ' A' ' 243' ' ' VAL . 7.7 mp -56.34 -54.43 45.55 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.168 -0.469 . . . . 65.33 110.941 -179.983 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.474 ' O ' ' HB2' ' A' ' 219' ' ' ALA . 3.2 m -56.02 -31.0 62.71 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 53.13 111.107 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.406 ' HB3' ' HB2' ' A' ' 137' ' ' ALA . . . -70.55 -47.42 60.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.208 -0.451 . . . . 75.44 111.093 179.879 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.901 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -54.56 -58.87 2.86 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.24 -0.436 . . . . 71.31 111.082 179.991 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.743 ' HB2' HG13 ' A' ' 235' ' ' VAL . 2.2 t-80 -62.37 -29.94 70.83 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.144 -0.48 . . . . 73.3 110.888 179.961 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.474 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.51 -45.52 92.61 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.2 -0.455 . . . . 74.43 111.129 179.933 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.65 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -69.28 -34.94 65.3 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.257 -0.428 . . . . 75.01 111.079 179.997 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.93 -44.84 41.14 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.81 -0.71 . . . . 61.23 112.487 179.943 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.478 ' O ' ' O ' ' A' ' 185' ' ' PHE . 45.8 m-70 -67.32 -40.67 85.99 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.744 0.307 . . . . 75.23 110.806 -179.99 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.644 ' OG ' HG23 ' A' ' 159' ' ' ILE . 2.9 m -62.59 -27.33 69.12 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.242 -0.436 . . . . 64.13 110.853 -179.731 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . . . . . . . . . 62.4 mt -74.57 -28.45 60.94 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.14 -0.482 . . . . 75.1 110.907 179.974 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.826 ' HA3' HG12 ' A' ' 108' ' ' VAL . . . 121.11 15.17 4.78 Favored Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.75 -0.738 . . . . 63.31 112.455 179.91 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.677 HD21 ' HA ' ' A' ' 258' ' ' ILE . 11.6 mt -83.01 156.03 23.63 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.811 0.338 . . . . 75.31 110.887 -179.919 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.439 ' O ' ' HE2' ' A' ' 236' ' ' MET . . . -102.5 -133.29 7.98 Favored Glycine 0 N--CA 1.452 -0.274 0 C-N-CA 120.694 -0.765 . . . . 55.04 112.52 179.803 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.451 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 1.6 m170 -125.7 142.95 51.25 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.844 0.354 . . . . 61.3 110.882 -179.936 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 38.1 m -104.19 166.06 10.65 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.219 -0.446 . . . . 52.41 110.91 -179.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 42.8 m -108.51 1.87 21.82 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.137 -0.483 . . . . 75.52 110.908 -179.831 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.615 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -66.31 140.38 96.74 Favored Pre-proline 0 C--N 1.328 -0.329 0 CA-C-O 121.592 0.711 . . . . 75.24 110.824 179.976 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.7 -3.35 11.79 Favored 'Trans proline' 0 C--N 1.341 0.177 0 C-N-CA 122.758 2.305 . . . . 64.14 112.35 -179.969 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -144.45 24.89 1.55 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.119 -0.491 . . . . 75.35 110.882 -179.995 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.615 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -88.85 140.39 29.49 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.266 -0.425 . . . . 71.53 111.141 179.798 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.743 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.8 t -63.43 -38.06 81.2 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.214 -0.448 . . . . 62.43 111.183 179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.458 ' HE3' ' HA ' ' A' ' 236' ' ' MET . 32.1 mmm -66.05 -14.06 61.05 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.16 -0.473 . . . . 74.41 110.873 179.909 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.606 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.5 t80 -57.91 143.62 76.84 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.635 0.731 . . . . 74.31 110.866 -179.891 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.606 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.4 Cg_endo -69.77 -1.62 8.8 Favored 'Trans proline' 0 C--O 1.232 0.223 0 C-N-CA 122.674 2.249 . . . . 75.42 112.34 -179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.401 ' HG1' ' HD2' ' A' ' 237' ' ' PHE . 6.6 m -100.41 139.66 35.76 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 75.52 111.073 -179.882 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 61.6 t80 -118.75 128.66 54.7 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.208 -0.451 . . . . 73.35 110.876 -179.918 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.22 126.27 12.86 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.043 -0.526 . . . . 71.42 110.803 179.914 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.55 ' O ' HG13 ' A' ' 243' ' ' VAL . 35.9 t80 -57.18 147.39 25.15 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.147 -0.479 . . . . 75.13 110.897 179.987 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.559 ' CG2' HD21 ' A' ' 214' ' ' LEU . 0.6 OUTLIER -160.07 132.93 1.15 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.07 -0.514 . . . . 64.44 111.091 179.915 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 13.2 t0 -46.77 133.59 10.57 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 61.12 110.854 179.947 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.424 HD12 ' CE2' ' A' ' 213' ' ' PHE . 5.9 tt -53.32 -34.35 22.38 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.176 -0.466 . . . . 75.44 111.181 179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.701 HD22 HG23 ' A' ' 247' ' ' THR . 0.5 OUTLIER -72.15 -17.05 61.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.169 -0.469 . . . . 72.51 110.867 179.928 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.701 HG23 HD22 ' A' ' 246' ' ' ASN . 24.6 p -107.61 -21.91 12.71 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.168 -0.469 . . . . 73.45 111.182 -179.97 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 8.7 t80 -72.36 137.82 46.85 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.168 -0.469 . . . . 73.25 110.829 -179.959 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 13.3 ptm180 -174.48 136.8 0.47 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.147 -0.479 . . . . 72.12 110.882 179.987 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.914 HD12 HG11 ' A' ' 144' ' ' VAL . 29.2 mt -49.78 129.33 19.76 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.185 -0.461 . . . . 65.11 110.921 -179.932 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 32.5 t -71.3 171.0 11.92 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 63.43 110.849 -179.887 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -56.16 -37.11 69.1 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.125 -0.489 . . . . 71.44 111.186 179.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.6 t0 -65.3 -47.49 76.41 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.193 -0.458 . . . . 75.14 110.856 179.936 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.6 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 4.8 m-20 -61.99 -52.04 65.6 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.194 -0.457 . . . . 74.24 110.825 179.954 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 30.0 mt -61.36 -35.47 66.57 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.218 -0.447 . . . . 71.53 111.107 -179.917 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 22.2 mmt180 -69.68 -39.42 77.0 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.129 -0.487 . . . . 73.55 110.892 179.949 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.48 -50.1 7.6 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.791 -0.719 . . . . 43.32 112.459 -179.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.677 ' HA ' HD21 ' A' ' 226' ' ' LEU . 7.0 tp -52.07 -35.25 18.57 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.703 0.287 . . . . 62.21 111.115 -179.976 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.415 ' O ' ' N ' ' A' ' 263' ' ' GLY . 72.1 mt-30 -87.32 -16.68 34.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.221 -0.445 . . . . 74.23 110.897 179.942 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.9 t -70.85 -14.54 62.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.258 -0.428 . . . . 72.21 110.896 -179.838 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.853 HD22 ' HA ' ' A' ' 107' ' ' PRO . 5.3 mt -121.95 -18.92 6.85 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.122 -0.49 . . . . 71.44 110.868 -179.994 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.821 ' CG ' HD21 ' A' ' 147' ' ' LEU . 33.6 m-85 -113.12 -34.37 5.72 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.248 -0.433 . . . . 74.3 110.951 179.949 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.415 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.335 0 CA-C-O 119.097 -0.835 . . . . 44.24 112.545 179.946 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 004 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 21.7 m-85 . . . . . 0 N--CA 1.457 -0.092 0 CA-C-O 120.837 0.351 . . . . 53.1 110.907 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.5 mtm180 55.46 51.88 12.14 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.154 -0.475 . . . . 73.2 110.86 -179.888 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.478 ' HB2' HD11 ' A' ' 261' ' ' LEU . 0.0 OUTLIER 176.84 146.3 0.1 Allowed 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.203 -0.453 . . . . 70.11 110.906 -179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.487 ' HG3' ' HD2' ' A' ' 104' ' ' PRO . 0.0 OUTLIER -50.82 146.44 10.07 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.565 0.698 . . . . 64.42 110.917 -179.974 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.487 ' HD2' ' HG3' ' A' ' 103' ' ' MET . 54.0 Cg_endo -69.78 79.43 0.95 Allowed 'Trans proline' 0 C--O 1.23 0.122 0 C-N-CA 122.685 2.257 . . . . 73.15 112.371 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 144.79 -119.11 1.2 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.761 -0.733 . . . . 54.32 112.512 -179.977 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.527 ' N ' ' CD ' ' A' ' 107' ' ' PRO . . . -159.0 47.83 0.42 Allowed Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.684 -0.77 . . . . 63.31 112.431 -179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.527 ' CD ' ' N ' ' A' ' 106' ' ' GLY . 54.1 Cg_endo -69.72 -30.19 22.85 Favored 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.766 2.311 . . . . 72.44 112.3 -179.927 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.878 HG11 HD13 ' A' ' 261' ' ' LEU . 21.0 m -44.4 138.94 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.225 -0.443 . . . . 75.52 111.185 179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.449 ' CZ3' HD23 ' A' ' 224' ' ' LEU . 3.0 m0 -64.11 -26.97 68.78 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.205 -0.452 . . . . 70.22 110.859 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.701 ' HG3' HG23 ' A' ' 108' ' ' VAL . 47.7 mtp180 61.83 33.65 17.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.301 -0.408 . . . . 71.12 110.882 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.441 ' HG2' ' HB3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -122.76 158.29 30.49 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.196 -0.456 . . . . 73.53 110.983 179.978 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 9.1 p80 -101.69 31.36 3.85 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.259 -0.428 . . . . 74.12 110.868 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.2 m-85 -134.2 106.71 7.29 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.246 -0.434 . . . . 73.25 110.939 -179.879 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.585 HG22 ' N ' ' A' ' 115' ' ' THR . 4.7 mp -138.13 162.71 30.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.147 -0.478 . . . . 62.54 111.179 179.856 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.59 ' O ' HD12 ' A' ' 159' ' ' ILE . 0.5 OUTLIER -158.65 163.8 36.56 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.233 -0.44 . . . . 64.44 111.113 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.598 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.0 p90 -132.73 149.02 52.33 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.177 -0.465 . . . . 74.43 110.928 -179.971 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.458 ' HD2' HD11 ' A' ' 160' ' ' LEU . 4.2 tmt_? -143.93 112.4 6.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.083 -0.508 . . . . 70.34 110.862 179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.0 mt -72.79 106.64 2.99 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.174 -0.466 . . . . 65.55 111.151 179.946 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -60.17 -46.38 89.91 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.183 -0.462 . . . . 75.13 110.949 179.916 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.738 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.0 p-10 -146.46 166.08 27.48 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.15 -0.477 . . . . 71.32 110.892 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.708 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.1 m-85 -117.47 139.33 51.05 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.144 -0.48 . . . . 73.15 110.87 -179.869 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.49 HG22 ' HB2' ' A' ' 124' ' ' ASP . 1.0 OUTLIER -91.22 139.31 25.52 Favored Pre-proline 0 C--N 1.329 -0.301 0 CA-C-O 121.549 0.69 . . . . 71.05 111.183 179.945 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.404 ' HD2' HG23 ' A' ' 122' ' ' THR . 54.2 Cg_endo -69.75 42.16 0.34 Allowed 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.742 2.295 . . . . 51.3 112.353 179.932 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.49 ' HB2' HG22 ' A' ' 122' ' ' THR . 2.3 m-20 -126.85 -25.61 3.32 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.184 -0.462 . . . . 53.23 110.764 179.944 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.491 ' CE ' HG22 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -110.69 165.22 12.0 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.328 -0.396 . . . . 61.35 110.861 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 8.2 m120 -94.45 142.2 27.7 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.159 -0.473 . . . . 72.43 110.882 179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 27.9 ptt180 -44.22 -36.38 2.67 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.14 -0.482 . . . . 73.1 110.892 -179.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 40.2 mt-10 -83.85 -39.18 20.24 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.11 -0.495 . . . . 61.12 110.91 -179.96 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 58.4 m-20 -63.52 -33.25 75.18 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.112 -0.495 . . . . 30.01 110.888 179.932 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.708 HG11 ' CE2' ' A' ' 121' ' ' TYR . 73.8 t -63.38 -46.58 95.04 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.214 -0.448 . . . . 70.11 111.16 -179.991 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.464 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 0.3 OUTLIER -78.71 -23.62 45.44 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.198 -0.455 . . . . 63.01 110.814 179.981 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.2 t80 -75.53 -49.42 18.73 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.171 -0.468 . . . . 75.23 110.909 -179.811 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.71 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -68.57 -30.48 69.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.097 -0.502 . . . . 61.04 111.124 179.888 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.2 mp -74.15 -54.65 14.37 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.243 -0.435 . . . . 71.53 111.175 179.93 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.526 ' N ' HG22 ' A' ' 134' ' ' ILE . 3.3 ptm180 -49.08 -37.39 21.17 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.264 -0.425 . . . . 73.14 110.93 179.875 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.63 ' O ' HG23 ' A' ' 140' ' ' VAL . 7.2 mmpt? -75.48 -36.02 60.71 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.095 -0.502 . . . . 73.51 110.942 179.998 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.686 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -59.87 -49.53 77.35 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 74.43 111.091 179.814 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.626 ' HE2' HD13 ' A' ' 159' ' ' ILE . 92.1 m-85 -70.71 -22.7 62.41 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.288 -0.415 . . . . 74.32 110.935 -179.952 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.565 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.9 tt0 -77.4 -7.09 55.57 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.069 -0.514 . . . . 65.11 110.867 -179.941 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.63 HG23 ' O ' ' A' ' 136' ' ' LYS . 89.6 t -95.75 -17.28 7.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.236 -0.438 . . . . 43.45 111.138 179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.85 ' NE1' HG12 ' A' ' 217' ' ' VAL . 95.9 m95 -106.11 -36.12 7.02 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.214 -0.448 . . . . 73.21 110.958 179.924 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -70.42 -11.37 60.87 Favored 'General case' 0 C--N 1.33 -0.283 0 CA-C-N 116.258 -0.428 . . . . 64.32 110.867 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.617 HD22 ' N ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER -95.3 -17.68 21.45 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.139 -0.482 . . . . 72.2 110.906 -179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.816 HG11 HD12 ' A' ' 250' ' ' LEU . 18.2 m -99.38 1.77 10.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.207 -0.451 . . . . 72.23 111.112 179.922 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.653 HG21 HG13 ' A' ' 258' ' ' ILE . 22.8 p -152.48 146.56 18.42 Favored Pre-proline 0 C--N 1.329 -0.29 0 CA-C-O 121.576 0.703 . . . . 61.02 111.103 -179.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.75 29.72 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.178 0 C-N-CA 122.788 2.325 . . . . 64.14 112.297 179.974 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.728 HD21 ' CG ' ' A' ' 262' ' ' TYR . 0.7 OUTLIER -91.15 179.22 5.78 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.196 -0.456 . . . . 65.11 110.924 179.968 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 15.3 mttt -141.53 126.17 17.91 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.183 -0.462 . . . . 74.43 110.894 179.832 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.575 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.7 m-30 -115.41 143.72 44.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.208 -0.451 . . . . 52.51 110.911 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 5.9 t -140.23 151.78 45.44 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.177 -0.465 . . . . 71.12 110.833 -179.749 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.438 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 10.2 tttp -101.59 145.21 29.35 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.091 -0.504 . . . . 74.32 110.804 179.981 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.583 HD12 ' CA ' ' A' ' 155' ' ' GLY . 21.6 pt -151.74 143.54 16.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.164 -0.471 . . . . 61.52 111.038 179.892 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -105.26 -11.44 16.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.169 -0.469 . . . . 73.22 110.831 179.954 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.1 t -157.73 62.96 0.47 Allowed 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.152 -0.476 . . . . 72.25 111.068 -179.854 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.583 ' CA ' HD12 ' A' ' 152' ' ' ILE . . . -149.8 -155.08 6.64 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.749 -0.738 . . . . 41.01 112.528 179.885 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 36.3 mmt -106.94 91.7 3.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.773 0.321 . . . . 75.42 110.836 -179.981 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.518 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -103.15 156.31 17.79 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.265 -0.425 . . . . 70.14 111.109 179.87 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -85.82 -52.31 5.84 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.206 -0.452 . . . . 75.31 110.811 -179.966 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.783 HG12 HG23 ' A' ' 220' ' ' ILE . 1.9 mp -89.7 94.9 5.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.218 -0.446 . . . . 63.41 111.1 -179.934 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.458 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.4 tp -87.17 109.28 19.35 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.189 -0.459 . . . . 75.24 110.849 179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.406 HG13 ' CE1' ' A' ' 197' ' ' PHE . 83.9 t -87.33 120.48 36.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 63.33 111.157 179.82 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.738 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.2 p -139.52 106.51 2.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.153 -0.476 . . . . 73.43 111.168 179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.42 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 41.6 m-85 -74.1 112.32 10.13 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.157 -0.474 . . . . 73.41 110.952 179.973 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.79 168.4 17.87 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-N 116.151 -0.477 . . . . 72.11 111.084 179.989 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.427 ' CG ' ' HB3' ' A' ' 199' ' ' GLU . 37.8 mtp180 -113.07 137.6 51.18 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.179 -0.464 . . . . 73.24 110.843 -179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.663 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 41.18 -151.99 0.13 Allowed Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.841 -0.695 . . . . 74.21 112.486 -179.974 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.804 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -66.41 117.3 8.45 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-O 120.875 0.369 . . . . 64.11 111.061 -179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.711 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -109.27 -20.22 13.03 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.226 -0.443 . . . . 73.23 110.9 179.952 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 129.85 30.03 0.66 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.771 -0.728 . . . . 74.43 112.478 -179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.635 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.72 0.21 14.47 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.787 0.327 . . . . 71.23 110.826 179.988 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.2 m-85 74.25 38.73 0.52 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.248 -0.433 . . . . 71.33 110.872 -179.983 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.711 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.3 -41.2 0.81 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 54.35 110.806 -179.915 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.804 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.36 99.42 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.16 -0.473 . . . . 65.33 111.074 179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.663 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.7 m-85 -60.23 -168.95 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.25 -0.432 . . . . 53.02 110.8 -179.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.89 19.6 3.26 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.093 -0.503 . . . . 64.13 110.898 -179.953 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.574 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 53.25 -157.8 4.59 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.773 -0.727 . . . . 32.21 112.461 -179.942 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.2 OUTLIER -33.82 134.27 0.17 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.829 0.347 . . . . 73.13 110.926 -179.979 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.32 165.66 0.15 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.677 -0.773 . . . . 44.02 112.508 179.933 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.3 -144.06 23.26 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.714 -0.755 . . . . 42.43 112.537 -179.924 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -49.44 97.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.865 0.364 . . . . 60.44 111.177 179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 96.0 mt -66.79 -41.28 87.89 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.097 -0.501 . . . . 73.4 110.938 179.949 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.42 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -170.96 169.16 6.79 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.19 -0.459 . . . . 74.41 111.123 179.786 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.476 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.2 p80 -163.75 143.48 8.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.254 -0.43 . . . . 74.15 110.824 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.745 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -138.09 173.23 11.84 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.242 -0.435 . . . . 73.13 111.069 179.938 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.522 ' O ' ' HA ' ' A' ' 223' ' ' SER . 54.0 m-85 -98.82 -140.88 0.32 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.226 -0.443 . . . . 62.41 110.831 -179.908 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -171.56 -87.57 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.748 -0.739 . . . . 71.11 112.493 -179.984 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.67 54.21 1.12 Allowed 'Trans proline' 0 C--N 1.341 0.157 0 C-N-CA 122.648 2.232 . . . . 65.3 112.357 -179.969 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.579 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.16 149.56 16.83 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.713 -0.756 . . . . 33.41 112.452 -179.982 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.64 145.72 29.93 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.988 0.423 . . . . 74.05 110.804 -179.766 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.64 -63.7 0.03 OUTLIER Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.799 -0.715 . . . . 53.11 112.479 179.962 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.524 ' N ' ' O ' ' A' ' 189' ' ' SER . 5.5 tp -105.29 6.54 10.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-O 120.906 0.384 . . . . 73.3 111.14 -179.993 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.579 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -67.82 169.78 37.7 Favored Glycine 0 N--CA 1.452 -0.255 0 C-N-CA 120.803 -0.713 . . . . 61.3 112.442 179.901 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.408 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 45.32 18.9 0.2 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.733 -0.746 . . . . 51.32 112.561 -179.886 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.419 ' N ' ' O ' ' A' ' 192' ' ' GLY . 0.9 OUTLIER -63.15 103.41 0.47 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.772 0.32 . . . . 50.32 110.913 -179.98 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.745 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -77.76 131.15 37.51 Favored 'General case' 0 C--N 1.327 -0.384 0 CA-C-N 116.223 -0.444 . . . . 63.31 111.067 -179.976 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.476 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.7 m170 -121.37 130.23 53.5 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.209 -0.45 . . . . 73.3 110.856 -179.948 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.483 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 41.8 m-85 -115.13 134.22 55.35 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.213 -0.449 . . . . 63.51 110.88 -179.917 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.5 t0 -67.52 104.69 1.63 Allowed 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.146 -0.479 . . . . 55.33 110.886 -179.991 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.427 ' HB3' ' CG ' ' A' ' 165' ' ' ARG . 4.2 tm-20 -57.24 -36.7 71.25 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.198 -0.455 . . . . 72.21 110.875 -179.898 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.574 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 14.3 m-20 -50.41 -22.18 1.76 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.152 -0.476 . . . . 73.31 110.839 -179.988 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -82.12 164.21 21.48 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.267 -0.424 . . . . 74.15 110.816 -179.842 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.544 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -100.73 91.77 4.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 75.34 110.892 -179.907 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.549 ' CZ3' HG21 ' A' ' 215' ' ' THR . 33.1 m95 -82.64 123.54 29.35 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.155 -0.475 . . . . 73.55 110.887 -179.975 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.7 p -140.3 -172.4 3.42 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.177 -0.465 . . . . 63.4 111.164 -179.999 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -114.6 17.34 17.3 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.217 -0.447 . . . . 71.5 111.098 -179.957 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.26 -176.59 3.85 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.202 -0.454 . . . . 74.51 110.782 179.97 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.2 p -66.06 -18.54 65.41 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.141 -0.481 . . . . 72.43 110.951 -179.826 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.91 -108.85 0.01 OUTLIER Glycine 0 N--CA 1.449 -0.47 0 C-N-CA 120.799 -0.715 . . . . 44.15 112.496 179.968 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.38 178.26 0.15 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.76 -0.733 . . . . 63.45 112.495 -179.936 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 90.0 m -66.52 97.69 0.45 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.83 0.347 . . . . 72.11 111.185 -179.843 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.3 t-20 -41.65 116.83 0.83 Allowed 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.22 -0.446 . . . . 70.04 110.908 179.965 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.449 HD23 ' HA ' ' A' ' 130' ' ' VAL . 17.4 tp -63.88 -36.01 82.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.171 -0.468 . . . . 62.11 110.894 179.962 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.71 ' CA ' ' HB1' ' A' ' 133' ' ' ALA . 2.4 t80 -53.68 -64.27 0.88 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.188 -0.46 . . . . 71.15 110.855 179.986 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.549 HD11 ' H ' ' A' ' 243' ' ' VAL . 19.3 mt -54.81 -54.32 43.7 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.165 -0.471 . . . . 52.42 110.913 179.99 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.549 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.5 m -54.53 -34.64 62.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.201 -0.454 . . . . 72.11 111.212 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.409 ' HB3' ' HB2' ' A' ' 137' ' ' ALA . . . -65.77 -48.98 70.0 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.146 -0.479 . . . . 71.3 111.159 179.771 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.85 HG12 ' NE1' ' A' ' 141' ' ' TRP . 0.8 OUTLIER -52.5 -58.89 1.95 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.185 -0.461 . . . . 53.51 111.127 179.963 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.736 ' HB2' HG13 ' A' ' 235' ' ' VAL . 3.4 t-80 -63.29 -29.38 70.71 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.169 -0.469 . . . . 70.31 110.932 179.88 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.41 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -63.84 -44.5 92.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.184 -0.462 . . . . 71.43 111.111 179.963 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.783 HG23 HG12 ' A' ' 159' ' ' ILE . 2.4 mt -71.03 -34.23 54.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.233 -0.439 . . . . 64.45 111.108 -179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.423 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -52.63 -44.81 60.16 Favored Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.76 -0.734 . . . . 71.5 112.392 179.995 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.508 ' O ' ' O ' ' A' ' 185' ' ' PHE . 3.4 m-70 -69.46 -40.85 76.88 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.804 0.335 . . . . 74.24 110.913 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.522 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 43.9 p -64.38 -20.55 66.2 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.151 -0.477 . . . . 64.23 110.842 -179.859 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.449 HD23 ' CZ3' ' A' ' 109' ' ' TRP . 61.3 mt -81.74 -26.03 34.89 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.157 -0.474 . . . . 62.14 110.886 -179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 121.97 10.49 6.27 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.784 -0.722 . . . . 64.43 112.454 179.893 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.89 HD21 ' HA ' ' A' ' 258' ' ' ILE . 46.0 mt -79.77 149.41 31.11 Favored 'General case' 0 C--N 1.327 -0.411 0 CA-C-O 120.865 0.364 . . . . 75.33 110.935 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.449 ' H ' ' HA ' ' A' ' 102' ' ' GLU . . . -95.35 -141.35 11.68 Favored Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.737 -0.745 . . . . 62.43 112.558 179.877 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.423 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 0.2 OUTLIER -119.08 142.6 47.73 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.801 0.334 . . . . 74.54 110.86 179.997 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 49.3 m -103.5 163.65 12.15 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.224 -0.444 . . . . 74.43 110.913 -179.85 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 3.4 t -108.51 0.74 21.08 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.123 -0.489 . . . . 65.31 110.891 -179.788 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.61 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -65.14 141.57 98.32 Favored Pre-proline 0 C--N 1.329 -0.284 0 CA-C-O 121.601 0.715 . . . . 71.24 110.883 179.966 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.84 -3.84 12.88 Favored 'Trans proline' 0 C--N 1.341 0.155 0 C-N-CA 122.695 2.263 . . . . 41.43 112.352 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 5.0 ptmt -144.27 25.63 1.53 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.209 -0.451 . . . . 63.44 110.806 179.943 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.61 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -89.28 139.21 30.73 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.291 -0.413 . . . . 71.21 111.025 179.84 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.736 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.7 t -62.42 -37.92 79.97 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 74.34 111.126 179.92 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.423 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 37.1 mmm -65.79 -14.41 61.32 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.145 -0.48 . . . . 65.14 110.899 179.89 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.617 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.4 t80 -58.69 143.93 81.19 Favored Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.61 0.719 . . . . 71.55 110.91 -179.989 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.617 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.1 Cg_endo -69.71 -0.99 7.67 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.689 2.259 . . . . 64.03 112.405 179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.411 ' HG1' ' HD2' ' A' ' 237' ' ' PHE . 17.0 m -98.52 139.65 33.94 Favored 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.127 -0.488 . . . . 65.44 111.249 179.95 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 53.1 t80 -122.1 133.34 54.77 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.187 -0.46 . . . . 71.41 110.96 -179.913 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 8.5 tptm -151.87 134.43 15.41 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.168 -0.469 . . . . 62.22 110.927 179.871 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.542 ' O ' HG13 ' A' ' 243' ' ' VAL . 83.2 t80 -59.62 144.8 46.73 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.209 -0.45 . . . . 74.34 110.947 -179.958 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.549 ' H ' HD11 ' A' ' 214' ' ' LEU . 0.4 OUTLIER -160.33 131.66 0.94 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.086 -0.506 . . . . 54.31 111.114 179.956 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 48.9 t0 -53.95 134.8 43.22 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.204 -0.453 . . . . 50.13 110.912 179.928 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.458 HD12 ' CE2' ' A' ' 213' ' ' PHE . 7.2 tt -54.2 -29.74 19.67 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.175 -0.466 . . . . 62.0 111.104 -179.978 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.456 ' ND2' HG23 ' A' ' 247' ' ' THR . 0.2 OUTLIER -70.96 -19.47 62.55 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.213 -0.449 . . . . 74.34 110.933 179.921 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.456 HG23 ' ND2' ' A' ' 246' ' ' ASN . 11.9 p -111.21 -20.28 12.38 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.109 -0.496 . . . . 75.34 111.145 -179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.425 ' CD2' HD22 ' A' ' 214' ' ' LEU . 10.2 t80 -74.44 133.91 42.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 74.41 110.88 179.996 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -170.1 136.13 1.42 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.097 -0.501 . . . . 73.31 110.931 -179.818 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.816 HD12 HG11 ' A' ' 144' ' ' VAL . 36.5 mt -48.65 127.38 13.46 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.235 -0.439 . . . . 65.41 110.927 179.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 4.6 p -69.77 164.6 23.22 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.232 -0.44 . . . . 74.13 110.866 -179.971 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.14 -34.77 32.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.067 -0.515 . . . . 74.25 111.093 179.937 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -67.52 -48.02 68.25 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.289 -0.414 . . . . 73.04 110.864 179.931 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.496 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 8.9 m-20 -61.27 -50.87 71.28 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.444 . . . . 73.32 110.878 179.98 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 31.5 mt -61.83 -35.1 65.86 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 74.43 111.155 179.973 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 1.7 tpt180 -69.5 -39.23 77.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.201 -0.454 . . . . 63.15 110.908 179.978 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.32 -50.27 8.51 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.737 -0.744 . . . . 71.01 112.536 -179.993 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.89 ' HA ' HD21 ' A' ' 226' ' ' LEU . 5.6 tp -52.56 -35.29 20.45 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.285 0 CA-C-O 120.812 0.339 . . . . 74.35 111.091 -179.923 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.407 ' O ' ' N ' ' A' ' 263' ' ' GLY . 74.7 mt-30 -86.77 -16.45 36.29 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.158 -0.474 . . . . 74.41 110.882 179.926 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.0 t -70.31 -13.77 62.3 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.252 -0.431 . . . . 65.01 110.845 -179.847 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.878 HD13 HG11 ' A' ' 108' ' ' VAL . 3.1 mt -123.59 -18.06 6.25 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.186 -0.461 . . . . 73.14 110.961 -179.968 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.728 ' CG ' HD21 ' A' ' 147' ' ' LEU . 37.3 m-85 -115.31 -33.56 5.27 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.138 -0.483 . . . . 74.53 110.861 -179.959 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.407 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.453 -0.227 0 CA-C-O 119.13 -0.817 . . . . 71.23 112.419 -179.975 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.403 ' HA ' ' HA ' ' A' ' 229' ' ' SER . 18.1 p90 . . . . . 0 C--O 1.231 0.109 0 CA-C-O 120.914 0.388 . . . . 74.24 110.952 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 3.1 mtp180 176.72 -175.59 0.12 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 54.33 110.879 -179.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.786 ' CB ' HD11 ' A' ' 261' ' ' LEU . 0.4 OUTLIER -39.79 148.69 0.07 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.196 -0.456 . . . . 74.43 110.883 -179.948 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.431 ' HG3' ' HA2' ' A' ' 227' ' ' GLY . 0.0 OUTLIER -50.82 161.17 0.7 Allowed Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.536 0.684 . . . . 70.51 110.884 179.946 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.71 -7.1 20.18 Favored 'Trans proline' 0 C--N 1.341 0.149 0 C-N-CA 122.701 2.267 . . . . 73.22 112.359 179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -160.33 45.35 0.42 Allowed Glycine 0 N--CA 1.45 -0.385 0 C-N-CA 120.734 -0.746 . . . . 61.52 112.51 -179.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -108.74 87.32 0.48 Allowed Glycine 0 N--CA 1.452 -0.279 0 C-N-CA 120.753 -0.736 . . . . 55.44 112.501 -179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.75 84.48 0.65 Allowed 'Trans proline' 0 C--N 1.342 0.218 0 C-N-CA 122.664 2.242 . . . . 74.15 112.326 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.719 HG23 ' O ' ' A' ' 224' ' ' LEU . 9.1 p -46.77 160.61 0.07 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.147 -0.479 . . . . 54.44 111.174 179.832 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.432 ' N ' HG22 ' A' ' 108' ' ' VAL . 4.1 m0 -68.02 -22.33 64.98 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.172 -0.467 . . . . 75.1 110.908 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 24.7 mtp180 66.03 27.78 10.57 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.301 -0.409 . . . . 51.42 110.925 -179.899 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.64 149.29 44.21 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.149 -0.478 . . . . 74.43 110.923 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.567 ' HA ' HD22 ' A' ' 147' ' ' LEU . 12.2 p80 -96.91 19.35 12.83 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.317 -0.401 . . . . 61.44 110.892 179.837 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.4 m-85 -121.62 101.18 7.44 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.191 -0.458 . . . . 65.32 110.87 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.579 HG22 ' N ' ' A' ' 115' ' ' THR . 5.1 mp -126.77 162.25 31.68 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.133 -0.485 . . . . 53.24 111.156 179.869 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.579 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -155.9 166.91 32.07 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.204 -0.453 . . . . 61.54 111.188 179.903 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.634 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.5 p90 -137.16 146.27 44.76 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.257 -0.429 . . . . 72.2 110.909 -179.912 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.547 ' NE ' HD11 ' A' ' 160' ' ' LEU . 3.7 tmm_? -139.2 112.46 8.14 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 55.1 110.945 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 58.1 mt -74.08 105.7 3.47 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.392 0 CA-C-N 116.202 -0.454 . . . . 74.45 111.108 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 22.3 t-20 -57.75 -47.57 82.1 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.15 -0.477 . . . . 72.01 110.919 179.926 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.758 ' OD1' HG23 ' A' ' 162' ' ' VAL . 1.4 p-10 -144.82 163.81 32.96 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.116 -0.493 . . . . 74.15 110.914 179.953 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.66 ' CE2' HG11 ' A' ' 130' ' ' VAL . 4.4 m-85 -116.01 139.63 50.08 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.169 -0.469 . . . . 55.34 110.902 -179.887 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.732 HG22 ' CE ' ' A' ' 125' ' ' MET . 2.5 t -89.95 142.62 29.04 Favored Pre-proline 0 C--N 1.33 -0.266 0 CA-C-O 121.608 0.718 . . . . 72.33 111.138 -179.976 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -3.99 13.16 Favored 'Trans proline' 0 C--N 1.342 0.206 0 C-N-CA 122.638 2.225 . . . . 52.04 112.344 179.976 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.422 ' H ' HG23 ' A' ' 122' ' ' THR . 21.8 m-20 -79.28 -23.28 43.71 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.243 -0.435 . . . . 75.33 110.901 179.881 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.732 ' CE ' HG22 ' A' ' 122' ' ' THR . 12.9 mtm -115.99 166.15 12.31 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.129 -0.487 . . . . 63.04 110.878 179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.1 m120 -97.23 145.03 26.46 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.145 -0.48 . . . . 74.04 110.836 -179.871 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 11.2 ptm180 -45.58 -35.39 3.96 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.235 -0.439 . . . . 65.44 110.864 -179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 14.3 mt-10 -82.47 -38.84 23.34 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 43.14 110.891 -179.914 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 52.9 m-20 -65.31 -29.44 70.19 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.129 -0.487 . . . . 61.21 110.903 179.961 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.66 HG11 ' CE2' ' A' ' 121' ' ' TYR . 65.4 t -66.04 -45.34 90.93 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.163 -0.471 . . . . 73.34 111.153 179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -79.69 -23.29 42.53 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.18 -0.464 . . . . 73.21 110.842 179.961 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -74.55 -46.81 36.55 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.218 -0.447 . . . . 73.42 110.958 -179.857 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.737 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -72.34 -31.12 65.36 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.099 -0.501 . . . . 70.24 111.118 179.868 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.541 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -72.71 -54.97 14.47 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.275 0 CA-C-N 116.155 -0.475 . . . . 72.21 111.172 179.951 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.541 ' N ' HG22 ' A' ' 134' ' ' ILE . 5.3 ttt180 -48.66 -43.2 36.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.166 -0.47 . . . . 41.42 110.868 179.979 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.657 ' O ' HG23 ' A' ' 140' ' ' VAL . 6.9 mmpt? -70.64 -34.57 72.21 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.181 -0.463 . . . . 74.35 110.991 179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.943 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.41 -49.24 78.35 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.219 -0.446 . . . . 65.44 111.103 179.8 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.634 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.9 m-85 -72.29 -22.82 61.15 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.204 -0.453 . . . . 74.45 110.884 -179.972 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.496 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.8 tt0 -76.87 -5.57 48.93 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.15 -0.477 . . . . 65.15 110.937 -179.938 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.657 HG23 ' O ' ' A' ' 136' ' ' LYS . 85.9 t -98.83 -16.82 6.92 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 71.31 111.19 179.866 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.796 ' NE1' HG12 ' A' ' 217' ' ' VAL . 94.9 m95 -107.37 -37.16 6.31 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.174 -0.466 . . . . 74.22 110.9 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -72.67 -11.92 60.83 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.216 -0.447 . . . . 73.23 110.775 -179.802 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.582 HD22 ' N ' ' A' ' 143' ' ' ASN . 1.0 OUTLIER -95.21 -16.3 22.62 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.185 -0.461 . . . . 72.42 110.974 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.709 HG11 HD12 ' A' ' 250' ' ' LEU . 19.5 m -98.8 0.67 10.47 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.109 -0.496 . . . . 74.03 111.182 179.852 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.604 HG21 HG13 ' A' ' 258' ' ' ILE . 62.6 p -150.19 149.14 26.34 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.637 0.732 . . . . 72.54 111.204 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.74 32.84 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.675 2.25 . . . . 61.32 112.357 179.945 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.807 HD11 ' CD2' ' A' ' 262' ' ' TYR . 13.8 mt -97.98 177.62 5.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.241 -0.436 . . . . 74.42 110.884 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -141.42 126.18 18.03 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.234 -0.439 . . . . 70.34 110.862 179.801 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.569 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.6 m-30 -114.44 143.78 44.38 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.266 -0.425 . . . . 74.01 110.878 179.974 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -137.38 152.51 49.73 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.136 -0.483 . . . . 62.4 110.856 -179.826 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.487 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.3 OUTLIER -100.08 148.27 24.74 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.123 -0.489 . . . . 73.41 110.879 179.866 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.492 HD11 ' HB2' ' A' ' 157' ' ' ALA . 3.9 pt -152.12 168.87 1.36 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.146 -0.479 . . . . 62.5 111.07 179.897 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.51 15.88 2.37 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 75.14 110.892 179.889 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.3 p -93.55 -54.34 3.7 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.193 -0.458 . . . . 73.31 111.192 -179.949 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.416 ' H ' HD12 ' A' ' 152' ' ' ILE . . . 146.38 7.29 0.32 Allowed Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.804 -0.713 . . . . 73.54 112.52 179.942 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 36.9 mmt -106.98 76.52 1.1 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-O 120.828 0.347 . . . . 63.23 110.862 -179.936 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.492 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -145.85 162.97 36.5 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.263 -0.426 . . . . 32.43 111.131 179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.8 -53.36 5.17 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.192 -0.458 . . . . 65.5 110.864 179.975 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.658 HG12 HG23 ' A' ' 220' ' ' ILE . 2.6 mp -90.51 96.22 6.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.228 -0.442 . . . . 74.05 111.075 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.547 HD11 ' NE ' ' A' ' 117' ' ' ARG . 8.0 tp -87.03 109.57 19.49 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.208 -0.451 . . . . 60.45 110.861 179.908 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.409 HG13 ' CE1' ' A' ' 197' ' ' PHE . 93.9 t -89.09 120.07 37.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.234 -0.439 . . . . 75.32 111.145 179.814 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.758 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.4 p -139.76 105.21 2.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.228 -0.442 . . . . 72.43 111.066 179.883 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 42.2 m-85 -72.69 108.22 5.58 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.126 -0.488 . . . . 74.03 110.886 179.956 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.05 166.08 19.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.104 -0.498 . . . . 72.14 111.207 179.878 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.99 137.98 50.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.262 -0.426 . . . . 73.3 110.893 -179.981 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.677 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.09 -156.03 0.14 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.721 -0.752 . . . . 73.25 112.453 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.798 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -64.58 116.55 6.3 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.769 0.319 . . . . 64.34 111.101 -179.999 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.13 -21.48 12.57 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.216 -0.447 . . . . 74.04 110.849 -179.941 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.32 29.38 0.6 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.683 -0.77 . . . . 61.0 112.507 -179.889 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.647 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.33 1.36 15.11 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.854 0.359 . . . . 64.43 110.945 179.981 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 13.8 m-85 72.63 40.22 0.64 Allowed 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.176 -0.466 . . . . 73.21 110.956 -179.859 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.51 -41.64 0.7 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.107 -0.497 . . . . 71.54 110.819 -179.92 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.798 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.52 100.05 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.264 -0.425 . . . . 52.24 111.079 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.677 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.9 m-85 -60.87 -168.56 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.204 -0.453 . . . . 63.23 110.865 -179.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.87 19.43 3.5 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.137 -0.483 . . . . 51.21 110.918 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.581 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.43 -156.63 8.93 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.783 -0.722 . . . . 53.12 112.475 -179.878 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 25.4 ttmt -37.67 136.54 0.52 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.855 0.359 . . . . 64.13 110.864 -179.991 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.97 163.98 0.09 OUTLIER Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.75 -0.738 . . . . 72.45 112.48 179.883 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.411 ' O ' HD22 ' A' ' 181' ' ' LEU . . . 82.92 -142.28 21.46 Favored Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.813 -0.708 . . . . 63.42 112.479 -179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.56 95.74 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.856 0.36 . . . . 63.32 111.104 -179.901 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.416 HD13 ' HA ' ' A' ' 181' ' ' LEU . 2.9 mm? -65.86 -43.56 88.04 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.225 -0.443 . . . . 74.53 110.904 179.946 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.438 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -169.99 162.62 9.21 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.19 -0.459 . . . . 33.41 111.063 179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.533 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.5 p80 -154.37 140.9 18.85 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-N 116.235 -0.439 . . . . 72.33 110.81 179.985 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.757 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -138.46 172.92 12.17 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.174 -0.466 . . . . 71.13 111.133 179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 223' ' ' SER . 13.0 m-85 -101.53 -148.46 0.37 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.225 -0.443 . . . . 64.04 110.891 -179.923 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -159.0 -96.31 0.11 Allowed Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.789 -0.719 . . . . 52.23 112.531 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.68 59.31 1.58 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.799 2.333 . . . . 72.14 112.301 -179.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.605 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.98 153.51 16.78 Favored Glycine 0 N--CA 1.45 -0.371 0 C-N-CA 120.772 -0.728 . . . . 53.54 112.531 179.947 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.575 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.18 148.39 26.36 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.887 0.375 . . . . 35.01 110.862 -179.695 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.55 -66.94 0.01 OUTLIER Glycine 0 N--CA 1.453 -0.214 0 C-N-CA 120.746 -0.74 . . . . 24.13 112.416 -179.982 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.575 ' N ' ' O ' ' A' ' 189' ' ' SER . 1.1 mp -103.58 6.08 10.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-O 120.807 0.337 . . . . 44.52 111.135 -179.939 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.605 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -63.93 165.29 30.19 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.697 -0.763 . . . . 63.33 112.481 179.983 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.453 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 45.51 19.07 0.24 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.789 -0.719 . . . . 71.31 112.473 -179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.413 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 0.8 OUTLIER -63.67 107.65 1.22 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.88 0.371 . . . . 72.43 110.795 -179.928 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.757 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -82.71 128.95 34.85 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.229 -0.441 . . . . 70.34 111.089 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.533 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 9.2 m170 -120.04 130.16 54.57 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.305 -0.407 . . . . 74.25 110.886 179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.509 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 44.2 m-85 -115.29 133.72 55.78 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.442 . . . . 74.33 110.849 -179.877 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 60.5 t0 -66.92 110.15 3.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.15 -0.477 . . . . 73.23 110.857 179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.25 -37.67 81.11 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.23 -0.441 . . . . 62.12 110.878 -179.947 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.581 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 5.5 m-20 -50.62 -21.48 1.59 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.178 -0.465 . . . . 74.4 110.807 -179.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.41 ' HG3' HD13 ' A' ' 181' ' ' LEU . 6.3 mm-40 -81.52 162.47 23.2 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.308 -0.406 . . . . 71.4 110.879 -179.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.547 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.4 OUTLIER -100.54 90.0 4.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 70.43 110.85 -179.852 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.521 ' HZ3' HG21 ' A' ' 215' ' ' THR . 27.0 m95 -81.6 121.72 26.69 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.133 -0.485 . . . . 74.54 110.951 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 40.6 p -140.21 -175.72 4.35 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.244 -0.434 . . . . 73.33 111.112 -179.916 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.93 20.79 17.16 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.2 -0.455 . . . . 72.32 111.201 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.4 m80 -127.91 -176.45 3.78 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 75.24 110.766 -179.99 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 4.2 p -68.96 -19.18 64.16 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.145 -0.48 . . . . 63.3 110.882 -179.815 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.48 -107.82 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.715 -0.755 . . . . 72.24 112.39 -179.927 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.547 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -51.9 175.89 0.12 Allowed Glycine 0 N--CA 1.451 -0.333 0 C-N-CA 120.718 -0.753 . . . . 54.22 112.432 -179.798 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 43.7 m -64.3 98.81 0.25 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.786 0.327 . . . . 72.04 111.173 -179.846 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -44.96 115.36 0.88 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.198 -0.455 . . . . 50.31 110.834 -179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.654 HD23 ' HB3' ' A' ' 133' ' ' ALA . 12.5 tp -60.33 -39.12 85.95 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.16 -0.473 . . . . 71.12 110.834 -179.971 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.772 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.4 t80 -51.67 -63.66 1.06 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.198 -0.456 . . . . 72.41 110.935 179.949 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.548 HD21 ' CG2' ' A' ' 243' ' ' VAL . 8.6 mp -54.43 -55.46 28.58 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.159 -0.473 . . . . 63.42 110.929 -180.0 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.521 HG21 ' HZ3' ' A' ' 203' ' ' TRP . 1.3 m -54.81 -36.15 64.66 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.191 -0.459 . . . . 73.51 111.197 179.926 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.32 -48.55 72.68 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.183 -0.462 . . . . 35.24 111.152 179.855 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.943 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.1 t -53.8 -57.93 4.48 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.166 -0.47 . . . . 64.44 111.201 179.922 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.75 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.8 t-80 -64.48 -28.16 69.47 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.124 -0.489 . . . . 73.02 110.847 179.962 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.434 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -64.68 -45.42 86.74 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.173 -0.467 . . . . 64.43 111.071 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.658 HG23 HG12 ' A' ' 159' ' ' ILE . 2.4 mt -69.5 -35.78 68.21 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.25 -0.432 . . . . 72.34 111.094 -179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.67 -44.74 38.66 Favored Glycine 0 N--CA 1.453 -0.206 0 C-N-CA 120.848 -0.692 . . . . 65.43 112.402 179.979 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.461 ' O ' ' O ' ' A' ' 185' ' ' PHE . 3.8 m-70 -68.85 -39.37 79.97 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.808 0.337 . . . . 75.33 110.851 -179.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.572 ' OG ' HG23 ' A' ' 159' ' ' ILE . 5.0 m -63.05 -25.61 68.46 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.158 -0.474 . . . . 55.22 110.814 -179.789 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.719 ' O ' HG23 ' A' ' 108' ' ' VAL . 40.3 mt -77.29 -26.1 51.99 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 73.44 110.912 179.986 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 122.21 15.23 4.26 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.773 -0.727 . . . . 60.13 112.466 179.894 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.877 HD21 ' HA ' ' A' ' 258' ' ' ILE . 40.4 mt -82.18 155.66 24.84 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-O 120.779 0.324 . . . . 71.31 110.944 -179.99 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.431 ' HA2' ' HG3' ' A' ' 103' ' ' MET . . . -104.89 -140.68 10.48 Favored Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.699 -0.762 . . . . 70.34 112.473 179.924 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 1.2 m170 -120.97 149.45 42.63 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-O 120.754 0.311 . . . . 74.41 110.87 -179.966 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.535 ' N ' ' HB3' ' A' ' 236' ' ' MET . 43.8 m -116.66 164.14 15.07 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.267 -0.424 . . . . 61.43 110.781 -179.778 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -104.26 4.38 33.7 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.038 -0.528 . . . . 74.31 110.881 -179.787 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.536 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.3 OUTLIER -69.68 135.77 88.07 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.49 0.662 . . . . 75.1 110.978 179.907 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.8 Cg_endo -69.57 -1.34 8.15 Favored 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.759 2.306 . . . . 70.41 112.356 -179.973 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -143.8 23.95 1.71 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.209 -0.45 . . . . 72.24 110.89 -179.991 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.536 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -99.19 130.36 45.49 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.193 -0.458 . . . . 52.12 111.098 179.823 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.75 HG13 ' HB2' ' A' ' 218' ' ' HIS . 2.0 t -54.59 -31.49 23.6 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.192 -0.458 . . . . 74.21 111.164 179.959 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.535 ' HB3' ' N ' ' A' ' 229' ' ' SER . 0.0 OUTLIER -65.61 -14.24 60.75 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.17 -0.468 . . . . 64.14 110.883 179.882 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.582 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.4 t80 -64.06 143.06 98.27 Favored Pre-proline 0 C--N 1.329 -0.315 0 CA-C-O 121.623 0.725 . . . . 75.33 110.866 -179.907 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.582 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.7 Cg_endo -69.77 -7.53 21.3 Favored 'Trans proline' 0 C--N 1.341 0.165 0 C-N-CA 122.688 2.259 . . . . 64.23 112.381 179.957 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 14.1 m -92.87 149.81 21.01 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.171 -0.468 . . . . 55.42 111.048 -179.91 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 69.1 t80 -125.82 137.39 53.77 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.152 -0.476 . . . . 62.23 110.905 -179.954 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 7.9 ttpt -152.63 128.94 10.55 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.043 -0.526 . . . . 71.53 110.877 179.951 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.547 ' O ' HG13 ' A' ' 243' ' ' VAL . 80.1 t80 -58.4 145.82 37.04 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 70.03 110.926 -179.928 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.548 ' CG2' HD21 ' A' ' 214' ' ' LEU . 0.4 OUTLIER -160.35 132.21 1.01 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.162 -0.472 . . . . 71.13 111.082 179.924 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 14.6 t0 -46.86 135.2 9.42 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.127 -0.488 . . . . 71.11 110.892 179.843 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.648 HD11 ' HD3' ' A' ' 136' ' ' LYS . 7.3 tt -53.97 -33.49 24.23 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.255 0 CA-C-N 116.147 -0.479 . . . . 72.42 111.154 179.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.677 HD22 HG23 ' A' ' 247' ' ' THR . 0.5 OUTLIER -73.49 -17.19 61.25 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.227 -0.442 . . . . 73.21 110.905 179.916 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.677 HG23 HD22 ' A' ' 246' ' ' ASN . 24.5 p -106.01 -23.2 12.7 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.162 -0.472 . . . . 51.21 111.185 -179.995 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -73.06 130.59 40.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.195 -0.457 . . . . 73.15 110.881 -179.995 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.9 ptt180 -166.37 136.6 3.31 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 74.23 110.84 -179.931 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.709 HD12 HG11 ' A' ' 144' ' ' VAL . 50.8 mt -50.41 124.91 11.49 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.129 -0.487 . . . . 74.34 110.99 -179.97 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.73 170.37 12.56 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.154 -0.475 . . . . 45.12 110.858 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.85 -40.96 61.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.126 -0.488 . . . . 62.03 111.075 179.887 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -61.31 -47.6 85.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.29 -0.414 . . . . 65.11 110.844 -179.959 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.44 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 31.0 m-20 -61.3 -54.76 39.89 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.182 -0.463 . . . . 72.23 110.846 -179.978 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.406 ' HA ' HG22 ' A' ' 258' ' ' ILE . 22.7 mt -60.73 -32.84 52.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.449 . . . . 73.54 111.123 179.992 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 4.5 mmp_? -68.97 -41.31 78.11 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.164 -0.471 . . . . 75.21 110.845 179.969 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.5 -49.66 8.96 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.744 -0.741 . . . . 62.54 112.418 -179.896 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.877 ' HA ' HD21 ' A' ' 226' ' ' LEU . 8.3 tp -53.34 -34.34 22.49 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-O 120.855 0.359 . . . . 75.41 111.107 -179.929 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.42 ' O ' ' N ' ' A' ' 263' ' ' GLY . 49.2 mt-30 -87.67 -16.25 34.88 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.178 -0.464 . . . . 74.14 110.919 179.936 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.4 t -69.63 -14.73 62.97 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.206 -0.452 . . . . 74.54 110.83 -179.717 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.786 HD11 ' CB ' ' A' ' 102' ' ' GLU . 1.0 OUTLIER -123.22 -18.68 6.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.137 -0.483 . . . . 72.3 110.879 -179.982 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.807 ' CD2' HD11 ' A' ' 147' ' ' LEU . 40.6 m-85 -114.22 -33.06 5.78 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.239 -0.437 . . . . 74.12 110.942 179.977 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.42 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.347 0 CA-C-O 119.085 -0.842 . . . . 72.23 112.552 179.978 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 15.9 p90 . . . . . 0 CA--C 1.527 0.064 0 CA-C-O 120.84 0.352 . . . . 75.1 110.873 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER 175.94 -175.89 0.11 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.155 -0.475 . . . . 70.13 110.856 -179.841 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.787 ' HB3' HD11 ' A' ' 261' ' ' LEU . 2.1 pp20? -39.57 146.64 0.09 Allowed 'General case' 0 C--N 1.331 -0.212 0 CA-C-N 116.186 -0.461 . . . . 74.4 110.887 -179.916 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 12.4 tpp -56.14 136.28 74.49 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.547 0.689 . . . . 71.55 110.908 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.75 78.39 1.01 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.651 2.234 . . . . 63.25 112.389 -179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 126.46 14.81 2.84 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.723 -0.751 . . . . 51.51 112.461 -180.0 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -109.33 85.54 0.41 Allowed Glycine 0 N--CA 1.452 -0.277 0 C-N-CA 120.719 -0.753 . . . . 64.24 112.397 -179.852 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.83 95.99 0.58 Allowed 'Trans proline' 0 C--N 1.341 0.147 0 C-N-CA 122.726 2.284 . . . . 62.5 112.346 -179.982 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.82 HG12 ' HA3' ' A' ' 225' ' ' GLY . 18.5 m -51.86 171.71 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.243 0 CA-C-N 116.162 -0.472 . . . . 71.4 111.129 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.412 ' CZ3' HD23 ' A' ' 224' ' ' LEU . 5.7 m0 -64.31 -29.67 70.74 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.093 -0.503 . . . . 72.43 110.949 179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 44.3 mtm-85 65.72 33.29 8.38 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.213 -0.449 . . . . 72.1 110.9 -179.936 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 4.6 mtmt -121.62 171.07 9.1 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.158 -0.474 . . . . 73.12 110.957 179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.441 ' HA ' ' HG ' ' A' ' 147' ' ' LEU . 1.7 p80 -114.4 30.14 7.51 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.353 -0.385 . . . . 65.44 110.891 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -136.47 108.38 7.12 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.174 -0.466 . . . . 74.23 110.955 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.569 HG22 ' N ' ' A' ' 115' ' ' THR . 5.1 mp -136.97 161.26 36.07 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.082 -0.508 . . . . 62.35 111.176 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.569 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -158.41 163.5 37.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.227 -0.442 . . . . 53.22 111.108 179.969 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.634 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.9 p90 -133.04 145.85 51.18 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.213 -0.449 . . . . 72.01 110.924 -179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.568 ' HD2' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -139.56 115.2 10.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.056 -0.52 . . . . 71.52 110.863 -179.965 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 62.8 mt -76.58 107.78 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.251 -0.431 . . . . 75.02 111.128 179.976 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.7 t-20 -60.49 -49.4 77.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.164 -0.471 . . . . 73.33 110.863 179.939 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.658 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.0 p-10 -142.1 167.56 21.82 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.213 -0.449 . . . . 63.4 110.902 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 2.5 m-85 -118.4 148.93 42.04 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.136 -0.484 . . . . 74.34 110.933 -179.931 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.501 HG23 ' HD2' ' A' ' 123' ' ' PRO . 87.7 m -100.21 135.48 20.3 Favored Pre-proline 0 C--N 1.33 -0.253 0 CA-C-O 121.551 0.691 . . . . 72.31 111.187 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.501 ' HD2' HG23 ' A' ' 122' ' ' THR . 54.2 Cg_endo -69.73 21.22 0.17 Allowed 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.611 2.207 . . . . 72.41 112.347 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.473 ' H ' ' C ' ' A' ' 122' ' ' THR . 1.6 m-20 -101.12 -24.75 14.23 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-N 116.224 -0.444 . . . . 74.42 110.879 179.928 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.405 ' HE3' HG22 ' A' ' 130' ' ' VAL . 0.0 OUTLIER -116.19 166.2 12.29 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.191 -0.459 . . . . 72.34 110.835 -179.985 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 2.8 m120 -89.56 147.93 23.67 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.233 -0.44 . . . . 74.22 110.86 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 3.6 ptp180 -47.87 -35.27 10.12 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.127 -0.488 . . . . 70.22 110.92 179.998 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.8 pt-20 -81.88 -37.21 27.23 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.164 -0.471 . . . . 74.33 110.891 -179.973 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.406 ' HB3' HG23 ' A' ' 205' ' ' THR . 76.1 m-20 -64.86 -31.41 72.62 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.146 -0.479 . . . . 74.31 110.841 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.405 HG22 ' HE3' ' A' ' 125' ' ' MET . 62.4 t -64.65 -44.85 96.65 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 73.52 111.048 -179.971 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -81.2 -23.19 38.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.191 -0.459 . . . . 72.34 110.803 179.97 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.9 t80 -75.54 -46.67 30.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.261 -0.427 . . . . 61.43 110.839 -179.73 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.71 ' HB1' ' N ' ' A' ' 213' ' ' PHE . . . -69.43 -35.69 75.96 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.145 -0.48 . . . . 75.04 111.14 179.891 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.542 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.4 mp -70.59 -55.17 15.26 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 74.11 111.134 179.968 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.542 ' N ' HG22 ' A' ' 134' ' ' ILE . 0.6 OUTLIER -48.34 -44.15 34.04 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.081 -0.509 . . . . 62.44 110.929 179.986 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.634 ' O ' HG23 ' A' ' 140' ' ' VAL . 5.9 mmpt? -69.88 -35.14 74.42 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.116 -0.493 . . . . 72.12 110.889 179.882 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.916 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -59.84 -49.35 78.05 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.297 -0.411 . . . . 71.44 111.116 179.895 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.634 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.8 m-85 -72.47 -22.16 61.11 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.197 -0.456 . . . . 70.15 110.848 -179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.499 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.6 OUTLIER -77.89 -5.87 52.43 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.225 -0.443 . . . . 74.45 110.936 -179.988 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.76 ' O ' HD11 ' A' ' 250' ' ' LEU . 87.4 t -97.23 -18.65 6.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.453 . . . . 65.34 111.185 179.88 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.805 ' NE1' HG12 ' A' ' 217' ' ' VAL . 95.7 m95 -103.73 -40.19 6.38 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.149 -0.478 . . . . 62.05 110.962 179.898 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -68.87 -13.57 62.5 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.25 -0.432 . . . . 75.51 110.817 -179.817 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.592 HD22 ' N ' ' A' ' 143' ' ' ASN . 1.0 OUTLIER -94.07 -4.04 50.1 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.151 -0.477 . . . . 71.13 110.876 -179.951 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.822 HG11 HD12 ' A' ' 250' ' ' LEU . 31.3 m -120.96 3.59 6.52 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.207 -0.452 . . . . 61.23 111.047 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.717 HG23 ' HD2' ' A' ' 146' ' ' PRO . 3.2 m -145.98 141.66 16.89 Favored Pre-proline 0 C--N 1.33 -0.27 0 CA-C-O 121.675 0.75 . . . . 71.44 111.077 -179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . 0.717 ' HD2' HG23 ' A' ' 145' ' ' THR . 54.1 Cg_endo -69.78 35.64 0.22 Allowed 'Trans proline' 0 C--O 1.232 0.217 0 C-N-CA 122.695 2.264 . . . . 72.44 112.328 179.957 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.785 HD21 ' CE1' ' A' ' 262' ' ' TYR . 3.1 mp -103.22 -177.34 3.34 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.251 -0.431 . . . . 71.23 110.88 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 9.3 mttm -141.64 126.91 18.61 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.109 -0.496 . . . . 64.0 110.854 179.838 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.418 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.8 m-30 -114.06 146.45 40.21 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.278 -0.419 . . . . 74.24 110.887 179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.455 ' H ' ' HA ' ' A' ' 115' ' ' THR . 5.8 t -142.27 151.51 42.12 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.135 -0.484 . . . . 72.02 110.877 -179.799 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 7.2 tttp -102.54 143.13 32.64 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.101 -0.5 . . . . 74.43 110.925 179.918 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.573 HD12 ' CA ' ' A' ' 155' ' ' GLY . 21.8 pt -151.94 142.02 15.4 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.172 -0.467 . . . . 72.1 111.144 179.903 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.518 HD22 ' N ' ' A' ' 153' ' ' ASN . 1.3 m-80 -101.42 -19.79 15.43 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.14 -0.482 . . . . 64.44 110.828 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 3.1 t -150.5 66.07 0.94 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.214 -0.448 . . . . 64.41 111.116 -179.885 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.573 ' CA ' HD12 ' A' ' 152' ' ' ILE . . . -152.12 -155.61 7.11 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.743 -0.741 . . . . 53.31 112.473 179.94 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -104.82 94.17 5.13 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.747 0.308 . . . . 53.43 110.911 -179.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.52 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -106.96 155.16 20.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 73.01 111.151 179.946 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.26 -53.33 5.31 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.275 -0.42 . . . . 73.51 110.918 179.966 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.659 HG12 HG23 ' A' ' 220' ' ' ILE . 2.5 mp -88.68 94.1 4.61 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.138 -0.483 . . . . 72.5 111.078 -179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.568 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.5 tp -85.76 108.87 18.28 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.145 -0.479 . . . . 74.15 110.904 179.905 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 98.2 t -86.96 119.11 34.25 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.223 -0.444 . . . . 73.01 111.152 179.832 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.658 HG23 ' OD1' ' A' ' 120' ' ' ASN . 1.9 p -138.24 104.91 2.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.154 -0.475 . . . . 74.05 111.081 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.419 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 39.6 m-85 -73.22 111.68 8.56 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-N 116.195 -0.457 . . . . 71.34 110.862 -179.956 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.92 166.41 21.72 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.167 -0.469 . . . . 75.32 111.131 179.959 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 7.7 ptt180 -114.41 136.16 53.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.217 -0.447 . . . . 62.33 110.987 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.679 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 44.57 -157.78 0.19 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.773 -0.727 . . . . 72.43 112.499 -179.919 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.819 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -62.53 116.45 5.13 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.832 0.348 . . . . 62.24 110.999 180.0 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.25 -22.12 12.23 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 74.23 110.884 179.991 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.71 30.35 0.54 Allowed Glycine 0 N--CA 1.452 -0.276 0 C-N-CA 120.708 -0.758 . . . . 53.53 112.515 -179.942 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.633 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.97 0.1 14.27 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.912 0.387 . . . . 73.12 110.899 179.995 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.7 m-85 74.33 39.04 0.5 Allowed 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.204 -0.453 . . . . 75.32 110.954 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.96 -41.21 0.75 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.169 -0.469 . . . . 71.51 110.853 -179.922 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.819 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.2 100.63 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.208 -0.451 . . . . 65.32 111.102 179.932 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.679 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.1 m-85 -61.18 -168.39 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.159 -0.473 . . . . 74.01 110.898 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.17 18.84 3.42 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.13 -0.486 . . . . 71.22 110.825 -179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.587 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.07 -158.04 5.57 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.786 -0.721 . . . . 62.43 112.477 -179.977 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.452 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.8 OUTLIER -33.76 133.94 0.18 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-O 120.833 0.349 . . . . 75.43 110.884 -179.935 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.45 165.44 0.15 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.715 -0.755 . . . . 62.04 112.541 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.64 -143.56 22.58 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.692 -0.766 . . . . 71.41 112.486 -179.945 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.02 96.93 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-O 120.83 0.348 . . . . 75.23 111.169 179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 13.3 mt -66.32 -44.0 84.6 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.176 -0.465 . . . . 71.22 110.9 179.93 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.424 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -170.09 163.09 9.17 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.208 -0.451 . . . . 73.24 111.08 179.783 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.488 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -155.62 142.66 19.13 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.154 -0.476 . . . . 75.23 110.81 179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.744 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -139.02 172.26 13.11 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.166 -0.47 . . . . 72.41 111.101 179.986 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.46 ' O ' ' HA ' ' A' ' 223' ' ' SER . 48.4 m-85 -100.7 -151.39 0.41 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.267 -0.424 . . . . 62.1 110.858 -179.901 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -154.99 -97.07 0.13 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.74 -0.743 . . . . 74.23 112.481 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.75 61.31 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.224 0 C-N-CA 122.685 2.256 . . . . 73.42 112.329 -179.926 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.617 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.65 153.76 17.34 Favored Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.731 -0.747 . . . . 53.24 112.473 179.999 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.58 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.75 149.71 25.38 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.931 0.396 . . . . 62.51 110.829 -179.687 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.23 -66.77 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.749 -0.739 . . . . 71.34 112.475 -179.966 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.58 ' N ' ' O ' ' A' ' 189' ' ' SER . 1.1 mp -104.78 6.61 10.2 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-O 120.809 0.338 . . . . 62.33 111.098 -179.933 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.617 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -65.33 164.33 37.45 Favored Glycine 0 N--CA 1.45 -0.389 0 C-N-CA 120.763 -0.732 . . . . 40.15 112.482 179.887 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.514 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 47.21 16.73 0.29 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.777 -0.725 . . . . 54.23 112.457 -179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.409 ' CG ' ' HB3' ' A' ' 160' ' ' LEU . 1.1 m-20 -63.31 111.77 2.42 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.78 0.324 . . . . 65.23 110.898 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.744 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -85.49 128.76 34.84 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.216 -0.447 . . . . 74.35 111.076 179.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.488 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.8 m170 -119.29 128.65 54.34 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.171 -0.468 . . . . 71.12 110.846 -179.981 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.525 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 47.8 m-85 -114.27 134.23 55.09 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.208 -0.451 . . . . 71.1 110.89 -179.969 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.8 t0 -67.19 108.91 2.86 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.151 -0.477 . . . . 71.41 110.871 -179.977 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.1 tm-20 -59.94 -36.91 78.06 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.249 -0.432 . . . . 65.32 110.843 -179.871 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.587 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 16.8 m-20 -51.38 -21.06 2.03 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.139 -0.482 . . . . 74.33 110.854 -179.988 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -82.61 162.72 21.81 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.16 -0.473 . . . . 71.42 110.885 -179.932 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.522 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -100.66 92.46 5.11 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.084 -0.507 . . . . 70.25 110.887 -179.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.525 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 30.0 m95 -82.7 122.47 28.2 Favored 'General case' 0 C--N 1.327 -0.371 0 CA-C-N 116.02 -0.536 . . . . 63.1 110.948 -179.982 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.2 p -139.42 -170.85 2.99 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.263 -0.426 . . . . 74.1 111.204 179.996 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.406 HG23 ' HB3' ' A' ' 129' ' ' ASP . 0.2 OUTLIER -116.09 17.24 15.87 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.278 -0.419 . . . . 61.02 111.151 -179.954 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.58 -177.55 4.23 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.228 -0.442 . . . . 73.11 110.804 179.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.3 p -64.95 -18.66 65.44 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.223 -0.444 . . . . 72.44 110.831 -179.748 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.31 -108.3 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.246 0 C-N-CA 120.744 -0.741 . . . . 43.2 112.452 179.975 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.522 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.09 177.45 0.14 Allowed Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.698 -0.763 . . . . 72.31 112.474 -179.868 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 96.3 m -66.76 94.55 0.31 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.8 0.334 . . . . 70.31 111.187 -179.886 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -38.12 117.09 0.57 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.2 -0.454 . . . . 73.44 110.875 -179.912 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.502 HD23 ' HB3' ' A' ' 133' ' ' ALA . 25.0 tp -63.66 -36.59 84.33 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.18 -0.464 . . . . 73.02 110.921 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.71 ' N ' ' HB1' ' A' ' 133' ' ' ALA . 3.2 t80 -52.82 -64.63 0.75 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.138 -0.483 . . . . 75.42 110.932 179.925 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.44 HD11 ' H ' ' A' ' 243' ' ' VAL . 15.2 mt -53.53 -55.54 24.63 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.168 -0.469 . . . . 73.54 110.902 -179.951 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.523 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 1.7 m -55.52 -32.99 63.38 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.169 -0.468 . . . . 63.43 111.065 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.415 ' HB3' ' HB2' ' A' ' 137' ' ' ALA . . . -68.0 -46.24 71.83 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.298 -0.41 . . . . 75.34 111.026 179.944 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.916 HG22 ' HA ' ' A' ' 137' ' ' ALA . 1.9 t -55.96 -59.4 2.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.279 -0.419 . . . . 71.32 111.104 179.991 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.526 ' HB2' ' CG1' ' A' ' 235' ' ' VAL . 1.1 t-80 -60.6 -31.7 70.85 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 63.1 110.925 179.979 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -60.25 -46.75 88.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.131 -0.486 . . . . 70.41 111.075 179.949 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.659 HG23 HG12 ' A' ' 159' ' ' ILE . 2.3 mt -68.75 -34.54 65.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.203 -0.453 . . . . 72.24 111.167 179.936 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.01 -42.69 48.42 Favored Glycine 0 N--CA 1.451 -0.348 0 C-N-CA 120.788 -0.72 . . . . 64.34 112.418 179.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.44 ' O ' ' O ' ' A' ' 185' ' ' PHE . 24.1 m-70 -67.62 -39.94 84.7 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-O 120.802 0.334 . . . . 64.04 110.89 -179.914 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.586 ' OG ' HG23 ' A' ' 159' ' ' ILE . 2.1 m -60.76 -28.87 69.04 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 72.22 110.877 -179.835 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.412 HD23 ' CZ3' ' A' ' 109' ' ' TRP . 52.3 mt -76.21 -26.42 56.09 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.144 -0.48 . . . . 72.14 110.88 179.961 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.82 ' HA3' HG12 ' A' ' 108' ' ' VAL . . . 117.67 16.53 5.9 Favored Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.803 -0.713 . . . . 65.42 112.458 179.899 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.945 HD11 HD13 ' A' ' 258' ' ' ILE . 53.4 mt -77.45 159.25 29.53 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.883 0.373 . . . . 62.11 110.894 -179.85 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -103.71 -140.14 10.56 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.702 -0.761 . . . . 73.45 112.504 179.857 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.405 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 1.3 m170 -123.35 136.19 54.54 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-O 120.814 0.34 . . . . 63.14 110.934 -179.992 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 29.8 t -104.92 162.56 13.23 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.263 -0.426 . . . . 73.5 110.89 -179.787 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.6 t -107.75 5.85 27.05 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.1 -0.5 . . . . 74.55 110.751 -179.795 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.553 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -68.53 140.45 92.31 Favored Pre-proline 0 C--N 1.326 -0.417 0 CA-C-O 121.673 0.749 . . . . 71.15 110.806 179.982 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.74 0.55 5.47 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.757 2.305 . . . . 75.43 112.365 179.964 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 10.7 ptmt -143.62 14.66 1.77 Allowed 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.194 -0.457 . . . . 51.12 110.813 179.9 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.553 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -77.33 140.3 39.95 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.254 -0.43 . . . . 73.2 111.129 179.795 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.565 HG21 HD23 ' A' ' 250' ' ' LEU . 51.6 t -69.8 -26.18 29.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.191 -0.459 . . . . 62.41 111.138 -179.96 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.405 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 55.6 mmm -81.92 -7.03 59.58 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.151 -0.477 . . . . 62.41 110.955 179.834 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.496 ' CD1' ' HD2' ' A' ' 238' ' ' PRO . 2.4 t80 -50.9 138.28 24.48 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.681 0.753 . . . . 64.34 110.882 179.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.496 ' HD2' ' CD1' ' A' ' 237' ' ' PHE . 53.6 Cg_endo -69.75 -7.87 22.15 Favored 'Trans proline' 0 C--N 1.341 0.158 0 C-N-CA 122.622 2.215 . . . . 64.54 112.335 179.964 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.41 ' HB ' ' CD2' ' A' ' 237' ' ' PHE . 22.3 m -110.91 130.99 55.42 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.223 -0.444 . . . . 53.31 111.18 179.976 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 54.3 t80 -92.24 146.82 23.41 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-O 120.958 0.409 . . . . 73.43 110.953 -179.934 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 17.3 ttmm -161.87 132.02 4.83 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.147 -0.479 . . . . 42.01 110.848 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.536 ' O ' HG13 ' A' ' 243' ' ' VAL . 65.0 t80 -61.89 149.06 41.51 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.193 -0.458 . . . . 74.13 110.915 -179.959 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.536 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -160.76 137.48 2.01 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.198 -0.456 . . . . 74.33 111.12 179.886 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -60.76 127.39 31.42 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.109 -0.496 . . . . 51.33 110.825 179.897 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.559 HD11 ' HD3' ' A' ' 136' ' ' LYS . 14.4 tt -54.0 -29.48 18.65 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.151 -0.477 . . . . 75.24 111.152 179.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -69.08 -21.26 64.08 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.185 -0.461 . . . . 74.24 110.849 179.997 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 18.8 p -111.89 -18.2 12.73 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 63.14 111.119 -179.901 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.567 ' HE2' HG21 ' A' ' 140' ' ' VAL . 36.8 t80 -62.72 142.2 58.23 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.209 -0.451 . . . . 73.3 110.903 179.967 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -177.11 136.25 0.21 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.14 -0.482 . . . . 74.01 110.831 -179.971 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.822 HD12 HG11 ' A' ' 144' ' ' VAL . 8.7 mt -51.57 127.71 21.06 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.23 -0.441 . . . . 64.22 110.914 179.963 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 35.8 t -66.89 161.68 23.47 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.137 -0.483 . . . . 74.11 110.863 -179.941 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.27 -30.17 11.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.148 -0.478 . . . . 72.05 111.128 179.89 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.5 m-20 -71.75 -45.87 60.33 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.232 -0.44 . . . . 64.13 110.9 -179.999 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.447 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 2.1 m-20 -62.36 -50.57 71.06 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.184 -0.462 . . . . 74.01 110.82 179.984 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 24.2 mt -62.29 -35.63 70.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 54.25 111.158 179.991 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 29.1 mmt-85 -71.08 -38.04 72.42 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.158 -0.474 . . . . 74.5 110.848 179.993 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.13 -49.93 7.17 Favored Glycine 0 N--CA 1.453 -0.226 0 C-N-CA 120.673 -0.775 . . . . 63.24 112.523 179.944 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.945 HD13 HD11 ' A' ' 226' ' ' LEU . 8.4 tp -52.4 -34.84 19.23 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.357 0 CA-C-O 120.786 0.327 . . . . 72.42 111.141 -179.989 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.409 ' O ' ' N ' ' A' ' 263' ' ' GLY . 30.5 mt-30 -87.81 -16.18 34.79 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.187 -0.46 . . . . 72.53 110.925 179.985 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.6 t -70.16 -14.25 62.55 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.202 -0.454 . . . . 73.25 110.809 -179.737 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.787 HD11 ' HB3' ' A' ' 102' ' ' GLU . 0.4 OUTLIER -122.37 -19.33 6.47 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.17 -0.468 . . . . 63.34 110.923 179.958 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.785 ' CE1' HD21 ' A' ' 147' ' ' LEU . 37.6 m-85 -113.8 -35.06 5.27 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.213 -0.448 . . . . 74.01 110.955 179.996 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.409 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.325 0 CA-C-O 119.157 -0.801 . . . . 43.21 112.498 179.979 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 3.2 t80 . . . . . 0 C--O 1.23 0.071 0 CA-C-O 120.894 0.378 . . . . 74.22 110.884 . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 15.0 mtm180 50.88 49.5 20.95 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.116 -0.493 . . . . 74.25 110.833 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.531 ' CD ' HD21 ' A' ' 261' ' ' LEU . 1.7 tt0 176.44 136.75 0.06 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.202 -0.453 . . . . 62.1 110.904 -179.862 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.48 ' HG3' ' HD2' ' A' ' 104' ' ' PRO . 1.1 tpt -52.51 137.75 41.26 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.632 0.729 . . . . 72.43 110.873 179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.48 ' HD2' ' HG3' ' A' ' 103' ' ' MET . 54.8 Cg_endo -69.71 87.12 0.55 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.656 2.237 . . . . 75.55 112.415 179.896 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 141.75 -136.67 7.5 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.698 -0.763 . . . . 70.24 112.511 179.965 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.719 ' N ' ' CD ' ' A' ' 107' ' ' PRO . . . -136.27 34.93 2.19 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.74 -0.743 . . . . 54.41 112.514 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.719 ' CD ' ' N ' ' A' ' 106' ' ' GLY . 54.4 Cg_endo -69.69 -8.92 24.84 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.701 2.267 . . . . 72.5 112.375 -179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.048 HG11 HD13 ' A' ' 261' ' ' LEU . 2.2 p -96.87 103.68 14.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.179 -0.464 . . . . 52.0 111.157 179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.45 ' CZ3' HD23 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -50.97 108.03 0.21 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.141 -0.481 . . . . 64.21 110.881 -179.966 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 6.2 mtp180 -75.06 56.17 0.76 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.169 -0.469 . . . . 70.41 110.806 -179.952 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 1.7 pttm -121.8 151.28 40.77 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-N 116.253 -0.431 . . . . 74.41 110.963 179.931 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.464 ' HA ' HD22 ' A' ' 147' ' ' LEU . 9.9 p80 -95.65 39.5 1.13 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.265 -0.425 . . . . 70.24 110.854 179.953 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.3 m-85 -141.92 98.67 3.38 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.149 -0.478 . . . . 73.25 110.904 -179.862 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.652 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.6 mp -132.12 163.19 38.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.097 -0.501 . . . . 60.23 111.136 179.884 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.589 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -160.26 163.44 33.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.184 -0.462 . . . . 72.41 111.238 179.964 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.595 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.7 p90 -133.72 155.71 49.26 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.184 -0.462 . . . . 75.04 110.854 -179.905 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.709 ' HD2' HD11 ' A' ' 160' ' ' LEU . 3.8 tmt_? -144.87 111.56 5.78 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 73.3 110.923 -179.938 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.0 mt -73.37 104.18 2.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.367 0 CA-C-N 116.31 -0.405 . . . . 74.43 111.206 179.94 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 43.3 t30 -57.82 -45.72 85.72 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.194 -0.457 . . . . 55.52 110.896 179.939 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.743 ' OD1' HG23 ' A' ' 162' ' ' VAL . 1.6 p-10 -146.92 164.24 33.54 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.106 -0.497 . . . . 74.4 110.862 -179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.592 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.3 m-85 -116.5 144.82 43.86 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.161 -0.472 . . . . 75.41 110.923 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.715 HG22 ' CE ' ' A' ' 125' ' ' MET . 3.0 t -94.33 142.15 24.48 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.564 0.697 . . . . 72.05 111.17 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.87 -3.17 11.54 Favored 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.643 2.229 . . . . 62.2 112.339 -179.959 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.401 ' H ' HG23 ' A' ' 122' ' ' THR . 22.8 m-20 -79.96 -23.38 41.7 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.143 -0.481 . . . . 43.1 110.933 179.841 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.715 ' CE ' HG22 ' A' ' 122' ' ' THR . 16.6 mtm -115.94 166.63 11.76 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.186 -0.461 . . . . 72.51 110.858 179.991 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.409 ' O ' HG23 ' A' ' 130' ' ' VAL . 46.7 t30 -96.32 143.95 26.93 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.231 -0.44 . . . . 70.35 110.909 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -44.88 -32.83 1.73 Allowed 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.201 -0.454 . . . . 73.22 110.911 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 10.7 mt-10 -85.73 -40.44 16.1 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.176 -0.465 . . . . 70.41 110.9 -179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 33.5 m-20 -64.88 -29.24 70.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.206 -0.452 . . . . 73.2 110.906 179.982 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.62 ' O ' HD13 ' A' ' 134' ' ' ILE . 78.9 t -67.39 -45.36 85.9 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.135 -0.484 . . . . 71.4 111.168 179.933 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 4.2 t0 -80.12 -22.72 41.8 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.205 -0.452 . . . . 73.54 110.878 179.943 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -73.75 -47.02 42.22 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.149 -0.478 . . . . 72.14 110.955 -179.936 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.774 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -73.84 -30.01 62.44 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.099 -0.5 . . . . 74.32 111.094 179.885 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.656 HD13 HD21 ' A' ' 212' ' ' LEU . 1.4 mp -73.84 -55.85 11.1 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.214 -0.448 . . . . 73.53 111.202 179.934 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.558 ' N ' HG22 ' A' ' 134' ' ' ILE . 2.1 ttt180 -48.02 -42.12 27.32 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.131 -0.486 . . . . 64.53 110.868 179.958 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.551 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.1 OUTLIER -75.88 -33.35 59.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.224 -0.444 . . . . 64.12 110.902 179.94 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.848 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.35 -50.78 72.25 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.201 -0.454 . . . . 71.11 111.145 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.616 ' HE2' HD13 ' A' ' 159' ' ' ILE . 80.7 m-85 -67.37 -32.55 73.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.211 -0.45 . . . . 61.43 110.832 -179.942 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.581 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.7 tt0 -63.42 -44.2 95.29 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 50.45 110.991 -179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.551 HG23 ' O ' ' A' ' 136' ' ' LYS . 79.3 t -49.35 -24.81 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.212 -0.449 . . . . 73.32 111.077 179.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.791 ' NE1' HG12 ' A' ' 217' ' ' VAL . 97.6 m95 -98.99 -28.36 13.45 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.253 -0.43 . . . . 75.2 110.867 179.974 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 2.2 p -76.14 -12.54 60.12 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.282 -0.417 . . . . 63.43 110.842 -179.825 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.581 ' ND2' ' O ' ' A' ' 139' ' ' GLN . 57.8 m-20 -92.73 -24.75 18.48 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.175 -0.466 . . . . 62.14 110.867 -179.949 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.64 HG11 HD12 ' A' ' 250' ' ' LEU . 4.4 m -93.28 0.8 9.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.185 -0.461 . . . . 62.33 111.079 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.559 HG21 HG13 ' A' ' 258' ' ' ILE . 77.6 p -152.93 143.98 16.01 Favored Pre-proline 0 C--N 1.329 -0.303 0 CA-C-O 121.642 0.734 . . . . 74.53 111.146 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.81 29.33 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.205 0 C-N-CA 122.604 2.202 . . . . 74.02 112.333 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.751 HD11 ' CD2' ' A' ' 262' ' ' TYR . 29.4 mt -87.71 175.59 7.8 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.222 -0.444 . . . . 70.14 110.937 179.895 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.7 mttm -137.67 126.47 23.94 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.234 -0.439 . . . . 73.53 110.983 179.712 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.652 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.4 m-85 -116.6 140.28 49.57 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.227 -0.442 . . . . 74.11 110.83 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 49.9 m -136.09 145.94 46.49 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.117 -0.492 . . . . 64.55 110.847 -179.84 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.424 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 5.5 tttt -94.22 144.87 25.14 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.157 -0.474 . . . . 64.23 110.893 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.627 HD11 ' HB2' ' A' ' 157' ' ' ALA . 14.8 pt -151.25 132.85 5.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.24 -0.436 . . . . 72.52 111.081 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -104.33 -0.17 28.48 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.155 -0.475 . . . . 73.44 110.866 179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.7 t -160.54 55.61 0.33 Allowed 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 62.12 111.126 -179.974 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.405 ' C ' HD12 ' A' ' 152' ' ' ILE . . . -151.06 -155.46 6.94 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.652 -0.785 . . . . 75.14 112.454 179.963 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.65 96.63 6.53 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 120.7 0.286 . . . . 65.25 110.914 -179.968 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.627 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -105.27 157.03 17.58 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.288 -0.414 . . . . 73.21 111.104 179.912 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.94 -50.95 7.56 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.225 -0.443 . . . . 72.52 110.849 179.973 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.65 HG23 ' OG ' ' A' ' 223' ' ' SER . 2.6 mp -93.14 98.95 8.93 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.277 -0.419 . . . . 75.1 111.203 179.969 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.709 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.4 tp -88.67 109.89 20.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.158 -0.474 . . . . 71.04 110.995 179.892 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.442 HG13 ' CE1' ' A' ' 197' ' ' PHE . 98.3 t -89.07 121.44 39.18 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.247 0 CA-C-N 116.204 -0.453 . . . . 72.42 111.144 179.863 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.743 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -140.98 106.43 1.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.303 0 CA-C-N 116.213 -0.449 . . . . 75.11 111.175 179.898 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 47.7 m-85 -73.66 108.57 6.57 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.222 -0.445 . . . . 72.41 110.819 -179.945 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.91 165.61 20.73 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.029 -0.532 . . . . 64.03 111.163 179.895 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.08 137.69 51.4 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.256 -0.429 . . . . 63.34 110.879 -179.946 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.68 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.82 -155.48 0.23 Allowed Glycine 0 N--CA 1.452 -0.262 0 C-N-CA 120.772 -0.728 . . . . 53.45 112.473 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.805 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.45 117.07 7.43 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-O 120.883 0.373 . . . . 73.41 111.113 179.951 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.28 -22.51 12.04 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.215 -0.448 . . . . 75.44 110.831 -179.976 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.32 29.68 0.54 Allowed Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.805 -0.712 . . . . 33.52 112.518 -179.971 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.624 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.1 -0.45 14.69 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-O 120.824 0.345 . . . . 50.03 110.882 -179.96 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 74.77 39.39 0.43 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.215 -0.448 . . . . 74.14 110.946 -179.883 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -135.02 -41.28 0.74 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.084 -0.507 . . . . 74.12 110.82 -179.958 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.805 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.19 99.9 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.253 -0.43 . . . . 74.5 111.093 179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.68 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -60.4 -168.66 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 71.51 110.911 -179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.69 19.12 3.55 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.152 -0.476 . . . . 72.42 110.798 -179.989 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.575 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.5 -157.99 6.18 Favored Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.789 -0.72 . . . . 63.45 112.508 -179.911 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.44 ' C ' ' O ' ' A' ' 176' ' ' GLY . 9.6 ptpt -34.59 134.05 0.23 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-O 120.787 0.327 . . . . 73.52 110.966 179.937 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.84 165.42 0.18 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.777 -0.725 . . . . 75.2 112.491 179.995 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.441 ' O ' HD22 ' A' ' 181' ' ' LEU . . . 82.69 -142.9 22.1 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.775 -0.726 . . . . 41.51 112.488 -179.85 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.47 96.31 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.953 0.406 . . . . 72.44 111.145 -179.912 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.441 HD22 ' O ' ' A' ' 179' ' ' GLY . 3.0 mm? -65.56 -42.71 91.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.143 -0.48 . . . . 63.43 110.903 179.906 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.433 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -171.25 163.55 7.11 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.217 -0.447 . . . . 62.3 111.163 179.84 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.493 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -156.11 142.13 18.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.251 -0.431 . . . . 60.12 110.88 -179.954 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.742 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -137.79 172.93 12.21 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.193 -0.458 . . . . 40.12 111.123 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.499 ' O ' ' HA ' ' A' ' 223' ' ' SER . 12.2 m-85 -101.7 -148.48 0.37 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.24 -0.436 . . . . 75.02 110.796 -179.871 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -164.03 -86.85 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.739 -0.744 . . . . 63.4 112.483 -179.942 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.82 55.51 1.31 Allowed 'Trans proline' 0 C--N 1.343 0.255 0 C-N-CA 122.564 2.176 . . . . 74.12 112.374 -179.969 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.582 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.82 149.79 16.91 Favored Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.716 -0.754 . . . . 63.21 112.502 179.972 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.541 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.13 146.48 28.69 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 120.916 0.388 . . . . 71.41 110.805 -179.668 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.03 -64.77 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.406 0 C-N-CA 120.796 -0.716 . . . . 64.33 112.512 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.541 ' N ' ' O ' ' A' ' 189' ' ' SER . 8.2 pt -105.25 8.86 9.61 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-O 120.871 0.367 . . . . 73.51 111.214 179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.582 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -68.91 169.75 41.83 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.701 -0.761 . . . . 75.23 112.433 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.456 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 44.67 20.78 0.23 Allowed Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.727 -0.749 . . . . 74.24 112.542 -179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.406 ' N ' ' O ' ' A' ' 192' ' ' GLY . 2.3 m-20 -64.98 107.34 1.47 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.784 0.326 . . . . 72.42 110.892 -179.909 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.742 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -81.4 129.06 34.49 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.178 -0.465 . . . . 71.14 111.094 179.982 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.493 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.8 m170 -119.86 129.82 54.58 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.312 -0.403 . . . . 65.12 110.805 -179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.484 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 47.7 m-85 -114.47 133.9 55.41 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.204 -0.453 . . . . 55.21 110.876 -179.875 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.9 t0 -66.76 107.3 2.12 Favored 'General case' 0 C--N 1.327 -0.402 0 CA-C-N 116.128 -0.487 . . . . 75.13 110.769 -179.957 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -58.4 -37.51 75.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.12 -0.491 . . . . 75.22 110.794 -179.917 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.575 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 14.6 m-20 -50.48 -22.51 1.96 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.175 -0.466 . . . . 62.51 110.875 -179.902 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -80.79 162.96 23.82 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.184 -0.462 . . . . 62.31 110.853 -179.972 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.571 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -101.22 88.53 3.52 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.073 -0.512 . . . . 71.42 110.853 -179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.553 ' CZ3' HG21 ' A' ' 215' ' ' THR . 31.1 m95 -79.54 123.9 28.01 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.116 -0.493 . . . . 75.21 110.913 -179.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 25.1 p -142.7 -175.96 4.69 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.196 -0.457 . . . . 73.13 111.086 -179.977 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -111.12 21.45 16.35 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.188 -0.46 . . . . 73.54 111.158 179.967 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.0 m80 -128.29 -174.86 3.33 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.233 -0.44 . . . . 51.15 110.884 179.89 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 18.4 p -70.87 -19.2 62.65 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.238 -0.437 . . . . 65.45 110.758 -179.751 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.76 -105.23 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.261 0 C-N-CA 120.717 -0.754 . . . . 72.03 112.519 -179.962 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.571 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.5 177.23 0.11 Allowed Glycine 0 N--CA 1.452 -0.264 0 C-N-CA 120.735 -0.745 . . . . 42.14 112.503 -179.918 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 68.7 m -66.93 98.14 0.53 Allowed 'General case' 0 C--N 1.328 -0.357 0 CA-C-O 120.819 0.342 . . . . 72.32 111.107 -179.848 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -42.13 115.72 0.72 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.183 -0.462 . . . . 75.14 110.85 179.986 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.774 HD23 ' HB3' ' A' ' 133' ' ' ALA . 5.8 tp -63.93 -36.62 84.55 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.169 -0.469 . . . . 53.35 110.957 179.879 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.718 ' O ' HG23 ' A' ' 217' ' ' VAL . 4.5 t80 -51.93 -64.05 0.94 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 74.44 110.874 179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.434 HD11 ' H ' ' A' ' 243' ' ' VAL . 18.2 mt -56.1 -54.84 40.17 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.122 -0.49 . . . . 74.51 110.855 -179.923 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.553 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.5 m -54.5 -34.52 61.81 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.225 -0.443 . . . . 74.25 111.155 179.983 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.83 -49.35 66.04 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.202 -0.454 . . . . 54.45 111.069 179.915 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.848 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -52.81 -58.03 3.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.276 0 CA-C-N 116.326 -0.397 . . . . 74.54 111.17 179.932 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.64 ' HB2' HG13 ' A' ' 235' ' ' VAL . 4.3 t-80 -63.36 -30.81 71.88 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.083 -0.508 . . . . 73.3 110.799 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.414 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.48 -43.27 99.22 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.222 -0.445 . . . . 75.4 111.087 -179.981 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.636 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -71.65 -35.42 55.76 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.201 -0.454 . . . . 64.34 111.053 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.24 -43.95 43.18 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.644 -0.789 . . . . 74.21 112.515 179.919 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.464 ' O ' ' O ' ' A' ' 185' ' ' PHE . 31.5 m-70 -68.52 -39.52 81.17 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-O 120.825 0.345 . . . . 74.34 110.915 179.96 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.65 ' OG ' HG23 ' A' ' 159' ' ' ILE . 5.0 m -62.15 -27.39 68.92 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.177 -0.465 . . . . 73.44 110.843 -179.784 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.62 ' O ' HG23 ' A' ' 108' ' ' VAL . 68.2 mt -76.8 -27.23 55.14 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.167 -0.47 . . . . 73.55 110.911 -179.966 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.446 ' HA3' ' HB ' ' A' ' 108' ' ' VAL . . . 117.05 16.76 6.08 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.752 -0.737 . . . . 51.33 112.468 179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.899 HD11 HD13 ' A' ' 258' ' ' ILE . 32.3 mt -78.85 149.08 32.6 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-O 120.9 0.381 . . . . 62.42 110.874 -179.952 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.494 ' H ' ' HA ' ' A' ' 102' ' ' GLU . . . -90.94 -142.65 10.4 Favored Glycine 0 N--CA 1.451 -0.354 0 C-N-CA 120.733 -0.746 . . . . 65.31 112.487 179.931 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.445 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 0.4 OUTLIER -122.31 142.07 50.87 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-O 120.807 0.337 . . . . 72.41 110.833 -179.938 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 28.7 t -103.49 161.58 13.75 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.138 -0.483 . . . . 65.11 110.824 -179.763 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -106.25 -1.7 23.22 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.112 -0.495 . . . . 74.32 110.875 -179.86 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.621 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -62.3 140.91 96.37 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.564 0.697 . . . . 73.3 110.907 179.957 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.71 -2.78 10.71 Favored 'Trans proline' 0 N--CA 1.465 -0.155 0 C-N-CA 122.703 2.269 . . . . 70.2 112.367 -179.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 3.6 ptmt -143.85 21.07 1.8 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.2 -0.455 . . . . 71.42 110.898 -179.999 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.621 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -85.19 135.56 33.9 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.164 -0.471 . . . . 62.02 111.062 179.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.64 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.3 t -60.56 -35.68 64.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.226 -0.443 . . . . 54.04 111.105 179.98 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.445 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 41.1 mmm -65.44 -17.99 64.97 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.212 -0.449 . . . . 73.31 110.95 179.888 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.569 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.2 t80 -56.78 142.72 71.57 Favored Pre-proline 0 C--N 1.33 -0.272 0 CA-C-O 121.729 0.776 . . . . 72.32 110.896 -179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.569 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.6 Cg_endo -69.7 -1.4 8.36 Favored 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.669 2.246 . . . . 72.34 112.387 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.5 m -96.77 144.33 26.85 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.231 -0.441 . . . . 51.33 111.163 179.988 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 49.5 t80 -123.88 140.29 53.13 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.187 -0.461 . . . . 72.41 110.899 -179.918 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -160.42 135.31 7.71 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.172 -0.467 . . . . 70.54 110.899 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.564 ' O ' HG13 ' A' ' 243' ' ' VAL . 70.8 t80 -59.04 148.69 29.98 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.252 -0.431 . . . . 73.51 110.976 -179.984 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.564 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.3 OUTLIER -161.2 133.09 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.163 -0.471 . . . . 65.22 111.183 179.926 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 36.3 t0 -49.47 131.55 20.77 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.116 -0.493 . . . . 70.02 110.811 179.993 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 4.3 tt -54.44 -30.86 22.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.168 -0.469 . . . . 72.13 111.103 179.958 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 7.7 m-80 -77.41 -17.62 57.97 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.195 -0.457 . . . . 74.25 110.928 179.888 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 50.9 p -104.14 -23.06 13.32 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.19 -0.459 . . . . 74.4 111.107 -179.916 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 40.0 t80 -67.9 140.92 56.51 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.215 -0.448 . . . . 74.01 110.86 179.979 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.4 ptt85 -175.59 132.24 0.28 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.074 -0.512 . . . . 70.44 110.819 -179.922 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.64 HD12 HG11 ' A' ' 144' ' ' VAL . 26.9 mt -48.24 125.48 9.45 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.148 -0.478 . . . . 74.23 110.998 179.941 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.1 p -68.34 166.15 17.17 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.254 -0.43 . . . . 72.23 110.806 -179.845 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.32 -38.46 41.86 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.153 -0.476 . . . . 63.41 111.085 179.97 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 7.1 m-20 -63.34 -46.69 85.45 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.276 -0.42 . . . . 72.21 110.947 179.937 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.436 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 4.9 m-20 -62.22 -53.53 53.87 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.133 -0.485 . . . . 53.2 110.867 179.957 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.419 ' HA ' HG22 ' A' ' 258' ' ' ILE . 26.3 mt -59.99 -36.06 64.86 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.193 -0.458 . . . . 72.31 111.136 -179.975 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 14.8 mmt180 -68.23 -39.75 82.25 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.156 -0.474 . . . . 65.35 110.901 179.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.3 -53.17 5.74 Favored Glycine 0 N--CA 1.451 -0.307 0 C-N-CA 120.712 -0.756 . . . . 53.3 112.514 179.949 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.899 HD13 HD11 ' A' ' 226' ' ' LEU . 6.4 tp -52.21 -35.5 19.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-O 120.673 0.273 . . . . 74.54 111.083 179.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.413 ' O ' ' N ' ' A' ' 263' ' ' GLY . 70.0 mt-30 -85.81 -17.51 35.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.188 -0.46 . . . . 71.23 110.894 179.979 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 10.4 t -70.6 -13.63 62.17 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.213 -0.448 . . . . 75.3 110.817 -179.777 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 1.048 HD13 HG11 ' A' ' 108' ' ' VAL . 4.7 mt -122.35 -17.74 6.98 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.155 -0.475 . . . . 71.14 110.883 -179.965 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.751 ' CD2' HD11 ' A' ' 147' ' ' LEU . 33.3 m-85 -115.75 -34.77 4.71 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.259 -0.428 . . . . 73.23 110.987 179.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.413 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.279 0 CA-C-O 119.156 -0.802 . . . . 64.45 112.464 179.926 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 008 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.472 ' C ' ' HG2' ' A' ' 101' ' ' ARG . 10.6 m-85 . . . . . 0 C--O 1.231 0.083 0 CA-C-O 120.954 0.407 . . . . 74.35 110.939 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.472 ' HG2' ' C ' ' A' ' 100' ' ' PHE . 14.6 ptt180 34.25 48.53 0.27 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.149 -0.478 . . . . 75.34 110.784 -179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.435 ' HB3' ' O ' ' A' ' 101' ' ' ARG . 2.0 pp20? 179.1 135.2 0.09 Allowed 'General case' 0 C--N 1.331 -0.229 0 CA-C-N 116.166 -0.47 . . . . 75.24 110.808 -179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.9 mmm -50.9 143.93 14.41 Favored Pre-proline 0 C--N 1.328 -0.353 0 CA-C-O 121.544 0.688 . . . . 74.32 110.893 179.911 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.68 -23.7 30.87 Favored 'Trans proline' 0 N--CA 1.465 -0.162 0 C-N-CA 122.714 2.276 . . . . 70.42 112.407 179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -150.11 35.61 0.98 Allowed Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.795 -0.717 . . . . 71.41 112.521 179.978 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -107.42 91.38 0.69 Allowed Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.821 -0.704 . . . . 55.24 112.497 -179.897 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.406 ' O ' ' C ' ' A' ' 108' ' ' VAL . 53.0 Cg_endo -69.74 77.68 1.05 Allowed 'Trans proline' 0 C--O 1.233 0.229 0 C-N-CA 122.627 2.218 . . . . 73.42 112.299 -179.911 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.763 HG22 ' HA3' ' A' ' 225' ' ' GLY . 61.2 t -36.9 144.01 0.08 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.273 -0.421 . . . . 74.43 111.121 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 2.0 m0 -52.3 -31.02 31.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.153 -0.476 . . . . 75.21 110.866 -179.986 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.736 ' H ' HG12 ' A' ' 108' ' ' VAL . 16.1 mtp180 63.45 30.72 15.3 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.197 -0.456 . . . . 71.11 110.872 -179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.92 138.0 54.79 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.146 -0.479 . . . . 71.12 110.915 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.634 ' HA ' HD12 ' A' ' 147' ' ' LEU . 0.5 OUTLIER -84.09 43.55 0.94 Allowed 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 64.42 110.843 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.7 m-85 -143.73 82.69 1.73 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.242 -0.435 . . . . 72.12 110.963 -179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.632 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.2 mp -115.63 164.0 12.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.138 -0.483 . . . . 73.11 111.12 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.584 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -159.51 162.21 35.46 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.198 -0.456 . . . . 75.31 111.112 -179.967 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.605 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.5 p90 -133.13 148.79 52.12 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.242 -0.436 . . . . 74.45 110.904 -179.962 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.674 ' HE ' HD11 ' A' ' 160' ' ' LEU . 3.7 tmm_? -142.51 113.37 7.49 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.108 -0.496 . . . . 73.43 110.875 -179.997 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.4 mt -73.93 106.03 3.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.209 -0.45 . . . . 75.22 111.164 179.93 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.8 t-20 -59.24 -47.25 86.06 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.173 -0.467 . . . . 53.22 110.902 179.941 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.728 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.1 p-10 -143.29 162.88 34.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.145 -0.48 . . . . 74.15 110.857 179.985 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.602 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.2 m-85 -117.25 137.66 52.24 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.157 -0.474 . . . . 54.32 110.955 -179.919 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.731 HG22 ' CE ' ' A' ' 125' ' ' MET . 2.6 t -87.43 143.23 33.91 Favored Pre-proline 0 C--N 1.33 -0.281 0 CA-C-O 121.639 0.733 . . . . 72.2 111.128 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.414 ' HD2' ' OG1' ' A' ' 122' ' ' THR . 53.2 Cg_endo -69.88 -3.62 12.45 Favored 'Trans proline' 0 C--N 1.343 0.245 0 C-N-CA 122.588 2.192 . . . . 73.52 112.338 -179.994 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.44 ' H ' HG23 ' A' ' 122' ' ' THR . 15.7 m-20 -80.02 -23.74 41.27 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.163 -0.471 . . . . 65.25 110.875 179.859 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.731 ' CE ' HG22 ' A' ' 122' ' ' THR . 15.6 mtm -115.67 166.73 11.6 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.261 -0.427 . . . . 72.33 110.916 -179.951 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 9.3 m120 -97.69 143.93 27.84 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.255 -0.429 . . . . 72.12 110.92 -179.98 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.47 -35.09 3.55 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.146 -0.479 . . . . 72.45 110.869 -179.976 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 33.6 mt-10 -83.36 -38.65 21.72 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.227 -0.442 . . . . 73.2 110.914 179.991 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 32.3 m-20 -65.26 -30.48 71.36 Favored 'General case' 0 C--N 1.327 -0.398 0 CA-C-N 116.22 -0.445 . . . . 62.24 110.776 -179.985 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.602 HG11 ' CE2' ' A' ' 121' ' ' TYR . 60.8 t -65.31 -47.37 87.41 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.284 0 CA-C-N 116.168 -0.469 . . . . 50.21 111.22 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -77.99 -23.18 48.45 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.182 -0.463 . . . . 64.4 110.845 179.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -74.26 -46.71 39.7 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.233 -0.439 . . . . 73.42 110.95 -179.837 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.706 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -72.8 -31.48 64.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.16 -0.473 . . . . 71.1 111.116 179.796 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.55 HD13 ' O ' ' A' ' 130' ' ' VAL . 1.4 mp -71.95 -53.79 18.96 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.358 0 CA-C-N 116.228 -0.442 . . . . 74.21 111.152 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.537 ' N ' HG22 ' A' ' 134' ' ' ILE . 0.3 OUTLIER -48.92 -41.88 35.23 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.229 -0.441 . . . . 73.13 110.897 179.946 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.662 ' O ' HG23 ' A' ' 140' ' ' VAL . 8.0 mmpt? -70.97 -36.29 72.49 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.157 -0.474 . . . . 53.01 110.94 179.914 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.654 ' O ' HG13 ' A' ' 217' ' ' VAL . . . -59.05 -50.83 72.59 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.226 -0.443 . . . . 63.23 111.11 179.78 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.605 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 93.4 m-85 -69.92 -22.96 63.15 Favored 'General case' 0 C--N 1.327 -0.373 0 CA-C-N 116.249 -0.432 . . . . 74.24 110.926 -179.912 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.477 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.7 tt0 -77.52 -6.87 55.14 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.119 -0.491 . . . . 72.22 110.905 -179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.719 ' O ' HD11 ' A' ' 250' ' ' LEU . 91.5 t -96.08 -18.34 6.6 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.214 -0.448 . . . . 65.34 111.086 -179.95 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.874 ' NE1' HG12 ' A' ' 217' ' ' VAL . 96.1 m95 -106.02 -39.82 5.87 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.243 -0.435 . . . . 72.33 110.933 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -71.73 -9.79 58.8 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.21 -0.45 . . . . 72.31 110.859 -179.791 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.556 HD22 ' N ' ' A' ' 143' ' ' ASN . 1.1 m-80 -99.87 -7.92 24.7 Favored 'General case' 0 C--N 1.331 -0.216 0 CA-C-N 116.084 -0.507 . . . . 72.43 110.888 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.893 HG11 HD12 ' A' ' 250' ' ' LEU . 19.8 m -110.61 -5.24 11.13 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.152 -0.476 . . . . 74.45 111.152 179.915 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.744 ' CB ' HD23 ' A' ' 147' ' ' LEU . 44.8 p -141.36 149.62 55.3 Favored Pre-proline 0 C--N 1.331 -0.231 0 CA-C-O 121.555 0.693 . . . . 74.2 111.132 -179.947 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.77 34.85 0.21 Allowed 'Trans proline' 0 C--O 1.232 0.193 0 C-N-CA 122.726 2.284 . . . . 70.32 112.27 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.928 HD21 ' HB3' ' A' ' 262' ' ' TYR . 2.9 mm? -104.98 167.09 9.93 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.254 -0.43 . . . . 54.14 110.924 179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.9 mttm -131.12 127.93 39.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.201 -0.454 . . . . 54.21 110.932 179.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.632 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.3 m-30 -114.6 146.52 40.71 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.192 -0.458 . . . . 64.1 110.871 179.956 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.415 ' H ' ' HA ' ' A' ' 115' ' ' THR . 49.3 m -137.14 155.33 49.72 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 72.13 110.781 -179.72 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.475 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.4 OUTLIER -106.78 142.36 36.54 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.107 -0.497 . . . . 61.55 110.83 179.951 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.6 HD11 ' HB2' ' A' ' 157' ' ' ALA . 20.3 pt -151.26 147.97 15.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.196 -0.456 . . . . 71.13 111.197 179.789 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -120.81 12.67 11.37 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.202 -0.453 . . . . 63.4 110.924 179.924 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.8 t -173.53 49.73 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.125 -0.488 . . . . 74.42 111.094 -179.973 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.423 ' CA ' HD12 ' A' ' 152' ' ' ILE . . . -146.27 -149.63 5.03 Favored Glycine 0 N--CA 1.451 -0.301 0 C-N-CA 120.718 -0.753 . . . . 32.13 112.502 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -109.89 92.76 4.18 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-O 120.729 0.3 . . . . 74.43 110.93 -179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.6 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -103.31 154.79 19.0 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.243 -0.435 . . . . 43.0 111.097 179.96 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -84.25 -54.67 4.64 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.188 -0.46 . . . . 74.22 110.863 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.663 HG12 HG23 ' A' ' 220' ' ' ILE . 2.5 mp -87.34 92.8 3.89 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.136 -0.483 . . . . 72.41 111.123 179.999 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.674 HD11 ' HE ' ' A' ' 117' ' ' ARG . 7.4 tp -84.83 108.61 17.58 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.234 -0.439 . . . . 73.23 110.959 179.849 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.419 HG13 ' CE1' ' A' ' 197' ' ' PHE . 90.3 t -87.14 120.6 36.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.255 -0.429 . . . . 71.45 111.091 179.857 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.728 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.2 p -139.45 105.61 2.43 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.139 -0.482 . . . . 72.41 111.124 179.902 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 43.6 m-85 -73.23 108.17 5.96 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.194 -0.457 . . . . 63.43 110.908 -179.958 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.64 165.79 20.15 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.14 -0.482 . . . . 73.01 111.064 179.989 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -113.91 137.65 51.38 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.272 -0.422 . . . . 74.03 110.851 -179.832 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.68 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.49 -155.67 0.19 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.705 -0.76 . . . . 63.55 112.565 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.808 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -64.88 116.9 6.82 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-O 120.908 0.385 . . . . 74.54 111.126 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.696 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.17 -23.09 11.8 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.289 -0.414 . . . . 64.44 110.839 -179.927 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.92 29.7 0.51 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.723 -0.751 . . . . 42.41 112.486 -179.943 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.627 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.28 -0.17 14.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-O 120.804 0.335 . . . . 64.34 110.877 -179.989 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.1 m-85 74.26 39.72 0.47 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.182 -0.463 . . . . 62.11 110.924 -179.88 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.696 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.24 -41.29 0.73 Allowed 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.042 -0.526 . . . . 73.15 110.869 179.934 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.808 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.2 100.51 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.179 -0.464 . . . . 24.23 111.224 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.68 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.2 m-85 -60.71 -168.57 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.21 -0.45 . . . . 62.41 110.84 -179.872 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.8 18.95 3.52 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.118 -0.492 . . . . 72.41 110.827 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.65 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.46 -157.17 6.61 Favored Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.789 -0.72 . . . . 72.45 112.482 -179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.451 ' N ' ' HB3' ' A' ' 200' ' ' ASP . 5.7 tmtt? -34.42 133.86 0.23 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-O 120.856 0.36 . . . . 74.23 110.893 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.41 166.5 0.18 Allowed Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.681 -0.771 . . . . 65.43 112.565 179.963 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.18 -143.71 23.15 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.712 -0.756 . . . . 74.11 112.496 -179.982 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -49.99 96.02 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-O 120.896 0.379 . . . . 73.31 111.101 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 25.0 mt -65.51 -42.7 91.8 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 44.43 110.869 179.876 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.418 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -171.32 162.74 6.88 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.248 -0.433 . . . . 63.55 111.2 179.873 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.472 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.3 p80 -155.64 143.11 19.49 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.289 -0.414 . . . . 64.25 110.879 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.753 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -139.3 171.59 14.05 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.258 -0.428 . . . . 73.0 111.068 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.492 ' O ' ' O ' ' A' ' 222' ' ' HIS . 50.2 m-85 -98.67 -146.79 0.32 Allowed 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.127 -0.488 . . . . 75.42 110.834 -179.941 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -157.41 -101.44 0.18 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.797 -0.716 . . . . 63.14 112.552 -179.967 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.66 63.14 1.73 Allowed 'Trans proline' 0 C--N 1.341 0.17 0 C-N-CA 122.709 2.273 . . . . 73.33 112.361 -179.994 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.619 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.06 155.66 17.31 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.727 -0.749 . . . . 71.25 112.553 179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.589 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.94 150.19 24.43 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.859 0.361 . . . . 71.31 110.881 -179.737 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 59.35 -67.6 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.7 -0.762 . . . . 63.35 112.492 -179.966 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.589 ' N ' ' O ' ' A' ' 189' ' ' SER . 24.3 pt -104.48 7.84 9.86 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.419 0 CA-C-O 120.816 0.341 . . . . 74.2 111.174 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.619 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -64.32 162.37 36.76 Favored Glycine 0 N--CA 1.452 -0.295 0 C-N-CA 120.731 -0.747 . . . . 40.42 112.532 179.885 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.461 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 46.58 17.7 0.28 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.736 -0.745 . . . . 54.21 112.528 -179.897 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.401 ' N ' ' C ' ' A' ' 192' ' ' GLY . 1.7 m-20 -63.09 111.13 2.06 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-O 120.898 0.38 . . . . 61.2 110.859 -179.916 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.753 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -84.31 129.39 34.88 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.173 -0.467 . . . . 65.3 111.124 179.944 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.472 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.0 m170 -120.16 129.31 54.08 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.219 -0.446 . . . . 63.45 110.875 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.488 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 42.5 m-85 -114.52 133.71 55.58 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.246 -0.434 . . . . 74.23 110.88 -179.867 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.7 t0 -66.14 107.09 1.82 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.154 -0.476 . . . . 74.43 110.883 179.92 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -58.38 -37.41 75.19 Favored 'General case' 0 C--N 1.331 -0.225 0 CA-C-N 116.147 -0.479 . . . . 75.0 110.868 -179.845 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.65 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 9.9 m-20 -50.2 -23.62 2.32 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.092 -0.504 . . . . 65.41 110.81 -179.961 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.2 mm-40 -80.17 162.95 24.43 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.275 -0.421 . . . . 72.21 110.868 -179.955 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.572 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -100.67 89.91 4.07 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.159 -0.473 . . . . 72.51 110.819 -179.877 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.534 ' CZ3' HG21 ' A' ' 215' ' ' THR . 33.0 m95 -80.94 123.51 28.37 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.193 -0.458 . . . . 72.21 111.007 179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 23.0 p -141.18 -175.08 4.2 Favored 'General case' 0 C--N 1.331 -0.238 0 CA-C-N 116.225 -0.443 . . . . 75.43 111.118 -179.877 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.2 18.39 18.68 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.202 -0.454 . . . . 53.03 111.148 -179.937 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.87 -177.98 4.43 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.133 -0.485 . . . . 73.2 110.847 179.927 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 17.4 p -65.07 -19.15 65.85 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.227 -0.442 . . . . 74.11 110.814 -179.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.02 -108.53 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.706 -0.759 . . . . 73.21 112.446 -179.895 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.572 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.92 177.5 0.12 Allowed Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.795 -0.717 . . . . 74.45 112.525 -179.888 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 91.6 m -65.86 97.32 0.34 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-O 120.851 0.358 . . . . 75.14 111.156 -179.814 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -42.11 116.81 0.87 Allowed 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.223 -0.444 . . . . 75.42 110.903 -179.965 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.57 HD22 ' SD ' ' A' ' 125' ' ' MET . 11.8 tp -63.89 -38.46 91.17 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.192 -0.458 . . . . 43.51 110.964 179.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.706 ' CA ' ' HB1' ' A' ' 133' ' ' ALA . 2.3 t80 -49.25 -64.93 0.66 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.205 -0.452 . . . . 73.44 110.888 179.891 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.562 HD11 ' H ' ' A' ' 243' ' ' VAL . 21.8 mt -55.3 -54.95 37.14 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.238 -0.437 . . . . 73.33 110.873 -179.958 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.534 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.1 m -54.51 -31.75 56.76 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.182 -0.463 . . . . 74.43 111.082 -179.979 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.31 -48.88 60.27 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.255 -0.429 . . . . 72.34 111.169 179.833 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.874 HG12 ' NE1' ' A' ' 141' ' ' TRP . 0.6 OUTLIER -52.61 -57.85 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.17 -0.468 . . . . 72.53 111.051 180.0 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.743 ' HB2' HG13 ' A' ' 235' ' ' VAL . 2.0 t-80 -64.16 -30.21 71.28 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.087 -0.506 . . . . 71.35 110.889 -179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.455 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.3 -43.95 97.65 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.191 -0.459 . . . . 73.31 111.082 179.889 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.663 HG23 HG12 ' A' ' 159' ' ' ILE . 2.4 mt -70.59 -35.34 60.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.201 -0.454 . . . . 71.4 111.148 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -49.91 -44.61 40.76 Favored Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.708 -0.758 . . . . 73.45 112.533 179.878 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.492 ' O ' ' O ' ' A' ' 185' ' ' PHE . 34.1 m-70 -67.21 -40.19 86.39 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.832 0.349 . . . . 72.03 110.894 179.984 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.584 ' OG ' HG23 ' A' ' 159' ' ' ILE . 2.7 m -62.35 -26.25 68.35 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.211 -0.449 . . . . 71.5 110.885 -179.806 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.722 ' O ' HG13 ' A' ' 108' ' ' VAL . 72.9 mt -76.66 -27.87 55.78 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.129 -0.487 . . . . 72.31 110.911 -179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.763 ' HA3' HG22 ' A' ' 108' ' ' VAL . . . 120.44 18.57 4.05 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.673 -0.775 . . . . 71.03 112.51 179.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.848 HD21 ' HA ' ' A' ' 258' ' ' ILE . 13.3 mt -82.84 159.74 22.35 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-O 120.795 0.331 . . . . 75.42 110.948 -179.918 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -106.57 -135.23 7.92 Favored Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.758 -0.734 . . . . 72.13 112.477 179.908 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.427 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 1.6 m170 -127.64 143.83 51.13 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-O 120.83 0.348 . . . . 73.45 110.821 -179.953 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 62.2 m -108.95 163.52 13.22 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.128 -0.487 . . . . 74.14 110.86 -179.852 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -104.03 0.69 30.15 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 73.1 110.845 -179.807 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.571 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -65.18 136.57 96.62 Favored Pre-proline 0 C--N 1.328 -0.344 0 CA-C-O 121.629 0.728 . . . . 64.35 110.836 179.966 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.81 -0.46 6.99 Favored 'Trans proline' 0 C--N 1.342 0.215 0 C-N-CA 122.699 2.266 . . . . 71.1 112.346 -179.99 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.15 19.57 1.93 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.197 -0.456 . . . . 71.54 110.956 179.909 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.571 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -91.07 129.93 37.03 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.223 -0.444 . . . . 65.43 111.088 179.905 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.743 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.2 t -54.11 -34.93 27.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.202 -0.454 . . . . 62.4 111.163 179.97 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.427 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 39.7 mmm -62.16 -21.14 64.82 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.092 -0.504 . . . . 62.31 110.885 179.959 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.545 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -56.22 142.53 67.02 Favored Pre-proline 0 C--N 1.33 -0.282 0 CA-C-O 121.681 0.753 . . . . 72.5 110.831 -179.939 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.545 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.1 Cg_endo -69.73 -1.28 8.18 Favored 'Trans proline' 0 C--O 1.233 0.237 0 C-N-CA 122.691 2.26 . . . . 61.24 112.343 179.946 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.8 m -95.55 140.35 30.51 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.221 -0.445 . . . . 71.22 111.191 179.962 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 52.1 t80 -120.32 137.14 54.43 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.186 -0.461 . . . . 75.12 110.854 -179.841 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 45.5 mtmt -154.57 132.14 11.33 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.071 -0.513 . . . . 73.13 110.86 179.933 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.503 ' O ' HG13 ' A' ' 243' ' ' VAL . 88.4 t80 -59.65 142.85 52.09 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.93 -179.926 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.562 ' H ' HD11 ' A' ' 214' ' ' LEU . 0.8 OUTLIER -158.46 128.85 0.82 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.169 -0.469 . . . . 72.12 111.185 179.959 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 53.0 t0 -51.29 134.37 27.92 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.244 -0.434 . . . . 72.53 110.876 179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.449 HD11 ' HD3' ' A' ' 136' ' ' LYS . 10.8 tt -54.58 -30.13 21.54 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.259 0 CA-C-N 116.156 -0.475 . . . . 71.35 111.183 179.952 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.426 HD22 HG23 ' A' ' 247' ' ' THR . 0.3 OUTLIER -73.81 -18.1 60.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.182 -0.463 . . . . 71.51 110.924 179.893 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.426 HG23 HD22 ' A' ' 246' ' ' ASN . 28.1 p -107.56 -23.31 12.2 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.149 -0.478 . . . . 74.44 111.115 -179.935 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 50.9 t80 -68.64 146.43 53.02 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.275 -0.42 . . . . 73.51 110.833 -179.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 9.4 ptp180 -176.28 129.58 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.48 . . . . 73.4 110.802 -179.926 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.893 HD12 HG11 ' A' ' 144' ' ' VAL . 15.1 mt -48.99 131.99 18.79 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.146 -0.479 . . . . 75.33 110.955 179.991 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.475 ' O ' HD12 ' A' ' 255' ' ' ILE . 47.0 t -77.35 166.31 23.32 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.186 -0.461 . . . . 72.14 110.818 -179.895 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.03 -37.99 35.59 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.059 -0.519 . . . . 71.13 111.074 179.848 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -64.31 -45.01 89.78 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.219 -0.446 . . . . 72.35 110.852 -179.93 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 12.8 m-20 -61.37 -54.8 39.1 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.213 -0.449 . . . . 72.44 110.875 179.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.475 HD12 ' O ' ' A' ' 251' ' ' SER . 2.6 mp -60.76 -37.07 75.18 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.201 -0.454 . . . . 71.3 111.052 179.973 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 21.5 mmt180 -68.36 -37.77 80.78 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.245 -0.434 . . . . 73.01 110.881 -179.974 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.419 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -78.23 -51.23 5.81 Favored Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.682 -0.771 . . . . 44.51 112.456 -179.981 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.848 ' HA ' HD21 ' A' ' 226' ' ' LEU . 6.3 tp -52.8 -33.72 19.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-O 120.763 0.316 . . . . 61.54 111.159 -179.998 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.414 ' O ' ' N ' ' A' ' 263' ' ' GLY . 30.8 mt-30 -87.66 -16.49 34.25 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.137 -0.483 . . . . 73.12 110.855 -179.982 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.419 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 2.6 t -68.98 -16.24 63.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.194 -0.457 . . . . 74.42 110.856 -179.771 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.491 HD22 HG23 ' A' ' 108' ' ' VAL . 1.3 mt -121.13 -19.23 7.21 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.098 -0.501 . . . . 75.13 110.893 179.975 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.928 ' HB3' HD21 ' A' ' 147' ' ' LEU . 31.2 m-85 -110.45 -36.67 5.71 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.157 -0.474 . . . . 72.13 110.971 -180.0 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.414 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.294 0 C-N-CA 120.638 -0.791 . . . . 51.33 112.479 179.946 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 C--O 1.232 0.149 0 CA-C-O 120.847 0.356 . . . . 71.13 110.911 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -69.92 99.39 1.4 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.207 -0.451 . . . . 73.22 110.924 -179.878 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.595 ' HB3' HD11 ' A' ' 261' ' ' LEU . 2.6 pp20? -100.34 147.83 25.36 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.256 -0.429 . . . . 65.24 110.898 -179.876 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.417 ' HB3' ' HG3' ' A' ' 107' ' ' PRO . 4.5 mtt -48.48 151.98 1.78 Allowed Pre-proline 0 C--N 1.329 -0.294 0 CA-C-O 121.516 0.674 . . . . 72.12 110.899 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.83 135.42 30.25 Favored 'Trans proline' 0 N--CA 1.465 -0.186 0 C-N-CA 122.686 2.258 . . . . 70.24 112.299 -179.991 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . 0.403 ' O ' ' C ' ' A' ' 106' ' ' GLY . . . 86.22 19.98 56.03 Favored Glycine 0 N--CA 1.451 -0.321 0 C-N-CA 120.759 -0.734 . . . . 42.23 112.577 -179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.41 ' N ' ' CD ' ' A' ' 107' ' ' PRO . . . 38.32 54.61 2.1 Favored Glycine 0 N--CA 1.453 -0.218 0 C-N-CA 120.719 -0.753 . . . . 74.31 112.423 -179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.419 ' HB3' ' HG3' ' A' ' 187' ' ' PRO . 54.2 Cg_endo -69.82 -22.54 31.68 Favored 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.64 2.227 . . . . 75.03 112.339 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.856 HG11 HD22 ' A' ' 261' ' ' LEU . 5.8 p -46.81 122.78 0.99 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.218 -0.446 . . . . 74.53 111.105 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.576 ' CZ3' HD23 ' A' ' 224' ' ' LEU . 3.0 m0 -57.02 -32.19 65.9 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.2 -0.454 . . . . 75.54 110.911 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.549 ' HG3' HG13 ' A' ' 108' ' ' VAL . 11.7 mtt-85 62.92 35.55 13.35 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.247 -0.433 . . . . 64.01 110.894 -179.965 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.469 ' HG2' ' HB3' ' A' ' 109' ' ' TRP . 0.0 OUTLIER -121.76 168.02 12.3 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.185 -0.461 . . . . 74.31 110.96 179.955 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -107.55 36.05 2.86 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.275 -0.42 . . . . 60.35 110.822 179.973 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.401 ' C ' HD12 ' A' ' 114' ' ' ILE . 3.2 m-85 -140.59 108.95 5.82 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.152 -0.476 . . . . 62.01 110.881 -179.835 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.634 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.7 mp -142.48 164.01 17.74 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 73.33 111.111 179.91 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.605 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -160.37 163.13 33.43 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.198 -0.456 . . . . 64.21 111.155 179.973 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.572 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.2 p90 -134.2 153.97 51.53 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.299 -0.41 . . . . 70.24 110.888 -179.891 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.603 ' HD2' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -145.88 110.65 5.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.164 -0.471 . . . . 73.54 110.838 179.997 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 59.5 mt -73.14 106.0 2.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.291 0 CA-C-N 116.246 -0.433 . . . . 63.32 111.072 179.979 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.6 t30 -59.42 -51.03 71.65 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.267 -0.424 . . . . 74.23 110.933 179.878 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.682 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.7 p-10 -138.41 166.28 24.66 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.205 -0.452 . . . . 74.32 110.884 179.979 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -116.05 154.36 30.05 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.477 . . . . 75.12 110.919 -179.994 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.496 ' CG2' ' HD2' ' A' ' 123' ' ' PRO . 11.0 m -102.67 137.42 19.34 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.571 0.7 . . . . 74.11 111.149 -179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.496 ' HD2' ' CG2' ' A' ' 122' ' ' THR . 53.3 Cg_endo -69.67 3.45 2.72 Favored 'Trans proline' 0 C--N 1.341 0.145 0 C-N-CA 122.688 2.258 . . . . 65.01 112.362 179.924 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.47 ' H ' HG22 ' A' ' 122' ' ' THR . 2.1 m-20 -87.6 -28.59 21.82 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.189 -0.459 . . . . 74.31 110.797 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.595 ' SD ' HD22 ' A' ' 212' ' ' LEU . 5.8 mtm -110.19 167.01 10.5 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.207 -0.452 . . . . 74.33 110.861 -179.991 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 1.9 t-20 -90.14 142.58 27.57 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.25 -0.432 . . . . 73.43 110.878 -179.921 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -45.36 -37.07 4.63 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.199 -0.455 . . . . 75.03 110.898 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 9.0 pt-20 -82.53 -36.88 25.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.182 -0.463 . . . . 71.42 110.887 -179.969 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 37.2 m-20 -64.84 -32.0 73.5 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.148 -0.478 . . . . 62.4 110.868 179.99 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.569 HG22 ' HE3' ' A' ' 125' ' ' MET . 62.4 t -64.78 -43.86 96.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.222 -0.445 . . . . 70.05 111.124 179.983 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -82.4 -23.27 35.0 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.224 -0.444 . . . . 75.34 110.926 179.886 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.0 t80 -75.33 -48.1 24.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.123 -0.49 . . . . 73.44 110.865 -179.815 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.594 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -71.41 -30.67 66.36 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.175 -0.466 . . . . 62.12 111.088 179.901 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.62 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -73.09 -55.58 12.31 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.192 -0.458 . . . . 75.31 111.112 -179.917 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.531 ' N ' HG22 ' A' ' 134' ' ' ILE . 7.0 ttt180 -48.2 -41.75 28.07 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.214 -0.448 . . . . 74.42 110.835 179.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.454 ' O ' HG23 ' A' ' 140' ' ' VAL . 7.6 mmtt -75.66 -31.75 59.9 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.213 -0.449 . . . . 72.31 110.873 179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.656 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -61.9 -50.83 70.62 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.303 -0.408 . . . . 61.42 111.119 179.79 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.655 ' HE2' HD13 ' A' ' 159' ' ' ILE . 75.5 m-85 -66.21 -30.89 71.43 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.217 -0.447 . . . . 75.12 110.972 179.971 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.593 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 3.7 tt0 -63.99 -42.62 97.14 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.477 . . . . 72.14 110.87 -179.952 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.454 HG23 ' O ' ' A' ' 136' ' ' LYS . 74.1 t -50.23 -24.43 2.1 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-N 116.207 -0.451 . . . . 54.11 111.088 -179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.806 ' NE1' HG12 ' A' ' 217' ' ' VAL . 98.1 m95 -98.1 -30.35 12.72 Favored 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.185 -0.461 . . . . 75.44 110.967 179.978 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 12.8 t -72.52 -14.74 61.72 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.188 -0.46 . . . . 63.44 110.863 -179.813 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.593 ' ND2' ' O ' ' A' ' 139' ' ' GLN . 63.7 m-80 -89.32 -25.71 21.5 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.079 -0.51 . . . . 41.23 110.914 -179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.6 HG21 ' CD1' ' A' ' 250' ' ' LEU . 7.0 m -94.74 2.82 9.37 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.155 -0.475 . . . . 71.11 111.132 179.882 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.472 ' C ' ' H ' ' A' ' 147' ' ' LEU . 23.6 p -154.45 142.61 14.26 Favored Pre-proline 0 C--N 1.328 -0.336 0 CA-C-O 121.502 0.667 . . . . 61.44 111.191 179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.69 19.26 0.18 Allowed 'Trans proline' 0 C--O 1.233 0.231 0 C-N-CA 122.685 2.257 . . . . 71.43 112.414 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.794 HD21 ' CG ' ' A' ' 262' ' ' TYR . 0.6 OUTLIER -74.27 -177.57 3.07 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.215 -0.448 . . . . 75.53 110.903 -179.965 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.4 mttm -144.4 124.52 13.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.219 -0.446 . . . . 71.34 110.91 179.84 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.634 ' HE1' HD13 ' A' ' 114' ' ' ILE . 2.4 m-85 -116.79 140.2 49.71 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.238 -0.437 . . . . 72.43 110.815 -179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.5 t -136.21 145.33 45.58 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.191 -0.459 . . . . 64.52 110.821 -179.872 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.478 ' HG3' ' N ' ' A' ' 152' ' ' ILE . 0.0 OUTLIER -93.7 144.25 25.58 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.104 -0.498 . . . . 64.01 110.857 179.946 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.605 HD11 ' HB2' ' A' ' 157' ' ' ALA . 11.4 pt -150.65 130.49 3.69 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.243 -0.435 . . . . 43.11 111.127 179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 3.1 m120 -98.12 -7.5 29.45 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.138 -0.483 . . . . 73.21 110.893 179.946 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.9 t -157.13 60.19 0.51 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.163 -0.471 . . . . 65.33 111.111 179.925 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.434 ' C ' HD12 ' A' ' 152' ' ' ILE . . . -151.81 -155.79 7.16 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.752 -0.737 . . . . 50.05 112.482 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.19 97.67 7.4 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.794 0.331 . . . . 74.41 110.919 179.956 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.605 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -107.23 157.7 17.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.241 -0.436 . . . . 74.44 111.075 179.915 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.92 -50.87 7.14 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.088 -0.505 . . . . 64.11 110.92 179.939 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.694 HG12 HG23 ' A' ' 220' ' ' ILE . 2.9 mp -92.65 96.52 6.3 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.185 -0.461 . . . . 72.42 111.098 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.603 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.3 tp -87.26 110.49 20.23 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.225 -0.443 . . . . 75.32 110.961 179.793 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.459 ' HA ' ' O ' ' A' ' 195' ' ' ALA . 88.2 t -88.54 119.07 35.21 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.225 0 CA-C-N 116.112 -0.494 . . . . 74.24 111.139 179.829 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.682 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.1 p -138.38 106.18 3.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.263 0 CA-C-N 116.197 -0.456 . . . . 74.34 111.125 179.945 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.448 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 34.4 m-85 -75.88 111.78 11.6 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.135 -0.484 . . . . 74.13 110.901 -179.96 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -130.93 172.7 11.75 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.211 -0.45 . . . . 63.52 111.106 179.885 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.431 ' CG ' ' HB3' ' A' ' 199' ' ' GLU . 9.1 mtt180 -115.54 139.57 49.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.155 -0.475 . . . . 62.23 110.912 -179.94 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.664 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 39.28 -149.05 0.11 Allowed Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.773 -0.727 . . . . 74.14 112.476 -179.974 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.802 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -69.4 117.02 10.5 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-O 120.866 0.365 . . . . 74.51 111.125 179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.43 -20.65 13.05 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.205 -0.452 . . . . 64.13 110.91 -179.933 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.12 29.79 0.65 Allowed Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.783 -0.722 . . . . 74.44 112.496 -179.971 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.636 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.2 0.28 14.85 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.82 0.343 . . . . 74.41 110.812 -179.929 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.7 m-85 74.1 38.73 0.54 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.263 -0.426 . . . . 75.21 110.895 -179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.703 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.2 -41.74 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.17 -0.468 . . . . 73.15 110.876 -179.972 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.802 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.52 99.82 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.209 -0.45 . . . . 74.01 111.046 179.858 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.664 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -60.5 -168.36 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.325 -0.398 . . . . 71.3 110.865 -179.928 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -136.15 19.88 3.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.166 -0.47 . . . . 71.24 110.907 179.995 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.571 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 53.74 -157.94 5.18 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.727 -0.749 . . . . 71.13 112.536 -179.936 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.437 ' C ' ' O ' ' A' ' 176' ' ' GLY . 9.9 tttt -34.58 134.43 0.21 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.811 0.339 . . . . 71.54 110.937 179.948 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.55 165.77 0.17 Allowed Glycine 0 N--CA 1.45 -0.392 0 C-N-CA 120.663 -0.78 . . . . 40.41 112.508 179.897 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.3 -143.45 22.84 Favored Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.734 -0.746 . . . . 73.22 112.553 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -49.66 96.53 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.36 0 CA-C-O 120.875 0.369 . . . . 71.13 111.154 -179.995 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 84.4 mt -65.96 -42.49 89.86 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.198 -0.455 . . . . 64.42 110.962 179.845 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.425 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -171.11 166.69 7.29 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.288 -0.414 . . . . 45.1 111.091 179.769 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.516 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -159.68 140.74 12.54 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.134 -0.485 . . . . 63.43 110.831 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.759 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -135.94 173.14 12.04 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.189 -0.46 . . . . 71.52 111.086 179.938 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.571 ' O ' ' HA ' ' A' ' 223' ' ' SER . 10.4 m-85 -104.66 -151.82 0.45 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.206 -0.452 . . . . 64.04 110.837 -179.877 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.412 ' H ' ' HB3' ' A' ' 185' ' ' PHE . . . -161.29 -81.74 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.745 -0.74 . . . . 53.31 112.531 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.419 ' HG3' ' HB3' ' A' ' 107' ' ' PRO . 52.3 Cg_endo -69.87 53.92 1.17 Allowed 'Trans proline' 0 C--N 1.342 0.184 0 C-N-CA 122.639 2.226 . . . . 65.42 112.333 -179.899 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.567 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -124.15 147.37 16.56 Favored Glycine 0 N--CA 1.451 -0.337 0 C-N-CA 120.775 -0.726 . . . . 54.04 112.487 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.526 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.63 144.2 31.75 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-O 120.937 0.399 . . . . 74.24 110.81 -179.738 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.46 -63.12 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.721 -0.752 . . . . 74.22 112.506 -179.942 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.526 ' N ' ' O ' ' A' ' 189' ' ' SER . 2.2 pp -106.2 9.54 9.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.924 0.392 . . . . 75.52 111.133 -179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.567 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -70.72 171.43 44.65 Favored Glycine 0 N--CA 1.45 -0.405 0 C-N-CA 120.734 -0.746 . . . . 70.11 112.45 179.994 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.44 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 44.24 20.44 0.18 Allowed Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.734 -0.745 . . . . 75.23 112.476 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.422 ' N ' ' O ' ' A' ' 192' ' ' GLY . 4.1 m-20 -64.24 108.59 1.62 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.776 0.322 . . . . 72.43 110.954 179.989 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.759 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -82.14 121.7 26.93 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.463 . . . . 64.31 111.1 179.959 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.516 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.7 m170 -112.13 130.42 55.9 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.258 -0.428 . . . . 75.32 110.893 179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.48 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 46.6 m-85 -115.23 136.12 53.44 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.184 -0.462 . . . . 62.01 110.897 -179.931 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 26.1 t0 -69.29 104.03 2.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.164 -0.471 . . . . 73.11 110.827 -179.944 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.431 ' HB3' ' CG ' ' A' ' 165' ' ' ARG . 4.2 tm-20 -55.87 -37.99 69.53 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.193 -0.458 . . . . 73.24 110.863 -179.859 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.571 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 12.7 m-20 -49.26 -22.72 1.12 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.117 -0.492 . . . . 54.25 110.836 179.963 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.4 mm-40 -81.05 161.13 24.32 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.262 -0.426 . . . . 73.43 110.867 -179.905 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.491 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -97.95 89.83 4.7 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.118 -0.492 . . . . 74.21 110.919 -179.938 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.537 ' CZ3' HG21 ' A' ' 215' ' ' THR . 28.3 m95 -81.54 123.11 28.37 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 73.35 110.905 -179.955 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 1.9 p -135.56 -174.23 3.58 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.292 -0.413 . . . . 70.24 111.225 179.903 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.53 12.78 18.67 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.279 -0.419 . . . . 64.12 111.167 -179.925 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 5.4 p-80 -131.04 -176.0 3.86 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.196 -0.456 . . . . 75.24 110.897 179.948 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.2 p -51.25 -36.06 40.13 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.246 -0.433 . . . . 63.31 110.835 -179.762 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -64.08 159.64 39.95 Favored Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.704 -0.76 . . . . 70.41 112.451 -179.935 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.491 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . 49.15 -173.71 0.05 OUTLIER Glycine 0 N--CA 1.45 -0.396 0 C-N-CA 120.707 -0.759 . . . . 54.43 112.597 -179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 47.7 m -85.66 93.44 8.84 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.76 0.314 . . . . 75.45 111.122 -179.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.8 t-20 -38.91 111.47 0.18 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.182 -0.463 . . . . 72.22 110.822 179.982 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.62 HD21 HD13 ' A' ' 134' ' ' ILE . 9.0 tp -60.18 -36.78 78.39 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.162 -0.472 . . . . 74.14 110.869 179.957 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.594 ' CA ' ' HB1' ' A' ' 133' ' ' ALA . 3.6 t80 -51.97 -62.8 1.4 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.185 -0.462 . . . . 71.45 110.935 179.926 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.547 HD11 ' H ' ' A' ' 243' ' ' VAL . 31.6 mt -57.52 -52.4 65.56 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.192 -0.458 . . . . 71.22 110.93 -179.988 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.537 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 1.7 m -53.64 -38.07 63.72 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.221 -0.445 . . . . 53.34 111.137 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.429 ' HB3' ' CB ' ' A' ' 137' ' ' ALA . . . -61.74 -51.92 66.36 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.121 -0.491 . . . . 65.32 111.09 179.879 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.806 HG12 ' NE1' ' A' ' 141' ' ' TRP . 1.4 t -50.21 -58.87 1.32 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.191 -0.458 . . . . 61.41 111.154 -179.992 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.65 ' HB2' HG13 ' A' ' 235' ' ' VAL . 2.8 t-80 -62.86 -31.81 72.91 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 73.31 110.854 179.913 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . . . . . . . . . . . -62.37 -43.29 99.18 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.227 -0.442 . . . . 42.34 111.121 179.896 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.694 HG23 HG12 ' A' ' 159' ' ' ILE . 2.4 mt -70.51 -33.43 53.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.232 -0.44 . . . . 75.51 111.093 179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.92 -43.45 48.8 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.738 -0.744 . . . . 34.52 112.474 179.909 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.428 ' O ' ' O ' ' A' ' 185' ' ' PHE . 47.8 m-70 -68.37 -39.73 81.67 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.734 0.302 . . . . 74.31 110.814 -179.898 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.601 ' OG ' HG23 ' A' ' 159' ' ' ILE . 2.0 m -62.16 -26.7 68.48 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.187 -0.46 . . . . 74.33 110.902 -179.772 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.576 HD23 ' CZ3' ' A' ' 109' ' ' TRP . 79.5 mt -77.25 -26.55 52.65 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.125 -0.489 . . . . 75.01 110.934 179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 112.16 22.05 6.04 Favored Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.766 -0.731 . . . . 54.42 112.487 179.853 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.742 HD11 ' HA ' ' A' ' 258' ' ' ILE . 0.1 OUTLIER -87.66 146.86 25.52 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.9 0.381 . . . . 74.11 110.887 -179.833 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.417 ' H ' ' HA ' ' A' ' 102' ' ' GLU . . . -88.04 -160.12 35.4 Favored Glycine 0 N--CA 1.449 -0.455 0 C-N-CA 120.731 -0.747 . . . . 73.3 112.546 179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -102.57 125.97 49.48 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.778 0.323 . . . . 71.22 110.872 -179.977 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 5.4 m -80.55 162.77 24.15 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.223 -0.444 . . . . 71.23 110.836 -179.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.82 -1.1 19.49 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.494 . . . . 70.5 110.894 -179.832 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.638 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -63.44 142.75 97.9 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.582 0.706 . . . . 54.22 110.88 179.927 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.8 -4.24 13.66 Favored 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.637 2.224 . . . . 63.11 112.344 -179.968 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -144.68 23.61 1.58 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.194 -0.457 . . . . 64.42 110.867 179.897 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.638 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -81.54 143.0 32.32 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.277 -0.42 . . . . 71.21 111.068 179.866 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.65 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.3 t -65.78 -38.91 83.33 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.219 -0.446 . . . . 74.15 111.146 179.942 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 83.1 mmm -68.57 -12.27 61.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.146 -0.479 . . . . 65.23 110.878 179.874 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.657 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.5 t80 -57.8 145.1 72.28 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.582 0.706 . . . . 70.44 110.892 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.657 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.8 Cg_endo -69.77 0.89 5.0 Favored 'Trans proline' 0 C--O 1.231 0.174 0 C-N-CA 122.666 2.244 . . . . 75.43 112.372 179.944 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 24.6 m -101.72 143.91 31.07 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.225 -0.443 . . . . 73.13 111.101 -179.987 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 55.3 t80 -123.11 138.31 54.7 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.197 -0.456 . . . . 74.35 110.915 -179.901 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 12.5 ptmm? -157.13 129.61 7.46 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.167 -0.469 . . . . 74.22 110.854 179.959 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.576 ' O ' HG13 ' A' ' 243' ' ' VAL . 86.3 t80 -59.66 145.83 43.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.246 -0.433 . . . . 74.23 110.949 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.576 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.3 OUTLIER -161.21 131.27 0.79 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.315 0 CA-C-N 116.175 -0.466 . . . . 65.41 111.143 179.911 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -52.72 133.67 36.68 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.053 -0.521 . . . . 75.11 110.924 179.918 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 13.2 tt -53.69 -30.19 18.4 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.371 0 CA-C-N 116.289 -0.414 . . . . 74.22 111.151 179.975 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.667 ' ND2' HG23 ' A' ' 247' ' ' THR . 0.0 OUTLIER -69.84 -20.26 63.43 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.198 -0.455 . . . . 73.24 110.96 179.847 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.667 HG23 ' ND2' ' A' ' 246' ' ' ASN . 6.3 p -110.45 -21.24 12.27 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.173 -0.467 . . . . 63.24 111.175 -179.972 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 45.3 t80 -69.4 142.13 53.97 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.21 -0.45 . . . . 73.14 110.905 179.997 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 12.9 ptm180 -176.5 133.69 0.22 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.14 -0.482 . . . . 72.3 110.927 -179.877 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.6 ' CD1' HG21 ' A' ' 144' ' ' VAL . 40.0 mt -47.52 123.58 5.92 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.22 -0.445 . . . . 74.11 110.987 -179.981 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 7.1 t -58.3 158.36 7.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.234 -0.439 . . . . 62.33 110.954 -179.949 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.52 -30.49 8.48 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.226 -0.443 . . . . 74.54 111.07 179.898 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 8.4 t0 -72.89 -45.69 56.83 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.22 -0.445 . . . . 75.24 110.846 -179.978 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 2.8 m-20 -62.12 -41.26 98.06 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.166 -0.47 . . . . 64.41 110.845 -179.939 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.463 HG12 HG11 ' A' ' 144' ' ' VAL . 42.8 mt -69.6 -43.36 80.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.248 -0.433 . . . . 75.33 111.145 179.997 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -69.07 -28.99 67.01 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.136 -0.484 . . . . 74.1 110.919 179.9 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.42 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -85.06 -49.77 4.36 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.648 -0.787 . . . . 60.34 112.527 -179.999 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.742 ' HA ' HD11 ' A' ' 226' ' ' LEU . 4.4 tp -54.22 -32.06 23.0 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.734 0.302 . . . . 74.02 111.123 179.964 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.461 ' O ' ' N ' ' A' ' 263' ' ' GLY . 69.6 mt-30 -86.72 -17.58 33.31 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.186 -0.461 . . . . 74.52 110.942 179.954 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.42 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 2.4 t -67.79 -14.35 62.88 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.269 -0.423 . . . . 75.15 110.896 -179.873 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.856 HD22 HG11 ' A' ' 108' ' ' VAL . 4.5 mt -121.8 -19.68 6.68 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.177 -0.465 . . . . 53.32 110.932 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.794 ' CG ' HD21 ' A' ' 147' ' ' LEU . 42.5 m-85 -113.41 -35.19 5.36 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.15 -0.477 . . . . 74.24 110.871 -179.941 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.461 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 C--O 1.229 -0.218 0 CA-C-O 119.199 -0.778 . . . . 43.4 112.471 179.976 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 4.1 t80 . . . . . 0 C--O 1.231 0.129 0 CA-C-O 120.881 0.372 . . . . 74.43 110.914 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER 177.6 -174.19 0.13 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.145 -0.479 . . . . 52.52 110.898 -179.919 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.811 ' HB3' HD11 ' A' ' 261' ' ' LEU . 0.0 OUTLIER -39.23 147.81 0.06 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.195 -0.457 . . . . 65.23 110.944 -179.956 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.28 158.97 0.9 Allowed Pre-proline 0 C--N 1.327 -0.37 0 CA-C-O 121.548 0.689 . . . . 61.11 110.85 179.996 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.87 68.95 1.73 Allowed 'Trans proline' 0 C--N 1.341 0.159 0 C-N-CA 122.629 2.219 . . . . 62.44 112.273 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 111.04 30.93 3.02 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.774 -0.727 . . . . 71.34 112.457 179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -112.73 75.32 0.23 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.777 -0.725 . . . . 72.35 112.442 -179.864 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.71 107.79 1.93 Allowed 'Trans proline' 0 C--O 1.232 0.215 0 C-N-CA 122.68 2.254 . . . . 52.33 112.373 -179.973 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.763 HG12 ' HA3' ' A' ' 225' ' ' GLY . 18.5 m -50.83 170.45 0.05 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.274 0 CA-C-N 116.273 -0.421 . . . . 73.14 111.115 179.938 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.467 ' CZ3' HD23 ' A' ' 224' ' ' LEU . 2.7 m-90 -56.32 -19.77 15.91 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.13 -0.486 . . . . 75.33 111.006 179.918 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.72 ' H ' HG23 ' A' ' 108' ' ' VAL . 6.7 mtt180 66.0 28.4 10.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.194 -0.457 . . . . 74.51 110.862 -179.972 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 4.2 mtmm -121.53 146.1 47.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.263 -0.426 . . . . 72.21 110.899 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.536 ' HA ' HD22 ' A' ' 147' ' ' LEU . 14.2 p80 -94.04 19.82 8.67 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.198 -0.455 . . . . 64.01 110.939 179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.1 m-85 -123.77 95.23 4.49 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.153 -0.476 . . . . 73.31 110.892 -179.869 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.636 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.8 mp -121.93 162.53 21.24 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.102 -0.499 . . . . 53.12 111.144 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.591 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -156.87 164.77 37.69 Favored 'General case' 0 C--N 1.331 -0.222 0 CA-C-N 116.12 -0.491 . . . . 73.04 111.073 179.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.594 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.4 p90 -134.81 148.57 50.22 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.251 -0.431 . . . . 74.41 110.835 -179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.438 ' HB3' HD12 ' A' ' 160' ' ' LEU . 4.2 tmt_? -140.72 110.71 6.54 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.02 -0.536 . . . . 72.52 110.908 179.958 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 57.0 mt -73.11 104.8 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.202 -0.453 . . . . 52.31 111.049 -179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -56.41 -48.97 75.84 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.158 -0.474 . . . . 70.42 110.836 179.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.74 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.8 p-10 -143.54 163.57 32.8 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.189 -0.46 . . . . 75.22 110.876 -179.943 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.569 ' CE2' HG11 ' A' ' 130' ' ' VAL . 4.9 m-85 -116.38 138.47 51.32 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.128 -0.487 . . . . 71.52 110.903 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.646 HG22 ' CE ' ' A' ' 125' ' ' MET . 9.1 t -87.86 141.95 32.0 Favored Pre-proline 0 C--N 1.329 -0.295 0 CA-C-O 121.55 0.69 . . . . 74.44 111.154 179.955 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.78 -3.77 12.69 Favored 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.638 2.226 . . . . 61.2 112.363 179.936 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 33.8 m-20 -78.43 -23.3 46.68 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 74.14 110.93 179.867 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.659 ' CE ' HG22 ' A' ' 130' ' ' VAL . 12.7 mtm -116.79 166.78 11.75 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.151 -0.477 . . . . 71.11 110.9 179.983 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.461 ' O ' HG23 ' A' ' 130' ' ' VAL . 23.9 t-20 -94.46 144.01 25.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.239 -0.437 . . . . 62.14 110.867 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 34.6 mtp180 -45.42 -36.92 4.64 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.186 -0.461 . . . . 44.02 110.86 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 5.5 pt-20 -82.57 -36.14 26.51 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.216 -0.447 . . . . 72.43 110.919 -179.987 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.7 m-20 -66.99 -30.17 70.21 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.166 -0.47 . . . . 73.4 110.828 -179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.659 HG22 ' CE ' ' A' ' 125' ' ' MET . 82.0 t -66.57 -46.35 86.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.193 -0.458 . . . . 65.43 111.142 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.428 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 0.4 OUTLIER -77.54 -24.72 49.85 Favored 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.187 -0.46 . . . . 71.43 110.796 179.944 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -73.22 -47.84 40.04 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.201 -0.454 . . . . 73.42 110.856 -179.776 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.747 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -69.36 -31.42 69.84 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.175 -0.466 . . . . 51.24 111.122 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.626 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -74.26 -53.46 17.15 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.343 0 CA-C-N 116.199 -0.455 . . . . 71.01 111.102 -179.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.509 ' N ' HG22 ' A' ' 134' ' ' ILE . 7.0 ptp180 -49.22 -37.2 22.24 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.189 -0.459 . . . . 73.35 110.806 179.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.641 ' O ' HG23 ' A' ' 140' ' ' VAL . 7.3 mmtt -76.88 -34.47 57.78 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.267 -0.424 . . . . 74.03 110.869 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.931 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -59.98 -48.66 80.79 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.216 -0.447 . . . . 72.22 111.082 179.878 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.623 ' HE2' HD13 ' A' ' 159' ' ' ILE . 94.1 m-85 -72.5 -22.69 61.01 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.229 -0.441 . . . . 72.04 110.899 -179.897 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.487 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.2 OUTLIER -77.13 -5.5 49.27 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.115 -0.493 . . . . 71.4 110.89 -179.95 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.641 HG23 ' O ' ' A' ' 136' ' ' LYS . 84.1 t -98.74 -17.05 6.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.201 -0.454 . . . . 74.33 111.125 179.922 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.808 ' NE1' HG12 ' A' ' 217' ' ' VAL . 94.1 m95 -107.01 -37.03 6.44 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.209 -0.451 . . . . 73.3 110.906 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -71.78 -11.81 60.99 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.262 -0.427 . . . . 62.42 110.88 -179.829 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.604 HD22 ' N ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER -94.99 -17.09 22.24 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.159 -0.473 . . . . 75.52 110.912 179.981 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.684 HG11 HD12 ' A' ' 250' ' ' LEU . 21.2 m -98.76 2.19 10.49 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.139 -0.482 . . . . 65.43 111.098 179.945 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.548 HG21 HG13 ' A' ' 258' ' ' ILE . 51.4 p -151.66 149.49 24.13 Favored Pre-proline 0 C--N 1.33 -0.265 0 CA-C-O 121.525 0.679 . . . . 23.03 111.219 -179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.77 32.01 0.19 Allowed 'Trans proline' 0 C--O 1.232 0.183 0 C-N-CA 122.698 2.265 . . . . 61.33 112.386 179.95 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.788 HD11 ' CD2' ' A' ' 262' ' ' TYR . 13.2 mt -97.8 175.92 5.99 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.21 -0.45 . . . . 75.03 110.929 179.948 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.4 mttm -140.1 125.53 19.01 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.172 -0.467 . . . . 74.1 110.954 179.818 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.636 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.2 m-30 -114.39 139.88 49.13 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.212 -0.449 . . . . 71.45 110.864 -179.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.1 m -134.94 149.4 50.24 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.214 -0.448 . . . . 65.54 110.906 -179.82 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.472 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 1.8 tttt -95.58 148.22 22.74 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.104 -0.498 . . . . 61.34 110.883 179.934 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.543 HD11 ' HB2' ' A' ' 157' ' ' ALA . 3.6 pt -152.46 165.06 1.87 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.248 -0.433 . . . . 74.11 111.153 179.866 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -137.45 17.94 2.92 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.236 -0.438 . . . . 43.51 110.99 179.899 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 1.1 p -94.63 -49.62 5.55 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.062 -0.517 . . . . 64.11 111.235 179.999 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.432 ' H ' HD12 ' A' ' 152' ' ' ILE . . . 139.6 8.2 0.97 Allowed Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.765 -0.731 . . . . 65.2 112.49 179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.405 ' O ' HD13 ' A' ' 152' ' ' ILE . 23.7 mtm -108.17 75.78 1.01 Allowed 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.766 0.317 . . . . 64.31 110.907 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.543 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -145.69 163.78 33.84 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.232 -0.44 . . . . 53.23 111.118 179.879 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.67 -53.12 5.59 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.198 -0.455 . . . . 75.42 110.846 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.771 HG12 HG23 ' A' ' 220' ' ' ILE . 2.3 mp -90.53 97.61 7.39 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 71.23 111.165 -179.982 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.438 HD12 ' HB3' ' A' ' 117' ' ' ARG . 8.5 tp -89.29 109.3 20.21 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.201 -0.454 . . . . 64.35 110.875 179.99 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.428 HG13 ' CE1' ' A' ' 197' ' ' PHE . 95.7 t -89.06 123.49 41.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.211 -0.45 . . . . 71.53 111.122 179.855 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.74 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -142.64 107.8 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.165 -0.47 . . . . 72.32 111.144 179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 32.6 m-85 -77.18 109.3 10.93 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.237 -0.438 . . . . 71.03 110.87 -179.945 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -130.56 169.76 15.16 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.269 -0.423 . . . . 41.24 111.09 179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . 0.498 ' HG3' ' HB3' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -112.88 139.22 48.7 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.243 -0.435 . . . . 74.42 110.826 -179.883 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.664 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 41.43 -150.87 0.2 Allowed Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.667 -0.778 . . . . 64.53 112.457 -179.984 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.8 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -68.04 117.93 10.54 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.723 0.297 . . . . 55.43 111.163 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.706 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.79 -21.56 12.62 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.312 -0.404 . . . . 55.31 110.906 -179.972 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.08 29.54 0.61 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.738 -0.744 . . . . 62.04 112.499 -179.967 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.621 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.73 -0.32 15.07 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-O 120.88 0.372 . . . . 54.52 110.825 -179.927 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.6 m-85 74.76 38.67 0.46 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.177 -0.465 . . . . 74.23 110.87 -179.884 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.706 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -134.29 -41.24 0.81 Allowed 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.111 -0.495 . . . . 73.33 110.898 179.983 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.8 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 55.04 99.97 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.183 -0.462 . . . . 63.22 111.106 179.913 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.664 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.7 m-85 -60.73 -166.86 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.181 -0.463 . . . . 72.13 110.829 -179.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -139.59 19.5 2.53 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.056 -0.52 . . . . 65.42 110.862 -179.977 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.585 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.7 -157.53 6.73 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.756 -0.735 . . . . 62.25 112.453 -179.935 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.405 ' C ' ' O ' ' A' ' 176' ' ' GLY . 12.4 mmtm -36.7 135.15 0.44 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-O 120.764 0.316 . . . . 75.23 110.917 179.976 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.76 162.85 0.15 Allowed Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.7 -0.762 . . . . 33.23 112.521 179.932 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.53 -140.01 20.02 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.68 -0.772 . . . . 54.0 112.513 -179.879 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 2.6 mt -49.92 93.46 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-O 120.819 0.342 . . . . 71.03 111.206 179.969 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.665 HD11 HG21 ' A' ' 210' ' ' THR . 1.7 tm? -67.44 -33.34 74.94 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.204 -0.453 . . . . 74.41 110.944 179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -178.89 169.31 1.6 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.17 -0.468 . . . . 35.14 111.06 179.769 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.505 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.3 p80 -165.28 139.43 4.82 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.143 -0.48 . . . . 74.2 110.855 -179.907 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.726 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -137.93 173.47 11.6 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.267 -0.424 . . . . 32.44 111.125 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.488 ' O ' ' O ' ' A' ' 222' ' ' HIS . 10.2 m-85 -98.85 -141.98 0.32 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-O 121.006 0.432 . . . . 74.33 110.809 -179.877 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -164.42 -101.13 0.15 Allowed Glycine 0 N--CA 1.451 -0.336 0 C-N-CA 120.736 -0.745 . . . . 72.4 112.507 179.975 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.73 61.42 1.72 Allowed 'Trans proline' 0 C--N 1.342 0.193 0 C-N-CA 122.66 2.24 . . . . 63.14 112.349 -179.96 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.601 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.94 154.66 16.74 Favored Glycine 0 N--CA 1.451 -0.31 0 C-N-CA 120.736 -0.745 . . . . 64.02 112.442 -179.963 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.569 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.05 147.95 26.8 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-O 120.938 0.399 . . . . 63.52 110.821 -179.704 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 60.66 -67.2 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.752 -0.737 . . . . 53.13 112.545 -179.956 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.569 ' N ' ' O ' ' A' ' 189' ' ' SER . 5.2 mm -103.39 6.58 10.19 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-O 120.901 0.381 . . . . 70.11 111.118 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.601 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -64.14 165.43 30.81 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.8 -0.714 . . . . 71.52 112.483 179.906 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.425 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 45.35 19.17 0.22 Allowed Glycine 0 N--CA 1.45 -0.394 0 C-N-CA 120.735 -0.745 . . . . 73.45 112.471 -179.925 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.423 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 0.8 OUTLIER -63.5 105.5 0.78 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.885 0.374 . . . . 62.24 110.846 179.971 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.726 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -81.84 131.65 35.26 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.211 -0.45 . . . . 72.42 111.127 179.926 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.505 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 7.7 m170 -122.82 129.77 52.09 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.249 -0.432 . . . . 75.3 110.884 179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.58 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 34.1 m-85 -115.5 135.5 54.03 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.292 -0.413 . . . . 75.33 110.963 179.993 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 59.6 t0 -69.36 106.82 3.06 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.166 -0.47 . . . . 71.11 110.961 179.942 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.498 ' HB3' ' HG3' ' A' ' 165' ' ' ARG . 3.9 tm-20 -58.35 -37.53 75.35 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.157 -0.474 . . . . 75.51 110.916 -179.872 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.585 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 14.9 m-20 -49.18 -23.22 1.21 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.088 -0.506 . . . . 64.51 110.852 -179.986 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -79.75 163.4 24.5 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.184 -0.462 . . . . 64.3 110.88 -179.935 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.493 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.2 OUTLIER -96.9 96.35 8.47 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.148 -0.478 . . . . 73.42 110.855 -179.879 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.58 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 34.0 m95 -87.89 123.89 33.11 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.154 -0.475 . . . . 64.22 110.891 -179.94 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 5.8 p -143.73 -179.13 6.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.243 -0.435 . . . . 54.32 111.127 -179.887 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -109.24 18.64 20.29 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.216 -0.447 . . . . 54.32 111.128 -179.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.85 -175.51 3.56 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.216 -0.447 . . . . 63.44 110.796 179.975 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 24.1 p -66.91 -18.11 65.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.191 -0.458 . . . . 62.54 110.835 -179.765 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.95 -108.7 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.61 -0.805 . . . . 42.23 112.538 179.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.493 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.04 178.18 0.12 Allowed Glycine 0 N--CA 1.452 -0.296 0 C-N-CA 120.818 -0.706 . . . . 73.34 112.492 -179.911 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.665 HG21 HD11 ' A' ' 181' ' ' LEU . 96.3 m -66.08 97.42 0.37 Allowed 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.809 0.338 . . . . 72.25 111.044 -179.842 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -41.48 111.93 0.27 Allowed 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.278 -0.419 . . . . 75.21 110.843 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.747 HD23 ' HB3' ' A' ' 133' ' ' ALA . 9.6 tp -58.8 -38.08 77.8 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.145 -0.48 . . . . 73.32 110.869 179.971 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.771 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.7 t80 -52.5 -64.28 0.87 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.212 -0.449 . . . . 61.41 110.845 179.989 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.458 HD11 ' H ' ' A' ' 243' ' ' VAL . 19.3 mt -52.45 -56.22 16.55 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 75.04 110.92 -179.978 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.423 ' O ' ' HB2' ' A' ' 219' ' ' ALA . 3.0 m -54.87 -37.93 66.88 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.215 -0.448 . . . . 74.55 111.164 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.06 -48.28 79.36 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.236 -0.438 . . . . 32.45 111.059 179.881 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.931 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.1 t -53.84 -58.52 3.26 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.168 -0.469 . . . . 54.41 111.182 179.988 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.753 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.7 t-80 -64.78 -27.65 69.04 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.191 -0.459 . . . . 71.24 110.931 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.423 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -64.14 -44.77 91.14 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.126 -0.488 . . . . 73.11 111.074 179.87 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.771 HG23 HG12 ' A' ' 159' ' ' ILE . 2.6 mt -69.33 -34.54 63.11 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.183 -0.462 . . . . 70.55 111.16 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.46 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -52.43 -45.25 58.99 Favored Glycine 0 N--CA 1.451 -0.308 0 C-N-CA 120.698 -0.763 . . . . 64.22 112.494 179.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.488 ' O ' ' O ' ' A' ' 185' ' ' PHE . 3.8 m-70 -68.49 -40.22 81.0 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.784 0.326 . . . . 73.42 110.847 -179.98 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.484 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 29.8 p -65.39 -21.29 66.66 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.195 -0.457 . . . . 75.12 110.84 -179.785 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.467 HD23 ' CZ3' ' A' ' 109' ' ' TRP . 59.6 mt -79.81 -26.84 40.37 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.18 -0.464 . . . . 61.51 110.941 179.981 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.763 ' HA3' HG12 ' A' ' 108' ' ' VAL . . . 122.35 12.88 5.0 Favored Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.699 -0.762 . . . . 54.04 112.447 179.951 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.509 HD21 ' HA ' ' A' ' 258' ' ' ILE . 11.3 mt -81.71 156.09 25.2 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-O 120.83 0.348 . . . . 72.11 110.933 -179.874 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -99.89 -140.5 11.43 Favored Glycine 0 N--CA 1.45 -0.384 0 C-N-CA 120.797 -0.716 . . . . 65.51 112.493 179.924 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -120.91 141.98 50.13 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-O 120.853 0.359 . . . . 70.41 110.808 179.994 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 60.9 p -99.16 163.05 12.72 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.19 -0.459 . . . . 72.2 110.904 -179.826 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.67 1.22 21.07 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 55.32 110.824 -179.802 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -76.17 132.35 73.69 Favored Pre-proline 0 C--N 1.327 -0.377 0 CA-C-O 121.553 0.692 . . . . 74.5 110.864 179.903 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . 0.403 ' HG2' ' HE2' ' A' ' 233' ' ' LYS . 52.8 Cg_endo -69.87 4.15 2.4 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.638 2.225 . . . . 51.22 112.321 -179.928 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . 0.403 ' HE2' ' HG2' ' A' ' 232' ' ' PRO . 0.0 OUTLIER -136.01 11.12 3.34 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.228 -0.442 . . . . 74.03 110.884 179.891 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . . . . . . . . . . . -88.82 150.22 23.02 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.222 -0.445 . . . . 73.15 111.151 179.829 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.753 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -71.73 -39.67 69.01 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.326 0 CA-C-N 116.224 -0.444 . . . . 71.11 111.136 179.993 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 48.0 mmm -61.73 -15.12 37.96 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.189 -0.46 . . . . 74.14 110.861 179.933 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.618 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -56.53 144.49 63.66 Favored Pre-proline 0 C--N 1.328 -0.345 0 CA-C-O 121.649 0.738 . . . . 75.43 110.9 -179.956 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.618 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.0 Cg_endo -69.84 -1.75 9.06 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.582 2.188 . . . . 63.2 112.313 -179.964 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 22.0 m -97.88 141.07 31.32 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.279 -0.419 . . . . 75.23 111.19 179.978 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 51.0 t80 -122.64 135.36 54.58 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.255 -0.43 . . . . 54.53 110.932 -179.893 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 36.8 tttm -156.27 137.04 13.37 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.144 -0.48 . . . . 60.44 110.905 179.862 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.504 ' O ' HG13 ' A' ' 243' ' ' VAL . 66.4 t80 -59.2 146.28 39.66 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 73.14 110.997 179.97 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.504 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.6 OUTLIER -158.96 133.01 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.253 0 CA-C-N 116.185 -0.461 . . . . 75.32 111.082 179.966 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 49.7 t0 -51.13 129.32 23.93 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.132 -0.485 . . . . 71.44 110.835 179.915 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.42 HD12 ' CE2' ' A' ' 213' ' ' PHE . 9.7 tt -53.84 -30.88 19.79 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.211 -0.449 . . . . 74.43 111.157 179.946 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 10.9 m-80 -73.43 -21.15 60.54 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.159 -0.473 . . . . 71.52 110.926 179.94 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 69.8 p -104.05 -22.41 13.44 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.165 -0.471 . . . . 61.43 111.176 -179.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 45.2 t80 -67.03 141.86 57.39 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.17 -0.468 . . . . 74.14 110.91 179.986 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 9.7 ptm180 -175.41 132.41 0.29 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.128 -0.487 . . . . 74.54 110.83 -179.898 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.684 HD12 HG11 ' A' ' 144' ' ' VAL . 55.5 mt -49.89 122.78 7.01 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.198 -0.456 . . . . 75.32 110.907 179.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 8.6 t -65.96 167.21 10.09 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.233 -0.44 . . . . 73.51 110.898 -179.997 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.01 -38.05 35.63 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.12 -0.491 . . . . 53.51 111.048 179.948 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.5 m-20 -61.86 -49.12 77.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.152 -0.476 . . . . 65.53 110.826 -179.994 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.436 ' OD2' ' HB ' ' A' ' 235' ' ' VAL . 2.0 m-20 -59.25 -55.79 30.37 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.244 -0.435 . . . . 73.44 110.813 -179.914 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 18.3 mt -59.68 -33.46 52.14 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.149 -0.478 . . . . 61.01 111.201 179.97 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 4.3 mmm180 -69.2 -41.06 77.61 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 71.24 110.874 179.947 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.84 -49.87 7.43 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.75 -0.738 . . . . 73.34 112.542 -179.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.548 HG13 HG21 ' A' ' 145' ' ' THR . 7.5 tp -53.08 -33.67 20.15 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.321 0 CA-C-O 120.72 0.295 . . . . 73.43 111.098 -179.884 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.412 ' O ' ' N ' ' A' ' 263' ' ' GLY . 52.8 mt-30 -88.21 -16.21 33.88 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.132 -0.485 . . . . 75.33 110.933 179.876 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.7 t -69.54 -14.16 62.71 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.215 -0.448 . . . . 73.2 110.826 -179.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.811 HD11 ' HB3' ' A' ' 102' ' ' GLU . 0.8 OUTLIER -123.99 -18.65 5.89 Favored 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.144 -0.48 . . . . 75.44 110.934 179.96 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.788 ' CD2' HD11 ' A' ' 147' ' ' LEU . 41.1 m-85 -114.3 -32.88 5.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.164 -0.471 . . . . 74.35 110.896 -179.979 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.412 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.369 0 CA-C-O 119.22 -0.767 . . . . 64.12 112.468 -179.972 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 21.8 m-85 . . . . . 0 C--O 1.231 0.099 0 CA-C-O 120.808 0.337 . . . . 70.24 110.902 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -73.38 69.85 1.18 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.149 -0.478 . . . . 73.31 110.905 -179.896 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 176.86 126.79 0.04 OUTLIER 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.189 -0.46 . . . . 74.45 110.968 -179.867 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 34.1 ttm -50.88 130.6 29.2 Favored Pre-proline 0 C--N 1.329 -0.291 0 CA-C-O 121.594 0.712 . . . . 63.3 110.855 -179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.78 67.1 1.77 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.661 2.241 . . . . 61.31 112.414 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -160.97 21.9 0.23 Allowed Glycine 0 N--CA 1.452 -0.28 0 C-N-CA 120.805 -0.712 . . . . 75.32 112.507 179.989 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . 90.97 -156.3 24.32 Favored Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.682 -0.77 . . . . 60.14 112.431 -179.942 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.487 ' HA ' HD22 ' A' ' 261' ' ' LEU . 53.5 Cg_endo -69.85 137.67 35.74 Favored 'Trans proline' 0 C--N 1.342 0.227 0 C-N-CA 122.692 2.261 . . . . 73.32 112.344 -179.903 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.868 HG12 ' HA3' ' A' ' 225' ' ' GLY . 0.0 OUTLIER -44.0 -84.72 0.0 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.227 -0.442 . . . . 72.51 111.116 179.974 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.706 ' CZ3' HD23 ' A' ' 224' ' ' LEU . 30.5 m0 -133.22 -31.43 1.25 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.162 -0.472 . . . . 72.14 110.824 179.986 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 56.7 mtp180 72.29 19.84 4.27 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.295 -0.412 . . . . 70.12 110.911 -179.898 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 20.2 pttt -122.63 138.23 54.66 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.205 -0.452 . . . . 64.21 110.841 -179.993 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.615 ' HA ' HD12 ' A' ' 147' ' ' LEU . 2.1 p80 -93.79 42.38 1.1 Allowed 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.212 -0.449 . . . . 71.13 110.894 179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 4.9 m-85 -144.62 90.94 2.12 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.187 -0.461 . . . . 74.41 110.972 -179.799 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.587 HG22 ' N ' ' A' ' 115' ' ' THR . 5.0 mp -121.09 162.49 19.88 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.167 -0.469 . . . . 75.5 111.216 179.914 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.587 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.2 OUTLIER -160.09 162.71 34.13 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.271 -0.422 . . . . 62.34 111.102 179.949 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.594 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.1 p90 -133.4 149.71 51.82 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.108 -0.496 . . . . 74.42 110.952 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.688 ' HD2' HD11 ' A' ' 160' ' ' LEU . 3.9 tmt_? -142.5 115.06 8.53 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.142 -0.481 . . . . 72.35 110.823 -179.927 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 52.7 mt -75.35 103.43 3.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.268 -0.424 . . . . 70.43 111.128 179.975 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 46.7 t-20 -57.15 -45.72 83.35 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.206 -0.452 . . . . 74.21 110.933 179.879 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.736 ' OD1' HG23 ' A' ' 162' ' ' VAL . 1.7 p-10 -145.01 161.38 39.53 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.253 -0.431 . . . . 65.24 110.914 179.983 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.57 ' CD2' HG11 ' A' ' 130' ' ' VAL . 4.7 m-85 -115.53 134.05 55.44 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.22 -0.446 . . . . 62.0 110.906 -179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.708 HG22 ' CE ' ' A' ' 125' ' ' MET . 2.3 t -82.41 142.05 46.32 Favored Pre-proline 0 C--N 1.331 -0.235 0 CA-C-O 121.55 0.691 . . . . 72.55 111.195 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.89 -5.78 17.11 Favored 'Trans proline' 0 C--N 1.341 0.169 0 C-N-CA 122.646 2.231 . . . . 64.25 112.308 -179.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 40.3 m-20 -77.07 -22.15 53.32 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.233 -0.439 . . . . 62.43 110.876 179.902 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.708 ' CE ' HG22 ' A' ' 122' ' ' THR . 18.2 mtm -117.74 167.15 11.63 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.227 -0.442 . . . . 71.12 110.884 -179.991 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.41 ' O ' HG23 ' A' ' 130' ' ' VAL . 45.6 t30 -94.09 143.17 26.6 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.265 -0.425 . . . . 74.35 110.934 -179.959 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 5.6 ptm180 -44.72 -35.23 2.57 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.226 -0.443 . . . . 70.44 110.853 -179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 87.9 mt-10 -84.26 -38.35 20.59 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.172 -0.467 . . . . 74.13 110.932 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.7 m-20 -65.7 -30.02 70.64 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.201 -0.454 . . . . 63.24 110.783 -179.998 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.612 HG22 ' CE ' ' A' ' 125' ' ' MET . 79.7 t -66.79 -46.78 84.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.232 -0.44 . . . . 32.13 111.07 -179.881 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.45 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 0.6 OUTLIER -77.22 -24.29 51.27 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.252 -0.431 . . . . 61.25 110.894 179.928 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -73.89 -47.01 41.03 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.21 -0.45 . . . . 64.11 110.91 -179.774 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.886 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -68.93 -32.19 71.63 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.148 -0.478 . . . . 63.14 111.134 179.778 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.616 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -74.72 -53.65 16.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.195 -0.457 . . . . 71.04 111.161 179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.526 ' N ' HG22 ' A' ' 134' ' ' ILE . 6.8 ptp180 -49.18 -38.07 24.59 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.181 -0.463 . . . . 72.33 110.937 179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.652 ' O ' HG23 ' A' ' 140' ' ' VAL . 1.6 mmtp -77.18 -31.93 55.77 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.135 -0.484 . . . . 74.35 110.916 179.928 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.917 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -61.58 -49.14 77.82 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.182 -0.463 . . . . 43.15 111.066 179.848 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.665 ' HE2' HD13 ' A' ' 159' ' ' ILE . 95.6 m-85 -72.82 -22.09 60.86 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.257 -0.429 . . . . 74.01 110.844 -179.845 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.49 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 0.6 OUTLIER -77.4 -5.54 50.12 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.141 -0.481 . . . . 61.14 110.888 -179.88 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.652 HG23 ' O ' ' A' ' 136' ' ' LYS . 97.8 t -98.11 -17.21 6.81 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.245 0 CA-C-N 116.182 -0.463 . . . . 73.23 111.152 -179.962 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.855 ' NE1' HG12 ' A' ' 217' ' ' VAL . 95.9 m95 -106.87 -37.19 6.43 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.104 -0.498 . . . . 73.51 110.906 179.945 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.25 -10.84 60.32 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.219 -0.446 . . . . 73.13 110.815 -179.774 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.59 HD22 ' N ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER -97.07 -19.4 18.73 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.159 -0.473 . . . . 65.1 110.939 -179.975 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.81 HG11 HD12 ' A' ' 250' ' ' LEU . 18.3 m -100.23 -2.27 9.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.249 0 CA-C-N 116.167 -0.47 . . . . 71.22 111.075 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.739 ' CB ' HD23 ' A' ' 147' ' ' LEU . 34.3 p -142.39 147.45 43.36 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.517 0.675 . . . . 72.43 111.212 -179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.79 34.72 0.21 Allowed 'Trans proline' 0 C--O 1.232 0.19 0 C-N-CA 122.649 2.233 . . . . 60.25 112.336 179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.909 HD21 ' HB3' ' A' ' 262' ' ' TYR . 3.0 mm? -104.57 166.47 10.37 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.188 -0.46 . . . . 61.43 110.883 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 2.1 mttm -128.99 125.69 37.93 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.209 -0.45 . . . . 50.43 110.926 179.824 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.46 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.3 m-30 -114.55 143.49 44.9 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.17 -0.468 . . . . 70.01 110.909 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.405 ' H ' ' HA ' ' A' ' 115' ' ' THR . 44.4 m -140.75 148.24 40.37 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 75.1 110.821 -179.755 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.424 ' HD2' ' CD2' ' A' ' 116' ' ' TYR . 12.4 tptm -97.36 146.13 25.47 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.207 -0.451 . . . . 75.42 110.813 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.614 HD11 ' N ' ' A' ' 157' ' ' ALA . 16.3 pt -150.31 142.85 17.31 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.144 -0.48 . . . . 62.15 111.076 179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.5 m120 -112.02 3.31 17.33 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.125 -0.489 . . . . 65.41 111.007 179.801 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 7.3 t -166.5 52.29 0.08 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.141 -0.481 . . . . 73.14 111.167 -179.971 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.494 ' CA ' HD12 ' A' ' 152' ' ' ILE . . . -145.87 -156.19 6.79 Favored Glycine 0 C--N 1.33 0.244 0 C-N-CA 120.726 -0.749 . . . . 60.24 112.436 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 30.9 mmt -106.18 88.74 2.86 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 120.761 0.315 . . . . 71.05 110.907 -179.941 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.614 ' N ' HD11 ' A' ' 152' ' ' ILE . . . -96.37 153.26 17.92 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.192 -0.458 . . . . 61.31 111.141 179.905 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.51 -52.87 6.44 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.227 -0.442 . . . . 65.1 110.813 -179.886 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.724 HG12 HG23 ' A' ' 220' ' ' ILE . 2.4 mp -91.52 97.96 7.83 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.174 -0.466 . . . . 75.05 111.151 179.992 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.688 HD11 ' HD2' ' A' ' 117' ' ' ARG . 6.9 tp -88.8 110.69 21.24 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.176 -0.466 . . . . 73.42 110.947 179.887 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 90.6 t -88.81 119.51 36.08 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.195 -0.457 . . . . 70.51 111.16 179.796 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.736 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -138.82 104.52 2.4 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.231 0 CA-C-N 116.174 -0.467 . . . . 72.12 111.238 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 54.1 m-85 -70.98 110.48 5.71 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.181 -0.463 . . . . 64.03 110.891 -179.934 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -130.32 166.38 20.51 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.153 -0.476 . . . . 51.41 111.054 179.964 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 21.3 ptt-85 -114.7 140.0 49.22 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.204 -0.453 . . . . 55.32 110.82 -179.925 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.664 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 41.39 -150.85 0.2 Allowed Glycine 0 N--CA 1.451 -0.328 0 C-N-CA 120.761 -0.733 . . . . 63.4 112.471 -179.955 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.804 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -70.21 117.33 11.63 Favored 'General case' 0 C--N 1.33 -0.255 0 CA-C-O 120.773 0.32 . . . . 71.1 111.122 -179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.698 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.99 -21.09 12.79 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.27 -0.423 . . . . 75.13 110.778 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.29 29.4 0.66 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.761 -0.733 . . . . 64.33 112.587 -179.863 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.646 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.46 0.03 15.43 Favored 'General case' 0 C--N 1.327 -0.381 0 CA-C-O 120.78 0.324 . . . . 74.21 110.863 -179.919 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.9 m-85 74.32 38.95 0.5 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.134 -0.485 . . . . 75.33 110.916 -179.873 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.698 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.74 -41.02 0.77 Allowed 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.144 -0.48 . . . . 70.42 110.849 179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.804 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 53.44 99.22 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.224 -0.444 . . . . 61.24 111.098 179.96 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.664 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.9 m-85 -59.88 -168.77 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 53.3 110.861 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.59 19.11 3.59 Favored 'General case' 0 C--N 1.327 -0.404 0 CA-C-N 116.195 -0.457 . . . . 74.41 110.96 -179.995 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.591 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.62 -157.09 6.88 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.758 -0.734 . . . . 74.2 112.48 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.426 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.1 OUTLIER -35.23 134.46 0.27 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.836 0.351 . . . . 61.51 110.89 -179.931 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.45 165.44 0.15 Allowed Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.659 -0.781 . . . . 54.32 112.467 179.918 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.96 -143.34 22.13 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.726 -0.749 . . . . 53.42 112.447 179.955 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -49.95 97.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-O 120.869 0.366 . . . . 73.43 111.166 -179.982 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 30.9 mt -67.75 -38.65 83.76 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.177 -0.465 . . . . 73.3 110.946 179.952 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.431 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -172.72 167.87 5.24 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.196 -0.456 . . . . 54.01 111.047 179.721 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.522 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -161.13 143.04 12.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.262 -0.426 . . . . 74.34 110.89 -179.988 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.667 ' HB1' ' HB2' ' A' ' 223' ' ' SER . . . -134.94 176.44 8.66 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.304 -0.407 . . . . 74.1 111.048 179.964 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.436 ' O ' ' O ' ' A' ' 222' ' ' HIS . 7.9 m-85 -100.77 -120.37 0.16 Allowed 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.2 -0.455 . . . . 71.41 110.947 -179.943 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.559 ' HA2' ' O ' ' A' ' 223' ' ' SER . . . 166.75 -92.74 0.1 Allowed Glycine 0 N--CA 1.45 -0.372 0 C-N-CA 120.715 -0.755 . . . . 44.51 112.501 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.91 55.37 1.33 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.615 2.21 . . . . 62.13 112.369 -179.972 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.57 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.32 151.52 16.93 Favored Glycine 0 N--CA 1.451 -0.351 0 C-N-CA 120.729 -0.748 . . . . 53.51 112.401 179.997 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.525 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.82 145.1 30.6 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.898 0.38 . . . . 72.21 110.82 -179.719 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.63 -65.18 0.02 OUTLIER Glycine 0 N--CA 1.453 -0.221 0 C-N-CA 120.7 -0.762 . . . . 64.03 112.37 179.901 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.525 ' N ' ' O ' ' A' ' 189' ' ' SER . 1.9 mp -103.63 6.81 10.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-O 120.855 0.36 . . . . 70.42 111.126 -179.919 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.57 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -66.82 170.43 32.69 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.782 -0.723 . . . . 34.21 112.485 179.925 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.516 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 42.66 24.74 0.26 Allowed Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.722 -0.751 . . . . 74.05 112.455 -179.879 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -68.87 102.23 1.52 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-O 120.775 0.321 . . . . 65.4 110.911 179.99 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.582 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -77.21 128.78 34.98 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.29 -0.414 . . . . 54.42 111.073 -179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.522 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 8.5 m170 -118.53 131.15 56.23 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.249 -0.432 . . . . 73.51 110.827 -179.965 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.459 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 51.4 m-85 -115.23 134.74 54.87 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.112 -0.495 . . . . 75.32 110.858 -179.935 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.3 t0 -67.57 109.07 3.1 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.089 -0.505 . . . . 63.43 110.802 -179.986 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.2 tm-20 -60.55 -37.19 80.45 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.224 -0.444 . . . . 73.33 111.005 -179.983 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.591 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 5.0 m-20 -50.41 -22.68 1.97 Allowed 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.106 -0.497 . . . . 72.14 110.825 179.951 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -79.84 163.17 24.6 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.25 -0.432 . . . . 74.11 110.889 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.565 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -100.64 88.23 3.56 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.166 -0.47 . . . . 72.32 110.938 -179.929 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.533 ' HZ3' HG21 ' A' ' 215' ' ' THR . 33.6 m95 -79.48 124.71 28.72 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.196 -0.457 . . . . 72.51 110.944 -179.985 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 22.7 p -142.6 -177.79 5.46 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.252 -0.431 . . . . 74.43 111.178 -179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -110.07 19.76 18.64 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.459 . . . . 72.52 111.219 179.974 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -129.11 -175.62 3.62 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.177 -0.465 . . . . 74.44 110.914 179.958 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 5.9 p -68.77 -18.31 64.19 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.274 -0.421 . . . . 74.44 110.826 -179.737 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.18 -107.26 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.667 -0.777 . . . . 72.23 112.515 179.999 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.565 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.42 176.87 0.12 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.763 -0.732 . . . . 72.13 112.428 -179.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 94.3 m -64.89 97.37 0.22 Allowed 'General case' 0 C--N 1.33 -0.254 0 CA-C-O 120.757 0.313 . . . . 74.44 111.2 -179.939 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.2 t-20 -41.45 116.42 0.76 Allowed 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.21 -0.45 . . . . 74.04 110.888 179.969 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.886 HD23 ' HB3' ' A' ' 133' ' ' ALA . 8.6 tp -64.12 -38.39 90.89 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.12 -0.491 . . . . 51.33 110.916 179.95 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.801 ' O ' HG23 ' A' ' 217' ' ' VAL . 4.1 t80 -51.97 -66.9 0.3 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.221 -0.445 . . . . 73.22 110.939 179.949 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.477 HD11 ' H ' ' A' ' 243' ' ' VAL . 21.9 mt -52.84 -54.96 26.93 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.141 -0.482 . . . . 54.24 110.879 -179.982 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.618 ' O ' ' HB2' ' A' ' 219' ' ' ALA . 5.1 m -54.8 -37.19 65.77 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.252 -0.431 . . . . 63.2 111.092 179.963 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -65.81 -50.57 64.16 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.224 -0.443 . . . . 74.14 111.115 179.9 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.917 HG22 ' HA ' ' A' ' 137' ' ' ALA . 1.8 t -52.42 -56.61 6.21 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 74.0 111.106 179.954 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.792 ' HB2' HG22 ' A' ' 235' ' ' VAL . 1.8 t-80 -69.12 -26.49 64.93 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.171 -0.468 . . . . 63.32 110.904 179.904 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.618 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -64.83 -45.22 87.1 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.227 -0.442 . . . . 71.14 111.126 179.876 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.724 HG23 HG12 ' A' ' 159' ' ' ILE . 3.1 mt -67.68 -37.41 78.59 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.254 -0.43 . . . . 65.31 111.149 179.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.494 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -52.57 -46.39 58.84 Favored Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.804 -0.712 . . . . 74.5 112.428 179.895 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.436 ' O ' ' O ' ' A' ' 185' ' ' PHE . 2.5 m-70 -69.39 -38.64 78.09 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.798 0.332 . . . . 70.4 110.824 -179.865 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.667 ' HB2' ' HB1' ' A' ' 184' ' ' ALA . 0.3 OUTLIER -74.8 -9.77 58.87 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-O 121.005 0.431 . . . . 55.43 110.934 -179.828 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.706 HD23 ' CZ3' ' A' ' 109' ' ' TRP . 13.5 mt -90.1 -25.9 20.5 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.123 -0.49 . . . . 72.45 110.923 -179.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.868 ' HA3' HG12 ' A' ' 108' ' ' VAL . . . 124.48 12.94 4.0 Favored Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.785 -0.722 . . . . 63.32 112.529 179.952 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.847 HD11 ' HA ' ' A' ' 258' ' ' ILE . 0.2 OUTLIER -85.61 160.99 19.48 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-O 120.829 0.347 . . . . 71.41 110.964 -179.93 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -105.89 -144.92 12.63 Favored Glycine 0 N--CA 1.452 -0.236 0 C-N-CA 120.754 -0.736 . . . . 74.42 112.487 179.907 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -115.86 146.94 41.58 Favored 'General case' 0 C--N 1.331 -0.23 0 CA-C-O 120.775 0.321 . . . . 74.5 110.862 -179.953 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 37.3 m -103.08 162.56 12.84 Favored 'General case' 0 C--N 1.331 -0.233 0 CA-C-N 116.179 -0.464 . . . . 52.24 110.846 -179.717 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.2 t -107.07 1.26 24.13 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.063 -0.517 . . . . 72.24 110.852 -179.84 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.655 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -68.05 141.29 94.1 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.6 0.714 . . . . 74.22 110.801 -179.986 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.8 Cg_endo -69.67 -3.36 11.79 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.634 2.222 . . . . 73.23 112.384 179.922 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.72 17.16 1.99 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.208 -0.451 . . . . 63.31 110.922 179.889 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.655 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -78.06 137.94 38.51 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.269 -0.423 . . . . 61.34 111.024 179.9 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.792 HG22 ' HB2' ' A' ' 218' ' ' HIS . 6.9 p -63.99 -29.59 47.72 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.259 -0.428 . . . . 64.52 111.108 179.946 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 61.2 mmm -73.81 -12.61 60.74 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.204 -0.453 . . . . 73.53 110.89 179.913 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.664 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -59.09 146.27 78.1 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.59 0.71 . . . . 72.04 110.831 -179.85 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.664 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.8 Cg_endo -69.75 1.2 4.64 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.739 2.293 . . . . 75.22 112.33 179.956 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 53.2 m -102.89 129.02 49.45 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.242 -0.436 . . . . 71.55 111.152 -179.946 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 63.6 t80 -110.4 136.33 49.72 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.246 -0.434 . . . . 74.04 110.921 -179.893 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 18.3 mtpp -155.69 133.86 11.5 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 74.33 110.851 179.855 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.525 ' O ' HG13 ' A' ' 243' ' ' VAL . 71.1 t80 -59.24 147.77 34.37 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.25 -0.432 . . . . 74.45 110.983 179.989 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.525 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.4 OUTLIER -159.64 133.24 1.28 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.251 0 CA-C-N 116.235 -0.439 . . . . 75.44 111.091 179.886 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 46.2 t0 -49.94 133.26 22.59 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.177 -0.465 . . . . 53.43 110.768 179.916 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 8.4 tt -55.17 -30.89 25.13 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.185 -0.461 . . . . 72.33 111.063 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 7.9 m-80 -77.3 -17.43 58.35 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.171 -0.468 . . . . 74.24 110.836 -179.994 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 66.6 p -103.21 -24.43 13.56 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.186 -0.461 . . . . 63.21 111.195 179.99 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 35.3 t80 -65.7 144.31 56.99 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.212 -0.449 . . . . 72.24 110.891 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 10.0 ptm180 -176.8 128.65 0.18 Allowed 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.159 -0.473 . . . . 74.32 110.909 -179.847 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.81 HD12 HG11 ' A' ' 144' ' ' VAL . 54.7 mt -48.66 127.14 13.08 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.276 -0.42 . . . . 62.35 110.875 -179.94 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 38.9 m -72.05 167.27 20.54 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.196 -0.456 . . . . 74.14 110.897 180.0 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -52.4 -38.93 60.19 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.089 -0.505 . . . . 73.21 111.11 179.924 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.78 -46.67 84.19 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.157 -0.474 . . . . 74.11 110.868 179.92 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.591 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 7.0 m-20 -61.92 -52.12 65.38 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.237 -0.438 . . . . 73.5 110.848 -179.938 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 21.1 mt -62.99 -34.66 67.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-N 116.125 -0.488 . . . . 74.3 111.102 179.962 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 5.2 mmp_? -69.51 -40.04 77.19 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.234 -0.439 . . . . 71.3 110.922 179.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.3 -49.26 7.53 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.811 -0.709 . . . . 33.22 112.525 -179.987 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.847 ' HA ' HD11 ' A' ' 226' ' ' LEU . 3.8 tp -53.01 -32.84 18.77 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.344 0 CA-C-O 120.78 0.324 . . . . 74.42 111.142 -179.996 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.408 ' O ' ' N ' ' A' ' 263' ' ' GLY . 47.6 mt-30 -88.08 -17.38 31.2 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.154 -0.475 . . . . 64.22 110.889 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 3.4 t -69.17 -16.51 63.65 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.186 -0.461 . . . . 73.31 110.792 -179.821 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.716 ' HB3' HG22 ' A' ' 108' ' ' VAL . 4.7 mt -118.81 -23.03 7.12 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.183 -0.462 . . . . 73.22 110.857 -179.923 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.909 ' HB3' HD21 ' A' ' 147' ' ' LEU . 27.7 m-85 -106.3 -38.33 6.27 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 74.33 110.951 -179.981 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.408 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.32 0 CA-C-O 119.149 -0.806 . . . . 73.51 112.446 179.985 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.434 ' O ' ' C ' ' A' ' 101' ' ' ARG . 2.6 t80 . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.871 0.367 . . . . 71.03 110.909 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.477 ' H ' ' NE ' ' A' ' 101' ' ' ARG . 0.5 OUTLIER -35.36 138.18 0.15 Allowed 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.168 -0.469 . . . . 65.52 110.903 -179.857 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.432 ' HB2' HD11 ' A' ' 261' ' ' LEU . 0.0 OUTLIER -177.04 145.59 0.48 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.239 -0.437 . . . . 61.4 110.854 -179.894 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -50.53 152.71 3.12 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.562 0.696 . . . . 63.02 110.888 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.65 64.47 1.74 Allowed 'Trans proline' 0 C--O 1.231 0.15 0 C-N-CA 122.784 2.323 . . . . 62.23 112.317 -179.966 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -159.23 -84.2 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.687 -0.768 . . . . 72.53 112.419 -179.954 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.43 ' N ' ' HD2' ' A' ' 107' ' ' PRO . . . 144.91 -62.01 0.48 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.704 -0.76 . . . . 62.14 112.452 -179.899 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.43 ' HD2' ' N ' ' A' ' 106' ' ' GLY . 53.4 Cg_endo -69.83 79.13 0.99 Allowed 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.619 2.213 . . . . 63.03 112.401 -179.964 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.509 HG21 HD13 ' A' ' 261' ' ' LEU . 16.6 m -94.94 34.65 0.14 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.137 -0.483 . . . . 74.03 111.109 179.911 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.437 ' C ' ' O ' ' A' ' 108' ' ' VAL . 0.5 OUTLIER 34.14 88.01 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.19 -0.459 . . . . 71.42 110.917 179.955 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 17.6 mtt85 -75.83 57.65 1.05 Allowed 'General case' 0 C--N 1.327 -0.388 0 CA-C-N 116.269 -0.423 . . . . 72.33 110.85 -179.923 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.471 ' O ' HD11 ' A' ' 114' ' ' ILE . 19.8 mtmt -98.92 141.44 31.69 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.204 -0.453 . . . . 62.41 110.889 179.978 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.429 ' HA ' HD22 ' A' ' 147' ' ' LEU . 0.5 OUTLIER -91.46 19.1 6.44 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 75.24 110.905 179.897 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.5 m-85 -128.74 92.47 3.42 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.224 -0.444 . . . . 75.42 110.926 -179.896 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.67 HD13 ' HE1' ' A' ' 149' ' ' PHE . 3.9 mp -121.22 165.71 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.282 0 CA-C-N 116.05 -0.523 . . . . 71.31 111.078 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.612 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.3 OUTLIER -159.29 160.36 35.1 Favored 'General case' 0 C--N 1.33 -0.243 0 CA-C-N 116.166 -0.47 . . . . 64.41 111.139 179.925 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.592 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 1.9 p90 -132.33 144.32 50.48 Favored 'General case' 0 C--N 1.327 -0.393 0 CA-C-N 116.267 -0.424 . . . . 75.13 110.994 -179.887 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.72 ' HD2' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -136.23 113.34 10.52 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.141 -0.481 . . . . 73.22 110.842 -179.965 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 63.0 mt -76.04 105.4 4.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.205 -0.452 . . . . 74.42 111.086 179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 18.5 t-20 -56.2 -51.28 68.63 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.213 -0.449 . . . . 44.54 110.971 179.833 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.636 ' OD1' HG23 ' A' ' 162' ' ' VAL . 1.8 p-10 -141.97 166.52 24.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.184 -0.462 . . . . 60.41 110.86 179.965 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . . . . . . . . . 1.9 m-85 -117.07 146.22 43.25 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.129 -0.487 . . . . 72.04 110.923 -179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.717 HG22 ' CE ' ' A' ' 125' ' ' MET . 3.5 t -93.58 142.67 25.47 Favored Pre-proline 0 C--N 1.331 -0.218 0 CA-C-O 121.634 0.73 . . . . 72.41 111.125 -179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.89 -1.79 9.18 Favored 'Trans proline' 0 C--O 1.232 0.177 0 C-N-CA 122.643 2.229 . . . . 73.42 112.291 179.993 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.416 ' H ' HG23 ' A' ' 122' ' ' THR . 15.7 m-20 -81.82 -23.07 36.68 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.216 -0.447 . . . . 71.01 110.887 179.802 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.717 ' CE ' HG22 ' A' ' 122' ' ' THR . 13.2 mtm -116.5 166.51 12.0 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.204 -0.453 . . . . 74.31 110.892 -179.988 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.433 ' O ' HG23 ' A' ' 130' ' ' VAL . 7.4 t-20 -96.22 145.92 25.14 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.189 -0.459 . . . . 75.52 110.816 -179.873 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 7.2 ptm180 -45.52 -34.91 3.53 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.151 -0.477 . . . . 75.52 110.887 -179.94 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 56.9 mt-10 -83.29 -38.96 21.44 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.212 -0.449 . . . . 74.22 110.941 -179.924 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 52.1 m-20 -65.67 -29.77 70.37 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.143 -0.48 . . . . 61.14 110.812 179.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.585 HG22 ' CE ' ' A' ' 125' ' ' MET . 79.5 t -65.79 -45.86 90.44 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.281 0 CA-C-N 116.282 -0.417 . . . . 75.25 111.132 179.995 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -79.75 -23.07 42.51 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.168 -0.469 . . . . 71.21 110.925 179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.1 t80 -74.83 -47.78 28.67 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.152 -0.477 . . . . 64.2 110.924 -179.827 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.881 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -71.39 -31.32 67.15 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.144 -0.48 . . . . 65.13 110.99 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.754 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -73.87 -55.57 11.94 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.251 -0.432 . . . . 64.32 111.106 -179.973 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.544 ' N ' HG22 ' A' ' 134' ' ' ILE . 13.3 ttt180 -48.67 -42.91 36.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.152 -0.476 . . . . 62.41 110.85 179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.688 ' O ' HG23 ' A' ' 140' ' ' VAL . 4.3 mmpt? -70.56 -34.46 72.26 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.255 -0.43 . . . . 70.41 110.855 -179.996 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.687 ' O ' HG13 ' A' ' 217' ' ' VAL . . . -60.99 -50.48 73.22 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.262 -0.426 . . . . 72.14 111.001 179.888 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.592 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.2 m-85 -70.97 -21.82 62.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.24 -0.436 . . . . 72.21 110.94 -179.881 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.574 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.5 tt0 -78.71 -5.93 54.44 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.101 -0.5 . . . . 74.01 110.916 -179.992 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.688 HG23 ' O ' ' A' ' 136' ' ' LYS . 95.3 t -95.59 -17.41 6.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.229 -0.441 . . . . 54.22 111.096 179.947 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.886 ' NE1' HG12 ' A' ' 217' ' ' VAL . 95.8 m95 -105.47 -36.73 7.05 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.211 -0.449 . . . . 64.13 110.896 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.98 -11.94 61.25 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.286 -0.416 . . . . 72.44 110.846 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.619 HD22 ' N ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER -94.5 -18.57 21.34 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.114 -0.494 . . . . 74.33 110.909 -179.96 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.808 HG11 HD12 ' A' ' 250' ' ' LEU . 16.9 m -98.03 2.5 10.38 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.161 -0.472 . . . . 64.22 111.189 179.902 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.487 ' C ' ' H ' ' A' ' 147' ' ' LEU . 49.9 p -151.2 149.11 23.93 Favored Pre-proline 0 C--N 1.33 -0.251 0 CA-C-O 121.619 0.723 . . . . 44.32 111.146 -179.918 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.83 31.57 0.19 Allowed 'Trans proline' 0 C--N 1.343 0.247 0 C-N-CA 122.665 2.244 . . . . 62.02 112.345 179.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.801 HD11 ' CG ' ' A' ' 262' ' ' TYR . 14.4 mt -98.46 173.41 6.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.198 -0.456 . . . . 65.43 110.895 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 7.3 mtmt -137.59 127.33 25.4 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.148 -0.478 . . . . 75.44 110.893 179.822 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.67 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.5 m-30 -114.47 143.8 44.36 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.199 -0.455 . . . . 70.14 110.851 179.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 6.2 t -138.85 147.87 43.0 Favored 'General case' 0 C--N 1.331 -0.221 0 CA-C-N 116.12 -0.491 . . . . 72.31 110.845 -179.821 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.47 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 2.6 tptm -97.42 141.84 30.0 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.112 -0.494 . . . . 71.12 110.922 179.981 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.533 HD11 ' N ' ' A' ' 157' ' ' ALA . 17.2 pt -150.07 133.23 7.19 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.27 -0.423 . . . . 72.45 111.13 179.924 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 2.0 m-80 -100.63 -6.82 24.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.152 -0.476 . . . . 74.4 110.915 179.991 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.2 t -155.61 58.48 0.62 Allowed 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.166 -0.47 . . . . 73.15 111.167 179.983 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.49 ' C ' HD12 ' A' ' 152' ' ' ILE . . . -151.57 -156.62 7.51 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.755 -0.736 . . . . 62.11 112.512 179.95 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 33.4 mmt -105.44 97.4 7.24 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.743 0.306 . . . . 70.24 110.915 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.533 ' N ' HD11 ' A' ' 152' ' ' ILE . . . -107.21 154.39 21.29 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.21 -0.45 . . . . 73.35 111.116 179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -82.88 -53.03 6.17 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.226 -0.443 . . . . 73.53 110.799 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.618 HG12 HG23 ' A' ' 220' ' ' ILE . 2.8 mp -91.06 97.91 7.79 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.38 0 CA-C-N 116.26 -0.427 . . . . 71.41 111.145 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.72 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.1 tp -87.4 109.92 19.9 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.133 -0.485 . . . . 74.35 111.009 179.857 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.459 HG13 ' CE1' ' A' ' 197' ' ' PHE . 95.9 t -88.01 123.22 40.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.185 -0.461 . . . . 64.03 111.109 179.898 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.636 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -142.1 105.56 1.35 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.258 0 CA-C-N 116.134 -0.485 . . . . 64.43 111.143 179.949 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 52.3 m-85 -71.61 108.22 4.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.207 -0.451 . . . . 60.54 110.845 -179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.1 166.19 18.93 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.208 -0.451 . . . . 75.31 111.089 179.916 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 6.0 ptt180 -114.25 137.25 52.02 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.292 -0.413 . . . . 75.41 110.831 -179.899 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.68 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.3 -154.92 0.2 Allowed Glycine 0 N--CA 1.451 -0.322 0 C-N-CA 120.761 -0.733 . . . . 71.41 112.458 179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.806 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.64 116.96 7.42 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-O 120.847 0.356 . . . . 52.23 111.094 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.704 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.96 -22.69 12.06 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.211 -0.45 . . . . 73.33 110.855 -179.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.76 28.86 0.55 Allowed Glycine 0 N--CA 1.451 -0.325 0 C-N-CA 120.675 -0.774 . . . . 64.04 112.527 -179.948 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.624 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.43 0.14 15.5 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-O 120.778 0.323 . . . . 72.41 110.837 -179.927 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 74.04 39.08 0.53 Allowed 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.219 -0.446 . . . . 71.31 110.927 -179.884 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.704 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.38 -40.94 0.8 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.1 -0.5 . . . . 64.3 110.861 179.99 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.806 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 53.8 99.98 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.255 -0.43 . . . . 55.31 111.131 179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.68 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.1 m-85 -60.63 -168.4 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.154 -0.475 . . . . 72.42 110.903 -179.879 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.75 19.03 3.53 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.201 -0.454 . . . . 75.21 110.837 179.993 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.582 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.5 -158.1 6.1 Favored Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.766 -0.73 . . . . 42.42 112.492 -179.93 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.445 ' C ' ' O ' ' A' ' 176' ' ' GLY . 2.1 ttmm -34.25 134.22 0.2 Allowed 'General case' 0 C--N 1.328 -0.342 0 CA-C-O 120.836 0.351 . . . . 74.3 110.828 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.4 165.55 0.15 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.826 -0.702 . . . . 73.44 112.524 179.994 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.37 -144.01 23.16 Favored Glycine 0 N--CA 1.451 -0.32 0 C-N-CA 120.81 -0.71 . . . . 73.32 112.533 -179.795 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -49.51 97.0 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.843 0.354 . . . . 72.41 111.152 -179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 42.9 mt -67.04 -41.88 85.8 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.22 -0.445 . . . . 73.35 110.953 179.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -169.52 169.34 8.86 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.191 -0.458 . . . . 71.15 111.138 179.729 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.491 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -163.24 143.54 9.04 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.269 -0.423 . . . . 75.45 110.884 -179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.669 ' HB1' ' HB3' ' A' ' 223' ' ' SER . . . -135.44 174.79 10.22 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.293 -0.412 . . . . 71.23 111.159 179.989 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.534 ' O ' ' O ' ' A' ' 222' ' ' HIS . 94.9 m-85 -96.93 -122.53 0.12 Allowed 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.336 -0.393 . . . . 64.02 110.905 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.478 ' HA2' ' O ' ' A' ' 223' ' ' SER . . . 172.21 -98.34 0.13 Allowed Glycine 0 N--CA 1.452 -0.284 0 C-N-CA 120.721 -0.752 . . . . 32.13 112.431 -179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 53.9 Cg_endo -69.72 57.13 1.43 Allowed 'Trans proline' 0 C--N 1.341 0.174 0 C-N-CA 122.686 2.257 . . . . 71.44 112.321 -179.895 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.568 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -122.16 153.12 16.82 Favored Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.772 -0.728 . . . . 71.13 112.557 179.967 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.519 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.63 145.92 29.66 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-O 120.85 0.357 . . . . 63.21 110.841 -179.72 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.67 -64.71 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.42 0 C-N-CA 120.742 -0.742 . . . . 63.25 112.554 179.942 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.519 ' N ' ' O ' ' A' ' 189' ' ' SER . 1.2 mp -104.88 6.18 10.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.805 0.336 . . . . 70.14 111.099 -179.979 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.568 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -64.66 168.14 27.96 Favored Glycine 0 N--CA 1.45 -0.369 0 C-N-CA 120.702 -0.761 . . . . 71.21 112.486 179.987 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.503 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 42.77 23.2 0.18 Allowed Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.757 -0.735 . . . . 72.44 112.43 -179.897 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.422 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 0.9 OUTLIER -66.52 99.34 0.57 Allowed 'General case' 0 C--N 1.327 -0.4 0 CA-C-O 120.806 0.336 . . . . 75.11 110.856 -179.992 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.625 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -74.0 132.87 42.81 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.277 -0.42 . . . . 73.33 111.069 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.8 m170 -123.41 131.27 53.6 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.236 -0.438 . . . . 71.3 110.923 -179.999 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.459 ' CE1' HG13 ' A' ' 161' ' ' VAL . 40.9 m-85 -115.5 135.07 54.47 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.165 -0.471 . . . . 71.34 110.866 -179.851 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -68.03 107.48 2.72 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.151 -0.477 . . . . 64.14 110.827 -179.958 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.4 tm-20 -59.54 -35.93 75.18 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.115 -0.493 . . . . 71.0 110.904 -179.909 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.582 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 15.6 m-20 -51.47 -21.59 2.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.18 -0.463 . . . . 73.13 110.83 179.939 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.5 mm-40 -81.39 163.29 22.93 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.192 -0.458 . . . . 72.03 110.893 -179.825 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.577 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.5 OUTLIER -101.75 85.96 2.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.245 -0.434 . . . . 75.12 110.917 -179.958 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.634 ' CZ3' HG21 ' A' ' 215' ' ' THR . 30.9 m95 -76.62 123.58 26.33 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.107 -0.497 . . . . 72.33 110.862 -179.908 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 35.8 p -141.54 -178.01 5.43 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.199 -0.455 . . . . 73.22 111.151 -179.978 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.45 20.94 17.65 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.216 -0.447 . . . . 72.25 111.129 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.5 m80 -127.81 -172.97 2.8 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.251 -0.432 . . . . 74.41 110.903 179.932 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.1 p -73.14 -18.84 61.24 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.252 -0.431 . . . . 73.3 110.856 -179.853 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -61.24 -104.91 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.751 -0.737 . . . . 71.52 112.427 -179.959 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.577 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -51.77 176.18 0.1 Allowed Glycine 0 N--CA 1.451 -0.303 0 C-N-CA 120.734 -0.746 . . . . 70.42 112.462 -179.86 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 73.1 m -65.9 97.62 0.36 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-O 120.842 0.353 . . . . 73.11 111.14 -179.877 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -41.88 116.46 0.8 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.151 -0.477 . . . . 65.15 110.885 179.986 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.881 HD23 ' HB3' ' A' ' 133' ' ' ALA . 7.0 tp -65.44 -36.74 84.81 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.223 -0.444 . . . . 74.34 110.945 179.935 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.636 ' CA ' ' HB1' ' A' ' 133' ' ' ALA . 3.6 t80 -51.88 -64.85 0.68 Allowed 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.148 -0.478 . . . . 73.15 110.87 179.936 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.485 HD11 ' H ' ' A' ' 243' ' ' VAL . 15.1 mt -56.47 -52.98 62.68 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.22 -0.445 . . . . 54.43 110.911 179.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.634 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 8.0 m -53.69 -38.01 63.8 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.105 -0.498 . . . . 63.4 111.184 179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.437 ' HB3' ' HB2' ' A' ' 137' ' ' ALA . . . -62.97 -50.89 68.99 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.208 -0.451 . . . . 43.12 111.14 179.847 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.886 HG12 ' NE1' ' A' ' 141' ' ' TRP . 0.3 OUTLIER -52.16 -57.58 3.64 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.19 -0.459 . . . . 73.35 111.17 179.978 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.706 ' HB2' HG13 ' A' ' 235' ' ' VAL . 4.3 t-80 -65.29 -29.09 69.82 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.112 -0.494 . . . . 55.11 110.891 179.885 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.441 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -64.42 -46.66 82.25 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.214 -0.448 . . . . 53.44 111.059 179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.618 HG23 HG12 ' A' ' 159' ' ' ILE . 2.4 mt -69.2 -35.5 68.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.383 0 CA-C-N 116.285 -0.416 . . . . 74.45 111.126 -179.963 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.47 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -51.98 -46.34 55.68 Favored Glycine 0 N--CA 1.452 -0.241 0 C-N-CA 120.845 -0.693 . . . . 53.32 112.396 179.922 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.534 ' O ' ' O ' ' A' ' 185' ' ' PHE . 3.0 m-70 -69.54 -40.11 77.05 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.835 0.35 . . . . 52.33 110.824 -179.842 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.669 ' HB3' ' HB1' ' A' ' 184' ' ' ALA . 0.0 OUTLIER -72.23 -11.37 60.69 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.17 -0.468 . . . . 72.11 110.881 -179.743 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.414 HD23 ' CH2' ' A' ' 109' ' ' TRP . 21.4 mt -88.88 -25.11 22.31 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.102 -0.499 . . . . 75.44 110.872 179.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.434 ' O ' HG11 ' A' ' 108' ' ' VAL . . . 122.66 11.19 5.58 Favored Glycine 0 N--CA 1.452 -0.29 0 C-N-CA 120.743 -0.741 . . . . 73.11 112.515 179.906 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.879 HD11 ' HA ' ' A' ' 258' ' ' ILE . 0.2 OUTLIER -88.52 152.4 21.89 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.876 0.37 . . . . 74.34 110.891 -179.853 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -98.02 -141.25 12.02 Favored Glycine 0 N--CA 1.45 -0.374 0 C-N-CA 120.788 -0.72 . . . . 75.44 112.52 179.885 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -112.95 141.94 46.2 Favored 'General case' 0 C--N 1.331 -0.228 0 CA-C-O 120.846 0.355 . . . . 74.31 110.844 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.421 ' HA ' ' HD2' ' A' ' 101' ' ' ARG . 49.4 m -92.23 160.55 15.11 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 74.31 110.801 -179.745 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 1.2 t -109.68 9.75 24.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.066 -0.515 . . . . 61.11 110.874 -179.869 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.523 ' HB2' ' HB2' ' A' ' 234' ' ' ALA . 0.1 OUTLIER -80.95 143.32 53.21 Favored Pre-proline 0 C--N 1.328 -0.331 0 CA-C-O 121.562 0.696 . . . . 62.14 110.929 179.942 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.81 -3.87 12.92 Favored 'Trans proline' 0 C--O 1.232 0.2 0 C-N-CA 122.765 2.31 . . . . 71.11 112.289 -179.987 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.27 30.8 1.12 Allowed 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.259 -0.428 . . . . 72.43 110.836 179.943 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.693 ' HB1' ' OD1' ' A' ' 254' ' ' ASP . . . -92.59 145.54 24.36 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.248 -0.433 . . . . 62.34 111.162 179.836 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.706 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.5 t -65.46 -42.2 92.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.301 -0.409 . . . . 75.32 111.226 179.946 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.44 ' HE3' ' CE1' ' A' ' 222' ' ' HIS . 54.0 mmm -64.74 -14.66 59.64 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.157 -0.474 . . . . 73.23 110.902 179.862 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.67 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.0 t80 -57.72 146.24 66.95 Favored Pre-proline 0 C--N 1.329 -0.306 0 CA-C-O 121.621 0.724 . . . . 62.34 110.874 -179.919 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.67 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.1 Cg_endo -69.77 1.0 4.83 Favored 'Trans proline' 0 C--O 1.231 0.164 0 C-N-CA 122.662 2.241 . . . . 71.32 112.42 179.997 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 38.6 m -102.17 130.0 48.69 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.179 -0.464 . . . . 74.14 111.144 -179.985 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 55.9 t80 -113.78 135.85 53.5 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.2 -0.455 . . . . 74.11 110.922 -179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.5 mmtt -155.51 137.39 14.45 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.118 -0.492 . . . . 64.22 110.825 179.898 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.534 ' O ' HG13 ' A' ' 243' ' ' VAL . 65.9 t80 -62.0 145.21 53.73 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.157 -0.474 . . . . 65.12 110.939 -179.998 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.534 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -160.29 133.31 1.18 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-N 116.101 -0.5 . . . . 71.14 111.077 179.908 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 52.0 t0 -57.47 131.32 49.78 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.113 -0.494 . . . . 74.13 110.903 179.93 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.532 HD11 ' HD3' ' A' ' 136' ' ' LYS . 16.7 tt -53.2 -30.25 16.72 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.237 -0.438 . . . . 73.42 111.161 -179.969 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.511 ' ND2' HG23 ' A' ' 247' ' ' THR . 0.2 OUTLIER -67.95 -21.85 65.07 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.143 -0.481 . . . . 73.22 110.859 179.969 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.511 HG23 ' ND2' ' A' ' 246' ' ' ASN . 3.8 p -110.84 -19.63 12.75 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.138 -0.483 . . . . 44.52 111.173 -179.991 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 35.9 t80 -67.44 142.78 56.55 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.231 -0.441 . . . . 73.54 110.911 -179.969 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 12.5 ptm180 -176.32 132.36 0.23 Allowed 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.157 -0.474 . . . . 73.21 110.919 -179.872 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.808 HD12 HG11 ' A' ' 144' ' ' VAL . 43.9 mt -49.26 132.64 19.86 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.207 -0.452 . . . . 65.15 110.999 179.952 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 32.9 t -74.15 172.8 11.09 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.186 -0.461 . . . . 64.25 110.853 -179.912 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -57.1 -37.61 72.18 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.115 -0.493 . . . . 73.44 111.112 179.934 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 14.5 m-20 -64.33 -50.56 67.3 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.252 -0.431 . . . . 60.34 110.928 179.944 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.693 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 5.0 m-20 -59.06 -50.91 72.28 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.179 -0.464 . . . . 71.34 110.917 179.98 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 20.5 mt -63.46 -34.07 65.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 75.24 111.214 179.91 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 9.5 mmt180 -69.65 -40.19 76.64 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.137 -0.483 . . . . 72.21 110.872 179.937 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -76.65 -50.0 7.52 Favored Glycine 0 N--CA 1.45 -0.386 0 C-N-CA 120.731 -0.747 . . . . 74.33 112.486 -179.961 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.879 ' HA ' HD11 ' A' ' 226' ' ' LEU . 3.8 tp -53.5 -33.63 22.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-O 120.729 0.299 . . . . 64.13 111.061 -179.931 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.416 ' O ' ' N ' ' A' ' 263' ' ' GLY . 70.8 mt-30 -88.16 -16.1 34.29 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.203 -0.453 . . . . 75.24 110.903 -179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 2.5 t -69.23 -15.25 63.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.182 -0.463 . . . . 61.05 110.849 -179.794 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.509 HD13 HG21 ' A' ' 108' ' ' VAL . 2.6 mt -122.83 -18.61 6.44 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.085 -0.507 . . . . 64.51 110.915 -179.982 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.801 ' CG ' HD11 ' A' ' 147' ' ' LEU . 38.4 m-85 -113.77 -33.9 5.65 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.16 -0.473 . . . . 74.21 110.931 -179.958 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.416 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.362 0 CA-C-O 119.155 -0.803 . . . . 61.15 112.481 179.957 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 11.6 m-85 . . . . . 0 N--CA 1.457 -0.117 0 CA-C-O 120.895 0.379 . . . . 61.24 110.953 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.0 mpt_? 59.94 -170.38 0.14 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.065 -0.516 . . . . 72.01 110.933 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.837 ' HB2' HD11 ' A' ' 261' ' ' LEU . 3.9 pm0 -38.21 147.86 0.05 OUTLIER 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.168 -0.469 . . . . 62.21 110.945 -179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 0.1 OUTLIER -49.29 161.77 0.45 Allowed Pre-proline 0 C--N 1.328 -0.36 0 CA-C-O 121.603 0.716 . . . . 75.31 110.865 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 52.5 Cg_endo -69.8 95.72 0.57 Allowed 'Trans proline' 0 C--N 1.342 0.22 0 C-N-CA 122.65 2.233 . . . . 71.32 112.317 -179.925 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 130.49 -131.62 6.6 Favored Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.763 -0.732 . . . . 63.33 112.416 179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -146.37 58.94 0.49 Allowed Glycine 0 N--CA 1.451 -0.362 0 C-N-CA 120.745 -0.74 . . . . 53.23 112.45 -179.77 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.69 -19.33 36.62 Favored 'Trans proline' 0 C--N 1.342 0.199 0 C-N-CA 122.669 2.246 . . . . 74.12 112.421 179.997 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.82 HG11 ' HB3' ' A' ' 261' ' ' LEU . 9.3 p -62.91 148.7 10.91 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.212 -0.449 . . . . 72.21 111.143 179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.501 ' CZ3' HD23 ' A' ' 224' ' ' LEU . 4.8 m0 -75.08 -28.24 60.24 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.176 -0.466 . . . . 65.42 110.863 179.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.645 ' H ' HG22 ' A' ' 108' ' ' VAL . 23.5 mtt180 68.54 28.35 5.91 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.276 -0.42 . . . . 73.43 110.877 -179.907 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.451 ' HG2' ' HB2' ' A' ' 109' ' ' TRP . 32.9 pttt -122.62 155.65 35.9 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.232 -0.44 . . . . 74.15 110.905 179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.564 ' HA ' ' CD1' ' A' ' 147' ' ' LEU . 1.8 p80 -102.51 42.78 1.12 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.142 -0.481 . . . . 61.43 110.897 179.878 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 5.7 m-85 -146.21 92.87 2.24 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 116.204 -0.453 . . . . 73.51 110.93 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.577 HG22 ' N ' ' A' ' 115' ' ' THR . 4.9 mp -122.66 162.61 22.35 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.26 0 CA-C-N 116.085 -0.507 . . . . 75.41 111.086 179.915 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.577 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -158.66 163.32 37.0 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.179 -0.464 . . . . 63.25 111.18 179.903 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.608 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 2.7 p90 -133.68 148.29 51.48 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.239 -0.437 . . . . 74.32 110.915 -179.869 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.57 ' HD2' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -140.37 112.61 7.79 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.081 -0.509 . . . . 74.1 110.912 -179.993 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 54.2 mt -74.16 105.31 3.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.163 -0.471 . . . . 73.1 111.172 179.942 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 19.5 t-20 -56.59 -45.96 81.09 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.196 -0.456 . . . . 72.3 110.81 180.0 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.437 HD21 ' N ' ' A' ' 163' ' ' PHE . 0.1 OUTLIER -150.1 169.12 22.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.138 -0.483 . . . . 75.11 110.872 -179.927 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.595 ' CE2' HG11 ' A' ' 130' ' ' VAL . 4.6 m-85 -117.09 157.83 25.22 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.215 -0.448 . . . . 73.24 110.916 -179.983 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.509 HG23 ' HG3' ' A' ' 125' ' ' MET . 0.1 OUTLIER -107.95 146.7 34.02 Favored Pre-proline 0 C--N 1.33 -0.256 0 CA-C-O 121.634 0.73 . . . . 65.31 111.204 -179.987 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.81 -2.49 10.29 Favored 'Trans proline' 0 C--O 1.233 0.225 0 C-N-CA 122.711 2.274 . . . . 72.03 112.25 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 15.1 m-20 -83.64 -25.82 30.46 Favored 'General case' 0 C--N 1.328 -0.367 0 CA-C-N 116.314 -0.403 . . . . 72.23 110.936 179.858 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.689 ' CE ' HG22 ' A' ' 130' ' ' VAL . 6.9 mtm -114.66 164.14 14.45 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.091 -0.504 . . . . 72.14 110.77 -179.909 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.529 ' O ' HG23 ' A' ' 130' ' ' VAL . 0.2 OUTLIER -96.43 143.76 27.17 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.227 -0.442 . . . . 71.14 110.974 179.977 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 8.6 ptt180 -45.09 -37.05 3.97 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.224 -0.443 . . . . 75.21 110.836 -179.906 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 8.6 pt-20 -82.92 -36.11 25.53 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.196 -0.456 . . . . 75.55 110.792 -179.87 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 17.9 m-20 -67.69 -29.46 68.73 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.186 -0.461 . . . . 55.23 110.871 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.689 HG22 ' CE ' ' A' ' 125' ' ' MET . 94.9 t -66.56 -46.58 85.92 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.219 -0.446 . . . . 54.24 111.148 179.982 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.447 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 10.1 t0 -77.13 -25.82 52.52 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.223 -0.444 . . . . 65.13 110.866 179.933 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -72.72 -49.26 32.35 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.234 -0.439 . . . . 72.11 110.931 -179.857 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.627 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -69.44 -30.42 68.34 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.158 -0.474 . . . . 75.2 111.09 179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.693 HD13 HD21 ' A' ' 212' ' ' LEU . 1.2 mp -74.64 -53.77 16.04 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.296 -0.411 . . . . 61.31 111.128 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.507 ' N ' HG22 ' A' ' 134' ' ' ILE . 7.2 ptp180 -49.45 -35.4 19.37 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.142 -0.481 . . . . 71.2 110.911 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.614 ' O ' HG23 ' A' ' 140' ' ' VAL . 6.8 mmtp -78.85 -34.1 45.34 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.216 -0.447 . . . . 64.42 110.873 179.981 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.653 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -61.07 -49.16 78.48 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.232 -0.44 . . . . 72.01 111.059 179.84 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.608 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 89.4 m-85 -70.39 -23.54 62.79 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.279 -0.419 . . . . 65.3 110.966 -179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.47 ' O ' ' HB3' ' A' ' 143' ' ' ASN . 0.2 OUTLIER -75.4 -15.11 60.49 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.094 -0.503 . . . . 55.44 110.936 -179.963 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.614 HG23 ' O ' ' A' ' 136' ' ' LYS . 93.6 t -85.03 -19.62 8.68 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.189 -0.459 . . . . 71.03 111.147 -179.992 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.844 ' NE1' HG12 ' A' ' 217' ' ' VAL . 96.9 m95 -104.74 -27.0 12.05 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.117 -0.492 . . . . 74.51 110.916 179.959 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.63 -7.59 59.64 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.204 -0.453 . . . . 72.33 110.846 -179.79 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.47 ' HB3' ' O ' ' A' ' 139' ' ' GLN . 0.1 OUTLIER -99.15 -18.39 17.7 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.133 -0.485 . . . . 73.14 110.867 -179.97 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.773 HG23 HG23 ' A' ' 145' ' ' THR . 28.9 m -100.14 -7.9 9.08 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.248 0 CA-C-N 116.17 -0.468 . . . . 73.52 111.139 179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.773 HG23 HG23 ' A' ' 144' ' ' VAL . 32.5 p -141.97 147.21 43.75 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.642 0.734 . . . . 74.23 111.096 -179.934 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.1 Cg_endo -69.76 32.43 0.19 Allowed 'Trans proline' 0 C--O 1.233 0.249 0 C-N-CA 122.718 2.279 . . . . 74.54 112.27 179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.768 HD21 ' HB3' ' A' ' 262' ' ' TYR . 3.8 mm? -94.49 170.07 9.75 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.307 -0.406 . . . . 71.31 111.004 179.889 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -134.24 126.35 29.65 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.205 -0.452 . . . . 63.42 110.92 179.816 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.441 ' HE1' HD13 ' A' ' 114' ' ' ILE . 2.4 m-85 -117.53 144.04 45.49 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.225 -0.443 . . . . 74.45 110.796 -179.991 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.403 ' H ' ' HA ' ' A' ' 115' ' ' THR . 6.1 t -137.66 153.03 49.89 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.093 -0.503 . . . . 74.03 110.844 -179.796 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.468 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 10.7 tttt -103.37 146.31 28.68 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.083 -0.508 . . . . 75.42 110.928 179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.563 HD12 ' CA ' ' A' ' 155' ' ' GLY . 24.7 pt -152.12 143.89 15.78 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.331 0 CA-C-N 116.252 -0.431 . . . . 63.33 111.167 179.835 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 1.3 m120 -104.34 -18.14 14.55 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.177 -0.465 . . . . 64.54 110.829 -179.994 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 4.0 t -151.55 63.22 0.87 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.225 -0.443 . . . . 64.53 111.162 -179.92 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.563 ' CA ' HD12 ' A' ' 152' ' ' ILE . . . -149.94 -156.31 7.2 Favored Glycine 0 N--CA 1.452 -0.259 0 C-N-CA 120.676 -0.774 . . . . 73.2 112.409 -179.97 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 30.1 mmt -106.85 94.11 4.93 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.783 0.325 . . . . 73.2 110.914 -179.936 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.526 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -104.67 159.05 16.08 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.234 -0.439 . . . . 61.43 111.077 179.996 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -86.63 -52.82 5.31 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.218 -0.447 . . . . 70.44 110.795 179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.674 HG12 HG23 ' A' ' 220' ' ' ILE . 2.6 mp -90.4 95.86 5.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.234 -0.439 . . . . 73.13 111.042 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.57 HD11 ' HD2' ' A' ' 117' ' ' ARG . 8.4 tp -86.75 108.92 18.91 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.18 -0.464 . . . . 73.14 110.865 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.464 HG13 ' CE1' ' A' ' 197' ' ' PHE . 96.7 t -87.85 120.02 36.27 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.2 -0.455 . . . . 74.15 111.142 179.799 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . . . . . . . . . 2.3 p -138.72 104.31 2.4 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.309 0 CA-C-N 116.133 -0.485 . . . . 61.45 111.169 179.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.448 ' CZ ' ' HE1' ' A' ' 125' ' ' MET . 35.5 m-85 -73.73 106.49 5.5 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.203 -0.453 . . . . 74.13 110.926 -179.948 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.03 164.13 23.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.174 -0.466 . . . . 75.22 111.103 179.976 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 3.9 ptm180 -110.87 140.72 45.09 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.202 -0.454 . . . . 64.31 110.885 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.7 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.67 -151.56 0.31 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.732 -0.747 . . . . 34.21 112.542 -179.896 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.806 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -68.74 119.24 12.82 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.79 0.329 . . . . 74.51 111.084 179.961 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.705 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -111.17 -21.55 11.86 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.244 -0.435 . . . . 72.24 110.842 179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 131.16 30.67 0.56 Allowed Glycine 0 N--CA 1.451 -0.309 0 C-N-CA 120.724 -0.751 . . . . 40.22 112.466 -179.921 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.634 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -114.26 0.23 14.1 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 120.87 0.367 . . . . 62.14 110.835 -179.892 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 6.0 m-85 74.13 38.91 0.53 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.214 -0.448 . . . . 75.04 110.796 -179.957 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.705 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -134.71 -41.04 0.77 Allowed 'General case' 0 C--N 1.327 -0.385 0 CA-C-N 116.164 -0.471 . . . . 73.34 110.842 -179.988 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.806 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 52.94 100.47 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.238 -0.437 . . . . 63.11 111.153 -179.98 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.7 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.6 m-85 -60.72 -169.82 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.168 -0.469 . . . . 73.42 110.883 -179.89 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . 0.442 ' OD2' ' HA3' ' A' ' 179' ' ' GLY . 40.9 p30 -134.07 18.92 3.76 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.185 -0.461 . . . . 73.22 110.945 179.989 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.578 ' HA2' ' CB ' ' A' ' 200' ' ' ASP . . . 57.81 -162.12 9.43 Favored Glycine 0 N--CA 1.453 -0.209 0 C-N-CA 120.743 -0.741 . . . . 73.42 112.519 -179.865 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.427 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -35.3 136.94 0.18 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-O 120.847 0.356 . . . . 70.24 110.963 -179.975 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 62.76 155.56 0.07 OUTLIER Glycine 0 N--CA 1.451 -0.364 0 C-N-CA 120.734 -0.746 . . . . 73.51 112.469 179.969 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.442 ' HA3' ' OD2' ' A' ' 175' ' ' ASP . . . 86.04 -142.68 19.22 Favored Glycine 0 C--N 1.331 0.281 0 C-N-CA 120.647 -0.787 . . . . 73.02 112.366 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . 0.415 HG22 ' HE1' ' A' ' 174' ' ' PHE . 2.0 mt -48.68 98.33 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-O 120.81 0.338 . . . . 72.42 111.213 -179.979 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 33.8 mt -71.4 -42.96 67.7 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.223 -0.444 . . . . 74.13 110.952 179.93 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -170.03 154.35 5.07 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.206 -0.452 . . . . 73.14 111.145 179.767 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.491 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.1 p80 -148.36 141.65 25.15 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.28 -0.418 . . . . 74.23 110.857 -179.936 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.744 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -137.97 172.78 12.43 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.218 -0.447 . . . . 24.24 111.145 179.951 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.516 ' O ' ' HA ' ' A' ' 223' ' ' SER . 37.5 m-85 -102.85 -149.65 0.4 Allowed 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.227 -0.442 . . . . 73.44 110.853 -179.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -162.66 -86.6 0.06 OUTLIER Glycine 0 N--CA 1.451 -0.323 0 C-N-CA 120.84 -0.695 . . . . 73.01 112.593 -179.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.3 Cg_endo -69.74 55.8 1.31 Allowed 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.661 2.241 . . . . 70.22 112.346 -179.992 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.585 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -124.31 150.39 17.04 Favored Glycine 0 N--CA 1.451 -0.331 0 C-N-CA 120.79 -0.719 . . . . 51.13 112.427 -179.972 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.537 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.46 147.28 27.75 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.837 0.351 . . . . 74.11 110.884 -179.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.17 -64.73 0.02 OUTLIER Glycine 0 N--CA 1.45 -0.379 0 C-N-CA 120.715 -0.755 . . . . 65.22 112.525 179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.537 ' N ' ' O ' ' A' ' 189' ' ' SER . 21.9 pt -105.81 7.69 9.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-O 120.873 0.368 . . . . 74.43 111.112 179.997 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.585 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -67.55 168.04 39.81 Favored Glycine 0 N--CA 1.45 -0.415 0 C-N-CA 120.777 -0.725 . . . . 73.3 112.502 179.908 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.447 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 46.35 18.41 0.32 Allowed Glycine 0 N--CA 1.451 -0.347 0 C-N-CA 120.743 -0.741 . . . . 73.2 112.523 -179.863 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 2.3 m-20 -64.09 108.72 1.61 Allowed 'General case' 0 C--N 1.328 -0.363 0 CA-C-O 120.881 0.372 . . . . 65.01 110.789 -179.995 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.744 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -83.32 127.69 33.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.136 -0.484 . . . . 45.42 111.114 179.901 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.491 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.2 m170 -118.37 127.0 53.27 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.19 -0.459 . . . . 73.42 110.866 -179.949 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.531 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 37.9 m-85 -111.09 132.04 54.59 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.236 -0.438 . . . . 72.31 110.848 -179.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 43.1 t0 -65.08 107.75 1.63 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.123 -0.49 . . . . 72.35 110.902 179.965 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . 0.408 ' O ' ' CD ' ' A' ' 199' ' ' GLU . 0.0 OUTLIER -58.72 -38.41 78.28 Favored 'General case' 0 C--N 1.331 -0.223 0 CA-C-N 116.187 -0.461 . . . . 71.33 110.905 -179.876 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.578 ' CB ' ' HA2' ' A' ' 176' ' ' GLY . 19.3 m-20 -49.92 -21.32 1.14 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.186 -0.461 . . . . 63.03 110.835 -179.947 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 51.3 mm-40 -81.31 164.39 22.23 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.193 -0.458 . . . . 63.41 110.903 -179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.499 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.4 OUTLIER -100.94 89.75 3.95 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.107 -0.497 . . . . 75.55 110.862 -179.909 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.531 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 31.1 m95 -81.87 122.33 27.6 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.107 -0.497 . . . . 64.45 110.904 -179.929 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.8 p -137.35 -175.27 4.0 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.282 -0.417 . . . . 75.3 111.147 -179.968 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.35 15.68 19.15 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.181 -0.463 . . . . 74.42 111.138 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 3.0 m80 -129.73 -174.81 3.41 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.239 -0.437 . . . . 63.35 110.917 179.851 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.7 p -54.79 -34.91 63.27 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.248 -0.433 . . . . 73.31 110.855 -179.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -65.8 162.54 41.88 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.759 -0.734 . . . . 62.12 112.483 179.999 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.499 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . 48.65 -172.38 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.363 0 C-N-CA 120.73 -0.748 . . . . 61.41 112.571 -179.874 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 29.8 m -87.3 93.53 9.41 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-O 120.85 0.357 . . . . 71.43 111.125 -179.881 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -40.06 110.85 0.16 Allowed 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.214 -0.448 . . . . 54.43 110.921 179.991 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.693 HD21 HD13 ' A' ' 134' ' ' ILE . 6.9 tp -57.28 -40.86 78.62 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.178 -0.465 . . . . 65.21 110.948 -179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.627 ' CA ' ' HB1' ' A' ' 133' ' ' ALA . 2.6 t80 -48.23 -64.27 0.84 Allowed 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.176 -0.465 . . . . 63.43 110.923 179.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.517 HD11 ' H ' ' A' ' 243' ' ' VAL . 17.4 mt -55.81 -52.3 64.47 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.135 -0.484 . . . . 70.52 110.865 179.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.515 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 1.0 OUTLIER -54.12 -37.31 64.19 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.239 -0.437 . . . . 75.45 111.134 179.985 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.8 -51.57 64.18 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.195 -0.457 . . . . 73.31 111.04 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.844 HG12 ' NE1' ' A' ' 141' ' ' TRP . 0.9 OUTLIER -49.96 -57.5 2.18 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.23 -0.441 . . . . 72.05 111.106 -179.949 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.713 ' HB2' HG13 ' A' ' 235' ' ' VAL . 3.6 t-80 -66.32 -29.37 69.56 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.278 -0.419 . . . . 70.25 110.9 179.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.432 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -63.5 -42.76 98.5 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.214 -0.448 . . . . 75.11 111.069 179.855 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.674 HG23 HG12 ' A' ' 159' ' ' ILE . 2.2 mt -71.57 -35.0 54.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-N 116.263 -0.426 . . . . 71.43 111.232 179.922 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -50.45 -43.34 44.5 Favored Glycine 0 N--CA 1.452 -0.269 0 C-N-CA 120.623 -0.798 . . . . 53.24 112.495 179.958 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.438 ' O ' ' O ' ' A' ' 185' ' ' PHE . 32.7 m-70 -69.27 -39.9 78.13 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-O 120.797 0.332 . . . . 71.2 110.86 -179.945 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.625 ' OG ' HG23 ' A' ' 159' ' ' ILE . 3.4 m -62.54 -27.03 68.88 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.235 -0.439 . . . . 44.43 110.807 -179.8 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.501 HD23 ' CZ3' ' A' ' 109' ' ' TRP . 74.2 mt -75.72 -27.39 58.15 Favored 'General case' 0 C--N 1.327 -0.394 0 CA-C-N 116.244 -0.435 . . . . 62.24 110.988 179.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 118.0 16.16 5.89 Favored Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.691 -0.766 . . . . 63.45 112.521 179.967 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.842 HD11 ' CD1' ' A' ' 258' ' ' ILE . 29.3 mt -80.78 155.06 26.85 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-O 120.874 0.369 . . . . 72.35 110.856 -179.822 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.403 ' H ' ' HA ' ' A' ' 102' ' ' GLU . . . -98.43 -137.09 9.56 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.7 -0.762 . . . . 60.23 112.513 179.847 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.471 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 1.1 m170 -125.34 149.78 47.78 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 120.861 0.362 . . . . 72.31 110.848 -179.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 67.7 m -110.87 163.88 13.35 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.192 -0.458 . . . . 74.15 110.886 -179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -103.66 -3.01 25.68 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.167 -0.469 . . . . 63.14 110.892 -179.814 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.533 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -67.75 137.23 92.72 Favored Pre-proline 0 C--N 1.329 -0.324 0 CA-C-O 121.598 0.713 . . . . 71.42 110.872 179.922 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.2 Cg_endo -69.82 -3.86 12.91 Favored 'Trans proline' 0 C--N 1.342 0.209 0 C-N-CA 122.694 2.262 . . . . 61.53 112.311 -179.943 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -132.21 3.07 3.96 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.233 -0.44 . . . . 74.13 110.852 179.913 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.533 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -74.98 128.51 35.75 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.279 -0.419 . . . . 73.35 111.109 179.781 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.713 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -55.33 -34.53 33.96 Favored 'Isoleucine or valine' 0 C--N 1.331 -0.232 0 CA-C-N 116.162 -0.472 . . . . 74.01 111.187 179.982 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.471 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 41.9 mmm -62.21 -21.18 64.92 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.171 -0.468 . . . . 74.01 110.937 179.899 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.541 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -56.72 142.65 71.2 Favored Pre-proline 0 C--N 1.33 -0.278 0 CA-C-O 121.582 0.706 . . . . 73.21 110.895 -179.952 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.541 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.9 Cg_endo -69.74 -2.24 9.82 Favored 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.647 2.231 . . . . 71.51 112.382 179.986 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 42.1 m -93.7 143.14 26.59 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-N 116.135 -0.484 . . . . 53.03 111.066 -179.929 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 52.6 t80 -123.68 140.48 52.95 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.184 -0.462 . . . . 74.03 110.918 -179.954 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -161.32 128.01 3.95 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.143 -0.48 . . . . 71.11 110.917 179.849 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.502 ' O ' HG13 ' A' ' 243' ' ' VAL . 84.3 t80 -54.01 144.55 18.92 Favored 'General case' 0 C--N 1.328 -0.364 0 CA-C-N 116.251 -0.431 . . . . 63.34 110.94 -179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.517 ' H ' HD11 ' A' ' 214' ' ' LEU . 1.1 m -158.27 130.78 1.09 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.124 -0.489 . . . . 54.22 111.223 179.954 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 51.4 t0 -52.33 133.01 34.9 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.177 -0.465 . . . . 74.4 110.925 179.938 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.414 HD12 ' CE2' ' A' ' 213' ' ' PHE . 9.2 tt -53.57 -29.46 17.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.193 -0.458 . . . . 72.21 111.171 179.984 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.522 HD22 HG23 ' A' ' 247' ' ' THR . 0.3 OUTLIER -70.16 -21.12 63.1 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.141 -0.481 . . . . 64.11 110.909 179.914 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.522 HG23 HD22 ' A' ' 246' ' ' ASN . 44.3 p -109.95 -20.66 12.66 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.17 -0.468 . . . . 75.53 111.201 -179.967 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.444 ' HE2' HG21 ' A' ' 217' ' ' VAL . 9.9 t80 -72.47 130.69 41.26 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.173 -0.467 . . . . 64.33 110.863 179.987 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 8.6 ptm180 -166.87 137.33 3.14 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.141 -0.482 . . . . 74.24 110.877 -179.909 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.631 HD12 HG11 ' A' ' 144' ' ' VAL . 64.5 mt -49.36 124.19 8.79 Favored 'General case' 0 C--N 1.327 -0.383 0 CA-C-N 116.247 -0.433 . . . . 61.33 110.881 -179.965 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 8.4 t -70.26 166.62 19.72 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.125 -0.489 . . . . 52.2 110.87 -179.912 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.63 -40.75 40.47 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.18 -0.464 . . . . 73.14 111.063 179.952 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -60.8 -45.76 93.13 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.283 -0.417 . . . . 75.33 110.948 179.994 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.592 ' O ' HG22 ' A' ' 258' ' ' ILE . 5.2 m-20 -62.99 -54.62 35.48 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.11 -0.496 . . . . 64.22 110.827 179.912 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 18.7 mt -61.87 -28.08 43.56 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.197 -0.456 . . . . 75.3 111.144 -179.932 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 16.7 mmm180 -75.26 -41.47 57.23 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.185 -0.461 . . . . 65.15 110.848 179.985 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.401 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -76.92 -50.46 6.92 Favored Glycine 0 N--CA 1.45 -0.381 0 C-N-CA 120.732 -0.746 . . . . 64.22 112.491 -179.977 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.842 ' CD1' HD11 ' A' ' 226' ' ' LEU . 3.3 tp -54.55 -32.9 25.74 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.421 0 CA-C-O 120.748 0.308 . . . . 71.32 111.097 179.973 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.457 ' O ' ' N ' ' A' ' 263' ' ' GLY . 36.8 mt-30 -87.84 -16.78 33.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.249 -0.432 . . . . 75.41 110.885 179.937 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.401 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 2.5 t -68.21 -15.51 63.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.218 -0.446 . . . . 74.15 110.783 -179.802 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.837 HD11 ' HB2' ' A' ' 102' ' ' GLU . 5.8 mt -120.34 -20.68 7.18 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.205 -0.452 . . . . 75.45 110.917 179.963 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.768 ' HB3' HD21 ' A' ' 147' ' ' LEU . 34.8 m-85 -111.56 -36.45 5.5 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.2 -0.455 . . . . 72.03 110.991 179.944 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.355 0 CA-C-O 119.147 -0.807 . . . . 54.4 112.555 179.913 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 59.4 m-85 . . . . . 0 C--O 1.232 0.177 0 CA-C-O 120.8 0.333 . . . . 52.32 110.908 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 2.7 mtm-85 50.65 55.84 8.9 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.236 -0.438 . . . . 73.05 110.86 -179.881 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.61 ' HB2' HD11 ' A' ' 261' ' ' LEU . 1.2 pp20? 178.72 132.41 0.08 Allowed 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.187 -0.461 . . . . 75.03 110.848 -179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.423 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . 0.2 OUTLIER -51.93 143.98 21.47 Favored Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.585 0.707 . . . . 75.53 110.86 -179.964 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.42 ' HD2' ' CG ' ' A' ' 103' ' ' MET . 52.9 Cg_endo -69.81 136.18 32.22 Favored 'Trans proline' 0 N--CA 1.465 -0.176 0 C-N-CA 122.751 2.3 . . . . 73.51 112.289 -179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 95.52 -12.19 67.93 Favored Glycine 0 N--CA 1.452 -0.298 0 C-N-CA 120.702 -0.761 . . . . 54.52 112.376 179.931 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.704 ' N ' ' CD ' ' A' ' 107' ' ' PRO . . . 70.44 35.27 68.53 Favored Glycine 0 N--CA 1.451 -0.341 0 C-N-CA 120.775 -0.726 . . . . 53.24 112.436 -179.898 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.704 ' CD ' ' N ' ' A' ' 106' ' ' GLY . 53.6 Cg_endo -69.74 59.1 1.59 Allowed 'Trans proline' 0 C--O 1.233 0.253 0 C-N-CA 122.671 2.247 . . . . 65.24 112.281 -179.921 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.948 HG21 ' HB3' ' A' ' 261' ' ' LEU . 11.6 m -130.24 151.09 35.33 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.297 -0.41 . . . . 63.31 111.124 179.9 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . . . . . . . . . 0.0 OUTLIER -91.11 107.44 19.2 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.214 -0.448 . . . . 74.1 110.92 179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 30.5 mtt180 -70.56 56.79 0.18 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.17 -0.468 . . . . 74.43 110.888 -179.959 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 2.6 mtmt -124.04 166.11 16.31 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.195 -0.457 . . . . 75.1 110.845 -179.952 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 1.7 p80 -114.99 34.24 4.96 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.221 -0.445 . . . . 72.51 110.861 179.852 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.5 m-85 -137.9 103.26 4.94 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.163 -0.472 . . . . 71.41 110.948 -179.922 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.566 HG22 ' N ' ' A' ' 115' ' ' THR . 5.4 mp -132.2 160.66 42.34 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.302 0 CA-C-N 116.12 -0.491 . . . . 71.41 111.156 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.566 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -157.98 164.46 36.77 Favored 'General case' 0 C--N 1.331 -0.209 0 CA-C-N 116.227 -0.442 . . . . 75.3 111.059 -179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.607 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.9 p90 -134.53 149.14 50.63 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.172 -0.467 . . . . 72.22 110.938 -179.927 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.544 ' HD2' HD11 ' A' ' 160' ' ' LEU . 4.1 tmt_? -142.44 113.84 7.81 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.133 -0.485 . . . . 62.31 110.943 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . 0.421 HD12 ' OH ' ' A' ' 121' ' ' TYR . 48.4 mt -74.87 106.24 4.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.175 -0.466 . . . . 53.33 111.075 -179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -59.41 -47.03 87.03 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.199 -0.455 . . . . 75.34 110.932 179.857 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.735 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.0 p-10 -142.71 161.84 37.03 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.189 -0.46 . . . . 72.53 110.96 179.98 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.695 ' CE2' HG11 ' A' ' 130' ' ' VAL . 4.7 m-85 -117.4 146.75 43.23 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.2 -0.454 . . . . 71.44 110.926 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.505 HG22 ' HE1' ' A' ' 125' ' ' MET . 2.1 t -93.39 141.28 23.74 Favored Pre-proline 0 C--N 1.33 -0.257 0 CA-C-O 121.536 0.684 . . . . 63.25 111.167 -179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 53.7 Cg_endo -69.78 -1.66 8.87 Favored 'Trans proline' 0 C--O 1.232 0.18 0 C-N-CA 122.732 2.288 . . . . 61.3 112.289 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -82.11 -30.26 31.29 Favored 'General case' 0 C--N 1.328 -0.365 0 CA-C-N 116.268 -0.424 . . . . 74.22 110.868 179.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.706 ' HE3' HG22 ' A' ' 130' ' ' VAL . 8.1 mtm -108.06 163.63 12.98 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.234 -0.439 . . . . 74.32 110.918 179.901 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . 0.527 ' O ' HG23 ' A' ' 130' ' ' VAL . 2.8 m120 -95.02 146.42 24.28 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.251 -0.431 . . . . 71.24 110.842 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.33 -32.52 3.2 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.155 -0.475 . . . . 71.32 110.919 -179.961 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 23.4 mt-10 -83.73 -38.94 20.74 Favored 'General case' 0 C--N 1.328 -0.359 0 CA-C-N 116.171 -0.468 . . . . 74.34 110.917 -179.914 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 39.1 m-20 -66.0 -30.26 70.78 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.132 -0.485 . . . . 64.13 110.853 179.937 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.706 HG22 ' HE3' ' A' ' 125' ' ' MET . 84.7 t -65.2 -47.01 89.14 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.131 -0.486 . . . . 55.31 111.158 179.995 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -78.12 -24.1 47.57 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.168 -0.469 . . . . 74.33 110.806 -179.994 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -73.12 -47.02 47.8 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.21 -0.45 . . . . 63.32 110.887 -179.823 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.75 ' HB3' HD23 ' A' ' 212' ' ' LEU . . . -72.31 -31.21 65.49 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.157 -0.474 . . . . 75.13 111.065 179.923 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.669 HD13 HD21 ' A' ' 212' ' ' LEU . 1.3 mp -73.93 -54.15 15.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.247 -0.433 . . . . 64.21 111.148 -179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.526 ' N ' HG22 ' A' ' 134' ' ' ILE . 4.2 ttm180 -48.88 -43.03 38.67 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.164 -0.471 . . . . 72.31 110.812 179.968 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.686 ' O ' HG23 ' A' ' 140' ' ' VAL . 5.1 mmpt? -70.79 -34.64 71.98 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.254 -0.43 . . . . 55.31 110.939 179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.918 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.07 -49.36 77.96 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.223 -0.444 . . . . 74.13 111.128 179.777 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.639 ' HE1' HD13 ' A' ' 159' ' ' ILE . 95.8 m-85 -72.68 -22.19 60.95 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.228 -0.442 . . . . 64.5 110.883 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.529 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.6 tt0 -78.0 -6.34 54.19 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.068 -0.514 . . . . 72.12 110.927 -179.862 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.686 HG23 ' O ' ' A' ' 136' ' ' LYS . 99.1 t -97.65 -16.93 6.94 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.128 -0.487 . . . . 71.22 111.056 -179.935 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.829 ' NE1' HG12 ' A' ' 217' ' ' VAL . 89.9 m95 -106.33 -37.74 6.44 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.177 -0.465 . . . . 72.3 110.921 -179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.18 -12.54 61.76 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.237 -0.438 . . . . 42.1 110.831 -179.809 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.61 HD22 ' N ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER -93.6 -19.47 21.13 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.091 -0.504 . . . . 74.41 110.866 -179.931 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.782 HG11 HD12 ' A' ' 250' ' ' LEU . 17.8 m -98.91 3.19 10.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.318 0 CA-C-N 116.186 -0.461 . . . . 63.3 111.214 179.844 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.514 HG21 HG13 ' A' ' 258' ' ' ILE . 23.4 p -149.46 145.04 18.53 Favored Pre-proline 0 C--N 1.329 -0.288 0 CA-C-O 121.603 0.716 . . . . 75.25 111.097 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.9 Cg_endo -69.75 29.96 0.18 Allowed 'Trans proline' 0 C--N 1.341 0.18 0 C-N-CA 122.711 2.274 . . . . 73.43 112.344 179.875 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.729 HD21 ' CD1' ' A' ' 262' ' ' TYR . 5.0 mp -96.88 176.91 5.81 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.177 -0.465 . . . . 71.55 110.94 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -137.51 126.58 24.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.234 -0.439 . . . . 71.23 110.923 179.858 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.414 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.8 m-30 -112.76 145.29 40.82 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.252 -0.431 . . . . 73.53 110.88 179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.431 ' H ' ' HA ' ' A' ' 115' ' ' THR . 3.1 t -139.34 155.2 47.84 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 72.45 110.789 -179.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.463 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.5 OUTLIER -106.02 141.0 38.15 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.114 -0.494 . . . . 73.55 110.836 179.993 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.481 HD12 ' CA ' ' A' ' 155' ' ' GLY . 20.5 pt -150.82 144.74 16.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.139 -0.482 . . . . 60.44 111.056 179.857 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -116.9 8.46 13.53 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.171 -0.468 . . . . 53.42 110.892 179.916 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 8.1 t -167.81 50.9 0.06 Allowed 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.218 -0.446 . . . . 74.32 111.158 179.963 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.481 ' CA ' HD12 ' A' ' 152' ' ' ILE . . . -148.47 -152.74 5.78 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.71 -0.757 . . . . 61.41 112.461 179.958 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 30.1 mmt -107.11 96.76 6.65 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-O 120.836 0.35 . . . . 61.44 110.915 -179.971 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.48 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -105.94 155.15 19.64 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 116.246 -0.434 . . . . 74.2 111.144 179.86 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -84.61 -51.07 7.13 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.232 -0.44 . . . . 73.25 110.85 179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.728 HG12 HG23 ' A' ' 220' ' ' ILE . 2.0 mp -92.85 97.41 7.17 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.205 -0.452 . . . . 65.53 111.18 -179.965 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.544 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.5 tp -88.58 109.56 20.19 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.16 -0.473 . . . . 72.34 110.873 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.443 HG13 ' CE1' ' A' ' 197' ' ' PHE . 85.8 t -87.49 123.39 40.17 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 63.22 111.225 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.735 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -142.2 106.11 1.4 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 71.51 111.125 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 46.6 m-85 -73.18 107.59 5.6 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.123 -0.489 . . . . 72.33 110.913 -179.975 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.5 164.26 23.16 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.114 -0.494 . . . . 44.33 111.093 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -111.82 138.26 48.66 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.166 -0.47 . . . . 72.11 110.902 -179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.684 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 41.83 -154.16 0.12 Allowed Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.793 -0.718 . . . . 60.24 112.402 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.807 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.41 117.06 7.38 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.86 0.362 . . . . 51.31 111.025 -179.955 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.691 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -109.5 -22.34 12.04 Favored 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 116.25 -0.432 . . . . 71.44 110.818 179.982 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.01 29.68 0.55 Allowed Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.746 -0.74 . . . . 72.44 112.534 -179.917 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.639 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -112.97 0.18 14.99 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-O 120.861 0.362 . . . . 71.44 110.859 179.963 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 4.6 m-85 73.96 39.54 0.51 Allowed 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.213 -0.449 . . . . 73.21 110.901 -179.863 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.691 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.16 -41.53 0.73 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.111 -0.495 . . . . 73.32 110.851 -179.99 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.807 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.26 99.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.195 -0.457 . . . . 72.15 111.058 179.954 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.684 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.1 m-85 -59.73 -169.02 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.279 -0.418 . . . . 65.42 110.842 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -133.68 19.41 3.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.138 -0.483 . . . . 64.22 110.884 179.952 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.574 ' HA2' ' CB ' ' A' ' 200' ' ' ASP . . . 55.26 -162.72 4.74 Favored Glycine 0 N--CA 1.451 -0.352 0 C-N-CA 120.707 -0.759 . . . . 70.22 112.517 -179.964 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.454 ' C ' ' O ' ' A' ' 176' ' ' GLY . 1.7 ptpp? -33.42 136.0 0.11 Allowed 'General case' 0 C--N 1.328 -0.329 0 CA-C-O 120.843 0.354 . . . . 71.42 110.904 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 61.02 160.84 0.1 Allowed Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.74 -0.743 . . . . 62.0 112.552 179.957 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.515 ' O ' HD22 ' A' ' 181' ' ' LEU . . . 84.06 -141.41 20.0 Favored Glycine 0 N--CA 1.452 -0.286 0 C-N-CA 120.817 -0.706 . . . . 73.24 112.444 -179.897 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.6 97.71 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.861 0.362 . . . . 74.2 111.103 -179.948 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.57 HD13 ' HG3' ' A' ' 201' ' ' GLU . 2.8 mm? -68.63 -36.97 79.34 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.13 -0.487 . . . . 71.34 110.868 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.446 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -174.08 169.96 3.87 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.209 -0.45 . . . . 51.43 111.097 179.773 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.493 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.3 p80 -163.79 142.12 7.6 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 116.133 -0.485 . . . . 73.34 110.867 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.744 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -136.28 173.37 11.78 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.299 -0.409 . . . . 65.21 111.174 179.836 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.544 ' O ' ' O ' ' A' ' 222' ' ' HIS . 16.7 m-85 -98.69 -141.15 0.31 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.238 -0.437 . . . . 65.41 110.774 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -174.89 -81.96 0.05 OUTLIER Glycine 0 N--CA 1.451 -0.319 0 C-N-CA 120.799 -0.715 . . . . 64.53 112.541 -179.896 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.405 ' HG3' ' HB2' ' A' ' 107' ' ' PRO . 54.1 Cg_endo -69.73 47.46 0.55 Allowed 'Trans proline' 0 C--N 1.342 0.203 0 C-N-CA 122.706 2.271 . . . . 75.42 112.369 -180.0 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.558 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -119.71 147.47 18.1 Favored Glycine 0 N--CA 1.452 -0.288 0 C-N-CA 120.71 -0.757 . . . . 72.44 112.508 179.943 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.531 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.88 144.96 30.81 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 120.83 0.347 . . . . 74.05 110.816 -179.663 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.56 -64.02 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.358 0 C-N-CA 120.725 -0.75 . . . . 64.53 112.481 179.964 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.531 ' N ' ' O ' ' A' ' 189' ' ' SER . 14.6 tt -104.43 8.84 9.53 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.337 0 CA-C-O 120.85 0.357 . . . . 74.35 111.183 179.998 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.558 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -70.76 174.21 40.0 Favored Glycine 0 N--CA 1.453 -0.213 0 C-N-CA 120.672 -0.775 . . . . 52.04 112.467 179.945 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.426 ' O ' ' CB ' ' A' ' 223' ' ' SER . . . 42.76 23.19 0.18 Allowed Glycine 0 N--CA 1.452 -0.297 0 C-N-CA 120.723 -0.751 . . . . 71.11 112.486 -179.915 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.42 ' N ' ' O ' ' A' ' 192' ' ' GLY . 1.9 m-20 -65.49 101.2 0.56 Allowed 'General case' 0 C--N 1.328 -0.33 0 CA-C-O 120.903 0.383 . . . . 74.21 110.917 179.96 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.744 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -74.72 130.36 39.36 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.157 -0.474 . . . . 62.32 111.124 179.948 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.493 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.2 m170 -121.05 130.19 53.67 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.242 -0.436 . . . . 71.13 110.837 -179.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.532 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 47.6 m-85 -114.91 133.7 55.77 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.302 -0.408 . . . . 73.13 110.847 -179.929 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 50.7 t0 -64.72 112.84 3.4 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.131 -0.486 . . . . 72.41 110.823 179.942 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 6.5 tp10 -68.2 -18.99 64.73 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.148 -0.478 . . . . 73.21 110.961 -179.945 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.574 ' CB ' ' HA2' ' A' ' 176' ' ' GLY . 14.4 m-20 -68.89 -8.57 45.25 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.131 -0.486 . . . . 74.03 110.841 179.977 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.57 ' HG3' HD13 ' A' ' 181' ' ' LEU . 50.4 mm-40 -97.27 162.17 13.47 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.178 -0.464 . . . . 72.43 110.891 -179.926 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.514 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.2 OUTLIER -95.94 94.18 7.46 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.141 -0.481 . . . . 75.4 110.942 -179.938 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.532 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 45.4 m95 -82.95 124.69 30.61 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.223 -0.444 . . . . 72.12 110.926 -179.996 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 36.0 p -145.97 -177.6 5.68 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 60.52 111.159 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -110.59 21.08 17.0 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.248 -0.433 . . . . 73.45 111.192 179.991 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.7 m80 -128.13 -177.72 4.25 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.119 -0.491 . . . . 73.54 110.875 179.954 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.7 t -67.59 -19.22 65.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.237 -0.438 . . . . 44.44 110.864 -179.796 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.29 -104.82 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.769 -0.729 . . . . 72.12 112.45 -179.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.514 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.24 177.98 0.14 Allowed Glycine 0 N--CA 1.451 -0.353 0 C-N-CA 120.782 -0.723 . . . . 51.45 112.437 -179.861 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 95.9 m -67.79 97.22 0.62 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.721 0.295 . . . . 74.11 111.127 -179.793 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -41.06 116.31 0.71 Allowed 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.303 -0.408 . . . . 72.1 110.853 179.994 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.75 HD23 ' HB3' ' A' ' 133' ' ' ALA . 9.9 tp -63.26 -39.4 94.48 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.189 -0.46 . . . . 74.2 110.873 179.985 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.732 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.7 t80 -50.46 -65.29 0.58 Allowed 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.165 -0.47 . . . . 70.23 110.879 179.89 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.469 HD11 ' H ' ' A' ' 243' ' ' VAL . 15.4 mt -54.02 -55.43 27.39 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.147 -0.478 . . . . 73.32 110.897 -179.894 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.514 ' O ' ' HB2' ' A' ' 219' ' ' ALA . 2.6 m -55.67 -32.22 63.05 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.146 -0.479 . . . . 74.44 111.119 179.919 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -69.31 -48.04 62.72 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.257 -0.428 . . . . 71.35 111.027 179.91 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.918 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -54.06 -58.44 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.222 -0.445 . . . . 73.54 111.196 179.981 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.717 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.9 t-80 -64.0 -28.8 70.05 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.175 -0.466 . . . . 73.22 110.819 179.931 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.514 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.9 -45.66 91.48 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.153 -0.476 . . . . 65.25 111.162 179.939 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.728 HG23 HG12 ' A' ' 159' ' ' ILE . 2.6 mt -68.19 -33.95 63.67 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.208 -0.451 . . . . 52.21 111.12 179.984 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -52.43 -43.13 58.0 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.834 -0.698 . . . . 51.03 112.505 179.889 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.544 ' O ' ' O ' ' A' ' 185' ' ' PHE . 41.1 m-70 -70.32 -41.36 73.36 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 120.815 0.341 . . . . 71.34 110.833 -179.912 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.527 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 29.5 p -64.95 -20.35 66.43 Favored 'General case' 0 C--N 1.33 -0.254 0 CA-C-N 116.205 -0.452 . . . . 73.21 110.903 -179.774 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.428 HD21 HG21 ' A' ' 114' ' ' ILE . 36.5 mt -81.64 -25.79 35.35 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.134 -0.485 . . . . 75.14 110.902 179.947 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.881 ' HA3' HG12 ' A' ' 108' ' ' VAL . . . 120.55 11.7 6.49 Favored Glycine 0 N--CA 1.452 -0.257 0 C-N-CA 120.774 -0.726 . . . . 43.22 112.487 179.874 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.803 HD11 ' CD1' ' A' ' 258' ' ' ILE . 12.4 mt -76.95 158.88 30.38 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.863 0.364 . . . . 65.42 110.967 179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -104.71 -134.49 8.08 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.806 -0.711 . . . . 63.55 112.499 179.864 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.441 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 0.7 OUTLIER -129.5 145.1 51.49 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.338 . . . . 72.5 110.866 -179.89 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 27.4 t -108.45 165.56 11.43 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.274 -0.421 . . . . 72.0 110.811 -179.698 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -105.93 -2.99 22.29 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.11 -0.495 . . . . 61.34 110.902 -179.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.623 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -62.2 136.51 95.5 Favored Pre-proline 0 C--N 1.329 -0.322 0 CA-C-O 121.579 0.704 . . . . 73.15 110.845 179.921 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.71 -0.44 6.87 Favored 'Trans proline' 0 C--N 1.341 0.173 0 C-N-CA 122.706 2.271 . . . . 75.52 112.422 179.939 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.81 15.52 1.94 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.154 -0.475 . . . . 73.14 110.889 179.918 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.623 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -84.74 133.48 34.36 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.269 -0.423 . . . . 75.41 111.19 179.758 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.717 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -56.78 -37.8 55.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.308 0 CA-C-N 116.331 -0.395 . . . . 74.15 111.145 -179.944 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.441 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 47.1 mmm -59.73 -23.21 63.0 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.17 -0.468 . . . . 74.23 110.889 179.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.542 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.7 t80 -54.39 142.72 49.22 Favored Pre-proline 0 C--N 1.328 -0.343 0 CA-C-O 121.68 0.753 . . . . 75.33 110.861 -179.941 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.542 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.7 Cg_endo -69.69 -1.21 8.02 Favored 'Trans proline' 0 C--O 1.232 0.176 0 C-N-CA 122.667 2.245 . . . . 74.43 112.387 179.987 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.409 ' HG1' ' HD2' ' A' ' 237' ' ' PHE . 50.0 m -93.9 141.72 28.2 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-N 116.201 -0.454 . . . . 63.34 111.129 179.997 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 56.0 t80 -122.74 141.52 51.71 Favored 'General case' 0 C--N 1.327 -0.39 0 CA-C-N 116.269 -0.423 . . . . 62.14 110.928 179.969 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 19.5 ttpt -161.02 138.79 9.37 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.114 -0.494 . . . . 75.44 110.87 179.87 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.55 ' O ' HG13 ' A' ' 243' ' ' VAL . 66.8 t80 -62.43 146.67 50.86 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.234 -0.439 . . . . 75.13 110.971 -179.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.55 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -160.88 132.1 0.92 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.293 0 CA-C-N 116.219 -0.446 . . . . 60.43 111.095 179.92 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 46.1 t0 -50.46 133.21 24.98 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.172 -0.467 . . . . 74.11 110.902 179.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.625 HD11 ' HD3' ' A' ' 136' ' ' LYS . 6.4 tt -54.7 -30.39 22.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.333 0 CA-C-N 116.223 -0.444 . . . . 72.34 111.147 179.95 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 9.1 m-80 -75.36 -18.39 59.99 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.18 -0.463 . . . . 44.31 110.906 179.879 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 43.4 p -107.63 -20.25 13.29 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.19 -0.459 . . . . 73.21 111.105 -179.947 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.467 ' C ' ' HG3' ' A' ' 249' ' ' ARG . 10.4 t80 -72.65 120.54 18.41 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.213 -0.448 . . . . 72.35 110.886 -179.971 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.467 ' HG3' ' C ' ' A' ' 248' ' ' PHE . 16.1 mtt180 -152.42 141.92 21.71 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.107 -0.497 . . . . 64.41 110.854 -179.893 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.782 HD12 HG11 ' A' ' 144' ' ' VAL . 45.4 mt -59.0 123.44 16.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.201 -0.454 . . . . 73.43 110.895 -179.962 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 15.8 m -67.11 162.48 22.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.152 -0.476 . . . . 71.04 110.937 -179.929 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -48.18 -36.2 13.18 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.178 -0.465 . . . . 50.34 111.133 179.961 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -65.04 -47.87 75.87 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.228 -0.442 . . . . 72.14 110.837 179.988 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.419 ' O ' HG22 ' A' ' 258' ' ' ILE . 9.4 m-20 -60.45 -51.79 67.96 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.164 -0.471 . . . . 74.24 110.824 -179.93 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 20.6 mt -62.49 -33.48 59.65 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.312 0 CA-C-N 116.218 -0.447 . . . . 75.13 111.236 179.956 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 2.0 tpt180 -71.26 -39.81 71.37 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.087 -0.506 . . . . 75.15 110.916 179.86 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -75.85 -51.23 7.19 Favored Glycine 0 N--CA 1.451 -0.342 0 C-N-CA 120.749 -0.739 . . . . 73.11 112.467 -179.973 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.803 ' CD1' HD11 ' A' ' 226' ' ' LEU . 2.8 tp -52.65 -35.05 20.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-O 120.869 0.366 . . . . 75.01 111.198 179.974 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.419 ' O ' ' N ' ' A' ' 263' ' ' GLY . 71.2 mt-30 -87.02 -16.49 35.53 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 70.0 110.929 179.942 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.7 t -69.63 -13.98 62.59 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.237 -0.438 . . . . 73.11 110.875 -179.82 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.948 ' HB3' HG21 ' A' ' 108' ' ' VAL . 3.5 mt -123.72 -17.74 6.29 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.089 -0.505 . . . . 63.25 110.908 179.975 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.729 ' CD1' HD21 ' A' ' 147' ' ' LEU . 35.1 m-85 -115.04 -33.39 5.41 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.184 -0.462 . . . . 64.33 110.904 -179.99 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.419 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.289 0 CA-C-O 119.034 -0.87 . . . . 61.41 112.517 -179.978 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.508 ' HZ ' ' HG ' ' A' ' 230' ' ' SER . 42.9 p90 . . . . . 0 N--CA 1.457 -0.086 0 CA-C-O 120.8 0.333 . . . . 74.42 110.899 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.613 HH22 HD22 ' A' ' 226' ' ' LEU . 0.0 OUTLIER -50.43 99.6 0.02 OUTLIER 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.118 -0.492 . . . . 74.02 110.87 -179.905 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 46.7 mt-10 -159.42 129.2 5.52 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.09 -0.504 . . . . 75.41 110.861 -179.863 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 3.9 tpp -52.02 134.32 39.35 Favored Pre-proline 0 C--N 1.328 -0.364 0 CA-C-O 121.604 0.716 . . . . 72.44 110.767 -179.956 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.2 Cg_endo -69.79 139.54 40.39 Favored 'Trans proline' 0 C--O 1.231 0.143 0 C-N-CA 122.719 2.279 . . . . 72.33 112.407 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 93.99 13.61 54.23 Favored Glycine 0 N--CA 1.452 -0.252 0 C-N-CA 120.688 -0.767 . . . . 33.12 112.443 -179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.446 ' N ' ' CD ' ' A' ' 107' ' ' PRO . . . 39.95 52.68 3.27 Favored Glycine 0 N--CA 1.451 -0.344 0 C-N-CA 120.68 -0.771 . . . . 62.34 112.525 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.446 ' CD ' ' N ' ' A' ' 106' ' ' GLY . 53.5 Cg_endo -69.8 -24.58 29.34 Favored 'Trans proline' 0 C--N 1.342 0.201 0 C-N-CA 122.63 2.22 . . . . 70.22 112.344 -179.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 1.026 HG21 HD13 ' A' ' 261' ' ' LEU . 40.7 t -48.89 130.65 6.25 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.234 -0.439 . . . . 73.14 111.146 179.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.627 ' HZ3' HD23 ' A' ' 224' ' ' LEU . 2.8 m-90 -60.94 -29.11 69.43 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.284 -0.416 . . . . 75.21 110.829 -179.976 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.692 ' H ' HG12 ' A' ' 108' ' ' VAL . 27.9 mtm180 64.21 32.55 12.4 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.253 -0.431 . . . . 73.14 110.895 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.453 ' HG2' ' HB3' ' A' ' 109' ' ' TRP . 0.2 OUTLIER -123.11 165.7 16.4 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.281 -0.418 . . . . 72.41 110.919 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 8.6 p80 -104.96 36.67 2.38 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.201 -0.454 . . . . 60.12 110.905 179.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . 0.434 ' C ' HD12 ' A' ' 114' ' ' ILE . 2.7 m-85 -139.04 108.9 6.28 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.198 -0.456 . . . . 74.14 110.976 -179.793 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.614 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.6 mp -142.93 162.97 17.36 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 CA-C-N 116.203 -0.453 . . . . 72.2 111.172 179.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.588 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.1 OUTLIER -159.67 163.46 34.84 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.232 -0.44 . . . . 75.54 111.136 -179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.605 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 1.5 p90 -133.13 151.43 51.99 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.177 -0.465 . . . . 72.34 110.889 -179.963 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.538 ' HD2' HD11 ' A' ' 160' ' ' LEU . 4.7 tmt_? -141.87 112.66 7.28 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.137 -0.483 . . . . 73.3 110.856 179.961 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.4 mt -74.4 106.23 4.08 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.131 -0.486 . . . . 72.22 111.125 179.979 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 39.9 t30 -59.14 -48.49 81.4 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.165 -0.471 . . . . 75.2 110.858 179.926 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.503 HD21 ' N ' ' A' ' 163' ' ' PHE . 0.2 OUTLIER -146.33 171.84 14.38 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.167 -0.47 . . . . 64.22 110.818 -179.949 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.603 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.5 m-85 -119.72 151.85 38.1 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.093 -0.503 . . . . 64.13 110.91 -179.82 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.554 HG23 ' HD2' ' A' ' 123' ' ' PRO . 36.9 m -103.53 136.17 19.26 Favored Pre-proline 0 C--N 1.329 -0.308 0 CA-C-O 121.573 0.702 . . . . 75.01 111.095 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.554 ' HD2' HG23 ' A' ' 122' ' ' THR . 54.7 Cg_endo -69.72 32.6 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.186 0 C-N-CA 122.657 2.238 . . . . 70.32 112.431 179.842 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.483 ' H ' ' C ' ' A' ' 122' ' ' THR . 1.6 m-20 -113.99 -23.75 9.41 Favored 'General case' 0 C--N 1.327 -0.386 0 CA-C-N 116.137 -0.483 . . . . 75.24 110.851 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.663 ' SD ' HD22 ' A' ' 212' ' ' LEU . 0.0 OUTLIER -117.6 166.82 11.94 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.215 -0.448 . . . . 74.41 110.848 -179.984 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 6.2 m120 -87.96 141.46 28.56 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.15 -0.477 . . . . 72.54 110.931 -179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.2 OUTLIER -46.05 -33.5 3.48 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.223 -0.444 . . . . 63.12 110.93 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 32.1 mt-10 -84.82 -38.64 19.3 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.122 -0.49 . . . . 74.12 110.895 -179.93 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 36.8 m-20 -64.29 -32.87 74.63 Favored 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.177 -0.465 . . . . 61.11 110.814 -179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.603 HG11 ' CE2' ' A' ' 121' ' ' TYR . 78.1 t -63.78 -44.99 98.42 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.182 -0.463 . . . . 43.2 111.148 179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.77 -23.2 39.51 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.209 -0.45 . . . . 64.55 110.871 179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.3 t80 -76.08 -46.86 26.96 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.161 -0.472 . . . . 73.42 110.939 -179.855 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.636 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -72.04 -30.23 64.96 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.146 -0.479 . . . . 65.53 111.088 179.885 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.535 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.3 mp -73.49 -55.62 11.99 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.192 -0.458 . . . . 65.15 111.172 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.535 ' N ' HG22 ' A' ' 134' ' ' ILE . 1.1 ttt85 -48.09 -40.97 24.95 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.166 -0.47 . . . . 74.31 110.904 179.894 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.413 ' O ' HG23 ' A' ' 140' ' ' VAL . 3.3 mmpt? -76.13 -32.42 59.13 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.164 -0.471 . . . . 74.13 110.919 179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.843 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -61.23 -49.98 74.94 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.187 -0.46 . . . . 63.14 111.09 179.839 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.619 ' HE2' HD13 ' A' ' 159' ' ' ILE . 80.3 m-85 -68.38 -31.14 70.29 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.137 -0.483 . . . . 71.15 110.851 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.567 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 3.4 tt0 -63.42 -44.69 93.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.167 -0.47 . . . . 65.32 110.944 -179.934 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.413 HG23 ' O ' ' A' ' 136' ' ' LYS . 55.0 t -49.21 -25.2 1.49 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.206 -0.452 . . . . 73.03 111.146 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.788 ' NE1' HG12 ' A' ' 217' ' ' VAL . 97.8 m95 -98.17 -28.9 13.51 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.157 -0.474 . . . . 71.11 110.91 179.96 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 4.3 p -74.49 -13.32 60.67 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.222 -0.444 . . . . 42.52 110.982 -179.915 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.567 ' ND2' ' O ' ' A' ' 139' ' ' GLN . 57.7 m-20 -91.88 -24.7 19.24 Favored 'General case' 0 C--N 1.331 -0.21 0 CA-C-N 116.085 -0.507 . . . . 43.55 110.978 179.932 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.585 HG21 ' CD1' ' A' ' 250' ' ' LEU . 5.7 m -94.86 2.7 9.48 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-N 116.177 -0.465 . . . . 75.12 111.222 179.821 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.49 ' C ' ' H ' ' A' ' 147' ' ' LEU . 27.4 p -154.71 141.49 13.34 Favored Pre-proline 0 C--N 1.329 -0.31 0 CA-C-O 121.611 0.719 . . . . 63.12 111.152 -179.941 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.84 28.33 0.18 Allowed 'Trans proline' 0 C--N 1.342 0.191 0 C-N-CA 122.691 2.26 . . . . 74.23 112.269 179.961 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.843 HD21 ' CG ' ' A' ' 262' ' ' TYR . 0.4 OUTLIER -84.1 -178.0 6.83 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.257 -0.429 . . . . 70.24 110.925 179.969 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 11.8 mttt -142.56 125.8 16.49 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.215 -0.448 . . . . 75.42 110.863 179.83 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.614 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.5 m-85 -117.94 137.49 52.8 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.164 -0.471 . . . . 71.33 110.847 179.907 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 53.9 m -132.34 139.46 48.15 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.075 -0.511 . . . . 55.01 110.796 -179.799 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.452 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 0.3 OUTLIER -91.9 146.48 23.71 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.059 -0.519 . . . . 71.12 110.808 179.998 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . . . . . . . . . 6.3 pt -150.22 168.13 2.29 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-N 116.171 -0.468 . . . . 74.51 111.117 179.862 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -132.77 13.56 4.4 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.189 -0.46 . . . . 75.24 110.87 179.916 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.6 p -90.79 -58.48 2.46 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.154 -0.476 . . . . 75.21 111.092 -179.986 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . . . . . . . . . . . 143.22 12.33 0.37 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.717 -0.754 . . . . 71.11 112.443 -179.993 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 9.9 mtm -108.05 72.71 0.86 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.822 0.344 . . . . 72.13 110.863 -179.946 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.569 ' HA ' HG23 ' A' ' 115' ' ' THR . . . -143.53 170.07 16.51 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.211 -0.45 . . . . 75.42 111.058 179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -86.9 -50.56 6.61 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.222 -0.445 . . . . 65.15 110.864 179.986 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.7 HG12 HG23 ' A' ' 220' ' ' ILE . 2.6 mp -94.55 97.33 6.78 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.177 -0.465 . . . . 74.45 111.146 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.538 HD11 ' HD2' ' A' ' 117' ' ' ARG . 9.2 tp -87.57 110.25 20.23 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.242 -0.435 . . . . 75.32 110.93 179.896 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 92.4 t -88.33 117.33 31.76 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.348 0 CA-C-N 116.233 -0.44 . . . . 75.54 111.075 179.843 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.411 HG13 ' O ' ' A' ' 162' ' ' VAL . 2.3 p -137.16 102.43 2.56 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.132 -0.485 . . . . 74.43 111.017 179.929 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.503 ' N ' HD21 ' A' ' 120' ' ' ASN . 47.0 m-85 -70.49 110.8 5.58 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.047 -0.524 . . . . 71.42 110.85 -179.999 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.54 166.75 20.69 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.155 -0.475 . . . . 61.04 111.035 179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 5.7 ptm180 -114.65 138.57 50.52 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.22 -0.446 . . . . 73.43 110.879 -179.928 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.681 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 42.89 -154.83 0.16 Allowed Glycine 0 N--CA 1.451 -0.327 0 C-N-CA 120.764 -0.731 . . . . 54.14 112.434 179.975 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.805 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.85 116.55 7.14 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.839 0.352 . . . . 71.32 111.098 179.953 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.704 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -108.73 -23.04 11.96 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.284 -0.417 . . . . 74.04 110.878 179.953 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.95 29.58 0.51 Allowed Glycine 0 N--CA 1.451 -0.339 0 C-N-CA 120.762 -0.732 . . . . 42.13 112.488 179.929 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.622 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.06 0.39 14.98 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-O 120.851 0.358 . . . . 44.0 110.85 -179.963 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.5 m-85 73.93 39.2 0.54 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.132 -0.486 . . . . 75.14 110.941 -179.886 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.704 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -134.55 -41.23 0.78 Allowed 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.16 -0.473 . . . . 72.22 110.884 -179.979 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.805 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.18 99.64 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.149 -0.478 . . . . 45.44 111.163 -179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.681 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -60.3 -168.14 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.392 0 CA-C-N 116.208 -0.451 . . . . 61.33 110.798 -179.833 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -135.33 18.54 3.39 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.111 -0.495 . . . . 63.2 110.876 -179.99 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.593 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.84 -155.64 11.54 Favored Glycine 0 C--N 1.33 0.248 0 C-N-CA 120.688 -0.768 . . . . 61.11 112.509 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 31.1 mmtt -37.5 135.42 0.57 Allowed 'General case' 0 C--N 1.328 -0.356 0 CA-C-O 120.803 0.335 . . . . 54.42 110.902 -179.975 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.0 164.75 0.1 Allowed Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.727 -0.749 . . . . 71.24 112.453 179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 82.86 -142.75 21.83 Favored Glycine 0 N--CA 1.453 -0.231 0 C-N-CA 120.789 -0.72 . . . . 73.23 112.455 -179.875 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.32 96.2 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.286 0 CA-C-O 120.785 0.326 . . . . 64.23 111.099 -179.899 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 66.7 mt -66.53 -40.44 89.11 Favored 'General case' 0 C--N 1.327 -0.387 0 CA-C-N 116.306 -0.407 . . . . 61.04 110.888 179.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.443 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -171.65 168.54 6.24 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.152 -0.476 . . . . 72.43 111.061 179.825 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.497 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -161.93 140.83 9.5 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.178 -0.465 . . . . 75.31 110.854 179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.742 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -136.51 173.57 11.56 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.283 -0.417 . . . . 74.44 111.013 -179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.528 ' O ' ' HA ' ' A' ' 223' ' ' SER . 37.8 m-85 -104.0 -149.91 0.41 Allowed 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.183 -0.462 . . . . 62.33 110.869 -179.972 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -163.78 -81.92 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.239 0 C-N-CA 120.754 -0.736 . . . . 52.13 112.511 179.983 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.41 ' HG3' ' HB3' ' A' ' 107' ' ' PRO . 53.9 Cg_endo -69.76 53.9 1.13 Allowed 'Trans proline' 0 C--N 1.341 0.156 0 C-N-CA 122.689 2.259 . . . . 70.05 112.351 -179.957 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.57 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -124.83 147.96 16.63 Favored Glycine 0 N--CA 1.452 -0.267 0 C-N-CA 120.753 -0.737 . . . . 55.33 112.524 179.892 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.522 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -103.9 143.92 32.2 Favored 'General case' 0 C--N 1.329 -0.32 0 CA-C-O 120.902 0.382 . . . . 63.1 110.82 -179.668 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 63.5 -63.26 0.04 OUTLIER Glycine 0 N--CA 1.452 -0.272 0 C-N-CA 120.733 -0.746 . . . . 51.04 112.497 -179.982 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.522 ' N ' ' O ' ' A' ' 189' ' ' SER . 4.2 mt -105.4 7.93 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-O 120.892 0.377 . . . . 74.33 111.113 -179.962 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.57 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -69.78 171.81 40.86 Favored Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.77 -0.729 . . . . 62.43 112.511 179.91 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.442 ' HA3' ' HB3' ' A' ' 223' ' ' SER . . . 44.0 19.93 0.14 Allowed Glycine 0 N--CA 1.451 -0.355 0 C-N-CA 120.733 -0.746 . . . . 53.11 112.523 -179.913 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.438 ' CG ' ' HB3' ' A' ' 160' ' ' LEU . 1.9 m-20 -63.83 107.96 1.34 Allowed 'General case' 0 C--N 1.327 -0.397 0 CA-C-O 120.801 0.334 . . . . 74.33 110.908 -179.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.742 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -82.14 126.16 31.72 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.217 -0.447 . . . . 73.12 111.086 179.977 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.497 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.4 m170 -116.67 130.74 56.91 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.195 -0.457 . . . . 73.41 110.851 -179.992 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.531 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 46.8 m-85 -115.7 133.71 55.75 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.168 -0.469 . . . . 74.4 110.893 -179.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 59.4 t0 -66.76 109.86 3.04 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.163 -0.471 . . . . 75.41 110.814 -179.987 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 3.9 tm-20 -60.36 -37.88 82.09 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.178 -0.465 . . . . 74.04 110.82 -179.903 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.593 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 5.9 m-20 -50.05 -22.15 1.51 Allowed 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.145 -0.48 . . . . 53.41 110.815 -179.921 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.3 mm-40 -81.32 160.67 24.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.259 -0.428 . . . . 72.4 110.919 -179.994 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.526 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -98.21 93.43 6.24 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.193 -0.458 . . . . 73.45 110.96 179.96 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.531 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 34.0 m95 -83.65 123.02 29.38 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.142 -0.481 . . . . 74.01 110.95 179.987 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 18.2 p -140.92 -176.25 4.6 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.262 -0.426 . . . . 73.24 111.073 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.37 18.11 19.52 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.164 -0.471 . . . . 73.25 111.147 -179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.43 -175.82 3.63 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.143 -0.48 . . . . 74.45 110.878 179.895 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 6.9 p -67.06 -18.73 65.48 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.186 -0.461 . . . . 65.3 110.842 -179.833 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.95 -108.54 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.419 0 C-N-CA 120.788 -0.72 . . . . 73.23 112.491 -179.955 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.526 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.92 177.52 0.12 Allowed Glycine 0 N--CA 1.452 -0.281 0 C-N-CA 120.741 -0.742 . . . . 65.3 112.519 -179.984 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 97.0 m -65.95 97.74 0.38 Allowed 'General case' 0 C--N 1.329 -0.293 0 CA-C-O 120.85 0.357 . . . . 75.13 111.123 -179.869 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -41.26 113.38 0.39 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.152 -0.476 . . . . 72.22 110.855 -179.968 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.663 HD22 ' SD ' ' A' ' 125' ' ' MET . 43.1 tp -62.26 -34.47 76.6 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.263 -0.426 . . . . 74.51 110.939 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.702 ' O ' HG23 ' A' ' 217' ' ' VAL . 3.3 t80 -54.92 -62.05 1.91 Allowed 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.167 -0.469 . . . . 72.15 110.904 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.572 HD11 ' H ' ' A' ' 243' ' ' VAL . 12.9 mt -57.18 -53.78 54.25 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.163 -0.471 . . . . 64.22 110.919 -179.973 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.489 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.2 m -54.76 -34.93 63.22 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.247 -0.433 . . . . 61.14 111.074 179.924 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.38 -49.49 66.69 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.288 -0.414 . . . . 62.13 111.021 179.932 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.843 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -52.08 -58.77 1.98 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.353 0 CA-C-N 116.251 -0.431 . . . . 44.25 111.165 179.983 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.67 ' HB2' HG13 ' A' ' 235' ' ' VAL . 2.6 t-80 -62.94 -31.55 72.66 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.064 -0.516 . . . . 75.22 110.854 179.919 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.403 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -61.73 -43.14 99.42 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.23 -0.441 . . . . 41.35 111.062 -179.969 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.7 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -70.97 -33.46 51.95 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.257 -0.429 . . . . 73.53 111.06 179.993 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.521 ' CA ' HD12 ' A' ' 226' ' ' LEU . . . -51.05 -43.29 49.68 Favored Glycine 0 N--CA 1.45 -0.376 0 C-N-CA 120.769 -0.729 . . . . 74.14 112.485 179.974 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.436 ' O ' ' O ' ' A' ' 185' ' ' PHE . 50.7 m-70 -68.83 -39.61 79.88 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-O 120.733 0.301 . . . . 65.0 110.846 -179.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.617 ' OG ' HG23 ' A' ' 159' ' ' ILE . 2.8 m -62.22 -26.66 68.49 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.165 -0.47 . . . . 64.12 110.891 -179.832 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.627 HD23 ' HZ3' ' A' ' 109' ' ' TRP . 28.8 mt -77.57 -25.71 50.24 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.169 -0.469 . . . . 54.32 110.924 179.931 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 114.01 14.61 9.11 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.766 -0.73 . . . . 53.13 112.53 179.939 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.781 HD21 HD12 ' A' ' 258' ' ' ILE . 13.3 mt -79.27 148.12 32.27 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.909 0.385 . . . . 74.55 110.924 -179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.418 ' O ' ' HE2' ' A' ' 236' ' ' MET . . . -93.95 -160.37 34.73 Favored Glycine 0 N--CA 1.451 -0.36 0 C-N-CA 120.816 -0.707 . . . . 72.21 112.448 179.94 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.404 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 1.1 m170 -103.07 149.2 24.82 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.891 0.377 . . . . 65.51 110.821 -179.886 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.454 ' HA ' ' HB3' ' A' ' 101' ' ' ARG . 2.5 p -111.53 164.41 13.01 Favored 'General case' 0 C--N 1.331 -0.234 0 CA-C-N 116.165 -0.471 . . . . 72.32 110.824 -179.716 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . 0.508 ' HG ' ' HZ ' ' A' ' 100' ' ' PHE . 0.2 OUTLIER -105.43 -0.58 25.9 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.127 -0.488 . . . . 73.34 110.913 -179.906 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.429 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.3 OUTLIER -67.23 132.82 93.38 Favored Pre-proline 0 C--N 1.33 -0.279 0 CA-C-O 121.52 0.676 . . . . 64.31 110.899 179.993 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 52.6 Cg_endo -69.82 4.95 1.91 Allowed 'Trans proline' 0 C--O 1.231 0.168 0 C-N-CA 122.662 2.241 . . . . 63.32 112.283 -179.868 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.9 13.46 2.07 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.224 -0.444 . . . . 62.44 110.925 179.9 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.429 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -82.51 149.54 27.49 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.2 -0.455 . . . . 64.34 111.086 179.884 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.67 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -71.46 -40.07 71.85 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.306 0 CA-C-N 116.284 -0.416 . . . . 75.12 111.16 179.966 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.418 ' HE2' ' O ' ' A' ' 227' ' ' GLY . 38.7 mmm -64.32 -18.97 65.12 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.068 -0.515 . . . . 73.35 110.846 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.605 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.1 t80 -49.26 143.97 8.9 Favored Pre-proline 0 C--N 1.329 -0.313 0 CA-C-O 121.728 0.775 . . . . 54.12 110.881 -179.899 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.605 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.8 Cg_endo -69.78 -0.76 7.4 Favored 'Trans proline' 0 C--N 1.342 0.221 0 C-N-CA 122.709 2.272 . . . . 71.34 112.388 -179.998 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 18.6 m -100.16 146.71 26.52 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.16 -0.473 . . . . 72.04 111.156 -179.98 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 56.4 t80 -125.45 137.22 53.98 Favored 'General case' 0 C--N 1.327 -0.378 0 CA-C-N 116.203 -0.453 . . . . 72.12 110.978 -179.95 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 2.4 tppp? -153.89 139.71 18.09 Favored 'General case' 0 C--N 1.328 -0.357 0 CA-C-N 116.139 -0.482 . . . . 70.44 110.849 179.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.582 ' O ' HG13 ' A' ' 243' ' ' VAL . 72.2 t80 -65.24 144.41 57.19 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.2 -0.455 . . . . 73.43 110.923 179.958 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.582 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.1 OUTLIER -162.18 133.98 0.98 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.234 0 CA-C-N 116.109 -0.496 . . . . 73.33 111.11 179.848 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 16.5 t0 -60.71 134.34 56.98 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 74.24 110.83 179.988 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 17.1 tt -52.91 -31.06 16.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.207 -0.452 . . . . 74.45 111.081 179.96 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.663 ' ND2' HG23 ' A' ' 247' ' ' THR . 0.0 OUTLIER -69.14 -21.25 64.02 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.218 -0.446 . . . . 72.33 110.933 179.918 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.663 HG23 ' ND2' ' A' ' 246' ' ' ASN . 11.9 p -115.95 -6.99 12.01 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.201 -0.454 . . . . 64.45 111.213 179.964 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . 0.468 ' CD2' HD22 ' A' ' 214' ' ' LEU . 8.9 t80 -88.05 115.45 25.53 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.196 -0.456 . . . . 74.05 110.933 179.985 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . 0.404 ' HG3' ' C ' ' A' ' 248' ' ' PHE . 0.1 OUTLIER -144.73 139.72 28.08 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.161 -0.472 . . . . 74.52 110.885 -179.921 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.585 ' CD1' HG21 ' A' ' 144' ' ' VAL . 26.3 mt -53.54 123.42 12.09 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.11 -0.495 . . . . 55.4 110.932 -179.925 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 10.0 p -59.67 160.0 7.87 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.239 -0.437 . . . . 74.43 110.833 -179.918 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -48.8 -33.28 10.14 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.03 -0.532 . . . . 74.01 111.208 179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 3.9 t0 -67.14 -44.16 80.52 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.139 -0.482 . . . . 74.42 110.845 179.972 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . . . . . . . . . 2.1 m-20 -64.77 -49.51 70.45 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.233 -0.44 . . . . 74.02 110.873 179.991 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.451 HG12 HG11 ' A' ' 144' ' ' VAL . 34.3 mt -63.63 -36.33 76.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.222 -0.444 . . . . 74.14 111.184 179.966 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 8.1 mmp_? -70.26 -38.63 75.17 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.131 -0.486 . . . . 72.1 110.868 179.997 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -77.37 -50.66 6.53 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.725 -0.75 . . . . 41.11 112.458 -179.941 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.781 HD12 HD21 ' A' ' 226' ' ' LEU . 3.3 tp -52.21 -34.82 18.5 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.841 0.353 . . . . 73.22 111.182 -179.956 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.404 ' O ' ' N ' ' A' ' 263' ' ' GLY . 66.7 mt-30 -86.48 -17.29 34.58 Favored 'General case' 0 C--N 1.331 -0.226 0 CA-C-N 116.156 -0.475 . . . . 71.02 110.889 179.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.1 t -69.85 -13.62 62.35 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.235 -0.439 . . . . 50.51 110.862 -179.846 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 1.026 HD13 HG21 ' A' ' 108' ' ' VAL . 1.8 mt -123.81 -18.15 6.12 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.167 -0.469 . . . . 65.5 110.95 -179.989 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.843 ' CG ' HD21 ' A' ' 147' ' ' LEU . 42.1 m-85 -114.85 -33.9 5.3 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.154 -0.475 . . . . 74.22 110.888 179.945 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.404 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.339 0 CA-C-O 119.105 -0.83 . . . . 35.1 112.472 -179.989 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.431 ' O ' ' C ' ' A' ' 101' ' ' ARG . 36.3 p90 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.826 0.346 . . . . 74.15 110.855 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.431 ' C ' ' O ' ' A' ' 100' ' ' PHE . 0.2 OUTLIER 35.08 61.51 0.61 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.133 -0.485 . . . . 54.13 110.835 -179.949 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.769 ' HG2' HD11 ' A' ' 261' ' ' LEU . 0.3 OUTLIER 176.47 111.18 0.02 OUTLIER 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.186 -0.461 . . . . 74.43 110.877 -179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.444 ' HB3' ' HG2' ' A' ' 107' ' ' PRO . 33.9 tpp -51.38 134.83 32.78 Favored Pre-proline 0 C--N 1.329 -0.3 0 CA-C-O 121.664 0.745 . . . . 73.13 110.828 -179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.77 139.46 40.23 Favored 'Trans proline' 0 C--N 1.342 0.214 0 C-N-CA 122.674 2.249 . . . . 72.43 112.45 179.929 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 92.7 7.01 63.41 Favored Glycine 0 N--CA 1.451 -0.349 0 C-N-CA 120.768 -0.73 . . . . 65.01 112.577 -179.902 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.55 ' N ' ' CD ' ' A' ' 107' ' ' PRO . . . 49.29 45.68 35.32 Favored Glycine 0 N--CA 1.452 -0.3 0 C-N-CA 120.729 -0.748 . . . . 75.4 112.439 -179.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.55 ' CD ' ' N ' ' A' ' 106' ' ' GLY . 54.0 Cg_endo -69.79 -5.31 15.92 Favored 'Trans proline' 0 C--O 1.232 0.224 0 C-N-CA 122.617 2.211 . . . . 52.43 112.342 179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.855 HG11 HD13 ' A' ' 261' ' ' LEU . 1.8 p -80.08 99.9 4.16 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.283 -0.417 . . . . 74.31 111.104 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.471 ' CZ3' HD23 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -45.08 107.55 0.1 Allowed 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.099 -0.5 . . . . 72.54 110.922 179.895 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -74.79 56.18 0.71 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.337 -0.392 . . . . 71.21 110.946 179.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . 0.406 ' HG2' ' HB2' ' A' ' 109' ' ' TRP . 5.5 pttt -122.78 149.58 43.93 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.144 -0.48 . . . . 63.43 110.919 179.994 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 11.9 p80 -93.66 40.42 1.07 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.239 -0.437 . . . . 72.44 110.86 179.908 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.9 m-85 -141.34 101.53 4.03 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.195 -0.457 . . . . 74.11 110.898 -179.825 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.61 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.7 mp -134.73 162.9 37.96 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.297 0 CA-C-N 116.106 -0.497 . . . . 70.4 111.152 179.922 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.586 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -158.68 161.26 37.1 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.204 -0.453 . . . . 51.34 111.109 179.996 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.625 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.7 p90 -132.86 148.79 52.3 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.173 -0.467 . . . . 71.2 110.92 179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.424 ' HB3' HD12 ' A' ' 160' ' ' LEU . 4.1 tmt_? -142.67 113.89 7.75 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.092 -0.504 . . . . 62.44 110.956 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 45.6 mt -74.59 105.29 3.58 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.456 . . . . 75.13 111.166 -179.953 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.6 t-20 -58.8 -48.98 79.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.161 -0.472 . . . . 70.21 110.813 -179.943 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.73 ' OD1' HG23 ' A' ' 162' ' ' VAL . 1.7 p-10 -140.66 162.63 34.94 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.151 -0.477 . . . . 64.1 110.884 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.661 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.3 m-85 -117.15 142.95 46.38 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 64.13 110.895 -179.885 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.515 HG23 ' HD2' ' A' ' 123' ' ' PRO . 24.5 m -94.92 137.51 22.29 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 121.632 0.729 . . . . 70.21 111.134 179.954 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.515 ' HD2' HG23 ' A' ' 122' ' ' THR . 52.8 Cg_endo -69.82 7.77 0.94 Allowed 'Trans proline' 0 C--N 1.342 0.196 0 C-N-CA 122.659 2.239 . . . . 74.4 112.283 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.498 ' H ' HG22 ' A' ' 122' ' ' THR . 1.6 m-20 -84.89 -29.42 25.24 Favored 'General case' 0 C--N 1.33 -0.268 0 CA-C-N 116.254 -0.43 . . . . 64.01 110.849 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.656 ' SD ' HD22 ' A' ' 212' ' ' LEU . 0.0 OUTLIER -112.73 166.56 11.25 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.255 -0.43 . . . . 72.52 110.899 179.961 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 10.1 t-20 -88.93 145.75 25.34 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.287 -0.415 . . . . 71.31 110.891 -179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -47.1 -34.86 6.39 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.162 -0.472 . . . . 72.1 110.943 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 27.6 mt-10 -82.38 -37.3 25.78 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-N 116.148 -0.478 . . . . 74.43 110.886 -179.925 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 62.8 m-20 -64.58 -32.8 74.61 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.146 -0.479 . . . . 75.21 110.839 179.989 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.661 HG11 ' CE2' ' A' ' 121' ' ' TYR . 77.9 t -63.43 -47.25 92.63 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.223 -0.444 . . . . 73.33 111.078 -179.968 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -78.03 -23.45 48.2 Favored 'General case' 0 C--N 1.328 -0.356 0 CA-C-N 116.101 -0.499 . . . . 73.01 110.879 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 5.2 t80 -75.71 -47.23 27.02 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.217 -0.447 . . . . 62.21 110.972 -179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.729 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -70.12 -32.91 71.16 Favored 'General case' 0 C--N 1.329 -0.322 0 CA-C-N 116.132 -0.485 . . . . 63.33 111.165 179.759 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.534 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.3 mp -72.1 -55.07 14.55 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.334 0 CA-C-N 116.25 -0.432 . . . . 74.35 111.158 179.926 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.534 ' N ' HG22 ' A' ' 134' ' ' ILE . 6.1 ttt180 -48.93 -42.26 36.61 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.215 -0.448 . . . . 72.45 110.932 179.921 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.622 ' O ' HG23 ' A' ' 140' ' ' VAL . 0.0 OUTLIER -71.32 -34.76 70.87 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.165 -0.471 . . . . 72.41 110.896 179.925 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.903 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.36 -49.35 77.94 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.187 -0.46 . . . . 72.05 111.165 179.802 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.625 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 95.4 m-85 -72.72 -21.84 60.98 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.183 -0.462 . . . . 70.2 110.84 -179.875 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.52 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 3.1 tt0 -77.48 -6.38 53.31 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.147 -0.479 . . . . 63.02 110.824 -179.877 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.622 HG23 ' O ' ' A' ' 136' ' ' LYS . 96.2 t -97.71 -16.96 6.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.359 0 CA-C-N 116.288 -0.414 . . . . 63.43 111.212 179.936 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.783 ' NE1' HG12 ' A' ' 217' ' ' VAL . 89.2 m95 -105.41 -38.08 6.61 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.143 -0.481 . . . . 70.35 110.886 -179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -70.8 -12.68 61.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.248 -0.433 . . . . 54.42 110.876 -179.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.596 HD22 ' N ' ' A' ' 143' ' ' ASN . 1.0 OUTLIER -93.97 -19.58 20.78 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.077 -0.511 . . . . 61.33 110.916 -179.992 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.859 HG11 HD12 ' A' ' 250' ' ' LEU . 18.5 m -97.1 1.65 10.43 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.152 -0.476 . . . . 74.33 111.083 179.959 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.584 HG21 HG13 ' A' ' 258' ' ' ILE . 52.2 p -151.93 147.57 20.14 Favored Pre-proline 0 C--N 1.33 -0.277 0 CA-C-O 121.583 0.706 . . . . 74.31 111.152 -179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.5 Cg_endo -69.71 31.91 0.19 Allowed 'Trans proline' 0 C--N 1.342 0.185 0 C-N-CA 122.667 2.245 . . . . 64.15 112.318 179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.76 HD11 ' CG ' ' A' ' 262' ' ' TYR . 19.5 mt -95.65 173.83 7.29 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.236 -0.438 . . . . 63.31 110.884 -179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -136.28 126.2 25.87 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.143 -0.48 . . . . 72.22 110.882 179.812 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.61 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.7 m-30 -114.46 145.96 41.24 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.308 -0.405 . . . . 54.15 110.91 179.91 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.401 ' H ' ' HA ' ' A' ' 115' ' ' THR . 5.8 t -139.44 153.33 47.55 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.173 -0.467 . . . . 72.33 110.847 -179.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.442 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 1.4 tttt -104.37 142.79 33.95 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.129 -0.487 . . . . 41.42 110.897 179.943 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.592 HD12 ' CA ' ' A' ' 155' ' ' GLY . 16.4 pt -152.56 159.26 3.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.295 0 CA-C-N 116.199 -0.455 . . . . 64.45 111.089 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 10.3 m120 -119.34 -21.65 7.4 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.133 -0.485 . . . . 74.1 110.883 179.952 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 6.6 t -144.02 53.24 1.29 Allowed 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.231 -0.441 . . . . 52.04 111.148 -179.928 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.592 ' CA ' HD12 ' A' ' 152' ' ' ILE . . . -139.34 -155.31 6.6 Favored Glycine 0 N--CA 1.452 -0.234 0 C-N-CA 120.709 -0.758 . . . . 74.52 112.514 179.939 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 34.3 mmt -107.73 89.58 3.04 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-O 120.815 0.34 . . . . 60.0 110.914 179.97 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.467 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -101.01 154.63 18.54 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.261 -0.427 . . . . 74.21 111.06 179.927 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.86 -51.4 6.77 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.194 -0.457 . . . . 53.03 110.835 179.932 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.623 HG12 HG23 ' A' ' 220' ' ' ILE . 2.7 mp -92.51 97.3 7.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.338 0 CA-C-N 116.136 -0.483 . . . . 54.41 111.121 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.424 HD12 ' HB3' ' A' ' 117' ' ' ARG . 7.8 tp -88.42 109.13 19.77 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.231 -0.44 . . . . 74.04 110.984 179.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.428 HG13 ' CE1' ' A' ' 197' ' ' PHE . 84.5 t -85.71 121.1 36.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.339 0 CA-C-N 116.229 -0.441 . . . . 72.31 111.089 179.919 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.73 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.2 p -140.5 103.67 1.54 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.356 0 CA-C-N 116.237 -0.438 . . . . 73.54 111.175 179.856 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 44.6 m-85 -71.17 110.16 5.66 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.22 -0.445 . . . . 71.41 110.89 -179.986 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.94 165.83 21.29 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.105 -0.498 . . . . 74.52 111.064 179.982 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -115.02 136.9 52.61 Favored 'General case' 0 C--N 1.331 -0.237 0 CA-C-N 116.151 -0.477 . . . . 73.21 110.862 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.675 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.43 -155.87 0.18 Allowed Glycine 0 N--CA 1.451 -0.334 0 C-N-CA 120.707 -0.758 . . . . 72.55 112.508 -179.953 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.799 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -65.02 116.44 6.44 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-O 120.786 0.327 . . . . 72.44 111.084 -179.979 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.694 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.08 -22.44 12.13 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.218 -0.447 . . . . 62.11 110.792 -179.959 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.34 29.51 0.54 Allowed Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.722 -0.751 . . . . 72.42 112.521 -179.923 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.631 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.13 0.45 14.95 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-O 120.8 0.333 . . . . 74.45 110.885 -179.898 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 73.63 39.63 0.55 Allowed 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.184 -0.462 . . . . 74.13 110.931 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.694 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -134.97 -41.65 0.74 Allowed 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.07 -0.514 . . . . 44.51 110.839 179.95 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.799 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.52 99.59 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.225 -0.443 . . . . 52.1 111.097 179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.675 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.9 m-85 -60.2 -168.96 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.289 0 CA-C-N 116.252 -0.431 . . . . 72.44 110.84 -179.933 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -134.16 19.03 3.72 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.029 -0.532 . . . . 74.12 110.85 179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.574 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.34 -157.75 6.1 Favored Glycine 0 N--CA 1.452 -0.294 0 C-N-CA 120.735 -0.745 . . . . 41.42 112.464 -179.984 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 176' ' ' GLY . 12.0 mmtp -34.64 134.71 0.21 Allowed 'General case' 0 C--N 1.328 -0.336 0 CA-C-O 120.817 0.341 . . . . 64.03 110.959 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.0 165.14 0.11 Allowed Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.741 -0.742 . . . . 63.33 112.459 179.948 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . . . . . . . . . . . 83.37 -143.35 21.78 Favored Glycine 0 N--CA 1.452 -0.242 0 C-N-CA 120.732 -0.747 . . . . 73.35 112.472 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.0 97.85 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-O 120.881 0.372 . . . . 64.34 111.092 -179.939 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . . . . . . . . . 21.9 mt -66.99 -40.57 87.4 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.18 -0.464 . . . . 75.42 110.903 179.87 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.444 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -171.12 170.21 6.22 Favored 'General case' 0 C--N 1.328 -0.358 0 CA-C-N 116.246 -0.434 . . . . 45.11 111.117 179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.503 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -164.11 141.17 6.75 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.194 -0.457 . . . . 74.1 110.889 -179.972 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.781 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -135.76 173.64 11.5 Favored 'General case' 0 C--N 1.328 -0.326 0 CA-C-N 116.307 -0.406 . . . . 71.41 111.07 179.94 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.523 ' O ' ' HA ' ' A' ' 223' ' ' SER . 47.9 m-85 -101.11 -145.81 0.35 Allowed 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.131 -0.486 . . . . 74.54 110.829 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -165.09 -86.17 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.256 0 C-N-CA 120.768 -0.729 . . . . 60.13 112.507 -179.962 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.407 ' HB3' ' HB2' ' A' ' 107' ' ' PRO . 54.3 Cg_endo -69.65 55.6 1.25 Allowed 'Trans proline' 0 C--N 1.341 0.15 0 C-N-CA 122.683 2.255 . . . . 73.51 112.357 -179.976 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.536 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.53 147.66 16.67 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.718 -0.754 . . . . 52.32 112.476 179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.524 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -102.98 142.36 34.2 Favored 'General case' 0 C--N 1.33 -0.24 0 CA-C-O 120.997 0.427 . . . . 73.05 110.759 -179.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 64.14 -62.4 0.06 OUTLIER Glycine 0 N--CA 1.45 -0.387 0 C-N-CA 120.75 -0.738 . . . . 73.4 112.526 -179.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.524 ' N ' ' O ' ' A' ' 189' ' ' SER . 2.3 pp -105.99 10.07 9.22 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.265 0 CA-C-O 120.897 0.38 . . . . 75.12 111.213 179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.536 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -69.47 170.62 42.07 Favored Glycine 0 N--CA 1.45 -0.382 0 C-N-CA 120.797 -0.716 . . . . 74.44 112.548 179.848 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . . . . . . . . . . . 42.19 22.82 0.13 Allowed Glycine 0 N--CA 1.451 -0.332 0 C-N-CA 120.711 -0.757 . . . . 65.34 112.442 179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.445 ' N ' ' O ' ' A' ' 192' ' ' GLY . 3.2 m-20 -64.48 103.62 0.68 Allowed 'General case' 0 C--N 1.327 -0.38 0 CA-C-O 120.792 0.33 . . . . 73.34 110.896 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.781 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -76.71 125.75 29.8 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.255 -0.43 . . . . 74.52 111.046 179.983 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.503 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 6.3 m170 -115.88 129.68 56.51 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.116 -0.493 . . . . 75.55 110.865 -179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.519 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 50.3 m-85 -113.88 134.26 54.92 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.229 -0.441 . . . . 74.23 110.827 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 28.1 t0 -66.87 108.89 2.71 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.11 -0.495 . . . . 72.33 110.923 179.972 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -60.09 -37.4 79.84 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.22 -0.445 . . . . 74.42 110.792 -179.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.574 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 11.3 m-20 -50.51 -22.1 1.8 Allowed 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.155 -0.475 . . . . 74.03 110.811 -179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.1 mm-40 -81.36 160.83 24.02 Favored 'General case' 0 C--N 1.331 -0.206 0 CA-C-N 116.165 -0.47 . . . . 61.23 110.925 -179.854 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.544 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -98.73 91.47 5.12 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.215 -0.448 . . . . 75.53 110.894 -179.938 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.519 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 33.1 m95 -81.56 124.25 29.35 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.141 -0.481 . . . . 75.44 110.896 -179.95 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 7.9 p -141.81 -170.45 3.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.247 -0.433 . . . . 75.05 111.208 179.945 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.2 OUTLIER -116.87 17.42 15.06 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.197 -0.456 . . . . 70.1 111.176 179.98 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.74 -178.73 4.72 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.171 -0.468 . . . . 70.25 110.81 179.948 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 8.4 t -63.41 -19.62 64.84 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.16 -0.473 . . . . 75.34 110.926 -179.831 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -58.89 -107.86 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.813 -0.708 . . . . 72.5 112.386 -179.963 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.544 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -53.5 177.9 0.18 Allowed Glycine 0 N--CA 1.451 -0.366 0 C-N-CA 120.719 -0.753 . . . . 72.12 112.48 -179.836 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 95.7 m -68.47 96.86 0.72 Allowed 'General case' 0 C--N 1.33 -0.249 0 CA-C-O 120.793 0.33 . . . . 74.21 111.076 -179.763 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.0 t-20 -40.11 118.46 0.9 Allowed 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.27 -0.423 . . . . 73.32 110.858 179.994 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.656 HD22 ' SD ' ' A' ' 125' ' ' MET . 19.3 tp -64.87 -36.24 83.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.114 -0.494 . . . . 50.23 110.888 179.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.729 ' CA ' ' HB1' ' A' ' 133' ' ' ALA . 2.4 t80 -54.17 -64.93 0.67 Allowed 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.243 -0.435 . . . . 75.1 110.915 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.515 HD11 ' H ' ' A' ' 243' ' ' VAL . 21.0 mt -53.21 -55.32 25.25 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.146 -0.479 . . . . 55.31 110.935 179.998 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.495 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.6 m -55.27 -34.87 64.45 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.182 -0.463 . . . . 62.21 111.141 179.958 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -66.1 -47.86 72.82 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.227 -0.442 . . . . 54.23 111.092 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.903 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.0 t -53.58 -60.11 1.5 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.197 -0.456 . . . . 34.35 111.079 179.955 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.624 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.8 t-80 -63.31 -28.52 70.06 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.353 -0.385 . . . . 72.45 110.8 -179.978 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.485 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.96 -44.37 96.24 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 74.43 111.115 179.917 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.623 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -68.99 -35.24 68.09 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.323 0 CA-C-N 116.217 -0.447 . . . . 74.11 111.155 179.991 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . . . . . . . . . . . -51.21 -44.46 51.79 Favored Glycine 0 N--CA 1.451 -0.357 0 C-N-CA 120.806 -0.711 . . . . 72.54 112.442 179.913 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.49 ' O ' ' O ' ' A' ' 185' ' ' PHE . 19.6 m-70 -68.03 -38.52 82.64 Favored 'General case' 0 C--N 1.33 -0.282 0 CA-C-O 120.792 0.329 . . . . 60.35 110.804 -179.914 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.619 ' OG ' HG23 ' A' ' 159' ' ' ILE . 13.0 m -64.05 -24.79 67.84 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.28 -0.418 . . . . 72.41 110.831 -179.763 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.522 ' O ' HG23 ' A' ' 108' ' ' VAL . 44.3 mt -76.29 -27.06 56.47 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.106 -0.497 . . . . 73.22 110.952 179.99 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 121.03 10.56 6.76 Favored Glycine 0 N--CA 1.453 -0.199 0 C-N-CA 120.722 -0.751 . . . . 44.51 112.454 179.91 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.489 HD11 HD13 ' A' ' 258' ' ' ILE . 8.5 mt -76.61 137.7 39.65 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-O 120.864 0.364 . . . . 63.05 110.939 -179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . 0.432 ' H ' ' HA ' ' A' ' 102' ' ' GLU . . . -76.8 -135.14 0.64 Allowed Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.68 -0.771 . . . . 52.42 112.484 179.988 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -131.82 135.31 46.63 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 120.83 0.348 . . . . 71.34 110.799 -179.904 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 98.4 p -94.94 160.88 14.38 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.14 -0.482 . . . . 61.22 110.863 -179.808 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -106.22 0.55 25.32 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-N 116.139 -0.482 . . . . 72.12 110.835 -179.822 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.472 ' HB3' ' HB2' ' A' ' 234' ' ' ALA . 0.3 OUTLIER -71.68 132.0 85.64 Favored Pre-proline 0 C--N 1.327 -0.374 0 CA-C-O 121.558 0.694 . . . . 71.5 110.831 -179.985 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.1 Cg_endo -69.74 0.93 4.92 Favored 'Trans proline' 0 C--O 1.231 0.172 0 C-N-CA 122.714 2.276 . . . . 61.53 112.361 179.991 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.8 pttt -136.73 14.06 3.15 Favored 'General case' 0 C--N 1.328 -0.363 0 CA-C-N 116.205 -0.452 . . . . 71.41 110.855 -179.961 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.514 ' O ' ' HB2' ' A' ' 237' ' ' PHE . . . -92.53 128.2 38.3 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.205 -0.452 . . . . 70.33 111.088 179.872 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.624 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -52.81 -37.95 26.77 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.278 0 CA-C-N 116.125 -0.489 . . . . 64.42 111.092 -179.999 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 70.8 mmm -58.94 -23.69 61.7 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.263 -0.426 . . . . 73.02 110.836 179.927 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.594 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.5 t80 -52.67 143.36 29.35 Favored Pre-proline 0 C--N 1.328 -0.339 0 CA-C-O 121.669 0.747 . . . . 64.54 110.841 -179.888 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.594 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.5 Cg_endo -69.78 -9.88 27.19 Favored 'Trans proline' 0 C--O 1.232 0.225 0 C-N-CA 122.654 2.236 . . . . 52.1 112.252 -179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 23.3 m -85.42 150.22 24.87 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.342 -0.39 . . . . 62.52 111.157 -179.968 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 52.9 t80 -124.78 139.1 54.16 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.193 -0.458 . . . . 74.11 110.919 -179.94 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 21.3 mmtt -155.26 121.35 5.17 Favored 'General case' 0 C--N 1.328 -0.327 0 CA-C-N 116.052 -0.522 . . . . 65.31 110.922 179.985 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.567 ' O ' HG13 ' A' ' 243' ' ' VAL . 87.3 t80 -52.65 146.78 9.61 Favored 'General case' 0 C--N 1.328 -0.34 0 CA-C-N 116.255 -0.429 . . . . 73.2 110.929 -179.97 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.567 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.5 OUTLIER -161.03 130.84 0.76 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.125 -0.489 . . . . 74.13 111.171 179.926 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 18.7 t0 -48.43 138.39 10.25 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.17 -0.468 . . . . 73.02 110.865 -179.969 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.585 HD11 ' HD3' ' A' ' 136' ' ' LYS . 7.6 tt -56.26 -31.28 32.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-N 116.276 -0.42 . . . . 53.33 111.085 -179.941 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.651 HD22 HG23 ' A' ' 247' ' ' THR . 0.5 OUTLIER -77.72 -15.81 58.88 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.229 -0.441 . . . . 73.02 110.89 179.888 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.651 HG23 HD22 ' A' ' 246' ' ' ASN . 33.4 p -105.3 -23.38 12.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.233 -0.44 . . . . 71.31 111.11 179.981 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 28.9 t80 -70.82 142.27 51.3 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.236 -0.438 . . . . 71.13 110.784 -179.905 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 10.2 ptp180 -177.71 132.13 0.16 Allowed 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.138 -0.483 . . . . 72.12 110.821 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.859 HD12 HG11 ' A' ' 144' ' ' VAL . 34.1 mt -49.52 122.8 6.69 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.118 -0.492 . . . . 73.24 110.932 179.989 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 32.1 t -64.13 157.81 24.54 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.241 -0.436 . . . . 73.1 110.895 -179.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -46.36 -34.77 4.85 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.157 -0.474 . . . . 75.5 111.106 179.912 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -68.74 -46.26 69.34 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.325 -0.398 . . . . 75.42 110.787 179.969 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.418 ' O ' HG22 ' A' ' 258' ' ' ILE . 28.6 m-20 -60.37 -49.94 75.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.134 -0.484 . . . . 72.51 110.811 -179.861 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.41 ' HA ' HG22 ' A' ' 258' ' ' ILE . 24.8 mt -66.31 -31.5 53.9 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.35 0 CA-C-N 116.129 -0.487 . . . . 74.44 111.17 -179.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 0.5 OUTLIER -71.63 -39.41 70.44 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.09 -0.505 . . . . 52.5 110.912 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.63 -52.01 6.19 Favored Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.74 -0.743 . . . . 74.31 112.396 -179.954 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.584 HG13 HG21 ' A' ' 145' ' ' THR . 7.6 tp -52.55 -34.08 18.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.322 0 CA-C-O 120.833 0.349 . . . . 75.22 111.086 -179.931 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.457 ' O ' ' N ' ' A' ' 263' ' ' GLY . 85.8 mt-30 -84.38 -19.2 33.98 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-N 116.115 -0.493 . . . . 75.01 110.933 -179.996 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 10.7 t -68.65 -12.91 61.96 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.2 -0.454 . . . . 60.31 110.872 -179.776 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.855 HD13 HG11 ' A' ' 108' ' ' VAL . 2.1 mt -122.36 -18.1 6.87 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.116 -0.493 . . . . 74.42 110.927 -179.985 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.76 ' CG ' HD11 ' A' ' 147' ' ' LEU . 38.1 m-85 -115.63 -36.12 4.34 Favored 'General case' 0 C--N 1.33 -0.256 0 CA-C-N 116.166 -0.47 . . . . 73.41 110.948 179.977 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.457 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.301 0 CA-C-O 119.145 -0.808 . . . . 70.1 112.473 179.965 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 18.3 p90 . . . . . 0 C--O 1.23 0.054 0 CA-C-O 120.846 0.355 . . . . 54.34 110.84 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -75.74 66.2 2.0 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.137 -0.483 . . . . 74.21 110.863 -179.899 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . . . . . . . . . 1.5 pp20? 178.35 126.01 0.05 Allowed 'General case' 0 C--N 1.329 -0.32 0 CA-C-N 116.223 -0.444 . . . . 71.04 110.884 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . 0.414 ' HG3' ' HD2' ' A' ' 104' ' ' PRO . 3.0 tpt -51.07 135.72 28.99 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.535 0.683 . . . . 73.11 110.837 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . 0.414 ' HD2' ' HG3' ' A' ' 103' ' ' MET . 52.7 Cg_endo -69.81 136.13 32.09 Favored 'Trans proline' 0 C--O 1.231 0.144 0 C-N-CA 122.733 2.289 . . . . 51.3 112.301 179.999 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 96.22 -9.46 67.46 Favored Glycine 0 N--CA 1.452 -0.266 0 C-N-CA 120.779 -0.724 . . . . 41.41 112.46 -179.987 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.712 ' N ' ' CD ' ' A' ' 107' ' ' PRO . . . 69.41 35.58 76.17 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.745 -0.74 . . . . 73.4 112.496 -179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.712 ' CD ' ' N ' ' A' ' 106' ' ' GLY . 53.1 Cg_endo -69.73 34.02 0.2 Allowed 'Trans proline' 0 C--N 1.342 0.211 0 C-N-CA 122.691 2.26 . . . . 52.53 112.381 -179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.795 HG23 ' O ' ' A' ' 224' ' ' LEU . 7.5 p -116.03 137.89 48.29 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.294 0 CA-C-N 116.243 -0.435 . . . . 63.31 111.066 179.9 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.456 ' CZ3' HD23 ' A' ' 224' ' ' LEU . 0.0 OUTLIER -79.62 107.32 12.31 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.088 -0.505 . . . . 74.34 110.876 179.95 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 39.1 mtm180 -73.59 56.85 0.54 Allowed 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.187 -0.46 . . . . 71.35 110.919 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -122.18 145.07 48.54 Favored 'General case' 0 C--N 1.33 -0.264 0 CA-C-N 116.215 -0.448 . . . . 74.21 110.917 179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . . . . . . . . . 6.6 p80 -94.05 37.59 1.09 Allowed 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.212 -0.449 . . . . 72.15 110.893 179.896 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 2.8 m-85 -142.02 91.85 2.39 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.161 -0.472 . . . . 73.14 110.876 -179.808 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.656 HD13 ' HE1' ' A' ' 149' ' ' PHE . 4.6 mp -122.49 163.94 20.34 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.273 0 CA-C-N 116.076 -0.511 . . . . 74.13 111.107 179.964 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.606 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.5 OUTLIER -157.88 161.94 38.31 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.158 -0.473 . . . . 75.55 111.199 179.985 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.573 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 1.4 p90 -136.32 148.7 48.05 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.252 -0.431 . . . . 65.22 110.902 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.733 ' NE ' HD11 ' A' ' 160' ' ' LEU . 3.7 tmm_? -141.83 120.01 12.18 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.147 -0.479 . . . . 61.44 110.864 -179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 67.7 mt -79.82 104.13 7.63 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.277 0 CA-C-N 116.234 -0.439 . . . . 73.15 111.192 179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 51.9 t30 -56.44 -46.42 80.3 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.138 -0.483 . . . . 63.43 110.932 179.946 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.735 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.5 p-10 -146.82 165.5 29.52 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.119 -0.491 . . . . 64.3 110.912 179.928 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.544 ' CE2' HG11 ' A' ' 130' ' ' VAL . 4.3 m-85 -114.95 142.09 47.08 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.179 -0.464 . . . . 71.0 110.944 -179.921 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.632 HG22 ' H ' ' A' ' 124' ' ' ASP . 1.0 OUTLIER -88.97 137.99 29.45 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.602 0.715 . . . . 65.14 111.102 -179.899 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . . . . . . . . . 55.2 Cg_endo -69.71 33.61 0.2 Allowed 'Trans proline' 0 C--N 1.341 0.181 0 C-N-CA 122.656 2.237 . . . . 63.43 112.435 179.866 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.632 ' H ' HG22 ' A' ' 122' ' ' THR . 1.8 m-20 -123.36 -17.44 6.56 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.204 -0.453 . . . . 71.21 110.915 179.884 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.599 ' SD ' HD22 ' A' ' 212' ' ' LEU . 6.6 mtm -117.28 165.55 13.32 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.219 -0.446 . . . . 71.42 110.926 179.914 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 27.8 t30 -92.86 140.57 29.36 Favored 'General case' 0 C--N 1.33 -0.246 0 CA-C-N 116.254 -0.43 . . . . 71.14 110.861 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 17.9 ptt-85 -44.6 -36.91 3.27 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.174 -0.467 . . . . 74.03 110.813 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 21.5 mt-10 -84.01 -39.27 19.86 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.195 -0.457 . . . . 71.45 110.879 -179.85 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 35.7 m-20 -63.51 -32.1 73.45 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.103 -0.499 . . . . 74.32 110.906 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.544 HG11 ' CE2' ' A' ' 121' ' ' TYR . 58.3 t -65.48 -44.46 94.19 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.246 0 CA-C-N 116.18 -0.464 . . . . 75.35 111.13 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -81.45 -22.42 38.14 Favored 'General case' 0 C--N 1.328 -0.36 0 CA-C-N 116.18 -0.464 . . . . 63.13 110.924 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.5 t80 -76.15 -47.89 22.59 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.198 -0.455 . . . . 74.25 110.854 -179.87 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.552 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -72.52 -30.65 64.67 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.203 -0.453 . . . . 74.11 111.026 179.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.526 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.2 mp -71.95 -55.37 13.69 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-N 116.312 -0.404 . . . . 74.14 111.124 -179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.526 ' N ' HG22 ' A' ' 134' ' ' ILE . 5.1 ttt180 -48.0 -40.38 22.41 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.065 -0.516 . . . . 73.45 110.919 179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.555 ' O ' HG23 ' A' ' 140' ' ' VAL . 4.8 mmtp -76.47 -33.37 58.71 Favored 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.206 -0.452 . . . . 72.22 110.873 179.998 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.823 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.27 -50.93 71.68 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.266 -0.425 . . . . 62.32 111.137 179.794 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.627 ' CZ ' HG12 ' A' ' 220' ' ' ILE . 79.0 m-85 -67.01 -33.55 75.81 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.24 -0.436 . . . . 74.12 110.889 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.583 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.8 tt0 -61.92 -43.84 98.01 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.188 -0.46 . . . . 73.3 110.905 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.555 HG23 ' O ' ' A' ' 136' ' ' LYS . 73.2 t -49.56 -25.05 1.77 Allowed 'Isoleucine or valine' 0 C--N 1.331 -0.239 0 CA-C-N 116.163 -0.471 . . . . 71.23 111.125 -179.947 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.799 ' NE1' HG12 ' A' ' 217' ' ' VAL . 97.1 m95 -98.33 -29.66 13.03 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.11 -0.496 . . . . 74.45 110.891 179.959 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 3.5 t -73.4 -15.1 61.36 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.284 -0.417 . . . . 74.33 110.896 -179.843 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.583 ' ND2' ' O ' ' A' ' 139' ' ' GLN . 63.9 m-80 -89.36 -26.14 21.22 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.177 -0.465 . . . . 75.54 110.795 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.551 HG21 ' CD1' ' A' ' 250' ' ' LEU . 4.7 m -93.61 3.71 8.32 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.288 0 CA-C-N 116.22 -0.445 . . . . 74.31 111.104 -179.985 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.491 ' C ' ' H ' ' A' ' 147' ' ' LEU . 59.5 p -153.69 143.1 14.97 Favored Pre-proline 0 C--N 1.331 -0.208 0 CA-C-O 121.596 0.712 . . . . 52.32 111.09 179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 53.3 Cg_endo -69.77 30.36 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.221 0 C-N-CA 122.683 2.256 . . . . 54.05 112.328 179.986 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.797 HD11 ' CG ' ' A' ' 262' ' ' TYR . 20.1 mt -91.93 173.1 8.03 Favored 'General case' 0 C--N 1.328 -0.344 0 CA-C-N 116.241 -0.436 . . . . 70.33 110.884 179.957 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 4.9 mtmt -135.12 126.55 28.56 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.19 -0.459 . . . . 71.42 110.927 179.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.656 ' HE1' HD13 ' A' ' 114' ' ' ILE . 2.7 m-85 -116.41 141.27 48.39 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.259 -0.428 . . . . 74.15 110.938 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 50.7 m -136.73 147.71 46.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.169 -0.468 . . . . 63.11 110.802 -179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.432 ' HB2' ' CE2' ' A' ' 116' ' ' TYR . 16.4 tptm -98.9 146.45 25.97 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.099 -0.501 . . . . 74.25 110.897 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.578 HD12 ' CA ' ' A' ' 155' ' ' GLY . 18.4 pt -150.89 147.02 16.02 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.251 -0.431 . . . . 74.33 111.108 179.911 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . 0.411 ' N ' HD22 ' A' ' 153' ' ' ASN . 1.9 m-80 -113.07 4.54 16.69 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.201 -0.454 . . . . 74.02 110.916 179.918 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 5.1 t -169.98 58.3 0.04 OUTLIER 'General case' 0 C--N 1.331 -0.235 0 CA-C-N 116.135 -0.484 . . . . 71.2 111.169 179.983 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.578 ' CA ' HD12 ' A' ' 152' ' ' ILE . . . -150.53 -154.23 6.4 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.739 -0.743 . . . . 55.41 112.505 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 0.0 OUTLIER -107.0 96.21 6.27 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-O 120.813 0.339 . . . . 64.53 110.906 -179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.416 ' HB2' HD11 ' A' ' 152' ' ' ILE . . . -106.72 156.14 18.94 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.227 -0.442 . . . . 63.12 111.097 179.971 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.65 -51.13 7.06 Favored 'General case' 0 C--N 1.328 -0.369 0 CA-C-N 116.228 -0.442 . . . . 74.24 110.822 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.636 HG12 HG23 ' A' ' 220' ' ' ILE . 3.4 mp -94.16 98.55 8.28 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.325 0 CA-C-N 116.212 -0.449 . . . . 64.32 111.163 179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.733 HD11 ' NE ' ' A' ' 117' ' ' ARG . 7.0 tp -88.35 110.98 21.22 Favored 'General case' 0 C--N 1.329 -0.319 0 CA-C-N 116.138 -0.483 . . . . 71.23 110.934 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.413 HG13 ' CE1' ' A' ' 197' ' ' PHE . 87.7 t -88.24 121.59 38.77 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.316 0 CA-C-N 116.242 -0.436 . . . . 71.11 111.139 179.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.735 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.3 p -140.72 106.09 1.9 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.32 0 CA-C-N 116.242 -0.435 . . . . 51.1 111.157 179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.414 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 46.8 m-85 -73.38 109.98 7.32 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.165 -0.47 . . . . 70.11 110.859 -179.896 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -129.07 166.62 18.9 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.079 -0.51 . . . . 75.1 111.182 179.913 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.36 135.06 54.5 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.289 -0.414 . . . . 74.41 110.888 -179.861 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.674 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 44.52 -156.91 0.22 Allowed Glycine 0 N--CA 1.452 -0.285 0 C-N-CA 120.739 -0.743 . . . . 74.41 112.542 -179.933 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.811 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -63.17 117.67 6.87 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-O 120.811 0.338 . . . . 73.44 111.105 179.97 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.715 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -110.59 -22.5 11.6 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.213 -0.449 . . . . 62.05 110.945 179.927 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.29 30.45 0.51 Allowed Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.738 -0.744 . . . . 51.32 112.433 179.943 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.624 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -114.28 0.68 14.24 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-O 120.841 0.353 . . . . 75.05 110.837 179.976 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 15.4 m-85 73.49 39.76 0.55 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.267 -0.424 . . . . 71.24 110.864 -179.979 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.715 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.26 -40.77 0.73 Allowed 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.084 -0.507 . . . . 60.43 110.859 179.911 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.811 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.1 99.52 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.159 -0.473 . . . . 64.51 111.107 179.954 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.674 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 1.8 m-85 -60.45 -168.61 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.191 -0.459 . . . . 74.43 110.892 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -135.69 18.66 3.3 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.132 -0.485 . . . . 71.2 110.872 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.573 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.58 -156.35 9.69 Favored Glycine 0 N--CA 1.452 -0.293 0 C-N-CA 120.799 -0.715 . . . . 65.43 112.461 -179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -37.74 135.56 0.61 Allowed 'General case' 0 C--N 1.328 -0.334 0 CA-C-O 120.841 0.353 . . . . 70.42 110.859 -179.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 59.49 165.03 0.14 Allowed Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.737 -0.744 . . . . 71.21 112.476 179.994 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.495 ' O ' HD22 ' A' ' 181' ' ' LEU . . . 81.97 -142.49 22.46 Favored Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.749 -0.738 . . . . 74.54 112.431 -179.912 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.7 mt -50.42 95.76 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-O 120.8 0.333 . . . . 75.51 111.214 -179.959 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.495 HD22 ' O ' ' A' ' 179' ' ' GLY . 3.1 mm? -65.1 -46.76 79.74 Favored 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.158 -0.474 . . . . 71.2 110.894 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . . . . . . . . . . . -163.24 174.21 12.38 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.189 -0.459 . . . . 51.44 111.048 179.838 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.473 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.4 p80 -169.33 139.71 2.21 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.232 -0.44 . . . . 73.25 110.823 179.948 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.727 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -135.08 174.62 10.4 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.209 -0.451 . . . . 61.12 111.007 -179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.534 ' O ' ' O ' ' A' ' 222' ' ' HIS . 64.3 m-85 -98.51 -134.25 0.25 Allowed 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.133 -0.485 . . . . 71.24 110.835 -179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.439 ' HA2' ' O ' ' A' ' 223' ' ' SER . . . 179.02 -84.87 0.07 OUTLIER Glycine 0 N--CA 1.452 -0.265 0 C-N-CA 120.676 -0.774 . . . . 62.1 112.437 179.992 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 54.4 Cg_endo -69.8 50.52 0.83 Allowed 'Trans proline' 0 C--N 1.34 0.115 0 C-N-CA 122.727 2.285 . . . . 71.21 112.367 -179.949 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.564 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -121.81 148.78 17.21 Favored Glycine 0 N--CA 1.451 -0.33 0 C-N-CA 120.809 -0.71 . . . . 72.23 112.544 -179.994 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.534 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.43 145.9 29.62 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.941 0.4 . . . . 71.41 110.856 -179.711 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 62.33 -64.79 0.02 OUTLIER Glycine 0 N--CA 1.451 -0.306 0 C-N-CA 120.705 -0.759 . . . . 72.31 112.551 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.534 ' N ' ' O ' ' A' ' 189' ' ' SER . 14.8 tt -104.22 7.82 9.84 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.351 0 CA-C-O 120.919 0.39 . . . . 72.0 111.165 179.978 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.564 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -69.39 172.92 37.48 Favored Glycine 0 N--CA 1.451 -0.305 0 C-N-CA 120.801 -0.714 . . . . 74.3 112.497 179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.504 ' O ' ' HB3' ' A' ' 223' ' ' SER . . . 43.2 23.17 0.23 Allowed Glycine 0 N--CA 1.452 -0.253 0 C-N-CA 120.683 -0.77 . . . . 50.13 112.526 -179.925 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.408 ' N ' ' O ' ' A' ' 192' ' ' GLY . 1.6 m-20 -67.0 101.15 0.81 Allowed 'General case' 0 C--N 1.329 -0.315 0 CA-C-O 120.854 0.359 . . . . 41.43 110.817 -179.955 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.727 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -75.09 130.82 39.91 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.192 -0.458 . . . . 72.23 111.069 179.908 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.473 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 5.2 m170 -121.21 130.94 53.94 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.188 -0.46 . . . . 75.22 110.82 -179.965 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.452 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 38.0 m-85 -115.44 134.94 54.62 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.246 -0.434 . . . . 74.43 110.88 -179.997 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 55.7 t0 -67.22 107.02 2.2 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.088 -0.506 . . . . 61.12 110.81 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.0 tm-20 -57.55 -37.84 73.77 Favored 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.112 -0.495 . . . . 74.14 111.012 -179.976 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.573 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 12.9 m-20 -50.64 -20.78 1.31 Allowed 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.166 -0.47 . . . . 74.11 110.889 179.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . . . . . . . . . 6.7 mm-40 -82.42 162.45 22.12 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.172 -0.467 . . . . 74.21 110.882 -179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.472 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -101.81 87.82 3.23 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.099 -0.5 . . . . 64.33 110.856 -179.921 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.572 ' CZ3' HG21 ' A' ' 215' ' ' THR . 23.5 m95 -80.09 120.09 23.77 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.096 -0.502 . . . . 74.54 110.995 -179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 3.0 p -131.46 -173.84 3.23 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.236 -0.438 . . . . 71.34 111.209 -179.875 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -113.63 12.85 18.56 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.267 -0.424 . . . . 70.14 111.164 179.987 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 5.6 p-80 -131.49 -175.74 3.8 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.235 -0.439 . . . . 65.01 110.901 179.92 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 3.6 p -51.48 -36.73 45.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.258 -0.428 . . . . 33.42 110.856 -179.837 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -63.13 160.71 34.73 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.69 -0.767 . . . . 71.32 112.524 -179.972 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.472 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . 48.39 -173.17 0.04 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.67 -0.776 . . . . 75.31 112.501 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.418 HG21 HD12 ' A' ' 181' ' ' LEU . 51.5 m -86.47 94.11 9.33 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.851 0.358 . . . . 74.24 111.197 -179.932 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -38.54 113.59 0.31 Allowed 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.236 -0.438 . . . . 73.52 110.88 179.984 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.599 HD22 ' SD ' ' A' ' 125' ' ' MET . 13.0 tp -62.64 -35.69 80.43 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.182 -0.463 . . . . 73.11 110.923 179.94 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.663 ' O ' HG23 ' A' ' 217' ' ' VAL . 3.5 t80 -53.27 -64.37 0.84 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.156 -0.474 . . . . 74.33 110.852 -179.977 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.524 HD11 ' H ' ' A' ' 243' ' ' VAL . 21.8 mt -56.01 -54.34 46.06 Favored 'General case' 0 C--N 1.328 -0.345 0 CA-C-N 116.138 -0.483 . . . . 52.32 110.93 179.983 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.572 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 3.7 m -53.73 -37.41 63.3 Favored 'General case' 0 C--N 1.33 -0.267 0 CA-C-N 116.165 -0.471 . . . . 74.53 111.112 179.931 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . 0.401 ' O ' HG13 ' A' ' 220' ' ' ILE . . . -63.13 -50.56 69.96 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.226 -0.443 . . . . 62.15 111.19 179.876 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.823 HG22 ' HA ' ' A' ' 137' ' ' ALA . 1.9 t -51.96 -57.76 3.24 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.24 -0.436 . . . . 64.14 111.136 179.961 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.699 ' HB2' HG13 ' A' ' 235' ' ' VAL . 3.9 t-80 -65.23 -30.75 71.66 Favored 'General case' 0 C--N 1.331 -0.231 0 CA-C-N 116.16 -0.473 . . . . 74.44 110.898 179.886 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.437 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -62.87 -41.86 99.54 Favored 'General case' 0 C--N 1.33 -0.244 0 CA-C-N 116.162 -0.472 . . . . 74.2 111.071 -179.958 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.636 HG23 HG12 ' A' ' 159' ' ' ILE . 2.9 mt -71.98 -35.31 53.66 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.234 -0.439 . . . . 70.54 111.088 -179.991 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.441 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -51.31 -45.23 52.72 Favored Glycine 0 N--CA 1.451 -0.326 0 C-N-CA 120.703 -0.761 . . . . 63.34 112.544 179.907 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.534 ' O ' ' O ' ' A' ' 185' ' ' PHE . 37.3 m-70 -68.2 -41.77 80.86 Favored 'General case' 0 C--N 1.33 -0.242 0 CA-C-O 120.885 0.374 . . . . 74.41 110.855 -179.976 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.519 ' OG ' ' HA ' ' A' ' 220' ' ' ILE . 2.1 p -66.45 -18.11 65.17 Favored 'General case' 0 C--N 1.33 -0.247 0 CA-C-N 116.131 -0.486 . . . . 54.33 110.885 -179.742 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.795 ' O ' HG23 ' A' ' 108' ' ' VAL . 39.9 mt -83.42 -27.19 29.73 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.172 -0.467 . . . . 74.24 110.943 179.937 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 119.99 14.06 5.74 Favored Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.735 -0.745 . . . . 42.25 112.498 179.955 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.776 HD21 ' HA ' ' A' ' 258' ' ' ILE . 12.7 mt -81.0 158.32 25.2 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-O 120.895 0.379 . . . . 75.54 110.943 -179.96 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -100.11 -133.49 8.14 Favored Glycine 0 N--CA 1.451 -0.34 0 C-N-CA 120.767 -0.73 . . . . 72.32 112.518 179.867 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.4 ' HA ' ' HB3' ' A' ' 236' ' ' MET . 0.3 OUTLIER -129.02 139.72 51.94 Favored 'General case' 0 C--N 1.33 -0.251 0 CA-C-O 120.851 0.357 . . . . 74.2 110.804 -179.924 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 53.9 m -97.67 162.74 13.14 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.206 -0.452 . . . . 60.22 110.906 -179.813 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -108.66 -1.44 19.49 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.173 -0.467 . . . . 72.02 110.9 -179.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.604 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -63.45 141.91 97.87 Favored Pre-proline 0 C--N 1.328 -0.337 0 CA-C-O 121.58 0.705 . . . . 71.22 110.824 179.965 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 54.0 Cg_endo -69.78 -3.88 12.92 Favored 'Trans proline' 0 C--O 1.231 0.157 0 C-N-CA 122.737 2.291 . . . . 72.22 112.399 179.966 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 4.5 ptmt -144.27 25.01 1.57 Allowed 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.177 -0.465 . . . . 73.22 110.818 179.977 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.604 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -86.7 140.22 29.99 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.327 -0.397 . . . . 30.4 111.137 179.875 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.699 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.0 OUTLIER -62.81 -38.67 82.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.345 0 CA-C-N 116.287 -0.415 . . . . 70.24 111.14 179.955 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.4 ' HB3' ' HA ' ' A' ' 228' ' ' HIS . 54.0 mmm -65.57 -16.97 64.22 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.186 -0.461 . . . . 74.31 110.888 179.956 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.633 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.2 t80 -55.48 144.81 51.77 Favored Pre-proline 0 C--N 1.329 -0.292 0 CA-C-O 121.678 0.751 . . . . 62.11 110.937 179.981 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.633 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 54.0 Cg_endo -69.73 0.83 5.06 Favored 'Trans proline' 0 C--O 1.231 0.171 0 C-N-CA 122.779 2.319 . . . . 74.44 112.359 179.993 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.1 m -100.99 139.52 36.57 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.198 -0.455 . . . . 71.22 111.103 -179.942 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 54.5 t80 -120.44 137.85 54.1 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.16 -0.473 . . . . 75.35 110.975 -179.934 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 24.6 tptt -156.85 136.87 12.65 Favored 'General case' 0 C--N 1.328 -0.35 0 CA-C-N 116.15 -0.477 . . . . 71.04 110.915 179.916 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.578 ' O ' HG13 ' A' ' 243' ' ' VAL . 80.0 t80 -63.13 146.03 54.19 Favored 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 116.273 -0.421 . . . . 75.43 110.905 -179.902 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.578 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.2 OUTLIER -161.79 131.53 0.77 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.305 0 CA-C-N 116.124 -0.489 . . . . 64.22 111.068 179.956 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 23.8 t0 -54.6 132.02 44.32 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.116 -0.493 . . . . 72.33 110.918 179.884 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . . . . . . . . . 15.6 tt -53.65 -30.16 18.24 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.34 0 CA-C-N 116.251 -0.432 . . . . 72.14 111.113 -179.935 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . 0.661 HD21 HG23 ' A' ' 247' ' ' THR . 0.0 OUTLIER -69.5 -20.34 63.72 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.164 -0.471 . . . . 70.44 110.874 179.918 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . 0.661 HG23 HD21 ' A' ' 246' ' ' ASN . 5.0 p -110.95 -20.5 12.41 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.15 -0.477 . . . . 62.21 111.254 179.969 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 33.5 t80 -69.5 142.96 53.6 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.187 -0.461 . . . . 73.22 110.849 -179.965 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 7.9 ptm180 -176.07 133.61 0.25 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.136 -0.484 . . . . 64.32 110.847 -179.897 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.551 ' CD1' HG21 ' A' ' 144' ' ' VAL . 34.7 mt -48.8 137.74 12.05 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.131 -0.486 . . . . 54.32 110.994 179.989 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.576 ' O ' HD12 ' A' ' 255' ' ' ILE . 23.2 t -80.61 168.06 19.33 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.222 -0.445 . . . . 71.43 110.848 -179.905 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -51.95 -38.46 56.56 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.074 -0.512 . . . . 53.25 111.07 179.956 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -63.33 -51.15 67.17 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-N 116.257 -0.429 . . . . 60.44 110.908 179.975 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.514 ' OD1' ' HB1' ' A' ' 234' ' ' ALA . 7.2 m-20 -57.55 -53.38 58.77 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.237 -0.438 . . . . 61.23 110.848 179.966 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.576 HD12 ' O ' ' A' ' 251' ' ' SER . 2.6 mt -60.12 -36.81 70.21 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.27 0 CA-C-N 116.218 -0.447 . . . . 71.43 111.105 -179.946 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 15.7 mmt85 -67.61 -39.6 84.75 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.119 -0.491 . . . . 74.14 110.861 179.989 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.87 -52.59 5.74 Favored Glycine 0 N--CA 1.452 -0.283 0 C-N-CA 120.822 -0.704 . . . . 64.2 112.416 -179.933 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.776 ' HA ' HD21 ' A' ' 226' ' ' LEU . 5.6 tp -52.59 -34.5 19.44 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.314 0 CA-C-O 120.832 0.349 . . . . 74.31 111.194 -179.91 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.424 ' O ' ' N ' ' A' ' 263' ' ' GLY . 70.7 mt-30 -86.33 -17.96 33.17 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.069 -0.514 . . . . 73.23 110.94 179.852 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 4.4 t -69.36 -13.97 62.66 Favored 'General case' 0 C--N 1.33 -0.252 0 CA-C-N 116.207 -0.452 . . . . 71.3 110.874 -179.791 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.577 ' HB3' HG11 ' A' ' 108' ' ' VAL . 3.2 mt -123.02 -17.51 6.69 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.175 -0.466 . . . . 73.43 110.924 -179.988 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.797 ' CG ' HD11 ' A' ' 147' ' ' LEU . 35.9 m-85 -114.69 -35.51 4.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.108 -0.496 . . . . 75.55 110.887 -179.974 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.424 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.452 -0.282 0 CA-C-O 119.118 -0.823 . . . . 72.02 112.516 179.967 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . 0.427 ' O ' ' C ' ' A' ' 101' ' ' ARG . 98.1 m-85 . . . . . 0 C--O 1.231 0.103 0 CA-C-O 120.82 0.343 . . . . 71.22 110.906 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.427 ' C ' ' O ' ' A' ' 100' ' ' PHE . 23.3 ptt180 36.13 68.36 0.25 Allowed 'General case' 0 C--N 1.329 -0.312 0 CA-C-N 116.201 -0.454 . . . . 65.42 110.893 -179.957 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.795 ' HG2' HD11 ' A' ' 261' ' ' LEU . 1.6 mt-10 -175.22 131.54 0.3 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.249 -0.432 . . . . 75.22 110.916 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 16.6 mmt -51.37 159.51 1.13 Allowed Pre-proline 0 C--N 1.329 -0.297 0 CA-C-O 121.547 0.689 . . . . 73.41 110.86 -179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.82 -4.52 14.24 Favored 'Trans proline' 0 C--N 1.342 0.187 0 C-N-CA 122.714 2.276 . . . . 70.55 112.311 -179.966 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . -81.6 -56.15 3.03 Favored Glycine 0 N--CA 1.451 -0.343 0 C-N-CA 120.706 -0.759 . . . . 61.44 112.523 179.94 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . 0.41 ' HA3' ' HD2' ' A' ' 107' ' ' PRO . . . 144.21 -131.49 4.41 Favored Glycine 0 N--CA 1.453 -0.197 0 C-N-CA 120.666 -0.778 . . . . 34.0 112.433 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.41 ' HD2' ' HA3' ' A' ' 106' ' ' GLY . 54.1 Cg_endo -69.65 130.18 19.01 Favored 'Trans proline' 0 C--N 1.341 0.182 0 C-N-CA 122.641 2.228 . . . . 65.23 112.315 -179.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.82 HG13 ' H ' ' A' ' 110' ' ' ARG . 10.0 p -49.66 166.69 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.301 0 CA-C-N 116.17 -0.468 . . . . 74.34 111.174 179.842 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.538 ' N ' HG22 ' A' ' 108' ' ' VAL . 5.5 m0 -47.44 -24.52 0.83 Allowed 'General case' 0 C--N 1.327 -0.379 0 CA-C-N 116.196 -0.457 . . . . 63.24 110.958 179.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . 0.82 ' H ' HG13 ' A' ' 108' ' ' VAL . 7.3 mtt180 70.82 26.3 3.76 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.234 -0.439 . . . . 73.44 110.866 -179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 8.7 mttt -121.74 145.46 48.01 Favored 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.178 -0.465 . . . . 75.45 110.935 179.919 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.814 ' HA ' HD12 ' A' ' 147' ' ' LEU . 5.3 p80 -100.51 29.39 4.45 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.288 -0.414 . . . . 65.04 110.864 179.933 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 1.3 m-85 -130.75 82.69 2.07 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.156 -0.475 . . . . 74.43 110.903 -179.855 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.585 HG22 ' N ' ' A' ' 115' ' ' THR . 5.0 mp -109.99 163.36 7.0 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.268 0 CA-C-N 116.124 -0.489 . . . . 73.25 111.153 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.699 HG23 ' HA ' ' A' ' 157' ' ' ALA . 0.0 OUTLIER -160.65 164.71 31.57 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.245 -0.434 . . . . 73.4 111.111 -179.977 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.632 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 5.1 p90 -133.56 145.12 49.8 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.143 -0.481 . . . . 72.22 110.977 -179.93 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.665 ' HD2' HD11 ' A' ' 160' ' ' LEU . 3.9 tmt_? -136.42 110.06 8.05 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.142 -0.481 . . . . 71.13 110.849 -179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 52.5 mt -70.73 105.83 1.6 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.289 0 CA-C-N 116.179 -0.464 . . . . 74.53 111.077 -179.979 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 20.0 t-20 -60.51 -47.47 86.0 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.138 -0.483 . . . . 62.3 110.822 179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.669 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.2 p-10 -141.53 162.9 34.35 Favored 'General case' 0 C--N 1.328 -0.368 0 CA-C-N 116.199 -0.455 . . . . 74.4 110.849 -179.941 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.835 ' CE2' HG11 ' A' ' 130' ' ' VAL . 4.1 m-85 -116.57 144.29 44.56 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.115 -0.493 . . . . 75.24 110.964 -179.971 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.507 HG22 ' H ' ' A' ' 124' ' ' ASP . 30.4 m -99.12 135.63 20.75 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.572 0.701 . . . . 65.53 111.133 -179.965 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.471 ' HD2' HG23 ' A' ' 122' ' ' THR . 54.0 Cg_endo -69.74 10.87 0.44 Allowed 'Trans proline' 0 C--N 1.341 0.146 0 C-N-CA 122.728 2.285 . . . . 63.12 112.338 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . 0.507 ' H ' HG22 ' A' ' 122' ' ' THR . 1.6 m-20 -87.89 -26.73 22.6 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.207 -0.451 . . . . 62.25 110.861 179.901 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.697 ' HE2' HD22 ' A' ' 212' ' ' LEU . 0.1 OUTLIER -112.76 160.12 18.28 Favored 'General case' 0 C--N 1.329 -0.301 0 CA-C-N 116.202 -0.454 . . . . 71.11 110.851 -179.935 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 29.8 t-20 -86.84 152.02 22.84 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.164 -0.471 . . . . 74.15 110.956 179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 23.2 ptt180 -45.44 -39.63 7.31 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.173 -0.467 . . . . 74.13 110.885 179.967 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 42.2 mt-10 -77.01 -38.22 53.44 Favored 'General case' 0 C--N 1.33 -0.28 0 CA-C-N 116.135 -0.484 . . . . 74.41 110.939 -179.933 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . 0.775 ' OD1' HG23 ' A' ' 205' ' ' THR . 38.8 t0 -61.39 -35.87 78.69 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.081 -0.509 . . . . 70.44 110.89 179.994 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.835 HG11 ' CE2' ' A' ' 121' ' ' TYR . 95.0 t -60.9 -44.86 98.74 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.252 0 CA-C-N 116.126 -0.488 . . . . 70.2 111.122 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.446 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 1.0 OUTLIER -83.18 -23.04 33.06 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-N 116.136 -0.484 . . . . 60.13 110.92 179.937 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 3.8 t80 -76.43 -51.87 10.97 Favored 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.155 -0.475 . . . . 74.4 110.888 -179.807 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.721 ' HB1' ' N ' ' A' ' 213' ' ' PHE . . . -66.59 -30.62 70.95 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.123 -0.49 . . . . 72.53 111.161 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.538 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.4 mp -77.31 -58.17 4.7 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.287 0 CA-C-N 116.148 -0.478 . . . . 64.44 111.094 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.538 ' N ' HG22 ' A' ' 134' ' ' ILE . 6.2 ttm180 -48.06 -47.06 34.14 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.161 -0.472 . . . . 73.53 110.884 179.924 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.689 ' O ' HG23 ' A' ' 140' ' ' VAL . 5.8 mmpt? -67.62 -33.98 76.07 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.164 -0.471 . . . . 71.04 110.879 179.986 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.972 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -61.55 -49.47 76.54 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.258 -0.428 . . . . 71.22 111.119 179.85 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.632 ' CZ ' ' CG ' ' A' ' 116' ' ' TYR . 96.5 m-85 -73.63 -21.9 60.16 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.259 -0.428 . . . . 64.12 110.856 -179.923 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.475 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.6 tt0 -77.8 -5.21 50.01 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.126 -0.488 . . . . 75.04 110.916 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.689 HG23 ' O ' ' A' ' 136' ' ' LYS . 94.9 t -99.14 -17.59 6.63 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.292 0 CA-C-N 116.24 -0.436 . . . . 62.31 111.112 179.982 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.821 ' NE1' HG12 ' A' ' 217' ' ' VAL . 97.0 m95 -106.89 -38.23 6.12 Favored 'General case' 0 C--N 1.327 -0.375 0 CA-C-N 116.1 -0.5 . . . . 74.21 110.919 -179.98 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -73.99 -10.72 59.93 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-O 121.008 0.432 . . . . 61.42 110.912 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.561 HD22 ' N ' ' A' ' 143' ' ' ASN . 1.1 m-80 -97.24 -17.49 19.8 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.157 -0.474 . . . . 73.42 110.873 -179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.803 HG11 HD12 ' A' ' 250' ' ' LEU . 18.1 m -100.2 -3.89 9.41 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.341 0 CA-C-N 116.23 -0.441 . . . . 64.24 111.087 -179.996 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.779 ' CB ' HD23 ' A' ' 147' ' ' LEU . 44.6 p -142.89 148.4 45.58 Favored Pre-proline 0 C--N 1.329 -0.285 0 CA-C-O 121.572 0.701 . . . . 73.21 111.119 -180.0 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 52.7 Cg_endo -69.82 35.01 0.22 Allowed 'Trans proline' 0 C--N 1.341 0.16 0 C-N-CA 122.663 2.242 . . . . 71.33 112.34 179.958 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.916 HD21 ' HB3' ' A' ' 262' ' ' TYR . 2.8 mm? -104.58 166.28 10.5 Favored 'General case' 0 C--N 1.329 -0.308 0 CA-C-N 116.198 -0.455 . . . . 65.21 110.95 179.921 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . 0.416 ' HD2' ' HB2' ' A' ' 112' ' ' HIS . 0.5 OUTLIER -129.21 129.36 44.93 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.241 -0.436 . . . . 74.02 110.869 179.885 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.453 ' HE1' HD13 ' A' ' 114' ' ' ILE . 4.1 m-30 -115.48 137.66 51.83 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.261 -0.427 . . . . 74.45 110.909 179.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . 0.455 ' H ' ' HA ' ' A' ' 115' ' ' THR . 6.3 t -125.26 162.77 23.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.18 -0.464 . . . . 42.21 110.852 -179.785 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.461 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 7.9 tttt -119.5 142.2 48.51 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.107 -0.497 . . . . 73.22 110.853 179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.917 ' CD1' ' HB2' ' A' ' 157' ' ' ALA . 0.3 OUTLIER -150.95 166.68 2.11 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.372 0 CA-C-N 116.279 -0.419 . . . . 72.42 111.158 179.805 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 9.8 m120 -131.36 18.55 4.86 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.127 -0.488 . . . . 73.04 110.867 179.975 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . 0.447 HG23 ' N ' ' A' ' 155' ' ' GLY . 10.1 t -95.3 -42.6 8.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.186 -0.461 . . . . 71.24 111.209 -179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.447 ' N ' HG23 ' A' ' 154' ' ' THR . . . 133.53 7.17 2.49 Favored Glycine 0 N--CA 1.451 -0.316 0 C-N-CA 120.758 -0.734 . . . . 41.41 112.482 179.892 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . 0.41 ' H ' HG23 ' A' ' 154' ' ' THR . 2.9 ttp -103.62 80.98 1.85 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.884 0.373 . . . . 62.42 110.913 -179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.917 ' HB2' ' CD1' ' A' ' 152' ' ' ILE . . . -151.13 163.37 38.97 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.205 -0.452 . . . . 74.21 111.12 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . 0.461 ' O ' ' O ' ' A' ' 192' ' ' GLY . 0.4 OUTLIER -85.93 -50.93 6.71 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.27 -0.423 . . . . 73.34 110.907 179.887 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.612 HG12 HG23 ' A' ' 220' ' ' ILE . 2.3 mp -92.57 91.59 3.45 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.355 0 CA-C-N 116.21 -0.45 . . . . 73.12 111.177 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.665 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.4 tp -83.11 109.02 16.8 Favored 'General case' 0 C--N 1.327 -0.389 0 CA-C-N 116.219 -0.446 . . . . 71.41 110.902 179.922 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . 0.443 HG13 ' CE1' ' A' ' 197' ' ' PHE . 97.2 t -87.48 119.05 34.49 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.261 0 CA-C-N 116.2 -0.454 . . . . 61.32 111.178 179.817 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.669 HG23 ' OD1' ' A' ' 120' ' ' ASN . 1.8 p -137.75 103.89 2.82 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.194 -0.457 . . . . 72.11 111.114 179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . 0.418 ' CD2' ' HB2' ' A' ' 197' ' ' PHE . 36.7 m-85 -72.66 110.25 6.87 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.085 -0.507 . . . . 63.11 110.871 179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -131.57 166.9 20.37 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.109 -0.496 . . . . 71.21 111.115 179.85 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -114.16 137.74 51.36 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.24 -0.436 . . . . 72.35 110.837 -179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.684 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.93 -155.74 0.23 Allowed Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.716 -0.754 . . . . 63.32 112.512 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.811 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -64.51 116.73 6.44 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-O 120.77 0.319 . . . . 64.34 111.105 -179.991 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.706 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.3 OUTLIER -109.15 -22.22 12.21 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.226 -0.443 . . . . 73.32 110.94 179.992 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 132.04 30.35 0.53 Allowed Glycine 0 N--CA 1.451 -0.314 0 C-N-CA 120.67 -0.776 . . . . 62.32 112.456 -179.945 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.638 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -114.47 1.24 14.28 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-O 120.766 0.317 . . . . 70.52 110.824 -179.936 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 17.5 m-85 73.05 39.75 0.6 Allowed 'General case' 0 C--N 1.328 -0.337 0 CA-C-N 116.235 -0.439 . . . . 72.24 110.763 179.968 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.706 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.3 OUTLIER -135.25 -41.23 0.73 Allowed 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.256 -0.429 . . . . 71.14 110.955 179.959 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.811 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.02 100.38 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.176 -0.466 . . . . 73.4 111.11 179.877 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.684 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -60.56 -168.45 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.256 -0.429 . . . . 64.24 110.909 -179.904 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -134.87 19.07 3.5 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.195 -0.457 . . . . 71.1 110.835 179.989 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.589 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 54.64 -158.22 6.22 Favored Glycine 0 N--CA 1.45 -0.421 0 C-N-CA 120.758 -0.734 . . . . 61.35 112.559 -179.881 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.442 ' C ' ' O ' ' A' ' 176' ' ' GLY . 5.4 tmtt? -34.69 134.25 0.23 Allowed 'General case' 0 C--N 1.328 -0.341 0 CA-C-O 120.878 0.371 . . . . 72.01 110.908 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 60.02 164.66 0.16 Allowed Glycine 0 N--CA 1.452 -0.26 0 C-N-CA 120.739 -0.743 . . . . 71.03 112.494 179.978 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.469 ' O ' HD22 ' A' ' 181' ' ' LEU . . . 82.97 -142.85 21.8 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.741 -0.742 . . . . 61.54 112.509 -179.929 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.9 mt -50.45 96.35 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.819 0.343 . . . . 53.42 111.094 -179.956 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.469 HD22 ' O ' ' A' ' 179' ' ' GLY . 3.0 mm? -65.94 -42.94 89.38 Favored 'General case' 0 C--N 1.328 -0.328 0 CA-C-N 116.186 -0.461 . . . . 74.4 110.92 179.87 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.408 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -171.09 163.36 7.3 Favored 'General case' 0 C--N 1.329 -0.317 0 CA-C-N 116.207 -0.452 . . . . 64.31 111.158 179.76 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.48 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.2 p80 -156.06 142.96 18.89 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.245 -0.434 . . . . 72.34 110.881 179.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.734 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -139.01 172.51 12.74 Favored 'General case' 0 C--N 1.33 -0.26 0 CA-C-N 116.228 -0.442 . . . . 74.25 111.074 179.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.537 ' O ' ' O ' ' A' ' 222' ' ' HIS . 46.9 m-85 -101.12 -145.51 0.35 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.193 -0.458 . . . . 61.03 110.918 -179.873 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . . . . . . . . . . . -168.0 -86.21 0.06 OUTLIER Glycine 0 N--CA 1.452 -0.258 0 C-N-CA 120.774 -0.726 . . . . 63.04 112.456 -179.883 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . . . . . . . . . 52.9 Cg_endo -69.73 54.15 1.14 Allowed 'Trans proline' 0 C--N 1.342 0.21 0 C-N-CA 122.755 2.304 . . . . 75.04 112.305 -179.914 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.574 ' C ' ' HA3' ' A' ' 192' ' ' GLY . . . -123.32 150.64 16.88 Favored Glycine 0 N--CA 1.45 -0.38 0 C-N-CA 120.773 -0.727 . . . . 71.33 112.47 179.976 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . 0.565 ' O ' ' N ' ' A' ' 191' ' ' ILE . 0.0 OUTLIER -104.08 147.01 27.9 Favored 'General case' 0 C--N 1.33 -0.271 0 CA-C-O 120.85 0.357 . . . . 43.31 110.83 -179.723 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 61.02 -66.21 0.01 OUTLIER Glycine 0 N--CA 1.45 -0.367 0 C-N-CA 120.845 -0.693 . . . . 60.44 112.441 -179.964 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . 0.565 ' N ' ' O ' ' A' ' 189' ' ' SER . 5.8 mm -102.76 6.89 10.05 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.366 0 CA-C-O 120.777 0.322 . . . . 74.5 111.068 -179.913 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.574 ' HA3' ' C ' ' A' ' 188' ' ' GLY . . . -66.96 168.85 36.18 Favored Glycine 0 N--CA 1.451 -0.3 0 C-N-CA 120.748 -0.739 . . . . 75.33 112.47 179.909 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.403 ' HA2' ' HA ' ' A' ' 223' ' ' SER . . . 45.27 18.71 0.18 Allowed Glycine 0 N--CA 1.451 -0.304 0 C-N-CA 120.753 -0.737 . . . . 70.41 112.488 -179.834 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . 0.425 ' HB3' ' NE2' ' A' ' 196' ' ' HIS . 1.1 m-20 -63.08 102.5 0.38 Allowed 'General case' 0 C--N 1.328 -0.333 0 CA-C-O 120.8 0.333 . . . . 73.01 110.85 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.734 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -76.99 132.22 38.88 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.2 -0.455 . . . . 74.44 111.06 179.964 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.48 ' HB2' ' CD2' ' A' ' 183' ' ' HIS . 4.8 m170 -123.22 129.53 51.52 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.238 -0.437 . . . . 71.34 110.868 -179.987 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.499 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 42.5 m-85 -114.54 135.57 53.98 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.197 -0.456 . . . . 73.41 110.846 -179.772 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 29.7 t0 -68.43 109.38 3.65 Favored 'General case' 0 C--N 1.327 -0.37 0 CA-C-N 116.216 -0.447 . . . . 71.12 110.945 179.901 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.3 tm-20 -61.03 -36.1 78.66 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.191 -0.458 . . . . 73.44 110.935 -179.896 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.589 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 18.0 m-20 -52.18 -20.7 2.74 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.133 -0.485 . . . . 53.33 110.849 179.974 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.4 ' HG3' HD13 ' A' ' 181' ' ' LEU . 6.5 mm-40 -81.57 161.14 23.66 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.196 -0.457 . . . . 51.32 110.823 -179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.542 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -100.13 90.93 4.54 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.086 -0.506 . . . . 73.15 110.801 -179.92 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.499 ' CZ2' ' HB3' ' A' ' 197' ' ' PHE . 22.2 m95 -81.26 123.92 28.89 Favored 'General case' 0 C--N 1.328 -0.33 0 CA-C-N 116.141 -0.481 . . . . 71.32 110.858 -179.947 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 43.5 p -140.47 -176.36 4.6 Favored 'General case' 0 C--N 1.33 -0.265 0 CA-C-N 116.201 -0.454 . . . . 62.11 111.06 -179.913 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . 0.775 HG23 ' OD1' ' A' ' 129' ' ' ASP . 0.1 OUTLIER -110.28 19.86 18.43 Favored 'General case' 0 C--N 1.33 -0.273 0 CA-C-N 116.247 -0.433 . . . . 74.22 111.201 -179.998 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 4.1 m80 -128.34 -173.24 2.9 Favored 'General case' 0 C--N 1.33 -0.248 0 CA-C-N 116.194 -0.457 . . . . 73.34 110.861 179.959 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 9.3 t -71.71 -18.84 62.13 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.24 -0.436 . . . . 65.21 110.869 -179.824 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -60.06 -106.79 0.01 OUTLIER Glycine 0 N--CA 1.452 -0.282 0 C-N-CA 120.686 -0.769 . . . . 52.31 112.491 -179.926 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.542 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.07 177.01 0.1 OUTLIER Glycine 0 N--CA 1.451 -0.324 0 C-N-CA 120.692 -0.766 . . . . 54.13 112.469 -179.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . 0.404 HG21 HD12 ' A' ' 181' ' ' LEU . 89.8 m -66.63 97.54 0.45 Allowed 'General case' 0 C--N 1.329 -0.295 0 CA-C-O 120.829 0.347 . . . . 75.14 111.249 -179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -42.14 114.75 0.59 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.216 -0.447 . . . . 72.21 110.947 -179.984 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.697 HD22 ' HE2' ' A' ' 125' ' ' MET . 27.1 tp -61.18 -32.46 72.21 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.127 -0.488 . . . . 62.24 111.0 179.946 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.782 ' O ' HG23 ' A' ' 217' ' ' VAL . 3.0 t80 -58.11 -65.23 0.68 Allowed 'General case' 0 C--N 1.33 -0.255 0 CA-C-N 116.096 -0.502 . . . . 75.44 110.98 179.914 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.581 HD21 ' CG2' ' A' ' 243' ' ' VAL . 8.9 mp -51.88 -54.43 29.32 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.179 -0.464 . . . . 74.11 110.957 179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.49 HG21 ' CZ3' ' A' ' 203' ' ' TRP . 2.7 m -55.64 -38.93 70.2 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-N 116.214 -0.448 . . . . 74.44 111.023 179.949 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.08 -48.81 77.04 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.258 -0.428 . . . . 63.43 111.093 179.939 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.972 HG22 ' HA ' ' A' ' 137' ' ' ALA . 1.9 t -54.83 -57.57 6.38 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.33 0 CA-C-N 116.149 -0.478 . . . . 63.01 111.093 -179.978 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.775 ' HB2' HG13 ' A' ' 235' ' ' VAL . 1.3 t-80 -64.87 -28.11 69.33 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.167 -0.47 . . . . 73.15 110.989 179.863 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.446 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -63.8 -46.53 84.72 Favored 'General case' 0 C--N 1.329 -0.297 0 CA-C-N 116.15 -0.477 . . . . 61.53 111.067 179.891 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.612 HG23 HG12 ' A' ' 159' ' ' ILE . 2.5 mt -68.02 -35.23 71.03 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.304 0 CA-C-N 116.138 -0.483 . . . . 72.33 111.123 -179.944 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.41 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -49.47 -45.91 36.96 Favored Glycine 0 N--CA 1.452 -0.271 0 C-N-CA 120.671 -0.776 . . . . 62.32 112.474 179.955 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . 0.537 ' O ' ' O ' ' A' ' 185' ' ' PHE . 4.9 m-70 -68.32 -39.89 81.84 Favored 'General case' 0 C--N 1.329 -0.289 0 CA-C-O 120.801 0.334 . . . . 73.24 110.866 -179.928 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.563 ' OG ' HG23 ' A' ' 159' ' ' ILE . 14.0 m -66.15 -24.66 66.7 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.17 -0.468 . . . . 62.11 110.827 -179.781 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.734 ' O ' HG23 ' A' ' 108' ' ' VAL . 43.1 mt -75.67 -25.92 57.2 Favored 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.146 -0.479 . . . . 62.41 110.964 -179.993 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . . . . . . . . . . . 124.45 11.16 4.7 Favored Glycine 0 N--CA 1.452 -0.249 0 C-N-CA 120.746 -0.74 . . . . 64.12 112.454 179.83 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.611 HD21 ' HA ' ' A' ' 258' ' ' ILE . 14.4 mt -90.03 142.71 27.44 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-O 120.847 0.356 . . . . 75.3 110.912 -179.888 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -93.05 -137.01 8.01 Favored Glycine 0 N--CA 1.453 -0.23 0 C-N-CA 120.71 -0.757 . . . . 41.43 112.47 179.905 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -115.96 144.23 44.36 Favored 'General case' 0 C--N 1.33 -0.257 0 CA-C-O 120.835 0.35 . . . . 75.25 110.872 -179.919 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . . . . . . . . . 77.6 p -102.85 167.05 10.11 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-N 116.21 -0.45 . . . . 60.13 110.836 -179.773 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 65.6 m -109.54 5.07 22.85 Favored 'General case' 0 C--N 1.329 -0.288 0 CA-C-N 116.131 -0.486 . . . . 71.04 110.853 -179.814 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.527 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -72.75 135.55 80.83 Favored Pre-proline 0 C--N 1.328 -0.357 0 CA-C-O 121.524 0.678 . . . . 74.3 110.88 179.953 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.6 Cg_endo -69.73 -0.41 6.85 Favored 'Trans proline' 0 C--O 1.232 0.197 0 C-N-CA 122.706 2.271 . . . . 75.5 112.326 -179.963 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -144.11 26.39 1.51 Allowed 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.265 -0.425 . . . . 75.14 110.944 179.917 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.527 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -97.55 144.34 27.34 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.197 -0.456 . . . . 73.12 111.042 179.867 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.775 HG13 ' HB2' ' A' ' 218' ' ' HIS . 0.9 OUTLIER -63.94 -41.54 92.84 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.3 0 CA-C-N 116.248 -0.433 . . . . 71.13 111.143 179.903 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . . . . . . . . . 34.7 mmm -59.86 -18.76 46.76 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.124 -0.489 . . . . 71.24 110.83 -179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.604 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 1.9 t80 -57.38 144.62 70.69 Favored Pre-proline 0 C--N 1.328 -0.328 0 CA-C-O 121.68 0.753 . . . . 74.21 110.875 -179.94 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.604 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.1 Cg_endo -69.95 -1.78 9.2 Favored 'Trans proline' 0 C--O 1.232 0.188 0 C-N-CA 122.709 2.273 . . . . 51.53 112.34 -179.931 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . . . . . . . . . 28.7 m -95.24 137.28 34.5 Favored 'General case' 0 C--N 1.331 -0.196 0 CA-C-N 116.159 -0.473 . . . . 53.35 111.177 179.995 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 62.2 t80 -118.76 135.88 54.27 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.209 -0.451 . . . . 75.24 110.932 -179.881 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 21.7 tptt -154.93 131.43 10.52 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.093 -0.503 . . . . 61.22 110.926 179.953 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.53 ' O ' HG13 ' A' ' 243' ' ' VAL . 80.1 t80 -60.15 145.43 46.98 Favored 'General case' 0 C--N 1.327 -0.399 0 CA-C-N 116.18 -0.464 . . . . 71.04 110.87 -179.876 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.581 ' CG2' HD21 ' A' ' 214' ' ' LEU . 0.3 OUTLIER -159.87 132.51 1.12 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.266 0 CA-C-N 116.113 -0.494 . . . . 73.43 111.141 179.902 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 43.9 t0 -50.16 128.17 18.58 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.119 -0.491 . . . . 75.44 110.894 179.924 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.618 HD11 ' HD3' ' A' ' 136' ' ' LYS . 14.0 tt -51.13 -33.77 13.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.381 0 CA-C-N 116.208 -0.451 . . . . 73.14 111.078 -179.968 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 12.1 m-80 -69.68 -23.27 63.42 Favored 'General case' 0 C--N 1.329 -0.298 0 CA-C-N 116.164 -0.471 . . . . 74.5 110.837 179.998 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 29.6 p -101.33 -24.42 14.22 Favored 'General case' 0 C--N 1.33 -0.269 0 CA-C-N 116.225 -0.443 . . . . 74.1 111.125 -179.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 55.6 t80 -64.31 144.28 57.27 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.195 -0.457 . . . . 63.33 110.834 -179.934 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 19.1 ptt180 -175.04 131.19 0.31 Allowed 'General case' 0 C--N 1.33 -0.278 0 CA-C-N 116.13 -0.486 . . . . 74.22 110.846 -179.93 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.803 HD12 HG11 ' A' ' 144' ' ' VAL . 33.8 mt -49.81 124.56 10.02 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.168 -0.469 . . . . 75.44 110.891 -179.983 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -68.34 167.08 15.25 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.167 -0.47 . . . . 54.21 110.785 -179.86 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -50.61 -39.17 49.38 Favored 'General case' 0 C--N 1.33 -0.249 0 CA-C-N 116.089 -0.505 . . . . 71.03 111.159 179.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 1.5 m-20 -62.9 -46.92 85.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.212 -0.449 . . . . 74.42 110.821 179.974 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.433 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 6.9 m-20 -61.36 -54.49 43.1 Favored 'General case' 0 C--N 1.329 -0.313 0 CA-C-N 116.194 -0.457 . . . . 65.43 110.866 -179.935 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . . . . . . . . . 23.0 mt -60.58 -35.01 60.62 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.212 -0.449 . . . . 74.01 111.159 -179.994 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 15.9 mmm180 -68.75 -39.78 80.14 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.202 -0.454 . . . . 71.11 110.861 179.96 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . . . . . . . . . . . -76.03 -51.19 7.09 Favored Glycine 0 N--CA 1.451 -0.311 0 C-N-CA 120.773 -0.727 . . . . 73.33 112.506 179.986 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.663 HG13 HG21 ' A' ' 145' ' ' THR . 6.2 tp -53.23 -34.37 21.96 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-O 120.794 0.33 . . . . 72.14 111.205 -179.97 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.401 ' O ' ' N ' ' A' ' 263' ' ' GLY . 31.2 mt-30 -87.86 -16.13 34.83 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.11 -0.496 . . . . 71.13 110.942 179.841 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . . . . . . . . . 2.4 t -69.33 -16.52 63.56 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.158 -0.474 . . . . 70.21 110.902 -179.777 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.795 HD11 ' HG2' ' A' ' 102' ' ' GLU . 2.1 mt -120.76 -19.42 7.37 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.079 -0.509 . . . . 72.0 110.86 -179.975 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.916 ' HB3' HD21 ' A' ' 147' ' ' LEU . 29.7 m-85 -110.17 -37.25 5.61 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 62.15 110.908 179.96 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.401 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.451 -0.335 0 CA-C-O 119.194 -0.781 . . . . 72.05 112.475 179.895 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' PHE . . . . . . . . . . . . . 73.2 m-85 . . . . . 0 C--O 1.231 0.093 0 CA-C-O 120.827 0.346 . . . . 75.21 110.848 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' ARG . . . . . 0.402 ' HG2' ' HB3' ' A' ' 229' ' ' SER . 0.0 OUTLIER 50.09 59.95 4.17 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.118 -0.492 . . . . 71.31 110.874 -179.98 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' GLU . . . . . 0.655 ' HB2' HD11 ' A' ' 261' ' ' LEU . 4.6 pt-20 -178.66 135.83 0.14 Allowed 'General case' 0 C--N 1.331 -0.22 0 CA-C-N 116.123 -0.489 . . . . 72.23 110.867 -179.89 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' MET . . . . . . . . . . . . . 1.4 tpt -51.76 135.35 36.16 Favored Pre-proline 0 C--N 1.328 -0.333 0 CA-C-O 121.557 0.694 . . . . 71.14 110.869 -179.994 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' PRO . . . . . . . . . . . . . 54.5 Cg_endo -69.7 73.95 1.3 Allowed 'Trans proline' 0 C--N 1.342 0.204 0 C-N-CA 122.639 2.226 . . . . 74.11 112.394 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' GLY . . . . . . . . . . . . . . . 110.38 25.88 5.08 Favored Glycine 0 N--CA 1.451 -0.361 0 C-N-CA 120.714 -0.755 . . . . 72.52 112.46 179.952 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' GLY . . . . . . . . . . . . . . . -114.83 111.53 2.54 Favored Glycine 0 N--CA 1.452 -0.275 0 C-N-CA 120.78 -0.724 . . . . 53.33 112.428 -179.885 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' PRO . . . . . 0.601 ' O ' HG22 ' A' ' 108' ' ' VAL . 54.1 Cg_endo -69.78 4.2 2.34 Favored 'Trans proline' 0 C--N 1.342 0.217 0 C-N-CA 122.665 2.243 . . . . 62.32 112.299 179.981 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.73 HG11 HD13 ' A' ' 261' ' ' LEU . 17.7 m 45.16 30.65 0.15 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.327 0 CA-C-N 116.305 -0.407 . . . . 74.32 111.14 179.877 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' TRP . . . . . 0.417 ' HB2' ' O ' ' A' ' 108' ' ' VAL . 10.4 m0 76.22 -40.67 0.4 Allowed 'General case' 0 C--N 1.327 -0.377 0 CA-C-N 116.137 -0.483 . . . . 74.15 110.828 179.936 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' ARG . . . . . . . . . . . . . 4.7 mtt-85 70.9 31.94 2.49 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.294 -0.412 . . . . 74.33 110.906 -179.959 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -122.34 161.44 23.4 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.13 -0.486 . . . . 64.55 110.895 -179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' HIS . . . . . 0.464 ' HA ' HD22 ' A' ' 147' ' ' LEU . 3.3 p80 -109.63 20.64 17.9 Favored 'General case' 0 C--N 1.329 -0.299 0 CA-C-N 116.196 -0.456 . . . . 62.04 110.859 179.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' TYR . . . . . . . . . . . . . 3.2 m-85 -125.96 96.41 4.74 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.187 -0.461 . . . . 73.51 110.975 -179.91 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ILE . . . . . 0.613 HG22 ' N ' ' A' ' 115' ' ' THR . 4.8 mp -123.29 163.93 21.64 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.342 0 CA-C-N 116.114 -0.494 . . . . 71.24 111.161 179.903 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' THR . . . . . 0.613 ' N ' HG22 ' A' ' 114' ' ' ILE . 0.4 OUTLIER -157.72 163.64 37.93 Favored 'General case' 0 C--N 1.33 -0.266 0 CA-C-N 116.177 -0.465 . . . . 72.44 111.226 179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' TYR . . . . . 0.593 ' CG ' ' CZ ' ' A' ' 138' ' ' PHE . 3.7 p90 -133.53 144.63 49.49 Favored 'General case' 0 C--N 1.328 -0.342 0 CA-C-N 116.258 -0.428 . . . . 64.53 110.926 -179.868 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' ARG . . . . . 0.646 ' HD2' HD11 ' A' ' 160' ' ' LEU . 0.0 OUTLIER -138.84 108.86 6.34 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.132 -0.486 . . . . 53.35 110.83 -179.967 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' ILE . . . . . . . . . . . . . 53.2 mt -70.66 106.03 1.63 Allowed 'Isoleucine or valine' 0 C--N 1.33 -0.254 0 CA-C-N 116.134 -0.485 . . . . 74.12 111.124 179.941 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' ASN . . . . . . . . . . . . . 24.8 t-20 -60.39 -47.43 86.11 Favored 'General case' 0 C--N 1.33 -0.277 0 CA-C-N 116.173 -0.467 . . . . 71.52 110.921 179.906 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ASN . . . . . 0.701 ' OD1' HG23 ' A' ' 162' ' ' VAL . 2.3 p-10 -141.17 162.52 35.29 Favored 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.121 -0.49 . . . . 75.24 110.96 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' TYR . . . . . 0.575 ' CE2' HG11 ' A' ' 130' ' ' VAL . 5.1 m-85 -116.35 145.55 43.13 Favored 'General case' 0 C--N 1.326 -0.42 0 CA-C-N 116.187 -0.46 . . . . 73.33 110.927 -179.932 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' THR . . . . . 0.522 ' CG2' ' HD2' ' A' ' 123' ' ' PRO . 3.6 m -93.01 137.9 23.53 Favored Pre-proline 0 C--N 1.33 -0.276 0 CA-C-O 121.581 0.705 . . . . 51.24 111.147 -179.963 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' PRO . . . . . 0.522 ' HD2' ' CG2' ' A' ' 122' ' ' THR . 54.2 Cg_endo -69.85 0.6 5.48 Favored 'Trans proline' 0 C--N 1.341 0.161 0 C-N-CA 122.635 2.223 . . . . 75.04 112.323 179.957 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -84.08 -24.23 30.45 Favored 'General case' 0 C--N 1.329 -0.307 0 CA-C-N 116.22 -0.446 . . . . 71.33 110.844 179.876 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' MET . . . . . 0.67 ' SD ' HD22 ' A' ' 212' ' ' LEU . 3.8 mtm -113.12 167.37 10.59 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-N 116.211 -0.45 . . . . 74.32 110.853 179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' ASN . . . . . . . . . . . . . 13.1 t30 -92.96 143.41 26.27 Favored 'General case' 0 C--N 1.329 -0.286 0 CA-C-N 116.211 -0.449 . . . . 73.44 110.974 179.979 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ARG . . . . . . . . . . . . . 16.8 ptt180 -45.36 -36.22 4.06 Favored 'General case' 0 C--N 1.329 -0.311 0 CA-C-N 116.241 -0.436 . . . . 71.3 110.877 -179.965 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLU . . . . . . . . . . . . . 35.5 mt-10 -83.38 -38.23 22.25 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.218 -0.446 . . . . 74.33 110.908 -179.936 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' ASP . . . . . . . . . . . . . 44.8 m-20 -64.12 -31.8 73.13 Favored 'General case' 0 C--N 1.327 -0.372 0 CA-C-N 116.143 -0.48 . . . . 75.21 110.828 179.999 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' VAL . . . . . 0.575 HG11 ' CE2' ' A' ' 121' ' ' TYR . 56.4 t -65.61 -46.21 90.11 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.352 0 CA-C-N 116.217 -0.447 . . . . 74.21 111.105 -179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' ASP . . . . . 0.436 ' O ' ' HB3' ' A' ' 135' ' ' ARG . 0.2 OUTLIER -78.49 -23.53 46.36 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.186 -0.461 . . . . 51.43 110.88 179.902 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' TYR . . . . . . . . . . . . . 4.4 t80 -74.93 -48.02 26.7 Favored 'General case' 0 C--N 1.328 -0.334 0 CA-C-N 116.217 -0.447 . . . . 74.04 110.955 -179.823 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' ALA . . . . . 0.672 ' HB1' ' CA ' ' A' ' 213' ' ' PHE . . . -68.88 -31.18 69.93 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.12 -0.491 . . . . 35.41 111.112 179.835 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' ILE . . . . . 0.518 HG22 ' N ' ' A' ' 135' ' ' ARG . 1.3 mp -73.8 -53.93 16.46 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.298 0 CA-C-N 116.189 -0.459 . . . . 62.13 111.161 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' ARG . . . . . 0.518 ' N ' HG22 ' A' ' 134' ' ' ILE . 3.8 ptm180 -49.22 -37.34 22.71 Favored 'General case' 0 C--N 1.327 -0.382 0 CA-C-N 116.177 -0.465 . . . . 74.2 110.832 179.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' LYS . . . . . 0.731 ' O ' HG23 ' A' ' 140' ' ' VAL . 5.6 mmpt? -76.97 -34.34 57.57 Favored 'General case' 0 C--N 1.329 -0.284 0 CA-C-N 116.19 -0.459 . . . . 73.14 110.854 -179.988 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 137' ' ' ALA . . . . . 0.911 ' HA ' HG22 ' A' ' 217' ' ' VAL . . . -60.12 -48.66 80.79 Favored 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 116.294 -0.412 . . . . 60.41 111.134 179.821 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 138' ' ' PHE . . . . . 0.623 ' HE1' HD13 ' A' ' 159' ' ' ILE . 96.0 m-85 -72.84 -22.79 60.74 Favored 'General case' 0 C--N 1.329 -0.315 0 CA-C-N 116.22 -0.445 . . . . 75.34 110.942 -179.975 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 139' ' ' GLN . . . . . 0.493 ' O ' ' ND2' ' A' ' 143' ' ' ASN . 2.4 tt0 -77.78 -5.78 51.86 Favored 'General case' 0 C--N 1.33 -0.259 0 CA-C-N 116.116 -0.493 . . . . 65.21 110.917 -179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 140' ' ' VAL . . . . . 0.731 HG23 ' O ' ' A' ' 136' ' ' LYS . 83.8 t -97.94 -16.77 6.98 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.313 0 CA-C-N 116.18 -0.464 . . . . 71.53 111.066 179.959 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 141' ' ' TRP . . . . . 0.813 ' NE1' HG12 ' A' ' 217' ' ' VAL . 92.1 m95 -107.09 -38.26 6.06 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-N 116.264 -0.426 . . . . 72.41 110.917 179.934 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 142' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -69.95 -11.53 60.94 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.298 -0.41 . . . . 51.03 110.814 -179.753 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 143' ' ' ASN . . . . . 0.604 HD22 ' N ' ' A' ' 143' ' ' ASN . 0.9 OUTLIER -95.53 -17.49 21.39 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 116.18 -0.464 . . . . 72.41 110.849 -179.951 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 144' ' ' VAL . . . . . 0.685 HG11 HD12 ' A' ' 250' ' ' LEU . 22.4 m -99.86 2.72 10.57 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.279 0 CA-C-N 116.235 -0.439 . . . . 75.34 111.084 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 145' ' ' THR . . . . . 0.587 HG21 HG13 ' A' ' 258' ' ' ILE . 44.5 p -150.99 148.69 23.34 Favored Pre-proline 0 C--N 1.328 -0.342 0 CA-C-O 121.537 0.684 . . . . 73.41 111.208 179.982 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 146' ' ' PRO . . . . . . . . . . . . . 54.6 Cg_endo -69.71 31.09 0.18 Allowed 'Trans proline' 0 C--O 1.232 0.185 0 C-N-CA 122.673 2.249 . . . . 72.12 112.357 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 147' ' ' LEU . . . . . 0.772 HD11 ' CD2' ' A' ' 262' ' ' TYR . 15.4 mt -97.44 175.01 6.39 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.208 -0.451 . . . . 71.42 110.937 179.94 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 148' ' ' LYS . . . . . . . . . . . . . 3.4 mtmm -139.05 126.77 22.0 Favored 'General case' 0 C--N 1.329 -0.291 0 CA-C-N 116.153 -0.476 . . . . 74.41 110.768 179.866 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 149' ' ' PHE . . . . . 0.57 ' HE1' HD13 ' A' ' 114' ' ' ILE . 3.7 m-85 -115.4 138.36 51.08 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.138 -0.483 . . . . 75.2 110.898 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 150' ' ' SER . . . . . . . . . . . . . 58.5 m -132.57 149.26 52.34 Favored 'General case' 0 C--N 1.329 -0.296 0 CA-C-N 116.199 -0.455 . . . . 71.24 110.919 -179.832 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 151' ' ' LYS . . . . . 0.483 ' HB2' ' CZ ' ' A' ' 116' ' ' TYR . 4.4 tttt -99.52 141.05 32.82 Favored 'General case' 0 C--N 1.328 -0.341 0 CA-C-N 116.124 -0.489 . . . . 64.23 110.9 179.947 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 152' ' ' ILE . . . . . 0.597 HD11 ' N ' ' A' ' 157' ' ' ALA . 15.5 pt -150.75 139.26 14.7 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.28 0 CA-C-N 116.19 -0.459 . . . . 72.34 111.121 179.95 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 153' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -112.41 5.35 18.08 Favored 'General case' 0 C--N 1.329 -0.302 0 CA-C-N 116.247 -0.433 . . . . 55.32 110.896 179.941 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 154' ' ' THR . . . . . . . . . . . . . 10.0 t -163.5 47.05 0.13 Allowed 'General case' 0 C--N 1.329 -0.287 0 CA-C-N 116.163 -0.471 . . . . 70.1 111.16 -179.981 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 155' ' ' GLY . . . . . 0.507 ' CA ' HD12 ' A' ' 152' ' ' ILE . . . -144.4 -153.19 5.8 Favored Glycine 0 N--CA 1.452 -0.289 0 C-N-CA 120.702 -0.761 . . . . 51.33 112.431 179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 156' ' ' MET . . . . . . . . . . . . . 38.9 mmt -107.61 95.63 5.83 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.823 0.344 . . . . 75.01 110.862 179.951 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 157' ' ' ALA . . . . . 0.597 ' N ' HD11 ' A' ' 152' ' ' ILE . . . -105.64 158.23 16.85 Favored 'General case' 0 C--N 1.329 -0.294 0 CA-C-N 116.266 -0.425 . . . . 51.44 111.075 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 158' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -88.02 -57.41 2.94 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.221 -0.445 . . . . 73.11 110.875 -179.986 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 159' ' ' ILE . . . . . 0.683 HG12 HG23 ' A' ' 220' ' ' ILE . 2.8 mp -82.52 86.26 1.83 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.347 0 CA-C-N 116.162 -0.472 . . . . 64.12 111.139 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 160' ' ' LEU . . . . . 0.646 HD11 ' HD2' ' A' ' 117' ' ' ARG . 7.9 tp -79.76 102.78 9.23 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.14 -0.482 . . . . 70.45 110.84 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 161' ' ' VAL . . . . . . . . . . . . . 96.7 t -82.3 123.08 37.91 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.283 0 CA-C-N 116.222 -0.445 . . . . 63.45 111.148 179.772 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 162' ' ' VAL . . . . . 0.701 HG23 ' OD1' ' A' ' 120' ' ' ASN . 2.1 p -140.97 100.05 1.0 Allowed 'Isoleucine or valine' 0 C--N 1.329 -0.296 0 CA-C-N 116.181 -0.463 . . . . 64.51 111.173 179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 163' ' ' PHE . . . . . . . . . . . . . 48.8 m-85 -67.53 109.39 3.22 Favored 'General case' 0 C--N 1.328 -0.332 0 CA-C-N 116.23 -0.441 . . . . 75.01 110.877 -179.9 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 164' ' ' ALA . . . . . . . . . . . . . . . -128.76 165.76 20.3 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.112 -0.495 . . . . 60.41 111.065 179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 165' ' ' ARG . . . . . . . . . . . . . 9.7 ptt180 -113.65 134.85 54.49 Favored 'General case' 0 C--N 1.33 -0.281 0 CA-C-N 116.175 -0.466 . . . . 74.24 110.847 -179.938 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 166' ' ' GLY . . . . . 0.665 ' CA ' ' HB2' ' A' ' 174' ' ' PHE . . . 43.83 -156.98 0.16 Allowed Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.677 -0.773 . . . . 55.13 112.509 179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 167' ' ' ALA . . . . . 0.81 ' HA ' ' HA ' ' A' ' 173' ' ' ALA . . . -62.76 115.37 4.27 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-O 120.883 0.373 . . . . 72.03 111.072 -179.994 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 168' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 172' ' ' HIS . 0.4 OUTLIER -108.39 -21.07 12.9 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.227 -0.442 . . . . 75.45 110.876 -179.983 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 169' ' ' GLY . . . . . . . . . . . . . . . 130.89 30.1 0.59 Allowed Glycine 0 N--CA 1.451 -0.315 0 C-N-CA 120.684 -0.77 . . . . 42.31 112.482 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 170' ' ' ASP . . . . . 0.638 ' O ' ' OD1' ' A' ' 170' ' ' ASP . 0.0 OUTLIER -113.49 -0.96 14.26 Favored 'General case' 0 C--N 1.328 -0.355 0 CA-C-O 120.888 0.375 . . . . 45.04 110.872 -179.954 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 171' ' ' PHE . . . . . . . . . . . . . 5.3 m-85 75.37 38.05 0.42 Allowed 'General case' 0 C--N 1.33 -0.282 0 CA-C-N 116.194 -0.457 . . . . 73.42 110.877 -179.883 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 172' ' ' HIS . . . . . 0.701 ' CE1' ' CE1' ' A' ' 168' ' ' HIS . 0.4 OUTLIER -133.95 -41.14 0.83 Allowed 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.181 -0.463 . . . . 71.04 110.853 179.953 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 173' ' ' ALA . . . . . 0.81 ' HA ' ' HA ' ' A' ' 167' ' ' ALA . . . 54.26 100.33 0.01 OUTLIER 'General case' 0 C--N 1.33 -0.242 0 CA-C-N 116.225 -0.443 . . . . 74.43 111.172 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 174' ' ' PHE . . . . . 0.665 ' HB2' ' CA ' ' A' ' 166' ' ' GLY . 2.0 m-85 -61.03 -168.87 0.01 OUTLIER 'General case' 0 C--N 1.329 -0.306 0 CA-C-N 116.224 -0.444 . . . . 72.15 110.862 -179.864 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 175' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -133.12 17.5 4.11 Favored 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.142 -0.481 . . . . 54.45 110.883 179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 176' ' ' GLY . . . . . 0.577 ' HA2' ' HB2' ' A' ' 200' ' ' ASP . . . 55.06 -157.41 7.36 Favored Glycine 0 N--CA 1.45 -0.377 0 C-N-CA 120.748 -0.739 . . . . 54.14 112.5 -179.974 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 177' ' ' LYS . . . . . 0.439 ' C ' ' O ' ' A' ' 176' ' ' GLY . 0.0 OUTLIER -34.41 134.42 0.2 Allowed 'General case' 0 C--N 1.329 -0.314 0 CA-C-O 120.905 0.383 . . . . 65.22 110.868 -179.97 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 178' ' ' GLY . . . . . . . . . . . . . . . 58.62 165.95 0.12 Allowed Glycine 0 N--CA 1.451 -0.313 0 C-N-CA 120.687 -0.768 . . . . 62.54 112.555 179.968 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 179' ' ' GLY . . . . . 0.422 ' O ' HD22 ' A' ' 181' ' ' LEU . . . 82.56 -143.19 22.41 Favored Glycine 0 N--CA 1.451 -0.317 0 C-N-CA 120.708 -0.758 . . . . 64.33 112.488 -179.878 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 180' ' ' ILE . . . . . . . . . . . . . 1.8 mt -50.23 96.86 0.01 OUTLIER 'Isoleucine or valine' 0 C--N 1.329 -0.311 0 CA-C-O 120.867 0.365 . . . . 73.5 111.139 -179.977 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 181' ' ' LEU . . . . . 0.499 HD13 ' HG3' ' A' ' 201' ' ' GLU . 2.7 mm? -66.98 -36.04 81.3 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-N 116.188 -0.46 . . . . 60.45 110.949 179.894 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 182' ' ' ALA . . . . . 0.455 ' HB1' ' O ' ' A' ' 196' ' ' HIS . . . -174.74 169.0 3.61 Favored 'General case' 0 C--N 1.329 -0.3 0 CA-C-N 116.242 -0.435 . . . . 52.34 111.11 179.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 183' ' ' HIS . . . . . 0.45 ' CD2' ' HB2' ' A' ' 196' ' ' HIS . 1.2 p80 -161.27 142.28 11.36 Favored 'General case' 0 C--N 1.33 -0.272 0 CA-C-N 116.275 -0.421 . . . . 75.4 110.881 179.968 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 184' ' ' ALA . . . . . 0.607 ' HB2' ' HA ' ' A' ' 195' ' ' ALA . . . -140.75 170.3 16.03 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.169 -0.469 . . . . 71.45 111.135 179.966 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 185' ' ' PHE . . . . . 0.641 ' O ' ' HA ' ' A' ' 223' ' ' SER . 1.8 m-85 -125.64 167.93 14.42 Favored 'General case' 0 C--N 1.329 -0.323 0 CA-C-N 116.211 -0.45 . . . . 74.44 110.93 -179.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 186' ' ' GLY . . . . . 0.739 ' N ' ' CD ' ' A' ' 187' ' ' PRO . . . -138.18 32.69 2.32 Favored Glycine 0 N--CA 1.45 -0.417 0 C-N-CA 120.787 -0.721 . . . . 74.02 112.569 -179.992 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 187' ' ' PRO . . . . . 0.739 ' CD ' ' N ' ' A' ' 186' ' ' GLY . 53.9 Cg_endo -69.75 -23.27 31.05 Favored 'Trans proline' 0 C--N 1.34 0.104 0 C-N-CA 122.694 2.263 . . . . 72.21 112.325 -179.926 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 188' ' ' GLY . . . . . 0.423 ' H ' ' CA ' ' A' ' 192' ' ' GLY . . . 90.2 135.41 6.0 Favored Glycine 0 N--CA 1.451 -0.318 0 C-N-CA 120.763 -0.732 . . . . 75.24 112.5 -179.983 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 189' ' ' SER . . . . . . . . . . . . . 8.0 t 64.46 148.08 0.03 OUTLIER 'General case' 0 C--N 1.328 -0.353 0 CA-C-O 120.827 0.346 . . . . 75.42 110.871 -179.781 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 190' ' ' GLY . . . . . . . . . . . . . . . 47.95 -102.07 0.05 OUTLIER Glycine 0 N--CA 1.452 -0.268 0 C-N-CA 120.731 -0.747 . . . . 71.04 112.432 -179.998 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 191' ' ' ILE . . . . . . . . . . . . . 40.3 pt -77.84 6.63 0.91 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.375 0 CA-C-O 120.85 0.357 . . . . 64.23 111.118 -179.921 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 192' ' ' GLY . . . . . 0.483 ' HA2' ' HD2' ' A' ' 187' ' ' PRO . . . -74.76 121.54 6.75 Favored Glycine 0 N--CA 1.451 -0.302 0 C-N-CA 120.766 -0.731 . . . . 63.23 112.483 179.97 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 193' ' ' GLY . . . . . 0.566 ' O ' ' HA ' ' A' ' 159' ' ' ILE . . . 75.2 -9.39 13.13 Favored Glycine 0 N--CA 1.451 -0.329 0 C-N-CA 120.75 -0.738 . . . . 45.01 112.514 -179.862 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 194' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -52.17 109.51 0.39 Allowed 'General case' 0 C--N 1.329 -0.311 0 CA-C-O 120.885 0.374 . . . . 72.21 110.883 -179.995 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 195' ' ' ALA . . . . . 0.607 ' HA ' ' HB2' ' A' ' 184' ' ' ALA . . . -98.83 138.04 36.54 Favored 'General case' 0 C--N 1.33 -0.279 0 CA-C-N 116.143 -0.481 . . . . 74.55 111.151 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 196' ' ' HIS . . . . . 0.455 ' O ' ' HB1' ' A' ' 182' ' ' ALA . 4.9 m170 -125.26 137.62 54.09 Favored 'General case' 0 C--N 1.327 -0.374 0 CA-C-N 116.316 -0.402 . . . . 73.42 110.859 180.0 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 197' ' ' PHE . . . . . 0.415 ' HB3' ' CZ2' ' A' ' 203' ' ' TRP . 37.8 m-85 -120.03 142.44 48.83 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.205 -0.452 . . . . 74.43 110.869 -179.875 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 198' ' ' ASP . . . . . . . . . . . . . 27.4 t0 -73.8 109.11 7.05 Favored 'General case' 0 C--N 1.328 -0.351 0 CA-C-N 116.145 -0.48 . . . . 75.4 110.779 -179.948 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 199' ' ' GLU . . . . . . . . . . . . . 4.6 tm-20 -62.1 -35.66 79.37 Favored 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.149 -0.478 . . . . 74.24 110.85 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 200' ' ' ASP . . . . . 0.577 ' HB2' ' HA2' ' A' ' 176' ' ' GLY . 12.0 m-20 -51.24 -21.56 2.16 Favored 'General case' 0 C--N 1.328 -0.339 0 CA-C-N 116.23 -0.441 . . . . 71.52 110.87 179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 201' ' ' GLU . . . . . 0.499 ' HG3' HD13 ' A' ' 181' ' ' LEU . 5.8 mm-40 -81.54 161.29 23.63 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.148 -0.478 . . . . 74.42 110.97 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 202' ' ' PHE . . . . . 0.564 ' O ' ' HA3' ' A' ' 209' ' ' GLY . 0.3 OUTLIER -99.47 88.32 3.84 Favored 'General case' 0 C--N 1.328 -0.352 0 CA-C-N 116.203 -0.453 . . . . 73.45 110.917 -179.887 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 203' ' ' TRP . . . . . 0.491 ' CZ3' HG21 ' A' ' 215' ' ' THR . 33.7 m95 -78.15 123.22 26.64 Favored 'General case' 0 C--N 1.328 -0.338 0 CA-C-N 116.229 -0.441 . . . . 71.42 110.887 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 204' ' ' THR . . . . . . . . . . . . . 32.6 p -139.64 -176.32 4.51 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.237 -0.438 . . . . 70.22 111.146 -179.963 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 205' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -111.77 17.27 19.99 Favored 'General case' 0 C--N 1.33 -0.262 0 CA-C-N 116.217 -0.447 . . . . 72.14 111.112 -179.87 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 206' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -128.77 -176.05 3.73 Favored 'General case' 0 C--N 1.329 -0.326 0 CA-C-N 116.17 -0.468 . . . . 54.54 110.843 -179.98 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 207' ' ' SER . . . . . . . . . . . . . 7.8 t -66.69 -18.51 65.41 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.272 -0.422 . . . . 73.44 110.86 -179.828 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 208' ' ' GLY . . . . . . . . . . . . . . . -59.49 -108.3 0.01 OUTLIER Glycine 0 N--CA 1.451 -0.335 0 C-N-CA 120.714 -0.755 . . . . 71.22 112.528 179.944 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 209' ' ' GLY . . . . . 0.564 ' HA3' ' O ' ' A' ' 202' ' ' PHE . . . -52.63 176.82 0.13 Allowed Glycine 0 N--CA 1.452 -0.273 0 C-N-CA 120.788 -0.72 . . . . 43.45 112.415 -179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 210' ' ' THR . . . . . . . . . . . . . 94.5 m -65.62 97.95 0.35 Allowed 'General case' 0 C--N 1.33 -0.26 0 CA-C-O 120.799 0.333 . . . . 72.31 111.105 -179.858 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 211' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -42.0 117.11 0.9 Allowed 'General case' 0 C--N 1.329 -0.318 0 CA-C-N 116.228 -0.442 . . . . 72.2 110.95 179.958 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 212' ' ' LEU . . . . . 0.67 HD22 ' SD ' ' A' ' 125' ' ' MET . 30.4 tp -64.82 -36.72 85.24 Favored 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.181 -0.463 . . . . 61.51 110.901 -179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 213' ' ' PHE . . . . . 0.761 ' O ' HG23 ' A' ' 217' ' ' VAL . 2.4 t80 -53.84 -65.45 0.57 Allowed 'General case' 0 C--N 1.329 -0.316 0 CA-C-N 116.165 -0.471 . . . . 44.25 110.791 179.989 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 214' ' ' LEU . . . . . 0.511 HD11 ' H ' ' A' ' 243' ' ' VAL . 18.8 mt -53.12 -54.97 27.9 Favored 'General case' 0 C--N 1.328 -0.349 0 CA-C-N 116.123 -0.489 . . . . 74.13 110.894 -179.872 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 215' ' ' THR . . . . . 0.493 ' O ' ' HB2' ' A' ' 219' ' ' ALA . 6.2 m -54.81 -38.41 67.31 Favored 'General case' 0 C--N 1.33 -0.25 0 CA-C-N 116.148 -0.478 . . . . 74.12 111.099 179.977 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 216' ' ' ALA . . . . . . . . . . . . . . . -63.19 -50.04 71.88 Favored 'General case' 0 C--N 1.329 -0.293 0 CA-C-N 116.218 -0.446 . . . . 61.41 111.134 179.867 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 217' ' ' VAL . . . . . 0.911 HG22 ' HA ' ' A' ' 137' ' ' ALA . 2.1 t -51.67 -59.6 1.33 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.329 0 CA-C-N 116.201 -0.454 . . . . 60.12 111.115 179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 218' ' ' HIS . . . . . 0.741 ' HB2' HG13 ' A' ' 235' ' ' VAL . 2.1 t-80 -65.07 -28.11 69.24 Favored 'General case' 0 C--N 1.33 -0.258 0 CA-C-N 116.168 -0.469 . . . . 62.0 110.856 179.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 219' ' ' ALA . . . . . 0.493 ' HB2' ' O ' ' A' ' 215' ' ' THR . . . -63.81 -46.07 86.81 Favored 'General case' 0 C--N 1.329 -0.29 0 CA-C-N 116.22 -0.445 . . . . 42.42 111.112 179.908 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 220' ' ' ILE . . . . . 0.683 HG23 HG12 ' A' ' 159' ' ' ILE . 2.8 mt -66.05 -34.66 71.73 Favored 'Isoleucine or valine' 0 C--N 1.329 -0.31 0 CA-C-N 116.208 -0.451 . . . . 73.33 111.197 179.997 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 221' ' ' GLY . . . . . 0.454 ' O ' ' HB2' ' A' ' 226' ' ' LEU . . . -53.69 -44.38 69.34 Favored Glycine 0 C--N 1.33 0.24 0 C-N-CA 120.753 -0.736 . . . . 32.44 112.499 179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 222' ' ' HIS . . . . . . . . . . . . . 30.2 m-70 -69.54 -34.92 74.92 Favored 'General case' 0 C--N 1.33 -0.261 0 CA-C-O 120.724 0.297 . . . . 70.41 110.811 -179.914 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 223' ' ' SER . . . . . 0.641 ' HA ' ' O ' ' A' ' 185' ' ' PHE . 4.0 p -70.41 -24.85 63.0 Favored 'General case' 0 C--N 1.328 -0.348 0 CA-C-N 116.275 -0.42 . . . . 71.33 110.895 -179.795 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 224' ' ' LEU . . . . . 0.461 HD21 HG21 ' A' ' 114' ' ' ILE . 45.6 mt -76.93 -27.35 54.83 Favored 'General case' 0 C--N 1.328 -0.354 0 CA-C-N 116.188 -0.46 . . . . 71.22 110.962 179.949 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 225' ' ' GLY . . . . . 0.547 ' HA3' HG12 ' A' ' 108' ' ' VAL . . . 120.29 16.32 4.78 Favored Glycine 0 N--CA 1.45 -0.407 0 C-N-CA 120.779 -0.724 . . . . 72.44 112.553 179.873 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 226' ' ' LEU . . . . . 0.888 HD21 ' HA ' ' A' ' 258' ' ' ILE . 15.3 mt -79.59 162.87 25.06 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-O 120.782 0.325 . . . . 75.52 110.937 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 227' ' ' GLY . . . . . . . . . . . . . . . -105.38 -133.17 7.55 Favored Glycine 0 N--CA 1.452 -0.299 0 C-N-CA 120.755 -0.736 . . . . 43.31 112.411 179.919 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 228' ' ' HIS . . . . . 0.415 ' CD2' ' O ' ' A' ' 236' ' ' MET . 0.3 OUTLIER -131.2 148.86 52.75 Favored 'General case' 0 C--N 1.329 -0.292 0 CA-C-O 120.804 0.335 . . . . 64.12 110.805 -179.851 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 229' ' ' SER . . . . . 0.402 ' HB3' ' HG2' ' A' ' 101' ' ' ARG . 86.7 p -108.62 166.44 10.79 Favored 'General case' 0 C--N 1.329 -0.285 0 CA-C-N 116.184 -0.462 . . . . 73.41 110.864 -179.846 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 230' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -108.53 0.46 20.88 Favored 'General case' 0 C--N 1.328 -0.335 0 CA-C-N 116.117 -0.492 . . . . 64.21 110.872 -179.826 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 231' ' ' ASP . . . . . 0.532 ' CB ' ' HB2' ' A' ' 234' ' ' ALA . 0.2 OUTLIER -68.64 133.9 90.6 Favored Pre-proline 0 C--N 1.328 -0.341 0 CA-C-O 121.606 0.717 . . . . 73.04 110.85 179.872 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 232' ' ' PRO . . . . . . . . . . . . . 53.4 Cg_endo -69.79 0.59 5.44 Favored 'Trans proline' 0 C--O 1.231 0.165 0 C-N-CA 122.706 2.271 . . . . 73.55 112.277 -179.937 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 233' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.91 19.07 2.14 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 116.253 -0.43 . . . . 72.35 110.926 179.904 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 234' ' ' ALA . . . . . 0.532 ' HB2' ' CB ' ' A' ' 231' ' ' ASP . . . -91.49 140.26 29.92 Favored 'General case' 0 C--N 1.33 -0.276 0 CA-C-N 116.206 -0.452 . . . . 55.14 111.082 179.801 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 235' ' ' VAL . . . . . 0.741 HG13 ' HB2' ' A' ' 218' ' ' HIS . 1.0 OUTLIER -61.16 -41.18 88.46 Favored 'Isoleucine or valine' 0 C--N 1.33 -0.244 0 CA-C-N 116.235 -0.439 . . . . 75.02 111.137 179.896 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 236' ' ' MET . . . . . 0.415 ' O ' ' CD2' ' A' ' 228' ' ' HIS . 53.9 mmm -58.68 -20.75 51.16 Favored 'General case' 0 C--N 1.33 -0.27 0 CA-C-N 116.186 -0.461 . . . . 73.24 110.895 179.895 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 237' ' ' PHE . . . . . 0.6 ' CG ' ' HD2' ' A' ' 238' ' ' PRO . 2.0 t80 -55.63 144.03 56.44 Favored Pre-proline 0 C--N 1.329 -0.311 0 CA-C-O 121.712 0.768 . . . . 62.5 110.902 -179.985 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 238' ' ' PRO . . . . . 0.6 ' HD2' ' CG ' ' A' ' 237' ' ' PHE . 53.8 Cg_endo -69.67 0.79 5.07 Favored 'Trans proline' 0 C--O 1.233 0.243 0 C-N-CA 122.749 2.299 . . . . 74.42 112.315 179.998 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 239' ' ' THR . . . . . 0.434 ' HG1' ' HD2' ' A' ' 237' ' ' PHE . 30.7 m -97.32 138.91 34.06 Favored 'General case' 0 C--N 1.329 -0.321 0 CA-C-N 116.211 -0.449 . . . . 65.22 111.166 -179.955 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 240' ' ' TYR . . . . . . . . . . . . . 62.6 t80 -120.87 137.05 54.76 Favored 'General case' 0 C--N 1.329 -0.325 0 CA-C-N 116.182 -0.463 . . . . 71.13 110.937 -179.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 241' ' ' LYS . . . . . . . . . . . . . 15.5 ttpt -157.4 137.27 12.41 Favored 'General case' 0 C--N 1.329 -0.314 0 CA-C-N 116.147 -0.479 . . . . 61.31 110.912 179.892 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 242' ' ' TYR . . . . . 0.548 ' O ' HG13 ' A' ' 243' ' ' VAL . 73.9 t80 -61.44 146.91 46.86 Favored 'General case' 0 C--N 1.328 -0.346 0 CA-C-N 116.249 -0.432 . . . . 72.45 110.913 -179.954 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 243' ' ' VAL . . . . . 0.548 HG13 ' O ' ' A' ' 242' ' ' TYR . 0.3 OUTLIER -160.46 132.52 1.03 Allowed 'Isoleucine or valine' 0 C--N 1.328 -0.335 0 CA-C-N 116.172 -0.467 . . . . 75.31 111.183 179.894 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 244' ' ' ASP . . . . . . . . . . . . . 39.9 t0 -50.11 132.05 23.45 Favored 'General case' 0 C--N 1.329 -0.309 0 CA-C-N 116.153 -0.476 . . . . 64.43 110.874 179.933 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 245' ' ' ILE . . . . . 0.458 HD11 ' HD3' ' A' ' 136' ' ' LYS . 7.3 tt -54.65 -30.63 22.48 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.362 0 CA-C-N 116.252 -0.431 . . . . 71.21 111.138 179.971 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 246' ' ' ASN . . . . . . . . . . . . . 8.6 m-80 -76.17 -18.24 59.19 Favored 'General case' 0 C--N 1.328 -0.331 0 CA-C-N 116.166 -0.47 . . . . 73.25 110.885 179.924 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 247' ' ' THR . . . . . . . . . . . . . 60.1 p -105.01 -22.77 13.06 Favored 'General case' 0 C--N 1.33 -0.263 0 CA-C-N 116.174 -0.466 . . . . 73.42 111.072 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 248' ' ' PHE . . . . . . . . . . . . . 40.8 t80 -69.67 142.97 53.3 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.257 -0.429 . . . . 61.23 110.889 -179.942 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 249' ' ' ARG . . . . . . . . . . . . . 17.0 ptt180 -176.43 131.68 0.22 Allowed 'General case' 0 C--N 1.329 -0.303 0 CA-C-N 116.148 -0.478 . . . . 73.2 110.857 -179.902 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 250' ' ' LEU . . . . . 0.685 HD12 HG11 ' A' ' 144' ' ' VAL . 80.2 mt -49.42 128.85 17.96 Favored 'General case' 0 C--N 1.328 -0.336 0 CA-C-N 116.236 -0.438 . . . . 74.33 110.95 179.952 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 251' ' ' SER . . . . . 0.448 ' O ' HD12 ' A' ' 255' ' ' ILE . 8.2 m -76.52 169.97 17.27 Favored 'General case' 0 C--N 1.329 -0.305 0 CA-C-N 116.215 -0.448 . . . . 74.3 110.899 -179.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 252' ' ' ALA . . . . . . . . . . . . . . . -49.74 -43.24 47.77 Favored 'General case' 0 C--N 1.33 -0.275 0 CA-C-N 116.169 -0.469 . . . . 70.31 111.069 179.907 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 253' ' ' ASP . . . . . . . . . . . . . 2.4 m-20 -59.17 -49.08 79.24 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.145 -0.479 . . . . 75.51 110.821 -179.935 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 254' ' ' ASP . . . . . 0.464 ' HB2' ' HB3' ' A' ' 250' ' ' LEU . 16.3 m-20 -57.22 -54.8 42.73 Favored 'General case' 0 C--N 1.328 -0.366 0 CA-C-N 116.243 -0.435 . . . . 71.34 110.811 -179.939 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 255' ' ' ILE . . . . . 0.448 HD12 ' O ' ' A' ' 251' ' ' SER . 2.9 mt -59.73 -39.59 80.14 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.349 0 CA-C-N 116.24 -0.437 . . . . 73.51 111.17 179.956 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 256' ' ' ARG . . . . . . . . . . . . . 1.9 mpt_? -64.1 -39.84 94.92 Favored 'General case' 0 C--N 1.329 -0.295 0 CA-C-N 116.205 -0.452 . . . . 75.43 110.909 179.928 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 257' ' ' GLY . . . . . 0.403 ' O ' ' HB3' ' A' ' 260' ' ' SER . . . -75.28 -54.01 5.83 Favored Glycine 0 N--CA 1.452 -0.291 0 C-N-CA 120.766 -0.731 . . . . 54.33 112.459 -179.933 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 258' ' ' ILE . . . . . 0.888 ' HA ' HD21 ' A' ' 226' ' ' LEU . 4.5 tp -53.09 -35.72 23.43 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.336 0 CA-C-O 120.775 0.322 . . . . 65.15 111.075 -179.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 259' ' ' GLN . . . . . 0.411 ' O ' ' N ' ' A' ' 263' ' ' GLY . 87.0 mt-30 -85.82 -17.22 36.3 Favored 'General case' 0 C--N 1.329 -0.31 0 CA-C-N 116.168 -0.469 . . . . 53.14 110.948 179.972 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 260' ' ' SER . . . . . 0.403 ' HB3' ' O ' ' A' ' 257' ' ' GLY . 3.2 t -69.0 -14.29 62.96 Favored 'General case' 0 C--N 1.33 -0.274 0 CA-C-N 116.211 -0.45 . . . . 72.4 110.834 -179.804 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 261' ' ' LEU . . . . . 0.73 HD13 HG11 ' A' ' 108' ' ' VAL . 2.7 mt -123.91 -18.4 6.0 Favored 'General case' 0 C--N 1.328 -0.333 0 CA-C-N 116.145 -0.48 . . . . 63.24 110.838 -179.902 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 262' ' ' TYR . . . . . 0.772 ' CD2' HD11 ' A' ' 147' ' ' LEU . 36.8 m-85 -113.43 -33.98 5.74 Favored 'General case' 0 C--N 1.328 -0.353 0 CA-C-N 116.223 -0.444 . . . . 64.42 110.925 -179.961 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 263' ' ' GLY . . . . . 0.411 ' N ' ' O ' ' A' ' 259' ' ' GLN . . . . . . . . 0 N--CA 1.45 -0.429 0 CA-C-O 119.133 -0.815 . . . . 71.3 112.507 179.997 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 264' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 265' ' ' ' ZN' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 266' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 267' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 268' ' ' ' CA' . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . . 0 0 . 1 stop_ save_